PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nichenametla, SN; Lazarus, P; Richie, JP				Nichenametla, Sailendra N.; Lazarus, Philip; Richie, John P., Jr.			A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation	FASEB JOURNAL			English	Article						gamma-glutamylcysteine ligase; short tandem repeats; 5 ' untranslated region	LIGASE CATALYTIC SUBUNIT; FRAGILE-X-SYNDROME; PREMUTATION CARRIERS; MESSENGER-RNA; HUMAN-DISEASE; ASSOCIATION; REGION; CELL; ELEMENTS; BINDING	A guanine-adenine-guanine (GAG) repeat polymorphism with 5 different alleles (4, 7, 8, 9, and 10 repeats) in the 5' untranslated region (UTR) of GCLC has been associated with altered GCL activity and glutathione (GSH) levels. We investigated whether this polymorphism affects either transcription or translation using luciferase reporter constructs containing variant GCLC 5' UTRs. Higher luciferase activity was observed in HepG2 and human embryonic kidney 293 (HEK293) cells transfected with constructs containing either 8 or 9 repeats than in constructs containing 4, 7, or 10 repeats (P < 0.05). In cell-free lysates, GAG repeat number had no effect on luciferase mRNA yield. In vitro translation of mRNAs from luciferase constructs resulted in differences similar to those found in cell cultures (P < 0.05). A similar association of GAG repeat with GCLC phenotype was observed in vivo in healthy adults, as individuals with GAG-7/7 genotype had lower GCL activity and GSH levels in lymphocytes compared to those with GAG-9/9 (P < 0.05). Higher GCL activity and GSH levels observed in red blood cells (RBCs) from individuals with GAG-7/7 compared to GAG-9/9 are likely due to differences in GCL regulation in RBCs. Altogether, these results suggest that GAG polymorphism affects GCLC expression via translation, and thus may be associated with altered risk for GSH-related diseases and toxicities.-Nichenametla, S. N., Lazarus, P., Richie, J. P., Jr. A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation. FASEB J. 25, 2180-2187 (2011). www.fasebj.org	[Nichenametla, Sailendra N.; Lazarus, Philip; Richie, John P., Jr.] Penn State Univ, Coll Med, Penn State Canc Inst, Mol Epidemiol & Canc Control Program, Hershey, PA USA; [Nichenametla, Sailendra N.; Lazarus, Philip; Richie, John P., Jr.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Lazarus, Philip] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Richie, JP (corresponding author), Penn State Coll Med, Penn State Canc Inst, H069,500 Univ Dr, Hershey, PA 17033 USA.	jrichie@psu.edu	Nichenametla, Sailendra Nath/B-2733-2009	Nichenametla, Sailendra Nath/0000-0002-5969-3572; Richie, John/0000-0001-8239-2850	U. S. National Institutes of Health [P01-CA68384, R01-DE13158]; NATIONAL CANCER INSTITUTE [P01CA068384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013158] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by Public Health Service grants P01-CA68384 (P.L., principal investigator; J.P.R, project leader) and R01-DE13158 (P.L.) from the U. S. National Institutes of Health.	Bekris LM, 2007, EXP CLIN ENDOCR DIAB, V115, P221, DOI 10.1055/s-2007-970574; Bekris LM, 2006, J OCCUP ENVIRON MED, V48, P599, DOI 10.1097/01.jom.0000201845.02369.ba; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Butticaz C, 2011, FREE RADICAL BIO MED, V50, P617, DOI 10.1016/j.freeradbiomed.2010.12.002; Chave Karen J., 1997, Biochemical Society Transactions, V25, p53S; Custodio HM, 2004, ARCH ENVIRON HEALTH, V59, P588, DOI 10.1080/00039890409603438; Ellouk-Achard S, 1995, Arch Toxicol Suppl, V17, P209; Ennis S, 2006, EUR J HUM GENET, V14, P253, DOI 10.1038/sj.ejhg.5201510; Fairbanks VF, 1987, FUNDAMENTALS CLIN CH, P789; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GASTIER JM, 1995, HUM MOL GENET, V4, P1829, DOI 10.1093/hmg/4.10.1829; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; Iglesias AR, 2004, GENE, V341, P149, DOI 10.1016/j.gene.2004.06.035; Jollow D J, 1980, Arch Toxicol Suppl, V3, P95; JULIUS M, 1994, J CLIN EPIDEMIOL, V47, P1021, DOI 10.1016/0895-4356(94)90117-1; Kleinman WA, 2000, BIOCHEM PHARMACOL, V60, P19, DOI 10.1016/S0006-2952(00)00293-8; Koide S, 2003, J AM COLL CARDIOL, V41, P539, DOI 10.1016/S0735-1097(02)02866-8; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Maiti A K, 2001, BMC Mol Biol, V2, P11, DOI 10.1186/1471-2199-2-11; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Nenonen HA, 2011, INT J ANDROL, V34, P327, DOI 10.1111/j.1365-2605.2010.01084.x; Nichenarnetla SN, 2008, FREE RADICAL BIO MED, V45, P645, DOI 10.1016/j.freeradbiomed.2008.05.012; Nuttall SL, 1998, LANCET, V351, P645, DOI 10.1016/S0140-6736(05)78428-2; Ohashi Y, 2004, ONCOGENE, V23, P7772, DOI 10.1038/sj.onc.1208058; Peprah E, 2010, J HUM GENET, V55, P66, DOI 10.1038/jhg.2009.121; Raca G, 2000, NUCLEIC ACIDS RES, V28, P3943, DOI 10.1093/nar/28.20.3943; Richie JP, 1996, CLIN CHEM, V42, P64; Schenborn ET., 1995, PROMEGA NOTES, V50, P2; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sulek Anna, 2004, Journal of Applied Genetics, V45, P101; Syagailo YV, 2002, GENE, V294, P259, DOI 10.1016/S0378-1119(02)00798-9; Tew KD, 1996, MOL PHARMACOL, V50, P149; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Unt E, 2008, J SPORT SCI MED, V7, P344; Vassos E, 2008, J PSYCHIATR RES, V42, P544, DOI 10.1016/j.jpsychires.2007.05.008; Vina J., 1990, GLUTATHIONE METABOLI; VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P; Walsh AC, 2001, TOXICOL SCI, V61, P218, DOI 10.1093/toxsci/61.2.218; Yang P, 2004, CARCINOGENESIS, V25, P1935, DOI 10.1093/carcin/bgh203; Zitouni K, 2005, DIABETES CARE, V28, P1698, DOI 10.2337/diacare.28.7.1698	48	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2180	2187		10.1096/fj.10-174011	http://dx.doi.org/10.1096/fj.10-174011			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21444626	Green Published			2022-12-25	WOS:000292242200010
J	Sasaki, J; Tsai, AI; Spudich, JL				Sasaki, Jun; Tsai, Ah-Iim; Spudich, John L.			Opposite Displacement of Helix F in Attractant and Repellent Signaling by Sensory Rhodopsin-Htr Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSLOCATION; MOLECULAR-MECHANISM; TRANSDUCER PROTEIN; STRUCTURAL-CHANGES; N INTERMEDIATE; TRANSPORT; PHARAONIS; BACTERIORHODOPSIN; INSIGHTS; RECEPTOR	Two forms of the phototaxis receptor sensory rhodopsin I distinguished by differences in its photoactive site have been shown to be directly correlated with attractant and repellent signaling by the dual-signaling protein. In prior studies, differences in the photoactive site defined the two forms, namely the direction of light-induced proton transfer from the chromophore and the pK(a) of an Asp counterion to the protonated chromophore. Here, we show by both in vivo and in vitro measurements that the two forms are distinct protein conformers with structural similarities to two conformers seen in the light-driven proton transport cycle of the related protein bacteriorhodopsin. Measurements of spontaneous cell motility reversal frequencies, an in vivo measure of histidine kinase activity in the phototaxis system, indicate that the two forms are a photointerconvertible pair, with one conformer activating and the other inhibiting the kinase. Protein conformational changes in these photoconversions monitored by site-directed spin labeling show that opposite structural changes in helix F, distant from the photoactive site, correspond to the opposite phototaxis signals. The results provide the first direct evidence that displacements of helix F are directly correlated with signaling and impact our understanding of the sensory rhodopsin I signaling mechanism and the evolution of diverse functionality in this protein family.	[Sasaki, Jun; Spudich, John L.] Univ Texas Houston, Sch Med, Ctr Membrane Biol, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Tsai, Ah-Iim] Univ Texas Houston, Sch Med, Div Hematol, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	John.L.Spudich@uth.tmc.edu			National Institutes of Health [R37GM27750, RO1HL095820]; Department of Energy [DE-FG02-07ER15867]; Robert A. Welch Foundation [AU-0009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM27750 (to J. L. S.) and Grant RO1HL095820 (to A.-L. T.). This work was also supported by Department of Energy Grant DE-FG02-07ER15867 and Endowed Chair AU-0009 from the Robert A. Welch Foundation (to J. L. S.).	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Bergo V, 2000, BIOCHEMISTRY-US, V39, P2823, DOI 10.1021/bi991676d; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Chen XP, 2002, BIOCHEMISTRY-US, V41, P3891, DOI 10.1021/bi015966h; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P9889, DOI 10.1021/bi980934o; Furutani Y, 2008, BIOCHEMISTRY-US, V47, P2875, DOI 10.1021/bi702050c; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Inoue K, 2007, BIOPHYS J, V92, P2028, DOI 10.1529/biophysj.106.097493; Jung KH, 1998, J BACTERIOL, V180, P2033, DOI 10.1128/JB.180.8.2033-2042.1998; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kamikubo H, 1996, P NATL ACAD SCI USA, V93, P1386, DOI 10.1073/pnas.93.4.1386; Kamo N, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1277, DOI 10.1023/A:1013187403599; Klare Johann P., 2008, V45, P73, DOI 10.1007/400_2007_041; Klare JP, 2004, FEBS LETT, V564, P219, DOI 10.1016/S0014-5793(04)00193-0; LANYI JK, 1990, PHYSIOL REV, V70, P319, DOI 10.1152/physrev.1990.70.2.319; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; OESTERHELT D, 1992, J BIOENERG BIOMEMBR, V24, P181, DOI 10.1007/BF00762676; Rath P, 1996, BIOCHEMISTRY-US, V35, P6690, DOI 10.1021/bi9600355; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; Sasaki J, 2000, BBA-BIOENERGETICS, V1460, P230, DOI 10.1016/S0005-2728(00)00142-0; Sasaki J, 1998, BIOPHYS J, V75, P2435, DOI 10.1016/S0006-3495(98)77687-8; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Sasaki J, 2007, MOL MICROBIOL, V66, P1321, DOI 10.1111/j.1365-2958.2007.05983.x; Sasaki J, 2007, BIOPHYS J, V92, P4045, DOI 10.1529/biophysj.106.101121; Sasaki J, 2011, BIOPHYS J, V100, P2178, DOI 10.1016/j.bpj.2011.03.026; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2008, P NATL ACAD SCI USA, V105, P16159, DOI 10.1073/pnas.0807486105; Sineshchekov OA, 2010, BIOCHEMISTRY-US, V49, P6696, DOI 10.1021/bi100798w; Spudich EN, 1997, P NATL ACAD SCI USA, V94, P4960, DOI 10.1073/pnas.94.10.4960; SPUDICH JL, 1988, ANNU REV BIOPHYS BIO, V17, P193; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; Trivedi VD, 2003, BIOCHEMISTRY-US, V42, P13887, DOI 10.1021/bi034399q; Vonck J, 1996, BIOCHEMISTRY-US, V35, P5870, DOI 10.1021/bi952663c; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Xiao WZ, 2000, J MOL BIOL, V304, P715, DOI 10.1006/jmbi.2000.4255; YAN B, 1991, P NATL ACAD SCI USA, V88, P9412, DOI 10.1073/pnas.88.21.9412	50	6	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18868	18877		10.1074/jbc.M110.200345	http://dx.doi.org/10.1074/jbc.M110.200345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454480	Green Published, hybrid			2022-12-25	WOS:000290785700059
J	LeNoue-Newton, M; Watkins, GR; Zou, P; Germane, KL; McCorvey, LR; Wadzinski, BE; Spiller, BW				LeNoue-Newton, Michele; Watkins, Guy R.; Zou, Ping; Germane, Katherine L.; McCorvey, Lisa R.; Wadzinski, Brian E.; Spiller, Benjamin W.			The E3 Ubiquitin Ligase- and Protein Phosphatase 2A (PP2A)-binding Domains of the Alpha4 Protein Are Both Required for Alpha4 to Inhibit PP2A Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; TPR DOMAIN; OPITZ-SYNDROME; BINDING; REGULATOR; COMPLEX; PHOSPHORYLATION; ASSOCIATION; MUTATIONS; SYSTEM	Protein phosphatase 2A (PP2A) is regulated through a variety of mechanisms, including post-translational modifications and association with regulatory proteins. Alpha4 is one such regulatory protein that binds the PP2A catalytic subunit (PP2Ac) and protects it from polyubiquitination and degradation. Alpha4 is a multidomain protein with a C-terminal domain that binds Mid1, a putative E3 ubiquitin ligase, and an N-terminal domain containing the PP2Ac-binding site. In this work, we present the structure of the N-terminal domain of mammalian Alpha4 determined by x-ray crystallography and use double electron-electron resonance spectroscopy to show that it is a flexible tetratricopeptide repeat-like protein. Structurally, Alpha4 differs from its yeast homolog, Tap42, in two important ways: 1) the position of the helix containing the PP2Ac-binding residues is in a more open conformation, showing flexibility in this region; and 2) Alpha4 contains a ubiquitin-interacting motif. The effects of wild-type and mutant Alpha4 on PP2Ac ubiquitination and stability were examined in mammalian cells by performing tandem ubiquitin-binding entity precipitations and cycloheximide chase experiments. Our results reveal that both the C-terminal Mid1-binding domain and the PP2Ac-binding determinants are required for Alpha4-mediated protection of PP2Ac from polyubiquitination and degradation.	[LeNoue-Newton, Michele; Watkins, Guy R.; McCorvey, Lisa R.; Wadzinski, Brian E.; Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Germane, Katherine L.; Spiller, Benjamin W.] Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Zou, Ping] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Spiller, BW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	benjamin.spiller@vanderbilt.edu		germane, katherine/0000-0002-5191-2670	National Institutes of Health [GM051366, DK070787, T32 GM07628]; American Cancer Society [IRG-58-009-49]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R56GM051366, R01GM051366, T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG039947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051366 and DK070787 (to B. E. W.) and T32 GM07628 (to M.L.-N. and G. R. W.). This work was also supported by American Cancer Society Grant IRG-58-009-49 (to B. W. S.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fontanella B, 2008, HUM MUTAT, V29, P584, DOI 10.1002/humu.20706; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kowluru A, 2005, BIOCHEM PHARMACOL, V69, P1681, DOI 10.1016/j.bcp.2005.03.018; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	49	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17665	17671		10.1074/jbc.M111.222414	http://dx.doi.org/10.1074/jbc.M111.222414			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454489	hybrid, Green Published			2022-12-25	WOS:000290585200030
J	Veitinger, T; Riffell, JR; Veitinger, S; Nascimento, JM; Triller, A; Chandsawangbhuwana, C; Schwane, K; Geerts, A; Wunder, F; Berns, MW; Neuhaus, EM; Zimmer, RK; Spehr, M; Hatt, H				Veitinger, Thomas; Riffell, Jeffrey R.; Veitinger, Sophie; Nascimento, Jaclyn M.; Triller, Annika; Chandsawangbhuwana, Charlie; Schwane, Katlen; Geerts, Andreas; Wunder, Frank; Berns, Michael W.; Neuhaus, Eva M.; Zimmer, Richard K.; Spehr, Marc; Hatt, Hanns			Chemosensory Ca2+ Dynamics Correlate with Diverse Behavioral Phenotypes in Human Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLFACTORY RECEPTOR GENES; SEA-URCHIN SPERM; ODORANT RECEPTORS; MAMMALIAN SPERM; GERM-CELLS; INTRACELLULAR CALCIUM; HUMAN SPERMATOZOA; CUMULUS CELLS; EXPRESSION; MOTILITY	In the female reproductive tract, mammalian sperm undergo a regulated sequence of prefusion changes that "prime" sperm for fertilization. Among the least understood of these complex processes are the molecular mechanisms that underlie sperm guidance by environmental chemical cues. A "hard-wired" Ca2+ signaling strategy that orchestrates specific motility patterns according to given functional requirements is an emerging concept for regulation of sperm swimming behavior. The molecular players involved, the spatiotemporal characteristics of such motility-associated Ca2+ dynamics, and the relation between a distinct Ca2+ signaling pattern and a behavioral sperm phenotype, however, remain largely unclear. Here, we report the functional characterization of two human sperm chemoreceptors. Using complementary molecular, physiological, and behavioral approaches, we comparatively describe sperm Ca2+ responses to specific agonists of these novel receptors and bourgeonal, a known sperm chemoattractant. We further show that individual receptor activation induces specific Ca2+ signaling patterns with unique spatiotemporal dynamics. These distinct Ca2+ dynamics are correlated to a set of stimulus-specific stereotyped behavioral responses that could play vital roles during various stages of prefusion sperm-egg chemical communication.	[Spehr, Marc] Rhein Westfal TH Aachen, LuF Chemosensor, Inst Biol 2, Dept Chemosensat, D-52074 Aachen, Germany; [Veitinger, Thomas; Veitinger, Sophie; Triller, Annika; Schwane, Katlen; Hatt, Hanns] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Riffell, Jeffrey R.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Nascimento, Jaclyn M.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Chandsawangbhuwana, Charlie; Berns, Michael W.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Geerts, Andreas; Wunder, Frank] Bayer Schering Pharma AG, Pharma Res Ctr, D-42096 Wuppertal, Germany; [Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA; [Neuhaus, Eva M.] Charite NeuroSci Res Ctr, D-10117 Berlin, Germany; [Zimmer, Richard K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Neurosci Program, Los Angeles, CA 90095 USA; [Zimmer, Richard K.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	RWTH Aachen University; Ruhr University Bochum; University of Arizona; University of California System; University of California San Diego; University of California System; University of California San Diego; Bayer AG; Bayer Healthcare Pharmaceuticals; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Spehr, M (corresponding author), Rhein Westfal TH Aachen, LuF Chemosensor, Inst Biol 2, Dept Chemosensat, D-52074 Aachen, Germany.	m.spehr@sensorik.rwth-aachen.de	Spehr, Marc/AAK-3162-2021; Neuhaus, Eva M./L-1428-2015; Spehr, Marc/B-3140-2011	Spehr, Marc/0000-0001-6616-4196; Neuhaus, Eva M./0000-0003-3363-1231; Spehr, Marc/0000-0001-6616-4196; Wunder, Frank/0000-0002-1311-2357; Berns, Michael/0000-0002-9640-2885	National Institutes of Health [2 K12 GM000708-06]; Volkswagen Foundation; Deutsche Forschungsgemeinschaft; National Science Foundation [IOS 08-20645]; Graduate Research Fellowship; Heinrich und Alma Vogelsang-Foundation; United States Department of Defense; Beckman Laser Institute Inc. Foundation; UCLA Council on Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Graduate Research Fellowship; Heinrich und Alma Vogelsang-Foundation; United States Department of Defense(United States Department of Defense); Beckman Laser Institute Inc. Foundation; UCLA Council on Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 K12 GM000708-06 (to J. R. R.). This work was also supported by grants from the Volkswagen Foundation (to M. S.), the Deutsche Forschungsgemeinschaft (to H. H. and M. S.), National Science Foundation Grant IOS 08-20645 (to R. K. Z.), a Graduate Research Fellowship (to C. C.), the Heinrich und Alma Vogelsang-Foundation (to K. S.), the United States Department of Defense (to C. C.) (National Defense Science and Engineering Graduate Fellowship), the Beckman Laser Institute Inc. Foundation (to M. W. B. and J. M. N.), and the UCLA Council on Research (to R. K. Z.).	Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; BEDFORD JM, 1993, J EXP ZOOL, V265, P321, DOI 10.1002/jez.1402650314; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Branscomb A, 2000, GENETICS, V156, P785; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Breitbart H, 1999, REV REPROD, V4, P151; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Castillo K, 2010, EUR J NEUROSCI, V32, P932, DOI 10.1111/j.1460-9568.2010.07393.x; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2007, Soc Reprod Fertil Suppl, V65, P229; De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Fukuda N, 2006, GENES CELLS, V11, P71, DOI 10.1111/j.1365-2443.2005.00915.x; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Gee CC, 1997, J EXP BIOL, V200, P3185; Goto T, 2001, MOL HUM REPROD, V7, P553, DOI 10.1093/molehr/7.6.553; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Marrakchi M, 2007, EUR BIOPHYS J BIOPHY, V36, P1015, DOI 10.1007/s00249-007-0187-6; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nascimento JL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337559; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Publicover SJ, 2008, FRONT BIOSCI, V13, P5623; Riffell JA, 2002, J EXP BIOL, V205, P1439; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shi LZ, 2008, BIOMED MICRODEVICES, V10, P573, DOI 10.1007/s10544-008-9169-4; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Sun F, 2005, HUM REPROD, V20, P761, DOI 10.1093/humrep/deh657; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; TOFFLE RC, 1985, FERTIL STERIL, V43, P743; Triller A, 2008, CHEM BIODIVERS, V5, P862, DOI 10.1002/cbdv.200890101; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Vanderhaeghen P, 1997, BIOCHEM BIOPH RES CO, V237, P283, DOI 10.1006/bbrc.1997.7043; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; WALENSKY LD, 1995, MOL MED, V1, P130, DOI 10.1007/BF03401561; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	79	55	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17311	17325		10.1074/jbc.M110.211524	http://dx.doi.org/10.1074/jbc.M110.211524			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454470	Green Published, hybrid			2022-12-25	WOS:000290301900079
J	Farrona, S; Hurtado, L; March-Diaz, R; Schmitz, RJ; Florencio, FJ; Turck, F; Amasino, RM; Reyes, JC				Farrona, Sara; Hurtado, Lidia; March-Diaz, Rosana; Schmitz, Robert J.; Florencio, Francisco J.; Turck, Franziska; Amasino, Richard M.; Reyes, Jose C.			Brahma Is Required for Proper Expression of the Floral Repressor FLC in Arabidopsis	PLOS ONE			English	Article							FLOWERING-LOCUS-C; CHROMATIN-REMODELING COMPLEXES; SWR1 COMPLEX; FT PROTEIN; GENE; ENCODES; TIME; CONSTANS; VERNALIZATION; INDUCTION	Background: BRAHMA (BRM) is a member of a family of ATPases of the SWI/SNF chromatin remodeling complexes from Arabidopsis. BRM has been previously shown to be crucial for vegetative and reproductive development. Methodology/Principal Findings: Here we carry out a detailed analysis of the flowering phenotype of brm mutant plants which reveals that, in addition to repressing the flowering promoting genes CONSTANS (CO), FLOWERING LOCUS T (FT) and SUPPRESSOR OF OVEREXPRESSION OF CO1 (SOC1), BRM also represses expression of the general flowering repressor FLOWERING LOCUS C (FLC). Thus, in brm mutant plants FLC expression is elevated, and FLC chromatin exhibits increased levels of histone H3 lysine 4 tri-methylation and decreased levels of H3 lysine 27 tri-methylation, indicating that BRM imposes a repressive chromatin configuration at the FLC locus. However, brm mutants display a normal vernalization response, indicating that BRM is not involved in vernalization-mediated FLC repression. Analysis of double mutants suggests that BRM is partially redundant with the autonomous pathway. Analysis of genetic interactions between BRM and the histone H2A. Z deposition machinery demonstrates that brm mutations overcome a requirement of H2A. Z for FLC activation suggesting that in the absence of BRM, a constitutively open chromatin conformation renders H2A. Z dispensable. Conclusions/Significance: BRM is critical for phase transition in Arabidopsis. Thus, BRM represses expression of the flowering promoting genes CO, FT and SOC1 and of the flowering repressor FLC. Our results indicate that BRM controls expression of FLC by creating a repressive chromatin configuration of the locus.	[Farrona, Sara; Turck, Franziska] Max Planck Inst Plant Breeding, Cologne, Germany; [Hurtado, Lidia; March-Diaz, Rosana; Reyes, Jose C.] CSIC, CABIMER, E-41080 Seville, Spain; [Schmitz, Robert J.; Amasino, Richard M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Florencio, Francisco J.] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Wisconsin System; University of Wisconsin Madison; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Farrona, S (corresponding author), Max Planck Inst Plant Breeding, Cologne, Germany.	farrona@mpipz.mpg.de	Turck, Franziska/G-1240-2013; IBIS, NEURONAL/O-9910-2015; Florencio, Francisco J/K-7716-2014; Schmitz, Robert/AAY-7659-2020; Reyes, Jose C/K-3699-2014; Hurtado, Lidia/G-5998-2015	Turck, Franziska/0000-0002-4982-5949; Florencio, Francisco J/0000-0002-2068-7861; Schmitz, Robert/0000-0001-7538-6663; Reyes, Jose C/0000-0002-8042-5142; Hurtado, Lidia/0000-0002-3193-3693; Farrona, Sara/0000-0002-6855-2237	Ministerio de Educacin y Ciencia [BFU2008-00238, CSD2006-00049]; Junta de Andaluca [P06-CVI-01400]; National Institutes of Health [1R01GM079525]; National Science Foundation [0446440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079525] Funding Source: NIH RePORTER	Ministerio de Educacin y Ciencia(Spanish Government); Junta de Andaluca(Junta de Andalucia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Ministerio de Educacin y Ciencia (BFU2008-00238, CSD2006-00049), and by Junta de Andaluca (P06-CVI-01400) to J.C.R. and by the National Institutes of Health (grant no. 1R01GM079525), and the National Science Foundation (grant no. 0446440) to R. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Bezhani S, 2007, PLANT CELL, V19, P403, DOI 10.1105/tpc.106.048272; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; DOYLE MR, 2009, PLANT PHYSL; Farrona S, 2007, J MOL BIOL, V373, P240, DOI 10.1016/j.jmb.2007.07.012; Farrona S, 2004, DEVELOPMENT, V131, P4965, DOI 10.1242/dev.01363; Farrona S, 2008, SEMIN CELL DEV BIOL, V19, P560, DOI 10.1016/j.semcdb.2008.07.015; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Hurtado L, 2006, PLANT MOL BIOL, V62, P291, DOI 10.1007/s11103-006-9021-2; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Knizewski L, 2008, TRENDS PLANT SCI, V13, P557, DOI 10.1016/j.tplants.2008.08.004; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; March-Diaz R, 2007, PLANT PHYSIOL, V143, P893, DOI 10.1104/pp.106.092270; March-Diaz R, 2009, MOL PLANT, V2, P565, DOI 10.1093/mp/ssp019; Martin-Trillo M, 2006, DEVELOPMENT, V133, P1241, DOI 10.1242/dev.02301; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mlynarova L, 2007, PLANT J, V51, P874, DOI 10.1111/j.1365-313X.2007.03185.x; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Ratcliffe OJ, 2001, PLANT PHYSIOL, V126, P122, DOI 10.1104/pp.126.1.122; Sanda SL, 1996, MOL GEN GENET, V251, P69; Sarnowski TJ, 2005, PLANT CELL, V17, P2454, DOI 10.1105/tpc.105.031203; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tang XR, 2008, PLANT PHYSIOL, V147, P1143, DOI 10.1104/pp.108.121996; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wagner D, 2002, CURR BIOL, V12, P85, DOI 10.1016/S0960-9822(01)00651-0; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	58	39	41	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17997	10.1371/journal.pone.0017997	http://dx.doi.org/10.1371/journal.pone.0017997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445315	gold, Green Published			2022-12-25	WOS:000288613300027
J	Fritzsching, B; Haas, J; Konig, F; Kunz, P; Fritzsching, E; Poschl, J; Krammer, PH; Bruck, W; Suri-Payer, E; Wildemann, B				Fritzsching, Benedikt; Haas, Juergen; Koenig, Fatima; Kunz, Pierre; Fritzsching, Eva; Poeschl, Johannes; Krammer, Peter H.; Brueck, Wolfgang; Suri-Payer, Elisabeth; Wildemann, Brigitte			Intracerebral Human Regulatory T Cells: Analysis of CD4(+)CD25(+)FOXP3(+) T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUPPRESSIVE FUNCTION; DIAGNOSTIC-CRITERIA; PROTEIN TRANSFER; APOPTOSIS; DEMYELINATION; LYMPHOCYTES; RECRUITMENT; EXPRESSION; GUIDELINES	Impaired suppressive capacity of CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) from peripheral blood of patients with multiple sclerosis (MS) has been reported by multiple laboratories. It is, however, currently unresolved whether Treg dysfunction in MS patients is limited to reduced control of peripheral T cell activation since most studies analyzed peripheral blood samples only. Here, we assessed early active MS lesions in brain biopsies obtained from 16 patients with MS by FOXP3 immunohistochemistry. In addition, we used six-color flow cytometry to determine numbers of Treg by analysis of FOXP3/CD127 expression in peripheral blood and cerebrospinal fluid (CSF) of 17 treatment-naive MS patients as well as quantities of apoptosis sensitive CD45RO(hi)CD95(hi) cells in circulating and CSF Treg subsets. Absolute numbers of FOXP3(+) and CD4(+) cells were rather low in MS brain lesions and Treg were not detectable in 30% of MS biopsies despite the presence of CD4(+) cell infiltrates. In contrast, Treg were detectable in all CSF samples and Treg with a CD45RO(hi)CD95(hi) phenotype previously shown to be highly apoptosis sensitive were found to be enriched in the CSF compared to peripheral blood of MS patients. We suggest a hypothetical model of intracerebral elimination of Treg by CD95L-mediated apoptosis within the MS lesion.	[Fritzsching, Benedikt; Fritzsching, Eva; Poeschl, Johannes] Univ Heidelberg Hosp, Ctr Child & Adolescent Med, Dept Neonatol, Heidelberg, Germany; [Haas, Juergen; Wildemann, Brigitte] Univ Heidelberg Hosp, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany; [Koenig, Fatima; Brueck, Wolfgang] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany; [Kunz, Pierre] Univ Heidelberg Hosp, Dept Orthoped Surg, Heidelberg, Germany; [Krammer, Peter H.; Suri-Payer, Elisabeth] German Canc Res Ctr, Div Immunogenet, Heidelberg, Germany; [Koenig, Fatima] Univ Hosp, Dept Neuropathol, Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Gottingen; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fritzsching, B (corresponding author), Univ Heidelberg Hosp, Ctr Child & Adolescent Med, Dept Neonatol, Heidelberg, Germany.	brigitte.wildemann@med.uni-heidelberg.de	Suri-Payer, Elisabeth/ABC-2448-2021	Haas, Juergen/0000-0002-2314-7465	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (Research Alliance "Understand MS", All). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Chen AS, 2007, CANCER RES, V67, P1291, DOI 10.1158/0008-5472.CAN-06-2622; Comi C, 2000, NEUROLOGY, V55, P921, DOI 10.1212/WNL.55.7.921; CVETANOVICH GL, 2010, CURR OPIN IMMUNOL; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Franz B, 2007, ARTHRITIS RHEUM-US, V56, P1910, DOI 10.1002/art.22699; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, J NEUROL SCI, V251, P91, DOI 10.1016/j.jns.2006.09.006; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Gritzapis AD, 2010, CANCER RES, V70, P2686, DOI 10.1158/0008-5472.CAN-09-2517; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Klemke CD, 2006, LEUKEMIA, V20, P1123, DOI 10.1038/sj.leu.2404182; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Liu SR, 2007, J IMMUNOL, V178, P3301, DOI 10.4049/jimmunol.178.5.3301; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Macchi B, 1999, NEUROREPORT, V10, P399, DOI 10.1097/00001756-199902050-00034; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; NYLAND H, 1982, NEUROPATH APPL NEURO, V8, P403, DOI 10.1111/j.1365-2990.1982.tb00308.x; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Pender MP, 1998, LANCET, V351, P978; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Prineas JW., 1985, HDB CLIN NEUROLOGY, V3, P213; PULLEN AM, 1989, J IMMUNOL, V142, P3033; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schneider-Hohendorf T, 2010, EUR J IMMUNOL, V40, P3581, DOI 10.1002/eji.201040558; Sharief MK, 2000, J NEUROIMMUNOL, V109, P236, DOI 10.1016/S0165-5728(00)00325-8; Sonabend AM, 2008, ANTICANCER RES, V28, P1143; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; VUKMANOVICSTEJI.M, J CLIN INVEST, V116, P2423; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0	45	74	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17988	10.1371/journal.pone.0017988	http://dx.doi.org/10.1371/journal.pone.0017988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437244	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100053
J	Ulrich, PN; Jimenez, V; Park, M; Martins, VP; Atwood, J; Moles, K; Collins, D; Rohloff, P; Tarleton, R; Moreno, SNJ; Orlando, R; Docampo, R				Ulrich, Paul N.; Jimenez, Veronica; Park, Miyoung; Martins, Vicente P.; Atwood, James, III; Moles, Kristen; Collins, Dalis; Rohloff, Peter; Tarleton, Rick; Moreno, Silvia N. J.; Orlando, Ron; Docampo, Roberto			Identification of Contractile Vacuole Proteins in Trypanosoma cruzi	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; DICTYOSTELIUM-DISCOIDEUM; TRANSMEMBRANE TOPOLOGY; MEMBRANE TRAFFICKING; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; CA2+ TRANSPORT; CHAGAS-DISEASE; R-SNARES; COMPLEX	Contractile vacuole complexes are critical components of cell volume regulation and have been shown to have other functional roles in several free-living protists. However, very little is known about the functions of the contractile vacuole complex of the parasite Trypanosoma cruzi, the etiologic agent of Chagas disease, other than a role in osmoregulation. Identification of the protein composition of these organelles is important for understanding their physiological roles. We applied a combined proteomic and bioinfomatic approach to identify proteins localized to the contractile vacuole. Proteomic analysis of a T. cruzi fraction enriched for contractile vacuoles and analyzed by one-dimensional gel electrophoresis and LC-MS/MS resulted in the addition of 109 newly detected proteins to the group of expressed proteins of epimastigotes. We also identified different peptides that map to at least 39 members of the dispersed gene family 1 (DGF-1) providing evidence that many members of this family are simultaneously expressed in epimastigotes. Of the proteins present in the fraction we selected several homologues with known localizations in contractile vacuoles of other organisms and others that we expected to be present in these vacuoles on the basis of their potential roles. We determined the localization of each by expression as GFP-fusion proteins or with specific antibodies. Six of these putative proteins (Rab11, Rab32, AP180, ATPase subunit B, VAMP1, and phosphate transporter) predominantly localized to the vacuole bladder. TcSNARE2.1, TcSNARE2.2, and calmodulin localized to the spongiome. Calmodulin was also cytosolic. Our results demonstrate the utility of combining subcellular fractionation, proteomic analysis, and bioinformatic approaches for localization of organellar proteins that are difficult to detect with whole cell methodologies. The CV localization of the proteins investigated revealed potential novel roles of these organelles in phosphate metabolism and provided information on the potential participation of adaptor protein complexes in their biogenesis.	[Ulrich, Paul N.; Jimenez, Veronica; Park, Miyoung; Martins, Vicente P.; Moles, Kristen; Collins, Dalis; Rohloff, Peter; Tarleton, Rick; Moreno, Silvia N. J.; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Ulrich, Paul N.; Jimenez, Veronica; Park, Miyoung; Martins, Vicente P.; Moles, Kristen; Collins, Dalis; Rohloff, Peter; Tarleton, Rick; Moreno, Silvia N. J.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Atwood, James, III; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ulrich, PN (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	rdocampo@uga.edu	de paulo martins, vicente/H-7182-2019; Martins, Vicente P/F-8395-2012; Tarleton, Rick/AES-8572-2022; Rohloff, Peter/P-8722-2017	de paulo martins, vicente/0000-0001-7611-861X; Martins, Vicente P/0000-0001-7611-861X; Rohloff, Peter/0000-0001-7274-8315; Tarleton, Rick/0000-0002-9589-5243; Collins, Dalis/0000-0003-2484-1640	U.S. National Institutes of Health [AI-068647]; American Heart Association; National Institutes of Health [RR-022685]; NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR022685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (grant AI-068647 to RD), and postdoctoral fellowships from the American Heart Association (to PNU and VJ). KM and DC were supported in part by a summer training grant from the National Institutes of Health (RR-022685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi A, 2010, J CELL SCI, V123, P3215, DOI 10.1242/jcs.063941; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Atwood JA, 2006, J PROTEOME RES, V5, P3376, DOI 10.1021/pr060364b; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; BENAIM G, 1991, BIOCHEM J, V280, P715, DOI 10.1042/bj2800715; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; CHUNG SH, 1990, NUCLEIC ACIDS RES, V18, P4561, DOI 10.1093/nar/18.15.4561; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; DEMENDONCA SM, 2000, CHARACTERIZATION, V243, P179; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Du F, 2008, EMBO J, V27, P2064, DOI 10.1038/emboj.2008.131; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Field H, 2000, MOL BIOCHEM PARASIT, V106, P21, DOI 10.1016/S0166-6851(99)00192-9; Fok AK, 2008, J EUKARYOT MICROBIOL, V55, P481, DOI 10.1111/j.1550-7408.2008.00347.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Harris E, 2001, J CELL SCI, V114, P3035; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; HORTON P, P 4 ANN AS PAC BIOIN, P39; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Iwamoto M, 2004, J HISTOCHEM CYTOCHEM, V52, P557, DOI 10.1177/002215540405200501; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lefkir Y, 2003, MOL BIOL CELL, V14, P1835, DOI 10.1091/mbc.E02-10-0627; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; MADDY AH, 1976, J THEOR BIOL, V62, P315, DOI 10.1016/0022-5193(76)90123-5; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Moniakis J, 1999, J CELL SCI, V112, P405; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; OHALLORAN TJ, 1992, J CELL BIOL, V118, P1371, DOI 10.1083/jcb.118.6.1371; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Schilde C, 2006, TRAFFIC, V7, P440, DOI 10.1111/j.1600-0854.2006.00397.x; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; Schoijet AC, 2011, MOL MICROBIOL, V79, P50, DOI 10.1111/j.1365-2958.2010.07429.x; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Sesaki H, 1997, J CELL BIOL, V138, P939, DOI 10.1083/jcb.138.4.939; Stavrou I, 2006, MOL BIOL CELL, V17, P5381, DOI 10.1091/mbc.E06-06-0531; Stenmark H, 2001, GENOME BIOL, V2; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TELLEZINON MT, 1985, MOL BIOCHEM PARASIT, V17, P143, DOI 10.1016/0166-6851(85)90013-1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wen YJ, 2009, MOL BIOL CELL, V20, P4278, DOI 10.1091/mbc.E09-03-0243; Xie YY, 1996, J CELL SCI, V109, P489; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	86	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18013	10.1371/journal.pone.0018013	http://dx.doi.org/10.1371/journal.pone.0018013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437209	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100058
J	Yamamoto, Y; Takase, K; Kishino, J; Fujita, M; Okamura, N; Sakaeda, T; Fujimoto, M; Yagami, T				Yamamoto, Yasuhiro; Takase, Kenkichi; Kishino, Junji; Fujita, Megumi; Okamura, Noboru; Sakaeda, Toshiyuki; Fujimoto, Masafumi; Yagami, Tatsurou			Proteomic Identification of Protein Targets for 15-Deoxy-Delta(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; PROLIFERATOR-ACTIVATED RECEPTOR; ALZHEIMERS-DISEASE BRAIN; SMOOTH-MUSCLE-CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; RAT-BRAIN; CYCLOPENTENONE PROSTAGLANDINS; GLYCOLYTIC-ENZYMES; TERMINAL FRAGMENTS; PRECURSOR PROTEIN	15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is one of factors contributed to the neurotoxicity of amyloid beta (A beta), a causative protein of Alzheimer's disease. Type 2 receptor for prostaglandin D-2 (DP2) and peroxysome-proliferator activated receptor gamma (PPAR gamma) are identified as the membrane receptor and the nuclear receptor for 15d-PGJ(2), respectively. Previously, we reported that the cytotoxicity of 15d-PGJ(2) was independent of DP2 and PPAR gamma, and suggested that 15d-PGJ(2) induced apoptosis through the novel specific binding sites of 15d-PGJ(2) different from DP2 and PPAR gamma. To relate the cytotoxicity of 15d-PGJ(2) to amyloidoses, we performed binding assay [H-3]15d-PGJ(2) and specified targets for 15d-PGJ(2) associated with cytotoxicity. In the various cell lines, there was a close correlation between the susceptibilities to 15d-PGJ(2) and fibrillar A beta. Specific binding sites of [H-3]15d-PGJ(2) were detected in rat cortical neurons and human bronchial smooth muscle cells. When the binding assay was performed in subcellular fractions of neurons, the specific binding sites of [H-3]15d-PGJ(2) were detected in plasma membrane, nuclear and cytosol, but not in microsome. A proteomic approach was used to identify protein targets for 15d-PGJ(2) in the plasma membrane. By using biotinylated 15d-PGJ(2), eleven proteins were identified as biotin-positive spots and classified into three different functional proteins: glycolytic enzymes (Enolase2, pyruvate kinase M1 (PKM1) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)), molecular chaperones (heat shock protein 8 and T-complex protein 1 subunit alpha), cytoskeletal proteins (Actin beta, F-actin-capping protein, Tubulin beta and Internexin alpha). GAPDH, PKM1 and Tubulin beta are A beta-interacting proteins. Thus, the present study suggested that 15d-PGJ(2) plays an important role in amyloidoses not only in the central nervous system but also in the peripheral tissues.	[Yamamoto, Yasuhiro; Takase, Kenkichi; Yagami, Tatsurou] Himeji Dokkyo Univ, Div Physiol, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan; [Kishino, Junji; Okamura, Noboru; Sakaeda, Toshiyuki; Fujimoto, Masafumi; Yagami, Tatsurou] Shionogi & Co Ltd, Discovery Res Labs, Osaka, Japan; [Fujita, Megumi; Okamura, Noboru] Mukogawa Womens Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Sakaeda, Toshiyuki] Kyoto Univ, Ctr Integrat Educ Pharm Frontier, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Fujimoto, Masafumi] Chiba Inst Sci, Lab Appl Pharmacol, Fac Pharm, Choshi, Japan	Himeji Dokkyo University; Shionogi & Company Limited; Mukogawa Women's University; Kyoto University	Yamamoto, Y (corresponding author), Himeji Dokkyo Univ, Div Physiol, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan.	yagami@himeji-du.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20500346]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors acknowledge the following sources of support: Grant-in-Aid 20500346 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JK, NO, TS, MF and TY are employed by Shionogi and Co., Ltd. The present study includes data provided by JK, NO, TS, MF and TY when at Shiogi and Co., Ltd. Since the data were not applied to pharmaceutical development, Shionogi approved the submission of the present study to contribute to the development of academic study.	Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arias C, 2002, EXP NEUROL, V176, P163, DOI 10.1006/exnr.2002.7912; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Baumann MH, 1996, BIOCHEM BIOPH RES CO, V219, P238, DOI 10.1006/bbrc.1996.0211; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bulliard C, 1997, BIOCHEM J, V324, P555, DOI 10.1042/bj3240555; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Ching GY, 1998, J CELL SCI, V111, P321; Chow SK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090035; Dale RC, 2006, J NEUROIMMUNOL, V172, P187, DOI 10.1016/j.jneuroim.2005.10.014; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Ishitani R, 1996, J NEUROCHEM, V66, P928; Islam K, 1997, AM J PATHOL, V151, P265; IWAMOTO N, 1989, J NEUROL, V236, P80, DOI 10.1007/BF00314401; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lovell MA, 2005, NEUROCHEM RES, V30, P113, DOI 10.1007/s11064-004-9692-5; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Oyama R, 2000, BBA-PROTEIN STRUCT M, V1479, P91, DOI 10.1016/S0167-4838(00)00057-1; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; SASAGURI T, 1992, EXP CELL RES, V200, P351, DOI 10.1016/0014-4827(92)90182-8; Schuller E, 2001, LIFE SCI, V69, P263, DOI 10.1016/S0024-3205(01)01126-2; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Tamaoka A, 1996, NEUROBIOL AGING, V17, P405, DOI 10.1016/0197-4580(96)00031-0; Toda Tosifusa, 1997, Japanese Journal of Electrophoresis, V41, P13; Ueta H, 2004, NEUROSCI RES, V48, P379, DOI 10.1016/j.neures.2003.12.006; Verdier Y, 2005, J NEUROCHEM, V94, P617, DOI 10.1111/j.1471-4159.2005.03158.x; Ward JE, 2004, BRIT J PHARMACOL, V141, P517, DOI 10.1038/sj.bjp.0705630; WHATLEY SA, 1986, J NEUROCHEM, V47, P1576, DOI 10.1111/j.1471-4159.1986.tb00797.x; Wright DH, 1999, EUR J PHARMACOL, V377, P101, DOI 10.1016/S0014-2999(99)00358-1; YAGAMI T, 1995, MOL PHARMACOL, V48, P849; YAGAMI T, 1990, JPN J PHARMACOL, V54, P365, DOI 10.1254/jjp.54.365; Yagami T, 2004, NEUROBIOL DIS, V16, P481, DOI 10.1016/j.nbd.2004.04.013; Yagami T, 2003, EXP CELL RES, V291, P212, DOI 10.1016/S0014-4827(03)00369-0; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; Yagami T, 2001, BRIT J PHARMACOL, V134, P673, DOI 10.1038/sj.bjp.0704261	53	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17552	10.1371/journal.pone.0017552	http://dx.doi.org/10.1371/journal.pone.0017552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445266	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100016
J	Bollig-Fischer, A; Dewey, TG; Ethier, SP				Bollig-Fischer, Aliccia; Dewey, T. Gregory; Ethier, Stephen P.			Oncogene Activation Induces Metabolic Transformation Resulting in Insulin-Independence in Human Breast Cancer Cells	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; GROWTH-FACTOR INDEPENDENCE; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; GLUT4 TRAFFICKING; FACTOR-I; PROLIFERATION; DEHYDROGENASE; GLUTAMINE; MODEL	Normal breast epithelial cells require insulin and EGF for growth in serum-free media. We previously demonstrated that over expression of breast cancer oncogenes transforms MCF10A cells to an insulin-independent phenotype. Additionally, most breast cancer cell lines are insulin-independent for growth. In this study, we investigated the mechanism by which oncogene over expression transforms MCF10A cells to an insulin-independent phenotype. Analysis of the effects of various concentrations of insulin and/or IGF-I on proliferation of MCF10A cells demonstrated that some of the effects of insulin were independent from those of IGF-I, suggesting that oncogene over expression drives a true insulin-independent proliferative phenotype. To test this hypothesis, we examined metabolic functions of insulin signaling in insulin-dependent and insulin-independent cells. HER2 over expression in MCF10A cells resulted in glucose uptake in the absence of insulin at a rate equal to insulin-induced glucose uptake in non-transduced cells. We found that a diverse set of oncogenes induced the same result. To gain insight into how HER2 oncogene signaling affected increased insulin-independent glucose uptake we compared HER2-regulated gene expression signatures in MCF10A and HER2 over expressing MCF10A cells by differential analysis of time series gene expression data from cells treated with a HER2 inhibitor. This analysis identified genes specifically regulated by the HER2 oncogene, including VAMP8 and PHGDH, which have known functions in glucose uptake and processing of glycolytic intermediates, respectively. Moreover, these genes specifically implicated in HER2 oncogene-driven transformation are commonly altered in human breast cancer cells. These results highlight the diversity of oncogene effects on cell regulatory pathways and the importance of oncogene-driven metabolic transformation in breast cancer.	[Bollig-Fischer, Aliccia; Ethier, Stephen P.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Bollig-Fischer, Aliccia] Karmanos Canc Inst, Breast Canc Biol Program, Detroit, MI USA; [Dewey, T. Gregory] Univ La Verne, Los Angeles, CA USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; University of La Verne	Bollig-Fischer, A (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.	ethier@karmanos.org		Bollig-Fischer, Aliccia/0000-0003-4832-9457	Department of Defense; Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH-10-2-0068]	Department of Defense(United States Department of Defense); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD	This research and development project was conducted by the Barbara Ann Karmanos Cancer Institute and is made possible by a contract with the Department of Defense that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD, under Contract Number: W81XWH-10-2-0068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views, opinions and/or findings contained in this research/presentation/publication are those of the author(s)/company and do not necessarily reflect the views of the Department of Defense and should not be construed as an official DoD/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made.	Blum R, 2005, CANCER RES, V65, P999; Bollig-Fischer A, 2010, CANCER RES, V70, P7862, DOI 10.1158/0008-5472.CAN-10-1529; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Ethier SP, 1996, CANCER RES, V56, P899; ETHIER SP, 1993, CANCER RES, V53, P627; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ignatoski KMW, 2005, NEOPLASIA, V7, P788, DOI 10.1593/neo.05106; Ignatoski KMW, 1999, ENDOCRINOLOGY, V140, P3615, DOI 10.1210/en.140.8.3615; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Mankoff DA, 2007, CLIN CANCER RES, V13, P3460, DOI 10.1158/1078-0432.CCR-07-0074; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Peters K, 2009, CELL PHYSIOL BIOCHEM, V24, P483, DOI 10.1159/000257490; POLLARI S, 2010, BREAST CANC RES TREA; PRESTON RSP, 2010, ONCOGENE; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; ROSENFELD RG, 1985, ENDOCRINOLOGY, V117, P2008, DOI 10.1210/endo-117-5-2008; SCHMIDT M, 2009, J CANC RES CLIN ONCO; SEMENZA GL, 2010, BIOCH BIOPHYS ACTA; Shirvani SM, 2007, PHYSIOL GENOMICS, V30, P61, DOI 10.1152/physiolgenomics.00277.2006; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2007, INT J CANCER, V121, P1265, DOI 10.1002/ijc.22831; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	47	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17959	10.1371/journal.pone.0017959	http://dx.doi.org/10.1371/journal.pone.0017959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437235	Green Submitted, Green Published, gold			2022-12-25	WOS:000288514600018
J	Lafforgue, G; Sardanyes, J; Elena, SF				Lafforgue, Guillaume; Sardanyes, Josep; Elena, Santiago F.			Differences in Accumulation and Virulence Determine the Outcome of Competition during Tobacco etch virus Coinfection	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; LOCAL ADAPTATION; SPORE PRODUCTION; MOSAIC-VIRUS; PLANT; MODEL; TRANSMISSION; PATHOGENS; HOSTS	Understanding the evolution of virulence for RNA viruses is essential for developing appropriate control strategies. Although it has been usually assumed that virulence is a consequence of within-host replication of the parasite, viral strains may be highly virulent without experiencing large accumulation as a consequence of immunopathological host responses. Using two strains of Tobacco etch potyvirus (TEV) that show a negative relationship between virulence and accumulation rate, we first explored the evolution of virulence and fitness traits during simple and mixed infections. Short-term evolution experiments initiated with each strain independently confirmed the genetic and evolutionary stability of virulence and viral load, although infectivity significantly increased for both strains. Second, competition experiments between hypo- and hypervirulent TEV strains have shown that the outcome of competition is driven by differences in replication rate. A simple mathematical model has been developed to analyze the dynamics of these two strains during coinfection. The model qualitatively reproduced the experimental results using biologically meaningful parameters. Further analyses of the model also revealed a wide parametric region in which a low-fitness but hypovirulent virus can still outcompete a high-fitness but hypervirulent one. These results provide additional support to the observation that virulence and within-host replication may not necessarily be strongly tied in plant RNA viruses.	[Lafforgue, Guillaume; Sardanyes, Josep; Elena, Santiago F.] Consejo Super Invest Cientificas UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Lafforgue, G (corresponding author), Consejo Super Invest Cientificas UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain.	sfelena@ibmcp.upv.es	SARDANES, JOSEP/M-3799-2015; Elena, Santiago F./A-4191-2011; LAFFORGUE, Guillaume/M-2972-2019; Lafforgue, Guillaume/Q-7580-2016	SARDANES, JOSEP/0000-0001-7225-5158; Elena, Santiago F./0000-0001-8249-5593; Lafforgue, Guillaume/0000-0003-2215-2825	Human Frontier Science Program Organization [RGP12/2008]; Spanish Ministerio de Ciencia e Innovacion [BFU2009-06993]; Generalitat Valenciana [PROMETEO2010/019]; Santa Fe Institute	Human Frontier Science Program Organization(Human Frontier Science Program); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Santa Fe Institute	Funding: This work was funded by grants from the Human Frontier Science Program Organization (RGP12/2008), the Spanish Ministerio de Ciencia e Innovacion (BFU2009-06993) and the Generalitat Valenciana (PROMETEO2010/019). The authors also acknowledge support from the Santa Fe Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, THEOR POPUL BIOL, V74, P6, DOI 10.1016/j.tpb.2008.04.003; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; BREMERMANN HJ, 1983, J THEOR BIOL, V100, P411, DOI 10.1016/0022-5193(83)90438-1; Carr DE, 2006, HEREDITY, V96, P29, DOI 10.1038/sj.hdy.6800743; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Elena SF, 2008, HEREDITY, V100, P478, DOI 10.1038/sj.hdy.6801088; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Escriu F, 2003, EVOLUTION, V57, P755, DOI 10.1111/j.0014-3820.2003.tb00287.x; FOX DT, 1984, CAN J PLANT PATHOL, V6, P175, DOI 10.1080/07060668409501580; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gal-On A, 2007, MOL PLANT PATHOL, V8, P139, DOI 10.1111/J.1364-3703.2007.00381.X; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; KLECZKOWSKI A, 1950, J GEN MICROBIOL, V4, P53, DOI 10.1099/00221287-4-1-53; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Montarry J, 2006, J EVOLUTION BIOL, V19, P522, DOI 10.1111/j.1420-9101.2005.01005.x; Mosquera J, 1998, J THEOR BIOL, V195, P293, DOI 10.1006/jtbi.1998.0793; Pagan I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000786; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Roossinck MJ, 2003, CURR OPIN MICROBIOL, V6, P406, DOI 10.1016/S1369-5274(03)00087-0; Sole RV, 1999, J THEOR BIOL, V198, P47, DOI 10.1006/jtbi.1999.0901; Stewart AD, 2005, EVOLUTION, V59, P730, DOI 10.1111/j.0014-3820.2005.tb01749.x; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Zhan J, 2002, J EVOLUTION BIOL, V15, P634, DOI 10.1046/j.1420-9101.2002.00428.x	31	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17917	10.1371/journal.pone.0017917	http://dx.doi.org/10.1371/journal.pone.0017917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423618	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900044
J	Gill, A; Scanlon, TC; Osipovitch, DC; Madden, DR; Griswold, KE				Gill, Avinash; Scanlon, Thomas C.; Osipovitch, Daniel C.; Madden, Dean R.; Griswold, Karl E.			Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity	PLOS ONE			English	Article							ELECTROSTATIC INTERACTIONS; ANTIMICROBIAL ACTIVITY; PULMONARY INFECTIONS; F-ACTIN; PATHOPHYSIOLOGY; MANAGEMENT	Human lysozyme is a key component of the innate immune system, and recombinant forms of the enzyme represent promising leads in the search for therapeutic agents able to treat drug-resistant infections. The wild type protein, however, fails to participate effectively in clearance of certain infections due to inherent functional limitations. For example, wild type lysozymes are subject to electrostatic sequestration and inactivation by anionic biopolymers in the infected airway. A charge engineered variant of human lysozyme has recently been shown to possess improved antibacterial activity in the presence of disease associated inhibitory molecules. Here, the 2.04 angstrom crystal structure of this variant is presented along with an analysis that provides molecular level insights into the origins of the protein's enhanced performance. The charge engineered variant's two mutated amino acids exhibit stabilizing interactions with adjacent native residues, and from a global perspective, the mutations cause no gross structural perturbations or loss of stability. Importantly, the two substitutions dramatically expand the negative electrostatic potential that, in the wild type enzyme, is restricted to a small region near the catalytic residues. The net result is a reduction in the overall strength of the engineered enzyme's electrostatic potential field, and it appears that the specific nature of this remodeled field underlies the variant's reduced susceptibility to inhibition by anionic biopolymers.	[Gill, Avinash; Scanlon, Thomas C.; Griswold, Karl E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Osipovitch, Daniel C.] Dartmouth Coll, Program Expt & Mol Med, Hanover, NH 03755 USA; [Madden, Dean R.] Dartmouth Coll, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Madden, Dean R.; Griswold, Karl E.] Dartmouth Coll, Program Mol & Cellular Biol, Hanover, NH 03755 USA; [Griswold, Karl E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Gill, A (corresponding author), Bioarchitecture Lab, Berkeley, CA USA.	Karl.E.Griswold@Dartmouth.edu	Griswold, Karl/B-3449-2012	Griswold, Karl/0000-0002-9835-3394	Wallace H. Coulter Foundation; Cystic Fibrosis Foundation [SCANLO08F0, P20RR018787-06]; National Center for Research Resources (NCRR), a component of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER	Wallace H. Coulter Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Center for Research Resources (NCRR), a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Wallace H. Coulter Foundation (http://www.whcf.org/) Early Career Award, a Cystic Fibrosis Foundation (http://www.cff.org/) Carol Basbaum Memorial Postdoctoral Fellowship (SCANLO08F0), and P20RR018787-06 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GOVAN JRW, 1992, BRIT MED BULL, V48, P912, DOI 10.1093/oxfordjournals.bmb.a072585; Higo J, 2002, J COMPUT CHEM, V23, P1323, DOI 10.1002/jcc.10100; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koshiba T, 2000, BIOCHEMISTRY-US, V39, P3248, DOI 10.1021/bi991525a; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Projan SJ, 2007, ANTIMICROB AGENTS CH, V51, P1133, DOI 10.1128/AAC.01370-06; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rogers DF, 2007, RESP CARE, V52, P1134; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; Sanders LK, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108302; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; Scanlon TC, 2010, ACS CHEM BIOL, V5, P809, DOI 10.1021/cb1001119; SHIRE SJ, 1996, PHARM BIOTECHNOLOGY, P393; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; SONG HW, 1994, J MOL BIOL, V244, P522, DOI 10.1006/jmbi.1994.1750; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC	32	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16788	10.1371/journal.pone.0016788	http://dx.doi.org/10.1371/journal.pone.0016788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408218	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800007
J	Gezen-Ak, D; Dursun, E; Yilmazer, S				Gezen-Ak, Duygu; Dursun, Erdinc; Yilmazer, Selma			The Effects of Vitamin D Receptor Silencing on the Expression of LVSCC-A1C and LVSCC-A1D and the Release of NGF in Cortical Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; D DEFICIENCY; D HORMONE; GENE; 1,25-DIHYDROXYVITAMIN-D3; NEUROTOXICITY; POLYMORPHISM; ASSOCIATION; VDR	Background: Recent studies have suggested that vitamin D can act on cells in the nervous system. Associations between polymorphisms in the vitamin D receptor (VDR), age-dependent cognitive decline, and insufficient serum 25 hydroxyvitamin D3 levels in Alzheimer's patients and elderly people with cognitive decline have been reported. We have previously shown that amyloid beta (A beta) treatment eliminates VDR protein in cortical neurons. These results suggest a potential role for vitamin D and vitamin D-mediated mechanisms in Alzheimer's disease (AD) and neurodegeneration. Vitamin D has been shown to down-regulate the L-type voltage-sensitive calcium channels, LVSCC-A1C and LVSCC-A1D, and up-regulate nerve growth factor (NGF). However, expression of these proteins when VDR is repressed is unknown. The aim of this study is to investigate LVSCC-A1C, LVSCC-A1D expression levels and NGF release in VDR-silenced primary cortical neurons prepared from Sprague-Dawley rat embryos. Methodology/Principal Findings: qRT-PCR and western blots were performed to determine VDR, LVSCC-A1C and -A1D expression levels. NGF and cytotoxicity levels were determined by ELISA. Apoptosis was determined by TUNEL. Our findings illustrate that LVSCC-A1C mRNA and protein levels increased rapidly in cortical neurons when VDR is down-regulated, whereas, LVSCC-A1D mRNA and protein levels did not change and NGF release decreased in response to VDR downregulation. Although vitamin D regulates LVSCC-A1C through VDR, it may not regulate LVSCC-A1D through VDR. Conclusions/Significance: Our results indicate that suppression of VDR disrupts LVSCC-A1C and NGF production. In addition, when VDR is suppressed, neurons could be vulnerable to aging and neurodegeneration, and when combined with Ab toxicity, it is possible to explain some of the events that occur during neurodegeneration.	[Gezen-Ak, Duygu; Dursun, Erdinc; Yilmazer, Selma] Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Istanbul, Turkey	Istanbul University; Istanbul University - Cerrahpasa	Gezen-Ak, D (corresponding author), Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Istanbul, Turkey.	selmayilmazer@mynet.com	Gezen-Ak, Duygu/D-2679-2019; Dursun, Erdinc/D-2666-2019; Dursun, Erdinc/AAH-9516-2019	Gezen-Ak, Duygu/0000-0001-7611-2111; Dursun, Erdinc/0000-0003-3701-6674; Dursun, Erdinc/0000-0003-3701-6674	Istanbul University [T-942/06102006, 548]; Scientific and Technological Research Council of Turkey-TUBITAK [107S041]	Istanbul University(Istanbul University); Scientific and Technological Research Council of Turkey-TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present work was supported by the Research Fund of Istanbul University (http://bilimap.istanbul.edu.tr/en_index.htm) (Project No. T-942/06102006 and 548) and by the Scientific and Technological Research Council of Turkey-TUBITAK (http://www.tubitak.gov.tr/en/ot/10/;jsessionid=7858A45C2E6CB391140969EB6419650B) (Project No. 107S041).	Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Bouillon R, 1998, OSTEOPOROSIS INT, V8, pS13, DOI 10.1007/PL00022727; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Dursun E, 2009, DEMENT GERIATR COGN, V27, P82, DOI 10.1159/000193627; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Fleet JC, 2004, J NUTR, V134, P3215, DOI 10.1093/jn/134.12.3215; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; HOLICK MF, 1995, BONE, V17, pS107, DOI 10.1016/8756-3282(95)00195-J; Kato S, 1998, J BONE MINER METAB, V16, P65, DOI 10.1007/s007740050028; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Khazai Natasha, 2008, Curr Rheumatol Rep, V10, P110, DOI 10.1007/s11926-008-0020-y; Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001; Landfield PW, 1998, NEUROBIOL AGING, V19, P469, DOI 10.1016/S0197-4580(98)00079-7; Larrosa M, 2001, MED CLIN-BARCELONA, V117, P611, DOI 10.1016/S0025-7753(01)72195-1; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Llewellyn DJ, 2009, J GERIATR PSYCH NEUR, V22, P188, DOI 10.1177/0891988708327888; LUINE V N, 1987, Steroids, V49, P133, DOI 10.1016/0039-128X(87)90082-1; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Peeraully MR, 2004, AM J PHYSIOL-ENDOC M, V287, pE331, DOI 10.1152/ajpendo.00076.2004; Price P., 1998, PROTOCOLS NEURAL CEL, P255; Rozema D. B., 2003, TARGETS, V2, P253; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; WION D, 1991, J NEUROSCI RES, V28, P110, DOI 10.1002/jnr.490280111; YAMAGUCHI M, 2002, ADV CELL AGING GERON, V10, P47; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	38	88	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17553	10.1371/journal.pone.0017553	http://dx.doi.org/10.1371/journal.pone.0017553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408608	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200024
J	Perini, F; Casabianca, A; Battocchi, C; Accoroni, S; Totti, C; Penna, A				Perini, Federico; Casabianca, Anna; Battocchi, Cecilia; Accoroni, Stefano; Totti, Cecilia; Penna, Antonella			New Approach Using the Real-Time PCR Method for Estimation of the Toxic Marine Dinoflagellate Ostreopsis cf. ovata in Marine Environment	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PALYTOXIN-LIKE; ALEXANDRIUM-MINUTUM; QUANTITATIVE PCR; QUANTIFICATION; ASSAY; DINOPHYCEAE; RDNA; SEA; IDENTIFICATION	Background: We describe the development and validation of a new quantitative real time PCR (qrt-PCR) method for the enumeration of the toxic benthic dinoflagellate Ostreopsis cf. ovata in marine environment. The benthic Ostreopsis sp. has a world-wide distribution and is associated during high biomass proliferation with the production of potent palytoxin-like compounds affecting human health and environment. Species-specific identification, which is relevant for the complex of different toxins production, by traditional methods of microscopy is difficult due to the high morphological variability, and thus different morphotypes can be easily misinterpreted. Methodology/Findings: The method is based on the SYBR I Green real-time PCR technology and combines the use of a plasmid standard curve with a "gold standard" created with pooled crude extracts from environmental samples collected during a bloom event of Ostreopsis cf. ovata in the Mediterranean Sea. Based on their similar PCR efficiencies (95% and 98%, respectively), the exact rDNA copy number per cell was obtained in cultured and environmental samples. Cell lysates were used as the templates to obtain total recovery of DNA. The analytical sensitivity of the PCR was set at two rDNA copy number and 8.0x10(-4) cell per reaction for plasmid and gold standards, respectively; the sensitivity of the assay was of cells g(-1) fw or 1(-1) in macrophyte and seawater samples, respectively. The reproducibility was determined on the total linear quantification range of both curves confirming the accuracy of the technical set-up in the complete ranges of quantification over time. Conclusions/Significance: We developed a qrt-PCR assay specific, robust and high sample throughput for the absolute quantification of the toxic dinoflagellate Ostreopsis cf. ovata in the environmental samples. This molecular approach may be considered alternative to traditional microscopy and applied for the monitoring of benthic toxic microalgal species in the marine ecosystems.	[Perini, Federico; Casabianca, Anna; Battocchi, Cecilia; Penna, Antonella] Univ Urbino, Dept Biomol Sci, Pesaro, Italy; [Accoroni, Stefano; Totti, Cecilia] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy	University of Urbino; Marche Polytechnic University	Penna, A (corresponding author), Univ Urbino, Dept Biomol Sci, Pesaro, Italy.	antonella.penna@uniurb.it	Accoroni, Stefano/F-5818-2014; Totti, Cecilia Maria/A-9178-2016	Accoroni, Stefano/0000-0002-1134-7849; Totti, Cecilia Maria/0000-0002-1532-6009	Sixth Framework Programme [GOCE-003875]	Sixth Framework Programme(European Commission)	The work was supported by ISPRA Project "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita microalgale nei mari italiani"; PRIN 2007 Grant prot. FXSCL2; EC Contract No. GOCE-003875, funded by the Sixth Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligizaki K, 2008, TOXICON, V51, P418, DOI 10.1016/j.toxicon.2007.10.016; Battocchi C, 2010, MAR POLLUT BULL, V60, P1074, DOI 10.1016/j.marpolbul.2010.01.017; Casabianca A, 2007, MOL CELL PROBE, V21, P368, DOI 10.1016/j.mcp.2007.05.005; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; Edler L., 2010, MICROSCOPIC MOL METH, P13, DOI DOI 10.1016/J.RESP.2011.02.009; Erdner DL, 2010, DEEP-SEA RES PT II, V57, P279, DOI 10.1016/j.dsr2.2009.09.006; Galluzzi L, 2004, APPL ENVIRON MICROB, V70, P1199, DOI 10.1128/AEM.70.2.1199-1206.2004; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Greenwood SJ, 2001, NUCLEIC ACIDS RES, V29, P2191, DOI 10.1093/nar/29.10.2191; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenoir S, 2004, J PHYCOL, V40, P1042, DOI 10.1111/j.1529-8817.2004.04016.x; Torres-Machorro AL, 2010, FEMS MICROBIOL REV, V34, P59, DOI 10.1111/j.1574-6976.2009.00196.x; Mangialajo L, 2008, MAR POLLUT BULL, V56, P1209, DOI 10.1016/j.marpolbul.2008.02.028; Maruyama S, 2007, J EUKARYOT MICROBIOL, V54, P333, DOI 10.1111/j.1550-7408.2007.00273.x; Penna A, 2005, J PHYCOL, V41, P212, DOI 10.1111/j.1529-8817.2005.04011.x; Penna A, 2010, J BIOGEOGR, V37, P830, DOI 10.1111/j.1365-2699.2009.02265.x; Riobo P, 2006, ANAL CHIM ACTA, V566, P217, DOI 10.1016/j.aca.2006.03.013; Rott E, 2007, HYDROBIOLOGIA, V578, P141, DOI 10.1007/s10750-006-0440-5; Saito K, 2002, APPL ENVIRON MICROB, V68, P5394, DOI 10.1128/AEM.68.11.5394-5407.2002; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; TOTTI C, 2004, MEDITERRANEAN MARINE, P247; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Touzet N, 2009, FEMS MICROBIOL ECOL, V67, P329, DOI 10.1111/j.1574-6941.2008.00627.x; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; Vila M, 2001, AQUAT MICROB ECOL, V26, P51, DOI 10.3354/ame026051; YASUMOTO T, 1987, BIOL BULL, V172, P128, DOI 10.2307/1541612; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	33	67	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17699	10.1371/journal.pone.0017699	http://dx.doi.org/10.1371/journal.pone.0017699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408606	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200036
J	Tsuchiya, Y; Yamashita, S				Tsuchiya, Yuichi; Yamashita, Shigeru			Anti-apoptotic Activity and Proteasome-mediated Degradation of Xenopus Mcl-1 Protein in Egg Extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BCL-2 FAMILY-MEMBERS; CELL-FREE APOPTOSIS; CYTOCHROME-C; BID CLEAVAGE; BH3 DOMAINS; BAX; LAEVIS; DEATH; PERMEABILIZATION	Xenopus egg extracts execute spontaneous apoptosis without the requirement of transcription and translation, and this intrinsic mechanism is supposed to be involved in the physiological elimination of aged eggs. Although apoptosis in this system is carried out by maternally stockpiled materials, the endogenous apoptosis regulators present in egg extracts are still poorly characterized. Here we examined the mRNA expression profiles and apoptosis-regulating functions of 13 Xenopus Bcl-2 family proteins in egg extracts. Among these, we found that endogenous Xenopus Mcl-1 (xMcl-1) physiologically inhibited apoptosis by counteracting the pro-apoptotic activity of endogenous Xenopus Bid in egg extracts. Exogenously added recombinant xMcl-1 was rapidly degraded by proteasome in egg extracts, and we identified the destabilizing region in the N terminus of xMcl-1. Our results suggest that the proteolytic decay of xMcl-1 may change the functional balance between pro-and anti-apoptotic activities of Bcl-2 family proteins, thereby regulating the timing of cytochrome c release in egg extracts.	[Tsuchiya, Yuichi; Yamashita, Shigeru] Toho Univ, Sch Med, Dept Biochem, Ota Ku, Tokyo 1438540, Japan		Yamashita, S (corresponding author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	yamasita@med.toho-u.ac.jp	Yamashita, Shigeru/AAM-1563-2020		Toho University School of Medicine [20-19]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Toho University School of Medicine(Toho University); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Toho University School of Medicine Project Research Grant 20-19 and in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; Blaineau SV, 2009, APOPTOSIS, V14, P923, DOI 10.1007/s10495-009-0376-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Coen L, 2001, P NATL ACAD SCI USA, V98, P7869, DOI 10.1073/pnas.141226798; Coen L, 2007, P NATL ACAD SCI USA, V104, P8502, DOI 10.1073/pnas.0608877104; Cosulich SC, 1999, CURR BIOL, V9, P147, DOI 10.1016/S0960-9822(99)80068-2; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Cosulich SC, 1996, CURR BIOL, V6, P997, DOI 10.1016/S0960-9822(02)00644-9; Coultas L, 2002, CELL DEATH DIFFER, V9, P1163, DOI 10.1038/sj.cdd.4401096; CRUZREYES J, 1995, GENE, V158, P171, DOI 10.1016/0378-1119(95)00159-4; De Marco N, 2010, CELL DEATH DIFFER, V17, P360, DOI 10.1038/cdd.2009.128; Deming Paula, 2006, V322, P379; Du Pasquier D, 2007, GENESIS, V45, P1, DOI 10.1002/dvg.20252; Du Pasquier D, 2006, DEV DYNAM, V235, P2083, DOI 10.1002/dvdy.20874; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Freel CD, 2008, J BIOL CHEM, V283, P367, DOI 10.1074/jbc.M708931200; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Guillemin Y, 2009, J MOL MED, V87, P923, DOI 10.1007/s00109-009-0495-7; Johnson CE, 2010, CELL DEATH DIFFER, V17, P170, DOI 10.1038/cdd.2009.120; Johnston J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-20; Kloc M, 2007, GENESIS, V45, P523, DOI 10.1002/dvg.20322; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kominami K, 2006, GENES CELLS, V11, P701, DOI 10.1111/j.1365-2443.2006.00983.x; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Moradi-Ameli M, 2002, BIOCHEMISTRY-US, V41, P8540, DOI 10.1021/bi0110286; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Newmeyer DD, 2000, CELL DEATH DIFFER, V7, P402, DOI 10.1038/sj.cdd.4400665; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Rowe I, 2005, DEV DYNAM, V233, P76, DOI 10.1002/dvdy.20312; Sachs LM, 2004, DEV DYNAM, V231, P671, DOI 10.1002/dvdy.20166; Saitoh T, 2009, BIOCHEM BIOPH RES CO, V384, P491, DOI 10.1016/j.bbrc.2009.05.004; Saitoh Tomohiro, 2009, Reproductive Medicine and Biology, V8, P3, DOI 10.1007/s12522-008-0001-x; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Tribulo C, 2004, DEV BIOL, V275, P325, DOI 10.1016/j.ydbio.2004.07.041; Tsuchiya Y, 2005, FEBS J, V272, P2237, DOI 10.1111/j.1742-4658.2005.04648.x; Tsuchiya Yuichi, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-5; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; von Ahsen O, 2000, METHOD ENZYMOL, V322, P183; Yoon SJ, 2009, BIOL REPROD, V81, P497, DOI 10.1095/biolreprod.108.073759; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000106	50	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.175927	http://dx.doi.org/10.1074/jbc.M110.175927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454490	Green Published, hybrid			2022-12-25	WOS:000290022800021
J	Nevo, Y; Aga-Mizrachi, S; Elmakayes, E; Yanay, N; Ettinger, K; Elbaz, M; Brunschwig, Z; Dadush, O; Elad-Sfadia, G; Haklai, R; Kloog, Y; Chapman, J; Reif, S				Nevo, Yoram; Aga-Mizrachi, Shlomit; Elmakayes, Edva; Yanay, Nurit; Ettinger, Keren; Elbaz, Moran; Brunschwig, Zivia; Dadush, Oshrat; Elad-Sfadia, Galit; Haklai, Roni; Kloog, Yoel; Chapman, Joab; Reif, Shimon			The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy(2J)/dy(2J) Mouse Model of Muscular Dystrophy	PLOS ONE			English	Article							INDUCED LIVER-CIRRHOSIS; DEPENDENT CELL-GROWTH; GTP-BINDING PROTEINS; MATRIX METALLOPROTEINASES; SKELETAL-MUSCLE; INFLAMMATORY MYOPATHIES; DY(2J) MICE; INHIBITION; ACTIVATION; EXPRESSION	The Ras superfamily of guanosine-triphosphate (GTP)-binding proteins regulates a diverse spectrum of intracellular processes involved in inflammation and fibrosis. Farnesythiosalicylic acid (FTS) is a unique and potent Ras inhibitor which decreased inflammation and fibrosis in experimentally induced liver cirrhosis and ameliorated inflammatory processes in systemic lupus erythematosus, neuritis and nephritis animal models. FTS effect on Ras expression and activity, muscle strength and fibrosis was evaluated in the dy 2J/dy 2J mouse model of merosin deficient congenital muscular dystrophy. The dy 2J/dy 2J mice had significantly increased RAS expression and activity compared with the wild type mice. FTS treatment significantly decreased RAS expression and activity. In addition, phosphorylation of ERK, a Ras downstream protein, was significantly decreased following FTS treatment in the dy 2J/dy 2J mice. Clinically, FTS treated mice showed significant improvement in hind limb muscle strength measured by electronic grip strength meter. Significant reduction of fibrosis was demonstrated in the treated group by quantitative Sirius Red staining and lower muscle collagen content. FTS effect was associated with significantly inhibition of both MMP-2 and MMP-9 activities. We conclude that active RAS inhibition by FTS was associated with attenuated fibrosis and improved muscle strength in the dy 2J/dy 2J mouse model of congenital muscular dystrophy.	[Nevo, Yoram; Aga-Mizrachi, Shlomit; Elmakayes, Edva; Yanay, Nurit; Ettinger, Keren; Elbaz, Moran; Brunschwig, Zivia; Dadush, Oshrat] Hadassah Hebrew Univ Hosp, Pediat Neuromuscular Lab, Jerusalem, Israel; [Nevo, Yoram; Aga-Mizrachi, Shlomit; Elmakayes, Edva; Yanay, Nurit; Ettinger, Keren; Elbaz, Moran; Brunschwig, Zivia; Dadush, Oshrat] Hadassah Hebrew Univ Hosp, Neuropediat Unit, Jerusalem, Israel; [Elad-Sfadia, Galit; Haklai, Roni; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Dept Neurol, Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Reif, Shimon] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Dept Pediat, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Nevo, Y (corresponding author), Hadassah Hebrew Univ Hosp, Pediat Neuromuscular Lab, Jerusalem, Israel.	nevo@hadassah.org.il	Chapman, Joab/E-4598-2010	Chapman, Joab/0000-0002-2161-9764				BALLIN M, 1988, BIOCHEM BIOPH RES CO, V154, P832, DOI 10.1016/0006-291X(88)90215-X; Bani C, 2008, MUSCLE NERVE, V37, P583, DOI 10.1002/mus.20970; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65; Clarke HC, 2003, J AM SOC NEPHROL, V14, P848, DOI 10.1097/01.ASN.0000057543.55318.8B; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Dadush O, 2010, NEUROMUSCULAR DISORD, V20, P267, DOI 10.1016/j.nmd.2010.02.002; Downward J, 2006, SCIENCE, V314, P433, DOI 10.1126/science.1134727; Egozi Y, 1999, INT J CANCER, V80, P911, DOI 10.1002/(SICI)1097-0215(19990315)80:6<911::AID-IJC18>3.0.CO;2-4; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kafri M, 2005, J NEUROIMMUNOL, V168, P46, DOI 10.1016/j.jneuroim.2005.07.008; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Katzav A, 2001, CLIN EXP IMMUNOL, V126, P570, DOI 10.1046/j.1365-2249.2001.01674.x; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kloog, 1999, Expert Opin Investig Drugs, V8, P2121, DOI 10.1517/13543784.8.12.2121; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Lattanzi G, 2000, BIOCHEM BIOPH RES CO, V277, P639, DOI 10.1006/bbrc.2000.3735; Le DT, 2002, CURR OPIN HEMATOL, V9, P308, DOI 10.1097/00062752-200207000-00008; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; MARCIANO D, 1995, J MED CHEM, V38, P1267, DOI 10.1021/jm00008a004; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Nevo Y, 2010, MUSCLE NERVE, V42, P218, DOI 10.1002/mus.21706; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Reif S, 2004, J HEPATOL, V41, P235, DOI 10.1016/j.jhep.2004.04.010; Reif S, 1999, J HEPATOL, V31, P1053, DOI 10.1016/S0168-8278(99)80318-3; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rubio N, 2008, J NEUROCHEM, V104, P100, DOI 10.1111/j.1471-4159.2007.05020.x; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; Schoser BGH, 2002, ACTA NEUROL SCAND, V105, P309, DOI 10.1034/j.1600-0404.2002.1o104.x; SHORER Z, 1995, J CHILD NEUROL, V10, P472, DOI 10.1177/088307389501000610; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; VanSaun Michael N., 2006, Birth Defects Research, V78, P69, DOI 10.1002/bdrc.20061; Vilquin JT, 2000, NEUROMUSCULAR DISORD, V10, P59, DOI 10.1016/S0960-8966(99)00056-5; Weijzen S, 1999, LEUKEMIA, V13, P502, DOI 10.1038/sj.leu.2401367; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297	49	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18049	10.1371/journal.pone.0018049	http://dx.doi.org/10.1371/journal.pone.0018049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445359	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100025
J	Shiroiwa, Y; Hayashi, T; Fujita, Y; Villar-Briones, A; Ikai, N; Takeda, K; Ebe, M; Yanagida, M				Shiroiwa, Yoshiharu; Hayashi, Takeshi; Fujita, Yohta; Villar-Briones, Alejandro; Ikai, Nobuyasu; Takeda, Kojiro; Ebe, Masahiro; Yanagida, Mitsuhiro			Mis17 Is a Regulatory Module of the Mis6-Mal2-Sim4 Centromere Complex That Is Required for the Recruitment of CenH3/CENP-A in Fission Yeast	PLOS ONE			English	Article							CELL-DIVISION CYCLE; CENP-A NUCLEOSOMES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; PROTEIN-KINASES; BUDDING YEAST; OUTER KINETOCHORE; GROWTH POLARITY; GENETIC-CONTROL	Background: The centromere is the chromosome domain on which the mitotic kinetochore forms for proper segregation. Deposition of the centromeric histone H3 (CenH3, CENP-A) is vital for the formation of centromere-specific chromatin. The Mis6-Mal2-Sim4 complex of the fission yeast S. pombe is required for the recruitment of CenH3 (Cnp1), but its function remains obscure. Methodology/Principal Findings: Mass spectrometry was performed on the proteins precipitated with Mis6- and Mis17-FLAG. The results together with the previously identified Sim4- and Mal2-TAP precipitated proteins indicated that the complex contains 12 subunits, Mis6, Sim4, Mal2, Mis15, Mis17, Cnl2, Fta1-4, Fta6-7, nine of which have human centromeric protein (CENP) counterparts. Domain dissection indicated that the carboxy-half of Mis17 is functional, while its amino-half is regulatory. Overproduction of the amino-half caused strong negative dominance, which led to massive chromosome missegregation and hypersensitivity to the histone deacetylase inhibitor TSA. Mis17 was hyperphosphorylated and overproduction-induced negative dominance was abolished in six kinase-deletion mutants, ssp2 (AMPK), ppk9 (AMPK), ppk15 (Yak1), ppk30 (Ark1), wis4 (Ssk2), and lsk1 (P-TEFb). Conclusions: Mis17 may be a regulatory module of the Mis6 complex. Negative dominance of the Mis17 fragment is exerted while the complex and CenH3 remain at the centromere, a result that differs from the mislocalization seen in the mis17-362 mutant. The known functions of the kinases suggest an unexpected link between Mis17 and control of the cortex actin, nutrition, and signal/transcription. Possible interpretations are discussed.	[Shiroiwa, Yoshiharu; Hayashi, Takeshi; Fujita, Yohta; Ikai, Nobuyasu; Ebe, Masahiro; Yanagida, Mitsuhiro] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan; [Hayashi, Takeshi; Villar-Briones, Alejandro; Takeda, Kojiro; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Promot Corp, Okinawa, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University	Shiroiwa, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan.	yanagida@kozo.lif.kyoto-ac.jp		Villar-Briones, Alejandro/0000-0002-4246-3877	Japan Science and Technology Corporation (JST); Okinawa Institute of Science and Technology	Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University)	The present work was supported by grants from the Japan Science and Technology Corporation (JST, CREST research project; http://www.jst.go.jp/kisoken/crest/en/index.html) and from the Initial Research Project for the Okinawa Institute of Science and Technology (http://www.oist.jp/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; CLARKE L, 1985, ANNU REV GENET, V19, P29, DOI 10.1146/annurev.ge.19.120185.000333; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hayashi A, 2006, MOL BIOL CELL, V17, P5173, DOI 10.1091/mbc.E06-05-0388; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kabir MA, 2005, YEAST, V22, P219, DOI 10.1002/yea.1210; Karagiannis J, 2005, MOL BIOL CELL, V16, P358, DOI 10.1091/mbc.E04-06-0502; Karagiannis J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000433; Kimata Y, 2008, J CELL SCI, V121, P1107, DOI 10.1242/jcs.024224; Koyano T, 2010, BIOSCI BIOTECH BIOCH, V74, P1129, DOI 10.1271/bbb.100223; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; SPENCER F, 1990, GENETICS, V124, P237; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Toda T, 1996, J CELL SCI, V109, P2331; Tsuduki T, 2006, MOL CELL BIOL, V26, P7682, DOI 10.1128/MCB.00355-06; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yanagida M, 2005, PHILOS T R SOC B, V360, P609, DOI 10.1098/rstb.2004.1615; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004	61	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17761	10.1371/journal.pone.0017761	http://dx.doi.org/10.1371/journal.pone.0017761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445296	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300013
J	Crosio, C; Valle, C; Casciati, A; Iaccarino, C; Carri, MT				Crosio, Claudia; Valle, Cristiana; Casciati, Arianna; Iaccarino, Ciro; Carri, Maria Teresa			Astroglial Inhibition of NF-kappa B Does Not Ameliorate Disease Onset and Progression in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; REACTIVE ASTROCYTES; TRANSGENIC INHIBITION; INNATE IMMUNITY; NERVOUS-SYSTEM; CELL-DEATH; INFLAMMATION; EXPRESSION; SURVIVAL; ABLATION	Motor neuron death in amyotrophic lateral sclerosis (ALS) is considered a "non-cell autonomous" process, with astrocytes playing a critical role in disease progression. Glial cells are activated early in transgenic mice expressing mutant SOD1, suggesting that neuroinflammation has a relevant role in the cascade of events that trigger the death of motor neurons. An inflammatory cascade including COX2 expression, secretion of cytokines and release of NO from astrocytes may descend from activation of a NF-kappa B-mediated pathway observed in astrocytes from ALS patients and in experimental models. We have attempted rescue of transgenic mutant SOD1 mice through the inhibition of the NF-kappa B pathway selectively in astrocytes. Here we show that despite efficient inhibition of this major pathway, double transgenic mice expressing the mutant SOD1(G93A) ubiquitously and the dominant negative form of I kappa B alpha (I kappa B alpha AA) in astrocytes under control of the GFAP promoter show no benefit in terms of onset and progression of disease. Our data indicate that motor neuron death in ALS cannot be prevented by inhibition of a single inflammatory pathway because alternative pathways are activated in the presence of a persistent toxic stimulus.	[Crosio, Claudia; Iaccarino, Ciro] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy; [Crosio, Claudia; Valle, Cristiana; Casciati, Arianna; Iaccarino, Ciro; Carri, Maria Teresa] Fdn Santa Lucia IRCCS, CERC, Rome, Italy; [Valle, Cristiana] CNR, Cell Biol & Neurobiol Inst, Monterotondo, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Sassari; IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata	Crosio, C (corresponding author), Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy.	ccrosio@uniss.it	valle, cristiana/J-7302-2018; Carri, Maria Teresa/K-5480-2016	valle, cristiana/0000-0002-0914-6511; Carri, Maria Teresa/0000-0002-1789-1546	Telethon [GGP07018]; Sisal	Telethon(Fondazione Telethon); Sisal	This work was supported by Telethon (GGP07018) and Sisal to M.T.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Aggarwal S, 2008, NEUROTHERAPEUTICS, V5, P516, DOI 10.1016/j.nurt.2008.08.002; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAMPER SA, 1987, BIOTECHNIQUES, V5, P638; Carri MT, 2006, TRENDS PHARMACOL SCI, V27, P267, DOI 10.1016/j.tips.2006.03.009; Casciati A, 2002, J NEUROCHEM, V83, P1019, DOI 10.1046/j.1471-4159.2002.01232.x; Cereda C, 2008, J NEUROIMMUNOL, V194, P123, DOI 10.1016/j.jneuroim.2007.10.028; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferri A, 2004, FASEB J, V18, P1261, DOI 10.1096/fj.03-1199fje; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Juttler E, 2007, J NEUROIMMUNOL, V189, P41, DOI 10.1016/j.jneuroim.2007.06.020; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KEILHOFF G, 1991, NEUROSCIENCE, V43, P35, DOI 10.1016/0306-4522(91)90414-J; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Li B, 2008, BRAIN RES, V1226, P199, DOI 10.1016/j.brainres.2008.06.024; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Migheli A, 1997, J NEUROPATH EXP NEUR, V56, P1314, DOI 10.1097/00005072-199712000-00006; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; MUCKE L, 1991, NEW BIOL, V3, P465; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Nolte C, 2001, GLIA, V33, P72; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Phulwani NK, 2008, J IMMUNOL, V181, P3841, DOI 10.4049/jimmunol.181.6.3841; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Staats KA, 2009, J BIOL PHYS, V35, P337, DOI 10.1007/s10867-009-9141-4; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TOLOSA L, 2010, MOL CELL NEUROSCI; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; WANG L, 2010, HUM MOL GENET; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004	61	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17187	10.1371/journal.pone.0017187	http://dx.doi.org/10.1371/journal.pone.0017187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445241	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100011
J	Ria, M; Lagercrantz, J; Samnegard, A; Boquist, S; Hamsten, A; Eriksson, P				Ria, Massimiliano; Lagercrantz, Jacob; Samnegard, Ann; Boquist, Susanna; Hamsten, Anders; Eriksson, Per			A Common Polymorphism in the Promoter Region of the TNFSF4 Gene Is Associated with Lower Allele-Specific Expression and Risk of Myocardial Infarction	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED T-CELLS; OX40 LIGAND; MAST-CELLS; ATHEROSCLEROSIS SUSCEPTIBILITY; RECEPTOR; TRANSCRIPTION; POPULATION; MICE; DIFFERENTIATION	Background: The TNFSF4/TNFRSF4 system, along with several other receptor-ligand pairs, is involved in the recruitment and activation of T-cells and is therefore tentatively implicated in atherosclerosis and acute coronary syndromes. We have previously shown that genetic variants in TNFSF4 are associated with myocardial infarction (MI) in women. This prompted functional studies of TNFSF4 expression. Methods and Results: Based on a screening of the TNFSF4 genomic region, a promoter polymorphism (rs45454293) and a haplotype were identified, conceivably involved in gene regulation. The rs45454293T-allele, in agreement with the linked rs3850641G-allele, proved to be associated with increased risk of MI in women. Haplotype-specific chromatin immunoprecipitation of activated polymerase II, as a measure of transcriptional activity in vivo, suggested that the haplotype including the rs45454293 and rs3850641 polymorphisms is functionally important, the rs45454293T- and rs3850641G-alleles being associated with lower transcriptional activity in cells heterozygous for both polymorphisms. The functional role of rs45454293 on transcriptional levels of TNFSF4 was clarified by luciferase reporter assays, where the rs45454293T-allele decreased gene expression when compared with the rs45454293C-allele, while the rs3850641 SNP did not have any effect on TNFSF4 promoter activity. Electromobility shift assay showed that the rs45454293 polymorphism, but not rs3850641, affects the binding of nuclear factors, thus suggesting that the lower transcriptional activity is attributed to binding of one or more transcriptional repressor(s) to the T-allele. Conclusions: Our data indicate that the TNFSF4 rs45454293T-allele is associated with lower TNFSF4 expression and increased risk of MI.	[Ria, Massimiliano; Lagercrantz, Jacob; Boquist, Susanna; Hamsten, Anders; Eriksson, Per] Karolinska Univ Hosp Solna, Atherosclerosis Res Unit, Ctr Mol Med, Dept Med, Stockholm, Sweden; [Samnegard, Ann] Danderyd Hosp, Div Cardiovasc Med, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Ria, M (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.	massimiliano.ria@well.ox.ac.uk		Eriksson, Per/0000-0002-5635-2692	Swedish Heart-Lung foundation; Swedish Medical Research Council [8691, 12660]; European Commission [LSHM-CT-2007-037273]; K&A Wallenberg Foundation; Leducq Foundation; AFA insurance; King Gustaf V 80th Birthday foundation; Stockholm County Council [550210, 560183]	Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leducq Foundation(Leducq Foundation); AFA insurance; King Gustaf V 80th Birthday foundation; Stockholm County Council(Stockholm County Council)	This study was supported by grants from the Swedish Heart-Lung foundation, the Swedish Medical Research Council (8691, 12660), the European Commission (LSHM-CT-2007-037273), the K&A Wallenberg Foundation, the Leducq Foundation, AFA insurance, the King Gustaf V 80th Birthday foundation and the Stockholm County Council (projects 550210 and 560183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKSNIS M, 1991, J BIOL CHEM, V266, P10078; Andersen MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040005; [Anonymous], 2004, SCIENCE, V306, P636; Barbaro M, 2009, EUR J HUM GENET, V17, P1439, DOI 10.1038/ejhg.2009.70; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; Dehbi M, 1996, ONCOGENE, V13, P447; DUBOIS PC, NAT GENET, V42, P295; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hikami K, 2000, GENES IMMUN, V1, P521, DOI 10.1038/sj.gene.6363709; Holmberg K, 2005, CLIN CHEM, V51, P1549, DOI 10.1373/clinchem.2005.049932; Hori T, 2006, INT J HEMATOL, V83, P17, DOI 10.1532/IJH97.05151; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; KALB VF, 1977, ANAL BIOCHEM, V82, P362, DOI 10.1016/0003-2697(77)90173-7; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Koch W, 2008, NAT GENET, V40, P1386, DOI 10.1038/ng1208-1386; Malarstig A, 2008, CLIN CHEM, V54, P833, DOI 10.1373/clinchem.2007.096479; Nishimoto H, 2005, BLOOD, V106, P4241, DOI 10.1182/blood-2005-04-1358; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; QIAO JH, 1994, ARTERIOSCLER THROMB, V14, P1480, DOI 10.1161/01.ATV.14.9.1480; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Samnegard A, 2005, J INTERN MED, V258, P411, DOI 10.1111/j.1365-2796.2005.01561.x; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stopfer P, 2004, J IMMUNOL, V172, P7459, DOI 10.4049/jimmunol.172.12.7459; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; van Wanrooij EJA, 2007, ARTERIOSCL THROM VAS, V27, P204, DOI 10.1161/01.ATV.0000251007.07648.81; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Weinberg AD, 2002, TRENDS IMMUNOL, V23, P102, DOI 10.1016/S1471-4906(01)02127-5; Whatling C, 2004, J LIPID RES, V45, P1768, DOI 10.1194/jlr.M400195-JLR200; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhu CY, 2006, BIOCHEM BIOPH RES CO, V348, P1150, DOI 10.1016/j.bbrc.2006.07.174	36	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17652	10.1371/journal.pone.0017652	http://dx.doi.org/10.1371/journal.pone.0017652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445270	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100024
J	Thulin, E; Kesvatera, T; Linse, S				Thulin, Eva; Kesvatera, Tonu; Linse, Sara			Molecular Determinants of S100B Oligomer Formation	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NEGATIVE REGULATORY DOMAIN; NMR-SPECTROSCOPY; RAGE ACTIVATION; PROTEINS; BINDING; P53; S100B(BETA-BETA); BRAIN; EXPRESSION	Background: S100B is a dimeric protein that can form tetramers, hexamers and higher order oligomers. These forms have been suggested to play a role in RAGE activation. Methodology/Principal Findings: Oligomerization was found to require a low molecular weight trigger/cofactor and could not be detected for highly pure dimer, irrespective of handling. Imidazol was identified as a substance that can serve this role. Oligomerization is dependent on both the imidazol concentration and pH, with optima around 90 mM imidazol and pH 7, respectively. No oligomerization was observed above pH 8, thus the protonated form of imidazol is the active species in promoting assembly of dimers to higher species. However, disulfide bonds are not involved and the process is independent of redox potential. The process was also found to be independent of whether Ca2+ is bound to the protein or not. Tetramers that are purified from dimers and imidazol by gel filtration are kinetically stable, but dissociate into dimers upon heating. Dimers do not revert to tetramer and higher oligomer unless imidazol is again added. Both tetramers and hexamers bind the target peptide from p53 with retained stoichiometry of one peptide per S100B monomer, and with high affinity (lgK = 7.3 +/- 0.2 and 7.2 +/- 0.2, respectively in 10 mM BisTris, 5 mM CaCl2, pH 7.0), which is less than one order of magnitude reduced compared to dimer under the same buffer conditions. Conclusion/Significance: S100B oligomerization requires protonated imidazol as a trigger/cofactor. Oligomers are kinetically stable after imidazol is removed but revert back to dimer if heated. The results underscore the importance of kinetic versus thermodynamic control of S100B protein aggregation.	[Thulin, Eva; Linse, Sara] Lund Univ, Dept Biochem, Lund, Sweden; [Kesvatera, Tonu] NICPB, Bioorgan Chem Lab, Tallinn, Estonia	Lund University; National Institute of Chemical Physics & Biophysics (NICPB)	Thulin, E (corresponding author), Lund Univ, Dept Biochem, Lund, Sweden.	sara.linse@biochemistry.lu.se		Linse, Sara/0000-0001-9629-7109	Swedish Research Council, VR; Crafoord Foundation; Estonian Ministry of Education and Research	Swedish Research Council, VR(Swedish Research Council); Crafoord Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the Swedish Research Council, VR (SL), the Crafoord Foundation ( SL) and Estonian Ministry of Education and Research (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Drohat AC, 1996, BIOCHEMISTRY-US, V35, P11577, DOI 10.1021/bi9612226; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; Ferguson PL, 2004, J BIOL CHEM, V279, P18806, DOI 10.1074/jbc.M313948200; Hakansson M, 2001, PROTEIN SCI, V10, P927, DOI 10.1110/ps.47501; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; Jonsson H, 2003, RESTOR NEUROL NEUROS, V21, P151; Kilby PM, 1996, STRUCTURE, V4, P1041, DOI 10.1016/S0969-2126(96)00111-6; Kilby PM, 1997, PROTEIN SCI, V6, P2494; Laan W, 2006, BIOCHEMISTRY-US, V45, P51, DOI 10.1021/bi051367p; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Smith SP, 1996, BIOCHEMISTRY-US, V35, P8805, DOI 10.1021/bi952698c; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Wilder PT, 2005, BIOCHEMISTRY-US, V44, P5690, DOI 10.1021/bi0475830; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14768	10.1371/journal.pone.0014768	http://dx.doi.org/10.1371/journal.pone.0014768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445240	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100004
J	Kaiser, R; Bunnell, R; Hightower, A; Kim, AA; Cherutich, P; Mwangi, M; Oluoch, T; Dadabhai, S; Mureithi, P; Mugo, N; Mermin, J				Kaiser, Reinhard; Bunnell, Rebecca; Hightower, Allen; Kim, Andrea A.; Cherutich, Peter; Mwangi, Mary; Oluoch, Tom; Dadabhai, Sufia; Mureithi, Patrick; Mugo, Nelly; Mermin, Jonathan		KAIS Study Grp	Factors Associated with HIV Infection in Married or Cohabitating Couples in Kenya: Results from a Nationally Representative Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MALE CIRCUMCISION; VIRAL LOAD; DISCORDANT COUPLES; CONTROLLED-TRIAL; UGANDA; TRANSMISSION; PREVENTION; MEN; ACQUISITION	Background: In order to inform prevention programming, we analyzed HIV discordance and concordance within couples in the Kenya AIDS Indicator Survey (KAIS) 2007. Methods: KAIS was a nationally representative population-based sero-survey that examined demographic and behavioral indicators and serologic testing for HIV, HSV-2, syphilis, and CD4 cell counts in 15,853 consenting adults aged 15-64 years. We analyzed interview and blood testing data at the sexual partnership level from married or cohabitating couples. Multivariable regression models were used to identify factors independently associated with HIV discordant and concordant status. Results: Of 3256 couples identified in the survey, 2748 (84.4%) had interview and blood testing data. Overall, 3.8% of couples were concordantly infected with HIV, and in 5.8% one partner was infected, translating to 338,000 discordant couples in Kenya. In 83.6% of HIV-infected Kenyans living in married or cohabitating couples neither partner knew their HIV status. Factors independently associated with HIV-discordance included young age in women (AOR 1.5, 95% CI: 1.2-1.8; p<0.0001), increasing number of lifetime sexual partners in women (AOR 1.5, 95% CI: 1.3-1.8; p<0.0001), HSV-2 infection in either or both partners (AOR 4.1, 95% CI: 2.3-7.2; p<0.0001), and lack of male circumcision (AOR 1.6, 95% CI: 1.0-2.5; p = 0.032). Independent factors for HIV-concordance included HSV-2 infection in both partners (AOR 6.5, 95% CI: 2.3-18.7; p = 0.001) and lack of male circumcision (AOR 1.8, 95% CI: 1.0-3.3; p = 0.043). Conclusions: Couple prevention interventions should begin early in relationships and include mutual knowledge of HIV status, reduction of outside sexual partners, and promotion of male circumcision among HIV-uninfected men. Mechanisms for effective prevention or suppression of HSV-2 infection are also needed.	[Kaiser, Reinhard; Bunnell, Rebecca; Hightower, Allen; Mwangi, Mary; Oluoch, Tom; Mermin, Jonathan] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Nairobi, Kenya; [Kim, Andrea A.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Cherutich, Peter] Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya; [Dadabhai, Sufia] Univ California San Francisco, Nairobi, Kenya; [Mureithi, Patrick] Natl AIDS Control Council NACC, Nairobi, Kenya; [Mugo, Nelly] Kenyatta Natl Hosp, Nairobi, Kenya; [Mugo, Nelly] Univ Nairobi, Nairobi, Kenya; [Bunnell, Rebecca] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Adult & Community Hlth, Atlanta, GA USA; [Hightower, Allen] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Nairobi, Kenya; [Mermin, Jonathan] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kenyatta National Hospital; University of Nairobi; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kaiser, R (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Nairobi, Kenya.	rkaiser@ke.cdc.gov	Oluoch, Tom/AGH-4170-2022; Oluoch, Tom/GPC-5771-2022; Mermin, Jonathan/J-9847-2012	Kim, Evelyn/0000-0002-9650-2093; Oluoch, Tom/0000-0001-9621-5900; Makokha, Ernest/0000-0002-3035-2491	Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention (CDC), Department of Health and Human Services	Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention (CDC), Department of Health and Human Services(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding: This study was funded through the United States President's Emergency Plan for AIDS Relief, through the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Several authors are employees of CDC and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; [Anonymous], REP GLOB AIDS EP 200; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baleta A, 2010, LANCET, V376, P320, DOI 10.1016/S0140-6736(10)61123-3; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Bunnell R, 2008, LANCET, V371, P2148, DOI 10.1016/S0140-6736(08)60929-0; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; CELUM C, 2010, N ENGL J MED; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; DONNELL D, 2010, C RETR OPP INF SAN F; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; NASCOP (National AIDS/ STI Control Programme) Kenya, 2009, KEN AIDS IND SURV; Olley BO, 2005, AIDS CARE, V17, P1, DOI 10.1080/095401204123315089; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, 2007, GUID PROV IN HIV TES	30	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17842	10.1371/journal.pone.0017842	http://dx.doi.org/10.1371/journal.pone.0017842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423615	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900037
J	Darling, JA				Darling, John A.			Interspecific Hybridization and Mitochondrial Introgression in Invasive Carcinus Shore Crabs	PLOS ONE			English	Article							EUROPEAN GREEN CRAB; GENETIC-VARIATION; MULTIPLE INTRODUCTIONS; EVOLUTIONARY GENETICS; POPULATION-STRUCTURE; ADAPTIVE EVOLUTION; RANGE EXPANSION; MAENAS; HISTORY; SUCCESS	Interspecific hybridization plays an important role in facilitating adaptive evolutionary change. More specifically, recent studies have demonstrated that hybridization may dramatically influence the establishment, spread, and impact of invasive populations. In Japan, previous genetic evidence for the presence of two non-native congeners, the European green crab Carcinus maenas and the Mediterranean green crab C. aestuarii, has raised questions regarding the possibility of hybridization between these sister species. Here I present analysis based on both nuclear microsatellites and the mitochondrial cytochrome C oxidase subunit I (COI) gene which unambiguously argues for a hybrid origin of Japanese Carcinus. Despite the presence of mitochondrial lineages derived from both C. maenas and C. aestuarii, the Japanese population is panmictic at nuclear loci and has achieved cytonuclear equilibrium throughout the sampled range in Japan. Furthermore, analysis of admixture at nuclear loci indicates dramatic introgression of the C. maenas mitochondrial genome into a predominantly C. aestuarii nuclear background. These patterns, along with inferences drawn from the observational record, argue for a hybridization event pre-dating the arrival of Carcinus in Japan. The clarification of both invasion history and evolutionary history afforded by genetic analysis provides information that may be critically important to future studies aimed at assessing risks posed by invasive Carcinus populations to Japan and the surrounding region.	US EPA, Mol Ecol Res Branch, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	United States Environmental Protection Agency	Darling, JA (corresponding author), US EPA, Mol Ecol Res Branch, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	darling.john@epa.gov	Darling, John/B-5451-2014	Darling, John/0000-0002-4776-9533	Office of Research and Development; EPA Region 9; EPA Region 10	Office of Research and Development; EPA Region 9; EPA Region 10	This work was funded in part through an internal EPA Regional Applied Research Effort between Office of Research and Development and EPA Regions 9 and 10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bagley MJ, 2000, MARINE BIOINVASIONS, P241; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basten CJ, 1997, GENETICS, V146, P1165; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; BERRILL M, 1982, B MAR SCI, V32, P632; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Carlton JT, 2003, J BIOGEOGR, V30, P1809, DOI 10.1111/j.1365-2699.2003.00962.x; Chan KMA, 2005, EVOLUTION, V59, P720; Chen RB, 2004, FISHERIES SCI, V70, P430, DOI 10.1111/j.1444-2906.2004.00822.x; Clark PF, 2001, J CRUSTACEAN BIOL, V21, P288, DOI 10.1651/0278-0372(2001)021[0288:AMAORV]2.0.CO;2; Compton TJ, 2010, DIVERS DISTRIB, V16, P243, DOI 10.1111/j.1472-4642.2010.00644.x; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Davidson SK, 1999, BIOL BULL, V196, P273, DOI 10.2307/1542952; DEMEUSY N, 1953, CR HEBD ACAD SCI, V236, P1088; Derivera CE, 2007, MAR BIOL, V150, P1275, DOI 10.1007/s00227-006-0451-9; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hall RJ, 2009, BIOL INVASIONS, V11, P1217, DOI 10.1007/s10530-008-9387-y; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Holsbeek G, 2008, MOL ECOL, V17, P5023, DOI 10.1111/j.1365-294X.2008.03984.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufbauer RA, 2008, DIVERS DISTRIB, V14, P252, DOI 10.1111/j.1472-4642.2007.00424.x; Koike F, 2011, BIOL INVASIONS, V13, P459, DOI 10.1007/s10530-010-9841-5; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2007, MOL ECOL, V16, P1579, DOI 10.1111/j.1365-294X.2006.03135.x; Largiader Carlo R., 2007, V193, P275; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; RAYMOND M, GENEPOP POPULATION G; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; See KE, 2010, BIOL INVASIONS, V12, P1305, DOI 10.1007/s10530-009-9548-7; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tepolt CK, 2006, MOL ECOL NOTES, V6, P343, DOI 10.1111/j.1471-8286.2006.01226.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vellend M, 2007, TRENDS ECOL EVOL, V22, P481, DOI 10.1016/j.tree.2007.02.017; Vila M., 2000, BIOL INVASIONS, V2, P207, DOI DOI 10.1023/A:1010003603310; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wissemann V, 2007, SYST BIODIVERS, V5, P243, DOI 10.1017/S1477200007002381; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Yamada SB, 2001, J SHELLFISH RES, V20, P905; Yamada SB, 2000, GLOBAL INVADER EUROP	66	31	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17828	10.1371/journal.pone.0017828	http://dx.doi.org/10.1371/journal.pone.0017828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423759	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400031
J	Schiappacassi, M; Lovisa, S; Lovat, F; Fabris, L; Colombatti, A; Belletti, B; Baldassarre, G				Schiappacassi, Monica; Lovisa, Sara; Lovat, Francesca; Fabris, Linda; Colombatti, Alfonso; Belletti, Barbara; Baldassarre, Gustavo			Role of T198 Modification in the Regulation of p27(Kip1) Protein Stability and Function	PLOS ONE			English	Article							DEPENDENT DEGRADATION; INHIBITOR P27(KIP1); CDK INHIBITOR; PHOSPHORYLATION; CYCLE; MIGRATION; P27; UBIQUITINATION; STATHMIN; CASPASE	The tumor suppressor gene p27(Kip1) plays a fundamental role in human cancer progression. Its expression and/or functions are altered in almost all the different tumor histotype analyzed so far. Recently, it has been demonstrated that the tumor suppression function of p27 resides not only in the ability to inhibit Cyclins/CDKs complexes through its N-terminal domain but also in the capacity to modulate cell motility through its C-terminal portion. Particular interest has been raised by the last amino-acid, ( Threonine 198) in the regulation of both protein stability and cell motility. Here, we describe that the presence of Threonine in position 198 is of primary importance for the regulation of the protein stability and for the control of cell motility. However, while the control of cell motility is dependent on the phosphorylation of T198, the stability of the protein is specifically controlled by the steric hindrance of the last amino acid. The effects of T198 modification on protein stability are not linked to the capacity of p27 to bind Cyclins/CDKs complexes and/or the F-box protein Skp2. Conversely, our results support the hypothesis that conformational changes in the disordered structure of the C-terminal portion of p27 are important in its ability to be degraded via a proteasome-dependent mechanism. On the other hand T198 phosphorylation favors p27/stathmin interaction eventually contributing to the regulation of cell motility, supporting the hypothesis that the presence of T198 is fundamental for the regulation of p27 functions.	[Schiappacassi, Monica; Lovisa, Sara; Lovat, Francesca; Fabris, Linda; Colombatti, Alfonso; Belletti, Barbara; Baldassarre, Gustavo] Natl Canc Inst, Div Expt Oncol 2, Ctr Riferimento Oncol, Aviano, Italy	IRCCS Aviano (CRO)	Schiappacassi, M (corresponding author), Natl Canc Inst, Div Expt Oncol 2, Ctr Riferimento Oncol, Aviano, Italy.	gbaldassarre@cro.it	Belletti, Barbara/J-2028-2018; Schiappacassi, Monica/AAX-5505-2020; Lovisa, Sara/AAB-1141-2020; Baldassarre, Gustavo/K-1350-2016	Belletti, Barbara/0000-0003-2249-0285; Schiappacassi, Monica/0000-0003-4804-4291; Lovisa, Sara/0000-0001-7776-2896; Baldassarre, Gustavo/0000-0002-9750-8825; colombatti, alfonso/0000-0002-3676-2379	AICR [06-0319]	AICR	This work is supported by AICR grant 06-0319 to GB (http://www.aicr.org.uk/index.stm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Belletti B, 2005, CURR MED CHEM, V12, P1589, DOI 10.2174/0929867054367149; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Berton S, 2009, MOL CELL BIOL, V29, P5031, DOI 10.1128/MCB.00144-09; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Frost V, 2001, ONCOGENE, V20, P2737, DOI 10.1038/sj.onc.1204367; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Medina-Palazon C, 2004, EUR J BIOCHEM, V271, P2716, DOI 10.1111/j.1432-1033.2004.04200.x; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Molatore S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-116; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Motti ML, 2004, CELL CYCLE, V3, P1074; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Schiappacassi M, 2008, MOL CANCER THER, V7, P1164, DOI 10.1158/1535-7163.MCT-07-2154; Tang PP, 2002, CELL SIGNAL, V14, P961, DOI 10.1016/S0898-6568(02)00043-8; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006	40	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17673	10.1371/journal.pone.0017673	http://dx.doi.org/10.1371/journal.pone.0017673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423803	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400019
J	Mouillot, D; Villeger, S; Scherer-Lorenzen, M; Mason, NWH				Mouillot, David; Villeger, Sebastien; Scherer-Lorenzen, Michael; Mason, Norman W. H.			Functional Structure of Biological Communities Predicts Ecosystem Multifunctionality	PLOS ONE			English	Article							PLANT DIVERSITY; GRASSLAND COMMUNITIES; EUROPEAN GRASSLANDS; CURRENT KNOWLEDGE; SPECIES RICHNESS; FISH COMMUNITIES; BIODIVERSITY; PRODUCTIVITY; EVENNESS; BIOMASS	The accelerating rate of change in biodiversity patterns, mediated by ever increasing human pressures and global warming, demands a better understanding of the relationship between the structure of biological communities and ecosystem functioning (BEF). Recent investigations suggest that the functional structure of communities, i.e. the composition and diversity of functional traits, is the main driver of ecological processes. However, the predictive power of BEF research is still low, the integration of all components of functional community structure as predictors is still lacking, and the multifunctionality of ecosystems (i.e. rates of multiple processes) must be considered. Here, using a multiple-processes framework from grassland biodiversity experiments, we show that functional identity of species and functional divergence among species, rather than species diversity per se, together promote the level of ecosystem multifunctionality with a predictive power of 80%. Our results suggest that primary productivity and decomposition rates, two key ecosystem processes upon which the global carbon cycle depends, are primarily sustained by specialist species, i.e. those that hold specialized combinations of traits and perform particular functions. Contrary to studies focusing on single ecosystem functions and considering species richness as the sole measure of biodiversity, we found a linear and non-saturating effect of the functional structure of communities on ecosystem multifunctionality. Thus, sustaining multiple ecological processes would require focusing on trait dominance and on the degree of community specialization, even in species-rich assemblages.	[Mouillot, David] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France; [Villeger, Sebastien] Univ Toulouse 3, Lab Evolut & Diversite Biol, UMR 5174, F-31062 Toulouse, France; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol Geobot, Freiburg, Germany; [Mason, Norman W. H.] Landcare Res, Hamilton, New Zealand	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Freiburg; Landcare Research - New Zealand	Mouillot, D (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France.	david.mouillot@univ-montp2.fr	Scherer-Lorenzen, Michael/AGB-4140-2022; Villéger, Sébastien/AAW-9949-2021; Villéger, Sébastien/C-6272-2011	Scherer-Lorenzen, Michael/0000-0001-9566-590X; Villéger, Sébastien/0000-0002-2362-7178; Villéger, Sébastien/0000-0002-2362-7178	European Commission [ENV-CT95-0008]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The BIODEPTH project ran from 1996 to 1998 and was funded by the European Commission within the Framework IV Environment and Climate programme (ENV-CT95-0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BURNHAM KP, 1998, MODEL SELECTION INFO; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fox J, 2008, APPL REGRESSION ANAL; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Heisse K, 2007, OECOLOGIA, V152, P435, DOI 10.1007/s00442-007-0666-6; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jenny H., 1941, FACTORS SOIL FORMATI; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Posada JM, 2009, ANN BOT-LONDON, V103, P795, DOI 10.1093/aob/mcn265; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Sonohat G, 2002, PLANT CELL ENVIRON, V25, P529, DOI 10.1046/j.1365-3040.2002.00833.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Stevens MHH, 2001, OIKOS, V92, P291, DOI 10.1034/j.1600-0706.2001.920211.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	57	286	306	14	259	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17476	10.1371/journal.pone.0017476	http://dx.doi.org/10.1371/journal.pone.0017476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423747	gold, Green Submitted, Green Published			2022-12-25	WOS:000288219100009
J	McKinney, SM; Thien, TDV; Buxton, OM; Solet, JM; Ellenbogen, JM				McKinney, Scott M.; Thien Thanh Dang-Vu; Buxton, Orfeu M.; Solet, Jo M.; Ellenbogen, Jeffrey M.			Covert Waking Brain Activity Reveals Instantaneous Sleep Depth	PLOS ONE			English	Article							AROUSAL THRESHOLD; ALPHA OSCILLATIONS; EEG; PERFORMANCE; FREQUENCY; COHERENCE; POWER; FLUCTUATIONS; ALERTNESS; DYNAMICS	The neural correlates of the wake-sleep continuum remain incompletely understood, limiting the development of adaptive drug delivery systems for promoting sleep maintenance. The most useful measure for resolving early positions along this continuum is the alpha oscillation, an 8-13 Hz electroencephalographic rhythm prominent over posterior scalp locations. The brain activation signature of wakefulness, alpha expression discloses immediate levels of alertness and dissipates in concert with fading awareness as sleep begins. This brain activity pattern, however, is largely ignored once sleep begins. Here we show that the intensity of spectral power in the alpha band actually continues to disclose instantaneous responsiveness to noise-a measure of sleep depth-throughout a night of sleep. By systematically challenging sleep with realistic and varied acoustic disruption, we found that sleepers exhibited markedly greater sensitivity to sounds during moments of elevated alpha expression. This result demonstrates that alpha power is not a binary marker of the transition between sleep and wakefulness, but carries rich information about immediate sleep stability. Further, it shows that an empirical and ecologically relevant form of sleep depth is revealed in real-time by EEG spectral content in the alpha band, a measure that affords prediction on the order of minutes. This signal, which transcends the boundaries of classical sleep stages, could potentially be used for real-time feedback to novel, adaptive drug delivery systems for inducing sleep.	[McKinney, Scott M.; Thien Thanh Dang-Vu; Ellenbogen, Jeffrey M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Thien Thanh Dang-Vu; Buxton, Orfeu M.; Solet, Jo M.; Ellenbogen, Jeffrey M.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Thien Thanh Dang-Vu] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Buxton, Orfeu M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Solet, Jo M.] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Liege; Harvard University; Brigham & Women's Hospital; Harvard University; Cambridge Health Alliance	McKinney, SM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	jeffrey_ellenbogen@hms.harvard.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604; Dang Vu, Thien Thanh/0000-0002-7235-2721; Buxton, Orfeu/0000-0001-5057-633X	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design; Massachusetts General Hospital	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design; Massachusetts General Hospital(General Electric)	This study was funded by the Academy of Architecture for Health, the Facilities Guidelines Institute, the Center for Health Design, and the Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1998, J SLEEP RES, V7, P36, DOI 10.1046/j.1365-2869.7.s1.6.x; AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Asyali MH, 2007, COMPUT BIOL MED, V37, P1600, DOI 10.1016/j.compbiomed.2007.03.001; BEATTY J, 1974, SCIENCE, V183, P871, DOI 10.1126/science.183.4127.871; BELYAVIN A, 1987, ELECTROEN CLIN NEURO, V66, P137, DOI 10.1016/0013-4694(87)90183-0; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BONNET MH, 1978, PSYCHOPHYSIOLOGY, V15, P412, DOI 10.1111/j.1469-8986.1978.tb01407.x; BORBELY AA, 1985, HUM NEUROBIOL, V4, P189; BRUNNER DP, 1991, PSYCHOPHARMACOLOGY, V104, P1, DOI 10.1007/BF02244546; BUSBY KA, 1994, PSYCHOPHYSIOLOGY, V31, P182, DOI 10.1111/j.1469-8986.1994.tb01038.x; Cantero JL, 1999, NEUROSCI LETT, V271, P167, DOI 10.1016/S0304-3940(99)00565-0; Cantero JL, 1999, NEUROPSYCHOBIOLOGY, V39, P110, DOI 10.1159/000026569; Cantero JL, 2002, NEUROPHYSIOL CLIN, V32, P54, DOI 10.1016/S0987-7053(01)00289-1; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; GATH I, 1983, INT J NEUROSCI, V20, P303, DOI 10.3109/00207458308986584; HOLM S, 1979, SCAND J STAT, V6, P65; Hori T., 1991, SLEEP RES, V20, P20; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Iber C., 2007, AASM MANUAL SCORING; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Lockley SW, 2006, SLEEP, V29, P161; Mackworth J, 1970, VIGILANCE ATTENTION; Magosso E, 2007, P ANN INT IEEE EMBS, P4006, DOI 10.1109/IEMBS.2007.4353212; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P23, DOI 10.1016/0013-4694(93)90064-3; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; Mitra P., 2007, OBSERVED BRAIN DYNAM; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; MORRELL LK, 1966, NEUROPSYCHOLOGIA, V4, P41, DOI 10.1016/0028-3932(66)90019-4; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; NECKELMANN D, 1993, SLEEP, V16, P467; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Perlis ML, 2001, SLEEP MED REV, V5, P365, DOI 10.1053/smrv.2001.0151; Perlis ML, 2001, SLEEP, V24, P110, DOI 10.1093/sleep/24.1.110; Proakis J. G., 1996, DIGIT SIGNAL PROCESS; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; SCHEIBEL MADGE E., 1967, BRAIN RES, V6, P60, DOI 10.1016/0006-8993(67)90183-7; Smit CM, 2006, INT J PSYCHOPHYSIOL, V61, P235, DOI 10.1016/j.ijpsycho.2005.10.004; Smit DJA, 2005, PSYCHOPHYSIOLOGY, V42, P691, DOI 10.1111/j.1469-8986.2005.00352.x; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; Steriade M., 1991, NORMAL ALTERED STATE, V9, P279, DOI [10.1007/978-1-4615-6622-9_8, DOI 10.1007/978-1-4615-6622-9_8]; TOWNSEND RE, 1979, ELECTROEN CLIN NEURO, V47, P272, DOI 10.1016/0013-4694(79)90279-7; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; WILKINSON RT, 1984, J ACOUST SOC AM, V75, P468, DOI 10.1121/1.390470	51	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17351	10.1371/journal.pone.0017351	http://dx.doi.org/10.1371/journal.pone.0017351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408616	Green Published, Green Submitted, gold			2022-12-25	WOS:000287965200014
J	Zhang, Y; Wang, C				Zhang, Y.; Wang, C.			Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells	ONCOGENE			English	Article						fusion transcription factor; rhabdomyosarcoma; skeletal muscle; transcription; matricellular protein; CCN3	GROWTH-FACTOR CTGF/CCN2; CCN FAMILY; DNA-BINDING; FUSION PROTEIN; MYOGENIC DIFFERENTIATION; IN-VIVO; PAX3; EXPRESSION; IDENTIFICATION; HOMEODOMAIN	The CCN (Cy61, CTGF and NOV) family of proteins is a group of matricellular biomolecules involved in both physiological and pathological processes. Elevated expression of the CCN3 (also known as NOV, Nephroblastoma overexpressed) gene has been detected in clinical samples of the skeletal muscle cancer rhabdomyosarcoma, with the highest expression found in the alveolar subtype (aRMS). Over 80% of aRMSs are characterized by a chromosomal translocation-derived fusion transcription factor PAX3-FKHR. In this study, we linked elevated CCN3 levels in aRMS cells to PAX3-FKHR expression. We found reduced CCN3 levels in aRMS cells following small interfering RNA knockdown of PAX3-FKHR, and increased CCN3 levels in C2 myoblasts following ectopic expression of PAX3-FKHR. Promoter, electrophoretic mobility shift assay and chromatin immunoprecipitation analyses confirmed that the CCN3 gene was a direct target for PAX3-FKHR transcriptional activation through a paired-domain DNA sequence in the first intron of the CCN3 gene. To determine the function of CCN3, we showed that knockdown and ectopic expression of CCN3 decreased survival and increased differentiation in aRMS cells, respectively. In addition, we found that exogenously supplied CCN3 protein promoted aRMS cell adhesion, migration and Matrigel invasion. Taken together, data from this study have (1) provided a mechanistic basis for the CCN3 overexpression in aRMS cells, and (2) identified CCN3 as an autocrine/paracrine factor that contributes to the aggressive behavior of aRMS cells, perhaps through a positive feedback loop. Thus, CCN3 may be an attractive target for therapeutic intervention in aRMS. Oncogene (2011) 30, 3549-3562; doi:10.1038/onc.2011.69; published online 21 March 2011	[Zhang, Y.; Wang, C.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, C (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,RM 530CB, Chicago, IL 60612 USA.	chiayeng@uic.edu			NIH [CA074904]; NATIONAL CANCER INSTITUTE [R01CA074907, R29CA074907, R01CA074904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Lester Lau (University of Illinois at Chicago) for providing antibody against mouse CCN3 protein, and Mr Jian Zhou for his technical assistance in protein and RNA analysis. We thank Dr Peter Tontonoz (Pathology and Laboratory Medicine, UCLA) for assisting in microarray analysis confirming the molecular link between CCN3 and PAX3-FKHR, and Drs Reed Graves and Peter Tontonoz for their valuable suggestions in the preparation of this manuscript. This work is supported by NIH Grant (CA074904) to C.W.	Anderson J, 2001, AM J PATHOL, V159, P1089, DOI 10.1016/S0002-9440(10)61784-1; Apuzzo S, 2004, J BIOL CHEM, V279, P33601, DOI 10.1074/jbc.M402949200; Armoni M, 2002, J CLIN ENDOCR METAB, V87, P5312, DOI 10.1210/jc.2002-020318; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Ayalon D., 2001, Growth Hormone and IGF Research, V11, P289, DOI 10.1054/ghir.2001.0244; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Begum S, 2005, ONCOGENE, V24, P1860, DOI 10.1038/sj.onc.1208315; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Bohlig L, 2008, CELL CYCLE, V7, P1254, DOI 10.4161/cc.7.9.5812; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Cao Y, 2000, J BIOL CHEM, V275, P9854, DOI 10.1074/jbc.275.13.9854; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1995, GENE, V162, P267, DOI 10.1016/0378-1119(95)00345-7; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Croci S, 2007, PATHOL ONCOL RES, V13, P336, DOI 10.1007/BF02940313; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Diomedi-Camassei F, 2004, J PEDIATR SURG, V39, P1673, DOI 10.1016/j.jpedsurg.2004.07.014; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Lafont J, 2005, CELL COMMUN ADHES, V12, P41, DOI 10.1080/15419060500383069; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Laurent M, 2003, FASEB J, V17, P1919, DOI 10.1096/fj.02-1023fje; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Manara MC, 2002, AM J PATHOL, V160, P849, DOI 10.1016/S0002-9440(10)64908-5; Mercado GE, 2008, GENE CHROMOSOME CANC, V47, P510, DOI 10.1002/gcc.20554; Natarajan D, 2000, DEV DYNAM, V219, P417, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1058>3.0.CO;2-2; Oberlin O, 2008, J CLIN ONCOL, V26, P2384, DOI 10.1200/JCO.2007.14.7207; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Perbal B, 2001, B CANCER, V88, P645; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal B, 2006, ADV EXP MED BIOL, V587, P23; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Perbal B, 2008, J CELL COMMUN SIGNAL, V2, P57, DOI 10.1007/s12079-008-0033-3; Perbal B, 2008, J CELL COMMUN SIGNAL, V2, P3, DOI 10.1007/s12079-008-0028-0; Phelan SA, 1998, J BIOL CHEM, V273, P19153, DOI 10.1074/jbc.273.30.19153; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; Rikhof B, 2009, J PATHOL, V217, P469, DOI 10.1002/path.2499; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Taniguchi E, 2008, ONCOGENE, V27, P6550, DOI 10.1038/onc.2008.255; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; Underhill DA, 1997, J BIOL CHEM, V272, P14175, DOI 10.1074/jbc.272.22.14175; Vallacchi V, 2008, CANCER RES, V68, P715, DOI 10.1158/0008-5472.CAN-07-2103; Wang W, 2005, INT J ONCOL, V27, P1087; Wang-Wuu S, 1988, Cancer Res, V48, P983; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; YUN K, 1992, LAB INVEST, V67, P653; ZHAN SL, 1994, J CLIN INVEST, V94, P445, DOI 10.1172/JCI117344; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958; Zhang YB, 2009, INT J CLIN EXP PATHO, V2, P370	68	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	32					3549	3562		10.1038/onc.2011.69	http://dx.doi.org/10.1038/onc.2011.69			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	806CR	21423212	Green Accepted, hybrid			2022-12-25	WOS:000293782300007
J	Gruszczyk, J; Fleurie, A; Olivares-Illana, V; Bechet, E; Zanella-Cleon, I; Morera, S; Meyer, P; Pompidor, G; Kahn, R; Grangeasse, C; Nessler, S				Gruszczyk, Jakub; Fleurie, Aurore; Olivares-Illana, Vanesa; Bechet, Emmanuelle; Zanella-Cleon, Isabelle; Morera, Solange; Meyer, Philippe; Pompidor, Guillaume; Kahn, Richard; Grangeasse, Christophe; Nessler, Sylvie			Structure Analysis of the Staphylococcus aureus UDP-N-acetyl-mannosamine Dehydrogenase Cap5O Involved in Capsular Polysaccharide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; SEROTYPE 5; INSIGHTS; PHOSPHATASE; RESIDUES; GENES; UGD	Bacterial UDP-sugar dehydrogenases are part of the biosynthesis pathway of extracellular polysaccharides. These compounds act as important virulence factors by protecting the cell from opsonophagocytosis and complement-mediated killing. In Staphylococcus aureus, the protein Cap5O catalyzes the oxidation of UDP-N-acetyl-mannosamine to UDP-N-acetyl-mannosaminuronic acid. Cap5O is crucial for the production of serotype 5 capsular polysaccharide that prevents the interaction of bacteria with both phagocytic and nonphagocytic eukaryotic cells. However, details of its catalytic mechanism remain unknown. We thus crystallized Cap5O and solved the first structure of an UDP-N-acetyl-mannosamine dehydrogenase. This study revealed that the catalytic cysteine makes a disulfide bond that has never been observed in other structurally characterized members of the NDP-sugar dehydrogenase family. Biochemical and mutagenesis experiments demonstrated that the formation of this disulfide bridge regulates the activity of Cap5O. We also identified two arginine residues essential for Cap5O activity. Previous data suggested that Cap5O is activated by tyrosine phosphorylation, so we characterized the phosphorylation site and examined the underlying regulatory mechanism.	[Fleurie, Aurore; Bechet, Emmanuelle; Zanella-Cleon, Isabelle; Grangeasse, Christophe] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon, France; [Gruszczyk, Jakub; Olivares-Illana, Vanesa; Morera, Solange; Meyer, Philippe; Nessler, Sylvie] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Pompidor, Guillaume; Kahn, Richard] UJF, CEA, CNRS, Inst Biol Struct JP Ebel,UMR 5075, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Grangeasse, C (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, 7 Passage Vercors, F-69367 Lyon, France.	c.grangeasse@ibcp.fr; nessler@lebs.cnrs-gif.fr	Meyer, Philippe/AAC-6038-2019; Olivares-Illana, Vanesa/AAF-9710-2021; Nessler, Sylvie/R-4296-2016	Meyer, Philippe/0000-0002-6220-0679; Nessler, Sylvie/0000-0003-4973-9941; Olivares-Illana, Vanesa/0000-0001-6949-5986; BECHET, Emmanuelle/0000-0001-5528-0263; Gruszczyk, Jakub/0000-0003-4536-2964; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; University of Lyon; Agence National de la Recherche [ANR-05-MIIM-031, ANR-07-JCJC0125, ANR-08-BLAN-0143]; Association pour la Recherche sur le Cancer; Direction Generale des Armees; Region Rhone-Alpes cluster; Region Ile de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon; Agence National de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Direction Generale des Armees; Region Rhone-Alpes cluster(Region Auvergne-Rhone-Alpes); Region Ile de France(Region Ile-de-France)	This work was supported in part by grants from the CNRS, the University of Lyon, and the Agence National de la Recherche (ANR-05-MIIM-031, ANR-07-JCJC0125, and ANR-08-BLAN-0143), the Association pour la Recherche sur le Cancer, and the "Direction Generale des Armees" (to E. B.), "Region Rhone-Alpes cluster 10" (to A. F.), and "Region Ile de France" (to J. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; KAWAMURA T, 1979, J BIOL CHEM, V254, P8457; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Pompidor G, 2008, ANGEW CHEM INT EDIT, V47, P3388, DOI 10.1002/anie.200704683; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Soufi B, 2008, BBA-PROTEINS PROTEOM, V1784, P186, DOI 10.1016/j.bbapap.2007.07.018; Soulat D, 2007, J MOL MICROB BIOTECH, V13, P45, DOI 10.1159/000103596; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005	36	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17112	17121		10.1074/jbc.M110.216002	http://dx.doi.org/10.1074/jbc.M110.216002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454499	Green Published, hybrid			2022-12-25	WOS:000290301900061
J	Lundstrom, E; Hartshorne, T; Li, K; Lindblad, S; Wick, MC; Bengtsson, C; Alfredsson, L; Klareskog, L; Padyukov, L				Lundstrom, Emeli; Hartshorne, Toinette; Li, Kelly; Lindblad, Staffan; Wick, Marius C.; Bengtsson, Camilla; Alfredsson, Lars; Klareskog, Lars; Padyukov, Leonid			Effects of GSTM1 in Rheumatoid Arthritis; Results from the Swedish EIRA study	PLOS ONE			English	Article							S-TRANSFERASE M1; AMERICAN PATIENTS; T1 POLYMORPHISMS; DISEASE-ACTIVITY; RISK-FACTOR; FOLLOW-UP; SMOKING; GENE; HLA-DRB1; SUSCEPTIBILITY	Objective: Glutathione-S-transferases (GSTs) play an important role in tobacco smoke detoxification, interestingly approximately 50% of individuals in most human populations lack the gene GSTM1 due to copy number variation (CNV). We aimed to investigate GSTM1 CNV in Rheumatoid Arthritis (RA) in relation to smoking and HLA-DRB1 shared epitope; the two best known risk factors for RA and in addition, to perform subanalyses in patients where relations between variations in GSTM1 and RA have previously been described. Methods: qPCR was performed using TaqMan Copy Number assays (Applied Biosystems) for 2426 incident RA cases and 1257 controls from the Swedish EIRA. Odds ratio (OR) together with 95% confidence intervals (CI) was calculated and used as a measure of the relative risk of developing RA. Results: No association between RA and GSTM1 CNV was observed when analyzing whole EIRA. However, >= 1 copy of GSTM1 appears to be a significant risk factor for autoantibody positive RA in non-smoking females >= 60 years (OR: 2.00 95% CI: 1.07-3.74), a population where such relationships have previously been described. Our data further suggest a protective effect of GSTM1 in ACPA-negative smoking men (OR: 0.56 95% CI: 0.35-0.90). Conclusion: We assessed the exact number of GSTM1 gene copies in relation to development and severity of RA. Our data provide support for the notion that variations in copy numbers of GSTM1 may influence risk in certain subsets of RA, but do not support a role for GSTM1 CNV as a factor that more generally modifies the influence of smoking on RA.	[Lundstrom, Emeli; Lindblad, Staffan; Wick, Marius C.; Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Rheumatol, Stockholm, Sweden; [Hartshorne, Toinette; Li, Kelly] Appl Biosyst Inc, Foster City, CA 94404 USA; [Wick, Marius C.] Innsbruck Med Univ, Dept Radiol, Innsbruck, Austria; [Bengtsson, Camilla; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Thermo Fisher Scientific; Applied Biosystems; Medical University of Innsbruck; Karolinska Institutet	Lundstrom, E (corresponding author), Karolinska Inst, Dept Rheumatol, Stockholm, Sweden.	emeli.lundstrom@ki.se	Alfredsson, Lars/AAC-9007-2019; Padyukov, Leonid/A-4890-2009	Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Swedish Research Council [521-2006-5752]; Swedish Rheumatism Foundation; AFA insurance company; Swedish Combine program; EUFp6	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Foundation; AFA insurance company; Swedish Combine program; EUFp6(European Commission)	This study was supported in part by the Swedish Research Council, the Swedish Rheumatism Foundation, the AFA insurance company, the Swedish Combine program, and the EUFp6 funded Autocure program. LP is supported by the Swedish Research Council grant 521-2006-5752. Applied Biosystems provided reagents for genotyping of GSTM1 for this study. No additional external funding was received for this study.	Bekris LM, 2005, AUTOIMMUNITY, V38, P567, DOI 10.1080/08916930500407238; CHENEVIXTRENCH G, 1995, CARCINOGENESIS, V16, P1655, DOI 10.1093/carcin/16.7.1655; Criswell LA, 2006, ANN RHEUM DIS, V65, P1163, DOI 10.1136/ard.2005.049676; Grabar PB, 2009, CLIN EXP RHEUMATOL, V27, P229; Holla LI, 2006, ALLERGY, V61, P265, DOI 10.1111/j.1398-9995.2006.01000.x; KEENAN BT, 2010, ARTHRITIS RHEUM; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Mattey DL, 1999, ANN RHEUM DIS, V58, P164, DOI 10.1136/ard.58.3.164; Mattey DL, 2002, ARTHRITIS RHEUM, V46, P640, DOI 10.1002/art.10174; MCDANIEL DO, 1995, ANN INTERN MED, V123, P181, DOI 10.7326/0003-4819-123-3-199508010-00004; McLellan RA, 1997, MOL PHARMACOL, V52, P958, DOI 10.1124/mol.52.6.958; MIL AHV, 2008, ARTHRITIS RES THER, V10, P205; Morinobu S, 2006, CLIN EXP RHEUMATOL, V24, P268; Norskov MS, 2009, CLIN BIOCHEM, V42, P201, DOI 10.1016/j.clinbiochem.2008.10.020; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Perricone C, 2009, AUTOIMMUN REV, V8, P697, DOI 10.1016/j.autrev.2009.02.020; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; SEIDEGARD J, 1990, CARCINOGENESIS, V11, P33, DOI 10.1093/carcin/11.1.33; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Teller K, 1996, J RHEUMATOL, V23, P1363; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; van der Helm-van Mil AHM, 2005, CURR OPIN RHEUMATOL, V17, P299, DOI 10.1097/01.bor.0000160780.13012.be; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM, V56, P425, DOI 10.1002/art.22373; Verpoort KN, 2007, ARTHRITIS RHEUM-US, V56, P2913, DOI 10.1002/art.22845; Wick M, 2003, ANN RHEUM DIS, V62, P579, DOI 10.1136/ard.62.6.579; Yun BR, 2005, J RHEUMATOL, V32, P992	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17880	10.1371/journal.pone.0017880	http://dx.doi.org/10.1371/journal.pone.0017880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445357	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100014
J	Rai, P; Shivaji, S				Rai, Priyanka; Shivaji, Sisinthy			The Role of DJ-1 in the Pathogenesis of Endometriosis	PLOS ONE			English	Article							EUTOPIC ENDOMETRIUM; OXIDATIVE STRESS; GENE-EXPRESSION; CELL-DEATH; IN-VITRO; IDENTIFICATION; PTEN; REGULATOR; CARCINOMA; MIGRATION	Background: Endometriosis is an estrogen-dependent disease causing pelvic pain and infertility in 10% of reproductive-aged women. Despite a long history of the disease the pathogenesis of endometriosis is poorly understood. It is known that the expression of several proteins is either up or down regulated during endometriosis, but their precise role remains to be determined. DJ-1 is one such protein that is upregulated in eutopic endometrium of women having endometriosis suggesting that DJ-1 may be involved in the pathogenesis of endometriosis. Methodology and Principal Findings: The role of DJ-1 in the pathogenesis of endometriosis was investigated. For this purpose the influence of DJ-1 on endometrial cell survival, attachment, proliferation, migration, and invasion either by overexpressing DJ-1 in normal endometrial cells or by knocking down DJ-1 expression in endometriotic cells using siRNA was investigated. The results indicated that DJ-1 protects endometrial cells from oxidative stress mediated apoptosis. Overexpression of DJ-1 in normal endometrial epithelial cells increases the adhesion on collagen type IV. However, no significant difference was observed incase of stromal cells. It was further demonstrated that DJ-1 regulates cell proliferation, migration, and invasion in normal endometrial and endometriotic epithelial cells whereas in the case of normal endometrial and endometriotic stromal cells, it regulates cell proliferation and invasion but not migration. Furthermore, the present study also indicated that DJ-1 regulates these cellular processes by modulating PI3K/Akt pathway by interacting and negatively regulating PTEN. Conclusions: Abnormally high levels of DJ-1 expression may be involved in endometriosis, possibly by stimulating endometrial cell survival, proliferation, migration, and invasion.	[Rai, Priyanka; Shivaji, Sisinthy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rai, P (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	shivas@ccmb.res.in		shivaji, sisinthy/0000-0003-0376-4658				Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Barbier CS, 2005, BIOL REPROD, V73, P106, DOI 10.1095/biolreprod.104.035063; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; DESAI NN, 1994, FERTIL STERIL, V61, P760; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Fowler PA, 2007, PROTEOMICS, V7, P130, DOI 10.1002/pmic.200600469; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu H, 2008, BIOCHEM BIOPH RES CO, V375, P477, DOI 10.1016/j.bbrc.2008.08.046; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; MacKeigan JP, 2003, CANCER RES, V63, P6928; Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Rai P, 2010, J PROTEOME RES, V9, P4407, DOI 10.1021/pr100657s; Shen ZS, 2011, MED ONCOL, V28, P601, DOI 10.1007/s12032-010-9474-7; Shinbo YM, 2005, INT J ONCOL, V26, P641; Stephens AN, 2010, J PROTEOME RES, V9, P2438, DOI 10.1021/pr901131p; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taira T, 2001, GENE, V263, P285, DOI 10.1016/S0378-1119(00)00590-4; Varma R, 2004, REPRODUCTION, V127, P293, DOI 10.1530/rep.1.00020; Vinatier D, 2000, EUR J OBSTET GYN R B, V91, P113, DOI 10.1016/S0301-2115(99)00263-8; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	34	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18074	10.1371/journal.pone.0018074	http://dx.doi.org/10.1371/journal.pone.0018074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445310	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300034
J	Nie, M; Wang, YJ; Yu, JY; Xiao, M; Jiang, LF; Yang, J; Fang, CM; Chen, JA; Li, B				Nie, Ming; Wang, Yijing; Yu, Jiayi; Xiao, Ming; Jiang, Lifen; Yang, Ji; Fang, Changming; Chen, Jiakuan; Li, Bo			Understanding Plant-Microbe Interactions for Phytoremediation of Petroleum-Polluted Soil	PLOS ONE			English	Article							NITROGEN MINERALIZATION; ORGANIC-MATTER; COMMUNITY; OIL; IMMOBILIZATION; DIVERSITY; ALFALFA; GROWTH; SLUDGE; GENES	Plant-microbe interactions are considered to be important processes determining the efficiency of phytoremediation of petroleum pollution, however relatively little is known about how these interactions are influenced by petroleum pollution. In this experimental study using a microcosm approach, we examined how plant ecophysiological traits, soil nutrients and microbial activities were influenced by petroleum pollution in Phragmites australis, a phytoremediating species. Generally, petroleum pollution reduced plant performance, especially at early stages of plant growth. Petroleum had negative effects on the net accumulation of inorganic nitrogen from its organic forms (net nitrogen mineralization (NNM)) most likely by decreasing the inorganic nitrogen available to the plants in petroleum-polluted soils. However, abundant dissolved organic nitrogen (DON) was found in petroleum-polluted soil. In order to overcome initial deficiency of inorganic nitrogen, plants by dint of high colonization of arbuscular mycorrhizal fungi might absorb some DON for their growth in petroleum-polluted soils. In addition, through using a real-time polymerase chain reaction method, we quantified hydrocarbon-degrading bacterial traits based on their catabolic genes (i.e. alkB (alkane monooxygenase), nah (naphthalene dioxygenase) and tol (xylene monooxygenase) genes). This enumeration of target genes suggests that different hydrocarbon-degrading bacteria experienced different dynamic changes during phytoremediation and a greater abundance of alkB was detected during vegetative growth stages. Because phytoremediation of different components of petroleum is performed by different hydrocarbon-degrading bacteria, plants' ability of phytoremediating different components might therefore vary during the plant life cycle. Phytoremediation might be most effective during the vegetative growth stages as greater abundances of hydrocarbon-degrading bacteria containing alkB and tol genes were observed at these stages. The information provided by this study enhances our understanding of the effects of petroleum pollution on plant-microbe interactions and the roles of these interactions in the phytoremediation of petroleum-polluted soil.	[Nie, Ming; Wang, Yijing; Yu, Jiayi; Jiang, Lifen; Yang, Ji; Fang, Changming; Chen, Jiakuan; Li, Bo] Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ,Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [Jiang, Lifen; Fang, Changming; Chen, Jiakuan; Li, Bo] Fudan Univ, Inst Global Environm Change Res, Shanghai 200433, Peoples R China; [Nie, Ming; Chen, Jiakuan; Li, Bo] Nanchang Univ, Ctr Watershed Ecol, Inst Life Sci, Nanchang, Jiangxi, Peoples R China; [Nie, Ming; Chen, Jiakuan; Li, Bo] Nanchang Univ, Key Lab Poyang Lake Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China; [Xiao, Ming] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China	Fudan University; Fudan University; Nanchang University; Nanchang University; Shanghai Normal University	Nie, M (corresponding author), Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ,Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	bool@fudan.edu.cn	Li, Bo/B-8016-2010; Nie, Ming/F-1880-2010; Li, Bo/AAA-8968-2020; Nie, Ming/F-1880-2010	Li, Bo/0000-0002-0439-5666; Nie, Ming/0000-0003-0702-8009; Li, Bo/0000-0002-7294-6888; Nie, Ming/0000-0003-3898-5389	National Basic Research Program of China [2006CB403305, 2010CB950602]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (grant no. 2006CB403305 and 2010CB950602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaeda T, 2006, ENVIRON EXP BOT, V57, P9, DOI 10.1016/j.envexpbot.2005.03.006; Baldwin BR, 2003, APPL ENVIRON MICROB, V69, P3350, DOI 10.1128/AEM.69.6.3350-3358.2003; Baran S, 2004, GEODERMA, V118, P221, DOI 10.1016/S0016-7061(03)00205-2; CAI WM, 2004, THESIS CHINA AGR U B; Chalot M, 1998, FEMS MICROBIOL REV, V22, P21, DOI 10.1111/j.1574-6976.1998.tb00359.x; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; DeBruyn JM, 2007, ENVIRON SCI TECHNOL, V41, P5426, DOI 10.1021/es070406c; Dowty RA, 2001, MAR ENVIRON RES, V52, P195, DOI 10.1016/S0141-1136(00)00268-3; Finlay RD, 2008, J EXP BOT, V59, P1115, DOI 10.1093/jxb/ern059; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Ghazali FM, 2004, INT BIODETER BIODEGR, V54, P61, DOI 10.1016/j.ibiod.2004.02.002; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gregory ST, 2005, ENVIRON SCI TECHNOL, V39, P5285, DOI 10.1021/es048028o; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Herrmann AM, 2008, EUR J SOIL SCI, V59, P653, DOI 10.1111/j.1365-2389.2008.01023.x; Hutchinson SL, 2001, J ENVIRON QUAL, V30, P395, DOI 10.2134/jeq2001.302395x; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kirk JL, 2005, PLANT SOIL, V270, P23, DOI 10.1007/s11104-004-1013-x; Kirk JL, 2005, ENVIRON POLLUT, V133, P455, DOI 10.1016/j.envpol.2004.06.002; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Langworthy DE, 1998, APPL ENVIRON MICROB, V64, P3422; Laurie AD, 2000, APPL ENVIRON MICROB, V66, P1814, DOI 10.1128/AEM.66.5.1814-1817.2000; Muratova AY, 2008, INT J PHYTOREMEDIAT, V10, P486, DOI 10.1080/15226510802114920; Muratova AY, 2003, APPL BIOCHEM MICRO+, V39, P599, DOI 10.1023/A:1026238720268; Newman LA, 2004, CURR OPIN BIOTECH, V15, P225, DOI 10.1016/j.copbio.2004.04.006; NIE M, 2010, EXPLORING RESPONSES; Nie M, 2011, ENVIRON POLLUT, V159, P157, DOI 10.1016/j.envpol.2010.09.013; Nie M, 2010, BIOL LETTERS, V6, P811, DOI 10.1098/rsbl.2010.0261; Nie M, 2009, SOIL BIOL BIOCHEM, V41, P2535, DOI 10.1016/j.soilbio.2009.09.012; PANSU M, 2006, HDB SOIL ANAL, P526; Peng SW, 2009, J HAZARD MATER, V168, P1490, DOI 10.1016/j.jhazmat.2009.03.036; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Powell SM, 2006, MICROB ECOL, V52, P523, DOI 10.1007/s00248-006-9131-z; Robertson SJ, 2007, BIOL REV, V82, P213, DOI 10.1111/j.1469-185X.2007.00012.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Susarla S, 2002, ECOL ENG, V18, P647, DOI 10.1016/S0925-8574(02)00026-5; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Thompson OA, 2008, WATER AIR SOIL POLL, V189, P37, DOI 10.1007/s11270-007-9552-4; Tordoff GM, 2000, CHEMOSPHERE, V41, P219, DOI 10.1016/S0045-6535(99)00414-2; Unterbrunner R, 2007, PLANT SOIL, V300, P117, DOI 10.1007/s11104-007-9394-2; van der Meer JR, 2006, FRONT ECOL ENVIRON, V4, P35, DOI 10.1890/1540-9295(2006)004[0035:EPPSOM]2.0.CO;2; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Walecka-Hutchison CM, 2007, BIODEGRADATION, V18, P133, DOI 10.1007/s10532-006-9049-7; Wenzel WW, 2009, PLANT SOIL, V321, P385, DOI 10.1007/s11104-008-9686-1; XIONG YS, 1993, GEOGR RES, V12, P23	51	64	65	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17961	10.1371/journal.pone.0017961	http://dx.doi.org/10.1371/journal.pone.0017961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437257	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100049
J	Theilacker, C; Kaczynski, Z; Kropec, A; Sava, I; Ye, LB; Bychowska, A; Holst, O; Huebner, J				Theilacker, Christian; Kaczynski, Zbigniew; Kropec, Andrea; Sava, Irina; Ye, Libin; Bychowska, Anna; Holst, Otto; Huebner, Johannes			Serodiversity of Opsonic Antibodies against Enterococcus faecalis -Glycans of the Cell Wall Revisited	PLOS ONE			English	Article							GROUP-D STREPTOCOCCI; O-SPECIFIC POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN-RESISTANT; PROLONGED BACTEREMIA; ANTIGEN; ACID; INFECTIONS; CLUSTER	In a typing system based on opsonic antibodies against carbohydrate antigens of the cell envelope, 60% of Enterococcus faecalis strains can be assigned to one of four serotypes (CPS-A to CPS-D). The structural basis for enterococcal serotypes, however, is still incompletely understood. Here we demonstrate that antibodies raised against lipoteichoic acid (LTA) from a CPS-A strain are opsonic to both CPS-A and CPS-B strains. LTA-specific antibodies also bind to LTA of CPS-C and CPS-D strains, but fail to opsonize them. From CPS-C and CPS-D strains resistant to opsonization by anti-LTA, we purified a novel diheteroglycan with a repeating unit of -> 6)-beta-Galf-(1 -> 3)-beta-D-Glcp-(1 -> with O-acetylation in position 5 and lactic acid substitution at position 3 of the Galf residue. The purified diheteroglycan, but not LTA absorbed opsonic antibodies from whole cell antiserum against E. faecalis type 2 (a CPS-C strain) and type 5 (CPS-D). Rabbit antiserum raised against purified diheteroglycan opsonized CPS-C and CPS-D strains and passive protection with diheteroglycan-specific antiserum reduced bacterial counts by 1.4 - 3.4 logs in mice infected with E. faecalis strains of the CPS-C and CPS-D serotype. Diheteroglycan-specific opsonic antibodies were absorbed by whole bacterial cells of E. faecalis FA2-2 (CPS-C) but not by its isogenic acapsular cpsI-mutant and on native PAGE purified diheteroglycan co-migrated with the gene product of the cps-locus, suggesting that it is synthesized by this locus. In summary, two polysaccharide antigens, LTA and a novel diheteroglycan, are targets of opsonic antibodies against typeable E. faecalis strains. These cell-wall associated polymers are promising candidates for active and passive vaccination and add to our armamentarium to fight this important nosocomial pathogen.	[Theilacker, Christian; Kropec, Andrea; Sava, Irina; Ye, Libin; Huebner, Johannes] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany; [Theilacker, Christian; Kropec, Andrea; Sava, Irina; Ye, Libin; Huebner, Johannes] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Kaczynski, Zbigniew; Bychowska, Anna] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, Borstel, Germany	University of Freiburg; University of Freiburg; Fahrenheit Universities; University of Gdansk; Forschungszentrum Borstel	Theilacker, C (corresponding author), Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany.	johannes.huebner@uniklinik-freiburg.de		Theilacker, Christian/0000-0003-0821-9202; Kaczynski, Zbigniew/0000-0002-4590-4690; Huebner, Johannes/0000-0003-1232-4646	Polish Ministry of Research and Higher Education [N N301 030134]	Polish Ministry of Research and Higher Education	ZK was supported by Polish Ministry of Research and Higher Education under grant no. N N301 030134. No other current external funding sources supported this this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; BLEIWEIS AS, 1965, J EXP MED, V122, P237, DOI 10.1084/jem.122.2.237; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1381, DOI 10.1128/JB.94.5.1381-1387.1967; BRADFORD M, 1976, ANAL BIOCHEM, V28, P350; Burnie JP, 2000, INFECT IMMUN, V68, P3200, DOI 10.1128/IAI.68.6.3200-3209.2000; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELLIOTT SD, 1960, J EXP MED, V111, P621, DOI 10.1084/jem.111.5.621; GOLD OG, 1975, ARCH ORAL BIOL, V20, P473, DOI 10.1016/0003-9969(75)90236-8; Hancock LE, 2003, J BACTERIOL, V185, P4393, DOI 10.1128/JB.185.15.4393-4401.2003; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Haseley SR, 1997, EUR J BIOCHEM, V244, P761, DOI 10.1111/j.1432-1033.1997.00761.x; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsu CT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-62; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; KNIREL YA, 1994, CARBOHYD RES, V259, pC1, DOI 10.1016/0008-6215(94)84208-6; KNIREL YA, 1992, CARBOHYD RES, V235, pC19, DOI 10.1016/0008-6215(92)80105-A; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; LOWRY OH, 1954, J BIOL CHEM, V207, P1; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; McNeely TB, 1998, INFECT IMMUN, V66, P3705, DOI 10.1128/IAI.66.8.3705-3710.1998; McNeil SA, 2006, CLIN INFECT DIS, V42, P195, DOI 10.1086/498903; PAZUR JH, 1973, J BIOL CHEM, V248, P279; PAZUR JH, 1971, J BIOL CHEM, V246, P1793; RHINEHART E, 1990, NEW ENGL J MED, V323, P1814, DOI 10.1056/NEJM199012273232606; RUOFF KL, 2010, PRINCIPLES PRACTICE, P2591; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; TENG F, 2009, INFECT IMMUN; Theilacker C, 2003, INFECT IMMUN, V71, P3875, DOI 10.1128/IAI.71.7.3875-3884.2003; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thurlow LR, 2009, INFECT IMMUN, V77, P5551, DOI 10.1128/IAI.00576-09; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Vincent Jean-Louis, 2009, Crit Care Med, V37, pS296, DOI 10.1097/CCM.0b013e3181b6f1e1; WICKEN AJ, 1963, J GEN MICROBIOL, V31, P231, DOI 10.1099/00221287-31-2-231; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000	48	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17839	10.1371/journal.pone.0017839	http://dx.doi.org/10.1371/journal.pone.0017839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437253	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100038
J	Yang, CH; Chang, HW; Ho, CH; Chou, YC; Chuang, LY				Yang, Cheng-Hong; Chang, Hsueh-Wei; Ho, Chang-Hsuan; Chou, Yii-Cheng; Chuang, Li-Yeh			Conserved PCR Primer Set Designing for Closely-Related Species to Complete Mitochondrial Genome Sequencing Using a Sliding Window-Based PSO Algorithm	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MULTIPLE-ALIGNMENT; DNA; IDENTIFICATION; HYBRIDIZATION; PATTERNS; AVES	Background: Complete mitochondrial (mt) genome sequencing is becoming increasingly common for phylogenetic reconstruction and as a model for genome evolution. For long template sequencing, i.e., like the entire mtDNA, it is essential to design primers for Polymerase Chain Reaction (PCR) amplicons which are partly overlapping each other. The presented chromosome walking strategy provides the overlapping design to solve the problem for unreliable sequencing data at the 59 end and provides the effective sequencing. However, current algorithms and tools are mostly focused on the primer design for a local region in the genomic sequence. Accordingly, it is still challenging to provide the primer sets for the entire mtDNA. Methodology/Principal Findings: The purpose of this study is to develop an integrated primer design algorithm for entire mt genome in general, and for the common primer sets for closely-related species in particular. We introduce ClustalW to generate the multiple sequence alignment needed to find the conserved sequences in closely-related species. These conserved sequences are suitable for designing the common primers for the entire mtDNA. Using a heuristic algorithm particle swarm optimization (PSO), all the designed primers were computationally validated to fit the common primer design constraints, such as the melting temperature, primer length and GC content, PCR product length, secondary structure, specificity, and terminal limitation. The overlap requirement for PCR amplicons in the entire mtDNA is satisfied by defining the overlapping region with the sliding window technology. Finally, primer sets were designed within the overlapping region. The primer sets for the entire mtDNA sequences were successfully demonstrated in the example of two closely-related fish species. The pseudo code for the primer design algorithm is provided. Conclusions/Significance: In conclusion, it can be said that our proposed sliding window-based PSO algorithm provides the necessary primer sets for the entire mt genome amplification and sequencing.	[Yang, Cheng-Hong; Ho, Chang-Hsuan] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Yang, Cheng-Hong] Toko Univ, Dept Network Syst, Chiayi, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chou, Yii-Cheng] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chung Hua University; I Shou University; I Shou University	Yang, CH (corresponding author), Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan.	changhw@kmu.edu.tw; chuang@isu.edu.tw	Chuang, Li-Yeh/E-5005-2011; Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Cheng-Hong/M-7984-2013	Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Cheng-Hong/0000-0002-2741-0072	National Science Council in Taiwan [NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, DOH99-TD-C-111-002, KMU-EM-99-1.4]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work is partly supported by the National Science Council in Taiwan under grants NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, the funds DOH99-TD-C-111-002 and KMU-EM-99-1.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1984, GENETICS, V108, P237; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOLTON ET, 1962, P NATL ACAD SCI USA, V48, P1390, DOI 10.1073/pnas.48.8.1390; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chang HW, 2010, METHODS MOL BIOL, V628, P259, DOI 10.1007/978-1-60327-367-1_14; Chang HW, 2010, BIOCHEM SYST ECOL, V38, P195, DOI 10.1016/j.bse.2009.12.016; Chang HW, 2009, OMICS, V13, P253, DOI 10.1089/omi.2008.0058; Chen YF, 2009, COMPUT BIOL CHEM, V33, P181, DOI 10.1016/j.compbiolchem.2008.12.003; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chuang LY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-379; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Delisle I, 2002, MOL BIOL EVOL, V19, P357, DOI 10.1093/oxfordjournals.molbev.a004090; Fernandes Rohan J, 2002, Bioinformatics, V18 Suppl 1, pS128; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kim KG, 2009, MOL CELLS, V27, P429, DOI 10.1007/s10059-009-0064-5; KURABAYASHI A, 2010, MOL PHYLOGENET EVOL; Lamprecht AL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S13; Lee HP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-132; Li DM, 2009, GENE, V429, P31, DOI 10.1016/j.gene.2008.10.010; LIU WT, 2005, PRIMER SET SELECTION; Ma LL, 2010, MITOCHONDR DNA, V21, P5, DOI 10.3109/19401730903552026; May-Collado L, 2006, MOL PHYLOGENET EVOL, V38, P344, DOI 10.1016/j.ympev.2005.09.019; Moyle RG, 2006, MOL PHYLOGENET EVOL, V40, P687, DOI 10.1016/j.ympev.2006.04.015; Muller J, 2010, BIOINFORMATICS, V26, P263, DOI 10.1093/bioinformatics/btp651; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nakato R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-224; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Pang H, 2008, MITOCHONDR DNA, V19, P411, DOI 10.1080/19401730802389517; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Rao N, 2009, COMPUT BIOL MED, V39, P392, DOI 10.1016/j.compbiomed.2009.01.010; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Simmler H, 2004, CONCURR COMP-PRACT E, V16, P855, DOI 10.1002/cpe.810; Stone AC, 2010, PHILOS T R SOC B, V365, P3277, DOI 10.1098/rstb.2010.0096; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE RB, 1979, NUCLEIC ACIDS RES, V6, P3543, DOI 10.1093/nar/6.11.3543; Webb DM, 2005, MOL PHYLOGENET EVOL, V36, P233, DOI 10.1016/j.ympev.2005.03.015; Wu JS, 2004, BIOINFORMATICS, V20, P1710, DOI 10.1093/bioinformatics/bth147; Wu LC, 2007, SOFT COMPUT, V11, P855, DOI 10.1007/s00500-006-0137-8; Yang C.-H., 2010, INT J CHEM BIOL ENG, V3, P18; Yang CH, 2009, BIOTECHNOL PROGR, V25, P745, DOI 10.1002/btpr.169; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang XY, 2009, MOL BIOL REP, V36, P981, DOI 10.1007/s11033-008-9271-y; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	53	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17729	10.1371/journal.pone.0017729	http://dx.doi.org/10.1371/journal.pone.0017729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445268	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100027
J	Paulmann, S; Ott, DVM; Kotz, SA				Paulmann, Silke; Ott, Derek V. M.; Kotz, Sonja A.			Emotional Speech Perception Unfolding in Time: The Role of the Basal Ganglia	PLOS ONE			English	Article							PARKINSONS-DISEASE; CORTICAL ACTIVATION; NEURAL MECHANISMS; BRAIN POTENTIALS; SEX-DIFFERENCES; ERP EVIDENCE; PROSODY; DISGUST; RECOGNITION; LESION	The basal ganglia (BG) have repeatedly been linked to emotional speech processing in studies involving patients with neurodegenerative and structural changes of the BG. However, the majority of previous studies did not consider that (i) emotional speech processing entails multiple processing steps, and the possibility that (ii) the BG may engage in one rather than the other of these processing steps. In the present study we investigate three different stages of emotional speech processing (emotional salience detection, meaning-related processing, and identification) in the same patient group to verify whether lesions to the BG affect these stages in a qualitatively different manner. Specifically, we explore early implicit emotional speech processing (probe verification) in an ERP experiment followed by an explicit behavioral emotional recognition task. In both experiments, participants listened to emotional sentences expressing one of four emotions (anger, fear, disgust, happiness) or neutral sentences. In line with previous evidence patients and healthy controls show differentiation of emotional and neutral sentences in the P200 component (emotional salience detection) and a following negative-going brain wave (meaning-related processing). However, the behavioral recognition (identification stage) of emotional sentences was impaired in BG patients, but not in healthy controls. The current data provide further support that the BG are involved in late, explicit rather than early emotional speech processing stages.	[Paulmann, Silke] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Ott, Derek V. M.; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Essex; Max Planck Society	Paulmann, S (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.	paulmann@essex.ac.uk		Paulmann, Silke/0000-0003-4148-3806	German Research Foundation (DFG) [FOR 499]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG FOR 499 to S. A. Kotz). DFG website: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; BLONDER LX, 1989, BRAIN LANG, V36, P193, DOI 10.1016/0093-934X(89)90061-8; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Breitenstein C, 2001, BRAIN COGNITION, V45, P277, DOI 10.1006/brcg.2000.1246; Breitenstein C, 1998, BEHAV NEUROL, V11, P29, DOI 10.1155/1998/579029; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; CANCELLIERE AEB, 1990, BRAIN COGNITION, V13, P133, DOI 10.1016/0278-2626(90)90046-Q; Dara C, 2008, BRAIN RES, V1188, P100, DOI 10.1016/j.brainres.2007.10.034; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; KEPPEL G, 1991, DESIGN ANAL RESEARCH; Kiehl KA, 1999, PSYCHOPHYSIOLOGY, V36, P765, DOI 10.1111/1469-8986.3660765; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kotz SA, 2003, J INT NEUROPSYCH SOC, V9, P1053, DOI 10.1017/S1355617703970093; KOTZ SA, 2006, SPEECH PROSODY; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Kotz SA, 2006, PROG BRAIN RES, V156, P285, DOI 10.1016/S0079-6123(06)56015-7; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Obleser J, 2006, CEREB CORTEX, V16, P1069, DOI 10.1093/cercor/bhj047; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; PAULMANN S, 2006, 12 ANN C ARCH MECH L; Paulmann S, 2008, BRAIN RES, V1217, P171, DOI 10.1016/j.brainres.2008.04.032; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, BRAIN LANG, V104, P262, DOI 10.1016/j.bandl.2007.03.002; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2010, SOC NEUROSCI-UK, V5, P59, DOI 10.1080/17470910903135668; Paulmann S, 2009, BRAIN RES, V1295, P159, DOI 10.1016/j.brainres.2009.07.102; Pell ID, 1996, CORTEX, V32, P693, DOI 10.1016/S0010-9452(96)80039-6; Pell MD, 2003, COGN AFFECT BEHAV NE, V3, P275, DOI 10.3758/CABN.3.4.275; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; PFEIFER E, 1995, M PLANCK I COGNITIVE, P51; Pihan H, 2000, BRAIN, V123, P2338, DOI 10.1093/brain/123.11.2338; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, COGNITIVE BRAIN RES, V21, P269, DOI 10.1016/j.cogbrainres.2004.04.003; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schroder C, 2006, MOVEMENT DISORD, V21, P1774, DOI 10.1002/mds.21038; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; SCOTT S, 1984, J NEUROL NEUROSUR PS, V47, P840, DOI 10.1136/jnnp.47.8.840; Sidtis DV, 2006, BRAIN LANG, V97, P135, DOI 10.1016/j.bandl.2005.09.001; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1997, P ROY SOC B-BIOL SCI, V264, P1767, DOI 10.1098/rspb.1997.0245; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Tisch S, 2004, PSYCHIAT CLIN N AM, V27, P757, DOI 10.1016/j.psc.2004.06.004; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Wang K, 2003, NEUROPSYCHOLOGIA, V41, P527, DOI 10.1016/S0028-3932(02)00171-9; Wieser MJ, 2006, CLIN NEUROPHYSIOL, V117, P94, DOI 10.1016/j.clinph.2005.09.009; Wildgruber D., 2009, INT J SPEECH-LANG PA, V11, P277, DOI [10.1080/17549500902943043, DOI 10.1080/17549500902943043]; YIP JTH, 2003, MOV DIS, V18, P115; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	66	41	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17694	10.1371/journal.pone.0017694	http://dx.doi.org/10.1371/journal.pone.0017694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SO	21437277	Green Published, gold, Green Accepted			2022-12-25	WOS:000288514600007
J	Chougule, MB; Patel, AR; Jackson, T; Singh, M				Chougule, Mahavir B.; Patel, Apurva R.; Jackson, Tanise; Singh, Mandip			Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; ANTICANCER ACTIVITY; LEUKEMIC-CELLS; MOUSE MODEL; APOPTOSIS; AGENTS; TUMORS; PROLIFERATION; FORMULATION; PROGRESSION	Background: The aim of this study was to investigate the anticancer activity and mechanism of action of Noscapine alone and in combination with Doxorubicin against triple negative breast cancer (TNBC). Methods: TNBC cells were pretreated with Noscapine or Doxorubicin or combination and combination index values were calculated using isobolographic method. Apoptosis was assessed by TUNEL staining. Female athymic Nu/nu mice were xenografted with MDA-MB-231 cells and the efficacy of Noscapine, Doxorubicin and combination was determined. Protein expression, immunohistochemical staining were evaluated in harvested tumor tissues. Results: Noscapine inhibited growth of MDA-MB-231 and MDA-MB-468 cells with the IC50 values of 36.16 +/- 3.76 and 42.7 +/- 4.3 mu M respectively. The CI values (<0.59) were suggestive of strong synergistic interaction between Noscapine and Doxorubicin and combination treatment showed significant increase in apoptotic cells. Noscapine showed dose dependent reduction in the tumor volumes at a dose of 150-550 mg/kg/day compared to controls. Noscapine (300 mg/kg), Doxorubicin (1.5 mg/kg) and combination treatment reduced tumor volume by 39.4 +/- 5.8, 34.2 +/- 5.7 and 82.9 +/- 4.5 percent respectively and showed decreased expression of NF-KB pathway proteins, VEGF, cell survival, and increased expression of apoptotic and growth inhibitory proteins compared to single-agent treatment and control groups. Conclusions: Noscapine potentiated the anticancer activity of Doxorubicin in a synergistic manner against TNBC tumors via inactivation of NF-KB and anti-angiogenic pathways while stimulating apoptosis. These findings suggest potential benefit for use of oral Noscapine and Doxorubicin combination therapy for treatment of more aggressive TNBC.	[Chougule, Mahavir B.] Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA; [Patel, Apurva R.; Jackson, Tanise; Singh, Mandip] Florida A&M Univ, Coll Pharm, Tallahassee, FL 32307 USA	University of Hawaii System; University Hawaii Hilo; State University System of Florida; Florida A&M University	Chougule, MB (corresponding author), Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA.	mandip.sachdeva@famu.edu			NIH [G12RR03020-11, 5S06GM008111-36]; NATIONAL CANCER INSTITUTE [SC1CA161676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the financial support provided by RCMI grant (G12RR03020-11) and NIGMS/MBRS award (5S06GM008111-36) from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Anderson JT, 2005, J MED CHEM, V48, P2756, DOI 10.1021/jm0494220; Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Barken I, 2008, ANTICANCER RES, V28, P3701; Buzdar AU, 2003, ONCOLOGIST, V8, P335, DOI 10.1634/theoncologist.8-4-335; Chougule M, 2010, LUNG CANC; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; Ewens A, 2006, CANCER RES, V66, P5419, DOI 10.1158/0008-5472.CAN-05-3963; Hardenbergh PH, 1999, INT J RADIAT ONCOL, V45, P69, DOI 10.1016/S0360-3016(99)00127-3; Heidari N, 2007, ANTI-CANCER DRUG, V18, P1139, DOI 10.1097/CAD.0b013e3282eea257; Hiser L, 2008, LEUKEMIA LYMPHOMA, V49, P1603, DOI 10.1080/10428190802213480; Ichite N, 2009, CLIN CANCER RES, V15, P543, DOI 10.1158/1078-0432.CCR-08-1558; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Karna P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-93; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Keam B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-203; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Liu M, 2010, CANC CHEMOTHER PHARM; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; Markman M, 2003, SUPPORT CARE CANCER, V11, P144, DOI 10.1007/s00520-002-0405-9; Menendez JA, 2001, EUR J CANCER, V37, P402, DOI 10.1016/S0959-8049(00)00408-1; Moulder S, 2008, CLIN PHARMACOL THER, V83, P26, DOI 10.1038/sj.clpt.6100449; Newcomb EW, 2008, INT J RADIAT ONCOL, V71, P1477, DOI 10.1016/j.ijrobp.2008.04.020; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Pan Q, 2003, MOL CANCER THER, V2, P617; Patlolla RR, 2010, J CONTROL RELEASE, V144, P233, DOI 10.1016/j.jconrel.2010.02.006; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Stockmans G, 2008, CURR OPIN ONCOL, V20, P614, DOI 10.1097/CCO.0b013e328312efba; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; van Zuylen L, 2001, INVEST NEW DRUG, V19, P125, DOI 10.1023/A:1010618632738; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Yamamoto Y, 2010, INT J CLIN ONCOL; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zamorano J, 2001, INT IMMUNOL, V13, P1479, DOI 10.1093/intimm/13.12.1479; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200	45	82	86	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17733	10.1371/journal.pone.0017733	http://dx.doi.org/10.1371/journal.pone.0017733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423660	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900018
J	Hishiya, A; Salman, MN; Carra, S; Kampinga, HH; Takayama, S				Hishiya, Akinori; Salman, Mortada Najem; Carra, Serena; Kampinga, Harm H.; Takayama, Shinichi			BAG3 Directly Interacts with Mutated alphaB-Crystallin to Suppress Its Aggregation and Toxicity	PLOS ONE			English	Article							DESMIN-RELATED MYOPATHY; B-CRYSTALLIN; MYOFIBRILLAR MYOPATHY; CHAPERONE ACTIVITY; CELL-DEATH; CARDIOMYOPATHY; COMPLEX; PROTEIN; MICE; R120G-ALPHA-B-CRYSTALLIN	A homozygous disruption or genetic mutation of the bag3 gene causes progressive myofibrillar myopathy in mouse and human skeletal and cardiac muscle disorder while mutations in the small heat shock protein aB-crystallin gene ( CRYAB) are reported to be responsible for myofibrillar myopathy. Here, we demonstrate that BAG3 directly binds to wild-type alpha B-crystallin and the alpha B-crystallin mutant R120G, via the intermediate domain of BAG3. Peptides that inhibit this interaction in an in vitro binding assay indicate that two conserved Ile-Pro-Val regions of BAG3 are involved in the interaction with alpha B-crystallin, which is similar to results showing BAG3 binding to HspB8 and HspB6. BAG3 overexpression increased alpha B-crystallin R120G solubility and inhibited its intracellular aggregation in HEK293 cells. BAG3 suppressed cell death induced by alpha B-crystallin R120G overexpression in differentiating C2C12 mouse myoblast cells. Our findings indicate a novel function for BAG3 in inhibiting protein aggregation caused by the genetic mutation of CRYAB responsible for human myofibrillar myopathy.	[Hishiya, Akinori; Salman, Mortada Najem; Takayama, Shinichi] Boston Biomed Res Inst, Cardiovasc Grp, Watertown, MA 02472 USA; [Carra, Serena; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, Groningen, Netherlands	Boston Biomedical Research Institute; University of Groningen	Hishiya, A (corresponding author), Boston Biomed Res Inst, Cardiovasc Grp, Watertown, MA 02472 USA.	Takayama@bbri.org	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140; Kampinga, Harm/0000-0002-8966-8466	National Institutes of Health (NIH) [AR052925]; Thoracic Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052925] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoracic Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the National Institutes of Health (NIH) (AR052925) and the Thoracic Foundation for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Engel AG, 1999, ANN NEUROL, V46, P681, DOI 10.1002/1531-8249(199911)46:5<681::AID-ANA1>3.0.CO;2-B; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Hishiya A, 2010, CIRCULATION IN PRESS; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Iwasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P413, DOI 10.1016/j.bbrc.2010.08.092; Jana NR, 2005, NEUROSCI LETT, V378, P171, DOI 10.1016/j.neulet.2004.12.031; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2010, CIRC RES, V106, P1524, DOI 10.1161/CIRCRESAHA.109.212639; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Reilich P, 2010, NEUROMUSCULAR DISORD, V20, P255, DOI 10.1016/j.nmd.2010.01.012; Rohde G, 2008, NEUROSCIENCE, V157, P844, DOI 10.1016/j.neuroscience.2008.09.055; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Selcen D, 2008, CURR OPIN NEUROL, V21, P585, DOI 10.1097/WCO.0b013e32830a752b; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Shelton GD, 2004, NEUROMUSCULAR DISORD, V14, P399, DOI 10.1016/j.nmd.2004.03.010; Takada H, 2003, MOL CELL BIOL, V23, P4026, DOI 10.1128/MCB.23.11.4026-4033.2003; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	36	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e16828	10.1371/journal.pone.0016828	http://dx.doi.org/10.1371/journal.pone.0016828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423662	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900004
J	Kaplan, F; Srinivasan, J; Mahanti, P; Ajredini, R; Durak, O; Nimalendran, R; Sternberg, PW; Teal, PEA; Schroeder, FC; Edison, AS; Alborn, HT				Kaplan, Fatma; Srinivasan, Jagan; Mahanti, Parag; Ajredini, Ramadan; Durak, Omer; Nimalendran, Rathika; Sternberg, Paul W.; Teal, Peter E. A.; Schroeder, Frank C.; Edison, Arthur S.; Alborn, Hans T.			Ascaroside Expression in Caenorhabditis elegans Is Strongly Dependent on Diet and Developmental Stage	PLOS ONE			English	Article							PHEROMONE; NEMATODE; TEMPERATURE	Background: The ascarosides form a family of small molecules that have been isolated from cultures of the nematode Caenorhabditis elegans. They are often referred to as "dauer pheromones" because most of them induce formation of long-lived and highly stress resistant dauer larvae. More recent studies have shown that ascarosides serve additional functions as social signals and mating pheromones. Thus, ascarosides have multiple functions. Until now, it has been generally assumed that ascarosides are constitutively expressed during nematode development. Methodology/Principal Findings: Cultures of C. elegans were developmentally synchronized on controlled diets. Ascarosides released into the media, as well as stored internally, were quantified by LC/MS. We found that ascaroside biosynthesis and release were strongly dependent on developmental stage and diet. The male attracting pheromone was verified to be a blend of at least four ascarosides, and peak production of the two most potent mating pheromone components, ascr#3 and asc#8 immediately preceded or coincided with the temporal window for mating. The concentration of ascr#2 increased under starvation conditions and peaked during dauer formation, strongly supporting ascr#2 as the main population density signal (dauer pheromone). After dauer formation, ascaroside production largely ceased and dauer larvae did not release any ascarosides. These findings show that both total ascaroside production and the relative proportions of individual ascarosides strongly correlate with these compounds' stage-specific biological functions. Conclusions/Significance: Ascaroside expression changes with development and environmental conditions. This is consistent with multiple functions of these signaling molecules. Knowledge of such differential regulation will make it possible to associate ascaroside production to gene expression profiles (transcript, protein or enzyme activity) and help to determine genetic pathways that control ascaroside biosynthesis. In conjunction with findings from previous studies, our results show that the pheromone system of C. elegans mimics that of insects in many ways, suggesting that pheromone signaling in C. elegans may exhibit functional homology also at the sensory level. In addition, our results provide a strong foundation for future behavioral modeling studies.	[Kaplan, Fatma; Teal, Peter E. A.; Alborn, Hans T.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Srinivasan, Jagan; Durak, Omer; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Srinivasan, Jagan; Durak, Omer; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mahanti, Parag; Nimalendran, Rathika; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Mahanti, Parag; Nimalendran, Rathika; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Ajredini, Ramadan; Edison, Arthur S.] Univ Florida, High Field Magnet Lab, Dept Biochem & Mol Biol, Gainesville, FL USA	United States Department of Agriculture (USDA); California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; State University System of Florida; University of Florida	Kaplan, F (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	hans.alborn@ars.usda.gov	Kaplan, Fatma/AAJ-7666-2020; Mahanti, Parag/AAK-8974-2021; Srinivasan, Jagan/B-6215-2015; Schroeder, Frank/H-5026-2012	Kaplan, Fatma/0000-0002-9565-0211; Durak, Omer/0000-0001-8426-6188; Schroeder, Frank/0000-0002-4420-0237; Srinivasan, Jagan/0000-0001-5449-7938; Edison, Arthur/0000-0002-5686-2350; Sternberg, Paul/0000-0002-7699-0173	National Institutes of Health [1R01GM085285-01A1, 3R01GM085285-01A1S1, GM088290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085285, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Partially funded by National Institutes of Health (1R01GM085285-01A1, 3R01GM085285-01A1S1, and GM088290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Edison AS, 2009, CURR OPIN NEUROBIOL, V19, P378, DOI 10.1016/j.conb.2009.07.007; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; HU PJ, 2007, COMMUNITY TCER, DOI DOI 10.1895/W0RMB00K.1891.1144.1891; JAFFE H, 1989, J CHEM ECOL, V15, P2031, DOI 10.1007/BF01207435; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Johnstone I.J., 1999, C ELEGANS PRACTICAL, P201; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; *PROTOCOLS, 2010, DAUER PUR SUCR FLOAT; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51	19	65	72	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17804	10.1371/journal.pone.0017804	http://dx.doi.org/10.1371/journal.pone.0017804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423575	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000288513900032
J	Etienne, RS; Rosindell, J				Etienne, Rampal S.; Rosindell, James			The Spatial Limitations of Current Neutral Models of Biodiversity	PLOS ONE			English	Article							SPECIES-AREA CURVES; ZERO-SUM ASSUMPTION; DISPERSAL-LIMITATION; TROPICAL FORESTS; MULTIPLE SAMPLES; BETA-DIVERSITY; PARAMETERS; SPECIATION; ABUNDANCE; FORMULA	The unified neutral theory of biodiversity and biogeography is increasingly accepted as an informative null model of community composition and dynamics. It has successfully produced macro-ecological patterns such as species-area relationships and species abundance distributions. However, the models employed make many unrealistic auxiliary assumptions. For example, the popular spatially implicit version assumes a local plot exchanging migrants with a large panmictic regional source pool. This simple structure allows rigorous testing of its fit to data. In contrast, spatially explicit models assume that offspring disperse only limited distances from their parents, but one cannot as yet test the significance of their fit to data. Here we compare the spatially explicit and the spatially implicit model, fitting the most-used implicit model (with two levels, local and regional) to data simulated by the most-used spatially explicit model (where offspring are distributed about their parent on a grid according to either a radially symmetric Gaussian or a 'fat-tailed' distribution). Based on these fits, we express spatially implicit parameters in terms of spatially explicit parameters. This suggests how we may obtain estimates of spatially explicit parameters from spatially implicit ones. The relationship between these parameters, however, makes no intuitive sense. Furthermore, the spatially implicit model usually fits observed species-abundance distributions better than those calculated from the spatially explicit model's simulated data. Current spatially explicit neutral models therefore have limited descriptive power. However, our results suggest that a fatter tail of the dispersal kernel seems to improve the fit, suggesting that dispersal kernels with even fatter tails should be studied in future. We conclude that more advanced spatially explicit models and tools to analyze them need to be developed.	[Etienne, Rampal S.] Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Rosindell, James] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Groningen; University of Leeds	Etienne, RS (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	r.s.etienne@rug.nl	Etienne, Rampal S./F-5835-2012	Etienne, Rampal S./0000-0003-2142-7612; Rosindell, James/0000-0002-5060-9346	Netherlands Organization for Scientific Research (NWO); Engineering and Physical Sciences Research Council (EPSRC) [EP/F043112/1]; Engineering and Physical Sciences Research Council [EP/F043112/1] Funding Source: researchfish; EPSRC [EP/F043112/1] Funding Source: UKRI	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RSE and JR acknowledge the financial support of the Netherlands Organization for Scientific Research (NWO) and Engineering and Physical Sciences Research Council (EPSRC, grant number EP/F043112/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2001, NATURE, V412, P858, DOI 10.1038/35091120; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Allouche O, 2009, ECOL LETT, V12, P1287, DOI 10.1111/j.1461-0248.2009.01379.x; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Bengtsson J, 2002, ECOL ECON, V42, P497, DOI 10.1016/S0921-8009(02)00131-3; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; de Mazancourt C, 2001, SCIENCE, V293, P1772; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2007, OIKOS, V116, P241, DOI [10.1111/j.2007.0030-1299.15438.x, 10.1111/j.0030-1299.2007.15438.x]; Etienne RS, 2009, J THEOR BIOL, V257, P510, DOI 10.1016/j.jtbi.2008.12.016; Etienne RS, 2009, ECOLOGY, V90, P847, DOI 10.1890/08-0750.1; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; ETIENNE RS, 2010, THEORETICAL ECOLOGY, V4, P87; FRIEDMAN M, 1953, ESSAYS POSITIVE EC C; Gray JS, 2006, J ANIM ECOL, V75, P752, DOI 10.1111/j.1365-2656.2006.01095.x; Haegeman B, 2008, J THEOR BIOL, V252, P288, DOI 10.1016/j.jtbi.2008.01.023; Haegeman B, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031911; Haegeman B, 2009, B MATH BIOL, V71, P1507, DOI 10.1007/s11538-009-9411-0; Hubbell Stephen P., 2001, V32, pi; Kimura MA, 1985, NEUTRAL THEORY MOL E; Leigh E. G., 2010, SCHOLARPEDIA, V5, P8822; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Munoz F, 2008, AM NAT, V172, P116, DOI 10.1086/587842; Munoz F, 2007, ECOLOGY, V88, P2482, DOI 10.1890/07-0049.1; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Rosindell J, 2008, ECOL INFORM, V3, P259, DOI 10.1016/j.ecoinf.2008.05.001; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Rosindell J, 2010, ECOL LETT, V13, P716, DOI 10.1111/j.1461-0248.2010.01463.x; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; Vanpeteghem D, 2010, J MATH BIOL, V61, P323, DOI 10.1007/s00285-009-0303-6; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030	41	29	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14717	10.1371/journal.pone.0014717	http://dx.doi.org/10.1371/journal.pone.0014717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423724	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400001
J	Yang, HL; Wang, YP; Xiao, Y; Wang, Y; Wu, J; Liu, CB; Ye, HH; Li, FL; Yu, HN; Lai, R				Yang, Hailong; Wang, Yipeng; Xiao, Yao; Wang, Ying; Wu, Jing; Liu, Cunbao; Ye, Huahu; Li, Fengliang; Yu, Haining; Lai, Ren			A Bi-Functional Anti-Thrombosis Protein Containing Both Direct-Acting Fibrin(ogen)olytic and Plasminogen-Activating Activities	PLOS ONE			English	Article							HORSEFLY SALIVARY-GLANDS; FIBRINOLYTIC-ACTIVITY; SERINE-PROTEASE; PURIFICATION; COAGULATION; HEMORRHAGE; FLY; THROMBOLYSIS; UROKINASE; DIPTERA	Direct-acting fibrin(ogen)olytic agents such as plasmin have been proved to contain effective and safety thrombolytic potential. Unfortunately, plasmin is ineffective when administered by the intravenous route because it was neutralized by plasma antiplasmin. Direct-acting fibrin(ogen) olytic agents with resistance against antiplasmin will brighten the prospect of anti-thrombosis. As reported in 'Compendium of Materia Medica', the insect of Eupolyphaga sinensis Walker has been used as traditional anti-thrombosis medicine without bleeding risk for several hundreds years. Currently, we have identified a fibrin(ogen) olytic protein (Eupolytin1) containing both fibrin(ogen) olytic and plasminogen-activating (PA) activities from the beetle, E. sinensis. Objectives: To investigate the role of native and recombinant eupolytin1 in fibrin(ogen) olytic and plasminogen-activating processes. Methods and Results: Using thrombus animal model, eupolytin1 was proved to contain strong and rapid thrombolytic ability and safety in vivo, which are better than that of urokinase. Most importantly, no bleeding complications were appeared even the intravenous dose up to 0.12 mu mol/kg body weight (3 times of tested dose which could completely lyse experimental thrombi) in rabbits. It is the first report of thrombolytic agents containing both direct-acting fibrin(ogen) olytic and plasminogen-activating activities. Conclusions: The study identified novel thrombolytic agent with prospecting clinical potential because of its bi-functional merits containing both plasmin-and PA-like activities and unique pharmacological kinetics in vivo.	[Yang, Hailong; Wang, Yipeng; Xiao, Yao; Wang, Ying; Wu, Jing; Liu, Cunbao; Lai, Ren] Chinese Acad Sci, Biotoxin Units Key Lab Anim Models & Human Dis Me, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Nanjing, Jiangsu, Peoples R China; [Yu, Haining] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China; [Li, Fengliang] First Peoples Hosp Yunnan Prov, Dept Lab Med, Kunming, Yunnan, Peoples R China; [Ye, Huahu] Acad Mil Med Sci, Inst Biotechnol, Beijing, Peoples R China; [Yang, Hailong; Wang, Yipeng; Xiao, Yao; Wang, Ying; Wu, Jing; Liu, Cunbao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Agricultural University; Dalian University of Technology; Academy of Military Medical Sciences - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, HL (corresponding author), Chinese Acad Sci, Biotoxin Units Key Lab Anim Models & Human Dis Me, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	yuhaining@dlut.edu.cn; rlai@mail.kiz.ac.cn	yang, hailong/GXH-9625-2022; Xiao, Yao/AAL-6013-2021; Wang, Yipeng/AAA-1499-2020	Wang, Yipeng/0000-0003-1385-4470	Chinese National Natural Science Foundation [30830021, 41076098]; Chinese Academy of Sciences [KSCXZ-YW-R-088, KSCX2-YW-G-024]; Ministry of Science [2008AA02Z133, 2010CB529800]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Chinese National Natural Science Foundation (30830021, 41076098), Chinese Academy of Sciences (KSCXZ-YW-R-088, KSCX2-YW-G-024), and the Ministry of Science (2008AA02Z133, 2010CB529800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 2003, THROMB RES, V112, P339, DOI 10.1016/j.thromres.2004.01.005; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; BEKEMEIER H, 1987, NATURWISSENSCHAFTEN, V74, P345, DOI 10.1007/BF00367934; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Dametto M, 2000, J PROTEIN CHEM, V19, P515, DOI 10.1023/A:1026557600429; Hahn BS, 1999, BBA-PROTEIN STRUCT M, V1430, P376, DOI 10.1016/S0167-4838(99)00024-2; Han Ya-Li, 2006, Zhong Yao Cai, V29, P765; Hindersin P, 1986, J Neurosurg Sci, V30, P183; HINDERSIN P, 1984, ACTA NEUR S IN PRESS; Kajimoto Y, 1997, NEUROSURGERY, V40, P572, DOI 10.1097/00006123-199703000-00029; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Marder VJ, 2009, THROMB RES, V123, pS56, DOI 10.1016/S0049-3848(09)70145-8; Marder VJ, 2001, THROMB HAEMOSTASIS, V86, P739; RIBEIRO JMC, 1992, J EXP BIOL, V165, P61; SHERRY S, 1959, PHYSIOL REV, V39, P343, DOI 10.1152/physrev.1959.39.2.343; Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x; Stewart D, 2003, BLOOD, V101, P3002, DOI 10.1182/blood-2002-08-2546; Sugimoto K, 2003, J VASC SURG, V37, P512, DOI 10.1067/mva.2003.41; Takac P, 2006, J EXP BIOL, V209, P343, DOI 10.1242/jeb.02003; WANG JD, 1989, CHEM PHARM BULL, V37, P2236; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200	21	24	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17519	10.1371/journal.pone.0017519	http://dx.doi.org/10.1371/journal.pone.0017519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423730	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400012
J	Guyot, R; Garavito, A; Gavory, F; Samain, S; Tohme, J; Ghesquiere, A; Lorieux, M				Guyot, Romain; Garavito, Andrea; Gavory, Frederick; Samain, Sylvie; Tohme, Joe; Ghesquiere, Alain; Lorieux, Mathias			Patterns of Sequence Divergence and Evolution of the S-1 Orthologous Regions between Asian and African Cultivated Rice Species	PLOS ONE			English	Article							HYBRID STERILITY; REPRODUCTIVE BARRIER; GAMETE ELIMINATOR; ORYZA; GENE; NUCLEAR; RESOURCE; GENOMES; DOMESTICATION; ANNOTATION	A strong postzygotic reproductive barrier separates the recently diverged Asian and African cultivated rice species, Oryza sativa and O. glaberrima. Recently a model of genetic incompatibilities between three adjacent loci: S(1)A, S-1 and S1B (called together the S-1 regions) interacting epistatically, was postulated to cause the allelic elimination of female gametes in interspecific hybrids. Two candidate factors for the S-1 locus (including a putative F-box gene) were proposed, but candidates for S(1)A and S1B remained undetermined. Here, to better understand the basis of the evolution of regions involved in reproductive isolation, we studied the genic and structural changes accumulated in the S-1 regions between orthologous sequences. First, we established an 813 kb genomic sequence in O. glaberrima, covering completely the S(1)A, S-1 and the majority of the S1B regions, and compared it with the orthologous regions of O. sativa. An overall strong structural conservation was observed, with the exception of three isolated regions of disturbed collinearity: (1) a local invasion of transposable elements around a putative F-box gene within S-1, (2) the multiple duplication and subsequent divergence of the same F-box gene within S(1)A, (3) an interspecific chromosomal inversion in S1B, which restricts recombination in our O. sativa x O. glaberrima crosses. Beside these few structural variations, a uniform conservative pattern of coding sequence divergence was found all along the S-1 regions. Hence, the S-1 regions have undergone no drastic variation in their recent divergence and evolution between O. sativa and O. glaberrima, suggesting that a small accumulation of genic changes, following a Bateson-Dobzhansky-Muller (BDM) model, might be involved in the establishment of the sterility barrier. In this context, genetic incompatibilities involving the duplicated F-box genes as putative candidates, and a possible strengthening step involving the chromosomal inversion might participate to the reproductive barrier between Asian and African rice species.	[Guyot, Romain; Garavito, Andrea; Ghesquiere, Alain; Lorieux, Mathias] IRD, Plant Genome & Dev Lab, UMR 5096, CNRS,UPVD, Montpellier, France; [Tohme, Joe; Lorieux, Mathias] CIAT, Agrobiodivers & Biotechnol Project, Cali, Colombia; [Gavory, Frederick; Samain, Sylvie] Inst Genom, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Alliance; International Center for Tropical Agriculture - CIAT; UDICE-French Research Universities; Universite Paris Saclay	Guyot, R (corresponding author), IRD, UMR DIADE, Montpellier, France.	romain.guyot@ird.fr	GHESQUIERE, Alain/K-3068-2016; guyot, romain/AAE-2262-2021; Lorieux, Mathias J/A-9448-2011; guyot, romain/M-1118-2015	guyot, romain/0000-0002-7016-7485; guyot, romain/0000-0002-7016-7485; Garavito, Andrea/0000-0002-0864-8608; Gavory, Frederick/0000-0003-1534-5725	Generation Challenge Program; Departement Soutien et Formation (DSF) from Institut de Recherche pour le Developpement (IRD); Centro Internacional de Agricultura Tropical (CIAT)	Generation Challenge Program; Departement Soutien et Formation (DSF) from Institut de Recherche pour le Developpement (IRD); Centro Internacional de Agricultura Tropical (CIAT)	This work was supported by the Generation Challenge Program. The Departement Soutien et Formation (DSF) from Institut de Recherche pour le Developpement (IRD), and Centro Internacional de Agricultura Tropical (CIAT) provided the PhD scholarship of A. Garavito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2000, BIOINFORMATICS, V16, P743, DOI 10.1093/bioinformatics/16.8.743; Ammiraju JSS, 2008, PLANT CELL, V20, P3191, DOI 10.1105/tpc.108.063727; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Bateson W., 1909, DARWIN MODERN SCI, P81; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaparro C, 2007, NUCLEIC ACIDS RES, V35, pD66, DOI 10.1093/nar/gkl780; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; COYNE JA, 2004, SPECIATION SUNDERLAN; Dobzhansky T, 1936, GENETICS, V21, P113; Doi K., 2003, Advances in rice genetics, Los Banos, Laguna, Philippines, 22-27 October 2000, P149, DOI 10.1142/9789812814319_0059; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Garavito A, 2010, GENETICS, V185, P1425, DOI 10.1534/genetics.110.116772; Gusti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004780; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kim H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r45; Koide Y, 2008, NEW PHYTOL, V179, P888, DOI 10.1111/j.1469-8137.2008.02490.x; Kulathinal RJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000550; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; MARTINEZ CP, 1994, JPN J GENET, V69, P513, DOI 10.1266/jjg.69.513; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Muller HJ, 1942, BIOL S, V6, P71; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Orjuela J, 2010, THEOR APPL GENET, V120, P563, DOI 10.1007/s00122-009-1176-1; Osada N, 2005, GENETICS, V169, P259, DOI 10.1534/genetics.104.029231; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; PORTERES R, 1962, J AFR HIST, V3, P195, DOI 10.1017/S0021853700003030; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANO Y, 1990, GENETICS, V125, P183; SANO Y, 1994, J HERED, V85, P310, DOI 10.1093/oxfordjournals.jhered.a111465; Sarla N, 2005, CURR SCI INDIA, V89, P955; SECOND G, 1985, GENET SEL EVOL, V17, P89, DOI 10.1186/1297-9686-17-1-89; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; Thibaud-Nissen F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-317; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Vaughan DA, 2005, BREEDING SCI, V55, P113, DOI 10.1270/jsbbs.55.113; Wang YX, 2006, PLANTA, V223, P613, DOI 10.1007/s00425-005-0154-3; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; [No title captured]	62	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17726	10.1371/journal.pone.0017726	http://dx.doi.org/10.1371/journal.pone.0017726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423767	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100030
J	Botbol, M; Roubertoux, PL; Carlier, M; Trabado, S; Brailly-Tabard, S; Perez-Diaz, F; Bonnot, O; Bronsard, G; Tordjman, S				Botbol, Michel; Roubertoux, Pierre L.; Carlier, Michele; Trabado, Severine; Brailly-Tabard, Sylvie; Perez-Diaz, Fernando; Bonnot, Olivier; Bronsard, Guillaume; Tordjman, Sylvie			Modulation of Brain beta-Endorphin Concentration by the Specific Part of the Y Chromosome in Mice	PLOS ONE			English	Article							LARGE-SCALE SCREEN; PERIAQUEDUCTAL GRAY; OPIATE RECEPTORS; OPIOID RECEPTORS; INBRED STRAINS; AGGRESSION; MORPHINE; INVOLVEMENT; BEHAVIOR; STRESS	Background: Several studies in animal models suggest a possible effect of the specific part of the Y-chromosome (Y-NPAR) on brain opioid, and more specifically on brain beta-endorphin (BE). In humans, male prevalence is found in autistic disorder in which observation of abnormal peripheral or central BE levels are also reported. This suggests gender differences in BE associated with genetic factors and more precisely with Y-NPAR. Methodology/Principal Findings: Brain BE levels and plasma testosterone concentrations were measured in two highly inbred strains of mice, NZB/BlNJ (N) and CBA/HGnc (H), and their consomic strains for the Y-NPAR. An indirect effect of the Y-NPAR on brain BE level via plasma testosterone was also tested by studying the correlation between brain BE concentration and plasma testosterone concentration in eleven highly inbred strains. There was a significant and major effect (P < 0.0001) of the Y-NPAR in interaction with the genetic background on brain BE levels. Effect size calculated using Cohen's procedure was large (56% of the total variance). The variations of BE levels were not correlated with plasma testosterone which was also dependent of the Y-NPAR. Conclusions/Significance: The contribution of Y-NPAR on brain BE concentration in interaction with the genetic background is the first demonstration of Y-chromosome mediated control of brain opioid. Given that none of the genes encompassed by the Y-NPAR encodes for BE or its precursor, our results suggest a contribution of the sex-determining region (Sry, carried by Y-NPAR) to brain BE concentration. Indeed, the transcription of the Melanocortin 2 receptor gene (Mc2R gene, identified as the proopiomelanocortin receptor gene) depends on the presence of Sry and BE is derived directly from proopiomelanocortin. The results shed light on the sex dependent differences in brain functioning and the role of Sry in the BE system might be related to the higher frequency of autistic disorder in males.	[Botbol, Michel] INSERM, U669, Paris, France; [Roubertoux, Pierre L.] Aix Marseille Univ, INSERM, U910, Marseille, France; [Carlier, Michele] Inst Univ France, CNRS, UMR 6146, Lab Psychol Cognit, Marseille, France; [Trabado, Severine; Brailly-Tabard, Sylvie] Univ Paris Sud, CHU Bicetre, AP HP,Serv Genet Mol Pharmacogenet & Hormonol, INSERM,U693,Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France; [Perez-Diaz, Fernando] Grp Hosp Pitie Salpetriere, UFR Serv Hosp Univ Psychiat Enfant & Adolescent C, Ctr Emot, F-75634 Paris, France; [Bonnot, Olivier] Hop La Pitie Salpetriere, Serv Hosp Univ Psychiat Enfant & Adolescent, Paris, France; [Bronsard, Guillaume] Ecole Med LaTimone, Lab Sante Publ EA3279, Marseille, France; [Tordjman, Sylvie] CHGR, Serv Hosp Univ Psychiat Enfant & Adolescent Renne, Rennes, France; [Tordjman, Sylvie] Univ Rennes 1, Rennes, France; [Tordjman, Sylvie] Univ Paris 05, Lab Psychol Percept, Paris, France; [Tordjman, Sylvie] CNRS, UMR 8158, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; CHU Rennes; Universite de Rennes; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Botbol, M (corresponding author), INSERM, U669, Paris, France.	s.tordjman@yahoo.fr		Bonnot, Olivier/0000-0003-0005-4765; Trabado, Severine/0000-0002-1925-1999	INSERM [U910]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work is funded by INSERM U910. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOGIANNI P, 1989, NEUROENDOCRINOLOGY, V50, P372, DOI 10.1159/000125251; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAILEY DW, 1985, J HERED, V76, P107, DOI 10.1093/oxfordjournals.jhered.a110033; Barraclough C A, 1966, Recent Prog Horm Res, V22, P503; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Canastar A, 2008, ARCH SEX BEHAV, V37, P2, DOI 10.1007/s10508-007-9257-1; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DIEZGUERRA FJ, 1987, BRAIN RES, V424, P225, DOI 10.1016/0006-8993(87)91465-X; ESPERT R, 1993, AGGRESSIVE BEHAV, V19, P377, DOI 10.1002/1098-2337(1993)19:5<377::AID-AB2480190507>3.0.CO;2-Y; GERRA G, 1992, PSYCHIAT RES, V41, P179, DOI 10.1016/0165-1781(92)90109-G; GUILLOT PV, 1995, BEHAV GENET, V25, P357, DOI 10.1007/BF02197285; HAMMER RP, 1984, BRAIN RES, V308, P172, DOI 10.1016/0006-8993(84)90932-6; HAMMER RP, 1985, BRAIN RES, V360, P65, DOI 10.1016/0006-8993(85)91221-1; HANEY M, 1989, PSYCHOPHARMACOLOGY, V98, P68, DOI 10.1007/BF00442008; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; HORTON RJE, 1989, J ENDOCRINOL, V122, P509, DOI 10.1677/joe.0.1220509; IBARRA P, 1994, J TRAUMA STRESS, V7, P303, DOI 10.1002/jts.2490070210; *JACKS LAB, 2009, MOUS GEN DAT MGD MOU; KJAER A, 1992, NEUROENDOCRINOLOGY, V56, P419, DOI 10.1159/000126258; Laarakker MC, 2008, BEHAV GENET, V38, P159, DOI 10.1007/s10519-007-9188-6; Le Roy I, 2001, GENETICS, V158, P333; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; MARTINI L, 1989, J STEROID BIOCHEM, V33, P673, DOI 10.1016/0022-4731(89)90477-9; MAXSON SC, 1989, BEHAV NEURAL BIOL, V52, P251, DOI 10.1016/S0163-1047(89)90369-5; MEITES J, 1979, LIFE SCI, V24, P1325, DOI 10.1016/0024-3205(79)90001-8; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; MINER LL, 1993, PSYCHOPHARMACOLOGY, V111, P17, DOI 10.1007/BF02257401; MOUTIER R, 1991, LAB ANIM-UK, V25, P303, DOI 10.1258/002367791780809986; Neidhardt L, 2000, MECH DEVELOP, V98, P77, DOI 10.1016/S0925-4773(00)00453-6; PFEIFFER DG, 1983, PEPTIDES, V4, P647, DOI 10.1016/0196-9781(83)90012-8; ROUBERTOUX PL, 1994, CR ACAD SCI III-VIE, V317, P523; Roubertoux PL, 1999, TEC BEHAV N, V13, P696; SHAIKH MB, 1991, BRAIN RES, V559, P109, DOI 10.1016/0006-8993(91)90293-5; SHAIKH MB, 1990, AGGRESSIVE BEHAV, V16, P191, DOI 10.1002/1098-2337(1990)16:3/4<191::AID-AB2480160306>3.0.CO;2-7; Sluyter F, 1996, BEHAV GENET, V26, P489, DOI 10.1007/BF02359753; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; TAYA K, 1989, J ENDOCRINOL, V120, P509, DOI 10.1677/joe.0.1200509; Tordjman S, 2003, BEHAV GENET, V33, P529, DOI 10.1023/A:1025774716976; TORDJMAN S, 1995, NEUROSCI LETT, V183, P190, DOI 10.1016/0304-3940(94)11148-C; TORDJMAN S, 2001, MOL PSYCHIATR, V5, P831; Tordjman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005289; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; WEINER S, 1991, PHYSIOL BEHAV, V49, P1099, DOI 10.1016/0031-9384(91)90337-N; Wertz K, 2000, MECH DEVELOP, V98, P51, DOI 10.1016/S0925-4773(00)00452-4; YONEKAWA H, 1982, DIFFERENTIATION, V22, P222, DOI 10.1111/j.1432-0436.1982.tb01255.x	49	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16704	10.1371/journal.pone.0016704	http://dx.doi.org/10.1371/journal.pone.0016704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408198	Green Submitted, gold, Green Published			2022-12-25	WOS:000288170000005
J	Fath, S; Bauer, AP; Liss, M; Spriestersbach, A; Maertens, B; Hahn, P; Ludwig, C; Schafer, F; Graf, M; Wagner, R				Fath, Stephan; Bauer, Asli Petra; Liss, Michael; Spriestersbach, Anne; Maertens, Barbara; Hahn, Peter; Ludwig, Christine; Schaefer, Frank; Graf, Marcus; Wagner, Ralf			Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIGH-LEVEL EXPRESSION; AU-RICH ELEMENTS; ESCHERICHIA-COLI; HETEROLOGOUS EXPRESSION; IMMEDIATELY DOWNSTREAM; EFFICIENT EXPRESSION; RECOMBINANT PROTEIN; INITIATION CODON; CPG CONTENT	Autologous expression of recombinant human proteins in human cells for biomedical research and product development is often hampered by low expression yields limiting subsequent structural and functional analyses. Following RNA and codon optimization, 50 candidate genes representing five classes of human proteins - transcription factors, ribosomal and polymerase subunits, protein kinases, membrane proteins and immunomodulators - all showed reliable, and 86% even elevated expression. Analysis of three representative examples showed no detrimental effect on protein solubility while unaltered functionality was demonstrated for JNK1, JNK3 and CDC2 using optimized constructs. Molecular analysis of a sequence-optimized transgene revealed positive effects at transcriptional, translational, and mRNA stability levels. Since improved expression was consistent in HEK293T, CHO and insect cells, it was not restricted to distinct mammalian cell systems. Additionally, optimized genes represent powerful tools in functional genomics, as demonstrated by the successful rescue of an siRNA-mediated knockdown using a sequence-optimized counterpart. This is the first large-scale study addressing the influence of multiparameter optimization on autologous human protein expression.	[Fath, Stephan; Liss, Michael; Ludwig, Christine; Graf, Marcus; Wagner, Ralf] Geneart AG, Regensburg, Germany; [Bauer, Asli Petra; Wagner, Ralf] Univ Regensburg, Mol Microbiol & Gene Therapy Unit, Inst Med Microbiol & Hyg, Regensburg, Germany; [Spriestersbach, Anne; Maertens, Barbara; Hahn, Peter; Schaefer, Frank] QIAGEN GmbH, Hilden, Germany	University of Regensburg; QIAGEN GmbH	Wagner, R (corresponding author), Geneart AG, BioPark, Regensburg, Germany.	ralf.wagner@geneart.com			Geneart AG; Qiagen GmbH; Bayerische Forschungsstiftung [288/02]; QIAGEN	Geneart AG; Qiagen GmbH; Bayerische Forschungsstiftung; QIAGEN	This work was funded by Geneart AG (primary funder) and in part by Qiagen GmbH. Assessment of Mip1a expression and analysis of underlying molecular mechanisms was funded by the Bayerische Forschungsstiftung, Grant 288/02 (ForImmun). The funders designed the study, collected and analysed data, decided to publish and prepared the manuscript. Geneart AG performed gene synthesis and codon and RNA optimized constructs, performed and analyzed mammalian gene expression experiments, performed and analyzed functionality of JNK1 expression, performed siRNA-mediated knockdown of optimized genes and wrote the manuscript. The molecular analysis of MIP1a-expression was performed by University of Regensburg, Germany. Qiagen GmbH performed and analyzed Sf9 expression experiments and performed and analyzed the CDC2 rescue study.; The authors declare competing financial interests: Geneart performed the gene design, optimization and synthesis; optimized genes are marketed as QIAgenes by QIAGEN. The authors also declare competing interests in the form of patent family WO04059556 including all national patents and pending applications. The authors declare that all other data and materials described in the manuscript adhere to all the PLoS ONE policies on sharing data and materials. S. F., M. L., C. L., M. G. and R. W. are employed by Geneart AG; A. S., B. M., P. H. and F. S. are employed by Qiagen GmbH and A. P. B. and R. W. are employed by the University of Regensburg.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Andre S, 1998, J VIROL, V72, P1497; Anson DS, 2005, MOL BIOTECHNOL, V31, P85, DOI 10.1385/MB:31:1:085; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Brondyk WH, 2009, METHOD ENZYMOL, V463, P131, DOI 10.1016/S0076-6879(09)63011-1; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; FURTH PA, 1991, J VIROL, V65, P5806, DOI 10.1128/JVI.65.11.5806-5812.1991; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; GRAF M, 2009, SYSTEMS BIOL SYNTHET, P411, DOI DOI 10.1002/9780470437988.CH12; Graf Marcus, 2004, Methods Mol Med, V94, P197; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; IVANOV IG, 1992, EUR J BIOCHEM, V209, P151, DOI 10.1111/j.1432-1033.1992.tb17271.x; KINK JA, 1991, J PROTOZOOL, V38, P441, DOI 10.1111/j.1550-7408.1991.tb04814.x; KOSOVAC D, 2010, GENE THER, P1; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Levy JP, 1996, NAT BIOTECHNOL, V14, P610, DOI 10.1038/nbt0596-610; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MALDARELLI F, 1991, J VIROL, V65, P5732, DOI 10.1128/JVI.65.11.5732-5743.1991; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Nishikubo T, 2005, J BIOTECHNOL, V120, P341, DOI 10.1016/j.jbiotec.2005.06.032; Nomura M, 1984, Nucleic Acids Symp Ser, P173; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Rao DVK, 2008, MOL BIOTECHNOL, V38, P221, DOI 10.1007/s12033-007-9018-3; Robinson F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001801; SALSER W, 1977, COLD SPRING HARB SYM, V42, P985; Schirrmann T, 2008, FRONT BIOSCI-LANDMRK, V13, P4576, DOI 10.2741/3024; Schmidt M, 2002, INT ARCH ALLERGY IMM, V128, P264, DOI 10.1159/000063865; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sokolowski M, 1998, J VIROL, V72, P1504, DOI 10.1128/JVI.72.2.1504-1515.1998; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	53	114	163	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17596	10.1371/journal.pone.0017596	http://dx.doi.org/10.1371/journal.pone.0017596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408612	Green Published, gold			2022-12-25	WOS:000287965200032
J	Li, J; Jiang, DG; Zhou, H; Li, F; Yang, JW; Hong, LF; Fu, XA; Li, ZB; Liu, ZL; Li, JM; Zhuang, CX				Li, Jing; Jiang, Dagang; Zhou, Hai; Li, Feng; Yang, Jiawei; Hong, Laifa; Fu, Xiao; Li, Zhibin; Liu, Zhenlan; Li, Jianming; Zhuang, Chuxiong			Expression of RNA-Interference/Antisense Transgenes by the Cognate Promoters of Target Genes Is a Better Gene-Silencing Strategy to Study Gene Functions in Rice	PLOS ONE			English	Article							FLOWER PIGMENTATION; DOWN-REGULATION; CELL-DEATH; T-DNA; SEQUENCE; PLANTS; ARABIDOPSIS; FAMILY; METALLOTHIONEIN; TRANSFORMATION	Antisense and RNA interference (RNAi)-mediated gene silencing systems are powerful reverse genetic methods for studying gene function. Most RNAi and antisense experiments used constitutive promoters to drive the expression of RNAi/antisense transgenes; however, several reports showed that constitutive promoters were not expressed in all cell types in cereal plants, suggesting that the constitutive promoter systems are not effective for silencing gene expression in certain tissues/organs. To develop an alternative method that complements the constitutive promoter systems, we constructed RNAi and/or antisense transgenes for four rice genes using a constitutive promoter or a cognate promoter of a selected rice target gene and generated many independent transgenic lines. Genetic, molecular, and phenotypic analyses of these RNAi/antisense transgenic rice plants, in comparison to previously- reported transgenic lines that silenced similar genes, revealed that expression of the cognate promoter- driven RNAi/antisense transgenes resulted in novel growth/developmental defects that were not observed in transgenic lines expressing constitutive promoter- driven gene- silencing transgenes of the same target genes. Our results strongly suggested that expression of RNAi/antisense transgenes by cognate promoters of target genes is a better gene-silencing approach to discovery gene function in rice.	[Li, Jing; Jiang, Dagang; Zhou, Hai; Li, Feng; Yang, Jiawei; Hong, Laifa; Fu, Xiao; Li, Zhibin; Liu, Zhenlan; Zhuang, Chuxiong] S China Agr Univ, Key Lab Plant Funct Genom & Biotechnol, Educ Dept Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Li, Jianming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	South China Agricultural University; University of Michigan System; University of Michigan	Li, J (corresponding author), S China Agr Univ, Key Lab Plant Funct Genom & Biotechnol, Educ Dept Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	zhuangcx@scau.edu.cn	Li, Jianming/O-1772-2014; Zhou, Hai/AAY-8690-2020	Li, Jianming/0000-0003-3231-0778; 	National Basic Research Program of China [2005CB120802]; National High Technology Research and Development Program of China [2007AA10A144]; National Natural Science Foundation of China [30470983]; Genetically Modified Organisms breeding Major Projects [2008ZX08001-004]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms breeding Major Projects	This work was supported by the National Basic Research Program of China (2005CB120802, http://www.973.gov.cn/English/Index.aspx), the National High Technology Research and Development Program of China (2007AA10A144, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the National Natural Science Foundation of China (30470983, http://www.973.gov.cn/English/Index.aspx) and Genetically Modified Organisms breeding Major Projects (2008ZX08001-004, http://www.most.gov.cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-ali T, 2003, PLANT BIOTECHNOL J, V1, P337, DOI 10.1046/j.1467-7652.2003.00030.x; An Gynheung, 2008, V62, P95; [Anonymous], RICE GENOME ANNOTATI; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bouchez D, 1998, PLANT PHYSIOL, V118, P725, DOI 10.1104/pp.118.3.725; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Cooper SR, 1999, PHARMACOL THERAPEUT, V82, P427, DOI 10.1016/S0163-7258(99)00002-9; Elomaa P, 1996, MOL BREEDING, V2, P41; Frantz JM, 2004, AGRON J, V96, P1172, DOI 10.2134/agronj2004.1172; Fu WQ, 2007, BIOCHEM BIOPH RES CO, V356, P843, DOI 10.1016/j.bbrc.2007.03.010; GATZ C, 1992, PLANT J, V2, P397, DOI 10.1046/j.1365-313X.1992.t01-37-00999.x; Good L, 2003, CELL MOL LIFE SCI, V60, P854, DOI 10.1007/s00018-003-3045-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirsche J, 2009, THEOR APPL GENET, V118, P235, DOI 10.1007/s00122-008-0892-2; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Jan A, 2006, PLANT CELL PHYSIOL, V47, P244, DOI 10.1093/pcp/pci241; Leszczyszyn OI, 2007, PROTEINS, V68, P922, DOI 10.1002/prot.21463; Lin HN, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-18; Masclaux F, 2004, BIOCHEM BIOPH RES CO, V321, P364, DOI 10.1016/j.bbrc.2004.06.154; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; METT VL, 1993, P NATL ACAD SCI USA, V90, P4567, DOI 10.1073/pnas.90.10.4567; Nakatsuka T, 2007, PLANT BIOTECHNOL REP, V1, P251, DOI 10.1007/s11816-007-0039-y; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pastuglia M, 2003, CELL BIOL INT, V27, P249, DOI 10.1016/S1065-6995(02)00306-2; Praveen S, 2005, PLANT SCI, V168, P1011, DOI 10.1016/j.plantsci.2004.12.008; Rooke L, 2000, ANN APPL BIOL, V136, P167, DOI 10.1111/j.1744-7348.2000.tb00022.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Steffens B, 2009, PLANT CELL, V21, P184, DOI 10.1105/tpc.108.061887; Suwannaketchanatit C., 2006, Kasetsart Journal, Natural Sciences, V40, P934; The Arabidopsis Genome Initiative, 2000, NATURE, V408, P796; Upadhyaya N. M., 2007, RICE FUNCTIONAL GENO; VANDERKROL AR, 1990, PLANT MOL BIOL, V14, P457, DOI 10.1007/BF00027492; VASIL IK, 1999, MOL IMPROVEMENT CERE; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Yadetie F, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-12; YU SM, 1991, J BIOL CHEM, V266, P21131; Yuan J, 2008, PLANT PHYSIOL, V146, P1637, DOI 10.1104/pp.107.110304; Zuo JR, 2000, CURR OPIN BIOTECH, V11, P146, DOI 10.1016/S0958-1669(00)00073-2	41	25	31	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17444	10.1371/journal.pone.0017444	http://dx.doi.org/10.1371/journal.pone.0017444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408609	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200016
J	Pal, J; Bertheau, R; Buon, L; Qazi, A; Batchu, RB; Bandyopadhyay, S; Ali-Fehmi, R; Beer, DG; Weaver, DW; Reis, RJS; Goyal, RK; Huang, Q; Munshi, NC; Shammas, MA				Pal, J.; Bertheau, R.; Buon, L.; Qazi, A.; Batchu, R. B.; Bandyopadhyay, S.; Ali-Fehmi, R.; Beer, D. G.; Weaver, D. W.; Reis, R. J. Shmookler; Goyal, R. K.; Huang, Q.; Munshi, N. C.; Shammas, M. A.			Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome	ONCOGENE			English	Article						Barrett's adenocarcinoma; recombination; evolution; alu; hsRad51	TELOMERASE INHIBITION; DNA-REPAIR; CHROMOSOMAL INSTABILITY; GENETIC-CONTROL; GROWTH ARREST; UP-REGULATION; T-ANTIGEN; APC GENE; CANCER; ESOPHAGUS	A prominent feature of most cancers including Barrett's adenocarcinoma (BAC) is genetic instability, which is associated with development and progression of disease. In this study, we investigated the role of recombinase (hsRAD51), a key component of homologous recombination (HR)/repair, in evolving genomic changes and growth of BAC cells. We show that the expression of RAD51 is elevated in BAC cell lines and tissue specimens, relative to normal cells. HR activity is also elevated and significantly correlates with RAD51 expression in BAC cells. The suppression of RAD51 expression, by short hairpin RNA (shRNA) specifically targeting this gene, significantly prevented BAC cells from acquiring genomic changes to either copy number or heterozygosity (P<0.02) in several independent experiments employing single-nucleotide polymorphism arrays. The reduction in copy-number changes, following shRNA treatment, was confirmed by Comparative Genome Hybridization analyses of the same DNA samples. Moreover, the chromosomal distributions of mutations correlated strongly with frequencies and locations of Alu interspersed repetitive elements on individual chromosomes. We conclude that the hsRAD51 protein level is systematically elevated in BAC, contributes significantly to genomic evolution during serial propagation of these cells and correlates with disease progression. Alu sequences may serve as substrates for elevated HR during cell proliferation in vitro, as they have been reported to do during the evolution of species, and thus may provide additional targets for prevention or treatment of this disease. Oncogene (2011) 30, 3585-3598; doi:10.1038/onc.2011.83; published online 21 March 2011	[Pal, J.; Bertheau, R.; Buon, L.; Munshi, N. C.; Shammas, M. A.] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; [Pal, J.; Bertheau, R.; Goyal, R. K.; Huang, Q.; Munshi, N. C.; Shammas, M. A.] VA Hlth Care Syst, Dept Med Pathol, Boston, MA USA; [Qazi, A.; Batchu, R. B.; Bandyopadhyay, S.; Ali-Fehmi, R.; Weaver, D. W.] Wayne State Univ, Dept Surg Pathol, Detroit, MI USA; [Qazi, A.; Batchu, R. B.; Bandyopadhyay, S.; Ali-Fehmi, R.; Weaver, D. W.] Karmanos Canc Inst, Detroit, MI USA; [Beer, D. G.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Reis, R. J. Shmookler] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA; [Reis, R. J. Shmookler] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Reis, R. J. Shmookler] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Goyal, R. K.; Munshi, N. C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; University of Michigan System; University of Michigan; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Harvard University; Harvard Medical School	Shammas, MA (corresponding author), Dana Farber Canc Inst, 1400 VFW Pkwy,Bldg 3,Room 2A111, W Roxbury, MA 02132 USA.	Masood_Shammas@DFCI.Harvard.Edu	Munshi, Nikhil/ABE-2338-2021; Qazi, Aamer M/V-4249-2018	Qazi, Aamer M/0000-0003-0425-4246	National Cancer Institute [R01CA125711]; Department of Veterans Affairs; National Institutes of Health [RO1-1375555, P50-100007, PO1-78378]; NATIONAL CANCER INSTITUTE [R01CA125711, R01CA124929] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Cheng Li, Department of Bioinformatics and Dr Samir Amin, Departments of Medical Oncology and Bioinformatics, Dana Farber Cancer Institute, Boston, MA, USA, for their critical review of paper and guidance in data analyses. This work was supported in part by grants from National Cancer Institute (R01CA125711 to MAS), from the Department of Veterans Affairs (Merit Review Awards to NCM and RJSR and a Research Career Scientist Award to RJSR) and from the National Institutes of Health (RO1-1375555, P50-100007 and PO1-78378 to NCM).	Abdurashitov MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-305; Aggarwal S, 2000, NEOPLASIA, V2, P346, DOI 10.1038/sj.neo.7900097; Akagi T, 2009, INT J CANCER, V125, P2349, DOI 10.1002/ijc.24620; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Barlund M, 2000, CANCER RES, V60, P5340; Bastos HN, 2009, THYROID, V19, P1067, DOI 10.1089/thy.2009.0099; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bishop AJR, 2003, EXP MOL PATHOL, V74, P94, DOI 10.1016/S0014-4800(03)00010-8; BROOKFIELD JFY, 1994, BIOESSAYS, V16, P793, DOI 10.1002/bies.950161104; BRUNNER AM, 1986, BIOCHEMISTRY-US, V25, P5028, DOI 10.1021/bi00366a009; Cai JC, 2008, WORLD J GASTROENTERO, V14, P4070, DOI 10.3748/wjg.14.4070; Cheng RZ, 1997, EXP CELL RES, V234, P300, DOI 10.1006/excr.1997.3649; Croft J, 2002, EUR J GASTROEN HEPAT, V14, P1179, DOI 10.1097/00042737-200211000-00004; ECONOMOUPACHNIS A, 1985, P NATL ACAD SCI USA, V82, P2857, DOI 10.1073/pnas.82.9.2857; ECONOMOUPACHNIS A, 1985, NUCLEIC ACIDS RES, V13, P8379, DOI 10.1093/nar/13.23.8379; FARBER E, 1984, CANCER RES, V44, P4217; Finley JC, 2006, CANCER EPIDEM BIOMAR, V15, P1451, DOI 10.1158/1055-9965.EPI-05-0837; Frank B, 2010, CARCINOGENESIS, V31, P442, DOI 10.1093/carcin/bgp293; GALLI A, 1995, MOL GEN GENET, V248, P301, DOI 10.1007/BF02191597; GEE CJ, 1979, J CELL SCI, V36, P223; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2004, REPROD FERT DEVELOP, V16, P527, DOI 10.1071/RD03096; Hansen LT, 2003, INT J CANCER, V105, P472, DOI 10.1002/ijc.11106; HESS JF, 1983, P NATL ACAD SCI-BIOL, V80, P5970, DOI 10.1073/pnas.80.19.5970; Honma M, 1997, MOL CELL BIOL, V17, P4774, DOI 10.1128/MCB.17.8.4774; HORII A, 1992, CANCER RES, V52, P3231; Jara L, 2010, BREAST CANCER RES TR, V122, P813, DOI 10.1007/s10549-009-0709-2; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Koppert LB, 2005, J SURG ONCOL, V92, P169, DOI 10.1002/jso.20359; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li HZ, 2001, GENOME BIOL, V2; Li J, 1997, MUTAT RES-DNA REPAIR, V385, P173, DOI 10.1016/S0921-8777(97)00054-2; Lynch HT, 1998, ONCOLOGY-BASEL, V55, P103, DOI 10.1159/000011843; Lynch HT, 1998, DIGESTION, V59, P481, DOI 10.1159/000007525; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Maciejewski JP, 2008, BLOOD, V112, P965, DOI 10.1182/blood-2008-02-130435; MIKI H, 1991, CANCER LETT, V58, P107, DOI 10.1016/0304-3835(91)90031-C; MIKI Y, 1992, CANCER RES, V52, P643; Munshi NC, 2004, BLOOD, V103, P1799, DOI 10.1182/blood-2003-02-0402; NEIMAN PE, 1991, NEW BIOL, V3, P347; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Pathak S., 1994, In Vivo (Attiki), V8, P843; Paulson TG, 2009, CLIN CANCER RES, V15, P3305, DOI 10.1158/1078-0432.CCR-08-2494; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; RADMAN M, 1982, MUTAT RES, V98, P249, DOI 10.1016/0165-1110(82)90035-5; RESNICK MA, 1989, P NATL ACAD SCI USA, V86, P2276, DOI 10.1073/pnas.86.7.2276; RODARTERAMON US, 1972, RADIAT RES, V49, P148, DOI 10.2307/3573379; Romagnoli S, 2001, LAB INVEST, V81, P241, DOI 10.1038/labinvest.3780232; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SCHIMENTI JC, 1984, NUCLEIC ACIDS RES, V12, P1641, DOI 10.1093/nar/12.3.1641; SENGSTAG C, 1994, CRIT REV TOXICOL, V24, P323, DOI 10.3109/10408449409017922; Shammas MA, 1997, GENETICS, V146, P1417; Shammas MA, 1999, ONCOGENE, V18, P6191, DOI 10.1038/sj.onc.1203069; Shammas MA, 2004, GASTROENTEROLOGY, V126, P1337, DOI 10.1053/j.gastro.2004.01.026; Shammas MA, 2003, MOL CANCER THER, V2, P825; Shammas MA, 2008, CLIN CANCER RES, V14, P4971, DOI 10.1158/1078-0432.CCR-08-0473; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Silva SN, 2010, CANCER EPIDEMIOL, V34, P85, DOI 10.1016/j.canep.2009.11.002; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Stilgenbauer S, 2007, HAEMATOLOGICA, V92, P1242, DOI 10.3324/haematol.10720; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Sturgis EM, 1999, ARCH OTOLARYNGOL, V125, P185, DOI 10.1001/archotol.125.2.185; Tal A, 2009, J MOL BIOL, V393, P1007, DOI 10.1016/j.jmb.2009.09.011; Tsancheva M, 1997, Khirurgiia (Sofiia), V50, P40; Tselepis C, 2003, GUT, V52, P174, DOI 10.1136/gut.52.2.174; van Dekken H, 2001, AM J PATHOL, V158, P1961, DOI 10.1016/S0002-9440(10)64666-4; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; YAMADA Y, 1991, CANCER RES, V51, P5800; Ye CJ, 2007, CYTOGENET GENOME RES, V118, P237, DOI 10.1159/000108306; Yoshida N, 2007, INT J MOL MED, V19, P335	79	30	30	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	33					3585	3598		10.1038/onc.2011.83	http://dx.doi.org/10.1038/onc.2011.83			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21423218	Green Accepted			2022-12-25	WOS:000294005100003
J	Muttukrishna, S; Swer, M; Suri, S; Jamil, A; Calleja-Agius, J; Gangooly, S; Ludlow, H; Jurkovic, D; Jauniaux, E				Muttukrishna, Shanthi; Swer, Michelle; Suri, Sangeeta; Jamil, Amna; Calleja-Agius, Jean; Gangooly, Subrata; Ludlow, Helen; Jurkovic, Davor; Jauniaux, Eric			Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss?	PLOS ONE			English	Article							MATERNO-EMBRYONIC INTERFACE; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; INTERVILLOUS CIRCULATION; THREATENED MISCARRIAGE; BLOOD-FLOW; EXPRESSION; PREECLAMPSIA; CYTOKINES; OXYGEN	Recent data have indicated a relationship between placental oxygen and angiogenic protein levels in the first trimester of normal pregnancies. Our objective was to investigate if maternal serum levels of angiogenic factors Soluble vascular endothelial growth factor (VEGF) receptor 1 (sFlt-1), soluble Endoglin and placental growth factor (PlGF) are altered in women with symptoms of threatened miscarriage (TM) and if they are predictive of a subsequent miscarriage. Blood samples were collected at 6-10 weeks from women presenting with TM (n = 40), from asymptomatic controls (n = 32) and from non-pregnant women in their luteal phase (n = 14). All samples were assayed for serum level of sFLT-1, PlGF, sEndoglin and HSP70 using commercial ELISAs. Samples were analysed retrospectively on the basis of pregnancy outcome. TM group included 21 women with a normal pregnancy outcome and 19 with subsequent complete miscarriage. The latter subgroup had significantly lower mean maternal serum (MS) sFlt-1 (83%, P < 0.001) and PlGF (44%, P < 0.001) compared to those with a normal pregnancy outcome. Asymptomatic control pregnant women had similar MS levels of sFlt-1 and PlGF compared to the TM patients with a normal outcome. The mean MS sFlt-1 (> 10 fold) and MS PlGF (similar to 2 fold) levels were significantly (P < 0.001) higher in control pregnant women compared to the non-pregnant group in the luteal phase of the menstrual cycle. Soluble Endoglin was not altered in the normal pregnant women compared to non pregnant women, although lower in the TM subgroup with a subsequent miscarriage (similar to 25%, P < 0.001) compared to TM with a live birth. There was no significant difference in the mean MS HSP 70 levels between the different groups. This study shows that sFlt1 and PlGF MS levels are increased by several folds in early pregnancy and that MS sFlt-1 and MS PlGF are markedly decreased in threatened miscarriage patients who subsequently have a miscarriage suggesting these proteins are sensitive predictive markers of subsequent pregnancy loss.	[Muttukrishna, Shanthi] Univ Coll Cork, Cork Univ Matern Hosp, Anu Res Ctr, Dept Obstet & Gynaecol, Cork, Ireland; [Swer, Michelle; Suri, Sangeeta; Jamil, Amna; Calleja-Agius, Jean; Gangooly, Subrata; Ludlow, Helen; Jurkovic, Davor; Jauniaux, Eric] UCL, Inst Womens Hlth, London, England	University College Cork; University of London; University College London	Muttukrishna, S (corresponding author), Univ Coll Cork, Cork Univ Matern Hosp, Anu Res Ctr, Dept Obstet & Gynaecol, Cork, Ireland.	S.Muttukrishna@ucc.ie		Calleja Agius, Jean/0000-0001-6369-0297	UCLH charities for early pregnancy research; Anu Research Centre	UCLH charities for early pregnancy research; Anu Research Centre	Funding was provided by UCLH charities for early pregnancy research and Anu Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter N, 2001, CLIN EXP IMMUNOL, V126, P529, DOI 10.1046/j.1365-2249.2001.01663.x; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Choi HK, 2003, MOL REPROD DEV, V66, P24, DOI 10.1002/mrd.10331; DUAN L, 2010, ARCH GYNECOL OBSTET, V404, P1367; Gastrich MD, 2010, J MATERN-FETAL NEO M, V23, P751, DOI 10.3109/14767058.2010.481316; Greenwold N, 2003, FERTIL STERIL, V79, P1373, DOI 10.1016/S0015-0282(03)00364-9; Hasan R, 2009, OBSTET GYNECOL, V114, P860, DOI 10.1097/AOG.0b013e3181b79796; HUSTIN J, 1990, PLACENTA, V11, P477, DOI 10.1016/S0143-4004(05)80193-6; JAUNIAUX E, 1992, HISTOPATHOLOGY, V21, P409, DOI 10.1111/j.1365-2559.1992.tb00424.x; Jauniaux E, 2005, PLACENTA, V26, P114, DOI 10.1016/j.placenta.2004.05.011; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, FERTIL STERIL, V79, P100, DOI 10.1016/S0015-0282(02)04568-5; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; JAUNIAUX E, 1994, HUM REPROD, V9, P2432, DOI 10.1093/oxfordjournals.humrep.a138465; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jauniaux E, 2010, CURR OPIN OBSTET GYN, V22, P452, DOI 10.1097/GCO.0b013e3283404e44; Jenkins C, 2000, ANTIOXID REDOX SIGN, V2, P623, DOI 10.1089/15230860050192369; Johns J, 2003, OBSTET GYNECOL, V102, P483, DOI 10.1016/S0029-7844(03)00580-5; Johns J, 2006, OBSTET GYNECOL, V107, P845, DOI 10.1097/01.AOG.0000206186.91335.9a; Makhseed M, 2000, HUM REPROD, V15, P2011, DOI 10.1093/humrep/15.9.2011; Molvarec A, 2010, CELL STRESS CHAPERON, V15, P237, DOI 10.1007/s12192-009-0146-5; MUTTUKRISHNA S, 2008, PLOS ONE, V31, P1; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Reddy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004453; Silver RK, 2005, OBSTET GYNECOL, V105, P587, DOI 10.1097/01.AOG.0000152343.08096.c3; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Venkatesha S, 2006, NAT MED, V12, P862, DOI 10.1038/nm0706-862c; von Wolff M, 2000, MOL HUM REPROD, V6, P627; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Xing YN, 2001, PROTEIN SCI, V10, P226, DOI 10.1110/ps.25901	34	44	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18041	10.1371/journal.pone.0018041	http://dx.doi.org/10.1371/journal.pone.0018041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448460	Green Published, gold			2022-12-25	WOS:000288810500030
J	Mima, A; Abe, H; Nagai, K; Arai, H; Matsubara, T; Araki, M; Torikoshi, K; Tominaga, T; Iehara, N; Fukatsu, A; Kita, T; Doi, T				Mima, Akira; Abe, Hideharu; Nagai, Kojiro; Arai, Hidenori; Matsubara, Takeshi; Araki, Makoto; Torikoshi, Kazuo; Tominaga, Tatsuya; Iehara, Noriyuki; Fukatsu, Atsushi; Kita, Toru; Doi, Toshio			Activation of Src Mediates PDGF-Induced Smad1 Phosphorylation and Contributes to the Progression of Glomerulosclerosis in Glomerulonephritis	PLOS ONE			English	Article							MESANGIAL CELL-PROLIFERATION; GROWTH-FACTOR; C-SRC; SIGNALING PATHWAY; MATRIX EXPANSION; TYROSINE PHOSPHORYLATION; PROTEIN-SYNTHESIS; BETA; KINASE; EXPRESSION	Platelet-derived growth factor (PDGF) plays critical roles in mesangial cell (MC) proliferation in mesangial proliferative glomerulonephritis. We showed previously that Smad1 contributes to PDGF-dependent proliferation of MCs, but the mechanism by which Smad1 is activated by PDGF is not precisely known. Here we examined the role of c-Src tyrosine kinase in the proliferative change of MCs. Experimental mesangial proliferative glomerulonephritis (Thy1 GN) was induced by a single intravenous injection of anti-rat Thy-1.1 monoclonal antibody. In Thy1 GN, MC proliferation and type IV collagen (Col4) expression peaked on day 6. Immunohistochemical staining for the expression of phospho-Src (pSrc), phospho-Smad1 (pSmad1), Col4, and smooth muscle alpha-actin (SMA) revealed that the activation of c-Src and Smad1 signals in glomeruli peaked on day 6, consistent with the peak of mesangial proliferation. When treated with PP2, a Src inhibitor, both mesangial proliferation and sclerosis were significantly reduced. PP2 administration also significantly reduced pSmad1, Col4, and SMA expression. PDGF induced Col4 synthesis in association with increased expression of pSrc and pSmad1 in cultured MCs. In addition, PP2 reduced Col4 synthesis along with decreased pSrc and pSmad1 protein expression in vitro. Moreover, the addition of siRNA against c-Src significantly reduced the phosphorylation of Smad1 and the overproduction of Col4. These results provide new evidence that the activation of Src/Smad1 signaling pathway plays a key role in the development of glomerulosclerosis in experimental glomerulonephritis.	[Mima, Akira; Abe, Hideharu; Nagai, Kojiro; Tominaga, Tatsuya; Doi, Toshio] Univ Tokushima, Dept Nephrol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Arai, Hidenori] Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Kyoto, Japan; [Mima, Akira; Matsubara, Takeshi; Araki, Makoto; Torikoshi, Kazuo; Iehara, Noriyuki; Fukatsu, Atsushi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Kita, Toru] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan	Tokushima University; Kyoto University; Kyoto University; Kyoto University	Mima, A (corresponding author), Univ Tokushima, Dept Nephrol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	abeabe@clin.med.tokushima-u.ac.jp	Arai, Hidenori/P-9816-2017; FUKATSU, ATSUSHI/R-7941-2019	Arai, Hidenori/0000-0002-9000-6849; Araki, Makoto/0000-0003-0854-4064	Japan Society for the Promotion [21591033, 19590973]	Japan Society for the Promotion(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion (no. 21591033 and 19590973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Catapano F, 2008, AM J KIDNEY DIS, V52, P475, DOI 10.1053/j.ajkd.2008.03.008; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; FLOEGE J, 1993, J CLIN INVEST, V92, P2952, DOI 10.1172/JCI116918; FLOEGE J, 1995, MINER ELECTROL METAB, V21, P271; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; FOGO A, 1989, SEMIN NEPHROL, V9, P329; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; JOHNSON RJ, 1993, J AM SOC NEPHROL, V4, P119; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1998, DEVELOPMENT, V125, P3313; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Mima A, 2006, LAB INVEST, V86, P927, DOI 10.1038/labinvest.3700445; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pan DB, 2007, BIOCHEM CELL BIOL, V85, P606, DOI 10.1139/O07-064; Peters H, 1998, KIDNEY INT, V54, P1570, DOI 10.1046/j.1523-1755.1998.00164.x; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; SILVER BJ, 1989, P NATL ACAD SCI USA, V86, P1056, DOI 10.1073/pnas.86.3.1056; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Spreafico A, 2008, FASEB J, V22, P1560, DOI 10.1096/fj.07-9873com; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; Takikita-Suzuki M, 2003, AM J PATHOL, V163, P277, DOI 10.1016/S0002-9440(10)63651-6; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; THROCKMORTON DC, 1995, KIDNEY INT, V48, P111, DOI 10.1038/ki.1995.274; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771	46	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17929	10.1371/journal.pone.0017929	http://dx.doi.org/10.1371/journal.pone.0017929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445358	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100017
J	Grespi, F; Ottina, E; Yannoutsos, N; Geley, S; Villunger, A				Grespi, Francesca; Ottina, Eleonora; Yannoutsos, Nikolaos; Geley, Stephan; Villunger, Andreas			Generation and Evaluation of an IPTG-Regulated Version of Vav-Gene Promoter for Mouse Transgenesis	PLOS ONE			English	Article							COLI LAC REPRESSOR; HEMATOPOIETIC COMPARTMENT; FLUORESCENT PROTEIN; IN-VIVO; EXPRESSION; SYSTEM; CELLS; MICE; MUTAGENESIS; LINEAGES	Different bacteria-derived systems for regulatable gene expression have been developed for the use in mammalian cells and some were also successfully adopted for in vivo use in vertebrate model organisms. However, certain limitations apply to most of these systems, including leakiness of transgene expression, inefficient transgene silencing or activation, as well as limited tissue accessibility of transgene-inducers or their unfavourable pharmacokinetics. In this study, we evaluated the suitability of the lac-operon/lac-repressor (lacO/lacI) system for the regulation of the well-established Vav-gene promoter that allows inducible transgene expression in different haematopoietic lineages in mice. Using the fluorescence marker protein Venus as a reporter, we observed that the lacO/lacI system could be amended to modulate transgene-expression in haematopoietic cells. However, reporter expression was not uniform and the lacO elements introduced into the Vav-gene promoter only conferred limited repression and reversion of lacI-mediated gene silencing after administration of IPTG. Although further optimization of the system is required, the lacO-modified version of the Vav-gene promoter may be adopted as a tool where low basal gene-expression and limited transient induction of protein expression are desired, e. g. for the activation of oncogenes or transgenes that act in a dominant-negative manner.	[Grespi, Francesca; Ottina, Eleonora; Villunger, Andreas] Med Univ Innsbruck, Div Dev Immunol, Innsbruck, Austria; [Yannoutsos, Nikolaos] Med Univ Innsbruck, Div Cell Biol, Innsbruck, Austria; [Geley, Stephan] Med Univ Innsbruck, Innsbruck Bioctr, Div Mol Pathophysiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Grespi, F (corresponding author), Med Univ Innsbruck, Div Dev Immunol, Innsbruck, Austria.	andreas.villunger@i-med.ac.at		Grespi, Francesca/0000-0002-0369-7793; Ottina, Eleonora/0000-0002-9630-496X	Austrian Science Fund (FWF) [SFB021]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Graduate School for Molecular Biology and Oncology (MCBO) and the SFB021, both funded by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Campbell KJ, 2010, BLOOD; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Cronin CA, 2001, GENE DEV, V15, P1506, DOI 10.1101/gad.892001; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Ogilvy S, 1999, BLOOD, V94, P1855; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Robertson A, 2002, GENE, V282, P65, DOI 10.1016/S0378-1119(01)00793-4; Ryan Amy, 2004, Mol Imaging, V3, P33, DOI 10.1162/153535004773861705; Scrable H, 2002, SEMIN CELL DEV BIOL, V13, P109, DOI 10.1016/S1084-9521(02)00017-4; Scrable H, 1997, GENETICS, V147, P297; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Williams A, 2008, NUCLEIC ACIDS RES, V36, P2320, DOI 10.1093/nar/gkn085; WYBORSKI DL, 1991, NUCLEIC ACIDS RES, V19, P4647, DOI 10.1093/nar/19.17.4647	21	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18051	10.1371/journal.pone.0018051	http://dx.doi.org/10.1371/journal.pone.0018051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445314	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300031
J	Oudiette, D; Constantinescu, I; Leclair-Visonneau, L; Vidailhet, M; Schwartz, S; Arnulf, I				Oudiette, Delphine; Constantinescu, Irina; Leclair-Visonneau, Laurene; Vidailhet, Marie; Schwartz, Sophie; Arnulf, Isabelle			Evidence for the Re-Enactment of a Recently Learned Behavior during Sleepwalking	PLOS ONE			English	Article							SLOW-WAVE SLEEP; REM-SLEEP; MEMORY CONSOLIDATION; DISORDER; EXPERIENCE	Animal studies have shown that sequenced patterns of neuronal activity may be replayed during sleep. However, the existence of such replay in humans has not yet been directly demonstrated. Here we studied patients who exhibit overt behaviors during sleep to test whether sequences of movements trained during the day may be spontaneously reenacted by the patients during sleep. We recruited 19 sleepwalkers (who displayed complex and purposeful behaviors emerging from non REM sleep), 20 patients with REM sleep behavior disorder (who enacted their dreams in REM sleep) and 18 healthy controls. Continuous video sleep recordings were performed during sleep following intensive training on a sequence of large movements (learned during a variant of the serial reaction time task). Both patient groups showed learning of the intensively trained motor sequence after sleep. We report the re-enactment of a fragment of the recently trained motor behavior during one sleepwalking episode. This study provides, to our knowledge, the first evidence of a temporally-structured replay of a learned behavior during sleep in humans. Our observation also suggests that the study of such sleep disorders may provide unique and critical information about cognitive functions operating during sleep.	[Oudiette, Delphine; Leclair-Visonneau, Laurene; Arnulf, Isabelle] Hop La Pitie Salpetriere, APHP, Sleep Disorders Unit, Paris, France; [Vidailhet, Marie; Arnulf, Isabelle] INSERM, U975, Paris, France; [Oudiette, Delphine; Leclair-Visonneau, Laurene; Vidailhet, Marie; Arnulf, Isabelle] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Constantinescu, Irina; Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Constantinescu, Irina; Schwartz, Sophie] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland; [Constantinescu, Irina; Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci NCCR, Geneva, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva; University of Geneva; University of Geneva	Oudiette, D (corresponding author), Hop La Pitie Salpetriere, APHP, Sleep Disorders Unit, Paris, France.	isabelle.arnulf@psl.aphp.fr	Leclair-Visonneau, Laurène/GZL-7934-2022; Oudiette, Delphine/AAE-1808-2019	Leclair-Visonneau, Laurène/0000-0001-6379-0765; Oudiette, Delphine/0000-0002-6598-4130; Schwartz, Sophie/0000-0001-7718-4053; Arnulf, Isabelle/0000-0002-2240-2516	Brain Research Federation (FRC); ADOREP (Association pour le Developpement et l'Organisation de la Recherche En Pneumologie); France Parkinson; French Sleep Society (SFRMS); Swiss National Science Foundation [310000-114008, 3200B0-104100]; European Sleep Research Society (ESRS)	Brain Research Federation (FRC); ADOREP (Association pour le Developpement et l'Organisation de la Recherche En Pneumologie); France Parkinson; French Sleep Society (SFRMS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Sleep Research Society (ESRS)	The study was funded by the Brain Research Federation (FRC) and ADOREP (Association pour le Developpement et l'Organisation de la Recherche En Pneumologie, grants to IA), France Parkinson and the French Sleep Society (SFRMS) (grants to DO), and by the Swiss National Science Foundation (grants # 310000-114008, # 3200B0-104100 to SS). IC was awarded a European Network of Sleep Training Laboratories (ENSTL) grant from the European Sleep Research Society (ESRS) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DECOCK VC, 2007, NAT NEUROSCI, V12, P919; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; EPSTEIN AW, 1985, AM J PSYCHIAT, V142, P123; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; Frauscher B, 2008, SLEEP, V31, P724, DOI 10.1093/sleep/31.5.724; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Leclair-Visonneau L, 2010, BRAIN, V133, P1737, DOI 10.1093/brain/awq110; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Oudiette D, 2009, NEUROLOGY, V72, P551, DOI 10.1212/01.wnl.0000341936.78678.3a; OUDIETTE D, 2010, SLEEP MED; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; SCHENCKCH, 1986, SLEEP, V9, P293; Schwartz S, 2003, TRENDS COGN SCI, V7, P325, DOI 10.1016/S1364-6613(03)00162-1; Sforza E, 1997, Sleep Med Rev, V1, P57, DOI 10.1016/S1087-0792(97)90006-X; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	32	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18056	10.1371/journal.pone.0018056	http://dx.doi.org/10.1371/journal.pone.0018056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445313	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300032
J	Cui, JA; Li, F; Wang, GQ; Fang, XD; Puett, JD; Xu, Y				Cui, Juan; Li, Fan; Wang, Guoqing; Fang, Xuedong; Puett, J. David; Xu, Ying			Gene-Expression Signatures Can Distinguish Gastric Cancer Grades and Stages	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HISTOLOGICAL CLASSIFICATION; MICROARRAY DATABASE; CLAUDIN-7	Microarray gene-expression data of 54 paired gastric cancer and adjacent noncancerous gastric tissues were analyzed, with the aim to establish gene signatures for cancer grades (well-, moderately-, poorly-or un-differentiated) and stages (I, II, III and IV), which have been determined by pathologists. Our statistical analysis led to the identification of a number of gene combinations whose expression patterns serve well as signatures of different grades and different stages of gastric cancer. A 19-gene signature was found to have discerning power between high-and low-grade gastric cancers in general, with overall classification accuracy at 79.6%. An expanded 198-gene panel allows the stratification of cancers into four grades and control, giving rise to an overall classification agreement of 74.2% between each grade designated by the pathologists and our prediction. Two signatures for cancer staging, consisting of 10 genes and 9 genes, respectively, provide high classification accuracies at 90.0% and 84.0%, among early-, advanced-stage cancer and control. Functional and pathway analyses on these signature genes reveal the significant relevance of the derived signatures to cancer grades and progression. To the best of our knowledge, this represents the first study on identification of genes whose expression patterns can serve as markers for cancer grades and stages.	[Cui, Juan; Puett, J. David; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Li, Fan; Wang, Guoqing] Jilin Univ, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China; [Fang, Xuedong] Jilin Univ, Affiliated Hosp 2, Changchun 130023, Jilin, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Cui, Juan; Puett, J. David; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Jilin University; Jilin University; Jilin University; University System of Georgia; University of Georgia	Cui, JA (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Puett, J. David/AIE-8612-2022		National Science Foundation [DEB-0830024, DBI-0542119]; National Institutes of Health [1R01GM075331]; Georgia Cancer Coalition; President's Venture Fund; Office of the Vice President for Research of the University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; President's Venture Fund; Office of the Vice President for Research of the University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Science Foundation (DEB-0830024, DBI-0542119), the National Institutes of Health (1R01GM075331), a "Distinguished Scholar" grant from the Georgia Cancer Coalition, and a seed fund jointly from the President's Venture Fund and the Office of the Vice President for Research of the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; *AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Chauhan SC, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-21; CUI J, 2010, NUCL ACIDS RES; de Souza BF, 2005, GENET MOL RES, V4, P599; Fontana MG, 2003, BRIT J CANCER, V88, P401, DOI 10.1038/sj.bjc.6600663; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; GOSEKI N, 1992, GUT, V33, P606, DOI 10.1136/gut.33.5.606; Hornsby CD, 2007, ARCH PATHOL LAB MED, V131, P1541; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim S, 2007, MOL CELLS, V24, P200; LAUREN T, 1965, ACTA PATHOL MIC SC, P34; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Lee JW, 2005, GYNECOL ONCOL, V97, P53, DOI 10.1016/j.ygyno.2004.11.058; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1; MARTIN IG, 1994, GUT, V35, P758, DOI 10.1136/gut.35.6.758; OOTA K, 1977, INT HISTOLOGICAL CLA, V18; Park JY, 2007, ONCOL REP, V18, P377; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Silva EM, 2008, GASTRIC CANCER, V11, P149, DOI 10.1007/s10120-008-0468-5; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; TAKENO A, 2009, ANN SURG ONCOL; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x	34	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17819	10.1371/journal.pone.0017819	http://dx.doi.org/10.1371/journal.pone.0017819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445269	gold, Green Published			2022-12-25	WOS:000288545100033
J	Salvagiotto, G; Burton, S; Daigh, CA; Rajesh, D; Slukvin, II; Seay, NJ				Salvagiotto, Giorgia; Burton, Sarah; Daigh, Christine A.; Rajesh, Deepika; Slukvin, Igor I.; Seay, Nicholas J.			A Defined, Feeder-Free, Serum-Free System to Generate In Vitro Hematopoietic Progenitors and Differentiated Blood Cells from hESCs and hiPSCs	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; CD34(+) CELLS; EFFICIENT DIFFERENTIATION; VASCULAR DEVELOPMENT; PLATELET PRODUCTION; STROMAL CELLS; MOUSE; EXPANSION; MESODERM	Human ESC and iPSC are an attractive source of cells of high quantity and purity to be used to elucidate early human development processes, for drug discovery, and in clinical cell therapy applications. To efficiently differentiate pluripotent cells into a pure population of hematopoietic progenitors we have developed a new 2-dimentional, defined and highly efficient protocol that avoids the use of feeder cells, serum or embryoid body formation. Here we showed that a single matrix protein in combination with growth factors and a hypoxic environment is sufficient to generate from pluripotent cells hematopoietic progenitors capable of differentiating further in mature cell types of different lineages of the blood system. We tested the differentiation method using hESCs and 9 iPSC lines generated from different tissues. These data indicate the robustness of the protocol providing a valuable tool for the generation of clinical-grade hematopoietic cells from pluripotent cells.	[Salvagiotto, Giorgia; Burton, Sarah; Daigh, Christine A.; Rajesh, Deepika; Seay, Nicholas J.] Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA; [Slukvin, Igor I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Salvagiotto, G (corresponding author), Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA.	giorgia.salvagiotto@gmail.com		Rajesh, Deepika/0000-0002-8820-4328	Cellular Dynamics International, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081962] Funding Source: NIH RePORTER	Cellular Dynamics International, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research funding from Cellular Dynamics International, Inc. to all authors. The funder had a role in the decision to publish the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Bruno S, 2004, STEM CELLS, V22, P135, DOI 10.1634/stemcells.22-2-135; Bruno S, 2003, HAEMATOLOGICA, V88, P379; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Decaudin D, 2004, BONE MARROW TRANSPL, V34, P1089, DOI 10.1038/sj.bmt.1704675; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; KIM K, 2010, NATURE; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; KULKEAW K, 2010, STEM CELL REV; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lengerke C, 2010, BLOOD REV, V24, P27, DOI 10.1016/j.blre.2009.10.001; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; LU SJ, 2011, CELL RES; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Mattia G, 2008, EXP HEMATOL, V36, P244, DOI 10.1016/j.exphem.2007.09.006; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Perez LE, 2001, BLOOD, V97, P1635, DOI 10.1182/blood.V97.6.1635; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Purpura KA, 2008, STEM CELLS, V26, P2832, DOI 10.1634/stemcells.2008-0237; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tijssen MR, 2008, LEUKEMIA, V22, P203, DOI 10.1038/sj.leu.2404979; van Hensbergen Y, 2006, EXP HEMATOL, V34, P943, DOI 10.1016/j.exphem.2006.04.009; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	56	47	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17829	10.1371/journal.pone.0017829	http://dx.doi.org/10.1371/journal.pone.0017829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445267	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100036
J	Shan, PF; Lu, Y; Cui, RR; Jiang, Y; Yuan, LQ; Liao, EY				Shan, Peng-Fei; Lu, Ying; Cui, Rong-Rong; Jiang, Yi; Yuan, Ling-Qing; Liao, Er-Yuan			Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							ENDOGENOUS LIGAND APELIN; ENDOTHELIAL-CELLS; PEPTIDE APELIN; APJ RECEPTOR; IN-VIVO; IMMUNOCYTOCHEMICAL LOCALIZATION; BETA-GLYCEROPHOSPHATE; CARDIAC CONTRACTILITY; TISSUE DISTRIBUTION; OXIDATIVE STRESS	Vascular calcification, which results from a process osteoblastic differentiation of vascular smooth muscle cells (VSMCs), is a major risk factor for cardiovascular morbidity and mortality. Apelin is a recently discovered peptide that is the endogenous ligand for the orphan G-protein-coupled receptor, APJ. Several studies have identified the protective effects of apelin on the cardiovascular system. However, the effects and mechanisms of apelin on the osteoblastic differentiation of VSMCs have not been elucidated. Using a culture of calcifying vascular smooth muscle cells (CVMSCs) as a model for the study of vascular calcification, the relationship between apelin and the osteoblastic differentiation of VSMCs and the signal pathway involved were investigated. Alkaline phosphatase (ALP) activity and osteocalcin secretion were examined in CVSMCs. The involved signal pathway was studied using the extracellular signal-regulated kinase (ERK) inhibitor, PD98059, the phosphatidylinositol 3-kinase (PI3-K) inhibitor, LY294002, and APJ siRNA. The results showed that apelin inhibited ALP activity, osteocalcin secretion, and the formation of mineralized nodules. APJ protein was detected in CVSMCs, and apelin activated ERK and AKT (a downstream effector of PI3-K). Suppression of APJ with siRNA abolished the apelin-induced activation of ERK and Akt. Furthermore, inhibition of APJ expression, and the activation of ERK or PI3-K, reversed the effects of apelin on ALP activity. These results showed that apelin inhibited the osteoblastic differentiation of CVSMCs through the APJ/ERK and APJ/PI3-K/AKT signaling pathway. Apelin appears to play a protective role against arterial calcification.	[Shan, Peng-Fei] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Ying] Peoples Hosp Zhongshan City, Dept Endocrinol & Metab, Zhongshan, Guangdong, Peoples R China; [Shan, Peng-Fei; Lu, Ying; Cui, Rong-Rong; Yuan, Ling-Qing; Liao, Er-Yuan] Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Cui, Rong-Rong] Cent S Univ, Xiang Ya Hosp 2, Dept Pediat, Changsha, Hunan, Peoples R China; [Jiang, Yi] Cent S Univ, Xiang Ya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China	Zhejiang University; Central South University; Central South University; Central South University	Yuan, LQ (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.	allenylq@hotmail.com	; Yuan, Ling-Qing/D-2102-2019	Shan, Peng-Fei/0000-0002-6684-9395; Yuan, Ling-Qing/0000-0001-8602-7113; Yi, Jiang/0000-0002-7877-0561	Health Department of Zhejiang Province [2009QN012]; National Natural Science Foundation of China [30801203]; Ph. D. Programs Foundation of Ministry of Education of China [200805331017]; China Postdoctoral Science Foundation [20100471240]	Health Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funding from the Health Department of Zhejiang Province (2009QN012), the National Natural Science Foundation of China (30801203), the Ph. D. Programs Foundation of Ministry of Education of China (No. 200805331017) and China Postdoctoral Science Foundation (20100471240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Alexander MY, 2005, ARTERIOSCL THROM VAS, V25, P1851, DOI 10.1161/01.ATV.0000175750.94742.46; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Cai Y, 2010, ACTA PHARMACOL SIN, V31, P1359, DOI 10.1038/aps.2010.89; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; Cui RR, 2010, AMINO ACIDS, V39, P1193, DOI 10.1007/s00726-010-0555-x; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Hashimoto T, 2007, AM J PATHOL, V171, P1705, DOI 10.2353/ajpath.2007.070471; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kanazawa I, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-51; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lee SK, 2009, BIOL PHARM BULL, V32, P1328, DOI 10.1248/bpb.32.1328; Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8; Liao XB, 2010, AMINO ACIDS, V39, P375, DOI 10.1007/s00726-009-0448-z; Lin IC, 2008, PLAST RECONSTR SURG, V121, P1554, DOI 10.1097/PRS.0b013e31816c3bd7; Liu CH, 2010, ACTA BIOCH BIOPH SIN, V42, P396, DOI 10.1093/abbs/gmq035; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Masri B, 2005, CELL SIGNAL, V17, P415, DOI 10.1016/j.cellsig.2004.09.018; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Nishiwaki-Yasuda K, 2007, ENDOCR J, V54, P103, DOI 10.1507/endocrj.K06-093; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Peltonen T, 2009, J HEART VALVE DIS, V18, P644; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000157671.47477.71; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shi YL, 2009, J CELL BIOCHEM, V108, P1184, DOI 10.1002/jcb.22348; Shi Y, 2009, BIOMETALS, V22, P317, DOI 10.1007/s10534-008-9168-1; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Xie H, 2006, REGUL PEPTIDES, V134, P118, DOI 10.1016/j.regpep.2006.02.004; You HZ, 2009, RENAL FAILURE, V31, P313, DOI 10.1080/08860220902875182	58	49	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17938	10.1371/journal.pone.0017938	http://dx.doi.org/10.1371/journal.pone.0017938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437254	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100046
J	Wang, DP; Yu, J				Wang, Dapeng; Yu, Jun			Both Size and GC-Content of Minimal Introns Are Selected in Human Populations	PLOS ONE			English	Article							HUMAN GENOME; DROSOPHILA; EVOLUTION; LENGTH; POLYMORPHISM; EQUILIBRIUM; CONSTRAINTS; SEQUENCE; DYNAMICS; MODEL	Background: We previously have studied the insertion and deletion polymorphism by sequencing no more than one hundred introns in a mixed human population and found that the minimal introns tended to maintain length at an optimal size. Here we analyzed re-sequenced 179 individual genomes (from African, European, and Asian populations) from the data released by the 1000 Genome Project to study the size dynamics of minimal introns. Principal Findings: We not only confirmed that minimal introns in human populations are selected but also found two major effects in minimal intron evolution: (i) Size-effect: minimal introns longer than an optimal size (87 nt) tend to have a higher ratio of deletion to insertion than those that are shorter than the optimal size; (ii) GC-effect: minimal introns with lower GC content tend to be more frequently deleted than those with higher GC content. The GC-effect results in a higher GC content in minimal introns than their flanking exons as opposed to larger introns (>= 125 nt) that always have a lower GC content than that of their flanking exons. We also observed that the two effects are distinguishable but not completely separable within and between populations. Conclusions: We validated the unique mutation dynamics of minimal introns in keeping their near-optimal size and GC content, and our observations suggest potentially important functions of human minimal introns in transcript processing and gene regulation.	[Wang, Dapeng; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wang, Dapeng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, DP (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn	Wang, Dapeng/AAK-5651-2020; 郑, 征/C-8514-2011; Wang, Dapeng/HGD-4818-2022	Wang, Dapeng/0000-0002-9925-4574; 	National Science and Technology [2008ZX1004-013]; 863 Program [2009AA01A130]; Ministry of Science and Technology of the People's Republic of China [2011CB944101]	National Science and Technology; 863 Program(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants from Key Project of National Science and Technology (2008ZX1004-013), 863 Program (2009AA01A130), and 973 Program (2011CB944101) of the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2010, GENOME RES; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Comeron JM, 2000, GENETICS, V156, P1175; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Fedorov A, 2003, GENOME RES, V13, P2236, DOI 10.1101/gr.1029803; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r67; Johnson KP, 2004, MOL BIOL EVOL, V21, P599, DOI 10.1093/molbev/msh051; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Parsch J, 2003, GENETICS, V165, P1843; Parsch J, 2010, MOL BIOL EVOL, V27, P1226, DOI 10.1093/molbev/msq046; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Presgraves DC, 2006, MOL BIOL EVOL, V23, P2203, DOI 10.1093/molbev/msl094; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2005, P NATL ACAD SCI USA, V102, P713, DOI 10.1073/pnas.0408274102; Sjodin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008650; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; Wang DP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-20; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang HF, 2007, BIOCHEM BIOPH RES CO, V354, P203, DOI 10.1016/j.bbrc.2006.12.184; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010144	31	11	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17945	10.1371/journal.pone.0017945	http://dx.doi.org/10.1371/journal.pone.0017945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437290	Green Published, gold, Green Submitted			2022-12-25	WOS:000288514600017
J	Shiheido, H; Takashima, H; Doi, N; Yanagawa, H				Shiheido, Hirokazu; Takashima, Hideaki; Doi, Nobuhide; Yanagawa, Hiroshi			mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction	PLOS ONE			English	Article							IN-VITRO; HIGH-AFFINITY; CURRENT STRATEGIES; P53 PATHWAY; CELL-DEATH; PROTEIN; ACTIVATION; BINDING; DESIGN; TARGET	p53 is a tumor suppressor protein that prevents tumorigenesis through cell cycle arrest or apoptosis of cells in response to cellular stress such as DNA damage. Because the oncoprotein MDM2 interacts with p53 and inhibits its activity, MDM2-p53 interaction has been a major target for the development of anticancer drugs. While previous studies have used phage display to identify peptides (such as DI) that inhibit the MDM2-p53 interaction, these peptides were not sufficiently optimized because the size of the phage-displayed random peptide libraries did not cover all of the possible sequences. In this study, we performed selection of MDM2-binding peptides from large random peptide libraries in two stages using mRNA display. We identified an optimal peptide named MIP that inhibited the MDM2-p53 and MDMX-p53 interactions 29- and 13-fold more effectively than DI, respectively. Expression of MIP fused to the thioredoxin scaffold protein in living cells by adenovirus caused stabilization of p53 through its interaction with MDM2, resulting in activation of the p53 pathway. Furthermore, expression of MIP also inhibited tumor cell proliferation in a p53-dependent manner more potently than DI. These results show that two-stage, mRNA-displayed peptide selection is useful for the rapid identification of potent peptides that target oncoproteins.	[Shiheido, Hirokazu; Takashima, Hideaki; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Shiheido, H (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	doi@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Shiheido, Hirokazu/0000-0002-1415-2019; Doi, Nobuhide/0000-0002-2402-6390	MEXT of Japan [19360377, 19657073, 22360351, S0801008]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: Financial support for this study was provided by a Grant-in-Aid for Scientific Research (19360377, 19657073, 22360351) and a Strategic Research Foundation Grant-aided Project for Private Universities (S0801008) from the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; Borghouts C, 2005, J PEPT SCI, V11, P713, DOI 10.1002/psc.717; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Bottger V, 1996, ONCOGENE, V13, P2141; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; Chene P, 2002, FEBS LETT, V529, P293, DOI 10.1016/S0014-5793(02)03362-8; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Frankel A, 2003, CHEM BIOL, V10, P1043, DOI 10.1016/j.chembiol.2003.11.004; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Guarracino DA, 2009, CHEM BIOL, V16, P919, DOI 10.1016/j.chembiol.2009.09.005; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Jackson MW, 2001, J BIOL CHEM, V276, P25336, DOI 10.1074/jbc.M010685200; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kanovsky M, 2001, P NATL ACAD SCI USA, V98, P12438, DOI 10.1073/pnas.211280698; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Matsumura N, 2010, FASEB J, V24, P2201, DOI 10.1096/fj.09-143008; Matsuura T, 2006, J BIOSCI BIOENG, V101, P449, DOI 10.1263/jbb.101.449; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rosal R, 2005, ADV DRUG DELIVER REV, V57, P653, DOI 10.1016/j.addr.2004.10.008; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	41	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17898	10.1371/journal.pone.0017898	http://dx.doi.org/10.1371/journal.pone.0017898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423613	gold, Green Published, Green Submitted			2022-12-25	WOS:000288513900043
J	Hamilton, CK; Revay, T; Domander, R; Favetta, LA; King, WA				Hamilton, Christine K.; Revay, Tamas; Domander, Robin; Favetta, Laura A.; King, W. Allan			A Large Expansion of the HSFY Gene Family in Cattle Shows Dispersion across Yq and Testis-Specific Expression	PLOS ONE			English	Article							COPY NUMBER VARIATION; HEAT-SHOCK RESPONSE; HUMAN GENOME; MALE-INFERTILITY; CHROMOSOME; SEQUENCE; PROTEIN; REGION; TSPY; QUANTIFICATION	Heat shock transcription factor, Y-linked (HSFY) is a member of the heat shock transcriptional factor (HSF) family that is found in multiple copies on the Y chromosome and conserved in a number of species. Its function still remains unknown but in humans it is thought to play a role in spermatogenesis. Through real time polymerase chain reaction (PCR) analyses we determined that the HSFY family is largely expanded in cattle (similar to 70 copies) compared with human (2 functional copies, 4 HSFY-similar copies). Unexpectedly, we found that it does not vary among individual bulls as a copy number variant (CNV). Using fluorescence in situ hybridization (FISH) we found that the copies are dispersed along the long arm of the Y chromosome (Yq). HSFY expression in cattle appears restricted to the testis and its mRNA correlates positively with mRNA markers of spermatogonial and spermatocyte cells (UCHL1 and TRPC2, respectively) which suggests that HSFY is expressed (at least in part) in early germ cells.	[Hamilton, Christine K.; Revay, Tamas; Domander, Robin; Favetta, Laura A.; King, W. Allan] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Hamilton, CK (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	waking@uoguelph.ca	Laura, Favetta/AAN-3927-2021; Revay, Tamas/AAU-7731-2020		National Sciences Engineering and Research Council; Canadian Research Chair program; L'Alliance Boviteq Incorporated; OECD	National Sciences Engineering and Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Research Chair program(Canada Research Chairs); L'Alliance Boviteq Incorporated; OECD	This work was funded by the National Sciences Engineering and Research Council, Canadian Research Chair program and L'Alliance Boviteq Incorporated. CKH was funded with a fellowship from the National Sciences Engineering and Research Council. TR was supported with a fellowship under the OECD Co-operative Research Programme: Biological Resource Management for Sustainable Agricultural Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUHLER EM, 1980, HUM GENET, V55, P145, DOI 10.1007/BF00291764; Curry E, 2008, BIOCHEM INSIGHTS, V1, P35; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferlin A, 2003, J MED GENET, V40, P18, DOI 10.1136/jmg.40.1.18; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Hamilton CK, 2009, SEX DEV, V3, P205, DOI 10.1159/000228721; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JAKUBICZKA S, 1993, GENOMICS, V17, P732, DOI 10.1006/geno.1993.1394; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Kinoshita K, 2006, J MED INVESTIG, V53, P117, DOI 10.2152/jmi.53.117; KOOPS WJ, 1995, J DAIRY SCI, V78, P921, DOI 10.3168/jds.S0022-0302(95)76707-8; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Li Z, 2008, J GENET GENOMICS, V35, P193, DOI 10.1016/S1673-8527(08)60027-2; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu W, 2010, REPROD GENOMICS DOME, P129; Liu WS, 2004, ANIM BIOTECHNOL, V15, P103, DOI 10.1081/labt-200032337; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; Nickkholgh B, 2010, FERTIL STERIL, V94, P1744, DOI 10.1016/j.fertnstert.2009.09.051; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Oatley JM, 2004, BIOL REPROD, V70, P625, DOI 10.1095/biolreprod.103.022483; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Raudsepp T, 2004, P NATL ACAD SCI USA, V101, P2386, DOI 10.1073/pnas.0308513100; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Rozen S, 2000, Methods Mol Biol, V132, P365; Shinka T, 2004, BIOL REPROD, V71, P297, DOI 10.1095/biolreprod.103.023580; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tessari A, 2004, MOL HUM REPROD, V10, P253, DOI 10.1093/molehr/gah036; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinci G, 2005, MOL HUM REPROD, V11, P295, DOI 10.1093/molehr/gah153; Wilkerson AJP, 2008, GENOMICS, V92, P329, DOI 10.1016/j.ygeno.2008.06.012; Wissenbach U, 1998, FEBS LETT, V429, P61, DOI 10.1016/S0014-5793(98)00561-4	41	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17790	10.1371/journal.pone.0017790	http://dx.doi.org/10.1371/journal.pone.0017790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408193	gold, Green Published, Green Submitted			2022-12-25	WOS:000288099800039
J	Maas, C; de Vries, E; Tait, SWG; Borst, J				Maas, C.; de Vries, E.; Tait, S. W. G.; Borst, J.			Bid can mediate a pro-apoptotic response to etoposide and ionizing radiation without cleavage in its unstructured loop and in the absence of p53	ONCOGENE			English	Article						Bid; apoptosis; DNA damage; p53	BH3-ONLY PROTEINS PUMA; CYTOCHROME-C RELEASE; DNA-DAMAGE; LYMPHOID-CELLS; MITOCHONDRIA; TRANSLOCATION; ACTIVATION; NOXA; DRUG; LIFE	BH3-only protein Bid is a key player in death receptor-induced apoptosis, because it provides the link with the mitochondrial route for caspase activation. In this pathway, Bid is activated upon cleavage by caspase-8. Its BH3 domain-containing carboxy-terminal fragment subsequently provokes mitochondrial outer membrane permeabilization by Bak/Bax activation. Bid has also been implicated in the apoptotic response to ionizing radiation (IR) and the topoisomerase inhibitor etoposide, anti-cancer regimens that cause double-strand (ds) DNA breaks. We confirm the existence of this pathway and show that it is p53-independent. However, the degree of Bid participation in the apoptotic response to dsDNA breaks depends on the nature of cell transformation. We used Bid-deficient mouse embryonic fibroblast (MEF) lines that were reconstituted with Bid to control the cellular background and demonstrated that the Bid-dependent apoptotic pathway induced by IR and etoposide operates in MEFs that are transformed by SV40, but is not evident in E1A/Ras-transformed MEFs. The Bid-dependent apoptotic response in p53-deficient SV40-transformed MEFs contributed to clonogenic execution of the cells, implying relevance for treatment outcome. In these cells, Bid acted in a conventional manner in that it required its BH3 domain to mediate apoptosis in response to IR and etoposide, and triggered apoptotic execution by indirect activation of Bak/Bax, mitochondrial permeabilization and caspase-9 activation. However, the mechanism of Bid activation was unconventional, because elimination of all known or suspected cleavage sites for caspases or other proteolytic enzymes and even complete elimination of its unstructured cleavage loop left Bid's pro-apoptotic role in the response to IR and etoposide unaffected. Oncogene (2011) 30, 3636-3647; doi:10.1038/onc.2011.75; published online 21 March 2011	[Maas, C.; de Vries, E.; Tait, S. W. G.; Borst, J.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.borst@nki.nl		Tait, Stephen/0000-0001-7697-132X; Borst, Jannie/0000-0002-8043-5009	Dutch Cancer Society [NKI 2008-4110]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by grant NKI 2008-4110 from the Dutch Cancer Society. We thank Dr Atan Gross for MEF cell lines, Rogier Rooswinkel for data analysis, Inge Verbrugge, Bert van de Kooij and Rogier Rooswinkel for discussions and critical reading of the manuscript, and personnel of the flow cytometry facility of the Netherlands Cancer Institute for experimental assistance.	Anguissola S, 2009, MOL PHARMACOL, V76, P998, DOI 10.1124/mol.109.058156; Brown JM, 1999, CANCER RES, V59, P1391; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Gross A, 2006, CELL CYCLE, V5, P582, DOI 10.4161/cc.5.6.2575; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kohler B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002844; Krajewska M, 2002, NEOPLASIA, V4, P129, DOI 10.1038/sj.neo.7900222; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Oberkovitz G, 2007, CELL DEATH DIFFER, V14, P1628, DOI 10.1038/sj.cdd.4402181; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang XD, 2001, GENE DEV, V15, P2922; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zinkel SS, 2003, GENE DEV, V17, P229, DOI 10.1101/gad.1045603	42	11	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	33					3636	3647		10.1038/onc.2011.75	http://dx.doi.org/10.1038/onc.2011.75			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21423217	Green Published, hybrid			2022-12-25	WOS:000294005100007
J	Kielbasa, OM; Reynolds, JG; Wu, CL; Snyder, CM; Cho, MY; Weiler, H; Kandarian, S; Naya, FJ				Kielbasa, Ondra M.; Reynolds, Joseph G.; Wu, Chia-Ling; Snyder, Christine M.; Cho, Min Y.; Weiler, Hartmut; Kandarian, Susan; Naya, Francisco J.			Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration	FASEB JOURNAL			English	Article						costamere; scaffolding protein; transgenic mice; calcineurin inhibitor; signaling	SIGNALING PATHWAYS; GENE-EXPRESSION; NFAT ACTIVATION; STRIATED-MUSCLE; BINDING PARTNER; PHOSPHORYLATION; IDENTIFICATION; STIMULATION; DYSTROPHIN; GROWTH	The calcium-calmodulin-regulated protein phosphatase calcineurin plays an important regulatory role in muscle differentiation, fiber-type determination, hypertrophy, and muscle regeneration. Because calcineurin functions in numerous processes in muscle, multiple mechanisms are likely necessary to ensure that the activity of this phosphatase is appropriately regulated. Here we demonstrate that the muscle-specific scaffolding protein myospryn modulates calcineurin signaling by inhibiting calcineurin-dependent transcriptional activity in C2C12 myoblasts through direct interaction with the enzyme via its noncanonical tripartite motif (TRIM-like). Consistent with these data, transgenic mice overexpressing both the TRIM-like domain of myospryn and constitutively active calcineurin displayed a severe attenuation in the ability of calcineurin to induce a slow-fiber phenotype. Furthermore, transgenic mice overexpressing the TRIM-like domain of myospryn displayed attenuated muscle regeneration after cardiotoxin-induced muscle injury. These results indicate that myospryn functions as a novel inhibitor of the calcineurin signaling pathway in skeletal muscle.-Kielbasa, O. M., Reynolds, J. G., Wu, C-l., Snyder, C. M., Cho, M. Y., Weiler, H., Kandarian, S., Naya, F. J. Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration. FASEB J. 25, 2276-2286 (2011). www.fasebj.org	[Kielbasa, Ondra M.; Reynolds, Joseph G.; Snyder, Christine M.; Cho, Min Y.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA; [Wu, Chia-Ling; Kandarian, Susan] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Weiler, Hartmut] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA	Boston University; Boston University; Versiti Blood Center of Wisconsin	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 24 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			U.S. National Institutes of Health/National Heart, Lung, and Blood Institute; Muscular Dystrophy Association	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported by grants from the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute and the Muscular Dystrophy Association to F.J.N. The authors are grateful to Jeffery Molkentin (Cincinnati Children's Hospital, Cincinnati, OH, USA) for the NFAT reporter construct. The authors also thank Eric Olson and Rhonda Bassel-Duby (University of Texas Southwestern, Dallas, TX, USA) for the FLAG-calcineurin constructs.	Abrenica B, 2009, J MOL CELL CARDIOL, V46, P674, DOI 10.1016/j.yjmcc.2009.01.018; Bassel-Duby R, 2003, BIOCHEM BIOPH RES CO, V311, P1133, DOI 10.1016/j.bbrc.2003.09.020; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Benson MA, 2004, J BIOL CHEM, V279, P10450, DOI 10.1074/jbc.M312664200; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fernandes JMO, 2005, PHYSIOL GENOMICS, V22, P327, DOI 10.1152/physiolgenomics.00087.2005; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Fruman David A., 1996, Methods (Orlando), V9, P146, DOI 10.1006/meth.1996.0020; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kouloumenta A, 2007, J BIOL CHEM, V282, P35211, DOI 10.1074/jbc.M704733200; Li JL, 2010, J MOL CELL CARDIOL, V48, P387, DOI 10.1016/j.yjmcc.2009.10.023; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sarparanta J, 2010, J BIOL CHEM, V285, P30304, DOI 10.1074/jbc.M110.108720; Sarparanta J, 2008, J MUSCLE RES CELL M, V29, P177, DOI 10.1007/s10974-008-9165-6; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; SENTER L, 1995, BIOCHEM BIOPH RES CO, V206, P57, DOI 10.1006/bbrc.1995.1009; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; Stupka N, 2008, AM J PHYSIOL-REG I, V294, pR983, DOI 10.1152/ajpregu.00375.2007; Stupka N, 2007, AM J PHYSIOL-REG I, V293, pR686, DOI 10.1152/ajpregu.00612.2006; Talmadge RJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-28; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; WALSH MP, 1995, BIOCHEMISTRY-US, V34, P5561, DOI 10.1021/bi00016a030; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	41	29	30	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2276	2286		10.1096/fj.10-169219	http://dx.doi.org/10.1096/fj.10-169219			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21427212	Green Published, Bronze			2022-12-25	WOS:000292242200019
J	Dixit, A; Ray, K; Lakowicz, JR; Black, LW				Dixit, Aparna; Ray, Krishanu; Lakowicz, Joseph R.; Black, Lindsay W.			Dynamics of the T4 Bacteriophage DNA Packasome Motor ENDONUCLEASE VII RESOLVASE RELEASE OF ARRESTED Y-DNA SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACKAGING MOTOR; PORTAL PROTEIN; GENE-20 PRODUCT; BACTERIOPHAGE-T4; FLUORESCENCE; TERMINASE; PHAGE-T4; TRANSLOCATION; SPECTROSCOPY; MECHANISM	Conserved bacteriophage ATP-based DNA translocation motors consist of a multimeric packaging terminase docked onto a unique procapsid vertex containing a portal ring. DNA is translocated into the empty procapsid through the portal ring channel to high density. In vivo the T4 phage packaging motor deals with Y- or X-structures in the replicative concatemer substrate by employing a portal-bound Holliday junction resolvase that trims and releases these DNA roadblocks to packaging. Here using dye-labeled packaging anchored 3.7-kb Y-DNAs or linear DNAs, we demonstrate FRET between the dye-labeled substrates and GFP portal-containing procapsids and between GFP portal and single dye-labeled terminases. We show using FRET-fluorescence correlation spectroscopy that purified T4 gp49 endonuclease VII resolvase can release DNA compression in vitro in prohead portal packaging motor anchored and arrested Y-DNA substrates. In addition, using active terminases labeled at the N- and C-terminal ends with a single dye molecule, we show by FRET distance of the N-terminal GFP-labeled portal protein containing prohead at 6.9 nm from the N terminus and at 5.7 nm from the C terminus of the terminase. Packaging with a C-terminal fluorescent terminase on a GFP portal prohead, FRET shows a reduction in distance to the GFP portal of 0.6 nm in the arrested Y-DNA as compared with linear DNA; the reduction is reversed by resolvase treatment. Conformational changes in both the motor proteins and the DNA substrate itself that are associated with the power stroke of the motor are consistent with a proposed linear motor employing a terminal-to-portal DNA grip-and-release mechanism.	[Dixit, Aparna; Ray, Krishanu; Lakowicz, Joseph R.; Black, Lindsay W.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Ray, Krishanu; Lakowicz, Joseph R.] Univ Maryland, Sch Med, Ctr Fluorescence Spect, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Black, LW (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	lblack@umaryland.edu			National Institutes of Health [AI11676, HG002655, K25AI087968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011676, R37AI011676, K25AI087968, R21AI011676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI11676 (to L. W. B.), HG002655 (to J. R. L.), and K25AI087968 (to K. R.).	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; Black LW, 2006, J BIOL CHEM, V281, P25635, DOI 10.1074/jbc.M602093200; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Black LW, 1993, MOL BIOL BACTERIOPHA; Cuervo A, 2007, J BIOL CHEM, V282, P18907, DOI 10.1074/jbc.M701808200; DRIEDONKS RA, 1983, J MOL BIOL, V166, P341, DOI 10.1016/S0022-2836(83)80089-8; DRIEDONKS RA, 1981, J MOL BIOL, V152, P641, DOI 10.1016/0022-2836(81)90121-2; Duckworth BP, 2007, CHEMBIOCHEM, V8, P98, DOI 10.1002/cbic.200600340; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Golz S, 1999, J MOL BIOL, V285, P1131, DOI 10.1006/jmbi.1998.2399; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; JENSCH F, 1986, EMBO J, V5, P181, DOI 10.1002/j.1460-2075.1986.tb04194.x; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kainov DE, 2006, CELL MOL LIFE SCI, V63, P1095, DOI 10.1007/s00018-005-5450-3; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lin HC, 1999, J MOL BIOL, V289, P249, DOI 10.1006/jmbi.1999.2781; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Oram M, 2008, J MOL BIOL, V381, P61, DOI 10.1016/j.jmb.2008.05.074; POTTMEYER S, 1992, J MOL BIOL, V223, P607, DOI 10.1016/0022-2836(92)90977-R; RAO VB, 1985, J MOL BIOL, V185, P565, DOI 10.1016/0022-2836(85)90072-5; Rao VB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-356; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Ray K, 2010, VIROLOGY, V398, P224, DOI 10.1016/j.virol.2009.11.047; Ray K, 2009, VIROLOGY, V391, P44, DOI 10.1016/j.virol.2009.05.029; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Sabanayagam CR, 2007, BIOPHYS J, V93, pL17, DOI 10.1529/biophysj.107.111526; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Sheaffer AK, 2001, J VIROL, V75, P687, DOI 10.1128/JVI.75.2.687-698.2001; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015	35	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18878	18889		10.1074/jbc.M111.222828	http://dx.doi.org/10.1074/jbc.M111.222828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454482	Green Published, hybrid			2022-12-25	WOS:000290785700060
J	Yoshizumi, A; Fletcher, JM; Yu, ZX; Persikov, AV; Bartlett, GJ; Boyle, AL; Vincent, TL; Woolfson, DN; Brodsky, B				Yoshizumi, Ayumi; Fletcher, Jordan M.; Yu, Zhuoxin; Persikov, Anton V.; Bartlett, Gail J.; Boyle, Aimee L.; Vincent, Thomas L.; Woolfson, Derek N.; Brodsky, Barbara			Designed Coiled Coils Promote Folding of a Recombinant Bacterial Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; CIRCULAR-DICHROISM; PROTEIN; NUCLEATION; MECHANISM; PEPTIDE; DOMAINS; MOTIFS; SITE	Collagen triple helices fold slowly and inefficiently, often requiring adjacent globular domains to assist this process. In the Streptococcus pyogenes collagen-like protein Scl2, a V domain predicted to be largely alpha-helical, occurs N-terminal to the collagen triple helix (CL). Here, we replace this natural trimerization domain with a de novo designed, hyperstable, parallel, three-stranded, alpha-helical coiled coil (CC), either at the N terminus (CC-CL) or the C terminus (CL-CC) of the collagen domain. CD spectra of the constructs are consistent with additivity of independently and fully folded CC and CL domains, and the proteins retain their distinctive thermal stabilities, CL at similar to 37 degrees C and CC at >90 degrees C. Heating the hybrid proteins to 50 degrees C unfolds CL, leavingCCintact, and upon cooling, the rate of CL refolding is somewhat faster for CL-CC than for CC-CL. A construct with coiled coils on both ends, CC-CL-CC, retains the similar to 37 degrees C thermal stability for CL but shows less triple helix at low temperature and less denaturation at 50 degrees C. Most strikingly however, in CC-CL-CC, the CL refolds slower than in either CC-CL or CL-CC by almost two orders of magnitude. We propose that a single CC promotes folding of the CL domain via nucleation and in-register growth from one end, whereas initiation and growth from both ends in CC-CL-CC results in mismatched registers that frustrate folding. Bioinformatics analysis of natural collagens lends support to this because, where present, there is generally only one coiled-coil domain close to the triple helix, and it is nearly always N-terminal to the collagen repeat.	[Fletcher, Jordan M.; Bartlett, Gail J.; Boyle, Aimee L.; Vincent, Thomas L.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Yoshizumi, Ayumi; Yu, Zhuoxin; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Persikov, Anton V.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Vincent, Thomas L.] Univ Bristol, Bristol Ctr Complex Sci, Bristol BS8 1TR, Avon, England; [Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	University of Bristol; Rutgers State University New Brunswick; Rutgers State University Medical Center; Princeton University; University of Bristol; University of Bristol; Tufts University	Woolfson, DN (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	D.N.Woolfson@bristol.ac.uk; Barbara.Brodsky@tufts.edu	Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015; Yu, Zhuoxin/L-1512-2013	Boyle, Aimee/0000-0003-4176-6080; Fletcher, Jordan/0000-0003-3203-4355; Woolfson, Derek/0000-0002-0394-3202	National Institutes of Health [GM60048]; Biotechnology and Biological Sciences Research Council [BB/G008833/1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER; BBSRC [BB/G008833/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to. B. B.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/G008833/1 (to D. N. W.).	Armstrong CT, 2009, FARADAY DISCUSS, V143, P305, DOI 10.1039/b901610d; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3725, DOI 10.1021/bi00821a011; Hayes D. B., 1995, SEDNTERP VERSION 1 0; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	29	24	25	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17512	17520		10.1074/jbc.M110.217364	http://dx.doi.org/10.1074/jbc.M110.217364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454493	Green Published, hybrid			2022-12-25	WOS:000290585200013
J	Gallo, M; Park, D; Luciani, DS; Kida, K; Palmieri, F; Blacque, OE; Johnson, JD; Riddle, DL				Gallo, Marco; Park, Donha; Luciani, Dan S.; Kida, Katarzyna; Palmieri, Ferdinando; Blacque, Oliver E.; Johnson, James D.; Riddle, Donald L.			MISC-1/OGC Links Mitochondrial Metabolism, Apoptosis and Insulin Secretion	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PERMEABILITY TRANSITION PORE; NEMATODE CAENORHABDITIS-ELEGANS; BCL-2-LIKE PROTEIN CED-9; C-ELEGANS; CYTOCHROME-C; 2-OXOGLUTARATE CARRIERS; GERMLINE PROLIFERATION; SIGNALING LIGAND; GENETIC-CONTROL	We identified MISC-1 (Mitochondrial Solute Carrier) as the C. elegans orthologue of mammalian OGC (2-oxoglutarate carrier). OGC was originally identified for its ability to transfer alpha-ketoglutarate across the inner mitochondrial membrane. However, we found that MISC-1 and OGC are not solely involved in metabolic control. Our data show that these orthologous proteins participate in phylogenetically conserved cellular processes, like control of mitochondrial morphology and induction of apoptosis. We show that MISC-1/OGC is required for proper mitochondrial fusion and fission events in both C. elegans and human cells. Transmission electron microscopy reveals that loss of MISC-1 results in a decreased number of mitochondrial cristae, which have a blebbed appearance. Furthermore, our pull-down experiments show that MISC-1 and OGC interact with the anti-apoptotic proteins CED-9 and Bcl-x(L), respectively, and with the pro-apoptotic protein ANT. Knock-down of misc-1 in C. elegans and OGC in mouse cells induces apoptosis through the caspase cascade. Genetic analysis suggests that MISC-1 controls apoptosis through the physiological pathway mediated by the LIN-35/Rb-like protein. We provide genetic and molecular evidence that absence of MISC-1 increases insulin secretion and enhances germline stem cell proliferation in C. elegans. Our study suggests that the mitochondrial metabolic protein MISC-1/OGC integrates metabolic, apoptotic and insulin secretion functions. We propose a novel mechanism by which mitochondria integrate metabolic and cell survival signals. Our data suggest that MISC-1/OGC functions by sensing the metabolic status of mitochondria and directly activate the apoptotic program when required. Our results suggest that controlling MISC-1/OGC function allows regulation of mitochondrial morphology and cell survival decisions by the metabolic needs of the cell.	[Gallo, Marco; Riddle, Donald L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Park, Donha; Riddle, Donald L.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Kida, Katarzyna; Blacque, Oliver E.] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Biochem Lab, Bari, Italy; [Palmieri, Ferdinando] CNR, Unit Study Mitochondria & Bioenerget, I-70126 Bari, Italy	University of British Columbia; University of British Columbia; University of British Columbia; University College Dublin; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Gallo, M (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mgallo@msl.ubc.ca	Blacque, Oliver/AAL-8860-2021; Johnson, James/B-3919-2008	Johnson, James/0000-0002-7523-9433; Gallo, Marco/0000-0002-8451-8207; Blacque, Oliver/0000-0003-1598-2695; Luciani, Dan/0000-0002-4318-4159	Canadian Institutes of Health Research [MOP 79458]; Natural Sciences and Engineering Research Council of Canada CGS; Michael Smith Foundation for Health Research; Izaak Walton Killam Memorial Pre-Doctoral Fellowship; William and Dorothy Gilbert Graduate Scholarship in Bio-Medical Sciences; Juvenile Diabetes Research Foundation; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada CGS; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Izaak Walton Killam Memorial Pre-Doctoral Fellowship; William and Dorothy Gilbert Graduate Scholarship in Bio-Medical Sciences; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Diabetes Association	This work was supported by a Canadian Institutes of Health Research grant (MOP 79458; http://www.cihr-irsc.gc.ca/e/193.html) to DLR and a Natural Sciences and Engineering Research Council of Canada CGS (http://www.nserc-crsng.gc.ca/), Michael Smith Foundation for Health Research Senior Graduate Studentship (http://www.msfhr.org/), Izaak Walton Killam Memorial Pre-Doctoral Fellowship (http://www.killamtrusts.ca/) and a William and Dorothy Gilbert Graduate Scholarship in Bio-Medical Sciences to MG. JDJ and DSL were supported by the Juvenile Diabetes Research Foundation (http://www.jdrf.ca/), the Canadian Institutes of Health Research and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Berry LW, 1997, DEVELOPMENT, V124, P925; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; BRENNER S, 1974, GENETICS, V77, P71; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Chen ZF, 2000, ARCH BIOCHEM BIOPHYS, V373, P193, DOI 10.1006/abbi.1999.1527; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Henderson ST, 1997, MOL BIOL CELL, V8, P1751, DOI 10.1091/mbc.8.9.1751; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Navarro RE, 2001, DEVELOPMENT, V128, P3221; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Park D, 2010, DEVELOPMENT, V137, P477, DOI 10.1242/dev.043752; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schertel C, 2007, DEVELOPMENT, V134, P3691, DOI 10.1242/dev.004606; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shen QF, 2009, MOL CELL BIOL, V29, P3881, DOI 10.1128/MCB.01509-08; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Timmons L, 1994, SCIENCE, V263, P802; Wang XD, 2001, GENE DEV, V15, P2922; Woodfield KY, 1997, BBA-GENE STRUCT EXPR, V1351, P27, DOI 10.1016/S0167-4781(97)00017-1; Xu F, 2006, J PHARMACOL EXP THER, V316, P1175, DOI 10.1124/jpet.105.094599; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	73	22	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17827	10.1371/journal.pone.0017827	http://dx.doi.org/10.1371/journal.pone.0017827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448454	Green Submitted, gold, Green Published			2022-12-25	WOS:000288810500014
J	Wang, HJ; Ding, Y; Tang, J; Dong, XA; He, B; Qiu, J; Wild, DJ				Wang, Huijun; Ding, Ying; Tang, Jie; Dong, Xiao; He, Bing; Qiu, Judy; Wild, David J.			Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA	PLOS ONE			English	Article								The overwhelming amount of available scholarly literature in the life sciences poses significant challenges to scientists wishing to keep up with important developments related to their research, but also provides a useful resource for the discovery of recent information concerning genes, diseases, compounds and the interactions between them. In this paper, we describe an algorithm called Bio-LDA that uses extracted biological terminology to automatically identify latent topics, and provides a variety of measures to uncover putative relations among topics and bio-terms. Relationships identified using those approaches are combined with existing data in life science datasets to provide additional insight. Three case studies demonstrate the utility of the Bio-LDA model, including association predication, association search and connectivity map generation. This combined approach offers new opportunities for knowledge discovery in many areas of biology including target identification, lead hopping and drug repurposing.	[Wang, Huijun; Dong, Xiao; Wild, David J.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Ding, Ying; He, Bing] Indiana Univ, Sch Lib & Informat Sci, Bloomington, IN 47401 USA; [Tang, Jie] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Qiu, Judy] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tsinghua University; Indiana University System; Indiana University Bloomington	Wang, HJ (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	djwild@indiana.edu	He, Bing/H-8271-2016; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022	Ding, Ying/0000-0003-2567-2009				Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Anyanwu K, 2002, SIGMOD REC, V31, P42, DOI 10.1145/637411.637418; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; BIZER C, 2006, 5 INT SEM WEB C ATH; Blei DM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-250; Blei D. M., 2010, SUPERVISED TOPIC MOD, V06, P11; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Cohen KB, 2004, COMPU BIOL, V5, P147; FELDMAN R, 2003, MINING BIOMEDICAL LI, V1, P69; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; HOFMANN T, 2009, PROBABILISTIC LATENT, P50; JENTZSCH A, 2009, LINKING OPEN DRUG DA; Morchen F., 2008, P 14 ACM SIGKDD INT, P954, DOI DOI 10.1145/1401890.1402004; MUIN M, 2006, AMIA ANN S P AMIA S, P1089; Newman D., 2007, ADV NEURAL INFORM PR, P1081; Rosen-Zvi M., 2004, AUTHOR TOPIC MODEL A, P487, DOI DOI 10.5555/1036843.1036902; Si X., 2009, J COMPUTATIONAL INFO; Steyvers M., 2004, P 10 ACM SIGKDD INT, P306, DOI [10.1145/1014052.1014087, DOI 10.1145/1014052.1014087, 10.1145/1014052, DOI 10.1145/1014052]; Tang J., 2008, P 14 ACM SIGKDD INT, P990, DOI DOI 10.1145/1401890.1402008; WANG X, 2007, TRACTOGRAPHY SEGMENT; WANG X, 2006, TOPICS TIME NONMARKO, P424; Wang Y, 2009, LECT NOTES COMPUT SC, V5564, P301, DOI 10.1007/978-3-642-02158-9_26; Wild DJ, 2009, EXPERT OPIN DRUG DIS, V4, P995, DOI 10.1517/17460440903233738; XU H, 2009, TAG REFINEMENT REGUL, P573; Zheng B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-58	26	60	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17243	10.1371/journal.pone.0017243	http://dx.doi.org/10.1371/journal.pone.0017243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448266	gold, Green Submitted, Green Published			2022-12-25	WOS:000288810500005
J	Yoder, KE; Espeseth, A; Wang, XH; Fang, QM; Russo, MT; Lloyd, RS; Hazuda, D; Sobol, RW; Fishel, R				Yoder, Kristine E.; Espeseth, Amy; Wang, Xiao-hong; Fang, Qingming; Russo, Maria Teresa; Lloyd, R. Stephen; Hazuda, Daria; Sobol, Robert W.; Fishel, Richard			The Base Excision Repair Pathway Is Required for Efficient Lentivirus Integration	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; PREINTEGRATION COMPLEXES; VIRUS INTEGRATION; HIV-1 INTEGRATION; IN-VITRO; GENE; PROTEIN; DAMAGE; CELLS; VECTORS	An siRNA screen has identified several proteins throughout the base excision repair (BER) pathway of oxidative DNA damage as important for efficient HIV infection. The proteins identified included early repair factors such as the base damage recognition glycosylases OGG1 and MYH and the late repair factor POL beta, implicating the entire BER pathway. Murine cells with deletions of the genes Ogg1, Myh, Neil1 and Pol beta recapitulate the defect of HIV infection in the absence of BER. Defective infection in the absence of BER proteins was also seen with the lentivirus FIV, but not the gammaretrovirus MMLV. BER proteins do not affect HIV infection through its accessory genes nor the central polypurine tract. HIV reverse transcription and nuclear entry appear unaffected by the absence of BER proteins. However, HIV integration to the host chromosome is reduced in the absence of BER proteins. Pre-integration complexes from BER deficient cell lines show reduced integration activity in vitro. Integration activity is restored by addition of recombinant BER protein POL beta. Lentiviral infection and integration efficiency appears to depend on the presence of BER proteins.	[Yoder, Kristine E.; Fishel, Richard] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Yoder, Kristine E.; Fishel, Richard] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Espeseth, Amy; Hazuda, Daria] Merck Res Labs, Dept Antiviral Res, West Point, PA USA; [Russo, Maria Teresa] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Dept Mol & Med Genet, Portland, OR 97201 USA; [Sobol, Robert W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Xiao-hong; Fang, Qingming; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Sobol, Robert W.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Merck & Company; Istituto Superiore di Sanita (ISS); Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yoder, KE (corresponding author), Ohio State Univ, Med Ctr, Columbus, OH 43210 USA.	yoder.176@osu.edu; rfishel@osu.edu	Fang, Qingming/B-6839-2008; Sobol, Robert W./E-4125-2013; Yoder, Kristine/E-4353-2011	Fang, Qingming/0000-0002-4006-0636; Sobol, Robert W./0000-0001-7385-3563; Yoder, Kristine/0000-0002-5598-9018; Lloyd, R. Stephen/0000-0001-7273-372X	NIH [AI82422, DK075974, CA148629]; Associazione Italiana Ricerca sul Cancro; Merck Research Laboratories; NATIONAL CANCER INSTITUTE [R01CA148629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK075974, R01DK075974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Merck Research Laboratories(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants AI82422 (KY and RF), DK075974 (RSL), CA148629 (RWS), a grant from Associazione Italiana Ricerca sul Cancro (MTR), and Merck Research Laboratories (AE and DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beitzel B, 2003, NUCLEIC ACIDS RES, V31, P5025, DOI 10.1093/nar/gkg684; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cannon PM, 1996, J VIROL, V70, P8234, DOI 10.1128/JVI.70.11.8234-8240.1996; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Coffin J, 1997, RETROVIRUSES; ELLISON V, 1990, J VIROL, V64, P2711, DOI 10.1128/JVI.64.6.2711-2715.1990; ESPESETH AS, 2010, SIRNA SCREENIN UNPUB; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2006, DNA REPAIR, V5, P189, DOI 10.1016/j.dnarep.2005.09.009; Hansen MST, 1999, NAT BIOTECHNOL, V17, P578, DOI 10.1038/9886; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Karolewski BA, 2003, HUM GENE THER, V14, P1287, DOI 10.1089/104303403322319372; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rumbaugh JA, 1998, J BIOL CHEM, V273, P28740, DOI 10.1074/jbc.273.44.28740; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Sobol RW, 2007, DNA REPAIR, V6, P3, DOI 10.1016/j.dnarep.2006.08.005; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Svilar D, 2010, ANTIOXID REDOX SIGNA; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Xie YL, 2008, CARCINOGENESIS, V29, P722, DOI 10.1093/carcin/bgn033; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17862	10.1371/journal.pone.0017862	http://dx.doi.org/10.1371/journal.pone.0017862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448280	Green Published, gold, Green Accepted			2022-12-25	WOS:000288810500019
J	Li, QA; Li, XD; Li, CH; Chen, LR; Song, J; Tang, YL; Xu, XJ				Li, Qian; Li, Xudong; Li, Canghai; Chen, Lirong; Song, Jun; Tang, Yalin; Xu, Xiaojie			A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FACTOR XA; 3-DIMENSIONAL STRUCTURE; THROMBIN INHIBITORS; DRUG-THERAPY; FACTOR IXA; BINDING; DESIGN; PERFORMANCE; DISCOVERY	Background: Traditional virtual screening method pays more attention on predicted binding affinity between drug molecule and target related to a certain disease instead of phenotypic data of drug molecule against disease system, as is often less effective on discovery of the drug which is used to treat many types of complex diseases. Virtual screening against a complex disease by general network estimation has become feasible with the development of network biology and system biology. More effective methods of computational estimation for the whole efficacy of a compound in a complex disease system are needed, given the distinct weightiness of the different target in a biological process and the standpoint that partial inhibition of several targets can be more efficient than the complete inhibition of a single target. Methodology: We developed a novel approach by integrating the affinity predictions from multi-target docking studies with biological network efficiency analysis to estimate the anticoagulant activities of compounds. From results of network efficiency calculation for human clotting cascade, factor Xa and thrombin were identified as the two most fragile enzymes, while the catalytic reaction mediated by complex IXa:VIIIa and the formation of the complex VIIIa: IXa were recognized as the two most fragile biological matter in the human clotting cascade system. Furthermore, the method which combined network efficiency with molecular docking scores was applied to estimate the anticoagulant activities of a serial of argatroban intermediates and eight natural products respectively. The better correlation (r = 0.671) between the experimental data and the decrease of the network deficiency suggests that the approach could be a promising computational systems biology tool to aid identification of anticoagulant activities of compounds in drug discovery. Conclusions: This article proposes a network-based multi-target computational estimation method for anticoagulant activities of compounds by combining network efficiency analysis with scoring function from molecular docking.	[Li, Qian; Li, Xudong; Chen, Lirong; Xu, Xiaojie] Peking Univ, Beijing Natl Lab Mol Sci, State Key Lab Rare Earth Mat Chem & Applicat, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci,Ctr Mol Sci, Beijing 100080, Peoples R China; [Li, Canghai; Song, Jun] China Acad Chinese Med Sci, Expt Res Ctr, Beijing, Peoples R China; [Li, Qian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Institute of Chemistry, CAS; China Academy of Chinese Medical Sciences; Experimental Research Center, CACMS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, QA (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, State Key Lab Rare Earth Mat Chem & Applicat, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	lirongchen@pku.edu.cn; tangyl@iccas.ac.cn; xiaojxu@pku.edu.cn			National Science and Technology Major Project [2008ZX09401-006, 2008ZX09202-007]	National Science and Technology Major Project	This project was supported by the National Science and Technology Major Project 2008ZX09401-006 and 2008ZX09202-007 (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2002, BIOCHEMISTRY-US, V41, P15514, DOI 10.1021/bi0264061; Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Bender A, 2004, J CHEM INF COMP SCI, V44, P1708, DOI 10.1021/ci0498719; Bender A, 2008, CURR OPIN DRUG DISC, V11, P327; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Davidson BL, 2003, J THROMB THROMBOLYS, V16, P49, DOI 10.1023/B:THRO.0000014593.16147.bf; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Everse SJ, 1999, BIOCHEMISTRY-US, V38, P2941, DOI 10.1021/bi982626w; Geppert H, 2010, J CHEM INF MODEL, V50, P205, DOI 10.1021/ci900419k; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guertin KR, 2007, CURR MED CHEM, V14, P2471, DOI 10.2174/092986707782023659; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Huang MD, 1998, J MOL BIOL, V275, P873, DOI 10.1006/jmbi.1997.1512; Jenkins JL, 2003, PROTEINS, V50, P81, DOI 10.1002/prot.10270; Jenwitheesuk E, 2008, TRENDS PHARMACOL SCI, V29, P62, DOI 10.1016/j.tips.2007.11.007; Jiang RW, 2005, CURR MED CHEM, V12, P237, DOI 10.2174/0929867053363397; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kontijevskis A, 2007, PLOS COMPUT BIOL, V3, P424, DOI 10.1371/journal.pcbi.0030048; Korcsmaros T, 2007, EXPERT OPIN DRUG DIS, V2, P799, DOI 10.1517/17460441.2.6.799; Kranjc A, 2004, CURR MED CHEM, V11, P2535, DOI 10.2174/0929867043364432; Krupinski Kazimierz, 1995, Materia Medica Polona, V27, P39; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li XD, 2005, ACTA PHYS-CHIM SIN, V21, P504, DOI 10.3866/PKU.WHXB20050509; Li Y, 2005, J ETHNOPHARMACOL, V98, P329, DOI 10.1016/j.jep.2005.01.020; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mestres J, 2002, BIOCHEM SOC T, V30, P797, DOI 10.1042/bst0300797; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nishio H, 2008, EXPERT OPIN PHARMACO, V9, P2509, DOI [10.1517/14656566.9.14.2509, 10.1517/14656566.9.14.2509 ]; Olivero AG, 2005, J BIOL CHEM, V280, P9160, DOI 10.1074/jbc.M409068200; ORTOLANI O, 1995, TRANSPLANT P, V27, P2877; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Qiao XB, 2002, J CHEM INF COMP SCI, V42, P481, DOI 10.1021/ci010113h; Rai R, 2001, CURR MED CHEM, V8, P101, DOI 10.2174/0929867013373822; Rester U, 2008, CURR OPIN DRUG DISC, V11, P559; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Sakharkar MK, 2008, INT J BIOL SCI, V4, P15; Satoh Y, 1996, YAKUGAKU ZASSHI, V116, P244, DOI 10.1248/yakushi1947.116.3_244; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Spiro Zoltan, 2008, J Biol, V7, P20, DOI 10.1186/jbiol81; Stephanou A, 2005, MATH COMPUT MODEL, V41, P1137, DOI 10.1016/j.mcm.2005.05.008; Stephen P, 2008, J COMPUT AID MOL DES, V22, P647, DOI 10.1007/s10822-007-9130-2; Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Tan F, 2002, ACTA BOT SIN, V44, P795; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Tucker TJ, 1998, J MED CHEM, V41, P3210, DOI 10.1021/jm9801713; Wei LP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000020; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Wist AD, 2009, GENOME MED, V1, DOI 10.1186/gm11; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zbinden KG, 2005, BIOORG MED CHEM LETT, V15, P817, DOI 10.1016/j.bmcl.2004.10.092	65	23	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14774	10.1371/journal.pone.0014774	http://dx.doi.org/10.1371/journal.pone.0014774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445339	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100001
J	Eddy, DR; Clarke, JA				Eddy, Drew R.; Clarke, Julia A.			New Information on the Cranial Anatomy of Acrocanthosaurus atokensis and Its Implications for the Phylogeny of Allosauroidea (Dinosauria: Theropoda)	PLOS ONE			English	Article							CRETACEOUS THEROPOD; CARCHARODONTOSAURID DINOSAURIA; CARNOSAUR DINOSAURIA; COMPUTED-TOMOGRAPHY; STRATIGRAPHIC FIT; CRESTED THEROPOD; EVOLUTION; OSTEOLOGY; SIZE; TYRANNOSAURUS	Background: Allosauroidea has a contentious taxonomic and systematic history. Within this group of theropod dinosaurs, considerable debate has surrounded the phylogenetic position of the large-bodied allosauroid Acrocanthosaurus atokensis from the Lower Cretaceous Antlers Formation of North America. Several prior analyses recover Acrocanthosaurus atokensis as sister taxon to the smaller-bodied Allosaurus fragilis known from North America and Europe, and others nest Acrocanthosaurus atokensis within Carcharodontosauridae, a large-bodied group of allosauroids that attained a cosmopolitan distribution during the Early Cretaceous. Methodology/Principal Findings: Re-evaluation of a well-preserved skull of Acrocanthosaurus atokensis (NCSM 14345) provides new information regarding the palatal complex and inner surfaces of the skull and mandible. Previously inaccessible internal views and articular surfaces of nearly every element of the skull are described. Twenty-four new morphological characters are identified as variable in Allosauroidea, combined with 153 previously published characters, and evaluated for eighteen terminal taxa. Systematic analysis of this dataset recovers a single most parsimonious topology placing Acrocanthosaurus atokensis as a member of Allosauroidea, in agreement with several recent analyses that nest the taxon well within Carcharodontosauridae. Conclusions/Significance: A revised diagnosis of Acrocanthosaurus atokensis finds that the species is distinguished by four primary characters, including: presence of a knob on the lateral surangular shelf; enlarged posterior surangular foramen; supraoccipital protruding as a double-boss posterior to the nuchal crest; and pneumatic recess within the medial surface of the quadrate. Furthermore, the recovered phylogeny more closely agrees with the stratigraphic record than hypotheses that place Acrocanthosaurus atokensis as more closely related to Allosaurus fragilis. Fitch optimization of body size is also more consistent with the placement of Acrocanthosaurus atokensis within a clade of larger carcharodontosaurid taxa than with smaller-bodied taxa near the base of Allosauroidea. This placement of Acrocanthosaurus atokensis supports previous hypotheses of a global carcharodontosaurid radiation during the Early Cretaceous.	[Eddy, Drew R.; Clarke, Julia A.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Eddy, DR (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	dreddy@mail.utexas.edu			North Carolina State University	North Carolina State University	This work was supported by North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2002, J VERTEBR PALEONTOL, V22, P548, DOI 10.1671/0272-4634(2002)022[0548:DOMDTI]2.0.CO;2; Alroy J, 2000, PALEOBIOLOGY, V26, P319, DOI 10.1666/0094-8373(2000)026<0319:UTDOTW>2.0.CO;2; [Anonymous], 2000, GAIA; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bell Christopher J., 2009, Records of the Western Australian Museum, V25, P201; BENSON RBJ, 2010, ZOOL J LINN SOC-LOND, P1; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2008, PALAEONTOLOGY, V51, P419, DOI 10.1111/j.1475-4983.2008.00751.x; Benson RBJ, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1931.1.5; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Bonner JT, 1965, SIZE CYCLE ESSAY STR; Boyd CA, 2011, CLADISTICS, V27, P52, DOI 10.1111/j.1096-0031.2010.00320.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; BROCHU C. A., 2002, MEMOIR SOC VERTEBRAT, V22, P1; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2010, ZOOTAXA, P1; Brusatte SL, 2010, ZOOL J LINN SOC-LOND, V158, P573, DOI 10.1111/j.1096-3642.2009.00563.x; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Buckland W., 1824, T GEOLOGICAL SOC LON, V1, P390, DOI DOI 10.1144/TRANSGSLB.1.2.390; CARR T, 2005, PHYLOGENY TYRANNOSAU; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; CHURE DJ, 2000, NEW SPECIES ALLOSAUR; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COPE E.D, 1871, P AM PHILOS SOC, V12, P41; COPE ED, 1887, AM NAT, V21, P367, DOI DOI 10.1086/274464; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P802, DOI 10.1671/0272-4634(2002)022[0802:TBOGCD]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; DeCourten FL., 1991, GEOLOGY E CENTRAL UT, P311; DEPERET CH, 1927, BULL SOC GEOL FRANCE, V27, P257; DONG ZM, 1978, KEXUE TONGBAO, V23, P298; EDDY DE, 2008, 14345 NCSM N CAR STA; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Forster CA, 1999, J AFR EARTH SCI, V28, P169, DOI 10.1016/S0899-5362(99)00023-8; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; FVON H, 1920, Z INDUKT ABSTAMM VER, V22, P209; Gaudin Timothy J., 2006, P1; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GILMORE CW, 1920, P US NATL MUS, V54, P383; Goloboff P, 2008, CLADISTICS, V24, P91; HAMMER WR, 1994, SCIENCE, V264, P828, DOI 10.1126/science.264.5160.828; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, 1995, J VERTEBE PALEONTO S, V15, pA35; Hu S. y., 1964, Vertebrata Palasiatica, V8, P42; HUELSENBECK JP, 1994, PALEOBIOLOGY, V20, P470, DOI 10.1017/S009483730001294X; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; HUTT S, 1996, NEUES JB GEOLOGIE PA, P635; HVON M, 1861, PALAEONTOGR, V7, P253; Canudo JI, 2009, B SOC GEOL FR, V180, P5, DOI 10.2113/gssgfbull.180.1.5; *INT COMM STRAT, 2008, INT STRAT CHART; Jablonski David, 1996, P256; KIRKLAND JI, 1995, J VERT PALEONTOL S, V15, pA39; Langston W. Jr., 1974, Geoscience Man, V8, P77; Larsson Hans C.E., 2001, P19; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Linneaus C., 1758, SYSTEMA NATURAE REGN, VI; Lipka, 1998, NEW MEXICO MUSEUM NA, V14, P229; Maddison W, MESQUITE MODULAR SYS; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Madsen Jr J.H., 2000, CERATOSAURUS DINOSAU, V00-2, P1; Marsh O.C, 1884, AM J SCI, V27, P329, DOI DOI 10.2475/AJS.S3-27.160.329; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Mateus Octavio, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P111; McIntosh J. S., 1981, BULL CARNEG MUS NAT, V18, P1; *MERC COMP SYST, 2007, AV VERS 5 0 1; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; NAISH D, 2001, DINOSAURS ISLE WIGHT, P242; Naish D, 2007, J GEOL SOC LONDON, V164, P493, DOI 10.1144/0016-76492006-032; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; NOVAS FE, 1992, PALAEONTOLOGY, V35, P51; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Olshevsky G., 1991, SAN DIEGO CALIFORNIA, P1; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Padian K, 1999, J VERTEBR PALEONTOL, V19, P69, DOI 10.1080/02724634.1999.10011123; PADIAN K, 1997, ENCY DINOSAURS, P6; Paul G., 1988, PREDATORY DINOSAURS; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Pol D, 2004, CLADISTICS, V20, P64, DOI 10.1111/j.1096-0031.2003.00002.x; Pol D, 2001, CLADISTICS, V17, P285, DOI 10.1111/j.1096-0031.2001.tb00125.x; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Prendini L, 2001, SYST BIOL, V50, P290, DOI 10.1080/10635150118650; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reig O. A., 1963, Ameghiniana, V3, P3; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; Rogers SW, 1999, ANAT RECORD, V257, P162; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; RUSSELL DA, 1970, NATL MUS NAT HIST PU, V1, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Siddall ME, 1996, SYST BIOL, V45, P111, DOI 10.2307/2413516; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith David K., 1999, P135; Smith DK, 1998, J VERTEBR PALEONTOL, V18, P126, DOI 10.1080/02724634.1998.10011039; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Stromer E., 1931, Abh bayer Akad Wiss Munchen (nf), V9, P1; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; SWOFFORD DL, PAUP PHYLOGENETIC AN; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1; Wagner A., 1861, ABHANDLUNGEN BAYERIS, V9, P30; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; WILLS M, GHOSTS SIGNIFICANCE; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; ZHAO XJ, 1993, CAN J EARTH SCI, V30, P2027, DOI 10.1139/e93-178; [No title captured]	140	56	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17932	10.1371/journal.pone.0017932	http://dx.doi.org/10.1371/journal.pone.0017932			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445312	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300023
J	Senghor, MW; Faye, MN; Faye, B; Diarra, K; Elguero, E; Gaye, O; Banuls, AL; Niang, AA				Senghor, Massila W.; Faye, Malick N.; Faye, Babacar; Diarra, Karamoko; Elguero, Eric; Gaye, Oumar; Banuls, Anne-Laure; Niang, Abdoul A.			Ecology of Phlebotomine Sand Flies in the Rural Community of Mont Rolland (Thies Region, Senegal): Area of Transmission of Canine Leishmaniasis	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; INFANTUM; SANDFLIES; DIPTERA; FOCUS; IDENTIFICATION; PERNICIOSUS; VECTORS; GAMBIA	Background: Different epidemiological studies previously indicated that canine leishmaniasis is present in the region of Thies (Senegal). However, the risks to human health, the transmission cycle and particularly the implicated vectors are unknown. Methodology/Principal Findings: To improve our knowledge on the population of phlebotomine sand flies and the potential vectors of canine leishmaniasis, sand flies were collected using sticky traps, light traps and indoor spraying method using pyrethroid insecticides in 16 villages of the rural community of Mont Rolland (Thies region) between March and July 2005. The 3788 phlebotomine sand flies we collected (2044 males, 1744 females) were distributed among 9 species of which 2 belonged to the genus Phlebotomus: P. duboscqi (vector of cutaneous leishmaniasis in Senegal) and P. rodhaini. The other species belonged to the genus Sergentomyia: S. adleri, S. clydei, S. antennata, S. buxtoni, S. dubia, S. schwetzi and S. magna. The number of individuals and the species composition differed according to the type of trap, suggesting variable, species-related degrees of endophily or exophily. The two species of the genus Phlebotomus were markedly under-represented in comparison to the species of the genus Sergentomyia. This study also shows a heterogeneous spatial distribution within the rural community that could be explained by the different ecosystems and particularly the soil characteristics of this community. Finally, the presence of the S. dubia species appeared to be significantly associated with canine leishmaniasis seroprevalence in dogs. Conclusions/Significance: Our data allow us to hypothesize that the species of the genus Sergentomyia and particularly the species S. dubia and S. schwetzi might be capable of transmitting canine leishmaniasis. These results challenge the dogma that leishmaniasis is exclusively transmitted by species of the genus Phlebotomus in the Old World. This hypothesis should be more thoroughly evaluated.	[Senghor, Massila W.; Faye, Malick N.; Niang, Abdoul A.] Univ Cheikh Anta Diop, Inst Fondamental Afr Noire Cheikh Anta Diop, Lab Zool Invertebres Terr, Dakar, Senegal; [Faye, Malick N.; Diarra, Karamoko] Univ Cheikh Anta Diop, Fac Sci, Dept Biol Anim, Dakar, Senegal; [Faye, Babacar; Gaye, Oumar] Univ Cheikh Anta Diop, Serv Parasitol Mycol Med, Dakar, Senegal; [Senghor, Massila W.; Elguero, Eric; Banuls, Anne-Laure] Univ Montpellier I, CNRS 5290, Lab MIVEGEC, UMR IRD 224, Montpellier, France	University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Senghor, MW (corresponding author), Univ Cheikh Anta Diop, Inst Fondamental Afr Noire Cheikh Anta Diop, Lab Zool Invertebres Terr, Dakar, Senegal.	mawasen@yahoo.fr	Elguero, Eric/J-3014-2012	Banuls, Anne-Laure/0000-0002-2106-8667	IFAN; Cheikh Anta Diop University of Dakar; AUF; French cooperation; ANR; SEST IAEL; IRD; CNRS	IFAN; Cheikh Anta Diop University of Dakar; AUF; French cooperation; ANR(French National Research Agency (ANR)); SEST IAEL; IRD; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by IFAN, Cheikh Anta Diop University of Dakar, AUF, French cooperation, ANR SEST IAEL, 2006-20 01, IRD and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABONNENC E., 1972, Mem. O. R. S. T. O. M.; [Anonymous], LEISHMANIASES BIOL M; Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; Azizi K, 2006, ANN TROP MED PARASIT, V100, P63, DOI 10.1179/136485906X78454; Ba Y, 1999, B SOC PATHOL EXOT, V92, P131; Blanchot M., 1984, Medecine Tropicale, V44, P35; By Y, 1998, PARASITE, V5, P143, DOI 10.1051/parasite/1998052143; CONTEH S, 1983, T ROY SOC TROP MED H, V77, P298, DOI 10.1016/0035-9203(83)90147-5; DEDET JP, 1980, B SOC PATHOL EXOT, V73, P266; Desjeux P., 1981, Afrique Medicale, V20, P347; DESJEUX P, 1983, T ROY SOC TROP MED H, V77, P143, DOI 10.1016/0035-9203(83)90052-4; DESJEUX P., 1981, Afrique Medicale, V20, P427; DESJEUX P, 1982, B SOC PATHOL EXOT, V75, P620; Faye B, 2010, MICROBES INFECT, V12, P1219, DOI 10.1016/j.micinf.2010.09.003; Izri MA, 1996, T ROY SOC TROP MED H, V90, P114, DOI 10.1016/S0035-9203(96)90104-2; IZRI MA, 1992, B SOC PATHOL EXOT, V85, P385; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; MORRISON AC, 1993, AM J TROP MED HYG, V49, P68, DOI 10.4269/ajtmh.1993.49.68; Niang AA, 1998, PARASITE, V5, P51, DOI 10.1051/parasite/1998051051; *R DEV COR, 2009, R LANG ENV STAT COMP; Ranque P., 1978, Medecine Tropicale, V38, P413; Ranque P, 1970, Bull Acad Natl Med, V154, P510; RANQUE P, 1971, Medecine d'Afrique Noire, V18, P761; RIOUX JA, 1984, ANN PARASIT HUM COMP, V59, P331, DOI 10.1051/parasite/1984594331; Trouillet J., 1994, Bulletin de l'Institut Fondamental d'Afrique Noire. Serie A, Sciences Naturelles, V47, P73; TROUILLET J, 1993, ANN PARASIT HUM COMP, V68, P101; TROUILLET J, 1990, Journal of African Zoology, V104, P477; TROUILLET J, 1983, B ECOL, V14, P1; TROUILLET J, 1995, PARASITE, V2, P289, DOI 10.1051/parasite/1995023289; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Waroqw L, 1981, AFRIQUE MED, V19, P439	32	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e14773	10.1371/journal.pone.0014773	http://dx.doi.org/10.1371/journal.pone.0014773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445295	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300003
J	Brown, NF; Coombes, BK; Bishop, JL; Wickham, ME; Lowden, MJ; Gal-Mor, O; Goode, DL; Boyle, EC; Sanderson, KL; Finlay, BB				Brown, Nat F.; Coombes, Brian K.; Bishop, Jenna L.; Wickham, Mark E.; Lowden, Michael J.; Gal-Mor, Ohad; Goode, David L.; Boyle, Erin C.; Sanderson, Kristy L.; Finlay, B. Brett			Salmonella Phage ST64B Encodes a Member of the SseK/NleB Effector Family	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; ESCHERICHIA-COLI; HOST-CELLS; IN-VIVO; EPITHELIAL-CELLS; VIRULENCE GENES; PROTEINS; MACROPHAGES	Salmonella enterica is a species of bacteria that is a major cause of enteritis across the globe, while certain serovars cause typhoid, a more serious disease associated with a significant mortality rate. Type III secreted effectors are major contributors to the pathogenesis of Salmonella infections. Genes encoding effectors are acquired via horizontal gene transfer, and a subset are encoded within active phage lysogens. Because the acquisition of effectors is in flux, the complement of effectors possessed by various Salmonella strains frequently differs. By comparing the genome sequences of S. enterica serovar Typhimurium strain SL1344 with LT2, we identified a gene with significant similarity to SseK/NleB type III secreted effector proteins within a phage ST64B lysogen that is absent from LT2. We have named this gene sseK3. SseK3 was co-regulated with the SPI-2 type III secretion system in vitro and inside host cells, and was also injected into infected host cells. While no role for SseK3 in virulence could be identified, a role for the other family members in murine typhoid was found. SseK3 and other phage-encoded effectors were found to have a significant but sparse distribution in the available Salmonella genome sequences, indicating the potential for more uncharacterised effectors to be present in less studied serovars. These phage-encoded effectors may be principle subjects of contemporary selective processes shaping Salmonella-host interactions.	[Brown, Nat F.; Sanderson, Kristy L.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Brown, Nat F.; Coombes, Brian K.; Bishop, Jenna L.; Wickham, Mark E.; Lowden, Michael J.; Gal-Mor, Ohad; Goode, David L.; Boyle, Erin C.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	Griffith University; University of British Columbia	Brown, NF (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	nfbrown@unimelb.edu.au; bfinlay@interchange.ubc.ca	Wickham, Mark/A-1396-2009; Gal-Mor, Ohad/U-5025-2017; Brown, Nat/HHN-8551-2022; Wickham, Mark E/HCI-4959-2022; Coombes, Brian K/A-1727-2009	Wickham, Mark/0000-0002-3473-7196; Gal-Mor, Ohad/0000-0002-2540-6790; Wickham, Mark E/0000-0002-3473-7196; Boyle, Erin C./0000-0002-5963-3633; Coombes, Brian/0000-0001-9883-1010; Goode, David/0000-0002-3277-6562	Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council (NHMRC); Howard Hughes Medical Institute	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	NFB, BKC, MEW and OG-M were supported by the Michael Smith Foundation for Health Research. BKC and MEW were also supported by Canadian Institutes of Health Research (CIHR) postdoctoral fellowships and NFB is supported by a National Health and Medical Research Council (NHMRC) Howard Florey Centenary fellowship. Research in NFB's laboratory is supported by a grant from NHMRC and research in BBF's laboratory is supported by grants from CIHR and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bishop JL, 2008, INFECT IMMUN, V76, P2913, DOI 10.1128/IAI.01596-07; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Brown NF, 2006, MICROBIOL-SGM, V152, P2323, DOI 10.1099/mic.0.28995-0; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Davis MA, 2002, J LAB CLIN MED, V140, P135, DOI 10.1067/mlc.2002.126411; Figueroa-Bossi N, 2004, J BACTERIOL, V186, P4038, DOI 10.1128/JB.186.12.4038-4041.2004; FRETER R, 1981, INFECT IMMUN, V34, P234, DOI 10.1128/IAI.34.1.234-240.1981; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gauthier A, 2000, INFECT IMMUN, V68, P4344, DOI 10.1128/IAI.68.7.4344-4348.2000; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Jiang XJ, 2004, MOL MICROBIOL, V54, P1186, DOI 10.1111/j.1365-2958.2004.04344.x; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Pelludat C, 2003, J BACTERIOL, V185, P5182, DOI 10.1128/JB.185.17.5182-5191.2003; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; YU XJ, 2010, SCIENCE; Zhang SP, 2002, FEMS MICROBIOL LETT, V217, P243, DOI 10.1111/j.1574-6968.2002.tb11482.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	53	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17824	10.1371/journal.pone.0017824	http://dx.doi.org/10.1371/journal.pone.0017824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445262	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100034
J	Lacruz, RS; Lakshminarayanan, R; Bromley, KM; Hacia, JG; Bromage, TG; Snead, ML; Moradian-Oldak, J; Paine, ML				Lacruz, Rodrigo S.; Lakshminarayanan, Rajamani; Bromley, Keith M.; Hacia, Joseph G.; Bromage, Timothy G.; Snead, Malcolm L.; Moradian-Oldak, Janet; Paine, Michael L.			Structural Analysis of a Repetitive Protein Sequence Motif in Strepsirrhine Primate Amelogenin	PLOS ONE			English	Article							MALAGASY LEMURS; GENETIC-BASIS; EVOLUTION; BIOMINERALIZATION; MICROSTRUCTURE; CHROMOSOMES; PEPTIDE; REGIONS; TEETH; LOCI	Strepsirrhines are members of a primate suborder that has a distinctive set of features associated with the development of the dentition. Amelogenin (AMEL), the better known of the enamel matrix proteins, forms 90% of the secreted organic matrix during amelogenesis. Although AMEL has been sequenced in numerous mammalian lineages, the only reported strepsirrhine AMEL sequences are those of the ring-tailed lemur and galago, which contain a set of additional proline-rich tandem repeats absent in all other primates species analyzed to date, but present in some non-primate mammals. Here, we first determined that these repeats are present in AMEL from three additional lemur species and thus are likely to be widespread throughout this group. To evaluate the functional relevance of these repeats in strepsirrhines, we engineered a mutated murine amelogenin sequence containing a similar proline-rich sequence to that of Lemur catta. In the monomeric form, the MQP insertions had no influence on the secondary structure or refolding properties, whereas in the assembled form, the insertions increased the hydrodynamic radii. We speculate that increased AMEL nanosphere size may influence enamel formation in strepsirrhine primates.	[Lacruz, Rodrigo S.; Bromley, Keith M.; Snead, Malcolm L.; Moradian-Oldak, Janet; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Lakshminarayanan, Rajamani] Singapore Eye Res Inst, Singapore, Singapore; [Hacia, Joseph G.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	University of Southern California; National University of Singapore; Singapore National Eye Center; University of Southern California; New York University; New York University	Lacruz, RS (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	rodrigo@usc.edu; paine@usc.edu	Lacruz, Rodrigo/AGY-8090-2022; Rajamani, Lakshminarayanan/AAG-5541-2019; bromage, timothy/H-8621-2015	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Bromley, Keith/0000-0002-8001-3818; LACRUZ, RODRIGO/0000-0002-0776-6143; bromage, timothy/0000-0002-9843-7993	NIH-NIDCR [DE013404, DE019629, DE20099, DE13414]; NIH-NIGMS [GM072447]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414, R01DE019629, R01DE020099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072447, R01GM072477] Funding Source: NIH RePORTER	NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH-NIDCR grants to: M.L.P. (DE013404; DE019629); J.M.O. (DE20099; DE13414) and NIH-NIGMS grant to J.G.H (GM072447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fleagle J.G., 1998, PRIMATE ADAPTATION E; Godfrey LR, 2005, FOLIA PRIMATOL, V76, P77, DOI 10.1159/000083615; Jin TQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000262; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Lacruz RS, 2007, AM J PHYS ANTHROPOL, V132, P175, DOI 10.1002/ajpa.20506; Lakshminarayanan R, 2010, J BIOL CHEM, V285, P40593, DOI 10.1074/jbc.M110.131136; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 1998, BIOPOLYMERS, V46, P225, DOI 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Moradian-Oldak J., 2010, AMELOGENINS MULTIFAC; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 1998, J DENT RES, V77, P496, DOI 10.1177/00220345980770030901; Papagerakis P, 2005, J DENT RES, V84, P613, DOI 10.1177/154405910508400706; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Sire JY, 2005, ARCH ORAL BIOL, V50, P205, DOI 10.1016/j.archoralbio.2004.09.004; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Zhang B, 2000, BIOPOLYMERS, V54, P464, DOI 10.1002/1097-0282(200011)54:6<464::AID-BIP90>3.0.CO;2-N; Zhu DH, 2006, J BIOL CHEM, V281, P21173, DOI 10.1074/jbc.M510757200; Zou Y, 2007, BIOCHEM J, V408, P347, DOI 10.1042/BJ20070881	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18028	10.1371/journal.pone.0018028	http://dx.doi.org/10.1371/journal.pone.0018028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437261	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100064
J	Li, A; Lim, TS; Shi, H; Yin, J; Tan, SJ; Li, ZJ; Low, BC; Tan, KSW; Lim, CT				Li, Ang; Lim, Tong Seng; Shi, Hui; Yin, Jing; Tan, Swee Jin; Li, Zhengjun; Low, Boon Chuan; Tan, Kevin Shyong Wei; Lim, Chwee Teck			Molecular Mechanistic Insights into the Endothelial Receptor Mediated Cytoadherence of Plasmodium falciparum-Infected Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; HUMAN CEREBRAL MALARIA; PARASITIZED ERYTHROCYTES; MEMBRANE GLYCOPROTEIN; FORCE; ADHESION; CD36; IDENTIFICATION; SELECTIN; LIGAND	Cytoadherence or sequestration is essential for the pathogenesis of the most virulent human malaria species, Plasmodium falciparum (P. falciparum). Similar to leukocyte-endothelium interaction in response to inflammation, cytoadherence of P. falciparum infected red blood cells (IRBCs) to endothelium occurs under physiological shear stresses in blood vessels and involves an array of molecule complexes which cooperate to form stable binding. Here, we applied single-molecule force spectroscopy technique to quantify the dynamic force spectra and characterize the intrinsic kinetic parameters for specific ligand-receptor interactions involving two endothelial receptor proteins: thrombospondin (TSP) and CD36. It was shown that CD36 mediated interaction was much more stable than that mediated by TSP at single molecule level, although TSP-IRBC interaction appeared stronger than CD36-IRBC interaction in the high pulling rate regime. This suggests that TSP-mediated interaction may initiate cell adhesion by capturing the fast flowing IRBCs whereas CD36 functions as the 'holder' for providing stable binding.	[Li, Ang; Shi, Hui] SMART, Singapore, Singapore; [Lim, Tong Seng] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore; [Yin, Jing; Tan, Kevin Shyong Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Tan, Swee Jin; Lim, Chwee Teck] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Li, Zhengjun; Low, Boon Chuan; Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Tan, Kevin Shyong Wei] Natl Univ Singapore, Inst Life Sci, Program Infect Dis, Singapore 117548, Singapore	Singapore-MIT Alliance for Research & Technology Centre (SMART); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Li, A (corresponding author), SMART, Singapore, Singapore.	mictank@nus.edu.sg; ctlim@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Tan, Kevin/C-9653-2014; Low, Boon Chuan/H-8049-2012; Lim, chwee Teck/B-3307-2011	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Lim, chwee Teck/0000-0003-4019-9782; /0000-0002-7437-5687				AIKAWA M, 1992, MEM I OSWALDO CRUZ, V87, P297, DOI 10.1590/S0074-02761992000700051; [Anonymous], REFORMA MED; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Baenziger N L, 1974, Methods Enzymol, V31, P149; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Baruch DI, 1999, BLOOD, V94, P2121, DOI 10.1182/blood.V94.6.2121.418k09_2121_2127; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; COOKE BM, 1995, EXP PARASITOL, V80, P116, DOI 10.1006/expr.1995.1013; Cooke BM, 1998, MOL MICROBIOL, V30, P83, DOI 10.1046/j.1365-2958.1998.01040.x; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; DAVIET L, 1995, BIOCHEM J, V305, P221, DOI 10.1042/bj3050221; Dobrowsky TM, 2008, J VIROL, V82, P7022, DOI 10.1128/JVI.00053-08; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Korn C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.138103; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Liu F, 2003, CELL BIOCHEM BIOPHYS, V38, P251, DOI 10.1385/CBB:38:3:251; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; O'Connell D, 2007, NAT REV MICROBIOL, V5, P655, DOI 10.1038/nrmicro1737; OCKENHOUSE CF, 1993, INFECT IMMUN, V61, P2229, DOI 10.1128/IAI.61.5.2229-2232.1993; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UDEINYA IJ, 1981, SCIENCE, V213, P555, DOI 10.1126/science.7017935; Winograd E, 2004, MOL BIOCHEM PARASIT, V136, P243, DOI 10.1016/j.molbiopara.2004.04.005; Yipp BG, 2007, MICROCIRCULATION, V14, P593, DOI 10.1080/10739680701404705	52	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e16929	10.1371/journal.pone.0016929	http://dx.doi.org/10.1371/journal.pone.0016929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437286	Green Published, Green Submitted, gold			2022-12-25	WOS:000288514600002
J	Brett, CL; Kallay, L; Hua, ZL; Green, R; Chyou, A; Zhang, YQ; Graham, TR; Donowitz, M; Rao, R				Brett, Christopher L.; Kallay, Laura; Hua, Zhaolin; Green, Richard; Chyou, Anthony; Zhang, Yongqiang; Graham, Todd R.; Donowitz, Mark; Rao, Rajini			Genome-Wide Analysis Reveals the Vacuolar pH-Stat of Saccharomyces cerevisiae	PLOS ONE			English	Article							ORGANELLE ACIDIFICATION; TRANSLOCASE ACTIVITY; PROTEIN TRAFFICKING; PLASMA-MEMBRANE; YEAST MUTANT; PROTON PUMPS; C DISEASE; H+-ATPASE; GOLGI; TRANSPORT	Protons, the smallest and most ubiquitous of ions, are central to physiological processes. Transmembrane proton gradients drive ATP synthesis, metabolite transport, receptor recycling and vesicle trafficking, while compartmental pH controls enzyme function. Despite this fundamental importance, the mechanisms underlying pH homeostasis are not entirely accounted for in any organelle or organism. We undertook a genome-wide survey of vacuole pH (pH(v)) in 4,606 single-gene deletion mutants of Saccharomyces cerevisiae under control, acid and alkali stress conditions to reveal the vacuolar pH-stat. Median pHv (5.27 +/- 0.13) was resistant to acid stress (5.28 +/- 0.14) but shifted significantly in response to alkali stress (5.83 +/- 0.13). Of 107 mutants that displayed aberrant pHv under more than one external pH condition, functional categories of transporters, membrane biogenesis and trafficking machinery were significantly enriched. Phospholipid flippases, encoded by the family of P4-type ATPases, emerged as pH regulators, as did the yeast ortholog of Niemann Pick Type C protein, implicated in sterol trafficking. An independent genetic screen revealed that correction of pHv dysregulation in a neo1(ts) mutant restored viability whereas cholesterol accumulation in human NPC1(-/-) fibroblasts diminished upon treatment with a proton ionophore. Furthermore, while it is established that lumenal pH affects trafficking, this study revealed a reciprocal link with many mutants defective in anterograde pathways being hyperacidic and retrograde pathway mutants with alkaline vacuoles. In these and other examples, pH perturbations emerge as a hitherto unrecognized phenotype that may contribute to the cellular basis of disease and offer potential therapeutic intervention through pH modulation.	[Brett, Christopher L.; Kallay, Laura; Chyou, Anthony; Zhang, Yongqiang; Donowitz, Mark; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Hua, Zhaolin; Green, Richard; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Vanderbilt University; Johns Hopkins University	Brett, CL (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	cbrett@alcor.concordia.ca; rrao@jhmi.edu		Hua, Zhaolin/0000-0001-9242-1387	National Institutes of Health [R01 DK54214, GM62367, DK26523]; Johns Hopkins University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214, R01DK026523, R01DK061765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 DK54214 to R.R., GM62367 to T.R.G. and DK26523 to M.D. C.L.B. was a predoctoral fellow of the American Heart Association. A.C. received support from a Provost's Undergraduate Research Award of the Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Battisti C, 2003, MOVEMENT DISORD, V18, P1405, DOI 10.1002/mds.10541; Berger AC, 2005, TRAFFIC, V6, P907, DOI 10.1111/j.1600-0854.2005.00327.x; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Borrelly G, 2001, P NATL ACAD SCI USA, V98, P9660, DOI 10.1073/pnas.161215198; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2006, FEBS LETT, V580, P717, DOI 10.1016/j.febslet.2005.12.103; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Jacobs NL, 1997, J LIPID RES, V38, P1973; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Lin M, 2009, FEBS J, V276, P7253, DOI 10.1111/j.1742-4658.2009.07433.x; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; MELLMAN I, 1992, J EXP BIOL, V172, P39; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nieland TJF, 2004, TRAFFIC, V5, P478, DOI 10.1111/j.1398-9219.2004.00193.x; NIKAWA J, 1983, EUR J BIOCHEM, V131, P223, DOI 10.1111/j.1432-1033.1983.tb07253.x; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; Palma M, 2009, FEMS YEAST RES, V9, P526, DOI 10.1111/j.1567-1364.2009.00511.x; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; PRESTON RA, 1992, GENETICS, V131, P551; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sakano K, 1998, PLANT CELL PHYSIOL, V39, P467, DOI 10.1093/oxfordjournals.pcp.a029393; Schellmann S, 2009, CURR OPIN PLANT BIOL, V12, P670, DOI 10.1016/j.pbi.2009.09.005; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; WALLS KC, J BIOL CHEM, V285, P10497; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	55	60	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17619	10.1371/journal.pone.0017619	http://dx.doi.org/10.1371/journal.pone.0017619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423800	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000288512400017
J	Keaton, MA; Taylor, CM; Layer, RM; Dutta, A				Keaton, Mignon A.; Taylor, Christopher M.; Layer, Ryan M.; Dutta, Anindya			Nuclear Scaffold Attachment Sites within ENCODE Regions Associate with Actively Transcribed Genes	PLOS ONE			English	Article							GENOME-TILING ARRAYS; DNA-REPLICATION; HISTONE MODIFICATIONS; MAMMALIAN-CELLS; PROTEIN MATRIX; CHROMATIN LOOP; HELA-CELLS; IDENTIFICATION; ORGANIZATION; CHROMOSOME	The human genome must be packaged and organized in a functional manner for the regulation of DNA replication and transcription. The nuclear scaffold/matrix, consisting of structural and functional nuclear proteins, remains after extraction of nuclei and anchors loops of DNA. In the search for cis-elements functioning as chromatin domain boundaries, we identified 453 nuclear scaffold attachment sites purified by lithium-3,5-iodosalicylate extraction of HeLa nuclei across 30 Mb of the human genome studied by the ENCODE pilot project. The scaffold attachment sites mapped predominately near expressed genes and localized near transcription start sites and the ends of genes but not to boundary elements. In addition, these regions were enriched for RNA polymerase II and transcription factor binding sites and were located in early replicating regions of the genome. We believe these sites correspond to genome-interactions mediated by transcription factors and transcriptional machinery immobilized on a nuclear substructure.	[Keaton, Mignon A.; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Taylor, Christopher M.] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA; [Layer, Ryan M.] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	University of Virginia; University of Louisiana System; University of New Orleans; University of Virginia	Keaton, MA (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	ad8q@virginia.edu	Taylor, Christopher M./AAF-5480-2020; Dutta, Anindya/P-3203-2016	Taylor, Christopher M./0000-0002-7983-5275; Dutta, Anindya/0000-0002-4319-0073	National Research Service Awards [F32GM087843]; National Institutes of Health [R01 GM084465]; NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084465, F32GM087843] Funding Source: NIH RePORTER	National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a National Research Service Awards fellowship F32GM087843 to MA Keaton and National Institutes of Health R01 GM084465 to A Dutta. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; BEREZNEY R, 1975, SCIENCE, V189, P291, DOI 10.1126/science.1145202; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dijkwel PA, 1999, METHODS, V18, P418, DOI 10.1006/meth.1999.0800; Djeliova V, 2001, NUCLEIC ACIDS RES, V29, P3181, DOI 10.1093/nar/29.15.3181; Donev RM, 2000, MOL CELL BIOCHEM, V214, P103; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; GAVRILOV AA, 2010, NUCL ACIDS RES; GERDES MG, 1994, J CELL BIOL, V126, P289, DOI 10.1083/jcb.126.2.289; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hancock R, 2000, CHROMOSOMA, V109, P219, DOI 10.1007/s004120000077; Iarovaia OV, 2005, NUCLEIC ACIDS RES, V33, P4157, DOI 10.1093/nar/gki733; Iarovaia OV, 2004, NUCLEIC ACIDS RES, V32, P2079, DOI 10.1093/nar/gkh532; Jackson DA, 1996, NUCLEIC ACIDS RES, V24, P1212, DOI 10.1093/nar/24.7.1212; JACKSON DA, 1988, EMBO J, V7, P3667, DOI 10.1002/j.1460-2075.1988.tb03248.x; JACKSON DA, 1981, NATURE, V292, P552, DOI 10.1038/292552a0; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; JACKSON DA, 1990, NUCLEIC ACIDS RES, V18, P4385, DOI 10.1093/nar/18.15.4385; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVYWILSON B, 1989, J BIOL CHEM, V264, P21196; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MESNER LD, 2011, GENOME RES; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Purbowasito N, 2004, DNA RES, V11, P391, DOI 10.1093/dnares/11.6.391; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shaposhnikov SA, 2007, GENOMICS, V89, P354, DOI 10.1016/j.ygeno.2006.11.003; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; VAUGHN JP, 1990, NUCLEIC ACIDS RES, V18, P1965, DOI 10.1093/nar/18.8.1965; VERHEIJEN R, 1988, J CELL SCI, V90, P11; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhang SB, 2002, CELL RES, V12, P411, DOI 10.1038/sj.cr.7290144; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z	62	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17912	10.1371/journal.pone.0017912	http://dx.doi.org/10.1371/journal.pone.0017912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423757	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400038
J	Panova, M; Blakeslee, AMH; Miller, AW; Makinen, T; Ruiz, GM; Johannesson, K; Andre, C				Panova, Marina; Blakeslee, April M. H.; Miller, A. Whitman; Maekinen, Tuuli; Ruiz, Gregory M.; Johannesson, Kerstin; Andre, Carl			Glacial History of the North Atlantic Marine Snail, Littorina saxatilis, Inferred from Distribution of Mitochondrial DNA Lineages	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; POPULATION-STRUCTURE; INTERGLACIAL CYCLE; GENETIC DIVERSITY; LARVAL DISPERSAL; ENGLISH-CHANNEL; PHYLOGEOGRAPHY; REFUGIA; MIGRATION; GROWTH	The North Atlantic intertidal gastropod, Littorina saxatilis (Olivi, 1792), exhibits extreme morphological variation between and within geographic regions and has become a model for studies of local adaptation; yet a comprehensive analysis of the species' phylogeography is lacking. Here, we examine phylogeographic patterns of the species' populations in the North Atlantic and one remote Mediterranean population using sequence variation in a fragment of the mitochondrial cytochrome b gene (607 bp). We found that, as opposed to many other rocky intertidal species, L. saxatilis has likely had a long and continuous history in the Northwest Atlantic, including survival during the last glacial maximum (LGM), possibly in two refugia. In the Northeast Atlantic, several areas likely harboured refugial populations that recolonized different parts of this region after glacial retreat, resulting in strong population structure. However, the outlying monomorphic Venetian population is likely a recent anthropogenic introduction from northern Europe and not a remnant of an earlier wider distribution in the Mediterranean Sea. Overall, our detailed phylogeography of L. saxatilis adds an important piece to the understanding of Pleistocene history in North Atlantic marine biota as well as being the first study to describe the species' evolutionary history in its natural range. The latter contribution is noteworthy because the snail has recently become an important model species for understanding evolutionary processes of speciation; thus our work provides integral information for such endeavours.	[Panova, Marina; Johannesson, Kerstin; Andre, Carl] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden; [Blakeslee, April M. H.; Miller, A. Whitman; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Marine Invas Lab, Edgewater, MD 21037 USA; [Maekinen, Tuuli] S African Inst Aquat Biodivers, Grahamstown, South Africa	University of Gothenburg; Smithsonian Institution; Smithsonian Environmental Research Center; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Panova, M (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden.	marina.panova@marecol.gu.se	Johannesson, Kerstin/B-5528-2013; Johannesson, Kerstin/X-7994-2019; Panova, Marina/D-2633-2015; Panova, Marina/V-3533-2019; Andre, Carl/B-4237-2010; Miller, Whitman/C-7811-2017	Johannesson, Kerstin/0000-0003-0176-7986; Johannesson, Kerstin/0000-0003-0176-7986; Panova, Marina/0000-0002-4147-6473; Panova, Marina/0000-0002-4147-6473; Andre, Carl/0000-0003-4404-7292; Ruiz, Gregory/0000-0003-2499-441X; Blakeslee, April/0000-0001-9667-2175; Miller, Whitman/0000-0003-0484-182X; Makinen, Tuuli Elina/0000-0001-5163-8459	Centre for Theoretical Biology at Gothenburg University; Swedish Royal Academy of Science; Swedish Research Council; Smithsonian Institution postdoctoral fellowship program; Helge Ax:son Johnson Foundation; Swedish Research Council VR; Swedish Research Council Formas	Centre for Theoretical Biology at Gothenburg University; Swedish Royal Academy of Science; Swedish Research Council(Swedish Research CouncilEuropean Commission); Smithsonian Institution postdoctoral fellowship program(Smithsonian Institution); Helge Ax:son Johnson Foundation; Swedish Research Council VR(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support was provided by the Centre for Theoretical Biology at Gothenburg University (MP, CA, KJ), the Swedish Royal Academy of Science (MP), the Swedish Research Council (KJ, CA), the Smithsonian Institution postdoctoral fellowship program (AMHB) and a grant from the Helge Ax:son Johnson Foundation (TM). This work was partly performed within the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se/) supported by a Linnaeus-grant from the Swedish Research Councils VR and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, VENICE MARITIME REPU, P241; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Blakeslee AMH, 2008, MOL ECOL, V17, P3684, DOI 10.1111/j.1365-294X.2008.03865.x; Blakeslee AMH, 2008, ECOLOGY, V89, P1068, DOI 10.1890/07-0832.1; Bowen DQ, 2002, QUATERNARY SCI REV, V21, P89, DOI 10.1016/S0277-3791(01)00102-0; Brawley SH, 2009, P NATL ACAD SCI USA, V106, P8239, DOI 10.1073/pnas.0812300106; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Carlton James T., 1992, Journal of Shellfish Research, V11, P489; Carlton JT, 1998, VELIGER, V41, P333; Charbit S, 2007, CLIM PAST, V3, P15, DOI 10.5194/cp-3-15-2007; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Dahlgren TG, 2000, MAR BIOL, V137, P487, DOI 10.1007/s002270000342; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hoarau G, 2007, MOL ECOL, V16, P3606, DOI 10.1111/j.1365-294X.2007.03408.x; INGOLFSSON A, 1992, J BIOGEOGR, V19, P705, DOI 10.2307/2845711; Ingolfsson A, 2009, ZOOL SCR, V38, P663, DOI 10.1111/j.1463-6409.2009.00405.x; JANSON K, 1983, OECOLOGIA, V59, P58, DOI 10.1007/BF00388072; JANSON K, 1985, BIOL J LINN SOC, V24, P51, DOI 10.1111/j.1095-8312.1985.tb00159.x; JANSON K, 1982, MAR BIOL, V69, P73, DOI 10.1007/BF00396963; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Jesus FF, 2006, GENET MOL RES, V5, P466; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; KNIGHT AJ, 1987, BIOL J LINN SOC, V32, P417, DOI 10.1111/j.1095-8312.1987.tb00441.x; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Olsen JL, 2010, J BIOGEOGR, V37, P842, DOI 10.1111/j.1365-2699.2009.02262.x; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provan J, 2005, MOL ECOL, V14, P793, DOI 10.1111/j.1365-294X.2005.02447.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Reid DG, 1996, PHILOS T R SOC B, V351, P877, DOI 10.1098/rstb.1996.0082; Reid DG, 1996, SYSTEMATIC EVOLUTION; Remerie T, 2009, J BIOGEOGR, V36, P39, DOI 10.1111/j.1365-2699.2008.01970.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Sejrup HP, 2005, MAR PETROL GEOL, V22, P1111, DOI 10.1016/j.marpetgeo.2004.09.007; Small MP, 2000, MOL ECOL, V9, P39, DOI 10.1046/j.1365-294x.2000.00824.x; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai YHE, 2010, P NATL ACAD SCI USA, V107, P17035, DOI 10.1073/pnas.1006225107; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Wares JP, 2001, EVOLUTION, V55, P2455; Wilding CS, 1999, J MOL EVOL, V48, P348, DOI 10.1007/PL00006479	60	70	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17511	10.1371/journal.pone.0017511	http://dx.doi.org/10.1371/journal.pone.0017511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412417	Green Published, gold			2022-12-25	WOS:000288247800009
J	Cortese, MS; Etxebeste, O; Garzia, A; Espeso, EA; Ugalde, U				Cortese, Marc S.; Etxebeste, Oier; Garzia, Aitor; Espeso, Eduardo A.; Ugalde, Unai			Elucidation of Functional Markers from Aspergillus nidulans Developmental Regulator FlbB and Their Phylogenetic Distribution	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FLBB; INTRINSICALLY UNSTRUCTURED PROTEINS; NUCLEAR EXPORT SIGNAL; DNA-BINDING ACTIVITY; ASEXUAL DEVELOPMENT; LEUCINE-ZIPPER; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; REDOX REGULATION; STRUCTURAL BASIS	Aspergillus nidulans is a filamentous fungus widely used as a model for biotechnological and clinical research. It is also used as a platform for the study of basic eukaryotic developmental processes. Previous studies identified and partially characterized a set of proteins controlling cellular transformations in this ascomycete. Among these proteins, the bZip type transcription factor FlbB is a key regulator of reproduction, stress responses and cell-death. Our aim here was the prediction, through various bioinformatic methods, of key functional residues and motifs within FlbB in order to inform the design of future laboratory experiments and further the understanding of the molecular mechanisms that control fungal development. A dataset of FlbB orthologs and those of its key interaction partner FlbE was assembled from 40 members of the Pezizomycotina. Unique features were identified in each of the three structural domains of FlbB. The N-terminal region encoded a bZip transcription factor domain with a novel histidine-containing DNA binding motif while the dimerization determinants exhibited two distinct profiles that segregated by class. The C-terminal region of FlbB showed high similarity with the AP-1 family of stress response regulators but with variable patterns of conserved cysteines that segregated by class and order. Motif conservation analysis revealed that nine FlbB orthologs belonging to the Eurotiales order contained a motif in the central region that could mediate interaction with FlbE. The key residues and motifs identified here provide a basis for the design of follow-up experimental investigations. Additionally, the presence or absence of these residues and motifs among the FlbB orthologs could help explain the differences in the developmental programs among fungal species as well as define putative complementation groups that could serve to extend known functional characterizations to other species.	[Cortese, Marc S.; Etxebeste, Oier; Garzia, Aitor; Ugalde, Unai] Univ Basque Country, Fac Chem, Dept Appl Chem, San Sebastian, Spain; [Cortese, Marc S.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Espeso, Eduardo A.] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain	University of Basque Country; Basque Foundation for Science; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Cortese, MS (corresponding author), Univ Basque Country, Fac Chem, Dept Appl Chem, San Sebastian, Spain.	marc_cortese@ehu.es	Espeso, Eduardo A/C-5259-2011; Espeso, Eduardo A/AAC-7238-2022; Etxebeste, Oier/H-8064-2019; Cortese, Marc/G-4026-2010	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Etxebeste, Oier/0000-0002-9786-6091; Garzia, Aitor/0000-0002-6270-1369; Cortese, Marc/0000-0002-5903-0525	Basque Government [IT393-10]; Spanish Ministerio de Educacion y Ciencia [BFU2009-08701]; University of the Basque Country	Basque Government(Basque Government); Spanish Ministerio de Educacion y Ciencia(Spanish Government); University of the Basque Country	This work was supported by the Basque Government (http://www.hezkuntza.ejgv.euskadi.net) through grant IT393-10 to U.U. and by the Spanish Ministerio de Educacion y Ciencia (www.mec.es) through grant BFU2009-08701 to E.A.E. M.S.C. was a contract researcher of the Ikerbasque program of the Basque Government (www.ikerbasque.net). O.E. was a contract researcher of the University of the Basque Country (www.ehu.es). A.G. held a predoctoral fellowship from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Amoutzias GD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-107; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Asano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1800, DOI 10.1271/bbb.70133; Bayram O, 2008, FUNGAL GENET BIOL, V45, P127, DOI 10.1016/j.fgb.2007.06.001; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; de Bakker PIW, 2001, BIOINFORMATICS, V17, P748, DOI 10.1093/bioinformatics/17.8.748; Deppmann CD, 2003, BIOCHEM J, V374, P423, DOI 10.1042/BJ20030455; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Durbin R., 1998, BIOL SEQUENCE ANAL P; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eddy Sean R, 2009, Genome Inform, V23, P205; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fleck CB, 2009, FUNGAL GENET BIOL, V46, P473, DOI 10.1016/j.fgb.2009.03.004; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hesse SJA, 2002, EUR J BIOCHEM, V269, P3485, DOI 10.1046/j.1432-1033.2002.03042.x; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; KAFER E, 1965, GENETICS, V52, P217; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; KUES M, 2006, MYCOTA GROWTH DIFFER, P263; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MARTINELLI SD, 1994, ASPERGILLUS 50 YEARS; Maruyama JI, 2005, BIOCHEM BIOPH RES CO, V331, P1081, DOI 10.1016/j.bbrc.2005.03.233; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MIMS C, 1988, PROTOPLASMA, V244, P132; Momany M, 2005, MED MYCOL, V43, pS23, DOI 10.1080/13693780400024263; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; POGGELER M, 2006, MYCOTA GROWTH DIFFER, P325; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Puttick J, 2008, BBA-PROTEINS PROTEOM, V1784, P100, DOI 10.1016/j.bbapap.2007.07.008; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Sharon Itai, 2009, V541, P61, DOI 10.1007/978-1-59745-243-4_4; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Shen WC, 1998, GENETICS, V148, P1031; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tanaka A, 2002, BBA-GENE STRUCT EXPR, V1576, P176, DOI 10.1016/S0167-4781(02)00286-5; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xiao P, 2010, EUKARYOT CELL, V9, P1711, DOI 10.1128/EC.00198-10; Yamada T, 2006, MED MYCOL, V44, P243, DOI 10.1080/13693780500410909; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	81	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17505	10.1371/journal.pone.0017505	http://dx.doi.org/10.1371/journal.pone.0017505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423749	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100010
J	Han, HJ; Kuwae, A; Abe, A; Arakawa, Y; Kamachi, K				Han, Hyun-Ja; Kuwae, Asaomi; Abe, Akio; Arakawa, Yoshichika; Kamachi, Kazunari			Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE FACTORS; SECRETION SYSTEM; ANTIGENIC DIVERGENCE; UNITED-STATES; IN-VITRO; TOXIN; PERTACTIN; VACCINE; BRONCHISEPTICA	Background: Bordetella pertussis is the primary etiologic agent of the disease pertussis. Universal immunization programs have contributed to a significant reduction in morbidity and mortality of pertussis; however, incidence of the disease, especially in adolescents and adults, has increased in several countries despite high vaccination coverage. During the last three decades, strains of Bordetella pertussis in circulation have shifted from the vaccine-type to the nonvaccine-type in many countries. A comparative proteomic analysis of the strains was performed to identify protein(s) involved in the type shift. Methodology/Principal Finding: Proteomic analysis identified one differentially expressed protein in the B. pertussis strains: the type III cytotoxic effector protein BteA, which is responsible for host cell death in Bordetella bronchiseptica infections. Immunoblot analysis confirmed the prominent expression of BteA protein in the nonvaccine-type strains but not in the vaccine-type strains. Sequence analysis of the vaccine-type strains revealed an IS481 insertion in the 5' untranslated region of bteA, -136 bp upstream of the bteA start codon. A high level of bteA transcripts from the IS481 promoter was detected in the vaccine-type strains, indicating that the transcript might be an untranslatable form. Furthermore, BteA mutant studies demonstrated that BteA expression in the vaccine-type strains is down-regulated by the IS481 insertion. Conclusion/Significance: The cytotoxic effector BteA protein is expressed at higher levels in B. pertussis nonvaccine-type strains than in vaccine-type strains. This type-dependent expression is due to an insertion of IS481 in B. pertussis clinical strains, suggesting that augmented expression of BteA protein might play a key role in the type shift of B. pertussis.	[Han, Hyun-Ja; Arakawa, Yoshichika; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Kuwae, Asaomi; Abe, Akio] Kitasato Univ, Lab Bacterial Infect, Kitasato Inst Life Sci, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Kitasato University	Han, HJ (corresponding author), Natl Fisheries Res & Dev Inst, Pusan, South Korea.	kamachi@nih.go.jp	Arakawa, Yoshichika/P-5997-2015; Abe, Akio/AAQ-2464-2020	Kamachi, Kazunari/0000-0001-5259-1744	Ministry of Health, Labor and Welfare of Japan [09158691, 09158699]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by grants for Research on Emerging and Re-emerging Infectious Diseases (09158691 and 09158699) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Caro V, 2008, J CLIN MICROBIOL, V46, P2125, DOI 10.1128/JCM.02484-07; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Craig NL, 2002, MOBILE DNA 2; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; DESHAZER D, 1994, MOL MICROBIOL, V14, P123, DOI 10.1111/j.1365-2958.1994.tb01272.x; Fennelly NK, 2008, INFECT IMMUN, V76, P1257, DOI 10.1128/IAI.00836-07; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Han HJ, 2008, VACCINE, V26, P1530, DOI 10.1016/j.vaccine.2008.01.020; He QS, 2003, J INFECT DIS, V187, P1200, DOI 10.1086/368412; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hellenbrand W, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-22; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; KOZAK NA, 2007, BORDETELLA MOL MICRO, P119; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Vidakovics ML, 2007, J PROTEOME RES, V6, P2518, DOI 10.1021/pr060681i; Pradel E, 2000, INFECT IMMUN, V68, P1919, DOI 10.1128/IAI.68.4.1919-1927.2000; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shrivastava R, 2009, CURR OPIN MICROBIOL, V12, P88, DOI 10.1016/j.mib.2009.01.001; Stefanelli P, 2006, J CLIN MICROBIOL, V44, P3397, DOI 10.1128/JCM.00247-06; Stibitz S, 1998, J BACTERIOL, V180, P4963, DOI 10.1128/JB.180.18.4963-4966.1998; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	44	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17797	10.1371/journal.pone.0017797	http://dx.doi.org/10.1371/journal.pone.0017797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423776	Green Submitted, gold, Green Published			2022-12-25	WOS:000288219100034
J	Hocher, B; Heiden, S; von Websky, K; Arafat, AM; Rahnenfuhrer, J; Alter, M; Kalk, P; Ziegler, D; Fischer, Y; Pfab, T				Hocher, Berthold; Heiden, Susi; von Websky, Karoline; Arafat, Ayman M.; Rahnenfuehrer, Jan; Alter, Markus; Kalk, Philipp; Ziegler, Dieter; Fischer, Yvan; Pfab, Thiemo			Renal Effects of the Novel Selective Adenosine A(1) Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats	PLOS ONE			English	Article							HEPATORENAL REFLEX; ANTAGONIST; HYPERTENSION; EXCRETION; FAILURE; KIDNEY	Liver cirrhosis is often complicated by an impaired renal excretion of water and sodium. Diuretics tend to further deteriorate renal function. It is unknown whether chronic selective adenosine A(1) receptor blockade, via inhibition of the hepatorenal reflex and the tubuloglomerular feedback, might exert diuretic and natriuretic effects without a reduction of the glomerular filtration rate. In healthy animals intravenous treatment with the novel A(1) receptor antagonist SLV329 resulted in a strong dose-dependent diuretic (up to 3.4-fold) and natriuretic (up to 13.5-fold) effect without affecting creatinine clearance. Male Wistar rats with thioacetamide-induced liver cirrhosis received SLV329, vehicle or furosemide for 12 weeks. The creatinine clearance of cirrhotic animals decreased significantly (-36.5%, p < 0.05), especially in those receiving furosemide (-41.9%, p < 0.01). SLV329 was able to prevent this decline of creatinine clearance. Mortality was significantly lower in cirrhotic animals treated with SLV329 in comparison to animals treated with furosemide (17% vs. 54%, p < 0.05). SLV329 did not relevantly influence the degree of liver fibrosis, kidney histology or expression of hepatic or renal adenosine receptors. In conclusion, chronic treatment with SLV329 prevented the decrease of creatinine clearance in a rat model of liver cirrhosis. Further studies will have to establish whether adenosine A(1) receptor antagonists are clinically beneficial at different stages of liver cirrhosis.	[Hocher, Berthold; von Websky, Karoline; Rahnenfuehrer, Jan] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Hocher, Berthold; Heiden, Susi; von Websky, Karoline; Rahnenfuehrer, Jan; Alter, Markus; Kalk, Philipp; Pfab, Thiemo] Charite, Cardiovasc Res Ctr, Inst Pharmacol, Berlin, Germany; [Arafat, Ayman M.] Charite Campus Benjamin Franklin, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Arafat, Ayman M.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany; [Alter, Markus; Kalk, Philipp; Pfab, Thiemo] Charite Campus Benjamin Franklin, Dept Nephrol, Berlin, Germany; [Ziegler, Dieter; Fischer, Yvan] Abbott Prod GmbH, Hannover, Germany	University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	berthold.hocher@charite.de	Hocher, Berthold/AAC-3510-2020	Heiden, Susi/0000-0001-8993-7120; Arafat, Ayman/0000-0003-3069-8385; Hocher, Berthold/0000-0001-8143-0579	Solvay Pharmaceuticals (now Abbott Products GmbH)	Solvay Pharmaceuticals (now Abbott Products GmbH)	This study was partially supported by a grant of the Dr. Werner Jackstadt-Stiftung to Markus Alter. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by Solvay Pharmaceuticals (now Abbott Products GmbH). Dieter Ziegler and Yvan Fischer are employees of Abbott Products GmbH and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. The study design was set up together with Solvay Pharmaceuticals. Solvay Pharmaceuticals agreed to publish the manuscript.	Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gottlieb SS, 2002, CIRCULATION, V105, P1348, DOI 10.1161/hc1102.105264; Hocher B, 2010, KIDNEY INT, V78, P438, DOI 10.1038/ki.2010.204; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Jackson EK, 2007, J PHARMACOL EXP THER, V320, P117, DOI 10.1124/jpet.106.112748; Jackson EK, 2002, AM J PHYSIOL-RENAL, V283, pF41, DOI 10.1152/ajprenal.00232.2001; Kalk P, 2007, BRIT J PHARMACOL, V151, P1025, DOI 10.1038/sj.bjp.0707319; KNIGHT RJ, 1993, BRIT J PHARMACOL, V109, P271, DOI 10.1111/j.1476-5381.1993.tb13564.x; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Ming Z, 2005, J HEPATOL, V42, P680, DOI 10.1016/j.jhep.2004.12.023; Ming Z, 2002, HEPATOLOGY, V35, P167, DOI 10.1053/jhep.2002.30425; Ming Z, 2006, CAN J PHYSIOL PHARM, V84, P1177, DOI 10.1139/Y06-063; Miracle CM, 2007, KIDNEY BLOOD PRESS R, V30, P388, DOI 10.1159/000108625; Pfab T, 2006, J AM SOC NEPHROL, V17, P1082, DOI 10.1681/ASN.2005080833; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; REYES AJ, 1993, J CARDIOVASC PHARM, V22, pS11, DOI 10.1097/00005344-199322003-00003; Sansoe G, 2005, DIGEST DIS SCI, V50, P955, DOI 10.1007/s10620-005-2671-0; Stanley AJ, 1998, GASTROENTEROLOGY, V115, P406, DOI 10.1016/S0016-5085(98)70207-0; TOYA Y, 1993, KIDNEY INT, V43, P928, DOI 10.1038/ki.1993.130; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Wilcox CS, 1999, J AM SOC NEPHROL, V10, P714	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17891	10.1371/journal.pone.0017891	http://dx.doi.org/10.1371/journal.pone.0017891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423778	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100044
J	Lammers, AJJ; Hoekstra, JBL; Speelman, P; Lombarts, KMJMH				Lammers, A. J. Jolanda; Hoekstra, Joost B. L.; Speelman, Peter; Lombarts, Kiki M. J. M. H.			Physicians Report Barriers to Deliver Best Practice Care for Asplenic Patients: A Cross-Sectional Survey	PLOS ONE			English	Article							VACCINATION COVERAGE; RESPONSE RATES; PROPHYLAXIS; INFECTION; SPLENECTOMY; GUIDELINES; KNOWLEDGE; PATTERNS; ABSENT; RISKS	Background: Current management of asplenic patients is not in compliance with best practice standards, such as defined by the British Committee for Standards in Haematology. To improve quality of care, factors inhibiting best practice care delivery need to be identified first. With this study, we aimed to identify and quantify physicians' barriers to adhere to best practice management of asplenic patients in the Netherlands. Methods and Principal Findings: A cross-sectional survey, preceded by multiple focus group discussions, was performed among Dutch physicians responsible for prevention of infections in asplenic patients, including specialists ( of Internal medicine and Surgery) and general practitioners (GPs). Forty seven GPs and seventy three hospital specialists returned the questionnaire, yielding response rates of 47% and 36,5% respectively. Physicians reported several barriers to deliver best practice. For both GPs and specialists, the most frequently listed barriers were: poor patient knowledge (> 80% of hospital specialists and GPs) and lack of clarity about which physician is responsible for the management of asplenic patients (50% of Internists, 46% of Surgeons, 55% of GPs). Both GPs and hospital specialists expressed to experience a lack of mutual trust: specialists were uncertain whether the GP would follow their advice given on patient discharge (33-59%), whereas half of GPs was not convinced that specialists' discharge letters contained the correct recommendations. Almost all physicians (> 90%) indicated that availability of a national guideline would improve adherence to best practice, especially if accessible online. Conclusion: This study showed that, in accordance with reports on international performance, care delivery for asplenic patients in the Netherlands is suboptimal. We identified and quantified perceived barriers by physicians that prevent adherence to post-splenectomy guidelines for the first time. Better transmural collaboration and better informed patients are likely to improve the quality of care of the asplenic patient population. A national, online-available guideline is urgently required.	[Lammers, A. J. Jolanda; Hoekstra, Joost B. L.; Speelman, Peter] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Lombarts, Kiki M. J. M. H.] Univ Amsterdam, Dept Qual & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Lammers, AJJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.	a.j.lammers@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620	Netherlands Organisation of Scientific Research (NWO) [945-17-001]	Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This project was supported by a ZonMw Grant form the Netherlands Organisation of Scientific Research (NWO, grant number 945-17-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour RS, 2005, MED EDUC, V39, P742, DOI 10.1111/j.1365-2929.2005.02200.x; Brigden ML, 2001, CAN J SURG, V44, P210; Bruni L, 2006, EPIDEMIOL INFECT, V134, P837, DOI 10.1017/S0950268805005704; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cavill I, 1996, BRIT MED J, V312, P430; Davies JM, 2002, CLIN MED, V2, P440, DOI 10.7861/clinmedicine.2-5-440; Deodhar M, 2004, J CLIN PATHOL, V57, P407, DOI 10.1136/jcp.2003.013896; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811; El-Alfy MS, 2004, HEMATOL J, V5, P77, DOI 10.1038/sj.thj.6200328; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Halasa NB, 2007, CLIN INFECT DIS, V44, P1428, DOI 10.1086/516781; Hasse B, 2005, SWISS MED WKLY, V135, P291; HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P1031, DOI 10.1002/bjs.1800780904; Kyaw MH, 2002, J CLIN PATHOL, V55, P472, DOI 10.1136/jcp.55.6.472; Lammers AJJ, 2010, EUR J CLIN MICROBIOL, V29, P399, DOI 10.1007/s10096-009-0870-x; Maue SK, 2004, AM J MANAG CARE, V10, P383; Meerveld-Eggink A, 2008, VACCINE, V26, P6975, DOI 10.1016/j.vaccine.2008.09.052; Mourtzoukou EG, 2008, BRIT J SURG, V95, P273, DOI 10.1002/bjs.6106; Ramachandra J, 2003, ANN ROY COLL SURG, V85, P252, DOI 10.1308/003588403766274962; Solberg LI, 1997, J FAM PRACTICE, V44, P451; STYRT B, 1990, AM J MED, V88, pN33; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17302	10.1371/journal.pone.0017302	http://dx.doi.org/10.1371/journal.pone.0017302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423748	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100005
J	Town, SM; McCabe, BJ				Town, Stephen Michael; McCabe, Brian John			Neuronal Plasticity and Multisensory Integration in Filial Imprinting	PLOS ONE			English	Article							SUPERIOR COLLICULUS; DOMESTIC CHICK; MEMORY SYSTEM; BRAIN; FAMILIARITY; TRACE	Many organisms sample their environment through multiple sensory systems and the integration of multisensory information enhances learning. However, the mechanisms underlying multisensory memory formation and their similarity to unisensory mechanisms remain unclear. Filial imprinting is one example in which experience is multisensory, and the mechanisms of unisensory neuronal plasticity are well established. We investigated the storage of audiovisual information through experience by comparing the activity of neurons in the intermediate and medial mesopallium of imprinted and naive domestic chicks (Gallus gallus domesticus) in response to an audiovisual imprinting stimulus and novel object and their auditory and visual components. We find that imprinting enhanced the mean response magnitude of neurons to unisensory but not multisensory stimuli. Furthermore, imprinting enhanced responses to incongruent audiovisual stimuli comprised of mismatched auditory and visual components. Our results suggest that the effects of imprinting on the unisensory and multisensory responsiveness of IMM neurons differ and that IMM neurons may function to detect unexpected deviations from the audiovisual imprinting stimulus.	[Town, Stephen Michael; McCabe, Brian John] Univ Cambridge, Subdept Anim Behav, Dept Zool, Cambridge CB3 8AA, England	University of Cambridge	Town, SM (corresponding author), Univ Cambridge, Subdept Anim Behav, Dept Zool, Cambridge CB3 8AA, England.	stephentown42@gmail.com		McCabe, Brian/0000-0003-4669-1364; Town, Stephen/0000-0003-1375-7769	BBSRC; Balfour Trust; BBSRC [BB/H018948/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [S18043, BB/H018948/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Balfour Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a BBSRC studentship and a research grant from the Balfour Trust fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BRADLEY P, 1985, J ANAT, V140, P577; BROWN MW, 1994, EUR J NEUROSCI, V6, P1479, DOI 10.1111/j.1460-9568.1994.tb01009.x; CIPOLLANETO J, 1979, J PHYSIOL-LONDON, V295, pP8; DAVIES DC, 1983, DEV BRAIN RES, V10, P251, DOI 10.1016/0165-3806(83)90141-4; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Horn G, 2001, P NATL ACAD SCI USA, V98, P5282, DOI 10.1073/pnas.091094798; Horn G, 2004, NAT REV NEUROSCI, V5, P108, DOI 10.1038/nrn1324; Jackson C, 2008, CURR BIOL, V18, P393, DOI 10.1016/j.cub.2008.01.062; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; MCCABE BJ, 1981, BRAIN RES, V205, P29, DOI 10.1016/0006-8993(81)90717-4; McCabe BJ, 2001, NEUROSCIENCE, V105, P317, DOI 10.1016/S0306-4522(01)00186-5; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Nakamori T, 2010, J NEUROSCI, V30, P4467, DOI 10.1523/JNEUROSCI.3532-09.2010; Naumer MJ, 2009, CEREB CORTEX, V19, P1641, DOI 10.1093/cercor/bhn200; NICOL AU, 1995, EUR J NEUROSCI, V7, P766, DOI 10.1111/j.1460-9568.1995.tb00680.x; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Sluckin W, 1972, IMPRINTING EARLY LEA; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE., 1993, MERGING SENSES; Tanabe HC, 2005, J NEUROSCI, V25, P6409, DOI 10.1523/JNEUROSCI.0636-05.2005; TAYLOR A, 1967, ANIM BEHAV, V15, P514, DOI 10.1016/0003-3472(67)90052-8; VANKAMPEN HS, 1991, BEHAVIOUR, V117, P303, DOI 10.1163/156853991X00607; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Zahar Y, 2009, J NEUROPHYSIOL, V101, P2380, DOI 10.1152/jn.91193.2008	33	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17777	10.1371/journal.pone.0017777	http://dx.doi.org/10.1371/journal.pone.0017777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423770	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100033
J	Twiner, MJ; Fire, S; Schwacke, L; Davidson, L; Wang, ZH; Morton, S; Roth, S; Balmer, B; Rowles, TK; Wells, RS				Twiner, Michael J.; Fire, Spencer; Schwacke, Lori; Davidson, Leigh; Wang, Zhihong; Morton, Steve; Roth, Stephen; Balmer, Brian; Rowles, Teresa K.; Wells, Randall S.			Concurrent Exposure of Bottlenose Dolphins (Tursiops truncatus) to Multiple Algal Toxins in Sarasota Bay, Florida, USA	PLOS ONE			English	Article							SENSITIVE SODIUM-CHANNELS; IN-VITRO EXPOSURE; DOMOIC ACID; KARENIA-BREVIS; RED-TIDE; SEA LIONS; BREVETOXIN METABOLITES; MONTEREY BAY; FOOD-WEB; CALIFORNIA	Sentinel species such as bottlenose dolphins (Tursiops truncatus) can be impacted by large-scale mortality events due to exposure to marine algal toxins. In the Sarasota Bay region (Gulf of Mexico, Florida, USA), the bottlenose dolphin population is frequently exposed to harmful algal blooms (HABs) of Karenia brevis and the neurotoxic brevetoxins (PbTx; BTX) produced by this dinoflagellate. Live dolphins sampled during capture-release health assessments performed in this region tested positive for two HAB toxins; brevetoxin and domoic acid (DA). Over a ten-year study period (2000-2009) we have determined that bottlenose dolphins are exposed to brevetoxin and/or DA on a nearly annual basis (i.e., DA: 2004, 2005, 2006, 2008, 2009; brevetoxin: 2000, 2004, 2005, 2008, 2009) with 36% of all animals testing positive for brevetoxin (n = 118) and 53% positive for DA (n = 83) with several individuals (14%) testing positive for both neurotoxins in at least one tissue/fluid. To date there have been no previously published reports of DA in southwestern Florida marine mammals, however the May 2008 health assessment coincided with a Pseudo-nitzschia pseudodelicatissima bloom that was the likely source of DA observed in seawater and live dolphin samples. Concurrently, both DA and brevetoxin were observed in common prey fish. Although no Pseudo-nitzschia bloom was identified the following year, DA was identified in seawater, fish, sediment, snails, and dolphins. DA concentrations in feces were positively correlated with hematologic parameters including an increase in total white blood cell (p = 0.001) and eosinophil (p < 0.001) counts. Our findings demonstrate that dolphins within Sarasota Bay are commonly exposed to two algal toxins, and provide the impetus to further explore the potential long-term impacts on bottlenose dolphin health.	[Twiner, Michael J.; Fire, Spencer; Davidson, Leigh; Wang, Zhihong; Morton, Steve] Natl Ocean Serv, Marine Biotoxins Program, Natl Ocean & Atmospher Adm, Charleston, SC USA; [Twiner, Michael J.] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA; [Schwacke, Lori] Natl Ocean Serv, Ctr Human Hlth Risks, Hollings Marine Lab, Natl Ocean & Atmospher Adm, Charleston, SC USA; [Roth, Stephen] Natl Ocean Serv, Coastal Ecol Program, Natl Ocean & Atmospher Adm, Charleston, SC USA; [Balmer, Brian; Wells, Randall S.] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Rowles, Teresa K.] Natl Ocean & Atmospher Adm Fisheries, Off Protected Resources, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA	Twiner, MJ (corresponding author), Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA.	mtwiner@umd.umich.edu	Fire, Spencer/P-6040-2014	Fire, Spencer/0000-0002-1657-790X; Balmer, Brian/0000-0001-9734-4042	NOAA; NOAA Fisheries; Batchelor Foundation; Dolphin Quest; Georgia Aquarium; Disney's Animal Programs; International Whaling Commission; National Marine Fisheries Service	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); Batchelor Foundation; Dolphin Quest; Georgia Aquarium; Disney's Animal Programs; International Whaling Commission; National Marine Fisheries Service	The authors would like to acknowledge their funding sources, including the NOAA Marine Biotoxins Program (www.chbr.noaa.gov/habar/default.aspx), NOAA Fisheries (www.nmfs.noaa.gov), the Batchelor Foundation, Dolphin Quest (www.dolphinquest.com), the Georgia Aquarium (www.georgiaaquarium.org), Disney's Animal Programs (disney.go.com/index), and the International Whaling Commission (iwcoffice.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sample collection during bottlenose dolphin health assessments in Sarasota Bay were made possible by the efforts of the staff, students, and volunteers of the Chicago Zoological Society's Sarasota Dolphin Research Program along with collaborating scientists and veterinarians from a number of institutions. Funding for health assessments and fish collections was provided by the National Marine Fisheries Service, Dolphin Quest, and Disney's Animal Programs. The authors would like to thank Dr. Gary Kirkpatrick of the Phytoplankton Ecology Program, Mote Marine Laboratory, Sarasota, FL for generously supplying cell count data, Hannah Giddens, Jen Maucher, Tod Leighfield, Seana Powers, Liz Symon, and Valeriy Palubok for technical help, and Larry Fulford for dolphin capturerelease and fish collections. Disclaimer: This publication does not constitute an endorsement of any commercial product or intend to be an opinion beyond scientific or other results obtained by the National Oceanic and Atmospheric Administration (NOAA). No reference shall be made to NOAA, or this publication furnished by NOAA, to any advertising or sales promotion which would indicate or imply that NOAA recommends or endorses any proprietary product mentioned herein, or which has as its purpose an interest to cause the advertised product to be used or purchased because of this publication.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5; BADEN DG, 1984, SEAFOOD TOXINS, P359; Bargu S, 2002, MAR ECOL PROG SER, V237, P209, DOI 10.3354/meps237209; Barros N.B., 1990, P309; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Blanco J, 2002, AQUAT TOXICOL, V60, P111, DOI 10.1016/S0166-445X(01)00274-0; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Burns JM, 2007, J ENVIRON MONITOR, V9, P1373, DOI 10.1039/b713101a; CATTERALL WA, 1981, MOL PHARMACOL, V19, P345; CATTET M, 1993, TOXICON, V31, P1483, DOI 10.1016/0041-0101(93)90214-4; DARCY G, SYNOPSIS BIOL DATA P; DAVIS CC, 1948, BOT GAZ, V109, P358, DOI 10.1086/335488; Dawes C.J., 1985, P S SUBTR TROP SEAGR, P25; DICKEY RW, 1992, TOXICON, V30, P355, DOI 10.1016/0041-0101(92)90877-8; Ferdin ME, 2002, TOXICON, V40, P1259, DOI 10.1016/S0041-0101(02)00129-0; FIRE SE, COOCCURRENC IN PRESS; Fire SE, 2008, MAR ECOL PROG SER, V368, P283, DOI 10.3354/meps07643; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Fire SE, 2007, MAR BIOL, V152, P827, DOI 10.1007/s00227-007-0733-x; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FRYXELL GA, 1990, NOVA HEDWIGIA S, V100, P171; Gannon DP, 2009, MAR ECOL PROG SER, V378, P171, DOI 10.3354/meps07853; Gulland FMD, 2002, VET REC, V150, P475; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, VVolume 6, P88; Hinton M, 2008, MAR ECOL PROG SER, V356, P251, DOI 10.3354/meps07267; HUANG JMC, 1984, J PHARMACOL EXP THER, V229, P615; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kvitek RG, 2008, MAR ECOL PROG SER, V367, P35, DOI 10.3354/meps07569; Leandro LF, 2010, MAR ECOL PROG SER, V398, P287, DOI 10.3354/meps08321; Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4; Lefebvre KA, 2001, MAR BIOL, V138, P693, DOI 10.1007/s002270000509; Lefebvre KA, 1999, NAT TOXINS, V7, P85, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<85::AID-NT39>3.0.CO;2-Q; Lefebvre KA, 2009, TOXICOL SCI, V107, P65, DOI 10.1093/toxsci/kfn207; Levin M, 2010, J WILDLIFE DIS, V46, P541, DOI 10.7589/0090-3558-46.2.541; Levin M, 2008, MAR DRUGS, V6, P636, DOI 10.3390/md6040636; Liefer JD, 2009, HARMFUL ALGAE, V8, P706, DOI 10.1016/j.hal.2009.02.003; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; MASE B, EPIZOOTIC BOTTLENOSE; Maucher JA, 2005, TOXICON, V45, P607, DOI 10.1016/j.toxicon.2005.01.002; Maucher JM, 2007, ENVIRON SCI TECHNOL, V41, P563, DOI 10.1021/es0612605; McFARREN E. F., 1965, TOXICON, V3, P111, DOI 10.1016/0041-0101(65)90005-X; Mendoza WG, 2008, CHEMOSPHERE, V73, P1373, DOI 10.1016/j.chemosphere.2008.07.089; Morton SL, 1998, BOT MAR, V41, P565, DOI 10.1515/botm.1998.41.1-6.565; MOTTA PJ, 1995, B MAR SCI, V56, P185; MOYLE PB, 1988, INTRO ICHTHYOLOGY, P559; Murrell RN, 2009, ARCH TOXICOL, V83, P1009, DOI 10.1007/s00204-009-0443-x; Naar JP, 2007, TOXICON, V50, P707, DOI 10.1016/j.toxicon.2007.06.005; Nelson J.S., 1994, FISHES WORLD, P600; Odum W. E., 1970, MARINE FOOD CHAINS, P222; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pan YL, 2001, MAR ECOL PROG SER, V220, P83, DOI 10.3354/meps220083; Parsons ML, 1999, J PHYCOL, V35, P1368, DOI 10.1046/j.1529-8817.1999.3561368.x; Plakas SM, 2004, TOXICON, V44, P677, DOI 10.1016/j.toxicon.2004.07.027; Plakas SM, 2008, TOXICON, V52, P32, DOI 10.1016/j.toxicon.2008.04.174; POLI MA, 1995, J AOAC INT, V78, P538; Poli MA, 2000, TOXICON, V38, P981, DOI 10.1016/S0041-0101(99)00191-9; POLI MA, 1986, MOL PHARMACOL, V30, P129; QUILLIAM MA, 1989, ANAL CHEM, V61, pA1053, DOI 10.1021/ac00193a745; Ramsdell John S., 2008, P519; Roth PB, 2007, TOXICON, V50, P1175, DOI 10.1016/j.toxicon.2007.08.003; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Schwacke LH, 2009, AM J VET RES, V70, P973, DOI 10.2460/ajvr.70.8.973; Sekula-Wood E, 2009, NAT GEOSCI, V2, P272, DOI 10.1038/NGEO472; STEIDINGER K, 1972, MARINE PHARMACOGNOSY, P179; Steidinger K.A., 1998, PHYSL ECOLOGY HARMFU, P133; SUZUKI CAM, 1993, FOOD CHEM TOXICOL, V31, P701, DOI 10.1016/0278-6915(93)90140-T; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Van Dolah F. M., 1994, Natural Toxins, V2, P189, DOI 10.1002/nt.2620020407; Van Dolah FM, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P85; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vigilant VL, 2007, MAR BIOL, V151, P2053, DOI 10.1007/s00227-007-0634-z; Virnstein R.W., 1983, Florida Scientist, V46, P363; Walsh CJ, 2008, MAR DRUGS, V6, P291, DOI 10.3390/md20080014; Wang ZH, 2004, TOXICON, V43, P455, DOI 10.1016/j.toxicon.2004.02.017; Wang ZH, 2007, J CHROMATOGR A, V1163, P169, DOI 10.1016/j.chroma.2007.06.054; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; WOODCOCK AH, 1948, J MAR RES, V7, P56; Woofter R, 2003, ENVIRON HEALTH PERSP, V111, P1595, DOI 10.1289/ehp.6166; Woofter RT, 2005, ENVIRON HEALTH PERSP, V113, P11, DOI 10.1289/ehp.7274; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	89	44	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17394	10.1371/journal.pone.0017394	http://dx.doi.org/10.1371/journal.pone.0017394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423740	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100008
J	Vazao, H; das Neves, RP; Graos, M; Ferreira, L				Vazao, Helena; das Neves, Ricardo Pires; Graos, Mario; Ferreira, Lino			Towards the Maturation and Characterization of Smooth Muscle Cells Derived from Human Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; PROGENITOR CELLS; GROWTH; EXPRESSION; MATRIX; CA2+; HETEROGENEITY; PROLIFERATION; MONOLAYER; INDUCTION	In this study we demonstrate that CD34(+) cells derived from human embryonic stem cells (hESCs) have higher smooth muscle cell (SMC) potential than CD34(-) cells. We report that from all inductive signals tested, retinoic acid (RA) and platelet derived growth factor (PDGF(BB)) are the most effective agents in guiding the differentiation of CD34(+) cells into smooth muscle progenitor cells (SMPCs) characterized by the expression of SMC genes and proteins, secretion of SMC-related cytokines, contraction in response to depolarization agents and vasoactive peptides and expression of SMC-related genes in a 3D environment. These cells are also characterized by a low organization of the contractile proteins and the contractility response is mediated by Ca2+, which involves the activation of Rho A/Rho kinase-and Ca2+/calmodulin (CaM)/myosin light chain kinase (MLCK)-dependent pathways. We further show that SMPCs obtained from the differentiation of CD34(+) cells with RA, but not with PDGF(BB), can be maturated in medium supplemented with endothelin-1 showing at the end individualized contractile filaments. Overall the hESC-derived SMCs presented in this work might be an unlimited source of SMCs for tissue engineering and regenerative medicine.	[Vazao, Helena; das Neves, Ricardo Pires; Ferreira, Lino] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Vazao, Helena; das Neves, Ricardo Pires; Graos, Mario; Ferreira, Lino] Biocant, Ctr Innovat Biotechnol, Cantanhede, Portugal	Universidade de Coimbra	Vazao, H (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	lino@biocant.pt	Neves, Ricardo/GXM-6159-2022; Grãos, Mário/O-7273-2017; Neves, Ricardo N Pires das/A-3322-2009; neves, ricardo/AAU-7959-2021	Grãos, Mário/0000-0002-2707-1488; Neves, Ricardo N Pires das/0000-0003-2291-6610; neves, ricardo/0000-0003-2291-6610; ferreira, lino/0000-0001-8985-9302; Vazao, Helena/0000-0002-5955-4804	Marie Curie-Reintegration Grant; MIT-Portugal program; Crioestaminal; Associacao Viver a Ciencia; Fundacao para a Ciencia e a Tecnologia [PTDC/SA-BEB/098468/2008, PTDC/CTM/099659/2008, SFRH/BD/40077/2007]	Marie Curie-Reintegration Grant(European Commission); MIT-Portugal program; Crioestaminal; Associacao Viver a Ciencia; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by a Marie Curie-Reintegration Grant, MIT-Portugal program, Crioestaminal, Associacao Viver a Ciencia and Fundacao para a Ciencia e a Tecnologia (PTDC/SA-BEB/098468/2008 and PTDC/CTM/099659/2008 to L.F.; SFRH/BD/40077/2007 to H.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dora KA, 2003, AM J PHYSIOL-HEART C, V285, pH119, DOI 10.1152/ajpheart.00643.2002; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; FRAMPTON JE, 1992, J PHYSIOL-LONDON, V453, P385, DOI 10.1113/jphysiol.1992.sp019234; FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O; Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0; Gerthoffer William T, 2002, Mol Interv, V2, P447, DOI 10.1124/mi.2.7.447; GRAIER WF, 1994, BIOCHEM J, V300, P637, DOI 10.1042/bj3000637; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Harnett KM, 2003, AM J MED, V115, p24S, DOI 10.1016/S0002-9343(03)00232-8; HATHAWAY DR, 1991, CIRCULATION, V83, P382, DOI 10.1161/01.CIR.83.2.382; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Hill KL, 2010, EXP HEMATOL, V38, P246, DOI 10.1016/j.exphem.2010.01.001; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Kansui Y, 2008, CELL CALCIUM, V44, P135, DOI 10.1016/j.ceca.2007.11.012; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; KIM MR, 2008, STEM CELLS; Le Ricousse-Roussanne S, 2004, CARDIOVASC RES, V62, P176, DOI 10.1016/j.cardiores.2004.01.017; Lee TH, 2010, CIRC RES, V106, P120, DOI 10.1161/CIRCRESAHA.109.207902; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a; Mayr M, 2008, CIRC RES, V102, P1046, DOI 10.1161/CIRCRESAHA.108.174623; MONTIEL M, 2003, SIGNAL T, V3, P201; Naito M, 1996, THROMB RES, V84, P129, DOI 10.1016/0049-3848(96)00168-5; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha Sanjay, 2009, V482, P345, DOI 10.1007/978-1-59745-060-7_22; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKEDA T, 1992, J CELL SCI, V101, P745; VO E, 2010, STEM CELL REV REP; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Walsh MJ, 2003, FASEB J, V17, pA1007; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1	55	25	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17771	10.1371/journal.pone.0017771	http://dx.doi.org/10.1371/journal.pone.0017771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423769	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100032
J	Guo, J; Gong, T; Gao, XD				Guo, Jia; Gong, Ting; Gao, Xiang-Dong			Identification of an Amphipathic Helix Important for the Formation of Ectopic Septin Spirals and Axial Budding in Yeast Axial Landmark Protein Bud3p	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL POLARITY; MEMBRANE-BINDING; SITE-SELECTION; HYDROPHOBIC RESIDUES; LOCALIZATION; CYCLE; ESTABLISHMENT; GENE; RING	Correct positioning of polarity axis in response to internal or external cues is central to cellular morphogenesis and cell fate determination. In the budding yeast Saccharomyces cerevisiae, Bud3p plays a key role in the axial bud-site selection (axial budding) process in which cells assemble the new bud next to the preceding cell division site. Bud3p is thought to act as a component of a spatial landmark. However, it is not clear how Bud3p interacts with other components of the landmark, such as the septins, to control axial budding. Here, we report that overexpression of Bud3p causes the formation of small septin rings (similar to 1 mu m in diameter) and arcs aside from previously reported spiral-like septin structures. Bud3p closely associates with the septins in vivo as Bud3p colocalizes with these aberrant septin structures and forms a complex with two septins, Cdc10p and Cdc11p. The interaction of Bud3p with the septins may involve multiple regions of Bud3p including 1-858, 850-1220, and 1221-1636 a. a. since they all target to the bud neck but exhibit different effects on septin organization when overexpressed. In addition, our study reveals that the axial budding function of Bud3p is mediated by the N-terminal region 1-858. This region shares an amphipathic helix (850-858) crucial for bud neck targeting with the middle portion 850-1103 involved in the formation of ectopic septin spirals and rings. Interestingly, the Dbl-homology domain located in 1-858 is dispensable for axial bud-site selection. Our findings suggest that multiple regions of Bud3p ensure efficient targeting of Bud3p to the bud neck in the assembly of the axial landmark and distinct domains of Bud3p are involved in axial bud-site selection and other cellular processes.	[Guo, Jia; Gong, Ting; Gao, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Guo, J (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324; Guo, Jia/0000-0002-9110-5574	National Natural Science Foundation of China [30770017, 30871347]; Chinese 111 Project [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (Grants Nos. 30770017 and 30871347 to XDG) and the Chinese 111 Project (No. B06018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bailly E, 2003, J CELL SCI, V116, P4119, DOI 10.1242/jcs.00706; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bouquin N, 2000, J CELL SCI, V113, P1435; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Fujita A, 2004, GENE, V327, P161, DOI 10.1016/j.gene.2003.11.021; Gale C, 2001, MOL BIOL CELL, V12, P3538, DOI 10.1091/mbc.12.11.3538; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Guthrie C, 1991, GUIDE YEAST GENETICS; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lord M, 2002, CURR BIOL, V12, P1347, DOI 10.1016/S0960-9822(02)01042-4; Lord M, 2000, J CELL BIOL, V151, P1501, DOI 10.1083/jcb.151.7.1501; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Orlando K, 2008, J BIOL CHEM, V283, P14205, DOI 10.1074/jbc.M708178200; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Schmidt K, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-43; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003	42	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16744	10.1371/journal.pone.0016744	http://dx.doi.org/10.1371/journal.pone.0016744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408200	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170000006
J	Roy, B; Copenhaver, GP; von Arnim, AG				Roy, Bijoyita; Copenhaver, Gregory P.; von Arnim, Albrecht G.			Fluorescence-Tagged Transgenic Lines Reveal Genetic Defects in Pollen Growth-Application to the Eif3 Complex	PLOS ONE			English	Article							MALE GAMETOPHYTE DEVELOPMENT; TRANSLATION INITIATION; ARABIDOPSIS-THALIANA; MATURE POLLEN; VISUAL ASSAY; PROTEIN; SUBUNIT; TRANSCRIPTOME; TOBACCO; REINITIATION	Background: Mutations in several subunits of eukaryotic translation initiation factor 3 (eIF3) cause male transmission defects in Arabidopsis thaliana. To identify the stage of pollen development at which eIF3 becomes essential it is desirable to examine viable pollen and distinguish mutant from wild type. To accomplish this we have developed a broadly applicable method to track mutant alleles that are not already tagged by a visible marker gene through the male lineage of Arabidopsis. Methodology/Principal Findings: Fluorescence tagged lines (FTLs) harbor a transgenic fluorescent protein gene (XFP) expressed by the pollen-specific LAT52 promoter at a defined chromosomal position. In the existing collection of FTLs there are enough XFP marker genes to track nearly every nuclear gene by virtue of its genetic linkage to a transgenic marker gene. Using FTLs in a quartet mutant, which yields mature pollen tetrads, we determined that the pollen transmission defect of the eif3h-1 allele is due to a combination of reduced pollen germination and reduced pollen tube elongation. We also detected reduced pollen germination for eif3e. However, neither eif3h nor eif3e, unlike other known gametophytic mutations, measurably disrupted the early stages of pollen maturation. Conclusion/Significance: eIF3h and eIF3e both become essential during pollen germination, a stage of vigorous translation of newly transcribed mRNAs. These data delimit the end of the developmental window during which paternal rescue is still possible. Moreover, the FTL collection of mapped fluorescent protein transgenes represents an attractive resource for elucidating the pollen development phenotypes of any fine-mapped mutation in Arabidopsis.	[Roy, Bijoyita; von Arnim, Albrecht G.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN USA; [Copenhaver, Gregory P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Copenhaver, Gregory P.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Copenhaver, Gregory P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Roy, B (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Mol Genet, Worcester, MA 01605 USA.	vonarnim@utk.edu	Copenhaver, Gregory/AFL-9831-2022; Copenhaver, Gregory/AAH-2031-2022; Copenhaver, Gregory P/A-7549-2014	Copenhaver, Gregory/0000-0002-7962-3862; Copenhaver, Gregory/0000-0002-7962-3862; Copenhaver, Gregory P/0000-0002-7962-3862; von Arnim, Albrecht/0000-0003-3472-3357; Roy, Bijoyita/0000-0003-1061-5482	DOE [DE-FG02-96ER20223, DE-FGO2-05ER15651]; NSF [DBI-0820047, MCB-0618691]	DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was supported by a grant from the DOE Energy Biosciences Program (DE-FG02-96ER20223) and the NSF Arabidopsis 2010 project DBI-0820047 to AGV. GPC thanks NSF (MCB-0618691) and the DOE (DE-FGO2-05ER15651) for financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Belostotsky DA, 1996, PLANT CELL, V8, P1261, DOI 10.1105/tpc.8.8.1261; Berchowitz LE, 2008, NAT PROTOC, V3, P41, DOI 10.1038/nprot.2007.491; Berchowitz LE, 2009, METHODS MOL BIOL, V557, P99, DOI 10.1007/978-1-59745-527-5_8; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Borg M, 2009, J EXP BOT, V60, P1465, DOI 10.1093/jxb/ern355; BRANDER KA, 1995, PLANT MOL BIOL, V27, P637, DOI 10.1007/BF00020219; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; Francis KE, 2007, P NATL ACAD SCI USA, V104, P3913, DOI 10.1073/pnas.0608936104; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Hasegawa Y, 2009, NEW PHYTOL, V182, P994, DOI 10.1111/j.1469-8137.2009.02806.x; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Honys D, 2009, J PROTEOME RES, V8, P2015, DOI 10.1021/pr8009897; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kim BH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r60; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Lalanne E, 2002, PLANT PHYSIOL, V129, P865, DOI 10.1104/pp.003301; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; op den Camp RGL, 1998, NUCLEIC ACIDS RES, V26, P2058, DOI 10.1093/nar/26.9.2058; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Yahalom A, 2008, PLANT J, V53, P300, DOI 10.1111/j.1365-313X.2007.03347.x; Zhou F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-193	36	10	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17640	10.1371/journal.pone.0017640	http://dx.doi.org/10.1371/journal.pone.0017640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408229	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800030
J	Wang, D; Jones, LM; Urwin, PE; Atkinson, HJ				Wang, Dong; Jones, Laura M.; Urwin, Peter E.; Atkinson, Howard J.			A Synthetic Peptide Shows Retro- and Anterograde Neuronal Transport before Disrupting the Chemosensation of Plant-Pathogenic Nematodes	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CAENORHABDITIS-ELEGANS; INTRAFLAGELLAR TRANSPORT; BEHAVIOR; IDENTIFICATION; CHEMOTAXIS; RESISTANCE; DYNAMICS; MOTORS; MOBILE	Cyst nematodes are a group of plant pathogens each with a defined host range that cause major losses to crops including potato, soybean and sugar beet. The infective mobile stage hatches from dormant eggs and moves a short distance through the soil to plant roots, which it then invades. A novel strategy for control has recently been proposed in which the plant is able to secrete a peptide which disorientates the infective stage and prevents invasion of the pathogen. This study provides indirect evidence to support the mechanism by which one such peptide disrupts chemosensory function in nematodes. The peptide is a disulphide-constrained 7-mer with the amino acid sequence CTTMHPRLC that binds to nicotinic acetylcholine receptors. A fluorescently tagged version of this peptide with both epifluorescent and confocal microscopy was used to demonstrate that retrograde transport occurs from an aqueous environment along bare-ending primary cilia of chemoreceptive sensilla. The peptide is transported to the cell bodies of these neurons and on to a limited number of other neurons to which they connect. It appears to be localised in both neuronal processes and organelles adjacent to nuclei of some neurons suggesting it could be transported through the Golgi apparatus. The peptide takes 2.5 h to reach the neuronal cell bodies. Comparative studies established that similar but less abundant uptake occurs for Caenorhabditis elegans along its well studied dye-filling chemoreceptive neurons. Incubation in peptide solution or root-exudate from transgenic plants that secrete the peptide disrupted normal orientation of infective cyst nematodes to host root diffusate. The peptide probably undergoes transport along the dye-filling non-cholinergic chemoreceptive neurons to their synapses where it is taken up by the interneurons to which they connect. Coordinated responses to chemoreception are disrupted when the sub-set of cholinergic interneurons secrete the peptide at synapses that have post-synaptic nicotinic acetylcholine receptors.	[Wang, Dong; Jones, Laura M.; Urwin, Peter E.; Atkinson, Howard J.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Wang, D (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.e.urwin@leeds.ac.uk		Urwin, Peter Edward/0000-0003-0398-2372	NERC/BP; Biotechnology and Biological Sciences Research Council [BB/D001749/1, BB/F004001/1] Funding Source: researchfish; BBSRC [BB/D001749/1, BB/F004001/1] Funding Source: UKRI	NERC/BP(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a Dorothy Hodgkin Postgraduate Award (NERC/BP, http://www.rcuk.ac.uk/hodgkin/dorothy.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton FT, 1999, VET PARASITOL, V84, P297, DOI 10.1016/S0304-4017(99)00037-0; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Brown LA, 2006, INT J PARASITOL, V36, P617, DOI 10.1016/j.ijpara.2006.01.016; Bumbarger DJ, 2009, J COMP NEUROL, V512, P271, DOI 10.1002/cne.21882; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; CLEMENS CD, 1994, FUND APPL NEMATOL, V17, P569; Costa JC, 2009, INT J PARASITOL, V39, P849, DOI 10.1016/j.ijpara.2008.12.007; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; GRAY GM, 2005, PNAS, V102, P3184; GRUNDLER F, 1991, PARASITOLOGY, V103, P149, DOI 10.1017/S0031182000059394; Hao LM, 2009, METHOD CELL BIOL, V93, P235, DOI 10.1016/S0091-679X(08)93013-2; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Inglis P. N., 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.126.2; Liu B, 2005, PLANT BIOTECHNOL J, V3, P487, DOI 10.1111/j.1467-7652.2005.00139.x; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Rand JB, 2000, FASEB J, V14, P2414, DOI 10.1096/fj.00-0313rev; Roy S, 2008, J NEUROSCI, V28, P5248, DOI 10.1523/JNEUROSCI.0309-08.2008; Roy S, 2007, J NEUROSCI, V27, P3131, DOI 10.1523/JNEUROSCI.4999-06.2007; SASSER JN, 1986, J NEMATOL, V18, P596; Sattelle DB, 2009, J PESTIC SCI, V34, P233, DOI 10.1584/jpestics.R09-02; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Trivedi N, 2007, J NEUROSCI, V27, P507, DOI 10.1523/JNEUROSCI.4227-06.2007; URWIN PE, 1995, PLANT J, V8, P121, DOI 10.1046/j.1365-313X.1995.08010121.x; Winter MD, 2002, PARASITOLOGY, V125, P561, DOI 10.1017/S0031182002002482; Yassin L, 2001, MOL CELL NEUROSCI, V17, P589, DOI 10.1006/mcne.2000.0944; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17475	10.1371/journal.pone.0017475	http://dx.doi.org/10.1371/journal.pone.0017475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408216	gold, Green Published, Green Submitted			2022-12-25	WOS:000288099800016
J	Suckale, J; Wendling, O; Masjkur, J; Jager, M; Munster, C; Anastassiadis, K; Stewart, F; Solimena, M				Suckale, Jakob; Wendling, Olivia; Masjkur, Jimmy; Jaeger, Melanie; Muenster, Carla; Anastassiadis, Konstantinos; Stewart, Francis; Solimena, Michele			PTBP1 Is Required for Embryonic Development before Gastrulation	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; POLYPYRIMIDINE TRACT; MESSENGER-RNA; MOUSE DEVELOPMENT; GENE-EXPRESSION; REGULATORY ROLE; PROMOTES; CELLS; DIFFERENTIATION; RECOGNITION	Polypyrimidine-tract binding protein 1 (PTBP1) is an important cellular regulator of messenger RNAs influencing the alternative splicing profile of a cell as well as its mRNA stability, location and translation. In addition, it is diverted by some viruses to facilitate their replication. Here, we used a novel PTBP1 knockout mouse to analyse the tissue expression pattern of PTBP1 as well as the effect of its complete removal during development. We found evidence of strong PTBP1 expression in embryonic stem cells and throughout embryonic development, especially in the developing brain and spinal cord, the olfactory and auditory systems, the heart, the liver, the kidney, the brown fat and cartilage primordia. This widespread distribution points towards a role of PTBP1 during embryonic development. Homozygous offspring, identified by PCR and immunofluorescence, were able to implant but were arrested or retarded in growth. At day 7.5 of embryonic development (E7.5) the null mutants were about 5x smaller than the control littermates and the gap in body size widened with time. At mid-gestation, all homozygous embryos were resorbed/degraded. No homozygous mice were genotyped at E12 and the age of weaning. Embryos lacking PTBP1 did not display differentiation into the 3 germ layers and cavitation of the epiblast, which are hallmarks of gastrulation. In addition, homozygous mutants displayed malformed ectoplacental cones and yolk sacs, both early supportive structure of the embryo proper. We conclude that PTBP1 is not required for the earliest isovolumetric divisions and differentiation steps of the zygote up to the formation of the blastocyst. However, further post-implantation development requires PTBP1 and stalls in homozygous null animals with a phenotype of dramatically reduced size and aberration in embryonic and extra-embryonic structures.	[Suckale, Jakob; Masjkur, Jimmy; Jaeger, Melanie; Muenster, Carla; Solimena, Michele] Tech Univ Dresden, Paul Langerhans Inst Dresden, Sch Med, D-8027 Dresden, Germany; [Suckale, Jakob; Masjkur, Jimmy; Jaeger, Melanie; Muenster, Carla; Solimena, Michele] Tech Univ Dresden, Univ Clin Carl Gustav Carus, D-8027 Dresden, Germany; [Wendling, Olivia] IGBMC, Dept Funct Gen, Illkirch Graffenstaden, France; [Suckale, Jakob] ICS, Illkirch Graffenstaden, France; [Anastassiadis, Konstantinos] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, BioInnovat Zentrum, D-8027 Dresden, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; Max Planck Society	Suckale, J (corresponding author), Tech Univ Dresden, Paul Langerhans Inst Dresden, Sch Med, D-8027 Dresden, Germany.	Michele.Solimena@tu-dresden.de	Anastassiadis, Konstantinos/A-8944-2010; Solimena, Michele/E-1275-2011; Stewart, A. Francis/E-7789-2010; Solimena, Michele/GVS-5990-2022	Anastassiadis, Konstantinos/0000-0002-9814-0559; 	German Federal Ministry of Education and Research (BMBF); German Center for Diabetes Research (DZD); Max Planck Society; Center for Regenerative Therapies Dresden (CRTD); Medical School of the Dresden University of Technology	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD); Max Planck Society(Max Planck Society); Center for Regenerative Therapies Dresden (CRTD); Medical School of the Dresden University of Technology	These studies have been supported with funds from the German Federal Ministry of Education and Research (BMBF; www.bmbf.de) to the Network of Competence for Diabetes (KKNDm), from the German Center for Diabetes Research (DZD), from the Max Planck Society (www.mpg.de) to MS, and from the Center for Regenerative Therapies Dresden (CRTD; www.crt-dresden.de) to KA. JS was the recipient of a MedDrive Grant from the Medical School of the Dresden University of Technology (www.medizin.tu-dresden.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashiya M, 1997, RNA, V3, P996; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Cross JC, 2005, PLACENTA, V26, pA6; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Ehehalt F, 2010, ISLETS, V2, P30, DOI 10.4161/isl.2.1.10098; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Gooding C, 2003, J BIOL CHEM, V278, P15201, DOI 10.1074/jbc.M210131200; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kafasla P, 2009, MOL CELL, V34, P556, DOI 10.1016/j.molcel.2009.04.015; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Motallebipour M, 2010, MOL BIOL REP, V37, P2021, DOI 10.1007/s11033-009-9653-9; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829	46	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16992	10.1371/journal.pone.0016992	http://dx.doi.org/10.1371/journal.pone.0016992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21423341	Green Published, gold			2022-12-25	WOS:000287482300026
J	Bug, M; Dobbelstein, M				Bug, M.; Dobbelstein, M.			Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms	ONCOGENE			English	Article						anthracyclines; doxorubicin; idarubicin; p53; WRAP53; E2F1	DRUG-INTERACTION DOMAINS; TOPOISOMERASE-II; DNA-DAMAGE; APOPTOTIC RESPONSE; MOUSE MODEL; TRANSCRIPTION; P73; PHOSPHORYLATION; GAIN; GENE	Mutant p53 frequently accumulates in cancer cells and promotes tumor cell invasion, as part of its gain of function. Its accumulation is partially due to enhanced stability, but little is known about how the mRNA levels of mutant p53 can be regulated. Likewise, the impact of cancer therapy on the levels of mutant p53 is poorly understood. We show here that the anthracyclines doxorubicin, daunorubicin and epirubicin further increase the amounts of mutant p53 mRNA and protein in cancer cells. Moreover, we show for the first time that the transcription factor E2F1 associates with the promoter DNA of TP53. Upon genotoxic treatment, E2F1 contributed to the expression of mutant p53, both directly and through induction of TAp73. In contrast, the anthracycline idarubicin and also another topoisomerase inhibitor, etoposide, failed to increase the levels of p53 mRNA, despite their ability to induce the synthesis of TAp73 mRNA. Instead, a natural antisense transcript of TP53, WRAP53, was strongly augmented by idarubicin and etoposide, but only less so by the other anthracyclines under study. RNA corresponding to the first exon of WRAP53 was mainly found in cell nuclei and it reduced the levels of mutant p53. Taken together, this suggests a reciprocal activation pattern of TP53 and WRAP53 by different chemotherapeutics. Reducing the levels of mutant p53 by small-interfering RNA increased chemosensitivity, and idarubicin prevented cell survival more efficiently than the mutant p53-inducing doxorubicin. We conclude that even closely related anthracyclines induce the synthesis of different, opposing transcripts from the TP53 locus. When using these drugs for cancer therapy, the increased levels of mutant p53 may augment its gain of function and thus favor unwanted chemoresistance and tumor progression. Oncogene (2011) 30, 3612-3624; doi:10.1038/onc.2011.72; published online 28 March 2011	[Bug, M.; Dobbelstein, M.] Univ Gottingen, Dept Mol Oncol, Gottingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany	University of Gottingen	Dobbelstein, M (corresponding author), Univ Gottingen, Dept Mol Oncol, Gottingen Ctr Mol Biosci GZMB, Ernst Caspari Haus,Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	mdobbel@uni-goettingen.de		Dobbelstein, Matthias/0000-0001-5052-3967	German excellence initiative; German Cancer Aid/Dr Mildred Scheel Stiftung; EU; German Research Foundation DFG; Wilhelm Sander Stiftung	German excellence initiative; German Cancer Aid/Dr Mildred Scheel Stiftung(Deutsche Krebshilfe); EU(European Commission); German Research Foundation DFG(German Research Foundation (DFG)); Wilhelm Sander Stiftung	We thank M Haubrock for the analysis of E2F1 promoter sequences and C Hippel and A Dickmanns for excellent technical assistance. We further thank M Farnebo, K Wiman, K Heyninck and C Bamberger for providing plasmids used in this study and helpful advice. MB was supported by the Master/PhD Program Molecular Biology and the Gottingen Graduate School of Neurosciences and Molecular Biosciences, funded by the German excellence initiative (funding line 1). Our work was supported by the German Cancer Aid/Dr Mildred Scheel Stiftung, the EU 6th Framework Program, the German Research Foundation DFG and the Wilhelm Sander Stiftung.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bush JA, 2002, INT J CANCER, V98, P323, DOI 10.1002/ijc.10226; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CAPRANICO G, 1995, CANCER RES, V55, P312; CAPRANICO G, 1990, BIOCHEMISTRY-US, V29, P562, DOI 10.1021/bi00454a033; Cashman DJ, 2004, J MED CHEM, V47, P1360, DOI 10.1021/jm030529h; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; CORBETT AH, 1993, J BIOL CHEM, V268, P14394; Crampton N, 2006, NUCLEIC ACIDS RES, V34, P5416, DOI 10.1093/nar/gkl668; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; HARGRAVE RM, 1995, ANTI-CANCER DRUG, V6, P432, DOI 10.1097/00001813-199506000-00011; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Liu HS, 2009, BIOCHEM J, V422, P543, DOI 10.1042/BJ20090342; Lotfi K, 2002, CANCER LETT, V178, P141, DOI 10.1016/S0304-3835(01)00824-2; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; ROBINSON MJ, 1993, BIOCHEMISTRY-US, V32, P3638, DOI 10.1021/bi00065a016; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; van Hille B, 1999, ANTI-CANCER DRUG, V10, P551, DOI 10.1097/00001813-199907000-00007; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	51	19	19	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	33					3612	3624		10.1038/onc.2011.72	http://dx.doi.org/10.1038/onc.2011.72			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21441950				2022-12-25	WOS:000294005100005
J	Pulimeno, P; Paschoud, S; Citi, S				Pulimeno, Pamela; Paschoud, Serge; Citi, Sandra			A Role for ZO-1 and PLEKHA7 in Recruiting Paracingulin to Tight and Adherens Junctions of Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CINGULIN; PROTEIN; EXPRESSION; ADHESION; COMPLEX; BINDING; GTPASE; PLAQUE; INHIBITION; ACTIVATION	Paracingulin is a 160-kDa protein localized in the cytoplasmic region of epithelial tight and adherens junctions, where it regulates RhoA and Rac1 activities by interacting with guanine nucleotide exchange factors. Here, we investigate the molecular mechanisms that control the recruitment of paracingulin to cell-cell junctions. We show that paracingulin forms a complex with the tight junction protein ZO-1, and the globular head domain of paracingulin interacts directly with ZO-1 through an N-terminal region containing a conserved ZIM (ZO-1-Interaction-Motif) sequence. Recruitment of paracingulin to cadherin-based cell-cell junctions in Rat1 fibroblasts requires the ZIM-containing region, whereas in epithelial cells removal of this region decreases the junctional localization of paracingulin at tight junctions but not at adherens junctions. Depletion of ZO-1, but not ZO-2, reduces paracingulin accumulation at tight junctions. A yeast two-hybrid screen identifies both ZO-1 and the adherens junction protein PLEKHA7 as paracingulin-binding proteins. Paracingulin forms a complex with PLEKHA7 and its interacting partner p120ctn, and the globular head domain of paracingulin interacts directly with a central region of PLEKHA7. Depletion of PLEKHA7 from Madin-Darby canine kidney cells results in the loss of junctional localization of paracingulin and a decrease in its expression. In summary, we characterize ZO-1 and PLEKHA7 as paracingulin-interacting proteins that are involved in its recruitment to epithelial tight and adherens junctions, respectively.	[Pulimeno, Pamela; Paschoud, Serge; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland	University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Mol Biol, 4 Blvd Yvoy, CH-1205 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	Swiss National Fonds [31003A103637, 31003A116763]; State of Geneva	Swiss National Fonds(Swiss National Science Foundation (SNSF)); State of Geneva	This work was supported by Swiss National Fonds Grants 31003A103637 and 31003A116763 and the State of Geneva.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Bordin M, 2004, MOL CANCER RES, V2, P692; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi S, 2001, CELL CELL INTERACTIO, P153; CITI S, 2001, TIGHT JUNCTIONS, P231; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; D'Atri F, 2002, J BIOL CHEM, V277, P27757, DOI 10.1074/jbc.M203717200; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot Laurent, 2006, P54; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Samarin S, 2009, FRONT BIOSCI-LANDMRK, V14, P1129, DOI 10.2741/3298; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; VanItallie CM, 1997, J CELL SCI, V110, P1113; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wittchen ES, 2003, MOL BIOL CELL, V14, P1757, DOI 10.1091/mbc.E02-08-0486	45	46	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16743	16750		10.1074/jbc.M111.230862	http://dx.doi.org/10.1074/jbc.M111.230862			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454477	Green Published, hybrid			2022-12-25	WOS:000290301900022
J	Zhang, YY; Wu, JW; Wang, ZX				Zhang, Yuan-Yuan; Wu, Jia-Wei; Wang, Zhi-Xin			Mitogen-activated Protein Kinase (MAPK) Phosphatase 3-mediated Cross-talk between MAPKs ERK2 and p38 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; DUAL-SPECIFICITY PHOSPHATASES; EXCHANGE MASS-SPECTROMETRY; SIGNAL-REGULATED KINASE-2; CRYSTAL-STRUCTURE; TYROSINE-PHOSPHATASE; PHYSIOLOGICAL FUNCTIONS; CATALYTIC ACTIVATION; P38; SUBSTRATE	MAPK phosphatase 3 (MKP3) is highly specific for ERK1/2 inactivation via dephosphorylation of both phosphotyrosine and phosphothreonine critical for enzymatic activation. Here, we show that MKP3 is able to effectively dephosphorylate the phosphotyrosine, but not phosphothreonine, in the activation loop of p38 alpha in vitro and in intact cells. The catalytic constant of the MKP3 reaction for p38 alpha is comparable with that for ERK2. Remarkably, MKP3, ERK2, and phosphorylated p38 alpha can form a stable ternary complex in solution, and the phosphatase activity of MKP3 toward p38 alpha substrate is allosterically regulated by ERK2-MKP3 interaction. This suggests that MKP3 not only controls the activities of ERK2 and p38 alpha but also mediates cross-talk between these two MAPK pathways. The crystal structure of bisphosphorylated p38 alpha has been determined at 2.1 angstrom resolution. Comparisons between the phosphorylated MAPK structures reveal the molecular basis of MKP3 substrate specificity.	[Zhang, Yuan-Yuan; Wu, Jia-Wei; Wang, Zhi-Xin] Tsinghua Univ, Sch Life Sci, Minist Educ Key Lab Bioinformat, Beijing 100084, Peoples R China; [Wang, Zhi-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, ZX (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ Key Lab Bioinformat, Beijing 100084, Peoples R China.	zhixinwang@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Ministry of Science and Technology of China [2007CB914400, 2011CB910803]; National Natural Science Foundation of China [30770476]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Ministry of Science and Technology of China Grants 2007CB914400 and 2011CB910803 and by National Natural Science Foundation of China Grant 30770476.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Jeong DG, 2006, J MOL BIOL, V360, P946, DOI 10.1016/j.jmb.2006.05.059; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Szafranska AE, 2005, FEBS J, V272, P4631, DOI 10.1111/j.1742-4658.2005.04827.x; Szafranska AE, 2005, ANAL BIOCHEM, V336, P1, DOI 10.1016/j.ab.2004.09.039; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wiland AM, 1996, J BIOL CHEM, V271, P33486, DOI 10.1074/jbc.271.52.33486; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou B, 2006, J BIOL CHEM, V281, P38834, DOI 10.1074/jbc.M608916200	49	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.203786	http://dx.doi.org/10.1074/jbc.M110.203786			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454500	Green Published, hybrid			2022-12-25	WOS:000290022800055
J	Banks, SML; Cho, B; Eun, SH; Lee, JH; Windler, SL; Xie, XH; Bilder, D; Fischer, JA				Banks, Susan M. L.; Cho, Bomsoo; Eun, Suk Ho; Lee, Ji-Hoon; Windler, Sarah L.; Xie, Xuanhua; Bilder, David; Fischer, Janice A.			The Functions of Auxilin and Rab11 in Drosophila Suggest That the Fundamental Role of Ligand Endocytosis in Notch Signaling Cells Is Not Recycling	PLOS ONE			English	Article							UBIQUITIN LIGASE; FAT-FACETS; MIND BOMB; DELTA-ENDOCYTOSIS; PATTERN-FORMATION; PLANAR POLARITY; EPSIN; PATHWAY; ACTIVATION; EYE	Notch signaling requires ligand internalization by the signal sending cells. Two endocytic proteins, epsin and auxilin, are essential for ligand internalization and signaling. Epsin promotes clathrin-coated vesicle formation, and auxilin uncoats clathrin from newly internalized vesicles. Two hypotheses have been advanced to explain the requirement for ligand endocytosis. One idea is that after ligand/receptor binding, ligand endocytosis leads to receptor activation by pulling on the receptor, which either exposes a cleavage site on the extracellular domain, or dissociates two receptor subunits. Alternatively, ligand internalization prior to receptor binding, followed by trafficking through an endosomal pathway and recycling to the plasma membrane may enable ligand activation. Activation could mean ligand modification or ligand transcytosis to a membrane environment conducive to signaling. A key piece of evidence supporting the recycling model is the requirement in signaling cells for Rab11, which encodes a GTPase critical for endosomal recycling. Here, we use Drosophila Rab11 and auxilin mutants to test the ligand recycling hypothesis. First, we find that Rab11 is dispensable for several Notch signaling events in the eye disc. Second, we find that Drosophila female germline cells, the one cell type known to signal without clathrin, also do not require auxilin to signal. Third, we find that much of the requirement for auxilin in Notch signaling was bypassed by overexpression of both clathrin heavy chain and epsin. Thus, the main role of auxilin in Notch signaling is not to produce uncoated ligand-containing vesicles, but to maintain the pool of free clathrin. Taken together, these results argue strongly that at least in some cell types, the primary function of Notch ligand endocytosis is not for ligand recycling.	[Banks, Susan M. L.; Cho, Bomsoo; Eun, Suk Ho; Lee, Ji-Hoon; Xie, Xuanhua; Fischer, Janice A.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Banks, Susan M. L.; Cho, Bomsoo; Eun, Suk Ho; Lee, Ji-Hoon; Xie, Xuanhua; Fischer, Janice A.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Windler, Sarah L.; Bilder, David] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley	Banks, SML (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	jaf@mail.utexas.edu	Tsai, Yu-Chen/B-5852-2008; Xie, xuanhua Peter/C-5267-2012	Xie, xuanhua Peter/0000-0001-8032-4715; Bilder, David/0000-0002-1842-4966; Banks, Susan/0000-0001-7088-4487	National Institutes of Health (NIH), Texas [R01HD30680]; NIH [R01GM068675]; ACS, California [RSG0704001]; California Cancer Research Coordinating Committee; NIH; University of Texas at Austin; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675, R01GM090150] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Texas(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS, California(American Cancer Society); California Cancer Research Coordinating Committee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas at Austin; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Janice Fischer is the PI on National Institutes of Health (NIH) grant R01HD30680 that funded the work in Texas. David Bilder is the PI on NIH grant R01GM068675 and ACS grant RSG0704001 that funded the work in California. Sarah Windler also had funding from a California Cancer Research Coordinating Committee Fellowship and an NIH Training Grant. Ji-Hoon Lee also received funding from a Continuing Fellowship from The University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alone DP, 2005, INT J DEV BIOL, V49, P873, DOI 10.1387/ijdb.051986da; Bai T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-7; Baker NE, 1997, CURR BIOL, V7, P122, DOI 10.1016/S0960-9822(06)00056-X; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Carthew RW, 2007, CURR OPIN GENET DEV, V17, P309, DOI 10.1016/j.gde.2007.05.001; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Eun SH, 2008, DEVELOPMENT, V135, P1089, DOI 10.1242/dev.009530; Eun SH, 2007, GENETICS, V175, P1163, DOI 10.1534/genetics.106.067959; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; HEUSS SF, 2008, J CELL SCI, V112, P3289; Horvath CAJ, 2007, INT J BIOCHEM CELL B, V39, P1765, DOI 10.1016/j.biocel.2006.12.004; Huang YZ, 1996, DEVELOPMENT, V122, P3207; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kandachar V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-50; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun X, 1997, DEVELOPMENT, V124, P3439; Tian XL, 2004, DEVELOPMENT, V131, P5807, DOI 10.1242/dev.01459; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Wolff Tanya, 1993, P1277; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9	61	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18259	10.1371/journal.pone.0018259	http://dx.doi.org/10.1371/journal.pone.0018259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448287	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500049
J	He, T; Wang, QO; Feng, GH; Hu, YO; Wang, L; Wang, YM				He, Tao; Wang, Qiong; Feng, Guihai; Hu, Yaou; Wang, Li; Wang, Yumin			Computational Detection and Functional Analysis of Human Tissue-Specific A-to-I RNA Editing	PLOS ONE			English	Article							SYSTEMATIC IDENTIFICATION; ADENOSINE DEAMINASES; PREDICTION; EXPRESSION; PROTEIN; CANCER; DISCOVERY; CLEAVAGE; TARGETS; SITES	A-to-I RNA editing is a widespread post-transcriptional modification event in vertebrates. It could increase transcriptome and proteome diversity through recoding the genomic information and cross-linking other regulatory events, such as those mediated by alternative splicing, RNAi and microRNA (miRNA). Previous studies indicated that RNA editing can occur in a tissue-specific manner in response to the requirements of the local environment. We set out to systematically detect tissue-specific A-to-I RNA editing sites in 43 human tissues using bioinformatics approaches based on the Fisher's exact test and the Benjamini & Hochberg false discovery rate (FDR) multiple testing correction. Twenty-three sites in total were identified to be tissue-specific. One of them resulted in an altered amino acid residue which may prevent the phosphorylation of PARP-10 and affect its activity. Eight and two tissue-specific A-to-I RNA editing sites were predicted to destroy putative exonic splicing enhancers (ESEs) and exonic splicing silencers (ESSs), respectively. Brain-specific and ovary-specific A-to-I RNA editing sites were further verified by comparing the cDNA sequences with their corresponding genomic templates in multiple cell lines from brain, colon, breast, bone marrow, lymph, liver, ovary and kidney tissue. Our findings help to elucidate the role of A-to-I RNA editing in the regulation of tissue-specific development and function, and the approach utilized here can be broadened to study other types of tissue-specific substitution editing.	[He, Tao; Feng, Guihai; Hu, Yaou; Wang, Li; Wang, Yumin] Beijing Inst Biotechnol, Beijing, Peoples R China; [Wang, Qiong] Beijing Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China	He, T (corresponding author), Beijing Inst Biotechnol, Beijing, Peoples R China.	liwang@tsinghua.edu.cn; wym66@vip.sina.com	Feng, Guihai/A-5105-2019	Feng, Guihai/0000-0002-8726-1734	National High-Tech RD Program (863) [2007AA022204]; National Key Technologies RD Program [2003A08-4-6]; Chinese Key Program for Drug Invention [2009ZX09501-027]; National Natural Science Foundation of China [30800644]	National High-Tech RD Program (863)(National High Technology Research and Development Program of China); National Key Technologies RD Program(National Key Technology R&D Program); Chinese Key Program for Drug Invention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the National High-Tech R&D Program (863) (2007AA022204), the National Key Technologies R&D Program (2003A08-4-6), Chinese Key Program for Drug Invention (2009ZX09501-027), and National Natural Science Foundation of China (30800644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gott JM, 2003, CR BIOL, V326, P901, DOI 10.1016/j.crvi.2003.09.004; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Guryev V, 2006, GENOME RES, V16, P491, DOI 10.1101/gr.4791006; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Jacobs MM, 2009, DEV NEUROSCI-BASEL, V31, P223, DOI 10.1159/000210185; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Maas Stefan, 2006, RNA Biol, V3, P1; Neeman Y, 2005, TRENDS GENET, V21, P544, DOI 10.1016/j.tig.2005.08.005; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Schmitt AO, 1999, NUCLEIC ACIDS RES, V27, P4251, DOI 10.1093/nar/27.21.4251; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	52	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18129	10.1371/journal.pone.0018129	http://dx.doi.org/10.1371/journal.pone.0018129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448465	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500042
J	Landgren, S; Simms, JA; Thelle, DS; Strandhagen, E; Bartlett, SE; Engel, JA; Jerlhag, E				Landgren, Sara; Simms, Jeffrey A.; Thelle, Dag S.; Strandhagen, Elisabeth; Bartlett, Selena E.; Engel, Jorgen A.; Jerlhag, Elisabet			The Ghrelin Signalling System Is Involved in the Consumption of Sweets	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; ETHANOL-CONSUMPTION; ALCOHOL-CONSUMPTION; 20-PERCENT ETHANOL; DOPAMINE-OVERFLOW; NUCLEUS-ACCUMBENS; LONG-EVANS; RATS	The gastric-derived orexigenic peptide ghrelin affects brain circuits involved in energy balance as well as in reward. Indeed, ghrelin activates an important reward circuit involved in natural-as well as drug-induced reward, the cholinergic-dopaminergic reward link. It has been hypothesized that there is a common reward mechanism for alcohol and sweet substances in both animals and humans. Alcohol dependent individuals have higher craving for sweets than do healthy controls and the hedonic response to sweet taste may, at least in part, depend on genetic factors. Rat selectively bred for high sucrose intake have higher alcohol consumption than non-sucrose preferring rats and vice versa. In the present study a group of alcohol-consuming individuals selected from a population cohort was investigated for genetic variants of the ghrelin signalling system in relation to both their alcohol and sucrose consumption. Moreover, the effects of GHS-R1A antagonism on voluntary sucrose-intake and operant self-administration, as well as saccharin intake were investigated in preclinical studies using rodents. The effects of peripheral grelin administration on sucrose intake were also examined. Here we found associations with the ghrelin gene haplotypes and increased sucrose consumption, and a trend for the same association was seen in the high alcohol consumers. The preclinical data show that a GHS-R1A antagonist reduces the intake and self-administration of sucrose in rats as well as saccharin intake in mice. Further, ghrelin increases the intake of sucrose in rats. Collectively, our data provide a clear indication that the GHS-R1A antagonists reduces and ghrelin increases the intake of rewarding substances and hence, the central ghrelin signalling system provides a novel target for the development of drug strategies to treat addictive behaviours.	[Landgren, Sara; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden; [Simms, Jeffrey A.; Bartlett, Selena E.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA; [Simms, Jeffrey A.; Engel, Jorgen A.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA; [Thelle, Dag S.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Strandhagen, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Gothenburg, Sweden	University of Gothenburg; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Oslo; University of Gothenburg	Landgren, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden.	elisabet.jerlhag@pharm.gu.se	Bartlett, Selena/J-1345-2012; Thelle, Dag Steinar/ABD-1867-2020	Bartlett, Selena/0000-0002-1741-3958; Thelle, Dag Steinar/0000-0002-4417-5967	Swedish Research Council [K2006-21X-04247-33-3, 2009-2782]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; Swedish Brain Foundation; Swedish Council for Tobacco Research; LUA/ALF, Sahlgrenska University Hospital [7341, 148251]; foundations of Signe; Olof Wallenius; Goljes Memory; Adlerbertska; Fredrik and Ingrid Thuring; Tore Nilsson; Langmanska; Torsten and Ragnar Soderberg; Wilhelm and Martina Lundgren; Knut and Alice Wallenberg; Magnus Bergvall; Swedish Council for Working Life and Social Research (EpiLife); Swedish Society of Medicine; State of California for Medical Research through UCSF; Department of Defense [W81XWH-07-1-0075]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; Swedish Brain Foundation; Swedish Council for Tobacco Research; LUA/ALF, Sahlgrenska University Hospital; foundations of Signe; Olof Wallenius; Goljes Memory; Adlerbertska; Fredrik and Ingrid Thuring; Tore Nilsson; Langmanska; Torsten and Ragnar Soderberg; Wilhelm and Martina Lundgren; Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Magnus Bergvall; Swedish Council for Working Life and Social Research (EpiLife)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society of Medicine; State of California for Medical Research through UCSF; Department of Defense(United States Department of Defense)	This work was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3 and 2009-2782), the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly, the Swedish Brain Foundation, Swedish Council for Tobacco Research, LUA/ALF (grant no. 7341, 148251) from the Sahlgrenska University Hospital, and the foundations of Signe and Olof Wallenius, Goljes Memory, Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, Knut and Alice Wallenberg, Magnus Bergvall, the Swedish Council for Working Life and Social Research (EpiLife), the Swedish Society of Medicine, the State of California for Medical Research through UCSF and the Department of Defense (grant no. W81XWH-07-1-0075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Carroll ME, 2008, BEHAV PHARMACOL, V19, P435, DOI 10.1097/FBP.0b013e32830c3632; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; JERLHAG E, 2010, ALCOHOL IN PRESS, DOI DOI 10.1016/J.ALCOHOL.2010.10.002; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2008, EUR NEUROPSYCHOPHARM, V18, P508, DOI 10.1016/j.euroneuro.2008.02.006; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ALCOHOL ALCOHOLISM, V41, P486, DOI 10.1093/alcalc/agl049; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kampov-Polevoy AB, 2004, ALCOHOL CLIN EXP RES, V28, P1291, DOI 10.1097/01.ALC.0000137808.69482.75; Kampov-Polevoy AB, 2003, ALCOHOL CLIN EXP RES, V27, P1929, DOI 10.1097/01.ALC.0000099265.60216.23; Kampov-Polevoy AB, 2003, ALCOHOL CLIN EXP RES, V27, P1743, DOI 10.1097/01.ALC.0000093739.05809.DD; Kampov-Polevoy AB, 1999, ALCOHOL ALCOHOLISM, V34, P386, DOI 10.1093/alcalc/34.3.386; KampovPolevoy A, 1997, AM J PSYCHIAT, V154, P269, DOI 10.1176/ajp.154.2.269; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Keen-Rhinehart K, 2005, AM J PHYSIOL-REG I, V288, pR716, DOI 10.1152/ajpregu.00705.2004; Keskitalo K, 2007, AM J CLIN NUTR, V86, P1663; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Landgren S, 2010, ALCOHOL CLIN EXP RES, V34, P1519, DOI 10.1111/j.1530-0277.2010.01236.x; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Lemon CH, 2004, J NEUROPHYSIOL, V92, P536, DOI 10.1152/jn.00097.2004; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; MCCALLUM SE, 2011, PSYCHOPHARMA IN PRES, DOI DOI 10.1007/S00213-010-2132-0; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; RAMIREZ I, 1978, PHYSIOL BEHAV, V20, P257, DOI 10.1016/0031-9384(78)90218-4; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Simms JA, 2010, NEUROPSYCHOPHARMACOL, V35, P1453, DOI 10.1038/npp.2010.15; SINCLAIR JD, 1992, ALCOHOL, V9, P155, DOI 10.1016/0741-8329(92)90027-8; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013	51	59	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18170	10.1371/journal.pone.0018170	http://dx.doi.org/10.1371/journal.pone.0018170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448464	gold, Green Published, Green Submitted			2022-12-25	WOS:000288810500047
J	Fang, Z; Rajewsky, N				Fang, Zhuo; Rajewsky, Nikolaus			The Impact of miRNA Target Sites in Coding Sequences and in 3 ' UTRs	PLOS ONE			English	Article							MICRORNA TARGETS; PROTEIN; IDENTIFICATION; DETERMINANTS; MAMMALS; SIRNAS	Animal miRNAs are a large class of small regulatory RNAs that are known to directly and negatively regulate the expression of a large fraction of all protein encoding genes. The identification and characterization of miRNA targets is thus a fundamental problemin biology. miRNAs regulate target genes by binding to 39 untranslated regions (3 ' UTRs) of target mRNAs, and multiple binding sites for the same miRNA in 3'UTRs can strongly enhance the degree of regulation. Recent experiments have demonstrated that a large fraction of miRNA binding sites reside in coding sequences. Overall, miRNA binding sites in coding regions were shown to mediate smaller regulation than 3'UTR binding. However, possible interactions between target sites in coding sequences and 3'UTRs have not been studied. Using transcriptomics and proteomics data of ten miRNA mis-expression experiments as well as transcriptome-wide experimentally identified miRNA target sites, we found that mRNA and protein expression of genes containing target sites both in coding regions and 3'UTRs were in general mildly but significantly more regulated than those containing target sites in 3'UTRs only. These effects were stronger for conserved target sites of length 7-8 nt in coding regions compared to non-conserved sites. Combined with our other finding that miRNA target sites in coding regions are under negative selection, our results shed light on the functional importance of miRNA targeting in coding regions.	[Fang, Zhuo; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Fang, Z (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	rajewsky@mdc-berlin.de		Rajewsky, Nikolaus/0000-0002-4785-4332	Federal Ministry for Education and Research	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Zhuo Fang is funded by the Federal Ministry for Education and Research through a FORSYS-Partner project (FORSYS, 0315267C; http://forsys.drfz.de/index.php/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	17	195	202	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18067	10.1371/journal.pone.0018067	http://dx.doi.org/10.1371/journal.pone.0018067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445367	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000288809100028
J	Khanna, A; Okkeri, J; Bilgen, T; Tiirikka, T; Vihinen, M; Visakorpi, T; Westermarck, J				Khanna, Anchit; Okkeri, Juha; Bilgen, Turker; Tiirikka, Timo; Vihinen, Mauno; Visakorpi, Tapio; Westermarck, Jukka			ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells	PLOS ONE			English	Article							ONCOGENIC ACTIVITY; GASTRIC-CANCER; GENE; PATHWAY; EGFR; FAMILY	EGFR-MEK-ERK signaling pathway has an established role in promoting malignant growth and disease progression in human cancers. Therefore identification of transcriptional targets mediating the oncogenic effects of the EGFR-MEK-ERK pathway would be highly relevant. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a recently characterized human oncoprotein. CIP2A promotes malignant cell growth and is over expressed at high frequency (40-80%) in most of the human cancer types. However, the mechanisms inducing its expression in cancer still remain largely unexplored. Here we present systematic analysis of contribution of potential gene regulatory mechanisms for high CIP2A expression in cancer. Our data shows that evolutionary conserved CpG islands at the proximal CIP2A promoter are not methylated both in normal and cancer cells. Furthermore, sequencing of the active CIP2A promoter region from altogether seven normal and malignant cell types did not reveal any sequence alterations that would increase CIP2A expression specifically in cancer cells. However, treatment of cancer cells with various signaling pathway inhibitors revealed that CIP2A mRNA expression was sensitive to inhibition of EGFR activity as well as inhibition or activation of MEK-ERK pathway. Moreover, MEK1/2-specific siRNAs decreased CIP2A protein expression. Series of CIP2A promoter-luciferase constructs were created to identify proximal 227 to 2107 promoter region responsible for MEK-dependent stimulation of CIP2A expression. Additional mutagenesis and chromatin immunoprecipitation experiments revealed ETS1 as the transcription factor mediating stimulation of CIP2A expression through EGFR-MEK pathway. Thus, ETS1 is probably mediating high CIP2A expression in human cancers with increased EGFR-MEK1/2-ERK pathway activity. These results also suggest that in addition to its established role in invasion and angiogenesis, ETS1 may support malignant cellular growth via regulation of CIP2A expression and protein phosphatase 2A inhibition.	[Khanna, Anchit; Bilgen, Turker; Tiirikka, Timo; Vihinen, Mauno; Visakorpi, Tapio; Westermarck, Jukka] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Khanna, Anchit; Bilgen, Turker; Tiirikka, Timo; Vihinen, Mauno; Visakorpi, Tapio; Westermarck, Jukka] Tampere Univ Hosp, Tampere, Finland; [Khanna, Anchit] Univ Tampere, TGPBB, FIN-33101 Tampere, Finland; [Okkeri, Juha; Bilgen, Turker; Westermarck, Jukka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Okkeri, Juha; Bilgen, Turker; Westermarck, Jukka] Abo Akad Univ, Turku, Finland; [Bilgen, Turker] Akdeniz Univ, Fac Med, Dept Med Biol & Genet, TR-07058 Antalya, Turkey; [Westermarck, Jukka] Univ Turku, Dept Pathol, Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; Abo Akademi University; Akdeniz University; University of Turku	Khanna, A (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	jukwes@utu.fi	Vihinen, Mauno/A-8452-2012; Westermarck, Jukka/AAL-6464-2020; Bilgen, Turker/N-6376-2018	Vihinen, Mauno/0000-0002-9614-7976; Westermarck, Jukka/0000-0001-7478-3018; Bilgen, Turker/0000-0002-3015-0929; Visakorpi, Tapio/0000-0002-5004-0364	Academy of Finland [217676, 217675]; Association for International Cancer Research [08-0614]; Foundation for the Finnish Cancer Institute; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Competitive Research Funding of the Pirkanmaa Hospital District [9K152, 9L115]; Tampere Graduate Program in Biomedicine and Biotechnology; The Scientific and Technological Research Council of Turkey	Academy of Finland(Academy of Finland); Association for International Cancer Research; Foundation for the Finnish Cancer Institute; Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Competitive Research Funding of the Pirkanmaa Hospital District; Tampere Graduate Program in Biomedicine and Biotechnology; The Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by Academy of Finland ( projects: 217676 and 217675), Association for International Cancer Research ( project 08-0614), Foundation for the Finnish Cancer Institute (J.W.), Emil Aaltonen Foundation, Sigrid Juselius Foundation, Competitive Research Funding of the Pirkanmaa Hospital District ( projects: 9K152 and 9L115), Tampere Graduate Program in Biomedicine and Biotechnology ( A. K.), and The Scientific and Technological Research Council of Turkey ( T. B.). The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	CHEN KF, 2010, ONCOGENE; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Dent P, 2009, DRUG RESIST UPDATE, V12, P65, DOI 10.1016/j.drup.2009.03.001; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dong Q.Z., 2010, ANN SURG ONCOL; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Holterman CE, 2010, CANCER RES, V70, P730, DOI 10.1158/0008-5472.CAN-09-2090; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rutter JL, 1998, CANCER RES, V58, P5321; Seth A, 2001, Expert Opin Ther Targets, V5, P87, DOI 10.1517/14728222.5.1.87; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SETH A, 1990, ONCOGENE, V5, P1761; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; WANG J, 2011, INT J LAB HEMATOL; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	39	51	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17979	10.1371/journal.pone.0017979	http://dx.doi.org/10.1371/journal.pone.0017979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445343	Green Submitted, gold, Green Published			2022-12-25	WOS:000288809100020
J	Schmidt, J; Musken, M; Becker, T; Magnowska, Z; Bertinetti, D; Moller, S; Zimmermann, B; Herberg, FW; Jansch, L; Haussler, S				Schmidt, Juliane; Muesken, Mathias; Becker, Tanja; Magnowska, Zofia; Bertinetti, Daniela; Moeller, Stefan; Zimmermann, Bastian; Herberg, Friedrich W.; Jaensch, Lothar; Haeussler, Susanne			The Pseudomonas aeruginosa Chemotaxis Methyltransferase CheR1 Impacts on Bacterial Surface Sampling	PLOS ONE			English	Article							BIOFILM FORMATION; TWITCHING MOTILITY; PROTEIN METHYLTRANSFERASE; CELL POLES; IV PILI; METHYLATION; SEQUENCE; RECEPTOR; SYSTEM; ROLES	The characterization of factors contributing to the formation and development of surface-associated bacterial communities known as biofilms has become an area of intense interest since biofilms have a major impact on human health, the environment and industry. Various studies have demonstrated that motility, including swimming, swarming and twitching, seems to play an important role in the surface colonization and establishment of structured biofilms. Thereby, the impact of chemotaxis on biofilm formation has been less intensively studied. Pseudomonas aeruginosa has a very complex chemosensory system with two Che systems implicated in flagella-mediated motility. In this study, we demonstrate that the chemotaxis protein CheR1 is a methyltransferase that binds S-adenosylmethionine and transfers a methyl group from this methyl donor to the chemoreceptor PctA, an activity which can be stimulated by the attractant serine but not by glutamine. We furthermore demonstrate that CheR1 does not only play a role in flagella-mediated chemotaxis but that its activity is essential for the formation and maintenance of bacterial biofilm structures. We propose a model in which motility and chemotaxis impact on initial attachment processes, dispersion and reattachment and increase the efficiency and frequency of surface sampling in P. aeruginosa.	[Schmidt, Juliane; Muesken, Mathias; Becker, Tanja; Magnowska, Zofia; Jaensch, Lothar; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany; [Muesken, Mathias; Becker, Tanja; Haeussler, Susanne] Ctr Expt & Clin Infect Res, TWINCORE, Hannover, Germany; [Muesken, Mathias; Becker, Tanja; Haeussler, Susanne] Hannover Med Sch, D-3000 Hannover, Germany; [Bertinetti, Daniela; Moeller, Stefan; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, Kassel, Germany; [Zimmermann, Bastian] Biaffin GmbH & Co KG, Kassel, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Universitat Kassel	Schmidt, J (corresponding author), Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany.	susanne.haeussler@twincore.de	Häussler, Susanne/I-2605-2014; Herberg, Friedrich W/B-5572-2015; Pohl, Sarah/B-3102-2016; Bertinetti, Daniela/B-5655-2015	Häussler, Susanne/0000-0001-6141-9102; Herberg, Friedrich W/0000-0001-7117-7653; Pohl, Sarah/0000-0003-2655-7037; Bertinetti, Daniela/0000-0003-1150-3765; Musken, Mathias/0000-0002-5624-1378	German Research Foundation (DFG) [SFB900]; EU [222635]	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	Financial support from the German Research Foundation (DFG) (SFB900) and of the Helmholtz-Gemeinschaft is gratefully acknowledged. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FWH and BZ are supported by the grant "Affinity Proteome" from EU (222635). The commercial company Biaffin GmbH & Co KG contributed to analysis tools.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; DeLange PA, 2007, CURR MICROBIOL, V55, P389, DOI 10.1007/s00284-007-9008-5; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Dotsch A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-29; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; GUTTLER A, 1998, THESIS; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kato J, 1999, BIOSCI BIOTECH BIOCH, V63, P155, DOI 10.1271/bbb.63.155; Kato J, 2008, J BIOSCI BIOENG, V106, P1, DOI 10.1263/jbb.106.1; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; KURODA A, 1995, J BACTERIOL, V177, P7019, DOI 10.1128/jb.177.24.7019-7025.1995; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MASDUKI A, 1995, J BACTERIOL, V177, P948, DOI 10.1128/jb.177.4.948-952.1995; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; Moorthy S, 2004, MOL MICROBIOL, V52, P573, DOI 10.1111/j.1365-2958.2004.04000.x; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Okumura H, 1998, J BACTERIOL, V180, P1862, DOI 10.1128/JB.180.7.1862-1868.1998; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Perez E, 2004, BIOCHEMISTRY-US, V43, P953, DOI 10.1021/bi035455q; Perez E, 2007, MOL MICROBIOL, V63, P363, DOI 10.1111/j.1365-2958.2006.05518.x; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rao CV, 2009, CONTRIB MICROBIOL, V16, P33, DOI 10.1159/000219372; RICE MS, 1991, J BIOL CHEM, V266, P9746; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Taguchi K, 1997, MICROBIOL-UK, V143, P3223, DOI 10.1099/00221287-143-10-3223; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Whitchurch CB, 2004, MOL MICROBIOL, V52, P873, DOI 10.1111/j.1365-2958.2004.04026.x; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; WOLFE AJ, 1988, P NATL ACAD SCI USA, V85, P6711, DOI 10.1073/pnas.85.18.6711; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	63	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18184	10.1371/journal.pone.0018184	http://dx.doi.org/10.1371/journal.pone.0018184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445368	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100033
J	Lee, CM; Yang, PL; Chen, LC; Chen, CC; Wu, SC; Cheng, HY; Chang, YS				Lee, Chiou-Mei; Yang, Polung; Chen, Lih-Chyang; Chen, Chia-Chun; Wu, Shinn-Chih; Cheng, Hsiao-Yun; Chang, Yu-Sun			A Novel Role of RASSF9 in Maintaining Epidermal Homeostasis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; DOMAIN-CONTAINING PROTEINS; TERMINAL DIFFERENTIATION; MOUSE KERATINOCYTES; ACTIVATION; CALCIUM; GROWTH; PATHWAY; FAMILY; ALPHA	The physiological role of RASSF9, a member of the Ras-association domain family (RASSF), is currently unclear. Here, we report a mouse line in which an Epstein-Barr virus Latent Membrane Protein 1 (LMP1) transgene insertion has created a 7.2-kb chromosomal deletion, which abolished RASSF9 gene expression. The RASSF9-null mice exhibited interesting phenotypes that resembled human ageing, including growth retardation, short lifespan, less subcutaneous adipose layer and alopecia. In the wild-type mice, RASSF9 is predominantly expressed in the epidermal keratinocytes of skin, as determined by quantitative reverse-transcription PCR, immunofluorescence and in situ hybridization. In contrast, RASSF9-/- mice presented a dramatic change in epithelial organization of skin with increased proliferation and aberrant differentiation as detected by bromodeoxyuridine incorporation assays and immunofluorescence analyses. Furthermore, characteristic functions of RASSF9-/- versus wild type (WT) mouse primary keratinocytes showed significant proliferation linked to a reduction of p21Cip1 expression under growth or early differentiation conditions. Additionally, in RASSF9-/- keratinocytes there was a drastic down-modulation of terminal differentiation markers, which could be rescued by infection with a recombinant adenovirus, Adv/HA-RASSF9. Our results indicate a novel and significant role of RASSF9 in epidermal homeostasis.	[Lee, Chiou-Mei] Chang Gung Mem Hosp Lin Kou, Dept Med Res & Dev, Tao Yuan, Taiwan; [Lee, Chiou-Mei; Chen, Lih-Chyang; Chang, Yu-Sun] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Yang, Polung; Chen, Chia-Chun; Cheng, Hsiao-Yun; Chang, Yu-Sun] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan; [Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University	Lee, CM (corresponding author), Chang Gung Mem Hosp Lin Kou, Dept Med Res & Dev, Tao Yuan, Taiwan.	lcm5132@mail.cgu.edu.tw		Chang, Yu-Sun/0000-0002-6457-3890; Wu, Shinn-Chih/0000-0001-8881-1550	Ministry of Education, Taiwan; Chang Gung University; Chang Gung Memorial Hospital [CMRPD 160053, BMRP021]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung University; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the grant from the Ministry of Education, Taiwan (to Chang Gung University), and grants from Chang Gung University and the Chang Gung Memorial Hospital (CMRPD 160053 and BMRP021 to YSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; CALLARD RE, 1988, IMMUNOLOGY, V65, P379; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chang MH, 1997, DNA CELL BIOL, V16, P829, DOI 10.1089/dna.1997.16.829; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen LH, 1998, J BIOL CHEM, V273, P33524, DOI 10.1074/jbc.273.50.33524; CHEN ML, 1992, ONCOGENE, V7, P2131; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dirksen WP, 2003, J BIOL CHEM, V278, P9722, DOI 10.1074/jbc.M207969200; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Fang NX, 2007, VIROLOGY, V365, P187, DOI 10.1016/j.virol.2007.03.038; Fitzsimons C, 2002, BIOCHEM PHARMACOL, V63, P1785, DOI 10.1016/S0006-2952(02)00975-9; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hovhannisyan RH, 2005, MOL CELL BIOL, V25, P250, DOI 10.1128/MCB.25.1.250-263.2005; Karlsson T, 2010, J DERMATOL SCI, V57, P207, DOI 10.1016/j.jdermsci.2009.12.013; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu BG, 2009, CELL CYCLE, V8, P527, DOI 10.4161/cc.8.4.7598; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; OCHMAN H, 1988, GENETICS, V120, P621; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Rahkonen O, 2004, CIRC RES, V94, P83, DOI 10.1161/01.RES.0000108263.74520.15; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Scamborova P, 2004, MOL CELL BIOL, V24, P1855, DOI 10.1128/MCB.24.5.1855-1869.2004; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; Todd C, 1998, AM J PATHOL, V153, P39, DOI 10.1016/S0002-9440(10)65543-5; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Tscharntke M, 2005, FASEB J, V19, P1836, DOI 10.1096/fj.04-3327fje; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vaughan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007908; Wagner EJ, 2005, J BIOL CHEM, V280, P14017, DOI 10.1074/jbc.M414492200; Wang XJ, 2000, MOL CARCINOGEN, V27, P200, DOI 10.1002/(SICI)1098-2744(200003)27:3<200::AID-MC7>3.3.CO;2-0; Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109; Yeh TS, 1997, DNA CELL BIOL, V16, P1311, DOI 10.1089/dna.1997.16.1311; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17867	10.1371/journal.pone.0017867	http://dx.doi.org/10.1371/journal.pone.0017867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445300	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300018
J	Karling, P; Danielsson, A; Wikgren, M; Soderstrom, I; Del-Favero, J; Adolfsson, R; Norrback, KF				Karling, Pontus; Danielsson, Ake; Wikgren, Mikael; Soderstrom, Ingegerd; Del-Favero, Jurgen; Adolfsson, Rolf; Norrback, Karl-Fredrik			The Relationship between the Val158Met Catechol-o-Methyltransferase (COMT) Polymorphism and Irritable Bowel Syndrome	PLOS ONE			English	Article							GENE POLYMORPHISM; DEPRESSION SCALE; HOSPITAL ANXIETY; PAIN; ASSOCIATION; DISORDERS; SYMPTOMS; METAANALYSIS; INDIVIDUALS; POPULATION	Background: The catechol-O-methyltransferase (COMT) enzyme has a key function in the degradation of catecholamines and a functional polymorphism is val158met. The val/val genotype results in a three to fourfold higher enzymatic activity compared with the met/met genotype, with the val/met genotype exhibiting intermediate activity. Since pain syndromes as well as anxiety and depression are associated to low and high COMT activity respectively and these conditions are all associated with irritable bowel syndrome (IBS) we wanted for the first time to explore the relationship between the polymorphism and IBS. Methodology/Principal Findings: 867 subjects (445 women) representative of the general population and 70 consecutively sampled patients with IBS (61 women) were genotyped for the val158met polymorphism and the IBS patients filled out the Hospital-Anxiety-and-Depression-Scale (HADS) questionnaire, and an IBS symptom diary. Results: There was a significantly higher occurrence of the val/val genotype in patients compared with controls (30% vs 20%; Chi(2) (1) 3.98; p = 0.046) and a trend toward a lower occurrence of the val/met genotype in IBS patients compared with controls (39% vs 49%; Chi(2) (1) 2.89; p = 0.089). Within the IBS patients the val/val carriers exhibited significantly increased bowel frequency (2.6 vs 1.8 stools per day; Chi(2) (1) 5.3; p = 0.03) and a smaller proportion of stools with incomplete defecation (41% vs 68%; Chi(2) (1) 4.3; p = 0.04) compared with the rest (val/met+ met/met carriers). The val/val carriers also showed a trend for a smaller proportion of hard stools (0% vs 15%; Chi(2) (1) 3.2; p = 0.08) and a higher frequency of postprandial defecation (26% vs 21%; Chi(2) (1) 3.0; p = 0.08). Conclusions/Significance: In this study we found an association between the val/val genotype of the val158met COMT gene and IBS as well as to specific IBS related bowel pattern in IBS patients.	[Karling, Pontus; Danielsson, Ake; Soderstrom, Ingegerd] Umea Univ, Div Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Wikgren, Mikael; Adolfsson, Rolf; Norrback, Karl-Fredrik] Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; [Del-Favero, Jurgen] VIB, Dept Mol Genet, Appl Mol Genom Grp, Antwerp, Belgium; [Del-Favero, Jurgen] Univ Antwerp, B-2020 Antwerp, Belgium	Umea University; Umea University; Flanders Institute for Biotechnology (VIB); University of Antwerp	Karling, P (corresponding author), Umea Univ, Div Med, Dept Publ Hlth & Clin Med, Umea, Sweden.	pontus.karling@vll.se		Adolfsson, Rolf/0000-0001-9785-8473; Del Favero, jurgen/0000-0002-7427-7489	Swedish Research Council [2003-5158, 2006-4472]; Medical faculty, Umea University; County Council of Norrbotten, Sweden; County Council of Vasterbotten, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical faculty, Umea University; County Council of Norrbotten, Sweden; County Council of Vasterbotten, Sweden	The research was funded by the Swedish Research Council (grants 2003-5158 and 2006-4472), the Medical faculty, Umea University, and the County Councils of Vasterbotten and Norrbotten, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo MA, 2010, ALIMENT PHARM THER, V32, P738, DOI 10.1111/j.1365-2036.2010.04409.x; Armero P, 2005, EUR J PAIN, V9, P229, DOI 10.1016/j.ejpain.2004.06.005; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cervero F, 1999, LANCET, V353, P2145, DOI 10.1016/S0140-6736(99)01306-9; DELVAUX MM, 1999, CAN J GASTROENTEL SA, V13, pS32; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Domschke K, 2007, AM J MED GENET B, V144B, P667, DOI 10.1002/ajmg.b.30494; Garakani Amir, 2003, Am J Ther, V10, P61, DOI 10.1097/00045391-200301000-00014; Geeraerts B, 2005, GASTROENTEROLOGY, V129, P1437, DOI 10.1053/j.gastro.2005.08.020; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Hagen K, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-34; Hagen K, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-40; Hagen Knut, 2006, J Headache Pain, V7, P70, DOI 10.1007/s10194-006-0281-7; Jones MP, 2006, NEUROGASTROENT MOTIL, V18, P91, DOI 10.1111/j.1365-2982.2005.00730.x; Karling P, 2007, NEUROGASTROENT MOTIL, V19, P896, DOI 10.1111/j.1365-2982.2007.00967.x; Karling P, 2007, SCAND J GASTROENTERO, V42, P1294, DOI 10.1080/00365520701395945; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Lachman HM, 1996, AM J MED GENET, V67, P468, DOI 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Mayer EA, 2000, GUT, V47, P861, DOI 10.1136/gut.47.6.861; MAYER EA, 2001, J CLIN PSYCHIAT, V62, pS28; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Ragnarsson G, 1998, EUR J GASTROEN HEPAT, V10, P415, DOI 10.1097/00042737-199805000-00011; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; TAHARA T, 2008, HEPATO-GASTROENTEROL, V55, P879; Tornblom H, 2005, SCAND J GASTROENTERO, V40, P1140, DOI 10.1080/00365520510023657; Van Den Bogaert A, 2006, PSYCHIAT GENET, V16, P209, DOI 10.1097/01.ypg.0000218623.03752.e4; Weiss EM, 2007, J INT NEUROPSYCH SOC, V13, P881; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; WICHERS M, 2007, NEUROPSYCHOPHARMACOL, V8, P1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	33	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18035	10.1371/journal.pone.0018035	http://dx.doi.org/10.1371/journal.pone.0018035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437260	Green Published, gold			2022-12-25	WOS:000288545100066
J	Suga, T; Kimura, E; Morioka, Y; Ikawa, M; Li, S; Uchino, K; Uchida, Y; Yamashita, S; Maeda, Y; Chamberlain, JS; Uchino, M				Suga, Tomohiro; Kimura, En; Morioka, Yuka; Ikawa, Masahito; Li, Sheng; Uchino, Katsuhisa; Uchida, Yuji; Yamashita, Satoshi; Maeda, Yasushi; Chamberlain, Jeffrey S.; Uchino, Makoto			Muscle Fiber Type-Predominant Promoter Activity in Lentiviral-Mediated Transgenic Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE-TRANSFER; SKELETAL-MUSCLE; MDX MICE; STABLE TRANSDUCTION; HEMATOPOIETIC-CELLS; ADENOVIRUS VECTOR; SATELLITE CELLS; LIFE-SPAN; EXPRESSION	Variations in gene promoter/enhancer activity in different muscle fiber types after gene transduction was noticed previously, but poorly analyzed. The murine stem cell virus (MSCV) promoter drives strong, stable gene expression in hematopoietic stem cells and several other cells, including cerebellar Purkinje cells, but it has not been studied in muscle. We injected a lentiviral vector carrying an MSCV-EGFP cassette (LvMSCV-EGFP) into tibialis anterior muscles and observed strong EGFP expression in muscle fibers, primary cultured myoblasts, and myotubes isolated from injected muscles. We also generated lentiviral-mediated transgenic mice carrying the MSCV-EGFP cassette and detected transgene expression in striated muscles. LvMSCV-EGFP transgenic mice showed fiber type-dependent variations in expression: highest in types I and IIA, intermediate in type IID/X, and lowest in type IIB fibers. The soleus and diaphragm muscles, consisting mainly of types I and IIA, are most severely affected in the mdx mouse model of muscular dystrophy. Further analysis of this promoter may have the potential to achieve certain gene expression in severely affected muscles of mdx mice. The Lv-mediated transgenic mouse may prove a useful tool for assessing the enhancer/promoter activities of a variety of different regulatory cassettes.	[Suga, Tomohiro; Kimura, En; Uchino, Katsuhisa; Uchida, Yuji; Yamashita, Satoshi; Maeda, Yasushi; Uchino, Makoto] Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto, Japan; [Morioka, Yuka] Hokkaido Univ, Res Ctr, Infect Associated Canc, Div Dis Model Innovat,Inst Genet Med, Sapporo, Hokkaido, Japan; [Morioka, Yuka; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Kimura, En; Li, Sheng; Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Neurol Med & Biochem, Seattle, WA USA; [Uchida, Yuji] Sojo Univ, Pharmacol Lab, Div Life Sci, Fac Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Hokkaido University; Osaka University; University of Washington; University of Washington Seattle; Sojo University	Suga, T (corresponding author), Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto, Japan.	enkimura@kumamoto-u.ac.jp	Kimura, En/B-3869-2010; ikawa, masahito/A-5315-2009	Kimura, En/0000-0002-7865-5918; ikawa, masahito/0000-0001-9859-6217; Yamashita, Satoshi/0000-0001-9315-3492; Chamberlain, Jeffrey/0000-0001-5299-0059	Gene Technology Center; Center for Animal Resources and Development of Kumamoto University; Japan Society for the Promotion of Science [20591004, 20591003]; Ministry of Health, Labour and Welfare [19A-7]; Kanae Foundation for the Promotion of Medical Science [37-C12]; Terumo Life Science Foundation [09-328]; National Institutes of Health [NS046788]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS046788] Funding Source: NIH RePORTER	Gene Technology Center; Center for Animal Resources and Development of Kumamoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Kanae Foundation for the Promotion of Medical Science; Terumo Life Science Foundation(Terumo Life Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Luigi Naldini (San Raffaele Telethon Institute for Gene Therapy, HSR-TIGET), William Osborne (University of Washington, UW), and Hiroyuki Miyoshi (RIKEN) for providing their Lentiviral vector backbones, Dusty Miller (Fred Hutchinson Cancer Research Center) for 293D cells, Stephen Hauschka (UW) for the primary culture conditions, and Glen Banks and Yutaka Ohsawa for technical advice about fiber type specific immunostaining. We acknowledge the support of the Gene Technology Center and Center for Animal Resources and Development of Kumamoto University.; Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to E.K. (20591004) and M.U. (20591003) URL: http://www.jsps.go.jp/english/e-grants/grants.html. Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare (19A-7) URL: http://www.ncnp.go.jp/research/cost.html. The Kanae Foundation for the Promotion of Medical Science to E.K. (37-C12) URL: http://kanae.sanofi-aventis.co.jp/english/index.html. The Terumo Life Science Foundation to E.K. (09-328) URL: http://www.terumozaidan.or.jp/. National Institutes of Health grant to J.S.C. (NS046788) URL: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcaitis S, 2005, GLIA, V50, P48, DOI 10.1002/glia.20146; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; CHAMBERLAIN JS, 1985, MOL CELL BIOL, V5, P484, DOI 10.1128/MCB.5.3.484; Chinnasamy D, 2000, BLOOD, V96, P1309, DOI 10.1182/blood.V96.4.1309.h8001309_1309_1316; Choi JK, 2001, STEM CELLS, V19, P236, DOI 10.1634/stemcells.19-3-236; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Dardalhon V, 2001, GENE THER, V8, P190, DOI 10.1038/sj.gt.3301378; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Foster H, 2008, MOL THER, V16, P1825, DOI 10.1038/mt.2008.186; GILGOFF I, 1989, CHEST, V95, P519, DOI 10.1378/chest.95.3.519; GORZA L, 1990, J HISTOCHEM CYTOCHEM, V38, P257, DOI 10.1177/38.2.2137154; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Gregory LG, 2004, GENE THER, V11, P1117, DOI 10.1038/sj.gt.3302268; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; HAWLEY RG, 1994, GENE THER, V1, P136; HEMATOPOIETIC C, STEM CELLS, V19, P236; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; Ikemoto M, 2007, MOL THER, V15, P2178, DOI 10.1038/sj.mt.6300295; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kawano R, 2008, MOL THER, V16, P825, DOI 10.1038/mt.2008.23; Kimura E, 2001, GENE THER, V8, P20, DOI 10.1038/sj.gt.3301359; Kimura E, 2008, HUM MOL GENET, V17, P2507, DOI 10.1093/hmg/ddn151; Kimura E, 2010, MOL THER, V18, P206, DOI 10.1038/mt.2009.253; Kobinger GP, 2003, HUM GENE THER, V14, P1441, DOI 10.1089/104303403769211655; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Li S, 2005, GENE THER, V12, P1099, DOI 10.1038/sj.gt.3302505; Lynch GS, 1997, AM J PHYSIOL-CELL PH, V272, pC2063, DOI 10.1152/ajpcell.1997.272.6.C2063; MacKenzie TC, 2005, J GENE MED, V7, P50, DOI 10.1002/jgm.649; MINETTI C, 1991, NEUROLOGY, V41, P1977, DOI 10.1212/WNL.41.12.1977; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; NAITO K, 1992, HUM REPROD, V7, P281, DOI 10.1093/oxfordjournals.humrep.a137633; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Sakamoto T, 2008, NEUROMUSCULAR DISORD, V18, P382, DOI 10.1016/j.nmd.2008.02.004; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; SHER J, 1976, ACTA NEUROL SCAND, V54, P45, DOI 10.1111/j.1600-0404.1976.tb07619.x; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Uchida Y, 2005, J GENE MED, V7, P1010, DOI 10.1002/jgm.745; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e16908	10.1371/journal.pone.0016908	http://dx.doi.org/10.1371/journal.pone.0016908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445245	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100008
J	de Langavant, LC; Remy, P; Trinkler, I; McIntyre, J; Dupoux, E; Berthoz, A; Bachoud-Levi, AC				de Langavant, Laurent Cleret; Remy, Philippe; Trinkler, Iris; McIntyre, Joseph; Dupoux, Emmanuel; Berthoz, Alain; Bachoud-Levi, Anne-Catherine			Behavioral and Neural Correlates of Communication via Pointing	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; EXTERNALLY TRIGGERED MOVEMENTS; VISUAL PERSPECTIVE; JOINT ATTENTION; BODY; PERCEPTION; LANGUAGE; CORTEX; BRAIN; SELF	Communicative pointing is a human specific gesture which allows sharing information about a visual item with another person. It sets up a three-way relationship between a subject who points, an addressee and an object. Yet psychophysical and neuroimaging studies have focused on non-communicative pointing, which implies a two-way relationship between a subject and an object without the involvement of an addressee, and makes such gesture comparable to touching or grasping. Thus, experimental data on the communicating function of pointing remain scarce. Here, we examine whether the communicative value of pointing modifies both its behavioral and neural correlates by comparing pointing with or without communication. We found that when healthy participants pointed repeatedly at the same object, the communicative interaction with an addressee induced a spatial reshaping of both the pointing trajectories and the endpoint variability. Our finding supports the hypothesis that a change in reference frame occurs when pointing conveys a communicative intention. In addition, measurement of regional cerebral blood flow using H2O15 PET-scan showed that pointing when communicating with an addressee activated the right posterior superior temporal sulcus and the right medial prefrontal cortex, in contrast to pointing without communication. Such a right hemisphere network suggests that the communicative value of pointing is related to processes involved in taking another person's perspective. This study brings to light the need for future studies on communicative pointing and its neural correlates by unraveling the three-way relationship between subject, object and an addressee.	[de Langavant, Laurent Cleret; Trinkler, Iris; Bachoud-Levi, Anne-Catherine] Inst Mondor Rech Biomed, INSERM, Equipe 1, U955, Creteil, France; [de Langavant, Laurent Cleret; Trinkler, Iris; Dupoux, Emmanuel; Bachoud-Levi, Anne-Catherine] ENS, Dept Etudes Cognit, F-75230 Paris 05, France; [de Langavant, Laurent Cleret; Remy, Philippe; Trinkler, Iris; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, Creteil, France; [de Langavant, Laurent Cleret; Remy, Philippe; Bachoud-Levi, Anne-Catherine] CHU Henri Mondor, AP HP, Serv Neurol, F-94010 Creteil, France; [Remy, Philippe] SHFJ, URA CNRS CEA 2210, Orsay, France; [McIntyre, Joseph; Berthoz, Alain] Coll France, LPPA, F-75231 Paris, France; [McIntyre, Joseph] Univ Paris 05, Inst Neurosci & Cognit, CESeM, UMR 8194, Paris, France; [McIntyre, Joseph] CNRS, Paris, France; [Dupoux, Emmanuel] ENS EHESS CNRS, Dept Etudes Cognit, LSCP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	de Langavant, LC (corresponding author), Inst Mondor Rech Biomed, INSERM, Equipe 1, U955, Creteil, France.	bachoud@gmail.com	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; McIntyre, Joseph/K-6395-2015	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; McIntyre, Joseph/0000-0003-4974-4257; Remy, Philippe/0000-0003-2150-2563; Trinkler, Iris/0000-0002-0405-161X; Cleret de Langavant, Laurent/0000-0001-6551-4641; Dupoux, Emmanuel/0000-0002-7814-2952				Abraham A, 2008, CONSCIOUS COGN, V17, P438, DOI 10.1016/j.concog.2008.03.011; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1989, BRIT J DEV PSYCHOL, V7, P113, DOI 10.1111/j.2044-835X.1989.tb00793.x; BARONCOHEN S, 2005, EMPATHIZING SYSTEM R; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; BOOKSTEIN FL, 1992, BEHAV BRAIN SCI, V15, P327, DOI 10.1017/S0140525X00068886; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Carrozzo M, 2002, EXP BRAIN RES, V147, P426, DOI 10.1007/s00221-002-1232-4; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Charman T., 2006, SOCIAL COMMUNICATION; Cook RD, 1982, RESIDUALS INFLUENCE; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; de Langavant LC, 2009, NEUROPSYCHOLOGIA, V47, P1745, DOI 10.1016/j.neuropsychologia.2009.02.016; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Degos JD, 1997, NEUROCASE, V3, P31, DOI 10.1080/13554799708404032; Diedrichsen J, 2004, PERCEPT PSYCHOPHYS, V66, P89, DOI 10.3758/BF03194864; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Felician O, 2003, NEUROPSYCHOLOGIA, V41, P1307, DOI 10.1016/S0028-3932(03)00046-0; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Franco F, 1996, J CHILD LANG, V23, P307, DOI 10.1017/S0305000900008813; FRANCO F, 2005, JOINT ATTENTION COMM, P129, DOI DOI 10.1093/ACPROF:OSO/9780199245635.003.0007; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Ganesan V, 2005, AM J PSYCHIAT, V162, P1545, DOI 10.1176/appi.ajp.162.8.1545; Gomez J. C., 2005, JOINT ATTENTION COMM, P65; Gomez JC, 1996, BEHAV BRAIN SCI, V19, P129, DOI 10.1017/S0140525X00041881; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Henderson LM, 2002, INT J DEV NEUROSCI, V20, P449, DOI 10.1016/S0736-5748(02)00038-2; HOBSON R, 2005, JOINT ATTENTION COMM, P129; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jellema T, 2004, CEREB CORTEX, V14, P781, DOI 10.1093/cercor/bhh038; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; LACQUANITI F, 1997, HANDB NEUR, V11, P27; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Liszkowski U, 2008, INFANT BEHAV DEV, V31, P157, DOI 10.1016/j.infbeh.2007.10.011; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pelphrey KA, 2003, NEUROPSYCHOLOGIA, V41, P156, DOI 10.1016/S0028-3932(02)00146-X; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; Phillips W, 1995, J CHILD PSYCHOL PSYC, V36, P1383, DOI 10.1111/j.1469-7610.1995.tb01670.x; Pick A, 1922, PSYCHOL FORSCH, V1, P303, DOI 10.1007/BF00410392; Puce A, 1998, J NEUROSCI, V18, P2188; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Simon O, 2004, NEUROIMAGE, V23, P1192, DOI 10.1016/j.neuroimage.2004.09.023; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Soechting J F, 1990, J Cogn Neurosci, V2, P32, DOI 10.1162/jocn.1990.2.1.32; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Tomasello M., 2009, CULTURAL ORIGINS HUM; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; Vindras P, 1998, J EXP PSYCHOL HUMAN, V24, P569, DOI 10.1037/0096-1523.24.2.569; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	72	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17719	10.1371/journal.pone.0017719	http://dx.doi.org/10.1371/journal.pone.0017719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SH	21423659	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900017
J	Li, Y; Zhu, Z; Zhang, SH; Yu, DH; Yu, HY; Liu, LN; Cao, XZ; Wang, L; Gao, HJ; Zhu, MH				Li, Yongmei; Zhu, Zhi; Zhang, Shuhui; Yu, Danghui; Yu, Hongyu; Liu, Lina; Cao, Xiaozhe; Wang, Li; Gao, Hengjun; Zhu, Minghua			ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CELL-CYCLE; CENP-A; CLINICOPATHOLOGICAL SIGNIFICANCE; NASOPHARYNGEAL CARCINOMA; NEGATIVE REGULATOR; COLORECTAL-CANCER; KINETOCHORE; EXPRESSION; OVEREXPRESSION	Background: Centromere protein A (CENP-A) plays important roles in cell-cycle regulation and genetic stability. Herein, we aimed to investigate its expression pattern, clinical significance, and biological function in hepatocellular carcinoma (HCC). Methodology/Principal Findings: CENP-A expression at the mRNA and protein levels was examined in 20 pairs of fresh HCCs and corresponding nontumor liver tissues. Immunohistochemistry for CENP-A was performed on 80 paraffin-embedded HCC specimens, and the clinical significance of its expression was analyzed. A human HCC cell line HepG2 with high abundance of CENP-A was used to study the effects of manipulating CENP-A on HCC growth. Quantitative real-time polymerase chain reaction arrays and Western blot analysis were employed to identify the cell-cycle control-and apoptosis-related genes regulated by CENP-A. The results showed that CENP-A was aberrantly overexpressed in HCCs relative to adjacent nontumor tissues. This overexpression was significantly associated with positive serum HBsAg status, increased histological grade, high Ki-67 index and P53 immunopositivity. Knockdown of CENP-A in HepG2 cells reduced cell proliferation, blocked cell cycle at the G1 phase, and increased apoptosis. The antiproliferative effects of CENP-A silencing were also observed in vivo. Conversely, CENP-A overexpression promoted HCC cell growth and reduced apoptosis. Furthermore, many genes implicated in cell-cycle regulation and apoptosis, including CHK2, P21waf1, P27 Kip1, SKP2, cyclin G1, MDM2, Bcl-2, and Bax, were deregulated by manipulating CENP-A. Conclusions/Significance: Overexpression of CENP-A is frequently observed in HCC. Targeting CENP-A can inhibit HCC growth, likely through the regulation of a large number genes involved in cell-cycle progression and apoptosis, and thereby represents a potential therapeutic strategy for this malignancy.	[Li, Yongmei; Zhu, Zhi; Yu, Danghui; Yu, Hongyu; Liu, Lina; Cao, Xiaozhe; Wang, Li; Zhu, Minghua] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Zhu, Minghua] Second Mil Med Univ, Inst Liver Dis, Shanghai, Peoples R China; [Zhang, Shuhui] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Pathol, Shanghai, Peoples R China; [Li, Yongmei] Tongji Univ, Coll Med, Dept Pathol, Shanghai 200092, Peoples R China; [Gao, Hengjun] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Tongji University	Li, Y (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China.	mhzhu2000@hotmail.com	liu, li/HGC-0900-2022		National Natural Science Foundation of China [30870976]; National Science Fund for Creative Research Groups [30921006]; Shanghai Natural Science Foundation of China [08ZR1419600]; Key Research Foundation of Shanghai Municipal Education Commission of China [08ZZ123]; Research Foundation from Shanghai Municipal Health Bureau, China [2007086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Foundation of Shanghai Municipal Education Commission of China; Research Foundation from Shanghai Municipal Health Bureau, China	Funding: Funding was provided by National Natural Science Foundation of China (no. 30870976) and National Science Fund for Creative Research Groups (no. 30921006) to MZ; Shanghai Natural Science Foundation of China (No. 08ZR1419600) and Key Research Foundation of Shanghai Municipal Education Commission of China (No. 08ZZ123) to SZ; Research Foundation from Shanghai Municipal Health Bureau, China (2007086) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Cao JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-237; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Chehab NH, 2000, GENE DEV, V14, P278; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; de la Guardia C, 2001, HEAD NECK-J SCI SPEC, V23, P104; Ecker K, 2009, NAT CELL BIOL, V11, P377, DOI [10.1038/ncb1859, 10.1038/ncb0409-377]; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; HAMILTON S, 2000, WHO CLASSIFICATION T, P167; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Li Yong-mei, 2008, Chinese Journal of Pathology, V37, P124; Liao WT, 2007, CLIN CANCER RES, V13, P508, DOI 10.1158/1078-0432.CCR-06-1512; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JX, 2006, P NATL ACAD SCI USA, V103, P383, DOI 10.1073/pnas.0509810102; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Marshall OJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000370; McIntyre M, 1999, ONCOGENE, V18, P4577, DOI 10.1038/sj.onc.1202815; Mellone BG, 2009, CELL, V137, P409, DOI 10.1016/j.cell.2009.04.035; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Orthaus S, 2006, BIOCHEM BIOPH RES CO, V348, P36, DOI 10.1016/j.bbrc.2006.06.187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podhraski V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010120; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Sanyal K, 2002, P NATL ACAD SCI USA, V99, P12969, DOI 10.1073/pnas.162488299; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Tomonaga T, 2003, CANCER RES, V63, P3511; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Xian ZH, 2006, MODERN PATHOL, V19, P280, DOI 10.1038/modpathol.3800530; Zeindl-Eberhart E, 2004, HEPATOLOGY, V39, P540, DOI 10.1002/hep.20060; Zeindl-Eberhart E, 2001, ELECTROPHORESIS, V22, P3009, DOI 10.1002/1522-2683(200108)22:14<3009::AID-ELPS3009>3.0.CO;2-V; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zhang SH, 2008, HUM PATHOL, V39, P1827, DOI 10.1016/j.humpath.2008.06.003; Zhu Z, 2009, HEPATOLOGY, V49, P504, DOI 10.1002/hep.22675	55	80	83	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17794	10.1371/journal.pone.0017794	http://dx.doi.org/10.1371/journal.pone.0017794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423629	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900030
J	Tia, B; Saimpont, A; Paizis, C; Mourey, F; Fadiga, L; Pozzo, T				Tia, Banty; Saimpont, Arnaud; Paizis, Christos; Mourey, France; Fadiga, Luciano; Pozzo, Thierry			Does Observation of Postural Imbalance Induce a Postural Reaction?	PLOS ONE			English	Article							BIOLOGICAL MOTION; UTILIZATION BEHAVIOR; MUSCLE-STIFFNESS; MOTOR IMAGERY; PERCEPTION; MOVEMENT; MODULATION; IMITATION; BALANCE; PICTURES	Background: Several studies bring evidence that action observation elicits contagious responses during social interactions. However automatic imitative tendencies are generally inhibited and it remains unclear in which conditions mere action observation triggers motor behaviours. In this study, we addressed the question of contagious postural responses when observing human imbalance. Methodology/Principal Findings: We recorded participants' body sway while they observed a fixation cross (control condition), an upright point-light display of a gymnast balancing on a rope, and the same point-light display presented upside down. Our results showed that, when the upright stimulus was displayed prior to the inverted one, centre of pressure area and antero-posterior path length were significantly greater in the upright condition compared to the control and upside down conditions. Conclusions/Significance: These results demonstrate a contagious postural reaction suggesting a partial inefficiency of inhibitory processes. Further, kinematic information was sufficient to trigger this reaction. The difference recorded between the upright and upside down conditions indicates that the contagion effect was dependent on the integration of gravity constraints by body kinematics. Interestingly, the postural response was sensitive to habituation, and seemed to disappear when the observer was previously shown an inverted display. The motor contagion recorded here is consistent with previous work showing vegetative output during observation of an effortful movement and could indicate that lower level control facilitates contagion effects.	[Tia, Banty; Saimpont, Arnaud; Paizis, Christos; Mourey, France; Pozzo, Thierry] Univ Bourgogne, INSERM, U887, Dijon, France; [Tia, Banty; Saimpont, Arnaud; Mourey, France] Ctr Hosp Univ Dijon, Dijon, France; [Paizis, Christos] Univ Bourgogne, UFR STAPS, Ctr Expertise Performance Gilles Cometti, Dijon, France; [Fadiga, Luciano] Univ Ferrara, Fac Med, Dept SBTA, Sect Human Physiol, I-44100 Ferrara, Italy; [Fadiga, Luciano; Pozzo, Thierry] Italian Inst Technol, RBCS Robot Brain & Cognit Sci Dept, Genoa, Italy; [Pozzo, Thierry] Univ Bourgogne, UFR STAPS, Inst Univ France, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; University of Ferrara; Istituto Italiano di Tecnologia - IIT; Institut Universitaire de France; Universite de Bourgogne	Tia, B (corresponding author), Univ Bourgogne, INSERM, U887, Dijon, France.	banty.tia@u-bourgogne.fr	PAIZIS, CHRISTOS/P-1848-2019; Mourey, France/AAF-1784-2020; Fadiga, Luciano/AAC-7404-2022	fadiga, luciano/0000-0001-5691-5080; Pozzo, Thierry/0000-0002-0585-7965	French Agence Nationale de la Recherche (ANR); Conseil Regional de Bourgogne	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	Funding: This study was supported by the French Agence Nationale de la Recherche (ANR TecSan projet SimAction) and the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bove M, 2009, BRAIN RES BULL, V80, P122, DOI 10.1016/j.brainresbull.2009.04.008; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Courtine G, 2002, NEUROSCI LETT, V332, P70, DOI 10.1016/S0304-3940(02)00909-6; DeRenzi E, 1996, J NEUROL NEUROSUR PS, V61, P396, DOI 10.1136/jnnp.61.4.396; Ehrenfried T, 2003, COGNITIVE BRAIN RES, V17, P140, DOI 10.1016/S0926-6410(03)00088-0; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Guillot A, 2007, INT J PSYCHOPHYSIOL, V66, P18, DOI 10.1016/j.ijpsycho.2007.05.009; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LIPPS T, 2006, AESTHETIC PSYCHOL SC; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; Morasso PG, 2002, J NEUROPHYSIOL, V88, P2157, DOI 10.1152/jn.2002.88.4.2157; Mulder T, 2005, EXP BRAIN RES, V163, P344, DOI 10.1007/s00221-004-2179-4; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; Paillard J., 1976, TRAITE PHYSL, VII, P521; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pozzo T, 2006, BEHAV BRAIN RES, V169, P75, DOI 10.1016/j.bbr.2005.12.005; Shiffrar M., 2007, SENSORIMOTOR FDN HIG, V22, P267; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Thirioux B, 2009, BRAIN COGNITION, V70, P191, DOI 10.1016/j.bandc.2009.02.006; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211	43	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17799	10.1371/journal.pone.0017799	http://dx.doi.org/10.1371/journal.pone.0017799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SH	21423622	gold, Green Submitted, Green Published			2022-12-25	WOS:000288513900031
J	Alfaro, C; Suarez, N; Martinez-Forero, I; Palazon, A; Rouzaut, A; Solano, S; Feijoo, E; Gurpide, A; Bolanos, E; Erro, L; Dubrot, J; Hervas-Stubbs, S; Gonzalez, A; Perez-Gracia, JL; Melero, I				Alfaro, Carlos; Suarez, Natalia; Martinez-Forero, Ivan; Palazon, Asis; Rouzaut, Ana; Solano, Sarai; Feijoo, Esperanza; Gurpide, Alfonso; Bolanos, Elixabet; Erro, Lorena; Dubrot, Juan; Hervas-Stubbs, Sandra; Gonzalez, Alvaro; Luis Perez-Gracia, Jose; Melero, Ignacio			Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation	PLOS ONE			English	Article							INTRATUMORAL INJECTION; TUMOR MICROENVIRONMENT; CANCER-IMMUNOTHERAPY; ANTITUMOR IMMUNITY; MELANOMA PATIENTS; GROWTH-FACTOR; CHEMOKINES; RECEPTOR; INFLAMMATION; EXPRESSION	Background: Interleukin-8 (IL-8, CXCL8) is readily produced by human malignant cells. Dendritic cells (DC) both produce IL-8 and express the IL-8 functional receptors CXCR1 and CXCR2. Most human colon carcinomas produce IL-8. IL-8 importance in malignancies has been ascribed to angiogeneis promotion. Principal Findings: IL-8 effects on human monocyte-derived DC biology were explored upon DC exposure to recombinant IL-8 and with the help of an IL-8 neutralizing mAb. In vivo experiments were performed in immunodeficient mice xenografted with IL-8-producing human colon carcinomas and comparatively with cell lines that do not produce IL-8. Allogenic T lymphocyte stimulation by DC was explored under the influence of IL-8. DC and neutrophil chemotaxis were measured by transwell-migration assays. Sera from tumor-xenografted mice contained increasing concentrations of IL-8 as the tumors progress. IL-8 production by carcinoma cells can be modulated by low doses of cyclophosphamide at the transcription level. If human DC are injected into HT29 or CaCo2 xenografted tumors, DC are retained intratumorally in an IL-8-dependent fashion. However, IL-8 did not modify the ability of DC to stimulate T cells. Interestingly, pre-exposure of DC to IL-8 desensitizes such cells for IL-8-mediated in vitro or in vivo chemoattraction. Thereby DC become disoriented to subsequently follow IL-8 chemotactic gradients towards malignant or inflamed tissue. Conclusions: IL-8 as produced by carcinoma cells changes DC migration cues, without directly interfering with DC-mediated T-cell stimulation.	[Alfaro, Carlos; Suarez, Natalia; Martinez-Forero, Ivan; Palazon, Asis; Rouzaut, Ana; Solano, Sarai; Feijoo, Esperanza; Bolanos, Elixabet; Erro, Lorena; Dubrot, Juan; Hervas-Stubbs, Sandra; Melero, Ignacio] CIMA, Gene Therapy & Hepatol Div, Pamplona, Spain; [Suarez, Natalia; Gonzalez, Alvaro] Univ Navarra Clin, Dept Biochem, Pamplona, Spain; [Gurpide, Alfonso; Bolanos, Elixabet; Luis Perez-Gracia, Jose; Melero, Ignacio] Univ Navarra Clin, Dept Med Oncol, Pamplona, Spain	University of Navarra; University of Navarra	Alfaro, C (corresponding author), CIMA, Gene Therapy & Hepatol Div, Pamplona, Spain.	imelero@unav.es	Dubrot, Juan/ABI-1676-2020; González, Álvaro/T-8122-2018; Perez-Gracia, Jose Luis/I-8372-2017; Palazon, Asis/ABI-1748-2020; Melero, Ignacio/T-7600-2019; Alfaro, Carlos/K-3566-2014; Rouzaut, Ana/I-2576-2017; Bolaños, Elixabet/I-8225-2017; Hervas-Stubbs, Sandra/C-9053-2018	Dubrot, Juan/0000-0002-8093-2208; González, Álvaro/0000-0002-1423-273X; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Palazon, Asis/0000-0002-7172-7229; Melero, Ignacio/0000-0002-1360-348X; Alfaro, Carlos/0000-0002-4812-7153; Rouzaut, Ana/0000-0003-3226-9162; Bolaños, Elixabet/0000-0003-3780-9244; Hervas-Stubbs, Sandra/0000-0003-3391-1516	MEC/MICINN [SAF2005-03131, SAF2008-03294]; Departamento de Educacion del Gobierno de Navarra; Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri); Redes tematicas de investigacion cooperativa RETIC [RD06/0020/0065]; Fondo de investigacion sanitaria [FIS PI060932]; European commission; SUDOE-IMMUNONET; Fundacion Mutua Madrilena; "UTE for project FIMA"; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); Ministerio de Educacion y Ciencia; FIS	MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departamento de Educacion del Gobierno de Navarra; Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri); Redes tematicas de investigacion cooperativa RETIC; Fondo de investigacion sanitaria(Instituto de Salud Carlos III); European commission(European CommissionEuropean Commission Joint Research Centre); SUDOE-IMMUNONET; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); "UTE for project FIMA"; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); Ministerio de Educacion y Ciencia(Spanish Government); FIS(Instituto de Salud Carlos III)	Financial support was from MEC/MICINN (SAF2005-03131 and SAF2008-03294), Departamento de Educacion del Gobierno de Navarra, Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri), Redes tematicas de investigacion cooperativa RETIC (RD06/0020/0065), Fondo de investigacion sanitaria (FIS PI060932), European commission 7th framework program (ENCITE) and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA". CA is supported by Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC). SH-S receives a Ramon y Cajal contract from Ministerio de Educacion y Ciencia and AP a scholarship from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Baggiolini M, 2000, IMMUNOL TODAY, V21, P418, DOI 10.1016/S0167-5699(00)01672-8; BAGGIOLINI M, 1994, CHEST, V105, pS95, DOI 10.1378/chest.105.3_Supplement.95S; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gasparini G, 2001, LANCET ONCOL, V2, P733, DOI 10.1016/S1470-2045(01)00587-3; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Gross MD, 2001, J NUCL MED, V42, P1656; Guo J, 2007, INT J CANCER, V120, P2418, DOI 10.1002/ijc.22551; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; HUANG D, CANC RES, V70, P1063; Huarte E, 2005, EXPERT OPIN BIOL TH, V5, P7, DOI 10.1517/14712598.5.1.7; Kikuchi T, 2000, BLOOD, V96, P91, DOI 10.1182/blood.V96.1.91.013k19_91_99; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Mazzolini G, 2005, J CLIN ONCOL, V23, P999, DOI 10.1200/JCO.2005.00.463; Melero I, 1999, GENE THER, V6, P1779, DOI 10.1038/sj.gt.3301010; Melero I, 2006, CLIN CANCER RES, V12, P2385, DOI 10.1158/1078-0432.CCR-06-0314; Melero I, 2000, GENE THER, V7, P1167, DOI 10.1038/sj.gt.3301234; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Meyer TPH, 2005, J IMMUNOL METHODS, V307, P150, DOI 10.1016/j.jim.2005.10.004; Miller PW, 2000, HUM GENE THER, V11, P53, DOI 10.1089/10430340050016157; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Nishioka Y, 1999, CANCER RES, V59, P4035; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rolny C, 2008, J EXP MED, V205, P1155, DOI 10.1084/jem.20072509; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Schraufstatter IU, 2003, J IMMUNOL, V171, P6714, DOI 10.4049/jimmunol.171.12.6714; Sozzani S, 1997, J IMMUNOL, V159, P1993; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; SUAREZ N, INT J CANC; Tirapu I, 2006, CANCER RES, V66, P2442, DOI 10.1158/0008-5472.CAN-05-1681; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093; Triozzi PL, 2000, CANCER-AM CANCER SOC, V89, P2646, DOI 10.1002/1097-0142(20001215)89:12<2646::AID-CNCR18>3.0.CO;2-A; UEDA T, 1994, J GASTROENTEROL, V29, P423, DOI 10.1007/BF02361238; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Verdijk P, 2008, EXPERT OPIN BIOL TH, V8, P865, DOI [10.1517/14712598.8.7.865, 10.1517/14712598.8.7.865 ]; Verdijk P, 2009, CLIN CANCER RES, V15, P2531, DOI 10.1158/1078-0432.CCR-08-2729; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	56	28	31	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17922	10.1371/journal.pone.0017922	http://dx.doi.org/10.1371/journal.pone.0017922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423807	Green Submitted, gold, Green Published			2022-12-25	WOS:000288512400040
J	Fairhurst, GD; Frey, MD; Reichert, JF; Szelest, I; Kelly, DM; Bortolotti, GR				Fairhurst, Graham D.; Frey, Matthew D.; Reichert, James F.; Szelest, Izabela; Kelly, Debbie M.; Bortolotti, Gary R.			Does Environmental Enrichment Reduce Stress? An Integrated Measure of Corticosterone from Feathers Provides a Novel Perspective	PLOS ONE			English	Article							FURNISHED CAGES; IMMUNE FUNCTION; BODY CONDITION; BATTERY CAGES; EXPLORATION; RESPONSES; BEHAVIOR; WELFARE; NEOPHOBIA; PARAMETERS	Enrichment is widely used as tool for managing fearfulness, undesirable behaviors, and stress in captive animals, and for studying exploration and personality. Inconsistencies in previous studies of physiological and behavioral responses to enrichment led us to hypothesize that enrichment and its removal are stressful environmental changes to which the hormone corticosterone and fearfulness, activity, and exploration behaviors ought to be sensitive. We conducted two experiments with a captive population of wild-caught Clark's nutcrackers (Nucifraga columbiana) to assess responses to short- (10-d) and long-term (3-mo) enrichment, their removal, and the influence of novelty, within the same animal. Variation in an integrated measure of corticosterone from feathers, combined with video recordings of behaviors, suggests that how individuals perceive enrichment and its removal depends on the duration of exposure. Short- and long-term enrichment elicited different physiological responses, with the former acting as a stressor and birds exhibiting acclimation to the latter. Non-novel enrichment evoked the strongest corticosterone responses of all the treatments, suggesting that the second exposure to the same objects acted as a physiological cue, and that acclimation was overridden by negative past experience. Birds showed weak behavioral responses that were not related to corticosterone. By demonstrating that an integrated measure of glucocorticoid physiology varies significantly with changes to enrichment in the absence of agonistic interactions, our study sheds light on potential mechanisms driving physiological and behavioral responses to environmental change.	[Fairhurst, Graham D.; Frey, Matthew D.; Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Reichert, James F.; Szelest, Izabela; Kelly, Debbie M.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Fairhurst, GD (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	graham.fairhurst@usask.ca	Fairhurst, Graham/ABB-1218-2020; Fairhurst, Graham/E-1639-2011	Fairhurst, Graham/0000-0001-8731-1298	Natural Sciences and Engineering Research Council of Canada [312379-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by Natural Sciences and Engineering Research Council of Canada grant #312379-2009 (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Balcombe JP, 2006, LAB ANIM-UK, V40, P217, DOI 10.1258/002367706777611488; Barnett JL, 2009, POULTRY SCI, V88, P456, DOI 10.3382/ps.2008-00168; Bateson M, 2007, ANIM WELFARE, V16, P33; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Boinski S, 1999, AM J PRIMATOL, V48, P49, DOI 10.1002/(SICI)1098-2345(1999)48:1<49::AID-AJP4>3.3.CO;2-Y; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bolhuis JE, 2005, APPL ANIM BEHAV SCI, V93, P213, DOI 10.1016/j.applanim.2005.01.006; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2010, ECOL APPL, V20, P1766, DOI 10.1890/09-1473.1; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Bortolotti GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004983; Bosson CO, 2009, PHYSIOL BIOCHEM ZOOL, V82, P291, DOI 10.1086/597530; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Carlsson HE, 2007, RES VET SCI, V82, P423, DOI 10.1016/j.rvsc.2006.09.005; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Cockrem JF, 2002, GEN COMP ENDOCR, V125, P248, DOI 10.1006/gcen.2001.7749; Cornelius JM, 2010, P ROY SOC B-BIOL SCI, V277, P2399, DOI 10.1098/rspb.2010.0164; Cummings D, 2007, ZOO BIOL, V26, P331, DOI 10.1002/zoo.20138; de Azevedo CS, 2007, APPL ANIM BEHAV SCI, V102, P329, DOI 10.1016/j.applanim.2006.05.034; deMonte M, 1997, ANIM WELFARE, V6, P53; DOBRAKOVOVA M, 1993, PSYCHONEUROENDOCRINO, V18, P163, DOI 10.1016/0306-4530(93)90001-2; DOBSON H, 1995, J REPROD FERTIL, P451; DYBKJAER L, 1992, APPL ANIM BEHAV SCI, V35, P135, DOI 10.1016/0168-1591(92)90004-U; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Fox RA, 2004, APPL ANIM BEHAV SCI, V89, P117, DOI 10.1016/j.applanim.2004.05.002; Fox RA, 2007, APPL ANIM BEHAV SCI, V104, P107, DOI 10.1016/j.applanim.2006.04.033; Fox RA, 2009, ANIM BEHAV, V77, P1441, DOI 10.1016/j.anbehav.2009.02.022; Gagliano H, 2008, BEHAV BRAIN RES, V187, P239, DOI 10.1016/j.bbr.2007.09.006; Gardner JM, 2001, APPL ANIM BEHAV SCI, V74, P135, DOI 10.1016/S0168-1591(01)00158-7; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Harms NJ, 2010, ENVIRON POLLUT, V158, P841, DOI 10.1016/j.envpol.2009.09.025; Hemsworth PH, 2003, APPL ANIM BEHAV SCI, V81, P185, DOI 10.1016/S0168-1591(02)00280-0; Ishiwata T, 2006, ANIM SCI J, V77, P352, DOI 10.1111/j.1740-0929.2006.00359.x; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Kells A, 2001, ANIM WELFARE, V10, P347; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Lutz CK, 2005, ILAR J, V46, P178, DOI 10.1093/ilar.46.2.178; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Meehan CL, 2002, APPL ANIM BEHAV SCI, V79, P75, DOI 10.1016/S0168-1591(02)00118-1; Menargues A, 2008, ANIM WELFARE, V17, P305; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mettke-Hofmann C, 2006, J ZOOL, V268, P405, DOI 10.1111/j.1469-7998.2005.00037.x; Mettke-Hofmann C, 2005, BEHAV ECOL, V16, P247, DOI 10.1093/beheco/arh159; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Mettke-Hofmann C, 2007, ETHOLOGY, V113, P174, DOI 10.1111/j.1439-0310.2006.01307.x; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Pohle K, 2009, POULTRY SCI, V88, P2042, DOI 10.3382/ps.2009-00171; Pohle K, 2009, POULTRY SCI, V88, P1559, DOI 10.3382/ps.2009-00045; Renner M.J., 1987, ENRICHED IMPOVERISHE; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Rushen J, 2000, BIOLOGY OF ANIMAL STRESS, P23, DOI 10.1079/9780851993591.0023; Sabbatini G, 2007, AM J PRIMATOL, V69, P457, DOI 10.1002/ajp.20365; Saino N, 2003, BEHAV ECOL, V14, P318, DOI 10.1093/beheco/14.3.318; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Staley AM, 2007, J COMP PHYSIOL B, V177, P609, DOI 10.1007/s00360-007-0159-2; Tomback Diana F., 1998, Birds of North America, V331, P1; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Veissier I, 1997, J ANIM SCI, V75, P356; Wasser SK, 2005, ANN NY ACAD SCI, V1046, P109, DOI 10.1196/annals.1343.010; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wayland M, 2002, ENVIRON RES, V90, P47, DOI 10.1006/enrs.2002.4384; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; Wingfield John C., 1999, P1; Wolfle TL, 2000, BIOLOGY OF ANIMAL STRESS, P355, DOI 10.1079/9780851993591.0355; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046	77	57	59	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17663	10.1371/journal.pone.0017663	http://dx.doi.org/10.1371/journal.pone.0017663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412426	gold, Green Published, Green Submitted			2022-12-25	WOS:000288247800022
J	Knower, KC; Kelly, S; Ludbrook, LM; Bagheri-Fam, S; Sim, H; Bernard, P; Sekido, R; Lovell-Badge, R; Harley, VR				Knower, Kevin C.; Kelly, Sabine; Ludbrook, Louisa M.; Bagheri-Fam, Stefan; Sim, Helena; Bernard, Pascal; Sekido, Ryohei; Lovell-Badge, Robin; Harley, Vincent R.			Failure of SOX9 Regulation in 46XY Disorders of Sex Development with SRY, SOX9 and SF1 Mutations	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; CAMPOMELIC DYSPLASIA; GONADAL-DYSGENESIS; MISSENSE MUTATIONS; DETERMINING REGION; TESTIS DEVELOPMENT; DETERMINING GENES; DNA-BINDING; BOX REGION; CELL LINE	Background: In human embryogenesis, loss of SRY (sex determining region on Y), SOX9 (SRY-related HMG box 9) or SF1 (steroidogenic factor 1) function causes disorders of sex development (DSD). A defining event of vertebrate sex determination is male-specific upregulation and maintenance of SOX9 expression in gonadal pre-Sertoli cells, which is preceded by transient SRY expression in mammals. In mice, Sox9 regulation is under the transcriptional control of SRY, SF1 and SOX9 via a conserved testis-specific enhancer of Sox9 (TES). Regulation of SOX9 in human sex determination is however poorly understood. Methodology/Principal Findings: We show that a human embryonal carcinoma cell line (NT2/D1) can model events in presumptive Sertoli cells that initiate human sex determination. SRY associates with transcriptionally active chromatin in NT2/D1 cells and over-expression increases endogenous SOX9 expression. SRY and SF1 co-operate to activate the human SOX9 homologous TES (hTES), a process dependent on phosphorylated SF1. SOX9 also activates hTES, augmented by SF1, suggesting a mechanism for maintenance of SOX9 expression by auto-regulation. Analysis of mutant SRY, SF1 and SOX9 proteins encoded by thirteen separate 46, XY DSD gonadal dysgenesis individuals reveals a reduced ability to activate hTES. Conclusions/Significance: We demonstrate how three human sex-determining factors are likely to function during gonadal development around SOX9 as a hub gene, with different genetic causes of 46, XY DSD due a common failure to upregulate SOX9 transcription.	[Knower, Kevin C.; Kelly, Sabine; Ludbrook, Louisa M.; Bagheri-Fam, Stefan; Sim, Helena; Bernard, Pascal; Harley, Vincent R.] Prince Henrys Inst, Melbourne, Vic, Australia; [Bagheri-Fam, Stefan] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Harley, Vincent R.] Monash Univ, Dept Mol Biol & Biochem, Melbourne, Vic 3004, Australia; [Sekido, Ryohei; Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Dev Genet, Ridgeway, London, England	Prince Henry's Institute of Medical Research; Monash University; Monash University	Knower, KC (corresponding author), Prince Henrys Inst, Melbourne, Vic, Australia.	vincent.harley@princehenrys.org	Knower, Kevin/C-2869-2014; Harley, Vincent/B-8092-2018; Bernard, Pascal/G-7615-2011	Harley, Vincent/0000-0002-2405-1262; Lovell-Badge, Robin/0000-0001-9364-4179; Sekido, Ryohei/0000-0003-2364-1882	National Health and Medical Research Council of Australia (NHMRC) [334314, 546517]; Victorian Government; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Program Grant number 334314 (2004-2009) and number 546517 (2010-2014); and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Albrecht KH, 2003, GENETICS, V164, P277; Assumpcao JG, 2002, J MOL MED, V80, P782, DOI 10.1007/s00109-002-0376-9; Bagheri-Fam S, 2010, INT J BIOCHEM CELL B, V42, P472, DOI 10.1016/j.biocel.2009.07.001; BARBOSA AS, 1995, HUM GENET, V95, P63; Benasayag S, 2001, J PEDIATR ENDOCR MET, V14, P797; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bernard P, 2008, INT J BIOCHEM CELL B, V40, P2889, DOI 10.1016/j.biocel.2008.06.006; Bilbao JR, 1996, HUM GENET, V97, P537, DOI 10.1007/s004390050088; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; Burgoyne PS, 2001, INT J DEV BIOL, V45, P509; Cameron FJ, 1997, HUM MUTAT, V9, P388; Canto P, 2000, J CLIN ENDOCR METAB, V85, P1908, DOI 10.1210/jc.85.5.1908; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; COHEN DR, 1994, P NATL ACAD SCI USA, V91, P4372, DOI 10.1073/pnas.91.10.4372; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; Crawford PA, 1997, MOL ENDOCRINOL, V11, P1626, DOI 10.1210/me.11.11.1626; Desclozeaux M, 1998, J BIOL CHEM, V273, P7988, DOI 10.1074/jbc.273.14.7988; Domenice S, 1998, HUM GENET, V102, P213, DOI 10.1007/s004390050680; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRIEDMAN AD, 1988, NATURE, V335, P452, DOI 10.1038/335452a0; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hageman RM, 1998, HUM MUTAT, pS112; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hanley NA, 2000, MECH DEVELOP, V91, P403, DOI 10.1016/S0925-4773(99)00307-X; HARLEY VR, 2003, P NATL ACAD SCI US; Hines RS, 1997, FERTIL STERIL, V67, P675, DOI 10.1016/S0015-0282(97)81365-9; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA., 2006, J PEDIATR UROL, V2, P148, DOI [DOI 10.1016/J.JPUROL.2006.03.004, 10.1101/gr.247007.118]; Ito M, 2000, J BIOL CHEM, V275, P31708, DOI 10.1074/jbc.M002892200; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Knower KC, 2007, SEX DEV, V1, P114, DOI 10.1159/000100033; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lau YFC, 2009, J GENET GENOMICS, V36, P193, DOI 10.1016/S1673-8527(08)60107-1; Lee CH, 2001, GENESIS, V30, P7, DOI 10.1002/gene.1026; LI B, 2001, J BIOL CHEM; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; LOVELLBADGE R, 1993, PHILOS T R SOC B, V339, P159, DOI 10.1098/rstb.1993.0012; Matoba S, 2005, J CELL SCI, V118, P1449, DOI 10.1242/jcs.01738; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; McElreavey K, 1999, AM J MED GENET, V89, P176, DOI 10.1002/(SICI)1096-8628(19991229)89:4<176::AID-AJMG2>3.0.CO;2-B; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Moreno-Mendoza N, 1999, J EXP ZOOL, V284, P705, DOI 10.1002/(SICI)1097-010X(19991101)284:6<705::AID-JEZ12>3.0.CO;2-1; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; Polanco JC, 2009, BIOL CELL, V101, P55, DOI 10.1042/BC20080061; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Preiss S, 2001, J BIOL CHEM, V276, P27864, DOI 10.1074/jbc.M101278200; Refai O, 2010, AM J MED GENET A, V152A, P422, DOI 10.1002/ajmg.a.33201; ROSSI P, 1993, MOL REPROD DEV, V34, P369, DOI 10.1002/mrd.1080340404; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmahl J, 2000, DEVELOPMENT, V127, P65; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tremblay JJ, 2003, J BIOL CHEM, V278, P42637, DOI 10.1074/jbc.M305485200; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Western PS, 1999, DEV DYNAM, V214, P171, DOI 10.1002/(SICI)1097-0177(199903)214:3<171::AID-AJA1>3.0.CO;2-S; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0	77	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17751	10.1371/journal.pone.0017751	http://dx.doi.org/10.1371/journal.pone.0017751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412441	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800029
J	Gaudeul, M; Giraud, T; Kiss, L; Shykoff, JA				Gaudeul, Myriam; Giraud, Tatiana; Kiss, Levente; Shykoff, Jacqui A.			Nuclear and Chloroplast Microsatellites Show Multiple Introductions in the Worldwide Invasion History of Common Ragweed, Ambrosia artemisiifolia	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-STRUCTURE; ADAPTIVE EVOLUTION; INFERENCE; DIFFERENTIATION; DISPERSAL; DIVERSITY; INCREASES; PROGRAM; WEEDS	Background: Ambrosia artemisiifolia is a North American native that has become one of the most problematic invasive plants in Europe and Asia. We studied its worldwide population genetic structure, using both nuclear and chloroplast microsatellite markers and an unprecedented large population sampling. Our goals were (i) to identify the sources of the invasive populations; (ii) to assess whether all invasive populations were founded by multiple introductions, as previously found in France; (iii) to examine how the introductions have affected the amount and structure of genetic variation in Europe; (iv) to document how the colonization of Europe proceeded; (v) to check whether populations exhibit significant heterozygote deficiencies, as previously observed. Principal Findings: We found evidence for multiple introductions of A. artemisiifolia, within regions but also within populations in most parts of its invasive range, leading to high levels of diversity. In Europe, introductions probably stem from two different regions of the native area: populations established in Central Europe appear to have originated from eastern North America, and Eastern European populations from more western North America. This may result from differential commercial exchanges between these geographic regions. Our results indicate that the expansion in Europe mostly occurred through long-distance dispersal, explaining the absence of isolation by distance and the weak influence of geography on the genetic structure in this area in contrast to the native range. Last, we detected significant heterozygote deficiencies in most populations. This may be explained by partial selfing, biparental inbreeding and/or a Wahlund effect and further investigation is warranted. Conclusions: This insight into the sources and pathways of common ragweed expansion may help to better understand its invasion success and provides baseline data for future studies on the evolutionary processes involved during range expansion in novel environments.	[Gaudeul, Myriam] Museum Natl Hist Nat, UMR CNRS Origine Struct & Evolut Biodiversite 720, F-75231 Paris, France; [Giraud, Tatiana; Shykoff, Jacqui A.] Univ Paris 11, UMR CNRS Ecol Systemat & Evolut 8079, Orsay, France; [Kiss, Levente] Hungarian Acad Sci, Dept Plant Pathol, Inst Plant Protect, Budapest, Hungary	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Saclay; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Gaudeul, M (corresponding author), Museum Natl Hist Nat, UMR CNRS Origine Struct & Evolut Biodiversite 720, F-75231 Paris, France.	gaudeul@mnhn.fr	Kiss, Levente/Q-3786-2018	Kiss, Levente/0000-0002-4785-4308; Giraud, Tatiana/0000-0002-2685-6478	Museum National d'Histoire Naturelle (Paris, France); Universite Paris-Sud (Orsay, France); Plant Protection Institute of the Hungarian Academy of Sciences (Budapest, Hungary);  [ANR 07-BDIV-003]	Museum National d'Histoire Naturelle (Paris, France); Universite Paris-Sud (Orsay, France); Plant Protection Institute of the Hungarian Academy of Sciences (Budapest, Hungary); 	This work was funded by the Museum National d'Histoire Naturelle (Paris, France), the Universite Paris-Sud (Orsay, France) and the Plant Protection Institute of the Hungarian Academy of Sciences (Budapest, Hungary). TG acknowledges the grant ANR 07-BDIV-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie LG, 2009, MOL ECOL RESOUR, V9, P1375, DOI 10.1111/j.1755-0998.2009.02746.x; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett S.C.H., 1986, P21; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Bass DJ, 2000, AEROBIOLOGIA, V16, P107, DOI DOI 10.1023/A:1007696112953; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; BOHREN C, 2008, AMBROSIA ARTEMISIIFO; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bryan GJ, 1999, THEOR APPL GENET, V99, P859, DOI 10.1007/s001220051306; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Chen H, 2007, LECT NOTES GEOINF CA, P105, DOI 10.1007/978-3-540-71318-0_8; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; CORNUET JM, 1996, GENETICS, V163; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; ElMousadik A, 1996, MOL ECOL, V5, P547, DOI 10.1046/j.1365-294X.1996.00123.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Falush D, 2003, GENETICS, V164, P1567; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; Fumanal B, 2007, ANN BOT-LONDON, V100, P305, DOI 10.1093/aob/mcm108; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Genton BJ, 2005, OECOLOGIA, V146, P404, DOI 10.1007/s00442-005-0234-x; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Hufbauer RA, 2008, DIVERS DISTRIB, V14, P252, DOI 10.1111/j.1472-4642.2007.00424.x; Jahodova S, 2007, DIVERS DISTRIB, V13, P99, DOI 10.1111/j.1366-9516.2006.00305.x; Jakobsson M, 2007, THEOR APPL GENET, V114, P223, DOI 10.1007/s00122-006-0425-9; JONES KL, 1936, L AM MIDL NAT, V17, P673; Kang M, 2007, MOL ECOL, V16, P4662, DOI 10.1111/j.1365-294X.2007.03536.x; Kiss L, 2006, J BIOGEOGR, V33, P2156, DOI 10.1111/j.1365-2699.2006.01633.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEWIS AJ, 1973, B TORREY BOT CLUB, V100, P333, DOI 10.2307/2484099; LI XM, 2009, INT C BIOL INV ICBI; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; Martin MD, 2009, AM J BOT, V96, P1703, DOI 10.3732/ajb.0800407; MCFADYEN R, 2008, 1 INT RAGW C 10 13 S; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Olivieri I, 2009, TRENDS ECOL EVOL, V24, P289, DOI 10.1016/j.tree.2009.01.015; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pons O, 1996, GENETICS, V144, P1237; Prentis PJ, 2009, DIVERS DISTRIB, V15, P822, DOI 10.1111/j.1472-4642.2009.00592.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Protopopova VV, 2006, EUPHYTICA, V148, P17, DOI 10.1007/s10681-006-5938-4; Pysek Petr, 2003, Biological Invasions, V5, P337, DOI 10.1023/B:BINV.0000005572.47560.1c; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REZNIK S, 2008, 1 INT RAGW C 10 13 S; Rohlf F.J., 1993, NTSYS PC; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SHIN HD, 2008, 1 INT RAGW C 10 13 S; SKJOTH CA, 2009, EARTH ENV SCI, V6; Taramarcaz P, 2005, SWISS MED WKLY, V135, P538; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Thuillet AC, 2002, MOL BIOL EVOL, V19, P122, DOI 10.1093/oxfordjournals.molbev.a003977; Torok K., 2003, Biological Invasions, V5, P349, DOI 10.1023/B:BINV.0000005570.19429.73; Valliant MT, 2007, AM J BOT, V94, P1156, DOI 10.3732/ajb.94.7.1156; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	73	83	83	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17658	10.1371/journal.pone.0017658	http://dx.doi.org/10.1371/journal.pone.0017658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423697	Green Published, Green Accepted, gold			2022-12-25	WOS:000288219100021
J	Hakansson, AP; Roche-Hakansson, H; Mossberg, AK; Svanborg, C				Hakansson, Anders P.; Roche-Hakansson, Hazeline; Mossberg, Ann-Kristin; Svanborg, Catharina			Apoptosis-Like Death in Bacteria Induced by HAMLET, a Human Milk Lipid-Protein Complex	PLOS ONE			English	Article							PNEUMOCOCCAL SURFACE PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION; PHARYNGEAL EPITHELIAL-CELLS; HUMAN ALPHA-LACTALBUMIN; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; CALCIUM REGULATION; ELICIT PROTECTION; FOLDING VARIANT; TRANSFORMATION	Background: Apoptosis is the primary means for eliminating unwanted cells in multicellular organisms in order to preserve tissue homeostasis and function. It is characterized by distinct changes in the morphology of the dying cell that are orchestrated by a series of discrete biochemical events. Although there is evidence of primitive forms of programmed cell death also in prokaryotes, no information is available to suggest that prokaryotic death displays mechanistic similarities to the highly regulated programmed death of eukaryotic cells. In this study we compared the characteristics of tumor and bacterial cell death induced by HAMLET, a human milk complex of alpha-lactalbumin and oleic acid. Methodology/Principal Findings: We show that HAMLET-treated bacteria undergo cell death with mechanistic and morphologic similarities to apoptotic death of tumor cells. In Jurkat cells and Streptococcus pneumoniae death was accompanied by apoptosis-like morphology such as cell shrinkage, DNA condensation, and DNA degradation into high molecular weight fragments of similar sizes, detected by field inverse gel electrophoresis. HAMLET was internalized into tumor cells and associated with mitochondria, causing a rapid depolarization of the mitochondrial membrane and bound to and induced depolarization of the pneumococcal membrane with similar kinetic and magnitude as in mitochondria. Membrane depolarization in both systems required calcium transport, and both tumor cells and bacteria were found to require serine protease activity (but not caspase activity) to execute cell death. Conclusions/Significance: Our results suggest that many of the morphological changes and biochemical responses associated with apoptosis are present in prokaryotes. Identifying the mechanisms of bacterial cell death has the potential to reveal novel targets for future antimicrobial therapy and to further our understanding of core activation mechanisms of cell death in eukaryote cells.	[Hakansson, Anders P.; Roche-Hakansson, Hazeline] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA; [Mossberg, Ann-Kristin; Svanborg, Catharina] Lund Univ, Sect Microbiol Immunol & Glycobiol MIG, Dept Lab Med, Lund, Sweden; [Svanborg, Catharina] ASTAR, Singapore Immunol Network, Singapore, Singapore	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Hakansson, AP (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	andersh@buffalo.edu	Hakansson, Anders/H-8190-2014; Hakansson, Anders P/AAX-1225-2020	Hakansson, Anders/0000-0002-2834-6009; Hakansson, Anders P/0000-0002-2834-6009	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; Royal Physiographic Society, Lund, Sweden; Swedish Society for Medical Research, Stockholm, Sweden; John and Augusta Perssons Foundation for Scientific Medical Research, Lund, Sweden; Anna-Lisa and Sven-Eric Lundgrens Foundation for Medical Research, Malmo, Sweden; Gunnar, Arvid and Elisabeth Nilssons Foundation for Fighting Cancer, Helsingborg, Sweden; Maggie Stephen's Foundation, Lund, Sweden; Swedish Cancer Foundation [3807-B97-01XAB, 96-1719]; American Cancer Society [RPG 97-157-01]; Swedish Heart and Lung Foundation; American Lung Association [RG-123721-N]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; Royal Physiographic Society, Lund, Sweden; Swedish Society for Medical Research, Stockholm, Sweden; John and Augusta Perssons Foundation for Scientific Medical Research, Lund, Sweden; Anna-Lisa and Sven-Eric Lundgrens Foundation for Medical Research, Malmo, Sweden; Gunnar, Arvid and Elisabeth Nilssons Foundation for Fighting Cancer, Helsingborg, Sweden; Maggie Stephen's Foundation, Lund, Sweden; Swedish Cancer Foundation; American Cancer Society(American Cancer Society); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); American Lung Association	This study was supported by grants from Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/, Grant 53085; AH), the JR Oishei Foundation (http://www.oisheifdt.org/, AH), The Royal Physiographic Society, Lund, Sweden (http://www.fysiografen.se/AH), The Swedish Society for Medical Research, Stockholm, Sweden (http://www.ssmf.se/AH), John and Augusta Perssons Foundation for Scientific Medical Research, Lund, Sweden (AH), Anna-Lisa and Sven-Eric Lundgrens Foundation for Medical Research, Malmo, Sweden (AH), Gunnar, Arvid and Elisabeth Nilssons Foundation for Fighting Cancer, Helsingborg, Sweden (AH), Maggie Stephen's Foundation, Lund, Sweden (AH), The Swedish Cancer Foundation (http://www.cancerfonden.se/ Grants no. 3807-B97-01XAB and 96-1719, CS), The American Cancer Society (http://www.cancer.org/ Grant no. RPG 97-157-01, CS), The Swedish Heart and Lung Foundation (http://www.hjart-lungfonden.se/ CS) and the American Lung Association (Grant RG-123721-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HE, 1951, J EXP MED, V93, P345, DOI 10.1084/jem.93.4.345; Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; ANDERSSON B, 1981, INFECT IMMUN, V32, P311, DOI 10.1128/IAI.32.1.311-317.1981; ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Ankarcrona M, 1996, NEUROREPORT, V7, P2659, DOI 10.1097/00001756-199611040-00050; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Davis MK, 1998, INT J CANCER, V78, P29; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Giorgi C, 2008, CURR MOL MED, V8, P119; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson A, 2001, INFECT IMMUN, V69, P3372, DOI 10.1128/IAI.69.5.3372-3381.2001; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; HEINE WE, 1991, J NUTR, V121, P277, DOI 10.1093/jn/121.3.277; JORGENSEN JH, 1992, J CLIN MICROBIOL, V30, P961, DOI 10.1128/JCM.30.4.961-966.1992; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; LINDAHL L, 1984, ANAL BIOCHEM, V140, P394, DOI 10.1016/0003-2697(84)90184-2; Lysenko E, 2000, MOL MICROBIOL, V35, P234, DOI 10.1046/j.1365-2958.2000.01707.x; MAJNO G, 1995, AM J PATHOL, V146, P3; MCDANIEL LS, 1992, MICROB PATHOGENESIS, V13, P261, DOI 10.1016/0882-4010(92)90036-N; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; PUYET A, 1990, J MOL BIOL, V213, P727, DOI 10.1016/S0022-2836(05)80259-1; PUYET A, 1989, J BACTERIOL, V171, P2278, DOI 10.1128/jb.171.5.2278-2286.1989; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; Smith AW, 2002, MOL MICROBIOL, V44, P431, DOI 10.1046/j.1365-2958.2002.02883.x; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TOMASZ A, 1988, J BACTERIOL, V170, P5931, DOI 10.1128/jb.170.12.5931-5934.1988; TROMBE MC, 1993, J GEN MICROBIOL, V139, P433, DOI 10.1099/00221287-139-3-433; TROMBE MC, 1992, J GEN MICROBIOL, V138, P77, DOI 10.1099/00221287-138-1-77; YOTHER J, 1992, J BACTERIOL, V174, P610, DOI 10.1128/jb.174.2.610-618.1992; YOTHER J, 1986, J BACTERIOL, V168, P1463, DOI 10.1128/jb.168.3.1463-1465.1986	60	83	85	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17717	10.1371/journal.pone.0017717	http://dx.doi.org/10.1371/journal.pone.0017717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423701	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100028
J	Grabowski, TB; Thorsteinsson, V; McAdam, BJ; Marteinsdottir, G				Grabowski, Timothy B.; Thorsteinsson, Vilhjalmur; McAdam, Bruce J.; Marteinsdottir, Gudrun			Evidence of Segregated Spawning in a Single Marine Fish Stock: Sympatric Divergence of Ecotypes in Icelandic Cod?	PLOS ONE			English	Article							GADUS-MORHUA L.; NORTH-SEA COD; ATLANTIC COD; LIFE-HISTORY; POPULATION-STRUCTURE; MIGRATORY BEHAVIOR; SPATIAL VARIATION; COASTAL COD; FISHERIES; PATTERNS	There is increasing recognition of intraspecific diversity and population structure within marine fish species, yet there is little direct evidence of the isolating mechanisms that maintain it or documentation of its ecological extent. We analyzed depth and temperature histories collected by electronic data storage tags retrieved from 104 Atlantic cod at liberty >= 1 year to evaluate a possible isolating mechanisms maintaining population structure within the Icelandic cod stock. This stock consists of two distinct behavioral types, resident coastal cod and migratory frontal cod, each occurring within two geographically distinct populations. Despite being captured together on the same spawning grounds, we show the behavioral types seem reproductively isolated by fine-scale differences in spawning habitat selection, primarily depth. Additionally, the different groups occupied distinct seasonal thermal and bathymetric niches that generally demonstrated low levels of overlap throughout the year. Our results indicate that isolating mechanisms, such as differential habitat selection during spawning, might contribute to maintaining diversity and fine-scale population structure in broadcast-spawning marine fishes.	[Grabowski, Timothy B.; McAdam, Bruce J.; Marteinsdottir, Gudrun] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Grabowski, Timothy B.] Texas Tech Univ, US Geol Survey, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Thorsteinsson, Vilhjalmur] Marine Res Inst Hafrannsoknastofnunin, Reykjavik, Iceland	University of Iceland; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Marine & Freshwater Research Institute (MFRI)	Grabowski, TB (corresponding author), Univ Iceland, Inst Biol, Reykjavik, Iceland.	t.grabowski@ttu.edu		Grabowski, Timothy/0000-0001-9763-8948; Marteinsdottir, Gudrun/0000-0001-6939-2434	Marine Research Institute, Iceland; University of Iceland; EU [Q5RS-2002-00813, Q5RS-2001-00953]; Icelandic Research Fund [070019023]; Icelandic Ministry of Fisheries and Agriculture	Marine Research Institute, Iceland; University of Iceland; EU(European Commission); Icelandic Research Fund; Icelandic Ministry of Fisheries and Agriculture	Funding for this project was provided by the Marine Research Institute, Iceland; the University of Iceland Research Fund; the EU projects "CODYSSEY" (Q5RS-2002-00813; 2003-2006) and "METACOD" (Q5RS-2001-00953; 2002-2005); the Icelandic Research Fund (070019023); and the Fisheries Project Fund of the Icelandic Ministry of Fisheries and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005529; Begg GA, 2002, MAR ECOL PROG SER, V229, P263, DOI 10.3354/meps229263; BRANDER K, 2005, 274 ICES COOP RES RE; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P177, DOI 10.1163/156853961X00114; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P107, DOI 10.1163/156853961X00295; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Fudge SB, 2009, ICES J MAR SCI, V66, P1259, DOI 10.1093/icesjms/fsp097; Grabowski TB, 2009, ENVIRON BIOL FISH, V86, P361, DOI 10.1007/s10641-009-9534-z; Harrald M, 2010, CAN J FISH AQUAT SCI, V67, P866, DOI 10.1139/F10-030; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hiddink JG, 2008, FISH RES, V90, P6, DOI 10.1016/j.fishres.2007.11.025; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V57, P1011; Hutchings JA, 2007, P ROY SOC B-BIOL SCI, V274, P1693, DOI 10.1098/rspb.2007.0263; Hutchinson WF, 2008, BIOL LETTERS, V4, P693, DOI 10.1098/rsbl.2008.0443; Jonsdottir IG, 2006, J FISH BIOL, V69, P136, DOI 10.1111/j.1095-8649.2006.01271.x; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; JONSSON E, 1982, RIT FISKIDEILDAR, V6; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kjesbu OS, 2010, CAN J FISH AQUAT SCI, V67, P605, DOI 10.1139/F10-011; Lawson GL, 2000, CAN J FISH AQUAT SCI, V57, P1011, DOI 10.1139/cjfas-57-5-1011; McIntyre TM, 2003, CAN J FISH AQUAT SCI, V60, P1111, DOI 10.1139/F03-090; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x; Nordeide JT, 1998, ICES J MAR SCI, V55, P134, DOI 10.1006/jmsc.1997.0261; Nordeide JT, 1998, SARSIA, V83, P373, DOI 10.1080/00364827.1998.10413696; Palsson OK, 2003, CAN J FISH AQUAT SCI, V60, P1409, DOI 10.1139/F03-117; Pampoulie C, 2008, BEHAV GENET, V38, P76, DOI 10.1007/s10519-007-9175-y; Pampoulie C, 2006, CAN J FISH AQUAT SCI, V63, P2660, DOI 10.1139/F06-150; Pardoe H, 2009, J FISH BIOL, V75, P282, DOI 10.1111/j.1095-8649.2009.02273.x; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Pogson GH, 2001, EVOLUTION, V55, P131, DOI 10.1111/j.0014-3820.2001.tb01279.x; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Righton D, 2001, NATURE, V411, P156, DOI 10.1038/35075667; Robichaud D, 2004, FISH FISH, V5, P185, DOI 10.1111/j.1467-2679.2004.00141.x; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; Ruzzante DE, 2000, J FISH BIOL, V56, P431, DOI 10.1111/j.1095-8649.2000.tb02116.x; Salvanes AGV, 2004, MAR ECOL PROG SER, V267, P241, DOI 10.3354/meps267241; Svedang H, 2006, J FISH BIOL, V69, P151, DOI 10.1111/j.1095-8649.2006.01272.x; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Syrjala SE, 1996, ECOLOGY, V77, P75, DOI 10.2307/2265656; THORSTEINSSON V, 1998, SIZE SPECIFIC TIME D; Westgaard JI, 2007, FISH RES, V85, P306, DOI 10.1016/j.fishres.2007.04.001; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x	46	54	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17528	10.1371/journal.pone.0017528	http://dx.doi.org/10.1371/journal.pone.0017528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408180	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800022
J	Lyman, SK; Crawley, SC; Gong, R; Adamkewicz, JI; McGrath, G; Chew, JY; Choi, J; Holst, CR; Goon, LH; Detmer, SA; Vaclavikova, J; Gerritsen, ME; Blake, RA				Lyman, Susan K.; Crawley, Suzanne C.; Gong, Ruoyu; Adamkewicz, Joanne I.; McGrath, Garth; Chew, Jason Y.; Choi, Jennifer; Holst, Charles R.; Goon, Leanne H.; Detmer, Scott A.; Vaclavikova, Jana; Gerritsen, Mary E.; Blake, Robert A.			High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888	PLOS ONE			English	Article							BREAST-CANCER CELLS; POLO-LIKE KINASE-1; SHOCK-PROTEIN 90; MITOTIC ENTRY; MUTANT P53; IN-VITRO; HEAT-SHOCK-PROTEIN-90 INHIBITOR; SPINDLE FORMATION; DOWN-REGULATION; P21 EXPRESSION	Background: Many proteins that are dysregulated or mutated in cancer cells rely on the molecular chaperone HSP90 for their proper folding and activity, which has led to considerable interest in HSP90 as a cancer drug target. The diverse array of HSP90 client proteins encompasses oncogenic drivers, cell cycle components, and a variety of regulatory factors, so inhibition of HSP90 perturbs multiple cellular processes, including mitogenic signaling and cell cycle control. Although many reports have investigated HSP90 inhibition in the context of the cell cycle, no large-scale studies have examined potential correlations between cell genotype and the cell cycle phenotypes of HSP90 inhibition. Methodology/Principal Findings: To address this question, we developed a novel high-content, high-throughput cell cycle assay and profiled the effects of two distinct small molecule HSP90 inhibitors (XL888 and 17-AAG [17-allylamino-17-demethoxygeldanamycin]) in a large, genetically diverse panel of cancer cell lines. The cell cycle phenotypes of both inhibitors were strikingly similar and fell into three classes: accumulation in M-phase, G2-phase, or G1-phase. Accumulation in M-phase was the most prominent phenotype and notably, was also correlated with TP53 mutant status. We additionally observed unexpected complexity in the response of the cell cycle-associated client PLK1 to HSP90 inhibition, and we suggest that inhibitor-induced PLK1 depletion may contribute to the striking metaphase arrest phenotype seen in many of the M-arrested cell lines. Conclusions/Significance: Our analysis of the cell cycle phenotypes induced by HSP90 inhibition in 25 cancer cell lines revealed that the phenotypic response was highly dependent on cellular genotype as well as on the concentration of HSP90 inhibitor and the time of treatment. M-phase arrest correlated with the presence of TP53 mutations, while G2 or G1 arrest was more commonly seen in cells bearing wt TP53. We draw upon previous literature to suggest an integrated model that accounts for these varying observations.	[Lyman, Susan K.; Crawley, Suzanne C.; Gong, Ruoyu; Adamkewicz, Joanne I.; McGrath, Garth; Chew, Jason Y.; Choi, Jennifer; Holst, Charles R.; Goon, Leanne H.; Detmer, Scott A.; Vaclavikova, Jana; Gerritsen, Mary E.; Blake, Robert A.] Exelixis Inc, Dept Mol & Cellular Pharmacol, San Francisco, CA USA; [Choi, Jennifer; Vaclavikova, Jana] Exelixis Inc, Dept Genome Biol, San Francisco, CA USA	Exelixis, Inc.; Exelixis, Inc.	Lyman, SK (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	xl888.mail@gmail.com		Holst, Charles/0000-0001-8010-1677; McGrath, Garth/0000-0002-4924-6269	Exelixis, Inc	Exelixis, Inc	This work (study design, data collection and analysis, manuscript preparation) was carried out at Exelixis, Inc. Permission to publish was granted by Exelixis, Inc.	Archambault V, 2008, MOL CELL, V30, P541, DOI 10.1016/j.molcel.2008.05.012; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Basto R, 2007, J CELL SCI, V120, P1278, DOI 10.1242/jcs.000604; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biamonte MA, 2010, J MED CHEM, V53, P3, DOI 10.1021/jm9004708; Borysov SI, 2008, MOL BIOL CELL, V19, P2907, DOI 10.1091/mbc.E07-07-0679; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Burrows F, 2004, CELL CYCLE, V3, P1530, DOI 10.4161/cc.3.12.1277; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Dai Chengkai, 2005, Future Oncol, V1, P529; Davies AE, 2010, J CELL BIOL, V189, P261, DOI 10.1083/jcb.200910036; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Georgakis GV, 2006, BRIT J HAEMATOL, V135, P68, DOI 10.1111/j.1365-2141.2006.06247.x; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hostein I, 2001, CANCER RES, V61, P4003; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Lesko E, 2007, ANTI-CANCER DRUG, V18, P1173, DOI 10.1097/CAD.0b013e3282ef532d; Lin K, 2008, ONCOGENE, V27, P2445, DOI 10.1038/sj.onc.1210893; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Moran DM, 2008, ONCOGENE, V27, P5567, DOI 10.1038/onc.2008.172; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller P, 2005, J BIOL CHEM, V280, P6682, DOI 10.1074/jbc.M412767200; Munster PN, 2001, CLIN CANCER RES, V7, P2228; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; OConnor PM, 1997, CANCER RES, V57, P4285; Okamoto J, 2008, J THORAC ONCOL, V3, P1089, DOI 10.1097/JTO.0b013e3181839693; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Rakitina TV, 2007, BIOCHEM PHARMACOL, V73, P1715, DOI 10.1016/j.bcp.2007.01.037; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Senju M, 2006, J CANCER RES CLIN, V132, P150, DOI 10.1007/s00432-005-0047-7; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Spankuch B, 2006, CANCER RES, V66, P5836, DOI 10.1158/0008-5472.CAN-06-0343; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sugimoto K, 2008, ONCOGENE, V27, P3091, DOI 10.1038/sj.onc.1210978; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tse AN, 2009, MOL PHARMACOL, V75, P124, DOI 10.1124/mol.108.050807; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wellcome Trust Sanger Institute, CAT SOM MUT CANC; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Workman P, 2007, NAT CHEM BIOL, V3, P455, DOI 10.1038/nchembio0807-455; Zajac M, 2008, MOL CANCER THER, V7, P2358, DOI 10.1158/1535-7163.MCT-08-0327; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	74	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17692	10.1371/journal.pone.0017692	http://dx.doi.org/10.1371/journal.pone.0017692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408192	Green Submitted, gold, Green Published			2022-12-25	WOS:000288099800033
J	Gibert, B; Hadchity, E; Czekalla, A; Aloy, MT; Colas, P; Rodriguez-Lafrasse, C; Arrigo, AP; Diaz-Latoud, C				Gibert, B.; Hadchity, E.; Czekalla, A.; Aloy, M-T; Colas, P.; Rodriguez-Lafrasse, C.; Arrigo, A-P; Diaz-Latoud, C.			Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers	ONCOGENE			English	Article						Hsp27; HspB1; peptide aptamers; proliferation; apoptosis; therapeutic target	INDUCED APOPTOSIS; TUMOR-CELLS; AKT ACTIVATION; CYTOCHROME-C; IN-VITRO; HSP27; CANCER; STRESS; ALPHA; OLIGOMERIZATION	Human heat shock protein 27 (Hsp27, HspB1) is an antiapoptotic protein characterized for its tumorigenic and metastatic properties, and now referenced as a major therapeutic target in many types of cancer. Hsp27 biochemical properties rely on a structural oligomeric and dynamic organization. Downregulation by small interfering RNA or inhibition with dominant-negative mutant have proven their efficiency to counteract the antiapoptotic and protective properties of Hsp27. In this study, we report the isolation and characterization of Hsp27-targeted molecules interfering with its structural organization. Using the peptide aptamer (PA) strategy, we isolated PAs that specifically interact with Hsp27 and not with the other members of the small heat shock protein family. In mammalian cell cultures, PAs expression perturbed the dimerization and oligomerization of Hsp27, and acted as negative regulators of the antiapoptotic and cytoprotective activities of this protein. Further studies analyzing SQ20B cell xenografts in immunocompromised mice showed that PAs strongly reduced tumor development through cell cycle arrest. Our data suggest that PAs could provide a potential tool to develop strategies for the discovery of Hsp27 chemical inhibitors. Oncogene (2011) 30, 3672-3681; doi:10.1038/onc.2011.73;published online 21 March 2011	[Gibert, B.; Czekalla, A.; Arrigo, A-P; Diaz-Latoud, C.] Univ Lyon 1, Ctr Genet Mol & Cellulaire, CNRS, UMR5534, F-69365 Lyon, France; [Hadchity, E.; Aloy, M-T; Rodriguez-Lafrasse, C.] Univ Lyon 1, Lab Radiobiol Cellulaire & Mol, EA 3738, Fac Med Lyon Sud, Oullins, France; [Colas, P.] CNRS, Biol Stn, USR 3151, Roscoff, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Diaz-Latoud, C (corresponding author), Univ Lyon 1, Ctr Genet Mol & Cellulaire, CNRS, UMR5534, 43,Bd 11 Novembre 1918, F-69365 Lyon, France.	chantal.diaz@univ-lyon1.fr	Rodriguez-Lafrasse, Claire/G-7741-2018	GIBERT, Benjamin/0000-0002-5295-3124; Colas, Pierre/0000-0001-7436-3718	Comite du Rhone of la Ligue Contre le Cancer; Region Rhone-Alpes and Retina France; La Region Rhone-Alpes	Comite du Rhone of la Ligue Contre le Cancer; Region Rhone-Alpes and Retina France(Region Auvergne-Rhone-Alpes); La Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	We wish to thank D Guillet for excellent technical assistance and Marc Bickle for helpful discussions. This work was supported by a research grant from the Comite du Rhone of la Ligue Contre le Cancer and the Region Rhone-Alpes and Retina France for APA. GB was supported by a PhD training grant from the La Region Rhone-Alpes.	Aloy MT, 2008, INT J RADIAT ONCOL, V70, P543, DOI 10.1016/j.ijrobp.2007.08.061; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Bickle MBT, 2006, NAT PROTOC, V1, P1066, DOI 10.1038/nprot.2006.32; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Buerger C, 2003, J BIOL CHEM, V278, P37610, DOI 10.1074/jbc.M301629200; Cervantes-Gomez F, 2009, CANCER RES, V69, P3947, DOI 10.1158/0008-5472.CAN-08-4406; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chattopadhyay A, 2006, ONCOGENE, V25, P2223, DOI 10.1038/sj.onc.1209252; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Diaz-Latoud C, 2005, ANTIOXID REDOX SIGN, V7, P436, DOI 10.1089/ars.2005.7.436; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Gonin S, 1999, ONCOGENE, V18, P8011, DOI 10.1038/sj.onc.1203319; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Hansen RK, 1999, BREAST CANCER RES TR, V56, P187; Javouhey E, 2008, VIROLOGY, V376, P31, DOI 10.1016/j.virol.2008.02.031; Kim EH, 2007, CANCER RES, V67, P6333, DOI 10.1158/0008-5472.CAN-06-4344; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Matsui Y, 2009, MOL CANCER THER, V8, P2402, DOI 10.1158/1535-7163.MCT-09-0148; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MEHLEN P, 1993, EUR J BIOCHEM, V215, P277, DOI 10.1111/j.1432-1033.1993.tb18032.x; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; Nouvion AL, 2007, ONCOGENE, V26, P701, DOI 10.1038/sj.onc.1209832; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090	35	67	69	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	34					3672	3681		10.1038/onc.2011.73	http://dx.doi.org/10.1038/onc.2011.73			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21423207				2022-12-25	WOS:000294244500003
J	Derichs, N; Jin, BJ; Song, YL; Finkbeiner, WE; Verkman, AS				Derichs, Nico; Jin, Byung-Ju; Song, Yuanlin; Finkbeiner, Walter E.; Verkman, A. S.			Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching	FASEB JOURNAL			English	Article						CFTR; mucins; diffusion; FRAP	SURFACE LIQUID; SUBMUCOSAL GLANDS; TRANSPORT; MUCINS; DEPTH; ION; PATHOGENESIS; SECRETIONS; EPITHELIUM; DIFFUSION	Airway surface liquid (ASL) volume depletion and mucus accumulation occur in cystic fibrosis (CF). The ASL comprises a superficial mucus layer (ML) overlying a periciliary fluid layer (PCL) that contacts surface epithelial cells. We measured viscosity of the ML and PCL from the diffusion of FITC-dextran dissolved in the ASL of unperturbed, well-differentiated primary cultures of human bronchial epithelia grown at an air-liquid interface. Diffusion was measured by fluorescence recovery after photobleaching, using a perfluorocarbon immersion lens and confocal fluorescence detection. Bleaching of an in-plane 6-mu m-wide region was done in which diffusion coefficients were computed using solution standards of specified viscosity and finite-element computations of 2-layer dye diffusion in 3 dimensions. We found remarkably elevated viscosity in both ML and PCL of CF vs. non-CF bronchial epithelial cell cultures. Relative viscosities (with saline = 1) were in the range 7-10 in the non-CF ML and PCL, and 25-30 in both ML and PCL in CF, and greatly reduced by amiloride treatment or mucin washout. These data indicate that the CF airway surface epithelium, even without hyperviscous secretions from submucosal glands, produces an intrinsically hyperviscous PCL and ML, which likely contributes to CF lung disease by impairment of mucociliary clearance. Our results challenge the view that the PCL is a relatively watery, nonviscous fluid layer in contact with a more viscous ML, and offer an explanation for CF lung disease in the gland-free lower airways.-Derichs, N., Jin, B. -J., Song, Y., Finkbeiner, W. E., Verkman, A. S. Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching. FASEB J. 25, 2325-2332 (2011). www.fasebj.org	[Derichs, Nico; Jin, Byung-Ju; Song, Yuanlin; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Derichs, Nico; Jin, Byung-Ju; Song, Yuanlin; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 HSE,Box 0521, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			U.S. National Institutes of Health [HL73856, DK72517, DK86125, DK35124, EB00415, EY13574]; Cystic Fibrosis Foundation; Cystic Fibrosis Research Inc.; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, RC1DK086125, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Research Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants HL73856, DK72517, DK86125, DK35124, EB00415, and EY13574 from the U.S. National Institutes of Health, and a Research Program Development grant from the Cystic Fibrosis Foundation. N.D. was supported in part by Cystic Fibrosis Research Inc.	Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Anderson Paula, 2010, Ther Adv Respir Dis, V4, P177, DOI 10.1177/1753465810371107; Blouquit-Laye S, 2007, RESP PHYSIOL NEUROBI, V159, P278, DOI 10.1016/j.resp.2007.03.007; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Donaldson Scott H, 2007, Proc Am Thorac Soc, V4, P399, DOI 10.1513/pats.200703-042BR; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Jiang C, 1997, J PHYSIOL-LONDON, V501, P637, DOI 10.1111/j.1469-7793.1997.637bm.x; Joo NS, 2009, AM J PHYSIOL-LUNG C, V296, pL811, DOI 10.1152/ajplung.90636.2008; Levin MH, 2006, J BIOL CHEM, V281, P25803, DOI 10.1074/jbc.M604332200; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9; ROSE MC, 1987, PEDIATR RES, V22, P545, DOI 10.1203/00006450-198711000-00015; RUBINSTEIN M, 2010, 24 AM CF C, V24; Salinas D, 2004, FASEB J, V18, P431, DOI 10.1096/fj.04-2879fje; Sheehan John K, 2006, Novartis Found Symp, V279, P155; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Tajima M, 2010, J BIOL CHEM, V285, P8163, DOI 10.1074/jbc.M109.093948; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Thiagarajah JR, 2010, J GEN PHYSIOL, V136, P353, DOI 10.1085/jgp.201010490; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002	31	65	67	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2325	2332		10.1096/fj.10-179549	http://dx.doi.org/10.1096/fj.10-179549			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21427214	Green Published			2022-12-25	WOS:000292242200024
J	MacPherson, M; Lek, HS; Prescott, A; Fagerholm, SC				MacPherson, Matthew; Lek, Hwee San; Prescott, Alan; Fagerholm, Susanna C.			A Systemic Lupus Erythematosus-associated R77H Substitution in the CD11b Chain of the Mac-1 Integrin Compromises Leukocyte Adhesion and Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; ALPHA-CHAIN; I DOMAIN; ACTIVATION; COMPLEMENT; ITGAM; PATHWAYS; LFA-1	The Mac-1 integrin is expressed mainly on myeloid cells and binds several ligands, including members of the ICAM family and the complement factor iC3b. It is involved in essential immunological processes, such as leukocyte extravasation and phagocytosis. In addition, Mac-1 has been described to negatively regulate immune cell signaling. Recently, a single nucleotide polymorphism conferring an amino acid change in the Mac-1 integrin extracellular domain, R77H, was shown to be associated with systemic lupus erythematosus. Here, we demonstrate that the R77H-substituted Mac-1 can be expressed on the cell surface in transfected cells and can undergo conformational changes in response to integrin activation. The affinity of the integrin for ICAMs is only partially reduced, but cell adhesion to ICAM-1 and ICAM-2 is severely compromised, and J beta 2.7 cells expressing R77H substituted integrins are deficient in adhesion to ICAM-1 under shear flow conditions. Importantly, cell adhesion to the complement factor iC3b is also diminished, and COS cells expressing R77H-substituted integrins display reduced iC3b-dependent phagocytosis. In addition, U937 cells expressing R77H-CD11b display increased IL-6 production as compared with WT-CD11b-expressing cells. These results suggest that the R77H substitution results in the deficiency of the mutated integrin to mediate cell adhesion to ligands such as ICAMs and iC3b. These deficiencies may ultimately lead to detrimental effects on the immune system and contribute to the development of systemic lupus erythematosus.	[MacPherson, Matthew] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Div Med Sci, Dundee DD1 9SY, Scotland; [Prescott, Alan] Univ Dundee, Coll Life Sci, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	MacPherson, M (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Div Med Sci, Mail Box 3, Dundee DD1 9SY, Scotland.	s.c.fagerholm@dundee.ac.uk; m.r.macpherson@dundee.ac.uk	Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Fagerholm, Susanna Carola/0000-0002-0354-8763	Cancer Research UK; Biotechnology and Biological Sciences Research Council; Tenovus Scotland; Biotechnology and Biological Sciences Research Council [BB/G017123/1] Funding Source: researchfish; BBSRC [BB/G017123/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Scotland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by Cancer Research UK, Biotechnology and Biological Sciences Research Council, and Tenovus Scotland.	Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chow C. W., 2004, CURR PROTOC CELL BIO, V15, P15; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Kelley JM, 2010, AUTOIMMUN REV, V9, P473, DOI 10.1016/j.autrev.2010.02.003; Kevil CG, 2004, AM J PATHOL, V165, P609, DOI 10.1016/S0002-9440(10)63325-1; Kim-Howard X, 2010, ANN RHEUM DIS, V69, P1329, DOI 10.1136/ard.2009.120543; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; Lomakina E, 2009, BLOOD CELL MOL DIS, V42, P177, DOI 10.1016/j.bcmd.2009.01.006; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Palucka AK, 2002, IMMUNOL CELL BIOL, V80, P484, DOI 10.1046/j.1440-1711.2002.01112.x; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Sachs UJH, 2004, BLOOD, V104, P727, DOI 10.1182/blood-2003-11-3809; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Weber KSC, 1997, J IMMUNOL, V158, P273; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199	33	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17303	17310		10.1074/jbc.M110.182998	http://dx.doi.org/10.1074/jbc.M110.182998			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454473	hybrid, Green Published			2022-12-25	WOS:000290301900078
J	Hribova, E; Cizkova, J; Christelova, P; Taudien, S; de Langhe, E; Dolezel, J				Hribova, Eva; Cizkova, Jana; Christelova, Pavla; Taudien, Stefan; de Langhe, Edmond; Dolezel, Jaroslav			The ITS1-5.8S-ITS2 Sequence Region in the Musaceae: Structure, Diversity and Use in Molecular Phylogeny	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; CONCERTED EVOLUTION; GENETIC DIVERSITY; ALLOPOLYPLOID SPECIATION; NRDNA POLYMORPHISM; HYBRID ORIGIN; RNA GENES; RDNA; GENOME	Genes coding for 45S ribosomal RNA are organized in tandem arrays of up to several thousand copies and contain 18S, 5.8S and 26S rRNA units separated by internal transcribed spacers ITS1 and ITS2. While the rRNA units are evolutionary conserved, ITS show high level of interspecific divergence and have been used frequently in genetic diversity and phylogenetic studies. In this work we report on the structure and diversity of the ITS region in 87 representatives of the family Musaceae. We provide the first detailed information on ITS sequence diversity in the genus Musa and describe the presence of more than one type of ITS sequence within individual species. Both Sanger sequencing of amplified ITS regions and whole genome 454 sequencing lead to similar phylogenetic inferences. We show that it is necessary to identify putative pseudogenic ITS sequences, which may have negative effect on phylogenetic reconstruction at lower taxonomic levels. Phylogenetic reconstruction based on ITS sequence showed that the genus Musa is divided into two distinct clades Callimusa and Australimusa and Eumusa and Rhodochlamys. Most of the intraspecific banana hybrids analyzed contain conserved parental ITS sequences, indicating incomplete concerted evolution of rDNA loci. Independent evolution of parental rDNA in hybrids enables determination of genomic constitution of hybrids using ITS. The observation of only one type of ITS sequence in some of the presumed interspecific hybrid clones warrants further study to confirm their hybrid origin and to unravel processes leading to evolution of their genomes.	[Hribova, Eva; Cizkova, Jana; Christelova, Pavla; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Taudien, Stefan] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [de Langhe, Edmond] Katholieke Univ Leuven, Lab Trop Crop Improvement, Leuven, Belgium	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); KU Leuven	Hribova, E (corresponding author), Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic.	dolezel@ueb.cas.cz	Dolezel, Jaroslav/B-7716-2008; hribova, eva/F-7291-2014; Cizkova, Jana/F-7673-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Hribova, Eva/0000-0002-6868-4344; Cizkova, Jana/0000-0001-7787-1849	Grant Agency of the Academy of Sciences of the Czech Republic [IAA600380703, KJB 500380901]; International Atomic Energy Agency [13192]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); International Atomic Energy Agency(International Atomic Energy Agency)	This work has been supported by the Grant Agency of the Academy of Sciences of the Czech Republic [grant awards no. IAA600380703 and KJB 500380901] and was performed in collaboration with the International Atomic Energy Agency [Research Agreement no. 13192]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amorim EP, 2009, GENET MOL BIOL, V32, P96, DOI 10.1590/S1415-47572009005000024; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barkman TJ, 2002, SYST BOT, V27, P209; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; BENNETT RI, 1991, PLANT MOL BIOL, V16, P685, DOI 10.1007/BF00023432; Buhariwalla HK, 2005, MOL ECOL NOTES, V5, P327, DOI 10.1111/j.1471-8286.2005.00916.x; Cheesman E. E, 1947, KEW BULL, P106, DOI DOI 10.2307/4109207; Christelova P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-103; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Dadejova M, 2007, NEW PHYTOL, V174, P658, DOI 10.1111/j.1469-8137.2007.02034.x; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; DOVER GA, 1982, SCIENCE, V218, P1069, DOI 10.1126/science.7146895; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Francisco-Ortega J, 2001, AM J BOT, V88, P161, DOI 10.2307/2657136; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GAWEL NJ, 1992, THEOR APPL GENET, V84, P286, DOI 10.1007/BF00229484; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakkinen Markku, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P27; Hakkinen Markku, 2004, APG Acta Phytotaxonomica et Geobotanica, V55, P79; Harpke D, 2008, J PLANT RES, V121, P261, DOI 10.1007/s10265-008-0156-x; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Hershkovitz MA, 1996, NUCLEIC ACIDS RES, V24, P2857, DOI 10.1093/nar/24.15.2857; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2004, BIOL J LINN SOC, V82, P615, DOI 10.1111/j.1095-8312.2004.00345.x; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LANAUD C, 1992, HEREDITY, V68, P147, DOI 10.1038/hdy.1992.23; Li LF, 2010, MOL PHYLOGENET EVOL, V57, P1, DOI 10.1016/j.ympev.2010.06.021; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Liu AZ, 2010, TAXON, V59, P20, DOI 10.1002/tax.591003; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Nwakanma DC, 2003, THEOR APPL GENET, V108, P154, DOI 10.1007/s00122-003-1402-1; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; OKane SL, 1996, SYST BOT, V21, P559, DOI 10.2307/2419615; Pettengill JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-264; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Renner SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-58; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Ritz CM, 2005, J HERED, V96, P4, DOI 10.1093/jhered/esi011; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; Safar J, 2004, GENOME, V47, P1182, DOI 10.1139/G04-062; Samuel R, 1998, PLANT SYST EVOL, V211, P129, DOI 10.1007/BF00984917; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Shepherd K., 1988, P INT WORKSH HELD LO, P158; SIMMOND NW, 1962, EVOLUTION BANANAS; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; SIMMONDS N. W., 1960, Kew Bulletin, V14, P198, DOI 10.2307/4114778; Smit A, 1996, REPEATMASKER OPEN 30; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Sun K, 2002, PLANT SYST EVOL, V235, P121, DOI 10.1007/s00606-002-0206-0; TOMLINSON PB, 1962, EVOLUTION, V16, P192, DOI 10.2307/2406197; Ude G, 2002, THEOR APPL GENET, V104, P1239, DOI 10.1007/s00122-001-0802-3; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Votkov RA, 2007, SYST BIODIVERS, V5, P261, DOI 10.1017/S1477200007002447; Wang QD, 2007, PLANT SYST EVOL, V267, P65, DOI 10.1007/s00606-006-0499-5; Wang XL, 2007, GENET RESOUR CROP EV, V54, P1125, DOI 10.1007/s10722-006-9004-9; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wissemann V, 2002, J APPL BOT-ANGEW BOT, V76, P176; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wong C, 2002, ANN BOT-LONDON, V90, P231, DOI 10.1093/aob/mcf170; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P175, DOI 10.1093/nar/29.1.175; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	83	69	77	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17863	10.1371/journal.pone.0017863	http://dx.doi.org/10.1371/journal.pone.0017863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445344	Green Submitted, gold, Green Published			2022-12-25	WOS:000288809100011
J	Kennedy, L; Pauriah, M; Godfrey, V; Howie, J; Dennis, H; Crowther, D; Struthers, A; Goddard, C; Feuerstein, G; Lang, C; Miele, G				Kennedy, Laura; Pauriah, Mahesh; Godfrey, Valerie; Howie, Jacqueline; Dennis, Helen; Crowther, Daniel; Struthers, Allan; Goddard, Catharine; Feuerstein, Giora; Lang, Chim; Miele, Gino			Global Array-Based Transcriptomics from Minimal Input RNA Utilising an Optimal RNA Isolation Process Combined with SPIA cDNA Probes	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; FINE-NEEDLE-ASPIRATION; BREAST-CANCER; SINGLE-CELL; ENDOTHELIAL FUNCTION; NANOGRAM AMOUNTS; MICROARRAY; AMPLIFICATION; SAMPLES; REPRODUCIBILITY	Background: Technical advances in the collection of clinical material, such as laser capture microdissection and cell sorting, provide the advantage of yielding more refined and homogenous populations of cells. However, these attractive advantages are counter balanced by the significant difficultly in obtaining adequate nucleic acid yields to allow transcriptomic analyses. Established technologies are available to carry out global transcriptomics using nanograms of input RNA, however, many clinical samples of low cell content would be expected to yield RNA within the picogram range. To fully exploit these clinical samples the challenge of isolating adequate RNA yield directly and generating sufficient microarray probes for global transcriptional profiling from this low level RNA input has been addressed in the current report. We have established an optimised RNA isolation workflow specifically designed to yield maximal RNA from minimal cell numbers. This procedure obtained RNA yield sufficient for carrying out global transcriptional profiling from vascular endothelial cell biopsies, clinical material not previously amenable to global transcriptomic approaches. In addition, by assessing the performance of two linear isothermal probe generation methods at decreasing input levels of good quality RNA we demonstrated robust detection of a class of low abundance transcripts (GPCRs) at input levels within the picogram range, a lower level of RNA input (50 pg) than previously reported for global transcriptional profiling and report the ability to interrogate the transcriptome from only 10 pg of input RNA. By exploiting an optimal RNA isolation workflow specifically for samples of low cell content, and linear isothermal RNA amplification methods for low level RNA input we were able to perform global transcriptomics on valuable and potentially informative clinically derived vascular endothelial biopsies here for the first time. These workflows provide the ability to robustly exploit ever more common clinical samples yielding extremely low cell numbers and RNA yields for global transcriptomics.	[Kennedy, Laura; Crowther, Daniel; Goddard, Catharine; Miele, Gino] Ninewells Hosp, TMRC Lab, Translat Med Res Collaborat, Dundee DD1 9SY, Scotland; [Pauriah, Mahesh; Godfrey, Valerie; Howie, Jacqueline; Dennis, Helen; Struthers, Allan; Lang, Chim] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Ctr Cardiovasc & Lung Biol, Dundee DD1 9SY, Scotland; [Crowther, Daniel; Goddard, Catharine; Feuerstein, Giora; Miele, Gino] Pfizer Global Res & Dev, Collegeville, PA USA; [Crowther, Daniel; Feuerstein, Giora; Miele, Gino] Pfizer Global Res & Dev, Dundee, Scotland	University of Dundee; University of Dundee; Pfizer; Pfizer	Kennedy, L (corresponding author), Ninewells Hosp, TMRC Lab, Translat Med Res Collaborat, Dundee DD1 9SY, Scotland.	c.c.lang@dundee.ac.uk; g.miele@dundee.ac.uk		Struthers, Allan/0000-0002-2926-2528; Lang, Chim/0000-0002-4530-3078	Translational Medicine Research Collaboration	Translational Medicine Research Collaboration	This study was funded by the Translational Medicine Research Collaboration. GM, CG, DC & GF were employees of Wyeth Research/PGRD and were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Assersohn L, 2002, CLIN CANCER RES, V8, P794; Bai XY, 2008, AM J HEMATOL, V83, P26, DOI 10.1002/ajh.20953; Bak M, 2006, ANAL BIOCHEM, V358, P111, DOI 10.1016/j.ab.2006.08.023; Barker CS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-57; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clarkson P, 2001, ATHEROSCLEROSIS, V154, P171, DOI 10.1016/S0021-9150(00)00455-X; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Colombo PC, 2005, CIRCULATION, V111, P58, DOI 10.1161/01.CIR.0000151611.89232.3B; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; HAN SH, 2009, ATHEROSCLEROSIS; Hansen A, 2007, NAT METHODS, V4, P35, DOI 10.1038/NMETH977; Hunter SM, 2008, J BIOCHEM BIOPH METH, V70, P1048, DOI 10.1016/j.jprot.2007.11.011; Kim C, 2006, MOL VIS, V12, P1640; King CL, 2005, J MOL DIAGN, V7, P57, DOI 10.1016/S1525-1578(10)60009-8; Klur S, 2004, GENOMICS, V83, P508, DOI 10.1016/j.ygeno.2003.09.005; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Lang JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-326; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Nygaard V, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-147; Onat D, 2007, J APPL PHYSIOL, V103, P1873, DOI 10.1152/japplphysiol.00367.2007; Oudes AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-92; Peterkova M, 2009, FOLIA BIOL-PRAGUE, V55, P53; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shearstone JR, 2006, GENOMICS, V88, P111, DOI 10.1016/j.ygeno.2006.03.004; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh R, 2005, AM J PHYSIOL-CELL PH, V288, pC1179, DOI 10.1152/ajpcell.00258.2004; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Toriello NM, 2008, P NATL ACAD SCI USA, V105, P20173, DOI 10.1073/pnas.0806355106; Viale Agnes, 2007, J Biomol Tech, V18, P150	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17625	10.1371/journal.pone.0017625	http://dx.doi.org/10.1371/journal.pone.0017625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445340	gold, Green Published, Green Submitted			2022-12-25	WOS:000288809100005
J	Xu, WH; Han, L; Lin, ZL				Xu, Wanghui; Han, Lu; Lin, Zhanglin			Screening of Random Peptide Library of Hemagglutinin from Pandemic 2009 A(H1N1) Influenza Virus Reveals Unexpected Antigenically Important Regions	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; RECEPTOR-BINDING; SURFACE DISPLAY; SITES; PROTEIN; BROAD; H5N1; IDENTIFICATION	The antigenic structure of the membrane protein hemagglutinin (HA) from the 2009 A(H1N1) influenza virus was dissected with a high-throughput screening method using complex antisera. The approach involves generating yeast cell libraries displaying a pool of random peptides of controllable lengths on the cell surface, followed by one round of fluorescence-activated cell sorting (FACS) against antisera from mouse, goat and human, respectively. The amino acid residue frequency appearing in the antigenic peptides at both the primary sequence and structural level was determined and used to identify "hot spots'' or antigenically important regions. Unexpectedly, different antigenic structures were seen for different antisera. Moreover, five antigenic regions were identified, of which all but one are located in the conserved HA stem region that is responsible for membrane fusion. Our findings are corroborated by several recent studies on cross-neutralizing H1 subtype antibodies that recognize the HA stem region. The antigenic peptides identified may provide clues for creating peptide vaccines with better accessibility to memory B cells and better induction of cross-neutralizing antibodies than the whole HA protein. The scheme used in this study enables a direct mapping of the antigenic regions of viral proteins recognized by antisera, and may be useful for dissecting the antigenic structures of other viral proteins.	[Xu, Wanghui; Han, Lu; Lin, Zhanglin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China	Tsinghua University	Xu, WH (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.	zhanglinlin@mail.tsinghua.edu.cn	Lin, Zhanglin/A-7232-2011		National Basic Research program of China [2009CB724700]; Tsinghua University [20091081428]	National Basic Research program of China(National Basic Research Program of China); Tsinghua University	This work was supported by a National Basic Research program of China grant (2009CB724700) and an innovative research grant from Tsinghua University (20091081428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Bowley DR, 2009, P NATL ACAD SCI USA, V106, P1380, DOI 10.1073/pnas.0812291106; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Christmann A, 2001, J IMMUNOL METHODS, V257, P163, DOI 10.1016/S0022-1759(01)00461-6; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Liang YF, 2005, CLIN CHEM, V51, P1382, DOI 10.1373/clinchem.2005.051045; Lin Zhanglin, 2009, V515, P261, DOI 10.1007/978-1-59745-559-6_18; Mischo Axel, 2003, Cancer Immun, V3, P5; NAKAJIMA S, 1983, VIROLOGY, V131, P116, DOI 10.1016/0042-6822(83)90538-X; Prodromou C, 2007, DRUG DISCOV TODAY, V12, P931, DOI 10.1016/j.drudis.2007.08.012; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WALTER G, 1981, NATURE, V290, P713; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILLIAMSON RA, 1993, P NATL ACAD SCI USA, V90, P4141, DOI 10.1073/pnas.90.9.4141; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	41	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18016	10.1371/journal.pone.0018016	http://dx.doi.org/10.1371/journal.pone.0018016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437206	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100059
J	Ding, VMY; Boersema, PJ; Foong, LY; Preisinger, C; Koh, G; Natarajan, S; Lee, DY; Boekhorst, J; Snel, B; Lemeer, S; Heck, AJR; Choo, A				Ding, Vanessa M. Y.; Boersema, Paul J.; Foong, Leong Yan; Preisinger, Christian; Koh, Geoffrey; Natarajan, Subaashini; Lee, Dong-Yup; Boekhorst, Jos; Snel, Berend; Lemeer, Simone; Heck, Albert J. R.; Choo, Andre			Tyrosine Phosphorylation Profiling in FGF-2 Stimulated Human Embryonic Stem Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR; SELF-RENEWAL; GENE-EXPRESSION; SRC; MAINTENANCE; PROTEINS; RECEPTOR; DYNAMICS; FAMILY	The role of fibroblast growth factor-2 (FGF-2) in maintaining undifferentiated human embryonic stem cells (hESC) was investigated using a targeted phosphoproteomics approach to specifically profile tyrosine phosphorylation events following FGF-2 stimulation. A cumulative total number of 735 unique tyrosine phosphorylation sites on 430 proteins were identified, by far the largest inventory to date for hESC. Early signaling events in FGF-2 stimulated hESC were quantitatively monitored using stable isotope dimethyl labeling, resulting in temporal tyrosine phosphorylation profiles of 316 unique phosphotyrosine peptides originating from 188 proteins. Apart from the rapid activation of all four FGF receptors, trans-activation of several other receptor tyrosine kinases (RTKs) was observed as well as induced tyrosine phosphorylation of downstream proteins such as PI3-K, MAPK and several Src family members. Both PI3-K and MAPK have been linked to hESC maintenance through FGF-2 mediated signaling. The observed activation of the Src kinase family members by FGF-2 and loss of pluripotent marker expression post Src kinase inhibition may point to the regulation of cytoskeletal and actin depending processes to maintain undifferentiated hESC.	[Ding, Vanessa M. Y.; Foong, Leong Yan; Koh, Geoffrey; Natarajan, Subaashini; Lee, Dong-Yup; Choo, Andre] ASTAR, Bioproc Technol Inst, Stem Cell Grp, Singapore, Singapore; [Ding, Vanessa M. Y.; Lee, Dong-Yup] NUS Grad Sch Integrat Sci & Engn NGS, Ctr Life Sci CeLS, Singapore, Singapore; [Boersema, Paul J.; Preisinger, Christian; Lemeer, Simone; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Boersema, Paul J.; Preisinger, Christian; Lemeer, Simone; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Boersema, Paul J.; Preisinger, Christian; Lemeer, Simone; Heck, Albert J. R.] Netherlands Prote Ctr, Utrecht, Netherlands; [Boekhorst, Jos; Snel, Berend; Choo, Andre] Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands; [Heck, Albert J. R.] Ctr Biomed Genet, Utrecht, Netherlands; [Choo, Andre] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; Utrecht University; Utrecht University; Utrecht University; National University of Singapore	Ding, VMY (corresponding author), ASTAR, Bioproc Technol Inst, Stem Cell Grp, Singapore, Singapore.	a.j.r.heck@uu.nl; andre_choo@bti.a-star.edu.sg	Lemeer, Simone/I-4363-2016; Lee, Dong-Yup/D-6650-2011; Heck, Albert/D-7098-2011; Snel, Berend/B-8886-2011	Lee, Dong-Yup/0000-0003-0901-708X; Heck, Albert/0000-0002-2405-4404; Snel, Berend/0000-0002-5804-8547; Boekhorst, Jos/0000-0002-4807-7838; Choo, Andre/0000-0001-9648-0755	Agency for Science Technology and Research (A*STAR), Singapore; Netherlands Proteomics Centre	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Netherlands Proteomics Centre	This work is supported by the Agency for Science Technology and Research (A*STAR), Singapore and the Netherlands Proteomics Centre (http://www.netherlandsproteomicscentre.nl), a program embedded in the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; BOERSEMA PJ, 2009, MOL CELL PROTEOMICS, V9, P1; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Ding V, 2006, BIOTECHNOL LETT, V28, P491, DOI 10.1007/s10529-006-0005-8; DING V, 2010, J CELL PHYS IN PRESS; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; LIVIA E, 2009, STEM CELLS, V8, P1847; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Nichols Amy M., 2009, V492, P143, DOI 10.1007/978-1-59745-493-3_8; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saito K, 2008, BIOCHEM BIOPH RES CO, V366, P969, DOI 10.1016/j.bbrc.2007.12.055; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Suzuki E, 2007, EXP CELL RES, V313, P2451, DOI 10.1016/j.yexcr.2007.03.041; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; van Breukelen B, 2009, BIOINFORMATICS, V25, P1472, DOI 10.1093/bioinformatics/btp181; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	61	51	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17538	10.1371/journal.pone.0017538	http://dx.doi.org/10.1371/journal.pone.0017538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437283	Green Submitted, gold, Green Published			2022-12-25	WOS:000288514600005
J	Cairns, S; Thomas, JG; Hooper, SJ; Wise, MP; Frost, PJ; Wilson, MJ; Lewis, MAO; Williams, DW				Cairns, Scott; Thomas, John Gilbert; Hooper, Samuel James; Wise, Matthew Peter; Frost, Paul John; Wilson, Melanie Julia; Lewis, Michael Alexander Oxenham; Williams, David Wynne			Molecular Analysis of Microbial Communities in Endotracheal Tube Biofilms	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; VENTILATOR-ASSOCIATED PNEUMONIA; CANDIDA-ALBICANS; BACTERIAL-COLONIZATION; STREPTOCOCCUS-MUTANS; ORAL DECONTAMINATION; IDENTIFICATION; DGGE; PCR; SILVER	Background: Ventilator-associated pneumonia is the most prevalent acquired infection of patients on intensive care units and is associated with considerable morbidity and mortality. Evidence suggests that an improved understanding of the composition of the biofilm communities that form on endotracheal tubes may result in the development of improved preventative strategies for ventilator-associated pneumonia. Methodology/Principal Findings: The aim of this study was to characterise microbial biofilms on the inner luminal surface of extubated endotracheal tubes from ICU patients using PCR and molecular profiling. Twenty-four endotracheal tubes were obtained from twenty mechanically ventilated patients. Denaturing gradient gel electrophoresis (DGGE) profiling of 16S rRNA gene amplicons was used to assess the diversity of the bacterial population, together with species specific PCR of key marker oral microorganisms and a quantitative assessment of culturable aerobic bacteria. Analysis of culturable aerobic bacteria revealed a range of colonisation from no growth to 2.1x10(8) colony forming units (cfu)/cm(2) of endotracheal tube (mean 1.4x10(7) cfu/cm(2)). PCR targeting of specific bacterial species detected the oral bacteria Streptococcus mutans (n = 5) and Porphyromonas gingivalis (n = 5). DGGE profiling of the endotracheal biofilms revealed complex banding patterns containing between 3 and 22 (mean 6) bands per tube, thus demonstrating the marked complexity of the constituent biofilms. Significant inter-patient diversity was evident. The number of DGGE bands detected was not related to total viable microbial counts or the duration of intubation. Conclusions/Significance: Molecular profiling using DGGE demonstrated considerable biofilm compositional complexity and inter-patient diversity and provides a rapid method for the further study of biofilm composition in longitudinal and interventional studies. The presence of oral microorganisms in endotracheal tube biofilms suggests that these may be important in biofilm development and may provide a therapeutic target for the prevention of ventilator-associated pneumonia.	[Cairns, Scott; Wise, Matthew Peter; Frost, Paul John] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; [Thomas, John Gilbert] W Virginia Univ, Morgantown, WV 26506 USA; [Hooper, Samuel James; Wilson, Melanie Julia; Lewis, Michael Alexander Oxenham; Williams, David Wynne] Cardiff Univ, Sch Dent, Cardiff, S Glam, Wales	Cardiff University; West Virginia University; Cardiff University	Cairns, S (corresponding author), Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales.	wilsonmj@cf.ac.uk	Williams, David/E-5506-2012	Williams, David/0000-0002-7351-5131; Wise, Matt/0000-0002-2763-4316				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; Amin A, 2009, CLIN INFECT DIS, V49, pS36, DOI 10.1086/599814; Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Bauer T T, 2002, Monaldi Arch Chest Dis, V57, P84; Berra L, 2004, ANESTHESIOLOGY, V100, P1446, DOI 10.1097/00000542-200406000-00017; Berra L, 2008, INTENS CARE MED, V34, P1020, DOI 10.1007/s00134-008-1099-3; Berra L, 2008, INTENS CARE MED, V34, P1030, DOI 10.1007/s00134-008-1100-1; BRANTING C, 1989, ARCH ORAL BIOL, V34, P347, DOI 10.1016/0003-9969(89)90108-8; Brennan MT, 2004, ORAL SURG ORAL MED O, V98, P665, DOI 10.1016/j.tripleo.2004.06.005; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Chan EY, 2009, AUST CRIT CARE, V22, P3, DOI 10.1016/j.aucc.2008.12.001; Chen Z, 2007, FEMS MICROBIOL LETT, V272, P154, DOI 10.1111/j.1574-6968.2007.00756.x; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; de Oliveira JCM, 2007, ORAL MICROBIOL IMMUN, V22, P14, DOI 10.1111/j.1399-302X.2007.00311.x; De Sordi L, 2009, FEMS YEAST RES, V9, P990, DOI 10.1111/j.1567-1364.2009.00573.x; Dijk F, 2000, J BIOMED MATER RES, V51, P408, DOI 10.1002/1097-4636(20000905)51:3<408::AID-JBM15>3.3.CO;2-D; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Forestier C, 2008, CRIT CARE, V12, DOI 10.1186/cc6907; Fujimoto C, 2003, J PERIODONTAL RES, V38, P440, DOI 10.1034/j.1600-0765.2003.02607.x; Gafan GP, 2005, FEMS MICROBIOL LETT, V253, P303, DOI 10.1016/j.femsle.2005.09.048; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Jackson Colin R., 2000, Molecular Biology Today, V1, P49; Jackson WL, 2006, CURR OPIN ANESTHESIO, V19, P117, DOI 10.1097/01.aco.0000192770.01904.dd; Koeman M, 2006, AM J RESP CRIT CARE, V173, P1348, DOI 10.1164/rccm.200505-820OC; Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805; Kulekci G, 2008, ANAEROBE, V14, P49, DOI 10.1016/J.anaerobe.2007.08.001; Lavenir R, 2007, J MICROBIOL METH, V70, P20, DOI 10.1016/j.mimet.2007.03.008; Le Berre R, 2006, MED MALADIES INFECT, V36, P349, DOI 10.1016/j.medmal.2006.01.008; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Liu ZM, 2007, DIAGN MICR INFEC DIS, V59, P379, DOI 10.1016/j.diagmicrobio.2007.06.011; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; O'keefe-McCarthy Sheila, 2006, Dynamics, V17, P8; Olson ME, 2002, CHEST, V121, P863, DOI 10.1378/chest.121.3.863; Palmer LB, 2009, CURR OPIN PULM MED, V15, P230, DOI 10.1097/MCP.0b013e3283292650; Park David R, 2005, Respir Care, V50, P742; Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014; Pfaller MA, 1996, J CLIN MICROBIOL, V34, P58, DOI 10.1128/JCM.34.1.58-61.1996; Pneumatikos IA, 2009, ANESTHESIOLOGY, V110, P673, DOI 10.1097/ALN.0b013e31819868e0; Ramirez P, 2007, CURR OPIN INFECT DIS, V20, P190, DOI 10.1097/QCO.0b013e328014daac; Rocas IN, 2004, ORAL SURG ORAL MED O, V98, P741, DOI 10.1016/j.tripleo.2004.09.006; Rolleke S, 1996, APPL ENVIRON MICROB, V62, P2059; Ruffell Alison, 2008, Nurs Crit Care, V13, P44, DOI 10.1111/j.1478-5153.2007.00248.x; Scannapieco FA, 2006, J AM DENT ASSOC, V137, p21S, DOI 10.14219/jada.archive.2006.0400; Schabereiter-Gurtner C, 2001, INVEST OPHTH VIS SCI, V42, P1164; Sheppard DC, 1998, J CLIN MICROBIOL, V36, P3726, DOI 10.1128/JCM.36.12.3726-3727.1998; Shinada K, 1995, Kokubyo Gakkai Zasshi, V62, P281; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001; Tantipong H, 2008, INFECT CONT HOSP EP, V29, P131, DOI 10.1086/526438; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; Zijnge V, 2003, ORAL MICROBIOL IMMUN, V18, P59, DOI 10.1034/j.1399-302X.2003.180110.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	58	40	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14759	10.1371/journal.pone.0014759	http://dx.doi.org/10.1371/journal.pone.0014759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423727	Green Published, gold			2022-12-25	WOS:000288512400005
J	Karim, R; Meyers, C; Backendorf, C; Ludigs, K; Offringa, R; van Ommen, GJB; Melief, CJM; van der Burg, SH; Boer, JM				Karim, Rezaul; Meyers, Craig; Backendorf, Claude; Ludigs, Kristina; Offringa, Rienk; van Ommen, Gert-Jan B.; Melief, Cornelis J. M.; van der Burg, Sjoerd H.; Boer, Judith M.			Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; SQUAMOUS INTRAEPITHELIAL LESIONS; CERVICAL-CANCER; RIG-I; HUMAN KERATINOCYTES; INNATE IMMUNITY; EPIDERMAL-KERATINOCYTES; CD4+T-CELL IMMUNITY; E7 ONCOPROTEIN	Despite the presence of intracellular pathogen recognition receptors that allow infected cells to attract the immune system, undifferentiated keratinocytes (KCs) are the main targets for latent infection with high-risk human papilloma viruses (hrHPVs). HPV infections are transient but on average last for more than one year suggesting that HPV has developed means to evade host immunity. To understand how HPV persists, we studied the innate immune response of undifferentiated human KCs harboring episomal copies of HPV16 and 18 by genome-wide expression profiling. Our data showed that the expression of the different virus-sensing receptors was not affected by the presence of HPV. Poly(I: C) stimulation of the viral RNA receptors TLR3, PKR, MDA5 and RIG-I, the latter of which indirectly senses viral DNA through non-self RNA polymerase III transcripts, showed dampening in downstream signalling of these receptors by HPVs. Many of the genes downregulated in HPV-positive KCs involved components of the antigen presenting pathway, the inflammasome, the production of antivirals, pro-inflammatory and chemotactic cytokines, and components downstream of activated pathogen receptors. Notably, gene and/or protein interaction analysis revealed the downregulation of a network of genes that was strongly interconnected by IL-1 beta, a crucial cytokine to activate adaptive immunity. In summary, our comprehensive expression profiling approach revealed that HPV16 and 18 coordinate a broad deregulation of the keratinocyte's inflammatory response, and contributes to the understanding of virus persistence.	[Karim, Rezaul; van Ommen, Gert-Jan B.; Boer, Judith M.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [Karim, Rezaul; Ludigs, Kristina; Offringa, Rienk; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Karim, Rezaul; van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Meyers, Craig] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Backendorf, Claude] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, Mol Genet Lab, NL-2300 RA Leiden, Netherlands; [Boer, Judith M.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Leiden University; Leiden University - Excl LUMC	Karim, R (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands.	j.m.boer@lumc.nl	van der Burg, Sjoerd H/T-1875-2017	van der Burg, Sjoerd H/0000-0002-6556-0354; Boer, Judith/0000-0003-4848-7789	Centre for Medical Systems Biology; Netherlands Genomics Initiative; Public Health Service Grant [AI057988]; Netherlands Organization for Health Research (NWO/ZonMw) [91209012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	Centre for Medical Systems Biology; Netherlands Genomics Initiative; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Netherlands Organization for Health Research (NWO/ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centre for Medical Systems Biology, a Centre of Excellence supported by the Netherlands Genomics Initiative. CJMM was supported by Public Health Service Grant AI057988. SHvdB and JMB were supported by the Netherlands Organization for Health Research (NWO/ZonMw) TOP grant 91209012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Barnard P, 1999, VIROLOGY, V259, P305, DOI 10.1006/viro.1999.9771; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; de Jong A, 2002, CANCER RES, V62, P472; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ferlay J, 2010, INT J CANC; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pivarcsi A, 2004, ARCH DERMATOL RES, V296, P120, DOI 10.1007/s00403-004-0475-2; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sankar S, 2006, CELL SIGNAL, V18, P982, DOI 10.1016/j.cellsig.2005.08.006; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Spitkovsky D, 2002, J BIOL CHEM, V277, P25576, DOI 10.1074/jbc.M201884200; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; van Poelgeest MIE, 2005, CLIN CANCER RES, V11, P5273, DOI 10.1158/1078-0432.CCR-05-0616; van Steenwijk PJD, 2008, CLIN CANCER RES, V14, P7188, DOI 10.1158/1078-0432.CCR-08-0994; Welters MJP, 2003, CANCER RES, V63, P636; Woo YL, 2008, BJOG-INT J OBSTET GY, V115, P1616, DOI 10.1111/j.1471-0528.2008.01936.x; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; WOODWORTH CD, 1992, ONCOGENE, V7, P619; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	62	111	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17848	10.1371/journal.pone.0017848	http://dx.doi.org/10.1371/journal.pone.0017848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423754	Green Submitted, Green Published, gold			2022-12-25	WOS:000288512400033
J	Sahay, S; Gupte, N; Brahme, RG; Nirmalkar, A; Bembalkar, S; Bollinger, RC; Mehendale, S				Sahay, Seema; Gupte, Nikhil; Brahme, Radhika G.; Nirmalkar, Amit; Bembalkar, Shilpa; Bollinger, Robert C.; Mehendale, Sanjay			Predictors of Retention among Men Attending STI Clinics in HIV Prevention Programs and Research: A Case Control Study in Pune, India	PLOS ONE			English	Article							TRANSMITTED-DISEASE CLINICS; SEX WORKERS; INFECTION; TRIAL; COHORT; WOMEN; PREVALENCE; ENROLLMENT; ATTRITION; DROPOUTS	Background: Retention is critical in HIV prevention programs and clinical research. We studied retention in the three modeled scenarios of primary prevention programs, cohort studies and clinical trials to identify predictors of retention. Methodology/Principal Findings: Men attending Sexually Transmitted Infection (STI) clinics (n = 10, 801) were followed in a cohort study spanning over a ten year period (1993-2002) in Pune, India. Using pre-set definitions, cases with optimal retention in prevention program (n = 1286), cohort study (n = 940) and clinical trial (n = 896) were identified from this cohort. Equal number of controls matched for age and period of enrollment were selected. A case control analysis using conditional logistic regression was performed. Being employed was a predictor of lower retention in all the three modeled scenarios. Presence of genital ulcer disease (GUD), history of commercial sex work and living away from the family were predictors of lower retention in primary prevention, cohort study and clinical trial models respectively. Alcohol consumption predicted lower retention in cohort study and clinical trial models. Married monogamous men were less likely to be retained in the primary prevention and cohort study models. Conclusions/Significance: Predicting potential drop-outs among the beneficiaries or research participants at entry point in the prevention programs and research respectively is possible. Suitable interventions might help in optimizing retention. Customized counseling to prepare the clients properly may help in their retention.	[Sahay, Seema] Natl AIDS Res Inst, Div Social & Behav Res, Pune, Maharashtra, India; [Gupte, Nikhil] Byramjee Jeejeebhoy Med Coll, Clin Trial Unit, Pune, Maharashtra, India; [Brahme, Radhika G.; Nirmalkar, Amit; Bembalkar, Shilpa] Natl AIDS Res Inst, Div Epidemiol & Biostat, Pune, Maharashtra, India; [Bollinger, Robert C.] Johns Hopkins Univ, Johns Hopkins Ctr Clin Global Hlth Educ, Baltimore, MD USA; [Mehendale, Sanjay] Natl Inst Epidemiol, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Sahay, S (corresponding author), Natl AIDS Res Inst, Div Social & Behav Res, Pune, Maharashtra, India.	ssahay@nariindia.org		Sahay, Seema/0000-0001-6064-827X; Bollinger, Robert/0000-0002-6798-6834	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [A1 41369]; NIAID, NIH through Family Health International (FHI) [A1 35173, A1 33879, RR-00722]; Indian Council Medical Research, New Delhi, India; Sassoon General Hospitals; Dr. Kotnis Municipal Dispensary; National Institute of Virology; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI035173, U01AI047968, R01AI041369, R21AI033879] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH through Family Health International (FHI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Indian Council Medical Research, New Delhi, India; Sassoon General Hospitals; Dr. Kotnis Municipal Dispensary; National Institute of Virology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding support was received from grants from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (A1 41369), and through a contract from the NIAID, NIH through Family Health International (FHI) (A1 35173, A1 33879 and RR-00722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Indian Council Medical Research, New Delhi, India. We thank the Director, National AIDS Research Institute (NARI) for continued support. We acknowledge the support received from the NARI institutional staff and the project staff of the PAVE, HIVNET and Acute Pathogenesis studies for counseling, clinical care of study participants, community work, laboratory work, data management, and statistical support from National AIDS Research Institute, Pune and Johns Hopkins University, Baltimore. We also thank B.J. Medical College, Pune, and Pune Municipal Corporation for facilitating clinical collaborations to conduct these studies. We acknowledge the support from Sassoon General Hospitals, Dr. Kotnis Municipal Dispensary and National Institute of Virology where the study clinics were situated in Pune. Finally we sincerely thank the participants who took part in the study.	A Kumar, 2008, Indian J Community Med, V33, P156, DOI 10.4103/0970-0218.42051; Brahme R, 2006, JAIDS-J ACQ IMM DEF, V41, P107, DOI 10.1097/01.qai.0000179428.49907.6d; Brahme RG, 2005, AIDS CARE, V17, P377, DOI 10.1080/09540120412331299771; CAMPSMITH ML, 1995, SEX TRANSM DIS, V22, P312, DOI 10.1097/00007435-199509000-00008; Clark O., 2001, FOREST PLOTS EXCEL S; De Weert-Van Oene GH, 2001, J SUBST ABUSE TREAT, V20, P253, DOI 10.1016/S0740-5472(01)00160-X; DENYER S, 1998, MENS HLTH C BUND DON; DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638; El-Khorazaty MN, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-233; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Honas JJ, 2003, OBES RES, V11, P888, DOI 10.1038/oby.2003.122; IIPS & ORC Macro, 2007, NATL FAMILY HLTH SUR; Jaggarajamma K, 2009, Indian J Tuberc, V56, P185; Janson SL, 2001, CONTROL CLIN TRIALS, V22, p236S, DOI 10.1016/S0197-2456(01)00171-4; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kim YJ, 2006, INT J NURS STUD, V43, P527, DOI 10.1016/j.ijnurstu.2005.07.005; LEVINE J, 2010, NEWS LETT; Mehendale SM, 2007, JAIDS-J ACQ IMM DEF, V45, P564, DOI 10.1097/QAI.0b013e3180d0a6ba; Mehendale SM, 1996, INDIAN J MED RES, V104, P327; Moser DK, 2000, NURS RES, V49, P109, DOI 10.1097/00006199-200003000-00008; *NACO, DEP AIDS CONTR MIN H; Naik Eknath, 2005, BMC Int Health Hum Rights, V5, P1, DOI 10.1186/1472-698X-5-1; *NHMP TRIAL, 1997, AIDS S, V11, pS13; Orellana ER, 2006, AIDS EDUC PREV, V18, P348, DOI 10.1521/aeap.2006.18.4.348; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Radwan I., 2005, INDIA PRIVATE HLTH S; RAO S, 2009, J INDIAN MED ASSOC, V107, P274; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; Rutledge S. E., 2002, AIDS BEHAV, V6, P69, DOI DOI 10.1023/A:1014580629524; Saharabuddhe V, 2008, PROSTITUTION, P239; Shepherd ME, 2003, J HEALTH POPUL NUTR, V21, P251; Shinde S, 2009, INDIAN J DERMATOL VE, V75, P41, DOI 10.4103/0378-6323.45219; Talukdar A, 2008, AIDS BEHAV, V12, P613, DOI 10.1007/s10461-007-9338-0; US Center for Disease Control and Prevention, 2001, MMWR, V50, P13; Villacorta V, 2007, CLIN TRIALS, V4, P32, DOI 10.1177/1740774506075869; *WHO NACO, 2008, TECHN CONS REV HIV S; Wu E, 2005, AIDS EDUC PREV, V17, P41, DOI 10.1521/aeap.17.1.41.58685	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17448	10.1371/journal.pone.0017448	http://dx.doi.org/10.1371/journal.pone.0017448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	733FF	21412414	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800006
J	Kulkarni, A; Dangat, K; Kale, A; Sable, P; Chavan-Gautam, P; Joshi, S				Kulkarni, Asmita; Dangat, Kamini; Kale, Anvita; Sable, Pratiksha; Chavan-Gautam, Preeti; Joshi, Sadhana			Effects of Altered Maternal Folic Acid, Vitamin B-12 and Docosahexaenoic Acid on Placental Global DNA Methylation Patterns in Wistar Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; S-ADENOSYLHOMOCYSTEINE; TOTAL HOMOCYSTEINE; FOLATE-DEFICIENCY; GENE-EXPRESSION; PLASMA; NUTRITION; SUPPLEMENTATION; METABOLISM; PREGNANCY	Potential adverse effects of excess maternal folic acid supplementation on a vegetarian population deficient in vitamin B-12 are poorly understood. We have previously shown in a rat model that maternal folic acid supplementation at marginal protein levels reduces brain omega-3 fatty acid levels in the adult offspring. We have also reported that reduced docosahexaenoic acid (DHA) levels may result in diversion of methyl groups towards DNA in the one carbon metabolic pathway ultimately resulting in DNA methylation. This study was designed to examine the effect of normal and excess folic acid in the absence and presence of vitamin B-12 deficiency on global methylation patterns in the placenta. Further, the effect of maternal omega 3 fatty acid supplementation on the above vitamin B-12 deficient diets was also examined. Our results suggest maternal folic acid supplementation in the absence of vitamin B-12 lowers plasma and placental DHA levels (p < 0.05) and reduces global DNA methylation levels (p < 0.05). When this group was supplemented with omega 3 fatty acids there was an increase in placental DHA levels and subsequently DNA methylation levels revert back to the levels of the control group. Our results suggest for the first time that DHA plays an important role in one carbon metabolism thereby influencing global DNA methylation in the placenta.	[Kulkarni, Asmita; Dangat, Kamini; Kale, Anvita; Sable, Pratiksha; Chavan-Gautam, Preeti; Joshi, Sadhana] Bharati Vidyapeeth Univ, Dept Med Nutr, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University	Kulkarni, A (corresponding author), Bharati Vidyapeeth Univ, Dept Med Nutr, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Chavan-Gautam, Preeti/0000-0001-8514-3171	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was partially funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHON M, 2000, WORKSH METH MET MOL, P303; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Bromberg A, 2008, SCHIZOPHR RES, V101, P50, DOI 10.1016/j.schres.2008.01.009; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; DANGAT K, 2011, METABOLISM IN PRESS; Dangat KD, 2010, NEONATOLOGY, V97, P190, DOI 10.1159/000252971; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DuttaRoy AK, 1997, J NUTR BIOCHEM, V8, P548, DOI 10.1016/S0955-2863(97)00087-9; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Friso S, 2005, CLIN CHEM LAB MED, V43, P1158, DOI 10.1515/CCLM.2005.201; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Grenier E, 2008, FASEB J, V22; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilari AS, 2009, J PERINAT MED, V37, P513, DOI 10.1515/JPM.2009.096; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; KULKARNI A, 2010, DNA CELL BI IN PRESS; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; LEE DSC, 1985, CLIN BIOCHEM, V18, P261, DOI 10.1016/S0009-9120(85)80028-X; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; McCabe DC, 2005, NUTR REV, V63, P183, DOI [10.1301/nr.2005.Jun.183-195, 10.1111/j.1753-4887.2005.tb00136.x]; Min H, 2009, NUTR RES PRACT, V3, P122, DOI 10.4162/nrp.2009.3.2.122; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; Owens S, 2008, T ROY SOC TROP MED H, V102, P103, DOI 10.1016/j.trstmh.2007.09.018; Pita ML, 2000, THROMB HAEMOSTASIS, V84, P420; Rao S, 2006, METABOLISM, V55, P628, DOI 10.1016/j.metabol.2005.12.008; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROY S, 2011, BRAIN DEV IN PRESS; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Selley ML, 2007, NEUROBIOL AGING, V28, P1834, DOI 10.1016/j.neurobiolaging.2006.08.003; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Uekawa A, 2009, J NUTRIGENET NUTRIGE, V2, P29, DOI 10.1159/000165374; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650; Windham GC, 2000, AM J MED GENET, V90, P261, DOI 10.1002/(SICI)1096-8628(20000131)90:3<261::AID-AJMG18>3.0.CO;2-L; Wyrwoll CS, 2006, ENDOCRINOLOGY, V147, P599, DOI 10.1210/en.2005-0748; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zighetti ML, 2002, HAEMATOLOGICA, V87, P89	52	157	161	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17706	10.1371/journal.pone.0017706	http://dx.doi.org/10.1371/journal.pone.0017706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423696	gold, Green Published, Green Submitted			2022-12-25	WOS:000288219100027
J	Osborne, K; Dolman, AM; Burgess, SC; Johns, KA				Osborne, Kate; Dolman, Andrew M.; Burgess, Scott C.; Johns, Kerryn A.			Disturbance and the Dynamics of Coral Cover on the Great Barrier Reef (1995-2009)	PLOS ONE			English	Article							ACANTHASTER-PLANCI; FISH ASSEMBLAGES; WATER-QUALITY; PHASE-SHIFTS; RESILIENCE; RECOVERY; BIODIVERSITY; DEGRADATION; COMMUNITIES; DECLINE	Coral reef ecosystems worldwide are under pressure from chronic and acute stressors that threaten their continued existence. Most obvious among changes to reefs is loss of hard coral cover, but a precise multi-scale estimate of coral cover dynamics for the Great Barrier Reef (GBR) is currently lacking. Monitoring data collected annually from fixed sites at 47 reefs across 1300 km of the GBR indicate that overall regional coral cover was stable (averaging 29% and ranging from 23% to 33% cover across years) with no net decline between 1995 and 2009. Subregional trends (10-100 km) in hard coral were diverse with some being very dynamic and others changing little. Coral cover increased in six subregions and decreased in seven subregions. Persistent decline of corals occurred in one subregion for hard coral and Acroporidae and in four subregions in non-Acroporidae families. Change in Acroporidae accounted for 68% of change in hard coral. Crown-of-thorns starfish (Acanthaster planci) outbreaks and storm damage were responsible for more coral loss during this period than either bleaching or disease despite two mass bleaching events and an increase in the incidence of coral disease. While the limited data for the GBR prior to the 1980's suggests that coral cover was higher than in our survey, we found no evidence of consistent, system-wide decline in coral cover since 1995. Instead, fluctuations in coral cover at subregional scales (10-100 km), driven mostly by changes in fast-growing Acroporidae, occurred as a result of localized disturbance events and subsequent recovery.	[Osborne, Kate; Dolman, Andrew M.; Burgess, Scott C.; Johns, Kerryn A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Osborne, K (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	k.osborne@aims.gov.au	Dolman, Andrew/G-2399-2011	Dolman, Andrew/0000-0002-6481-966X; Burgess, Scott/0000-0002-0348-3453	Australian Institute of Marine Science; The Australian Federal Government's Marine and Tropical Scientific Reseach Facility [1.1.2]	Australian Institute of Marine Science; The Australian Federal Government's Marine and Tropical Scientific Reseach Facility	This study was supported by the Australian Institute of Marine Science and by The Australian Federal Government's Marine and Tropical Scientific Reseach Facility (Project 1.1.2; www.rrrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADBO D, 2004, SURVEYS BENTHIC REEF; Ayling A. M., 2005, DYNAMICS CAIRNS CENT; AYLING AM, 1995, PRELIMINARY SURVEY B; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R., 2009, V205, P103; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burgess SC, 2010, GLOBAL ECOL BIOGEOGR, V19, P363, DOI 10.1111/j.1466-8238.2009.00516.x; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; DAVIDSON J, 1997, OPTIMISING USE VIDEO; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; DONE TJ, 1991, BROADSCALE SURVEY IM; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Gomez E.D., 1982, Proceedings of the International Coral Reef Symposium, P275; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2009, BIODIVERS CONSERV, V18, P3325, DOI 10.1007/s10531-009-9633-3; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lough J., 2007, CLIMATE CHANGE GREAT, P15; Lough J, 2006, B AUST METEOROL OCEA, V19, P53, DOI DOI 10.1201/9781420041675.CH17; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; MILLER I, 2002, P 10 INT COR REEF S, V2, P1273; Miller Ian, 2002, P1273; MILLER IR, 2003, CROWN THORNS STARFIS; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; OLIVER JK, 2009, CORAL BLEACHING PATT; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pratchett MS, 2010, CORAL REEFS, V29, P717, DOI 10.1007/s00338-010-0602-9; Schaffelke B., 2010, REEF RESCUE MARINE M; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; Thompson A., 2010, REEF RESCUE MARINE M; Thompson AA, 2010, CORAL REEFS, V29, P637, DOI 10.1007/s00338-009-0562-0; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Wilkinson C, 2008, STATUS CORAL REEFS W; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	69	170	172	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17516	10.1371/journal.pone.0017516	http://dx.doi.org/10.1371/journal.pone.0017516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423742	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100013
J	Zhao, X; Rodland, EA; Sorlie, T; Naume, B; Langerod, A; Frigessi, A; Kristensen, VN; Borresen-Dale, AL; Lingjaerde, OC				Zhao, Xi; Rodland, Einar Andreas; Sorlie, Therese; Naume, Bjorn; Langerod, Anita; Frigessi, Arnoldo; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingjaerde, Ole Christian			Combining Gene Signatures Improves Prediction of Breast Cancer Survival	PLOS ONE			English	Article							EXPRESSION DATA; BONE-MARROW; METASTASIS; RECURRENCE; SUBTYPES; CELLS	Background: Several gene sets for prediction of breast cancer survival have been derived from whole-genome mRNA expression profiles. Here, we develop a statistical framework to explore whether combination of the information from such sets may improve prediction of recurrence and breast cancer specific death in early-stage breast cancers. Microarray data from two clinically similar cohorts of breast cancer patients are used as training (n = 123) and test set (n = 81), respectively. Gene sets from eleven previously published gene signatures are included in the study. Principal Findings: To investigate the relationship between breast cancer survival and gene expression on a particular gene set, a Cox proportional hazards model is applied using partial likelihood regression with an L2 penalty to avoid overfitting and using cross-validation to determine the penalty weight. The fitted models are applied to an independent test set to obtain a predicted risk for each individual and each gene set. Hierarchical clustering of the test individuals on the basis of the vector of predicted risks results in two clusters with distinct clinical characteristics in terms of the distribution of molecular subtypes, ER, PR status, TP53 mutation status and histological grade category, and associated with significantly different survival probabilities (recurrence: p = 0.005; breast cancer death: p = 0.014). Finally, principal components analysis of the gene signatures is used to derive combined predictors used to fit a new Cox model. This model classifies test individuals into two risk groups with distinct survival characteristics (recurrence: p = 0.003; breast cancer death: p = 0.001). The latter classifier outperforms all the individual gene signatures, as well as Cox models based on traditional clinical parameters and the Adjuvant! Online for survival prediction. Conclusion: Combining the predictive strength of multiple gene signatures improves prediction of breast cancer survival. The presented methodology is broadly applicable to breast cancer risk assessment using any new identified gene set.	[Zhao, Xi; Sorlie, Therese; Langerod, Anita; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Dept Genet, Inst Canc Res, Oslo, Norway; [Zhao, Xi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Oslo, Norway; [Rodland, Einar Andreas; Lingjaerde, Ole Christian] Univ Oslo, Dept Informat, Biomed Res Grp, Fac Math & Nat Sci, N-0316 Oslo, Norway; [Rodland, Einar Andreas; Lingjaerde, Ole Christian] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Naume, Bjorn] Oslo Univ Hosp, Canc Clin, Oslo, Norway; [Frigessi, Arnoldo] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Frigessi, Arnoldo] Norwegian Comp Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Zhao, X (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Genet, Inst Canc Res, Oslo, Norway.	xi.zhao@medisin.uio.no	li, jie/A-3133-2011; Sørlie, Therese/B-1413-2015	Sørlie, Therese/0000-0002-5995-2319; Lingjaerde, Ole Christian/0000-0003-3565-4912; Frigessi, Arnoldo/0000-0001-7103-7589	Norwegian Research Council (NFR) [175240]; NFR Cancer program [193387]	Norwegian Research Council (NFR)(Research Council of Norway); NFR Cancer program	This study was supported by Norwegian Research Council (NFR) FUGE program, Grant 175240 and NFR Cancer program, Grant 193387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; GOEMAN J, 2010, PENALIZED R PACKAGE; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hastie T, 2001, ELEMENTS STAT LEARNI, V1.8, P371; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; SCHEMPER M, 1993, STAT MED, V12, P2377, DOI 10.1002/sim.4780122413; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	31	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17845	10.1371/journal.pone.0017845	http://dx.doi.org/10.1371/journal.pone.0017845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423775	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100039
J	Hagemann, S; Heil, O; Lyko, F; Brueckner, B				Hagemann, Sabine; Heil, Oliver; Lyko, Frank; Brueckner, Bodo			Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; HISTONE DEACETYLASE; GENOMIC DNA; METHYLATION; 5-AZA-2'-DEOXYCYTIDINE; METHYLTRANSFERASE; EPIGENOMICS; INHIBITION; RESISTANCE; DNMT1	The DNA methyltransferase inhibitors azacytidine and decitabine represent archetypal drugs for epigenetic cancer therapy. To characterize the demethylating activity of azacytidine and decitabine we treated colon cancer and leukemic cells with both drugs and used array-based DNA methylation analysis of more than 14,000 gene promoters. Additionally, drug-induced demethylation was compared to methylation patterns of isogenic colon cancer cells lacking both DNA methyltransferase 1 (DNMT1) and DNMT3B. We show that drug-induced demethylation patterns are highly specific, non-random and reproducible, indicating targeted remethylation of specific loci after replication. Correspondingly, we found that CG dinucleotides within CG islands became preferentially remethylated, indicating a role for DNA sequence context. We also identified a subset of genes that were never demethylated by drug treatment, either in colon cancer or in leukemic cell lines. These demethylation-resistant genes were enriched for Polycomb Repressive Complex 2 components in embryonic stem cells and for transcription factor binding motifs not present in demethylated genes. Our results provide detailed insights into the DNA methylation patterns induced by azacytidine and decitabine and suggest the involvement of complex regulatory mechanisms in drug-induced DNA demethylation.	[Hagemann, Sabine; Lyko, Frank; Brueckner, Bodo] Deutsch Krebsforschungszentrum, Div Epigenet, D-6900 Heidelberg, Germany; [Heil, Oliver] Deutsch Krebsforschungszentrum, Genom & Prote Core Facil, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hagemann, S (corresponding author), Deutsch Krebsforschungszentrum, Div Epigenet, D-6900 Heidelberg, Germany.	b.brueckner@dkfz.de			Deutsche Forschungsgemeinschaft [SPP1463]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SPP1463) to FL (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 1998, CANCER RES, V58, P95; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; MOMPARLER RL, 1984, CANCER CHEMOTH PHARM, V13, P191, DOI 10.1007/BF00269027; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; Mund C, 2005, CANCER RES, V65, P7086, DOI 10.1158/0008-5472.CAN-05-0695; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; SAKAI T, 1991, AM J HUM GENET, V48, P880; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Sarkar D, 2008, USE R, P1; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; STRESEMANN C, 2008, MOL CANC THER; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; Team RDC, 2010, R LANG ENV STAT COMP; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	46	103	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17388	10.1371/journal.pone.0017388	http://dx.doi.org/10.1371/journal.pone.0017388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408221	Green Published, gold, Green Submitted			2022-12-25	WOS:000288099800011
J	Ito, M; Johansson, J; Stromberg, R; Nilsson, L				Ito, Mika; Johansson, Jan; Stromberg, Roger; Nilsson, Lennart			Unfolding of the Amyloid beta-Peptide Central Helix: Mechanistic Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBRIL-FORMING PROTEINS; ALZHEIMERS-DISEASE; SECONDARY-STRUCTURE; FORCE-FIELDS; IN-SILICO; AGGREGATION; PREDICTION; WATER; A-BETA(1-42); SEQUENCE	Alzheimer's disease (AD) pathogenesis is associated with formation of amyloid fibrils caused by polymerization of the amyloid beta-peptide (A beta), which is a process that requires unfolding of the native helical structure of A beta. According to recent experimental studies, stabilization of the A beta central helix is effective in preventing A beta polymerization into toxic assemblies. To uncover the fundamental mechanism of unfolding of the A beta central helix, we performed molecular dynamics simulations for wild-type (WT), V18A/F19A/F20A mutant (MA), and V18L/F19L/F20L mutant (ML) models of the A beta central helix. It was quantitatively demonstrated that the stability of the alpha-helical conformation of both MA and ML is higher than that of WT, indicating that the alpha-helical propensity of the three nonpolar residues (18, 19, and 20) is the main factor for the stability of the whole A beta central helix and that their hydrophobicity plays a secondary role. WT was found to completely unfold by a three-step mechanism: 1) loss of alpha-helical backbone hydrogen bonds, 2) strong interactions between nonpolar sidechains, and 3) strong interactions between polar sidechains. WT did not completely unfold in cases when any of the three steps was omitted. MA and ML did not completely unfold mainly due to the lack of the first step. This suggests that disturbances in any of the three steps would be effective in inhibiting the unfolding of the A beta central helix. Our findings would pave the way for design of new drugs to prevent or retard AD.	[Ito, Mika; Stromberg, Roger; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Johansson, Jan] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Johansson, Jan] Karolinska Inst, Alzheimer Dis Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences; Karolinska Institutet	Ito, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	lennart.nilsson@ki.se	Nilsson, Lennart/B-7208-2009; Stromberg, Roger/C-2960-2013	Nilsson, Lennart/0000-0002-5067-6397; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council [621-2009-4590]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grant (621-2009-4590) from the Swedish Research Council (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INS 2 VERS 2000; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Caballero-Herrera A, 2005, BIOPHYS J, V89, P842, DOI 10.1529/biophysj.105.061978; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; DELOOF H, 1992, J AM CHEM SOC, V114, P4028, DOI 10.1021/ja00037a002; ELOFSSON A, 1993, J MOL BIOL, V233, P766, DOI 10.1006/jmbi.1993.1551; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; GAVEL Y, 1988, FEBS LETT, V235, P173, DOI 10.1016/0014-5793(88)81257-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh SG, 2008, J PHYS CHEM B, V112, P2767, DOI 10.1021/jp712170h; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mousseau N, 2005, ACCOUNTS CHEM RES, V38, P885, DOI 10.1021/ar050045a; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nilsson L, 2009, J COMPUT CHEM, V30, P1490, DOI 10.1002/jcc.21169; Nordling E, 2008, J COMPUT AID MOL DES, V22, P53, DOI 10.1007/s10822-007-9155-6; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shen L, 2008, J PHYS CHEM B, V112, P3164, DOI 10.1021/jp7108237; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; TIRADORIVES J, 1991, BIOCHEMISTRY-US, V30, P3864, DOI 10.1021/bi00230a009; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Triguero L, 2008, J PHYS CHEM B, V112, P7123, DOI 10.1021/jp801168v; Triguero L, 2008, J PHYS CHEM B, V112, P2159, DOI 10.1021/jp0771872; Watanabe K, 2002, BIOCHEM BIOPH RES CO, V290, P121, DOI 10.1006/bbrc.2001.6191; Watanabe K, 2001, J PEPT RES, V58, P342, DOI 10.1034/j.1399-3011.2001.00920.x; Wolf MG, 2008, J AM CHEM SOC, V130, P15772, DOI 10.1021/ja806606y; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	58	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17587	10.1371/journal.pone.0017587	http://dx.doi.org/10.1371/journal.pone.0017587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408230	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800026
J	Koprich, JB; Johnston, TH; Huot, P; Reyes, MG; Espinosa, M; Brotchie, JM				Koprich, James B.; Johnston, Tom H.; Huot, Philippe; Reyes, M. Gabriela; Espinosa, Maria; Brotchie, Jonathan M.			Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein	PLOS ONE			English	Article							TRANSGENIC MICE; RAT MODEL; OVEREXPRESSION; MUTATION; PHOSPHORYLATION; DUPLICATION; EXPRESSION; RESISTANT; NEURONS	The pathological hallmarks of Parkinson's disease (PD) are degeneration of dopamine (DA) neurons of the substantia nigra (SN) and the presence of alpha-synuclein (alpha-syn)-rich Lewy bodies in DA cells that remain. To model these aspects of the disease, we previously showed that high titer (5.1610exp12 gp/ml) AAV1/2 driven expression of A53T alpha-syn in the SN of rats caused nigrostriatal pathology including a loss of DA neurons, but also with toxicity in the GFP control group. In the current study, we evaluate the effects of two lower titers by dilution of the vector (1: 3 [1.7x10exp12] and 1: 10 [5.1x10exp11]) to define a concentration that produced pathology specific for alpha-syn. In GFP and empty vector groups there were no behavioural or post-mortem changes at 3 or 6 weeks post-administration at either vector dose. Dilution of the AAV1/2 A53T alpha-syn (1: 3) produced significant paw use asymmetry, reductions in striatal tyrosine hydroxylase (TH), and increases in DA turnover at 3 weeks in the absence of overt pathology. By 6 weeks greater evidence of pathology was observed and included, reductions in SN DA neurons, striatal DA, TH and DA-transporter, along with a sustained behavioural deficit. In contrast, the 1: 10 AAV1/2 A53T alpha-syn treated animals showed normalization between 3 and 6 weeks in paw use asymmetry, reductions in striatal TH, and increased DA turnover. Progression of dopaminergic deficits using the 1: 3 titer of AAV1/2 A53T alpha-syn provides a platform for evaluating treatments directed at preventing and/or reversing synucleinopathy. Use of the 1: 10 titer of AAV1/2 A53T alpha-syn provides an opportunity to study mechanisms of endogenous compensation. Furthermore, these data highlight the need to characterize the titer of vector being utilized, when using AAV to express pathogenic proteins and model disease process, to avoid producing non-specific effects.	[Koprich, James B.; Johnston, Tom H.; Huot, Philippe; Reyes, M. Gabriela; Espinosa, Maria; Brotchie, Jonathan M.] Toronto Western Hosp, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Koprich, JB (corresponding author), Toronto Western Hosp, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON M5T 2S8, Canada.	jkoprich@uhnres.utoronto.ca	Johnston, Tom H/D-2531-2018	Johnston, Tom H/0000-0002-1537-8175; Brotchie, Jonathan/0000-0003-2337-0816	Cure Parkinson's Trust; Krembil Foundation	Cure Parkinson's Trust; Krembil Foundation	This study was supported by The Cure Parkinson's Trust and the Krembil Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2010, MOVEMENT DISORD, V25, pS21, DOI 10.1002/mds.22722; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Madine J, 2008, MOL MEMBR BIOL, V25, P518, DOI 10.1080/09687680802467977; Maingay M, 2006, NEUROBIOL DIS, V23, P522, DOI 10.1016/j.nbd.2006.04.007; MARIEFRANCOISE C, 2008, PARKINSONISM RELAT D, V14, pS84; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mendritzki S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/375462; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; PAXINOS CWG, 1998, RAT BRAIN STEROTAXIC; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P742, DOI 10.1093/jnen/63.7.742; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TANJI K, 2010, ACTA NEUROPATHOL; Whishaw Ian Q., 2005, BEHAV LAB RAT HDB TE; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	41	68	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17698	10.1371/journal.pone.0017698	http://dx.doi.org/10.1371/journal.pone.0017698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408191	Green Submitted, gold, Green Published			2022-12-25	WOS:000288099800034
J	Rozovics, JM; Virgen-Slane, R; Semler, BL				Rozovics, Janet M.; Virgen-Slane, Richard; Semler, Bert L.			Engineered Picornavirus VPg-RNA Substrates: Analysis of a Tyrosyl-RNA Phosphodiesterase Activity	PLOS ONE			English	Article							GENOME-LINKED PROTEIN; POLIOVIRUS-INFECTED CELLS; DNA PHOSPHODIESTERASE; MESSENGER-RNA; VIRION RNA; INVITRO TRANSLATION; RETICULOCYTE LYSATE; COVALENT COMPLEXES; POLYRIBOSOMAL RNA; 5 END	Using poliovirus, the prototypic member of Picornaviridae, we have further characterized a host cell enzymatic activity found in uninfected cells, termed "unlinkase,'' that recognizes and cleaves the unique 5' tyrosyl-RNA phosphodiester bond found at the 5' end of picornavirus virion RNAs. This bond connects VPg, a viral-encoded protein primer essential for RNA replication, to the viral RNA; it is cleaved from virion RNA prior to its engaging in protein synthesis as mRNA. Due to VPg retention on nascent RNA strands and replication templates, but not on viral mRNA, we hypothesize that picornaviruses utilize unlinkase activity as a means of controlling the ratio of viral RNAs that are translated versus those that either serve as RNA replication templates or are encapsidated. To test our hypothesis and further characterize this enzyme, we have developed a novel assay to detect unlinkase activity. We demonstrate that unlinkase activity can be detected using this assay, that this unique activity remains unchanged over the course of a poliovirus infection in HeLa cells, and that unlinkase activity is unaffected by the presence of exogenous VPg or anti-VPg antibodies. Furthermore, we have determined that unlinkase recognizes and cleaves a human rhinovirus-poliovirus chimeric substrate with the same efficiency as the poliovirus substrate.	[Rozovics, Janet M.; Virgen-Slane, Richard; Semler, Bert L.] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Rozovics, JM (corresponding author), Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	blsemler@uci.edu	Semler, Bert/AAV-8795-2020	Semler, Bert/0000-0002-2424-5155; Virgen-Slane, Richard/0000-0002-0011-3844	American Asthma Foundation	American Asthma Foundation	This work was supported, in part, by research funds provided by the American Asthma Foundation, http://www.americanasthmafoundation.org/. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER SP, 1975, J BIOL CHEM, V250, P6264; AMBROS V, 1980, J BIOL CHEM, V255, P6739; AMBROS V, 1978, CELL, V15, P1439, DOI 10.1016/0092-8674(78)90067-3; AMBROS V, 1978, J BIOL CHEM, V253, P5263; ARABSHAHI A, 1986, BIOCHEMISTRY-US, V25, P5583, DOI 10.1021/bi00367a036; BALTIMOR.D, 1966, VIROLOGY, V29, P179, DOI 10.1016/0042-6822(66)90024-9; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Brunner JE, 2010, VIROLOGY, V400, P240, DOI 10.1016/j.virol.2010.01.031; CALIGUIRI LA, 1973, J GEN VIROL, V21, P99, DOI 10.1099/0022-1317-21-1-99; Cheney IW, 2003, J VIROL, V77, P7434, DOI 10.1128/JVI.77.13.7434-7443.2003; DEVARENNES A, 1986, J GEN VIROL, V67, P2347, DOI 10.1099/0022-1317-67-11-2347; DILDINE SL, 1992, J VIROL, V66, P4364, DOI 10.1128/JVI.66.7.4364-4376.1992; DOERSEN CJ, 1979, P NATL ACAD SCI USA, V76, P4549, DOI 10.1073/pnas.76.9.4549; DORNER AJ, 1981, FEBS LETT, V132, P219, DOI 10.1016/0014-5793(81)81164-7; DORNER AJ, 1984, J VIROL, V50, P507, DOI 10.1128/JVI.50.2.507-514.1984; Drygin Iu F, 1986, Biokhimiia, V51, P249; DRYGIN Y, 1988, FEBS LETT, V239, P343, DOI 10.1016/0014-5793(88)80948-7; Drygin YF, 1998, NUCLEIC ACIDS RES, V26, P4791, DOI 10.1093/nar/26.21.4791; FERNANDEZMUNOZ R, 1976, J VIROL, V18, P719, DOI 10.1128/JVI.18.2.719-726.1976; FERNANDEZMUNOZ R, 1977, J VIROL, V21, P820; FLANEGAN JB, 1977, P NATL ACAD SCI USA, V74, P961, DOI 10.1073/pnas.74.3.961; Geeganage S, 1998, BIOCHEMISTRY-US, V37, P14500, DOI 10.1021/bi9815546; GOLINI F, 1980, NATURE, V287, P600, DOI 10.1038/287600a0; Gulevich AY, 2002, BIOCHEMISTRY-MOSCOW+, V67, P615, DOI 10.1023/A:1016124202274; Haller AA, 1996, J VIROL, V70, P1467, DOI 10.1128/JVI.70.3.1467-1474.1996; HEWLETT MJ, 1976, P NATL ACAD SCI USA, V73, P327, DOI 10.1073/pnas.73.2.327; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; KUHN RJ, 1988, J VIROL, V62, P4207, DOI 10.1128/JVI.62.11.4207-4215.1988; KUHN RJ, 1988, P NATL ACAD SCI USA, V85, P519, DOI 10.1073/pnas.85.2.519; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; LEE YF, 1977, P NATL ACAD SCI USA, V74, P59, DOI 10.1073/pnas.74.1.59; Liu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001066; LLOYD RE, 1993, VIROLOGY, V194, P200, DOI 10.1006/viro.1993.1250; LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535; NOMOTO A, 1977, NATURE, V268, P208, DOI 10.1038/268208a0; NOMOTO A, 1977, P NATL ACAD SCI USA, V74, P5345, DOI 10.1073/pnas.74.12.5345; NOMOTO A, 1976, P NATL ACAD SCI USA, V73, P375, DOI 10.1073/pnas.73.2.375; NOVAK JE, 1994, GENE DEV, V8, P1726, DOI 10.1101/gad.8.14.1726; Nugent CI, 1999, J VIROL, V73, P427, DOI 10.1128/JVI.73.1.427-435.1999; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PETTERSSON RF, 1977, NATURE, V268, P270, DOI 10.1038/268270a0; PETTERSSON RF, 1978, J VIROL, V27, P357, DOI 10.1128/JVI.27.2.357-365.1978; PFISTER T, 1992, VIROLOGY, V188, P676, DOI 10.1016/0042-6822(92)90522-Q; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; ROTHBERG PG, 1978, P NATL ACAD SCI USA, V75, P4868, DOI 10.1073/pnas.75.10.4868; SANGAR DV, 1981, J VIROL, V39, P67, DOI 10.1128/JVI.39.1.67-74.1981; Shabanov AA, 1996, BIOCHEMISTRY-MOSCOW+, V61, P794; TOYODA H, 1987, J VIROL, V61, P2816, DOI 10.1128/JVI.61.9.2816-2822.1987; Walter BL, 2002, J VIROL, V76, P12008, DOI 10.1128/JVI.76.23.12008-12022.2002; WIMMER E, 1982, CELL, V28, P199, DOI 10.1016/0092-8674(82)90335-X; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	54	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16559	10.1371/journal.pone.0016559	http://dx.doi.org/10.1371/journal.pone.0016559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408223	Green Published, gold			2022-12-25	WOS:000288099800004
J	Zhao, JX; Yue, WF; Zhu, MJ; Du, M				Zhao, Jun-Xing; Yue, Wan-Fu; Zhu, Mei-Jun; Du, Min			AMP-activated Protein Kinase Regulates beta-Catenin Transcription via Histone Deacetylase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE REGENERATION; PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; NUCLEAR EXPORT; ADIPOCYTE DIFFERENTIATION; MYOGENIC DIFFERENTIATION; DIRECT PHOSPHORYLATION; CHROMATIN-STRUCTURE; 3T3-L1 CELLS; P19 CELLS	AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism; it is inhibited under obese conditions and is activated by exercise and by many anti-diabetic drugs. Emerging evidence also suggests that AMPK regulates cell differentiation, but the underlying mechanisms are unclear. We hypothesized that AMPK regulates cell differentiation via altering beta-catenin expression, which involves phosphorylation of class IIa histone deacetylase 5 (HDAC5). In both C3H10T1/2 cells and mouse embryonic fibroblasts (MEFs), AMPK activity was positively correlated with beta-catenin content. Chemical inhibition of HDAC5 increased beta-catenin mRNA expression. HDAC5 overexpression reduced and HDAC5 knockdown increased H3K9 acetylation and cellular beta-catenin content. HDAC5 formed a complex with myocyte enhancer factor-2 to down-regulate beta-catenin mRNA expression. AMPK phosphorylated HDAC5, which promoted HDAC5 exportation from the nucleus; mutation of two phosphorylation sites in HDAC5, Ser-259 and -498, abolished the regulatory role of AMPK on beta-catenin expression. In conclusion, AMPK promotes beta-catenin expression through phosphorylation of HDAC5, which reduces HDAC5 interaction with the beta-catenin promoter via myocyte enhancer factor-2. Thus, the data indicate that AMPK regulates cell differentiation and development via cross-talk with the wingless and Int (Wnt)/beta-catenin signaling pathway.	[Zhao, Jun-Xing; Yue, Wan-Fu; Zhu, Mei-Jun; Du, Min] Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Laramie, WY 82071 USA	University of Wyoming	Du, M (corresponding author), Dept 3684,1000 E Univ Ave, Laramie, WY 82071 USA.	mindu@uwyo.edu	Zhu, Mei-Jun/A-4248-2013; Du, Min/H-4311-2011	Du, Min/0000-0002-7232-072X	National Institutes of Health [1R01HD067449, INBRE P20RR016474, 1R03HD057506]; USDA-NRI [2008-35206-18826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057506] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NRI(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HD067449, INBRE P20RR016474, and 1R03HD057506, and by USDA-NRI 2008-35206-18826.	Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; De Santa F, 2007, MOL CELL BIOL, V27, P7248, DOI 10.1128/MCB.02199-06; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Inoue E, 2006, BIOCHEM BIOPH RES CO, V351, P793, DOI 10.1016/j.bbrc.2006.10.124; Kasai T, 2009, J CELL PHYSIOL, V221, P740, DOI 10.1002/jcp.21917; Kim J, 2004, J APPL PHYSIOL, V96, P575, DOI 10.1152/japplphysiol.00909.2003; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kuribayashi T, 2010, INT J MOL MED, V25, P25, DOI 10.3892/ijmm_00000309; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; LIU ML, 1994, J BIOL CHEM, V269, P28514; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2007, APPL PHYSIOL NUTR ME, V32, P852, DOI 10.1139/H07-082; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Osler ME, 2008, ENDOCRINOLOGY, V149, P935, DOI 10.1210/en.2007-1441; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Shang YC, 2007, CYTOTHERAPY, V9, P667, DOI 10.1080/14653240701508437; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Steinberg GR, 2009, FRONT BIOSCI-LANDMRK, V14, P1902, DOI 10.2741/3350; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Tamura Masato, 2010, Front Biosci (Elite Ed), V2, P1405; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Vaughan OA, 2001, J CELL SCI, V114, P2577; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Yamanouchi K, 2007, J REPROD DEVELOP, V53, P51, DOI 10.1262/jrd.18094; Yan X, 2010, ENDOCRINOLOGY, V151, P380, DOI 10.1210/en.2009-0849; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633	66	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.199372	http://dx.doi.org/10.1074/jbc.M110.199372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454484	Green Published, hybrid			2022-12-25	WOS:000290022800080
J	Delvenne, JF; Castronovo, J; Demeyere, N; Humphreys, GW				Delvenne, Jean-Francois; Castronovo, Julie; Demeyere, Nele; Humphreys, Glyn W.			Bilateral Field Advantage in Visual Enumeration	PLOS ONE			English	Article							MAGIC NUMBER 4; INTERHEMISPHERIC INTERACTION; NEUROPSYCHOLOGICAL EVIDENCE; HEMISPHERES; CAPACITY; SYSTEMS; SPECIALIZATION; INFORMATION; INTEGRATION; HEMIFIELDS	A number of recent studies have demonstrated superior visual processing when the information is distributed across the left and right visual fields than if the information is presented in a single hemifield (the bilateral field advantage). This effect is thought to reflect independent attentional resources in the two hemifields and the capacity of the neural responses to the left and right hemifields to process visual information in parallel. Here, we examined whether a bilateral field advantage can also be observed in a high-level visual task that requires the information from both hemifields to be combined. To this end, we used a visual enumeration task-a task that requires the assimilation of separate visual items into a single quantity-where the to-be-enumerated items were either presented in one hemifield or distributed between the two visual fields. We found that enumerating large number (> 4 items), but not small number (< 4 items), exhibited the bilateral field advantage: enumeration was more accurate when the visual items were split between the left and right hemifields than when they were all presented within the same hemifield. Control experiments further showed that this effect could not be attributed to a horizontal alignment advantage of the items in the visual field, or to a retinal stimulation difference between the unilateral and bilateral displays. These results suggest that a bilateral field advantage can arise when the visual task involves inter-hemispheric integration. This is in line with previous research and theory indicating that, when the visual task is attentionally demanding, parallel processing by the neural responses to the left and right hemifields can expand the capacity of visual information processing.	[Delvenne, Jean-Francois; Castronovo, Julie] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Castronovo, Julie] Univ Louvain, Louvain, Belgium; [Demeyere, Nele; Humphreys, Glyn W.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Leeds; University of Birmingham	Delvenne, JF (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	j.f.delvenne@leeds.ac.uk	Delvenne, Jean-Francois/B-4646-2008; Demeyere, Nele/G-3974-2015	Delvenne, Jean-Francois/0000-0002-1990-9738; Demeyere, Nele/0000-0003-0416-5147	Belgian National Fund for Scientific Research	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Belgian National Fund for Scientific Research (www.frs-fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; BELGER A, 1992, NEUROPSYCHOLOGIA, V30, P923, DOI 10.1016/0028-3932(92)90036-L; Castronovo J, 2007, J EXP PSYCHOL HUMAN, V33, P1089, DOI 10.1037/0096-1523.33.5.1089; Colvin MK, 2005, BRAIN COGNITION, V57, P43, DOI 10.1016/j.bandc.2004.08.019; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; DEHAENE S, 1994, J EXP PSYCHOL HUMAN, V20, P958, DOI 10.1037/0096-1523.20.5.958; Delvenne JF, 2005, COGNITION, V96, pB79, DOI 10.1016/j.cognition.2004.12.007; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FRIEDMAN A, 1981, J EXP PSYCHOL HUMAN, V7, P1031, DOI 10.1037/0096-1523.7.5.1031; Humphreys GW, 2000, VISION RES, V40, P1569, DOI 10.1016/S0042-6989(00)00042-0; Jackson N, 2004, LATERALITY, V9, P53, DOI 10.1080/13576500244000256; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Kimura D, 1966, NEUROPSYCHOLOGIA, V16, P593; Large ME, 2008, EUR J NEUROSCI, V27, P3299, DOI 10.1111/j.1460-9568.2008.06270.x; LUCK SJ, 1989, NATURE, V342, P543, DOI 10.1038/342543a0; Murray MM, 2001, NEUROPSYCHOLOGIA, V39, P828, DOI 10.1016/S0028-3932(01)00004-5; MYERS RE, 1958, ARCH NEURO PSYCHIATR, V80, P298, DOI 10.1001/archneurpsyc.1958.02340090034004; Pasini M, 2001, PSYCHOL RES-PSYCH FO, V65, P57, DOI 10.1007/s004260000036; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Pillow J, 2002, NEURON, V33, P805, DOI 10.1016/S0896-6273(02)00605-0; Ratinckx E, 2001, NEUROPSYCHOLOGIA, V39, P335, DOI 10.1016/S0028-3932(00)00143-3; Ratinckx E, 2007, CORTEX, V43, P207, DOI 10.1016/S0010-9452(08)70476-3; Reardon KM, 2009, VISION RES, V49, P691, DOI 10.1016/j.visres.2009.01.005; Reynvoet B, 2004, NEUROPSYCHOLOGIA, V42, P713, DOI 10.1016/j.neuropsychologia.2003.11.013; Reynvoet B, 2008, CORTEX, V44, P728, DOI 10.1016/j.cortex.2007.12.005; Sathian K, 1999, J COGNITIVE NEUROSCI, V11, P36, DOI 10.1162/089892999563238; Scalf PE, 2007, J EXP PSYCHOL HUMAN, V33, P298, DOI 10.1037/0096-1523.33.2.298; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Watson DG, 2006, PERCEPT PSYCHOPHYS, V68, P319, DOI 10.3758/BF03193679; Watson DG, 1999, COGNITIVE NEUROPSYCH, V16, P609, DOI 10.1080/026432999380663; Weissman DH, 2000, NEUROPSYCHOLOGY, V14, P41, DOI 10.1037/0894-4105.14.1.41; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120	38	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17743	10.1371/journal.pone.0017743	http://dx.doi.org/10.1371/journal.pone.0017743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740QW	21448271	Green Published, gold			2022-12-25	WOS:000288810500011
J	Krefis, AC; Schwarz, NG; Nkrumah, B; Acquah, S; Loag, W; Oldeland, J; Sarpong, N; Adu-Sarkodie, Y; Ranft, U; May, J				Krefis, Anne Caroline; Schwarz, Norbert Georg; Nkrumah, Bernard; Acquah, Samuel; Loag, Wibke; Oldeland, Jens; Sarpong, Nimako; Adu-Sarkodie, Yaw; Ranft, Ulrich; May, Juergen			Spatial Analysis of Land Cover Determinants of Malaria Incidence in the Ashanti Region, Ghana	PLOS ONE			English	Article							WESTERN KENYAN HIGHLANDS; ANOPHELES-ARABIENSIS; SATELLITE IMAGERY; ENVIRONMENTAL-CHANGE; LARVAL HABITATS; RAIN-FOREST; CHILDREN; RISK; AREA; TRANSMISSION	Malaria belongs to the infectious diseases with the highest morbidity and mortality worldwide. As a vector-borne disease malaria distribution is strongly influenced by environmental factors. The aim of this study was to investigate the association between malaria risk and different land cover classes by using high-resolution multispectral Ikonos images and Poisson regression analyses. The association of malaria incidence with land cover around 12 villages in the Ashanti Region, Ghana, was assessed in 1,988 children < 15 years of age. The median malaria incidence was 85.7 per 1,000 inhabitants and year (range 28.4-272.7). Swampy areas and banana/plantain production in the proximity of villages were strong predictors of a high malaria incidence. An increase of 10% of swampy area coverage in the 2 km radius around a village led to a 43% higher incidence (relative risk [RR] = 1.43, p < 0.001). Each 10% increase of area with banana/plantain production around a village tripled the risk for malaria (RR = 3.25, p < 0.001). An increase in forested area of 10% was associated with a 47% decrease of malaria incidence (RR = 0.53, p = 0.029). Distinct cultivation in the proximity of homesteads was associated with childhood malaria in a rural area in Ghana. The analyses demonstrate the usefulness of satellite images for the prediction of malaria endemicity. Thus, planning and monitoring of malaria control measures should be assisted by models based on geographic information systems.	[Krefis, Anne Caroline; Schwarz, Norbert Georg; Loag, Wibke; May, Juergen] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Ranft, Ulrich] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Nkrumah, Bernard; Acquah, Samuel; Sarpong, Nimako] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Oldeland, Jens] Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany; [Oldeland, Jens] Univ Hamburg, Bot Garden, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Hamburg; University of Hamburg	Krefis, AC (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	krefis@bni-hamburg.de	Oldeland, Jens/A-1587-2012; May, Jürgen/E-7857-2011; Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837; Oldeland, Jens/0000-0002-7833-4903; May, Jurgen/0000-0001-7831-8420; Acquah, Samuel/0000-0002-3896-2665	Swiss Foundation	Swiss Foundation(Swiss National Science Foundation (SNSF))	This work was supported by a Swiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; Anosike JC, 2007, ANN AGR ENV MED, V14, P31; BECK LR, 1994, AM J TROP MED HYG, V51, P271, DOI 10.4269/ajtmh.1994.51.271; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; CABRERA B D, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P398; De Jong S. M., 2004, REMOTE SENSING IMAGE; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, V2nd; Kalyani S., 2010, INT J ENG SCI TECH, V2, P175, DOI DOI 10.4314/IJEST.V2I3.59189; KERR J. A., 1933, BULL ENT RES [LONDON], V24, P493, DOI 10.1017/S0007485300035458; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lawrence R, 2006, PHOTOGRAMM ENG REM S, V72, P169, DOI 10.14358/PERS.72.2.169; Leonardo L. R., 2005, Parassitologia (Rome), V47, P105; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Nihei N, 2002, JPN J INFECT DIS, V55, P160; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Roberts DR, 1996, AM J TROP MED HYG, V54, P304, DOI 10.4269/ajtmh.1996.54.304; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Russell P. F., 1934, American Journal of Tropical Medicine, V14, P139; RUSSELL PAUL F., 1934, AMER JOUR TROP MED, V14, P407; Sharma V. P., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P834; Shililu J, 2003, J MED ENTOMOL, V40, P921, DOI 10.1603/0022-2585-40.6.921; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; Uguru NP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-7; WARREL DA, 2002, ESSENTIAL MALARIOLOG; *WHO, 2009, WHO WORLD MALARIA RE; *WHO, 1982, MANUAL ENV MANAGEMEN, V66; WIE W, 2008, ISPRS, V37, P667; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90; 2002, HI STAR HLTH IMPROVE; 2010, INFORM ALL DISTRICTS	47	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17905	10.1371/journal.pone.0017905	http://dx.doi.org/10.1371/journal.pone.0017905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448277	gold, Green Published			2022-12-25	WOS:000288810500020
J	Stern, CM; Luoma, JI; Meitzen, J; Mermelstein, PG				Stern, Christopher M.; Luoma, Jessie I.; Meitzen, John; Mermelstein, Paul G.			Corticotropin Releasing Factor-Induced CREB Activation in Striatal Neurons Occurs via a Novel G beta gamma Signaling Pathway	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; MEMBRANE ESTROGEN-RECEPTORS; ADENYLATE-CYCLASE ACTIVITY; NUCLEUS-ACCUMBENS; RAT-BRAIN; GENE-EXPRESSION; DOPAMINE NEURONS; DRUG-ADDICTION; CRF RECEPTORS	The peptide corticotropin-releasing factor (CRF) was initially identified as a critical component of the stress response. CRF exerts its cellular effects by binding to one of two cognate G-protein coupled receptors (GPCRs), CRF receptor 1 (CRFR1) or 2 (CRFR2). While these GPCRs were originally characterized as being coupled to G alpha(s), leading to downstream activation of adenylyl cyclase (AC) and subsequent increases in cAMP, it has since become clear that CRFRs couple to and activate numerous other downstream signaling cascades. In addition, CRF signaling influences the activity of many diverse brain regions, affecting a variety of behaviors. One of these regions is the striatum, including the nucleus accumbens (NAc). CRF exerts profound effects on striatal-dependent behaviors such as drug addiction, pair-bonding, and natural reward. Recent data indicate that at least some of these behaviors regulated by CRF are mediated through CRF activation of the transcription factor CREB. Thus, we aimed to elucidate the signaling pathway by which CRF activates CREB in striatal neurons. Here we describe a novel neuronal signaling pathway whereby CRF leads to a rapid G beta gamma- and MEK-dependent increase in CREB phosphorylation. These data are the first descriptions of CRF leading to activation of a G beta gamma-dependent signaling pathway in neurons, as well as the first description of G beta gamma activation leading to downstream CREB phosphorylation in any cellular system. Additionally, these data provide additional insight into the mechanisms by which CRF can regulate neuronal function.	[Stern, Christopher M.; Luoma, Jessie I.; Mermelstein, Paul G.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Stern, Christopher M.; Luoma, Jessie I.; Meitzen, John; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stern, CM (corresponding author), Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA.	pmerm@umn.edu			National Institutes of Health (NIH) [NS41302];  [DA07234]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant NS41302 to PGM. CMS was supported by the training grant DA07234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BATTAGLIA G, 1987, SYNAPSE, V1, P572, DOI 10.1002/syn.890010610; Bayatti N, 2003, ENDOCRINOLOGY, V144, P4051, DOI 10.1210/en.2003-0168; Beckstead MJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1926, DOI 10.1038/npp.2009.25; Behan DP, 1997, J NEUROCHEM, V68, P2053; Blank T, 2003, J NEUROSCI, V23, P700, DOI 10.1523/JNEUROSCI.23-02-00700.2003; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; BROWN SA, 1995, J STUD ALCOHOL, V56, P538, DOI 10.15288/jsa.1995.56.538; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHEN FM, 1986, BRAIN RES, V381, P49; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DESOUZA EB, 1987, J NEUROSCI, V7, P88; DESOUZA EB, 1987, BRAIN RES, V437, P355, DOI 10.1016/0006-8993(87)91651-9; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Facci L, 2003, NEUROPHARMACOLOGY, V45, P623, DOI 10.1016/S0028-3908(03)00211-9; Farrow B, 2003, SURGERY, V134, P197, DOI 10.1067/msy.2003.220; Freitag A, 1998, EUR J PHARMACOL, V354, P67, DOI 10.1016/S0014-2999(98)00439-7; Fu Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-26; GLASS DB, 1989, J BIOL CHEM, V264, P14579; GOEDERS NE, 1994, PSYCHOPHARMACOLOGY, V114, P63, DOI 10.1007/BF02245445; Groth RD, 2008, EUR J NEUROSCI, V27, P31, DOI 10.1111/j.1460-9568.2007.05980.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; Guan XW, 2010, J NEUROCHEM, V115, P795, DOI 10.1111/j.1471-4159.2010.06981.x; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; HANEY M, 1995, BRAIN RES, V698, P46, DOI 10.1016/0006-8993(95)00788-R; Hara M, 2010, J NEUROCHEM, V113, P1046, DOI 10.1111/j.1471-4159.2010.06668.x; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Holahan MR, 1997, PSYCHOPHARMACOLOGY, V130, P189, DOI 10.1007/s002130050228; Iredale PA, 2000, J NEUROCHEM, V74, P199, DOI 10.1046/j.1471-4159.2000.0740199.x; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kreibich AS, 2009, NEUROPSYCHOPHARMACOL, V34, P2609, DOI 10.1038/npp.2009.91; Lawrence AJ, 2002, BRIT J PHARMACOL, V136, P896, DOI 10.1038/sj.bjp.0704783; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Meitzen J, 2011, J NEUROCHEM, V116, P984, DOI 10.1111/j.1471-4159.2010.07137.x; MERCHENTHALER I, 1984, PEPTIDES, V5, P53, DOI 10.1016/0196-9781(84)90265-1; Miczek KA, 1996, PSYCHOPHARMACOLOGY, V128, P256, DOI 10.1007/s002130050133; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; PERRIN MH, 1993, ENDOCRINOLOGY, V133, P3058, DOI 10.1210/en.133.6.3058; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Primus RJ, 1997, NEUROPSYCHOPHARMACOL, V17, P308, DOI 10.1016/S0893-133X(97)00071-7; RAMSEY NF, 1993, BRAIN RES, V608, P216, DOI 10.1016/0006-8993(93)91461-Z; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Riegel AC, 2008, NEURON, V57, P559, DOI 10.1016/j.neuron.2007.12.029; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Sarnyai Z, 1998, ANN NY ACAD SCI, V851, P371, DOI 10.1111/j.1749-6632.1998.tb09011.x; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; SHAHAM Y, 1994, PSYCHOPHARMACOLOGY, V114, P523, DOI 10.1007/BF02249346; Sheng H, 2008, ENDOCRINOLOGY, V149, P1389, DOI 10.1210/en.2007-1378; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Teli T, 2005, MOL ENDOCRINOL, V19, P474, DOI 10.1210/me.2004-0275; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Weick JP, 2003, J NEUROSCI, V23, P3446; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	88	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18114	10.1371/journal.pone.0018114	http://dx.doi.org/10.1371/journal.pone.0018114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448293	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500038
J	Custodio, G; Taques, GR; Figueiredo, BC; Gugelmin, ES; Figueiredo, MMO; Watanabe, F; Pontarolo, R; Lalli, E; Torres, LFB				Custodio, Gislaine; Taques, Guilherme R.; Figueiredo, Bonald C.; Gugelmin, Elizabeth S.; Oliveira Figueiredo, Mirna M.; Watanabe, Flora; Pontarolo, Roberto; Lalli, Enzo; Bleggi Torres, Luiz Fernando			Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; LI-FRAUMENI SYNDROME; ADRENOCORTICAL TUMORS; CANCER; CHILDHOOD; EXPERIENCE; CHILDREN; GENE	Background: Choroid plexus carcinomas (CPC) are rare tumors predominantly found in children. Given the high frequency of the germline R337H mutation in the TP53 gene in southern Brazil, we have evaluated the frequency of the R337H mutation in families with CPC in children. Methodology/Principal Findings: The present series included 29 patients that were admitted to the same institution from 1992 to 2010, including 22 children with CPC (0.08-13.6 years of age at diagnosis) and 7 children with papilloma of the choroid plexus (Pp; 0.5-9.8 years of age). Surgical resection was possible in 28 children. Blood and/or tumor DNA was extracted and analyzed using PCR-RFLP and results were confirmed by sequencing 240 bp of the TP53 exon 10. The patients, all parents, and some relatives submitted samples for blood DNA analysis. In addition, we have also examined the presence of the mutation in DNA from paraffin-embedded tumor samples to evaluate loss of heterozygosity. We found 63.3% (14/22) of the CPC patients positive for the germline R337H mutation; CPC samples were either heterozygous (n = 7), lost only the wild-type (n = 4), or only the R337H copy (n = 2). One CPC sample was not available. All Pp cases (7/7, 100%) were negative for R337H. Cure (. 5 years survival free of disease) was observed in 18.1% of the CPC cases with the R337H mutation (2/11), 71.4% of the Pp (5/7), and 25% of CPC cases negative for the R337H mutation (2/8). Family history of cancer (with 2 or more cancer cases) was exclusively identified on the parental side segregating the R337H mutation, and 50% (7/14) of them were compatible with Li-Fraumeni-like syndrome. Significance: Our results show for the first time that the R337H TP53 mutation is responsible for 63% of the CPC cases in children, suggesting a higher incidence of CPC in southern Brazil.	[Custodio, Gislaine; Taques, Guilherme R.; Figueiredo, Bonald C.; Gugelmin, Elizabeth S.; Oliveira Figueiredo, Mirna M.; Bleggi Torres, Luiz Fernando] Pele Pequeno Principe Res Inst, Curitiba, Parana, Brazil; [Figueiredo, Bonald C.] Fac Pequeno Principe, Curitiba, Parana, Brazil; [Watanabe, Flora] Pequeno Principe Hosp, Curitiba, Parana, Brazil; [Pontarolo, Roberto] Univ Fed Parana, Dept Pharmaceut Sci, BR-80060000 Curitiba, Parana, Brazil; [Lalli, Enzo] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, Alpes Maritimes, France; [Lalli, Enzo] Univ Nice, Valbonne, Alpes Maritimes, France	Hospital Pequeno Principe; Hospital Pequeno Principe; Hospital Pequeno Principe; Universidade Federal do Parana; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Custodio, G (corresponding author), Pele Pequeno Principe Res Inst, Curitiba, Parana, Brazil.	bonaldf@pelepequenoprincipe.org.br	Pontarolo, Roberto/G-6948-2014; de Figueiredo, Bonald Cavalcante/AAD-6672-2021; Lalli, Enzo/F-7052-2013	Pontarolo, Roberto/0000-0002-7049-4363; de Figueiredo, Bonald Cavalcante/0000-0002-1051-2056; Lalli, Enzo/0000-0002-0584-5681	CNPQ Brazil [302841/2009-1]; Fundacao Araucaria, PR - Brazil [398/2009]; CNRS - France	CNPQ Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria, PR - Brazil(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNRS - France(Centre National de la Recherche Scientifique (CNRS))	This work was funded by CNPQ Brazil (302841/2009-1), Fundacao Araucaria, PR - Brazil (398/2009) and CNRS - France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUZZI A, 2000, CHOROID PLEXUS TUMOR; ANG LC, 1990, CANCER, V32, P131; Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; Berger C, 1998, NEUROSURGERY, V42, P470, DOI 10.1097/00006123-199803000-00006; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; BIRCH JM, 1994, CANCER RES, V54, P1298; BLEGGITORRES LF, 2004, ARQ NEURO-PSIQUIAT, V62, P127; Chow E, 1999, INT J RADIAT ONCOL, V44, P249, DOI 10.1016/S0360-3016(98)00560-4; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Farrugia A, 2010, FORENSIC SCI INT, V194, pE25, DOI 10.1016/j.forsciint.2009.09.004; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Gessl M, 2003, BRAIN PATHOL, V13, P409; GOTTSCHALK J, 1993, CANCER, V72, P1343, DOI 10.1002/1097-0142(19930815)72:4<1343::AID-CNCR2820720432>3.0.CO;2-G; Heymann S, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-104; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McEvoy AW, 2000, PEDIATR NEUROSURG, V32, P192, DOI 10.1159/000028933; McManamy CS, 2007, BRAIN PATHOL, V17, P151, DOI 10.1111/j.1750-3639.2007.00058.x; Melo Ernesto Lima Araújo, 2003, Radiol Bras, V36, P379, DOI 10.1590/S0100-39842003000600010; Mitchel REJ, 2004, RADIAT RES, V162, P20, DOI 10.1667/RR3190; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Pianovski MAD, 2006, PEDIATR BLOOD CANCER, V47, P56, DOI 10.1002/pbc.20624; PIERGA JY, 1993, MED PEDIATR ONCOL, V21, P480, DOI 10.1002/mpo.2950210705; Pinto EM, 2005, J CLIN ENDOCR METAB, V90, P2976, DOI 10.1210/jc.2004-0963; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Tinat J, 2009, J CLIN ONCOL, V27, pE108, DOI 10.1200/JCO.2009.22.7967; Wolff JEA, 2002, BRIT J CANCER, V87, P1086, DOI 10.1038/sj.bjc.6600609	32	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18015	10.1371/journal.pone.0018015	http://dx.doi.org/10.1371/journal.pone.0018015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445348	Green Submitted, gold, Green Published			2022-12-25	WOS:000288809100024
J	Fiorenza, L; Benazzi, S; Tausch, J; Kullmer, O; Bromage, TG; Schrenk, F				Fiorenza, Luca; Benazzi, Stefano; Tausch, Jeremy; Kullmer, Ottmar; Bromage, Timothy G.; Schrenk, Friedemann			Molar Macrowear Reveals Neanderthal Eco-Geographic Dietary Variation	PLOS ONE			English	Article							NITROGEN STABLE-ISOTOPES; TOOTH WEAR; JAW MOVEMENTS; KEBARA CAVE; MIDDLE; MORPHOLOGY; MAMMALS; ISRAEL; SITE; EXPLOITATION	Neanderthal diets are reported to be based mainly on the consumption of large and medium sized herbivores, while the exploitation of other food types including plants has also been demonstrated. Though some studies conclude that early Homo sapiens were active hunters, the analyses of faunal assemblages, stone tool technologies and stable isotopic studies indicate that they exploited broader dietary resources than Neanderthals. Whereas previous studies assume taxon-specific dietary specializations, we suggest here that the diet of both Neanderthals and early Homo sapiens is determined by ecological conditions. We analyzed molar wear patterns using occlusal fingerprint analysis derived from optical 3D topometry. Molar macrowear accumulates during the lifespan of an individual and thus reflects diet over long periods. Neanderthal and early Homo sapiens maxillary molar macrowear indicates strong eco-geographic dietary variation independent of taxonomic affinities. Based on comparisons with modern hunter-gatherer populations with known diets, Neanderthals as well as early Homo sapiens show high dietary variability in Mediterranean evergreen habitats but a more restricted diet in upper latitude steppe/coniferous forest environments, suggesting a significant consumption of high protein meat resources.	[Fiorenza, Luca; Kullmer, Ottmar; Schrenk, Friedemann] Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany; [Fiorenza, Luca] Univ New England, Palaeoanthropol Dept, Fac Arts & Sci, Armidale, NSW, Australia; [Benazzi, Stefano] Univ Vienna, Dept Anthropol, Vienna, Austria; [Tausch, Jeremy] Borough Manhattan Community Coll, Dept Sci, New York, NY USA; [Tausch, Jeremy; Schrenk, Friedemann] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	Senckenberg Gesellschaft fur Naturforschung (SGN); University of New England; University of Vienna; Goethe University Frankfurt; New York University; New York University	Fiorenza, L (corresponding author), Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany.	lfiorenza@senckenberg.de	Benazzi, Stefano/AAH-3923-2020; bromage, timothy/H-8621-2015	Kullmer, Ottmar/0000-0002-5929-8070; Benazzi, Stefano/0000-0003-4305-6920; bromage, timothy/0000-0002-9843-7993; Fiorenza, Luca/0000-0001-7110-3398	EU Marie Curie Training Network [MRTN-CT-2005-019564 EVAN]; Max Planck Society; Alexander von Humboldt Foundation; German Research Foundation (DFG); Research Unit 771	EU Marie Curie Training Network(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Research Unit 771	Funding was obtained from EU Marie Curie Training Network MRTN-CT-2005-019564 EVAN. Research support from the 2010 Max Planck Research Award to TGB was provided by the Max Planck Society and the Alexander von Humboldt Foundation in respect to the Hard Tissue Research Program in Human Paleobiomics, and from the German Research Foundation (DFG) and the Research Unit 771. Function and performance enhancement in the mammalian dentition - phylogenetic and ontogenetic impact on the masticatory apparatus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy M, 2006, MG ORAL SCI, V20, P17, DOI 10.1159/000093348; Albert RM, 2000, J ARCHAEOL SCI, V27, P931, DOI 10.1006/jasc.2000.0507; Ames K. M., 1999, PEOPLES NW COAST THE; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bailey S, 2002, THESIS ARIZONA STATE; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey S, 2006, PERIOD BIOL, V108, P253; Barton Nick, 2000, P211; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Benazzi S, 2011, AM J PHYS ANTHROPOL, V144, P309, DOI 10.1002/ajpa.21413; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2001, J HUM EVOL, V40, P497, DOI 10.1006/jhev.2000.0452; BOSINSKI G, 2000, HUNTERS GOLDEN AGE M, V30, P271; Brand-Miller JC, 1998, NUTR RES REV, V11, P5, DOI 10.1079/NRR19980003; Bridges E. Lucas, 1948, UTTERMOST PART EARTH; Burke A, 2004, INT J OSTEOARCHAEOL, V14, P155, DOI 10.1002/oa.752; Butler PM., 1981, DENT ANATOMY EMBRYOL; Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101; CROMPTON AW, 1970, L ZOOL J LINN SOC, V49, P21; Douglas G. D., 1997, SCI PRACTICE OCCLUSI, P69; Drucker D, 2004, INT J OSTEOARCHAEOL, V14, P162, DOI 10.1002/oa.753; ELZAATARI S, 2007, THESIS BROOK U; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Fiorenza L, 2011, ANAT REC, V294, P453, DOI 10.1002/ar.21325; Fiorenza L, 2010, AM J PHYS ANTHROPOL, V143, P306, DOI 10.1002/ajpa.21311; Fiorenza L, 2009, J ANTHROPOL SCI, V87, P211; FIZET M, 1995, J ARCHAEOL SCI, V22, P67, DOI 10.1016/S0305-4403(95)80163-4; FRAYER DW, 1987, AM J PHYS ANTHROPOL, V74, P393, DOI 10.1002/ajpa.1330740311; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; GORDON KD, 1984, ARCH ORAL BIOL, V29, P783, DOI 10.1016/0003-9969(84)90007-4; Grippo JO, 2004, J AM DENT ASSOC, V135, P1109, DOI 10.14219/jada.archive.2004.0369; HAHN J, 2000, HUNTERS GOLDEN AGE M; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hastorf Christine A., 1988, CURRENT PALEOETHNOBO, P119; Heinbecker P, 1928, J BIOL CHEM, V80, P461; HENRY GA, 2008, PALEOANTRHOPOLOGY 20, pA11; Hiiemae K.M., 1978, P359; Hillson S, 2003, DENT ANTHR; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; HYLANDER WL, 1980, AM J PHYS ANTHROPOL, V52, P239; Janis C.M., 1990, P241; JANIS CM, 1979, PALEOBIOLOGY, V5, P50, DOI 10.1017/S0094837300006291; Kaidonis JA, 2008, CLIN ORAL INVEST, V12, pS21, DOI 10.1007/s00784-007-0154-8; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; KAY RF, 1978, BIOL ARBOREAL FOLIVO, P173; Kraus B. S., 1969, DENT ANATOMY OCCLUSI; Krueger KL, 2008, AM J PHYS ANTHROPOL, V137, P485, DOI 10.1002/ajpa.20928; Kullmer Ottmar, 2002, BAR International Series, V1049, P71; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Lalueza C, 1996, AM J PHYS ANTHROPOL, V100, P367, DOI 10.1002/(SICI)1096-8644(199607)100:3<367::AID-AJPA5>3.0.CO;2-R; LEE R B, 1973, Ecology of Food and Nutrition, V2, P307; LEE RB, 1978, BUSHMEN SAN HUNTERS, P98; Lee RB., 1976, KALAHARI HUNTER GATH; Lev E, 2005, J ARCHAEOL SCI, V32, P475, DOI 10.1016/j.jas.2004.11.006; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lucas P., 2004, DENT FUNCTIONAL MORP; Madella M, 2002, J ARCHAEOL SCI, V29, P703, DOI 10.1006/jasc.2001.0743; MAIER W, 1981, Zeitschrift fuer Morphologie und Anthropologie, V72, P127; Maier W., 1980, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; Mann A.E., 1981, P10; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; MILLS JRE, 1967, ARCH ORAL BIOL, V12, P645, DOI 10.1016/0003-9969(67)90083-0; MOLNAR S, 1972, CURR ANTHROPOL, V13, P511, DOI 10.1086/201284; ODEA K, 1991, PHILOS T ROY SOC B, V334, P233, DOI 10.1098/rstb.1991.0112; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Patou-Mathis M, 2000, INT J OSTEOARCHAEOL, V10, P379, DOI 10.1002/1099-1212(200009/10)10:5<379::AID-OA558>3.0.CO;2-4; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; PERLES C, 2000, HUNTERS GOLDEN AGE M, P375; Popowics TE, 1997, ANN ZOOL FENN, V34, P73; Richards MP, 2008, J HUM EVOL, V55, P179, DOI 10.1016/j.jhevol.2008.02.007; Richards M, 2008, J ARCHAEOL SCI, V35, P1251, DOI 10.1016/j.jas.2007.08.018; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; SAHLINS M, 1968, MAN HUNTER, P85; Schulz D., 2003, NAT NATURGEMASSE A 1; SCHULZ D, 2004, BASISWISSEN DATENUBE; Silberbauer GeorgeB., 1981, HUNTER HABITAT CENTR; SINCLAIR HM, 1953, P NUTR SOC, V12, P69, DOI 10.1079/PNS19530016; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Stewart JR, 2004, INT J OSTEOARCHAEOL, V14, P178, DOI 10.1002/oa.754; Stiner MC, 1994, HONOR THIEVES; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; SVOBODA J, 2000, HUNTERS GOLDEN AGE M; Teaford M. F., 2007, EVOLUTION HOMININ DI, P106; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Ulhaas L, 2004, ANN ANAT, V186, P487, DOI 10.1016/S0940-9602(04)80090-6; Ulhaas L, 2007, VERTEBR PALEOBIOL PA, P369, DOI 10.1007/978-1-4020-5845-5_24; UNGAR PS, 2000, PALAEONTOLOGIA ELECT, V3; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Wall CE, 2006, AM J PHYS ANTHROPOL, V129, P215, DOI 10.1002/ajpa.20290; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; [No title captured]	98	84	85	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14769	10.1371/journal.pone.0014769	http://dx.doi.org/10.1371/journal.pone.0014769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	737CD	21445243	gold, Green Published			2022-12-25	WOS:000288545100005
J	Miyazawa, S				Miyazawa, Sanzo			Selective Constraints on Amino Acids Estimated by a Mechanistic Codon Substitution Model with Multiple Nucleotide Changes	PLOS ONE			English	Article							ESTIMATING EVOLUTIONARY RATES; DNA-SEQUENCES; PROTEIN; TRANSITION; PHYLOGENY; FREQUENCY; MATRICES; SITES	Background: Empirical substitution matrices represent the average tendencies of substitutions over various protein families by sacrificing gene-level resolution. We develop a codon-based model, in which mutational tendencies of codon, a genetic code, and the strength of selective constraints against amino acid replacements can be tailored to a given gene. First, selective constraints averaged over proteins are estimated by maximizing the likelihood of each 1-PAM matrix of empirical amino acid (JTT, WAG, and LG) and codon (KHG) substitution matrices. Then, selective constraints specific to given proteins are approximated as a linear function of those estimated from the empirical substitution matrices. Results: Akaike information criterion (AIC) values indicate that a model allowing multiple nucleotide changes fits the empirical substitution matrices significantly better. Also, the ML estimates of transition-transversion bias obtained from these empirical matrices are not so large as previously estimated. The selective constraints are characteristic of proteins rather than species. However, their relative strengths among amino acid pairs can be approximated not to depend very much on protein families but amino acid pairs, because the present model, in which selective constraints are approximated to be a linear function of those estimated from the JTT/WAG/LG/KHG matrices, can provide a good fit to other empirical substitution matrices including cpREV for chloroplast proteins and mtREV for vertebrate mitochondrial proteins. Conclusions/Significance: The present codon-based model with the ML estimates of selective constraints and with adjustable mutation rates of nucleotide would be useful as a simple substitution model in ML and Bayesian inferences of molecular phylogenetic trees, and enables us to obtain biologically meaningful information at both nucleotide and amino acid levels from codon and protein sequences.	Gunma Univ, Grad Sch Engn, Gunma, Japan	Gunma University	Miyazawa, S (corresponding author), Gunma Univ, Grad Sch Engn, Gunma, Japan.	miyazawa@smlab.sci.gunma-u.ac.jp	Miyazawa, Sanzo/V-5550-2017	Miyazawa, Sanzo/0000-0002-5063-3661	Gunma University	Gunma University	This work was supported by Gunma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; Choi SC, 2007, MOL BIOL EVOL, V24, P1769, DOI 10.1093/molbev/msm097; Conant GC, 2007, MOL PHYLOGENET EVOL, V42, P298, DOI 10.1016/j.ympev.2006.07.006; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Delport W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011587; Dimmic M W, 2000, Pac Symp Biocomput, P18; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; JIN L, 1990, MOL BIOL EVOL, V7, P82; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinjo AR, 2004, BIOINFORMATICS, V20, P2504, DOI 10.1093/bioinformatics/bth297; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Rodrigue N, 2008, GENETICS, V180, P1579, DOI 10.1534/genetics.108.092254; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Smith NGC, 2003, MOL BIOL EVOL, V20, P47, DOI 10.1093/molbev/msg003; TAKAHATA N, 1987, GENETICS, V116, P169; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2004, GENETICS, V167, P2027, DOI 10.1534/genetics.103.023226; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17244	10.1371/journal.pone.0017244	http://dx.doi.org/10.1371/journal.pone.0017244			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445250	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100012
J	Tan, CYQ; Ninove, L; Gaudart, J; Nougairede, A; Zandotti, C; Thirion-Perrier, L; Charrel, RN; de Lamballerie, X				Tan, Charlene Y. Q.; Ninove, Laetitia; Gaudart, Jean; Nougairede, Antoine; Zandotti, Christine; Thirion-Perrier, Laurence; Charrel, Remi N.; de Lamballerie, Xavier			A Retrospective Overview of Enterovirus Infection Diagnosis and Molecular Epidemiology in the Public Hospitals of Marseille, France (1985-2005)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ASEPTIC-MENINGITIS; FREQUENT RECOMBINATION; DIRECT IDENTIFICATION; ECHOVIRUS TYPE-30; EVOLUTION; VP1; OUTBREAK; SEQUENCE; GENOME	Human enteroviruses (HEV) are frequent human pathogens and, associated in particular with large outbreaks of aseptic meningitis. Here, we have compiled a database of clinical HEV isolates from the Public Hospitals of Marseille, from 1985 to 2005. Amongst 654 isolates that could be characterized by complete sequencing of the VP1 gene, 98% belonged to species HEV-B; the most frequently isolated serotypes were Echovirus E30, E11, E7, E6 and E4. The high incidence of E30 and the recent emergence of E13 are consistent with reports worldwide and peak HEV isolation occurred mostly in the late spring and summer months. The proportion of echoviruses has decreased across the years, while that of coxsackieviruses has increased. Stool (the most frequent sample type) allowed detection of all identified serotypes. MRC5 (Human lung fibroblasts) cell line was the most conducive cell line for HEV isolation (84.9% of 10 most common serotype isolates, 96.3% in association with BGM (Buffalo green monkey kidney cells)). Previous seroneutralization-based serotype identification demonstrated 55.4% accuracy when compared with molecular VP1 analysis. Our analysis of a large number of clinical strains over 20 years reinforced the validity of VP1 serotyping and showed that comparative p-distance scores can be coupled with phylogenetic analysis to provide non-ambiguous serotype identification. Phylogenetic analysis in the VP1, 2C and 3D regions also provided evidence for recombination events amongst clinical isolates. In particular, it identified isolates with dissimilar VP1 but almost identical nonstructural regions.	[Tan, Charlene Y. Q.; Ninove, Laetitia; Nougairede, Antoine; Thirion-Perrier, Laurence; Charrel, Remi N.; de Lamballerie, Xavier] Univ Mediterranee, Inst Rech Dev, Unite Virus Emergents UMR190, Marseille, France; [Ninove, Laetitia; Nougairede, Antoine; Zandotti, Christine; Charrel, Remi N.; de Lamballerie, Xavier] Assistance Publ Hop Marseille, Marseille, France; [Gaudart, Jean] Univ Mediterranee, Biostat Res Unit, LERTIM EA3283, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Tan, CYQ (corresponding author), Univ Mediterranee, Inst Rech Dev, Unite Virus Emergents UMR190, Marseille, France.	charlene.tanyq@gmail.com	gaudart, jean/D-9071-2013	gaudart, jean/0000-0001-9006-5729; Charrel, Remi/0000-0002-7675-8251	Universite de la Mediterranee - Institut de Recherche pour le Developpement	Universite de la Mediterranee - Institut de Recherche pour le Developpement	This study was funded by Universite de la Mediterranee - Institut de Recherche pour le Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4; Avellon A, 2003, EMERG INFECT DIS, V9, P934; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bernit E, 2004, MEDICINE, V83, P245, DOI 10.1097/01.md.0000133623.27828.27; BREIMAN L., 1984, CRC PRESS; Cabrerizo M, 2008, J MED VIROL, V80, P1018, DOI 10.1002/jmv.21197; Chen TC, 2008, J ANTIMICROB CHEMOTH, V62, P1169, DOI 10.1093/jac/dkn424; CHERRY JD, 1992, TXB PEDIAT INFECT DI, P1705; Davies M, 2003, LANCET, V361, P1187, DOI 10.1016/S0140-6736(03)12919-4; deLamballerie X, 1997, J GEN VIROL, V78, P45, DOI 10.1099/0022-1317-78-1-45; DIEDRICH S, 1995, J MED VIROL, V46, P148, DOI 10.1002/jmv.1890460212; dos Santos GPL, 2006, J MED VIROL, V78, P98, DOI 10.1002/jmv.20509; *GLOB POL ER IN, 2009, STRAT PLAN 2009 2013; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HEWLETT MJ, 1980, P NATL ACAD SCI-BIOL, V77, P303, DOI 10.1073/pnas.77.1.303; Hyypia T, 1997, J GEN VIROL, V78, P1; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitch ECM, 2009, J CLIN VIROL, V44, P119, DOI 10.1016/j.jcv.2008.11.015; LIM KA, 1960, J IMMUNOL, V84, P309; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Malvy Denis J.-M., 1993, Public Health Reviews, V21, P41; Melnick J, 1996, FIELDS VIROLOGY, P655; Mirand A, 2008, J CLIN MICROBIOL, V46, P87, DOI 10.1128/JCM.01020-07; Mizuta K, 2003, J INFECTION, V47, P243, DOI 10.1016/S0163-4453(03)00081-1; *MMWR, 2006, MMWR-MORBID MORTAL W, V55, P153; Montgomery DC., 2000, INTRO STAT QUALITY C; Mullins JA, 2004, CLIN INFECT DIS, V38, P70, DOI 10.1086/380462; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Ozkaya E, 2003, EUR J EPIDEMIOL, V18, P823, DOI 10.1023/A:1025334116364; Pallansch M., 2007, FIELDS VIROLOGY, P840; Poyry T, 1996, J GEN VIROL, V77, P1699, DOI 10.1099/0022-1317-77-8-1699; Rotbart HA, 2000, SEMIN NEUROL, V20, P277, DOI 10.1055/s-2000-9427; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Scrucca L, 2004, R NEWS, V4, P22; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Tebruegge M, 2009, SEMIN FETAL NEONAT M, V14, P222, DOI 10.1016/j.siny.2009.02.002; TRABELSI A, 1995, J CLIN MICROBIOL, V33, P2454, DOI 10.1128/JCM.33.9.2454-2457.1995; Trallero G, 2010, J CLIN VIROL, V47, P170, DOI 10.1016/j.jcv.2009.11.013; Wang JR, 2002, J CLIN MICROBIOL, V40, P4439, DOI 10.1128/JCM.40.12.4439-4444.2002; Watkins-Riedel T, 2002, DIAGN MICR INFEC DIS, V42, P99, DOI 10.1016/S0732-8893(01)00330-3; WINCKEL P, 2007, STAT DEV QUALITY MED; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	53	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18022	10.1371/journal.pone.0018022	http://dx.doi.org/10.1371/journal.pone.0018022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437207	gold, Green Submitted, Green Published			2022-12-25	WOS:000288545100061
J	Ungerback, J; Elander, N; Grunberg, J; Sigvardsson, M; Soderkvist, P				Ungerback, Jonas; Elander, Nils; Grunberg, John; Sigvardsson, Mikael; Soderkvist, Peter			The Notch-2 Gene Is Regulated by Wnt Signaling in Cultured Colorectal Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; TUMOR-SUPPRESSOR; PROGENITOR CELLS; COLON-CANCER; STEM-CELLS; TUMORIGENESIS; ACTIVATION; EXPRESSION; INTESTINE	Background: Notch and Wnt pathways are key regulators of intestinal homeostasis and alterations in these pathways may lead to the development of colorectal cancer (CRC). In CRC the Apc/beta-catenin genes in the Wnt signaling pathway are frequently mutated and active Notch signaling contributes to tumorigenesis by keeping the epithelial cells in a proliferative state. These pathways are simultaneously active in proliferative adenoma cells and a crosstalk between them has previously been suggested in normal development as well as in cancer. Principal Findings: In this study, in silico analysis of putative promoters involved in transcriptional regulation of genes coding for proteins in the Notch signaling pathway revealed several putative LEF-1/TCF sites as potential targets for beta-catenin and canonical Wnt signaling. Further results from competitive electrophoretic mobility-shift assay (EMSA) studies suggest binding of several putative sites in Notch pathway gene promoters to in vitro translated beta-catenin/Lef-1. Wild type (wt)-Apc negatively regulates beta-catenin. By induction of wt-Apc or beta-catenin silencing in HT29 cells, we observed that several genes in the Notch pathway, including Notch-2, were downregulated. Finally, active Notch signaling was verified in the Apc(Min/+) mouse model where Hes-1 mRNA levels were found significantly upregulated in intestinal tumors compared to normal intestinal mucosa. Luciferase assays showed an increased activity for the core and proximal Notch-2 promoter upon co-transfection of HCT116 cells with high expression recombinant Tcf-4, Lef-1 or beta-catenin. Conclusions: In this paper, we identified Notch-2 as a novel target for beta-catenin-dependent Wnt signaling. Furthermore our data supports the notion that additional genes in the Notch pathway might be transcriptionally regulated by Wnt signaling in colorectal cancer.	[Ungerback, Jonas; Elander, Nils; Grunberg, John; Sigvardsson, Mikael; Soderkvist, Peter] Linkoping Univ, Fac Hlth Sci, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Ungerback, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden.	jonas.ungerback@liu.se		Grunberg, John/0000-0002-7839-2302; Sigvardsson, Mikael/0000-0001-8527-7276	Swedish Research Council; Ostergotland County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ostergotland County Council	This work was funded by the Swedish Research Council and Ostergotland County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ambler CA, 2007, DEV DYNAM, V236, P1595, DOI 10.1002/dvdy.21151; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; CHU D, 2009, ANN SURG ONCOL; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Elander N, 2008, BIOCHEM BIOPH RES CO, V372, P249, DOI 10.1016/j.bbrc.2008.05.026; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Grego-Bessa J, 2004, CELL CYCLE, V3, P718; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jin YH, 2009, BBA-MOL CELL RES, V1793, P290, DOI 10.1016/j.bbamcr.2008.10.002; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schilham MW, 1998, SEMIN IMMUNOL, V10, P127, DOI 10.1006/smim.1998.0114; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sikandar S.S., CANC RES, V70, P1469; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhang MQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S3	67	49	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17957	10.1371/journal.pone.0017957	http://dx.doi.org/10.1371/journal.pone.0017957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437251	gold, Green Submitted, Green Published			2022-12-25	WOS:000288545100048
J	Varanese, S; Perfetti, B; Ghilardi, MF; Di Rocco, A				Varanese, Sara; Perfetti, Bernardo; Ghilardi, Maria Felice; Di Rocco, Alessandro			Apathy, but Not Depression, Reflects Inefficient Cognitive Strategies in Parkinson's Disease	PLOS ONE			English	Article							VERBAL-LEARNING TEST; RATING-SCALES; DYSFUNCTION; DEMENTIA; CRITIQUE	Background: The relationship between apathy, depression and cognitive impairment in Parkinson's disease (PD) is still controversial. The objective of this study is to investigate whether apathy and depression are associated with inefficient cognitive strategies in PD. Methods: In this prospective clinical cohort study conducted in a university-based clinical and research movement disorders center we studied 48 PD patients. Based on clinical evaluation, they were classified in two groups: PD with apathy (PD-A group, n = 23) and PD without apathy (PD-NA group, n = 25). Patients received clinical and neuropsychological evaluations. The clinical evaluation included: Apathy Evaluation Scale-patient version, Hamilton Depression Rating Scale-17 items, the Unified Parkinson's Disease Rating Scale and the Hoehn and Yahr staging system; the neuropsychological evaluation explored speed information processing, attention, working memory, executive function, learning abilities and memory, which included several measures of recall (immediate free, short delay free, long delay free and cued, and total recall). Findings: PD-A and PD-NA groups did not differ in age, disease duration, treatment, and motor condition, but differed in recall (p < 0.001) and executive tasks (p < 0.001). Immediate free recall had the highest predictive value for apathy (F = 10.94; p = 0.002). Depression and apathy had a weak correlation (Pearson index = 0.3; p < 0.07), with three items of the depression scale correlating with apathy (Pearson index between.3 and. 4; p < 0.04). The depressed and non-depressed PD patients within the non-apathetic group did not differ. Conclusion: Apathy, but not depression, is associated with deficit in implementing efficient cognitive strategies. As the implementation of efficient strategies relies on the fronto-striatal circuit, we conclude that apathy, unlike depression, is an early expression of executive impairment in PD.	[Varanese, Sara; Di Rocco, Alessandro] NYU, Dept Neurol, Sch Med, Div Movement Disorders, New York, NY 10016 USA; [Varanese, Sara; Perfetti, Bernardo] Univ G DAnnunzio, Dept Neurosci & Imaging, ITAB Inst Adv Biomed Technol, Chieti, Italy; [Perfetti, Bernardo; Ghilardi, Maria Felice] CUNY City Coll, Dept Physiol & Pharmacol, Sophie Davis Sch Med, New York, NY 10031 USA	New York University; G d'Annunzio University of Chieti-Pescara; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Varanese, S (corresponding author), NYU, Dept Neurol, Sch Med, Div Movement Disorders, New York, NY 10016 USA.	sara78_96@yahoo.it		Di Rocco (also publications under DiRocco), Alessandro/0000-0002-5508-5043				Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Butterfield LC, 2010, NEUROPSYCHOLOGY, V24, P721, DOI 10.1037/a0019650; CZERMECKI V, 2007, MOVEMENT DISORD, V22, P778; Delis C, 2001, DELISKAPLAN EXECUTIV; Delis C. E., 2002, CALIFORNIA VERBAL LE; Dujardin K, 2009, MOVEMENT DISORD, V24, P2391, DOI 10.1002/mds.22843; FANH S, 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Isella V, 2002, MOVEMENT DISORD, V17, P366, DOI 10.1002/mds.10041; Kirsch-Darrow L, 2006, NEUROLOGY, V67, P33, DOI 10.1212/01.wnl.0000230572.07791.22; Kongs SK, 2000, WISCONSIN CARD SORTI; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Levy G, 2000, NEUROLOGY, V55, P539, DOI 10.1212/WNL.55.4.539; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Pedersen KF, 2009, J NEUROL NEUROSUR PS, V80, P1279, DOI 10.1136/jnnp.2008.170043; Pedersen KF, 2009, PARKINSONISM RELAT D, V15, P295, DOI 10.1016/j.parkreldis.2008.07.006; Perfetti B, 2009, HUM BRAIN MAPP, V30, P497, DOI 10.1002/hbm.20519; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Shulman LM, 2000, INT REV PSYCHIATR, V12, P298, DOI 10.1080/09540260020002523; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Zgaljardic DJ, 2007, COGN BEHAV NEUROL, V20, P184, DOI 10.1097/WNN.0b013e318145a6f6	33	64	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17846	10.1371/journal.pone.0017846	http://dx.doi.org/10.1371/journal.pone.0017846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	737CD	21437255	gold, Green Published			2022-12-25	WOS:000288545100039
J	Everett, DB; Mukaka, M; Denis, B; Gordon, SB; Carrol, ED; van Oosterhout, JJ; Molyneux, EM; Molyneux, M; French, N; Heyderman, RS				Everett, Dean B.; Mukaka, Mavuto; Denis, Brigitte; Gordon, Stephen B.; Carrol, Enitan D.; van Oosterhout, Joep J.; Molyneux, Elizabeth M.; Molyneux, Malcolm; French, Neil; Heyderman, Robert S.			Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; PNEUMOCOCCAL CONJUGATE VACCINE; BACTERIAL-MENINGITIS; ANTIMICROBIAL RESISTANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE; SUSCEPTIBILITY PATTERNS; HIV-INFECTION; SOUTH-AFRICA; ADULTS; DISEASE	Objective: To document trends in invasive pneumococcal disease (IPD) in a central hospital in Malawi during the period of national scale-up of antiretroviral therapy (ART) and cotrimoxazole prophylaxis. Methods: Between 1 January 2000 and 31 December 2009 almost 100,000 blood cultures and 40,000 cerebrospinal fluid (CSF) cultures were obtained from adults and children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi with suspected severe bacterial infection. Results: 4,445 pneumococcal isolates were obtained over the 10 year period. 1,837 were from children: 885 (19.9%) from blood and 952 (21.4%) from CSF. 2,608 were from adults: 1,813 (40.8%) from blood and 795 (17.9%) from CSF. At the start of the surveillance period cotrimoxazole resistance was 73.8% and at the end was 92.6%. Multidrug resistance (MDR) was present in almost one third of isolates and was constant over time. Free ART was introduced in Malawi in 2004. From 2005 onwards there was a decline in invasive pneumococcal infections with a negative correlation between ART scale-up and the decline in IPD (Pearson's correlation r = -0.91; p<0.001). Conclusion: During 2004-2009, national ART scale-up in Malawi was associated with a downward trend in IPD at QECH. The introduction of cotrimoxazole prophylaxis in HIV-infected groups has not coincided with a further increase in pneumococcal cotrimoxazole or multidrug resistance. These data highlight the importance of surveillance for high disease burden infections such as IPD in the region, which will be vital for monitoring pneumococcal conjugate vaccine introduction into national immunisation programmes.	[Everett, Dean B.; Mukaka, Mavuto; Denis, Brigitte; Gordon, Stephen B.; Carrol, Enitan D.; Molyneux, Malcolm; Heyderman, Robert S.] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Gordon, Stephen B.; Molyneux, Malcolm; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Carrol, Enitan D.] Univ Liverpool, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England; [van Oosterhout, Joep J.] Coll Med, Dept Med, Blantyre, Malawi; [Molyneux, Elizabeth M.] Coll Med, Dept Pediat, Blantyre, Malawi; [French, Neil] London Sch Hyg & Trop Med, London WC1, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; University of Malawi; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Everett, DB (corresponding author), Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	Dean.Everett@liverpool.ac.uk	French, Neil/A-2994-2012	Carrol, Enitan/0000-0001-8357-7726; Gordon, Stephen/0000-0001-6576-1116; French, Neil/0000-0003-4814-8293; Everett, Dean/0000-0002-8458-6779	Wellcome Trust [084679/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: The invasive bacterial surveillance service is supported by the Wellcome Trust Major Overseas programme award (award no: 084679/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World, 2008, BRIT PARL, P1; Anglaret X, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a304; [Anonymous], 2001, BSAC DISC DIFFUSION; [Anonymous], 2008, EP FACT SHEET HIV AI; Barrow G.I., 1993, MANUAL IDENTIFICATIO, V3rd; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; CreweBrown HH, 1997, CLIN INFECT DIS, V25, P1165, DOI 10.1086/516104; Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Dowell SF, 2000, NEW ENGL J MED, V342, P1399, DOI 10.1056/NEJM200005113421904; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; French N, 2004, 4 INT S PNEUM PNEUM; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gill CJ, 2008, J INFECT DIS, V197, P1000, DOI 10.1086/528806; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Government of Malawi, 2008, MAL MILL DEV GOAL RE; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Grimwade K, 2001, CURR OPIN INFECT DIS, V14, P507, DOI 10.1097/00001432-200110000-00002; Gwanzura L, 2003, INT J ANTIMICROB AG, V21, P557, DOI 10.1016/S0924-8579(03)00052-9; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Jahn A, 2010, DATA ARV SCALE COTRI; Jones RN, INT J ANTIMICROB AGE; Kariuki S, 2003, East Afr Med J, V80, P213; Klein DL, 1999, MICROB DRUG RESIST, V5, P147, DOI 10.1089/mdr.1999.5.147; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Klugman KP, 2005, EMERG INFECT DIS, V11, P802, DOI 10.3201/eid1106.050147; Klugman KP, 2001, CLIN INFECT DIS, V33, P489, DOI 10.1086/322736; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Liebowitz LD, 2003, J CLIN PATHOL, V56, P344, DOI 10.1136/jcp.56.5.344; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P210, DOI 10.1055/s-0029-1202939; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; Malawi Antiretroviral Treatment Programme, 2010, Q REP RES 31 DEC 200, P1; [MalawiGo Health Mo], 2010, Q HIV PROGR REP; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Medina MJ, 2005, MICROB DRUG RESIST, V11, P9, DOI 10.1089/mdr.2005.11.9; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mtunthama N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-137; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Nunes MC, 2010, IMPACT ANTIRETROVIRA; Poland GA, 1999, VACCINE, V17, P1674, DOI 10.1016/S0264-410X(98)00435-6; Reinert RR, 2009, CLIN MICROBIOL INFEC, V15, P7, DOI 10.1111/j.1469-0691.2009.02724.x; Riou JY, 1996, B WORLD HEALTH ORGAN, V74, P181; Rogerson SR, 2004, T ROY SOC TROP MED H, V98, P544, DOI 10.1016/j.trstmh.2003.12.011; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Siira L, 2009, ANTIMICROB AGENTS CH, V53, P2066, DOI 10.1128/AAC.01464-08; Spratt BG, 2004, PNEUMOCCOCUS, P119; Talbot TR, 2005, AM J MED, V118, P285, DOI 10.1016/j.amjmed.2004.09.016; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Watera C, 2006, JAIDS-J ACQ IMM DEF, V42, P373, DOI 10.1097/01.qai.0000221679.14445.1b; Wolter N, 2008, INT J ANTIMICROB AG, V32, P62, DOI 10.1016/j.ijantimicag.2008.01.013	59	57	57	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17765	10.1371/journal.pone.0017765	http://dx.doi.org/10.1371/journal.pone.0017765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423577	Green Published, Green Accepted, gold			2022-12-25	WOS:000288513900026
J	Li, HH; Bradbury, P; Ersoz, E; Buckler, ES; Wang, JK				Li, Huihui; Bradbury, Peter; Ersoz, Elhan; Buckler, Edward S.; Wang, Jiankang			Joint QTL Linkage Mapping for Multiple-Cross Mating Design Sharing One Common Parent	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FLOWERING-TIME; GENETIC ARCHITECTURE; INBRED LINES; COMPLEX TRAITS; ASSOCIATION; MAIZE; POPULATIONS; GENOME; FAMILIES	Background: Nested association mapping (NAM) is a novel genetic mating design that combines the advantages of linkage analysis and association mapping. This design provides opportunities to study the inheritance of complex traits, but also requires more advanced statistical methods. In this paper, we present the detailed algorithm of a QTL linkage mapping method suitable for genetic populations derived from NAM designs. This method is called joint inclusive composite interval mapping (JICIM). Simulations were designed on the detected QTL in a maize NAM population and an Arabidopsis NAM population so as to evaluate the efficiency of the NAM design and the JICIM method. Principal Findings: Fifty-two QTL were identified in the maize population, explaining 89% of the phenotypic variance of days to silking, and nine QTL were identified in the Arabidopsis population, explaining 83% of the phenotypic variance of flowering time. Simulations indicated that the detection power of these identified QTL was consistently high, especially for large-effect QTL. For rare QTL having significant effects in only one family, the power of correct detection within the 5 cM support interval was around 80% for 1-day effect QTL in the maize population, and for 3-day effect QTL in the Arabidopsis population. For smaller-effect QTL, the power diminished, e. g., it was around 50% for maize QTL with an effect of 0.5 day. When QTL were linked at a distance of 5 cM, the likelihood of mapping them as two distinct QTL was about 70% in the maize population. When the linkage distance was 1 cM, they were more likely mapped as one single QTL at an intermediary position. Conclusions: Because it takes advantage of the large genetic variation among parental lines and the large population size, NAM is a powerful multiple-cross design for complex trait dissection. JICIM is an efficient and specialty method for the joint QTL linkage mapping of genetic populations derived from the NAM design.	[Li, Huihui; Wang, Jiankang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Li, Huihui; Wang, Jiankang] Chinese Acad Agr Sci, CIMMYT China, Beijing, Peoples R China; [Li, Huihui; Ersoz, Elhan; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Bradbury, Peter; Buckler, Edward S.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Cornell University; United States Department of Agriculture (USDA)	Li, HH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	wangjk@caas.net.cn	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; 	Natural Science Foundation of China [31000540]; United States National Science Foundation [DBI-0321467, DBI-0820619]; USDA-ARS; Consultative Group for International Agricultural Research (CGIAR)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Consultative Group for International Agricultural Research (CGIAR)(CGIAR)	This work was supported by the Natural Science Foundation of China (No. 31000540), the United States National Science Foundation (DBI-0321467 and DBI-0820619), the USDA-ARS, and the Generation Challenge Program of the Consultative Group for International Agricultural Research (CGIAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Beavis W.D., 1994, P 49 ANN CORN SORGH, P250; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; CHRISTIE BR, 1992, PLANT BREED REV, V9, P9; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Crepieux S, 2004, GENETICS, V168, P1737, DOI 10.1534/genetics.104.028993; DARVASI A, 1993, GENETICS, V134, P943; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Fang M, 2008, GENETICA, V134, P367, DOI 10.1007/s10709-008-9244-z; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Guo BH, 2010, GENETICS, V186, P373, DOI 10.1534/genetics.110.115782; Hayashi T, 2009, HEREDITY, V102, P497, DOI 10.1038/hdy.2009.6; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jannink JL, 2001, GENETICS, V157, P445; Jourjon MF, 2005, BIOINFORMATICS, V21, P128, DOI 10.1093/bioinformatics/bth481; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Lynch M., 1998, GENETICS ANAL QUANTI; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Rebai A, 2000, GENET RES, V75, P243, DOI 10.1017/S0016672399004358; REBAI A, 1993, THEOR APPL GENET, V86, P1014, DOI 10.1007/BF00211055; Roux F, 2006, TRENDS PLANT SCI, V11, P375, DOI 10.1016/j.tplants.2006.06.006; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xu SZ, 1998, GENETICS, V148, P517; Yi NJ, 2002, GENETICA, V114, P217, DOI 10.1023/A:1016296225065; Yi NJ, 2001, GENETICS, V157, P1759; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LY, 2008, GENETICS, V180, P1177, DOI 10.1534/genetics.108.092122; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z	43	75	79	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17573	10.1371/journal.pone.0017573	http://dx.doi.org/10.1371/journal.pone.0017573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423655	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900012
J	Ye, CT; Abraham, S; Wu, HQ; Shankar, P; Manjunath, N				Ye, Chunting; Abraham, Sojan; Wu, Haoquan; Shankar, Premlata; Manjunath, N.			Silencing Early Viral Replication in Macrophages and Dendritic Cells Effectively Suppresses Flavivirus Encephalitis	PLOS ONE			English	Article							WEST-NILE-VIRUS; RNA INTERFERENCE; DISSEMINATED INFECTION; BLOOD-TRANSFUSION; IMMUNITY; INNATE	West Nile (WN) and St. Louis encephalitis (SLE) viruses can cause fatal neurological infection and currently there is neither a specific treatment nor an approved vaccine for these infections. In our earlier studies, we have reported that siRNAs can be developed as broad-spectrum antivirals for the treatment of infection caused by related viruses and that a small peptide called RVG-9R can deliver siRNA to neuronal cells as well as macrophages. To increase the repertoire of broad-spectrum antiflaviviral siRNAs, we screened 25 siRNAs targeting conserved regions in the viral genome. Five siRNAs were found to inhibit both WNV and SLE replication in vitro reflecting broad-spectrum antiviral activity and one of these was also validated in vivo. In addition, we also show that RVG-9R delivers siRNA to macrophages and dendritic cells, resulting in effective suppression of virus replication. Mice were challenged intraperitoneally (i.p.) with West Nile virus (WNV) and treated i.v. with siRNA/peptide complex. The peritoneal macrophages isolated on day 3 post infection were isolated and transferred to new hosts. Mice receiving macrophages from the anti-viral siRNA treated mice failed to develop any disease while the control mice transferred with irrelevant siRNA treated mice all died of encephalitis. These studies suggest that early suppression of viral replication in macrophages and dendritic cells by RVG-9R-mediated siRNA delivery is key to preventing the development of a fatal neurological disease.	[Ye, Chunting; Abraham, Sojan; Wu, Haoquan; Shankar, Premlata; Manjunath, N.] Texas Tech Univ Hlth Sci Ctr, Ctr Excellence Infect Dis, Paul L Foster Sch Med, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University Health Science Center	Ye, CT (corresponding author), Texas Tech Univ Hlth Sci Ctr, Ctr Excellence Infect Dis, Paul L Foster Sch Med, El Paso, TX 79905 USA.	Manjunath.swamy@ttuhsc.edu		Wu, Haoquan/0000-0001-9386-3187	NIH [U01AI075419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by NIH grant U01AI075419 to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI F, J INFECT DIS, V202, P1804; Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507; Biggerstaff BJ, 2003, TRANSFUSION, V43, P1007, DOI 10.1046/j.1537-2995.2003.00480.x; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; FIELDS BN, FIELDS VIROLOGY, P931; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; KIM SS, MOL THER, V18, P993; Kirchhoff F, 2008, CELL, V134, P566, DOI 10.1016/j.cell.2008.08.004; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lares MR, TRENDS BIOTECHNOL, V28, P570; LIM PY, VIROLOGY, V400, P93; Manjunath N, 2006, TRENDS IMMUNOL, V27, P328, DOI 10.1016/j.it.2006.05.006; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; SU X, J IMMUNOL, V184, P401; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; Tyler KL, 2004, ARCH NEUROL-CHICAGO, V61, P1190, DOI 10.1001/archneur.61.8.1190; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07	23	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17889	10.1371/journal.pone.0017889	http://dx.doi.org/10.1371/journal.pone.0017889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423625	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900042
J	Tyack, PL; Zimmer, WMX; Moretti, D; Southall, BL; Claridge, DE; Durban, JW; Clark, CW; D'Amico, A; DiMarzio, N; Jarvis, S; McCarthy, E; Morrissey, R; Ward, J; Boyd, IL				Tyack, Peter L.; Zimmer, Walter M. X.; Moretti, David; Southall, Brandon L.; Claridge, Diane E.; Durban, John W.; Clark, Christopher W.; D'Amico, Angela; DiMarzio, Nancy; Jarvis, Susan; McCarthy, Elena; Morrissey, Ronald; Ward, Jessica; Boyd, Ian L.			Beaked Whales Respond to Simulated and Actual Navy Sonar	PLOS ONE			English	Article							KILLER WHALES; ORCINUS-ORCA; NOISE; BEHAVIOR	Beaked whales have mass stranded during some naval sonar exercises, but the cause is unknown. They are difficult to sight but can reliably be detected by listening for echolocation clicks produced during deep foraging dives. Listening for these clicks, we documented Blainville's beaked whales, Mesoplodon densirostris, in a naval underwater range where sonars are in regular use near Andros Island, Bahamas. An array of bottom-mounted hydrophones can detect beaked whales when they click anywhere within the range. We used two complementary methods to investigate behavioral responses of beaked whales to sonar: an opportunistic approach that monitored whale responses to multi-day naval exercises involving tactical mid-frequency sonars, and an experimental approach using playbacks of simulated sonar and control sounds to whales tagged with a device that records sound, movement, and orientation. Here we show that in both exposure conditions beaked whales stopped echolocating during deep foraging dives and moved away. During actual sonar exercises, beaked whales were primarily detected near the periphery of the range, on average 16 km away from the sonar transmissions. Once the exercise stopped, beaked whales gradually filled in the center of the range over 2-3 days. A satellite tagged whale moved outside the range during an exercise, returning over 2-3 days post-exercise. The experimental approach used tags to measure acoustic exposure and behavioral reactions of beaked whales to one controlled exposure each of simulated military sonar, killer whale calls, and band-limited noise. The beaked whales reacted to these three sound playbacks at sound pressure levels below 142 dB re 1 mu Pa by stopping echolocation followed by unusually long and slow ascents from their foraging dives. The combined results indicate similar disruption of foraging behavior and avoidance by beaked whales in the two different contexts, at exposures well below those used by regulators to define disturbance.	[Tyack, Peter L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Zimmer, Walter M. X.] N Atlantic Treaty Org Undersea Res Ctr, La Spezia, Italy; [Moretti, David; DiMarzio, Nancy; Jarvis, Susan; McCarthy, Elena; Morrissey, Ronald; Ward, Jessica] USN, Undersea Warfare Ctr Div, Newport, RI USA; [Southall, Brandon L.] Southall Environm Associates, Aptos, CA USA; [Southall, Brandon L.] Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA; [Claridge, Diane E.] Bahamas Marine Mammal Res Org, Marsh Harbour, Abaco, Bahamas; [Durban, John W.] Natl Ocean & Atmospher Adm, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Clark, Christopher W.] Cornell Univ, Bioacoust Res Program, Cornell Lab Ornithol, Ithaca, NY USA; [D'Amico, Angela] Space & Naval Warfare Syst Ctr Pacific, San Diego, CA USA; [Boyd, Ian L.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews KY16 9AJ, Fife, Scotland	Woods Hole Oceanographic Institution; United States Department of Defense; United States Navy; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Cornell University; Naval Information Warfare Center Pacific; University of St Andrews	Tyack, PL (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	ptyack@whoi.edu	Tyack, Peter/AAC-4513-2019; Tyack, Peter L/D-6209-2013	Tyack, Peter/0000-0002-8409-4790; Tyack, Peter L/0000-0002-8409-4790	United States (U.S.) Office of Naval Research [N00014-07-10988, N00014-07-11023, N00014-08-10990]; U.S. Strategic Environmental Research and Development Program [SI-1539]; Environmental Readiness Division of the U.S. Navy; U.S. Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology); U.S. National Oceanic and Atmospheric Administration; International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council [smru10001] Funding Source: researchfish	United States (U.S.) Office of Naval Research(Office of Naval Research); U.S. Strategic Environmental Research and Development Program; Environmental Readiness Division of the U.S. Navy; U.S. Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research reported here was financially supported by the United States (U.S.) Office of Naval Research (www.onr.navy.mil) Grants N00014-07-10988, N00014-07-11023, N00014-08-10990; the U.S. Strategic Environmental Research and Development Program (www.serdp.org) Grant SI-1539, the Environmental Readiness Division of the U.S. Navy (http://www.navy.mil/local/n45/), the U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance), the U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology) (http://www.st.nmfs.noaa.gov/), U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program (http://www.nmfs.noaa.gov/pr/acoustics/), and the Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers (www.soundandmarinelife.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; While the sponsors of this study come from an international mix of sound producers and a United States regulatory agency, the majority of funding for the research reported here comes from different divisions of the U.S. Navy, and all of the authors have had at least some of the research reported here partially funded by different divisions of the U.S. Navy. The following authors are employed by the U.S. Navy: David Moretti, Angela D'Amico, Nancy DiMarzio, Susan Jarvis, Elena McCarthy, Ronald Morrissey, and Jessica Ward. Their primary involvement was in designing, installing, and helping to operate the passive acoustic marine mammal monitoring system at the AUTEC range; providing the sound sources used in the experiments; and with analyzing and writing up the data. During the time period covered by this research the following authors were employed by the National Marine Fisheries Service of the U.S. National Oceanic and Atmospheric Administration, which acts as the federal regulatory agency for protection of marine mammals: Brandon Southall and John Durban. The following authors have been asked by the U.S. Department of Justice to act as expert witnesses in cases involving the effects of naval sonar on marine mammals: Christopher Clark, Brandon Southall, and Peter Tyack. Peter Tyack is a member of Natural Resources Defense Council, which is an advocacy organization that has sued the Navy concerning effects of sonar on marine mammals. None of the analysis nor write up of the paper involved or was influenced by the sponsors of the research.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; [Anonymous], 2008, CANADIAN ACOUSTICS; BALSIGER J, 2008, FED REGISTER, V73, P60877; Boyd I. L., 2007, BEHAV RESPONSE STUDY; Claridge D. E, 2006, THESIS U ABERDEEN AB; Cook MLH, 2006, J COMP PHYSIOL A, V192, P489, DOI 10.1007/s00359-005-0086-1; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; D'Spain Gerald L., 2005, Journal of Cetacean Research and Management, V7, P223; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; Finneran JJ, 2009, J ACOUST SOC AM, V126, P484, DOI 10.1121/1.3133241; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Lengagne T, 2008, BIOL CONSERV, V141, P2023, DOI 10.1016/j.biocon.2008.05.017; Madsen PT, 2006, J ACOUST SOC AM, V120, P2366, DOI 10.1121/1.2229287; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; MORETTI D, 2010, MAR MAMM SCI UNPUB; MYRBERG AA, 1990, ENVIRON INT, V16, P575, DOI 10.1016/0160-4120(90)90028-5; NOTARBARTOLODISCIARA G, 1987, MAR MAMMAL SCI, V3, P356, DOI 10.1111/j.1748-7692.1987.tb00324.x; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; ROLT KD, 1990, J ACOUST SOC AM, V87, P1340, DOI 10.1121/1.399507; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Ward J., 2008, CAN ACOUST, V36, P60; Wartzok D, 2005, MARINE MAMMAL POPULA; Weinberg H, 1996, J ACOUST SOC AM, V100, P1421, DOI 10.1121/1.415989; Zimmer WMX, 2007, MAR MAMMAL SCI, V23, P888, DOI 10.1111/j.1748-7692.2007.00152.x; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	37	233	240	7	227	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17009	10.1371/journal.pone.0017009	http://dx.doi.org/10.1371/journal.pone.0017009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423729	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400008
J	Zele, AJ; Feigl, B; Smith, SS; Markwell, EL				Zele, Andrew J.; Feigl, Beatrix; Smith, Simon S.; Markwell, Emma L.			The Circadian Response of Intrinsically Photosensitive Retinal Ganglion Cells	PLOS ONE			English	Article							PUPILLARY LIGHT REFLEX; MELANOPSIN; SLEEP; PHASE; MELATONIN; RHYTHMS; MODELS; DRIVEN; ONSET	Intrinsically photosensitive retinal ganglion cells (ipRGC) signal environmental light level to the central circadian clock and contribute to the pupil light reflex. It is unknown if ipRGC activity is subject to extrinsic (central) or intrinsic (retinal) network-mediated circadian modulation during light entrainment and phase shifting. Eleven younger persons (18-30 years) with no ophthalmological, medical or sleep disorders participated. The activity of the inner (ipRGC) and outer retina (cone photoreceptors) was assessed hourly using the pupil light reflex during a 24 h period of constant environmental illumination (10 lux). Exogenous circadian cues of activity, sleep, posture, caffeine, ambient temperature, caloric intake and ambient illumination were controlled. Dim-light melatonin onset (DLMO) was determined from salivary melatonin assay at hourly intervals, and participant melatonin onset values were set to 14 h to adjust clock time to circadian time. Here we demonstrate in humans that the ipRGC controlled post-illumination pupil response has a circadian rhythm independent of external light cues. This circadian variation precedes melatonin onset and the minimum ipRGC driven pupil response occurs post melatonin onset. Outer retinal photoreceptor contributions to the inner retinal ipRGC driven post-illumination pupil response also show circadian variation whereas direct outer retinal cone inputs to the pupil light reflex do not, indicating that intrinsically photosensitive (melanopsin) retinal ganglion cells mediate this circadian variation.	[Zele, Andrew J.; Feigl, Beatrix; Smith, Simon S.; Markwell, Emma L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Zele, Andrew J.; Feigl, Beatrix; Markwell, Emma L.] Queensland Univ Technol, Sch Optometry, Brisbane, Qld 4001, Australia; [Smith, Simon S.] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Zele, AJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	andrew.zele@qut.edu.au; b.feigl@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045; Feigl, Beatrix/0000-0001-7198-7373; Zele, Andrew/0000-0003-0291-9929	Australian Research Council [ARC-DP1096354]; QUT	Australian Research Council(Australian Research Council); QUT	This work was supported by Australian Research Council Discovery Projects ARC-DP1096354 (AJZ) and a QUT Vice Chancellor's Research Fellowship (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Borgmann H, 1966, Ber Zusammenkunft Dtsch Ophthalmol Ges, V67, P123; Burgess HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003055; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Figueiro Mariana G, 2005, J Circadian Rhythms, V3, P14, DOI 10.1186/1740-3391-3-14; FOSNAUGH JS, 1992, METHOD FIND EXP CLIN, V14, P545; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Kankipati L, 2010, INVEST OPHTH VIS SCI, V51, P2764, DOI 10.1167/iovs.09-4717; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kraemer S, 2000, BIOL PSYCHIAT, V48, P1069, DOI 10.1016/S0006-3223(00)00908-2; LOEWENFELD IE, 1999, PUPIL ANATOMY PHYSL, P11; Loving RT, 1996, AM J PHYSIOL-REG I, V271, pR320, DOI 10.1152/ajpregu.1996.271.2.R320; LOWENSTEIN O, 1964, ANN NY ACAD SCI, V117, P142, DOI 10.1111/j.1749-6632.1964.tb48169.x; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; Mathes A, 2007, J NEUROENDOCRINOL, V19, P952, DOI 10.1111/j.1365-2826.2007.01608.x; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; MONK TH, 1994, J SLEEP RES, V3, P111, DOI 10.1111/j.1365-2869.1994.tb00114.x; Pandi-Perumal SR, 2007, PROG NEURO-PSYCHOPH, V31, P1, DOI 10.1016/j.pnpbp.2006.06.020; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ranzijn R, 1997, PSYCHOPHYSIOLOGY, V34, P17, DOI 10.1111/j.1469-8986.1997.tb02411.x; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; TIEDT N, 1963, PFLUGERS ARCH GESAMT, V277; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; van Someren EJW, 2007, SLEEP MED, V8, P590, DOI 10.1016/j.sleep.2007.03.012; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Wilhelm B, 1998, SLEEP, V21, P258; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751	53	118	119	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17860	10.1371/journal.pone.0017860	http://dx.doi.org/10.1371/journal.pone.0017860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423755	Green Submitted, Green Published, gold			2022-12-25	WOS:000288512400035
J	Jensen, RA; Agardh, E; Lernmark, A; Gudbjornsdottir, S; Smith, NL; Siscovick, DS; Torn, C				Jensen, Richard A.; Agardh, Elisabet; Lernmark, Ake; Gudbjornsdottir, Soffia; Smith, Nicholas L.; Siscovick, David S.; Torn, Carina		DISS Grp	HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; BETA-CELL FUNCTION; INSULIN-DEPENDENT DIABETICS; PROTEIN-TYROSINE-PHOSPHATASE; GAMMA-AMINOBUTYRIC ACID; PROLIFERATIVE RETINOPATHY; COMPLICATIONS TRIAL; GAD AUTOANTIBODY; MULTIPLE FACTORS; HIGH PREVALENCE	Aims/Hypothesis: HLA genes, islet autoantibodies and residual C-peptide were studied to determine the independent association of each exposure with diabetic retinopathy (DR), 15 years after the clinical onset of type 1 diabetes in 15-34 year old individuals. Methods: The cohort was identified in 1992 and 1993 by the Diabetes Incidence Study in Sweden (DISS), which investigates incident cases of diabetes for patients between 15 and 34 years of age. Blood samples at diagnosis were analyzed to determine HLA genotype, islet autoantibodies and serum C-peptide. In 2009, fundus photographs were obtained from patient records. Study measures were supplemented with data from the Swedish National Diabetes Registry. Results: The prevalence of DR was 60.2% (148/246). Autoantibodies against the 65 kD isoform of glutamate decarboxylase (GADA) at the onset of clinical diabetes increased the risk of DR 15 years later, relative risk 1.12 for each 100 WHO units/ml, [95% CI 1.02 to 1.23]. This equates to risk estimates of 1.27, [95% CI 1.04 to 1.62] and 1.43, [95% CI 1.06 to 1.94] for participants in the highest 25(th) (GADA. 233 WHO units/ml) and 5(th) percentile (GADA. 319 WHO units/ml) of GADA, respectively. These were adjusted for duration of diabetes, HbA(1c), treated hypertension, sex, age at diagnosis, HLA and C-peptide. Islet cell autoantibodies, insulinoma-antigen 2 autoantibodies, residual C-peptide and the type 1 diabetes associated haplotypes DQ2, DQ8 and DQ6 were not associated with DR. Conclusions: Increased levels of GADA at the onset of type 1 diabetes were associated with DR 15 years later. These results, if confirmed, could provide additional insights into the pathogenesis of the most common microvascular complication of diabetes and lead to better risk stratification for both patient screenings and DR treatment trials.	[Jensen, Richard A.; Smith, Nicholas L.; Siscovick, David S.] Univ Washington, Sch Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Smith, Nicholas L.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Agardh, Elisabet] Univ Hosp MAS, Dept Clin Sci, Malmo, Sweden; [Lernmark, Ake; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Lernmark, Ake; Torn, Carina] Lund Univ, Clin Res Ctr, Dept Clin Sci, Malmo, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Smith, Nicholas L.] Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Nicholas L.] Off Res & Dev, Dept Vet Affairs, Seattle, WA USA; [Smith, Nicholas L.] Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle; Lund University; Sahlgrenska University Hospital; University of Gothenburg	Jensen, RA (corresponding author), Univ Washington, Sch Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.	richaj@uw.edu	Kockum, Ingrid/O-8781-2018; Lernmark, Åke/F-8140-2015	Kockum, Ingrid/0000-0002-0867-4726; Lernmark, Åke/0000-0003-1735-0499; Landin-Olsson, Mona/0000-0003-0510-9112	Knut and Alice Wallenberg Foundation; Jarnhardt Foundation; Foundation for Visually Impaired in Former Malmohus Lan; Lund University; Skane County Council; National Heart, Lung, And Blood Institute [T32HL007902]; Magnuson Scholars Program; National Institutes of Health [DK42654]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042654] Funding Source: NIH RePORTER	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Jarnhardt Foundation; Foundation for Visually Impaired in Former Malmohus Lan; Lund University; Skane County Council; National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Magnuson Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The Knut and Alice Wallenberg Foundation (CT, AL), The Jarnhardt Foundation (EA), The Foundation for Visually Impaired in Former Malmohus Lan (EA), Lund University and Skane County Council (EA, AL), National Heart, Lung, And Blood Institute Training Grant T32HL007902 (RAJ), The Magnuson Scholars Program (RAJ), The National Institutes of Health, DK42654 (AL). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, And Blood Institute or the National Institutes of Health.	Agardh D, 1998, DIABETES RES CLIN PR, V40, P9, DOI 10.1016/S0168-8227(98)00007-2; Agardh D, 1996, DIABETOLOGIA, V39, P1313, DOI 10.1007/s001250050575; AGARDH E, 1987, J COMP NEUROL, V258, P622, DOI 10.1002/cne.902580411; Agardh E, 2004, J DIABETES COMPLICAT, V18, P32, DOI 10.1016/S1056-8727(03)00040-0; AGARDH E, 1987, HISTOCHEMISTRY, V86, P485, DOI 10.1007/BF00500621; [Anonymous], 1993, NEW ENGL J MED, V329, P977; [Anonymous], 1998, LANCET, V352, P837; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BAKER RS, 1986, AM J OPHTHALMOL, V102, P693, DOI 10.1016/0002-9394(86)90395-8; Balme M, 2002, DIABETIC MED, V19, P602, DOI 10.1046/j.1464-5491.2002.00739.x; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BECKER B, 1977, DIABETES, V26, P997, DOI 10.2337/diabetes.26.10.997; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; Birinci A, 2002, EUR J OPHTHALMOL, V12, P89, DOI 10.1177/112067210201200203; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; Borg H, 2002, DIABETES, V51, P1754, DOI 10.2337/diabetes.51.6.1754; BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; DORNAN TL, 1982, DIABETES, V31, P226, DOI 10.2337/diabetes.31.3.226; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; Falck AAK, 1997, J DIABETES COMPLICAT, V11, P203, DOI 10.1016/S1056-8727(96)00051-7; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; GRAY RS, 1982, BRIT J OPHTHALMOL, V66, P280, DOI 10.1136/bjo.66.5.280; GROOP LC, 1986, DIABETES, V35, P1397, DOI 10.2337/diabetes.35.12.1397; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; HAWRAMI K, 1991, DIABETOLOGIA, V34, P441, DOI 10.1007/BF00403184; Henricsson M, 2003, DIABETES CARE, V26, P349, DOI 10.2337/diacare.26.2.349; Hoeldtke RD, 2000, J CLIN ENDOCR METAB, V85, P3297, DOI 10.1210/jc.85.9.3297; Huber PJ, 1967, BERK S MATH STAT PRO, V1, P221; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Jensen R, 2007, DIABETIC MED, V24, P1221, DOI 10.1111/j.1464-5491.2007.02235.x; Jensen RA, 2007, J DIABETES COMPLICAT, V21, P205, DOI 10.1016/j.jdiacomp.2006.01.004; Jeppsson JO, 1996, DIABETES CARE, V19, P142, DOI 10.2337/diacare.19.2.142; KARLSEN AE, 1992, DIABETES, V41, P1355, DOI 10.2337/diabetes.41.10.1355; KARLSEN AE, 1991, P NATL ACAD SCI USA, V88, P8337, DOI 10.1073/pnas.88.19.8337; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Kupila A, 2001, DIABETOLOGIA, V44, P290, DOI 10.1007/s001250051616; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LANDINOLSSON M, 1987, DIABETOLOGIA, V30, P327; LARKINS RG, 1978, BRIT MED J, V1, P1111, DOI 10.1136/bmj.1.6120.1111; LERNMARK A, 1978, NEW ENGL J MED, V299, P375, DOI 10.1056/NEJM197808242990802; Littorin B, 1996, DIABETES RES CLIN PR, V33, P129, DOI 10.1016/0168-8227(96)01282-X; MACCUISH AC, 1974, LANCET, V2, P1529; MALONE JI, 1984, PEDIATRICS, V73, P756; McCulloch D, 2007, UPTODATE; MIDDLETON D, 1985, INT OPHTHALMOL, V8, P33, DOI 10.1007/BF00136459; Mimura T, 2004, DIABETIC MED, V21, P559, DOI 10.1111/j.1464-5491.2004.01204.x; Mimura T, 2004, BRIT J OPHTHALMOL, V88, P303, DOI 10.1136/bjo.2003.023945; Mimura T, 2003, AM J OPHTHALMOL, V135, P844, DOI 10.1016/S0002-9394(02)02291-2; MIMURA T, 2005, OPHTHALMOLOGY; Mueller Patricia W, 2002, Diabetes Technol Ther, V4, P397, DOI 10.1089/152091502760098537; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; OLERUP O, 1993, TISSUE ANTIGENS, V41, P55; OSTMAN J, 1986, ACTA MED SCAND, V220, P437; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; PAYTON MA, 1995, J CLIN INVEST, V96, P1506, DOI 10.1172/JCI118188; PUGLIESE A, 1995, DIABETES, V44, P608, DOI 10.2337/diabetes.44.6.608; Quiroz-Mercado H, 2002, ARCH MED RES, V33, P123, DOI 10.1016/S0188-4409(01)00378-2; RABIN DU, 1994, J IMMUNOL, V152, P3183; Rakocevic G, 2004, ARCH NEUROL-CHICAGO, V61, P902, DOI 10.1001/archneur.61.6.902; RAND LI, 1985, NEW ENGL J MED, V313, P1433, DOI 10.1056/NEJM198512053132302; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Rolandsson O, 2003, J INTERN MED, V253, P447, DOI 10.1046/j.1365-2796.2003.01115.x; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Schranz DB, 1998, J IMMUNOL METHODS, V213, P87, DOI 10.1016/S0022-1759(98)00025-8; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Sterky G, 1986, Acta Paediatr Scand Suppl, V327, P1; Torn C, 2000, J CLIN ENDOCR METAB, V85, P4619, DOI 10.1210/jc.85.12.4619; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; WEBER B, 1986, DIABETOLOGIA, V29, P23, DOI 10.1007/BF02427276; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2002, OPHTHALMOLOGY, V109, P275, DOI 10.1016/S0161-6420(01)00925-3; World Health Organization, 2008, DIAB FACT SHEET 312; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; ZIEGLER AG, 1993, DIABETOLOGIA, V36, P402, DOI 10.1007/BF00402275	82	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17569	10.1371/journal.pone.0017569	http://dx.doi.org/10.1371/journal.pone.0017569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412422	gold, Green Published, Green Submitted			2022-12-25	WOS:000288247800016
J	Chen, YJ; Tsai, WH; Chen, YL; Ko, YC; Chou, SP; Chen, JY; Lin, SF				Chen, Yen-Ju; Tsai, Wan-Hua; Chen, Yu-Lian; Ko, Ying-Chieh; Chou, Sheng-Ping; Chen, Jen-Yang; Lin, Su-Fang			Epstein-Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells	PLOS ONE			English	Article							BINDING-PROTEIN-ALPHA; EPITHELIAL-CELLS; GENE-EXPRESSION; CELLULAR SENESCENCE; CYCLE ARREST; C-MYC; FATE DETERMINATION; VIRAL GENE; B-CELLS; REPLICATION	Epstein-Barr virus (EBV) Rta belongs to a lytic switch gene family that is evolutionarily conserved in all gamma-herpesviruses. Emerging evidence indicates that cell cycle arrest is a common means by which herpesviral immediate-early protein hijacks the host cell to advance the virus's lytic cycle progression. To examine the role of Rta in cell cycle regulation, we recently established a doxycycline (Dox)-inducible Rta system in 293 cells. In this cell background, inducible Rta modulated the levels of signature G1 arrest proteins, followed by induction of the cellular senescence marker, SA-beta-Gal. To delineate the relationship between Rta-induced cell growth arrest and EBV reactivation, recombinant viral genomes were transferred into Rta-inducible 293 cells. Somewhat unexpectedly, we found that Dox-inducible Rta reactivated both EBV and Kaposi's sarcoma-associated herpesvirus (KSHV), to similar efficacy. As a consequence, the Rta-mediated EBV and KSHV lytic replication systems, designated as EREV8 and ERKV, respectively, were homogenous, robust, and concurrent with cell death likely due to permissive lytic replication. In addition, the expression kinetics of EBV lytic genes in Dox-treated EREV8 cells was similar to that of their KSHV counterparts in Dox-induced ERKV cells, suggesting that a common pathway is used to disrupt viral latency in both cell systems. When the time course was compared, cell cycle arrest was achieved between 6 and 48 h, EBV or KSHV reactivation was initiated abruptly at 48 h, and the cellular senescence marker was not detected until 120 h after Dox treatment. These results lead us to hypothesize that in 293 cells, Rta-induced G1 cell cycle arrest could provide (1) an ideal environment for virus reactivation if EBV or KSHV coexists and (2) a preparatory milieu for cell senescence if no viral genome is available. The latter is hypothetical in a transient-lytic situation.	[Chen, Yen-Ju; Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Chen, Yen-Ju; Tsai, Wan-Hua; Chen, Yu-Lian; Ko, Ying-Chieh; Chou, Sheng-Ping; Chen, Jen-Yang; Lin, Su-Fang] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli Cty, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan	Chen, YJ (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	cjy@nhri.org.tw; sflin@nhri.org.tw		Lin, Su-Fang/0000-0001-8706-2439	Taiwan NHRI [CA-099-PP-17]; Department of Health [DOH99-TD-C-111-004]; NHRI [CA-099-PP-13]; National Science Council [NSC98-3112-B-400-002, NSC99-3112-B-400-009]	Taiwan NHRI; Department of Health; NHRI(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by Taiwan NHRI CA-099-PP-17 and Department of Health DOH99-TD-C-111-004 to S.-F. Lin; NHRI CA-099-PP-13, National Science Council NSC98-3112-B-400-002, and NSC99-3112-B-400-009 to J.-Y. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; Chen LW, 2005, J VIROL, V79, P9635, DOI 10.1128/JVI.79.15.9635-9650.2005; Chen YL, 2009, CELL CYCLE, V8, P58, DOI 10.4161/cc.8.1.7411; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Feederle R, 2007, INT J CANCER, V121, P588, DOI 10.1002/ijc.22727; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; GRUFFAT H, 1994, NUCLEIC ACIDS RES, V22, P1172, DOI 10.1093/nar/22.7.1172; Guo QW, 2010, MOL IMMUNOL, V47, P1783, DOI 10.1016/j.molimm.2010.02.017; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Harrington W, 1997, LANCET, V349, P774; Hobbs WE, 1999, J VIROL, V73, P8245, DOI 10.1128/JVI.73.10.8245-8255.1999; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang ES, 2002, MECH AGEING DEV, V123, P1681, DOI 10.1016/S0047-6374(02)00102-1; Inman GJ, 2001, J VIROL, V75, P2400, DOI 10.1128/JVI.75.5.2400-2410.2001; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; LI X, 2010, J VIROL; Li YL, 2004, J VIROL, V78, P11778, DOI 10.1128/JVI.78.21.11778-11785.2004; Li YL, 2004, J VIROL, V78, P4197, DOI 10.1128/JVI.78.8.4197-4206.2004; LIN CT, 1993, LAB INVEST, V68, P716; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Rodriguez A, 2001, J VIROL, V75, P4482, DOI 10.1128/JVI.75.10.4482-4489.2001; Schultz J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-53; Sekeri-Pataryas KE, 2007, ANN NY ACAD SCI, V1100, P361, DOI 10.1196/annals.1395.039; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun CC, 2007, J VIROL, V81, P13566, DOI 10.1128/JVI.01055-07; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Swenson JJ, 1999, J VIROL, V73, P6540, DOI 10.1128/JVI.73.8.6540-6550.1999; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wells R, 2009, J VIROL, V83, P4695, DOI 10.1128/JVI.02241-08; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Wells SI, 2003, P NATL ACAD SCI USA, V100, P7093, DOI 10.1073/pnas.1232309100; Wilson SJ, 2007, J VIROL, V81, P13578, DOI 10.1128/JVI.01663-07; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Wu FY, 2003, J VIROL, V77, P1481, DOI 10.1128/JVI.77.2.1481-1500.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991; Zacny VL, 1998, J VIROL, V72, P8043, DOI 10.1128/JVI.72.10.8043-8051.1998; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	60	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17809	10.1371/journal.pone.0017809	http://dx.doi.org/10.1371/journal.pone.0017809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423768	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100036
J	Gaida, A; Becker, MM; Schmid, CD; Buhlmann, T; Louis, EJ; Beck, HP				Gaida, Annette; Becker, Marion M.; Schmid, Christoph D.; Buehlmann, Tobias; Louis, Edward J.; Beck, Hans-Peter			Cloning of the Repertoire of Individual Plasmodium falciparum var Genes Using Transformation Associated Recombination (TAR)	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; DIFFERENTIAL EXPRESSION; ANTIGENIC VARIATION; GENOME SEQUENCE; MALARIA; YEAST; VIRULENCE; DNA; IDENTIFICATION; SURFACE	One of the major virulence factors of the malaria causing parasite is the Plasmodium falciparum encoded erythrocyte membrane protein 1 (PfEMP1). It is translocated to It the membrane of infected erythrocytes and expressed from approximately 60 var genes in a mutually exclusive manner. Switching of var genes allows the parasite to alter functional and antigenic properties of infected erythrocytes, to escape the immune defense and to establish chronic infections. We have developed an efficient method for isolating VAR genes from telomeric and other genome locations by adapting transformation-associated recombination (TAR) cloning, which can then be analyzed and sequenced. For this purpose, three plasmids each containing a homologous sequence representing the upstream regions of the group A, B, and C var genes and a sequence homologous to the conserved acidic terminal segment (ATS) of var genes were generated. Co-transfection with P. falciparum strain ITG2F6 genomic DNA in yeast cells yielded 200 TAR clones. The relative frequencies of clones from each group were not biased. Clones were screened by PCR, as well as Southern blotting, which revealed clones missed by PCR due to sequence mismatches with the primers. Selected clones were transformed into E. coli and further analyzed by RFLP and end sequencing. Physical analysis of 36 clones revealed 27 distinct types potentially representing 50% of the var gene repertoire. Three clones were selected for sequencing and assembled into single var gene containing contigs. This study demonstrates that it is possible to rapidly obtain the repertoire of var genes from P. falciparum within a single set of cloning experiments. This technique can be applied to individual isolates which will provide a detailed picture of the diversity of var genes in the field. This is a powerful tool to overcome the obstacles with cloning and assembly of multi-gene families by simultaneously cloning each member.	[Gaida, Annette; Schmid, Christoph D.; Buehlmann, Tobias; Beck, Hans-Peter] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Gaida, Annette; Schmid, Christoph D.; Buehlmann, Tobias; Beck, Hans-Peter] Univ Basel, Basel, Switzerland; [Becker, Marion M.; Louis, Edward J.] Univ Nottingham, Ctr Genet & Genom, Queens Med Ctr, Nottingham NG7 2RD, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Nottingham	Gaida, A (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	ed.louis@nottingham.ac.uk	Louis, Edward/B-7920-2008	Louis, Edward/0000-0003-1157-3608; Beck, Hans-Peter/0000-0001-8326-4834	Swiss National Science Foundation [3100A0-118456]; Wellcome Trust	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Swiss National Science Foundation [grant number 3100A0-118456] for AG and HPB, and by the Wellcome Trust for MMB and EJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Beck Hans-Peter, 2002, Methods Mol Med, V72, P159, DOI 10.1385/1-59259-271-6:159; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Blythe JE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-140; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cancilla MR, 1998, GENOMICS, V47, P399, DOI 10.1006/geno.1997.5129; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Chookajorn T, 2008, TRENDS PARASITOL, V24, P455, DOI 10.1016/j.pt.2008.07.005; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Kouprina N, 2003, NUCLEIC ACIDS RES, V31, P922, DOI 10.1093/nar/gkg182; Kouprina N, 1997, GENE, V197, P269, DOI 10.1016/S0378-1119(97)00271-0; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Larionov V, 1996, P NATL ACAD SCI USA, V93, P491, DOI 10.1073/pnas.93.1.491; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2004, MOL MICROBIOL, V53, P1011, DOI 10.1111/j.1365-2958.2004.04256.x; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; SILVERMAN GA, 1989, P NATL ACAD SCI USA, V86, P7485, DOI 10.1073/pnas.86.19.7485; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; WHO, 2008, PHARMAFORUM 0121; Young R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-385	41	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17782	10.1371/journal.pone.0017782	http://dx.doi.org/10.1371/journal.pone.0017782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408186	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800038
J	Kumar, K; Desai, V; Cheng, L; Khitrov, M; Grover, D; Satya, RV; Yu, CG; Zavaljevski, N; Reifman, J				Kumar, Kamal; Desai, Valmik; Cheng, Li; Khitrov, Maxim; Grover, Deepak; Satya, Ravi Vijaya; Yu, Chenggang; Zavaljevski, Nela; Reifman, Jaques			AGeS: A Software System for Microbial Genome Sequence Annotation	PLOS ONE			English	Article							RAPID ANNOTATION; PREDICTION; RESOURCE; INTERPRO; PROGRAM; SERVER; GENES; DNA	Background: The annotation of genomes from next-generation sequencing platforms needs to be rapid, high-throughput, and fully integrated and automated. Although a few Web-based annotation services have recently become available, they may not be the best solution for researchers that need to annotate a large number of genomes, possibly including proprietary data, and store them locally for further analysis. To address this need, we developed a standalone software application, the Annotation of microbial Genome Sequences (AGeS) system, which incorporates publicly available and in-house-developed bioinformatics tools and databases, many of which are parallelized for high-throughput performance. Methodology: The AGeS system supports three main capabilities. The first is the storage of input contig sequences and the resulting annotation data in a central, customized database. The second is the annotation of microbial genomes using an integrated software pipeline, which first analyzes contigs from high-throughput sequencing by locating genomic regions that code for proteins, RNA, and other genomic elements through the Do-It-Yourself Annotation (DIYA) framework. The identified protein-coding regions are then functionally annotated using the in-house-developed Pipeline for Protein Annotation (PIPA). The third capability is the visualization of annotated sequences using GBrowse. To date, we have implemented these capabilities for bacterial genomes. AGeS was evaluated by comparing its genome annotations with those provided by three other methods. Our results indicate that the software tools integrated into AGeS provide annotations that are in general agreement with those provided by the compared methods. This is demonstrated by a > 94% overlap in the number of identified genes, a significant number of identical annotated features, and a > 90% agreement in enzyme function predictions.	[Kumar, Kamal; Desai, Valmik; Cheng, Li; Khitrov, Maxim; Grover, Deepak; Satya, Ravi Vijaya; Yu, Chenggang; Zavaljevski, Nela; Reifman, Jaques] USA, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, DoD Biotechnol High Performance Comp Software App, Ft Detrick, MD USA		Kumar, K (corresponding author), USA, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, DoD Biotechnol High Performance Comp Software App, Ft Detrick, MD USA.	jaques.reifman@us.army.mil		Kumar, Kamal/0000-0002-9470-6682	United States Department of Defense High-Performance Computing Modernization Program (HPCMP) office, under the High-Performance Computing Software Applications Institutes (HSAI) Initiative	United States Department of Defense High-Performance Computing Modernization Program (HPCMP) office, under the High-Performance Computing Software Applications Institutes (HSAI) Initiative	This work was partially sponsored by the United States Department of Defense High-Performance Computing Modernization Program (HPCMP) office, under the High-Performance Computing Software Applications Institutes (HSAI) Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrett Alan J., 1997, European Journal of Biochemistry, V250, P1; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Donlin Maureen J, 2009, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s28; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Glasner JD, 2008, NUCLEIC ACIDS RES, V36, pD519, DOI 10.1093/nar/gkm973; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mulder NJ, 2008, MOL BIOTECHNOL, V38, P165, DOI 10.1007/s12033-007-9003-x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paulson LD, 2005, COMPUTER, V38, P14, DOI 10.1109/MC.2005.330; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Warren AS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-35; Yu CG, 2009, PROTEINS, V74, P449, DOI 10.1002/prot.22167; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52	37	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17469	10.1371/journal.pone.0017469	http://dx.doi.org/10.1371/journal.pone.0017469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408217	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800014
J	Ramanathan, R; Campbell, JL; Soni, SK; Bhargava, SK; Bansal, V				Ramanathan, Rajesh; Campbell, Jos L.; Soni, Sarvesh K.; Bhargava, Suresh K.; Bansal, Vipul			Cationic Amino Acids Specific Biomimetic Silicification in Ionic Liquid: A Quest to Understand the Formation of 3-D Structures in Diatoms	PLOS ONE			English	Article							FUNGUS FUSARIUM-OXYSPORUM; SILICA STRUCTURES; BIOINSPIRED SYNTHESIS; AMORPHOUS SILICA; BIOSYNTHESIS; BIOSILICIFICATION; NANOPARTICLES; PROTEIN; NANOTECHNOLOGY; BIOSILICA	The intricate, hierarchical, highly reproducible, and exquisite biosilica structures formed by diatoms have generated great interest to understand biosilicification processes in nature. This curiosity is driven by the quest of researchers to understand nature's complexity, which might enable reproducing these elegant natural diatomaceous structures in our laboratories via biomimetics, which is currently beyond the capabilities of material scientists. To this end, significant understanding of the biomolecules involved in biosilicification has been gained, wherein cationic peptides and proteins are found to play a key role in the formation of these exquisite structures. Although biochemical factors responsible for silica formation in diatoms have been studied for decades, the challenge to mimic biosilica structures similar to those synthesized by diatoms in their natural habitats has not hitherto been successful. This has led to an increasingly interesting debate that physico-chemical environment surrounding diatoms might play an additional critical role towards the control of diatom morphologies. The current study demonstrates this proof of concept by using cationic amino acids as catalyst/template/scaffold towards attaining diatom-like silica morphologies under biomimetic conditions in ionic liquids.	[Ramanathan, Rajesh; Campbell, Jos L.; Soni, Sarvesh K.; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Bhargava, SK (corresponding author), RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia.	suresh.bhargava@rmit.edu.au; vipul.bansal@rmit.edu.au	Soni, Sarvesh/H-4007-2012; Ramanathan, Rajesh/H-1617-2011; Bansal, Vipul/B-2485-2008; Bhargava, Suresh K./AAQ-2675-2020; Bhargava, Suresh K./C-5783-2011	Bansal, Vipul/0000-0002-3354-4317; Bhargava, Suresh K./0000-0002-3127-8166; Bhargava, Suresh K./0000-0002-3127-8166; Ramanathan, Rajesh/0000-0002-8500-9148	Australian Research Council (ARC) [DP0988099, DP110105125, LP100200859]; Commonwealth of Australia	Australian Research Council (ARC)(Australian Research Council); Commonwealth of Australia(Australian Government)	VB thanks the Australian Research Council (ARC) for APD Fellowship and financial support through the ARC Discovery Projects DP0988099 and DP110105125, and ARC Linkage Project LP100200859. VB also acknowledges the support of Ian Potter Foundation in establishing a multimode advanced spectroscopy facility at RMIT University. RR thanks the Commonwealth of Australia for an Australian Postgraduate Award (APA) towards his PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/NMAT2448, 10.1038/nmat2448]; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2005, ADV MATER, V17, P889, DOI 10.1002/adma.200401176; Bansal V, 2004, J MATER CHEM, V14, P3303, DOI 10.1039/b407904c; Bansal V, 2006, J AM CHEM SOC, V128, P11958, DOI 10.1021/ja063011m; Bansal V, 2007, LANGMUIR, V23, P4993, DOI 10.1021/la062535x; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; BARR TL, 1983, APPL SURF SCI, V15, P1, DOI 10.1016/0378-5963(83)90003-X; Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f; Bharde A, 2006, SMALL, V2, P135, DOI 10.1002/smll.200500180; Bradbury J, 2004, PLOS BIOL, V2, P1512, DOI 10.1371/journal.pbio.0020306; Brutchey RL, 2008, CHEM REV, V108, P4915, DOI 10.1021/cr078256b; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Drum RW, 2003, TRENDS BIOTECHNOL, V21, P325, DOI 10.1016/S0167-7799(03)00169-0; Estroff LA, 2001, CHEM MATER, V13, P3227, DOI 10.1021/cm010110k; Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011; Greaves TL, 2008, CHEM SOC REV, V37, P1709, DOI 10.1039/b801395k; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Iler R. K, 1979, CHEM SILICA; IMAI H, 2007, SELF ORGANIZED FORMA, P43; Kr?ger N., 2004, BIOMINERALIZATION PR, P137; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Lopez PJ, 2005, CURR NANOSCI, V1, P73, DOI 10.2174/1573413052953156; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Parkinson J, 1999, BBA-MOL CELL RES, V1452, P89, DOI 10.1016/S0167-4889(99)00116-0; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Patwardhan SV, 2003, CHEM COMMUN, P1122, DOI 10.1039/b302056h; Patwardhan SV, 2001, J INORG ORGANOMET P, V11, P117, DOI 10.1023/A:1014403932692; Pearson A, 2010, CHEM COMMUN, V46, P731, DOI 10.1039/b918866e; Pearson A, 2011, INORG CHEM, V50, P1705, DOI 10.1021/ic1021752; Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130; Ryu J. Hyung, 2008, ANGEW CHEM INT EDIT, V47, P7639; Schiffrin A, 2007, P NATL ACAD SCI USA, V104, P5279, DOI 10.1073/pnas.0607867104; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; SIMPSON TL, 1981, SILICON SILICEOUS ST; Soni SK, 2010, LANGMUIR, V26, P16020, DOI 10.1021/la101965j; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; Vrieling EG, 2007, P NATL ACAD SCI USA, V104, P10441, DOI 10.1073/pnas.0608980104	42	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17707	10.1371/journal.pone.0017707	http://dx.doi.org/10.1371/journal.pone.0017707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408611	Green Published, gold, Green Submitted			2022-12-25	WOS:000287965200037
J	Zucchelli, S; Marcuzzi, F; Codrich, M; Agostoni, E; Vilotti, S; Biagioli, M; Pinto, M; Carnemolla, A; Santoro, C; Gustincich, S; Persichetti, F				Zucchelli, Silvia; Marcuzzi, Federica; Codrich, Marta; Agostoni, Elena; Vilotti, Sandra; Biagioli, Marta; Pinto, Milena; Carnemolla, Alisia; Santoro, Claudio; Gustincich, Stefano; Persichetti, Francesca			Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANUCLEAR INCLUSIONS; POLYUBIQUITIN CHAINS; CELL-DEATH; DISEASE; DEGRADATION; CAG; P62/SQSTM1; AUTOPHAGY; DJ-1; GENE	Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of polyglutamines in the first exon of huntingtin (HTT), which confers aggregation-promoting properties to amino-terminal fragments of the protein (N-HTT). Mutant N-HTT aggregates are enriched for ubiquitin and contain ubiquitin E3 ligases, thus suggesting a role for ubiquitination in aggregate formation. Here, we report that tumor necrosis factor receptor-associated factor 6 (TRAF6) binds to WT and polyQ-expanded N-HTT in vitro as well as to endogenous full-length proteins in mouse and human brain in vivo. Endogenous TRAF6 is recruited to cellular inclusions formed by mutant N-HTT. Transient overexpression of TRAF6 promotes WT and mutant N-HTT atypical ubiquitination with Lys(6), Lys(27), and Lys(29) linkage formation. Both interaction and ubiquitination seem to be independent from polyQ length. In cultured cells, TRAF6 enhances mutant N-HTT aggregate formation, whereas it has no effect on WT N-HTT protein localization. Mutant N-HTT inclusions are enriched for ubiquitin staining only when TRAF6 and Lys(6), Lys(27), and Lys(29) ubiquitin mutants are expressed. Finally, we show that TRAF6 is up-regulated in postmortem brains from HD patients where it is found in the insoluble fraction. These results suggest that TRAF6 atypical ubiquitination warrants investigation in HD pathogenesis.	[Zucchelli, Silvia; Marcuzzi, Federica; Codrich, Marta; Agostoni, Elena; Vilotti, Sandra; Biagioli, Marta; Pinto, Milena; Carnemolla, Alisia; Gustincich, Stefano; Persichetti, Francesca] Int Sch Adv Studies SISSA, Sector Neurobiol, I-34136 Trieste, Italy; [Zucchelli, Silvia; Gustincich, Stefano] Italian Inst Technol, SISSA Unit, I-34136 Trieste, Italy; [Zucchelli, Silvia; Biagioli, Marta; Gustincich, Stefano] SISSA, Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy; [Santoro, Claudio] Univ Piemonte Orientale, Dept Med Sci, I-28100 Novara, Italy; [Persichetti, Francesca] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15121 Alessandria, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Persichetti, F (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Ambiente & Vita, Viale T Michel 11, I-15121 Alessandria, Italy.	francesca.persichetti@mfn.unipmn.it	Carnemolla, Alisia/AAV-2154-2021; santoro, claudio/G-6819-2012; Pinto, Milena/K-6095-2017; Codrich, Marta/AAC-7724-2022	Pinto, Milena/0000-0001-9202-1527; Zucchelli, Silvia/0000-0003-4556-2990; Biagioli, Marta/0000-0001-8295-8025; Persichetti, Francesca/0000-0002-9804-644X; Gustincich, Stefano/0000-0002-2749-2514	Telethon Foundation of Italy [GGP07185]; Italian Institute of Technology	Telethon Foundation of Italy(Fondazione Telethon); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	This work was supported by the Telethon Foundation of Italy (Grant GGP07185) and the Italian Institute of Technology.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hendricks AE, 2009, AM J MED GENET A, V149A, P1375, DOI 10.1002/ajmg.a.32901; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	37	46	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25108	25117		10.1074/jbc.M110.187591	http://dx.doi.org/10.1074/jbc.M110.187591			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21454471	Green Published, hybrid			2022-12-25	WOS:000292547900059
J	Bousquet, SM; Monet, M; Boulay, G				Bousquet, Simon M.; Monet, Michael; Boulay, Guylain			The Serine 814 of TRPC6 Is Phosphorylated under Unstimulated Conditions	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RECEPTOR POTENTIAL TRP; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE CK2; CALCIUM-ENTRY; CA2+ ENTRY; DEPENDENT PHOSPHORYLATION; STATISTICAL-MODEL; CHANNEL ACTIVITY; STORE DEPLETION	TRPC are nonselective cation channels involved in calcium entry. Their regulation by phosphorylation has been shown to modulate their routing and activity. TRPC6 activity increases following phosphorylation by Fyn, and is inhibited by protein kinase G and protein kinase C. A previous study by our group showed that TRPC6 is phosphorylated under unstimulated conditions in a human embryonic kidney cells line (HEK293). To investigate the mechanism responsible for this phosphorylation, we used a MS/MS approach combined with metabolic labeling and showed that the serine at position 814 is phosphorylated in unstimulated cells. The mutation of Ser(814) into Ala decreased basal phosphorylation but did not modify TRPC6 activity. Even though Ser(814) is within a consensus site for casein kinase II (CK2), we showed that CK2 is not involved in the phosphorylation of TRPC6 and does not modify its activity. In summary, we identified a new basal phosphorylation site (Ser(814)) on TRPC6 and showed that CK2 is not responsible for the phosphorylation of this site.	[Bousquet, Simon M.; Monet, Michael; Boulay, Guylain] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ, Canada	University of Sherbrooke	Bousquet, SM (corresponding author), Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	MONET, Michael/0000-0002-7864-862X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Quebec Heart & Stroke Foundation; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Heart & Stroke Foundation; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Quebec Heart & Stroke Foundation. GB is the recipient of a scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; BOUSQUET S, 2010, J BIOL CHEM; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Sambrook J, 2001, MOL CLONING LAB MAN; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	38	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18121	10.1371/journal.pone.0018121	http://dx.doi.org/10.1371/journal.pone.0018121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448286	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500041
J	Olling, A; Goy, S; Hoffmann, F; Tatge, H; Just, I; Gerhard, R				Olling, Alexandra; Goy, Sebastian; Hoffmann, Florian; Tatge, Helma; Just, Ingo; Gerhard, Ralf			The Repetitive Oligopeptide Sequences Modulate Cytopathic Potency but Are Not Crucial for Cellular Uptake of Clostridium difficile Toxin A	PLOS ONE			English	Article							BINDING DOMAINS; RECEPTOR; SYSTEM; MODEL; GENE	The pathogenicity of Clostridium difficile is primarily linked to secretion of the intracellular acting toxins A (TcdA) and B (TcdB) which monoglucosylate and thereby inactivate Rho GTPases of host cells. Although the molecular mode of action of TcdA and TcdB is well understood, far less is known about toxin binding and uptake. It is acknowledged that the C-terminally combined repetitive oligopeptides (CROPs) of the toxins function as receptor binding domain. The current study evaluates the role of the CROP domain with respect to functionality of TcdA and TcdB. Therefore, we generated truncated TcdA devoid of the CROPs (TcdA(1-1874)) and found that this mutant was still cytopathic. However, TcdA(1-1874) possesses about 5 to 10-fold less potency towards 3T3 and HT29 cells compared to the full length toxin. Interestingly, CHO-C6 cells even showed almost identical susceptibility towards truncated and full length TcdA concerning Rac1 glucosylation or cell rounding, respectively. FACS and Western blot analyses elucidated these differences and revealed a correlation between CROP-binding to the cell surface and toxin potency. These findings refute the accepted opinion of solely CROP-mediated toxin internalization. Competition experiments demonstrated that presence neither of TcdA CROPs nor of full length TcdA reduced binding of truncated TcdA(1-1874) to HT29 cells. We assume that toxin uptake might additionally occur through alternative receptor structures and/or other associated endocytotic pathways. The second assumption was substantiated by TER measurements showing that basolaterally applied TcdA(1-1874) exhibits considerably higher cytotoxic potency than apically applied mutant or even full length TcdA, the latter being almost independent of the side of application. Thus, different routes for cellular uptake might enable the toxins to enter a broader repertoire of cell types leading to the observed multifarious pathogenesis of C. difficile.	[Olling, Alexandra; Goy, Sebastian; Hoffmann, Florian; Tatge, Helma; Just, Ingo; Gerhard, Ralf] Hannover Med Sch, Inst Toxikol, D-30623 Hannover, Germany	Hannover Medical School	Olling, A (corresponding author), Hannover Med Sch, Inst Toxikol, D-30623 Hannover, Germany.	Gerhard.ralf@mh-hannover.de			Deutsche Forschungsgemeinschaft [SFB 621, B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB 621 (Project B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amimoto K, 2007, MICROBIOL-SGM, V153, P1198, DOI 10.1099/mic.0.2006/002287-0; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Demarest SJ, 2005, J MOL BIOL, V346, P1197, DOI 10.1016/j.jmb.2004.12.059; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; Teichert M, 2006, INFECT IMMUN, V74, P6006, DOI 10.1128/IAI.00545-06; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; van den Berg RJ, 2004, J CLIN MICROBIOL, V42, P1035, DOI 10.1128/JCM.42.3.1035-1041.2004; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	29	57	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17623	10.1371/journal.pone.0017623	http://dx.doi.org/10.1371/journal.pone.0017623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445253	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100021
J	Wang, W; Hansbro, PM; Foster, PS; Yang, M				Wang, Wan; Hansbro, Philip M.; Foster, Paul S.; Yang, Ming			An Alternate STAT6-Independent Pathway Promotes Eosinophil Influx into Blood during Allergic Airway Inflammation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; NK CELLS; INTERLEUKIN-5 PRODUCTION; EXPERIMENTAL ASTHMA; IL-5 PRODUCTION; BALB/C MICE; HYPERREACTIVITY; EOTAXIN; HYPERRESPONSIVENESS	Background: Enhanced eosinophil responses have critical roles in the development of allergic diseases. IL-5 regulates the maturation, migration and survival of eosinophils, and IL-5 and eotaxins mediate the trafficking and activation of eosinophils in inflamed tissues. CD4(+) Th2 cells are the main producers of IL-5 and other cells such as NK also release this cytokine. Although multiple signalling pathways may be involved, STAT6 critically regulates the differentiation and cytokine production of Th2 cells and the expression of eotaxins. Nevertheless, the mechanisms that mediate different parts of the eosinophilic inflammatory process in different tissues in allergic airway diseases remain unclear. Furthermore, the mechanisms at play may vary depending on the context of inflammation and microenvironment of the involved tissues. Methodology/Principal Findings: We employed a model of allergic airway disease in wild type and STAT6-deficient mice to explore the roles of STAT6 and IL-5 in the development of eosinophilic inflammation in this context. Quantitative PCR and ELISA were used to examine IL-5, eotaxins levels in serum and lungs. Eosinophils in lung, peripheral blood and bone marrow were characterized by morphological properties. CD4(+) T cell and NK cells were identified by flow cytometry. Antibodies were used to deplete CD4(+) and NK cells. We showed that STAT6 is indispensible for eosinophilic lung inflammation and the induction of eotaxin-1 and -2 during allergic airway inflammation. In the absence of these chemokines eosinophils are not attracted into lung and accumulate in peripheral blood. We also demonstrate the existence of an alternate STAT6-independent pathway of IL-5 production by CD4(+) and NK cells that mediates the development of eosinophils in bone marrow and their subsequent movement into the circulation. Conclusions: These results suggest that different points of eosinophilic inflammatory processes in allergic airway disease may be differentially regulated by the activation of STAT6-dependent and -independent pathways.	[Wang, Wan] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; Hunter Med Res Inst, Callaghan, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Wang, W (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au	Hansbro, Phil/G-7486-2013; Foster, Paul/G-5057-2013	Hansbro, Phil/0000-0002-4741-3035; , Paul/0000-0002-0827-8299	National Health & Medical Research Council of Australia; Cooperative Research Centre for Asthma and Airways	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding: This work was supported by project grants from the National Health & Medical Research Council of Australia (P. S. Foster and M. Yang) and the Cooperative Research Centre for Asthma and Airways (P. S. Foster and M. Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Chong LK, 2008, EUR J IMMUNOL, V38, P995, DOI 10.1002/eji.200737687; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Hogan SP, 1997, IMMUNOL CELL BIOL, V75, P284, DOI 10.1038/icb.1997.43; Hogan SP, 1998, J IMMUNOL, V161, P1501; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Katsumoto T, 2004, J IMMUNOL, V173, P4967, DOI 10.4049/jimmunol.173.8.4967; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Kon OM, 1998, LANCET, V352, P1109, DOI 10.1016/S0140-6736(97)12261-9; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; OWEN WF, 1989, J EXP MED, V170, P343, DOI 10.1084/jem.170.1.343; Radinger M, 2009, PHARMACOL THERAPEUT, V121, P174, DOI 10.1016/j.pharmthera.2008.10.008; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sakamoto Y, 2004, IMMUNOLOGY, V112, P615, DOI 10.1046/j.1365-2567.2004.01909.x; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Schwarze J, 1999, J IMMUNOL, V162, P4207; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TING CC, 1987, CELL IMMUNOL, V104, P115, DOI 10.1016/0008-8749(87)90012-8; Tomkinson A, 1999, AM J RESP CRIT CARE, V160, P1283, DOI 10.1164/ajrccm.160.4.9809065; Walker C, 1998, J IMMUNOL, V161, P1962; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; WARREN HS, 1995, J IMMUNOL, V154, P5144; Yang M, 2003, J ALLERGY CLIN IMMUN, V112, P935, DOI 10.1016/j.jaci.2003.08.010; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zimmermann N, 2000, J IMMUNOL, V165, P5839, DOI 10.4049/jimmunol.165.10.5839; Zimmermann N, 2004, J IMMUNOL, V172, P1815, DOI 10.4049/jimmunol.172.3.1815	52	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17766	10.1371/journal.pone.0017766	http://dx.doi.org/10.1371/journal.pone.0017766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423619	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900027
J	Eto, D; Lao, C; DiToro, D; Barnett, B; Escobar, TC; Kageyama, R; Yusuf, I; Crotty, S				Eto, Danelle; Lao, Christopher; DiToro, Daniel; Barnett, Burton; Escobar, Tania C.; Kageyama, Robin; Yusuf, Isharat; Crotty, Shane			IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; CHRONIC VIRAL-INFECTION; IMMUNOGLOBULIN PRODUCTION; MULTIPLE-MYELOMA; PLASMA-CELLS; ANTIBODY-PRODUCTION; HUMORAL IMMUNITY; BCL-6 EXPRESSION; DOWN-REGULATION; GROWTH-FACTOR	Cytokines are important modulators of lymphocytes, and both interleukin-21 (IL-21) and IL-6 have proposed roles in T follicular helper (Tfh) differentiation, and directly act on B cells. Here we investigated the absence of IL-6 alone, IL-21 alone, or the combined lack of IL-6 and IL-21 on Tfh differentiation and the development of B cell immunity in vivo. C57BL/6 or IL-21(-/-) mice were treated with a neutralizing monoclonal antibody against IL-6 throughout the course of an acute viral infection (lymphocytic choriomeningitis virus, LCMV). The combined absence of IL-6 and IL-21 resulted in reduced Tfh differentiation and reduced Bcl6 protein expression. In addition, we observed that these cytokines had a large impact on antigen-specific B cell responses. IL-6 and IL-21 collaborate in the acute T-dependent antiviral antibody response (90% loss of circulating antiviral IgG in the absence of both cytokines). In contrast, we observed reduced germinal center formation only in the absence of IL-21. Absence of IL-6 had no impact on germinal centers, and combined absence of both IL-21 and IL-6 revealed no synergistic effect on germinal center B cell development. Studying CD4 T cells in vitro, we found that high IL-21 production was not associated with high Bcl6 or CXCR5 expression. TCR stimulation of purified naive CD4 T cells in the presence of IL-6 also did not result in Tfh differentiation, as determined by Bcl6 or CXCR5 protein expression. Cumulatively, our data indicates that optimal Tfh formation requires IL-21 and IL-6, and that cytokines alone are insufficient to drive Tfh differentiation.	[Eto, Danelle; Lao, Christopher; DiToro, Daniel; Barnett, Burton; Escobar, Tania C.; Kageyama, Robin; Yusuf, Isharat; Crotty, Shane] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA	La Jolla Institute for Immunology	Eto, D (corresponding author), La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA.	shane@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	Pew Scholar Award; LIAI; NIH NIAID [R01 072543]	Pew Scholar Award; LIAI; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pew Scholar Award, LIAI Institutional Funds, and NIH NIAID R01 072543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; BATAILLE R, 1995, BLOOD, V86, P685, DOI 10.1182/blood.V86.2.685.bloodjournal862685; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; CROTTY S, 2011, ANN REV IMMUNOL; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hotson AN, 2009, J IMMUNOL, V182, P7558, DOI 10.4049/jimmunol.0803666; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jego G, 2001, BLOOD, V97, P1817, DOI 10.1182/blood.V97.6.1817; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kashiwakuma D, 2010, J IMMUNOL, V185, P2730, DOI 10.4049/jimmunol.0903839; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; SUTO A, 2008, DEVELOPMENT, V205, P1369; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; vanZaanen HCT, 1996, J CLIN INVEST, V98, P1441, DOI 10.1172/JCI118932; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	77	375	392	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17739	10.1371/journal.pone.0017739	http://dx.doi.org/10.1371/journal.pone.0017739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423809	Green Published, gold, Green Submitted			2022-12-25	WOS:000288512400024
J	Niibe, K; Kawamura, Y; Araki, D; Morikawa, S; Miura, K; Suzuki, S; Shimmura, S; Sunabori, T; Mabuchi, Y; Nagai, Y; Nakagawa, T; Okano, H; Matsuzaki, Y				Niibe, Kunimichi; Kawamura, Yoshimi; Araki, Daisuke; Morikawa, Satoru; Miura, Kyoko; Suzuki, Sadafumi; Shimmura, Shigeto; Sunabori, Takehiko; Mabuchi, Yo; Nagai, Yasuo; Nakagawa, Taneaki; Okano, Hideyuki; Matsuzaki, Yumi			Purified Mesenchymal Stem Cells Are an Efficient Source for iPS Cell Induction	PLOS ONE			English	Article							HUMAN FIBROBLASTS; ES CELLS; PLURIPOTENCY; MOUSE; GENERATION; EXPRESSION; CHIMERAS; NANOG	Background: Induced pluripotent stem (iPS) cells are generated from mouse and human somatic cells by the forced expression of defined transcription factors. Although most somatic cells are capable of acquiring pluripotency with minimal gene transduction, the poor efficiency of cell reprogramming and the uneven quality of iPS cells are still important problems. In particular, the choice of cell type most suitable for inducing high-quality iPS cells remains unclear. Methodology/Principal Findings: Here, we generated iPS cells from PDGFR alpha(+) Sca-1(+) (P alpha S) adult mouse mesenchymal stem cells (MSCs) and PDGFR alpha(-) Sca-1(-) osteo-progenitors (OP cells), and compared the induction efficiency and quality of individual iPS clones. MSCs had a higher reprogramming efficiency compared with OP cells and Tail Tip Fibroblasts (TTFs). The iPS cells induced from MSCs by Oct3/4, Sox2, and Klf4 appeared to be the closest equivalent to ES cells by DNA microarray gene profile and germline-transmission efficiency. Conclusions/Significance: Our findings suggest that a purified source of undifferentiated cells from adult tissue can produce high-quality iPS cells. In this context, prospectively enriched MSCs are a promising candidate for the efficient generation of high-quality iPS cells.	[Niibe, Kunimichi; Kawamura, Yoshimi; Araki, Daisuke; Miura, Kyoko; Suzuki, Sadafumi; Sunabori, Takehiko; Mabuchi, Yo; Nagai, Yasuo; Okano, Hideyuki; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Niibe, Kunimichi; Araki, Daisuke; Morikawa, Satoru; Nakagawa, Taneaki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Tokyo, Japan; [Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University; Keio University; Keio University	Niibe, K (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	penguin@a8.keio.jp	Mabuchi, Yo/L-1535-2013; Morikawa, Satoru/AFL-5621-2022; Miura, Kyoko/L-1750-2013; Okano, Hideyuki/I-7584-2019; Shimmura, Shigeto/J-4678-2013; Kawamura, Yoshimi/L-1289-2013	Mabuchi, Yo/0000-0001-8008-3966; Morikawa, Satoru/0000-0001-8859-2888; Miura, Kyoko/0000-0003-2208-149X; Matsuzaki, Yumi/0000-0002-3729-2997; Kawamura, Yoshimi/0000-0002-9864-7974	Japan Society for the Promotion of Science (JSPS); Ministry of Education, and Science and Culture of Japan of Keio University; Grants-in-Aid for Scientific Research [23791446] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, and Science and Culture of Japan of Keio University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by a grant from the Japan Society for the Promotion of Science (JSPS), and partly by a grant-in-aid from the Global Century COE program of the Ministry of Education, and Science and Culture of Japan of Keio University. K.N. is supported by a Research Fellowship for Young Scientists from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarkowski AK, 1998, INT J DEV BIOL, V42, P903; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	27	40	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17610	10.1371/journal.pone.0017610	http://dx.doi.org/10.1371/journal.pone.0017610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412425	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800018
J	Sharon, H; Amar, D; Levdansky, E; Mircus, G; Shadkchan, Y; Shamir, R; Osherov, N				Sharon, Haim; Amar, David; Levdansky, Emma; Mircus, Gabriel; Shadkchan, Yana; Shamir, Ron; Osherov, Nir			PrtT-Regulated Proteins Secreted by Aspergillus fumigatus Activate MAPK Signaling in Exposed A549 Lung Cells Leading to Necrotic Cell Death	PLOS ONE			English	Article							CANDIDA-ALBICANS; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; P38 MAPK; KAPPA-B; KINASE; MACROPHAGES; INDUCTION; INFECTION; INTERLEUKIN-8	Aspergillus fumigatus is the most commonly encountered mold pathogen of humans, predominantly infecting the respiratory system. Colonization and penetration of the lung alveolar epithelium is a key but poorly understood step in the infection process. This study focused on identifying the transcriptional and cell-signaling responses activated in A549 alveolar carcinoma cells incubated in the presence of A. fumigatus wild-type and Delta PrtT protease-deficient germinating conidia and culture filtrates (CF). Microarray analysis of exposed A549 cells identified distinct classes of genes whose expression is altered in the presence of germinating conidia and CF and suggested the involvement of both NFkB and MAPK signaling pathways in mediating the cellular response. Phosphoprotein analysis of A549 cells confirmed that JNK and ERK1/2 are phosphorylated in response to CF from wild-type A. fumigatus and not phosphorylated in response to CF from the Delta PrtT protease-deficient strain. Inhibition of JNK or ERK1/2 kinase activity substantially decreased CF-induced cell damage, including cell peeling, actin-cytoskeleton damage, and reduction in metabolic activity and necrotic death. These results suggest that inhibition of MAPK-mediated host responses to treatment with A. fumigatus CF decreases cellular damage, a finding with possible clinical implications.	[Sharon, Haim; Levdansky, Emma; Mircus, Gabriel; Shadkchan, Yana; Osherov, Nir] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Amar, David; Shamir, Ron] Tel Aviv Univ, Dept Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Sharon, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	nosherov@post.tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870	Israel Ministry of Health [3-5201]; Israel Cancer Research Fund (ICRF) [05-502 RCDA]; Israel Science Foundation [802/08]; Tel Aviv University	Israel Ministry of Health; Israel Cancer Research Fund (ICRF); Israel Science Foundation(Israel Science Foundation); Tel Aviv University	This work was supported by the Israel Ministry of Health grant 3-5201 and Israel Cancer Research Fund (ICRF) grant 05-502 RCDA to N.O. R.S. was supported in part by the Israel Science Foundation (grant 802/08). D.A. was supported in part by a fellowship from the Edmond J. Safra Bioinformatics program at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Bergmann A, 2009, INFECT IMMUN, V77, P4041, DOI 10.1128/IAI.00425-09; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; BRUNS S, PLOS PATHOG, V6; Copping VMS, 2005, J ANTIMICROB CHEMOTH, V55, P645, DOI 10.1093/jac/dki088; Daly P, 2002, MED MYCOL, V40, P27, DOI 10.1080/mmy.40.1.27.33; Daly P, 1999, MYCOPATHOLOGIA, V146, P67, DOI 10.1023/A:1007092112873; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Deva R, 2003, J IMMUNOL, V171, P3047, DOI 10.4049/jimmunol.171.6.3047; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Hargett D, 2005, J VIROL, V79, P8348, DOI 10.1128/JVI.79.13.8348-8360.2005; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kimberg M, 2008, MED MYCOL, V46, P631, DOI 10.1080/13693780802140907; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Lee HS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2661; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Mans Jeffrey J., 2006, Infectious Disorders - Drug Targets, V6, P299, DOI 10.2174/187152606778249926; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681; Moriyuki K, 2008, REGUL PEPTIDES, V145, P42, DOI 10.1016/j.regpep.2007.08.002; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Roeder A, 2004, J INFECT DIS, V190, P1318, DOI 10.1086/423854; Rydkina E, 2005, CELL MICROBIOL, V7, P1519, DOI 10.1111/j.1462-5822.2005.00574.x; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS157, DOI 10.1086/376523; Stergiopoulou T, 2007, AM J CLIN PATHOL, V127, P349, DOI 10.1309/UJRV9DLC11RM3G8R; Tang NF, 2004, INFECT IMMUN, V72, P2513, DOI 10.1128/IAI.72.5.2513-2520.2004; Tang P, 1998, INFECT IMMUN, V66, P1106, DOI 10.1128/IAI.66.3.1106-1112.1998; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x	54	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17509	10.1371/journal.pone.0017509	http://dx.doi.org/10.1371/journal.pone.0017509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412410	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800008
J	Perez-Losada, M; Jobes, DV; Sinangil, F; Crandall, KA; Arenas, M; Posada, D; Berman, PW				Perez-Losada, Marcos; Jobes, David V.; Sinangil, Faruk; Crandall, Keith A.; Arenas, Miguel; Posada, David; Berman, Phillip W.			Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand	PLOS ONE			English	Article							INJECTING DRUG-USERS; ESTIMATING EVOLUTIONARY RATES; MOLECULAR EPIDEMIOLOGY; SUBTYPE-B; TRANSMISSION CLUSTERS; GENOTYPIC CHARACTERIZATION; CIRCULATING RECOMBINANT; CRF01-AE/B RECOMBINANT; TYPE-1; INFECTION	Background: In 2003, a phase III placebo-controlled trial (VAX003) was completed in Bangkok, Thailand. Of the 2,546 individuals enrolled in the trial based on high risk for infection through injection drug use (IDU), we obtained clinical samples and HIV-1 sequence data (envelope glycoprotein gene gp120) from 215 individuals who became infected during the trial. Here, we used these data in combination with other publicly available gp120 sequences to perform a molecular surveillance and phylodynamic analysis of HIV-1 in Thailand. Methodology and Findings: Phylogenetic and population genetic estimators were used to assess HIV-1 gp120 diversity as a function of vaccination treatment, viral load (VL) and CD4(+) counts, to indentify transmission clusters and to investigate the timescale and demographics of HIV-1 in Thailand. Three HIV-1 subtypes were identified: CRF01_AE (85% of the infections), subtype B (13%) and CRF15_AE (2%). The Bangkok IDU cohort showed more gp120 diversity than other Asian IDU cohorts and similar diversity to that observed in sexually infected individuals. Moreover, significant differences (P < 0.02) in genetic diversity were observed in CRF01_AE IDU with different VL and CD4(+) counts. No phylogenetic structure was detected regarding any of the epidemiological and clinical factors tested, although high proportions (35% to 50%) of early infections fell into clusters, which suggests that transmission chains associated with acute infection play a key role on HIV-1 spread among IDU. CRF01_AE was estimated to have emerged in Thailand in 1984.5 (1983-1986), 3-6 years before the first recognition of symptomatic patients (1989). The relative genetic diversity of the HIV-1 population has remained high despite decreasing prevalence rates since the mid 1990s. Conclusions: Our study and recent epidemiological reports indicate that HIV-1 is still a major threat in Thailand and suggest that HIV awareness and prevention needs to be strengthened to avoid AIDS resurgence.	[Perez-Losada, Marcos] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Jobes, David V.] Jobes Consulting Serv, Rockville, MD USA; [Sinangil, Faruk] Global Solut Infect Dis, San Francisco, CA USA; [Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Arenas, Miguel; Posada, David] Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36310, Spain; [Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Universidade do Porto; Brigham Young University; Universidade de Vigo; University of California System; University of California Santa Cruz	Perez-Losada, M (corresponding author), Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal.	mlosada323@gmail.com	Posada, David/C-4502-2008; Perez-Losada, Marcos/I-4407-2013; Crandall, Keith A./H-2789-2019; Arenas, Miguel/C-4831-2009	Posada, David/0000-0003-1407-3406; Perez-Losada, Marcos/0000-0002-2585-4657; Crandall, Keith A./0000-0002-0836-3389; Arenas, Miguel/0000-0002-0516-2717	VaxGen; Bill and Melinda Gates Foundation	VaxGen; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The data collection, clinical and genetic, for this study was funded by VaxGen as part of their Vax003 Phase III vaccine trial. The analysis of the DNA sequence data presented in this paper was supported by funding from the Bill and Melinda Gates Foundation to the non-profit organization Global Solutions for Infectious Diseases (GSID). The funders had no role in study design, data analysis, decision to publish, or preparation of this manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2003, GENETICS, V164, P1229; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Cheng Chun-Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P720; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Crandall KA, 1999, EVOLUTION OF HIV, P153; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Silva UC, 2010, AIDS RES HUM RETROV, V26, P223, DOI 10.1089/aid.2009.0213; Drummond A. J., 2009, TRACER MCMC TRACE AN; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; Kato K, 2001, AIDS RES HUM RETROV, V17, P113, DOI 10.1089/08892220150217201; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kretzschmar M, 1998, AIDS, V12, P801, DOI 10.1097/00002030-199807000-00017; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; MARAIS H, 2004, THAILAND RESPONSE HI; MARJORAM P, 1994, GENETICS, V136, P673; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McCutchan FE, 1998, AIDS RES HUM RETROV, V14, P329, DOI 10.1089/aid.1998.14.329; MCCUTCHAN FE, 1992, AIDS RES HUM RETROV, V8, P1887, DOI 10.1089/aid.1992.8.1887; McVean G, 2002, GENETICS, V160, P1231; Migasena S, 2000, AIDS RES HUM RETROV, V16, P655, DOI 10.1089/088922200308882; Nguyen L, 2002, J ACQ IMMUN DEF SYND, V30, P248, DOI [10.1097/00042560-200206010-00014, 10.1097/01.QAI.0000014769.35851.92]; *NIAID, 2004, HIV CAUS AIDS US NAT; Oelrichs RB, 2003, CURR HIV RES, V1, P239, DOI 10.2174/1570162033485302; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Over M, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000279713.39675.1c; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Papathanasopoulos MA, 2003, VIRUS GENES, V26, P151, DOI 10.1023/A:1023435429841; Perez-Losada M, 2010, MOL BIOL EVOL, V27, P417, DOI 10.1093/molbev/msp254; Perez-Losada M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-67; PHANUPHAK P, 1985, ASIAN PAC J ALLERGY, V3, P195; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Punyacharoensin N, 2009, AIDS, V23, P1143, DOI 10.1097/QAD.0b013e32832baa1c; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Ramos A, 2003, AIDS RES HUM RETROV, V19, P667, DOI 10.1089/088922203322280892; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2003, GENETICS, V164, P1677; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Saengdidtha Boonterm, 2005, J Med Assoc Thai, V88 Suppl 3, pS378; Saengwonloey O, 2003, JAIDS-J ACQ IMM DEF, V32, pS63, DOI 10.1097/00126334-200302011-00010; Saidel T. J., 2003, International Journal of Drug Policy, V14, P63, DOI 10.1016/S0955-3959(02)00209-8; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Seo TK, 2002, BIOINFORMATICS, V18, P115, DOI 10.1093/bioinformatics/18.1.115; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Smith D G, 1990, Lancet, V335, P781, DOI 10.1016/0140-6736(90)90883-7; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subbarao S, 2000, AIDS RES HUM RETROV, V16, P699, DOI 10.1089/088922200308693; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; *THAIL MIN PUBL HL, 1984, ACQ IMM SYNDR AIDS; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Tovanabutra S, 2001, AIDS, V15, P1063, DOI 10.1097/00002030-200105250-00018; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2004, AIDS RES HUM RETROV, V20, P465, DOI 10.1089/088922204323087705; *UNAIDS, 2008, REP GLOB HIV AIDS EP; UNAIDS/WHO, 2008, EP FACT SHEET HIV AI; *USAID, 2008, HIV AIDS HLTH PROF S; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Vaccari M, 2010, EXPERT REV VACCINES, V9, P997, DOI [10.1586/erv.10.104, 10.1586/ERV.10.104]; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Viputtijul K, 2002, AIDS RES HUM RETROV, V18, P1235, DOI 10.1089/08892220260387986; WASI C, 1995, AIDS, V9, P843, DOI 10.1097/00002030-199508000-00003; Watanaveeradej V, 2006, AIDS RES HUM RETROV, V22, P801, DOI 10.1089/aid.2006.22.801; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Wirachsilp Piyanot, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P814; Xiridou M, 2007, JAIDS-J ACQ IMM DEF, V45, P468, DOI 10.1097/QAI.0b013e318093dea5; YANG Z, 2001, PAML PHYLOGENETIC AN; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; [No title captured]	106	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16902	10.1371/journal.pone.0016902	http://dx.doi.org/10.1371/journal.pone.0016902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423744	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100004
J	Garbuzova-Davis, S; Louis, MK; Haller, EM; Derasari, HM; Rawls, AE; Sanberg, PR				Garbuzova-Davis, Svitlana; Louis, Michael K.; Haller, Edward M.; Derasari, Hiranya M.; Rawls, Ashley E.; Sanberg, Paul R.			Blood-Brain Barrier Impairment in an Animal Model of MPS III B	PLOS ONE			English	Article							SANFILIPPO-SYNDROME; MUCOPOLYSACCHARIDOSE-IIIB; PERIVASCULAR MACROPHAGES; STORAGE DISORDERS; MOUSE MODELS; MICROGLIA; PERICYTES; CELLS; GANGLIOSIDES; MECHANISMS	Background: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of alpha-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction in this devastating disorder could contribute to neuropathological disease manifestations. Methodology/Principal Findings: In the present study, we investigated structural (electron microscope) and functional (vascular leakage) integrity of the BBB in a mouse model of MPS III B at different stages of disease, focusing on brain structures known to experience neuropathological changes. Major findings of our study were: (1) endothelial cell damage in capillary ultrastructure, compromising the BBB and resulting in vascular leakage, (2) formation of numerous large vacuoles in endothelial cells and perivascular cells (pericytes and perivascular macrophages) in the large majority of vessels, (3) edematous space around microvessels, (4) microaneurysm adjacent to a ruptured endothelium, (6) Evans Blue and albumin microvascular leakage in various brain structures, (7) GM3 ganglioside accumulation in endothelium of the brain microvasculature. Conclusions/Significance: These new findings of BBB structural and function impairment in MPS III B mice even at early disease stage may have implications for disease pathogenesis and should be considered in current and future development of treatments for MPS III B.	[Garbuzova-Davis, Svitlana; Louis, Michael K.; Derasari, Hiranya M.; Rawls, Ashley E.; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Garbuzova-Davis, Svitlana] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Haller, Edward M.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Garbuzova-Davis, Svitlana/Q-3687-2019	Sanberg, Paul/0000-0001-9130-4592; Haller, Edward/0000-0002-8535-2181	Children's Medical Research Foundation	Children's Medical Research Foundation	This study was supported by the Children's Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barone R, 1999, NEUROPEDIATRICS, V30, P270, DOI 10.1055/s-2007-973503; Beesley GE, 1998, J MED GENET, V35, P910, DOI 10.1136/jmg.35.11.910; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; Begley DJ, 2003, PROG DRUG RES, V61, P39; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; DAMORE PA, 1992, AM J RESP CELL MOL, V6, P1; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; FERRER I, 1988, NEUROPATH APPL NEURO, V14, P315, DOI 10.1111/j.1365-2990.1988.tb00891.x; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hamano K, 2008, ACTA NEUROPATHOL, V115, P547, DOI 10.1007/s00401-007-0325-3; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; KIDA SY, 1993, ACTA NEUROPATHOL, V85, P646, DOI 10.1007/BF00334675; Kutcher ME, 2009, MICROVASC RES, V77, P235, DOI 10.1016/j.mvr.2009.01.007; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Sasaki A, 1996, PATHOL INT, V46, P15, DOI 10.1111/j.1440-1827.1996.tb03528.x; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; Weber B, 1999, EUR J HUM GENET, V7, P34, DOI 10.1038/sj.ejhg.5200242; Zafeiriou DI, 2001, BRAIN DEV-JPN, V23, P385, DOI 10.1016/S0387-7604(01)00242-X	30	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16601	10.1371/journal.pone.0016601	http://dx.doi.org/10.1371/journal.pone.0016601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408219	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800005
J	Mukherjee, S; Santilli, G; Blundell, MP; Navarro, S; Bueren, JA; Thrasher, AJ				Mukherjee, Sayandip; Santilli, Giorgia; Blundell, Michael P.; Navarro, Susana; Bueren, Juan A.; Thrasher, Adrian J.			Generation of Functional Neutrophils from a Mouse Model of X-Linked Chronic Granulomatous Disorder Using Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC LINEAGES; EFFICIENT PRODUCTION; DEFINED FACTORS; GENE-THERAPY; DISEASE; FIBROBLASTS; PROGENITORS; ACTIVATION; INDUCTION; CULTURE	Murine models of human genetic disorders provide a valuable tool for investigating the scope for application of induced pluripotent stem cells (iPSC). Here we present a proof-of-concept study to demonstrate generation of iPSC from a mouse model of X-linked chronic granulomatous disease (X-CGD), and their successful differentiation into haematopoietic progenitors of the myeloid lineage. We further demonstrate that additive gene transfer using lentiviral vectors encoding gp91(phox) is capable of restoring NADPH-oxidase activity in mature neutrophils derived from X-CGD iPSC. In the longer term, correction of iPSC from human patients with CGD has therapeutic potential not only through generation of transplantable haematopoietic stem cells, but also through production of large numbers of autologous functional neutrophils.	[Mukherjee, Sayandip; Santilli, Giorgia; Blundell, Michael P.; Thrasher, Adrian J.] UCL Inst Child Hlth, Ctr Immunodeficiency, London, England; [Navarro, Susana; Bueren, Juan A.] Ctr Invest Energet Medioambient & Tecnol CIEMAT, Hematopoiesis & Gene Therapy Div, Madrid, Spain; [Thrasher, Adrian J.] Great Ormond St Hosp NHS Trust, London, England	University of London; University College London; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Thrasher, AJ (corresponding author), UCL Inst Child Hlth, Ctr Immunodeficiency, London, England.	a.thrasher@ich.ucl.ac.uk	Blundell, Michael P/M-1276-2015; Bueren, Juan/L-6112-2014; Navarro, Susana/L-9300-2014	Bueren, Juan/0000-0002-3228-7013; Navarro, Susana/0000-0002-0764-5384; Thrasher, Adrian/0000-0002-6097-6115; Blundell, Michael/0000-0002-9179-6870	European Program "7FWP, Health" [222878]; Chronic Granulomatous Disorder Research Trust [J4G/04B/GT09]; Biotechnology and Biological Sciences Research Council, UK [BB/F015526/1]; Wellcome Trust [090233/Z/09/Z]; GOSH Children's Charity; Ministry of Science and Innovation for Programa de Fomento de Cooperacion Cientifica Internacional [110-90.1]; Plan Nacional de Salud y Farmacia [SAF 2009-07164]; Fondo de Investigaciones Sanitarias, ISCIII [RETICS-RD06/0010/0015]; BBSRC [BB/F015526/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015526/1] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	European Program "7FWP, Health"; Chronic Granulomatous Disorder Research Trust; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); GOSH Children's Charity; Ministry of Science and Innovation for Programa de Fomento de Cooperacion Cientifica Internacional; Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, ISCIII(Instituto de Salud Carlos III); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Ormond Street Hospital Childrens Charity	This work was supported by generous funding from the following: European Program "7FWP, Health" (PERSIST; Ref Grant Agreement no: 222878); Chronic Granulomatous Disorder Research Trust (J4G/04B/GT09); Biotechnology and Biological Sciences Research Council, UK (BB/F015526/1); Wellcome Trust (090233/Z/09/Z); GOSH Children's Charity; Ministry of Science and Innovation for Programa de Fomento de Cooperacion Cientifica Internacional (110-90.1); Plan Nacional de Salud y Farmacia (SAF 2009-07164); Fondo de Investigaciones Sanitarias, ISCIII (Programa RETICS-RD06/0010/0015); Fundacion Marcelino Botin for promoting translational research at the Division de Hematopoyesis y Terapia Genica at the CIEMAT-CIBERER. CIBERER is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Alton E, 2007, GENE THER, V14, P1439, DOI 10.1038/sj.gt.3303001; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; GREZ M, 2010, MOL THER; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MORISHIMA T, 2010, J CELL PHYSL; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; OKADA M, 2010, BIOCH BIOPHYS ACTA; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Saeki K, 2009, STEM CELLS, V27, P59, DOI 10.1634/stemcells.2007-0980; SANTILLI G, 2010, MOL THER; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yokoyama Y, 2009, BLOOD, V113, P6584, DOI 10.1182/blood-2008-06-160838	29	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17565	10.1371/journal.pone.0017565	http://dx.doi.org/10.1371/journal.pone.0017565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408614	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200027
J	Dong, L; Jiang, CC; Thorne, RF; Croft, A; Yang, F; Liu, H; de Bock, CE; Hersey, P; Zhang, XD				Dong, L.; Jiang, C. C.; Thorne, R. F.; Croft, A.; Yang, F.; Liu, H.; de Bock, C. E.; Hersey, P.; Zhang, X. D.			Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress	ONCOGENE			English	Article						melanoma; Mcl-1; XBP-1; Ets-1; endoplasmic reticulum stress	ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR ETS-1; UNFOLDED PROTEIN RESPONSE; TRAIL-INDUCED APOPTOSIS; TRANSLATIONAL CONTROL; MALIGNANT-MELANOMA; BREAST-CANCER; EXPRESSION; INHIBITION; ACTIVATION	Past studies have shown that upregulation of the antiapoptotic Bcl-2 family protein Mcl-1 is a major adaptive mechanism of melanoma cells to endoplasmic reticulum (ER) stress, and has an important role in resistance of the cells to apoptosis. In this study, we show that the increase in transcription of Mcl-1 in melanoma cells triggered by pharmacological ER stress inducers is mediated by the transcription factor Ets-1. By incremental deletion analysis of the Mcl-1 promoter, we identified a DNA fragment containing an Ets-1 binding site that is transcriptionally responsive to ER stress. Mutations in the Ets-1 binding site or knockdown of Ets-1 inhibited the increase in Mcl-1, indicating that Ets-1 has a critical role in transcriptional upregulation of Mcl-1. Similar to Mcl-1, Ets-1 was transcriptionally upregulated by ER stress. This was mediated by the IRE1 alpha/XBP-1 branch of the unfolded protein response, as upregulation of Ets-1 was inhibited in melanoma cell lines deficient in IRE1 alpha or XBP-1 established by short hairpin RNA knockdown. Activation of the PI3k/Akt pathway downstream of XBP-1 was also involved, in that inhibition of the pathway blocked upregulation of Ets-1. Inhibition of Ets-1 enhanced ER stress-induced apoptosis in melanoma cell lines and in fresh melanoma isolates, recapitulating the effect of inhibition of Mcl-1. These results reveal a key mechanism by which Mcl-1 is transcriptionally upregulated in melanoma cells by ER stress, and identify Ets-1 as a potential target for inhibition to sensitize melanoma cells to apoptosis. Oncogene (2011) 30, 3716-3726; doi:10.1038/onc.2011.87; dpublished online 21 March 2011	[Dong, L.; Jiang, C. C.; Croft, A.; Yang, F.; Liu, H.; Hersey, P.; Zhang, X. D.] Calvary Mater Newcastle Hosp, Immunol & Oncol Unit, Newcastle, NSW 2300, Australia; [Thorne, R. F.; de Bock, C. E.] Univ Newcastle, Canc Res Unit, Sch Biomed Sci, Newcastle, NSW 2300, Australia	Calvary Mater Newcastle Hospital; University of Newcastle	Zhang, XD (corresponding author), Calvary Mater Newcastle Hosp, Immunol & Oncol Unit, Room 443,David Maddison Clin Sci Bldg,Cnr King &, Newcastle, NSW 2300, Australia.	Peter.Hersey@newcastle.edu.au; Xu.Zhang@newcastle.edu.au	de Bock, Charles/H-7699-2019; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022; Jiang, Chenchen/C-2902-2014; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022	de Bock, Charles/0000-0001-5182-8535; Zhang, Xu Dong/0000-0001-9457-8003	NSW State Cancer Council; Cancer Institute NSW; National Health and Medical Research Council (NHMRC), Australia; NHMRC	NSW State Cancer Council(Cancer Council New South Wales); Cancer Institute NSW; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the NSW State Cancer Council, Cancer Institute NSW, and National Health and Medical Research Council (NHMRC), Australia. L Dong is a recipient of Australia-China Exchange Fellowship of NHMRC. XD Zhang is supported by a senior research fellowship of NHMRC.	Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davidson B, 2001, AM J SURG PATHOL, V25, P1493, DOI 10.1097/00000478-200112000-00004; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fritsch RM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702673200; Gillespie S, 2005, MOL CANCER THER, V4, P668, DOI 10.1158/1535-7163.MCT-04-0332; Hahne JC, 2008, MINI-REV MED CHEM, V8, P1095, DOI 10.2174/138955708785909934; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Iglesias-Serret D, 2003, ARCH BIOCHEM BIOPHYS, V417, P141, DOI 10.1016/S0003-9861(03)00345-X; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jiang CC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.48; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2009, NEOPLASIA, V11, P945, DOI 10.1593/neo.09692; Jiang CC, 2009, NEOPLASIA, V11, P436, DOI 10.1593/neo.09208; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Jorcyk CL, 1997, CELL MOL BIOL, V43, P211; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Liu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-122; MAJERUS MA, 1992, NUCLEIC ACIDS RES, V20, P2699, DOI 10.1093/nar/20.11.2699; Mhaidat NM, 2007, CLIN CANCER RES, V13, P1308, DOI 10.1158/1078-0432.CCR-06-2216; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sato Y, 2001, ANN NY ACAD SCI, V947, P117; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Teruyama K, 2001, J CELL PHYSIOL, V188, P243, DOI 10.1002/jcp.1112; Torlakovic EE, 2004, MODERN PATHOL, V17, P1400, DOI 10.1038/modpathol.3800206; Wagner N, 2008, ONCOGENE, V27, P3662, DOI 10.1038/sj.onc.1211044; Wang JM, 2003, MOL CELL BIOL, V23, P1896, DOI 10.1128/MCB.23.6.1896-1909.2003; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; Warr MR, 2008, CURR MOL MED, V8, P138; Yang F, 2010, CELL DEATH DIFFER, V17, P1354, DOI 10.1038/cdd.2010.29; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129; Zhuang LQ, 2009, HISTOPATHOLOGY, V54, P462, DOI 10.1111/j.1365-2559.2009.03242.x	51	56	56	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	34					3716	3726		10.1038/onc.2011.87	http://dx.doi.org/10.1038/onc.2011.87			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21423203	hybrid, Green Published			2022-12-25	WOS:000294244500007
J	Wasylishen, AR; Stojanova, A; Oliveri, S; Rust, AC; Schimmer, AD; Penn, LZ				Wasylishen, A. R.; Stojanova, A.; Oliveri, S.; Rust, A. C.; Schimmer, A. D.; Penn, L. Z.			New model systems provide insights into Myc-induced transformation	ONCOGENE			English	Article						Myc; structure-function; cellular transformation; simian virus 40; hTERT	C-MYC; TRANSGENIC MICE; TRANSACTIVATION DOMAIN; CELL-TRANSFORMATION; ESSENTIAL COFACTOR; BURKITTS-LYMPHOMA; INDUCED APOPTOSIS; N-MYC; FIBROBLASTS; MUTATIONS	The ability of Myc to promote cellular transformation is well established; however, a better understanding of the mechanisms through which Myc mediates tumorigenesis is essential for the development of therapeutic approaches to target this potent oncoprotein. Structure-function studies in rodent fibroblast cells have provided the basis for much of our current understanding of these mechanisms. To build on these approaches, we have characterized three novel human cell line models of Myc-dependent transformation: MCF10A, SH-EP Tet21/N-Myc, and LF1/TERT/LT/ST cells. We have also evaluated Myc family proteins (c-Myc and L-Myc), a naturally occurring isoform of Myc (MycS), and a set of N-terminal domain mutants (DMBII, W135E, T58A) for their ability to promote anchorage-independent growth in these models. Taken together, these results provide the field with three new human cell-based models to study Myc activity, highlight the importance of cellular context, and challenge the paradigm that the ability of Myc to promote tumorigenesis is exclusively MBII-dependent. Oncogene (2011) 30, 3727-3734; doi:10.1038/onc.2011.88; published online 28 March 2011	[Wasylishen, A. R.; Stojanova, A.; Oliveri, S.; Rust, A. C.; Schimmer, A. D.; Penn, L. Z.] Princess Margaret Hosp, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 2M9, Canada; [Wasylishen, A. R.; Stojanova, A.; Oliveri, S.; Rust, A. C.; Schimmer, A. D.; Penn, L. Z.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Penn, LZ (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Campbell Family Inst Canc Res, 9-628,610 Univ Ave, Toronto, ON M5G 2M9, Canada.	lpenn@uhnres.utoronto.ca		Penn, Linda/0000-0001-8133-5459; Schimmer, Aaron/0000-0003-4023-3899; Wasylishen, Amanda/0000-0002-1940-5169	Canadian Cancer Society Research Institute; Ontario Graduate Scholarship; Canadian Breast Cancer Foundation; Ontario Ministry of Health and Long Term Care	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	We would like to acknowledge technical assistance from Ms Caitlin Latimer. We thank the members of the Penn Lab for helpful discussions and critical review of this manuscript. This research was funded by a grant from the Canadian Cancer Society Research Institute (LZP), an Ontario Graduate Scholarship (AS), and a Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowship (ARW). Additional support was provided by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; BREIT S, 1989, J NEUROSCI RES, V24, P21, DOI 10.1002/jnr.490240105; Callus BA, 2008, CELL DEATH DIFFER, V15, P213, DOI 10.1038/sj.cdd.4402245; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Chen W, 2003, HISTOL HISTOPATHOL, V18, P541, DOI 10.14670/HH-18.541; Cleveland J L, 1988, Oncogene Res, V3, P357; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Kuttler F, 2001, ONCOGENE, V20, P6084, DOI 10.1038/sj.onc.1204827; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lutz W, 1996, ONCOGENE, V13, P803; Malynn BA, 2000, GENE DEV, V14, P1390; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; SOULE HD, 1990, CANCER RES, V50, P6075; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wei WY, 2003, MOL CELL BIOL, V23, P2859, DOI 10.1128/MCB.23.8.2859-2870.2003; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866	38	21	29	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	34					3727	3734		10.1038/onc.2011.88	http://dx.doi.org/10.1038/onc.2011.88			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21441954	Green Accepted			2022-12-25	WOS:000294244500008
J	Marassio, G; Prange, T; David, HN; Santos, JSDO; Gabison, L; Delcroix, N; Abraini, JH; Colloc'h, N				Marassio, Guillaume; Prange, Thierry; David, Helene N.; Santos, Jana Sopkova-de Oliveira; Gabison, Laure; Delcroix, Nicolas; Abraini, Jacques H.; Colloc'h, Nathalie			Pressure-response analysis of anesthetic gases xenon and nitrous oxide on urate oxidase: a crystallographic study	FASEB JOURNAL			English	Article						inert gas; neuroprotection; hydrophobic cavity; enzymatic activity; dose response	NMDA ANTAGONIST; BINDING; MODEL; DRUG; SITE; NEUROTOXICITY; ISOFLURANE; INHIBITOR; MECHANISM; CHANNELS	The remarkably safe anesthetics xenon (Xe) and, to lesser extent, nitrous oxide (N2O) possess neuroprotective properties in preclinical studies. To investigate the mechanisms of pharmacological action of these gases, which are still poorly known, we performed both crystallography under a large range of gas pressure and biochemical studies on urate oxidase, a prototype of globular gas-binding proteins whose activity is modulated by inert gases. We show that Xe and N2O bind to, compete for, and expand the volume of a hydrophobic cavity located just behind the active site of urate oxidase and further inhibit urate oxidase enzymatic activity. By demonstrating a significant relationship between the binding and biochemical effects of Xe and N2O, given alone or in combination, these data from structure to function highlight the mechanisms by which chemically and metabolically inert gases can alter protein function and produce their pharmacological effects. Interestingly, the effects of a Xe:N2O equimolar mixture were found to be equivalent to those of Xe alone, thereby suggesting that gas mixtures containing Xe and N2O could be an alternative and efficient neuroprotective strategy to Xe alone, whose widespread clinical use is limited due to the cost of production and availability of this gas.-Marassio, G., Prange, T., David, H. N., Sopkova-de Oliveira Santos, J., Gabison, L., Delcroix, N., Abraini, J. H., Colloc'h, N. Pressure-response analysis of anesthetic gases xenon and nitrous oxide on urate oxidase: a crystallographic study. FASEB J. 25, 2266-2275 (2011). www.fasebj.org	[Colloc'h, Nathalie] UCBN, CNRS, Ctr Cyceron, ERTi 1083,CINAPS,UMR 6232, F-14074 Caen, France; [Prange, Thierry; Gabison, Laure] Univ Paris 05, CNRS, Fac Pharm, LCRB,UMR 8015, Paris, France; [Santos, Jana Sopkova-de Oliveira] UCBN, EA, CERMN, Caen, France; [Abraini, Jacques H.] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; Laval University	Colloc'h, N (corresponding author), UCBN, CNRS, Ctr Cyceron, ERTi 1083,CINAPS,UMR 6232, Blvd Becquerel, F-14074 Caen, France.	colloch@cyceron.fr	Colloc'h, Nathalie/L-1570-2015; Sopkova-de Oliveira, Jana/L-2891-2015; Prangé, Thierry/AAA-4009-2022; Santos, Jana Sopkova-de Oliveira/M-6115-2019	Prangé, Thierry/0000-0002-7129-7396; Santos, Jana Sopkova-de Oliveira/0000-0002-4829-8120	Centre National de la Recherche Scientifique; Universite de Caen-Basse-Normandie; Universite Paris Descartes; Direction Generale de l'Armement (DGA); Ministere de l'Education et de la Recherche; Conseil Regional de Basse-Normandie	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Caen-Basse-Normandie; Universite Paris Descartes; Direction Generale de l'Armement (DGA); Ministere de l'Education et de la Recherche; Conseil Regional de Basse-Normandie(Region Normandie)	The authors gratefully thank Bertrand Castro and Mohamed El Hajji (Sanofi-Aventis, Montpellier, France) for supplying UOX. The authors also thank Martin Walsh, Hassan Belrhali, and other members of the staff of the BM14 beamline, Gavin Fox and other members of the staff of the BM16 beamline, and Michel Pirocchi and other members of the staff of the BM30A beamline at the European Synchrotron Radiation Facility (Grenoble, France) for access and advice during data collection. This research was supported by the Centre National de la Recherche Scientifique, the Universite de Caen-Basse-Normandie, the Universite Paris Descartes, and the Direction Generale de l'Armement (DGA). G. M. and L. G. were supported by a grant from the Ministere de l'Education et de la Recherche. H.N.D. was supported by a grant from the Conseil Regional de Basse-Normandie. J.H.A. is coinventor with no financial interest of the patent "Inhalable gaseous medicament based on xenon and nitrous oxide" (owner: Air Liquide Sante International).	Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDES R, 1993, SCIENCE, V262, P427, DOI 10.1126/science.7692599; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cattano D, 2008, NEUROSCI LETT, V440, P217, DOI 10.1016/j.neulet.2008.05.086; Colloc'h N, 2007, BIOPHYS J, V92, P217, DOI 10.1529/biophysj.106.093807; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dinse A, 2005, BRIT J ANAESTH, V94, P479, DOI 10.1093/bja/aei080; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DYCK PJ, 1980, ANESTHESIOLOGY, V53, P205, DOI 10.1097/00000542-198009000-00005; Eckenhoff R G, 2001, Mol Interv, V1, P258; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENSTER M N, 1951, J Med Soc N J, V48, P281; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Girard E, 2010, BIOPHYS J, V98, P2365, DOI 10.1016/j.bpj.2010.01.058; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Haelewyn B, 2008, CRIT CARE MED, V36, P2651, DOI 10.1097/CCM.0b013e318183f646; Hayakawa N, 2008, J MOL BIOL, V384, P812, DOI 10.1016/j.jmb.2008.09.075; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Hopkins PM, 2005, BEST PRACT RES-CLIN, V19, P381, DOI 10.1016/j.bpa.2005.03.002; Hubbard SJ, 1996, J MOL BIOL, V261, P289, DOI 10.1006/jmbi.1996.0460; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Johansson JS, 2005, FEBS J, V272, P573, DOI 10.1111/j.1742-4658.2004.04500.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; Miller KW, 2002, BRIT J ANAESTH, V89, P17, DOI 10.1093/bja/aef167; Moschetti T, 2009, BIOPHYS J, V97, P1700, DOI 10.1016/j.bpj.2009.05.059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; SCHILTZ M, 1995, STRUCTURE, V3, P309, DOI 10.1016/S0969-2126(01)00161-7; SCHILTZ M, 1994, J APPL CRYSTALLOGR, V27, P950, DOI 10.1107/S0021889894005923; Sonner JM, 2005, MOL PHARMACOL, V68, P61, DOI 10.1124/mol.104.009936; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Voges D, 1995, ADV ENZYMOL RAMB, V71, P209; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	49	27	27	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2266	2275		10.1096/fj.11-183046	http://dx.doi.org/10.1096/fj.11-183046			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21421845				2022-12-25	WOS:000292242200018
J	Rossi, CA; Flaibani, M; Blaauw, B; Pozzobon, M; Figallo, E; Reggiani, C; Vitiello, L; Elvassore, N; De Coppi, P				Rossi, Carlo Alberto; Flaibani, Marina; Blaauw, Bert; Pozzobon, Michela; Figallo, Elisa; Reggiani, Carlo; Vitiello, Libero; Elvassore, Nicola; De Coppi, Paolo			In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel	FASEB JOURNAL			English	Article						muscle ablation; muscle reconstruction; biocompatible scaffold; cell transplantation	DIFFERENTIATION; TRANSPLANTATION; ACTIVATION; SCAFFOLDS	The success of skeletal muscle reconstruction depends on finding the most effective, clinically suitable strategy to engineer myogenic cells and biocompatible scaffolds. Satellite cells (SCs), freshly isolated or transplanted within their niche, are presently considered the best source for muscle regeneration. Here, we designed and developed the delivery of either SCs or muscle progenitor cells (MPCs) via an in situ photo-cross-linkable hyaluronan-based hydrogel, hyaluronic acid-photoinitiator (HA-PI) complex. Partially ablated tibialis anterior (TA) of C57BL/6J mice engrafted with freshly isolated satellite cells embedded in hydrogel showed a major improvement in muscle structure and number of new myofibers, compared to muscles receiving hydrogel + MPCs or hydrogel alone. Notably, SCs embedded in HA-PI also promoted functional recovery, as assessed by contractile force measurements. Tissue reconstruction was associated with the formation of both neural and vascular networks and the reconstitution of a functional SC niche. This innovative approach could overcome previous limitations in skeletal muscle tissue engineering.-Rossi, C. A., Flaibani, M., Blaauw, B., Pozzobon, M., Figallo, E., Reggiani, C., Vitiello, L., Elvassore, N., De Coppi, P. In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. FASEB J. 25, 2296-2304 (2011). www.fasebj.org	[Rossi, Carlo Alberto; De Coppi, Paolo] UCL, Inst Child Hlth, Surg Unit, London WC1N 1EH, England; [Rossi, Carlo Alberto; Pozzobon, Michela; De Coppi, Paolo] Univ Padua, Dept Pediat, Stem Cell Lab, I-35131 Padua, Italy; [Flaibani, Marina; Figallo, Elisa; Elvassore, Nicola] Univ Padua, Dept Chem Engn, I-35131 Padua, Italy; [Blaauw, Bert; Reggiani, Carlo] Univ Padua, Dept Human Anat & Physiol, I-35131 Padua, Italy; [Vitiello, Libero] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Flaibani, Marina; Blaauw, Bert; Elvassore, Nicola] Venetian Inst Mol Med, Padua, Italy	University of London; University College London; University of Padua; University of Padua; University of Padua; University of Padua; Veneto Institute Molecular Medicine	De Coppi, P (corresponding author), UCL, Inst Child Hlth, Surg Unit, 30 Guilford St, London WC1N 1EH, England.	nicola.elvassore@unipd.it; p.decoppi@ich.ucl.ac.uk	Pozzobon, Michela/X-7504-2019; blaauw, bert/A-7614-2014; Pozzobon, Michela/G-7974-2018; Vitiello, Libero/AAJ-6962-2021	Pozzobon, Michela/0000-0001-9213-402X; blaauw, bert/0000-0002-3893-1463; Pozzobon, Michela/0000-0001-9213-402X; Vitiello, Libero/0000-0003-0017-0838; Flaibani, Marina/0000-0001-6284-5699; De Coppi, Paolo/0000-0002-1659-0207; BLAAUW, BERT/0000-0002-4167-5106	Fondazione Telethon (Rome, Italy) [GGP07216]; Fondazione Il Sangue (Milan, Italy); Fondazione Citta della Speranza (Malo, Vicenza, Italy) [08/02]; Great Ormond Street Hospital Charity; Great Ormond Street Hospital Childrens Charity [V1230] Funding Source: researchfish	Fondazione Telethon (Rome, Italy)(Fondazione Telethon); Fondazione Il Sangue (Milan, Italy); Fondazione Citta della Speranza (Malo, Vicenza, Italy); Great Ormond Street Hospital Charity; Great Ormond Street Hospital Childrens Charity	The authors gratefully acknowledge Fidia Advanced Biopolymers (Abano Terme, Padua, Italy) for providing HA-PI. This work has been supported by Fondazione Telethon (Rome, Italy; grant GGP07216), Fondazione Il Sangue (Milan, Italy) and Fondazione Citta della Speranza (Malo, Vicenza, Italy; grant 08/02). P. D. C. has been supported by the Great Ormond Street Hospital Charity. C. A. R., M. F., M. P., C. R., L. V., N.E. and P. D. C. designed the experiments; C. A. R., M. F., B. B., E. F., and L. V. performed the experiments; C. A. R., L. V., N.E., and P. D. C. wrote the article. The authors declare no competing financial interests.	BEAUCHAMP JR, 2000, J CELL BIOL, V22, P1113; Beier JP, 2006, PLAST RECONSTR SURG, V118, P1113, DOI 10.1097/01.prs.0000221007.97115.1d; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blau HM, 2008, NEW ENGL J MED, V359, P1403, DOI 10.1056/NEJMcibr0805708; Boldrin L, 2007, TISSUE ENG, V13, P253, DOI 10.1089/ten.2006.0093; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Carnio S, 2011, J TISSUE ENG REGEN M, V5, P1, DOI 10.1002/term.282; CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228; CLELAND RL, 1970, BIOPOLYMERS, V9, P799, DOI 10.1002/bip.1970.360090706; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034; De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929; de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x; Hathcock JJ, 2000, J BIOMAT SCI-POLYM E, V11, P1211, DOI 10.1163/156856200744282; Huang LK, 1997, PHARMACEUT RES, V14, P475, DOI 10.1023/A:1012199500072; Malm C, 2001, ACTA PHYSIOL SCAND, V171, P233, DOI 10.1046/j.1365-201x.2001.00825.x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; REVELL PA, 2005, J MATER SCI-MATER M, V18, P303; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Rossi CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008523; Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419; Rumsey JW, 2008, BIOMATERIALS, V29, P994, DOI 10.1016/j.biomaterials.2007.10.042; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHIAFFINO S, 1986, EXP CELL RES, V163, P211, DOI 10.1016/0014-4827(86)90574-4; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109; Yan W, 2007, TISSUE ENG, V13, P2781, DOI 10.1089/ten.2006.0408	32	144	149	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2296	2304		10.1096/fj.10-174755	http://dx.doi.org/10.1096/fj.10-174755			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21450908				2022-12-25	WOS:000292242200021
J	White, MJ; Savaryn, JP; Bretl, DJ; He, HJ; Penoske, RM; Terhune, SS; Zahrt, TC				White, Mark J.; Savaryn, John P.; Bretl, Daniel J.; He, Hongjun; Penoske, Renee M.; Terhune, Scott S.; Zahrt, Thomas C.			The HtrA-Like Serine Protease PepD Interacts with and Modulates the Mycobacterium tuberculosis 35-kDa Antigen Outer Envelope Protein	PLOS ONE			English	Article							PHAGE-SHOCK; STRESS-RESPONSE; 2-COMPONENT SYSTEM; DELETION MUTANT; SIGMA-FACTOR; EXPRESSION; MPRAB; GENE; PSPA; DOMAIN	Mycobacterium tuberculosis remains a significant global health concern largely due to its ability to persist for extended periods within the granuloma of the host. While residing within the granuloma, the tubercle bacilli are likely to be exposed to stress that can result in formation of aberrant proteins with altered structures. Bacteria encode stress responsive determinants such as proteases and chaperones to deal with misfolded or unfolded proteins. pepD encodes an HtrA-like serine protease and is thought to process proteins altered following exposure of M. tuberculosis to extra-cytoplasmic stress. PepD functions both as a protease and chaperone in vitro, and is required for aspects of M. tuberculosis virulence in vivo. pepD is directly regulated by the stress-responsive two-component signal transduction system MprAB and indirectly by extracytoplasmic function (ECF) sigma factor SigE. Loss of PepD also impacts expression of other stress-responsive determinants in M. tuberculosis. To further understand the role of PepD in stress adaptation by M. tuberculosis, a proteomics approach was taken to identify binding proteins and possible substrates of this protein. Using subcellular fractionation, the cellular localization of wild-type and PepD variants was determined. Purified fractions as well as whole cell lysates from Mycobacterium smegmatis or M. tuberculosis strains expressing a catalytically compromised PepD variant were immunoprecipitated for PepD and subjected to LC-MS/MS analyses. Using this strategy, the 35-kDa antigen encoding a homolog of the PspA phage shock protein was identified as a predominant binding partner and substrate of PepD. We postulate that proteolytic cleavage of the 35-kDa antigen by PepD helps maintain cell wall homeostasis in Mycobacterium and regulates specific stress response pathways during periods of extracytoplasmic stress.	[White, Mark J.; Savaryn, John P.; Bretl, Daniel J.; He, Hongjun; Penoske, Renee M.; Terhune, Scott S.; Zahrt, Thomas C.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [White, Mark J.; Bretl, Daniel J.; He, Hongjun; Penoske, Renee M.; Zahrt, Thomas C.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Savaryn, John P.; Terhune, Scott S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	White, MJ (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	tzahrt@mcw.edu			National Institutes of Health and Infectious Disease [RO1 AI51669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051669] Funding Source: NIH RePORTER	National Institutes of Health and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by RO1 AI51669 from the National Institutes of Health and Infectious Disease and an Investigator in Pathogenesis award from the Burroughs Wellcome Fund to T.C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Amaral L, 2008, CURR DRUG TARGETS, V9, P816, DOI 10.2174/138945008785747798; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; [Anonymous], GLOB TUB CONTR SURV; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Dona V, 2008, J BACTERIOL, V190, P5963, DOI 10.1128/JB.00622-08; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; LEE BY, 1995, J CLIN INVEST, V96, P245, DOI 10.1172/JCI118028; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Miller JH., 1972, EXPT MOL GENETICS; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Pang XH, 2007, J BACTERIOL, V189, P6213, DOI 10.1128/JB.00492-07; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Skeiky YAW, 1999, INFECT IMMUN, V67, P3998, DOI 10.1128/IAI.67.8.3998-4007.1999; Stack HM, 2005, APPL ENVIRON MICROB, V71, P4241, DOI 10.1128/AEM.71.8.4241-4247.2005; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; TAKAYAMA K, 1975, J LIPID RES, V16, P308; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; White MJ, 2010, J BACTERIOL, V192, P1498, DOI 10.1128/JB.01167-09; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	54	36	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18175	10.1371/journal.pone.0018175	http://dx.doi.org/10.1371/journal.pone.0018175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445360	gold, Green Published, Green Submitted			2022-12-25	WOS:000288809100032
J	Kawazu, M; Saso, K; Tong, KI; McQuire, T; Goto, K; Son, DO; Wakeham, A; Miyagishi, M; Mak, TW; Okada, H				Kawazu, Masahito; Saso, Kayoko; Tong, Kit I.; McQuire, Tracy; Goto, Kouichiro; Son, Dong-Ok; Wakeham, Andrew; Miyagishi, Makoto; Mak, Tak W.; Okada, Hitoshi			Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development	PLOS ONE			English	Article							ANDROGEN-RECEPTOR; CHROMATIN STATE; GENE-EXPRESSION; BINDING-SITES; H3 LYSINE-9; TRANSCRIPTION; GENOME; CELLS; METHYLATION; ALPHA	Estrogen is a key regulator of normal function of female reproductive system and plays a pivotal role in the development and progression of breast cancer. Here, we demonstrate that JMJD2B (also known as KDM4B) constitutes a key component of the estrogen signaling pathway. JMJD2B is expressed in a high proportion of human breast tumors, and that expression levels significantly correlate with estrogen receptor (ER) positivity. In addition, 17-beta-estradiol (E2) induces JMJD2B expression in an ER alpha dependent manner. JMJD2B interacts with ER alpha and components of the SWI/SNF-B chromatin remodeling complex. JMJD2B is recruited to ER alpha target sites, demethylates H3K9me3 and facilitates transcription of ER responsive genes including MYB, MYC and CCND1. As a consequence, knockdown of JMJD2B severely impairs estrogen-induced cell proliferation and the tumor formation capacity of breast cancer cells. Furthermore, Jmjd2b-deletion in mammary epithelial cells exhibits delayed mammary gland development in female mice. Taken together, these findings suggest an essential role for JMJD2B in the estrogen signaling, and identify JMJD2B as a potential therapeutic target in breast cancer.	[Kawazu, Masahito; Saso, Kayoko; Tong, Kit I.; McQuire, Tracy; Goto, Kouichiro; Son, Dong-Ok; Wakeham, Andrew; Mak, Tak W.; Okada, Hitoshi] Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Miyagishi, Makoto] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Japan; [Mak, Tak W.; Okada, Hitoshi] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Mak, Tak W.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institute of Advanced Industrial Science & Technology (AIST); University of Toronto; University of Toronto	Kawazu, M (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada.	mkawz-tky@umin.ac.jp; hokada@uhnres.utoronto.ca	Kawazu, Masahito/AAE-6143-2022; Miyagishi, Makoto/L-8174-2016	Kawazu, Masahito/0000-0003-4146-3629; Miyagishi, Makoto/0000-0001-7654-3616	Canadian Institute for Health Reserach [MOP84353]; Uehara Memorial Foundation; CIHR Institute of Cancer Research; Ontario Ministry of Health and Long Term Care	Canadian Institute for Health Reserach(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); CIHR Institute of Cancer Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	The project was supported by Canadian Institute for Health Reserach (http://www.cihr-irsc.gc.ca/e/193.html; MOP84353); Uehara Memorial Foundation (http://www.ueharazaidan.com/) for Research Fellowship Program to MK and Postdoctoral Fellowship Program to KG; CIHR Institute of Cancer Research (Bridge Funding) to HO. This research was funded in part by the Ontario Ministry of Health and Long Term Care (http://www.health.gov.on.ca/en/). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GOMES NP, GENES DEV, V24, P1022; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MOSAMMAPARAST N, ANN REV BIOCH; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; MULLERTIDOW C, BLOOD; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YANG J, 2002, CANCER RES, V70, P6456	56	140	148	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17830	10.1371/journal.pone.0017830	http://dx.doi.org/10.1371/journal.pone.0017830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445275	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100037
J	Wu, DY; Wu, M; Halpern, A; Rusch, DB; Yooseph, S; Frazier, M; Venter, JC; Eisen, JA				Wu, Dongying; Wu, Martin; Halpern, Aaron; Rusch, Douglas B.; Yooseph, Shibu; Frazier, Marvin; Venter, J. Craig; Eisen, Jonathan A.			Stalking the Fourth Domain in Metagenomic Data: Searching for, Discovering, and Interpreting Novel, Deep Branches in Marker Gene Phylogenetic Trees	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MULTIPLE SEQUENCE ALIGNMENT; MICROBIAL DIVERSITY; PROTEIN; GENOME; EVOLUTION; IDENTIFICATION; PHOTOTROPHY; ALGORITHM; RESOURCE	Background: Most of our knowledge about the ancient evolutionary history of organisms has been derived from data associated with specific known organisms (i.e., organisms that we can study directly such as plants, metazoans, and culturable microbes). Recently, however, a new source of data for such studies has arrived: DNA sequence data generated directly from environmental samples. Such metagenomic data has enormous potential in a variety of areas including, as we argue here, in studies of very early events in the evolution of gene families and of species. Methodology/Principal Findings: We designed and implemented new methods for analyzing metagenomic data and used them to search the Global Ocean Sampling (GOS) Expedition data set for novel lineages in three gene families commonly used in phylogenetic studies of known and unknown organisms: small subunit rRNA and the recA and rpoB superfamilies. Though the methods available could not accurately identify very deeply branched ss-rRNAs (largely due to difficulties in making robust sequence alignments for novel rRNA fragments), our analysis revealed the existence of multiple novel branches in the recA and rpoB gene families. Analysis of available sequence data likely from the same genomes as these novel recA and rpoB homologs was then used to further characterize the possible organismal source of the novel sequences. Conclusions/Significance: Of the novel recA and rpoB homologs identified in the metagenomic data, some likely come from uncharacterized viruses while others may represent ancient paralogs not yet seen in any cultured organism. A third possibility is that some come from novel cellular lineages that are only distantly related to any organisms for which sequence data is currently available. If there exist any major, but so-far-undiscovered, deeply branching lineages in the tree of life, we suggest that methods such as those described herein currently offer the best way to search for them.	[Wu, Dongying; Wu, Martin; Eisen, Jonathan A.] Univ Calif Davis, Univ Calif Davis Genome Ctr, Dept Med Microbiol & Immunol, Dept Ecol & Evolut, Davis, CA 95616 USA; [Halpern, Aaron; Rusch, Douglas B.; Yooseph, Shibu; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, Rockville, MD USA; [Halpern, Aaron; Rusch, Douglas B.; Yooseph, Shibu; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, La Jolla, CA USA; [Wu, Martin] Univ Virginia, Charlottesville, VA USA	University of California System; University of California Davis; J. Craig Venter Institute; J. Craig Venter Institute; University of Virginia	Wu, DY (corresponding author), Univ Calif Davis, Univ Calif Davis Genome Ctr, Dept Med Microbiol & Immunol, Dept Ecol & Evolut, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Wu, Martin/0000-0003-3093-4077; Yooseph, Shibu/0000-0001-5581-5002	National Science Foundation [0228651]; Gordon and Betty Moore Foundation [0000951, 0001660]	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The development and main work on this project was supported by the National Science Foundation via an "Assembling the Tree of Life'' grant (number 0228651) to to Jonathan A. Eisen and Naomi Ward. The final work on this project was funded by the Gordon and Betty Moore Foundation (through grants 0000951 and 0001660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; BALCH WE, 1977, J MOL EVOL, V9, P305, DOI 10.1007/BF01796092; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 1995, J MOL EVOL, V41, P1105; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HASEGAWA M, 1993, NATURE, V361, P23, DOI 10.1038/361023b0; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KING KW, 1994, GENE, V139, P111, DOI 10.1016/0378-1119(94)90532-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; La Scola B, 2003, SCIENCE, V299, P2033; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; LLOYD AT, 1993, J MOL EVOL, V37, P399; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Oxelman B, 2004, MOL PHYLOGENET EVOL, V32, P462, DOI 10.1016/j.ympev.2004.01.014; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Poole AM, 2007, ASTROBIOLOGY, V7, P801, DOI 10.1089/ast.2006.0094; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sandler SJ, 1999, J BACTERIOL, V181, P907, DOI 10.1128/JB.181.3.907-915.1999; SHARPTON TJR, 2011, PLOS COMPUTATI UNPUB; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; STAHL DA, 1985, APPL ENVIRON MICROB, V49, P1379, DOI 10.1128/AEM.49.6.1379-1384.1985; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; TOMMASINO M, 1988, NUCLEIC ACIDS RES, V16, P5863, DOI 10.1093/nar/16.13.5863; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward N, 2006, FEMS MICROBIOL ECOL, V55, P331, DOI 10.1111/j.1574-6941.2005.00055.x; Ward N, 2005, CURR OPIN MICROBIOL, V8, P564, DOI 10.1016/j.mib.2005.08.011; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	81	63	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18011	10.1371/journal.pone.0018011	http://dx.doi.org/10.1371/journal.pone.0018011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437252	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100056
J	Mukherjee, DV; Tonry, JH; Kim, KS; Ramarao, N; Popova, TG; Bailey, C; Popov, S; Chung, MC				Mukherjee, Dhritiman V.; Tonry, Jessica H.; Kim, Kwang Sik; Ramarao, Nalini; Popova, Taissia G.; Bailey, Charles; Popov, Serguei; Chung, Myung-Chul			Bacillus anthracis Protease InhA Increases Blood-Brain Barrier Permeability and Contributes to Cerebral Hemorrhages	PLOS ONE			English	Article							TOXIN; EXPRESSION; METALLOPROTEASES; ACTIVATION; ADHESION; MATRIX; EDEMA; CELLS	Hemorrhagic meningitis is a fatal complication of anthrax, but its pathogenesis remains poorly understood. The present study examined the role of B. anthracis-secreted metalloprotease InhA on monolayer integrity and permeability of human brain microvasculature endothelial cells (HBMECs) which constitute the blood-brain barrier (BBB). Treatment of HBMECs with purified InhA resulted in a time-dependent decrease in trans-endothelial electrical resistance (TEER) accompanied by zonula occluden-1 (ZO-1) degradation. An InhA-expressing B. subtilis exhibited increased permeability of HBMECs, which did not occur with the isogenic inhA deletion mutant (Delta inhA) of B. anthracis, compared with the corresponding wild-type strain. Mice intravenously administered with purified InhA or nanoparticles-conjugated to InhA demonstrated a time-dependent Evans Blue dye extravasation, leptomeningeal thickening, leukocyte infiltration, and brain parenchymal distribution of InhA indicating BBB leakage and cerebral hemorrhage. Mice challenged with vegetative bacteria of the Delta inhA strain of B. anthracis exhibited a significant decrease in leptomeningeal thickening compared to the wildtype strain. Cumulatively, these findings indicate that InhA contributes to BBB disruption associated with anthrax meningitis through proteolytic attack on the endothelial tight junctional protein zonula occluden (ZO)-1.	[Mukherjee, Dhritiman V.; Tonry, Jessica H.; Popova, Taissia G.; Bailey, Charles; Popov, Serguei; Chung, Myung-Chul] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Div Pediat Infect Dis, Baltimore, MD USA; [Ramarao, Nalini] INRA, Unite MICALIS GME, La Miniere, Guyancourt, France	George Mason University; Johns Hopkins University; INRAE	Mukherjee, DV (corresponding author), Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY 10027 USA.	spopov@gmu.edu; mchung3@gmu.edu	Rama Rao, Nalini/GRR-7800-2022		U.S. Department of Defense [DAMD 17-03-C-01220]; U.S. Department of Energy [DE-FC52-FC04NA25455]	U.S. Department of Defense(United States Department of Defense); U.S. Department of Energy(United States Department of Energy (DOE))	This work has been supported by the U.S. Department of Defense grant DAMD 17-03-C-01220 and the U.S. Department of Energy grant DE-FC52-FC04NA25455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato TJ, 2002, J PHARM SCI-US, V91, P2525, DOI 10.1002/jps.10256; ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chung MC, 2008, J BIOL CHEM, V283, P9531, DOI 10.1074/jbc.M705871200; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Chung MC, 2009, J MED MICROBIOL, V58, P737, DOI 10.1099/jmm.0.007427-0; Chung MC, 2008, FEMS IMMUNOL MED MIC, V54, P309, DOI 10.1111/j.1574-695X.2008.00480.x; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kastrup CJ, 2008, NAT CHEM BIOL, V4, P742, DOI 10.1038/nchembio.124; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Lanska DJ, 2002, NEUROLOGY, V59, P327, DOI 10.1212/WNL.59.3.327; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Meyer MA, 2003, ARCH NEUROL-CHICAGO, V60, P483, DOI 10.1001/archneur.60.4.483; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Okamoto T, 1997, J BIOL CHEM, V272, P6059, DOI 10.1074/jbc.272.9.6059; Popov SG, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-25; Popova T, 2009, FEMS IMMUNOL MED MIC, V56, P129, DOI 10.1111/j.1574-695X.2009.00558.x; Popova TG, 2011, FEMS IMMUNOL MED MIC, V61, P15, DOI 10.1111/j.1574-695X.2010.00740.x; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; Sakata Y, 1996, MICROBIOL IMMUNOL, V40, P415, DOI 10.1111/j.1348-0421.1996.tb01088.x; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Supuran CT, 2002, MED RES REV, V22, P329, DOI 10.1002/med.10007; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	39	33	34	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17921	10.1371/journal.pone.0017921	http://dx.doi.org/10.1371/journal.pone.0017921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437287	Green Submitted, gold, Green Published			2022-12-25	WOS:000288514600016
J	Zaragoza, B; Evaristo, C; Kissenpfennig, A; Libri, V; Malissen, B; Rocha, B; Freitas, AA; Almeida, ARM				Zaragoza, Bruno; Evaristo, Cesar; Kissenpfennig, Adrien; Libri, Valentina; Malissen, Bernard; Rocha, Benedita; Freitas, Antonio A.; Almeida, Afonso R. M.			Cell-to-Cell Interactions and Signals Involved in the Reconstitution of Peripheral CD8(+) T-CM and T-EM Cell Pools	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; HOMEOSTATIC PROLIFERATION; IN-VIVO; LYMPHOPENIC HOSTS; REGULATORY-CELLS; CUTTING EDGE; MEMORY; CD4(+); EXPANSION; IMMUNE	We here describe novel aspects of CD8(+) and CD4(+) T cell subset interactions that may be clinically relevant and provide new tools for regulating the reconstitution of the peripheral CD8(+) T cell pools in immune-deficient states. We show that the reconstitution capacity of transferred isolated naive CD8(+) T cells and their differentiation of effector functions is limited, but both dramatically increase upon the co-transfer of CD4(+) T cells. This helper effect is complex and determined by multiple factors. It was directly correlated to the number of helper cells, required the continuous presence of the CD4(+) T cells, dependent on host antigen-presenting cells (APCs) expressing CD40 and on the formation of CD4/CD8/APC cell clusters. By comparing the recovery of (CD44(+)CD62L(high)) T-CM and (CD44(+)CD62L(low)) T-EM CD8(+) T cells, we found that the accumulation of TCM and TEM subsets is differentially regulated. T-CM-cell accumulation depended mainly on type I interferons, interleukin (IL)-6, and IL-15, but was independent of CD4(+) T-cell help. In contrast, TEM-cell expansion was mainly determined by CD4(+) T-cell help and dependent on the expression of IL-2R beta by CD8 cells, on IL-2 produced by CD4(+) T-cells, on IL-15 and to a minor extent on IL-6.	[Zaragoza, Bruno; Freitas, Antonio A.; Almeida, Afonso R. M.] Inst Pasteur, Lymphocyte Populat Biol Unit, CNRS, URA 1961, Paris, France; [Evaristo, Cesar; Rocha, Benedita] Univ Paris 05, INSERM, U591, Inst Federatif Rech 94, Paris, France; [Kissenpfennig, Adrien; Malissen, Bernard] Univ Mediterranne, INSERM, U631, CNRS,UMR6102,Ctr Immunol Marseille Luminy, Marseille, France; [Libri, Valentina] Inst Pasteur, U Signalisat Cytokines, CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zaragoza, B (corresponding author), Inst Pasteur, Lymphocyte Populat Biol Unit, CNRS, URA 1961, Paris, France.	antonio.freitas@pasteur.fr; afonsoalmeida@fm.ul.pt	freitas, antonio/A-2482-2013; Evaristo, Cesar/O-8430-2016; Malissen, Bernard/AAK-4659-2020	Libri, Valentina/0000-0002-2080-1089; Evaristo, Cesar/0000-0002-2281-1045; freitas, antonio/0000-0001-6392-7178; Kissenpfennig, Adrien/0000-0002-9633-3111; Almeida, Afonso/0000-0002-4292-8558; Malissen, Bernard/0000-0003-1340-9342	European Research Council (ERC); Ligue Nationale Contre le Cancer; Association pour la Recherche Contre le Cancer (ARC); Agence Nationale de la Recherche Contre le SIDA (ANRS); Agence Nationale pour la Recherche (ANR); Association Francaise des Myopathies (AFM); Centre National de la Recherche Scientifique (CNRS); Institut Pasteur; MRT; ARC, France; FCT, Portugal	European Research Council (ERC)(European Research Council (ERC)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche Contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise des Myopathies (AFM)(Association Francaise contre les Myopathies); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); MRT; ARC, France; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the European Research Council (ERC), Ligue Nationale Contre le Cancer, Association pour la Recherche Contre le Cancer (ARC), Agence Nationale de la Recherche Contre le SIDA (ANRS), Agence Nationale pour la Recherche (ANR), Association Francaise des Myopathies (AFM), Centre National de la Recherche Scientifique (CNRS) and the Institut Pasteur. BZ was supported by the MRT and ARC, France and ARMA by the FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hagen KA, 2004, J IMMUNOL, V173, P3909, DOI 10.4049/jimmunol.173.6.3909; Hamilton SE, 2008, P NATL ACAD SCI USA, V105, P18484, DOI 10.1073/pnas.0806487105; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kursar M, 2002, J EXP MED, V196, P1585, DOI 10.1084/jem.20011347; La Gruta NL, 2000, EUR J IMMUNOL, V30, P3380; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; ROCHA B, 1989, IMMUNOLOGY, V19, P905; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 2002, J IMMUNOL, V168, P5042, DOI 10.4049/jimmunol.168.10.5042; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17423	10.1371/journal.pone.0017423	http://dx.doi.org/10.1371/journal.pone.0017423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423804	Green Published, gold, Green Submitted			2022-12-25	WOS:000288512400010
J	Dulik, MC; Osipova, LP; Schurr, TG				Dulik, Matthew C.; Osipova, Ludmila P.; Schurr, Theodore G.			Y-Chromosome Variation in Altaian Kazakhs Reveals a Common Paternal Gene Pool for Kazakhs and the Influence of Mongolian Expansions	PLOS ONE			English	Article							CENTRAL-ASIAN POPULATIONS; SHORT TANDEM REPEATS; SIBERIAN POPULATIONS; HUNTER-GATHERER; HAPLOGROUP C; EAST-ASIA; DIVERSITY; DIVERGENCE; RESOLUTION; ADMIXTURE	Kazakh populations have traditionally lived as nomadic pastoralists that seasonally migrate across the steppe and surrounding mountain ranges in Kazakhstan and southern Siberia. To clarify their population history from a paternal perspective, we analyzed the non-recombining portion of the Y-chromosome from Kazakh populations living in southern Altai Republic, Russia, using a high-resolution analysis of 60 biallelic markers and 17 STRs. We noted distinct differences in the patterns of genetic variation between maternal and paternal genetic systems in the Altaian Kazakhs. While they possess a variety of East and West Eurasian mtDNA haplogroups, only three East Eurasian paternal haplogroups appear at significant frequencies (C3*, C3c and O3a3c*). In addition, the Y-STR data revealed low genetic diversity within these lineages. Analysis of the combined biallelic and STR data also demonstrated genetic differences among Kazakh populations from across Central Asia. The observed differences between Altaian Kazakhs and indigenous Kazakhs were not the result of admixture between Altaian Kazakhs and indigenous Altaians. Overall, the shared paternal ancestry of Kazakhs differentiates them from other Central Asian populations. In addition, all of them showed evidence of genetic influence by the 13(th) century CE Mongol Empire. Ultimately, the social and cultural traditions of the Kazakhs shaped their current pattern of genetic variation.	[Dulik, Matthew C.; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Osipova, Ludmila P.] Russian Acad Sci SB RAS, Siberian Branch, Inst Cytol & Genet, Novosibirsk, Russia	University of Pennsylvania; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Dulik, MC (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	tgschurr@sas.upenn.edu	Osipova, Ludmila P/O-6480-2014	Osipova, Ludmila P/0000-0001-7602-1156	University of Pennsylvania; National Science Foundation [BCS-0726623]; Social Sciences and Humanities Research Council of Canada [MCRI 412-2005-1004]; Russian Basic Fund for Research	University of Pennsylvania; National Science Foundation(National Science Foundation (NSF)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Russian Basic Fund for Research	This project was supported by the University of Pennsylvania (TGS), the National Science Foundation (BCS-0726623) (TGS, MCD), the Social Sciences and Humanities Research Council of Canada (MCRI 412-2005-1004) (TGS) and the Russian Basic Fund for Research (LPO). TGS would also like to acknowledge the infrastructural support provided by the National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; Cox MP, 2006, ANTHROPOL SCI, V114, P69, DOI 10.1537/ase.050712; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Di Benedetto G, 2001, AM J PHYS ANTHROPOL, V115, P144, DOI 10.1002/ajpa.1064; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; GOKCUMEN O, 2010, AM ANTHR IN PRESS; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Golden P. B., 1998, NOMADS SEDENTARY SOC; Golden Peter B, 1992, INTRO HIST TURKIC PE; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Heyer E, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-49; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Kim K, 2010, AM J PHYS ANTHROPOL, V142, P429, DOI 10.1002/ajpa.21242; Krader Lawrence, 1963, SOCIAL ORG MONGOL TU; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Menges K.H., 1995, VER FFENTLICHUNGEN S; Oktyabrskaya I.V., 2006, ARCHAEOLOGY ETHNOLOG, V25, P132; Olcott MB, 1995, KAZAKHS; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; RENFREW C, 1989, SCI AM, V261, P106, DOI 10.1038/scientificamerican1089-106; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Segurel L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000200; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sinor D., 1990, CAMBRIDGE HIST EARLY; SOUCEK S, 2000, HIST INNER ASIA, pR13; SPSS Inc, 2001, SPSS WIND REL 11 0 0; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue Y., 2008, SIMULATIONS GENETICS, P79; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Xue YL, 2005, AM J HUM GENET, V77, P1112, DOI 10.1086/498583; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	52	46	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17548	10.1371/journal.pone.0017548	http://dx.doi.org/10.1371/journal.pone.0017548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412412	Green Published, gold, Green Submitted			2022-12-25	WOS:000288247800014
J	Moura, RS; Coutinho-Borges, JP; Pacheco, AP; daMota, PO; Correia-Pinto, J				Moura, Rute S.; Coutinho-Borges, Jose P.; Pacheco, Ana P.; daMota, Paulo O.; Correia-Pinto, Jorge			FGF Signaling Pathway in the Developing Chick Lung: Expression and Inhibition Studies	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; BRANCHING MORPHOGENESIS; EMBRYONIC-DEVELOPMENT; MOUSE ORGANOGENESIS; FACTOR FAMILY; RAT LUNG; SPROUTY; SYSTEM; GENES; FETAL	Background: Fibroblast growth factors (FGF) are essential key players during embryonic development. Through their specific cognate receptors (FGFR) they activate intracellular cascades, finely regulated by modulators such as Sprouty. Several FGF ligands (FGF1, 2, 7, 9, 10 and 18) signaling through the four known FGFRs, have been implicated in lung morphogenesis. Although much is known about mammalian lung, so far, the avian model has not been explored for lung studies. Methodology/Principal Findings: In this study we provide the first description of fgf10, fgfr1-4 and spry2 expression patterns in early stages of chick lung development by in situ hybridization and observe that they are expressed similarly to their mammalian counterparts. Furthermore, aiming to determine a role for FGF signaling in chick lung development, in vitro FGFR inhibition studies were performed. Lung explants treated with an FGF receptor antagonist (SU5402) presented an impairment of secondary branch formation after 48 h of culture; moreover, abnormal lung growth with a cystic appearance of secondary bronchi and reduction of the mesenchymal tissue was observed. Branching and morphometric analysis of lung explants confirmed that FGFR inhibition impaired branching morphogenesis and induced a significant reduction of the mesenchyme. Conclusions/Significance: This work demonstrates that FGFRs are essential for the epithelial-mesenchymal interactions that determine epithelial branching and mesenchymal growth and validate the avian embryo as a good model for pulmonary studies, namely to explore the FGF pathway as a therapeutic target.	[Moura, Rute S.; Coutinho-Borges, Jose P.; Pacheco, Ana P.; daMota, Paulo O.; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal	Universidade do Minho	Moura, RS (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	rutemoura@ecsaude.uminho.pt	Moura, Rute S/B-4208-2011; Moura, Rute/GYV-3259-2022; Correia-Pinto, Jorge/B-3344-2012	Moura, Rute S/0000-0003-1763-9014; Correia-Pinto, Jorge/0000-0002-9265-6896; Mota, Paulo/0000-0002-2316-373X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OBD/108051/2008]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/15408/2005]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OBD/108051/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This project was funded by Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-OBD/108051/2008). RSM was supported by Fundacao para a Ciencia e Tecnologia (grant number SFRH/BPD/15408/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gonzaga S, 2008, AM J RESP CELL MOL, V39, P346, DOI 10.1165/rcmb.2007-0290OC; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Muehlethaler V, 2008, AM J PHYSIOL-LUNG C, V294, pL110, DOI 10.1152/ajplung.00407.2007; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; PETERS KG, 1992, DEVELOPMENT, V114, P233; Powell PP, 1998, AM J RESP CELL MOL, V19, P563, DOI 10.1165/ajrcmb.19.4.2994; Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880; Sakiyama J, 2003, DEVELOPMENT, V130, P1225, DOI 10.1242/dev.00345; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wang O, 2001, DEVELOPMENT, V128, P3867; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	36	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17660	10.1371/journal.pone.0017660	http://dx.doi.org/10.1371/journal.pone.0017660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412430	Green Published, gold			2022-12-25	WOS:000288247800021
J	Ong, ZY; Muhlhausler, BS				Ong, Z. Y.; Muhlhausler, B. S.			Maternal "junk-food" feeding of rat dams alters food choices and development of the mesolimbic reward pathway in the offspring	FASEB JOURNAL			English	Article						nutrition; programming	HIGH-FAT DIET; HYPOTHALAMIC NEURONS; DOPAMINE TRANSPORTER; OPIOID RECEPTOR; GENE-EXPRESSION; NEUROPEPTIDE-Y; OBESITY; PREGNANCY; TERM; LACTATION	Individuals exposed to high-fat, high-sugar diets before birth have an increased risk of obesity in later life. Recent studies have shown that these offspring exhibit increased preference for fat, leading to suggestions that perinatal exposure to high-fat, high-sugar foods results in permanent changes within the central reward system that increase the subsequent drive to overconsume palatable foods. The present study has determined the effect of a maternal "junk-food" diet on the expression of key components of the mesolimbic reward pathway in the offspring of rat dams at 6 wk and 3 mo of age. We show that offspring of junk-food-fed (JF) dams exhibit higher fat intake from weaning until at least 3 mo of age (males: 16 +/- 0.6 vs. 11 +/- 0.8 g/kg/d; females: 19 +/- 1.3 vs. 13 +/- 0.4 g/kg/d; P < 0.01). mRNA expression of mu-opioid receptor (Mu) was 1.6-fold higher (P < 0.01) and dopamine active transporter (DAT) was 2-fold lower (P < 0.05) in JF offspring at 6 wk of age. By 3 mo, these differences were reversed, and Mu mRNA expression was 2.8-fold lower (P < 0.01) and DAT mRNA expression was 1.9-fold higher (P < 0.01) in the JF offspring. These findings suggest that perinatal exposure to high-fat, high-sugar diets results in altered development of the central reward system, resulting in increased fat intake and altered response of the reward system to excessive junk-food intake in postnatal life.-Ong, Z. Y., Muhlhausler, B. S. Maternal "junk-food" feeding of rat dams alters food choices and development of the mesolimbic reward pathway in the offspring. FASEB J. 25, 2167-2179 (2011). www.fasebj.org	[Muhlhausler, B. S.] Univ Adelaide, Sch Agr Food & Wine, FOODplus Res Ctr, Adelaide, SA 5064, Australia; [Ong, Z. Y.; Muhlhausler, B. S.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of Adelaide; University of South Australia	Muhlhausler, BS (corresponding author), Univ Adelaide, Sch Agr Food & Wine, FOODplus Res Ctr, Adelaide, SA 5064, Australia.	beverly.muhlhausler@adelaide.edu.au	Ong, Zhi Yi/AFP-0699-2022	Ong, Zhi Yi/0000-0002-8300-6955; Muhlhausler, Beverly/0000-0002-9021-6790	Clive and Vera Ramaciotti Establishment Grant; National Health and Medical Research Council of Australia; University of South Australia	Clive and Vera Ramaciotti Establishment Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia	This work was supported by a Clive and Vera Ramaciotti Establishment Grant (awarded to B. M). B. M. is supported by a Peter Doherty Training Fellowship from the National Health and Medical Research Council of Australia. Z.Y. is supported by a President's Scholarship from the University of South Australia. The authors acknowledge the expert assistance of Jayne Skinner, David Phuong, and Lauren Astill with animal protocols. The authors also thank John Carragher for editorial assistance.	Antonopoulos J, 2002, NEUROSCIENCE, V110, P245, DOI 10.1016/S0306-4522(01)00575-9; Barnes MJ, 2006, PEPTIDES, V27, P3292, DOI 10.1016/j.peptides.2006.08.008; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Berthoud HR, 2006, OBESITY, V14, P197; Bhasin KKS, 2009, DIABETES, V58, P559, DOI 10.2337/db07-1530; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brand-Miller JC, 2002, AM J CLIN NUTR, V76, p281S, DOI 10.1093/ajcn/76.1.281S; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2007, OBSTET GYNECOL, V109, P419, DOI 10.1097/01.AOG.0000253311.44696.85; CERRUTI C, 1994, MOL BRAIN RES, V22, P132, DOI 10.1016/0169-328X(94)90040-X; Cripps RL, 2009, CLIN SCI, V117, P85, DOI 10.1042/CS20080393; Davidowa H, 2003, EUR J NEUROSCI, V18, P613, DOI 10.1046/j.1460-9568.2003.02789.x; Erlanson-Albertsson C, 2005, BASIC CLIN PHARMACOL, V97, P61, DOI 10.1111/j.1742-7843.2005.pto_179.x; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Fulton S, 2010, FRONT NEUROENDOCRIN, V31, P85, DOI 10.1016/j.yfrne.2009.10.003; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mennella JA, 2009, ADV EXP MED BIOL, V639, P113, DOI 10.1007/978-1-4020-8749-3_9; Mennella JA, 2002, EARLY HUM DEV, V68, P71, DOI 10.1016/S0378-3782(02)00008-7; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Naef L, 2008, PSYCHOPHARMACOLOGY, V197, P83, DOI 10.1007/s00213-007-1008-4; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; Rajasingam D, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.047; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; ROLLS BJ, 1982, PHYSIOL BEHAV, V28, P393, DOI 10.1016/0031-9384(82)90130-5; Silverman BL, 1998, DIABETES CARE, V21, pB142; Svingos AL, 1999, SYNAPSE, V34, P1; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Trottier G, 1998, ENDOCRINOLOGY, V139, P3704, DOI 10.1210/en.139.9.3704; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Vigano D, 2003, NEUROSCIENCE, V117, P921, DOI 10.1016/S0306-4522(02)00825-4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Walker CD, 2008, ANN NY ACAD SCI, V1144, P189, DOI 10.1196/annals.1418.023; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	52	167	171	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2167	2179		10.1096/fj.10-178392	http://dx.doi.org/10.1096/fj.10-178392			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21427213	Green Published			2022-12-25	WOS:000292242200009
J	Litvack, ML; Post, M; Palaniyar, N				Litvack, Michael L.; Post, Martin; Palaniyar, Nades			IgM Promotes the Clearance of Small Particles and Apoptotic Microparticles by Macrophages	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; NATURAL IGM; PATTERN-RECOGNITION; ISCHEMIA/REPERFUSION INJURY; COMPLEMENT ACTIVATION; IN-VIVO; MEDIATED PHAGOCYTOSIS; INFLUENZA-VIRUS; NECROTIC CELLS; SECRETED IGM	Background: Antibodies are often involved in enhancing particle clearance by macrophages. Although the mechanisms of antibody-dependent phagocytosis have been studied for IgG in greater detail, very little is known about IgM-mediated clearance. It has been generally considered that IgM does not support phagocytosis. Recent studies indicate that natural IgM is important to clear microbes and other bioparticles, and that shape is critical to particle uptake by macrophages; however, the relevance of IgM and particle size in their clearance remains unclear. Here we show that IgM has a size-dependent effect on clearance. Methodology/Principal Findings: We used antibody-opsonized sheep red blood cells, different size beads and apoptotic cells to determine the effect of human and mouse IgM on phagocytosis by mouse alveolar macrophages. Our microscopy (light, epifluorescence, confocal) and flow cytometry data show that IgM greatly enhances the clearance of small particles (about 1-2 micron) by these macrophages. There is an inverse relationship between IgM-mediated clearance by macrophages and the particle size; however, macrophages bind and internalize many different size particles coated with IgG. We also show that IgM avidly binds to small size late apoptotic cells or bodies (2-5 micron) and apoptotic microparticles (< 2 mu m) released from dying cells. IgM also promotes the binding and uptake of microparticle-coated beads. Conclusions/Significance: Therefore, while the shape of the particles is important for non-opsonized particle uptake, the particle size matters for antibody-mediated clearance by macrophages. IgM particularly promotes the clearance of small size particles. This finding may have wider implications in IgM-mediated clearing of antigens, microbial pathogens and dying cells by the host.	[Litvack, Michael L.; Palaniyar, Nades] Hosp Sick Children, Lung Innate Immun Res Lab, Toronto, ON M5G 1X8, Canada; [Litvack, Michael L.; Post, Martin; Palaniyar, Nades] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Post, Martin; Palaniyar, Nades] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Litvack, ML (corresponding author), Hosp Sick Children, Lung Innate Immun Res Lab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	nades.palaniyar@sickkids.ca		Palaniyar, Nades/0000-0002-2170-8548	Canadian Institutes of Health [MOP-84312, MOP-134761]; Sickkids Restracomp/Ontario Student Opportunity Trust; Peterborough K.M. Hunter Graduate Studentship	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Sickkids Restracomp/Ontario Student Opportunity Trust; Peterborough K.M. Hunter Graduate Studentship	This study was funded by Canadian Institutes of Health Research grants MOP-84312 and MOP-134761 to NP. MLL is a recipient of Sickkids Restracomp/Ontario Student Opportunity Trust Funds Awards and of the Peterborough K.M. Hunter Graduate Studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; CHOW CW, 2004, CURR PROTOC CELL BIO; Ciurana CLF, 2006, CELL IMMUNOL, V239, P14, DOI 10.1016/j.cellimm.2006.02.006; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Clark H, 2002, J IMMUNOL, V169, P2892, DOI 10.4049/jimmunol.169.6.2892; Cline AM, 2004, CLIN IMMUNOL, V112, P175, DOI 10.1016/j.clim.2004.02.017; Connolly SE, 2004, J IMMUNOL, V172, P1191, DOI 10.4049/jimmunol.172.2.1191; Davizon P, 2009, CURR OPIN HEMATOL, V16, P334, DOI 10.1097/MOH.0b013e32832ea49c; Dignat-George F, 2004, THROMB HAEMOSTASIS, V91, P667, DOI 10.1160/TH03-07-0487; Fu M, 2007, APOPTOSIS, V12, P355, DOI 10.1007/s10495-006-0581-z; Gaiha GD, 2008, J IMMUNOL, V181, P601, DOI 10.4049/jimmunol.181.1.601; GEISER M, 2010, J AEROSOL MED PULM D; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kang YH, 2009, ADV EXP MED BIOL, V653, P117; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Litvack ML, 2010, MOL IMMUNOL, V48, P37, DOI 10.1016/j.molimm.2010.09.014; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Nadesalingam J, 2005, FEBS LETT, V579, P4449, DOI 10.1016/j.febslet.2005.07.012; Nakanishi Y, 2009, ADV EXP MED BIOL, V653, P129; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ojewole E, 2008, EUR J PHARM BIOPHARM, V70, P697, DOI 10.1016/j.ejpb.2008.06.020; Palaniyar N, 2005, J IMMUNOL, V174, P7352, DOI 10.4049/jimmunol.174.11.7352; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Palaniyar N, 2010, INNATE IMMUN-LONDON, V16, P131, DOI 10.1177/1753425910370498; Peng YF, 2005, MOL IMMUNOL, V42, P781, DOI 10.1016/j.molimm.2004.07.045; Quartier P, 2005, EUR J IMMUNOL, V35, P252, DOI 10.1002/eji.200425497; Rapaka RR, 2010, J EXP MED, V207, P2907, DOI 10.1084/jem.20100034; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Schulze C, 2008, AUTOIMMUN REV, V8, P5, DOI 10.1016/j.autrev.2008.07.049; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Vaculik C, 2008, CLIN EXP IMMUNOL, V151, P146, DOI 10.1111/j.1365-2249.2007.03534.x; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2008, MOL IMMUNOL, V45, P4036, DOI 10.1016/j.molimm.2008.06.013; Zhang M, 2007, MOL IMMUNOL, V44, P103, DOI 10.1016/j.molimm.2006.06.022; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727; Zwart B, 2004, AUTOIMMUNITY, V37, P95, DOI 10.1080/0891693042000196183	51	52	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17223	10.1371/journal.pone.0017223	http://dx.doi.org/10.1371/journal.pone.0017223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448268	gold, Green Published, Green Submitted			2022-12-25	WOS:000288810500004
J	Agarwal, G; Mahajan, S; Srinivasan, N; de Brevern, AG				Agarwal, Garima; Mahajan, Swapnil; Srinivasan, Narayanaswamy; de Brevern, Alexandre G.			Identification of Local Conformational Similarity in Structurally Variable Regions of Homologous Proteins Using Protein Blocks	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; CRYSTAL-STRUCTURE; FUNCTIONAL CONSTRAINTS; SEQUENCE ALIGNMENT; TERTIARY STRUCTURE; EVOLUTION; CLASSIFICATION; PREDICTION; ALPHABET; DATABASE	Structure comparison tools can be used to align related protein structures to identify structurally conserved and variable regions and to infer functional and evolutionary relationships. While the conserved regions often superimpose well, the variable regions appear non superimposable. Differences in homologous protein structures are thought to be due to evolutionary plasticity to accommodate diverged sequences during evolution. One of the kinds of differences between 3-D structures of homologous proteins is rigid body displacement. A glaring example is not well superimposed equivalent regions of homologous proteins corresponding to a-helical conformation with different spatial orientations. In a rigid body superimposition, these regions would appear variable although they may contain local similarity. Also, due to high spatial deviation in the variable region, one-to-one correspondence at the residue level cannot be determined accurately. Another kind of difference is conformational variability and the most common example is topologically equivalent loops of two homologues but with different conformations. In the current study, we present a refined view of the "structurally variable" regions which may contain local similarity obscured in global alignment of homologous protein structures. As structural alphabet is able to describe local structures of proteins precisely through Protein Blocks approach, conformational similarity has been identified in a substantial number of 'variable' regions in a large data set of protein structural alignments; optimal residue-residue equivalences could be achieved on the basis of Protein Blocks which led to improved local alignments. Also, through an example, we have demonstrated how the additional information on local backbone structures through protein blocks can aid in comparative modeling of a loop region. In addition, understanding on sequence-structure relationships can be enhanced through our approach. This has been illustrated through examples where the equivalent regions in homologous protein structures share sequence similarity to varied extent but do not preserve local structure.	[Agarwal, Garima; Mahajan, Swapnil; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mahajan, Swapnil] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [de Brevern, Alexandre G.] INSERM, U665, Paris, France; [de Brevern, Alexandre G.] Univ Paris 07, UMR S665, Paris, France; [de Brevern, Alexandre G.] Inst Natl Transfus Sanguine, F-75015 Paris, France	Indian Institute of Science (IISC) - Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Agarwal, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in	Mahajan, Swapnil/J-4732-2019; de Brevern, Alexandre G./B-4788-2009	Mahajan, Swapnil/0000-0003-2136-1801; de Brevern, Alexandre G./0000-0001-7112-5626	Council of Scientific and Industrial Research; Department of Biotechnology; CEFIPRA [3903-E]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; CEFIPRA	GA and SM are supported by fellowships from Council of Scientific and Industrial Research and Department of Biotechnology respectively. NS and AdB acknowledge the support from CEFIPRA collaborative grant (number 3903-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GR, 2000, J MOL BIOL, V297, P421, DOI 10.1006/jmbi.2000.3564; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Balaji S, 2001, PROTEIN ENG, V14, P219, DOI 10.1093/protein/14.4.219; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; BRUCCOLERI RE, 1987, BIOPOLYMERS, V26, P137, DOI 10.1002/bip.360260114; Carpentier M, 2005, PROTEINS, V61, P137, DOI 10.1002/prot.20517; Chothia C, 1997, NATURE, V385, P579, DOI 10.1038/385579a0; De Brevern AG, 2007, J BIOSCIENCES, V32, P51, DOI 10.1007/s12038-007-0006-3; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; FAURE G, 2009, BIOCHIMIE; Fetrow JS, 1998, J MOL BIOL, V282, P703, DOI 10.1006/jmbi.1998.2061; FINE R M, 1986, Proteins Structure Function and Genetics, V1, P342, DOI 10.1002/prot.340010408; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2002, ACCOUNTS CHEM RES, V35, P413, DOI 10.1021/ar010061h; Fourrier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-58; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Ghozlane A, 2009, BIOINFORMATION, V3, P367, DOI 10.6026/97320630003367; Godzik A, 1996, PROTEIN SCI, V5, P1325, DOI 10.1002/pro.5560050711; GREER J, 1980, P NATL ACAD SCI-BIOL, V77, P3393, DOI 10.1073/pnas.77.6.3393; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JAKONCIC J, 2010, CRYSTAL STR IN PRESS; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; JOHNSON MS, 1990, METHOD ENZYMOL, V183, P670; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MOULT J, 1986, Proteins Structure Function and Genetics, V1, P146, DOI 10.1002/prot.340010207; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Oliva B, 1997, J MOL BIOL, V266, P814, DOI 10.1006/jmbi.1996.0819; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Orengo CA, 2001, J STRUCT BIOL, V134, P145, DOI 10.1006/jsbi.2001.4398; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Parmeggiani A, 2006, BIOCHEMISTRY-US, V45, P6846, DOI 10.1021/bi0525122; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Pisanti N, 2009, J COMPUT BIOL, V16, P1635, DOI 10.1089/cmb.2008.0019; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Sandhya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004981; Shatsky M, 2004, J COMPUT BIOL, V11, P83, DOI 10.1089/106652704773416902; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SRINIVASAN N, 1993, PROTEIN ENG, V6, P501, DOI 10.1093/protein/6.5.501; Swindells MB, 1998, BIOESSAYS, V20, P884; TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; vanVlijmen HWT, 1997, J MOL BIOL, V267, P975, DOI 10.1006/jmbi.1996.0857; Williams SG, 2009, MOL BIOL EVOL, V26, P1055, DOI 10.1093/molbev/msp020; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; ZHU ZY, 1992, PROTEIN ENG, V5, P43, DOI 10.1093/protein/5.1.43	81	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17826	10.1371/journal.pone.0017826	http://dx.doi.org/10.1371/journal.pone.0017826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445259	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100035
J	Hemmert, AC; Otto, TC; Chica, RA; Wierdl, M; Edwards, JS; Lewis, SL; Edwards, CC; Tsurkan, L; Cadieux, CL; Kasten, SA; Cashman, JR; Mayo, SL; Potter, PM; Cerasoli, DM; Redinbo, MR				Hemmert, Andrew C.; Otto, Tamara C.; Chica, Roberto A.; Wierdl, Monika; Edwards, Jonathan S.; Lewis, Steven L.; Edwards, Carol C.; Tsurkan, Lyudmila; Cadieux, C. Linn; Kasten, Shane A.; Cashman, John R.; Mayo, Stephen L.; Potter, Philip M.; Cerasoli, Douglas M.; Redinbo, Matthew R.			Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme	PLOS ONE			English	Article							ANHYDRIDE HYDROLASE ACTIVITY; INHIBITION; REACTIVATION; EXPRESSION; CATALYSIS; KINETICS; TARGETS	Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activity into the human drug metabolism enzyme carboxylesterase 1. Using crystal structures of the target enzyme in complex with nerve agent as a guide, a pair of histidine and glutamic acid residues were designed proximal to the enzyme's native catalytic triad. The resultant variant protein demonstrated significantly increased rates of reactivation following exposure to sarin, soman, and cyclosarin. Importantly, the addition of these residues did not alter the high affinity binding of nerve agents to this protein. Thus, using two amino acid substitutions, a novel enzyme was created that efficiently converted a group of hemisubstrates, compounds that can start but not complete a reaction cycle, into bona fide substrates. Such approaches may lead to novel countermeasures for nerve agent poisoning.	[Hemmert, Andrew C.; Edwards, Jonathan S.; Lewis, Steven L.; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem Biophys & Chem, Chapel Hill, NC 27515 USA; [Otto, Tamara C.; Cadieux, C. Linn; Kasten, Shane A.; Cerasoli, Douglas M.] USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA; [Chica, Roberto A.; Mayo, Stephen L.] CALTECH, Dept Biol & Chem, Pasadena, CA 91125 USA; [Wierdl, Monika; Edwards, Carol C.; Tsurkan, Lyudmila; Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Cashman, John R.] Human BioMol Res Inst, San Diego, CA USA	University of North Carolina; University of North Carolina Chapel Hill; Research Institute of Chemical Defense - China; California Institute of Technology; St Jude Children's Research Hospital	Hemmert, AC (corresponding author), Univ N Carolina, Dept Biochem Biophys & Chem, Chapel Hill, NC 27515 USA.	redinbo@unc.edu	; Potter, Philip/J-4515-2013	Cadieux, C. Linn/0000-0002-1440-2284; Potter, Philip/0000-0001-8922-8535; Kasten, Shane/0000-0003-1986-8064	National Institutes of Health through National Institute of Neurological Disorders and Stroke [UO1 NS58089, UO1 NS058038]; American Lebanese and Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058038, U01NS058089] Funding Source: NIH RePORTER	National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Lebanese and Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke (UO1 NS58089, MRR; UO1 NS058038, JRC). This work was also supported by the American Lebanese and Syrian Associated Charities (ALSAC) and St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurbek N, 2006, TOXICOLOGY, V224, P91, DOI 10.1016/j.tox.2006.04.030; Casida JE, 2005, CHEM-BIOL INTERACT, V157, P277, DOI 10.1016/j.cbi.2005.10.036; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dixon M., 1979, ENZYMES, Vthird; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Elcock AH, 1999, J MOL BIOL, V291, P149, DOI 10.1006/jmbi.1999.2919; Fleming CD, 2007, BIOCHEMISTRY-US, V46, P5063, DOI 10.1021/bi700246n; Gilley C, 2009, CHEM RES TOXICOL, V22, P1680, DOI 10.1021/tx900090m; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hemmert AC, 2010, MOL PHARMACOL, V77, P508, DOI 10.1124/mol.109.062356; HOVANEC JW, 1977, BIOCHIM BIOPHYS ACTA, V483, P312, DOI 10.1016/0005-2744(77)90059-6; Jett DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000752; Kuca K, 2007, DRUG CHEM TOXICOL, V30, P31, DOI 10.1080/01480540601017637; Lenz D. E., 2008, Chemical warfare agents: chemistry, pharmacology, toxicology and therapeutics, P175; Lockridge O, 1997, BIOCHEMISTRY-US, V36, P786, DOI 10.1021/bi961412g; Marcel V, 2000, J BIOL CHEM, V275, P11603, DOI 10.1074/jbc.275.16.11603; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Millard CB, 1995, BIOCHEMISTRY-US, V34, P15925, DOI 10.1021/bi00049a007; Millard CB, 1998, BIOCHEMISTRY-US, V37, P237, DOI 10.1021/bi972057c; Morton CL, 2000, MOL BIOTECHNOL, V16, P193, DOI 10.1385/MB:16:3:193; Newmark J, 2007, NEUROLOGIST, V13, P20, DOI 10.1097/01.nrl.0000252923.04894.53; Ohbu S, 1997, SOUTHERN MED J, V90, P587, DOI 10.1097/00007611-199706000-00002; QIAN NF, 1993, FEBS LETT, V336, P263, DOI 10.1016/0014-5793(93)80816-D; Redinbo MR, 2005, DRUG DISCOV TODAY, V10, P313, DOI 10.1016/S1359-6446(05)03383-0; Shortle D, 2003, PROTEIN SCI, V12, P1298, DOI 10.1110/ps.0306903; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wadkins RM, 2001, MOL PHARMACOL, V60, P355, DOI 10.1124/mol.60.2.355; Wierdl M, 2008, CANCER GENE THER, V15, P183, DOI 10.1038/sj.cgt.7701112; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y	30	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17441	10.1371/journal.pone.0017441	http://dx.doi.org/10.1371/journal.pone.0017441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445272	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000288545100014
J	Muendlein, A; Saely, CH; Geller-Rhomberg, S; Sonderegger, G; Rein, P; Winder, T; Beer, S; Vonbank, A; Drexel, H				Muendlein, Axel; Saely, Christoph H.; Geller-Rhomberg, Simone; Sonderegger, Gudrun; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz			Single Nucleotide Polymorphisms of TCF7L2 Are Linked to Diabetic Coronary Atherosclerosis	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GENE; RISK; GLUCOSE; CHOLESTEROL; EXPRESSION; PREVENTION; RECEPTORS	Background: Coronary artery disease (CAD) shares common risk factors with type 2 diabetes (T2DM). Variations in the transcription factor 7-like 2 (TCF7L2) gene, particularly rs7903146, increase T2DM risk. Potential links between genetic variants of the TCF7L2 locus and coronary atherosclerosis are uncertain. We therefore investigated the association between TCF7L2 polymorphisms and angiographically determined CAD in diabetic and non-diabetic patients. Methodology/Principal Findings: We genotyped TCF7L2 variants rs7903146, rs12255372, and rs11196205 in a cross-sectional study including 1,650 consecutive patients undergoing coronary angiography for the evaluation of established or suspected stable CAD. Significant CAD was diagnosed in the presence of coronary stenoses >= 50%. Variant rs7903146 in the total study cohort was significantly associated with significant CAD (adjusted additive OR = 1.29 [1.09-1.53]; p = 0.003). This association was strong and significant in T2DM patients (n = 393; OR = 1.91 [1.32-2.75]; p = 0.001) but not in non-diabetic subjects (OR = 1.09 [0.90-1.33]; p = 0.370). The interaction risk allele by T2DM was significant (p(interaction) = 0.002), indicating a significantly stronger impact of the polymorphism on CAD in T2DM patients than in non-diabetic subjects. TCF7L2 polymorphisms rs12255372 and rs11196205 were also significantly associated with CAD in diabetic patients (adjusted additive OR = 1.90 [1.31-2.74]; p = 0.001 and OR = 1.75 [1.22-2.50]; p = 0.002, respectively). Further, haplotype analysis demonstrated that haplotypes including the rare alleles of all investigated variants were significantly associated with CAD in the whole cohort as well as in diabetic subjects (OR = 1.22 [1.04-1.43]; p = 0.013 and OR = 1.67 [1.19-2.22]; p = 0.003, respectively). Conclusions/Significance: These results suggest that TCF7L2 variants rs7903146 rs12255372, and rs11196205 are significantly associated with angiographically diagnosed CAD, specifically in patients with T2DM. TCF7L2 therefore appears as a genetic link between diabetes and atherosclerosis.	[Muendlein, Axel; Saely, Christoph H.; Geller-Rhomberg, Simone; Sonderegger, Gudrun; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz] Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria; [Muendlein, Axel; Saely, Christoph H.; Geller-Rhomberg, Simone; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Saely, Christoph H.; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Muendlein, A (corresponding author), Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria.	vivit@lkhf.at	Muendlein, Axel/AAS-5313-2021	Vonbank, Alexander/0000-0001-5648-5623; Muendlein, Axel/0000-0002-5582-4125	Kurt und Senta Herrmann Stiftung (Liechtenstein); Land Vorarlberg; Europaeischer Fonds fuer regionale Entwicklung (EFRE)	Kurt und Senta Herrmann Stiftung (Liechtenstein); Land Vorarlberg; Europaeischer Fonds fuer regionale Entwicklung (EFRE)	Funding: The study was part-financed by the 'Kurt und Senta Herrmann Stiftung' (Liechtenstein), the 'Land Vorarlberg' and the 'Europaeischer Fonds fuer regionale Entwicklung' (EFRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Bielinski SJ, 2008, DIABETOLOGIA, V51, P968, DOI 10.1007/s00125-008-1004-1; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Drexel H, 2005, DIABETES CARE, V28, P101, DOI 10.2337/diacare.28.1.101; DREXEL H, 1994, CIRCULATION, V90, P2230, DOI 10.1161/01.CIR.90.5.2230; Duval A, 2000, CYTOGENET CELL GENET, V88, P264, DOI 10.1159/000015534; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gable DR, 2006, ATHEROSCLEROSIS, V188, P231, DOI 10.1016/j.atherosclerosis.2006.02.010; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Genuth S, 2003, DIABETES CARE, V26, P3160; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; JUDKINS MP, 1967, RADIOLOGY, V89, P815, DOI 10.1148/89.5.815; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1956, DOI 10.1210/jc.2006-2514; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Mulnier HE, 2008, DIABETOLOGIA, V51, P1639, DOI 10.1007/s00125-008-1076-y; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Pearson ER, 2009, DIABETOLOGIA, V52, P1227, DOI 10.1007/s00125-009-1356-1; Piga R, 2007, ATHEROSCLEROSIS, V193, P328, DOI 10.1016/j.atherosclerosis.2006.09.016; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Saegusa M, 2007, J PATHOL, V213, P35, DOI 10.1002/path.2198; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; XIE X, 1993, AM J HUM GENET, V53, P1107; YAN SD, 1994, J BIOL CHEM, V269, P9889	38	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17978	10.1371/journal.pone.0017978	http://dx.doi.org/10.1371/journal.pone.0017978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423583	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900049
J	Shoji, A; Elliott, KH; Aris-Brosou, S; Crump, D; Gaston, AJ				Shoji, Akiko; Elliott, Kyle H.; Aris-Brosou, Stephane; Crump, Doug; Gaston, Anthony J.			Incubation Patterns in a Central-Place Forager Affect Lifetime Reproductive Success: Scaling of Patterns from a Foraging Bout to a Lifetime	PLOS ONE			English	Article							FULMARS FULMARUS-GLACIALIS; GUILLEMOTS URIA-LOMVIA; BODY CONDITION; EGG NEGLECT; ENERGY-EXPENDITURE; NORTHERN FULMARS; EUDYPTULA-MINOR; CASSINS AUKLET; COMMON EIDERS; STORM-PETRELS	Background: Long-lived seabirds face a conflict between current and lifelong reproductive success. During incubation shifts, egg neglect is sometimes necessary to avoid starvation, but may compromise the current reproductive attempt. However, factors underlying this decision process are poorly understood. We focus on the ancient murrelet, Synthliboramphus antiquus, an alcid with exceptionally long incubation shift lengths, and test the impact of environmental factors on incubation shift length in relation to reproductive success. Methodology/Principal Findings: Using an information theoretic approach, we show that incubation shift length was a strong predictor of reproductive success for ancient murrelets at Reef Island, Haida Gwaii, British Columbia, Canada during the 2007 and 2008 breeding seasons. The most important factors explaining an individual's shift length were egg size, wind speed and the length of the mate's previous shift. Wind speed and tide height were the two most important factors for determining foraging behavior, as measured by dive frequency and depth. Conclusions/Significance: Our study demonstrates that (i) species-specific reproductive strategies interact with environmental conditions such as wind speed to form multiple incubation patterns and (ii) maintaining regular incubation shifts is an essential component of reproductive success.	[Shoji, Akiko; Aris-Brosou, Stephane; Gaston, Anthony J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Shoji, Akiko; Crump, Doug; Gaston, Anthony J.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Elliott, Kyle H.] Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada	University of Ottawa; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Manitoba	Shoji, A (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	akikosho@gmail.com	Elliott, Kyle/S-9185-2019	Aris-Brosou, Stephane/0000-0003-4987-0296; Elliott, Kyle/0000-0001-5304-3993	Environment Canada; Natural Sciences and Engineering Research Council of Canada; Foundation For International Education Exchange	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Foundation For International Education Exchange	This project was funded by Environment Canada; SAB was partially supported by the Natural Sciences and Engineering Research Council of Canada. AS received the full scholarship from Ito Foundation For International Education Exchange for the MSc program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2007, AUK, V124, P63, DOI 10.1642/0004-8038(2007)124[63:TPFCRT]2.0.CO;2; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Amundsen T, 1996, J ANIM ECOL, V65, P545, DOI 10.2307/5735; Ashmole N.P., 1971, AVIAN BIOL, P224; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; BIRKHEAD TR, 1976, BRIT BIRDS, V69, P490; Blight LK, 1999, CONDOR, V101, P871, DOI 10.2307/1370079; BURGER AE, 1990, CAN J ZOOL, V68, P1572, DOI 10.1139/z90-232; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chastel O, 1995, AUK, V112, P964, DOI 10.2307/4089027; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; CODY ML, 1973, ECOLOGY, V54, P31, DOI 10.2307/1934372; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; Dale S, 1996, BEHAV ECOL SOCIOBIOL, V39, P31, DOI 10.1007/s002650050264; DAVIS LS, 1988, AUK, V105, P428, DOI 10.1093/auk/105.3.428; DeForest LN, 1996, ECOLOGY, V77, P1501, DOI 10.2307/2265547; DRENT RH, 1980, ARDEA, V68, P225; Egloff C, 2009, MOL ECOL RESOUR, V9, P19, DOI 10.1111/j.1755-0998.2008.02214.x; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Elliott KH, 2010, AQUAT BIOL, V8, P221, DOI 10.3354/ab00236; Elliott KH, 2009, WATERBIRDS, V32, P183, DOI 10.1675/063.032.0123; Elliott KH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1773, DOI 10.1007/s00265-009-0801-y; Falk K, 1997, IBIS, V139, P270, DOI 10.1111/j.1474-919X.1997.tb04625.x; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Gaston, 1992, ANCIENT MURRELET NAT; Gaston A.J., 1998, AUKS ALCIDAE; Gaston A.J., 2004, SEABIRDS NATURAL HIS; GASTON AJ, 1988, COLON WATERBIRD, V11, P58, DOI 10.2307/1521170; Gaston AJ, 2006, J AVIAN BIOL, V37, P101; Gaston AJ, 2006, IBIS, V148, P106, DOI 10.1111/j.1474-919X.2006.00489.x; GASTON AJ, 1992, CONDOR, V94, P1019, DOI 10.2307/1369303; GASTON AJ, 1989, AUK, V106, P653; GASTON AJ, 1989, AUK, V106, P433; GASTON AJ, 1990, CONDOR, V92, P998, DOI 10.2307/1368736; Gaston AJ, 1996, COLON WATERBIRD, V19, P116, DOI 10.2307/1521814; GASTON AJ, 1994, BIRDS N AM, V132; Gray CM, 2005, J AVIAN BIOL, V36, P374, DOI 10.1111/j.0908-8857.2005.03597.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Guigueno MF, 2010, CONDOR, V112, P399, DOI 10.1525/cond.2010.090135; HAMER KC, 1994, J AVIAN BIOL, V25, P198, DOI 10.2307/3677075; Hamer KC, 1997, IBIS, V139, P31, DOI 10.1111/j.1474-919X.1997.tb04501.x; HARRIS SW, 1974, CONDOR, V76, P249, DOI 10.2307/1366338; Hatch JJ, 2011, IBIS, V153, P185, DOI 10.1111/j.1474-919X.2010.01076.x; Heath JP, 2007, ANIM BEHAV, V73, P877, DOI 10.1016/j.anbehav.2006.10.015; Heath JP, 2006, J EXP BIOL, V209, P3974, DOI 10.1242/jeb.02482; Heath JP, 2008, WATERBIRDS, V31, P71; Hipfner JM, 1997, J AVIAN BIOL, V28, P271, DOI 10.2307/3676939; Holm HJ, 2002, WATERBIRDS, V25, P312; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; IMBER M J, 1975, Notornis, V22, P302; JONES IL, 1990, CAN J ZOOL, V68, P433, DOI 10.1139/z90-064; Kato A, 2008, AUK, V125, P588, DOI 10.1525/auk.2008.06273; Keitt Bradford S., 2004, Marine Ornithology, V32, P173; Lack D., 1968, pvii; Litzow MA, 2004, J ANIM ECOL, V73, P1149, DOI 10.1111/j.0021-8790.2004.00890.x; LLOYD CS, 1979, IBIS, V121, P165, DOI 10.1111/j.1474-919X.1979.tb04959.x; Lovvorn JR, 2010, AQUAT BIOL, V8, P203, DOI 10.3354/ab00210; Mallory ML, 2008, MAR BIOL, V154, P1031, DOI 10.1007/s00227-008-0994-z; Martin TE, 1999, AM NAT, V153, P131, DOI 10.1086/303153; Michl G, 2000, ANIM BEHAV, V59, P623, DOI 10.1006/anbe.1999.1352; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Ojowski U, 2001, MAR BIOL, V139, P1193; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; R Development Core Team, 2009, LANG ENV STAT COMP V; Reid JM, 2002, AUK, V119, P54, DOI 10.1642/0004-8038(2002)119[0054:ECOCTA]2.0.CO;2; Riou S, 2008, ANIM BEHAV, V76, P1743, DOI 10.1016/j.anbehav.2008.08.012; Ronconi RA, 2009, CAN J ZOOL, V87, P415, DOI 10.1139/Z09-027; SEALY SG, 1975, CAN J ZOOL, V53, P418, DOI 10.1139/z75-055; SEALY SG, 1976, CONDOR, V78, P294, DOI 10.2307/1367688; Shoji AM, 2010, WATERBIRDS, V33, P260, DOI 10.1675/063.033.0217; Smith PA, 2009, CONDOR, V111, P414, DOI 10.1525/cond.2009.090002; Smith PA, 2007, CONDOR, V109, P15; Stearns S.C., 1992, pi; Tveraa T, 1997, BEHAV ECOL, V8, P465, DOI 10.1093/beheco/8.5.465; WANLESS S, 1993, IBIS, V135, P19, DOI 10.1111/j.1474-919X.1993.tb02805.x; WARHAM J, 1990, PETRELS THEIR ECOLOG; WATANUKI Y, 1986, AUK, V103, P14, DOI 10.1093/auk/103.1.14; Weimerskirch H, 2002, J EXP BIOL, V205, P475; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Wilson RP, 2001, J AVIAN BIOL, V32, P83, DOI 10.1034/j.1600-048X.2001.320113.x; [No title captured], DOI DOI 10.2307/1367282	82	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17760	10.1371/journal.pone.0017760	http://dx.doi.org/10.1371/journal.pone.0017760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423631	gold, Green Submitted, Green Published			2022-12-25	WOS:000288513900023
J	Srinivasan, D; Muthukrishnan, N; Johnson, GA; Erazo-Oliveras, A; Lim, J; Simanek, EE; Pellois, JP				Srinivasan, Divyamani; Muthukrishnan, Nandhini; Johnson, Gregory A.; Erazo-Oliveras, Alfredo; Lim, Jongdoo; Simanek, Eric E.; Pellois, Jean-Philippe			Conjugation to the Cell-Penetrating Peptide TAT Potentiates the Photodynamic Effect of Carboxytetramethylrhodamine	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; BIOLOGICAL-MEMBRANES; INDUCED ENDOCYTOSIS; LIPID-PEROXIDATION; MECHANISM; THERAPY; PROTEOGLYCANS; TRANSLOCATION; EXPRESSION; LYSOSOMES	Background: Cell-penetrating peptides (CPPs) can transport macromolecular cargos into live cells. However, the cellular delivery efficiency of these reagents is often suboptimal because CPP-cargo conjugates typically remain trapped inside endosomes. Interestingly, irradiation of fluorescently labeled CPPs with light increases the release of the peptide and its cargos into the cytosol. However, the mechanism of this phenomenon is not clear. Here we investigate the molecular basis of the photo-induced endosomolytic activity of the prototypical CPPs TAT labeled to the fluorophore 5(6)carboxytetramethylrhodamine (TMR). Methodology/Principal Findings: We report that TMR-TAT acts as a photosensitizer that can destroy membranes. TMR-TAT escapes from endosomes after exposure to moderate light doses. However, this is also accompanied by loss of plasma membrane integrity, membrane blebbing, and cell-death. In addition, the peptide causes the destruction of cells when applied extracellularly and also triggers the photohemolysis of red blood cells. These photolytic and photocytotoxic effects were inhibited by hydrophobic singlet oxygen quenchers but not by hydrophilic quenchers. Conclusions/Significance: Together, these results suggest that TAT can convert an innocuous fluorophore such as TMR into a potent photolytic agent. This effect involves the targeting of the fluorophore to cellular membranes and the production of singlet oxygen within the hydrophobic environment of the membranes. Our findings may be relevant for the design of reagents with photo-induced endosomolytic activity. The photocytotoxicity exhibited by TMR-TAT also suggests that CPP-chromophore conjugates could aid the development of novel Photodynamic Therapy agents.	[Srinivasan, Divyamani; Muthukrishnan, Nandhini; Johnson, Gregory A.; Erazo-Oliveras, Alfredo; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Lim, Jongdoo; Simanek, Eric E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Srinivasan, D (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pellois@tamu.edu	Muthukrishnan, Nandhini/P-8906-2018; Johnson, Gregory/F-3793-2012	Pellois, Jean-Philippe/0000-0001-8528-4652; Johnson, Gregory/0000-0001-6917-4322	National Institute of General Medical Sciences [R01GM087227]; National Institutes of Health (NIH) [R01GM087227, T32GM065088, T32 GM008523]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008523, R01GM087227, T32GM065088] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Award Number R01GM087227 from the National Institute of General Medical Sciences. G.J. was supported by the National Institutes of Health (NIH) Molecular Biophysics training grant T32GM065088 and by grant R01GM087227. A.E.-O. was supported by the NIH Chemistry-Biology Interface training grant T32 GM008523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1966, NATURE, V209, P874, DOI 10.1038/209874a0; Bagdonas S, 2005, PHOTOCH PHOTOBIO SCI, V4, P497, DOI 10.1039/b503790e; BERG K, 1994, INT J CANCER, V59, P814, DOI 10.1002/ijc.2910590618; BIRCHMEIER W, 1979, J BIOL CHEM, V254, P9298; BLUM A, 1985, PHOTOCHEM PHOTOBIOL, V41, P27, DOI 10.1111/j.1751-1097.1985.tb03443.x; Bourre L, 2010, PHOTOCH PHOTOBIO SCI, V9, P1613, DOI 10.1039/c0pp00146e; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; Choi Y, 2006, CHEMMEDCHEM, V1, P458, DOI 10.1002/cmdc.200500036; Ciobanasu C, 2009, BIOCHEMISTRY-US, V48, P4728, DOI 10.1021/bi900365s; COLIN FC, 1991, AM J HEMATOL, V37, P34, DOI 10.1002/ajh.2830370108; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; DOLEIDEN FH, 1974, PHOTOCHEM PHOTOBIOL, V20, P519, DOI 10.1111/j.1751-1097.1974.tb06613.x; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Drzeniek Z, 1999, BLOOD, V93, P2884; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Eggeling C, 1998, ANAL CHEM, V70, P2651, DOI 10.1021/ac980027p; EISENBERG WC, 1984, PHOTOCHEM PHOTOBIOL, V40, P55, DOI 10.1111/j.1751-1097.1984.tb04553.x; Endoh T, 2009, J CONTROL RELEASE, V137, P241, DOI 10.1016/j.jconrel.2009.04.015; EVANS EA, 1974, BIOPHYS J, V14, P923, DOI 10.1016/S0006-3495(74)85959-X; Geissbuehler M, 2010, BIOPHYS J, V98, P339, DOI 10.1016/j.bpj.2009.10.006; Grossweiner L I, 1984, Prog Clin Biol Res, V170, P391; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Hong SB, 2005, PHOTODERMATOL PHOTO, V21, P322, DOI 10.1111/j.1600-0781.2005.00181.x; JAY AWL, 1975, J PHYSIOL-LONDON, V252, P817, DOI 10.1113/jphysiol.1975.sp011172; Maiolo JR, 2004, J AM CHEM SOC, V126, P15376, DOI 10.1021/ja044867z; Matsushita M, 2004, FEBS LETT, V572, P221, DOI 10.1016/j.febslet.2004.07.033; MORLIERE P, 1991, BIOCHIM BIOPHYS ACTA, V1084, P261, DOI 10.1016/0005-2760(91)90068-S; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Ouedraogo GD, 2003, PHOTOCHEM PHOTOBIOL, V77, P192, DOI 10.1562/0031-8655(2003)077<0192:SROSET>2.0.CO;2; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; REYFTMANN JP, 1986, PHOTOCHEM PHOTOBIOL, V44, P461, DOI 10.1111/j.1751-1097.1986.tb04693.x; RUBEN S, 1989, J VIROL, V63, P1; Schmidt-Erfurth U, 1999, ARCH OPHTHALMOL-CHIC, V117, P1177; Sehgal I, 2008, J MED CHEM, V51, P6014, DOI 10.1021/jm800444c; SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; VALENZENO DP, 1987, PHOTOCHEM PHOTOBIOL, V46, P147, DOI 10.1111/j.1751-1097.1987.tb04749.x; Vogt AM, 2004, BIOCHEM J, V381, P593, DOI 10.1042/BJ20040762; WILSON PD, 1987, J CELL BIOL, V104, P1223, DOI 10.1083/jcb.104.5.1223; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	44	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17732	10.1371/journal.pone.0017732	http://dx.doi.org/10.1371/journal.pone.0017732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423812	Green Published, gold, Green Submitted			2022-12-25	WOS:000288512400023
J	Yu, XL; Yuan, L; Huang, Y; Xu, WS; Fang, ZM; Liu, SW; Shao, YM; Jiang, SB; Ma, LY				Yu, Xiaoling; Yuan, Lin; Huang, Yang; Xu, Weisi; Fang, Zhiming; Liu, Shuwen; Shao, Yiming; Jiang, Shibo; Ma, Liying			Susceptibility of HIV-1 Subtypes B ', CRF07_BC and CRF01_AE that Are Predominantly Circulating in China to HIV-1 Entry Inhibitors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANT HIV-1; CCR5 ANTAGONIST MARAVIROC; FUSION INHIBITOR; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; ANTIVIRAL ACTIVITY; GP41; ENFUVIRTIDE; PEPTIDE	Background: The B', CRF07_BC and CRF01_AE are the predominant HIV-1 subtypes in China. It is essential to determine their baseline susceptibility to HIV entry inhibitors before these drugs are used in China. Methodology/Principal Findings: The baseline susceptibility of 14 representative HIV-1 isolates (5 CRF07_BC, 4 CRF01_AE, and 5 B'), most of which were R5 viruses, obtained from drug-naive patients to HIV entry inhibitors, including two fusion inhibitors (enfuvirtide and C34), two CCR5 antagonists (maraviroc and TAK779) and one CXCR4 antagonist (AMD3100), were determined by virus inhibition assay. The sequences of their env genes were amplified and analyzed. These isolates possessed similar susceptibility to C34, but they exhibited different sensitivity to enfuvirtide, maraviroc or TAK779. CRF07_BC isolates, which carried polymorphisms of A578T and V583I in the N-terminal heptad repeat and E630Q, E662A, K665S, A667K and S668N in the C-terminal heptad repeat of gp41, were about 5-fold less sensitive than B' and CRF01_AE isolates to enfuvirtide. Subtype B' isolates with a unique polymorphism site of F317W in V3 loop, were about 4- to 5-fold more sensitive than CRF07_BC and CRF01_AE isolates to maraviroc and TAK779. AMD3100 at the concentration as high as 5 mu M exhibited no significant inhibitory activity against any of the isolates tested. Conclusion: Our results suggest that there are significant differences in baseline susceptibility to HIV entry inhibitors among the predominant HIV-1 subtypes in China and the differences may partly result from the naturally occurring polymorphisms in these subtypes. This study provides useful information for rational design of optimal therapeutic regimens for HIV-1-infected patients in China.	[Yu, Xiaoling; Yuan, Lin; Huang, Yang; Xu, Weisi; Fang, Zhiming; Shao, Yiming; Ma, Liying] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yu, Xiaoling; Liu, Shuwen; Jiang, Shibo] So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Southern Medical University - China; New York Blood Center; Fudan University; Fudan University	Yu, XL (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao@bbn.cn; sjiang@nybloodcenter.org; liyingma5566@chinaaids.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; Liu, Shuwen/0000-0001-6346-5006	National Nature Science Foundation of China [30872232, U0832001]; National Science and Technology Major Project [2008ZX10001-004, 2008ZX10001-013, 2008ZX10001-015]; United States National Institutes of Health [AI046221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from National Nature Science Foundation of China (30872232, U0832001) and National Science and Technology Major Project (2008ZX10001-004, 2008ZX10001-013 and 2008ZX10001-015) and a United States National Institutes of Health grant (AI046221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Carmona R, 2005, J CLIN VIROL, V32, P248, DOI 10.1016/j.jcv.2004.11.009; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Han J, 2009, INT J STD AIDS, V20, P249, DOI 10.1258/ijsa.2008.008480; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Izumi K, 2009, J BIOL CHEM, V284, P4914, DOI 10.1074/jbc.M807169200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Leung PHM, 2010, J CLIN VIROL, V47, P273, DOI 10.1016/j.jcv.2010.01.002; LEVIN J, 2010, 17 CROI C RETR OPP I; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; LIU Z, 2010, J BIOL CHEM; Lobritz MA, 2007, J VIROL, V81, P8258, DOI 10.1128/JVI.02739-06; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Luo MQ, 2009, JAIDS-J ACQ IMM DEF, V50, P1, DOI 10.1097/QAI.0b013e31818ffcdc; Ma LY, 2007, JAIDS-J ACQ IMM DEF, V44, P14, DOI 10.1097/01.qai.0000243049.27580.cc; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; McCutchan FE, 2000, AIDS, V14, pS31; Ogert RA, 2008, VIROLOGY, V373, P387, DOI 10.1016/j.virol.2007.12.009; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Pang Wei, 2009, Antivir Chem Chemother, V20, P1, DOI 10.3851/IMP1369; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Schurmann D, 2007, AIDS, V21, P1293, DOI 10.1097/QAD.0b013e3280f00f9f; Shao YM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-87; SHIMURA K, 2010, J BIOL CHEM; Simon V, 2002, AIDS, V16, P1511, DOI 10.1097/00002030-200207260-00008; Sun JP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-201; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Toma J, 2010, AIDS, V24, P2181, DOI 10.1097/QAD.0b013e32833c543f; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang M, 2008, JPN J INFECT DIS, V61, P361	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17605	10.1371/journal.pone.0017605	http://dx.doi.org/10.1371/journal.pone.0017605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412427	Green Submitted, gold, Green Published			2022-12-25	WOS:000288247800017
J	Galeote, V; Bigey, F; Beyne, E; Novo, M; Legras, JL; Casaregola, S; Dequin, S				Galeote, Virginie; Bigey, Frederic; Beyne, Emmanuelle; Novo, Maite; Legras, Jean-Luc; Casaregola, Serge; Dequin, Sylvie			Amplification of a Zygosaccharomyces bailii DNA Segment in Wine Yeast Genomes by Extrachromosomal Circular DNA Formation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HORIZONTAL-GENE-TRANSFER; SACCHAROMYCES-CEREVISIAE; EVOLUTION; SEQUENCE; REPAIR; POLYMORPHISM; DIVERSITY; PLASMIDS; PATHWAYS	We recently described the presence of large chromosomal segments resulting from independent horizontal gene transfer (HGT) events in the genome of Saccharomyces cerevisiae strains, mostly of wine origin. We report here evidence for the amplification of one of these segments, a 17 kb DNA segment from Zygosaccharomyces bailii, in the genome of S. cerevisiae strains. The copy number, organization and location of this region differ considerably between strains, indicating that the insertions are independent and that they are post-HGT events. We identified eight different forms in 28 S. cerevisiae strains, mostly of wine origin, with up to four different copies in a single strain. The organization of these forms and the identification of an autonomously replicating sequence functional in S. cerevisiae, strongly suggest that an extrachromosomal circular DNA (eccDNA) molecule serves as an intermediate in the amplification of the Z. bailii region in yeast genomes. We found little or no sequence similarity at the breakpoint regions, suggesting that the insertions may be mediated by nonhomologous recombination. The diversity between these regions in S. cerevisiae represents roughly one third the divergence among the genomes of wine strains, which confirms the recent origin of this event, posterior to the start of wine strain expansion. This is the first report of a circle-based mechanism for the expansion of a DNA segment, mediated by nonhomologous recombination, in natural yeast populations.	[Galeote, Virginie; Bigey, Frederic; Beyne, Emmanuelle; Novo, Maite; Legras, Jean-Luc; Dequin, Sylvie] INRA, Sci OEnol UMR1083, F-34060 Montpellier, France; [Casaregola, Serge] AgroParisTech, CIRM Levures, INRA, Micalis UMR1319, Thiverval Grignon, France	INRAE; Universite de Montpellier; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Galeote, V (corresponding author), INRA, Sci OEnol UMR1083, F-34060 Montpellier, France.	sylvie.dequin@supagro.inra.fr	Bigey, Frédéric/F-2517-2010; Legras, Jean-Luc/A-7589-2008; Novo, Maite/G-2002-2016	Bigey, Frédéric/0000-0002-6240-3038; Legras, Jean-Luc/0000-0002-4006-4389; Novo, Maite/0000-0002-2454-1990	French Agence Nationale de la Recherche (ANR) [ANR-07-BLAN-0205]; French National Institute for Agricultural Research (INRA); Generalitat de Catalunya	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French National Institute for Agricultural Research (INRA); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the French Agence Nationale de la Recherche (ANR Project GENYEASTRAIT, ANR-07-BLAN-0205) and post doc fellowships of French National Institute for Agricultural Research (INRA) to EB and of the Generalitat de Catalunya to MN, http://www.international.inra.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKI H, 1985, J MOL BIOL, V182, P191, DOI 10.1016/0022-2836(85)90338-9; ARGUESO JL, 2009, GENOME RES, V7, P7; BIDENNE C, 1992, CURR GENET, V22, P1, DOI 10.1007/BF00351734; Borneman AR, 2008, FEMS YEAST RES, V8, P1185, DOI 10.1111/j.1567-1364.2008.00434.x; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; Cohen Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006126; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; DAMON C, ISME J IN PRESS; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Frank AC, 2009, EUKARYOT CELL, V8, P1521, DOI 10.1128/EC.00110-09; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOROWITZ H, 1985, MOL CELL BIOL, V5, P2369, DOI 10.1128/MCB.5.9.2369; HOURCADE D, 1973, P NATL ACAD SCI USA, V70, P2926, DOI 10.1073/pnas.70.10.2926; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Koszul R, 2009, CR BIOL, V332, P254, DOI 10.1016/j.crvi.2008.07.005; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Moore IK, 2000, ENVIRON MOL MUTAGEN, V36, P113, DOI 10.1002/1098-2280(2000)36:2<113::AID-EM5>3.0.CO;2-T; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Sacerdot C, 2008, FEMS YEAST RES, V8, P846, DOI 10.1111/j.1567-1364.2008.00409.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOHE A, 1985, NUCLEIC ACIDS RES, V13, P4267, DOI 10.1093/nar/13.12.4267; UTATSU I, 1987, J BACTERIOL, V169, P5537, DOI 10.1128/jb.169.12.5537-5545.1987; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; VANLOON N, 1994, NUCLEIC ACIDS RES, V22, P2447, DOI 10.1093/nar/22.13.2447; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17872	10.1371/journal.pone.0017872	http://dx.doi.org/10.1371/journal.pone.0017872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423766	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100042
J	Leclerc, EA; Gazeilles, L; Serre, G; Guerrin, M; Jonca, N				Leclerc, Emilie A.; Gazeilles, Leila; Serre, Guy; Guerrin, Marina; Jonca, Nathalie			The Ubiquitous Dermokine Delta Activates Rab5 Function in the Early Endocytic Pathway	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; IDENTIFICATION; GENE; LOCALIZATION; TRAFFICKING; ENDOSOMES; NETWORKS; PROTEINS; GROWTH	The expression of the recently identified dermokine (Dmkn) gene leads to four families of proteins with as yet unknown functions. The secreted alpha, beta and gamma isoforms share an epidermis-restricted expression pattern, whereas the delta isoform is intracellular and ubiquitous. To get an insight into Dmkn delta function, we performed yeast two-hybrid screening and identified the small GTPases Rab5 as partners for Dmkn delta. The Rab5 proteins are known to regulate membrane docking and fusion in the early endocytic pathway. GST pull-down assays confirmed the direct interaction between Rab5 and Dmkn delta. Transient expression of Dmkn delta in HeLa cells led to the formation of punctate structures colocalized with endogenous Rab5 and clathrin, indicating Dmkn delta involvement in the early steps of endocytosis. Dmkn delta indeed colocalized with transferrin at early stages of endocytosis, but did not modulate its endocytosis or recycling kinetics. We also showed that Dmkn delta was able to bind both inactive (GDP-bound) and active (GTP-bound) forms of Rab5 in vitro but preferentially targeted GDP-bound form in HeLa cells. Interestingly, Dmkn delta expression rescued the Rab5S34N-mediated inhibition of endosome fusion. Moreover, Dmkn delta caused the enlargement of vesicles positive for Rab5 by promoting GTP loading onto the small GTPase. Together our data reveal that Dmkn delta activates Rab5 function and thus is involved in the early endosomal trafficking.	[Leclerc, Emilie A.; Gazeilles, Leila; Serre, Guy; Guerrin, Marina; Jonca, Nathalie] Univ Toulouse 3, UMR 516,Epidermis Differentiat & Rheumatoid Autoi, CNRS,IFR 150,INSERM, CHU,CHU Purpan, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Leclerc, EA (corresponding author), Univ Toulouse 3, UMR 516,Epidermis Differentiat & Rheumatoid Autoi, CNRS,IFR 150,INSERM, CHU,CHU Purpan, F-31062 Toulouse, France.	Nathalie.Jonca@udear.cnrs.fr	Jonca, Nathalie/AAX-3870-2020	Jonca, Nathalie/0000-0003-3602-0102	"Centre National de la Recherche Scientifique" (CNRS); Toulouse III University	"Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Toulouse III University	This work was supported by grants from the "Centre National de la Recherche Scientifique" (CNRS) and Toulouse III University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHEN PI, 2009, J BIOL CHEM; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Moffatt P, 2004, GENE, V334, P123, DOI 10.1016/j.gene.2004.03.010; Naso MF, 2007, J INVEST DERMATOL, V127, P1622, DOI 10.1038/sj.jid.5700779; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Toulza E, 2006, J INVEST DERMATOL, V126, P503, DOI 10.1038/sj.jid.5700033; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	36	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17816	10.1371/journal.pone.0017816	http://dx.doi.org/10.1371/journal.pone.0017816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423773	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100038
J	Reis, M; Sousa-Guimaraes, S; Vieira, CP; Sunkel, CE; Vieira, J				Reis, Micael; Sousa-Guimaraes, Sofia; Vieira, Cristina P.; Sunkel, Claudio E.; Vieira, Jorge			Drosophila Genes That Affect Meiosis Duration Are among the Meiosis Related Genes That Are More Often Found Duplicated	PLOS ONE			English	Article							CONCERTED EVOLUTION; VIRILIS GROUP; POLO KINASE; GENOME; YEAST; COMPLEX; MELANOGASTER; MECHANISMS; SOFTWARE; PROTEINS	Using a phylogenetic approach, the examination of 33 meiosis/meiosis-related genes in 12 Drosophila species, revealed nine independent gene duplications, involving the genes cav, mre11, meiS332, polo and mtrm. Evidence is provided that at least eight out of the nine gene duplicates are functional. Therefore, the rate at which Drosophila meiosis/meiosis-related genes are duplicated and retained is estimated to be 0.0012 per gene per million years, a value that is similar to the average for all Drosophila genes. It should be noted that by using a phylogenetic approach the confounding effect of concerted evolution, that is known to lead to overestimation of the duplication and retention rate, is avoided. This is an important issue, since even in our moderate size sample, evidence for long-term concerted evolution ( lasting for more than 30 million years) was found for the meiS332 gene pair in species of the Drosophila subgenus. Most striking, in contrast to theoretical expectations, is the finding that genes that encode proteins that must follow a close stoichiometric balance, such as polo, mtrm and meiS332 have been found duplicated. The duplicated genes may be examples of gene neofunctionalization. It is speculated that meiosis duration may be a trait that is under selection in Drosophila and that it has different optimal values in different species.	[Reis, Micael; Sousa-Guimaraes, Sofia; Vieira, Cristina P.; Sunkel, Claudio E.; Vieira, Jorge] Univ Porto, IBMC, P-4100 Oporto, Portugal	Universidade do Porto	Reis, M (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Cristina P./K-1775-2013; Vieira, Jorge/J-7477-2013; Sunkel, Claudio E/J-3352-2013	Vieira, Cristina P./0000-0002-7139-2107; Vieira, Jorge/0000-0001-7032-5220; Sunkel, Claudio E/0000-0002-2963-9380; Reis, Micael/0000-0002-2601-0886	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BDE/66765/2006, PTDC/BIA-BEC/099933/2008]; Programa Operacional para a Ciencia e Inovacao [POCI-2010]; Fundo Europeu para o Desenvolvimento Regional (FEDER); Programa Operacional para a Promocao da competividade (COMPETE)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional para a Ciencia e Inovacao; Fundo Europeu para o Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional para a Promocao da competividade (COMPETE)	This work was funded by the Fundacao para a Ciencia e Tecnologia (FCT) through research projects PTDC/BIA-BDE/66765/2006 and PTDC/BIA-BEC/099933/2008 and through PhD grants attributed to MR and SG, funded by Programa Operacional para a Ciencia e Inovacao (POCI-2010), co-funded by Fundo Europeu para o Desenvolvimento Regional (FEDER) and Programa Operacional para a Promocao da competividade (COMPETE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2009, GENETICS, V181, P177, DOI 10.1534/genetics.108.093807; Badugu R, 2003, J BIOL CHEM, V278, P34491, DOI 10.1074/jbc.M305262200; Beisswanger S, 2008, P NATL ACAD SCI USA, V105, P5447, DOI 10.1073/pnas.0710892105; BENNETT MD, 1977, PHILOS T R SOC B, V277, P201, DOI 10.1098/rstb.1977.0012; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; Carmon A, 2010, J MOL EVOL, V70, P260, DOI 10.1007/s00239-010-9327-1; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Gao GJ, 2009, P NATL ACAD SCI USA, V106, P10728, DOI 10.1073/pnas.0902707106; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; HICKEY DA, 1991, P NATL ACAD SCI USA, V88, P1611, DOI 10.1073/pnas.88.5.1611; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kahn T, 2000, MOL CELL BIOL, V20, P7634, DOI 10.1128/MCB.20.20.7634-7642.2000; KLASTERSKA I, 1990, GENETICA, V80, P181, DOI 10.1007/BF00137324; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2000, GENETICS, V154, P459; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Osada N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000305; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Reis M, 2008, GENE, V425, P48, DOI 10.1016/j.gene.2008.08.010; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Shareef MM, 2003, GENETICA, V117, P127; Smith SK, 2008, CELL CYCLE, V7, P698, DOI 10.4161/cc.7.6.5568; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Soyer OS, 2010, J EVOLUTION BIOL, V23, P2410, DOI 10.1111/j.1420-9101.2010.02101.x; TAJIMA F, 1993, GENETICS, V135, P599; Vieira CP, 2006, GENET RES, V87, P163, DOI 10.1017/S0016672306008147; Villasante A, 2007, GENOME RES, V17, P1909, DOI 10.1101/gr.6365107; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wang SJ, 1999, MOL BIOL EVOL, V16, P1117, DOI 10.1093/oxfordjournals.molbev.a026202; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Yang J, 2004, GENE, V340, P237, DOI 10.1016/j.gene.2004.06.057	41	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17512	10.1371/journal.pone.0017512	http://dx.doi.org/10.1371/journal.pone.0017512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423746	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100012
J	Steelandt, S; Dufour, V; Broihanne, MH; Thierry, B				Steelandt, Sophie; Dufour, Valerie; Broihanne, Marie-Helene; Thierry, Bernard			Can Monkeys Make Investments Based on Maximized Pay-off?	PLOS ONE			English	Article							SEQUENTIALLY PRESENTED SETS; BY-ONE ADDITION; RHESUS MACAQUES; DEMAND DETERMINE; SMALL NUMBERS; CHIMPANZEES; SUMMATION; FOOD; REPRESENTATION; TROGLODYTES	Animals can maximize benefits but it is not known if they adjust their investment according to expected pay-offs. We investigated whether monkeys can use different investment strategies in an exchange task. We tested eight capuchin monkeys (Cebus apella) and thirteen macaques (Macaca fascicularis, Macaca tonkeana) in an experiment where they could adapt their investment to the food amounts proposed by two different experimenters. One, the doubling partner, returned a reward that was twice the amount given by the subject, whereas the other, the fixed partner, always returned a constant amount regardless of the amount given. To maximize pay-offs, subjects should invest a maximal amount with the first partner and a minimal amount with the second. When tested with the fixed partner only, one third of monkeys learned to remove a maximal amount of food for immediate consumption before investing a minimal one. With both partners, most subjects failed to maximize pay-offs by using different decision rules with each partner' quality. A single Tonkean macaque succeeded in investing a maximal amount to one experimenter and a minimal amount to the other. The fact that only one of over 21 subjects learned to maximize benefits in adapting investment according to experimenters' quality indicates that such a task is difficult for monkeys, albeit not impossible.	[Steelandt, Sophie; Dufour, Valerie; Thierry, Bernard] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Steelandt, Sophie; Dufour, Valerie; Thierry, Bernard] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Dufour, Valerie] Univ St Andrews, Scottish Primate Res Grp, Ctr Social Learning & Cognit Evolut, Sch Psychol, St Andrews KY16 9AJ, Fife, Scotland; [Broihanne, Marie-Helene] Univ Strasbourg, Lab Rech Gest & Econ, EM Strasbourg Business Sch, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of St Andrews; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Steelandt, S (corresponding author), CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France.	sophie.steelandt@c-strasbourg.fr		Broihanne, Marie-Helene/0000-0002-3651-2740	Agence Nationale de la Recherche [ANR-08-BLAN-0042-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The research was supported by a grant from the Agence Nationale de la Recherche (ANR-08-BLAN-0042-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESSI E, 2007, P ROY SOC LOND B BIO, V274, P2709; Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Anderson US, 2005, J COMP PSYCHOL, V119, P285, DOI 10.1037/0735-7036.119.3.285; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; Beran MJ, 2008, ANIM COGN, V11, P109, DOI 10.1007/s10071-007-0094-3; Beran MJ, 2004, J COMP PSYCHOL, V118, P25, DOI 10.1037/0735-7036.118.1.25; Beran MJ, 2004, PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2004.01502004.x; Beran MJ, 2002, J GEN PSYCHOL, V129, P49, DOI 10.1080/00221300209602032; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Blaye A, 2001, BRIT J DEV PSYCHOL, V19, P395, DOI 10.1348/026151001166173; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Brosnan SF, 2009, INT J PRIMATOL, V30, P663, DOI 10.1007/s10764-009-9366-x; Brosnan SF, 2005, PRIMATES, V46, P173, DOI 10.1007/s10329-005-0125-0; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Call J, 2000, J COMP PSYCHOL, V114, P136, DOI 10.1037/0735-7036.114.2.136; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Cantlon JF, 2005, P NATL ACAD SCI USA, V102, P16507, DOI 10.1073/pnas.0506463102; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Cordes S, 2007, CURR DIR PSYCHOL SCI, V16, P156, DOI 10.1111/j.1467-8721.2007.00495.x; Drapier M, 2005, PRIMATES, V46, P241, DOI 10.1007/s10329-005-0132-1; Dufour V, 2007, J COMP PSYCHOL, V121, P145, DOI 10.1037/0735-7036.121.2.145; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Hare B, 2003, ANIM BEHAV, V65, P131, DOI 10.1006/anbe.2002.2017; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, COGNITIVE PSYCHOL, V47, P367, DOI 10.1016/S0010-0285(03)00050-1; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; Hyatt CW, 1998, BEHAV PROCESS, V42, P177, DOI 10.1016/S0376-6357(97)00075-2; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; Lakshminaryanan V, 2008, PHILOS T R SOC B, V363, P3837, DOI 10.1098/rstb.2008.0149; McNamara JM, 1996, AM ZOOL, V36, P484; Mitchell RW, 1997, J COMP PSYCHOL, V111, P351, DOI 10.1037/0735-7036.111.4.351; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Nofsinger JR, 2005, PSYCHOL INVESTMENT; Pele M, 2010, ANIM COGN, V13, P263, DOI 10.1007/s10071-009-0264-6; PERUSSE R, 1990, INT J PRIMATOL, V11, P425, DOI 10.1007/BF02196130; POVINELLI DJ, 1991, J COMP PSYCHOL, V105, P318, DOI 10.1037/0735-7036.105.4.318; Ramseyer A, 2006, P ROY SOC B-BIOL SCI, V273, P179, DOI 10.1098/rspb.2005.3300; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Rumbaugh D.M., 1984, P569; RUMBAUGH DM, 1987, J EXP PSYCHOL ANIM B, V13, P107, DOI 10.1037/0097-7403.13.2.107; Silk JB, 2007, ADV STUD BEHAV, V37, P1, DOI 10.1016/S0065-3454(07)37001-0; STEELANDT S, ARE MONKEYS SE UNPUB; Stephens D., 2007, FORAGING BEHAV ECOLO; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Sulkowski GM, 2001, COGNITION, V79, P239, DOI 10.1016/S0010-0277(00)00112-8; THOMAS RK, 1993, DEV NUMERICAL COMPET, P127; Tomasello M, 1997, PRIMATE COGNITION; vanMarle K, 2006, J COMP PSYCHOL, V120, P416, DOI 10.1037/0735-7036.120.4.416; Westergaard GC, 2004, ANIM COGN, V7, P19, DOI 10.1007/s10071-003-0181-z; Wood JN, 2008, COGNITION, V106, P207, DOI 10.1016/j.cognition.2007.01.004; Zelazo PD, 2003, MONOGR SOC RES CHILD, V68, P1, DOI 10.1111/j.0037-976X.2003.00261.x; [No title captured]	61	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17801	10.1371/journal.pone.0017801	http://dx.doi.org/10.1371/journal.pone.0017801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732VZ	21423777	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100035
J	Timmusk, S; Paalme, V; Pavlicek, T; Bergquist, J; Vangala, A; Danilas, T; Nevo, E				Timmusk, Salme; Paalme, Viiu; Pavlicek, Tomas; Bergquist, Jonas; Vangala, Ameraswar; Danilas, Triin; Nevo, Eviatar			Bacterial Distribution in the Rhizosphere of Wild Barley under Contrasting Microclimates	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; PLANT-GROWTH; PAENIBACILLUS-POLYMYXA; ACC DEAMINASE; GENE-EXPRESSION; CONFER RESISTANCE; EVOLUTION-CANYON; ETHYLENE LEVELS; STRESS; DIVERSITY	Background: All plants in nature harbor a diverse community of rhizosphere bacteria which can affect the plant growth. Our samples are isolated from the rhizosphere of wild barley Hordeum spontaneum at the Evolution Canyon ('EC'), Israel. The bacteria which have been living in close relationship with the plant root under the stressful conditions over millennia are likely to have developed strategies to alleviate plant stress. Methodology/Principal Findings: We studied distribution of culturable bacteria in the rhizosphere of H. spontaneum and characterized the bacterial 1-aminocyclopropane-1-carboxylate deaminase (ACCd) production, biofilm production, phosphorus solubilization and halophilic behavior. We have shown that the H. spontaneum rhizosphere at the stressful South Facing Slope (SFS) harbors significantly higher population of ACCd producing biofilm forming phosphorus solubilizing osmotic stress tolerant bacteria. Conclusions/Significance: The long-lived natural laboratory 'EC' facilitates the generation of theoretical testable and predictable models of biodiversity and genome evolution on the area of plant microbe interactions. It is likely that the bacteria isolated at the stressful SFS offer new opportunities for the biotechnological applications in our agro-ecological systems.	[Timmusk, Salme; Vangala, Ameraswar] Swedish Univ Agr Sci SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, Uppsala, Sweden; [Paalme, Viiu] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Pavlicek, Tomas; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Bergquist, Jonas] Uppsala Univ, Dept Analyt & Phys Chem, Uppsala, Sweden; [Danilas, Triin] Estonian Univ Life Sci, Inst Forestry & Rural Engn, Tartu, Estonia	Swedish University of Agricultural Sciences; Tallinn University of Technology; University of Haifa; Uppsala University; Estonian University of Life Sciences	Timmusk, S (corresponding author), Swedish Univ Agr Sci SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, Uppsala, Sweden.	salme.timmusk@mykopat.slu.se	Pavlicek, Tomas/C-4768-2008; Bergquist, Jonas/C-5894-2015	timmusk, s/0000-0001-8465-1043; Bergquist, Jonas/0000-0002-4597-041X	FORMAS/Sweden; Ancell-Teicher Research Foundation of Molecular Genetics and Evolution	FORMAS/Sweden(Swedish Research Council Formas); Ancell-Teicher Research Foundation of Molecular Genetics and Evolution	This work was supported by FORMAS/Sweden (to S. Timmusk) and the Ancell-Teicher Research Foundation of Molecular Genetics and Evolution (to E. Nevo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASEA PEA, 1988, SOIL BIOL BIOCHEM, V20, P459, DOI 10.1016/0038-0717(88)90058-2; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Cheng ZY, 2008, CAN J MICROBIOL, V54, P128, DOI 10.1139/w07-128; Czarny JC, 2006, BIOTECHNOL ADV, V24, P410, DOI 10.1016/j.biotechadv.2006.01.003; DAN J, 1979, SOIL CLASSIFICATION; Duan Jin, 2009, Microb Ecol, V57, P423, DOI 10.1007/s00248-008-9407-6; Echigo Akinobu, 2005, Saline Syst, V1, P8, DOI 10.1186/1746-1448-1-8; EDIPREMOTO M, 1996, JCROP SCI, V11, P13; FIERER N, 2008, ACCESSING UNCULTIVAT, P95; Gamalero E, 2009, MICROBIAL STRATEGIES FOR CROP IMPROVEMENT, P1, DOI 10.1007/978-3-642-01979-1_1; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Haggag WM, 2008, J APPL MICROBIOL, V104, P961, DOI 10.1111/j.1365-2672.2007.03611.x; HAO Y, 2009, ENVIRON MICROBIOL, V3, P112; Kis-Papo T, 2003, P NATL ACAD SCI USA, V100, P14970, DOI 10.1073/pnas.2036284100; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McDonnell L, 2009, PHYSIOL PLANTARUM, V136, P94, DOI 10.1111/j.1399-3054.2009.01208.x; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; NEVO E, 1987, ISOZYMES-CURR T BIOL, V16, P247; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E., 2002, EVOLUTION WILD EMMER; PAVLICEK T, 2003, EVOLUTION, V52, P1; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Raz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005214; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Selezska K, 2007, MYCOLOGIA BALCANICA, V4, P51; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Timmusk S, 2009, J APPL MICROBIOL, V107, P736, DOI 10.1111/j.1365-2672.2009.04265.x; Timmusk S, 2009, J APPL MICROBIOL, V106, P1473, DOI 10.1111/j.1365-2672.2009.04123.x; Timmusk S, 1999, SOIL BIOL BIOCHEM, V31, P1847, DOI 10.1016/S0038-0717(99)00113-3; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Timmusk S, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P285, DOI 10.1007/978-3-642-21061-7_12; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004	40	116	126	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17968	10.1371/journal.pone.0017968	http://dx.doi.org/10.1371/journal.pone.0017968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448272	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500024
J	Ho, PL; Lo, WU; Yeung, MK; Lin, CH; Chow, KH; Ang, I; Tong, AHY; Bao, JYJ; Lok, S; Lo, JYC				Ho, Pak Leung; Lo, Wai U.; Yeung, Man Kiu; Lin, Chi Ho; Chow, Kin Hung; Ang, Irene; Tong, Amy Hin Yan; Bao, Jessie Yun-Juan; Lok, Si; Lo, Janice Yee Chi			Complete Sequencing of pNDM-HK Encoding NDM-1 Carbapenemase from a Multidrug-Resistant Escherichia coli Strain Isolated in Hong Kong	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; COMPLETE NUCLEOTIDE-SEQUENCE; KLEBSIELLA-PNEUMONIAE; AMINOGLYCOSIDE-RESISTANCE; BLA(CTX-M) GENES; PLASMIDS; EMERGENCE; ELEMENTS; SYSTEMS; SPREAD	Background: The emergence of plasmid-mediated carbapenemases, such as NDM-1 in Enterobacteriaceae is a major public health issue. Since they mediate resistance to virtually all beta-lactam antibiotics and there is often co-resistance to other antibiotic classes, the therapeutic options for infections caused by these organisms are very limited. Methodology: We characterized the first NDM-1 producing E. coli isolate recovered in Hong Kong. The plasmid encoding the metallo-beta-lactamase gene was sequenced. Principal Findings: The plasmid, pNDM-HK readily transferred to E. coli J53 at high frequencies. It belongs to the broad host range IncL/M incompatibility group and is 88803 bp in size. Sequence alignment showed that pNDM-HK has a 55 kb backbone which shared 97% homology with pEL60 originating from the plant pathogen, Erwina amylovora in Lebanon and a 28.9 kb variable region. The plasmid backbone includes the mucAB genes mediating ultraviolet light resistance. The 28.9 kb region has a composite transposon-like structure which includes intact or truncated genes associated with resistance to beta-lactams (bla(TEM-1), bla(NDM-1), Delta bla(DHA-1)), aminoglycosides (aacC2, armA), sulphonamides (sul1) and macrolides (mel, mph2). It also harbors the following mobile elements: IS26, ISCR1, tnpU, tnpAcp2, tnpD, Delta tnpATn1 and insL. Certain blocks within the 28.9 kb variable region had homology with the corresponding sequences in the widely disseminated plasmids, pCTX-M3, pMUR050 and pKP048 originating from bacteria in Poland in 1996, in Spain in 2002 and in China in 2006, respectively. Significance: The genetic support of NDM-1 gene suggests that it has evolved through complex pathways. The association with broad host range plasmid and multiple mobile genetic elements explain its observed horizontal mobility in multiple bacterial taxa.	[Ho, Pak Leung; Lo, Wai U.; Yeung, Man Kiu; Chow, Kin Hung; Ang, Irene] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ho, Pak Leung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Lin, Chi Ho; Tong, Amy Hin Yan; Bao, Jessie Yun-Juan; Lok, Si] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Lo, Janice Yee Chi] Ctr Hlth Protect, Publ Hlth Lab Serv Branch, Hong Kong, Hong Kong, Peoples R China; [Lo, Janice Yee Chi] Ctr Hlth Protect, Dept Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Ho, PL (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	plho@hkucc.hku.hk	何栢良, Pak-Leung HO/C-4310-2009; Lo, Wai U/J-3053-2019; CHOW, Kin Hung/AAZ-3739-2020	何栢良, Pak-Leung HO/0000-0002-8811-1308; Lo, Wai U/0000-0002-2182-0222; /0000-0002-7386-8236	Health and Food Bureau of the Hong Kong, Special Administrative Region government	Health and Food Bureau of the Hong Kong, Special Administrative Region government	This work was supported by a commission grant from the Research Fund for the Control of Infectious Diseases (RFCID) of the Health and Food Bureau of the Hong Kong, Special Administrative Region government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertini A, 2007, ANTIMICROB AGENTS CH, V51, P2324, DOI 10.1128/AAC.01502-06; BRADLEY DE, 1980, J BACTERIOL, V143, P1466, DOI 10.1128/JB.143.3.1466-1470.1980; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CASTANHEIRA M, 2010, ANTIMICROB AGENTS CH; Chu YW, 2011, EMERG INFECT DIS, V17, P130, DOI 10.3201/eid1701.101443; Clinical and Laboratory Standards Institute, 2010, M100S20U CLIN LAB ST; Cullik A, 2010, J MED MICROBIOL, V59, P580, DOI 10.1099/jmm.0.016188-0; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Gonzalez-Zorn B, 2005, EMERG INFECT DIS, V11, P954; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Ho PL, 2007, J ANTIMICROB CHEMOTH, V60, P140, DOI 10.1093/jac/dkm144; Ho PL, 2010, J MED MICROBIOL, V59, P702, DOI 10.1099/jmm.0.015032-0; Ho PL, 2005, J ANTIMICROB CHEMOTH, V55, P326, DOI 10.1093/jac/dki010; Jiang Y, 2010, ANTIMICROB AGENTS CH, V54, P3967, DOI 10.1128/AAC.00137-10; Kac G, 2010, INFECT CONT HOSP EP, V31, P165, DOI 10.1086/649794; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Literacka E, 2009, ANTIMICROB AGENTS CH, V53, P1630, DOI 10.1128/AAC.01431-08; Lo WU, 2010, J INFECTION, V60, P286, DOI 10.1016/j.jinf.2010.02.002; Loli A, 2006, J ANTIMICROB CHEMOTH, V58, P669, DOI 10.1093/jac/dkl302; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Muir A, 2010, J HOSP INFECT, V75, P239, DOI 10.1016/j.jhin.2010.02.005; POIREL L, 2010, ANTIMICROB AGENTS CH; SAMUELSEN O, 2010, J ANTIMICROB CHEMOTH; Shahid M, 2010, J CLIN MICROBIOL, V48, P1833, DOI 10.1128/JCM.01467-09; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Yu WL, 2006, CLIN MICROBIOL INFEC, V12, P806, DOI 10.1111/j.1469-0691.2006.01488.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhu WH, 2009, ANTIMICROB AGENTS CH, V53, P5291, DOI 10.1128/AAC.00032-09	36	146	173	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17989	10.1371/journal.pone.0017989	http://dx.doi.org/10.1371/journal.pone.0017989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445317	gold, Green Published, Green Submitted			2022-12-25	WOS:000288613300025
J	Madzivhandila, M; Adrian, PV; Cutland, CL; Kuwanda, L; Schrag, SJ; Madhi, SA				Madzivhandila, Mashudu; Adrian, Peter V.; Cutland, Clare L.; Kuwanda, Locadiah; Schrag, Stephanie J.; Madhi, Shabir A.			Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn Dyads	PLOS ONE			English	Article							PREGNANT-WOMEN; CARRIAGE; IMMUNIZATION; COLONIZATION; EPIDEMIOLOGY; PNEUMONIAE; MOTHERS; ASSAY	Background: Serotype-specific polysaccharide based group B streptococcus (GBS) vaccines are being developed. An understanding of the serotype epidemiology associated with maternal colonization and invasive disease in infants is necessary to determine the potential coverage of serotype-specific GBS vaccines. Methods: Colonizing GBS isolates were identified by vaginal swabbing of mothers during active labor and from skin of their newborns post-delivery. Invasive GBS isolates from infants were identified through laboratory-based surveillance. GBS serotyping was done by latex agglutination. Serologically non-typeable isolates were typed by a serotype-specific PCR method. The invasive potential of GBS serotypes associated with sepsis within seven days of birth was evaluated in association to maternal colonizing serotypes. Results: GBS was identified in 289 (52.4%) newborns born to 551 women with GBS-vaginal colonization and from 113 (5.6%) newborns born to 2,010 mothers in whom GBS was not cultured from vaginal swabs. The serotype distribution among vaginal-colonizing isolates was as follows: III (37.3%), Ia (30.1%), and II (11.3%), V (10.2%), Ib (6.7%) and IV (3.7%). There were no significant differences in serotype distribution between vaginal and newborn colonizing isolates (P = 0.77). Serotype distribution of invasive GBS isolates were significantly different to that of colonizing isolates (P < 0.0001). Serotype III was the most common invasive serotype in newborns less than 7 days (57.7%) and in infants 7 to 90 days of age (84.3%; P < 0.001). Relative to serotype III, other serotypes showed reduced invasive potential: Ia (0.49; 95% CI 0.31-0.77), II (0.30; 95% CI 0.13-0.67) and V (0.38; 95% CI 0.17-0.83). Conclusion: In South Africa, an anti-GBS vaccine including serotypes Ia, Ib and III has the potential of preventing 74.1%, 85.4% and 98.2% of GBS associated with maternal vaginal-colonization, invasive disease in neonates less than 7 days and invasive disease in infants between 7-90 days of age, respectively.	[Madzivhandila, Mashudu; Adrian, Peter V.; Cutland, Clare L.; Kuwanda, Locadiah; Madhi, Shabir A.] Univ Witwatersrand, Vaccine Preventable Dis & Resp & Meningeal Pathog, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa; [Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Research Foundation - South Africa; University of Witwatersrand; Centers for Disease Control & Prevention - USA	Madzivhandila, M (corresponding author), Univ Witwatersrand, Vaccine Preventable Dis & Resp & Meningeal Pathog, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa.	madhis@rmpru.co.za	Cutland, Clare L./GXE-9967-2022	Cutland, Clare L./0000-0001-8250-8307	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (Vaccine Preventable Diseases Research Chair Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sweih Noura, 2005, Archives of Gynecology and Obstetrics, V272, P131, DOI 10.1007/s00404-004-0705-z; Amin A, 2002, J INFECTION, V45, P42, DOI 10.1053/jinf.2001.0990; BAIDI MS, 1977, J INFECT DIS, V135, P308; Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574; Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Baker CJ, 2003, ARCH DIS CHILD, V88, P375, DOI 10.1136/adc.88.5.375; Beal S., 2006, REV GYNAECOL P RINAT, V6, P218, DOI [10.1016/j.rigapp.2006.05.006, DOI 10.1016/J.RIGAPP.2006.05.006]; BEHRMAN RE, 1973, FETAL NEONATAL MED, V82, P703; Berg S, 2000, CLIN MICROBIOL INFEC, V6, P9, DOI 10.1046/j.1469-0691.2000.00007.x; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; BLACK RE, 2010, LANCET, V6736, P39; Brimil N, 2006, INT J MED MICROBIOL, V296, P39, DOI 10.1016/j.ijmm.2005.11.001; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Buttery J, 2002, BRIT MED BULL, V61, P63, DOI 10.1093/bmb/61.1.63; CUTLAND CL, 2009, LANCET, V6736, P1; DILLON HC, 1982, J INFECT DIS, V145, P794, DOI 10.1093/infdis/145.6.794; Eren A, 2005, TURKISH J PEDIATR, V47, P28; Fluegge K, 2005, CLIN INFECT DIS, V40, P760, DOI 10.1086/427942; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HOOGKAMPKORSTANJE JAA, 1982, J INFECT DIS, V145, P800, DOI 10.1093/infdis/145.6.800; Kovavisarach Ekachai, 2007, Journal of the Medical Association of Thailand, V90, P1710; Lancefield RC, 1934, J EXP MED, V59, P459, DOI 10.1084/jem.59.4.459; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Moyo SR, 2002, J MED MICROBIOL, V51, P595, DOI 10.1099/0022-1317-51-7-595; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; QINLAN JD, 2000, J MED MICROBIOL, V49, P447; QUINLAN JD, 2000, J FAMILY PRACTICE, V49, P448; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Slotved HC, 2003, J CLIN MICROBIOL, V41, P4445, DOI 10.1128/JCM.41.9.4445-4447.2003; Strus M, 2009, J MED MICROBIOL, V58, P228, DOI 10.1099/jmm.0.002865-0; SUARA RO, 1994, J INFECT DIS, V170, P1316, DOI 10.1093/infdis/170.5.1316; van Elzakker E, 2009, EUR J CLIN MICROBIOL, V28, P921, DOI 10.1007/s10096-009-0726-4; Weisner AM, 2004, CLIN INFECT DIS, V38, P1203, DOI 10.1086/382881; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; 2006, WEEKLY EPIDEMIOL REC, V81, P198	41	72	79	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17861	10.1371/journal.pone.0017861	http://dx.doi.org/10.1371/journal.pone.0017861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445302	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300017
J	Uraki, R; Sakudo, A; Michibata, K; Ano, Y; Kono, J; Yukawa, M; Onodera, T				Uraki, Ryuta; Sakudo, Akikazu; Michibata, Kosuke; Ano, Yasuhisa; Kono, Jyuri; Yukawa, Masayoshi; Onodera, Takashi			Blocking of FcR Suppresses the Intestinal Invasion of Scrapie Agents	PLOS ONE			English	Article							PRION PROTEIN; LAMININ RECEPTOR; DENDRITIC CELLS; MICE; PATHOGENESIS; TRANSPORT; BINDING; MUCOSA; SHEEP	Prion diseases are a family of neurodegenerative zoonotic foodborne disorders. Although prions can be transmitted orally, the mechanism by which prions are incorporated into the intestine remains unclear. Our previous studies have shown that an abnormal isoform of prion protein (PrP(Sc)), which is the main component of prions, was efficiently incorporated into the intestine in suckling mice but not in weaned mice. Furthermore, suckling SCID mice lacking maternal antibodies showed decreased uptake of PrP(Sc) into the intestine compared with suckling wild-type mice, while the lack of PrP(Sc) uptake into the intestine of suckling SCID mice was rescued by the oral administration of IgG. These findings raise the possibility that the neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, plays a role in PrP(Sc) incorporation into the intestine. The present immunohistochemical study further showed that the FcR blocker Z-epsilon-aminocaproic acid (ZAA) inhibited PrP(Sc) incorporation into the intestinal villi of suckling mice, supporting the above mentioned concept. Therefore, our findings provide strong evidence that nFcR and maternal antibodies are involved in PrP(Sc) incorporation into the intestine before the weaning period.	[Uraki, Ryuta; Michibata, Kosuke; Ano, Yasuhisa; Onodera, Takashi] Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Tokyo, Japan; [Sakudo, Akikazu] Univ Ryukyus, Sch Hlth Sci, Fac Med, Lab Biometab Chem, Okinawa, Japan; [Kono, Jyuri; Yukawa, Masayoshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Sci, Kanagawa, Japan	University of Tokyo; University of the Ryukyus; Nihon University	Uraki, R (corresponding author), Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Tokyo, Japan.	aonoder@mail.ecc.u-tokyo.ac.jp	Sakudo, Akikazu/B-1368-2014		Japanese Food Safety Commission [0503]	Japanese Food Safety Commission	Funding was provided by a Grant-in-Aid from the Japanese Food Safety Commission (no. 0503; http://www.fsc.go.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2010, INT J MOL MED, V26, P845, DOI 10.3892/ijmm_00000533; Beekes M, 2000, NEUROSCI LETT, V278, P181, DOI 10.1016/S0304-3940(99)00934-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Ghosh S, 2004, ADV DRUG DELIVER REV, V56, P915, DOI 10.1016/j.addr.2003.10.035; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Hirogari Y, 2003, MICROBIOL IMMUNOL, V47, P871, DOI 10.1111/j.1348-0421.2003.tb03453.x; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; KRAMER DR, 1995, J IMMUNOL, V154, P2051; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Rodewald HR, 1999, P NATL ACAD SCI USA, V96, P15068, DOI 10.1073/pnas.96.26.15068; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P775, DOI 10.1093/jnen/63.7.775; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17928	10.1371/journal.pone.0017928	http://dx.doi.org/10.1371/journal.pone.0017928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437246	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100044
J	Fleming, EJ; Langdon, AE; Martinez-Garcia, M; Stepanauskas, R; Poulton, NJ; Masland, EDP; Emerson, D				Fleming, Emily J.; Langdon, Amy E.; Martinez-Garcia, Manuel; Stepanauskas, Ramunas; Poulton, Nicole J.; Masland, E. Dashiell P.; Emerson, David			What's New Is Old: Resolving the Identity of Leptothrix ochracea Using Single Cell Genomics, Pyrosequencing and FISH	PLOS ONE			English	Article							IRON-OXIDIZING BACTERIA; FRESH-WATER HABITATS; RNA-TARGETED PROBES; FILAMENTOUS BACTERIA; SPHAEROTILUS-NATANS; ACTIVATED-SLUDGE; MARINE-BACTERIA; NEUTRAL PH; IN-SITU; MANGANESE	Leptothrix ochracea is a common inhabitant of freshwater iron seeps and iron-rich wetlands. Its defining characteristic is copious production of extracellular sheaths encrusted with iron oxyhydroxides. Surprisingly, over 90% of these sheaths are empty, hence, what appears to be an abundant population of iron-oxidizing bacteria, consists of relatively few cells. Because L. ochracea has proven difficult to cultivate, its identification is based solely on habitat preference and morphology. We utilized cultivation-independent techniques to resolve this long-standing enigma. By selecting the actively growing edge of a Leptothrix-containing iron mat, a conventional SSU rRNA gene clone library was obtained that had 29 clones (42% of the total library) related to the Leptothrix/Sphaerotilus group (<= 96% identical to cultured representatives). A pyrotagged library of the V4 hypervariable region constructed from the bulk mat showed that 7.2% of the total sequences also belonged to the Leptothrix/Sphaerotilus group. Sorting of individual L. ochracea sheaths, followed by whole genome amplification (WGA) and PCR identified a SSU rRNA sequence that clustered closely with the putative Leptothrix clones and pyrotags. Using these data, a fluorescence in-situ hybridization (FISH) probe, Lepto175, was designed that bound to ensheathed cells. Quantitative use of this probe demonstrated that up to 35% of microbial cells in an actively accreting iron mat were L. ochracea. The SSU rRNA gene of L. ochracea shares 96% homology with its closet cultivated relative, L. cholodnii, This establishes that L. ochracea is indeed related to this group of morphologically similar, filamentous, sheathed microorganisms.	[Fleming, Emily J.; Langdon, Amy E.; Martinez-Garcia, Manuel; Stepanauskas, Ramunas; Poulton, Nicole J.; Masland, E. Dashiell P.; Emerson, David] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Langdon, Amy E.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	Bigelow Laboratory for Ocean Sciences; Swarthmore College	Fleming, EJ (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA.	efleming@bigelow.org	t, lf/AAJ-4924-2020; Fleming, Emily/I-8927-2012; Martínez-García, Manuel/AAT-1935-2021	Martínez-García, Manuel/0000-0001-5056-1525; Stepanauskas, Ramunas/0000-0003-4458-3108; Langdon, Amy/0000-0002-0797-8939; Poulton, Nicole/0000-0003-3020-4509	NSF [IOS 0951077]; NASA Astrobiology Institute; Swarthmore College; NSF MRI [OCE-821374, OCE-1019242]; Maine Technology Institute; NSF SGER [EF-0633142, MCB-738232]; Division Of Integrative Organismal Systems [0951077] Funding Source: National Science Foundation; Division Of Ocean Sciences [0755142] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA Astrobiology Institute; Swarthmore College; NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); Maine Technology Institute; NSF SGER(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	EJF and DE were funded in part by NSF grant IOS 0951077 (http://www.nsf.gov/) and the NASA Astrobiology Institute (http://astrobiology.nasa.gov/nai/). AEL was funded by Bigelow Laboratory NSF REU program and a Swarthmore College summer HHMI grant (http://www.swarthmore.edu/hhmi.xml). Instrumentation and infrastructure for the Bigelow Laboratory Single Cell Genomics Center were sponsored by the NSF MRI grants OCE-821374 and OCE-1019242 to RS and by the Maine Technology Institute (http://www.mainetechnology.org/). The development of single cell genomics methods was supported by NSF SGER grants EF-0633142 and MCB-738232 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; ADAMS LF, 1987, J BACTERIOL, V169, P1279, DOI 10.1128/jb.169.3.1279-1285.1987; ADAMS LF, 1985, APPL ENVIRON MICROB, V49, P556, DOI 10.1128/AEM.49.3.556-562.1985; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Blothe M, 2009, APPL ENVIRON MICROB, V75, P468, DOI 10.1128/AEM.01817-08; Bruun AM, 2010, GEOMICROBIOL J, V27, P15, DOI 10.1080/01490450903232165; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CORSTJENS P, 1993, SYST APPL MICROBIOL, V16, P219; CORSTJENS PLAM, 1992, APPL ENVIRON MICROB, V58, P450, DOI 10.1128/AEM.58.2.450-454.1992; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Duckworth OW, 2009, CHEM GEOL, V260, P149, DOI 10.1016/j.chemgeo.2008.08.027; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson D, 2005, METHOD ENZYMOL, V397, P112, DOI 10.1016/S0076-6879(05)97006-7; Emerson D, 2004, GEOMICROBIOL J, V21, P405, DOI 10.1080/01490450490485881; EMERSON D, 1994, APPL ENVIRON MICROB, V60, P4022, DOI 10.1128/AEM.60.11.4022-4031.1994; EMERSON D, 1997, APPL ENVIRON MICROB, V68, P3085; EMERSON D, 1994, APPL ENVIRON MICROB, P4032; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Fuchs BM., 2007, METHODS GEN MOL MICR, V5, P886; GHIORSE WC, 1984, ANNU REV MICROBIOL, V38, P515, DOI 10.1146/annurev.mi.38.100184.002503; GHIORSE WC, 1993, CATENA S21, V21; Haaijer SCM, 2008, ISME J, V2, P1231, DOI 10.1038/ismej.2008.75; HALLBECK L, 1991, J GEN MICROBIOL, V137, P2657, DOI 10.1099/00221287-137-11-2657; Harder EC, 1915, SCIENCE, V42, P310, DOI 10.1126/science.42.1079.310; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Katsoylannis IA, 2006, WATER QUAL RES J CAN, V41, P117, DOI 10.2166/wqrj.2006.014; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; KUTZING FT, 1843, PHYCOLOGIA GEN ORDER; LANE DJ, 1992, J BACTERIOL, V174, P269, DOI 10.1128/jb.174.1.269-278.1992; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Langley S, 2009, CHEM GEOL, V262, P217, DOI 10.1016/j.chemgeo.2009.01.019; Little BJ., 2007, MICROBIOLOGICALLY IN; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; MOUCHET P, 1992, J AM WATER WORKS ASS, V84, P158; MULDER EG, 1963, ANTON VAN LEE J M S, V29, P121, DOI 10.1007/BF02046045; MULDER EG, 1964, J APPL BACTERIOL, V27, P151, DOI 10.1111/j.1365-2672.1964.tb04824.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Neubauer SC, 2002, APPL ENVIRON MICROB, V68, P3988, DOI 10.1128/AEM.68.8.3988-3995.2002; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Polz MF, 2003, BIOL BULL-US, V204, P196, DOI 10.2307/1543558; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rentz JA, 2009, WATER RES, V43, P2029, DOI 10.1016/j.watres.2009.02.021; Roden EE, 2004, GEOMICROBIOL J, V21, P379, DOI 10.1080/01490450490485872; Schauer M, 2005, APPL ENVIRON MICROB, V71, P1931, DOI 10.1128/AEM.71.4.1931-1940.2005; Siering PL, 1997, APPL ENVIRON MICROB, V63, P644, DOI 10.1128/AEM.63.2.644-651.1997; Siering PL, 1996, INT J SYST BACTERIOL, V46, P173, DOI 10.1099/00207713-46-1-173; Spring S, 2004, INT J SYST EVOL MICR, V54, P99, DOI 10.1099/ijs.0.02727-0; SPRING S, 2006, BERGEYS MANUAL DETER, P740; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; STOKES JL, 1954, J BACTERIOL, V67, P278, DOI 10.1128/JB.67.3.278-291.1954; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Thomsen TR, 2002, ENVIRON MICROBIOL, V4, P383, DOI 10.1046/j.1462-2920.2002.00316.x; VANVEEN WL, 1978, MICROBIOL REV, V42, P329, DOI 10.1128/MMBR.42.2.329-356.1978; WALLNER G, 1995, APPL ENVIRON MICROB, V61, P1859, DOI 10.1128/AEM.61.5.1859-1866.1995; Wallner G, 1997, APPL ENVIRON MICROB, V63, P4223, DOI 10.1128/AEM.63.11.4223-4231.1997; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P65, DOI 10.1099/00207713-41-1-65; Winogradsky S., 1888, BOTANISHE ZEITUNG, V46, P261; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995	67	78	84	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17769	10.1371/journal.pone.0017769	http://dx.doi.org/10.1371/journal.pone.0017769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437234	gold, Green Published, Green Submitted			2022-12-25	WOS:000288514600013
J	Zhang, JS; Ye, JM; Altafaj, A; Cardona, M; Bahi, N; Llovera, M; Canas, X; Cook, SA; Comella, JX; Sanchis, D				Zhang, Jisheng; Ye, Junmei; Altafaj, Albert; Cardona, Maria; Bahi, Nuria; Llovera, Marta; Canas, Xavier; Cook, Stuart A.; Comella, Joan X.; Sanchis, Daniel			EndoG Links Bnip3-Induced Mitochondrial Damage and Caspase-Independent DNA Fragmentation in Ischemic Cardiomyocytes	PLOS ONE			English	Article							CARDIAC MYOCYTE DEATH; CELL-DEATH; ENDONUCLEASE-G; GENE-TRANSFER; BNIP3; APOPTOSIS; EXPRESSION; HYPOXIA; HEART; PROTECTS	Mitochondrial dysfunction, caspase activation and caspase-dependent DNA fragmentation are involved in cell damage in many tissues. However, differentiated cardiomyocytes repress the expression of the canonical apoptotic pathway and their death during ischemia is caspase-independent. The atypical BH3-only protein Bnip3 is involved in the process leading to caspase-independent DNA fragmentation in cardiomyocytes. However, the pathway by which DNA degradation ensues following Bnip3 activation is not resolved. To identify the mechanism involved, we analyzed the interdependence of Bnip3, Nix and EndoG in mitochondrial damage and DNA fragmentation during experimental ischemia in neonatal rat ventricular cardiomyocytes. Our results show that the expression of EndoG and Bnip3 increases in the heart throughout development, while the caspase-dependent machinery is silenced. TUNEL-positive DNA damage, which depends on caspase activity in other cells, is caspase-independent in ischemic cardiomyocytes and ischemia-induced DNA high and low molecular weight fragmentation is blocked by repressing EndoG expression. Ischemia-induced EndoG translocation and DNA degradation are prevented by silencing the expression of Bnip3, but not Nix, or by overexpressing Bcl-x(L). These data establish a link between Bnip3 and EndoG-dependent, TUNEL-positive, DNA fragmentation in ischemic cardiomyocytes in the absence of caspases, defining an alternative cell death pathway in postmitotic cells.	[Zhang, Jisheng; Ye, Junmei; Cardona, Maria; Bahi, Nuria; Llovera, Marta; Sanchis, Daniel] Columbia Univ, Irving Comprehens Canc Ctr, Med Ctr, New York, NY 10027 USA; [Zhang, Jisheng; Ye, Junmei; Cardona, Maria; Bahi, Nuria; Llovera, Marta; Sanchis, Daniel] Univ Lleida, Inst Recerca Biomed Lleida IRBLLEIDA, Lleida, Spain; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, London, England; [Comella, Joan X.] UAB, Hosp Vall Hebro, Inst Neurociencies, Ciberned, Barcelona, Spain	Columbia University; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Autonomous University of Barcelona; CIBERNED; Hospital Universitari Vall d'Hebron	Zhang, JS (corresponding author), Columbia Univ, Irving Comprehens Canc Ctr, Med Ctr, New York, NY 10027 USA.	daniel.sanchis@cmb.udl.cat	Zhang, Jisheng/AAT-6495-2020; Pla, Nuria Bahi/B-8022-2009; Llovera, Marta/B-5585-2009; Llovera, Marta/AAE-4230-2021; Comella, Joan/GQA-4279-2022; Cook, Stuart/G-9567-2011; Zhang, Jisheng/A-1928-2010; Cañas, Xavier/D-7656-2015; Sanchis, Daniel/C-8077-2009; Comella, Joan X/D-7333-2012; Bahi, Nuria/ABE-9680-2021	Pla, Nuria Bahi/0000-0003-2845-0313; Llovera, Marta/0000-0001-8399-6867; Cañas, Xavier/0000-0002-0512-2248; Sanchis, Daniel/0000-0003-0047-8533; Comella, Joan X/0000-0002-6218-0786; Bahi, Nuria/0000-0003-2845-0313; Cook, Stuart/0000-0001-6628-194X	Ministry of Science and Innovation of Spain [SAF2005-02197, SAF2008-02271]; Government of Catalonia (AGAUR) [SGR2005-00628]; Spanish Government; Instituto de Salud Carlos III -Ministerio de Sanidad y Consumo (FIS) [PI04/2537, PS09/00140]; Ministry of Education and Science of Spain; Universitat de Lleida; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; MRC [MC_U120085815] Funding Source: UKRI	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Catalonia (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Spanish Government(Spanish GovernmentEuropean Commission); Instituto de Salud Carlos III -Ministerio de Sanidad y Consumo (FIS)(Instituto de Salud Carlos III); Ministry of Education and Science of Spain(Spanish Government); Universitat de Lleida; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Ministry of Science and Innovation of Spain (SAF2005-02197 and SAF2008-02271) to DS and Programa de Suport a Grups de Recerca de Catalunya from the Government of Catalonia (AGAUR) (SGR2005-00628) and Ciberned from the Spanish Government to JXC, Instituto de Salud Carlos III -Ministerio de Sanidad y Consumo (FIS) (PI04/2537 and PS09/00140) to ML. JZ was recipient of a pre-doctoral fellowship (FPI program) from the Ministry of Education and Science of Spain and JY is recipient of a fellowship from the Universitat de Lleida. URLs: Ministry of Science and Innovation of Spain: http://www.micinn.es; AGAUR: http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp; Ministry of Education: http://www.educacion.es/portada.html; Instituto de Salud Carlos III: http://www.isciii.es/htdocs/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Chatterjee S, 2002, CIRCULATION, V106, pI212, DOI 10.1161/01.cir.0000032907.33237.55; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; French CJ, 2009, FASEB J, V23, P1177, DOI 10.1096/fj.08-116509; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; GERSCHENSON M, 1995, NUCLEIC ACIDS RES, V23, P88, DOI 10.1093/nar/23.1.88; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Huang JH, 2003, BIOCHEM BIOPH RES CO, V311, P64, DOI 10.1016/j.bbrc.2003.09.160; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Nakagawa Y, 2009, CIRC RES, V105, P746, DOI 10.1161/CIRCRESAHA.109.206037; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ohno M, 1998, CIRCULATION, V98, P1422, DOI 10.1161/01.CIR.98.14.1422; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Saraste A, 1997, CIRCULATION, V95, P320; Sowter HM, 2001, CANCER RES, V61, P6669; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; Zhang JS, 2007, FEBS LETT, V581, P5781, DOI 10.1016/j.febslet.2007.11.046; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129; Zhao ST, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-113	43	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17998	10.1371/journal.pone.0017998	http://dx.doi.org/10.1371/journal.pone.0017998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437288	Green Published, gold, Green Submitted			2022-12-25	WOS:000288514600021
J	French, SS; Gonzalez-Suarez, M; Young, JK; Durham, S; Gerber, LR				French, Susannah S.; Gonzalez-Suarez, Manuela; Young, Julie K.; Durham, Susan; Gerber, Leah R.			Human Disturbance Influences Reproductive Success and Growth Rate in California Sea Lions (Zalophus californianus)	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; STRESS-RESPONSE; BODY-SIZE; CORTICOSTERONE; PATTERNS; EXPOSURE; PENGUINS; IMMUNITY; BEHAVIOR; HORMONE	The environment is currently undergoing changes at both global (e. g., climate change) and local (e. g., tourism, pollution, habitat modification) scales that have the capacity to affect the viability of animal and plant populations. Many of these changes, such as human disturbance, have an anthropogenic origin and therefore may be mitigated by management action. To do so requires an understanding of the impact of human activities and changing environmental conditions on population dynamics. We investigated the influence of human activity on important life history parameters (reproductive rate, and body condition, and growth rate of neonate pups) for California sea lions (Zalophus californianus) in the Gulf of California, Mexico. Increased human presence was associated with lower reproductive rates, which translated into reduced long-term population growth rates and suggested that human activities are a disturbance that could lead to population declines. We also observed higher body growth rates in pups with increased exposure to humans. Increased growth rates in pups may reflect a density dependent response to declining reproductive rates (e. g., decreased competition for resources). Our results highlight the potentially complex changes in life history parameters that may result from human disturbance, and their implication for population dynamics. We recommend careful monitoring of human activities in the Gulf of California and emphasize the importance of management strategies that explicitly consider the potential impact of human activities such as ecotourism on vertebrate populations.	[French, Susannah S.; Durham, Susan] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [French, Susannah S.; Durham, Susan] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Gonzalez-Suarez, Manuela; Young, Julie K.; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Gonzalez-Suarez, Manuela] Univ Paris 06, CNRS, Lab Ecol & Evolut, UMR 7625, Paris, France	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	French, SS (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	sfrench@biology.usu.edu	González-Suárez, Manuela/B-9740-2008	González-Suárez, Manuela/0000-0001-5069-8900; Young, Julie/0000-0003-4522-0157; Gerber, Leah/0000-0002-6763-6842	National Science Foundation [0347960]; European Community [235897]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS]	National Science Foundation(National Science Foundation (NSF)); European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by a grant to LRG from the National Science Foundation (Animal Behavior, Biological Oceanography, and International Programs; Award # 0347960; www.nsf.gov) and a grant to MGS by the European Community's Seventh Framework Programme (FP7/2007-2013; http://cordis.europa.eu/fp7) under grant agreement nu 235897, and the Spanish Ministry of Science and Innovation (Project: CGL2009-07301/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; BARLOW SM, 1978, TERATOLOGY, V18, P211, DOI 10.1002/tera.1420180206; Bliese PD, 2002, ORGAN RES METHODS, V5, P362, DOI 10.1177/109442802237116; BONESS DJ, 1991, PINNIPEDS EL NINO RE, P173; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Carabias-Lillo J, 2000, PROGRAMA MANEJO AREA; CASTELLINI MA, 1993, MAR MAMMAL SCI, V9, P48, DOI 10.1111/j.1748-7692.1993.tb00425.x; CASTELLINI MA, 1990, MAR MAMMAL SCI, V6, P75, DOI 10.1111/j.1748-7692.1990.tb00227.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Crone EE, 2001, EVOLUTION, V55, P2611; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Demas GE, 2003, P ROY SOC B-BIOL SCI, V270, P905, DOI 10.1098/rspb.2003.2341; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Dendrinos P, 2007, MAR MAMMAL SCI, V23, P615, DOI 10.1111/j.1748-7692.2007.00121.x; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Flather Curtis H., 1995, P3; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; Garcia-Aguilar Maria Concepcion, 2003, Aquatic Mammals, V29, P67, DOI 10.1578/016754203101024086; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Gonzalez-Suarez M, 2006, ANIM CONSERV, V9, P219, DOI 10.1111/j.1469-1795.2006.00022.x; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Gonzalez-Suarez M, 2008, J MAMMAL, V89, P1521, DOI 10.1644/08-MAMM-A-109.1; HARRINGTON FH, 1992, ARCTIC, V45, P213; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hurlbert SH, 2009, ANN ZOOL FENN, V46, P311, DOI 10.5735/086.046.0501; Jacobs DF, 2008, J MAMMAL, V89, P1212, DOI 10.1644/07-MAMM-A-171.1; KENYON KW, 1972, J MAMMAL, V53, P687, DOI 10.2307/1379207; Kight CR, 2007, BIOL CONSERV, V138, P189, DOI 10.1016/j.biocon.2007.04.014; Labrada-Martagon Vanessa, 2005, Latin American Journal of Aquatic Mammals, V4, P175; LABRADAMARTAGON V, 2003, INFLUENCIA TURISMO C; le Boeuf B.J., 1983, Proceedings of the California Academy of Sciences, V43, P77; Lourdais O, 2003, J ZOOL, V259, P123, DOI 10.1017/S0952836902003059; Luque SP, 2001, MAR MAMMAL SCI, V17, P147, DOI 10.1111/j.1748-7692.2001.tb00985.x; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Ono KA, 1996, BEHAV ECOL SOCIOBIOL, V38, P31, DOI 10.1007/s002650050214; Pauli JN, 2007, J APPL ECOL, V44, P1219, DOI 10.1111/j.1365-2664.2007.01337.x; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; PICKERING AD, 1991, GEN COMP ENDOCR, V83, P86, DOI 10.1016/0016-6480(91)90108-I; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Robertson KL, 2008, CAN J ZOOL, V86, P237, DOI 10.1139/Z07-136; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Romero LM, 2002, BIOL CONSERV, V108, P371, DOI 10.1016/S0006-3207(02)00128-3; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Salvante KG, 2003, GEN COMP ENDOCR, V130, P205, DOI 10.1016/S0016-6480(02)00637-8; SEGGIE JA, 1975, CAN J PHYSIOL PHARM, V53, P629, DOI 10.1139/y75-087; Szteren D, 2006, LOW WAKE FI, P369; Taylor EN, 2005, OECOLOGIA, V144, P206, DOI 10.1007/s00442-005-0056-x; Tershy BR, 1997, ENVIRON CONSERV, V24, P261, DOI 10.1017/S0376892997000349; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/revreprod/5.2.105; *UNESCO, UNESCO DEC 29COM 8B; VELARDE E, 1994, ICBP TECHNICAL PUBLI, P229; Walker BG, 2006, CONSERV BIOL, V20, P146, DOI 10.1111/j.1523-1739.2005.00271.x; Walker BG, 2005, CONSERV BIOL, V19, P1571, DOI 10.1111/j.1523-1739.2005.00104.x; WHITE CM, 1985, CONDOR, V87, P14, DOI 10.2307/1367125; Wielgus J, 2008, ECOL APPL, V18, P1287, DOI 10.1890/07-0892.1; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; YARMOLOY C, 1988, CAN FIELD NAT, V102, P425; Young JK, 2008, BEHAVIOUR, V145, P1797, DOI 10.1163/156853908786279646	66	59	61	0	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17686	10.1371/journal.pone.0017686	http://dx.doi.org/10.1371/journal.pone.0017686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436887	Green Published, gold			2022-12-25	WOS:000288514000006
J	Lu, HY; Liu, XF; Wei, SP; Zhang, YM				Lue, Hai-Yan; Liu, Xiao-Fen; Wei, Shi-Ping; Zhang, Yuan-Ming			Epistatic Association Mapping in Homozygous Crop Cultivars	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MARKER-ASSISTED SELECTION; HASEMAN-ELSTON REGRESSION; INBRED LINES; POPULATION-STRUCTURE; GENETIC ASSOCIATION; VARIANCE-COMPONENTS; MOLECULAR MARKERS; GENERAL PEDIGREES; LINKAGE ANALYSIS	The genetic dissection of complex traits plays a crucial role in crop breeding. However, genetic analysis and crop breeding have heretofore been performed separately. In this study, we designed a new approach that integrates epistatic association analysis in crop cultivars with breeding by design. First, we proposed an epistatic association mapping (EAM) approach in homozygous crop cultivars. The phenotypic values of complex traits, along with molecular marker information, were used to perform EAM. In our EAM, all the main-effect quantitative trait loci (QTLs), environmental effects, QTL-by-environment interactions and QTL-by-QTL interactions were included in a full model and estimated by empirical Bayes approach. A series of Monte Carlo simulations was performed to confirm the reliability of the new method. Next, the information from all detected QTLs was used to mine novel alleles for each locus and to design elite cross combination. Finally, the new approach was adopted to dissect the genetic basis of seed length in 215 soybean cultivars obtained, by stratified random sampling, from 6 geographic ecotypes in China. As a result, 19 main-effect QTLs and 3 epistatic QTLs were identified, more than 10 novel alleles were mined and 3 elite parental combinations, such as Daqingdou and Zhengzhou790034, were predicted.	[Lue, Hai-Yan; Liu, Xiao-Fen; Wei, Shi-Ping; Zhang, Yuan-Ming] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Sect Stat Gen, Nanjing, Jiangsu, Peoples R China; [Lue, Hai-Yan] Henan Agr Univ, Coll Informat & Management Sci, Zhengzhou, Henan, Peoples R China	Nanjing Agricultural University; Henan Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Sect Stat Gen, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AAT-2899-2021; Zhang, Yuan-Ming/AFQ-8637-2022	Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109300]; National Natural Science Foundation of China [30971848, 30671333]; Fundamental Research Funds for the Central Universities [KYT201002]; 111 Project [B08025]; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funding: This work was supported by grant 2011CB109300 from the National Basic Research Program of China, grants 30971848 and 30671333 from the National Natural Science Foundation of China, grant KYT201002 from the Fundamental Research Funds for the Central Universities, grant B08025 from the 111 Project, and grant 20100097110035 from Specialized Research Fund for the Doctoral Program of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AM, 2001, THEOR APPL GENET, V102, P222, DOI 10.1007/s001220051639; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen WM, 2004, GENET EPIDEMIOL, V26, P265, DOI 10.1002/gepi.10315; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; CHO YG, 1994, THEOR APPL GENET, V89, P54, DOI 10.1007/BF00226982; Diao G, 2005, AM J HUM GENET, V77, P97, DOI 10.1086/431683; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Dong YS, 2001, THEOR APPL GENET, V103, P98, DOI 10.1007/s001220000522; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Dwivedi SL, 2007, ADV AGRON, V95, P163, DOI 10.1016/S0065-2113(07)95003-8; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; Friesen ML, 2010, CURR OPIN PLANT BIOL, V13, P119, DOI 10.1016/j.pbi.2009.11.003; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; He XH, 2008, HEREDITY, V101, P39, DOI 10.1038/hdy.2008.23; He XH, 2011, THEOR APPL GENET, V122, P33, DOI 10.1007/s00122-010-1420-8; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; HOLLAND JB, 2004, P 4 INT CROP SCI C 2; Hoti F, 2006, HEREDITY, V97, P4, DOI 10.1038/sj.hdy.6800817; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Iwata H, 2009, THEOR APPL GENET, V118, P865, DOI 10.1007/s00122-008-0945-6; Jahufer MZZ, 2002, AUST J AGR RES, V53, P239, DOI 10.1071/AR01110; [李灿东 Li Candong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1091; Li MY, 2010, BIOINFORMATICS, V26, P798, DOI 10.1093/bioinformatics/btq025; Liang HZ, 2008, HENAN AGR SCI, V45, P54; Lipp M, 1999, J AOAC INT, V82, P923; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Lu HY, 2009, HEREDITY, V103, P346, DOI 10.1038/hdy.2009.66; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Peleman JD, 2003, TRENDS PLANT SCI, V8, P330, DOI 10.1016/S1360-1385(03)00134-1; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2005, THEOR APPL GENET, V111, P906, DOI 10.1007/s00122-005-0016-1; Ribaut JM, 1999, MOL BREEDING, V5, P531, DOI 10.1023/A:1009631718036; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Salas P, 2006, THEOR APPL GENET, V113, P1459, DOI 10.1007/s00122-006-0392-1; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sax K, 1923, GENETICS, V8, P552; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; SMOUSE PE, 1990, CAN J FISH AQUAT SCI, V47, P620, DOI 10.1139/f90-070; STUBER CW, 1995, TRENDS GENET, V11, P477, DOI 10.1016/S0168-9525(00)89156-8; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; Wan X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-13; Wang T, 2005, GENET EPIDEMIOL, V29, P12, DOI 10.1002/gepi.20075; WANG YS, 2002, CHIN J APPL ECOL, V13, P71; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; ZHANG XQ, 2002, CHINESE ACAD CANON 2, P25; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zhang YM, 2008, THEOR APPL GENET, V117, P683, DOI 10.1007/s00122-008-0809-0; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863	71	38	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17773	10.1371/journal.pone.0017773	http://dx.doi.org/10.1371/journal.pone.0017773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423630	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900028
J	Manji, SSM; Williams, LH; Miller, KA; Ooms, LM; Bahlo, M; Mitchell, CA; Dahl, HHM				Manji, Shehnaaz S. M.; Williams, Louise H.; Miller, Kerry A.; Ooms, Lisa M.; Bahlo, Melanie; Mitchell, Christina A.; Dahl, Hans-Henrik M.			A Mutation in Synaptojanin 2 Causes Progressive Hearing Loss in the ENU-Mutagenised Mouse Strain Mozart	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 5-PHOSPHATASES; HAIR-CELLS; TARGETED DISRUPTION; SUPPORTING CELLS; PHOSPHATASE; PHOSPHOINOSITIDES; MECHANISM; COCHLEA; MICE; INS(1,4,5)P-3	Background: Hearing impairment is the most common sensory impairment in humans, affecting 1:1,000 births. We have identified an ENU generated mouse mutant, Mozart, with recessively inherited, non-syndromic progressive hearing loss caused by a mutation in the synaptojanin 2 (Synj2), a central regulatory enzyme in the phosphoinositide-signaling cascade. Methodology/Principal Findings: The hearing loss in Mozart is caused by a p.Asn538Lys mutation in the catalytic domain of the inositol polyphosphate 5-phosphatase synaptojanin 2. Within the cochlea, Synj2 mRNA expression was detected in the inner and outer hair cells but not in the spiral ganglion. Synj2(N538K) mutant protein showed loss of lipid phosphatase activity, and was unable to degrade phosphoinositide signaling molecules. Mutant Mozart mice (Synj2(N538K/N538K)) exhibited progressive hearing loss and showed signs of hair cell degeneration as early as two weeks of age, with fusion of stereocilia followed by complete loss of hair bundles and ultimately loss of hair cells. No changes in vestibular or neurological function, or other clinical or behavioral manifestations were apparent. Conclusions/Significance: Phosphoinositides are membrane associated signaling molecules that regulate many cellular processes including cell death, proliferation, actin polymerization and ion channel activity. These results reveal Synj2 as a critical regulator of hair cell survival that is essential for hair cell maintenance and hearing function.	[Manji, Shehnaaz S. M.; Williams, Louise H.; Miller, Kerry A.; Dahl, Hans-Henrik M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Melbourne Hosp, Dept Pediat, Parkville, Vic, Australia; [Ooms, Lisa M.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat, Parkville, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; University of Melbourne; Monash University; Walter & Eliza Hall Institute	Manji, SSM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	hdahl@bigpond.net.au	Ooms, Lisa/AGZ-7420-2022	Ooms, Lisa Michelle/0000-0002-8918-9932; Mitchell, Christina A/0000-0001-9372-3192; Bahlo, Melanie/0000-0001-5132-0774	HEARingCRC; NHMRC [284550, 436944]; J. & J. Calvert-Jones	HEARingCRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. & J. Calvert-Jones	This work was supported by the The HEARingCRC, NHMRC Project grants 284550 and 436944, and by J. & J. Calvert-Jones. HHMD is a NHMRC Principal Research Fellow (ID 334313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwardt BA, 2001, J NEUROSCI, V21, P2330, DOI 10.1523/JNEUROSCI.21-07-02330.2001; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; Astle MV, 2006, IUBMB LIFE, V58, P451, DOI 10.1080/15216540600871159; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bruzzone R, 2005, NAT CELL BIOL, V7, P14, DOI 10.1038/ncb0105-14; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hellsten E, 2002, BIOL REPROD, V66, P1522, DOI 10.1095/biolreprod66.5.1522; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Jiang H, 2006, J NEUROCHEM, V99, P269, DOI 10.1111/j.1471-4159.2006.04117.x; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Khvotchev M, 1998, J BIOL CHEM, V273, P2306, DOI 10.1074/jbc.273.4.2306; Kim CH, 1999, J CLIN INVEST, V104, P1751, DOI 10.1172/JCI7310; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lesniak W, 2005, CHEM RES TOXICOL, V18, P357, DOI 10.1021/tx0496946; Maison SF, 2006, J NEUROSCI, V26, P10315, DOI 10.1523/JNEUROSCI.2395-06.2006; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Mitchell CA, 2002, IUBMB LIFE, V53, P25, DOI 10.1080/15216540210815; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Ooms Lisa M., 2009, V462, P223, DOI 10.1007/978-1-60327-115-8_15; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; SCHACHT J, 1986, HEARING RES, V22, P297, DOI 10.1016/0378-5955(86)90105-X; Schimenti JC, 2005, P NATL ACAD SCI USA, V102, P3342, DOI 10.1073/pnas.0407970102; Sha SH, 2010, HEARING RES, V264, P86, DOI 10.1016/j.heares.2009.09.002; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Volpicelli-Daley L, 2007, NAT MED, V13, P784, DOI 10.1038/nm0707-784; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Whisstock JC, 2000, J BIOL CHEM, V275, P37055, DOI 10.1074/jbc.M006244200; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102	62	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17607	10.1371/journal.pone.0017607	http://dx.doi.org/10.1371/journal.pone.0017607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423608	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900013
J	Su, TX; Das, SK; Xiao, M; Purohit, PK				Su, Tianxiang; Das, Somes K.; Xiao, Ming; Purohit, Prashant K.			Transition between Two Regimes Describing Internal Fluctuation of DNA in a Nanochannel	PLOS ONE			English	Article							NANOFLUIDIC CHANNELS; SINGLE-MOLECULE; STATISTICS; DYNAMICS; CONFINEMENT; MECHANICS; POLYMERS; TUBE	We measure the thermal fluctuation of the internal segments of a piece of DNA confined in a nanochannel about 50-100 nm wide. This local thermodynamic property is key to accurate measurement of distances in genomic analysis. For DNA in similar to 100 nm channels, we observe a critical length scale similar to 10 mu m for the mean extension of internal segments, below which the de Gennes' theory describes the fluctuations with no fitting parameters, and above which the fluctuation data falls into Odijk's deflection theory regime. By analyzing the probability distributions of the extensions of the internal segments, we infer that folded structures of length 150-250 nm, separated by similar to 10 mu m exist in the confined DNA during the transition between the two regimes. For similar to 50 nm channels we find that the fluctuation is significantly reduced since the Odijk regime appears earlier. This is critical for genomic analysis. We further propose a more detailed theory based on small fluctuations and incorporating the effects of confinement to explicitly calculate the statistical properties of the internal fluctuations. Our theory is applicable to polymers with heterogeneous mechanical properties confined in non-uniform channels. We show that existing theories for the end-to-end extension/fluctuation of polymers can be used to study the internal fluctuations only when the contour length of the polymer is many times larger than its persistence length. Finally, our results suggest that introducing nicks in the DNA will not change its fluctuation behavior when the nick density is below 1 nick per kbp DNA.	[Su, Tianxiang; Purohit, Prashant K.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Das, Somes K.; Xiao, Ming] BioNanomatrix Inc, Philadelphia, PA USA	University of Pennsylvania	Su, TX (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	purohit@seas.upenn.edu	Xiao, Ming/E-7448-2012		NSF [CMMI-0953548]; Nano/Bio Interface Center at the University of Pennsylvania [NSF NSEC DMR08-32802]	NSF(National Science Foundation (NSF)); Nano/Bio Interface Center at the University of Pennsylvania	Mr. Tianxiang Su is supported by the start-up funds of Dr. Prashant K. Purohit. Dr. S. K. Das and Dr. M. Xiao are employees of the commercial company BioNanomatrix. Dr. Prashant K. Purohit acknowledges partial support from grant NSF CMMI-0953548 and the Nano/Bio Interface Center at the University of Pennsylvania through grant NSF NSEC DMR08-32802. Funder's role: The experiments were carried out at the premises of BioNanomatrix.	Bonthuis DJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108303; Burkhardt TW, 1997, J PHYS A-MATH GEN, V30, pL167, DOI 10.1088/0305-4470/30/7/004; Cao H, 2002, APPL PHYS LETT, V81, P174, DOI 10.1063/1.1489102; Cao H, 2002, APPL PHYS LETT, V81, P3058, DOI 10.1063/1.1515115; Cifra P, 2008, FARADAY DISCUSS, V139, P377, DOI 10.1039/b716546c; DAOUD M, 1977, J PHYS-PARIS, V38, P85, DOI 10.1051/jphys:0197700380108500; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; DEGENNES PG, 1979, SCALING CONCEPTS POL, pCH3; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Douville N, 2008, ANAL BIOANAL CHEM, V391, P2395, DOI 10.1007/s00216-008-1995-y; Jun S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.138101; Jung Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061912; ODIJK T, 1983, MACROMOLECULES, V16, P1340, DOI 10.1021/ma00242a015; Odijk T, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400227; Odijk T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060901; Persson F, 2010, CHEM SOC REV, V39, P985, DOI 10.1039/b912918a; Persson F, 2009, SMALL, V5, P190, DOI 10.1002/smll.200800423; Purohita PK, 2008, INT J NONLIN MECH, V43, P1056, DOI 10.1016/j.ijnonlinmec.2008.05.009; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; Reisner W, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058302; Riehn R, 2005, P NATL ACAD SCI USA, V102, P10012, DOI 10.1073/pnas.0503809102; SCHAEFER DW, 1980, MACROMOLECULES, V13, P1280, DOI 10.1021/ma60077a048; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; Su TX, 2010, J MECH PHYS SOLIDS, V58, P164, DOI 10.1016/j.jmps.2009.10.007; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Wang J, 2007, J MATER SCI, V42, P8838, DOI 10.1007/s10853-007-1846-9; Wang YM, 2005, P NATL ACAD SCI USA, V102, P9796, DOI 10.1073/pnas.0502917102; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Yang YZ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011804; Zhang YL, 2003, BIOPHYS J, V84, P136, DOI 10.1016/S0006-3495(03)74838-3	30	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e16890	10.1371/journal.pone.0016890	http://dx.doi.org/10.1371/journal.pone.0016890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423606	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900005
J	Giagulli, C; Marsico, S; Magiera, AK; Bruno, R; Caccuri, F; Barone, I; Fiorentini, S; Ando, S; Caruso, A				Giagulli, Cinzia; Marsico, Stefania; Magiera, Anna K.; Bruno, Rosalinda; Caccuri, Francesca; Barone, Ines; Fiorentini, Simona; Ando, Sebastiano; Caruso, Arnaldo			Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells	PLOS ONE			English	Article							MATRIX PROTEIN P17; VIRUS; PHOSPHORYLATION; BINDING; PATHWAY; CANCER; PROLIFERATION; MECHANISMS; ANTIBODIES; INHIBITOR	The HIV-1 matrix protein p17 is a structural protein that can act in the extracellular environment to deregulate several functions of immune cells, through the interaction of its NH2-terminal region with a cellular surface receptor (p17R). The intracellular events triggered by p17/p17R interaction have been not completely characterized yet. In this study we analyze the signal transduction pathways induced by p17/p17R interaction and show that in Raji cells, a human B cell line stably expressing p17R on its surface, p17 induces a transient activation of the transcriptional factor AP-1. Moreover, it was found to upregulate pERK1/2 and downregulate pAkt, which are the major intracellular signalling components involved in AP-1 activation. These effects are mediated by the COOH-terminal region of p17, which displays the capability of keeping PTEN, a phosphatase that regulates the PI3K/Akt pathway, in an active state through the serin/threonin (Ser/Thr) kinase ROCK. Indeed, the COOH-terminal truncated form of p17 (p17 Delta 36) induced activation of the PI3K/Akt pathway by maintaining PTEN in an inactive phosphorylated form. Interestingly, we show that among different p17s, a variant derived from a Ugandan HIV-1 strain, named S75X, triggers an activation of PI3K/Akt signalling pathway, and leads to an increased B cell proliferation and malignant transformation. In summary, this study shows the role of the COOH-terminal region in modulating the p17 signalling pathways so highlighting the complexity of p17 binding to and signalling through its receptor(s). Moreover, it provides the first evidence on the presence of a p17 natural variant mimicking the p17 Delta 36-induced signalling in B cells and displaying the capacity of promoting B cell growth and tumorigenesis.	[Giagulli, Cinzia; Caccuri, Francesca; Fiorentini, Simona; Caruso, Arnaldo] Univ Brescia, Dept Expt & Appl Med, Brescia, Italy; [Marsico, Stefania; Bruno, Rosalinda] Univ Calabria, Dept Pharmaco Biol, I-87036 Cosenza, Italy; [Barone, Ines; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87036 Cosenza, Italy; [Magiera, Anna K.] Medestea Res, Turin, Italy	University of Brescia; University of Calabria; University of Calabria	Giagulli, C (corresponding author), Univ Brescia, Dept Expt & Appl Med, Brescia, Italy.	caruso@med.unibs.it	Caruso, Arnaldo/H-7818-2014; Caccuri, Francesca/AAC-1281-2022; MARSICO, Stefania/J-9938-2019	Caccuri, Francesca/0000-0002-1923-9033; MARSICO, Stefania/0000-0003-1598-0526; FIORENTINI, SIMONA/0000-0002-1866-314X; BARONE, Ines/0000-0002-9769-1615; CARUSO, Arnaldo/0000-0001-5178-566X	Italian Ministry of University and Scientific Research; Istituto Superiore di Sanita [40G.16]; Bonino-Pulejo Foundation (Messina, Italy)	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; Bonino-Pulejo Foundation (Messina, Italy)	This work was supported by the Italian Ministry of University and Scientific Research (Programmi di Ricerca di Rilevante Interesse Nazionale projects) and Istituto Superiore di Sanita (AIDS Grant 40G.16). This work was also supported in part by the Bonino-Pulejo Foundation (Messina, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey NB, 2000, CANCER RES, V60, P35; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; BUDKA H, 1990, ACTA NEUROPATHOL, V79, P611, DOI 10.1007/BF00294238; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2008, VACCINE, V26, P4758, DOI 10.1016/j.vaccine.2008.06.082; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gucalp A, 2010, CURR OPIN HEMATOL, V17, P362, DOI 10.1097/MOH.0b013e328338f6b6; Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li L, 2005, PROSTATE CANCER P D, V8, P108, DOI 10.1038/sj.pcan.4500776; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Marini E, 2008, CELL MICROBIOL, V10, P655, DOI 10.1111/j.1462-5822.2007.01073.x; Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Tiberio GAM, 2007, HEPATO-GASTROENTEROL, V54, P878; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Meili R, 2005, NAT CELL BIOL, V7, P334, DOI 10.1038/ncb0405-334; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; PAPSIDERO LD, 1989, J VIROL, V63, P267, DOI 10.1128/JVI.63.1.267-272.1989; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shin S, 2009, MOL CANCER RES, V7, P745, DOI 10.1158/1541-7786.MCR-08-0462; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Tiberio L, 2006, CYTOKINE, V34, P131, DOI 10.1016/j.cyto.2006.04.009; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vandergeeten C, 2007, BIOCHEM PHARMACOL, V73, P1738, DOI 10.1016/j.bcp.2007.02.011; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009; Vitale M, 2003, BRIT J HAEMATOL, V120, P337, DOI 10.1046/j.1365-2141.2003.04053.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587	58	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17831	10.1371/journal.pone.0017831	http://dx.doi.org/10.1371/journal.pone.0017831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423810	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400032
J	Sule, S; Rosen, A; Petri, M; Akhter, E; Andrade, F				Sule, Sangeeta; Rosen, Antony; Petri, Michelle; Akhter, Ehtisham; Andrade, Felipe			Abnormal Production of Pro- and Anti-Inflammatory Cytokines by Lupus Monocytes in Response to Apoptotic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; SYSTEMIC AUTOIMMUNE-DISEASE; BLOOD MONONUCLEAR-CELLS; IN-VITRO PRODUCTION; TOLL-LIKE RECEPTORS; FACTOR-ALPHA; TNF-ALPHA; RHEUMATOID-ARTHRITIS; HUMAN KERATINOCYTES	Monocytes are a key component of the innate immune system involved in the regulation of the adaptive immune response. Previous studies have focused on apoptotic cell clearance abnormalities in systemic lupus erythematosus (SLE) monocytes. However, whether SLE monocytes might express unique patterns of cytokine secretion in response to apoptotic cells is still unknown. Here, we used monocytes from healthy controls and SLE patients to evaluate the production of TNF-alpha and TGF-beta in response to apoptotic cells. Upon recognition of apoptotic material, monocytes from healthy controls showed prominent TGF-beta secretion (mean +/- SD: 824.6 +/- 144.3 pg/ml) and minimal TNF-alpha production (mean +/- SD: 32.6 +/- 2.1 pg/ml). In contrast, monocytes from SLE patients had prominent TNF-alpha production (mean +/- SD: 302.2 +/- 337.5 pg/ml) and diminished TGF-beta secretion (mean +/- SD: 685.9 +/- 615.9 pg/ml), a difference that was statistically significant compared to normal monocytes (p <= 10(-6) for TNF-alpha secretion, and p = 0.0031 for TGF-beta, respectively). Interestingly, the unique cytokine response by SLE monocytes was independent of their phagocytic clearance efficiency, opsonizing autoantibodies and disease activity. We further showed that nucleic acids from apoptotic cells play important role in the induction of TNF-alpha by lupus monocytes. Together, these observations suggest that, in addition to potential clearance defects, monocytes from SLE patients have an abnormal balance in the secretion of anti-and pro-inflammatory cytokines in response to apoptotic cells. Since the abnormal cytokine response to apoptotic material in SLE is not related to disease activity and opsonizing autoantibodies, it is possible that this response might be an intrinsic property of lupus monocytes. The studies focus attention on toll-like receptors (TLRs) and their downstream pathways as mediators of this response.	[Sule, Sangeeta] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Rosen, Antony; Petri, Michelle; Akhter, Ehtisham; Andrade, Felipe] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Rosen, Antony] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sule, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	andrade@jhmi.edu			NIH [AR43727, DE12354]; Johns Hopkins University School of Medicine General Clinical Research Center [M01-RR00052]; Dana Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727, R55AR043727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Dana Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The Hopkins Lupus Cohort is supported by NIH grant AR43727 and the Johns Hopkins University School of Medicine General Clinical Research Center (M01-RR00052). A.R. was supported by NIH grant DE12354. F.A is a Lowe Family Scholar in the Johns Hopkins Bayview Center for Innovative Medicine and was supported by the Dana Foundation Scholars Program in Human Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade F, 2005, ARTHRITIS RHEUM, V52, P1160, DOI 10.1002/art.20992; Andrade F, 2000, RHEUM DIS CLIN N AM, V26, P215, DOI 10.1016/S0889-857X(05)70136-8; Aringer M, 2005, LUPUS, V14, P13, DOI 10.1191/0961203305lu2053oa; Aringer M, 2004, ARTHRITIS RHEUM-US, V50, P3161, DOI 10.1002/art.20576; Aringer M, 2002, LUPUS, V11, P102, DOI 10.1191/0961203302lu160oa; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; BOSWELL JM, 1988, J IMMUNOL, V141, P3050; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; CasciolaRosen L, 1997, LUPUS, V6, P175, DOI 10.1177/096120339700600213; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Demirci FYK, 2007, J RHEUMATOL, V34, P1708; DUCLOS TW, 1994, CLIN IMMUNOL IMMUNOP, V70, P22, DOI 10.1006/clin.1994.1005; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FURUKAWA F, 1990, J INVEST DERMATOL, V94, P77, DOI 10.1111/1523-1747.ep12873930; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hepburn AL, 2007, ANN RHEUM DIS, V66, P1106, DOI 10.1136/ard.2006.065003; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; HORWITZ DA, 1994, LUPUS, V3, P423, DOI 10.1177/096120339400300511; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; Jones BM, 1999, AUTOIMMUNITY, V31, P117, DOI 10.3109/08916939908994055; KASHIWA H, 1987, J IMMUNOL, V138, P1383; Kelley J, 2007, ARTHRITIS RHEUM, V56, P3375, DOI 10.1002/art.22916; Lee YH, 2006, EUR J HUM GENET, V14, P364, DOI 10.1038/sj.ejhg.5201566; LEFEBER WP, 1984, J CLIN INVEST, V74, P1545, DOI 10.1172/JCI111569; Lemay S, 1996, KIDNEY INT, V50, P85, DOI 10.1038/ki.1996.290; Liou LB, 2001, CLIN EXP RHEUMATOL, V19, P515; Liou LB, 2003, CLIN EXP RHEUMATOL, V21, P437; MALAVE I, 1989, INT ARCH ALLER A IMM, V89, P355, DOI 10.1159/000234975; MALIDE D, 1995, HUM PATHOL, V26, P558, DOI 10.1016/0046-8177(95)90253-8; Manfredi AA, 1998, ARTHRITIS RHEUM-US, V41, P205; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; MAURY CPJ, 1989, ARTHRITIS RHEUM, V32, P146, DOI 10.1002/anr.1780320206; MEIJER C, 1993, LUPUS, V2, P359, DOI 10.1177/096120339300200605; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Paul E, 2002, EUR J IMMUNOL, V32, P2672, DOI 10.1002/1521-4141(200209)32:9<2672::AID-IMMU2672>3.0.CO;2-X; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Robak E, 2004, EUR CYTOKINE NETW, V15, P222; Robak Ewa, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P375; Rodriguez W, 2005, ARTHRITIS RHEUM-US, V52, P642, DOI 10.1002/art.20846; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Steinbach F, 2000, ANN RHEUM DIS, V59, P283, DOI 10.1136/ard.59.4.283; StudnickaBenke A, 1996, BRIT J RHEUMATOL, V35, P1067; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Szalai AJ, 2003, ARTHRITIS RHEUM-US, V48, P1602, DOI 10.1002/art.11026; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Zou YF, 2010, AUTOIMMUNITY, V43, P264, DOI 10.3109/08916930903509049; ZOU YF, 2010, RHEUMATOL INT 2 0324	62	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17495	10.1371/journal.pone.0017495	http://dx.doi.org/10.1371/journal.pone.0017495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423726	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400011
J	Badhai, J; Schuster, J; Gidlof, O; Dahl, N				Badhai, Jitendra; Schuster, Jens; Gidlof, Olof; Dahl, Niklas			5 ' UTR Variants of Ribosomal Protein S19 Transcript Determine Translational Efficiency: Implications for Diamond-Blackfan Anemia and Tissue Variability	PLOS ONE			English	Article							5' UNTRANSLATED REGIONS; RPS19 GENE; MESSENGER-RNAS; MUTATION; EXPRESSION; DISEASE; HETEROGENEITY; BIOGENESIS; INITIATION; DISORDER	Background: Diamond-Blackfan anemia (DBA) is a lineage specific and congenital erythroblastopenia. The disease is associated with mutations in genes encoding ribosomal proteins resulting in perturbed ribosomal subunit biosynthesis. The RPS19 gene is mutated in approximately 25% of DBA patients and a variety of coding mutations have been described, all presumably leading to haploinsufficiency. A subset of patients carries rare polymorphic sequence variants within the 5'untranslated region (5'UTR) of RPS19. The functional significance of these variants remains unclear. Methodology/Principal Findings: We analyzed the distribution of transcriptional start sites (TSS) for RPS19 mRNAs in testis and K562 cells. Twenty-nine novel RPS19 transcripts were identified with different 5'UTR length. Quantification of expressed w.t. 5'UTR variants revealed that a short 5'UTR correlates with high levels of RPS19. The total levels of RPS19 transcripts showed a broad variation between tissues. We also expressed three polymorphic RPS19 5'UTR variants identified in DBA patients. The sequence variants include two insertions (c.-147_-146insGCCA and c.-147_-146insAGCC) and one deletion (c.-144_-141delTTTC). The three 5'UTR polymorphisms are associated with a 20-30% reduction in RPS19 protein levels when compared to the wild-type (w.t.) 5'UTR of corresponding length. Conclusions: The RPS19 gene uses a broad range of TSS and a short 5'UTR is associated with increased levels of RPS19. Comparisons between tissues showed a broad variation in the total amount of RPS19 mRNA and in the distribution of TSS used. Furthermore, our results indicate that rare polymorphic 5'UTR variants reduce RPS19 protein levels with implications for Diamond-Blackfan anemia.	Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Badhai, J (corresponding author), Netherlands Canc Inst NKI, Div Med Genet, Amsterdam, Netherlands.	niklas.dahl@igp.uu.se	Schuster, Jens/D-2005-2010	Schuster, Jens/0000-0002-4383-9880; Badhai, Jitendra/0000-0002-9526-3748; Gidlof, Olof/0000-0002-7402-3139	Swedish Research Council; Uppsala University; 272 National Institutes of Health USA [5R01-HL079567-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079567] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; 272 National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swedish Research Council, Uppsala University and the 272 National Institutes of Health USA (grant number 5R01-HL079567-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badhai J, 2009, BBA-MOL BASIS DIS, V1792, P1036, DOI 10.1016/j.bbadis.2009.08.002; Barrio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006172; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; CHEN TR, 1988, CYTOGENET CELL GENET, V48, P19, DOI 10.1159/000132579; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Cretien A, 2010, AM J HEMATOL, V85, P111, DOI 10.1002/ajh.21601; Dahlqvist J, 2010, AM J HUM GENET, V86, P596, DOI 10.1016/j.ajhg.2010.02.018; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ellis SR, 2006, MED HYPOTHESES, V66, P643, DOI 10.1016/j.mehy.2005.09.010; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; Gregory LA, 2007, NUCLEIC ACIDS RES, V35, P5913, DOI 10.1093/nar/gkm626; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Huang QL, 2006, BRIT J HAEMATOL, V135, P745, DOI 10.1111/j.1365-2141.2006.06368.x; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; KONDOH N, 1992, CANCER RES, V52, P791; Landers JE, 1997, CANCER RES, V57, P3562; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Proust Alexis, 2003, Hematol J, V4, P132, DOI 10.1038/sj.thj.6200230; Ramenghi U, 2000, BLOOD CELL MOL DIS, V26, P417, DOI 10.1006/bcmd.2000.0324; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; Roberts AG, 2005, FEBS LETT, V579, P1061, DOI 10.1016/j.febslet.2004.12.080; Schuster J, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-58; Schuster J, 2010, BLOOD CELL MOL DIS, V45, P23, DOI 10.1016/j.bcmd.2010.03.007; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Stoneley M, 2003, CURR MOL MED, V3, P597, DOI 10.2174/1566524033479474; Strausberg R. L., 2002, Pharmacogenomics Journal, V2, P156, DOI 10.1038/sj.tpj.6500103; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17672	10.1371/journal.pone.0017672	http://dx.doi.org/10.1371/journal.pone.0017672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412415	Green Published, gold, Green Submitted			2022-12-25	WOS:000288247800024
J	Bagnaud-Baule, A; Reynard, O; Perret, M; Berland, JL; Maache, M; Peyrefitte, C; Vernet, G; Volchkov, V; Paranhos-Baccala, G				Bagnaud-Baule, Audrey; Reynard, Olivier; Perret, Magali; Berland, Jean-Luc; Maache, Mimoun; Peyrefitte, Christophe; Vernet, Guy; Volchkov, Viktor; Paranhos-Baccala, Glaucia			The Human Metapneumovirus Matrix Protein Stimulates the Inflammatory Immune Response In Vitro	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; DENDRITIC CELLS; EPITHELIAL-CELLS; TRACT DISEASE; TAT PROTEIN; INFECTION; CHEMOKINES; CHILDREN; NUCLEOCAPSIDS; INTERFERONS	Each year, during winter months, human Metapneumovirus (hMPV) is associated with epidemics of bronchiolitis resulting in the hospitalization of many infants. Bronchiolitis is an acute illness of the lower respiratory tract with a consequent inflammation of the bronchioles. The rapid onset of inflammation suggests the innate immune response may have a role to play in the pathogenesis of this hMPV infection. Since, the matrix protein is one of the most abundant proteins in the Paramyxoviridae family virion, we hypothesized that the inflammatory modulation observed in hMPV infected patients may be partly associated with the matrix protein (M-hMPV) response. By western blot analysis, we detected a soluble form of M-hMPV released from hMPV infected cell as well as from M-hMPV transfected HEK 293T cells suggesting that M-hMPV may be directly in contact with antigen presenting cells (APCs) during the course of infection. Moreover, flow cytometry and confocal microscopy allowed determining that M-hMPV was taken up by dendritic cells (moDCs) and macrophages inducing their activation. Furthermore, these moDCs enter into a maturation process inducing the secretion of a broad range of inflammatory cytokines when exposed to M-hMPV. Additionally, M-hMPV activated DCs were shown to stimulate IL-2 and IFN-gamma production by allogeneic T lymphocytes. This M-hMPV-mediated activation and antigen presentation of APCs may in part explain the marked inflammatory immune response observed in pathology induced by hMPV in patients.	[Bagnaud-Baule, Audrey; Maache, Mimoun; Paranhos-Baccala, Glaucia] Inst Federatif Rech 128 BioSci Lyon Gerland, Emerging Pathogens Dept, bioMerieux, Lyon, France; [Bagnaud-Baule, Audrey; Perret, Magali; Berland, Jean-Luc; Peyrefitte, Christophe; Vernet, Guy; Paranhos-Baccala, Glaucia] Fdn Merieux, Lab Pathogenes Emergents, Lyon, France; [Reynard, Olivier; Volchkov, Viktor] INSERM, U758, IFR128, F-69008 Lyon, France; [Peyrefitte, Christophe] Inst Rech Biomed Armees, Grenoble, France	bioMerieux; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bagnaud-Baule, A (corresponding author), Inst Federatif Rech 128 BioSci Lyon Gerland, Emerging Pathogens Dept, bioMerieux, Lyon, France.	glaucia.baccala@fondation-merieux.org	reynard, olivier AJ/M-8069-2014; Volchkov, Viktor/M-7846-2014	reynard, olivier AJ/0000-0001-7536-355X; Volchkov, Viktor/0000-0001-7896-8706; Berland, Jean-Luc/0000-0002-6337-3715	bioMerieux S.A; French Ministry of the Economy, Finance and Employment (DEMINAP); bioMerieux	bioMerieux S.A; French Ministry of the Economy, Finance and Employment (DEMINAP); bioMerieux	This work was supported by bioMerieux S.A and by grants from the French Ministry of the Economy, Finance and Employment (DEMINAP). The authors, hereby, declare that bioMerieux financed Audrey Bagnaud-Baule for her PhD study, Mimoun Maache for his post-doctoral position and Glaucia Paranhos-Baccala as the research director of the lab and Audrey Bagnaud-Baule's PhD supervisor. bioMerieux provided funding to support the cost of a part of the materials used for this study. The study design has been done by GPB, ABB, OR and VV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribillaga L, 2002, VACCINE, V21, P202, DOI 10.1016/S0264-410X(02)00456-5; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; BILYK N, 1995, IMMUNOLOGY, V86, P231; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ghildyal R, 2002, J GEN VIROL, V83, P753, DOI 10.1099/0022-1317-83-4-753; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grayson MH, 2007, J MOL MED, V85, P1057, DOI 10.1007/s00109-007-0212-3; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Henderson G, 2002, VIROLOGY, V300, P244, DOI 10.1006/viro.2002.1540; KAPTUR PE, 1991, J VIROL, V65, P1057, DOI 10.1128/JVI.65.3.1057-1065.1991; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Latiff K, 2004, CLIN MICROBIOL INFEC, V10, P945, DOI 10.1111/j.1469-0691.2004.00980.x; Lenard J, 1996, VIROLOGY, V216, P289, DOI 10.1006/viro.1996.0064; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Principi N, 2006, CLIN MICROBIOL INFEC, V12, P301, DOI 10.1111/j.1469-0691.2005.01325.x; Rodriguez L, 2004, J GEN VIROL, V85, P709, DOI 10.1099/vir.0.19707-0; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Tan MC, 2007, VIROLOGY, V357, P1, DOI 10.1016/j.virol.2006.08.004; Taub D D, 1994, Ther Immunol, V1, P229; Taub DD, 1996, J LEUKOCYTE BIOL, V59, P81, DOI 10.1002/jlb.59.1.81; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Veyret R, 2005, ANAL BIOCHEM, V346, P59, DOI 10.1016/j.ab.2005.07.036; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001	45	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17818	10.1371/journal.pone.0017818	http://dx.doi.org/10.1371/journal.pone.0017818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412439	gold, Green Submitted, Green Published			2022-12-25	WOS:000288247800032
J	Ivie, SE; Fennessey, CM; Sheng, JS; Rubin, DH; McClain, MS				Ivie, Susan E.; Fennessey, Christine M.; Sheng, Jinsong; Rubin, Donald H.; McClain, Mark S.			Gene-Trap Mutagenesis Identifies Mammalian Genes Contributing to Intoxication by Clostridium perfringens epsilon-Toxin	PLOS ONE			English	Article							PORE-FORMING TOXINS; HEPATITIS-A VIRUS; CAVEOLIN-1 BINDING MOTIF; INJURY MOLECULE-1 KIM1; CANINE KIDNEY-CELLS; ALPHA-HEMOLYSIN; ANTHRAX TOXIN; CELLULAR RECEPTOR; PROTEIN LRP6; GAS-GANGRENE	The Clostridium perfringens epsilon-toxin is an extremely potent toxin associated with lethal toxemias in domesticated ruminants and may be toxic to humans. Intoxication results in fluid accumulation in various tissues, most notably in the brain and kidneys. Previous studies suggest that the toxin is a pore-forming toxin, leading to dysregulated ion homeostasis and ultimately cell death. However, mammalian host factors that likely contribute to epsilon-toxin-induced cytotoxicity are poorly understood. A library of insertional mutant Madin Darby canine kidney (MDCK) cells, which are highly susceptible to the lethal affects of epsilon-toxin, was used to select clones of cells resistant to epsilon-toxin-induced cytotoxicity. The genes mutated in 9 surviving resistant cell clones were identified. We focused additional experiments on one of the identified genes as a means of validating the experimental approach. Gene expression microarray analysis revealed that one of the identified genes, hepatitis A virus cellular receptor 1 (HAVCR1, KIM-1, TIM1), is more abundantly expressed in human kidney cell lines than it is expressed in human cells known to be resistant to epsilon-toxin. One human kidney cell line, ACHN, was found to be sensitive to the toxin and expresses a larger isoform of the HAVCR1 protein than the HAVCR1 protein expressed by other, toxin-resistant human kidney cell lines. RNA interference studies in MDCK and in ACHN cells confirmed that HAVCR1 contributes to epsilon-toxin-induced cytotoxicity. Additionally, epsilon-toxin was shown to bind to HAVCR1 in vitro. The results of this study indicate that HAVCR1 and the other genes identified through the use of gene-trap mutagenesis and RNA interference strategies represent important targets for investigation of the process by which epsilon-toxin induces cell death and new targets for potential therapeutic intervention.	[Ivie, Susan E.; Fennessey, Christine M.; Sheng, Jinsong; Rubin, Donald H.; McClain, Mark S.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA; [Rubin, Donald H.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Rubin, Donald H.] VA Tennessee Valley Healthcare Syst, Res Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ivie, SE (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.	mark.mcclain@vanderbilt.edu	McClain, Mark S/A-6942-2009	McClain, Mark S/0000-0002-9857-4883	National Institutes of Health [R21-AI065435, R01-AI079123]; Vanderbilt University Digestive Disease Research Center [P30-DK058404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079123, R21AI065435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants R21-AI065435 and R01-AI079123 to MSM. Cell imaging studies were supported by core resources of the Vanderbilt University Digestive Disease Research Center (P30-DK058404). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, or the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Banks DJ, 2007, NAT METHODS, V4, P51, DOI 10.1038/NMETH991; Beal DR, 2003, HUM EXP TOXICOL, V22, P593, DOI 10.1191/0960327103ht397oa; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; BUXTON D, 1976, J COMP PATHOL, V86, P67, DOI 10.1016/0021-9975(76)90029-3; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; de Souza AJ, 2008, J IMMUNOL, V180, P6518, DOI 10.4049/jimmunol.180.10.6518; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; FERNANDEZMIYAKA.ME, 2007, INFECT IMMUN; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Ghabriel MN, 2000, ACTA NEUROCHIR SUPPL, V76, P231; GLEESONWHITE MH, 1955, LANCET, V1, P384; Goldstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007065; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Graves PE, 2005, J ALLERGY CLIN IMMUN, V116, P650, DOI 10.1016/j.jaci.2005.05.004; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hauer P J, 1999, Dev Biol Stand, V101, P85; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; KOHN J, 1955, LANCET, V1, P385; Kotsis F, 2007, PFLUG ARCH EUR J PHY, V453, P819, DOI 10.1007/s00424-006-0168-0; Kuehn EW, 2007, BIOCHEM BIOPH RES CO, V364, P861, DOI 10.1016/j.bbrc.2007.10.103; Lewis M, 2010, TOXINS, V2, P1825, DOI 10.3390/toxins2071825; Lindsay CD, 1996, HUM EXP TOXICOL, V15, P904, DOI 10.1177/096032719601501107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; Miller C, 2004, LIVER TRANSPLANT, V10, P1315, DOI 10.1002/lt.20227; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; NAGAHAMA M, 1991, FEMS MICROBIOL LETT, V84, P41, DOI [10.1111/j.1574-6968.1991.tb04566.x, 10.1016/S0378-1097(99)00655-2]; Nakajima T, 2005, GENES IMMUN, V6, P398, DOI 10.1038/sj.gene.6364215; NOPHAR Y, 1988, J IMMUNOL, V140, P3456; Osipovich AB, 2004, NUCLEIC ACIDS RES, V32, P2912, DOI 10.1093/nar/gkh604; Oyston PCF, 1998, MICROBIOL-SGM, V144, P333, DOI 10.1099/00221287-144-2-333; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pany S, 2007, BIOCHEM BIOPH RES CO, V363, P197, DOI 10.1016/j.bbrc.2007.08.132; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; PELISH TM, 2009, J BIOL CHEM; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Shimamoto S, 2005, MICROBIOL IMMUNOL, V49, P245, DOI 10.1111/j.1348-0421.2005.tb03726.x; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; SIDORENKO GI, 1967, J HYG EPID MICROB IM, V11, P171; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Smith LDS, 1984, PATHOGENIC ANAEROBIC, V3rd; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Soletti RC, 2010, ANTICANCER RES, V30, P1209; Song C, 2007, J VIROL, V81, P11946, DOI 10.1128/JVI.00620-07; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thompson P, 1998, J VIROL, V72, P3751, DOI 10.1128/JVI.72.5.3751-3761.1998; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2002, J COMP PATHOL, V126, P71, DOI 10.1053/jcpa.2001.0514; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1124, DOI 10.1016/j.bbrc.2004.09.165; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; WORTHINGTON R W, 1975, Onderstepoort Journal of Veterinary Research, V42, P25; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	78	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17787	10.1371/journal.pone.0017787	http://dx.doi.org/10.1371/journal.pone.0017787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412435	Green Submitted, Green Published, gold			2022-12-25	WOS:000288247800030
J	Lowry, JE; Isaak, DD; Leonhardt, JA; Vernati, G; Pate, JC; Andrews, GP				Lowry, Jake E.; Isaak, Dale D.; Leonhardt, Jack A.; Vernati, Giulia; Pate, Jessie C.; Andrews, Gerard P.			Vaccination with Brucella abortus Recombinant In Vivo-Induced Antigens Reduces Bacterial Load and Promotes Clearance in a Mouse Model for Infection	PLOS ONE			English	Article							STRAIN RB51 VACCINATION; IV SECRETION SYSTEM; IMMUNE-RESPONSES; BALB/C MICE; SUPEROXIDE-DISMUTASE; YERSINIA-PESTIS; PREGNANT MOUSE; PROTECTS MICE; CHALLENGE; VACCINES	Current vaccines used for the prevention of brucellosis are ineffective in inducing protective immunity in animals that are chronically infected with Brucella abortus, such as elk. Using a gene discovery approach, in vivo-induced antigen technology (IVIAT) on B. abortus, we previously identified ten loci that encode products up-regulated during infection in elk and consequently may play a role in virulence. In our present study, five of the loci (D15, 0187, VirJ, Mdh, AfuA) were selected for further characterization and compared with three additional antigens with virulence potential (Hia, PrpA, MltA). All eight genes were PCR-amplified from B. abortus and cloned into E. coli. The recombinant products were then expressed, purified, adjuvanted, and delivered subcutaneously to BALB/c mice. After primary immunization and two boosts, mice were challenged i.p. with 5 x 10(4) CFU of B. abortus strain 19. Spleens from challenged animals were harvested and bacterial loads determined by colony count at various time points. While vaccination with four of the eight individual proteins appeared to have some effect on clearance kinetics, mice vaccinated with recombinant Mdh displayed the most significant reduction in bacterial colonization. Furthermore, mice immunized with Mdh maintained higher levels of IFN-c in spleens compared to other treatment groups. Collectively, our in vivo data gathered from the S19 murine colonization model suggest that vaccination with at least three of the IVIAT antigens conferred an enhanced ability of the host to respond to infection, reinforcing the utility of this methodology for the identification of potential vaccine candidates against brucellosis. Mechanisms for immunity to one protein, Mdh, require further in vitro exploration and evaluation against wild-type B. abortus challenge in mice, as well as other hosts. Additional studies are being undertaken to clarify the role of Mdh and other IVI antigens in B. abortus virulence and induction of protective immunity.	[Lowry, Jake E.; Leonhardt, Jack A.; Vernati, Giulia; Pate, Jessie C.; Andrews, Gerard P.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Isaak, Dale D.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Lowry, Jake E.] Colorado State Univ, Coll Vet Med & Biomed Sci, Profess Vet Med Program, Ft Collins, CO 80523 USA	University of Wyoming; University of Wyoming; Colorado State University	Lowry, JE (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA.	jake.lowry@colostate.edu; Gandrews@uwyo.edu		Lowry, John/0000-0003-2382-9594	U.S. Department of Agriculture (USDA) [CSRE45229]	U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This study was supported by the U.S. Department of Agriculture (USDA) Special Projects Grant, CSRE45229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2001, INFECT IMMUN, V69, P4816, DOI 10.1128/IAI.69.8.4816-4822.2001; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Andrews GP, 2010, VECTOR-BORNE ZOONOT, V10, P749, DOI 10.1089/vbz.2009.0179; Baldwin C L, 1994, Immunol Ser, V60, P363; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; BOSSERAY N, 1992, DEV BIOL STAND, V79, P121; BOSSERAY N, 1990, VACCINE, V8, P462, DOI 10.1016/0264-410X(90)90247-J; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; CHEERS C, 1984, DEV BIOL STAND, V56, P237; Chirhart-Gilleland RL, 1998, INFECT IMMUN, V66, P4000, DOI 10.1128/IAI.66.8.4000-4003.1998; Cook WE, 2002, J WILDLIFE DIS, V38, P18, DOI 10.7589/0090-3558-38.1.18; Davis DS, 2002, VET MICROBIOL, V90, P533, DOI 10.1016/S0378-1135(02)00233-X; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Elzer PH, 1998, J WILDLIFE DIS, V34, P825, DOI 10.7589/0090-3558-34.4.825; Elzer PH, 1998, AM J VET RES, V59, P1575; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; He YQ, 2002, INFECT IMMUN, V70, P2535, DOI 10.1128/IAI.70.5.2535-2543.2002; Kaushik P, 2010, VET RES COMMUN, V34, P119, DOI 10.1007/s11259-009-9337-x; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kreeger TJ, 2002, J WILDLIFE DIS, V38, P27, DOI 10.7589/0090-3558-38.1.27; Lowry JE, 2010, VET MICROBIOL, V142, P367, DOI 10.1016/j.vetmic.2009.10.010; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Olsen SC, 2006, CLIN VACCINE IMMUNOL, V13, P1098, DOI 10.1128/CVI.00213-06; Olsen SC, 2009, CLIN VACCINE IMMUNOL, V16, P535, DOI 10.1128/CVI.00419-08; Olsen SC, 2003, J WILDLIFE DIS, V39, P824, DOI 10.7589/0090-3558-39.4.824; Olsen SC, 1999, AM J VET RES, V60, P905; Palmer MV, 1996, VET PATHOL, V33, P682, DOI 10.1177/030098589603300607; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Sofer-Podesta C, 2009, INFECT IMMUN, V77, P1561, DOI 10.1128/IAI.00856-08; TOBIAS L, 1992, RES VET SCI, V53, P179, DOI 10.1016/0034-5288(92)90107-D; TOBIAS L, 1993, VET PATHOL, V30, P119, DOI 10.1177/030098589303000204; Vemulapalli R, 2004, VET MICROBIOL, V102, P237, DOI 10.1016/j.vetmic.2004.07.001; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Zhong ZJ, 2009, MICROBIOL-SGM, V155, P3392, DOI 10.1099/mic.0.030619-0	36	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17425	10.1371/journal.pone.0017425	http://dx.doi.org/10.1371/journal.pone.0017425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412420	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800005
J	Lim, YH; Charette, JM; Baserga, SJ				Lim, Young H.; Charette, J. Michael; Baserga, Susan J.			Assembling a Protein-Protein Interaction Map of the SSU Processome from Existing Datasets	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; SMALL-SUBUNIT PROCESSOME; INTERACTION NETWORK; FUNCTIONAL-CHARACTERIZATION; INTERACTION DATABASE; 2-HYBRID ANALYSIS; U3 SNORNP; IN-VIVO; YEAST; DOMAIN	Background: The small subunit (SSU) processome is a large ribonucleoprotein complex involved in small ribosomal subunit assembly. It consists of the U3 snoRNA and similar to 72 proteins. While most of its components have been identified, the protein-protein interactions (PPIs) among them remain largely unknown, and thus the assembly, architecture and function of the SSU processome remains unclear. Methodology: We queried PPI databases for SSU processome proteins to quantify the degree to which the three genome-wide high-throughput yeast two-hybrid (HT-Y2H) studies, the genome-wide protein fragment complementation assay (PCA) and the literature-curated (LC) datasets cover the SSU processome interactome. Conclusions: We find that coverage of the SSU processome PPI network is remarkably sparse. Two of the three HT-Y2H studies each account for four and six PPIs between only six of the 72 proteins, while the third study accounts for as little as one PPI and two proteins. The PCA dataset has the highest coverage among the genome-wide studies with 27 PPIs between 25 proteins. The LC dataset was the most extensive, accounting for 34 proteins and 38 PPIs, many of which were validated by independent methods, thereby further increasing their reliability. When the collected data were merged, we found that at least 70% of the predicted PPIs have yet to be determined and 26 proteins (36%) have no known partners. Since the SSU processome is conserved in all Eukaryotes, we also queried HT-Y2H datasets from six additional model organisms, but only four orthologues and three previously known interologous interactions were found. This provides a starting point for further work on SSU processome assembly, and spotlights the need for a more complete genome-wide Y2H analysis.	[Lim, Young H.; Charette, J. Michael; Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Charette, J. Michael; Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Lim, YH (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	Susan.Baserga@Yale.edu			National Institutes of Health [GM052581]; Yale University; NIH-Ruth L. Kirschstein National Research Service Award, Institutional Research Training Grant [T32 CA009259]; NATIONAL CANCER INSTITUTE [T32CA009259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052581, R29GM052581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NIH-Ruth L. Kirschstein National Research Service Award, Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (www.nih.gov) grant GM052581 (to SJB), the Science, Technology and Research Scholars II (STARS II) program (http://yalecollege.yale.edu/content/stars-ii-program) at Yale University (to YHL) and a post-doctoral NIH-Ruth L. Kirschstein National Research Service Award, Institutional Research Training Grant: Radiation Therapy, Biology, Physics (http://grants.nih.gov/training/nrsa.htm) T32 CA009259 (to JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2010, MOL BIOSYST, V6, P2296, DOI 10.1039/c004430j; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Blow N, 2009, NATURE, V460, P415, DOI 10.1038/460415a; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Charette JM, 2010, RNA, V16, P2156, DOI 10.1261/rna.2359810; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FREED EF, 2010, NUCL ACIDS RES; Gallagher JEG, 2004, NUCLEIC ACIDS RES, V32, P1404, DOI 10.1093/nar/gkh318; Gentleman R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-112; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldfeder MB, 2010, FEBS J, V277, P2838, DOI 10.1111/j.1742-4658.2010.07701.x; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; Grigoriev A, 2003, NUCLEIC ACIDS RES, V31, P4157, DOI 10.1093/nar/gkg466; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Huang YC, 2010, BIOCHEM BIOPH RES CO, V393, P297, DOI 10.1016/j.bbrc.2010.02.003; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lebaron S, 2005, MOL CELL BIOL, V25, P9269, DOI 10.1128/MCB.25.21.9269-9282.2005; Lebaron S, 2009, EMBO J, V28, P3808, DOI 10.1038/emboj.2009.335; Lee SM, 1999, MRS INTERNET J N S R, V4; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Pandit S, 2009, GENETICS, V183, P195, DOI 10.1534/genetics.109.106955; Pang EL, 2010, MOL BIOSYST, V6, P2164, DOI 10.1039/c0mb00038h; Park YU, 2002, BIOCHEM BIOPH RES CO, V293, P733, DOI 10.1016/S0006-291X(02)00288-7; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Rajagopala SV, 2009, METHODS MOL BIOL, V548, P223, DOI 10.1007/978-1-59745-540-4_13; Rajagopala SV, 2008, BIOINFORMATICS, V24, P2622, DOI 10.1093/bioinformatics/btn481; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schwartz AS, 2009, NAT METHODS, V6, P55, DOI [10.1038/nmeth.1283, 10.1038/NMETH.1283]; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uetz P, 2005, FEBS LETT, V579, P1821, DOI 10.1016/j.febslet.2005.02.001; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Wu XM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S16; Xin XF, 2009, GENOME RES, V19, P1262, DOI 10.1101/gr.090019.108; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	89	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17701	10.1371/journal.pone.0017701	http://dx.doi.org/10.1371/journal.pone.0017701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423703	gold, Green Submitted, Green Published			2022-12-25	WOS:000288219100026
J	Moller, IE; Licht, HHDF; Harholt, J; Willats, WGT; Boomsma, JJ				Moller, Isabel E.; Licht, Henrik H. De Fine; Harholt, Jesper; Willats, William G. T.; Boomsma, Jacobus J.			The Dynamics of Plant Cell-Wall Polysaccharide Decomposition in Leaf-Cutting Ant Fungus Gardens	PLOS ONE			English	Article							SYMBIOTIC FUNGUS; LEUCOAGARICUS-GONGYLOPHORUS; WASTE MANAGEMENT; DEGRADATION; METABOLISM; ENZYMES; SUBSTRATE; CULTIVAR; NESTS	The degradation of live plant biomass in fungus gardens of leaf-cutting ants is poorly characterised but fundamental for understanding the mutual advantages and efficiency of this obligate nutritional symbiosis. Controversies about the extent to which the garden-symbiont Leucocoprinus gongylophorus degrades cellulose have hampered our understanding of the selection forces that induced large scale herbivory and of the ensuing ecological footprint of these ants. Here we use a recently established technique, based on polysaccharide microarrays probed with antibodies and carbohydrate binding modules, to map the occurrence of cell wall polymers in consecutive sections of the fungus garden of the leaf-cutting ant Acromyrmex echinatior. We show that pectin, xyloglucan and some xylan epitopes are degraded, whereas more highly substituted xylan and cellulose epitopes remain as residuals in the waste material that the ants remove from their fungus garden. These results demonstrate that biomass entering leaf-cutting ant fungus gardens is only partially utilized and explain why disproportionally large amounts of plant material are needed to sustain colony growth. They also explain why substantial communities of microbial and invertebrate symbionts have evolved associations with the dump material from leaf-cutting ant nests, to exploit decomposition niches that the ant garden-fungus does not utilize. Our approach thus provides detailed insight into the nutritional benefits and shortcomings associated with fungus-farming in ants.	[Moller, Isabel E.; Willats, William G. T.] Univ Copenhagen, Dept Biol, Copenhagen Bioctr, Copenhagen, Denmark; [Licht, Henrik H. De Fine; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Harholt, Jesper] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biochem, VKR Res Ctr Proact Plants,Sect Plant Glycobiol, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Moller, IE (corresponding author), Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia.	imoller@unimelb.edu.au	de Fine Licht, Henrik Hjarvard/G-3307-2014; Moller, Isabel/C-2680-2008; Harholt, Jesper/F-3760-2011; Boomsma, Jacobus J/M-2785-2014; Harholt, Jesper/F-6865-2014	de Fine Licht, Henrik Hjarvard/0000-0003-3326-5729; Boomsma, Jacobus J/0000-0002-3598-1609; Harholt, Jesper/0000-0002-7984-0066; Willats, William/0000-0003-2064-4025	Danish National Research Foundation; Villum Kann Rasmussen Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Kann Rasmussen Foundation(Villum Fonden)	The authors IEM, HHDFL, and JJB were supported by the Danish National Research Foundation. JH was supported by the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril AB, 2004, APPL SOIL ECOL, V26, P243, DOI 10.1016/j.apsoil.2003.12.008; Abril AB, 2002, ECOL LETT, V5, P325, DOI 10.1046/j.1461-0248.2002.00327.x; Alonso-Simon A, 2010, BIOTECHNOL BIOENG, V105, P509, DOI 10.1002/bit.22546; BACCI M, 1995, BRAZ J MED BIOL RES, V28, P79; BACCI M, 1995, ANTON LEEUW INT J G, V67, P385, DOI 10.1007/BF00872939; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boomsma JJ, 2009, P NATL ACAD SCI USA, V106, P17611, DOI 10.1073/pnas.0910004106; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Bucher EH, 2004, BIOTROPICA, V36, P327, DOI 10.1646/04005; Cherrett J.M., 1989, P93; COOKE RC, 1984, ECOLOGY SAPROTROPHIC; D'Ettorre P, 2002, J COMP PHYSIOL B, V172, P169, DOI 10.1007/s00360-001-0241-0; De Siqueira CG, 1998, APPL ENVIRON MICROB, V64, P4820; Deacon JW., 2005, FUNGAL BIOL; Erthal M, 2009, COMP BIOCHEM PHYS B, V152, P54, DOI 10.1016/j.cbpb.2008.09.086; Esquerre-Tugaye MT, 2000, PLANT PHYSIOL BIOCH, V38, P157, DOI 10.1016/S0981-9428(00)00161-3; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Holldobler B., 1990, pi; Holldobler B, 2008, SUPERORGANISM BEAUTY; Licht HHD, 2010, ECOL ENTOMOL, V35, P259, DOI 10.1111/j.1365-2311.2010.01193.x; Little AEF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-124; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MARTIN MM, 1969, ANN ENTOMOL SOC AM, V62, P1386, DOI 10.1093/aesa/62.6.1386; MATCHAM SE, 1985, APPL MICROBIOL BIOT, V21, P108; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Moutinho P, 2003, ECOLOGY, V84, P1265, DOI 10.1890/0012-9658(2003)084[1265:IOLANO]2.0.CO;2; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Murdoch L, 1999, PROTOPLASMA, V210, P59, DOI 10.1007/BF01314956; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; POULSEN M, 2006, INSECT SYMBIOSIS, V2, P57; Richard FJ, 2005, J COMP PHYSIOL B, V175, P297, DOI 10.1007/s00360-005-0485-1; Rodrigues A, 2009, ANTON LEEUW INT J G, V96, P331, DOI 10.1007/s10482-009-9350-7; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Silva A, 2006, MICROBIOL RES, V161, P299, DOI 10.1016/j.micres.2005.11.001; Silva A, 2006, CURR MICROBIOL, V53, P68, DOI 10.1007/s00284-005-0431-1; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SINSABAUGH RL, 1997, MYCOTA, V4, P347; Sorensen I, 2008, PLANT J, V54, P510, DOI 10.1111/j.1365-313X.2008.03453.x; Sorensen I, 2009, CARBOHYD RES, V344, P1872, DOI 10.1016/j.carres.2008.12.008; Sternberg LD, 2007, P ROY SOC B-BIOL SCI, V274, P315, DOI 10.1098/rspb.2006.3746; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Wirth R, 2003, HERBIVORY LEAF CUTTI	54	38	39	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17506	10.1371/journal.pone.0017506	http://dx.doi.org/10.1371/journal.pone.0017506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423735	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100011
J	Mao, CH; Brown, CR; Griesenbeck, J; Boeger, H				Mao, Changhui; Brown, Christopher R.; Griesenbeck, Joachim; Boeger, Hinrich			Occlusion of Regulatory Sequences by Promoter Nucleosomes In Vivo	PLOS ONE			English	Article							HISTONE CHAPERONE ASF1; PHO5 PROMOTER; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; MAJOR DETERMINANT; CRYSTAL-STRUCTURE; DNA INTERACTIONS; CORE PARTICLE; YEAST PHO5; CHROMATIN	Nucleosomes are believed to inhibit DNA binding by transcription factors. Theoretical attempts to understand the significance of nucleosomes in gene expression and regulation are based upon this assumption. However, nucleosomal inhibition of transcription factor binding to DNA is not complete. Rather, access to nucleosomal DNA depends on a number of factors, including the stereochemistry of transcription factor- DNA interaction, the in vivo kinetics of thermal fluctuations in nucleosome structure, and the intracellular concentration of the transcription factor. In vitro binding studies must therefore be complemented with in vivo measurements. The inducible PHO5 promoter of yeast has played a prominent role in this discussion. It bears two binding sites for the transcriptional activator Pho4, which at the repressed promoter are positioned within a nucleosome and in the linker region between two nucleosomes, respectively. Earlier studies suggested that the nucleosomal binding site is inaccessible to Pho4 binding in the absence of chromatin remodeling. However, this notion has been challenged by several recent reports. We therefore have reanalyzed transcription factor binding to the PHO5 promoter in vivo, using 'chromatin endogenous cleavage' (ChEC). Our results unambiguously demonstrate that nucleosomes effectively interfere with the binding of Pho4 and other critical transcription factors to regulatory sequences of the PHO5 promoter. Our data furthermore suggest that Pho4 recruits the TATA box binding protein to the PHO5 promoter.	[Mao, Changhui; Brown, Christopher R.; Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Griesenbeck, Joachim] Univ Regensburg, Dept Biochem 3, Regensburg, Germany	University of California System; University of California Santa Cruz; University of Regensburg	Mao, CH (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	hboeger@ucsc.edu		Brown, Christopher/0000-0001-6076-4035; Griesenbeck, Joachim/0000-0002-7817-6095	National Institutes of Health [F32GM087867, GM078111-01]; DFG [GR 1706/4-1, GR 1706/5-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078111, F32GM087867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RB was supported by National Research Service Award (NRSA) grant F32GM087867 from the National Institutes of Health. JG was supported by two DFG travel grants, GR 1706/4-1 and GR 1706/5-1. HB acknowledges support from National Institutes of Health grant GM078111-01 and the Pew Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Carvin CD, 2003, P NATL ACAD SCI USA, V100, P7743, DOI 10.1073/pnas.1332672100; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; Eisfeld K, 1997, NUCLEIC ACIDS RES, V25, P3733, DOI 10.1093/nar/25.18.3733; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Magbanua JPV, 1997, J BIOCHEM, V121, P1182; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Terrell AR, 2002, J BIOL CHEM, V277, P31038, DOI 10.1074/jbc.M204662200; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Wu WH, 1999, P NATL ACAD SCI USA, V96, P2764, DOI 10.1073/pnas.96.6.2764; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	46	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17521	10.1371/journal.pone.0017521	http://dx.doi.org/10.1371/journal.pone.0017521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408617	Green Published, Green Submitted, gold			2022-12-25	WOS:000287965200020
J	Nogueira, L; Ruiz-Ontanon, P; Vazquez-Barquero, A; Lafarga, M; Berciano, MT; Aldaz, B; Grande, L; Casafont, I; Segura, V; Robles, EF; Suarez, D; Garcia, LF; Martinez-Climent, JA; Fernandez-Luna, JL				Nogueira, L.; Ruiz-Ontanon, P.; Vazquez-Barquero, A.; Lafarga, M.; Berciano, M. T.; Aldaz, B.; Grande, L.; Casafont, I.; Segura, V.; Robles, E. F.; Suarez, D.; Garcia, L. F.; Martinez-Climent, J. A.; Fernandez-Luna, J. L.			Blockade of the NF kappa B pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo	ONCOGENE			English	Article						NF kappa B; glioblastoma-initiating cells; senescence; differentiation	CANCER STEM-CELLS; BRAIN-TUMORS; ACTIVATION; PHENOTYPE; PROLIFERATION; EXPRESSION; SURVIVAL; THERAPY; GROWTH; MICE	Glioblastoma multiforme is one of the most devastating cancers and presents unique challenges to therapy because of its aggressive behavior. Cancer-initiating or progenitor cells have been described to be the only cell population with tumorigenic capacity in glioblastoma. Therefore, effective therapeutic strategies targeting these cells or the early precursors may be beneficial. We have established different cultures of glioblastoma-initiating cells (GICs) derived from surgical specimens and found that, after induction of differentiation, the NF kappa B transcriptional pathway was activated, as determined by analyzing key proteins such as p65 and I kappa B and the upregulation of a number of target genes. We also showed that blockade of nuclear factor (NF)kappa B signaling in differentiating GICs by different genetic strategies or treatment with small-molecule inhibitors, promoted replication arrest and senescence. This effect was partly mediated by reduced levels of the NF kappa B target gene cyclin D1, because its downregulation by RNA interference reproduced a similar phenotype. Furthermore, these results were confirmed in a xenograft model. Intravenous treatment of immunodeficient mice bearing human GIC-derived tumors with a novel small-molecule inhibitor of the NF kappa B pathway induced senescence of tumor cells but no ultrastructural alterations of the brain parenchyma were detected. These findings reveal that activation of NF kappa B may keep differentiating GICs from acquiring a mature postmitotic phenotype, thus allowing cell proliferation, and support the rationale for therapeutic strategies aimed to promote premature senescence of differentiating GICs by blocking key factors within the NF kappa B pathway. Oncogene (2011) 30, 3537-3548; doi:10.1038/onc.2011.74; published online 21 March 2011	[Nogueira, L.; Ruiz-Ontanon, P.; Grande, L.; Fernandez-Luna, J. L.] Hosp Valdecilla, Mol Genet Unit, Santander 39011, Spain; [Nogueira, L.; Ruiz-Ontanon, P.; Grande, L.; Fernandez-Luna, J. L.] Inst Formac & Invest Marques de Valdecilla IFIMAV, Santander, Spain; [Vazquez-Barquero, A.; Suarez, D.] Hosp Valdecilla, Neurosurg Serv, Santander 39011, Spain; [Lafarga, M.; Berciano, M. T.; Casafont, I.] Univ Cantabria IFIMAV, Dept Anat & Cell Biol, Santander, Spain; [Lafarga, M.; Berciano, M. T.; Casafont, I.] Univ Cantabria IFIMAV, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Santander, Spain; [Aldaz, B.; Robles, E. F.; Martinez-Climent, J. A.] Univ Navarra, Ctr Appl Med Res CIMA, Div Oncol, E-31080 Pamplona, Spain; [Segura, V.] Univ Navarra, Ctr Appl Med Res CIMA, Bioinformat Unit, E-31080 Pamplona, Spain; [Garcia, L. F.] PharmaMar, Madrid, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBERNED; Universidad de Cantabria; University of Navarra; University of Navarra; PharmaMar	Fernandez-Luna, JL (corresponding author), Hosp Valdecilla, Mol Genet Unit, Edificio IFIMAV,Av Cardenal Herrera Oria S-N, Santander 39011, Spain.	fluna@humv.es	Martinez-Climent, Jose A/I-9199-2012; Segura, Victor/E-4531-2010; Lafarga, Miguel/K-3733-2014	Martinez-Climent, Jose A/0000-0002-7938-3950; Segura, Victor/0000-0002-7740-6290; CASAFONT, INIGO/0000-0001-5691-6841; Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) [RD06/0020/0074, RD06/0020/0088]; Fundacion Marques de Valdecilla [API08/01];  [PI070196];  [PI081878]	Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marques de Valdecilla(Instituto de Salud Carlos III); ; 	This work was supported by Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) grants RD06/0020/0074 (JLF-L) and RD06/0020/0088 (JAM-C) (Red Tematica de Investigacion Cooperativa en Cancer), PI070196, PI081878, and Accion Transversal del Cancer 2008, and grant API08/01 from Fundacion Marques de Valdecilla (JLF-L). We thank Francisco Moris (EntreChem, Spain) for providing the NF kappa B inhibitor 70124, and Ainara Sagardoy, Silvia Mora, Maria Collantes and Ivan Penuelas (University of Navarra, Spain) for support with intracraneal injections and microPET studies.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Chang BD, 1999, CANCER RES, V59, P3761; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Kang HB, 2007, STEM CELLS DEV, V16, P615, DOI 10.1089/scd.2007.0014; Kawamata H, 2006, CURR PHARM DESIGN, V12, P379, DOI 10.2174/138161206775201947; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee J, 2009, FASEB J, V23, P1739, DOI 10.1096/fj.08-121046; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Ozes ON, 1999, NATURE, V401, P82; Pena E, 2001, J COMP NEUROL, V430, P250, DOI 10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Sabolek M, 2006, NEUROREPORT, V17, P1719, DOI 10.1097/01.wnr.0000236862.08834.50; Sanchez C, 2009, CHEM COMMUN, P4118, DOI 10.1039/b905068j; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Singh SK, 2003, CANCER RES, V63, P5821; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Young KM, 2006, J NEUROSCI RES, V83, P39, DOI 10.1002/jnr.20702; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144	42	60	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	32					3537	3548		10.1038/onc.2011.74	http://dx.doi.org/10.1038/onc.2011.74			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	806CR	21423202				2022-12-25	WOS:000293782300006
J	Xiao, ZS; Dallas, M; Qiu, N; Nicolella, D; Cao, L; Johnson, M; Bonewald, L; Quarles, LD				Xiao, Zhousheng; Dallas, Mark; Qiu, Ni; Nicolella, Daniel; Cao, Li; Johnson, Mark; Bonewald, Lynda; Quarles, L. Darryl			Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice	FASEB JOURNAL			English	Article						polycystin-1; mechanical loading; fluid flow	POLYCYSTIC KIDNEY-DISEASE; FLUID SHEAR; ESTROGEN-RECEPTOR; MECHANICAL STRAIN; GENE-PRODUCT; BONE-CELLS; IN-VIVO; PARATHYROID-HORMONE; EARLY RESPONSES; PRIMARY CILIUM	We investigated whether polycystin-1 is a bone mechanosensor. We conditionally deleted Pkd1 in mature osteoblasts/osteocytes by crossing Dmp1-Cre with Pkd1(flox/m1Bei) mice, in which the m1Bei allele is nonfunctional. We assessed in wild-type and Pkd1-deficient mice the response to mechanical loading in vivo by ulna loading and ex vivo by measuring the response of isolated osteoblasts to fluid shear stress. We found that conditional Pkd1 heterozygotes (Dmp1-Cre; Pkd1(flox/+)) and null mice (Pkd1(Dmp1-cKO)) exhibited a similar to 40 and similar to 90% decrease, respectively, in functional Pkd1 transcripts in bone. Femoral bone mineral density (12 vs. 27%), trabecular bone volume (32 vs. 48%), and cortical thickness (6 vs. 17%) were reduced proportionate to the reduction of Pkd1 gene dose, as were mineral apposition rate (MAR) and expression of Runx2-II, Osteocalcin, Dmp1, and Phex. Anabolic load-induced periosteal lamellar MAR (0.58 +/- 0.14; Pkd1(Dmp1-cKO) vs. 1.68 +/- 0.34 mu m/d; control) and increases in Cox-2, c-Jun, Wnt10b, Axin2, and Runx2-II gene expression were significantly attenuated in Pkd1(Dmp1-cKO) mice compared with controls. Application of fluid shear stress to immortalized osteoblasts from Pkd1(null/null) and Pkd1(m1Bei/m1Bei)-derived osteoblasts failed to elicit the increments in cytosolic calcium observed in wild-type controls. These data indicate that polycystin-1 is essential for the anabolic response to skeletal loading in osteoblasts/osteocytes.-Xiao, Z., Dallas, M., Qiu, N., Nicolella, D., Cao, L., Johnson, M., Bonewald, L., Quarles, L. D. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice. FASEB J. 25, 2418-2432 (2011). www.fasebj.org	[Xiao, Zhousheng; Qiu, Ni; Cao, Li; Quarles, L. Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38165 USA; [Dallas, Mark; Johnson, Mark; Bonewald, Lynda] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO USA; [Nicolella, Daniel] SW Res Inst, San Antonio, TX USA	University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; University of Missouri Kansas City; Southwest Research Institute	Xiao, ZS (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38165 USA.	zxiao2@uthsc.edu; dquarles@uthsc.edu	Bonewald, Lynda/Q-3638-2019	xiao, zhousheng/0000-0002-3363-5673; Quarles, L. Darryl/0000-0002-5082-7896	U.S. National Institutes of Health [R01-DK083303, R21-AR056794, P01-AR46798]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798, R21AR056794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083303] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants R01-DK083303 to L. D. Q., R21-AR056794 to Z.S.X., and P01-AR46798 to L.F.B.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Bonewald L. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P239; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2007, CELL METAB, V5, P410, DOI 10.1016/j.cmet.2007.05.008; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Bravenboer N, 2001, J ORTHOP RES, V19, P945, DOI 10.1016/S0736-0266(01)00026-2; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593; Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; Cowin SC, 1998, BONE, V22, p119S, DOI 10.1016/S8756-3282(98)00011-8; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Garcia M, 2010, J ORTHOP RES, V28, P510, DOI 10.1002/jor.21025; Gattone VH, 2009, J AM SOC NEPHROL, V20, P1527, DOI 10.1681/ASN.2008090927; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grimston SK, 2008, J BONE MINER RES, V23, P879, DOI [10.1359/jbmr.080222, 10.1359/JBMR.080222]; Gu GL, 2005, BIOCHEM BIOPH RES CO, V335, P1095, DOI 10.1016/j.bbrc.2005.06.211; Haasper C, 2008, EXP TOXICOL PATHOL, V59, P355, DOI [10.1016/j.etp.2007.11.013, 10.1016/j.etp.2007.11.008]; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jansen JHW, 2010, J ORTHOP RES, V28, P390, DOI 10.1002/jor.20991; Johnson M. L., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P135; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Kamioka H, 2006, J BONE MINER RES, V21, P1012, DOI 10.1359/JBMR.060408; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; LANYON LE, 1987, J BIOMECH, V20, P1083, DOI 10.1016/0021-9290(87)90026-1; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Malhas AN, 2002, J AM SOC NEPHROL, V13, P19, DOI 10.1681/ASN.V13119; MATTHEWS JL, 1981, CLIN ORTHOP RELAT R, P27; McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; MikuniTakagaki Y, 1996, ENDOCRINOLOGY, V137, P2028, DOI 10.1210/en.137.5.2028; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Oswald E. S., 2006, C P IEEE ENG MED BIO, V1, P3659; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Paterson AD, 2002, AM J KIDNEY DIS, V40, P16, DOI 10.1053/ajkd.2002.33908; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; Rawlinson SCF, 1996, BONE, V19, P609, DOI 10.1016/S8756-3282(96)00260-8; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; SANTOS A, 2003, BIOCHEM BIOPH RES CO, V391, P364; Sato N, 2009, J DENT RES, V88, P812, DOI 10.1177/0022034509343101; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Silva MJ, 2000, J BIOMECH, V33, P231, DOI 10.1016/S0021-9290(99)00158-X; Skerry TM, 2008, ARCH BIOCHEM BIOPHYS, V473, P117, DOI 10.1016/j.abb.2008.02.028; Starremans PG, 2008, KIDNEY INT, V73, P1394, DOI 10.1038/ki.2008.111; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Tanaka SM, 2002, FASEB J, V16, P313, DOI 10.1096/fj.02-0561fje; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; TURCO AE, 1993, J MED GENET, V30, P419, DOI 10.1136/jmg.30.5.419; VAILAS AC, 1990, FASEB J, V4, P47, DOI 10.1096/fasebj.4.1.2295378; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Wilson PD, 1999, LAB INVEST, V79, P1311; Xiao Y, 2010, MOL CELL BIOCHEM, V339, P155, DOI 10.1007/s11010-009-0379-8; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zerath E, 1998, ADV SPACE RES, V21, P1049, DOI 10.1016/S0273-1177(98)00026-X; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	105	83	86	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2418	2432		10.1096/fj.10-180299	http://dx.doi.org/10.1096/fj.10-180299			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21454365	Green Published			2022-12-25	WOS:000292242200033
J	Guo, NX; Woeller, CF; Feldon, SE; Phipps, RP				Guo, Naxin; Woeller, Collynn F.; Feldon, Steven E.; Phipps, Richard P.			Peroxisome Proliferator-activated Receptor gamma Ligands Inhibit Transforming Growth Factor-beta-induced, Hyaluronan-dependent, T Cell Adhesion to Orbital Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; GRAVES OPHTHALMOPATHY; PPAR-GAMMA; TGF-BETA; EXTRACELLULAR-MATRIX; MESANGIAL CELLS; EYE DISEASE; LUNG INJURY; EXPRESSION; CD44	Thyroid eye disease is characterized by the infiltration of leukocytes and accumulation of hyaluronan (HA) in orbital tissue. Inflamed orbital tissue expands in size due to excessive HA and to the formation of scar tissue (fibrosis) and/or adipose accumulation. Transforming growth factor beta (TGF-beta) acts as a key inducer of fibrosis by enhancing extracellular matrix production. Treatment of primary human orbital fibroblasts with TGF-beta led to significant increases in both HA synthesis and secretion. TGF-beta also strongly induced hyaluronan synthase 1 (HAS1) and HAS2 mRNA levels, which increased 50- and 6-fold, respectively. Remarkably, the addition of the peroxisome proliferator-activated receptor (PPAR gamma) ligands pioglitazone (Pio) or rosiglitazone (Rosi) to TGF-beta-treated orbital fibroblasts attenuated HA synthesis and reduced HAS1 and HAS2 mRNA levels. The attenuation of TGF-beta function by Pio and Rosi was independent of PPAR gamma activity. Furthermore, Pio and Rosi treatment inhibited TGF-beta-induced T cell adhesion to orbital fibroblasts. Our findings demonstrate that TGF-beta plays an important role in HA synthesis and in the inflammatory response by enhancing or facilitating inflammatory cell infiltration and adhesion to orbital tissue. Pio and Rosi exhibit anti-fibrotic and anti-inflammatory activity and may be useful in treating thyroid eye disease.	[Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [Guo, Naxin; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Richard_Phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Feldon, Steven/0000-0003-0603-9312; Woeller, Collynn/0000-0001-7197-5057	National Institutes of Health, NEI [EY017123]; Research to Prevent Blindness Foundation; NIEHS, National Institutes of Health [ES07026]; NATIONAL EYE INSTITUTE [R01EY017123] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY017123 from NEI. This work was also supported by a Research to Prevent Blindness Foundation grant.; Supported by NIEHS, National Institutes of Health Training Grant ES07026.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Aniszewski JP, 2000, J CLIN ENDOCR METAB, V85, P776, DOI 10.1210/jc.85.2.776; Antonelli A, 2006, J CLIN ENDOCR METAB, V91, P614, DOI 10.1210/jc.2005-1689; Antonelli A, 2009, J CLIN ENDOCR METAB, V94, P1803, DOI 10.1210/jc.2008-2450; Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Asman P, 2003, ACTA OPHTHALMOL SCAN, V81, P437, DOI 10.1034/j.1600-0420.2003.00147.x; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bahn RS, 2002, THYROID, V12, P193, DOI 10.1089/105072502753600124; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bartley GB, 1996, AM J OPHTHALMOL, V121, P284, DOI 10.1016/S0002-9394(14)70276-4; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Cheng HC, 2008, MOL VIS, V14, P95; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dorkhan M, 2006, CLIN ENDOCRINOL, V65, P35, DOI 10.1111/j.1365-2265.2006.02542.x; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; FELDON SE, 1982, ARCH OPHTHALMOL-CHIC, V100, P1266, DOI 10.1001/archopht.1982.01030040244006; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Guo BL, 2004, DIABETES, V53, P200, DOI 10.2337/diabetes.53.1.200; Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200; Guo NX, 2010, J BIOL CHEM, V285, P15794, DOI 10.1074/jbc.M109.074534; Han R, 2006, ENDOCRINOLOGY, V147, P13, DOI 10.1210/en.2005-1018; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; HEUFELDER AE, 1993, MED KLIN, V88, P181; HEUFELDER AE, 1994, INVEST OPHTH VIS SCI, V35, P120; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KORDUCKI JM, 1992, INVEST OPHTH VIS SCI, V33, P2037; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lee Seongmu, 2007, BMC Ophthalmol, V7, P8, DOI 10.1186/1471-2415-7-8; Lehmann GM, 2008, PPAR RES, V2008, DOI 10.1155/2008/895901; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Levin F, 2005, ARCH OPHTHALMOL-CHIC, V123, P119, DOI 10.1001/archopht.123.1.119; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; MOURITS MP, 1989, BRIT J OPHTHALMOL, V73, P639, DOI 10.1136/bjo.73.8.639; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Saika S, 2007, AM J PHYSIOL-CELL PH, V293, pC75, DOI 10.1152/ajpcell.00332.2006; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Skoog T, 2006, EXP DERMATOL, V15, P775, DOI 10.1111/j.1600-0625.2006.00460.x; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Smith TJ, 2002, J CLIN ENDOCR METAB, V87, P385, DOI 10.1210/jc.87.1.385; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; Starkey K, 2003, J CLIN ENDOCR METAB, V88, P55, DOI 10.1210/jc.2002-020987; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Steensel L, 2009, INVEST OPHTH VIS SCI, V50, P3091, DOI 10.1167/iovs.08-2443; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; WEETMAN AP, 1989, CLIN EXP IMMUNOL, V75, P222; Yamanaka O, 2009, INVEST OPHTH VIS SCI, V50, P187, DOI 10.1167/iovs.08-2282; Zhang GY, 2010, J PLAST RECONSTR AES, V63, P1209, DOI 10.1016/j.bjps.2009.06.032	61	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18856	18867		10.1074/jbc.M110.179317	http://dx.doi.org/10.1074/jbc.M110.179317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454487	hybrid, Green Published			2022-12-25	WOS:000290785700058
J	Liu, SL; Needham, KM; May, JR; Nolen, BJ				Liu, Su-Ling; Needham, Karen M.; May, Jordan R.; Nolen, Brad J.			Mechanism of a Concentration-dependent Switch between Activation and Inhibition of Arp2/3 Complex by Coronin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT NETWORK FORMATION; BINDING PROTEIN CORONIN; ACTIN-FILAMENT; FISSION YEAST; F-ACTIN; CONFORMATIONAL-CHANGES; WASP/SCAR PROTEINS; BRANCH FORMATION; DISTINCT ROLES; CROSS-LINKING	Arp2/3 complex is a key actin filament nucleator that assembles branched actin networks in response to cellular signals. The activity of Arp2/3 complex is regulated by both activating and inhibitory proteins. Coronins make up a large class of actin-binding proteins previously shown to inhibit Arp2/3 complex. Although coronins are known to play a role in controlling actin dynamics in diverse processes, including endocytosis and cell motility, the precise mechanism by which they regulate Arp2/3 complex is unclear. We conducted a detailed biochemical analysis of budding yeast coronin, Crn1, and found that it not only inhibits Arp2/3 complex but also activates it. We mapped regions required for activation and found that Crn1 contains a sequence called CA, which is conserved in WASp/Scar proteins, the prototypical activators of Arp2/3 complex. Point mutations in CA abolished activation of Arp2/3 complex by Crn1 in vitro. Confocal microscopy and quantitative actin patch tracking showed that these mutants had defective endocytic actin patch dynamics in Saccharomyces cerevisiae, indicating that activation of Arp2/3 complex by coronin is required for normal actin dynamics in vivo. The switch between the dual modes of regulation by Crn1 is controlled by concentration, and low concentrations of Crn1 enhance filament binding by Arp2/3 complex, whereas high concentrations block binding. Our data support a direct tethering recruitment model for activation of Arp2/3 complex by Crn1 and suggest that Crn1 indirectly inhibits Arp2/3 complex by blocking it from binding actin filaments.	Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Nolen, BJ (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Nolen, Brad/0000-0002-0224-9980	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (to B. J. N).	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gandhi M, 2010, J BIOL CHEM, V285, P34899, DOI 10.1074/jbc.M110.171496; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200	55	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17039	17046		10.1074/jbc.M111.219964	http://dx.doi.org/10.1074/jbc.M111.219964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454476	Green Published, hybrid			2022-12-25	WOS:000290301900054
J	Harvey, A; Zukoff, S				Harvey, Alan; Zukoff, Sarah			Wind-Powered Wheel Locomotion, Initiated by Leaping Somersaults, in Larvae of the Southeastern Beach Tiger Beetle (Cicindela dorsalis media)	PLOS ONE			English	Article							PARASITIC NEMATODE; SOUTH-CAROLINA; BEHAVIOR; COLEOPTERA; KINEMATICS; DISPERSAL; MECHANISM; MOISTURE; DIPTERA	Rapid movement is challenging for elongate, soft-bodied animals with short or no legs. Leaping is known for only a few animals with this "worm-like" morphology. Wheel locomotion, in which the animal's entire body rolls forward along a central axis, has been reported for only a handful of animals worldwide. Here we present the first documented case of wind-powered wheel locomotion, in larvae of the coastal tiger beetle Cicindela dorsalis media. When removed from their shallow burrows, larvae easily can be induced to enter a behavioral sequence that starts with leaping; while airborne, larvae loop their body into a rotating wheel and usually either "hit the ground rolling" or leap again. The direction larvae wheel is closely related to the direction in which winds are blowing; thus, all our larvae wheeled up-slope, as winds at our study site consistently blew from sea to land. Stronger winds increased both the proportion of larvae wheeling, and the distance traveled, exceeding 60 m in some cases. In addition, the proportion of larvae that wheel and the distance traveled by wheeling larvae are significantly greater on smooth sandy beaches than on beach surfaces made rough and irregular by pedestrian, equestrian, and vehicular traffic. Like other coastal species of tiger beetles, C. dorsalis media has suffered major declines in recent years that are clearly correlated with increased human impacts. The present study suggests that the negative effects of beach traffic may be indirect, preventing larvae from escaping from predators using wheel locomotion by disrupting the flat, hard surface necessary for efficient wheeling.	[Harvey, Alan] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Zukoff, Sarah] Univ Missouri, Div Plant Sci, Columbia, MO USA	University System of Georgia; Georgia Southern University; University of Missouri System; University of Missouri Columbia	Harvey, A (corresponding author), Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA.	aharvey@georgiasouthern.edu		Zukoff, Sarah/0000-0002-4918-3667	University of Missouri	University of Missouri	The only funding support for this research was a $500 travel grant to Sarah Zukoff from the University of Missouri graduate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Cohen Y, 2005, STRAIN, V41, P19, DOI 10.1111/j.1475-1305.2004.00161.x; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; Bonduriansky R, 2002, CAN ENTOMOL, V134, P647, DOI 10.4039/Ent134647-5; Brackenbury J, 1999, J INSECT PHYSIOL, V45, P525, DOI 10.1016/S0022-1910(98)00157-7; Brackenbury J, 1997, NATURE, V390, P453, DOI 10.1038/37253; Brust ML, 2006, J INSECT BEHAV, V19, P251, DOI 10.1007/s10905-006-9021-8; CALDWELL RL, 1979, NATURE, V282, P71, DOI 10.1038/282071a0; CAMAZINE S, 1986, ANN ENTOMOL SOC AM, V79, P140, DOI 10.1093/aesa/79.1.140; Campbell JF, 1999, NATURE, V397, P485, DOI 10.1038/17254; Campbell JF, 1999, CAN J ZOOL, V77, P1947, DOI 10.1139/cjz-77-12-1947; CASEY TM, 1991, SCIENCE, V252, P112, DOI 10.1126/science.252.5002.112; Ciegler JC, 1997, COLEOPTS BULL, V51, P177; CIEGLER JC, 2005, WHITE BEACH TIGER BE; GOULD SJ, 1981, NAT HIST, V90, P42; HENSCHEL JR, 1990, S AFR J SCI, V86, P151; Knisley C. B., 1997, BIOL TIGER BEETLES G; LaBarbera M., 1983, AM NAT, V121, P385; MAITLAND DP, 1992, NATURE, V355, P159, DOI 10.1038/355159a0; MAITLAND DP, 1991, S AFR J SCI, V87, P85; Menzel D, 1993, OCEAN PROCESSES US S; *NAT PARKS CONS AS, 2009, CUMB ISL NAT SEASH R; NOTHNAGLE P, 1990, ECOLOGY NE BEACH TIG; Pearson DL, 2006, FIELD GUIDE TIGER BE; PEARSON DL, 2001, TIGER BEETLES EVOLUT; REED EM, 1965, NATURE, V206, P210, DOI 10.1038/206210a0; Schurr FM, 2005, J ECOL, V93, P1017, DOI 10.1111/j.1365-2745.2005.01018.x; US Fish and Wildlife Service, 1994, NE BEACH TIG BEETL C; VOGLER AP, 1993, EVOLUTION, V47, P1192, DOI 10.1111/j.1558-5646.1993.tb02146.x; WILSON EO, 1973, ANIM BEHAV, V21, P292, DOI 10.1016/S0003-3472(73)80069-7; YARBROUGH WW, 1994, ENTOMOL NEWS, V105, P189	30	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17746	10.1371/journal.pone.0017746	http://dx.doi.org/10.1371/journal.pone.0017746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448275	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500012
J	Shultz, JL; Voziyanova, E; Konieczka, JH; Voziyanov, Y				Shultz, Jeffry L.; Voziyanova, Eugenia; Konieczka, Jay H.; Voziyanov, Yuri			A Genome-Wide Analysis of FRT-Like Sequences in the Human Genome	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINASE; HIDDEN MARKOV MODEL; FLP RECOMBINASE; CRE RECOMBINASE; TARGET SITES; SPECIFICITY; EVOLUTION; CHROMOSOME; MUTATIONS; VARIANTS	Efficient and precise genome manipulations can be achieved by the Flp/FRT system of site-specific DNA recombination. Applications of this system are limited, however, to cases when target sites for Flp recombinase, FRT sites, are pre-introduced into a genome locale of interest. To expand use of the Flp/FRT system in genome engineering, variants of Flp recombinase can be evolved to recognize pre-existing genomic sequences that resemble FRT and thus can serve as recombination sites. To understand the distribution and sequence properties of genomic FRT-like sites, we performed a genome-wide analysis of FRT-like sites in the human genome using the experimentally-derived parameters. Out of 642,151 identified FRT-like sequences, 581,157 sequences were unique and 12,452 sequences had at least one exact duplicate. Duplicated FRT-like sequences are located mostly within LINE1, but also within LTRs of endogenous retroviruses, Alu repeats and other repetitive DNA sequences. The unique FRT-like sequences were classified based on the number of matches to FRT within the first four proximal bases pairs of the Flp binding elements of FRT and the nature of mismatched base pairs in the same region. The data obtained will be useful for the emerging field of genome engineering.	[Shultz, Jeffry L.; Voziyanova, Eugenia; Voziyanov, Yuri] Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71270 USA; [Konieczka, Jay H.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA	University of Louisiana System; Louisiana Technical University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shultz, JL (corresponding author), Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71270 USA.	voziyan@latech.edu			NIH [NIGMS R01GM085848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085848] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NIH (NIGMS R01GM085848) to YV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kalari Krishna R., 2006, In Silico Biology, V6, P237; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Konieczka JH, 2004, J MOL BIOL, V339, P365, DOI 10.1016/j.jmb.2004.03.060; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rufer AW, 2002, NUCLEIC ACIDS RES, V30, P2764, DOI 10.1093/nar/gkf399; Sambrook J, 2001, MOL CLONING LAB MANU; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Sellis D, 2007, MOL BIOL EVOL, V24, P2385, DOI 10.1093/molbev/msm181; SENECOFF JF, 1988, J MOL BIOL, V201, P405, DOI 10.1016/0022-2836(88)90147-7; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tay Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1089; UMLAUF SW, 1988, EMBO J, V7, P1845, DOI 10.1002/j.1460-2075.1988.tb03017.x; Voziyanov Y, 2003, J MOL BIOL, V326, P65, DOI 10.1016/S0022-2836(02)01364-5; Voziyanov Y, 2002, NUCLEIC ACIDS RES, V30, P1656, DOI 10.1093/nar/30.7.1656; Yada T, 1998, BIOINFORMATICS, V14, P317, DOI 10.1093/bioinformatics/14.4.317	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18077	10.1371/journal.pone.0018077	http://dx.doi.org/10.1371/journal.pone.0018077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448289	gold, Green Published, Green Submitted			2022-12-25	WOS:000288810500033
J	Badisco, L; Huybrechts, J; Simonet, G; Verlinden, H; Marchal, E; Huybrechts, R; Schoofs, L; De Loof, A; Broeck, JV				Badisco, Liesbeth; Huybrechts, Jurgen; Simonet, Gert; Verlinden, Heleen; Marchal, Elisabeth; Huybrechts, Roger; Schoofs, Liliane; De Loof, Arnold; Broeck, Jozef Vanden			Transcriptome Analysis of the Desert Locust Central Nervous System: Production and Annotation of a Schistocerca gregaria EST Database	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; NEUROPEPTIDE-F-RECEPTOR; CRUSTACEAN CARDIOACTIVE PEPTIDE; 2 CARDIOACCELERATORY PEPTIDES; FOLLICLE-STIMULATING-HORMONE; AFRICAN MALARIA MOSQUITO; PROHORMONE CONVERTASE 2; AMINO-ACID-SEQUENCE; CORPORA-CARDIACA; DROSOPHILA-MELANOGASTER	Background: The desert locust (Schistocerca gregaria) displays a fascinating type of phenotypic plasticity, designated as 'phase polyphenism'. Depending on environmental conditions, one genome can be translated into two highly divergent phenotypes, termed the solitarious and gregarious (swarming) phase. Although many of the underlying molecular events remain elusive, the central nervous system (CNS) is expected to play a crucial role in the phase transition process. Locusts have also proven to be interesting model organisms in a physiological and neurobiological research context. However, molecular studies in locusts are hampered by the fact that genome/transcriptome sequence information available for this branch of insects is still limited. Methodology: We have generated 34,672 raw expressed sequence tags (EST) from the CNS of desert locusts in both phases. These ESTs were assembled in 12,709 unique transcript sequences and nearly 4,000 sequences were functionally annotated. Moreover, the obtained S. gregaria EST information is highly complementary to the existing orthopteran transcriptomic data. Since many novel transcripts encode neuronal signaling and signal transduction components, this paper includes an overview of these sequences. Furthermore, several transcripts being differentially represented in solitarious and gregarious locusts were retrieved from this EST database. The findings highlight the involvement of the CNS in the phase transition process and indicate that this novel annotated database may also add to the emerging knowledge of concomitant neuronal signaling and neuroplasticity events. Conclusions: In summary, we met the need for novel sequence data from desert locust CNS. To our knowledge, we hereby also present the first insect EST database that is derived from the complete CNS. The obtained S. gregaria EST data constitute an important new source of information that will be instrumental in further unraveling the molecular principles of phase polyphenism, in further establishing locusts as valuable research model organisms and in molecular evolutionary and comparative entomology.	[Badisco, Liesbeth; Huybrechts, Jurgen; Simonet, Gert; Verlinden, Heleen; Marchal, Elisabeth; Huybrechts, Roger; Schoofs, Liliane; De Loof, Arnold; Broeck, Jozef Vanden] Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Leuven, Belgium	KU Leuven	Badisco, L (corresponding author), Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Leuven, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	schoofs, liliane/ABD-2943-2020; Huybrechts, Roger R/D-1650-2009; Verlinden, Heleen/D-1033-2011; Schoofs, Liliane/F-2815-2010	Huybrechts, Roger R/0000-0003-3950-8920; Verlinden, Heleen/0000-0001-6721-3973; Marchal, Elisabeth/0000-0003-1310-4792; Vanden Broeck, Jozef/0000-0001-7653-0516; Schoofs, Liliane/0000-0002-1673-432X	K.U. Leuven Research Foundation [GOA 2005/06]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program [P6/14]; 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT); FWO	K.U. Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO(FWO)	This work was supported by grants from the K.U. Leuven Research Foundation (GOA 2005/06, www.kuleuven.be/bof), the Research Foundation of Flanders (FWO-Flanders, www.fwo.be) and the Interuniversity Attraction Poles program (Belgian Science Policy Grant P6/14, www.belspo.be). L.B., H.V. and E.M. were supported by a scholarship from the 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT) and J.H. obtained a postdoctoral research fellowship from the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Mena MA, 2009, CURR TOP MED CHEM, V9, P880; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUDSLEY N, 1992, J EXP BIOL, V173, P261; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; AXELROD J, 1977, NATURE, V265, P501, DOI 10.1038/265501a0; Badisco L, 2008, J MOL ENDOCRINOL, V40, P137, DOI 10.1677/JME-07-0161; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; BENJANNET S, 1995, FEBS LETT, V362, P151, DOI 10.1016/0014-5793(95)00228-2; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; Berthier K, 2010, ADV INSECT PHYSIOL, V39, P1, DOI 10.1016/S0065-2806(10)39001-1; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; BOUREME D, 1989, J INSECT PHYSIOL, V35, P265, DOI 10.1016/0022-1910(89)90073-5; BOYAN G, 1995, DEVELOPMENT, V121, P75; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199; Broeck JV, 2001, ARCH INSECT BIOCHEM, V48, P1, DOI 10.1002/arch.1054; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; CHRISTENSON JG, 1972, P NATL ACAD SCI USA, V69, P343, DOI 10.1073/pnas.69.2.343; Claeys I, 2005, VITAM HORM, V73, P217, DOI 10.1016/S0083-6729(05)73007-7; Claeys I, 2006, BIOCHEM BIOPH RES CO, V341, P599, DOI 10.1016/j.bbrc.2006.01.011; Claeys I, 2005, INSECT MOL BIOL, V14, P415, DOI 10.1111/j.1365-2583.2005.00572.x; Claeys I, 2003, INSECT MOL BIOL, V12, P473, DOI 10.1046/j.1365-2583.2003.00431.x; Clynen E, 2003, BIOCHEM BIOPH RES CO, V300, P422, DOI 10.1016/S0006-291X(02)02869-3; Clynen E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-201; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Clynen E, 2009, ANN NY ACAD SCI, V1163, P60, DOI 10.1111/j.1749-6632.2008.03624.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORLESS CL, 1987, J CELL BIOL, V104, P1173, DOI 10.1083/jcb.104.5.1173; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; CURRY WJ, 1992, COMP BIOCHEM PHYS C, V101, P269, DOI 10.1016/0742-8413(92)90272-9; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Donini A, 2001, J INSECT PHYSIOL, V47, P277, DOI 10.1016/S0022-1910(00)00112-8; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; FOURNIER B, 1987, GEN COMP ENDOCR, V68, P49, DOI 10.1016/0016-6480(87)90059-1; FRAENKEL G, 1966, SCIENCE, V151, P91, DOI 10.1126/science.151.3706.91; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Gade G, 2005, PHYSIOL ENTOMOL, V30, P103, DOI 10.1111/j.1365-3032.2005.00442.x; GADE G, 1984, H-S Z PHYSIOL CHEM, V365, P393, DOI 10.1515/bchm2.1984.365.1.393; Gade G, 2009, ANN NY ACAD SCI, V1163, P125, DOI 10.1111/j.1749-6632.2008.03625.x; Garczynski SF, 2005, PEPTIDES, V26, P99, DOI 10.1016/j.peptides.2004.07.014; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Garczynski SF, 2007, PEPTIDES, V28, P109, DOI 10.1016/j.peptides.2006.09.019; Geva N, 2010, NEUROBIOL LEARN MEM, V93, P175, DOI 10.1016/j.nlm.2009.09.008; GIRARDIE J, 1991, EUR J BIOCHEM, V202, P1121, DOI 10.1111/j.1432-1033.1991.tb16479.x; Girardie J, 1998, INSECT BIOCHEM MOLEC, V28, P641, DOI 10.1016/S0965-1748(98)00053-8; GIRARDIE J, 1989, FEBS LETT, V245, P4, DOI 10.1016/0014-5793(89)80179-6; Goldsworthy GJ, 1997, COMP BIOCHEM PHYS B, V117, P483, DOI 10.1016/S0305-0491(97)00186-7; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Hagele BF, 2000, J INSECT PHYSIOL, V46, P1295, DOI 10.1016/S0022-1910(00)00051-2; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; HIETTER H, 1991, INSECT BIOCHEM, V21, P259, DOI 10.1016/0020-1790(91)90015-7; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Hoste B, 2002, ENTOMOL EXP APPL, V104, P281, DOI 10.1023/A:1021207518712; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; HUESMANN GR, 1995, FEBS LETT, V371, P311, DOI 10.1016/0014-5793(95)00929-4; Huising MO, 2005, ENDOCRINOLOGY, V146, P2165, DOI 10.1210/en.2004-1514; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huybrechts J, 2003, PHYSIOL ENTOMOL, V28, P46, DOI 10.1046/j.1365-3032.2003.00321.x; Hwang JR, 2000, J BIOL CHEM, V275, P17886, DOI 10.1074/jbc.M000032200; ICHIYAMA A, 1970, J BIOL CHEM, V245, P1699; Isaac RE, 2002, PEPTIDES, V23, P725, DOI 10.1016/S0196-9781(01)00653-2; Isaac RE, 1998, BIOCHEM J, V330, P61, DOI 10.1042/bj3300061; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Ja WW, 2009, PROTEIN SCI, V18, P2203, DOI 10.1002/pro.221; Janssen T, 2001, INSECT MOL BIOL, V10, P183, DOI 10.1046/j.1365-2583.2001.00257.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; KATAOKA H, 1989, P NATL ACAD SCI USA, V86, P2976, DOI 10.1073/pnas.86.8.2976; KAY I, 1991, BIOL CHEM H-S, V372, P929, DOI 10.1515/bchm3.1991.372.2.929; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kloppenburg P, 2008, ANNU REV ENTOMOL, V53, P179, DOI 10.1146/annurev.ento.53.103106.093408; Knoepfel Thomas, 2008, V44, P163, DOI 10.1007/400_2007_035; Kumar CG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-176; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; LAGUEUX M, 1992, INSECT BIOCHEM MOLEC, V22, P511, DOI 10.1016/0965-1748(92)90027-C; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LEHMBERG E, 1991, BIOCHEM BIOPH RES CO, V179, P1036, DOI 10.1016/0006-291X(91)91923-Z; Lester RL, 2005, J INSECT PHYSIOL, V51, P737, DOI 10.1016/j.jinsphys.2005.03.015; LEUNG PS, 1992, REGUL PEPTIDES, V41, P71, DOI 10.1016/0167-0115(92)90515-V; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Macdonald LE, 2005, P NATL ACAD SCI USA, V102, P2496, DOI 10.1073/pnas.0409849102; Macins A, 1999, ARCH INSECT BIOCHEM, V40, P107, DOI 10.1002/(SICI)1520-6327(1999)40:2&lt;107::AID-ARCH5&gt;3.0.CO;2-B; Macours N, 2004, INT REV CYTOL, V239, P47, DOI 10.1016/S0074-7696(04)39002-9; Macours N, 2004, INSECT BIOCHEM MOLEC, V34, P501, DOI 10.1016/j.ibmb.2004.03.007; Macours N, 2003, J INSECT PHYSIOL, V49, P739, DOI 10.1016/S0022-1910(03)00110-0; Macours N, 2003, INSECT MOL BIOL, V12, P233, DOI 10.1046/j.1365-2583.2003.00406.x; MARSHALL J, 1988, BIOCHEM SOC T, V16, P463, DOI 10.1042/bst0160463; MARSHALL J, 1990, EMBO J, V9, P4391, DOI 10.1002/j.1460-2075.1990.tb07889.x; MAULE AG, 1992, PARASITOLOGY, V105, P505, DOI 10.1017/S0031182000074680; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; Mercer AR, 1996, J NEUROBIOL, V29, P49, DOI 10.1002/(SICI)1097-4695(199601)29:1<49::AID-NEU4>3.0.CO;2-7; Meredith J, 1996, J EXP BIOL, V199, P1053; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; MINTH CD, 1984, P NATL ACAD SCI-BIOL, V81, P4577, DOI 10.1073/pnas.81.14.4577; Molina Y, 2008, DEV NEUROBIOL, V68, P950, DOI 10.1002/dneu.20633; Molina Y, 2007, BRAIN BEHAV EVOLUT, V70, P137, DOI 10.1159/000102975; MOREAU R, 1988, ARCH INSECT BIOCHEM, V8, P135, DOI 10.1002/arch.940080207; Morris MB, 2009, INT J BIOCHEM CELL B, V41, P721, DOI 10.1016/j.biocel.2008.04.025; MURPHYULLRICH JE, 1991, J CELL BIOL, V115, P1127, DOI 10.1083/jcb.115.4.1127; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; PAEMEN L, 1991, PEPTIDES, V12, P7, DOI 10.1016/0196-9781(91)90158-L; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; PENER MP, 1991, ADV INSECT PHYSL; Phillips JE, 1996, J EXP ZOOL, V275, P292, DOI 10.1002/(SICI)1097-010X(19960701)275:4&lt;292::AID-JEZ7&gt;3.0.CO;2-K; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rahman MM, 2008, J INSECT PHYSIOL, V54, P543, DOI 10.1016/j.jinsphys.2007.12.003; Rahman MM, 2003, COMP BIOCHEM PHYS A, V135, P221, DOI 10.1016/S1095-6433(03)00050-3; Rahman MM, 2002, PEPTIDES, V23, P1907, DOI 10.1016/S0196-9781(02)00175-4; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Riveros AJ, 2010, BRAIN BEHAV EVOLUT, V75, P138, DOI 10.1159/000306506; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1989, J MOL CELL CARDIOL, V21, P13, DOI 10.1016/0022-2828(89)90833-X; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Schoofs L, 1998, BRAIN RES, V785, P215, DOI 10.1016/S0006-8993(97)01398-X; SCHOOFS L, 1990, FEBS LETT, V261, P397, DOI 10.1016/0014-5793(90)80601-E; Schoofs L, 1997, PEPTIDES, V18, P145, DOI 10.1016/S0196-9781(96)00236-7; SCHOOFS L, 1993, INSECT BIOCHEM MOLEC, V23, P859, DOI 10.1016/0965-1748(93)90104-Z; SCHOOFS L, 1990, REGUL PEPTIDES, V31, P199, DOI 10.1016/0167-0115(90)90006-I; SCHULZAELLEN MF, 1989, NEURON, V2, P1369, DOI 10.1016/0896-6273(89)90075-5; Seidah N G, 1992, NIDA Res Monogr, V126, P132; SEIDAH NG, 1991, ENZYME, V45, P271, DOI 10.1159/000468901; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P175; Siegert KJ, 1999, FEBS LETT, V447, P237, DOI 10.1016/S0014-5793(99)00299-9; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; SONG H, 2011, PSYCHE IN PRESS; Song Hojun, 2005, Journal of Orthoptera Research, V14, P235, DOI 10.1665/1082-6467(2005)14[235:PPOTEO]2.0.CO;2; Song H, 2008, CLADISTICS, V24, P515, DOI 10.1111/j.1096-0031.2007.00190.x; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; STANGIER J, 1987, P NATL ACAD SCI USA, V84, P575, DOI 10.1073/pnas.84.2.575; STANGIER J, 1989, J COMP PHYSIOL B, V159, P5, DOI 10.1007/BF00692677; STONE JV, 1976, NATURE, V263, P207, DOI 10.1038/263207a0; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Towner P, 1997, VISION RES, V37, P495, DOI 10.1016/S0042-6989(96)00198-8; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; TUBLITZ NJ, 1985, J EXP BIOL, V116, P395; TUBLITZ NJ, 1985, J EXP BIOL, V114, P381; TUBLITZ NJ, 1985, J EXP BIOL, V114, P365; TUBLITZ NJ, 1985, SCIENCE, V228, P1013, DOI 10.1126/science.4001929; Uvarov B, 1977, GRASSHOPPERS LOCUSTS; Uvarov BP, 1966, GRASSHOPPERS LOCUSTS; Van der Horst DJ, 2001, INT REV CYTOL, V211, P179, DOI 10.1016/S0074-7696(01)11019-3; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Van Loy T, 2007, GEN COMP ENDOCR, V153, P59, DOI 10.1016/j.ygcen.2006.12.004; Vanden Broeck J J, 1996, Int Rev Cytol, V164, P189; VandenBroeck J, 1996, MOL CELL ENDOCRINOL, V122, P191, DOI 10.1016/0303-7207(96)03890-7; VANDENBROECK J, 1995, J NEUROCHEM, V64, P2387; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; VANHEMS E, 1990, EUR J NEUROSCI, V2, P776, DOI 10.1111/j.1460-9568.1990.tb00468.x; Veelaert D, 1997, ENDOCRINOLOGY, V138, P138, DOI 10.1210/en.138.1.138; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P161, DOI 10.1016/j.ibmb.2008.10.014; Verleyen P, 2009, PEPTIDES, V30, P522, DOI 10.1016/j.peptides.2008.12.006; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; Wegener C, 2002, PEPTIDES, V23, P605, DOI 10.1016/S0196-9781(01)00665-9; Wegener C, 1999, ARCH INSECT BIOCHEM, V40, P203, DOI 10.1002/(SICI)1520-6327(1999)40:4&lt;203::AID-ARCH5&gt;3.0.CO;2-C; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; WILMORE PJ, 1975, CHROMOSOMA, V51, P337, DOI 10.1007/BF00326320; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Wu RX, 2006, J MOL MED, V84, P241, DOI 10.1007/s00109-005-0026-0; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	225	74	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17274	10.1371/journal.pone.0017274	http://dx.doi.org/10.1371/journal.pone.0017274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445293	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300006
J	Billard, MJ; Gruver, AL; Sempowski, GD				Billard, Matthew J.; Gruver, Amanda L.; Sempowski, Gregory D.			Acute Endotoxin-Induced Thymic Atrophy Is Characterized By Intrathymic Inflammatory and Wound Healing Responses	PLOS ONE			English	Article							T-CELL-ACTIVATION; DOUBLE-POSITIVE THYMOCYTES; LEUKEMIA INHIBITORY FACTOR; NF-KAPPA-B; HELPER-CELLS; MATRIX METALLOPROTEINASES; NEGATIVE SELECTION; ACTIN CYTOSKELETON; LEPTIN PROTECTS; MICE	Background: Productive thymopoiesis is essential for a robust and healthy immune system. Thymus unfortunately is acutely sensitive to stress resulting in involution and decreased T cell production. Thymic involution is a complication of many clinical settings, including infection, malnutrition, starvation, and irradiation or immunosuppressive therapies. Systemic rises in glucocorticoids and inflammatory cytokines are known to contribute to thymic atrophy. Little is known, however, about intrathymic mechanisms that may actively contribute to thymus atrophy or initiate thymic recovery following stress events. Methodology/Principal Findings: Phenotypic, histologic and transcriptome/pathway analysis of murine thymic tissue during the early stages of endotoxemia-induced thymic involution was performed to identify putative mechanisms that drive thymic involution during stress. Thymus atrophy in this murine model was confirmed by down-regulation of genes involved in T cell development, cell activation, and cell cycle progression, correlating with observed phenotypic and histologic thymus involution. Significant gene changes support the hypothesis that multiple key intrathymic pathways are differentially activated during stress-induced thymic involution. These included direct activation of thymus tissue by LPS through TLR signaling, local expression of inflammatory cytokines, inhibition of T cell signaling, and induction of wound healing/tissue remodeling. Conclusions/Significance: Taken together, these observations demonstrated that in addition to the classic systemic response, a direct intrathymic response to endotoxin challenge concurrently contributes to thymic involution during endotoxemia. These findings are a substantial advancement over current understanding of thymus response to stress and may lead to the development of novel therapeutic approaches to ameliorate immune deficiency associated with stress events.	[Billard, Matthew J.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Gruver, Amanda L.; Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Gruver, Amanda L.; Sempowski, Gregory D.] Duke Univ, Dept Pathol, Dept Med, Durham, NC 27706 USA	Duke University; Duke University; Duke University	Billard, MJ (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA.	gsem@duke.edu		Sempowski, Gregory/0000-0003-0391-6594	NIH (Regional Biocontainment Laboratory at Duke University Medical Center) [RO1 AG25150, NO1 HHSN266200500019C, UC6 AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025150] Funding Source: NIH RePORTER	NIH (Regional Biocontainment Laboratory at Duke University Medical Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by the following NIH grants and contracts: RO1 AG25150, NO1 HHSN266200500019C, and UC6 AI058607 (Regional Biocontainment Laboratory at Duke University Medical Center). Publication content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Brownlie R, 2009, IMMUNITY, V31, P174, DOI 10.1016/j.immuni.2009.08.002; Buhlmann JE, 2003, J IMMUNOL, V170, P5421, DOI 10.4049/jimmunol.170.11.5421; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Chendil D, 2002, CANCER BIOL THER, V1, P152, DOI 10.4161/cbt.61; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gravestein LA, 1996, J EXP MED, V184, P675, DOI 10.1084/jem.184.2.675; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gruver AL, 2009, J ENDOCRINOL, V203, P75, DOI 10.1677/JOE-09-0179; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Huang F, 2006, IMMUNITY, V25, P571, DOI 10.1016/j.immuni.2006.08.021; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue KI, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/101659; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Kwon H, 2004, J IMMUNOL, V173, P6645, DOI 10.4049/jimmunol.173.11.6645; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Liepinsh DJ, 2009, EUR J IMMUNOL, V39, P2906, DOI 10.1002/eji.200839191; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Mastorakos G, 2006, ANN NY ACAD SCI, V1088, P373, DOI 10.1196/annals.1366.021; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; *R PROJ RDCT, 2009, R LANG ENV STAT COMP; Saluk-Juszczak Joanna, 2005, Postepy Biochem, V51, P280; Savino W, 1999, NEUROIMMUNOMODULAT, V6, P126, DOI 10.1159/000026372; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sempowski GD, 2002, EUR J IMMUNOL, V32, P3066, DOI 10.1002/1521-4141(200211)32:11<3066::AID-IMMU3066>3.0.CO;2-J; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sohn SJ, 2003, CURR OPIN IMMUNOL, V15, P209, DOI 10.1016/S0952-7915(03)00004-9; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Takahashi S, 2005, EUR J IMMUNOL, V35, P399, DOI 10.1002/eji.200324746; Takeoka Y, 1999, J AUTOIMMUN, V13, P325, DOI 10.1006/jaut.1999.0325; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035; Wagner DH, 1996, J EXP MED, V184, P1631, DOI 10.1084/jem.184.5.1631; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WANG SD, 1994, J IMMUNOL, V152, P5014; Wang X, 2006, SCAND J IMMUNOL, V64, P287, DOI 10.1111/j.1365-3083.2006.01813.x	64	45	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17940	10.1371/journal.pone.0017940	http://dx.doi.org/10.1371/journal.pone.0017940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437240	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100047
J	Goh, L; Chen, GB; Cutcutache, I; Low, B; Teh, BT; Rozen, S; Tan, P				Goh, Liang; Chen, Geng Bo; Cutcutache, Ioana; Low, Benjamin; Teh, Bin Tean; Rozen, Steve; Tan, Patrick			Assessing Matched Normal and Tumor Pairs in Next-Generation Sequencing Studies	PLOS ONE			English	Article							SOMATIC MUTATIONS; CANCER GENOME; ASSOCIATION	Next generation sequencing technology has revolutionized the study of cancers. Through matched normal-tumor pairs, it is now possible to identify genome-wide germline and somatic mutations. The generation and analysis of the data requires rigorous quality checks and filtering, and the current analytical pipeline is constantly undergoing improvements. We noted however that in analyzing matched pairs, there is an implicit assumption that the sequenced data are matched, without any quality check such as those implemented in association studies. There are serious implications in this assumption as identification of germline and rare somatic variants depend on the normal sample being the matched pair. Using a genetics concept on measuring relatedness between individuals, we demonstrate that the matchedness of tumor pairs can be quantified and should be included as part of a quality protocol in analysis of sequenced data. Despite the mutation changes in cancer samples, matched tumor-normal pairs are still relatively similar in sequence compared to non-matched pairs. We demonstrate that the approach can be used to assess the mutation landscape between individuals.	[Goh, Liang; Chen, Geng Bo; Low, Benjamin; Tan, Patrick] Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Goh, Liang] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Goh, Liang] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cutcutache, Ioana; Rozen, Steve] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore; [Teh, Bin Tean] Natl Canc Ctr, Cellular & Mol Res Natl Canc Ctr Singapore, Van Andel Res Inst, Translat Canc Res Lab, Singapore, Singapore; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Tan, Patrick] Canc Sci Inst Singapore, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Van Andel Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Goh, L (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore.	liang.goh@duke-nus.edu.sg	; Rozen, Steven G./J-5939-2013	Teh, Bin Tean/0000-0003-1514-1124; Rozen, Steven G./0000-0002-4288-0056	Khoo Discovery Award [KDP/2008/0002, KDP/2009/0006]; Singapore Biomedical Research Council [BMRC 05/1/31/19/423]; National Medical Research Council [NMRC TCR/0001/2007]	Khoo Discovery Award; Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LG is supported by Khoo Discovery Award KDP/2008/0002 and KDP/2009/0006. PT is supported by Singapore Biomedical Research Council BMRC 05/1/31/19/423 and National Medical Research Council NMRC TCR/0001/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LI YJ, 2010, OPHTHALMOLOGY; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberson EDO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006711; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Zang ZJ, 2011, CANCER RES, V71, P29, DOI 10.1158/0008-5472.CAN-10-1749	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17810	10.1371/journal.pone.0017810	http://dx.doi.org/10.1371/journal.pone.0017810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445261	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100032
J	Madsen, KM; Udatha, GDBRK; Semba, S; Otero, JM; Koetter, P; Nielsen, J; Ebizuka, Y; Kushiro, T; Panagiotou, G				Madsen, Karina M.; Udatha, Gupta D. B. R. K.; Semba, Saori; Otero, Jose M.; Koetter, Peter; Nielsen, Jens; Ebizuka, Yutaka; Kushiro, Tetsuo; Panagiotou, Gianni			Linking Genotype and Phenotype of Saccharomyces cerevisiae Strains Reveals Metabolic Engineering Targets and Leads to Triterpene Hyper-Producers	PLOS ONE			English	Article							BETA-AMYRIN SYNTHASE; PROTEIN STABILITY; SQUALENE SYNTHASE; CRYSTAL-STRUCTURE; PREDICTION; ACID; ENZYME; BIOSYNTHESIS; EVOLUTION; SEQUENCE	Background: Metabolic engineering is an attractive approach in order to improve the microbial production of drugs. Triterpenes is a chemically diverse class of compounds and many among them are of interest from a human health perspective. A systematic experimental or computational survey of all feasible gene modifications to determine the genotype yielding the optimal triterpene production phenotype is a laborious and time-consuming process. Methodology/Principal Findings: Based on the recent genome-wide sequencing of Saccharomyces cerevisiae CEN. PK 113-7D and its phenotypic differences with the S288C strain, we implemented a strategy for the construction of a beta-amyrin production platform. The genes Erg8, Erg9 and HFA1 contained non-silent SNPs that were computationally analyzed to evaluate the changes that cause in the respective protein structures. Subsequently, Erg8, Erg9 and HFA1 were correlated with the increased levels of ergosterol and fatty acids in CEN. PK 113-7D and single, double, and triple gene over-expression strains were constructed. Conclusions: The six out of seven gene over-expression constructs had a considerable impact on both ergosterol and beta-amyrin production. In the case of beta-amyrin formation the triple over-expression construct exhibited a nearly 500% increase over the control strain making our metabolic engineering strategy the most successful design of triterpene microbial producers.	[Madsen, Karina M.; Otero, Jose M.; Panagiotou, Gianni] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Semba, Saori; Ebizuka, Yutaka; Kushiro, Tetsuo; Panagiotou, Gianni] Univ Tokyo, Bunkyo Ku, Grad Sch Pharmaceut Sci, Tokyo 113, Japan; [Koetter, Peter] Goethe Univ Frankfurt, Inst Microbiol, Frankfurt, Germany; [Udatha, Gupta D. B. R. K.; Otero, Jose M.; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Panagiotou, Gianni] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Tokyo; Goethe University Frankfurt; Chalmers University of Technology; Technical University of Denmark	Madsen, KM (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	gpa@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Nielsen, Jens/Q-1347-2017	Kushiro, Tetsuo/0000-0002-7598-4791; Nielsen, Jens/0000-0002-9955-6003; Udatha, D.B.R.K. Gupta/0000-0003-0163-9407	Danish Research Council for Production and Technology Sciences; Swedish Research Council	Danish Research Council for Production and Technology Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors would like to thank the Danish Research Council for Production and Technology Sciences and the Swedish Research Council for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Carr TP, 2006, ADV FOOD NUTR RES, V51, P165, DOI 10.1016/S1043-4526(06)51003-4; Cheng TMK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000135; Dai MH, 2007, PROTEIN ENG DES SEL, V20, P69, DOI 10.1093/protein/gzl056; Daum G, 1999, YEAST, V15, P601, DOI 10.1002/(SICI)1097-0061(199905)15:7<601::AID-YEA390>3.0.CO;2-N; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; ESCHENMOSER A, 1955, HELV CHIM ACTA, V38, P1890, DOI 10.1002/hlca.19550380728; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Gong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009186; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Houten SM, 2001, MOL GENET METAB, V72, P273, DOI 10.1006/mgme.2000.3133; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lee SY, 2009, DRUG DISCOV TODAY, V14, P78, DOI 10.1016/j.drudis.2008.08.004; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; LEE SY, 1999, METAB ENG, P1; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Morita M, 2000, EUR J BIOCHEM, V267, P3453, DOI 10.1046/j.1432-1327.2000.01357.x; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Newman JRS, 2006, NATURE, V444, P561, DOI 10.1038/nature05407; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen KF, 2000, J CHROMATOGR A, V898, P227, DOI 10.1016/S0021-9673(00)00873-6; Otero JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-723; Panagiotou G, 2006, METAB ENG, V8, P474, DOI 10.1016/j.ymben.2006.04.004; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Randles LG, 2006, J BIOL CHEM, V281, P24216, DOI 10.1074/jbc.M603593200; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Stephanopoulos G, 2004, NAT BIOTECHNOL, V22, P1261, DOI 10.1038/nbt1016; TOH H, 1993, EUR J BIOCHEM, V215, P687, DOI 10.1111/j.1432-1033.1993.tb18080.x; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	76	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14763	10.1371/journal.pone.0014763	http://dx.doi.org/10.1371/journal.pone.0014763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445244	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100003
J	Garrido, D; Kim, JH; German, JB; Raybould, HE; Mills, DA				Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Raybould, Helen E.; Mills, David A.			Oligosaccharide Binding Proteins from Bifidobacterium longum subsp infantis Reveal a Preference for Host Glycans	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; INTESTINAL EPITHELIAL-CELLS; BLOOD-GROUP; ESCHERICHIA-COLI; GENOME SEQUENCE; CACO-2 CELLS; SHIGA TOXIN; GLYCOSPHINGOLIPIDS; LACTOBACILLUS; MICROBIOTA	Bifidobacterium longum subsp. infantis (B. infantis) is a common member of the infant intestinal microbiota, and it has been characterized by its foraging capacity for human milk oligosaccharides (HMO). Its genome sequence revealed an overabundance of the Family 1 of solute binding proteins (F1SBPs), part of ABC transporters and associated with the import of oligosaccharides. In this study we have used the Mammalian Glycan Array to determine the specific affinities of these proteins. This was correlated with binding protein expression induced by different prebiotics including HMO. Half of the F1SBPs in B. infantis were determined to bind mammalian oligosaccharides. Their affinities included different blood group structures and mucin oligosaccharides. Related to HMO, other proteins were specific for oligomers of lacto-N-biose (LNB) and polylactosamines with different degrees of fucosylation. Growth on HMO induced the expression of specific binding proteins that import HMO isomers, but also bind blood group and mucin oligosaccharides, suggesting coregulated transport mechanisms. The prebiotic inulin induced other family 1 binding proteins with affinity for intestinal glycans. Most of the host glycan F1SBPs in B. infantis do not have homologs in other bifidobacteria. Finally, some of these proteins were found to be adherent to intestinal epithelial cells in vitro. In conclusion, this study represents further evidence for the particular adaptations of B. infantis to the infant gut environment, and helps to understand the molecular mechanisms involved in this process.	[Garrido, Daniel; German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Raybould, Helen E.; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Raybould, Helen E.; Mills, David A.] Univ Calif Davis, Funct Glycobiol Program, Davis, CA 95616 USA; [Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Davis, CA 95616 USA; [Kim, Jae Han; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Raybould, Helen E.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Garrido, D (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	damills@ucdavis.edu	Garrido, Daniel/F-8229-2013; Mills, David Andrew/G-2282-2011; Mills, David/GXF-1821-2022	Garrido, Daniel/0000-0002-4982-134X; Mills, David Andrew/0000-0003-1913-9865; kim, Jaehan/0000-0001-9719-9957	University of California; California Dairy Research Foundation; United States Department of Agriculture National Research Initiative [2008-35200-18776]; National Institutes of Health-National Institute of Child Health & Human Development [1R01HD061923]; Fulbright-Conicyt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061923] Funding Source: NIH RePORTER	University of California(University of California System); California Dairy Research Foundation; United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); National Institutes of Health-National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fulbright-Conicyt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible in part by grant support from the University of California Discovery Grant Program, the California Dairy Research Foundation, United States Department of Agriculture National Research Initiative-Cooperative State Research, Education, and Extension Service Award 2008-35200-18776 and National Institutes of Health-National Institute of Child Health & Human Development award 1R01HD061923. DG is the recipient of a Fulbright-Conicyt scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barboza M, 2009, APPL ENVIRON MICROB, V75, P7319, DOI 10.1128/AEM.00842-09; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bouhnik Y, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-8; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Coppa GV, 2006, PEDIATR RES, V59, P377, DOI 10.1203/01.pdr.0000200805.45593.17; CROCIANI F, 1994, INT J FOOD MICROBIOL, V24, P199, DOI 10.1016/0168-1605(94)90119-8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; FINNE J, 1989, J BIOL CHEM, V264, P5720; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P4695, DOI 10.1128/AEM.00124-08; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; HOLGERSSON J, 1988, BIOCHIMIE, V70, P1565, DOI 10.1016/0300-9084(88)90292-1; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; KARLSSON KA, 1981, J BIOL CHEM, V256, P3512; KERANEN A, 1975, BIOCHIM BIOPHYS ACTA, V409, P320, DOI 10.1016/0005-2760(75)90028-4; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kleessen B, 1995, ACTA PAEDIATR, V84, P1347, DOI 10.1111/j.1651-2227.1995.tb13567.x; Kogelberg H, 2004, EUR J BIOCHEM, V271, P1172, DOI 10.1111/j.1432-1033.2004.04021.x; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; LARSON G, 1987, FEBS LETT, V214, P41, DOI 10.1016/0014-5793(87)80009-1; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; MACHER BA, 1980, J BIOL CHEM, V255, P2092; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; MORGAN WTJ, 1969, BRIT MED BULL, V25, P30, DOI 10.1093/oxfordjournals.bmb.a070666; NEWBURG DS, 1992, J INFECT DIS, V166, P832, DOI 10.1093/infdis/166.4.832; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; ORLANDI PA, 1994, BIOCHEMISTRY-US, V33, P12886, DOI 10.1021/bi00209a021; Parche S, 2006, J BACTERIOL, V188, P1260, DOI 10.1128/JB.188.4.1260-1265.2006; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; PODOLSKY DK, 1985, J BIOL CHEM, V260, P5510; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Ventura M, 2001, FEMS MICROBIOL ECOL, V36, P113, DOI 10.1111/j.1574-6941.2001.tb00831.x; Ventura M, 2007, INT J FOOD MICROBIOL, V120, P2, DOI 10.1016/j.ijfoodmicro.2007.06.011; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wu AM, 2003, J BIOMED SCI, V10, P676, DOI 10.1159/000073954; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08; ZIVKOVIC AM, 2010, P NATL ACAD IN PRESS	72	147	151	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17315	10.1371/journal.pone.0017315	http://dx.doi.org/10.1371/journal.pone.0017315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423604	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900006
J	Darpel, KE; Langner, KFA; Nimtz, M; Anthony, SJ; Brownlie, J; Takamatsu, HH; Mellor, PS; Mertens, PPC				Darpel, Karin E.; Langner, Kathrin F. A.; Nimtz, Manfred; Anthony, Simon J.; Brownlie, Joe; Takamatsu, Haru-Hisa; Mellor, Philip S.; Mertens, Peter P. C.			Saliva Proteins of Vector Culicoides Modify Structure and Infectivity of Bluetongue Virus Particles	PLOS ONE			English	Article							HOST IMMUNE-RESPONSE; VARIIPENNIS DIPTERA; GLAND EXTRACTS; FUNCTIONAL-CHARACTERIZATION; SONORENSIS DIPTERA; MOSQUITO SALIVA; AEDES-AEGYPTI; CELL-LINES; CERATOPOGONIDAE; NUBECULOSUS	Bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) are related orbiviruses, transmitted between their ruminant hosts primarily by certain haematophagous midge vectors (Culicoides spp.). The larger of the BTV outer-capsid proteins, 'VP2', can be cleaved by proteases (including trypsin or chymotrypsin), forming infectious subviral particles (ISVP) which have enhanced infectivity for adult Culicoides, or KC cells (a cell-line derived from C. sonorensis). We demonstrate that VP2 present on purified virus particles from 3 different BTV strains can also be cleaved by treatment with saliva from adult Culicoides. The saliva proteins from C. sonorensis (a competent BTV vector), cleaved BTV-VP2 more efficiently than those from C. nubeculosus (a less competent / non-vector species). Electrophoresis and mass spectrometry identified a trypsin-like protease in C. sonorensis saliva, which was significantly reduced or absent from C. nubeculosus saliva. Incubating purified BTV-1 with C. sonorensis saliva proteins also increased their infectivity for KC cells similar to 10 fold, while infectivity for BHK cells was reduced by 2-6 fold. Treatment of an 'eastern' strain of EHDV-2 with saliva proteins of either C. sonorensis or C. nubeculosus cleaved VP2, but a 'western' strain of EHDV-2 remained unmodified. These results indicate that temperature, strain of virus and protein composition of Culicoides saliva (particularly its protease content which is dependent upon vector species), can all play a significant role in the efficiency of VP2 cleavage, influencing virus infectivity. Saliva of several other arthropod species has previously been shown to increase transmission, infectivity and virulence of certain arboviruses, by modulating and/or suppressing the mammalian immune response. The findings presented here, however, demonstrate a novel mechanism by which proteases in Culicoides saliva can also directly modify the orbivirus particle structure, leading to increased infectivity specifically for Culicoides cells and, in turn, efficiency of transmission to the insect vector.	[Darpel, Karin E.; Anthony, Simon J.; Takamatsu, Haru-Hisa; Mellor, Philip S.; Mertens, Peter P. C.] AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England; [Langner, Kathrin F. A.] Univ Vet Med, Immunol Unit, Hannover, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Brownlie, Joe] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; University of London; University of London Royal Veterinary College	Darpel, KE (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England.	karin.darpel@bbsrc.ac.uk	Darpel, Karin/HIK-2423-2022	Mertens, Peter/0000-0002-3438-3738; Darpel, Karin/0000-0002-1488-3233	BBSRC [BB/F00852X/1]; IAH; BBSRC [BBS/E/I/00001441, BBS/E/I/00001445] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00852X/1, BBS/E/I/00001445, BBS/E/I/00001441] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); IAH; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly founded by BBSRC grant BB/F00852X/1 awarded to HHT and PPM. KED was for part of this work also funded by an IAH studentship (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; ANTHONY SJ, 2009, VIRUS GENES IN PRESS; Bishop JV, 2006, AM J TROP MED HYG, V75, P532, DOI 10.4269/ajtmh.2006.75.532; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; Campbell CL, 2005, INSECT MOL BIOL, V14, P121, DOI 10.1111/j.1365-2583.2004.00537.x; CROSS ML, 1994, TROP MED PARASITOL, V45, P119; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel K.E., 2007, THESIS U LONDON; Darpel KE, 2009, BIOL ANIM INFECT, P265, DOI 10.1016/B978-012369368-6.50016-2; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; FU H, THESIS U HERTFORDSHI; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; HOCKING B, 1971, ANNU REV ENTOMOL, V16, P1, DOI 10.1146/annurev.en.16.010171.000245; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; JENNINGS DM, 1987, ARCH VIROL, V95, P177, DOI 10.1007/BF01310778; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langner KFA, 2007, J MED ENTOMOL, V44, P238, DOI 10.1603/0022-2585(2007)44[238:CAAOSP]2.0.CO;2; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x; LUDWIG GV, 1989, VIROLOGY, V171, P108, DOI 10.1016/0042-6822(89)90516-3; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S., 2010, PLOS ONE, V5; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; MACLACHLAN NJ, 1994, COMP IMMUNOL MICROB, V17, P197, DOI 10.1016/0147-9571(94)90043-4; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1971, T ROY SOC TROP MED H, V65, P199, DOI 10.1016/0035-9203(71)90218-5; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Russell CL, 2009, INSECT MOL BIOL, V18, P383, DOI 10.1111/j.1365-2583.2009.00882.x; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Swist SL, 2002, J MED ENTOMOL, V39, P900, DOI 10.1603/0022-2585-39.6.900; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wellby MP, 1996, B ENTOMOL RES, V86, P715, DOI 10.1017/S0007485300039237; Wilson AD, 2008, VET IMMUNOL IMMUNOP, V122, P94, DOI 10.1016/j.vetimm.2007.10.011; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; WITTMANN EJ, THESIS U BRISTOL; [No title captured], DOI DOI 10.1007/BF01863914	52	29	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17545	10.1371/journal.pone.0017545	http://dx.doi.org/10.1371/journal.pone.0017545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423801	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400014
J	McDuff, FKE; Turner, SD				McDuff, Fiona Kate Elizabeth; Turner, Suzanne Dawn			Aberrant Anaplastic Lymphoma Kinase Activity Induces a p53 and Rb-Dependent Senescence-Like Arrest in the Absence of Detectable p53 Stabilization	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; RECEPTOR TYROSINE KINASE; EML4-ALK FUSION GENE; NPM-ALK; ACTIVATING MUTATIONS; HEALTHY-INDIVIDUALS; SUPPRESSOR P53; LUNG-CANCER	Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in a variety of tumor types, most notably in Anaplastic Large Cell Lymphoma (ALCL) where a chromosomal translocation generates the oncogenic fusion protein, Nucleophosmin-ALK (NPM-ALK). Whilst much is known regarding the mechanism of transformation by NPM-ALK, the existence of cellular defence pathways to prevent this pathological process has not been investigated. Employing the highly tractable primary murine embryonic fibroblast (MEF) system we show that cellular transformation is not an inevitable consequence of NPM-ALK activity but is combated by p53 and Rb. Activation of p53 and/or Rb by NPM-ALK triggers a potent proliferative block with features reminiscent of senescence. While loss of p53 alone is sufficient to circumvent NPM-ALK-induced senescence and permit cellular transformation, sole loss of Rb permits continued proliferation but not transformation due to p53-imposed restraints. Furthermore, NPM-ALK attenuates p53 activity in an Rb and MDM2 dependent manner but this activity is not sufficient to bypass senescence. These data indicate that senescence may constitute an effective barrier to ALK-induced malignancies that ultimately must be overcome for tumor development.	[McDuff, Fiona Kate Elizabeth; Turner, Suzanne Dawn] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1QP, England	University of Cambridge	McDuff, FKE (corresponding author), Univ Cambridge, Dept Pathol, Div Mol Histopathol, Tennis Court Rd, Cambridge CB2 1QP, England.	sdt36@cam.ac.uk	Turner, Suzanne Dawn/K-4405-2013	Turner, Suzanne Dawn/0000-0002-8439-4507	Leukaemia and Lymphoma Research [09004]; Wellcome Trust; Cancer Research UK [C19666]	Leukaemia and Lymphoma Research; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This study was sponsored with funding from Leukaemia and Lymphoma Research (09004 to sdt; http://www.beatbloodcancers.org/), Wellcome Trust (PhD studentship to FKEM; http://www.wellcome.ac.uk/), and Cancer Research UK (C19666 to sdt; http://www.cancerresearch-uk.org/charities/cancer-research-uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERNAUX C, 1995, BLOOD, V86, P3118; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cui YX, 2009, BLOOD, V113, P5217, DOI 10.1182/blood-2008-06-160168; Debelenko LV, 2003, LAB INVEST, V83, P1255, DOI 10.1097/01.LAB.0000088856.49388.EA; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Garcia MJ, 2002, BRIT J HAEMATOL, V119, P877, DOI 10.1046/j.1365-2141.2002.03870_3.x; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Ma ZG, 2003, GENE CHROMOSOME CANC, V37, P98, DOI 10.1002/gcc.10177; Maes B, 2001, AM J PATHOL, V158, P2185, DOI 10.1016/S0002-9440(10)64690-1; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Quina AS, 2000, GENE CHROMOSOME CANC, V29, P266, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1030>3.0.CO;2-#; Rassidakis GZ, 2005, LEUKEMIA, V19, P1663, DOI 10.1038/sj.leu.2403840; Rassidakis GZ, 2004, AM J PATHOL, V164, P2259, DOI 10.1016/S0002-9440(10)63782-0; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Summers KE, 2001, J CLIN ONCOL, V19, P420, DOI 10.1200/JCO.2001.19.2.420; TODARO GJ, 1963, J CELL COMPAR PHYSL, V62, P257, DOI 10.1002/jcp.1030620305; Trumper L, 1998, BRIT J HAEMATOL, V103, P1138; Turner SD, 2005, LEUKEMIA, V19, P1128, DOI 10.1038/sj.leu.2403797; Turner SD, 2003, ONCOGENE, V22, P7750, DOI 10.1038/sj.onc.1207048; Turner SD, 2006, ANTICANCER RES, V26, P3275; Yasukawa M, 2001, BLOOD, V98, P486, DOI 10.1182/blood.V98.2.486	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17854	10.1371/journal.pone.0017854	http://dx.doi.org/10.1371/journal.pone.0017854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423761	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400034
J	Bradshaw, CR; Surendranath, V; Henschel, R; Mueller, MS; Habermann, BH				Bradshaw, Charles Richard; Surendranath, Vineeth; Henschel, Robert; Mueller, Matthias Stefan; Habermann, Bianca Hermine			HMMerThread: Detecting Remote, Functional Conserved Domains in Entire Genomes by Combining Relaxed Sequence-Database Searches with Fold Recognition	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; HIDDEN MARKOV-MODELS; VIRUS CORE PROTEIN; KINASE-ANCHORING PROTEIN-2; VHS DOMAIN; TRANSCRIPTIONAL REPRESSION; FAMILIES DATABASE; ENDOSOME DYNAMICS; CRYSTAL-STRUCTURE; GENE ONTOLOGY	Conserved domains in proteins are one of the major sources of functional information for experimental design and genome-level annotation. Though search tools for conserved domain databases such as Hidden Markov Models (HMMs) are sensitive in detecting conserved domains in proteins when they share sufficient sequence similarity, they tend to miss more divergent family members, as they lack a reliable statistical framework for the detection of low sequence similarity. We have developed a greatly improved HMMerThread algorithm that can detect remotely conserved domains in highly divergent sequences. HMMerThread combines relaxed conserved domain searches with fold recognition to eliminate false positive, sequence-based identifications. With an accuracy of 90%, our software is able to automatically predict highly divergent members of conserved domain families with an associated 3-dimensional structure. We give additional confidence to our predictions by validation across species. We have run HMMerThread searches on eight proteomes including human and present a rich resource of remotely conserved domains, which adds significantly to the functional annotation of entire proteomes. We find similar to 4500 cross-species validated, remotely conserved domain predictions in the human proteome alone. As an example, we find a DNA-binding domain in the C-terminal part of the A-kinase anchor protein 10 (AKAP10), a PKA adaptor that has been implicated in cardiac arrhythmias and premature cardiac death, which upon stress likely translocates from mitochondria to the nucleus/nucleolus. Based on our prediction, we propose that with this HLH-domain, AKAP10 is involved in the transcriptional control of stress response. Further remotely conserved domains we discuss are examples from areas such as sporulation, chromosome segregation and signalling during immune response. The HMMerThread algorithm is able to automatically detect the presence of remotely conserved domains in proteins based on weak sequence similarity. Our predictions open up new avenues for biological and medical studies. Genome-wide HMMerThread domains are available at http://vm1-hmmerthread.age.mpg.de.	[Habermann, Bianca Hermine] Max Planck Inst Mol Cell Biol & Genet, Bioinformat Lab, Scionics, Dresden, Saxony, Germany; [Henschel, Robert; Mueller, Matthias Stefan] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp ZIH, Dresden, Saxony, Germany; [Henschel, Robert] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Max Planck Society; Technische Universitat Dresden; Indiana University System; Indiana University Bloomington	Bradshaw, CR (corresponding author), Univ Cambridge, Core Bioinformat Grp, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.	BHabermann@age.mpg.de	Habermann, Bianca/N-4886-2016	Habermann, Bianca/0000-0002-2457-7504; Bradshaw, Charles/0000-0002-3528-458X; Surendranath, Vineeth/0000-0003-1593-6461	BMBF [0313082H]; EU [027269]; Max Planck Society	BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	CRB was supported by BMBF Grant 0313082H "Hepatosys," and VS was supported by EU Grant 027269 "Sealife." This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAUER A, 1994, PROTEINS, V18, P254, DOI 10.1002/prot.340180306; Bradshaw CR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-466; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Burns-Hamuro LL, 2004, METHOD ENZYMOL, V390, P354; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gebauer D, 2004, BIOCHEMISTRY-US, V43, P14873, DOI 10.1021/bi049498y; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hadano S, 2004, FEBS LETT, V575, P64, DOI 10.1016/j.febslet.2004.07.092; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hofmann K, 2000, Brief Bioinform, V1, P167, DOI 10.1093/bib/1.2.167; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee S, 2001, VIROLOGY, V283, P167, DOI 10.1006/viro.2001.0892; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lohi O, 2002, FEBS LETT, V513, P19, DOI 10.1016/S0014-5793(01)03287-2; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; McGuffin LJ, 2004, NUCLEIC ACIDS RES, V32, pD196, DOI 10.1093/nar/gkh043; McNairn AJ, 2008, TRENDS GENET, V24, P382, DOI 10.1016/j.tig.2008.06.002; Mochizuki K, 2008, J CELL SCI, V121, P2148, DOI 10.1242/jcs.031799; Mooney C, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22429; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Oyen M, 2004, CURR GENET, V45, P76, DOI 10.1007/s00294-003-0462-8; Peters JM, 2009, MOL CELL, V34, P1, DOI 10.1016/j.molcel.2009.03.011; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; RAY RB, 1995, VIRUS RES, V37, P209, DOI 10.1016/0168-1702(95)00034-N; Ray RB, 1997, J BIOL CHEM, V272, P10983; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schultz J, 1997, PROTEIN SCI, V6, P249; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Skolnick J, 2001, PROTEINS, V42, P319; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Suzuki-Utsunomiya K, 2007, BIOCHEM BIOPH RES CO, V354, P491, DOI 10.1016/j.bbrc.2006.12.229; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Verni F, 2000, GENETICS, V154, P1693; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	95	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17568	10.1371/journal.pone.0017568	http://dx.doi.org/10.1371/journal.pone.0017568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423752	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100014
J	Guo, N; Parry, EM; Li, LS; Kembou, F; Lauder, N; Hussain, MA; Berggren, PO; Armanios, M				Guo, Nini; Parry, Erin M.; Li, Luo-Sheng; Kembou, Frant; Lauder, Naudia; Hussain, Mehboob A.; Berggren, Per-Olof; Armanios, Mary			Short Telomeres Compromise beta-Cell Signaling and Survival	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DYSKERATOSIS-CONGENITA; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; REPLICATION; TETRAHYMENA; MUTATIONS; APOPTOSIS; LOCI; RNA	The genetic factors that underlie the increasing incidence of diabetes with age are poorly understood. We examined whether telomere length, which is inherited and known to shorten with age, plays a role in the age-dependent increased incidence of diabetes. We show that in mice with short telomeres, insulin secretion is impaired and leads to glucose intolerance despite the presence of an intact beta-cell mass. In ex vivo studies, short telomeres induced cell-autonomous defects in beta-cells including reduced mitochondrial membrane hyperpolarization and Ca2+ influx which limited insulin release. To examine the mechanism, we looked for evidence of apoptosis but found no baseline increase in beta-cells with short telomeres. However, there was evidence of all the hallmarks of senescence including slower proliferation of beta-cells and accumulation of p16(INK4a). Specifically, we identified gene expression changes in pathways which are essential for Ca2+-mediated exocytosis. We also show that telomere length is additive to the damaging effect of endoplasmic reticulum stress which occurs in the late stages of type 2 diabetes. This additive effect manifests as more severe hyperglycemia in Akita mice with short telomeres which had a profound loss of beta-cell mass and increased beta-cell apoptosis. Our data indicate that short telomeres can affect beta-cell metabolism even in the presence of intact beta-cell number, thus identifying a novel mechanism of telomere-mediated disease. They implicate telomere length as a determinant of beta-cell function and diabetes pathogenesis.	[Guo, Nini] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Parry, Erin M.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD USA; [Parry, Erin M.; Kembou, Frant; Armanios, Mary] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Li, Luo-Sheng; Berggren, Per-Olof] Karolinska Inst, Roft Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Lauder, Naudia; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Armanios, Mary] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guo, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	marmani1@jhmi.edu		Parry, Erin/0000-0002-3382-9769; Berggren, Per-Olof/0000-0001-8991-413X	National Institutes of Health [GM007309, CA118416, AG27406]; Maryland Stem Cell Foundation; Sidney Kimmel Foundation; Doris Duke Charitable Foundation; Swedish Research Council; Family Erling-Persson Foundation; NATIONAL CANCER INSTITUTE [K08CA118416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Foundation; Sidney Kimmel Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health: A Ruth L. Kirschstein Award, GM007309, CA118416, AG27406 and awards from the Maryland Stem Cell, Sidney Kimmel, and Doris Duke Charitable Foundations. The in vitro islet work was supported by the Swedish Research Council and the Family Erling-Persson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Elder DA, 2008, PEDIATR BLOOD CANCER, V51, P256, DOI 10.1002/pbc.21589; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Gribbin J, 2009, RESP MED, V103, P927, DOI 10.1016/j.rmed.2008.11.001; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Healy JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000771; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; KUHLOW D, AGING ALBANY NY, V2, P650; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; *PREV CFDCA, 2008, NAT DIAB FACT SHEET; REICHEL M, 1992, PEDIATR DERMATOL, V9, P103, DOI 10.1111/j.1525-1470.1992.tb01223.x; SALPEA KD, 2009, ATHEROSCLEROSIS; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; STEIER W, 1972, BLOOD-J HEMATOL, V39, P510, DOI 10.1182/blood.V39.4.510.510; STEIN KM, 1993, CIRCULATION, V88, P127, DOI 10.1161/01.CIR.88.1.127; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Uhlen Per, 2004, Sci STKE, V2004, ppl15, DOI 10.1126/stke.2582004pl15; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100	50	75	78	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17858	10.1371/journal.pone.0017858	http://dx.doi.org/10.1371/journal.pone.0017858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423765	gold, Green Submitted, Green Published			2022-12-25	WOS:000288219100041
J	Singer, F; Stern, G; Thamrin, C; Fuchs, O; Riedel, T; Gustafsson, P; Frey, U; Latzin, P				Singer, Florian; Stern, Georgette; Thamrin, Cindy; Fuchs, Oliver; Riedel, Thomas; Gustafsson, Per; Frey, Urs; Latzin, Philipp			Tidal Volume Single Breath Washout of Two Tracer Gases - A Practical and Promising Lung Function Test	PLOS ONE			English	Article							PERIPHERAL AIRWAY INVOLVEMENT; ULTRASONIC FLOW SENSOR; VENTILATION DISTRIBUTION; SULFUR-HEXAFLUORIDE; NITROGEN WASHOUT; DISEASE; DIFFUSION; INFANTS; ASTHMA; VARIABILITY	Background: Small airway disease frequently occurs in chronic lung diseases and may cause ventilation inhomogeneity (VI), which can be assessed by washout tests of inert tracer gas. Using two tracer gases with unequal molar mass (MM) and diffusivity increases specificity for VI in different lung zones. Currently washout tests are underutilised due to the time and effort required for measurements. The aim of this study was to develop and validate a simple technique for a new tidal single breath washout test (SBW) of sulfur hexafluoride (SF6) and helium (He) using an ultrasonic flowmeter (USFM). Methods: The tracer gas mixture contained 5% SF6 and 26.3% He, had similar total MM as air, and was applied for a single tidal breath in 13 healthy adults. The USFM measured MM, which was then plotted against expired volume. USFM and mass spectrometer signals were compared in six subjects performing three SBW. Repeatability and reproducibility of SBW, i.e., area under the MM curve (AUC), were determined in seven subjects performing three SBW 24 hours apart. Results: USFM reliably measured MM during all SBW tests (n = 60). MM from USFM reflected SF6 and He washout patterns measured by mass spectrometer. USFM signals were highly associated with mass spectrometer signals, e.g., for MM, linear regression r-squared was 0.98. Intra-subject coefficient of variation of AUC was 6.8%, and coefficient of repeatability was 11.8%. Conclusion: The USFM accurately measured relative changes in SF6 and He washout. SBW tests were repeatable and reproducible in healthy adults. We have developed a fast, reliable, and straightforward USFM based SBW method, which provides valid information on SF6 and He washout patterns during tidal breathing.	[Singer, Florian; Stern, Georgette; Thamrin, Cindy; Fuchs, Oliver; Latzin, Philipp] Univ Childrens Hosp Bern, Dept Paediat, Div Resp Med, Bern, Switzerland; [Riedel, Thomas] Univ Childrens Hosp Bern, Dept Paediat, Paediat & Neonatal Intens Care Unit, Bern, Switzerland; [Gustafsson, Per] Cent Hosp Skovde, Dept Paediat, S-54185 Skovde, Sweden; [Frey, Urs] Univ Childrens Hosp Basel, Dept Paediat, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Basel	Singer, F (corresponding author), Univ Childrens Hosp Bern, Dept Paediat, Div Resp Med, Bern, Switzerland.	philipp.latzin@insel.ch	Singer, Florian/AAO-1460-2021; Singer, Florian/O-7651-2015; Latzin, Philipp/F-2206-2017	Singer, Florian/0000-0003-3471-5664; Singer, Florian/0000-0003-3471-5664; Thamrin, Cindy/0000-0003-3284-3558; Riedel, Thomas/0000-0002-7153-5251; Latzin, Philipp/0000-0002-5239-1571	Confederation's Innovation Promotion Agency [11661.1]; Eco Medics AG [2009/030058A1]	Confederation's Innovation Promotion Agency; Eco Medics AG	The work for this report was funded by the Confederation's Innovation Promotion Agency (CTI; http://www.bbt.admin.ch/kti/) grant no. 11661.1 PFLS-LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The current authors would like to thank Mr. Rudolf Isler for his extremely valuable input in the development of the method and his skilful technical assistance, and Eco Medics AG for supporting this study with their patented equipment (patent no. WO 2009/030058A1, priority date 09/07/2007).	Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; Aurora P, 2010, THORAX, V65, P373, DOI 10.1136/thx.2009.132100; AURORA P, 2010, AM J RESP CRIT CARE, DOI DOI 10.1164/RCCM.200911-16460C; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BUESS C, 1986, J APPL PHYSIOL, V61, P1195, DOI 10.1152/jappl.1986.61.3.1195; CHINN S, 1991, THORAX, V46, P454, DOI 10.1136/thx.46.6.454; Coates AL, 2000, PEDIATR PULM, V30, P1, DOI 10.1002/1099-0496(200007)30:1<1::AID-PPUL1>3.0.CO;2-Q; Contoli M, 2010, ALLERGY, V65, P141, DOI 10.1111/j.1398-9995.2009.02242.x; CRAWFORD ABH, 1985, J APPL PHYSIOL, V59, P838, DOI 10.1152/jappl.1985.59.3.838; CRAWFORD ABH, 1989, J APPL PHYSIOL, V66, P2502, DOI 10.1152/jappl.1989.66.6.2502; Dutrieue B, 1999, J APPL PHYSIOL, V86, P1594, DOI 10.1152/jappl.1999.86.5.1594; Estenne M, 2000, AM J RESP CRIT CARE, V162, P1047, DOI 10.1164/ajrccm.162.3.9912063; Frey U, 2000, EUR RESPIR J, V16, P1016, DOI 10.1183/09031936.00.16510160; Fuchs O, 2011, EUR RESPIR J, V37, P1208, DOI 10.1183/09031936.00125510; Fuchs SI, 2008, PEDIATR PULM, V43, P731, DOI 10.1002/ppul.20825; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Gronkvist M, 2002, J APPL PHYSIOL, V92, P634, DOI 10.1152/japplphysiol.00161.2001; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2007, PEDIATR PULM, V42, P168, DOI 10.1002/ppul.20554; Gustafsson PM, 2003, PEDIATR PULM, V35, P42, DOI 10.1002/ppul.10221; Gustafsson PM, 2003, EUR RESPIR J, V21, P1033, DOI 10.1183/09031936.03.00049302; LACQUET LM, 1982, B EUR PHYSIOPATH RES, V18, P239; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Latzin P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004635; PAIVA M, 1981, RESP PHYSIOL, V44, P325, DOI 10.1016/0034-5687(81)90027-X; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Riedel T, 2009, INTENS CARE MED, V35, P144, DOI 10.1007/s00134-008-1299-x; Robinson PD, 2009, RESPIRATION, V78, P339, DOI 10.1159/000225373; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Stanescu D, 1998, CHEST, V114, P416; Tang Y, 2007, BRIT J ANAESTH, V98, P828, DOI 10.1093/bja/aem090; TECULESCU DB, 1987, CLIN PHYSIOL, V7, P247, DOI 10.1111/j.1475-097X.1987.tb00166.x; TECULESCU DB, 1993, CLIN PHYSIOL, V13, P35, DOI 10.1111/j.1475-097X.1993.tb00315.x; Thamrin C, 2007, PEDIATR PULM, V42, P920, DOI 10.1002/ppul.20683; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Van Muylem A, 2000, PEDIATR PULM, V30, P3, DOI 10.1002/1099-0496(200007)30:1<3::AID-PPUL2>3.0.CO;2-L; VANMUYLEM A, 1992, AM REV RESPIR DIS, V146, P1167, DOI 10.1164/ajrccm/146.5_Pt_1.1167; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; WORTH H, 1978, RESP PHYSIOL, V32, P155, DOI 10.1016/0034-5687(78)90106-8; Yablonskiy DA, 2009, J APPL PHYSIOL, V107, P1258, DOI 10.1152/japplphysiol.00386.2009	42	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17588	10.1371/journal.pone.0017588	http://dx.doi.org/10.1371/journal.pone.0017588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423739	gold, Green Published, Green Submitted			2022-12-25	WOS:000288219100018
J	Guo, SJ; Sun, F; Guo, ZY; Li, W; Alfano, A; Chen, HG; Magyar, CE; Huang, JT; Chai, TC; Qiu, SP; Qiu, Y				Guo, Shengjie; Sun, Feng; Guo, Zhiyong; Li, Wei; Alfano, Alan; Chen, Hegang; Magyar, Clara E.; Huang, Jiaoti; Chai, Toby C.; Qiu, Shaopeng; Qiu, Yun			Tyrosine Kinase ETK/BMX Is Up-Regulated in Bladder Cancer and Predicts Poor Prognosis in Patients with Cystectomy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER; FACTOR RECEPTOR; EXPRESSION; SRC; ACTIVATION; SUPPRESSOR; DOMAIN; RISK; ETK	Deregulation of the non-receptor tyrosine kinase ETK/BMX has been reported in several solid tumors. In this report, we demonstrated that ETK expression is progressively increased during bladder cancer progression. We found that downregulation of ETK in bladder cancer cells attenuated STAT3 and AKT activity whereas exogenous overexpression of ETK had opposite effects, suggesting that deregulation of ETK may attribute to the elevated activity of STAT3 and AKT frequently detected in bladder cancer. The survival, migration and invasion of bladder cancer cells were significantly compromised when ETK expression was knocked down by a specific shRNA. In addition, we showed that ETK localizes to mitochondria in bladder cancer cells through interacting with Bcl-XL and regulating ROS production and drug sensitivity. Therefore, ETK may play an important role in regulating survival, migration and invasion by modulating multiple signaling pathways in bladder cancer cells. Immunohistochemistry analysis on tissue microarrays containing 619 human bladder tissue samples shows that ETK is significantly upregulated during bladder cancer development and progression and ETK expression level predicts the survival rate of patients with cystectomy. Taken together, our results suggest that ETK may potentially serve as a new drug target for bladder cancer treatment as well as a biomarker which could be used to identify patients with higher mortality risk, who may be benefited from therapeutics targeting ETK activity.	[Guo, Shengjie; Sun, Feng; Guo, Zhiyong; Li, Wei; Alfano, Alan; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Guo, Shengjie; Sun, Feng; Guo, Zhiyong; Li, Wei; Alfano, Alan; Qiu, Yun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Chai, Toby C.] Univ Maryland, Sch Med, Div Urol, Baltimore, MD 21201 USA; [Guo, Shengjie; Qiu, Shaopeng] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Magyar, Clara E.; Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Sun Yat Sen University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Guo, SJ (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.	urology@vip.163.com; yqiu@som.umaryland.edu		Chai, Toby/0000-0002-1119-546X; Huang, Jiaoti/0000-0003-1195-1998	NIH [CA106504]; DOD [W81XWH-08-1-0174]; China National Natural Science Foundation [30872584]; Guangdong Natural Science Foundation [8251008901000018]; NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (CA106504) and DOD (W81XWH-08-1-0174) grants to Y.Q., China National Natural Science Foundation (30872584) and Guangdong Natural Science Foundation (8251008901000018) to S. Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; Chau CH, 2005, AM J PHYSIOL-CELL PH, V289, pC444, DOI 10.1152/ajpcell.00410.2004; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chiang GJ, 2005, BJU INT, V96, P416, DOI 10.1111/j.1464-410X.2005.05642.x; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; HARTGE P, 1990, J NATL CANCER I, V82, P1636, DOI 10.1093/jnci/82.20.1636; Huang WT, 2009, KAOHSIUNG J MED SCI, V25, P640, DOI 10.1016/S1607-551X(09)70569-8; ISHIKAWA J, 1989, INT J CANCER, V44, P1000, DOI 10.1002/ijc.2910440610; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JEMAL A, 2010, CA CANC J CLIN; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; KURANAMI M, 1991, CANCER RES, V51, P4631; LEE I, 2010, MOL CANC THER; Mitra AP, 2009, J CLIN ONCOL, V27, P3929, DOI 10.1200/JCO.2008.18.5744; Mookerjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-267; NEAL DE, 1990, CANCER, V65, P1619, DOI 10.1002/1097-0142(19900401)65:7<1619::AID-CNCR2820650728>3.0.CO;2-Q; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; SMITH K, 1989, CANCER RES, V49, P5810; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Wen X, 1999, J BIOL CHEM, V274, P38204, DOI 10.1074/jbc.274.53.38204; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200	31	22	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17778	10.1371/journal.pone.0017778	http://dx.doi.org/10.1371/journal.pone.0017778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408190	Green Published, gold, Green Submitted			2022-12-25	WOS:000288099800037
J	Qian, JF; Hintze, A; Adami, C				Qian, Jifeng; Hintze, Arend; Adami, Christoph			Colored Motifs Reveal Computational Building Blocks in the C. elegans Brain	PLOS ONE			English	Article							NETWORK MOTIFS; EVOLUTIONARY CONSERVATION; NERVOUS-SYSTEM; CONNECTIVITY; SPECIFICITY; LOCOMOTION; NEURONS	Background: Complex networks can often be decomposed into less complex sub-networks whose structures can give hints about the functional organization of the network as a whole. However, these structural motifs can only tell one part of the functional story because in this analysis each node and edge is treated on an equal footing. In real networks, two motifs that are topologically identical but whose nodes perform very different functions will play very different roles in the network. Methodology/Principal Findings: Here, we combine structural information derived from the topology of the neuronal network of the nematode C. elegans with information about the biological function of these nodes, thus coloring nodes by function. We discover that particular colorations of motifs are significantly more abundant in the worm brain than expected by chance, and have particular computational functions that emphasize the feed-forward structure of information processing in the network, while evading feedback loops. Interneurons are strongly over-represented among the common motifs, supporting the notion that these motifs process and transduce the information from the sensor neurons towards the muscles. Some of the most common motifs identified in the search for significant colored motifs play a crucial role in the system of neurons controlling the worm's locomotion. Conclusions/Significance: The analysis of complex networks in terms of colored motifs combines two independent data sets to generate insight about these networks that cannot be obtained with either data set alone. The method is general and should allow a decomposition of any complex networks into its functional (rather than topological) motifs as long as both wiring and functional information is available.	[Qian, Jifeng; Hintze, Arend; Adami, Christoph] Keck Grad Inst, Claremont, CA USA; [Adami, Christoph] Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA; [Adami, Christoph] CALTECH, Pasadena, CA 91125 USA	Claremont Colleges; Keck Graduate Institute; Michigan State University; California Institute of Technology	Qian, JF (corresponding author), Keck Grad Inst, Claremont, CA USA.	adami@kgi.edu	Adami, Chris/A-9675-2011	Adami, Chris/0000-0002-2915-9504; Hintze, Arend/0000-0002-4872-1961	National Science Foundation [FIBR-0527023]; NSF's BEACON Center for Evolution in Action [DBI-0939454]	National Science Foundation(National Science Foundation (NSF)); NSF's BEACON Center for Evolution in Action	This work was supported in part by the National Science Foundation's Frontiers in Biological Research Grant FIBR-0527023 and NSF's BEACON Center for Evolution in Action, under contract No. DBI-0939454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHACOSO TB, 1992, AYS NEUROANATOMY G E; Alon U, 2007, INTRO SYSTEMS BIOL D; Barabasi A-L., 2002, LINKED EVERYTHING IS; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Callebaut W, 2005, MODULARITY UNDERSTAN; Chase Daniel L, 2007, WormBook, P1; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; HALL DH, 1991, J NEUROSCI, V11, P1; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Karbowski J, 2008, J COMPUT NEUROSCI, V24, P253, DOI 10.1007/s10827-007-0054-6; Lee WP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-89; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; NIEBUR E, 1993, MATH BIOSCI, V118, P51, DOI 10.1016/0025-5564(93)90033-7; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Rice JJ, 2005, P NATL ACAD SCI USA, V102, P3173, DOI 10.1073/pnas.0500130102; Richmond Janet E, 2006, WormBook, P1, DOI 10.1895/wormbook.1.112.1; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VARSHNEY LR, 2009, ARXIV09072373V4QBION; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1985, TRENDS NEUROSCI, V8, P277, DOI 10.1016/0166-2236(85)90102-X; *WORMATLAS, 2002, WORM DAT BEH STRUCT; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	36	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17013	10.1371/journal.pone.0017013	http://dx.doi.org/10.1371/journal.pone.0017013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408227	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000288099800010
J	Ulery, BD; Kumar, D; Ramer-Tait, AE; Metzger, DW; Wannemuehler, MJ; Narasimhan, B				Ulery, Bret D.; Kumar, Devender; Ramer-Tait, Amanda E.; Metzger, Dennis W.; Wannemuehler, Michael J.; Narasimhan, Balaji			Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases	PLOS ONE			English	Article							YERSINIA-PESTIS; POLYANHYDRIDE MICROSPHERES; IMMUNE-RESPONSE; BIOERODIBLE POLYANHYDRIDES; AFFINITY MATURATION; POLYMER CHEMISTRY; PNEUMONIC PLAGUE; DRUG DELIVERY; V-ANTIGEN; RELEASE	Despite the successes provided by vaccination, many challenges still exist with respect to controlling new and re-emerging infectious diseases. Innovative vaccine platforms composed of adaptable adjuvants able to appropriately modulate immune responses, induce long-lived immunity in a single dose, and deliver immunogens in a safe and stable manner via multiple routes of administration are needed. This work describes the development of a novel biodegradable polyanhydride nanoparticle-based vaccine platform administered as a single intranasal dose that induced long-lived protective immunity against respiratory disease caused by Yesinia pestis, the causative agent of pneumonic plague. Relative to the responses induced by the recombinant protein F1-V alone and MPLA-adjuvanted F1-V, the nanoparticle-based vaccination regimen induced an immune response that was characterized by high titer and high avidity IgG1 anti-F1-V antibody that persisted for at least 23 weeks post-vaccination. After challenge, no Y. pestis were recovered from the lungs, livers, or spleens of mice vaccinated with the nanoparticle-based formulation and histopathological appearance of lung, liver, and splenic tissues from these mice post-vaccination was remarkably similar to uninfected control mice.	[Ulery, Bret D.; Narasimhan, Balaji] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Kumar, Devender; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Ramer-Tait, Amanda E.; Wannemuehler, Michael J.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA	Iowa State University; Albany Medical College; Iowa State University	Narasimhan, B (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	nbalaji@iastate.edu	Metzger, Dennis W/I-2771-2019; Narasimhan, Balaji/A-5487-2008; Ramer-Tait, Amanda/B-4542-2008	Metzger, Dennis W/0000-0002-8000-9907; Narasimhan, Balaji/0000-0002-7955-5353; Ramer-Tait, Amanda/0000-0003-0950-7548; Kumar, Devender/0000-0001-5260-8606	US Department of Defense-Office of Naval Research (ONR) [N00014-06-1-1176]; Aileen S. Andrew Foundation	US Department of Defense-Office of Naval Research (ONR)(Office of Naval Research); Aileen S. Andrew Foundation	The authors acknowledge financial support from the US Department of Defense-Office of Naval Research (ONR Award no. N00014-06-1-1176). BDU acknowledges financial support from the Aileen S. Andrew Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airhart CL, 2008, VACCINE, V26, P5554, DOI 10.1016/j.vaccine.2008.08.007; Anderson GW, 1998, AM J TROP MED HYG, V58, P793, DOI 10.4269/ajtmh.1998.58.793; Carrillo-Conde B, 2010, J BIOMED MATER RES A, V95A, P40, DOI 10.1002/jbm.a.32815; Carrillo-Conde B, 2010, ACTA BIOMATER, V6, P3110, DOI 10.1016/j.actbio.2010.01.040; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Chiuchiolo MJ, 2006, J INFECT DIS, V194, P1249, DOI 10.1086/507644; Cowan C, 2005, INFECT IMMUN, V73, P6127, DOI 10.1128/IAI.73.9.6127-6137.2005; Dandekar P, 2010, J AEROSOL MED PULM D, V23, P343, DOI 10.1089/jamp.2009.0784; Determan AS, 2006, BIOMATERIALS, V27, P3312, DOI 10.1016/j.biomaterials.2006.01.054; Determan AS, 2004, J CONTROL RELEASE, V100, P97, DOI 10.1016/j.jconrel.2004.08.006; DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217; Elvin SJ, 2006, VACCINE, V24, P4433, DOI 10.1016/j.vaccine.2005.12.016; GIRARD G., 1963, BIOL MED [PARIS], V52, P631; Glynn A, 2005, VACCINE, V23, P1957, DOI 10.1016/j.vaccine.2004.10.025; Haffkine W.M., 1897, BMJ-BRIT MED J, V1, P1461, DOI [10.1136/bmj.1.1902.1461, DOI 10.1136/BMJ.1.1902.1461]; Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545; Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216; Lee LH, 2003, VACCINE, V21, P2190, DOI 10.1016/S0264-410X(03)00025-2; LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106; Mett V, 2007, VACCINE, V25, P3014, DOI 10.1016/j.vaccine.2007.01.017; Park YS, 2008, INFECT IMMUN, V76, P1952, DOI 10.1128/IAI.01722-07; Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069; Pitt M.L., 2004, PUBL WORKSH AN MOD C; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6; Siegrist CA, 2004, VACCINE, V23, P615, DOI 10.1016/j.vaccine.2004.07.014; TABATA Y, 1993, PHARMACEUT RES, V10, P487, DOI 10.1023/A:1018929531410; TAMADA J, 1992, J BIOMAT SCI-POLYM E, V3, P315, DOI 10.1163/156856292X00402; Thomas RJ, 2009, INFECT IMMUN, V77, P1315, DOI 10.1128/IAI.01473-08; Torres MP, 2007, BIOMATERIALS, V28, P108, DOI 10.1016/j.biomaterials.2006.08.047; Torres MP, 2006, J BIOMED MATER RES A, V76A, P102, DOI 10.1002/jbm.a.30510; Ulery BD, 2009, PHARM RES-DORDR, V26, P683, DOI 10.1007/s11095-008-9760-7; Uppada JB, 2009, MED MICROBIOL IMMUN, V198, P247, DOI 10.1007/s00430-009-0124-7; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:18<2226::AID-IMMU2226>3.0.CO;2-M; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	36	89	91	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17642	10.1371/journal.pone.0017642	http://dx.doi.org/10.1371/journal.pone.0017642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408610	Green Published, gold			2022-12-25	WOS:000287965200033
J	Jakel, H; Weinl, C; Hengst, L				Jaekel, H.; Weinl, C.; Hengst, L.			Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control	ONCOGENE			English	Article						cell cycle control; CDK inhibitors; p27(Kip1); tyrosine kinases; JAK2; JAK2V617F	POLYCYTHEMIA-VERA; TYROSINE KINASE; DEPENDENT KINASES; MYELOPROLIFERATIVE DISEASE; SUBCELLULAR-LOCALIZATION; INHIBITORY-ACTIVITY; PROTEIN-KINASE; P27(KIP1); MUTATION; EXPRESSION	Janus kinase 2 (JAK2) couples ligand activation of cell surface cytokine receptors to the regulation of cellular functions including cell cycle progression, differentiation and apoptosis. It thereby coordinates biological programs such as development and hematopoiesis. Unscheduled activation of JAK2 by point mutations or chromosomal translocations can induce hyperproliferation and hematological malignancies. Typical signal transduction by the JAK2 tyrosine kinase comprises phosphorylation of STAT transcription factors. In this study, we describe the identification of the cyclin-dependent kinase (CDK) inhibitor p27(Kip1) as a novel JAK2 substrate. JAK2 can directly bind and phosphorylate p27(Kip1). Both, the JAK2 FERM domain and its kinase domain bind to p27(Kip1). JAK2 phosphorylates tyrosine residue 88 (Y88) of p27(Kip1). We previously reported that Y88 phosphorylation of p27(Kip1) by oncogenic tyrosine kinases impairs p27(Kip1)-mediated CDK inhibition, and initiates its ubiquitindependent proteasomal degradation. Consistently, we now find that active oncogenic JAK2V617F reduces p27(Kip1) stability and protein levels in patient-derived cell lines harboring the mutant JAK2V617F allele. Moreover, tyrosine phosphorylation of p27(Kip1) is impaired and p27(Kip1) expression is restored upon JAK2V617F inactivation by small hairpin RNA-mediated knockdown or by the pyridone-containing tetracycle JAK inhibitor-I, indicating that direct phosphorylation of p27(Kip1) can contribute to hyperproliferation of JAK2V617F-transformed cells. Activation of endogenous JAK2 by interleukin-3 (IL-3) induces Y88 phosphorylation of p27(Kip1), thus unveiling a novel link between cytokine signaling and cell cycle control in non-transformed cells. Oncogenic tyrosine kinases could use this novel pathway to promote hyperproliferation in tumor cells. Oncogene (2011) 30, 3502-3512; doi:10.1038/onc.2011.68; published online 21 March 2011	[Jaekel, H.; Weinl, C.; Hengst, L.] Innsbruck Med Univ, Bioctr, Div Med Biochem, A-6020 Innsbruck, Tyrolia, Austria	Medical University of Innsbruck	Hengst, L (corresponding author), Innsbruck Med Univ, Bioctr, Div Med Biochem, Fritz Pregl Str 3,6, A-6020 Innsbruck, Tyrolia, Austria.	ludger.hengst@i-med.ac.at		Hengst, Ludger/0000-0002-0605-0223	FWF [SFB F21-B12, P18873-B1]	FWF(Austrian Science Fund (FWF))	We thank Jakob Troppmair and Justus Duyster for providing cell lines, Wolfgang Doppler for providing plasmids and antibodies and Stephan Geley for providing plasmids. We thank Wolfgang Doppler, Michael Kullmann, Jonathan Vosper and all members of the Hengst lab for support, stimulating discussions and critical reading of the manuscript. The work was funded by the FWF Grants SFB F21-B12 and P18873-B1.	Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Bruchova H, 2009, BLOOD CELL MOL DIS, V43, P81, DOI 10.1016/j.bcmd.2009.02.001; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Dawson MA, 2009, NATURE, V461, P819, DOI 10.1038/nature08448; Desrivieres S, 2006, J MAMMARY GLAND BIOL, V11, P75, DOI 10.1007/s10911-006-9014-4; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Furuhata A, 2009, BIOCHEM BIOPH RES CO, V383, P411, DOI 10.1016/j.bbrc.2009.04.015; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Halfter H, 2006, CANCER RES, V66, P6530, DOI 10.1158/0008-5472.CAN-04-3734; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; KELVIN DJ, 1986, J CELL PHYSIOL, V127, P403, DOI 10.1002/jcp.1041270308; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2007, CURR OPIN HEMATOL, V14, P43, DOI 10.1097/00062752-200701000-00009; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Neilson LM, 2007, MOL ENDOCRINOL, V21, P2218, DOI 10.1210/me.2007-0173; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Tossidou I, 2008, CELL CYCLE, V7, P3858, DOI 10.4161/cc.7.24.7260; Verstovsek Srdan, 2009, Hematology Am Soc Hematol Educ Program, P636, DOI 10.1182/asheducation-2009.1.636; Wallace TA, 2006, CELL BIOCHEM BIOPHYS, V44, P213, DOI 10.1385/CBB:44:2:213; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200; ZHAO YM, 1995, J BIOL CHEM, V270, P13814, DOI 10.1074/jbc.270.23.13814	41	42	48	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	32					3502	3512		10.1038/onc.2011.68	http://dx.doi.org/10.1038/onc.2011.68			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	806CR	21423214	Green Accepted			2022-12-25	WOS:000293782300003
J	Wu, YY; Peck, K; Chang, YL; Pan, SH; Cheng, YF; Lin, JC; Yang, RB; Hong, TM; Yang, PC				Wu, Y-Y; Peck, K.; Chang, Y-L; Pan, S-H; Cheng, Y-F; Lin, J-C; Yang, R-B; Hong, T-M; Yang, P-C			SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer	ONCOGENE			English	Article						SCUBE3; lung cancer; epithelial-mesenchymal transition; TGF-beta receptor signaling; tumor microenvironment	BREAST-CANCER; CUB DOMAIN; MATRIX-METALLOPROTEINASES; CLINICAL-SIGNIFICANCE; TRANSCRIPTION FACTORS; TUMOR PROGRESSION; REPRESSOR SNAIL; E-CADHERIN; INVASION; GROWTH	Signal peptide-CUB-EGF-like domain-containing protein 3 (SCUBE3) is a secreted glycoprotein that is overexpressed in lung cancer tumor tissues and is correlated with the invasive ability in a lung cancer cell line model. These observations suggest that SCUBE3 may have a role in lung cancer progression. By exogenous SCUBE3 treatment or knockdown of SCUBE3 expression, we found that SCUBE3 could promote lung cancer cell mobility and invasiveness. Knockdown of SCUBE3 expression also suppressed tumorigenesis and cancer metastasis in vivo. The secreted SCUBE3 proteins were cleaved by gelatinases (matrix metalloprotease-2 (MMP-2) and MMP-9) in media to release two major fragments: the N-terminal epidermal growth factor-like repeats and the C-terminal complement proteins C1r/C1s, Uegf and Bmp1 (CUB) domain. Both the purified SCUBE3 protein and the C-terminal CUB domain fragment, bound to transforming growth factor-beta (TGF-beta) type II receptor through the C-terminal CUB domain, activated TGF-beta signaling and triggered the epithelial-mesenchymal transition (EMT). This process includes the induction of Smad2/3 phosphorylation, the increase of Smad2/3 transcriptional activity and the upregulation of the expression of target genes involved in EMT and cancer progression (such as TGF-beta 1, MMP-2, MMP-9, plasminogen activator inhibitor type-1, vascular endothelial growth factor, Snail and Slug), thus promoting cancer cell mobility and invasion. In conclusion, in lung cancer cells, SCUBE3 could serve as an endogenous autocrine and paracrine ligand of TGF-beta type II receptor, which could regulate TGF-beta receptor signaling and modulate EMT and cancer progression. Oncogene (2011) 30, 3682-3693; doi:10.1038/onc.2011.85; published online 28 March 2011	[Yang, P-C] Natl Taiwan Univ, Dept Internal Med, Coll Med, NTU Ctr Genom Med, Taipei 100, Taiwan; [Wu, Y-Y] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Peck, K.; Pan, S-H; Cheng, Y-F; Yang, R-B; Yang, P-C] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Y-L] Natl Taiwan Univ, Dept Pathol, Taipei 100, Taiwan; [Chang, Y-L] Natl Taiwan Univ, Grad Inst Pathol, Taipei 100, Taiwan; [Lin, J-C] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Hong, T-M] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 704, Taiwan; [Hong, T-M] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 704, Taiwan; [Yang, P-C] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Defense Medical Center; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Fu Jen Catholic University; National Cheng Kung University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital	Yang, PC (corresponding author), Natl Taiwan Univ, Dept Internal Med, Coll Med, NTU Ctr Genom Med, 1,Sec 1,Ren Ai Rd, Taipei 100, Taiwan.	tmhong@mail.ncku.edu.tw; pcyang@ntu.edu.tw	Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714; Pan, Szu-Hua/0000-0002-0138-0434; CHANG, YIH-LEONG/0000-0001-5309-0554; YANG, PAN-CHYR/0000-0001-6330-6048	Academia Sinica [AS-97-FP-L16]; National Science Council, Taiwan [NSC98-2628-B-002-086-MY3, NSC97-2314-B-002-146-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We thank Ker-Chau Li (Institute of Statistical Science, Academia Sinica) for providing EKVX and Hop62 cells and Shih-Han Kao for English language editing. This work was supported by Academia Sinica (Grant AS-97-FP-L16) and the National Science Council, Taiwan (Grants NSC98-2628-B-002-086-MY3 and NSC97-2314-B-002-146-MY3). shRNA constructs were obtained from the National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan. T-M H and P-C Y co-directed the project and contributed equally to this work.	Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Foekens JA, 2000, CANCER RES, V60, P636; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hundsdorfer B, 2004, Mund Kiefer Gesichtschir, V8, P173; Iniesta P, 2007, ONCOL REP, V17, P217; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kuhn W, 1999, BRIT J CANCER, V79, P1746, DOI 10.1038/sj.bjc.6690278; Lader AS, 2004, CANCER BIOL THER, V3, P624, DOI 10.4161/cbt.3.7.914; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Providence KM, 2004, J CELL PHYSIOL, V200, P297, DOI 10.1002/jcp.20016; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Reichenberger F, 2001, SWISS MED WKLY, V131, P273; Roy HK, 2005, DIGEST DIS SCI, V50, P42, DOI 10.1007/s10620-005-1275-z; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stefansson S, 2003, CURR PHARM DESIGN, V9, P1545, DOI 10.2174/1381612033454621; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Werle B, 2004, ANTICANCER RES, V24, P4147; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang HY, 2007, CARDIOVASC RES, V75, P139, DOI 10.1016/j.cardiores.2007.03.014; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu Q, 2000, GENE DEV, V14, P163; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	44	67	70	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	34					3682	3693		10.1038/onc.2011.85	http://dx.doi.org/10.1038/onc.2011.85			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21441952				2022-12-25	WOS:000294244500004
J	Baillet, A; Xu, R; Grichine, A; Berthier, S; Morel, F; Paclet, MH				Baillet, Athan; Xu, Rang; Grichine, Alexei; Berthier, Sylvie; Morel, Francoise; Paclet, Marie-Helene			Coupling of 6-phosphogluconate dehydrogenase with NADPH oxidase in neutrophils: Nox2 activity regulation by NADPH availability	FASEB JOURNAL			English	Article						phox; siRNA transfection; cytochrome b(558)	CHRONIC GRANULOMATOUS-DISEASE; IMMORTALIZED B-LYMPHOCYTES; CYTOCHROME B(558); RESPIRATORY BURST; GLUCOSE-TRANSPORT; CYTOSOLIC SUBUNIT; N-TERMINUS; ACTIVATION; BINDING; P67(PHOX)	It is well known that activation of the phagocyte NADPH oxidase requires the association of cytosolic proteins (p67-phox, p47-phox, p40-phox, and Rac) with the membrane cytochrome b(558), leading to its conformation change. Recently, the phagocyte NADPH oxidase complex was isolated in a constitutively active form. In this complex, 6-phosphogluconate dehydrogenase (6PGDH), an enzyme involved in the production of intracellular NADPH, was identified. This protein was absent from the oxidase complex isolated from B lymphocytes, suggesting a specific interaction with the neutrophil NADPH oxidase. To clarify the implication of 6PGDH in the NADPH oxidase activity, a siRNA approach was conducted in neutrophil-like PLB985 cells. NADPH oxidase activity of siRNA-transfected cells was shown to be decreased. Similar results were obtained in vitro, after reconstitution of oxidase activity with subcellular fractions isolated from siRNA-transfected cells. Interestingly, the Michaelis constant (Km) of Nox2 for NADPH increases in 6PGDH-depleted cells. Moreover, 6PGDH coimmunoprecipitated with oxidase cytosolic factors from cytosol of stimulated cells. Data suggested that the affinity of Nox2 for NADPH is increased in the presence of 6PGDH on cell stimulation. The present work proposes a new way of NADPH oxidase activity regulation by modulating Nox2 affinity for NADPH.-Baillet, A., Xu, R., Grichine, A., Berthier, S., Morel, F., Paclet, M.-H. Coupling of 6-phosphogluconate dehydrogenase with NADPH oxidase in neutrophils: Nox2 activity regulation by NADPH availability. FASEB J. 25, 2333-2343 (2011). www.fasebj.org	[Paclet, Marie-Helene] UJF, CHU Albert Michallon, CNRS, GREPI TIMC IMAG UMR 5525, F-38043 Grenoble 9, France; [Baillet, Athan] CHU Grenoble, Clin Rheumatol, F-38043 Grenoble, France; [Berthier, Sylvie; Paclet, Marie-Helene] CHU Grenoble, Inst Biol & Pathol, Lab Biochim Enzymes & Prot, F-38043 Grenoble, France; [Grichine, Alexei] UJF, Inst Albert Bonniot, INSERM, U823, La Tronche, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Paclet, MH (corresponding author), UJF, CHU Albert Michallon, CNRS, GREPI TIMC IMAG UMR 5525, 6Eme Etage Unite E,BP 217, F-38043 Grenoble 9, France.	mhpaclet@chu-grenoble.fr	Grichine, Alexei/M-3923-2013; Grichine, Alexei/P-8377-2019; Paclet, Marie-Hélène/AAS-5029-2020	Grichine, Alexei/0000-0002-7335-9706; Grichine, Alexei/0000-0002-7335-9706; 	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; Region Rhone Alpes, Programme MIRA; Programme Emergence; Groupement des Entreprises Francaises dans la Lutte contre le Cancer, Delegation de Grenoble; Fondation pour la Recherche Medicale, Isere; Regionale de la Recherche Clinique; Association Francaise; la Ligue Nationale contre le Cancer; Societe Francaise de Rhumatologie	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; Region Rhone Alpes, Programme MIRA(Region Auvergne-Rhone-Alpes); Programme Emergence; Groupement des Entreprises Francaises dans la Lutte contre le Cancer, Delegation de Grenoble; Fondation pour la Recherche Medicale, Isere(Fondation pour la Recherche Medicale); Regionale de la Recherche Clinique; Association Francaise; la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Societe Francaise de Rhumatologie	This work was supported by grants from the Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; the Region Rhone Alpes, Programme MIRA 2001 and Programme Emergence 2003; the Groupement des Entreprises Francaises dans la Lutte contre le Cancer, Delegation de Grenoble; the Fondation pour la Recherche Medicale, Isere; the Direction Regionale de la Recherche Clinique; the Association Francaise; la Ligue Nationale contre le Cancer; and the Societe Francaise de Rhumatologie.	Baciou L, 2009, FEBS LETT, V583, P3225, DOI 10.1016/j.febslet.2009.09.011; Batot G, 1998, BBA-MOL BASIS DIS, V1406, P188, DOI 10.1016/S0925-4439(98)00004-0; BATOT G, 1995, EUR J BIOCHEM, V234, P208, DOI 10.1111/j.1432-1033.1995.208_c.x; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Campion Y, 2009, J INNATE IMMUN, V1, P556, DOI 10.1159/000231977; COTTON DJ, 1983, J INFECT DIS, V148, P194, DOI 10.1093/infdis/148.2.194; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dang PMC, 1999, BIOCHEMISTRY-US, V38, P5746, DOI 10.1021/bi982750f; Dang PMC, 2000, BIOCHEMISTRY-US, V39, P3069, DOI 10.1021/bi9919807; He WW, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-38; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Kindzelskii AL, 2004, J IMMUNOL, V172, P6373, DOI 10.4049/jimmunol.172.10.6373; KOBAYASHI S, 1995, J BIOCHEM, V117, P758, DOI 10.1093/oxfordjournals.jbchem.a124773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; MOREL F, 1993, BIOCHIM BIOPHYS ACTA, V1182, P101, DOI 10.1016/0925-4439(93)90159-X; Nauseef WM, 2008, SEMIN IMMUNOPATHOL, V30, P195, DOI 10.1007/s00281-008-0117-4; Paclet MH, 2007, FASEB J, V21, P1244, DOI 10.1096/fj.06-6852com; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; Segal BH, 2009, CELL MOL LIFE SCI, V66, P553, DOI 10.1007/s00018-009-8506-y; Smith RM, 1996, J CLIN INVEST, V98, P977, DOI 10.1172/JCI118882; SMITH RM, 1989, J BIOL CHEM, V264, P12243; Tan AS, 1998, BLOOD, V91, P649, DOI 10.1182/blood.V91.2.649.649_649_655; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vergnaud S, 2000, EUR J BIOCHEM, V267, P1059, DOI 10.1046/j.1432-1327.2000.01097.x; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; WEISDORF DJ, 1982, BLOOD, V60, P888; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288	32	12	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2333	2343		10.1096/fj.10-173807	http://dx.doi.org/10.1096/fj.10-173807			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21444627				2022-12-25	WOS:000292242200025
J	Sittig, LJ; Shukla, PK; Herzing, LBK; Redei, EE				Sittig, Laura J.; Shukla, Pradeep K.; Herzing, Laura B. K.; Redei, Eva E.			Strain-specific vulnerability to alcohol exposure in utero via hippocampal parent-of-origin expression of deiodinase-III	FASEB JOURNAL			English	Article						fetal alcohol spectrum disorder; thyroid hormone; imprinting; neurodevelopment; social interaction; memory	TYPE-3 IODOTHYRONINE DEIODINASE; SPATIAL WORKING-MEMORY; ACUTE ETHANOL EXPOSURE; THYROID-HORMONE LEVELS; SPECTRUM DISORDERS; MAGNETIC-RESONANCE; MONOALLELIC EXPRESSION; ANTISENSE TRANSCRIPTS; ALLELIC EXPRESSION; MOUSE-BRAIN	Prenatal exposure to alcohol is thought to be the most prevalent nongenetic cause of a wide range of neurodevelopmental deficits. Insufficient thyroid hormone levels are one mechanism that hampers development of the alcohol-exposed brain, and we hypothesized that altered dosage of the imprinted thyroid hormone-inactivating gene deiodinase-III (Dio3) is responsible. To follow parent-of-origin allelic expression of Dio3 in the fetal and adult offspring of alcohol-consuming and control dams, we reciprocally crossed 2 polymorphic rat strains. In the frontal cortex, prenatal alcohol exposure altered imprinting patterns and total expression of Dio3 in the fetus and produced a permanent hypothyroid milieu in the adult. In the hippocampus, alcohol affected the paternal and total expression of Dio3 in the fetus and in the adult male, where thyroid hormone levels were concomitantly increased. Hippocampus-dependent behavioral deficits were identified exclusively in males, suggesting they are dependent on aberrant allelic Dio3 expression. None of these effects were observed in offspring of the reciprocal cross. Thus, genetic background and sex modify vulnerability to prenatal alcohol via brain region-specific expression of Dio3. This finding implies that phenotypic heterogeneity in human fetal alcohol spectrum disorder can be linked to genetic vulnerability in affected brain regions.-Sittig, L. J., Shukla, P. K., Herzing, L. B. K., Redei, E. E. Strain-specific vulnerability to alcohol exposure in utero via hippocampal parent-of-origin expression of deiodinase-III. FASEB J. 25, 2313-2324 (2011). www.fasebj.org	[Sittig, Laura J.; Shukla, Pradeep K.; Redei, Eva E.] Northwestern Univ, Feinberg Sch Med, Asher Ctr, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Herzing, Laura B. K.] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Redei, EE (corresponding author), Northwestern Univ, Feinberg Sch Med, Asher Ctr, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	e-redei@northwestern.edu			U.S. National Institutes of Health (NIH) [RO1 AA017978, RO1 AA013452]; NIH [F31 AA018251]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017978, R01AA013452, F31AA018251] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Jelena Radulovic for helpful discussions. The authors thank Daniel Schaffer, Brian Andrus, Kanchi Batra, Timothy Ullmann, and Kristen Dennis for help in technical aspects of the study. The work was funded by U.S. National Institutes of Health (NIH) grants RO1 AA017978 and RO1 AA013452 to E.E.R. L.J.S. is a predoctoral fellow funded by NIH grant F31 AA018251.	Aird F, 1997, ALCOHOL CLIN EXP RES, V21, P1560, DOI 10.1111/j.1530-0277.1997.tb04490.x; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; Arfsten DP, 2004, INT J TOXICOL, V23, P47, DOI 10.1080/10915810490265450; ASTLEY SJ, 2009, ALCOHOL CLIN EXP RES, V16, pE178; Astley SJ, 2009, ALCOHOL CLIN EXP RES, V33, P1671, DOI 10.1111/j.1530-0277.2009.01004.x; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129; Boehm SL, 1997, ALCOHOL, V14, P389, DOI 10.1016/S0741-8329(97)87950-5; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Boyles AL, 2010, AM J EPIDEMIOL, V172, P924, DOI 10.1093/aje/kwq226; Calfa G, 2007, BEHAV BRAIN RES, V181, P23, DOI 10.1016/j.bbr.2007.03.020; Cheema ZF, 2000, ALCOHOL CLIN EXP RES, V24, P535, DOI 10.1111/j.1530-0277.2000.tb02022.x; CHRISTOFFEL KK, 1975, J PEDIATR-US, V87, P963, DOI 10.1016/S0022-3476(75)80919-X; Croteau S, 2005, MAMM GENOME, V16, P127, DOI 10.1007/s00335-004-2434-9; Das UG, 2004, ALCOHOL CLIN EXP RES, V28, P1598, DOI 10.1097/01.ALC.0000141816.14776.97; Downing C, 1999, BEHAV GENET, V29, P31, DOI 10.1023/A:1021485821842; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Green CR, 2009, J CHILD PSYCHOL PSYC, V50, P688, DOI 10.1111/j.1469-7610.2008.01990.x; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Herman LE, 2008, J POPUL THER CLIN PH, V15, pE411; Hernandez A, 2004, GENOMICS, V83, P413, DOI 10.1016/j.ygeno.2003.08.024; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Hernandez A, 2010, ENDOCRINOLOGY, V151, P5550, DOI 10.1210/en.2010-0450; Hofmann CE, 2007, ALCOHOL CLIN EXP RES, V31, P345, DOI 10.1111/j.1530-0277.2006.00316.x; Hogart A, 2008, HUM GENET, V124, P235, DOI 10.1007/s00439-008-0546-0; Huang SA, 2002, J CLIN ENDOCR METAB, V87, P4457, DOI 10.1210/jc.2002-020627; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jacobsen LK, 2007, J NEUROSCI, V27, P13491, DOI 10.1523/JNEUROSCI.2402-07.2007; Keen CL, 2010, BIOFACTORS, V36, P125, DOI 10.1002/biof.89; Kelly SJ, 2009, ALCOHOL ALCOHOLISM, V44, P555, DOI 10.1093/alcalc/agp061; Kilts CD, 2006, NEUROPSYCHOPHARMACOL, V31, P2243, DOI 10.1038/sj.npp.1301053; Kim CK, 1997, BEHAV NEUROSCI, V111, P985, DOI 10.1037/0735-7044.111.5.985; KOTKOSKIE LA, 1988, ALCOHOL CLIN EXP RES, V12, P831, DOI 10.1111/j.1530-0277.1988.tb01355.x; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lan N, 2006, J NEUROENDOCRINOL, V18, P672, DOI 10.1111/j.1365-2826.2006.01462.x; Lewis A, 2005, CURR BIOL, V15, pR291, DOI 10.1016/j.cub.2005.04.003; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Louis C, 2008, PHARMACOL BIOCHEM BE, V89, P36, DOI 10.1016/j.pbb.2007.10.020; Malisza KL, 2005, PEDIATR RES, V58, P1150, DOI 10.1203/01.pdr.0000185479.92484.a1; McCarver DG, 1997, J PHARMACOL EXP THER, V283, P1095; Meintjes EM, 2010, ALCOHOL CLIN EXP RES, V34, P1450, DOI 10.1111/j.1530-0277.2010.01230.x; MEYER LS, 1986, TERATOLOGY, V34, P1, DOI 10.1002/tera.1420340102; MILLER MW, 1995, ALCOHOL CLIN EXP RES, V19, P1359, DOI 10.1111/j.1530-0277.1995.tb01625.x; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; O'Hare ED, 2009, HUM BRAIN MAPP, V30, P3200, DOI 10.1002/hbm.20741; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PRACYK JB, 1992, J DEV PHYSIOL, V18, P105; Ranade SC, 2008, NEUROSCIENCE, V152, P859, DOI 10.1016/j.neuroscience.2008.01.002; Rasmussen C, 2005, ALCOHOL CLIN EXP RES, V29, P1359, DOI 10.1097/01.alc.0000175040.91007.d0; Royo H, 2007, MOL BIOL CELL, V18, P2817, DOI 10.1091/mbc.E06-10-0920; Schaefer HS, 2006, BIOL PSYCHIAT, V60, P974, DOI 10.1016/j.biopsych.2006.03.024; SCHAPIRO MB, 1984, NEUROBEH TOXICOL TER, V6, P351; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Shukla PK, 2011, ALCOHOL CLIN EXP RES, V35, P559, DOI 10.1111/j.1530-0277.2010.01373.x; Shukla PK, 2010, PSYCHONEUROENDOCRINO, V35, P791, DOI 10.1016/j.psyneuen.2009.10.019; Sinha P, 1997, ENDOCRINOLOGY, V138, P4792, DOI 10.1210/en.138.11.4792; Sittig LJ, 2011, MOL PSYCHIATR, V16, P786, DOI 10.1038/mp.2011.19; Sittig LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010058; Spadoni AD, 2009, ALCOHOL CLIN EXP RES, V33, P2067, DOI 10.1111/j.1530-0277.2009.01046.x; Spohr HL, 2007, J PEDIATR-US, V150, P175, DOI 10.1016/j.jpeds.2006.11.044; Stoler JM, 2002, J PEDIATR-US, V141, P780, DOI 10.1067/mpd.2002.128112; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; STREISSGUTH AP, 1980, SCIENCE, V209, P353, DOI 10.1126/science.6992275; SULIK KK, 1983, AM J ANAT, V166, P257, DOI 10.1002/aja.1001660303; Takahashi N, 2010, J BIOL CHEM, V285, P26121, DOI 10.1074/jbc.M109.075325; Thomas SE, 1998, ALCOHOL CLIN EXP RES, V22, P528, DOI 10.1111/j.1530-0277.1998.tb03684.x; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Tu HM, 1999, ENDOCRINOLOGY, V140, P784, DOI 10.1210/en.140.2.784; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; WALKER P, 1985, CAN J PHYSIOL PHARM, V63, P279, DOI 10.1139/y85-050; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; WEINBERG J, 1984, NEUROBEH TOXICOL TER, V6, P261; WEST JR, 1986, NEUROTOXICOLOGY, V7, P245; Wilcoxon JS, 2005, MOL PSYCHIATR, V10, P961, DOI 10.1038/sj.mp.4001694; Wilcoxon JS, 2004, AM J PHYSIOL-ENDOC M, V287, pE318, DOI 10.1152/ajpendo.00022.2004; Wilcoxon JS, 2003, AM J PHYSIOL-ENDOC M, V285, pE31, DOI 10.1152/ajpendo.00552.2002; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; Willoughby KA, 2008, J INT NEUROPSYCH SOC, V14, P1022, DOI 10.1017/S1355617708081368	86	34	36	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2313	2324		10.1096/fj.10-179234	http://dx.doi.org/10.1096/fj.10-179234			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21429942	Green Published			2022-12-25	WOS:000292242200023
J	Ruan, WJ; Lehmann, E; Thomm, M; Kostrewa, D; Cramer, P				Ruan, Wenjie; Lehmann, Elisabeth; Thomm, Michael; Kostrewa, Dirk; Cramer, Patrick			Evolution of Two Modes of Intrinsic RNA Polymerase Transcript Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TFIIS; STRUCTURAL BASIS; SUBUNIT; FIDELITY; MECHANISM; COMPLEX; ARCHITECTURE; TERMINATION; RESOLUTION; REQUIRES	During gene transcription, the RNA polymerase (Pol) active center can catalyze RNA cleavage. This intrinsic cleavage activity is strong for Pol I and Pol III but very weak for Pol II. The reason for this difference is unclear because the active centers of the polymerases are virtually identical. Here we show that Pol II gains strong cleavage activity when the C-terminal zinc ribbon domain (C-ribbon) of subunit Rpb9 is replaced by its counterpart from the Pol III subunit C11. X-ray analysis shows that the C-ribbon has detached from its site on the Pol II surface and is mobile. Mutagenesis indicates that the C-ribbon transiently inserts into the Pol II pore to complement the active center. This mechanism is also used by transcription factor IIS, a factor that can bind Pol II and induce strong RNA cleavage. Together with published data, our results indicate that Pol I and Pol III contain catalytic C-ribbons that complement the active center, whereas Pol II contains a non-catalytic C-ribbon that is immobilized on the enzyme surface. Evolution of the Pol II system may have rendered mRNA transcript cleavage controllable by the dissociable factor transcription factor IIS to enable promoter-proximal gene regulation and elaborate 3'-processing and transcription termination.	[Ruan, Wenjie; Lehmann, Elisabeth; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ruan, Wenjie; Lehmann, Elisabeth; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Dept Biochem, D-81377 Munich, Germany; [Thomm, Michael] Univ Regensburg, Inst Mikrobiol, D-93053 Regensburg, Germany	University of Munich; University of Munich; University of Regensburg	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Ruan, Wenjie/W-3957-2019	Ruan, Wenjie/0000-0002-8311-8738	Deutsche Forschungsgemeinschaft (DFG) [Th422/11-1, SFB646, TR5, FOR1068]; Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Supported by grants from Deutsche Forschungsgemeinschaft (DFG) Forschergruppe "Regulation und Mechanismus der Ribosomenbiogenese" (Grant Th422/11-1).; Supported by grants from the DFG, SFB646, TR5, FOR1068, Nanosystems Initiative Munich, the Elitenetzwerk Bayern, the Jung-Stiftung, and the Fonds der Chemischen Industrie. To whom correspondence should be addressed. Tel.: 49-89-2180-76951; Fax: 49-89-2180-76999; E-mail: cramer@LMB.uni-muenchen.de.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P2288, DOI 10.1074/jbc.275.4.2288; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Spitalny P, 2008, MOL MICROBIOL, V67, P958, DOI 10.1111/j.1365-2958.2007.06084.x; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Thuillier V, 1996, EMBO J, V15, P618, DOI 10.1002/j.1460-2075.1996.tb00394.x; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729	34	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18701	18707		10.1074/jbc.M111.222273	http://dx.doi.org/10.1074/jbc.M111.222273			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454497	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000290785700043
J	Lyzogubov, VV; Tytarenko, RG; Liu, J; Bora, NS; Bora, PS				Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Liu, Juan; Bora, Nalini S.; Bora, Puran S.			Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT MEMBRANE ATTACK; GROWTH-FACTOR SECRETION; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; FACTOR-H; TARGETED INHIBITOR; ACTIVATION; VEGF; CELLS; RPE	In this study, we describe a new method for inducing choroidal neovascularization (CNV) in C57BL/6 mice, an animal model of wet age-related macular degeneration (AMD). AMD is a disease that causes central blindness in humans. We injected PEG-8 subretinally in different doses (0.125-2 mg) to induce CNV. After PEG-8 injection, we examined CNV at several time points (days 3-42). We also used Western blotting, immunohistochemistry, and ELISA to examine the complement component C3 split products, C9, VEGF, TGF-beta 2, and basic FGF. As early as day 1 after treatment, we found that a single subretinal injection of 1 mg of PEG-8 increased the C3 split products and the C9, TGF-beta 2, and basic FGF levels in the retinal pigment epithelium-choroid tissue. By day 3 after PEG-8 injection, the intraocular activation of the complement system caused induction and progression of CNV, including new vessels penetrating the Bruch's membrane. At day 5 after PEG-8 injection, we observed a fully developed CNV and retinal degeneration. Thus, in this study, we present a new, inexpensive, and accelerated mouse model of CNV that may be useful to study AMD.	[Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Liu, Juan; Bora, Nalini S.; Bora, Puran S.] Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bora, PS (corresponding author), Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, 4301 W Markham St,Slot 523-7, Little Rock, AR 72205 USA.	pbora@uams.edu		Bora, Puran/0000-0003-4781-1217	University of Arkansas for Medical Sciences; Pat and Willard Walker Eye Research Center	University of Arkansas for Medical Sciences; Pat and Willard Walker Eye Research Center	This work was supported in part by grants from the University of Arkansas for Medical Sciences and the Pat and Willard Walker Eye Research Center.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; [Anonymous], 2006, INT J TOXICOL, V25, P121, DOI 10.1080/10915810600964642; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards Albert O., 2007, Angiogenesis, V10, P119, DOI 10.1007/s10456-007-9064-2; ELIZABETH RP, 2006, EXP EYE RES, V82, P741, DOI DOI 10.1016/J.EXER.2005.10.012; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hamada I, 2008, MOL IMMUNOL, V46, P225, DOI 10.1016/j.molimm.2008.08.276; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; KILLINGSWORTH MC, 1995, GRAEF ARCH CLIN EXP, V233, P313, DOI 10.1007/BF00200479; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lassota N, 2008, ACTA OPHTHALMOL, V86, P495, DOI [10.1111/j.1600-0420.2007.01127.x, 10.1111/j.1755-3768.2008.01412.x]; Li WB, 2010, MED SCI MONITOR, V16, pBR17; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Moghimi SM, 2006, J LIPOSOME RES, V16, P167, DOI 10.1080/08982100600848801; Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017; MORGAN BP, 1989, BIOCHEM J, V264, P1; Palarasah Y, 2010, J IMMUNOL METHODS, V362, P142, DOI 10.1016/j.jim.2010.09.024; Pawliuk R., 2001, WIPO Patent Application, Patent No. [WO/2001/087312, 2001087312]; Ramo K, 2008, INVEST OPHTH VIS SCI, V49, P4126, DOI 10.1167/iovs.08-2025; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Shen WY, 2001, ANTISENSE NUCLEIC A, V11, P257, DOI 10.1089/108729001317022250; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhao L, 2007, MOL VIS, V13, P873	39	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.204701	http://dx.doi.org/10.1074/jbc.M110.204701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454496	Green Published, hybrid			2022-12-25	WOS:000290022800062
J	Yu, H; Zhu, GY; Xu, RZ; Niu, HZ; Lu, Q; Li, GZ; Wang, ZY; Zhang, DS; Gu, N; Teng, GJ				Yu, Hui; Zhu, Guang-Yu; Xu, Rui-Zhi; Niu, Huan-Zhang; Lu, Qin; Li, Guo-Zhao; Wang, Zi-Yu; Zhang, Dong-Sheng; Gu, Ning; Teng, Gao-Jun			Arterial Embolization Hyperthermia Using As2O3 Nanoparticles in VX2 Carcinoma-Induced Liver Tumors	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; MAGNETIC FLUID HYPERTHERMIA; ENDOTHELIAL GROWTH-FACTOR; ARSENIC TRIOXIDE; TRANSARTERIAL CHEMOEMBOLIZATION; FERROMAGNETIC EMBOLIZATION; ANGIOGENESIS; METASTASIS; APOPTOSIS; MODEL	Background: Combination therapy for arterial embolization hyperthermia (AEH) with arsenic trioxide (As2O3) nanoparticles (ATONs) is a novel treatment for solid malignancies. This study was performed to evaluate the feasibility and therapeutic effect of AEH with As2O3 nanoparticles in a rabbit liver cancer model. The protocol was approved by our institutional animal use committee. Methodology/Principal Findings: In total, 60 VX2 liver-tumor-bearing rabbits were randomly assigned to five groups (n = 12/group) and received AEH with ATONs (Group 1), hepatic arterial embolization with ATONs (Group 2), lipiodol (Group 3), or saline (Group 4), on day 14 after tumor implantation. Twelve rabbits that received AEH with ATONs were prepared for temperature measurements, and were defined as Group 5. Computed tomography was used to measure the tumors' longest dimension, and evaluation was performed according to the Response Evaluation Criteria in Solid Tumors. Hepatic toxicity, tumor necrosis rate, vascular endothelial growth factor level, and microvessel density were determined. Survival rates were measured using the Kaplan-Meier method. The therapeutic temperature (42.5 degrees C) was obtained in Group 5. Hepatotoxicity reactions occurred but were transient in all groups. Tumor growth was delayed and survival was prolonged in Group 1 (treated with AEH and ATONs). Plasma and tumor vascular endothelial growth factor and microvessel density were significantly inhibited in Group 1, while tumor necrosis rates were markedly enhanced compared with those in the control groups. Conclusions: ATON-based AEH is a safe and effective treatment that can be targeted at liver tumors using the dual effects of hyperthermia and chemotherapy. This therapy can delay tumor growth and noticeably inhibit tumor angiogenesis.	[Yu, Hui; Zhu, Guang-Yu; Niu, Huan-Zhang; Lu, Qin; Li, Guo-Zhao; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhong Da Hosp,Med Sch, Nanjing, Peoples R China; [Xu, Rui-Zhi; Gu, Ning] Southeast Univ, Jiangsu Lab Biomat & Devices, State Key Lab BioElect, Sch Biol Sci & Med Engn, Nanjing, Peoples R China; [Wang, Zi-Yu; Zhang, Dong-Sheng] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhong Da Hosp,Med Sch, Nanjing, Peoples R China.	gjteng@vip.sina.com			National Natural Science Foundation of China [30470507, 30870703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (NSFC No. 30470507 and NSFC No. 30870703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biolato M, 2010, EUR REV MED PHARMACO, V14, P356; Gallagher RE, 1998, NEW ENGL J MED, V339, P1389, DOI 10.1056/NEJM199811053391909; Griffin RJ, 2000, NEOPLASIA, V2, P555, DOI 10.1038/sj.neo.7900123; Griffin RJ, 2003, INT J HYPERTHER, V19, P575, DOI 10.1080/0265673031000124316; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Hamaguchi S, 2003, CANCER SCI, V94, P834, DOI 10.1111/j.1349-7006.2003.tb01527.x; Hassouneh B, 2007, MOL CANCER THER, V6, P1039, DOI 10.1158/1535-7163.MCT-06-0524; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hines-Peralta A, 2006, RADIOLOGY, V240, P82, DOI 10.1148/radiol.2401050788; Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360; Jones SK, 2002, INT J HYPERTHER, V18, P117, DOI 10.1080/02656730110103519; Kinjo K, 2000, LEUKEMIA, V14, P431, DOI 10.1038/sj.leu.2401646; Kito M, 2003, CANCER SCI, V94, P1010, DOI 10.1111/j.1349-7006.2003.tb01393.x; Kito M, 2002, BIOCHEM BIOPH RES CO, V291, P861, DOI 10.1006/bbrc.2002.6525; Lew YS, 1999, CANCER RES, V59, P6033; Lew YS, 2002, CANCER RES, V62, P4202; Lin CC, 2007, INVEST NEW DRUG, V25, P77, DOI 10.1007/s10637-006-9004-9; Liu B, 2006, CANCER SCI, V97, P675, DOI 10.1111/j.1349-7006.2006.00230.x; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lu Q, 2008, CANCER BIOL THER, V7, P218, DOI 10.4161/cbt.7.2.5258; Maeda H, 2001, CANCER RES, V61, P5432; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Monzen Hajime, 2004, Radiat Med, V22, P205; Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785; Moroz P, 2002, PHYS MED BIOL, V47, P1591, DOI 10.1088/0031-9155/47/9/312; Moroz P, 2002, INT J HYPERTHER, V18, P129, DOI 10.1080/02656730110095609; Moroz P, 2001, J SURG ONCOL, V78, P22, DOI 10.1002/jso.1118; Pacella CM, 2001, RADIOLOGY, V219, P669, DOI 10.1148/radiology.219.3.r01ma02669; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Park MJ, 2003, INT J ONCOL, V22, P1271; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PATTERSON J, 1979, INT J RADIAT ONCOL, V5, P235, DOI 10.1016/0360-3016(79)90725-9; Roboz GJ, 2000, BLOOD, V96, P1525, DOI 10.1182/blood.V96.4.1525.h8001525_1525_1530; RUIZHI X, 2009, MAGNETICS IEEE T, V45, P3085; RUIZHI X, 2007, MAGNETICS IEEE T, V43, P1078; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vogl TJ, 2004, RADIOLOGY, V230, P450, DOI 10.1148/radiol.2302020646; Vogl TJ, 2003, RADIOLOGY, V229, P457, DOI 10.1148/radiol.2292021329; Wang ZY, 2009, WORLD J GASTROENTERO, V15, P2995, DOI 10.3748/wjg.15.2995; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xu HY, 2004, WORLD J GASTROENTERO, V10, P3677, DOI 10.3748/wjg.v10.i24.3677; Xu HY, 2000, WORLD J GASTROENTERO, V6, P681; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Yan SY, 2005, J NANOSCI NANOTECHNO, V5, P1185, DOI 10.1166/jnn.2005.219; Yoon CJ, 2003, RADIOLOGY, V229, P126, DOI 10.1148/radiol.2291021029; Yoshiji H, 2002, HEPATOLOGY, V35, P834, DOI 10.1053/jhep.2002.32541; Zhu AL, 2004, WORLD J GASTROENTERO, V10, P1659, DOI 10.3748/wjg.v10.i11.1659	50	23	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17926	10.1371/journal.pone.0017926	http://dx.doi.org/10.1371/journal.pone.0017926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448278	Green Submitted, gold, Green Published			2022-12-25	WOS:000288810500023
J	Fossati, A; Dolfini, D; Donati, G; Mantovani, R				Fossati, Andrea; Dolfini, Diletta; Donati, Giacomo; Mantovani, Roberto			NF-Y Recruits Ash2L to Impart H3K4 Trimethylation on CCAAT Promoters	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; TRANSCRIPTION FACTOR; HUMAN GENOME; METHYLATION; LEUKEMIA; GENES; MLL; COMPLEX; DIFFERENTIATION; BINDING	Background: Different histone post-translational modifications (PTMs) are crucial in the regulation of chromatin, including methylations of H3 at Lysine 4 by the MLL complex. A relevant issue is how this is causally correlated to the binding of specific transcription factors (TFs) in regulatory regions. NF-Y is a TF that regulates 30% of mammalian promoters containing the widespread CCAAT element. We and others established that the presence of H3K4me3 is dependent upon the binding of NF-Y. Here, we investigate the mechanisms of H3K4me3 deposition by NF-Y. Methods: We employed Chromatin Immunoprecipitation in cells in which Ash2L and NF-Y subunits were knocked down by RNAi, to monitor the presence of histones PTMs and components of the MLL complex. We performed gene expression profiling of Ash2L-knocked down cells and analyzed the regulated genes. We performed ChIPs in leukemic cells in which MLL1 is devoid of the methyltransferase domain and fused to the AF4 gene. Results: Knock down of the Ash2L subunit of MLL leads to a decrease in global H3K4me3 with a concomitant increase in H3K79me2. Knock down of NF-Y subunits prevents promoter association of Ash2L, but not MLL1, nor WDR5, and H3K4me3 drops dramatically. Endogenous NF-Y and Ash2L specifically interact in vivo. Analysis of the promoters of Ash2L regulated genes, identified by transcriptional profiling, suggests that a handful TF binding sites are moderately enriched, among which the CCAAT box. Finally, leukemic cells carrying the MLL-AF4 translocation show a decrease of H3K4me3, absence of Ash2L and increase in H3K79me2, while NF-Y binding was not significantly affected. Conclusions: Three types of conclusions are reached: (i) H3K4 methylation is not absolutely required for NF-Y promoter association. (ii) NF-Y acts upstream of H3K4me3 deposition by recruiting Ash2L. (iii) There is a general cross-talk between H3K4me3 and H3K79me2 which is independent from the presence of MLL oncogenic fusions.	[Fossati, Andrea; Dolfini, Diletta; Donati, Giacomo; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy	University of Milan	Fossati, A (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy.	mantor@unimi.it	Fossati, Andrea/AAN-3814-2020; DOLFINI, DILETTA/D-8286-2017	Fossati, Andrea/0000-0001-9368-4058; DOLFINI, DILETTA/0000-0002-5346-6096; DONATI, Giacomo/0000-0002-0370-8288	Associazione Italiana per la Ricerca sul Cancro (AIRC); Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel	The work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) and Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel grants to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; DOMASHENKO AD, 2010, BLOOD IN PRESS; Donati G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002066; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Gatta R, 2008, NUCLEIC ACIDS RES, V36, P6592, DOI 10.1093/nar/gkn699; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Imbriano C, 2001, J BIOL CHEM, V276, P26332, DOI 10.1074/jbc.M101553200; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Neff T, 2009, LEUKEMIA, V23, P1243, DOI 10.1038/leu.2009.40; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Tan CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008535; Tsutsumi S, 2003, CANCER RES, V63, P4882; van Wageningen S, 2008, HAEMATOL-HEMATOL J, V93, P1580, DOI 10.3324/haematol.12425; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	39	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17220	10.1371/journal.pone.0017220	http://dx.doi.org/10.1371/journal.pone.0017220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445285	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300005
J	Graham, ME; Prescott, GR; Johnson, JR; Jones, M; Walmesley, A; Haynes, LP; Morgan, A; Burgoyne, RD; Barclay, JW				Graham, Margaret E.; Prescott, Gerald R.; Johnson, James R.; Jones, Mathew; Walmesley, Alice; Haynes, Lee P.; Morgan, Alan; Burgoyne, Robert D.; Barclay, Jeff W.			Structure-Function Study of Mammalian Munc18-1 and C. elegans UNC-18 Implicates Domain 3b in the Regulation of Exocytosis	PLOS ONE			English	Article							PROTEIN-KINASE-C; MEMBRANE-FUSION; SYNAPTIC-TRANSMISSION; VESICLE DOCKING; BINDING; SNARE; SYNTAXIN; RELEASE; MUTAGENESIS; DEFECTS	Munc18-1 is an essential synaptic protein functioning during multiple stages of the exocytotic process including vesicle recruitment, docking and fusion. These functions require a number of distinct syntaxin-dependent interactions; however, Munc18-1 also regulates vesicle fusion via syntaxin-independent interactions with other exocytotic proteins. Although the structural regions of the Munc18-1 protein involved in closed-conformation syntaxin binding have been thoroughly examined, regions of the protein involved in other interactions are poorly characterised. To investigate this we performed a random transposon mutagenesis, identifying domain 3b of Munc18-1 as a functionally important region of the protein. Transposon insertion in an exposed loop within this domain specifically disrupted Mint1 binding despite leaving affinity for closed conformation syntaxin and binding to the SNARE complex unaffected. The insertion mutation significantly reduced total amounts of exocytosis as measured by carbon fiber amperometry in chromaffin cells. Introduction of the equivalent mutation in UNC-18 in Caenorhabditis elegans also reduced neurotransmitter release as assessed by aldicarb sensitivity. Correlation between the two experimental methods for recording changes in the number of exocytotic events was verified using a previously identified gain of function Munc18-1 mutation E466K (increased exocytosis in chromaffin cells and aldicarb hypersensitivity of C. elegans). These data implicate a novel role for an exposed loop in domain 3b of Munc18-1 in transducing regulation of vesicle fusion independent of closed-conformation syntaxin binding.	[Graham, Margaret E.; Prescott, Gerald R.; Johnson, James R.; Jones, Mathew; Walmesley, Alice; Haynes, Lee P.; Morgan, Alan; Burgoyne, Robert D.; Barclay, Jeff W.] Univ Liverpool, Inst Translat Med, Physiol Lab, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Graham, ME (corresponding author), Univ Liverpool, Inst Translat Med, Physiol Lab, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	barclayj@liv.ac.uk	Burgoyne, Robert D/P-6641-2019; Morgan, Alan/AAI-8875-2020; Burgoyne, Robert/C-6706-2008; Johnson, James R/D-9721-2014; Johnson, James R/A-8174-2012	Burgoyne, Robert D/0000-0002-9219-0387; Burgoyne, Robert/0000-0002-9219-0387; Johnson, James R/0000-0002-8849-0993; Barclay, Jeff W/0000-0003-4320-2094; Morgan, Alan/0000-0002-0346-1289	Wellcome Trust; BBSRC; National Institutes of Health National Center for Research Resources (NCRR); Biotechnology and Biological Sciences Research Council [BB/E006477/1] Funding Source: researchfish; BBSRC [BB/E006477/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust and BBSRC. GRP was supported by a Wellcome Trust Prize Studentship. The C. elegans strain used in this work was provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay JW, 2008, BIOPHYS J, V94, P1084, DOI 10.1529/biophysj.107.111203; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Boyd A, 2008, GENETICS, V180, P165, DOI 10.1534/genetics.108.090423; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bracher A, 2001, J MOL BIOL, V306, P7, DOI 10.1006/jmbi.2000.4347; BRENNER S, 1974, GENETICS, V77, P71; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Craig TJ, 2004, J BIOCHEM BIOPH METH, V60, P49, DOI 10.1016/j.jbbm.2004.04.015; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GengyoAndo K, 1996, J NEUROSCI, V16, P6695; GOFF SP, 1991, METHOD ENZYMOL, V208, P586; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Hafez I, 2005, P NATL ACAD SCI USA, V102, P13879, DOI 10.1073/pnas.0504098102; Hallet B, 1997, NUCLEIC ACIDS RES, V25, P1866, DOI 10.1093/nar/25.9.1866; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HU SH, 2011, P NATL ACAD IN PRESS; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lee HY, 2004, J BIOL CHEM, V279, P16339, DOI 10.1074/jbc.M310976200; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nonet ML, 1997, J NEUROSCI, V17, P8061; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Sassa T, 1999, J NEUROSCI, V19, P4772; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Tsuboi T, 2006, MOL BIOL CELL, V17, P2101, DOI 10.1091/mbc.E05-11-1047; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber M, 2010, MOL BIOL CELL, V21, P1362, DOI 10.1091/mbc.E09-07-0546; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	59	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17999	10.1371/journal.pone.0017999	http://dx.doi.org/10.1371/journal.pone.0017999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445306	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300028
J	Cicek, M; Vrabel, A; Sturchio, C; Pederson, L; Hawse, JR; Subramaniam, M; Spelsberg, TC; Oursler, MJ				Cicek, Muzaffer; Vrabel, Anne; Sturchio, Catherine; Pederson, Larry; Hawse, John R.; Subramaniam, Malayannan; Spelsberg, Thomas C.; Oursler, Merry Jo			TGF-beta Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways	PLOS ONE			English	Article							FINGER TRANSCRIPTION FACTOR; CALCIUM-SENSING RECEPTOR; KAPPA-B PATHWAYS; NUCLEAR-FACTOR; INHIBITORY LECTIN; MICE DISPLAY; ACTIVATION; INDUCTION; GROWTH; RANKL	TGF-beta Inducible Early Gene-1 (TIEG1) is a Kruppel-like transcription factor (KLF10) that was originally cloned from human osteoblasts as an early response gene to TGF-beta treatment. As reported previously, TIEG1(-/-) mice have decreased cortical bone thickness and vertebral bone volume and have increased spacing between the trabeculae in the femoral head relative to wildtype controls. Here, we have investigated the role of TIEG1 in osteoclasts to further determine their potential role in mediating this phenotype. We have found that TIEG1(-/-) osteoclast precursors differentiated more slowly compared to wildtype precursors in vitro and high RANKL doses are able to overcome this defect. We also discovered that TIEG1(-/-) precursors exhibit defective RANKL-induced phosphorylation and accumulation of NFATc1 and the NFATc1 target gene DC-STAMP. Higher RANKL concentrations reversed defective NFATc1 signaling and restored differentiation. After differentiation, wildtype osteoclasts underwent apoptosis more quickly than TIEG1(-/-) osteoclasts. We observed increased AKT and MEK/ERK signaling pathway activation in TIEG1(-/-) osteoclasts, consistent with the roles of these kinases in promoting osteoclast survival. Adenoviral delivery of TIEG1 (AdTIEG1) to TIEG1(-/-) cells reversed the RANKL-induced NFATc1 signaling defect in TIEG1(-/-) precursors and eliminated the differentiation and apoptosis defects. Suppression of TIEG1 with siRNA in wildtype cells reduced differentiation and NFATc1 activation. Together, these data provide evidence that TIEG1 controls osteoclast differentiation by reducing NFATc1 pathway activation and reduces osteoclast survival by suppressing AKT and MEK/ERK signaling.	[Cicek, Muzaffer; Hawse, John R.; Subramaniam, Malayannan; Spelsberg, Thomas C.; Oursler, Merry Jo] Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Vrabel, Anne; Sturchio, Catherine; Pederson, Larry; Oursler, Merry Jo] Mayo Clin Coll Med, Endocrine Res Unit, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Cicek, M (corresponding author), Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA.	cicek.muzaffer@mayo.edu			National Institutes of Health [AR52004]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (AR52004) to M.J. Oursler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; BLOK LJ, 1995, MOL ENDOCRINOL, V9, P1610, DOI 10.1210/me.9.11.1610; Bradley EW, 2008, J CELL PHYSIOL, V217, P752, DOI 10.1002/jcp.21550; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Crotti TN, 2008, J CELL PHYSIOL, V215, P636, DOI 10.1002/jcp.21344; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; JAWORSKI ZFG, 1981, J ANAT, V133, P397; Jiang L, 2009, CANCER LETT, V274, P101, DOI 10.1016/j.canlet.2008.09.017; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; Kawaguchi N, 2000, EXP CELL RES, V260, P284, DOI 10.1006/excr.2000.5020; Kim HH, 2003, EXP CELL RES, V289, P368, DOI 10.1016/S0014-4827(03)00288-X; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Michigami T, 2001, CANCER RES, V61, P1637; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; OURSLER M, 2010, J CELLULAR IN PRESS; Oursler MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC156, DOI 10.1152/ajpcell.00092.2004; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; SUBRAMANIAM M, BIOCH BIOPHYS RES CO, V392, P72; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sutherland KA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2681; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tau KR, 1998, ENDOCRINOLOGY, V139, P1346, DOI 10.1210/en.139.3.1346; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	47	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17522	10.1371/journal.pone.0017522	http://dx.doi.org/10.1371/journal.pone.0017522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423731	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400013
J	Fujimura, A; Michiue, H; Nishiki, T; Ohmori, I; Wei, FY; Matsui, H; Tomizawa, K				Fujimura, Atsushi; Michiue, Hiroyuki; Nishiki, Tei-ichi; Ohmori, Iori; Wei, Fan-Yan; Matsui, Hideki; Tomizawa, Kazuhito			Expression of a Constitutively Active Calcineurin Encoded by an Intron-Retaining mRNA in Follicular Keratinocytes	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; CYCLOSPORINE-A; CYCLIN G2; NFAT; INHIBITION; ACTIVATION; RETENTION; GROWTH; SKIN; DISEASE	Hair growth is a highly regulated cyclical process. Immunosuppressive immunophilin ligands such as cyclosporin A (CsA) and FK506 are known as potent hair growth modulatory agents in rodents and humans that induce active hair growth and inhibit hair follicle regression. The immunosuppressive effectiveness of these drugs has been generally attributed to inhibition of T cell activation through well-characterized pathways. Specifically, CsA and FK506 bind to intracellular proteins, principally cyclophilin A and FKBP12, respectively, and thereby inhibit the phosphatase calcineurin (Cn). The calcineurin (Cn)/NFAT pathway has an important, but poorly understood, role in the regulation of hair follicle development. Here we show that a novel-splicing variant of calcineurin A beta CnA beta-FK, which is encoded by an intron-retaining mRNA and is deficient in the autoinhibitory domain, is predominantly expressed in mature follicular keratinocytes but not in the proliferating keratinocytes of rodents. CnA beta-FK was weakly sensitive to Ca2+ and dephosphorylated NFATc2 under low Ca2+ levels in keratinocytes. Inhibition of Cn/NFAT induced hair growth in nude mice. Cyclin G2 was identified as a novel target of the Cn/NFATc2 pathway and its expression in follicular keratinocytes was reduced by inhibition of Cn/NFAT. Overexpression of cyclin G2 arrested the cell cycle in follicular keratinocytes in vitro and the Cn inhibitor, cyclosporin A, inhibited nuclear localization of NFATc2, resulting in decreased cyclin G2 expression in follicular keratinocytes of rats in vivo. We therefore suggest that the calcineurin/NFAT pathway has a unique regulatory role in hair follicle development.	[Fujimura, Atsushi; Michiue, Hiroyuki; Nishiki, Tei-ichi; Ohmori, Iori; Matsui, Hideki] Okayama Univ, Dept Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan; [Tomizawa, Kazuhito] Japan Sci Technol Agcy JST, PREST, Kawaguchi, Saitama, Japan	Okayama University; Kumamoto University; Japan Science & Technology Agency (JST)	Fujimura, A (corresponding author), Okayama Univ, Dept Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	tomikt@kumamoto-u.ac.jp	OHMORI, Iori/B-2292-2011; MICHIUE, Hiroyuki/B-2320-2011; Fujimura, Atsushi/AAA-4458-2021; Tomizawa, Kazuhito/F-2405-2015; Wei, Fan-Yan/AAD-8461-2021	OHMORI, Iori/0000-0001-6823-2762; Tomizawa, Kazuhito/0000-0002-5663-2627; Fujimura, Atsushi/0000-0002-8638-5460; Wei, Fan-Yan/0000-0002-4843-724X	Ministry of Education, Science, Sports, Culture and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan and by a Grant-in-aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; GUERINI D, 1989, P NATL ACAD SCI USA, V86, P9183, DOI 10.1073/pnas.86.23.9183; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hirano M, 2008, J PROTEOME RES, V7, P2471, DOI 10.1021/pr800025t; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; JIANG H, 1995, J INVEST DERMATOL, V104, P523, DOI 10.1111/1523-1747.ep12606018; KAHAN BD, 1987, TRANSPLANTATION, V43, P197, DOI 10.1097/00007890-198702000-00007; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Takenobu T, 2002, MOL CANCER THER, V1, P1043; Taniguchi I, 2007, P NATL ACAD SCI USA, V104, P13684, DOI 10.1073/pnas.0704922104; Tarrio R, 2008, P NATL ACAD SCI USA, V105, P7223, DOI 10.1073/pnas.0802941105; TOMIZAWA K, 1995, MOL BRAIN RES, V28, P122, DOI 10.1016/0169-328X(94)00199-O; Wu Hai-Yan, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P207, DOI 10.2174/1568015054863873; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17685	10.1371/journal.pone.0017685	http://dx.doi.org/10.1371/journal.pone.0017685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423799	Green Submitted, gold, Green Published			2022-12-25	WOS:000288512400020
J	Liao, QY; Cowling, BJ; Lam, WWT; Fielding, R				Liao, Qiuyan; Cowling, Benjamin J.; Lam, Wendy Wing Tak; Fielding, Richard			Factors Affecting Intention to Receive and Self-Reported Receipt of 2009 Pandemic (H1N1) Vaccine in Hong Kong: A Longitudinal Study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PLANNED BEHAVIOR; INFLUENZA VACCINE; IMPLEMENTATION INTENTIONS; A/H1N1 VACCINATION; COVERAGE RATES; OLDER CHINESE; OMISSION BIAS; METAANALYSIS; PERCEPTIONS	Background: Vaccination was a core component for mitigating the 2009 influenza pandemic (pH1N1). However, a vaccination program's efficacy largely depends on population compliance. We examined general population decision-making for pH1N1 vaccination using a modified Theory of Planned Behaviour (TBP). Methodology: We conducted a longitudinal study, collecting data before and after the introduction of pH1N1 vaccine in Hong Kong. Structural equation modeling (SEM) tested if a modified TPB had explanatory utility for vaccine uptake among adults. Principal Findings: Among 896 subjects who completed both the baseline and the follow-up surveys, 7% (67/896) reported being "likely/very likely/certain'' to be vaccinated (intent) but two months later only 0.8% (7/896) reported having received pH1N1 vaccination. Perception of low risk from pH1N1 (60%) and concerns regarding adverse effects of the vaccine (37%) were primary justifications for avoiding pH1N1 vaccination. Greater perceived vaccine benefits (beta = 0.15), less concerns regarding vaccine side-effects (beta = 20.20), greater adherence to social norms of vaccination (beta = 0.39), anticipated higher regret if not vaccinated (beta = 0.47), perceived higher self-efficacy for vaccination (beta = 0.12) and history of seasonal influenza vaccination (beta = 0.12) were associated with higher intention to receive the pH1N1 vaccine, which in turn predicted self-reported vaccination uptake (beta = 0.30). Social norm (beta = 0.70), anticipated regret (beta = 0.19) and vaccination intention (beta = 0.31) were positively associated with, and accounted for 70% of variance in vaccination planning, which, in turn subsequently predicted self-reported vaccination uptake (beta = 0.36) accounting for 36% of variance in reported vaccination behaviour. Conclusions/Significance: Perceived low risk from pH1N1 and perceived high risk from pH1N1 vaccine inhibited pH1N1 vaccine uptake. Both the TPB and the additional components contributed to intended vaccination uptake but social norms and anticipated regret predominantly associated with vaccination intention and planning. Vaccination planning is a more significant proximal determinant of uptake of pH1N1 vaccine than is intention. Intention alone is an unreliable predictor of future vaccine uptake.	[Liao, Qiuyan; Lam, Wendy Wing Tak; Fielding, Richard] Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Liao, Qiuyan; Cowling, Benjamin J.; Lam, Wendy Wing Tak; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Cowling, Benjamin J.] Univ Hong Kong, Infect Dis Res Grp, Dept Community Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Liao, QY (corresponding author), Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	fielding@hku.hk	Cowling, Benjamin John/C-4263-2009; Lam, Wendy Wing Tak/C-4319-2009	Cowling, Benjamin John/0000-0002-6297-7154; Liao, Qiuyan/0000-0002-1105-6857; Lam, Wendy Wing Tak/0000-0003-2383-0149	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR [PHE-01]; Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease [1 U54 GM088558]; Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong University Grants Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grant no. PHE-01), the Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease Agent Study program (grant no. 1 U54 GM088558), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2003, BRIT J SOC PSYCHOL, V42, P495, DOI 10.1348/014466603322595248; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 2005, ATTITUDES PERSONALIT, V2nd ed.; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; ASCH DA, 1994, MED DECIS MAKING, V14, P118, DOI 10.1177/0272989X9401400204; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brown KF, 2010, VACCINE, V28, P4181, DOI 10.1016/j.vaccine.2010.04.012; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chernoff RA, 2005, AIDS EDUC PREV, V17, P91, DOI 10.1521/aeap.17.3.91.62902; Clayton DA, 2008, INT J ENVIRON HEAL R, V18, P83, DOI 10.1080/09603120701358424; Cohen J., 1988, STAT POWER ANAL BEHA; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; CREWAL R, 2004, MARK SCI, V23, P519; *CTR HLTH PROT HON, 2010, HUM SWIN INFL VACC P; *CTR HLTH PROT HON, 2009, PUBL PLAN HUM SWIN I; *CTR HLTH PROT HON, 2009, NUMB NOT NOT INF DIS; *CTR HLTH PROT HON, 2010, STAT HUM SWIN INFL V; Department of health hong kong, 2009, HUM SWIN INFL VACC P; Dittmann S, 2001, VACCINE, V19, P2446, DOI 10.1016/S0264-410X(00)00470-9; Edmonds BMT, 2011, MATERN CHILD HLTH J, V15, P1203, DOI 10.1007/s10995-010-0693-5; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gallagher S, 2006, J PUBLIC HEALTH-UK, V28, P139, DOI 10.1093/pubmed/fdl008; Gaygisiz U, 2010, VACCINE, V29, P329, DOI 10.1016/j.vaccine.2010.10.030; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Harris KM, 2009, J GEN INTERN MED, V24, P1311, DOI 10.1007/s11606-009-1126-2; *HONG KONG CENS ST, 2006, MAIN TABL 2006 POP C; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kwon Y, 2010, VACCINE, V29, P161, DOI 10.1016/j.vaccine.2010.10.063; Kwong EWY, 2009, J CLIN NURS, V18, P960, DOI 10.1111/j.1365-2702.2008.02548.x; Lau JTF, 2010, VACCINE, V28, P4632, DOI 10.1016/j.vaccine.2010.04.076; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Maltezou HC, 2010, J INFECTION, V61, P252, DOI 10.1016/j.jinf.2010.06.004; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Offit PA, 2003, PEDIATRICS, V112, P1394, DOI 10.1542/peds.112.6.1394; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Rogers R. W., 1983, SOCIAL PSYCHOPHYSIOL, P153, DOI DOI 10.1002/9780470479216.CORPSY0897; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Sheeran P, 1999, J APPL SOC PSYCHOL, V29, P2107, DOI 10.1111/j.1559-1816.1999.tb02298.x; Sheeran P., 2002, EUR REV SOC PSYCHOL, P1, DOI DOI 10.1080/14792772143000003; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Syed Q, 2003, J EPIDEMIOL COMMUN H, V57, P855, DOI 10.1136/jech.57.11.855; Sypsa V, 2009, EUROSURVEILLANCE, V14; Szucs TD, 2005, VACCINE, V23, P5055, DOI 10.1016/j.vaccine.2005.06.005; Tang CSK, 2005, J AGING HEALTH, V17, P490, DOI 10.1177/0898264305277966; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; UNDERWOOD C, 2006, J ADOLESC HLTH, V55; Valle P.O., 2005, ENVIRON BEHAV, V37, P364, DOI DOI 10.1177/0013916504272563; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; WHO, 2009, PAND INFL VACC MAN P; *WHO, 2009, PREP 2 WAV LESS CURR; *WHO, 2009, SAF PAND H1N1 2009 V; *WHO, 2009, WHO REC PAND H1N1 VA; Zijtregtop EAM, 2009, VACCINE, V28, P207, DOI 10.1016/j.vaccine.2009.09.099	75	116	118	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17713	10.1371/journal.pone.0017713	http://dx.doi.org/10.1371/journal.pone.0017713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	733FF	21412418	gold, Green Published			2022-12-25	WOS:000288247800026
J	Yang, L; Chiu, SS; Chan, KP; Chan, KH; Wong, WHS; Peiris, JSM; Wong, CM				Yang, Lin; Chiu, Susan S.; Chan, King-Pan; Chan, Kwok-Hung; Wong, Wilfred Hing-Sang; Peiris, J. S. Malik; Wong, Chit-Ming			Validation of Statistical Models for Estimating Hospitalization Associated with Influenza and Other Respiratory Viruses	PLOS ONE			English	Article							SYNCYTIAL-VIRUS; AIR-POLLUTION; DEATHS; MORTALITY; CHILDREN	Background: Reliable estimates of disease burden associated with respiratory viruses are keys to deployment of preventive strategies such as vaccination and resource allocation. Such estimates are particularly needed in tropical and subtropical regions where some methods commonly used in temperate regions are not applicable. While a number of alternative approaches to assess the influenza associated disease burden have been recently reported, none of these models have been validated with virologically confirmed data. Even fewer methods have been developed for other common respiratory viruses such as respiratory syncytial virus (RSV), parainfluenza and adenovirus. Methods and Findings: We had recently conducted a prospective population-based study of virologically confirmed hospitalization for acute respiratory illnesses in persons < 18 years residing in Hong Kong Island. Here we used this dataset to validate two commonly used models for estimation of influenza disease burden, namely the rate difference model and Poisson regression model, and also explored the applicability of these models to estimate the disease burden of other respiratory viruses. The Poisson regression models with different link functions all yielded estimates well correlated with the virologically confirmed influenza associated hospitalization, especially in children older than two years. The disease burden estimates for RSV, parainfluenza and adenovirus were less reliable with wide confidence intervals. The rate difference model was not applicable to RSV, parainfluenza and adenovirus and grossly underestimated the true burden of influenza associated hospitalization. Conclusion: The Poisson regression model generally produced satisfactory estimates in calculating the disease burden of respiratory viruses in a subtropical region such as Hong Kong.	[Yang, Lin; Chan, King-Pan; Wong, Chit-Ming] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S.; Wong, Wilfred Hing-Sang] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Chan, King-Pan; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yang, L (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	malik@hkucc.hku.hk; hrmrwcm@hkucc.hku.hk	Wong, Wilfred/Q-8751-2019; YANG, Lin/F-9601-2014; Chan, Kwok Hung/ABD-5399-2021; Yang, Lin/E-5183-2011	YANG, Lin/0000-0002-5964-3233; Wong, Hing Sang Wilfred/0000-0001-8396-2368	Research Grants Council of Hong Kong [HKU 7396/03M]; University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/-06]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee of the Hong Kong Special Administrative Region Government	This work is supported by the Research Grants Council of Hong Kong (HKU 7396/03M) and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06) of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chiu SS, 2010, PEDIATR INFECT DIS J, V29, P1088, DOI 10.1097/INF.0b013e3181e9de24; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Gilca R, 2009, AM J EPIDEMIOL, V170, P925, DOI 10.1093/aje/kwp195; Glezen WP, 2003, JAMA-J AM MED ASSOC, V289, P2500, DOI 10.1001/jama.289.19.2500-a; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Hastie TJ., 1990, GEN ADDITIVE MODELS; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jackson ML, 2009, ANN EPIDEMIOL, V19, P681, DOI 10.1016/j.annepidem.2009.06.009; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Panozzo C. A., 2008, Morbidity and Mortality Weekly Report, V57, P1355; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	25	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17882	10.1371/journal.pone.0017882	http://dx.doi.org/10.1371/journal.pone.0017882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412433	gold, Green Published			2022-12-25	WOS:000288247800036
J	Huttunen, R; Hurme, M; Aittoniemi, J; Huhtala, H; Vuento, R; Laine, J; Jylhava, J; Syrjanen, J				Huttunen, Reetta; Hurme, Mikko; Aittoniemi, Janne; Huhtala, Heini; Vuento, Risto; Laine, Janne; Jylhava, Juulia; Syrjanen, Jaana			High Plasma Level of Long Pentraxin 3 (PTX3) Is Associated with Fatal Disease in Bacteremic Patients: A Prospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INNATE IMMUNITY; PULMONARY INFECTION; TRANSGENIC MICE; SEPSIS; SEVERITY; MARKER	Introduction: Long pentraxin 3 (PTX3) is an acute-phase protein secreted by various cells, including leukocytes and endothelial cells. Like C-reactive protein (CRP), it belongs to the pentraxin superfamily. Recent studies indicate that high levels of PTX3 may be associated with mortality in sepsis. The prognostic value of plasma PTX3 in bacteremic patients is unknown. Methods: Plasma PTX3 levels were measured in 132 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, beta-hemolytic streptococcae and Escherichia coli, using a commercial solid-phase enzyme-linked immunosorbent assay (ELISA). Values were measured on days 1-4 after positive blood culture, on day 13-18 and on recovery. Results: The maximum PTX3 values on days 1-4 were markedly higher in nonsurvivors compared to survivors (44.8 vs 6.4 ng/ml, p < 0.001) and the AUC(ROC) in the prediction of case fatality was 0.82 (95% CI 0.73-0.91). PTX3 at a cut-off level of 15 ng/ml showed 72% sensitivity and 81% specificity for fatal disease. High PTX3 (> 15 ng/ml) was associated with hypotension (MAP < 70 mmHg)(OR 7.9; 95% CI 3.3-19.0) and high SOFA score (>= 4)(OR 13.2; 95% CI 4.9-35.4). The CRP level (maximum value on days 1 to 4) did not predict case fatality at any cut-off level in the ROC curve (p = 0.132). High PTX3 (> 15 ng/ml) remained an independent risk factor for case fatality in a logistic regression model adjusted for potential confounders. Conclusions: PTX3 proved to be a specific independent prognostic biomarker in bacteremia. PTX3 during the first days after diagnosis showed better prognostic value as compared to CRP, a widely used biomarker in clinical settings. PTX3 measurement offers a novel opportunity for the prognostic stratification of bacteremia patients.	[Huttunen, Reetta; Laine, Janne; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Huttunen, Reetta; Syrjanen, Jaana] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Hurme, Mikko; Aittoniemi, Janne; Vuento, Risto] Pirkanmaa Hosp Dist, Ctr Lab Med, Tampere, Finland; [Hurme, Mikko; Jylhava, Juulia] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Pirkanmaa Hospital District; Tampere University; Tampere University	Huttunen, R (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	reetta.huttunen@uta.fi		Syrjanen, Jaana/0000-0002-7335-573X; Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491	Tampere University Hospital (Pirkanmaa Hospital District); Finnish Medical Foundation; Orion-Farmos Research Foundation	Tampere University Hospital (Pirkanmaa Hospital District); Finnish Medical Foundation; Orion-Farmos Research Foundation	This work was financially supported by the Competitive Research Funding of Tampere University Hospital (Pirkanmaa Hospital District), the Finnish Medical Foundation, and the Orion-Farmos Research Foundation. The authors' work was independent of the funders (the funding sources had no involvement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BOYD JC, 1997, SCAND J CLIN LAB INV, V227, P46; BrunBuisson C, 1996, AM J RESP CRIT CARE, V154, P617, DOI 10.1164/ajrccm.154.3.8810595; de Kruif MD, 2010, J INFECTION, V60, P122, DOI 10.1016/j.jinf.2009.11.010; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; MCCABE WR, 1962, ARCH INTERN MED, V110, P856, DOI 10.1001/archinte.1962.03620240038007; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004	22	49	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17653	10.1371/journal.pone.0017653	http://dx.doi.org/10.1371/journal.pone.0017653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423699	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100020
J	Lochlainn, SO; Bowen, HC; Fray, RG; Hammond, JP; King, GJ; White, PJ; Graham, NS; Broadley, MR				Lochlainn, Seosamh O.; Bowen, Helen C.; Fray, Rupert G.; Hammond, John P.; King, Graham J.; White, Philip J.; Graham, Neil S.; Broadley, Martin R.			Tandem Quadruplication of HMA4 in the Zinc (Zn) and Cadmium (Cd) Hyperaccumulator Noccaea caerulescens	PLOS ONE			English	Article							THLASPI-CAERULESCENS; METAL HYPERACCUMULATION; P-1B-TYPE ATPASE; GENES; HOMEOSTASIS; ATHMA4; EXPRESSION; HISTORY; TRANSLOCATION; CONSTRUCTION	Zinc (Zn) and cadmium (Cd) hyperaccumulation may have evolved twice in the Brassicaceae, in Arabidopsis halleri and in the Noccaea genus. Tandem gene duplication and deregulated expression of the Zn transporter, HMA4, has previously been linked to Zn/Cd hyperaccumulation in A. halleri. Here, we tested the hypothesis that tandem duplication and deregulation of HMA4 expression also occurs in Noccaea. A Noccaea caerulescens genomic library was generated, containing 36,864 fosmid pCC1FOS (TM) clones with insert sizes similar to 20-40 kbp, and screened with a PCR-generated HMA4 genomic probe. Gene copy number within the genome was estimated through DNA fingerprinting and pooled fosmid pyrosequencing. Gene copy numbers within individual clones was determined by PCR analyses with novel locus specific primers. Entire fosmids were then sequenced individually and reads equivalent to 20-fold coverage were assembled to generate complete whole contigs. Four tandem HMA4 repeats were identified in a contiguous sequence of 101,480 bp based on sequence overlap identities. These were flanked by regions syntenous with up and downstream regions of AtHMA4 in Arabidopsis thaliana. Promoter-reporter beta-glucuronidase (GUS) fusion analysis of a NcHMA4 in A. thaliana revealed deregulated expression in roots and shoots, analogous to AhHMA4 promoters, but distinct from AtHMA4 expression which localised to the root vascular tissue. This remarkable consistency in tandem duplication and deregulated expression of metal transport genes between N. caerulescens and A. halleri, which last shared a common ancestor > 40 mya, provides intriguing evidence that parallel evolutionary pathways may underlie Zn/Cd hyperaccumulation in Brassicaceae.	[Lochlainn, Seosamh O.; Fray, Rupert G.; Hammond, John P.; Graham, Neil S.; Broadley, Martin R.] Univ Nottingham, Plant & Crop Sci Div, Loughborough, Leics, England; [Bowen, Helen C.] Univ Warwick, Warwick HRI, Wellesbourne, Warwick, England; [King, Graham J.] Rothamsted Res, Harpenden, Herts, England; [King, Graham J.] So Cross Univ, Lismore, NSW 2480, Australia; [White, Philip J.] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	University of Nottingham; University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Southern Cross University; James Hutton Institute	Lochlainn, SO (corresponding author), Univ Nottingham, Plant & Crop Sci Div, Loughborough, Leics, England.	martin.broadley@nottingham.ac.uk	White, Philip John/C-5860-2008; Broadley, Martin/AAW-4638-2021; King, Graham J/AAW-3368-2020; Fray, Rupert G/A-9059-2016; Hammond, John P/A-1876-2012; broadley, martin r/E-9081-2011; Graham, Neil/C-5489-2008	White, Philip John/0000-0003-0827-288X; Broadley, Martin/0000-0003-3964-7226; King, Graham J/0000-0002-5975-6051; Fray, Rupert G/0000-0002-3935-8945; Hammond, John P/0000-0002-6241-3551; broadley, martin r/0000-0003-3964-7226; Graham, Neil/0000-0001-9080-8967	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBSSE200613215]; Scottish Government Rural and Environment Research and Analysis Directorate	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Research and Analysis Directorate	Seosamh O Lochlainn was funded by a UK Biotechnology and Biological Sciences Research Council (BBSRC) Studentship (BBSSE200613215). Rothamsted Research is an institute of the BBSRC. The Scottish Crop Research Institute is funded by the Scottish Government Rural and Environment Research and Analysis Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Dubois S, 2003, NEW PHYTOL, V157, P633, DOI 10.1046/j.1469-8137.2003.00684.x; Frey B, 2000, PLANT CELL ENVIRON, V23, P675, DOI 10.1046/j.1365-3040.2000.00590.x; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jimenez-Ambriz G, 2007, NEW PHYTOL, V173, P199, DOI 10.1111/j.1469-8137.2006.01923.x; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Koch M, 1998, BIOCHEM SYST ECOL, V26, P823, DOI 10.1016/S0305-1978(98)00057-X; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Lochlainn SO, 2011, NEW PHYTOL, V189, P409, DOI 10.1111/j.1469-8137.2010.03554.x; Lombi E, 2000, NEW PHYTOL, V145, P11, DOI 10.1046/j.1469-8137.2000.00560.x; Ma JF, 2005, PLANTA, V220, P731, DOI 10.1007/s00425-004-1392-5; Macnair MR, 2003, ADV BOT RES, V40, P63, DOI 10.1016/S0065-2296(05)40002-6; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mills RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013388; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; MUNAMENHOF K, 1994, SYSTEMATIC BOT, V19, P73; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nyren Pal, 2007, V373, P1; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Peer WA, 2003, NEW PHYTOL, V159, P421, DOI 10.1046/j.1469-8137.2003.00822.x; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pollard AJ, 1996, NEW PHYTOL, V132, P113, DOI 10.1111/j.1469-8137.1996.tb04515.x; Riley R., 1956, NEW PHYTOL, V55, P319, DOI DOI 10.1111/J.1469-8137.1956.TB05291.X; Roze D, 2004, GENETICS, V167, P1001, DOI 10.1534/genetics.103.025148; Sambrook J, 2001, MOL CLONING LAB MANU; Santuari L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r4; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; TAYLOR SI, 2004, EVOLUTION ZINC HYPER; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Wang XB, 2009, MAR BIOTECHNOL, V11, P236, DOI 10.1007/s10126-008-9137-2; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x	52	94	93	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17814	10.1371/journal.pone.0017814	http://dx.doi.org/10.1371/journal.pone.0017814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423774	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100037
J	Minguez, P; Dopazo, J				Minguez, Pablo; Dopazo, Joaquin			Assessing the Biological Significance of Gene Expression Signatures and Co-Expression Modules by Studying Their Network Properties	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORKS; GENOMIC DATA; MICROARRAY EXPERIMENTS; FUNCTION PREDICTION; STATISTICAL TESTS; SYSTEMS BIOLOGY; DATABASE; TOOL; ONTOLOGY; CANCER	Microarray experiments have been extensively used to define signatures, which are sets of genes that can be considered markers of experimental conditions (typically diseases). Paradoxically, in spite of the apparent functional role that might be attributed to such gene sets, signatures do not seem to be reproducible across experiments. Given the close relationship between function and protein interaction, network properties can be used to study to what extent signatures are composed of genes whose resulting proteins show a considerable level of interaction (and consequently a putative common functional role). We have analysed 618 signatures and 507 modules of co-expression in cancer looking for significant values of four main protein-protein interaction (PPI) network parameters: connection degree, cluster coefficient, betweenness and number of components. A total of 3904 gene ontology (GO) modules, 146 KEGG pathways, and 263 Biocarta pathways have been used as functional modules of reference. Co-expression modules found in microarray experiments display a high level of connectivity, similar to the one shown by conventional modules based on functional definitions (GO, KEGG and Biocarta). A general observation for all the classes studied is that the networks formed by the modules improve their topological parameters when an external protein is allowed to be introduced within the paths (up to the 70% of GO modules show network parameters beyond the random expectation). This fact suggests that functional definitions are incomplete and some genes might still be missing. Conversely, signatures are clearly not capturing the altered functions in the corresponding studies. This is probably because the way in which the genes have been selected in the signatures is too conservative. These results suggest that gene selection methods which take into account relationships among genes should be superior to methods that assume independence among genes outside their functional contexts.	[Minguez, Pablo; Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [Dopazo, Joaquin] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Dopazo, Joaquin] CIPF, INB, Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center	Minguez, P (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	jdopazo@cipf.es	Miguez, Pablo/D-4822-2013; Dopazo, Joaquin/A-9270-2014	Miguez, Pablo/0000-0003-4099-9421; Dopazo, Joaquin/0000-0003-3318-120X	Spanish Ministry of Science and Innovation (MICINN) [BIO2008-04212]; GVA-FEDER [PROMETEO/2010/001]; National Institute of Bioinformatics; CIBER de Enfermedades Raras; ISCIII, MICINN; Red Tematica de Investigacion Cooperativa en Cancer (RTICC), ISCIII, MICINN [RD06/0020/1019]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GVA-FEDER; National Institute of Bioinformatics; CIBER de Enfermedades Raras; ISCIII, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), ISCIII, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is supported by grants BIO2008-04212 from the Spanish Ministry of Science and Innovation (MICINN) and PROMETEO/2010/001 from the GVA-FEDER. The authors also thank the support of the National Institute of Bioinformatics (www.inab.org) and the CIBER de Enfermedades Raras, both initiatives of the ISCIII, MICINN. This work is also partly supported by a grant (RD06/0020/1019) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), ISCIII, MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Deng MH, 2004, BIOINFORMATICS, V20, P895, DOI 10.1093/bioinformatics/btg500; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dopazo J, 2006, OMICS, V10, P398, DOI 10.1089/omi.2006.10.398; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Hernandez P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-185; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Mateos A, 2002, GENOME RES, V12, P1703, DOI 10.1101/gr.192502; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Montaner D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-197; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wei P, 2008, BIOINFORMATICS, V24, P404, DOI 10.1093/bioinformatics/btm612; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; 2011, MICROARRAY DATABASE; COEXPRESSION CANC MO	47	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17474	10.1371/journal.pone.0017474	http://dx.doi.org/10.1371/journal.pone.0017474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408226	gold, Green Published, Green Submitted			2022-12-25	WOS:000288099800015
J	Cross, B; Chen, LH; Cheng, Q; Li, BZ; Yuan, ZM; Chen, JD				Cross, Brittany; Chen, Lihong; Cheng, Qian; Li, Baozong; Yuan, Zhi-Min; Chen, Jiandong			Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY FEEDBACK LOOP; MANTLE-CELL LYMPHOMA; EMBRYONIC LETHALITY; TUMOR-SUPPRESSOR; CORE DOMAIN; IN-VIVO; MDM2-DEFICIENT MICE; NUCLEAR EXPORT; UBIQUITINATION; GENE	MDM2 regulates p53 predominantly by promoting p53 ubiquitination. However, ubiquitination-independent mechanisms of MDM2 have also been implicated. Here we show that MDM2 inhibits p53 DNA binding activity in vitro and in vivo. MDM2 binding promotes p53 to adopt a mutant-like conformation, losing reactivity to antibody Pab1620, while exposing the Pab240 epitope. The acidic domain of MDM2 is required to induce p53 conformational change and inhibit p53 DNA binding. Alternate reading frame binding to the MDM2 acidic domain restores p53 wild type conformation and rescues DNA binding activity. Furthermore, histone methyl transferase SUV39H1 binding to the MDM2 acidic domain also restores p53 wild type conformation and allows p53-MDM2-SUV39H1 complex to bind DNA. These results provide further evidence for an ubiquitination-independent mechanism of p53 regulation by MDM2 and reveal how MDM2-interacting repressors gain access to p53 target promoters and repress transcription. Furthermore, we show that the MDM2 inhibitor Nutlin cooperates with the proteasome inhibitor Bortezomib by stimulating p53 DNA binding and transcriptional activity, providing a rationale for combination therapy using proteasome and MDM2 inhibitors.	[Cross, Brittany; Chen, Lihong; Cheng, Qian; Li, Baozong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Yuan, Zhi-Min] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA	H Lee Moffitt Cancer Center & Research Institute; University of Texas System; University of Texas Health San Antonio	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	li, baozong/K-4176-2012; Li, Baozong/ABD-4742-2020		National Institutes of Health [CA109636, CA141244, CA118210]; NATIONAL CANCER INSTITUTE [P01CA118210, R01CA109636, P30CA076292, R01CA141244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109636, CA141244, and CA118210.	Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Chen LH, 2010, EMBO J, V29, P2538, DOI 10.1038/emboj.2010.140; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Hansen S, 1996, J BIOL CHEM, V271, P3917; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hideshima Teru, 2003, Rev Clin Exp Hematol, V7, P191; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; LUNA RMD, 1995, NATURE, V378, P203; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ooi MG, 2009, CLIN CANCER RES, V15, P7153, DOI 10.1158/1078-0432.CCR-09-1071; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sivakolundu SG, 2008, J MOL BIOL, V384, P240, DOI 10.1016/j.jmb.2008.09.019; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; ZAUBERMAN A, 1993, EMBO J, V12, P2799, DOI 10.1002/j.1460-2075.1993.tb05941.x; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	63	43	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228981	http://dx.doi.org/10.1074/jbc.M111.228981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454483	hybrid, Green Published			2022-12-25	WOS:000290022800042
J	Muyskens, JB; Guillemin, K				Muyskens, Jonathan B.; Guillemin, Karen			Helicobacter pylori CagA Disrupts Epithelial Patterning by Activating Myosin Light Chain	PLOS ONE			English	Article							VIRULENCE FACTOR CAGA; KINASE RHO-KINASE; TYROSINE PHOSPHATASE; DROSOPHILA; CELLS; PHOSPHORYLATION; CARCINOGENESIS; POLARITY; EXPRESSION; OOGENESIS	Helicobacter pylori infection is a leading cause of ulcers and gastric cancer. We show that expression of the H. pylori virulence factor CagA in a model Drosophila melanogaster epithelium induces morphological disruptions including ectopic furrowing. We find that CagA alters the distribution and increases the levels of activated myosin regulatory light chain (MLC), a key regulator of epithelial integrity. Reducing MLC activity suppresses CagA-induced disruptions. A CagA mutant lacking EPIYA motifs (CagA(EPISA)) induces less epithelial disruption and is not targeted to apical foci like wild-type CagA. In a cell culture model in which CagA(EPISA) and CagA have equivalent subcellular localization, CagA(EPISA) is equally potent in activating MLC. Therefore, in our transgenic system, CagA is targeted by EPIYA motifs to a specific apical region of the epithelium where it efficiently activates MLC to disrupt epithelial integrity.	[Muyskens, Jonathan B.; Guillemin, Karen] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Muyskens, JB (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	guillemin@molbio.uoregon.edu		Guillemin, Karen/0000-0001-6004-9955	National Institutes of Health (NIH) [RO1 DK075667]; American Recovery and Reinvestment Act (ARRA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075667] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (NIH) grant number RO1 DK075667 to K. G. and by American Recovery and Reinvestment Act (ARRA) funds to J.M. through the above grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard JD, 1996, DEVELOPMENT, V122, P1137; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Botham CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000064; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Hamlet MRJ, 2001, GENETICS, V159, P1073; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lapointe TK, 2010, CELL MICROBIOL, V12, P692, DOI 10.1111/j.1462-5822.2010.01429.x; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pignoni F, 1997, P NATL ACAD SCI USA, V94, P9220, DOI 10.1073/pnas.94.17.9220; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107	37	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17856	10.1371/journal.pone.0017856	http://dx.doi.org/10.1371/journal.pone.0017856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445303	Green Submitted, Green Published, gold			2022-12-25	WOS:000288613300016
J	Georgiades, K; Raoult, D				Georgiades, Kalliopi; Raoult, Didier			Genomes of the Most Dangerous Epidemic Bacteria Have a Virulence Repertoire Characterized by Fewer Genes but More Toxin-Antitoxin Modules	PLOS ONE			English	Article							VI SECRETION SYSTEM; RICKETTSIA-PROWAZEKII; ESCHERICHIA-COLI; EVOLUTION; IDENTIFICATION; RNAS; EXPRESSION; PATHOGENS; DEATH; YEAST	Background: We conducted a comparative genomic study based on a neutral approach to identify genome specificities associated with the virulence capacity of pathogenic bacteria. We also determined whether virulence is dictated by rules, or if it is the result of individual evolutionary histories. We systematically compared the genomes of the 12 most dangerous pandemic bacteria for humans ("bad bugs") to their closest non-epidemic related species ("controls"). Methodology/Principal Findings: We found several significantly different features in the "bad bugs", one of which was a smaller genome that likely resulted from a degraded recombination and repair system. The 10 Cluster of Orthologous Group (COG) functional categories revealed a significantly smaller number of genes in the "bad bugs", which lacked mostly transcription, signal transduction mechanisms, cell motility, energy production and conversion, and metabolic and regulatory functions. A few genes were identified as virulence factors, including secretion system proteins. Five "bad bugs" showed a greater number of poly (A) tails compared to the controls, whereas an elevated number of poly (A) tails was found to be strongly correlated to a low GC% content. The "bad bugs" had fewer tandem repeat sequences compared to controls. Moreover, the results obtained from a principal component analysis (PCA) showed that the "bad bugs" had surprisingly more toxin-antitoxin modules than did the controls. Conclusions/Significance: We conclude that pathogenic capacity is not the result of "virulence factors" but is the outcome of a virulent gene repertoire resulting from reduced genome repertoires. Toxin-antitoxin systems could participate in the virulence repertoire, but they may have developed independently of selfish evolution.	[Georgiades, Kalliopi; Raoult, Didier] Univ Mediterranee, Fac Med, URMITE, CNRS IRD UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Georgiades, K (corresponding author), Univ Mediterranee, Fac Med, URMITE, CNRS IRD UMR 6236, Marseille, France.	didier.raoult@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; AUDOLY G, 2010, TOXIC EFFEC IN PRESS; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; BALLOUX F, 2010, BACTERIAL POPULATION, P114; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cohan FM, 2002, GENETICA, V116, P359, DOI 10.1023/A:1021232409545; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; DATE C, 2003, MOL BIOL EVOL, V20, P1188; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Eldredge N., 1972, P82; Feil E. J, 2010, BACTERIAL POPULATION, P19, DOI DOI 10.1002/9780470600122.CH2; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goulard C, 2010, J BACTERIOL, V192, P3669, DOI 10.1128/JB.00336-10; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; Kristoffersen P, 2000, APPL ENVIRON MICROB, V66, P5524, DOI 10.1128/AEM.66.12.5524-5526.2000; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Medina M, 2010, GENOMICS, V95, P129, DOI 10.1016/j.ygeno.2009.12.004; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Miyata ST, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00117; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Picardeau M, 2003, FEMS MICROBIOL LETT, V229, P277, DOI 10.1016/S0378-1097(03)00848-6; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Storz G, 2006, COLD SPRING HARB SYM, V71, P269, DOI 10.1101/sqb.2006.71.033; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wixon J, 2001, COMPAR FUNCT GENOM, V2, P44, DOI 10.1002/cfg.70; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yamamoto TAM, 2002, FEBS LETT, V519, P191, DOI 10.1016/S0014-5793(02)02764-3; Zomorodipour A, 1999, FEBS LETT, V452, P11, DOI 10.1016/S0014-5793(99)00563-3	70	86	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17962	10.1371/journal.pone.0017962	http://dx.doi.org/10.1371/journal.pone.0017962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437250	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100050
J	Li, XX; Zhang, MY; Zhang, HY				Li, Xiaoxue; Zhang, Mingyan; Zhang, Hongyu			RNA Interference of Four Genes in Adult Bactrocera dorsalis by Feeding Their dsRNAs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ORIENTAL FRUIT-FLY; ANTIVIRAL IMMUNITY; C-ELEGANS; EXPRESSION; INGESTION; PATHWAY; RESISTANCE; INFLUENZA; PROTEINS	Background: RNA interference (RNAi) is a powerful method to inhibit gene expression in a sequence specific manner. Recently silencing the target gene through feeding has been successfully carried out in many insect species. Methodology/Principal Findings: Escherichia coli strain HT115 was genetically engineered to express dsRNA targeting genes that encode ribosomal protein Rpl19, V type ATPase D subunit, the fatty acid elongase Noa and a small GTPase Rab11. qRT-PCR showed that mRNA level of four target genes was reduced compared to ds-egfp control by feeding either engineered bacteria or dsRNAs. The maximum down-regulation of each gene varied from 35% to 100%. Tissue specific examination indicated that RNAi could be observed not only in midgut but also in other tissues like the ovary, nervous system and fat body. Silencing of rab11 through ingestion of dsRNA killed 20% of adult flies. Egg production was affected through feeding ds-noa and ds-rab11 compared to ds-egfp group. Adult flies were continuously fed with dsRNA and bacteria expressing dsRNA for 14 days and up-regulations of target genes were observed during this process. The transcripts of noa showed up-regulation compared to ds-egfp control group in four tissues on day 7 after continuous feeding either dsRNA or engineered bacteria. The maximum over-expression is 21 times compared to ds-egfp control group. Up-regulation of rab11 mRNA level could be observed in testes on day 7 after continuous bacteria treatment and in midgut on day 2 after ds-rab11 treatment. This phenomenon could also be observed in rpl19 groups. Conclusions: Our results suggested that it is feasible to silence genes by feeding dsRNA and bacteria expressing dsRNA in Bactrocera dorsalis. Additionally the over-expression of the target gene after continuously feeding dsRNA or bacteria was observed.	[Li, Xiaoxue] Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, Inst Urban & Hort Pests, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Li, XX (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Wuhan, Hubei, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			earmarked fund for Modern Agro-industry Technology Research System (MATS); Special Fund for Agro-scientific Research in the Public Interest [200903047]	earmarked fund for Modern Agro-industry Technology Research System (MATS); Special Fund for Agro-scientific Research in the Public Interest	This work is supported by the earmarked fund for Modern Agro-industry Technology Research System (MATS) and Special Fund for Agro-scientific Research in the Public Interest (grant number 200903047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; BINZ L, 2008, CHINESE AGR SCI B, V24, P391; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang JH, 2003, J VIROL, V77, P11910, DOI 10.1128/JVI.77.22.11910-11917.2003; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; FEO S, 1992, GENOMICS, V13, P201, DOI 10.1016/0888-7543(92)90221-D; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geley S, 2004, EXP GERONTOL, V39, P985, DOI 10.1016/j.exger.2004.03.040; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Giansanti MG, 2007, MOL BIOL CELL, V18, P5034, DOI 10.1091/mbc.E07-05-0415; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Griebler M, 2008, J INSECT PHYSIOL, V54, P997, DOI 10.1016/j.jinsphys.2008.04.019; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Hannon, 2003, RNAI GUIDE GENE SILE; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haque SJ, 1998, SEMIN ONCOL, V25, P14; HOISSONA B, 2006, FEBS LETT, V580, P1988; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jung A, 2007, J CELL SCI, V120, P2924, DOI 10.1242/jcs.006551; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Solis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008424; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tiwari AK, 2008, CELL BIOL INT, V32, P1158, DOI 10.1016/j.cellbi.2008.04.002; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zheng ZM, 2005, ANN NY ACAD SCI, V1058, P105, DOI 10.1196/annals.1359.019; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	45	124	133	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17788	10.1371/journal.pone.0017788	http://dx.doi.org/10.1371/journal.pone.0017788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445257	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100031
J	Li, JW; Vandal, O; Sant'Angelo, DB				Li, Jianwei; Vandal, Omar; Sant'Angelo, Derek B.			TCR Affinity for Self-Ligands Influences the Development and Function of Encephalitogenic T Cells	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR TRANSGENIC MICE; MULTIPLE-SCLEROSIS; NEGATIVE SELECTION; POSITIVE SELECTION; ANTIGEN RECEPTOR; D10 TCR; REPERTOIRE; MHC	The specificity and affinity of self-reactive T cells is likely to impact the development of autoimmune-disease causing T cells in the thymus as well as their function in the periphery. We identified a naturally occurring, low affinity variant of an MBP Ac1-11/I-A(u) specific TCR that is known to induce EAE. Thymocytes in mice carrying the transgenes for this low affinity TCR were poorly positively selected, as compared to their high affinity TCR expressing counterparts. Nonetheless, CD4 T cells bearing the low affinity TCR accumulated in the periphery of the mice. Unlike mice expressing the high affinity TCR, these mice very rarely developed disease. However, if endogenous TCR expression was eliminated by breeding to RAG1 deficient mice, 100% of the mice carrying either the high or the low affinity versions of the TCR developed EAE. Intriguingly, while the incidence of EAE increased, the age of onset of disease in both mice was identical. These data suggest disease onset occurs during a short window of mouse development.	[Li, Jianwei; Vandal, Omar; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Li, JW (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	santangd@mskcc.org			National Institutes of Health (NIH) [R01 AI-41574, T32 CA 09149]; Rudin Family Foundation; Leonard and Claire Tow Charitable Trust; NATIONAL CANCER INSTITUTE [T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rudin Family Foundation; Leonard and Claire Tow Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.B.S. and O.V. were supported by National Institutes of Health (NIH) Grant R01 AI-41574, the Rudin Family Foundation and the Leonard and Claire Tow Charitable Trust. J.L. was supported by NIH training grant T32 CA 09149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anderton S, 1999, IMMUNOL REV, V169, P123, DOI 10.1111/j.1600-065X.1999.tb01311.x; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; BEVAN MJ, 1994, SCIENCE, V264, P796, DOI 10.1126/science.8171333; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Brabb T, 1997, J IMMUNOL, V159, P497; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cohen I R, 1993, Int Rev Immunol, V9, P243, DOI 10.3109/08830189309051209; Dao T, 2003, J IMMUNOL, V170, P48, DOI 10.4049/jimmunol.170.1.48; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Golub R, 2001, EUR J IMMUNOL, V31, P2919, DOI 10.1002/1521-4141(2001010)31:10<2919::AID-IMMU2919>3.0.CO;2-N; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; Janeway CA, 1997, CURR BIOL, V7, pR299, DOI 10.1016/S0960-9822(06)00142-4; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; KUMAR V, 1989, ANNU REV IMMUNOL, V7, P657, DOI 10.1146/annurev.iy.07.040189.003301; Kurschus FC, 2006, INT IMMUNOL, V18, P151, DOI 10.1093/intimm/dxh357; KYEWSKI B, 2006, ANNU REV IMMUNOL; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lo D, 1997, IMMUNOL RES, V16, P3, DOI 10.1007/BF02786320; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McHeyzer-Williams LJ, 2004, IMMUNITY, V20, P231, DOI 10.1016/S1074-7613(04)00028-7; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Sant'Angelo DB, 2002, P NATL ACAD SCI USA, V99, P6931, DOI 10.1073/pnas.102182499; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Sercarz EE, 2000, J AUTOIMMUN, V14, P275, DOI 10.1006/jaut.2000.0380; Smiley ST, 1997, SCAND J IMMUNOL, V45, P726, DOI 10.1046/j.1365-3083.1997.d01-445.x; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2003, IMMUNOL REV, V191, P97, DOI 10.1034/j.1600-065X.2003.00006.x; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; van den Elzen P, 2004, AUTOIMMUN REV, V3, P524, DOI 10.1016/j.autrev.2004.07.008; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; 1995, IMMUNOGENETICS, V42, P451	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17702	10.1371/journal.pone.0017702	http://dx.doi.org/10.1371/journal.pone.0017702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437282	Green Published, gold, Green Submitted			2022-12-25	WOS:000288514600009
J	Fushing, H; McAssey, MP; Beisner, B; McCowan, B				Fushing, Hsieh; McAssey, Michael P.; Beisner, Brianne; McCowan, Brenda			Ranking Network of a Captive Rhesus Macaque Society: A Sophisticated Corporative Kingdom	PLOS ONE			English	Article							DOMINANCE ORDER; HIERARCHIES	We develop a three-step computing approach to explore a hierarchical ranking network for a society of captive rhesus macaques. The computed network is sufficiently informative to address the question: Is the ranking network for a rhesus macaque society more like a kingdom or a corporation? Our computations are based on a three-step approach. These steps are devised to deal with the tremendous challenges stemming from the transitivity of dominance as a necessary constraint on the ranking relations among all individual macaques, and the very high sampling heterogeneity in the behavioral conflict data. The first step simultaneously infers the ranking potentials among all network members, which requires accommodation of heterogeneous measurement error inherent in behavioral data. Our second step estimates the social rank for all individuals by minimizing the network-wide errors in the ranking potentials. The third step provides a way to compute confidence bounds for selected empirical features in the social ranking. We apply this approach to two sets of conflict data pertaining to two captive societies of adult rhesus macaques. The resultant ranking network for each society is found to be a sophisticated mixture of both a kingdom and a corporation. Also, for validation purposes, we reanalyze conflict data from twenty longhorn sheep and demonstrate that our three-step approach is capable of correctly computing a ranking network by eliminating all ranking error.	[Fushing, Hsieh; McAssey, Michael P.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [McCowan, Brenda] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Fushing, H (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	bjmccowan@ucdavis.edu			NSF [HSD 0826844, DMS-1007219]; NIH [1R01AG025218-01A2, R24 RR024396, PR51 RR000169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024396, P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136, P51OD011107] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0826844] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1007219] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding: The first two authors are supported in part by the NSF under Grant No. HSD 0826844 and DMS-1007219, and by the NIH under Grant No. 1R01AG025218-01A2. The last two authors are supported in part by the NIH under Grant Nos. R24 RR024396 (BM) and PR51 RR000169 (CNPRC Base Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2005, ANIM BEHAV, V69, P1191, DOI 10.1016/j.anbehav.2004.08.011; BEISNER BA, 2010, AM J PRIMAT IN PRESS; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; HASS CC, 1991, J ZOOL, V225, P509, DOI 10.1111/j.1469-7998.1991.tb03832.x; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Isbell LA, 2002, BEHAVIOUR, V139, P177, DOI 10.1163/156853902760102645; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Thierry B, SOCIAL EPIGENESIS; Wasserman S., 1994, SOCIAL NETWORK ANAL	14	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17817	10.1371/journal.pone.0017817	http://dx.doi.org/10.1371/journal.pone.0017817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423627	Green Published, gold			2022-12-25	WOS:000288513900036
J	von Schack, D; Agostino, MJ; Murray, BS; Li, YZ; Reddy, PS; Chen, J; Choe, SE; Strassle, BW; Li, C; Bates, B; Zhang, L; Hu, HJ; Kotnis, S; Bingham, B; Liu, W; Whiteside, GT; Samad, TA; Kennedy, JD; Ajit, SK				von Schack, David; Agostino, Michael J.; Murray, B. Stuart; Li, Yizheng; Reddy, Padmalatha S.; Chen, Jin; Choe, Sung E.; Strassle, Brian W.; Li, Christine; Bates, Brian; Zhang, Lynn; Hu, Huijuan; Kotnis, Smita; Bingham, Brendan; Liu, Wei; Whiteside, Garth T.; Samad, Tarek A.; Kennedy, Jeffrey D.; Ajit, Seena K.			Dynamic Changes in the MicroRNA Expression Profile Reveal Multiple Regulatory Mechanisms in the Spinal Nerve Ligation Model of Neuropathic Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; TACTILE ALLODYNIA; PROTEIN-SYNTHESIS; P2X(4) RECEPTORS; GENE-EXPRESSION; UP-REGULATION; RAT; INJURY; IDENTIFICATION; SPECIFICITY	Neuropathic pain resulting from nerve lesions or dysfunction represents one of the most challenging neurological diseases to treat. A better understanding of the molecular mechanisms responsible for causing these maladaptive responses can help develop novel therapeutic strategies and biomarkers for neuropathic pain. We performed a miRNA expression profiling study of dorsal root ganglion (DRG) tissue from rats four weeks post spinal nerve ligation (SNL), a model of neuropathic pain. TaqMan low density arrays identified 63 miRNAs whose level of expression was significantly altered following SNL surgery. Of these, 59 were downregulated and the ipsilateral L4 DRG, not the injured L5 DRG, showed the most significant downregulation suggesting that miRNA changes in the uninjured afferents may underlie the development and maintenance of neuropathic pain. TargetScan was used to predict mRNA targets for these miRNAs and it was found that the transcripts with multiple predicted target sites belong to neurologically important pathways. By employing different bioinformatic approaches we identified neurite remodeling as a significantly regulated biological pathway, and some of these predictions were confirmed by siRNA knockdown for genes that regulate neurite growth in differentiated Neuro2A cells. In vitro validation for predicted target sites in the 3'-UTR of voltage-gated sodium channel Scn11a, alpha 2/delta1 subunit of voltage-dependent Ca-channel, and purinergic receptor P2rx ligand-gated ion channel 4 using luciferase reporter assays showed that identified miRNAs modulated gene expression significantly. Our results suggest the potential for miRNAs to play a direct role in neuropathic pain.	[von Schack, David; Agostino, Michael J.; Murray, B. Stuart; Li, Yizheng; Reddy, Padmalatha S.; Choe, Sung E.; Li, Christine; Bates, Brian; Zhang, Lynn; Liu, Wei] Pfizer Global Res & Dev, Biol Technol, Cambridge, MA USA; [Chen, Jin; Strassle, Brian W.; Hu, Huijuan; Kotnis, Smita; Bingham, Brendan; Whiteside, Garth T.; Samad, Tarek A.; Kennedy, Jeffrey D.; Ajit, Seena K.] Pfizer Global Res & Dev, Neurosci Discovery, Princeton, NJ USA; [Ajit, Seena K.] Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19104 USA	Pfizer; Pfizer; Drexel University	von Schack, D (corresponding author), Pfizer Global Res & Dev, Biol Technol, Cambridge, MA USA.	seena.ajit@drexelmed.edu	Ajit, Seena/AAA-5114-2022	Whiteside, Garth/0000-0001-8128-0806; Agostino, Michael/0000-0003-3204-8175; Hu, Huijuan/0000-0003-2306-2514; Choe, Sung/0000-0001-9140-4198	Wyeth Research	Wyeth Research(Wyeth)	This work was funded by Wyeth Research and all authors were employees of Wyeth Research at the time. Wyeth was acquired by Pfizer in October 2009. The funders therefore had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gold MS, 2000, PAIN, V84, P117, DOI 10.1016/S0304-3959(99)00309-7; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jang JH, 2007, EXP NEUROL, V204, P288, DOI 10.1016/j.expneurol.2006.11.004; JI RR, 2004, SCI STKE; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Komori N, 2007, PHYSIOL GENOMICS, V29, P215, DOI 10.1152/physiolgenomics.00255.2006; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai M, 2005, CEREBROVASC DIS, V20, P49, DOI 10.1159/000086281; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; LIU NK, 2009, EXP NEUROL; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/654346; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Murray BS, 2010, MOL BIOSYST, V6, P1853, DOI 10.1039/c003961f; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schmitt AB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-8; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHEEN K, 1993, BRAIN RES, V610, P62, DOI 10.1016/0006-8993(93)91217-G; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Taylor CP, 2009, PAIN, V142, P13, DOI 10.1016/j.pain.2008.11.019; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Vanderluit JL, 2000, EUR J NEUROSCI, V12, P3469, DOI 10.1046/j.1460-9568.2000.00241.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yoon YW, 1996, PAIN, V64, P27, DOI 10.1016/0304-3959(95)00096-8; Yun SJ, 2010, J CELL PHYSIOL, V225, P337, DOI 10.1002/jcp.22294	56	108	108	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17670	10.1371/journal.pone.0017670	http://dx.doi.org/10.1371/journal.pone.0017670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423802	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400018
J	Gray, JG; Dudas, S; Czub, S				Gray, John G.; Dudas, Sandor; Czub, Stefanie			A Study on the Analytical Sensitivity of 6 BSE Tests Used by the Canadian BSE Reference Laboratory	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; RAPID TESTS; DIAGNOSIS; CATTLE; EPIDEMIOLOGY	Bovine spongiform encephalopathy (BSE) surveillance programs have been employed in numerous countries to monitor BSE prevalence and to protect animal and human health. Since 1999, the European Commission (EC) authorized the evaluation and approval of 20 molecular based tests for the rapid detection of the pathological prion protein (PrPsc) in BSE infection. The diagnostic sensitivity, convenience, and speed of these tests have made molecular diagnostics the preferred method for BSE surveillance. The aim of this study was to determine the analytical sensitivity of 4 commercially available BSE rapid-test kits, including the Prionics (R)-Check WESTERN, the Prionics (R) Check-PrioSTRIP (TM), the BioRad (R) TeSeE (TM) ELISA, and the IDEXX (R) HerdChek (TM) EIA. Performances of these tests were then compared to 2 confirmatory tests, including the BioRad (R) TeSeE (TM) Western Blot and the modified Scrapie Associated Fibrils (SAF)/OIE Immunoblot. One 50% w/v homogenate was made from experimentally generated C-type BSE brain tissues in ddH(2)O. Homogenates were diluted through a background of BSE-negative brainstem homogenate. Masses of both positive and negative tissues in each dilution were calculated to maintain the appropriate tissue amounts for each test platform. Specific concentrated homogenization buffer was added accordingly to maintain the correct buffer condition for each test. ELISA-based tests were evaluated using their respective software/detection platforms. Blot-protocols were evaluated by manual measurements of blot signal density. Detection limitations were determined by fitted curves intersecting the manufacturers' positive/negative criteria. The confirmatory SAF Immunoblot displayed the highest analytical sensitivity, followed by the IDEXX (R) HerdChek (TM) EIA, Bio-Rad (R) TeSeE (TM) Western Blot, the Bio-Rad (R) TeSeE (TM) ELISA, PrionicsH-Check PrioSTRIP (TM), and PrionicsH-Check WESTERN (TM), respectively. Although the tests performed at different levels of sensitivity, the most sensitive and least sensitive of the rapid tests were separated by 2 logs in analytical sensitivity, meeting European performance requirements. All rapid tests appear suitable for targeted BSE surveillance programs, as implemented in Canada.	[Gray, John G.; Dudas, Sandor; Czub, Stefanie] Canadian Food Inspect Agcy, Lethbridge Lab, Lethbridge, AB, Canada	Canadian Food Inspection Agency	Gray, JG (corresponding author), Canadian Food Inspect Agcy, Lethbridge Lab, Lethbridge, AB, Canada.	stefanie.czub@inspection.gc.ca						Adam D, 2001, NATURE, V411, P728, DOI 10.1038/35081261; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; [Anonymous], 2010, EFSA J, V8, P1591; Bennion BJ, 2002, CLIN CHEM, V48, P2105; *BIOR BIOR LAB, 2006, TESEE W BLOT INSTR M; *BIOR LAB, 2003, TESEE PUR DET KIT US; Bounias M, 2002, SCI TOTAL ENVIRON, V297, P1, DOI 10.1016/S0048-9697(02)00140-7; Braun U, 1999, VET REC, V145, P198, DOI 10.1136/vr.145.7.198; Budka H., 2008, TRENDS FOOD SCI TECH, V19, pS34; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CZUB S, 2008, DETECTION PATHOLOGIC; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; *EUR COMM, 1999, OFFICIAL J L, V147, P1; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Heim D, 2005, MEAT SCI, V70, P555, DOI 10.1016/j.meatsci.2004.07.014; *IDEXX LAB, 2007, BOV SPONG ENC ANT TE; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981; Polak MP, 2008, ARCH VIROL, V153, P69, DOI 10.1007/s00705-007-1062-6; Polak MP, 2003, B VET I PULAWY, V47, P89; *PRION AG, 2001, BOV SPONG ENC BSE AN; *PRION AG, 2001, PRION CHECK WESTERN; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Schaller O, 1999, ACTA NEUROPATHOL, V98, P437, DOI 10.1007/s004010051106; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; 2005, EFSA J, V17, P1	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17633	10.1371/journal.pone.0017633	http://dx.doi.org/10.1371/journal.pone.0017633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412419	gold, Green Published, Green Submitted			2022-12-25	WOS:000288247800020
J	Kitt, KN; Nelson, WJ				Kitt, Khameeka N.; Nelson, W. James			Rapid Suppression of Activated Rac1 by Cadherins and Nectins during De Novo Cell-Cell Adhesion	PLOS ONE			English	Article							RHO-FAMILY GTPASES; ADHERENS JUNCTIONS; TRANS-INTERACTIONS; CDC42 GTPASES; ACTIN; MOLECULES; DOMAIN; ESTABLISHMENT; LAMELLIPODIA; SUFFICIENT	Cell-cell adhesion in simple epithelia involves the engagement of E-cadherin and nectins, and the reorganization of the actin cytoskeleton and membrane dynamics by Rho GTPases, particularly Rac1. However, it remains unclear whether E-cadherin and nectins up-regulate, maintain or suppress Rac1 activity during cell-cell adhesion. Roles for Rho GTPases are complicated by cell spreading and integrin-based adhesions to the extracellular matrix that occur concurrently with cell-cell adhesion, and which also require Rho GTPases. Here, we designed a simple approach to examine Rac1 activity upon cell-cell adhesion by MDCK epithelial cells, without cell spreading or integrin-based adhesion. Upon initiation of cell-cell contact in 3-D cell aggregates, we observed an initial peak of Rac1 activity that rapidly decreased by similar to 66% within 5 minutes, and further decreased to a low baseline level after 30 minutes. Inhibition of E-cadherin engagement with DECMA-1 Fab fragments or competitive binding of soluble E-cadherin, or nectin2alpha extracellular domain completely inhibited Rac1 activity. These results indicate that cadherins and nectins cooperate to induce and then rapidly suppress Rac1 activity during initial cell-cell adhesion, which may be important in inhibiting the migratory cell phenotype and allowing the establishment of initially weak cell-cell adhesions.	[Kitt, Khameeka N.; Nelson, W. James] Stanford Univ, Dept Biol, James H Clark Ctr, Bio X Program, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, James H Clark Ctr, Bio X Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Kitt, KN (corresponding author), Stanford Univ, Dept Biol, James H Clark Ctr, Bio X Program, Stanford, CA 94305 USA.	wjnelson@stanford.edu			National Institutes of Health (NIH) [GM35527]; National Cancer Institute [CA09302]; DHHS;  [NIH 5R37-GM35527-24]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R37GM035527] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DHHS; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a National Institutes of Health (NIH) grant (GM35527) to WJN and a Minority Supplement on Parent Grant NIH 5R37-GM35527-24 (WJN) awarded to KNK. Currently, PHS Grant Number CA09302 awarded by the National Cancer Institute, DHHS supports KNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Drees Frauke, 2004, V294, P303; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata Masaki, 2002, Methods Mol Biol, V189, P121; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Honda T, 2003, GENES CELLS, V8, P481, DOI 10.1046/j.1365-2443.2003.00649.x; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2004, MOL BIOL CELL, V15, P1077, DOI 10.1091/mbc.E03-05-0321; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kovacs EM, 2008, CURR BIOL, V18, pR667, DOI 10.1016/j.cub.2008.06.024; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Miyoshi J, 2007, AM J NEPHROL, V27, P590, DOI 10.1159/000108103; Nakagawa M, 2001, J CELL SCI, V114, P1829; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Ogita H, 2006, METHOD ENZYMOL, V406, P415, DOI 10.1016/S0076-6879(06)06030-7; Perez TD, 2008, J BIOL CHEM, V283, P5014, DOI 10.1074/jbc.M705209200; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Stewart DB, 2000, J BIOL CHEM, V275, P20707, DOI 10.1074/jbc.M000467200; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Troyanovsky S, 2005, EUR J CELL BIOL, V84, P225, DOI 10.1016/j.ejcb.2004.12.009; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	44	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17841	10.1371/journal.pone.0017841	http://dx.doi.org/10.1371/journal.pone.0017841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412440	Green Submitted, gold, Green Published			2022-12-25	WOS:000288247800034
J	Wang, SA; Xu, LA; Jonas, JB; You, QS; Wang, YX; Yang, H				Wang, Shuang; Xu, Liang; Jonas, Jost B.; You, Qi Sheng; Wang, Ya Xing; Yang, Hua			Prevalence and Associated Factors of Dyslipidemia in the Adult Chinese Population	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; DENSITY-LIPOPROTEIN CHOLESTEROL; SINO-MONICA PROJECT; RISK-FACTORS; CARDIOVASCULAR-DISEASES; HDL-CHOLESTEROL; GLOBAL BURDEN; PART I; MORTALITY; CORONARY	To determine the prevalence, associated factors, awareness and control of dyslipidemia in Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 Chinese adults (age: 45 to 89 years) as participants of the population-based Beijing Eye Study 2006. Additional information on treatment of dyslipidemia was obtained using a standard questionnaire. The mean concentrations of total, HDL cholesterol, LDL cholesterol and triglycerides were 4.92 +/- 1.01 mmol/L, 1.61 +/- 0.36 mmol/L, 2.88 +/- 0.85 mmol/L, and 1.76 +/- 1.29 mmol/L, respectively. Prevalence of dyslipidemia was 56.1 +/- 0.9%%. Presence of dyslipidemia was significantly associated with increasing age (odds ratio (OR): 1.02; 95% confidence interval (CI): 1.01, 1.03), female gender (OR:1.51; 95% CI: 1.25, 1.83), urban region (OR: 1.82; 95% CI: 1.30, 2.55), body mass index (OR: 1.13; 95% CI: 1.10, 1.15), income (OR: 1.11; 95% CI: 1.02, 1.21), blood glucose concentration (OR: 1.10; 95% CI: 1.05, 1.16), diastolic blood pressure (OR: 1.02; 95% CI: 1.01, 1.03), and smoking (OR:1.23; 1.01, 1.51). Among those who had dyslipidemia, the proportion of subjects who were aware, treated and controlled was 50.9%, 23.8%, and 39.91%, respectively. The awareness rate was associated with urban region (P = 0.001; OR: 6.50), body mass index (P = 0.001; OR: 1.06), and income (P = 0.02; OR: 1.14). The data suggest that dyslipidemia may be present in about 56% of the population aged 45+ years in Greater Beijing. Factors likely associated with dyslipidemia were higher age, female gender, urban region, higher body mass index, higher income, higher blood concentration of glucose, higher diastolic blood pressure, and smoking. In the examined study population, treatment rate was 24% with about 60% of the treated subjects still having uncontrolled dyslipidemia.	[Wang, Shuang; Xu, Liang; Jonas, Jost B.; You, Qi Sheng; Wang, Ya Xing; Yang, Hua] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, SA (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@gmail.com; Jost.Jonas@augen.ma.uni-heidelberg.de	You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320				[Anonymous], 5 CENS CHIN POP YEAR; [Anonymous], 1997, CHIN J CARDIOL, V25, P169; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; *BEIJ MUN STAT BUR, 2001, BEIJ STAT YB 2001; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; IRVING S, 1992, CIRCULATION, V85, P1083; Jia W P, 2002, Obes Rev, V3, P157; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Kang Wei-ming, 2009, Chinese Medical Sciences Journal, V24, P142; Li YH, 2002, NUTR METAB CARDIOVAS, V12, P118; Li ZY, 2005, CLIN CHEM, V51, P144, DOI 10.1373/clinchem.2004.038646; Liang Li-rong, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P363, DOI 10.3760/cma.j.issn.0253-3758.2009.04.017; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Rodgers A, 1998, LANCET, V352, P1801; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; TAO SC, 1989, INT J EPIDEMIOL, V18, pS159; VERSCHUREN WMM, 1994, INT J EPIDEMIOL, V23, P948, DOI 10.1093/ije/23.5.948; Wu Yang-feng, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P420; WU ZS, 1988, ACTA MED SCAND, P60; Wu ZS, 2004, EUR J CARDIOV PREV R, V11, P275, DOI 10.1097/01.hjr.0000136566.89429.63; Wu ZS, 2001, CIRCULATION, V103, P462; Xu L, 2008, EXP CLIN ENDOCR DIAB, V116, P69, DOI 10.1055/s-2007-985381; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Xu L, 2008, AM J HYPERTENS, V21, P1117, DOI 10.1038/ajh.2008.247; Yao C, 1993, Zhonghua Liu Xing Bing Xue Za Zhi, V14, P19; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zhang L, 2010, J EPIDEMIOL, V20, P237, DOI 10.2188/jea.JE20090119; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329; ZHOU BF, 1995, INT J EPIDEMIOL, V24, P528, DOI 10.1093/ije/24.3.528	32	75	81	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17326	10.1371/journal.pone.0017326	http://dx.doi.org/10.1371/journal.pone.0017326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423741	gold, Green Published, Green Submitted			2022-12-25	WOS:000288219100006
J	Nikitina, L; Ahammer, H; Blaschitz, A; Gismondi, A; Glasner, A; Schimek, MG; Dohr, G; Sedlmayr, P				Nikitina, Liudmila; Ahammer, Helmut; Blaschitz, Astrid; Gismondi, Angela; Glasner, Andreas; Schimek, Michael G.; Dohr, Gottfried; Sedlmayr, Peter			A New Method for Morphometric Analysis of Tissue Distribution of Mobile Cells in Relation to Immobile Tissue Structures	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; UTERINE LEUKOCYTES; HUMAN ENDOMETRIUM; PREGNANCY; RECRUITMENT; UTERUS; ACCUMULATION; MECHANISMS	The distribution of cells in stained tissue sections provides information that may be analyzed by means of morphometric computation. We developed an algorithm for automated analysis for the purpose of answering questions pertaining to the relative densities of wandering cells in the vicinity of comparatively immobile tissue structures such as vessels or tumors. As an example, we present the analysis of distribution of CD56-positive cells and of CXCR3-positive cells (relative densities of peri-vascular versus non-vascular cell populations) in relation to the endothelium of capillaries and venules of human parietal decidua tissue of first trimester pregnancy. In addition, the distibution of CD56-positive cells (mostly uterine NK cells) in relation to spiral arteries is analyzed. The image analysis is based on microphotographs of two-color immunohistological stainings. Discrete distances (10-50 mm) from the fixed structures were chosen for the purpose of definining the extent of neighborhood areas. For the sake of better comparison of cell distributions at different overall cell densities a model of random distribution of "cells" in relation to neighborhood areas and rest decidua of a specific sample was built. In the chosen instances, we found increased perivascular density of CD56-positive cells and of CXCR3-positive cells. In contrast, no accumulation of CD56-positive cells was found in the neighborhood of spiral arteries.	[Nikitina, Liudmila; Blaschitz, Astrid; Dohr, Gottfried; Sedlmayr, Peter] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Ahammer, Helmut] Med Univ Graz, Inst Biophys, Graz, Austria; [Gismondi, Angela] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Schimek, Michael G.] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz; Sapienza University Rome; Medical University of Graz	Nikitina, L (corresponding author), Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.	peter.sedlmayr@medunigraz.at	Dohr, Gottfried/E-8070-2010	Ahammer, Helmut/0000-0001-5400-294X	the European Commission (Network of Excellence, "The Control of Embryo Implantation (EMBIC)") [FP6-512040]	the European Commission (Network of Excellence, "The Control of Embryo Implantation (EMBIC)")(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the European Commission (Network of Excellence, "The Control of Embryo Implantation (EMBIC)", FP6-512040, lead researcher involved: P. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; BULMER JN, 1991, HUM REPROD, V6, P791, DOI 10.1093/oxfordjournals.humrep.a137430; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Chantakru S, 2001, J REPROD IMMUNOL, V49, P33, DOI 10.1016/S0165-0378(00)00076-0; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hazan AD, 2010, AM J PATHOL, V177, P1017, DOI 10.2353/ajpath.2010.091105; Kam EPY, 1999, HUM REPROD, V14, P2131, DOI 10.1093/humrep/14.8.2131; King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Santoni A, 2008, AM J REPROD IMMUNOL, V59, P417, DOI 10.1111/j.1600-0897.2008.00598.x; Sentman CL, 2004, J IMMUNOL, V173, P6760, DOI 10.4049/jimmunol.173.11.6760; Trowsdale J, 2008, SEMIN IMMUNOL, V20, P317, DOI 10.1016/j.smim.2008.06.002; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; van den Heuvel MJ, 2005, IMMUNOL INVEST, V34, P273, DOI 10.1081/IMM-200064488	16	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e15086	10.1371/journal.pone.0015086	http://dx.doi.org/10.1371/journal.pone.0015086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408197	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000003
J	Chitteti, BR; Liu, YL; Srour, EF				Chitteti, Brahmananda Reddy; Liu, Yunlong; Srour, Edward F.			Genomic and Proteomic Analysis of the Impact of Mitotic Quiescence on the Engraftment of Human CD34(+) Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; STEM-CELL; GENE-EXPRESSION; BONE-MARROW; REPOPULATING CAPACITY; STEM/PROGENITOR CELLS; MICROARRAY; PROTEIN; MODEL; DIFFERENTIATION	It is well established that in adults, long-term repopulating hematopoietic stem cells (HSC) are mitotically quiescent cells that reside in specialized bone marrow (BM) niches that maintain the dormancy of HSC. Our laboratory demonstrated that the engraftment potential of human HSC (CD34(+) cells) from BM and mobilized peripheral blood (MPB) is restricted to cells in the G0 phase of cell cycle but that in the case of umbilical cord blood (UCB) -derived CD34(+) cells, cell cycle status is not a determining factor in the ability of these cells to engraft and sustain hematopoiesis. We used this distinct in vivo behavior of CD34(+) cells from these tissues to identify genes associated with the engraftment potential of human HSC. CD34(+) cells from BM, MPB, and UCB were fractionated into G0 and G1 phases of cell cycle and subjected in parallel to microarray and proteomic analyses. A total of 484 target genes were identified to be associated with engraftment potential of HSC. System biology modeling indicated that the top four signaling pathways associated with these genes are Integrin signaling, p53 signaling, cytotoxic T lymphocyte-mediated apoptosis, and Myc mediated apoptosis signaling. Our data suggest that a continuum of functions of hematopoietic cells directly associated with cell cycle progression may play a major role in governing the engraftment potential of stem cells. While proteomic analysis identified a total of 646 proteins in analyzed samples, a very limited overlap between genomic and proteomic data was observed. These data provide a new insight into the genetic control of engraftment of human HSC from distinct tissues and suggest that mitotic quiescence may not be the requisite characteristic of engrafting stem cells, but instead may be the physiologic status conducive to the expression of genetic elements favoring engraftment.	[Chitteti, Brahmananda Reddy; Srour, Edward F.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Liu, Yunlong] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Srour, Edward F.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Srour, Edward F.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Chitteti, BR (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA.	esrour@iupui.edu			National Institutes of Health (NIH) [R01 HL55716]; National Cancer Institute (NCI) [P30 CA082709]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055716] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL55716 (EFS). The Flow Cytometry Research Facility is partially funded by National Cancer Institute (NCI) P30 CA082709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chulada PC, 2000, CANCER RES, V60, P4705; Colvin GA, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2006.09.005; DAWN PGF, 2007, PROTEOMICS CLIN APPL; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Evangelou A, 2002, ENDOCRINOLOGY, V143, P3897, DOI 10.1210/en.2002-220156; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gothot A, 1998, EXP HEMATOL, V26, P562; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Higgs Richard E., 2008, V428, P209; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kim YC, 2009, P NATL ACAD SCI USA, V106, P8278, DOI 10.1073/pnas.0903390106; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Liu F, 2006, PROTEOMICS, V6, P2673, DOI 10.1002/pmic.200500032; Mielcarek M, 1997, STEM CELLS, V15, P229, DOI 10.1002/stem.5530150831; Nunes SS, 2008, J CELL PHYSIOL, V214, P828, DOI 10.1002/jcp.21281; Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006; OGAWA M, 1993, BLOOD, V81, P2844; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Quesenberry PJ, 2006, CURR OPIN HEMATOL, V13, P216, DOI 10.1097/01.moh.0000231417.08031.ac; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; Rakeman AS, 2006, DEVELOPMENT, V133, P3075, DOI 10.1242/dev.02473; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Sheng QH, 2006, NAT GENET, V38, P1223, DOI 10.1038/ng1106-1223; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Tao W, 2004, STEM CELLS, V22, P1003, DOI 10.1634/stemcells.22-6-1003; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Wang ZQ, 2007, BIOCHEM BIOPH RES CO, V355, P312, DOI 10.1016/j.bbrc.2007.01.129; Wilpshaar J, 2000, BLOOD, V96, P2100; Wilpshaar J, 2002, BLOOD, V100, P120, DOI 10.1182/blood.V100.1.120; Yamauchi M, 2007, CANCER SCI, V98, P1491, DOI 10.1111/j.1349-7006.2007.00534.x; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2; Zhan QM, 1999, ONCOGENE, V18, P297, DOI 10.1038/sj.onc.1202310	58	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17498	10.1371/journal.pone.0017498	http://dx.doi.org/10.1371/journal.pone.0017498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408179	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800020
J	Kristiansen, T; Drinkwater, KF; Lough, RG; Sundby, S				Kristiansen, Trond; Drinkwater, Kenneth F.; Lough, R. Gregory; Sundby, Svein			Recruitment Variability in North Atlantic Cod and Match-Mismatch Dynamics	PLOS ONE			English	Article							GADUS-MORHUA; HABITAT SELECTION; CLASS STRENGTH; CLIMATE-CHANGE; LIFE-HISTORY; FISH EGGS; LARVAL; GROWTH; SIZE; TEMPERATURE	Background: Fisheries exploitation, habitat destruction, and climate are important drivers of variability in recruitment success. Understanding variability in recruitment can reveal mechanisms behind widespread decline in the abundance of key species in marine and terrestrial ecosystems. For fish populations, the match-mismatch theory hypothesizes that successful recruitment is a function of the timing and duration of larval fish abundance and prey availability. However, the underlying mechanisms of match-mismatch dynamics and the factors driving spatial differences between high and low recruitment remain poorly understood. Methodology/Principal Findings: We used empirical observations of larval fish abundance, a mechanistic individual-based model, and a reanalysis of ocean temperature data from 1960 to 2002 to estimate the survival of larval cod (Gadus morhua). From the model, we quantified how survival rates changed during the warmest and coldest years at four important cod spawning sites in the North Atlantic. The modeled difference in survival probability was not large for any given month between cold or warm years. However, the cumulative effect of higher growth rates and survival through the entire spawning season in warm years was substantial with 308%, 385%, 154%, and 175% increases in survival for Georges Bank, Iceland, North Sea, and Lofoten cod stocks, respectively. We also found that the importance of match-mismatch dynamics generally increased with latitude. Conclusions/Significance: Our analyses indicate that a key factor for enhancing survival is the duration of the overlap between larval and prey abundance and not the actual timing of the peak abundance. During warm years, the duration of the overlap between larval fish and their prey is prolonged due to an early onset of the spring bloom. This prolonged season enhances cumulative growth and survival, leading to a greater number of large individuals with enhanced potential for survival to recruitment.	[Kristiansen, Trond; Drinkwater, Kenneth F.; Sundby, Svein] Inst Marine Res, N-5024 Bergen, Norway; [Kristiansen, Trond; Drinkwater, Kenneth F.; Sundby, Svein] Bjerknes Ctr Climate Res, Bergen, Norway; [Lough, R. Gregory] NOAA, Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA	Institute of Marine Research - Norway; Bjerknes Centre for Climate Research; National Oceanic Atmospheric Admin (NOAA) - USA	Kristiansen, T (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	tk@trondkristiansen.com		Sundby, Svein/0000-0002-0815-9740; Kristiansen, Trond/0000-0001-6121-297X	Norwegian Research Council [178239]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was supported by the Norwegian Research Council through project ARCWARM #178239 to T. K. and K. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, CLIM RES, V41, P15, DOI 10.3354/cr00838; Bonnet D, 2005, PROG OCEANOGR, V65, P1, DOI 10.1016/j.pocean.2005.02.002; BRANDER KM, 1994, ICES J MAR SCI, V51, P71, DOI 10.1006/jmsc.1994.1007; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buckley LJ, 2010, MAR ECOL PROG SER, V405, P57, DOI 10.3354/meps08503; Carton JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002817; Cheung WWL, 2008, MAR ECOL PROG SER, V365, P187, DOI 10.3354/meps07414; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; CUSHING DH, 1996, D21385 OLDENDORF LUH, P1; Daewel U, 2008, J PLANKTON RES, V30, P1, DOI 10.1093/plankt/fbm094; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ S; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hare JA, 1997, ECOLOGY, V78, P2415; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; HENSON SA, 2009, J GEOPHYS RES-OCEANS, P114; HINRICHSEN HH, 2010, SURVIVAL PROBABILITY; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Houde ED, 1987, AM FISH SOC S, V2, P17; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; ICES, 2005, ICES COD PRACT INTR, P1; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Kaartvedt S, 2000, ICES J MAR SCI, V57, P1819, DOI 10.1006/jmsc.2000.0964; Kjesbu OS, 1996, CAN J FISH AQUAT SCI, V53, P610, DOI 10.1139/cjfas-53-3-610; Kristiansen T, 2009, BEHAV ECOL, V20, P490, DOI 10.1093/beheco/arp023; Kristiansen T, 2007, CAN J FISH AQUAT SCI, V64, P136, DOI 10.1139/F06-176; Kuzmina SI, 2008, TELLUS A, V60, P289, DOI [10.1111/j.1600-0870.2008.00303.x, 10.1111/J.1600-0870.2008.00303.X]; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Levitus S., 1994, NOAA ATLAS NESDIS, V4; Lough RG, 2010, FISH OCEANOGR, V19, P159, DOI 10.1111/j.1365-2419.2010.00535.x; Lough RG, 2005, FISH OCEANOGR, V14, P241, DOI 10.1111/j.1365-2419.2005.00330.x; MACKENZIE BR, 1993, MAR ECOL PROG SER, V94, P207, DOI 10.3354/meps094207; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; MILLER TJ, 1997, EARLY LIFE HIST RECR; Mueter FJ, 2009, PROG OCEANOGR, V81, P93, DOI 10.1016/j.pocean.2009.04.018; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Paradis AR, 1996, CAN J FISH AQUAT SCI, V53, P1226, DOI 10.1139/cjfas-53-6-1226; Peck MA, 2006, ENVIRON BIOL FISH, V75, P419, DOI 10.1007/s10641-006-0031-3; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; POPE JG, 1994, PHILOS T ROY SOC B, V343, P41, DOI 10.1098/rstb.1994.0006; RICHARDSON AJ, 2004, SCIENCE, P305; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; Skartveit A, 1998, SOL ENERGY, V63, P173, DOI 10.1016/S0038-092X(98)00067-X; Stock CA, 2008, J MARINE SYST, V74, P134, DOI 10.1016/j.jmarsys.2007.12.004; SUNDBY S, 1994, ICES MAR SC, V198, P393; SUNDBY S, 1989, RAP PROCES, V191, P351; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Vollset KW, 2009, J EXP MAR BIOL ECOL, V379, P16, DOI 10.1016/j.jembe.2009.08.013	58	109	109	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17456	10.1371/journal.pone.0017456	http://dx.doi.org/10.1371/journal.pone.0017456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408215	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800012
J	Ketchart, W; Ogba, N; Kresak, A; Albert, JM; Pink, JJ; Montano, MM				Ketchart, W.; Ogba, N.; Kresak, A.; Albert, J. M.; Pink, J. J.; Montano, M. M.			HEXIM1 is a critical determinant of the response to tamoxifen	ONCOGENE			English	Article						estrogen receptor; tamoxifen; HEXIM1; breast cancer	BREAST CELL-GROWTH; CYCLIN D1; P-TEFB; RESISTANCE; MECHANISMS; CANCER; DISEASE; EXPRESSION; INHIBITOR; RECEPTORS	Tamoxifen resistance is a major problem in the treatment of estrogen receptor (ER)-positive patients. We have previously reported that hexamethylene bis-acetamide-inducible protein 1 (HEXIM1) inhibits ER alpha activity by competing with ER alpha for binding to cyclin T1, a subunit of positive transcription elongation b (P-TEFb). This results in the inhibition of the phosphorylation of RNA polymerase II (RNAPII) at serine 2 and the inhibition of transcription elongation of ER alpha target genes. As HEXIM1 can inhibit ER activity, we examined whether it has a critical role in the inhibitory effects of tamoxifen on ER. We observed that tamoxifen-induced HEXIM1 recruitment to the promoter region of ER target genes and decreased the recruitment of cyclin T1 and serine 2 phosphorylated RNAPII to the coding regions of these genes. Conversely, in cells wherein HEXIM1 expression has been downregulated we observed attenuation of the inhibitory effects of tamoxifen on estrogen-induced cyclin T1 recruitment to coding regions of ER target genes. As a consequence, downregulation of HEXIM1 resulted in the attenuation of the repressive effects of tamoxifen on estrogen-induced gene expression and proliferation. Conferring clinical relevance to our studies is our analysis of human breast cancer tissue samples that indicated association of lower expression of HEXIM1 with tumor recurrence in patients who received tamoxifen. Our studies provide a better understanding of the mechanistic basis for the inhibitory effect of tamoxifen on ER activity and may suggest new therapeutic targets for the treatment of tamoxifen-resistant breast cancer. Oncogene (2011) 30, 3563-3569; doi:10.1038/onc.2011.76; published online 21 March 2011	[Montano, M. M.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kresak, A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Albert, J. M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Pink, J. J.] Case Western Reserve Univ, Div Gen Med Sci Oncol Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Montano, MM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, HG Wood Bldg W305,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mxm126@case.edu	Albert, Jeffrey/P-7273-2019; Ogba, Ndiya/K-8429-2014	Albert, Jeffrey/0000-0003-2245-1745; Ogba, Ndiya/0000-0003-0453-3763	National Institute of Health [CA92440]; American Cancer Society [RSG CCE-110689]; NATIONAL CANCER INSTITUTE [R01CA092440] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Wei Wang (CWRU Department of Epidemiology and Biostatistics) for help with construction of graphs representing the relationship between disease recurrence and expressions levels of HEXIM1 in breast tissue. This work was supported by National Institute of Health grant CA92440 to MMM and American Cancer Society grant RSG CCE-110689 to J.J.P.	Anderson H, 2007, J STEROID BIOCHEM, V106, P49, DOI 10.1016/j.jsbmb.2007.05.024; Cleator SJ, 2009, CLIN BREAST CANCER, V9, pS6, DOI 10.3816/CBC.2009.s.001; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; HURVITZ SA, 2008, CANCER, V9, P2385; Kusuhara M, 1999, BIOMED RES-TOKYO, V20, P273, DOI 10.2220/biomedres.20.273; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MUSGROVE EA, 1994, SEMIN CANCER BIOL, V5, P381; Ogba N, 2008, CANCER RES, V68, P7015, DOI 10.1158/0008-5472.CAN-08-0814; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Scott DJ, 2007, INT J ONCOL, V31, P557; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Webb P, 2003, J BIOL CHEM, V278, P6912, DOI 10.1074/jbc.M208501200; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zwart W, 2009, MOL ENDOCRINOL, V23, P1335, DOI 10.1210/me.2008-0268	23	17	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	33					3563	3569		10.1038/onc.2011.76	http://dx.doi.org/10.1038/onc.2011.76			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21423213	Green Accepted			2022-12-25	WOS:000294005100001
J	Hatzirodos, N; Bayne, RA; Irving-Rodgers, HF; Hummitzsch, K; Sabatier, L; Lee, S; Bonner, W; Gibson, MA; Rainey, WE; Carr, BR; Mason, HD; Reinhardt, DP; Anderson, RA; Rodgers, RJ				Hatzirodos, Nicholas; Bayne, Rosemary A.; Irving-Rodgers, Helen F.; Hummitzsch, Katja; Sabatier, Laetitia; Lee, Sam; Bonner, Wendy; Gibson, Mark A.; Rainey, William E.; Carr, Bruce R.; Mason, Helen D.; Reinhardt, Dieter P.; Anderson, Richard A.; Rodgers, Raymond J.			Linkage of regulators of TGF-beta activity in the fetal ovary to polycystic ovary syndrome	FASEB JOURNAL			English	Article						latent transforming growth factor-beta binding protein; fibrillin	TRANSFORMING-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MESSENGER-RNA; INSULIN-RESISTANCE; GENE-EXPRESSION; SEX STEROIDS; THECA CELLS; PROTEIN; FIBRILLIN-3; WOMEN	Although not often discussed, the ovaries of women with polycystic ovary syndrome (PCOS) show all the hallmarks of increased TGF-beta activity, with increased amounts of fibrous tissue and collagen in the ovarian capsule or tunica albuginea and ovarian stroma. Recent studies suggest that PCOS could have fetal origins. Genetic studies of PCOS have also found linkage with a microsatellite located in intron 55 of the extracellular matrix protein fibrillin 3. Fibrillins regulate TGF-beta bioactivity in tissues by binding latent TGF-beta binding proteins. We therefore examined expression of fibrillins 1-3, latent TGF-beta binding proteins 1-4, and TGF-beta 1-3 in bovine and human fetal ovaries at different stages of gestation and in adult ovaries. We also immunolocalized fibrillins 1 and 3. The results indicate that TGF-beta pathways operate during ovarian fetal development, but most important, we show fibrillin 3 is present in the stromal compartments of fetal ovaries and is highly expressed at a critical stage early in developing human and bovine fetal ovaries when stroma is expanding and follicles are forming. These changes in expression of fibrillin 3 in the fetal ovary could lead to a predisposition to develop PCOS in later life.-Hatzirodos, N., Bayne, R. A., Irving-Rodgers, H. F., Hummitzsch, K., Sabatier, L., Lee, S., Bonner, W., Gibson, M. A., Rainey, W. E., Carr, B. R., Mason, H. D., Reinhardt, D. P., Anderson, R. A., Rodgers, R. J. Linkage of regulators of TGF-beta activity in the fetal ovary to polycystic ovary syndrome. FASEB J. 25, 2256-2265 (2011). www.fasebj.org	[Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hummitzsch, Katja; Lee, Sam; Bonner, Wendy; Rodgers, Raymond J.] Univ Adelaide, Robinson Inst, Discipline Obstet & Gynaecol, Res Ctr Reprod Hlth, Adelaide, SA 5005, Australia; [Gibson, Mark A.] Univ Adelaide, Sch Med Sci, Discipline Pathol, Adelaide, SA 5005, Australia; [Bayne, Rosemary A.] Univ Edinburgh, Ctr Reprod Biol, Med Res Council Human Reprod Sci Unit, Edinburgh EH3 9EW, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, Ctr Reprod Biol, Div Reprod & Dev Sci, Edinburgh EH3 9EW, Midlothian, Scotland; [Sabatier, Laetitia] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Rainey, William E.] Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA; [Carr, Bruce R.] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Dallas, TX 75390 USA; [Mason, Helen D.] St Georges Univ London, Div Basic Med Sci, London, England	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Edinburgh; University of Edinburgh; McGill University; McGill University; University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas; St Georges University London	Rodgers, RJ (corresponding author), Univ Adelaide, Robinson Inst, Discipline Obstet & Gynaecol, Res Ctr Reprod Hlth, Adelaide, SA 5005, Australia.	ray.rodgers@adelaide.edu.au	Rodgers, Raymond J/C-3476-2009; Reinhardt, Dieter P/A-3102-2008; Hummitzsch, Katja/K-6940-2013	Reinhardt, Dieter P/0000-0001-6535-9872; Hummitzsch, Katja/0000-0001-5023-2668; Bayne, Rosemary (Rosey)/0000-0001-5820-6050	National Health and Medical Research Council of Australia; University of Adelaide; Clive and Vera Ramaciotti Foundation; Wellcome Trust; National Institute of Health; Medical Research Council UK; MRC [G1100357, G1002033, G0700916] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043140] Funding Source: NIH RePORTER; Medical Research Council [G1100357, G0700916, G1002033] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; Clive and Vera Ramaciotti Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Mr. Thomas Sullivan for assistance with the statistical analyses and T&R Pastoral for donation of bovine ovaries. Funding to support this research was obtained from the National Health and Medical Research Council of Australia, the University of Adelaide, the Clive and Vera Ramaciotti Foundation, the Wellcome Trust, the National Institute of Health, and the Medical Research Council UK. N.H., H.F.I-R., K.H., S.L., W.B., M.A.G., and R.J.R. planned the experiments, conducted RT-PCR, immunohistochemistry, and statistical analysis, and wrote the manuscript. R. A. B. and R. A. A. conducted RT-PCR and provided human fetal ovarian samples and reviewed the manuscript. W. E. R., B. R. C., and H. D. M. provided human adult ovarian samples and RNA and reviewed the manuscript. L. S. and D. P. R. expressed recombinant fibrillins, made antisera to FBN3 and adsorbed it against FBN2, established methods for immuno-staining, and reviewed the manuscript.	Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Amato P, 2004, BEST PRACT RES CL OB, V18, P707, DOI 10.1016/j.bpobgyn.2004.05.002; Azziz R, 2005, J CLIN ENDOCR METAB, V90, P4650, DOI 10.1210/jc.2005-0628; BARNES RB, 1994, J CLIN ENDOCR METAB, V79, P1328, DOI 10.1210/jcem.79.5.7962325; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Christner PJ, 2006, AMINO ACIDS, V30, P445, DOI 10.1007/s00726-005-0265-y; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; Diamanti-Kandarakis E, 2006, ENDOCRINE, V30, P19, DOI 10.1385/ENDO:30:1:19; Forsdike RA, 2007, J ENDOCRINOL, V192, P421, DOI 10.1677/joe.1.07097; Friel A, 2002, INT J ANDROL, V25, P59, DOI 10.1046/j.1365-2605.2002.00326.x; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; HAGUE WM, 1990, CLIN ENDOCRINOL, V33, P501, DOI 10.1111/j.1365-2265.1990.tb03887.x; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Jordan CD, 2010, J HISTOCHEM CYTOCHEM, V58, P903, DOI 10.1369/jhc.2010.956615; Kenney MC, 2003, EXP EYE RES, V77, P537, DOI 10.1016/S0014-4835(03)00218-5; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kielty CM, 2002, J CELL SCI, V115, P2817; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Legro RS, 2002, J CLIN ENDOCR METAB, V87, P2128, DOI 10.1210/jc.87.5.2128; MASON HD, 1994, J CLIN ENDOCR METAB, V79, P1355, DOI 10.1210/jc.79.5.1355; Natoli AK, 2005, HYPERTENSION, V46, P1129, DOI 10.1161/01.HYP.0000187016.06549.96; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Padmanabhan V, 2009, J CLIN ENDOCR METAB, V94, P1883, DOI 10.1210/jc.2009-0492; Prodoehl MJ, 2009, MOL HUM REPROD, V15, P829, DOI 10.1093/molehr/gap072; Prodoehl MJ, 2009, MOL CELL ENDOCRINOL, V307, P133, DOI 10.1016/j.mce.2009.03.002; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Ramirez F, 1999, INT J BIOCHEM CELL B, V31, P255, DOI 10.1016/S1357-2725(98)00109-5; Russe I, 1983, Bibl Anat, V24, P77; Sabatier L, 2010, MATRIX BIOL, V21, P21; Samuel CS, 2003, ARCH BIOCHEM BIOPHYS, V411, P47, DOI 10.1016/S0003-9861(02)00710-5; Son ED, 2005, J INVEST DERMATOL, V124, P1149, DOI 10.1111/j.0022-202X.2005.23736.x; Stewart DR, 2006, J CLIN ENDOCR METAB, V91, P4112, DOI 10.1210/jc.2006-0951; Sullivan TM, 2009, REPROD FERT DEVELOP, V21, P773, DOI 10.1071/RD09004; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; Veiga-Lopez A, 2008, BIOL REPROD, V78, P636, DOI 10.1095/biolreprod.107.065904; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8; Wen Y, 2006, HUM REPROD, V21, P1266, DOI 10.1093/humrep/dei485; Yildiz BO, 2003, J CLIN ENDOCR METAB, V88, P2031, DOI 10.1210/jc.2002-021499	48	62	63	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2256	2265		10.1096/fj.11-181099	http://dx.doi.org/10.1096/fj.11-181099			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21411746	Green Published			2022-12-25	WOS:000292242200017
J	Arai, N; Kagawa, W; Saito, K; Shingu, Y; Mikawa, T; Kurumizaka, H; Shibata, T				Arai, Naoto; Kagawa, Wataru; Saito, Kengo; Shingu, Yoshinori; Mikawa, Tsutomu; Kurumizaka, Hitoshi; Shibata, Takehiko			Vital Roles of the Second DNA-binding Site of Rad52 Protein in Yeast Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; COLI RECA PROTEIN; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; GENETIC-RECOMBINATION; BREAK REPAIR; MEDIATOR FUNCTION; JOINT MOLECULES; CIRCULAR DNA; EXCHANGE	RecA/Rad51 proteins are essential in homologous DNA recombination and catalyze the ATP-dependent formation of D-loops from a single-stranded DNA and an internal homologous sequence in a double-stranded DNA. RecA and Rad51 require a "recombination mediator" to overcome the interference imposed by the prior binding of single-stranded binding protein/replication protein A to the single-stranded DNA. Rad52 is the prototype of recombination mediators, and the human Rad52 protein has two distinct DNA-binding sites: the first site binds to single-stranded DNA, and the second site binds to either double-or single-stranded DNA. We previously showed that yeast Rad52 extensively stimulates Rad51-catalyzed D-loop formation even in the absence of replication protein A, by forming a 2: 1 stoichiometric complex with Rad51. However, the precise roles of Rad52 and Rad51 within the complex are unknown. In the present study, we constructed yeast Rad52 mutants in which the amino acid residues corresponding to the second DNA-binding site of the human Rad52 protein were replaced with either alanine or aspartic acid. We found that the second DNA-binding site is important for the yeast Rad52 function in vivo. Rad51-Rad52 complexes consisting of these Rad52 mutants were defective in promoting the formation of D-loops, and the ability of the complex to associate with double-stranded DNA was specifically impaired. Our studies suggest that Rad52 within the complex associates with double-stranded DNA to assist Rad51-mediated homologous pairing.	[Arai, Naoto] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa 2520880, Japan; [Kagawa, Wataru; Saito, Kengo; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Shingu, Yoshinori; Mikawa, Tsutomu; Shibata, Takehiko] RIKEN Adv Sci Inst, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; [Shingu, Yoshinori; Mikawa, Tsutomu; Shibata, Takehiko] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Tsurumi Ku, Kanagawa 2300045, Japan; [Mikawa, Tsutomu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Nihon University; Waseda University; RIKEN; Yokohama City University; RIKEN	Arai, N (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	narai@brs.nihon-u.ac.jp; tshibata@postman.riken.go.jp	Mikawa, Tsutomu/E-6510-2013	Mikawa, Tsutomu/0000-0003-2325-5084; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589; SAITO, Kengo/0000-0002-8714-6285	Ministry of Education, Culture, Science, Sports and Technology of Japan [21113004, 19570168]; Nihon University [08-125]; Grants-in-Aid for Scientific Research [22310119, 21113001, 10J02699] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas 21113004, Scientific Research (C) 19570168, from the Ministry of Education, Culture, Science, Sports and Technology of Japan and by Nihon University Individual Research Grant 08-125.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Arai N, 2005, J BIOL CHEM, V280, P32218, DOI 10.1074/jbc.M507521200; Bai Y, 1999, GENETICS, V153, P1117; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; CHOW SA, 1985, P NATL ACAD SCI USA, V82, P5646, DOI 10.1073/pnas.82.17.5646; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; CUNNINGHAM RP, 1980, CELL, V20, P223, DOI 10.1016/0092-8674(80)90250-0; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; KAHN R, 1981, P NATL ACAD SCI-BIOL, V78, P4786, DOI 10.1073/pnas.78.8.4786; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; SCOTT JF, 1977, P NATL ACAD SCI USA, V74, P193, DOI 10.1073/pnas.74.1.193; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHIBATA T, 1980, P NATL ACAD SCI-BIOL, V77, P2606, DOI 10.1073/pnas.77.5.2606; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; SHIBATA T, 1982, J BIOL CHEM, V257, P370; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; Wu Y, 2008, J BIOL CHEM, V283, P14883, DOI 10.1074/jbc.M801097200	53	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17607	17617		10.1074/jbc.M110.216739	http://dx.doi.org/10.1074/jbc.M110.216739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454474	Green Published, hybrid			2022-12-25	WOS:000290585200024
J	Wang, L; Liu, YT; Hao, R; Chen, L; Chang, ZJ; Wang, HR; Wang, ZX; Wu, JW				Wang, Le; Liu, Yi-Tong; Hao, Rui; Chen, Lei; Chang, Zhijie; Wang, Hong-Rui; Wang, Zhi-Xin; Wu, Jia-Wei			Molecular Mechanism of the Negative Regulation of Smad1/5 Protein by Carboxyl Terminus of Hsc70-interacting Protein (CHIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE CHIP; TGF-BETA SUPERFAMILY; MEDIATED DEGRADATION; SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; STRUCTURAL BASIS; QUALITY-CONTROL; BMP PATHWAY; CHAPERONE; TARGETS	The transforming growth factor-beta (TGF-beta) superfamily of ligands signals along two intracellular pathways, Smad2/3-mediated TGF-beta/activin pathway and Smad1/5/8-mediated bone morphogenetic protein pathway. The C terminus of Hsc70-interacting protein (CHIP) serves as an E3 ubiquitin ligase to mediate the degradation of Smad proteins and many other signaling proteins. However, the molecular mechanism for CHIP-mediated down-regulation of TGF-beta signaling remains unclear. Here we show that the extreme C-terminal sequence of Smad1 plays an indispensable role in its direct association with the tetratricopeptide repeat (TPR) domain of CHIP. Interestingly, Smad1 undergoes CHIP-mediated polyubiquitination in the absence of molecular chaperones, and phosphorylation of the C-terminal SXS motif of Smad1 enhances the interaction and ubiquitination. We also found that CHIP preferentially binds to Smad1/5 and specifically disrupts the core signaling complex of Smad1/5 and Smad4. We determined the crystal structures of CHIP-TPR in complex with the phosphorylated/pseudophosphorylated Smad1 peptides and with an Hsp70/Hsc70 C-terminal peptide. Structural analyses and subsequent biochemical studies revealed that the distinct CHIP binding affinities of Smad1/5 or Smad2/3 result from the nonconservative hydrophobic residues at R-Smad C termini. Unexpectedly, the C-terminal peptides from Smad1 and Hsp70/Hsc70 bind in the same groove of CHIP-TPR, and heat shock proteins compete with Smad1/5 for CHIP interaction and concomitantly suppress, rather than facilitate, CHIP-mediated Smad ubiquitination. Thus, we conclude that CHIP inhibits the signaling activities of Smad1/5 by recruiting Smad1/5 from the functional R-/Co-Smad complex and further promoting the ubiquitination/degradation of Smad1/5 in a chaperone-independent manner.	[Wang, Le; Liu, Yi-Tong; Hao, Rui; Chen, Lei; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China; [Chang, Zhijie] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Med, Beijing 100084, Peoples R China; [Wang, Hong-Rui] Xiamen Univ, MOE Key Lab Cell Biol & Tumor Cell Engn, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China	Tsinghua University; Tsinghua University; Xiamen University	Wu, JW (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022; Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227; Wang, Hong-Rui/0000-0002-2916-8849; Wang, Le/0000-0002-8687-239X	Ministry of Science and Technology of China [2007CB914400, 2011CB910803]; National Natural Science Foundation of China [31070643]; Tsinghua University [09THZ02235]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work was supported in part by Ministry of Science and Technology of China Grants 2007CB914400 and 2011CB910803, National Natural Science Foundation of China Grant 31070643, and Tsinghua University Grant 09THZ02235.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Daviau A, 2006, J BIOL CHEM, V281, P31467, DOI 10.1074/jbc.M607612200; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Li RF, 2007, J MOL BIOL, V374, P777, DOI 10.1016/j.jmb.2007.09.082; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Masaki M, 2005, CIRCULATION, V111, P2752, DOI 10.1161/CIRCULATIONAHA.104.490946; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	47	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201814	http://dx.doi.org/10.1074/jbc.M110.201814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454478	Green Published, hybrid			2022-12-25	WOS:000290022800029
J	Kayali, G; Webby, RJ; Ducatez, MF; El Shesheny, RA; Kandeil, AM; Govorkova, EA; Mostafa, A; Ali, MA				Kayali, Ghazi; Webby, Richard J.; Ducatez, Mariette F.; El Shesheny, Rabeh A.; Kandeil, Ahmed M.; Govorkova, Elena A.; Mostafa, Ahmed; Ali, Mohamed A.			The Epidemiological and Molecular Aspects of Influenza H5N1 Viruses at the Human-Animal Interface in Egypt	PLOS ONE			English	Article							A H5N1; NEURAMINIDASE INHIBITORS; CASE-FATALITY; INFECTION; VIRULENCE; INDONESIA; OUTBREAKS; DIARRHEA; DISEASE; BIRD	With 119 confirmed cases between March 2006 and December 2010, Egypt ranks second among countries reporting human H5N1 influenza virus infections. In 2009-2010, Egypt reported 68 new human cases and became the new epicenter for H5N1 infections. We conducted an epidemiological and molecular analysis in order to better understand the situation in Egypt. The onset of new cases peaked annually during the winter and spring months, with majority of cases reported in the Nile Delta region. Most cases were less than 18 years old (62%) and females (60%). The overall case-fatality rate was 34% and significantly increased by age. There was a significant difference between the case-fatality rates among females and males. We observed a significant drop (p = 0.004) in case fatality rate in 2009 (10%) as compared to higher rates (36%-56%) in other years. Hospitalization within 2 or 3 days after onset of symptoms significantly decreased mortality. Molecular analysis showed that variations do occur among viruses isolated from birds as well as from humans in Egypt, and these mutations were especially noted in 2009 viruses. As the epidemiological profile of Egyptian cases differs from other countries, there is an urgent need to conduct prospective studies to enhance our understanding of incidence, prevalence, and determinants of virulence of human infections with avian H5N1 influenza viruses.	[Kayali, Ghazi; Webby, Richard J.; Ducatez, Mariette F.; Govorkova, Elena A.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [El Shesheny, Rabeh A.; Kandeil, Ahmed M.; Mostafa, Ahmed; Ali, Mohamed A.] Natl Res Ctr, Virol Lab, Div Environm Res, Cairo, Egypt	St Jude Children's Research Hospital; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Kayali, G (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	ghazi.kayali@stjude.org	Kandeil, Ahmed/N-5473-2019; Kandeil, Ahmed Mohamed/B-3345-2016; Mostafa, Ahmed/S-7462-2016; Ali, Mohamed A/N-8768-2017; El-shesheny, Rabeh/S-7927-2016; Webby, Richard J/N-5657-2018	Kandeil, Ahmed/0000-0003-3253-6961; Kandeil, Ahmed Mohamed/0000-0003-3253-6961; Mostafa, Ahmed/0000-0002-2878-5714; Ali, Mohamed A/0000-0002-5615-3212; El-shesheny, Rabeh/0000-0002-8798-2240; Govorkova, Elena/0000-0001-9067-5682	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; American Lebanese Syrian Associated Charities	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN266200700005C, and by the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; Al-Azemi A, 2008, EMERG INFECT DIS, V14, P958, DOI 10.3201/eid1406.080056; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P410; Arabi Y, 2007, CRIT CARE MED, V35, P1397, DOI 10.1097/01.CCM.0000262940.34596.4B; Arafa A, 2010, AVIAN DIS, V54, P345, DOI 10.1637/8927-051509-ResNote.1; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; DUDLEY JP, 2009, EUROSURVEILL, V14; *EG CAB, 2006, AN POULTR IND STRUCT; FASINA FO, EUROSURVEILL, V15, P19473; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hui DSC, 2008, RESPIROLOGY, V13, pS10, DOI 10.1111/j.1440-1843.2008.01247.x; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Nicoll Angus, 2006, Euro Surveill, V11, P74; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Slomka MJ, 2007, AVIAN DIS, V51, P227, DOI 10.1637/7674-063006R1.1; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; WEBSTER RG, 1993, INTERVIROLOGY, V35, P16, DOI 10.1159/000150292; WHO, 2009, H5N1 AV INFL TIM MAJ; WHO, 2006, WKLY EPIDEMIOL REC, V81, P249; Wiwanitkit V, 2005, GUT, V54, P1506, DOI 10.1136/gut.2005.072488; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; World Health Organization, 2009, EP PAND AL RESP; World Health Organization, 2009, WHO INF LAB DIAGN PA; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	42	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17730	10.1371/journal.pone.0017730	http://dx.doi.org/10.1371/journal.pone.0017730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445292	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300011
J	Fan, YF; Fan, YB; Li, ZY; Lv, CS; Luo, DL				Fan, Yifang; Fan, Yubo; Li, Zhiyu; Lv, Changsheng; Luo, Donglin			Natural Gaits of the Non-Pathological Flat Foot and High-Arched Foot	PLOS ONE			English	Article							EVOLUTION; FOOTPRINT	There has been a controversy as to whether or not the non-pathological flat foot and high-arched foot have an effect on human walking activities. The 3D foot scanning system was employed to obtain static footprints from subjects adopting a half-weight-bearing stance. Based upon their footprints, the subjects were divided into two groups: the flat-footed and the high-arched. The plantar pressure measurement system was used to measure and record the subjects' successive natural gaits. Two indices were proposed: distribution of vertical ground reaction force (VGRF) of plantar and the rate of change of footprint areas. Using these two indices to compare the natural gaits of the two subject groups, we found that (1) in stance phase, there is a significant difference (p < 0.01) in the distributions of VGRF of plantar; (2) in a stride cycle, there is also a significant difference (p < 0.01) in the rate of change of footprint area. Our analysis suggests that when walking, the VGRF of the plantar brings greater muscle tension to the flat-footed while a smaller rate of change of footprint area brings greater stability to the high-arched.	[Fan, Yifang; Lv, Changsheng; Luo, Donglin] Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China; [Li, Zhiyu] Jinan Univ, Coll Foreign Studies, Guangzhou, Guangdong, Peoples R China	Guangzhou Sport University; Beihang University; Jinan University	Fan, YF (corresponding author), Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China.	tfyf@gipe.edu.cn; yubofan@buaa.edu.cn	Fan, Yifang/V-6281-2019	Fan, Yifang/0000-0001-5338-9847	National Natural Science Foundation of China [10772053, 10925208, 10972061]; Natural Science Research of Guangdong Higher Education [06Z019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research of Guangdong Higher Education	This project was funded by National Natural Science Foundation of China under the grant 10772053, 10925208, 10972061 and by Key Project of Natural Science Research of Guangdong Higher Education Grant No 06Z019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAN CW, 1994, MAYO CLIN PROC, V69, P448, DOI 10.1016/S0025-6196(12)61642-5; Chen CH, 2006, ARCH PHYS MED REHAB, V87, P235, DOI 10.1016/j.apmr.2005.10.014; Chen MJL, 2003, AM J PHYS MED REHAB, V82, P842, DOI 10.1097/01.PHM.0000087455.38062.79; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Colne P, 2008, GAIT POSTURE, V28, P164, DOI 10.1016/j.gaitpost.2007.11.006; Dowling AM, 2001, INT J OBESITY, V25, P845, DOI 10.1038/sj.ijo.0801598; Esterman A, 2005, MIL MED, V170, P623, DOI 10.7205/MILMED.170.7.623; Fan YF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/58003; FAN YF, 2010, DYNAMIC PRINCIPLES C; Gefen A, 2001, CLIN BIOMECH, V16, P921, DOI 10.1016/S0268-0033(01)00074-2; Igbigbi P S, 2002, J Foot Ankle Surg, V41, P394; Kanatli U, 2001, J PEDIATR ORTHOPED, V21, P225, DOI 10.1097/00004694-200103000-00018; Lin CJ, 2001, J PEDIATR ORTHOPED, V21, P378, DOI 10.1097/00004694-200105000-00022; Mochimaru M, 2000, ERGONOMICS, V43, P1301, DOI 10.1080/001401300421752; NATTIV A, 2000, WOMEN SPORT TRACK FI; Orlin MN, 2000, PHYS THER, V80, P399, DOI 10.1093/ptj/80.4.399; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; SALTZMAN CL, 1995, J ORTHOP SPORT PHYS, V21, P354, DOI 10.2519/jospt.1995.21.6.354; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Walczak Michal, 2003, Chir Narzadow Ruchu Ortop Pol, V68, P261; Wang WJ, 2004, J BIOMECH, V37, P1831, DOI 10.1016/j.jbiomech.2004.02.036; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Younger AS, 2005, FOOT ANKLE INT, V26, P820, DOI 10.1177/107110070502601006	25	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17749	10.1371/journal.pone.0017749	http://dx.doi.org/10.1371/journal.pone.0017749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445254	gold, Green Submitted, Green Published			2022-12-25	WOS:000288545100028
J	Shaner, PJL; Macko, SA				Shaner, Pei-Jen L.; Macko, Stephen A.			Trophic Shifts of a Generalist Consumer in Response to Resource Pulses	PLOS ONE			English	Article							STABLE-ISOTOPES; PEROMYSCUS-LEUCOPUS; CALLORHINUS-URSINUS; FOOD-HABITS; NITROGEN; CARBON; DIET; MAMMALS; RODENT; TISSUE	Trophic shifts of generalist consumers can have broad food-web and biodiversity consequences through altered trophic flows and vertical diversity. Previous studies have used trophic shifts as indicators of food-web responses to perturbations, such as species invasion, and spatial or temporal subsidies. Resource pulses, as a form of temporal subsidies, have been found to be quite common among various ecosystems, affecting organisms at multiple trophic levels. Although diet switching of generalist consumers in response to resource pulses is well documented, few studies have examined if the switch involves trophic shifts, and if so, the directions and magnitudes of the shifts. In this study, we used stable carbon and nitrogen isotopes with a Bayesian multi-source mixing model to estimate proportional contributions of three trophic groups (i.e. producer, consumer, and fungus-detritivore) to the diets of the White-footed mouse (Peromyscus leucopus) receiving an artificial seed pulse or a naturally-occurring cicadas pulse. Our results demonstrated that resource pulses can drive trophic shifts in the mice. Specifically, the producer contribution to the mouse diets was increased by 32% with the seed pulse at both sites examined. The consumer contribution to the mouse diets was also increased by 29% with the cicadas pulse in one of the two grids examined. However, the pattern was reversed in the second grid, with a 13% decrease in the consumer contribution with the cicadas pulse. These findings suggest that generalist consumers may play different functional roles in food webs under perturbations of resource pulses. This study provides one of the few highly quantitative descriptions on dietary and trophic shifts of a key consumer in forest food webs, which may help future studies to form specific predictions on changes in trophic interactions following resource pulses.	[Shaner, Pei-Jen L.] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Shaner, Pei-Jen L.; Macko, Stephen A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	National Taiwan Normal University; University of Virginia	Shaner, PJL (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	pshaner@ntnu.edu.tw	Shaner, Pei-Jen/B-2955-2012; Macko, Stephen/K-4588-2015	Shaner, Pei-Jen/0000-0001-8112-4299	National Science Foundation [NSF DEB 0411027]	National Science Foundation(National Science Foundation (NSF))	The study was partially supported by a National Science Foundation Dissertation Improvement Grant (NSF DEB 0411027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	CLARIDGE AW, 1994, AUST J ECOL, V19, P251, DOI 10.1111/j.1442-9993.1994.tb00489.x; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Davidson DL, 2001, FUNCT ECOL, V15, P575, DOI 10.1046/j.0269-8463.2001.00569.x; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Elias SP, 2004, J MAMMAL, V85, P743, DOI 10.1644/BER-025; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Johnson CN, 1996, TRENDS ECOL EVOL, V11, P503, DOI 10.1016/S0169-5347(96)10053-7; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kurle CM, 2002, MAR ECOL PROG SER, V236, P289, DOI 10.3354/meps236289; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; Marcello GJ, 2008, J ANIM ECOL, V77, P41, DOI 10.1111/j.1365-2656.2007.01310.x; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; McCracken KE, 1999, J MAMMAL, V80, P1288, DOI 10.2307/1383179; Mcilwee AP, 1998, FUNCT ECOL, V12, P223, DOI 10.1046/j.1365-2435.1998.00181.x; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; PAINE RT, 1980, J ANIM ECOL, V49, P667; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; PULLIAM HR, 1975, AM NAT, V109, P765, DOI 10.1086/283041; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Schnurr JL, 2002, OIKOS, V96, P402, DOI 10.1034/j.1600-0706.2002.960302.x; Sears ALW, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P359; Shaner PJ, 2007, ECOLOGY, V88, P87, DOI 10.1890/0012-9658(2007)88[87:GDADSI]2.0.CO;2; Stancampiano Anthony J., 1995, Proceedings of the Oklahoma Academy of Science, V75, P45; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Storm Jonathan J., 2007, Proceedings of the Indiana Academy of Science, V116, P196; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Vandegrift KJ, 2009, J ANIM ECOL, V78, P202, DOI 10.1111/j.1365-2656.2008.01456.x; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WHITAKER JO, 1966, J MAMMAL, V47, P473, DOI 10.2307/1377688; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; WOLFF JO, 1985, J MAMMAL, V66, P795, DOI 10.2307/1380812; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2006, P ROY SOC B-BIOL SCI, V273, P2993, DOI 10.1098/rspb.2006.3676; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; YONEYAMA T, 1983, Radioisotopes, V32, P330	55	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17970	10.1371/journal.pone.0017970	http://dx.doi.org/10.1371/journal.pone.0017970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437248	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100051
J	Tao, J; Shi, JA; Yan, L; Chen, Y; Duan, YH; Ye, P; Feng, Q; Zhang, JW; Shu, XQ; Ji, YH				Tao, Jie; Shi, Jian; Yan, Li; Chen, Ying; Duan, Yan Hong; Ye, Pin; Feng, Qi; Zhang, Jian Wei; Shu, Xue Qin; Ji, Yong Hua			Enhancement Effects of Martentoxin on Glioma BK Channel and BK Channel (alpha+beta 1) Subtypes	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; ACTION-POTENTIAL REPOLARIZATION; CA2+-ACTIVATED K+ CHANNEL; CA1 PYRAMIDAL NEURONS; SMOOTH-MUSCLE; BETA-SUBUNIT; CALCIUM; CELLS; CONDUCTANCE; EXPRESSION	Background: BK channels are usually activated by membrane depolarization and cytoplasmic Ca(2+). Especially, the activity of BK channel (alpha+beta 4) can be modulated by martentoxin, a 37 residues peptide, with Ca(2+) -dependent manner. gBK channel (glioma BK channel) and BK channel (alpha+beta 1) possessed higher Ca(2+) sensitivity than other known BK channel subtypes. Methodology and Principal Findings: The present study investigated the modulatory characteristics of martentoxin on these two BK channel subtypes by electrophysiological recordings, cell proliferation and Ca(2+) imaging. In the presence of cytoplasmic Ca(2+), martentoxin could enhance the activities of both gBK and BK channel (alpha+beta 1) subtypes in dose-dependent manner with EC(50) of 46.7 nM and 495 nM respectively, while not shift the steady-state activation of these channels. The enhancement ratio of martentoxin on gBK and BK channel (alpha+beta 1) was unrelated to the quantitive change of cytoplasmic Ca(2+) concentrations though the interaction between martentoxin and BK channel (alpha+beta 1) was accelerated under higher cytoplasmic Ca(2+). The selective BK pore blocker iberiotoxin could fully abolish the enhancement of these two BK subtypes induced by martentoxin, suggesting that the auxiliary beta subunit might contribute to the docking for martentoxin. However, in the absence of cytoplasmic Ca(2+), the activity of gBK channel would be surprisingly inhibited by martentoxin while BK channel (alpha+beta 1) couldn't be affected by the toxin. Conclusions and Significance: Thus, the results shown here provide the novel evidence that martentoxin could increase the two Ca(2+) -hypersensitive BK channel subtypes activities in a new manner and indicate that beta subunit of these BK channels plays a vital role in this enhancement by martentoxin.	[Tao, Jie; Shi, Jian; Yan, Li; Chen, Ying; Duan, Yan Hong; Ye, Pin; Feng, Qi; Zhang, Jian Wei; Shu, Xue Qin; Ji, Yong Hua] Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China	Shanghai University	Tao, J (corresponding author), Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China.	yhji@staff.shu.edu.cn	Ji, Yonghua/B-7769-2014; Tao, Jie/AAF-7766-2020		National Basic Research Program of China [2010CB529806]; National Nature Sciences Foundation of China [30772554]; Shanghai Municipal Education Commission; National Laboratory of Biomacromolecules [O5SY021097]; Institute of Biophysics, Chinese Academy of Sciences, Shanghai University	National Basic Research Program of China(National Basic Research Program of China); National Nature Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National Laboratory of Biomacromolecules; Institute of Biophysics, Chinese Academy of Sciences, Shanghai University(Shanghai UniversityChinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (grant 2010CB529806), the National Nature Sciences Foundation of China (grant 30772554), and the Leading Academic Discipline Project of Shanghai Municipal Education Commission "Molecular Physiology," National Laboratory of Biomacromolecules (grant O5SY021097), Institute of Biophysics, Chinese Academy of Sciences and Innovation Fund for Graduate Student, Shanghai University. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brenner S, 2000, CLIN DERMATOL, V18, P711, DOI 10.1016/S0738-081X(00)00154-1; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hurley BR, 1999, AM J PHYSIOL-GASTR L, V276, pG843, DOI 10.1152/ajpgi.1999.276.4.G843; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Ji YH, 2003, J NEUROCHEM, V84, P325, DOI 10.1046/j.1471-4159.2003.01516.x; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; Lingle C J, 1996, Ion Channels, V4, P261; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; MACDERMOTT AB, 1982, NATURE, V300, P185, DOI 10.1038/300185a0; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Navarro-Antolin J, 2005, CIRCULATION, V112, P1309, DOI 10.1161/CIRCULATIONAHA.104.529404; Nelson MT, 2004, J CLIN INVEST, V113, P955, DOI 10.1172/JCI200421388; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; PALLOTTA BS, 1985, J GEN PHYSIOL, V86, P601, DOI 10.1085/jgp.86.5.601; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Poolos NP, 1999, J NEUROSCI, V19, P5205; Ransom CB, 2002, GLIA, V38, P281, DOI 10.1002/glia.10064; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; SHI J, 2008, BIOPHYS J; Shi J, 2008, BIOPHYS J, V94, P3706, DOI 10.1529/biophysj.107.122150; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wiecha J, 1998, J VASC RES, V35, P363, DOI 10.1159/000025606; Yoshida J, 2004, HUM GENE THER, V15, P77, DOI 10.1089/10430340460732472; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e15896	10.1371/journal.pone.0015896	http://dx.doi.org/10.1371/journal.pone.0015896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445248	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100007
J	Kujjo, LL; Chang, EA; Pereira, RJG; Dhar, S; Marrero-Rosado, B; Sengupta, S; Wang, HB; Cibelli, JB; Perez, GI				Kujjo, Loro L.; Chang, Eun A.; Pereira, Ricardo J. G.; Dhar, Shilpa; Marrero-Rosado, Brenda; Sengupta, Satyaki; Wang, Hongbing; Cibelli, Jose B.; Perez, Gloria I.			Chemotherapy-Induced Late Transgenerational Effects in Mice	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; RING-SHAPED NUCLEI; CHILDHOOD-CANCER; ANTICANCER DRUGS; FEMALE SURVIVORS; BONE-MARROW; DOXORUBICIN; FERTILITY; APOPTOSIS; GENE	To our knowledge, there is no report on long-term reproductive and developmental side effects in the offspring of mothers treated with a widely used chemotherapeutic drug such as doxorubicin (DXR), and neither is there information on transmission of any detrimental effects to several filial generations. Therefore, the purpose of the present paper was to examine the long-term effects of a single intraperitoneal injection of DXR on the reproductive and behavioral performance of adult female mice and their progeny. C57BL/6 female mice (generation zero; G0) were treated with either a single intraperitoneal injection of DXR (G0-DXR) or saline (G0-CON). Data were collected on multiple reproductive parameters and behavioral analysis for anxiety, despair and depression. In addition, the reproductive capacity and health of the subsequent six generations were evaluated. G0-DXR females developed despair-like behaviors; delivery complications; decreased primordial follicle pool; and early lost of reproductive capacity. Surprisingly, the DXR-induced effects in oocytes were transmitted transgenerationally; the most striking effects being observed in G4 and G6, constituting: increased rates of neonatal death; physical malformations; chromosomal abnormalities (particularly deletions on chromosome 10); and death of mothers due to delivery complications. None of these effects were seen in control females of the same generations. Long-term effects of DXR in female mice and their offspring can be attributed to genetic alterations or cell-killing events in oocytes or, presumably, to toxicosis in non-ovarian tissues. Results from the rodent model emphasize the need for retrospective and long-term prospective studies of survivors of cancer treatment and their offspring.	[Kujjo, Loro L.; Pereira, Ricardo J. G.; Dhar, Shilpa; Marrero-Rosado, Brenda; Sengupta, Satyaki; Wang, Hongbing; Cibelli, Jose B.; Perez, Gloria I.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Kujjo, Loro L.] Michigan State Univ, Dept Human Anat, E Lansing, MI 48824 USA; [Chang, Eun A.; Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose B.; Perez, Gloria I.] LARCel, Programa Andaluz Terapia Celular & Med Regenerat, Seville, Spain	Michigan State University; Michigan State University; Michigan State University	Kujjo, LL (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	perezg@msu.edu	Perez, Gloria I/GMX-1286-2022; Sengupta, Satyaki/AAD-6065-2022; Pereira, Ricardo/C-7200-2012	Pereira, Ricardo/0000-0003-3908-1007; Cibelli, Jose/0000-0002-2176-3854	Department of Physiology at Michigan State University; Fundacion Progreso y Salud (Seville, Spain);  [05-IRGP-400 MSU]	Department of Physiology at Michigan State University; Fundacion Progreso y Salud (Seville, Spain); 	This work was supported by 05-IRGP-400 MSU, the Department of Physiology at Michigan State University, and Fundacion Progreso y Salud (Seville, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Aluise CD, 2010, ADV EXP MED BIOL, V678, P147; Bath LE, 2002, BJOG-INT J OBSTET GY, V109, P107, DOI 10.1111/j.1471-0528.2002.t01-1-01007.x; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Bishop JB, 1997, FUND APPL TOXICOL, V40, P191, DOI 10.1006/faat.1997.2379; Bishop JB, 2002, ADV EXP MED BIOL, V518, P1; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Chinnery PF, 1993, GENEREVIEWS; CHINNERY PF, 2010, MITOCHONDRIAL DISORD; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Critchley HOD, 2007, NAT CLIN PRACT ONCOL, V4, P84, DOI 10.1038/ncponc0697; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Dalvi A, 1999, PSYCHOPHARMACOLOGY, V147, P14, DOI 10.1007/s002130051131; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Falkenberg JH, 2002, MUSCLE NERVE, V25, P735, DOI 10.1002/mus.10082; Fox E, 2009, J NATL CANCER I, V101, P1105, DOI 10.1093/jnci/djp238; Grady MC, 2006, MATERN CHILD HLTH J, V10, pS165, DOI 10.1007/s10995-006-0103-1; Green DM, 2007, PEDIATR BLOOD CANCER, V48, P718, DOI 10.1002/pbc.21116; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; Green DM, 2009, J CLIN ONCOL, V27, P2677, DOI 10.1200/JCO.2008.20.1541; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Heck K E, 1997, Matern Child Health J, V1, P81, DOI 10.1023/A:1026218322723; Hofhaus G, 1999, BIOL CHEM, V380, P871, DOI 10.1515/BC.1999.107; Jacquet P, 1998, CANCER CHEMOTH PHARM, V41, P147; JANSEN CE, 2010, SUPPORT CARE CANC; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kasapovic J, 2010, CLIN BIOCHEM, V43, P1287, DOI 10.1016/j.clinbiochem.2010.08.009; KATOH MA, 1990, MUTAT RES, V230, P205, DOI 10.1016/0027-5107(90)90058-C; Kujjo LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009204; Lai HC, 2010, EUR J PHARMACOL, V644, P176, DOI 10.1016/j.ejphar.2010.07.010; LANGENHUIJSEN MMAC, 1984, BRIT J HAEMATOL, V58, P227, DOI 10.1111/j.1365-2141.1984.tb06080.x; LISTED NA, 1992, ONCOLOGY WILLISTON P, V6, P84; Madanat-Harjuoja LM, 2010, INT J CANCER, V127, P1669, DOI 10.1002/ijc.25157; Mariotto AB, 2009, CANCER EPIDEM BIOMAR, V18, P1033, DOI 10.1158/1055-9965.EPI-08-0988; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; McLoon LK, 2001, INVEST OPHTH VIS SCI, V42, P1254; Montaigne D, 2011, MITOCHONDRION, V11, P22, DOI 10.1016/j.mito.2010.06.001; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nagar S, 2010, ADV EXP MED BIOL, V678, P124; NAGY A, 2008, KARYOTYPING MOUSE CE; Nakayama K, 2008, NAT CLIN PRACT ONCOL, V5, P78, DOI 10.1038/ncponc1016; Oktay K, 2008, CURR OPIN OBSTET GYN, V20, P408, DOI 10.1097/GCO.0b013e328307ebad; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 2000, NATURE, V403, P500, DOI 10.1038/35000651; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rowan K, 2010, J NATL CANCER I, V102, P294, DOI 10.1093/jnci/djq053; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Schover LR, 2008, J CLIN ONCOL, V26, P753, DOI 10.1200/JCO.2007.14.1655; Schover LR, 2009, J CLIN ONCOL, V27, P321, DOI 10.1200/JCO.2008.19.7749; Signore LB, 2010, LANCET, V376, P624, DOI 10.1016/S0140-6736(10)60752-0; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; STAVEM P, 1985, BRIT J HAEMATOL, V59, P559, DOI 10.1111/j.1365-2141.1985.tb07346.x; Stovall M, 2004, INT J RADIAT ONCOL, V60, P542, DOI 10.1016/j.ijrobp.2004.03.017; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Takai Y, 2003, ENDOCRINOLOGY, V144, P69, DOI 10.1210/en.2002-220814; Ting AY, 2010, J ASSIST REPROD GEN, V27, P591, DOI 10.1007/s10815-010-9463-y; TRASLER JM, 1986, BIOL REPROD, V34, P275, DOI 10.1095/biolreprod34.2.275; Veitia RA, 2007, STEM CELLS, V25, P1334, DOI 10.1634/stemcells.2006-0770; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Winther JF, 2008, J CLIN ONCOL, V26, P4340, DOI 10.1200/JCO.2007.15.2884; Witt KL, 1996, MUTAT RES-FUND MOL M, V355, P209, DOI 10.1016/0027-5107(96)00029-2; Wyrobek AJ, 2007, ENVIRON MOL MUTAGEN, V48, P71, DOI 10.1002/em.20284	76	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17877	10.1371/journal.pone.0017877	http://dx.doi.org/10.1371/journal.pone.0017877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437292	gold, Green Published, Green Submitted			2022-12-25	WOS:000288514600014
J	Martino, NA; Lange-Consiglio, A; Cremonesi, F; Valentini, L; Caira, M; Guaricci, AC; Ambruosi, B; Sciorsci, RL; Lacalandra, GM; Reshkin, SJ; Dell'Aquila, ME				Martino, Nicola Antonio; Lange-Consiglio, Anna; Cremonesi, Fausto; Valentini, Luisa; Caira, Michele; Guaricci, Antonio Ciro; Ambruosi, Barbara; Sciorsci, Raffaele Luigi; Lacalandra, Giovanni Michele; Reshkin, Stephan Joel; Dell'Aquila, Maria Elena			Functional Expression of the Extracellular Calcium Sensing Receptor (CaSR) in Equine Umbilical Cord Matrix Size-Sieved Stem Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OUTWARD K+ CHANNEL; VITAMIN-D-RECEPTOR; CA2+-SENSING RECEPTOR; CALCIMIMETIC COMPOUND; PARATHYROID-GLAND; AMNIOTIC-FLUID; CA2+ RECEPTOR; UP-REGULATION; NPS R-467	Background: The present study investigates the effects of high external calcium concentration ([Ca2+](o)) and the calcimimetic NPS R-467, a known calcium-sensing receptor (CaSR) agonist, on growth/proliferation of two equine size-sieved umbilical cord matrix mesenchymal stem cell (eUCM-MSC) lines. The involvement of CaSR on observed cell response was analyzed at both the mRNA and protein level. Methodology/Principal Findings: A large (> 8 mu m in diameter) and a small (< 8 mu m) cell line were cultured in medium containing: 1) low [Ca2+](o) (0.37 mM); 2) high [Ca2+](o) (2.87 mM); 3) NPS R-467 (3 mu M) in presence of high [Ca2+](o) and 4) the CaSR antagonist NPS 2390 (10 mu M for 30 min.) followed by incubation in presence of NPS R-467 in medium with high [Ca2+](o). Growth/proliferation rates were compared between groups. In large cells, the addition of NPS R-467 significantly increased cell growth whereas increasing [Ca2+](o) was not effective in this cell line. In small cells, both higher [Ca2+](o) and NPS R-467 increased cell growth. In both cell lines, preincubation with the CaSR antagonist NPS 2390 significantly inhibited the agonistic effect of NPS R-467. In both cell lines, increased [Ca2+](o) and/or NPS R-467 reduced doubling time values. Treatment with NPS R-467 down-regulated CaSR mRNA expression in both cell lines. In large cells, NPS R-467 reduced CaSR labeling in the cytosol and increased it at cortical level. Conclusions/Significance: In conclusion, calcium and the calcimimetic NPS R-467 reduce CaSR mRNA expression and stimulate cell growth/proliferation in eUCM-MSC. Their use as components of media for eUCM-MSC culture could be beneficial to obtain enough cells for down-stream purposes.	[Martino, Nicola Antonio; Valentini, Luisa; Caira, Michele; Guaricci, Antonio Ciro; Ambruosi, Barbara; Sciorsci, Raffaele Luigi; Lacalandra, Giovanni Michele; Dell'Aquila, Maria Elena] Univ Bari, Dept Anim Prod, Fac Biotechnol Sci, Bari, Italy; [Lange-Consiglio, Anna; Cremonesi, Fausto] Univ Milan, Fac Vet Med, Reprod Unit, Large Anim Hosp, Lodi, Italy; [Reshkin, Stephan Joel] Univ Bari, Fac Sci, Dept Gen & Environm Physiol, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Milan; Universita degli Studi di Bari Aldo Moro	Martino, NA (corresponding author), Univ Bari, Dept Anim Prod, Fac Biotechnol Sci, Bari, Italy.	nicmartino@libero.it	Cremonesi, Fausto/J-2506-2014; Reshkin, Stephan/AAI-6680-2020; Lange-Consiglio, Anna/AAI-4146-2021; LACALANDRA, Giovanni Michele/P-4661-2014; Martino, Nicola/AAP-9891-2020; Martino, Nicola Antonio/N-4096-2014	Cremonesi, Fausto/0000-0001-8399-4626; Reshkin, Stephan/0000-0001-9757-5908; Lange-Consiglio, Anna/0000-0002-7748-3413; CAIRA, Michele/0000-0002-0394-9153; Martino, Nicola Antonio/0000-0001-6853-2757; Sciorsci, Raffaele Luigi/0000-0002-1141-3084; Dell'Aquila, Maria Elena/0000-0003-3629-7005; Valentini, Luisa/0000-0002-0030-5141; Lacalandra, Giovanni M/0000-0001-9109-3561	"Progetto di Ricerca finanziabile con Fondi di Ateneo per l'anno 2009". (Resp. Sci. Maria Elena Dell'Aquila) Universita degli Studi di Bari "Aldo Moro" [COD. ORBA09UDWX]; Academic Center of Excellence "Comparative Genomics: Genes Involved in Physiopathological Processes in the Biomedical And Agricultural Fields" University of Bari "Aldo Moro" Italy	"Progetto di Ricerca finanziabile con Fondi di Ateneo per l'anno 2009". (Resp. Sci. Maria Elena Dell'Aquila) Universita degli Studi di Bari "Aldo Moro"; Academic Center of Excellence "Comparative Genomics: Genes Involved in Physiopathological Processes in the Biomedical And Agricultural Fields" University of Bari "Aldo Moro" Italy	This work was supported by "Progetto di Ricerca finanziabile con Fondi di Ateneo per l'anno 2009". (Resp. Sci. Maria Elena Dell'Aquila) Universita degli Studi di Bari "Aldo Moro" (COD. ORBA09UDWX). This work was supported by the Academic Center of Excellence "Comparative Genomics: Genes Involved in Physiopathological Processes in the Biomedical And Agricultural Fields" University of Bari "Aldo Moro" Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom M, 2008, BONE, V42, P483, DOI 10.1016/j.bone.2007.10.025; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bhagavathula N, 2005, BRIT J CANCER, V93, P1364, DOI 10.1038/sj.bjc.6602852; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Carrillo-Lopez N, 2008, NEPHROL DIAL TRANSPL, V23, P3479, DOI 10.1093/ndt/gfn338; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chattopadhyay N, 1999, J NEUROCHEM, V72, P1915, DOI 10.1046/j.1471-4159.1999.0721915.x; Chattopadhyay N, 1998, GLIA, V24, P449, DOI 10.1002/(SICI)1098-1136(199812)24:4<449::AID-GLIA10>3.3.CO;2-0; Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003; Chen RA, 2004, AM J PHYSIOL-RENAL, V286, pF1005, DOI 10.1152/ajprenal.00013.2004; Chikatsu N, 2000, J BIOL CHEM, V275, P7553, DOI 10.1074/jbc.275.11.7553; Choi SA, 2010, REPROD FERT DEVELOP, V22, P346, DOI 10.1071/RDv22n1Ab380; Consiglio AL, 2010, REPROD FERT DEVELOP, V22, P349; Corradetti B, 2010, REPROD FERT DEVELOP, V22, P347; Cremonesi F, 2008, VET RES COMMUN, V32, pS139, DOI 10.1007/s11259-008-9116-0; De Santis T, 2009, REPRODUCTION, V138, P439, DOI 10.1530/REP-09-0078; Dell'Aquila ME, 2006, FERTIL STERIL, V85, P1240, DOI 10.1016/j.fertnstert.2005.11.033; Diao YZ, 2009, J BIOMED MATER RES A, V91A, P123, DOI 10.1002/jbm.a.32186; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fu-Jiang C, 2009, CHINESE MED J-PEKING, V122, P225, DOI 10.3760/cma.j.issn.0366-6999.2009.02.021; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; Hinrichs K, 2007, THERIOGENOLOGY, V68, P521, DOI 10.1016/j.theriogenology.2007.04.046; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; HUANG SX, 1995, BIOCHEM J, V310, P881, DOI 10.1042/bj3100881; Iacono E, 2010, REPROD FERT DEVELOP, V22, P348, DOI 10.1071/RDv22n1Ab384; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koch TG, 2009, CAN VET J, V50, P155; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lavreysen H, 2003, MOL PHARMACOL, V63, P1082, DOI 10.1124/mol.63.5.1082; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; McNeil L, 1998, AM J OBSTET GYNECOL, V178, P305, DOI 10.1016/S0002-9378(98)80017-3; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Mendoza FJ, 2009, AM J PHYSIOL-RENAL, V296, pF605, DOI 10.1152/ajprenal.90272.2008; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Noeske T, 2006, QSAR COMB SCI, V25, P134, DOI 10.1002/qsar.200510139; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Park KS, 2007, STEM CELLS, V25, P2044, DOI 10.1634/stemcells.2006-0735; Passeri S, 2009, CELL BIOL INT, V33, P100, DOI 10.1016/j.cellbi.2008.10.012; Pereira WC, 2008, J TISSUE ENG REGEN M, V2, P394, DOI 10.1002/term.107; Racz GZ, 2002, GUT, V51, P705, DOI 10.1136/gut.51.5.705; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Roussanne MC, 2001, EUR J CLIN INVEST, V31, P610, DOI 10.1046/j.1365-2362.2001.00809.x; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Shih YRV, 2009, CELL PROLIFERAT, V42, P461, DOI 10.1111/j.1365-2184.2009.00614.x; Straub SG, 2000, J BIOL CHEM, V275, P18777, DOI 10.1074/jbc.M000090200; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P1211, DOI 10.1210/en.2003-0749; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Tu CL, 1999, J INVEST DERMATOL, V113, P340, DOI 10.1046/j.1523-1747.1999.00698.x; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang LM, 2009, TISSUE ENG PT A, V15, P2259, DOI 10.1089/ten.tea.2008.0393; Xing WJ, 2010, MOL CELL BIOCHEM, V343, P13, DOI 10.1007/s11010-010-0493-7; Yamaguchi T, 2002, BIOCHEM BIOPH RES CO, V299, P532, DOI 10.1016/S0006-291X(02)02690-6; Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382, DOI 10.1152/ajpcell.2001.280.2.C382; Zeidan-Chulia Fares, 2009, Eur J Dent, V3, P240; Zhang ZX, 2002, J BIOL CHEM, V277, P33736, DOI 10.1074/jbc.M200978200; Zucconi E, 2010, STEM CELLS DEV, V19, P395, DOI 10.1089/scd.2008.0314	74	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17714	10.1371/journal.pone.0017714	http://dx.doi.org/10.1371/journal.pone.0017714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437284	Green Published, gold			2022-12-25	WOS:000288514600010
J	Rizzo, C; Ronca, R; Fiorentino, G; Verra, F; Mangano, V; Poinsignon, A; Sirima, SB; Nebie, I; Lombardo, F; Remoue, F; Coluzzi, M; Petrarca, V; Modiano, D; Arca, B				Rizzo, Cinzia; Ronca, Raffaele; Fiorentino, Gabriella; Verra, Federica; Mangano, Valentina; Poinsignon, Anne; Sirima, Sodiomon Bienvenu; Nebie, Issa; Lombardo, Fabrizio; Remoue, Franck; Coluzzi, Mario; Petrarca, Vincenzo; Modiano, David; Arca, Bruno			Humoral Response to the Anopheles gambiae Salivary Protein gSG6: A Serological Indicator of Exposure to Afrotropical Malaria Vectors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; GLAND ANTIGENS; SIALOME; TRANSMISSION; MOSQUITOS; INSIGHT; MARKER; TOOL	Salivary proteins injected by blood feeding arthropods into their hosts evoke a saliva-specific humoral response which can be useful to evaluate exposure to bites of disease vectors. However, saliva of hematophagous arthropods is a complex cocktail of bioactive factors and its use in immunoassays can be misleading because of potential cross-reactivity to other antigens. Toward the development of a serological marker of exposure to Afrotropical malaria vectors we expressed the Anopheles gambiae gSG6, a small anopheline-specific salivary protein, and we measured the anti-gSG6 IgG response in individuals from a malaria hyperendemic area of Burkina Faso, West Africa. The gSG6 protein was immunogenic and anti-gSG6 IgG levels and/or prevalence increased in exposed individuals during the malaria transmission/rainy season. Moreover, this response dropped during the intervening low transmission/dry season, suggesting it is sensitive enough to detect variation in vector density. Members of the Fulani ethnic group showed higher anti-gSG6 IgG response as compared to Mossi, a result consistent with the stronger immune reactivity reported in this group. Remarkably, anti-gSG6 IgG levels among responders were high in children and gradually declined with age. This unusual pattern, opposite to the one observed with Plasmodium antigens, is compatible with a progressive desensitization to mosquito saliva and may be linked to the continued exposure to bites of anopheline mosquitoes. Overall, the humoral anti-gSG6 IgG response appears a reliable serological indicator of exposure to bites of the main African malaria vectors (An. gambiae, Anopheles arabiensis and, possibly, Anopheles funestus) and it may be exploited for malaria epidemiological studies, development of risk maps and evaluation of anti-vector measures. In addition, the gSG6 protein may represent a powerful model system to get a deeper understanding of molecular and cellular mechanisms underlying the immune tolerance and progressive desensitization to insect salivary allergens.	[Rizzo, Cinzia; Verra, Federica; Mangano, Valentina; Lombardo, Fabrizio; Coluzzi, Mario; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [Rizzo, Cinzia; Petrarca, Vincenzo; Modiano, David] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Ronca, Raffaele; Fiorentino, Gabriella; Arca, Bruno] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Poinsignon, Anne; Remoue, Franck] Inst Rech Dev, Biol & Control Vectors UR016, Montpellier, France; [Petrarca, Vincenzo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Naples Federico II; Institut de Recherche pour le Developpement (IRD); Sapienza University Rome	Rizzo, C (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.	bruno.arca@unina.it	Fiorentino, Gabriella/E-2843-2017; mangano, valentina/I-2456-2012; Lombardo, Fabrizio/J-8511-2014; Arca, Bruno/C-8383-2012	Fiorentino, Gabriella/0000-0002-4089-3822; Lombardo, Fabrizio/0000-0002-8563-0612; Nebie, Issa/0000-0003-3051-3600; Poinsignon, Anne/0000-0003-2921-4486; Arca, Bruno/0000-0002-4029-0984; Ronca, Raffaele/0000-0003-2217-3378; Mangano, Valentina D/0000-0002-2021-6162; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211	BioMalPar European Network of Excellence [LSHP-CT-2004-503578]; EU [242095]; Fondazione "Compagnia di San Paolo" (Torino) through the Italian Malaria Network	BioMalPar European Network of Excellence; EU(European Commission); Fondazione "Compagnia di San Paolo" (Torino) through the Italian Malaria Network(Compagnia di San Paolo)	This work was initially funded by the BioMalPar European Network of Excellence (LSHP-CT-2004-503578) and continued as part of the EU-funded EVIMalaR NoE (242095). RR and FV were supported by Fondazione "Compagnia di San Paolo" (Torino) through the Italian Malaria Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-121; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; ESPOSITO F, 1988, T ROY SOC TROP MED H, V82, P827, DOI 10.1016/0035-9203(88)90007-7; FEINGOLD BF, 1968, ANNU REV ENTOMOL, V13, P137, DOI 10.1146/annurev.en.13.010168.001033; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lombardo F., 2006, Parassitologia (Rome), V48, P573; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 1998, AM J TROP MED HYG, V59, P336, DOI 10.4269/ajtmh.1998.59.336; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P284, DOI 10.1016/S0091-6749(98)70395-1; Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Trevejo RT, 2005, AM J TROP MED HYG, V72, P481, DOI 10.4269/ajtmh.2005.72.481; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004	40	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17980	10.1371/journal.pone.0017980	http://dx.doi.org/10.1371/journal.pone.0017980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437289	Green Published, Green Submitted, gold			2022-12-25	WOS:000288514600020
J	Francis, SMS; Larsen, JE; Pavey, SJ; Duhig, EE; Clarke, BE; Bowman, RV; Hayward, NK; Fong, KM; Yang, IA				Francis, Santiyagu M. Savarimuthu; Larsen, Jill E.; Pavey, Sandra J.; Duhig, Edwina E.; Clarke, Belinda E.; Bowman, Rayleen V.; Hayward, Nick K.; Fong, Kwun M.; Yang, Ian A.			Genes and Gene Ontologies Common to Airflow Obstruction and Emphysema in the Lungs of Patients with COPD	PLOS ONE			English	Article							EXPRESSION; PATHOGENESIS; TISSUE; DISEASE; SMOKERS; CELLS	Chronic obstructive pulmonary disease (COPD) is a major public health problem with increasing prevalence worldwide. The primary aim of this study was to identify genes and gene ontologies associated with COPD severity. Gene expression profiling was performed on total RNA extracted from lung tissue of 18 former smokers with COPD. Class comparison analysis on mild (n = 9, FEV1 80-110% predicted) and moderate (n = 9, FEV1 50-60% predicted) COPD patients identified 46 differentially expressed genes (p<0.01), of which 14 genes were technically confirmed by quantitative real-time-PCR. Biological replication in an independent test set of 58 lung samples confirmed the altered expression of ten genes with increasing COPD severity, with eight of these genes (NNMT, THBS1, HLA-DPB1, IGHD, ETS2, ELF1, PTGDS and CYRBD1) being differentially expressed by greater than 1.8 fold between mild and moderate COPD, identifying these as candidate determinants of COPD severity. These genes belonged to ontologies potentially implicated in COPD including angiogenesis, cell migration, proliferation and apoptosis. Our secondary aim was to identify gene ontologies common to airway obstruction, indicated by impaired FEV1 and KCO. Using gene ontology enrichment analysis we have identified relevant biological and molecular processes including regulation of cell-matrix adhesion, leukocyte activation, cell and substrate adhesion, cell adhesion, angiogenesis, cell activation that are enriched among genes involved in airflow obstruction. Exploring the functional significance of these genes and their gene ontologies will provide clues to molecular changes involved in severity of COPD, which could be developed as targets for therapy or biomarkers for early diagnosis.	[Francis, Santiyagu M. Savarimuthu; Larsen, Jill E.; Bowman, Rayleen V.; Fong, Kwun M.; Yang, Ian A.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Duhig, Edwina E.; Clarke, Belinda E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia; [Francis, Santiyagu M. Savarimuthu; Larsen, Jill E.; Pavey, Sandra J.; Bowman, Rayleen V.; Fong, Kwun M.; Yang, Ian A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Hayward, Nick K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Prince Charles Hospital; Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute	Francis, SMS (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	ss.francis@uqconnect.edu.au	hayward, nick/AAV-8802-2020; hayward, nicholas k/C-1367-2015; Bowman, Rayleen V/G-4144-2013; Larsen, Jill E/G-3787-2010; Fong, Kwun M/G-6369-2010; Yang, Ian A/B-9609-2008; Pavey, Sandra/B-3662-2011	hayward, nicholas k/0000-0003-4760-1033; Larsen, Jill E/0000-0001-7806-3931; Yang, Ian A/0000-0001-8338-1993; Fong, Kwun/0000-0002-6507-1403; Pavey, Sandra/0000-0003-4519-5932	Prince Charles Hospital Foundation; National Health and Medical Research Council (NHMRC)	Prince Charles Hospital Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The Prince Charles Hospital Foundation and The National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cotes JE, 1993, LUNG FUNCTION; Debigare R, 2008, COPD, V5, P75, DOI 10.1080/15412550801940457; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Francis SMS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-81; Golpon HA, 2004, AM J RESP CELL MOL, V31, P595, DOI 10.1165/rcmb.2004-0008OC; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; HOGG JC, 1994, THORAX, V49, P473, DOI 10.1136/thx.49.5.473; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Kim HC, 2010, AM J RESP CRIT CARE, V181, P797, DOI 10.1164/rccm.200906-0936OC; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Spira A, 2004, AM J RESP CELL MOL, V31, P601, DOI 10.1165/rcmb.2004-0273OC; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verducci JS, 2006, PHYSIOL GENOMICS, V25, P355, DOI 10.1152/physiolgenomics.00314.2004; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; Yang IA, 2003, GENES IMMUN, V4, P269, DOI 10.1038/sj.gene.6363961; Yang IA, 2009, RESPIROLOGY, V14, P313, DOI 10.1111/j.1440-1843.2009.01483.x; Zeskind Julie E, 2008, Proc Am Thorac Soc, V5, P834, DOI 10.1513/pats.200807-074TH; Zupo S, 2002, BLOOD, V99, P2277, DOI 10.1182/blood-2001-11-0126	28	19	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17442	10.1371/journal.pone.0017442	http://dx.doi.org/10.1371/journal.pone.0017442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423603	gold, Green Published, Green Submitted			2022-12-25	WOS:000288513900009
J	Guo, CP; Liu, KW; Luo, HB; Chen, HB; Zheng, Y; Sun, SN; Zhang, QA; Huang, LQ				Guo, Cai-ping; Liu, Ke-wei; Luo, Hai-bo; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang			Potent Anti-Tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RETINOBLASTOMA TUMOR-SUPPRESSOR; TYPE-16 E7 ONCOPROTEIN; CERVICAL-CARCINOMA; PROTEIN; GENE; CISPLATIN; BIND; PRB; TRANSCRIPTION	Human papillomavirus type 16 (HPV16) E7 is a viral oncoprotein believed to play a major role in cervical cancer. In this study, an antagonist peptide against HPV16E7 protein was first identified from screening the c7c phage display peptide library. The binding specificity and affinity of the selected peptide to HPV16E7 were tested by competitive enzyme-linked immunosorbent assay (ELISA). The antagonist peptide showed obvious anti-tumor efficacy both in cell lines and animal tumor models. Significant cell proliferation inhibition with high specificity was noted when HPV16-positive cells were treated with the peptide. This anti-tumor efficacy was resulted from overriding the activities of HPV16E7 and reactivating the pRb/E2F pathway, as shown by a series of experiments. Flow cytometry analysis revealed that the selected peptide induced G1 arrest in a dose-dependent manner. Competitive ELISA, pull down, and Co-IP experiments indicated that the selected peptide disrupted the interaction between HPV16E7 and pRb proteins both in vitro and in vivo. Luciferase reporter assay verified that transcription activities of E2F were suppressed by the peptide through restoration of pRb. RT-PCR and Western blot revealed that it reduced cyclins A, D1, and E1 expression, and led to HPV16E7 protein degradation, but pRb protein stabilization. The current study suggests that this specific peptide may serve as a potential therapeutic agent for HPV16-positive cervical cancer.	[Guo, Cai-ping; Luo, Hai-bo; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Guo, Cai-ping; Liu, Ke-wei; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang] Tsinghua Univ, Ctr Biotech & BioMed, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518057, Guangdong, Peoples R China; [Guo, Cai-ping; Liu, Ke-wei; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Guangdong, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Guo, CP (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	huanglq@tsinghua.edu.cn			Guangdong Province Natural Science Fund [06301451]; China MOST [2005CCA03500]; China NSFC [30671034]; Shenzhen Municipal Government	Guangdong Province Natural Science Fund(National Natural Science Foundation of Guangdong Province); China MOST(Ministry of Science and Technology, China); China NSFC(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government	This work was supported by grants to LQH from Guangdong Province Natural Science Fund (No. 06301451) and in part from China MOST National "973" Key Research Program (No. 2005CCA03500), China NSFC (No. 30671034), and from Shenzhen Municipal Government for the Shenzhen Key Lab of Gene & Antibody Therapy and for Upgrading the Building of the Shenzhen National Key Lab of Health Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Avvakumov N, 2003, ONCOGENE, V22, P3833, DOI 10.1038/sj.onc.1206562; BANKS L, 1990, ONCOGENE, V5, P833; BANKS L, 1990, ONCOGENE, V5, P1383; Berezutskaya E, 1997, CELL GROWTH DIFFER, V8, P1277; BONOMI P, 1985, J CLIN ONCOL, V3, P1079, DOI 10.1200/JCO.1985.3.8.1079; Boyer SN, 1996, CANCER RES, V56, P4620; Burnett AF, 2000, GYNECOL ONCOL, V76, P63, DOI 10.1006/gyno.1999.5657; Caldeira S, 2005, METH MOLEC MED, V119, P363; Chu NR, 2000, CLIN EXP IMMUNOL, V121, P216, DOI 10.1046/j.1365-2249.2000.01293.x; CLEMENS KE, 1995, VIROLOGY, V214, P289, DOI 10.1006/viro.1995.9926; De Falco G, 2003, ONCOGENE, V22, P6214, DOI 10.1038/sj.onc.1206637; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Dona MG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-25; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Helt AM, 2001, J VIROL, V75, P6737, DOI 10.1128/JVI.75.15.6737-6747.2001; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Jares P, 1996, AM J PATHOL, V148, P1591; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Kohashi K, 2008, J CANCER RES CLIN, V134, P1097, DOI 10.1007/s00432-008-0385-3; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Nauenburg S, 2001, FASEB J, V15, P592; Nie CL, 2008, CHINESE J CANCER RES, V20, P301, DOI 10.1007/s11670-008-0301-z; Nishimura A, 2006, MICROBES INFECT, V8, P984, DOI 10.1016/j.micinf.2005.10.015; Niwa H, 2003, CLIN CANCER RES, V9, P5028; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; PARKIN DM, 2006, VACCINE S3, V24, pCH2; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Rose PG, 1999, J CLIN ONCOL, V17, P2676, DOI 10.1200/JCO.1999.17.9.2676; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; SHILLITOE EJ, 1994, CANCER GENE THER, V1, P193; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; Stanley Margaret, 2003, J Natl Cancer Inst Monogr, P117; STEELE C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P153; TOM R, 2008, TRANSFECTION ADHEREN; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; WU EW, 1993, J VIROL, V67, P2402, DOI 10.1128/JVI.67.4.2402-2407.1993; *XJ XZS, 2009, PROG BIOCHEM BIOPHYS, V36, P6; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103	56	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17734	10.1371/journal.pone.0017734	http://dx.doi.org/10.1371/journal.pone.0017734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423621	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900019
J	Li, CH; Wang, E; Wang, J				Li, Chunhe; Wang, Erkang; Wang, Jin			Potential Landscape and Probabilistic Flux of a Predator Prey Network	PLOS ONE			English	Article							DISSIPATION COST; ENERGY LANDSCAPE; ROBUSTNESS	Predator-prey system, as an essential element of ecological dynamics, has been recently studied experimentally with synthetic biology. We developed a global probabilistic landscape and flux framework to explore a synthetic predator-prey network constructed with two Escherichia coli populations. We developed a self consistent mean field method to solve multidimensional problem and uncovered the potential landscape with Mexican hat ring valley shape for predator-prey oscillations. The landscape attracts the system down to the closed oscillation ring. The probability flux drives the coherent oscillations on the ring. Both the landscape and flux are essential for the stable and coherent oscillations. The landscape topography characterized by the barrier height from the top of Mexican hat to the closed ring valley provides a quantitative measure of global stability of system. The entropy production rate for the energy dissipation is less for smaller environmental fluctuations or perturbations. The global sensitivity analysis based on the landscape topography gives specific predictions for the effects of parameters on the stability and function of the system. This may provide some clues for the global stability, robustness, function and synthetic network design.	[Li, Chunhe; Wang, Erkang; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA; [Li, Chunhe] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CH (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	ekwang@ciac.jl.cn; jin.wang.1@stonybrook.edu	Li, Chunhe/C-8132-2011; , 汪尔康/P-1748-2019	Li, Chunhe/0000-0002-9127-3930; 	National Science Foundation; National Natural Science Foundation of China [90713022, 20735003]; 973 project [2009CB930100, 2010CB833600]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	Funding: J.W. acknowledges support from the National Science Foundation. C. H. L. and E. K. W. are supported by the National Natural Science Foundation of China (Grants 90713022 and 20735003) and the 973 project 2009CB930100 and 2010CB833600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao P, 2004, J PHYS A-MATH GEN, V37, pL25, DOI 10.1088/0305-4470/37/3/L01; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Han B, 2007, BIOPHYS J, V92, P3755, DOI 10.1529/biophysj.106.094821; Hatano T, 2001, PHYS REV LETT, V86, P3463, DOI 10.1103/PhysRevLett.86.3463; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; Hu G., 1994, STOCHASTIC FORCES NO, P68; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim KY, 2007, PLOS COMPUT BIOL, V3, P565, DOI 10.1371/journal.pcbi.0030060; Kim KY, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424933; Lapidus S, 2008, P NATL ACAD SCI USA, V105, P6039, DOI 10.1073/pnas.0708708105; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; May R.M., 1974, STABILITY COMPLEXITY; Murray J.D., 2002, MATH BIOL; QIAN H, 2001, PHYS REV E, V65, P61025; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Van Kampen N. G., 1992, STOCHASTIC PROCESSES, P120; VOLTERRA V, 1931, ANIMAL ECOLOGY, V2, P409; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Yoda M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2539037	26	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17888	10.1371/journal.pone.0017888	http://dx.doi.org/10.1371/journal.pone.0017888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423576	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900041
J	Zhang, ZJ; Chen, DM; Liu, WB; Racine, JS; Ong, S; Chen, Y; Zhao, GM; Jiang, QW				Zhang, Zhijie; Chen, Dongmei; Liu, Wenbao; Racine, Jeffrey S.; Ong, SengHuat; Chen, Yue; Zhao, Genming; Jiang, Qingwu			Nonparametric Evaluation of Dynamic Disease Risk: A Spatio-Temporal Kernel Approach	PLOS ONE			English	Article							SPATIAL RELATIVE RISK; GEOGRAPHICAL EPIDEMIOLOGY; DENSITY-ESTIMATION; BINARY REGRESSION; CROSS-VALIDATION; DISTRIBUTIONS; CHINA; SCHISTOSOMIASIS; ESTIMATORS; REGIONS	Quantifying the distributions of disease risk in space and time jointly is a key element for understanding spatio-temporal phenomena while also having the potential to enhance our understanding of epidemiologic trajectories. However, most studies to date have neglected time dimension and focus instead on the "average'' spatial pattern of disease risk, thereby masking time trajectories of disease risk. In this study we propose a new idea titled "spatio-temporal kernel density estimation (stKDE)'' that employs hybrid kernel (i.e., weight) functions to evaluate the spatio-temporal disease risks. This approach not only can make full use of sample data but also "borrows'' information in a particular manner from neighboring points both in space and time via appropriate choice of kernel functions. Monte Carlo simulations show that the proposed method performs substantially better than the traditional (i.e., frequency-based) kernel density estimation (trKDE) which has been used in applied settings while two illustrative examples demonstrate that the proposed approach can yield superior results compared to the popular trKDE approach. In addition, there exist various possibilities for improving and extending this method.	[Zhang, Zhijie; Chen, Dongmei; Liu, Wenbao] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada; [Zhang, Zhijie; Zhao, Genming; Jiang, Qingwu] Fudan Univ, Dept Epidemiol, Shanghai 200433, Peoples R China; [Racine, Jeffrey S.] McMaster Univ, Dept Econ, Hamilton, ON, Canada; [Ong, SengHuat] Univ Malaya, Dept Math Sci, Kuala Lumpur, Malaysia; [Chen, Yue] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Queens University - Canada; Fudan University; McMaster University; Universiti Malaya; University of Ottawa	Zhang, ZJ (corresponding author), Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada.	epistat@gmail.com; chendm@queensu.ca	ONG, Seng Huat/B-9454-2010; Racine, Jeffrey/N-9476-2014	ONG, Seng Huat/0000-0002-4288-7637; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317; Racine, Jeffrey/0000-0002-5680-3705	National Important Technologies Project of China [2008ZX10004-011]; Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada [PIV-005]	National Important Technologies Project of China; Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada	This research was supported by a grant from the National Important Technologies Project of China [grant number 2008ZX10004-011] and a grant from the Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada [grant number PIV-005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan JJ, 2008, ENVIRON HEALTH PERSP, V116, P1111, DOI 10.1289/ehp.10814; Bailey T, 1995, INTERACTIVE SPATIAL; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; Benschop J, 2008, VET RES, V39, DOI 10.1051/vetres:2007040; Berke O, 2003, J VET MED B, V50, P322, DOI 10.1046/j.1439-0450.2003.00689.x; BITHELL JF, 1991, STAT MED, V10, P1745, DOI 10.1002/sim.4780101112; BITHELL JF, 1990, STAT MED, V9, P691, DOI 10.1002/sim.4780090616; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Clark AB, 2004, COMPUT STAT DATA AN, V47, P63, DOI 10.1016/j.csda.2003.10.014; Davies TM, 2010, STAT MED, V29, P2423, DOI 10.1002/sim.3995; Diggle P.J., 1995, BERNOULLI, V1, DOI [10.2307/3318678, DOI 10.2307/3318678, 10.1002/sim.4780142106]; Griffith DA, 2010, J GEOGR SYST, V12, P111, DOI 10.1007/s10109-010-0120-x; Hall P, 2004, J AM STAT ASSOC, V99, P1015, DOI 10.1198/016214504000000548; Hayfield T., 2008, J STAT SOFTW, P27; Hazelton ML, 2008, STAT MED, V27, P2269, DOI 10.1002/sim.3047; Hazelton ML, 2007, COMPUT STAT DATA AN, V51, P4393, DOI 10.1016/j.csda.2006.06.012; Hazelton ML, 2009, BIOMETRICAL J, V51, P98, DOI 10.1002/bimj.200810495; KELSALL JE, 1995, STAT MED, V14, P2335, DOI 10.1002/sim.4780142106; Kelsall JE, 1998, J ROY STAT SOC C-APP, V47, P559, DOI 10.1111/1467-9876.00128; Kulldorff M., 2009, SATSCANTM V8 0 SOFTW; Li Q, 2004, STAT SINICA, V14, P485; Li Q, 2003, J MULTIVARIATE ANAL, V86, P266, DOI 10.1016/S0047-259X(02)00025-8; Li Q., 2007, NONPARAMETRIC ECONOM; Lo C.P., 2007, CONCEPTS TECHNIQUES, V2nd; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Mugdadi AR, 2004, COMPUT STAT DATA AN, V47, P49, DOI 10.1016/j.csda.2003.10.013; Orem Jackson, 2007, Afr Health Sci, V7, P166; Ouyang D, 2006, J NONPARAMETR STAT, V18, P69, DOI 10.1080/10485250600569002; Prince MI, 2001, HEPATOLOGY, V34, P1083, DOI 10.1053/jhep.2001.29760; Racine J, 2004, J ECONOMETRICS, V119, P99, DOI 10.1016/S0304-4076(03)00157-X; Rowlingson B., 2010, SPLANCS SPATIAL SPAC; Sabel CE, 2000, SOC SCI MED, V50, P1121, DOI 10.1016/S0277-9536(99)00360-3; Simonoff J.S., 1996, SMOOTING METHODS STA, V2nd; Turlach B.A., 1993, BANDWIDTH SELECTION; Wand M. P., 1994, KERNEL SMOOTHING; WANG MC, 1981, BIOMETRIKA, V68, P301, DOI 10.1093/biomet/68.1.301; Ward M, 2008, GEOJOURNAL LIB, V94, P257, DOI 10.1007/978-1-4020-8507-9_13; Wheeler DC, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-13; Wikle CK, 2002, STAT MODEL, V2, P299, DOI 10.1191/1471082x02st036oa; Zhang ZJ, 2009, PARASITOLOGY, V136, P737, DOI 10.1017/S0031182009005885; Zhang ZJ, 2008, ACTA TROP, V107, P217, DOI 10.1016/j.actatropica.2008.04.027; Zhang ZJ, 2009, T ROY SOC TROP MED H, V103, P1045, DOI 10.1016/j.trstmh.2008.11.012	42	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17381	10.1371/journal.pone.0017381	http://dx.doi.org/10.1371/journal.pone.0017381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423612	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900008
J	Novakova, M; Dolezal, T				Novakova, Milena; Dolezal, Tomas			Expression of Drosophila Adenosine Deaminase in Immune Cells during Inflammatory Response	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE; GROWTH-FACTORS; HEMATOPOIESIS; SYSTEM; PROLIFERATION; MACROPHAGES; BLOOD; ADA2	Extra-cellular adenosine is an important regulator of inflammatory responses. It is generated from released ATP by a cascade of ectoenzymes and degraded by adenosine deaminase (ADA). There are two types of enzymes with ADA activity: ADA1 and ADGF/ADA2. ADA2 activity originates from macrophages and dendritic cells and is associated with inflammatory responses in humans and rats. Drosophila possesses a family of six ADGF proteins with ADGF-A being the main regulator of extracellular adenosine during larval stages. Herein we present the generation of a GFP reporter for ADGF-A expression by a precise replacement of the ADGF-A coding sequence with GFP using homologous recombination. We show that the reporter is specifically expressed in aggregating hemocytes (Drosophila immune cells) forming melanotic capsules; a characteristic of inflammatory response. Our vital reporter thus confirms ADA expression in sites of inflammation in vivo and demonstrates that the requirement for ADA activity during inflammatory response is evolutionary conserved from insects to vertebrates. Our results also suggest that ADA activity is achieved specifically within sites of inflammation by an uncharacterized post-transcriptional regulation based mechanism. Utilizing various mutants that induce melanotic capsule formation and also a real immune challenge provided by parasitic wasps, we show that the acute expression of the ADGF-A protein is not driven by one specific signaling cascade but is rather associated with the behavior of immune cells during the general inflammatory response. Connecting the exclusive expression of ADGF-A within sites of inflammation, as presented here, with the release of energy stores when the ADGF-A activity is absent, suggests that extra-cellular adenosine may function as a signal for energy allocation during immune response and that ADGF-A/ADA2 expression in such sites of inflammation may regulate this role.	[Novakova, Milena; Dolezal, Tomas] Univ S Bohemia, Fac Sci, Dept Mol Biol, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Novakova, M (corresponding author), Univ S Bohemia, Fac Sci, Dept Mol Biol, Ceske Budejovice, Czech Republic.	tomas.dolezal@prf.jcu.cz	Dolezal, Tomas/AAF-2350-2020; Doležal, Tomáš/EXQ-6090-2022; Novakova, Milena/AAD-7503-2021	Dolezal, Tomas/0000-0001-5217-4465; 	Grant Agency of the Academy of Sciences of the Czech Republic [KJB501410602]; Grant Agency of the Czech Republic [204/09/1463]; Ministry of Education, Youth and Sports of the Czech Republic [MSM6007665801]; Grant Agency of the University of South Bohemia	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the University of South Bohemia	Funding was provided by KJB501410602, Grant Agency of the Academy of Sciences of the Czech Republic (http://www.gaav.cz/); 204/09/1463, Grant Agency of the Czech Republic (http://www.gacr.cz/); MSM6007665801, Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/); and the Grant Agency of the University of South Bohemia (http://www.jcu.cz/research/gaju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich MB, 2000, BIOCHEM BIOPH RES CO, V272, P311, DOI 10.1006/bbrc.2000.2773; Antonioli L, 2008, INFLAMM BOWEL DIS, V14, P566, DOI 10.1002/ibd.20316; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Conlon BA, 2004, CLIN EXP IMMUNOL, V138, P14, DOI 10.1111/j.1365-2249.2004.02591.x; Cortes D., 2009, Autonomic & Autacoid Pharmacology, V29, P157, DOI 10.1111/j.1474-8665.2009.00443.x; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Franco R, 1997, PROG NEUROBIOL, V52, P283, DOI 10.1016/S0301-0082(97)00013-0; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; NIEDZWICKI JG, 1991, BIOCHEM PHARMACOL, V41, P1615, DOI 10.1016/0006-2952(91)90162-X; NIEDZWICKI JG, 1991, AM J HEMATOL, V37, P152, DOI 10.1002/ajh.2830370303; Qiu P, 1998, DEVELOPMENT, V125, P1909; RATECH H, 1981, ENZYME, V26, P74, DOI 10.1159/000459153; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Sankar N, 2002, NUCLEIC ACIDS RES, V30, P4339, DOI 10.1093/nar/gkf564; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; Zavialov AV, 2010, J LEUKOCYTE BIOL, V88, P279, DOI 10.1189/jlb.1109764; Zavialov AV, 2010, J BIOL CHEM, V285, P12367, DOI 10.1074/jbc.M109.083527; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zuberova M, 2010, DIS MODEL MECH, V3, P773, DOI 10.1242/dmm.005389; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	31	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17741	10.1371/journal.pone.0017741	http://dx.doi.org/10.1371/journal.pone.0017741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412432	Green Submitted, Green Published, gold			2022-12-25	WOS:000288247800027
J	Maibach, EW; Leiserowitz, A; Roser-Renouf, C; Mertz, CK				Maibach, Edward W.; Leiserowitz, Anthony; Roser-Renouf, Connie; Mertz, C. K.			Identifying Like-Minded Audiences for Global Warming Public Engagement Campaigns: An Audience Segmentation Analysis and Tool Development	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNICATION; PREFERENCES	Background: Achieving national reductions in greenhouse gas emissions will require public support for climate and energy policies and changes in population behaviors. Audience segmentation - a process of identifying coherent groups within a population - can be used to improve the effectiveness of public engagement campaigns. Methodology/Principal Findings: In Fall 2008, we conducted a nationally representative survey of American adults (n = 2,164) to identify audience segments for global warming public engagement campaigns. By subjecting multiple measures of global warming beliefs, behaviors, policy preferences, and issue engagement to latent class analysis, we identified six distinct segments ranging in size from 7 to 33% of the population. These six segments formed a continuum, from a segment of people who were highly worried, involved and supportive of policy responses (18%), to a segment of people who were completely unconcerned and strongly opposed to policy responses (7%). Three of the segments (totaling 70%) were to varying degrees concerned about global warming and supportive of policy responses, two (totaling 18%) were unsupportive, and one was largely disengaged (12%), having paid little attention to the issue. Certain behaviors and policy preferences varied greatly across these audiences, while others did not. Using discriminant analysis, we subsequently developed 36-item and 15-item instruments that can be used to categorize respondents with 91% and 84% accuracy, respectively. Conclusions/Significance: In late 2008, Americans supported a broad range of policies and personal actions to reduce global warming, although there was wide variation among the six identified audiences. To enhance the impact of campaigns, government agencies, non-profit organizations, and businesses seeking to engage the public can selectively target one or more of these audiences rather than address an undifferentiated general population. Our screening instruments are available to assist in that process.	[Maibach, Edward W.; Roser-Renouf, Connie] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Leiserowitz, Anthony] Yale Univ, Yale Project Climate Change, New Haven, CT USA; [Mertz, C. K.] Decis Res, Eugene, OR USA	George Mason University; Yale University	Maibach, EW (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.	emaibach@gmu.edu	Leiserowitz, Anthony/ABE-6529-2020; Leiserowitz, Anthony/HGB-4208-2022; Maibach, Edward/A-7102-2009	Leiserowitz, Anthony/0000-0001-5349-409X; Maibach, Edward/0000-0003-3409-9187	Yale Center for Environmental Law and Policy; Betsy and Jessie Fink Foundation; 11th Hour Project; Pacific Foundation; Robert Wood Johnson Foundation	Yale Center for Environmental Law and Policy; Betsy and Jessie Fink Foundation; 11th Hour Project(Ministry of Education, China - 111 Project); Pacific Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was funded by the Yale Center for Environmental Law and Policy; the Betsy and Jessie Fink Foundation; the 11th Hour Project; the Pacific Foundation; and by a Robert Wood Johnson Foundation Investigator Award in Health Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlof K., 2008, GLOB STUD REV, V4, P4; Andreasen AlanR., 1995, MARKETING SOCIAL CHA; [Anonymous], 2009, PROT HLTH CLIM CHANG; [Anonymous], 2002, NEW TOOLS ENV PROTEC; Australian Public Service Commission, 2007, TACKL WICK PROBL PUB; Conklin, 2006, DIALOGUE MAPPING BUI; Dahlstrom MF, 2010, COMMUN RES, V37, P857, DOI 10.1177/0093650210362683; Dibb S., 1999, J STRATEGIC MARKETIN, V7, P107, DOI DOI 10.1080/096525499346477; Dowd Matthew J., 2006, APPLEBEES AM SUCCESS; HITZHUSEN G, 2010, CLIMATE CHANGE ED FA; Hornik R., 2002, PUBLIC HLTH COMMUNIC; Kotler P, 2008, SOCIAL MARKETING INF; Kotler P., 2008, MANAGEMENT MARKETING, V12th; LEISEROWITZ A, 2010, CONNECTIONS CLIMATE; Leiserowitz A., 2010, GLOBAL WARMINGS 6 AM; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Magidson J., 2002, CAN J MARKET RES, V20, P37, DOI DOI 10.1017/CBO9780511499531.004; MAGIDSON J, 2002, SAGE HDB QUANTITATIV, P175; Maibach E W, 1996, J Health Psychol, V1, P261, DOI 10.1177/135910539600100302; Maibach E, 2009, SCI COMMUN, V30, P299, DOI 10.1177/1075547008329202; Maibach EW, 2008, AM J PREV MED, V35, P488, DOI 10.1016/j.amepre.2008.08.016; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Maibach EW, 2006, J HEALTH COMMUN, V11, P717, DOI 10.1080/10810730600934633; MCDONALD M, 1995, MARKET SEGMENTATION; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; *NAT AC, 2010, WORKSH CLIM CHANG ED; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Ockwell D, 2009, SCI COMMUN, V30, P305, DOI 10.1177/1075547008328969; PHIPPS M, 2010, GLOBAL WARMINGS 6 AM; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Slater MD, 1995, DESIGNING HLTH MESSA, P186; Smith R, 2009, STRATEGIC PLANNING P; Weir MR, 2000, ARCH INTERN MED, V160, P481, DOI 10.1001/archinte.160.4.481; [No title captured]	34	171	174	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17571	10.1371/journal.pone.0017571	http://dx.doi.org/10.1371/journal.pone.0017571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732VZ	21423743	Green Published, gold			2022-12-25	WOS:000288219100015
J	Arstikaitis, P; Gauthier-Campbell, C; Huang, K; El-Husseini, A; Murphy, TH				Arstikaitis, Pamela; Gauthier-Campbell, Catherine; Huang, Kun; El-Husseini, Alaa; Murphy, Timothy H.			Proteins That Promote Filopodia Stability, but Not Number, Lead to More Axonal-Dendritic Contacts	PLOS ONE			English	Article							INHIBITORY SYNAPSE FORMATION; DEVELOPMENTAL REGULATION; POSTSYNAPTIC PROTEIN; MOLECULAR-MECHANISMS; RAPID FORMATION; IN-VIVO; SPINE; PLASTICITY; MOTILITY; AUTISM	Dendritic filopodia are dynamic protrusions that are thought to play an active role in synaptogenesis and serve as precursors to spine synapses. However, this hypothesis is largely based on a temporal correlation between filopodia formation and synaptogenesis. We investigated the role of filopodia in synapse formation by contrasting the roles of molecules that affect filopodia elaboration and motility, versus those that impact synapse induction and maturation. We used a filopodia inducing motif that is found in GAP-43, as a molecular tool, and found this palmitoylated motif enhanced filopodia number and motility, but reduced the probability of forming a stable axon-dendrite contact. Conversely, expression of neuroligin-1 (NLG-1), a synapse inducing cell adhesion molecule, resulted in a decrease in filopodia motility, but an increase in the number of stable axonal contacts. Moreover, RNAi knockdown of NLG-1 reduced the number of presynaptic contacts formed. Postsynaptic scaffolding proteins such as Shank1b, a protein that induces the maturation of spine synapses, increased the rate at which filopodia transformed into spines by stabilization of the initial contact with axons. Taken together, these results suggest that increased filopodia stability and not density, may be the rate-limiting step for synapse formation.	[Arstikaitis, Pamela] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Arstikaitis, P (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	thmurphy@interchange.ubc.ca	Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490	Canadian Institutes of Health Research [MOP12675]; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; EJLB Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); EJLB Foundation	This work was supported by funding from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to PA, to THM (MOP12675), and to AEH; the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to CGC; the Michael Smith Foundation for Health Research to AEH; and the EJLB Foundation (http://www.ejlb.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; ARSTIKAITIS P, 2008, MOL BIOL CELL; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Brocco MA, 2010, EUR J NEUROSCI, V31, P195, DOI 10.1111/j.1460-9568.2009.07064.x; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Dailey ME, 1996, J NEUROSCI, V16, P2983; Decourt B, 2009, J NEUROSCI RES, V87, P1057, DOI 10.1002/jnr.21937; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Fiala JC, 1998, J NEUROSCI, V18, P8900; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kohsaka H, 2009, DEVELOPMENT, V136, P1127, DOI 10.1242/dev.027920; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; KWINTER DM, 2009, J VIS EXP; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Portera-Cailliau C, 2001, REV NEUROLOGIA, V33, P1158, DOI 10.33588/rn.3312.2001338; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Ramakers GMJ, 2000, NEUROSCI LETT, V286, P53, DOI 10.1016/S0304-3940(00)01081-8; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Swedlow JR, 2002, CELL STRUCT FUNCT, V27, P335, DOI 10.1247/csf.27.335; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Wong WT, 2000, J NEUROSCI, V20, P5024; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yan J, 2008, PSYCHIAT GENET, V18, P204, DOI 10.1097/YPG.0b013e3282fb7fe6; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, NEUROSCIENTIST, V7, P365, DOI 10.1177/107385840100700505	64	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16998	10.1371/journal.pone.0016998	http://dx.doi.org/10.1371/journal.pone.0016998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408225	Green Published, gold, Green Submitted			2022-12-25	WOS:000288099800009
J	Novitsky, V; Wang, R; Margolin, L; Baca, J; Rossenkhan, R; Moyo, S; van Widenfelt, E; Essex, M				Novitsky, Vladimir; Wang, Rui; Margolin, Lauren; Baca, Jeannie; Rossenkhan, Raabya; Moyo, Sikhulile; van Widenfelt, Erik; Essex, M.			Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection	PLOS ONE			English	Article							DYNAMICS; IDENTIFICATION; INOCULATION; SEQUENCES; LOAD; TIME	To address whether sequences of viral gag and env quasispecies collected during the early post-acute period can be utilized to determine multiplicity of transmitted HIV's, recently developed approaches for analysis of viral evolution in acute HIV-1 infection [1,2] were applied. Specifically, phylogenetic reconstruction, inter-and intra-patient distribution of maximum and mean genetic distances, analysis of Poisson fitness, shape of highlighter plots, recombination analysis, and estimation of time to the most recent common ancestor (tMRCA) were utilized for resolving multiplicity of HIV-1 transmission in a set of viral quasispecies collected within 50 days post-seroconversion (p/s) in 25 HIV-infected individuals with estimated time of seroconversion. The decision on multiplicity of HIV infection was made based on the model's fit with, or failure to explain, the observed extent of viral sequence heterogeneity. The initial analysis was based on phylogeny, inter-patient distribution of maximum and mean distances, and Poisson fitness, and was able to resolve multiplicity of HIV transmission in 20 of 25 (80%) cases. Additional analysis involved distribution of individual viral distances, highlighter plots, recombination analysis, and estimation of tMRCA, and resolved 4 of the 5 remaining cases. Overall, transmission of a single viral variant was identified in 16 of 25 (64%) cases, and transmission of multiple variants was evident in 8 of 25 (32%) cases. In one case multiplicity of HIV-1 transmission could not be determined. In primary HIV-1 subtype C infection, samples collected within 50 days p/s and analyzed by a single-genome amplification/sequencing technique can provide reliable identification of transmission multiplicity in 24 of 25 (96%) cases. Observed transmission frequency of a single viral variant and multiple viral variants were within the ranges of 64% to 68%, and 32% to 36%, respectively.	[Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; Essex, M.] Harvard Univ, Sch Publ Hlth, Harvard Sch Publ Hlth AIDS Initiat, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Novitsky, Vladimir; Rossenkhan, Raabya; Moyo, Sikhulile; van Widenfelt, Erik; Essex, M.] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Wang, Rui] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health	Novitsky, V (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Sch Publ Hlth AIDS Initiat, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	Moyo, Sikhulile/E-1464-2015; Wang, Rui/X-1699-2019	Moyo, Sikhulile/0000-0003-3821-4592; Wang, Rui/0000-0001-5007-193X	NIH [R01 AI057027, D43 TW000004, R37 AI24643]; AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research(Lawrence Ellison Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary HIV-1 subtype C infection study in Botswana, the Tshedimoso study, was supported and funded by NIH grant R01 AI057027. This work was supported in part by the NIH grants D43 TW000004 (RR) and R37 AI24643 (RW), and also through the AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Drummond AJ, 2010, GENEIOUS V5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Greenier JL, 2001, J VIROL, V75, P3753, DOI 10.1128/JVI.75.8.3753-3765.2001; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; RAMBAUT A, 2008, BIOTECHNIQUES, V48, P405; Ritola K, 2004, J VIROL, V78, P11208, DOI 10.1128/JVI.78.20.11208-11218.2004; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sagar M, 2004, J VIROL, V78, P7279, DOI 10.1128/JVI.78.13.7279-7283.2004; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929	39	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16714	10.1371/journal.pone.0016714	http://dx.doi.org/10.1371/journal.pone.0016714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21415914	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700029
J	Xu, J; Zhu, DH; He, SK; Spee, C; Ryan, SJ; Hinton, DR				Xu, Jing; Zhu, Danhong; He, Shikun; Spee, Christine; Ryan, Stephen J.; Hinton, David R.			Transcriptional regulation of bone morphogenetic protein 4 by tumor necrosis factor and its relationship with age-related macular degeneration	FASEB JOURNAL			English	Article						choroidal neovascularization; CNV; c-Jun NH(2)-terminal kinase; JNK; specificity protein 1; Sp1; phosphorylation	INDUCED CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; TNF-ALPHA; SP1 PHOSPHORYLATION; GENE-TRANSCRIPTION; SIGNALING PATHWAY; MOUSE EMBRYO; EXPRESSION; BMP4	Bone morphogenetic protein-4 (BMP4) may be involved in the molecular switch that determines which late form of age-related macular degeneration (AMD) an individual develops. BMP4 expression is high in retinal pigment epithelium (RPE) cells in late, dry AMD patients, while BMP4 expression is low in the wet form of the disease, characterized by choroidal neovascularization (CNV). Here, we sought to determine the mechanism by which BMP4 is down-regulated in CNV. BMP4 expression was decreased within laser-induced CNV lesions in mice at a time when tumor necrosis factor (TNF) expression was high (7 d postlaser) and was reexpressed in RPE when TNF levels declined (14 d postlaser). We found that TNF, an important angiogenic stimulus, significantly down-regulates BMP4 expression in cultured human fetal RPE cells, ARPE-19 cells, and RPE cells in murine posterior eye cup explants. We identified two specificity protein 1 (Sp1) binding sites in the BMP4 promoter that are required for basal expression of BMP4 and its down-regulation by TNF. Through c-Jun NH(2)-terminal kinase (JNK) activation, TNF modulates Sp1 phosphorylation, thus decreasing its affinity to the BMP4 promoter. The down-regulation of BMP4 expression by TNF in CNV and mechanisms established might be useful for defining novel targets for AMD therapy.-Xu, J., Zhu, D., He, S., Spee, C., Ryan, S. J., Hinton, D. R. Transcriptional regulation of bone morphogenetic protein 4 by tumor necrosis factor and its relationship with age-related macular degeneration. FASEB J. 25, 2221-2233 (2011). www.fasebj.org	[Xu, Jing] Univ So Calif, Keck Sch Med, Grad Program Neurosci, Los Angeles, CA 90089 USA; [He, Shikun; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA; [Zhu, Danhong; He, Shikun; Spee, Christine; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90089 USA; [Xu, Jing; Zhu, Danhong; He, Shikun; Spee, Christine; Ryan, Stephen J.; Hinton, David R.] Doheny Eye Inst, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; Doheny Eye Institute	Hinton, DR (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Ophthalmol, 2011 Zonal Ave,HMR 209, Los Angeles, CA 90089 USA.	dhinton@hsc.usc.edu			U.S. National Institutes of Health [EY01545, EY03040]; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness Inc. (New York, NY, USA); NATIONAL EYE INSTITUTE [R01EY001545] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Research to Prevent Blindness Inc. (New York, NY, USA)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Ram Kannan, Dr. Jeannie Chen, and Dr. Harold Kochounian for discussion and comments on this manuscript. The authors thank Ernesto Barron and Eric Barron for assistance with figure preparation. This research was supported by U.S. National Institutes of Health grants EY01545 and EY03040, the Arnold and Mabel Beckman Foundation, and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness Inc. (New York, NY, USA).	Afonso V, 2006, FREE RADICAL BIO MED, V41, P709, DOI 10.1016/j.freeradbiomed.2006.05.014; An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; An EY, 2008, MOL VIS, V14, P2292; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bilsland AE, 2006, CANCER RES, V66, P1363, DOI 10.1158/0008-5472.CAN-05-1941; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Bramlage CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1923; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Denson LA, 2001, J CLIN INVEST, V107, P1451, DOI 10.1172/JCI10994; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; FOJAS DB, 2001, EMBO J, V20, P5737; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Garcia-Layana A, 2009, OPHTHALMIC RES, V42, P205, DOI 10.1159/000232946; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Hangai M, 2006, J NEUROIMMUNOL, V171, P45, DOI 10.1016/j.jneuroim.2005.09.018; Hangai M, 2001, INVEST OPHTH VIS SCI, V42, P1617; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Horiguchi M, 2000, CYTOKINE, V12, P526, DOI 10.1006/cyto.1999.0577; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Jin M, 2004, INVEST OPHTH VIS SCI, V45, P323, DOI 10.1167/iovs.03-0355; Kane R, 2008, MOL VIS, V14, P1138; Kiyono M, 2006, ONCOGENE, V25, P7131, DOI 10.1038/sj.onc.1209700; Kiyono M, 2003, MOL CELL BIOL, V23, P4627, DOI 10.1128/MCB.23.13.4627-4636.2003; Koga T, 2007, AM J PHYSIOL-LUNG C, V293, pL693, DOI 10.1152/ajplung.00491.2006; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; LEE JJ, ONCOGENE, V29, P561; Lichtlen P, 2010, INVEST OPHTH VIS SCI, V51, P4738, DOI 10.1167/iovs.09-4890; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Markomichelakis NN, 2005, AM J OPHTHALMOL, V139, P537, DOI 10.1016/j.ajo.2004.09.058; Mathura JR, 2000, INVEST OPHTH VIS SCI, V41, P592; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Olson JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1221, DOI 10.1001/archopht.125.9.1221; Park KM, 2009, J BIOL CHEM, V284, P27557, DOI 10.1074/jbc.M109.034504; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007; Shimizu T, 1998, BONE, V23, P127, DOI 10.1016/S8756-3282(98)00086-6; Singhatanadgit W, 2006, INT J BIOCHEM CELL B, V38, P1794, DOI 10.1016/j.biocel.2006.05.005; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004; Thompson DL, 2003, MOL CELL BIOL, V23, P2277, DOI 10.1128/MCB.23.7.2277-2286.2003; Trousse F, 2001, J NEUROSCI, V21, P1292; vandenWijngaard A, 1996, BIOCHEM BIOPH RES CO, V219, P789, DOI 10.1006/bbrc.1996.0312; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Yang P, 2005, INVEST OPHTH VIS SCI, V46, P1755, DOI 10.1167/iovs.04-1039; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200; Zhu GH, 2002, ONCOGENE, V21, P8477, DOI 10.1038/sj.onc.1206030; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	68	17	19	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2221	2233		10.1096/fj.10-178350	http://dx.doi.org/10.1096/fj.10-178350			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21411747	Green Published			2022-12-25	WOS:000292242200014
J	Vareed, SK; Bhat, VB; Thompson, C; Vasu, VT; Fermin, D; Choi, H; Creighton, CJ; Gayatri, S; Lan, L; Putluri, N; Thangjam, GS; Kaur, P; Shabahang, M; Giri, JG; Nesvizhskii, AI; Asea, AAA; Cashikar, AG; Rao, A; McLoughlin, J; Sreekumar, A				Vareed, Shaiju K.; Bhat, Vadiraja B.; Thompson, Christopher; Vasu, Vihas T.; Fermin, Damian; Choi, Hyungwon; Creighton, Chad J.; Gayatri, Sitaram; Lan, Ling; Putluri, Nagireddy; Thangjam, Gagan Singh; Kaur, Punit; Shabahang, Mohsen; Giri, Judith G.; Nesvizhskii, Alexey I.; Asea, Alexander A. A.; Cashikar, Anil G.; Rao, Arundhati; McLoughlin, James; Sreekumar, Arun			Metabolites of Purine Nucleoside Phosphorylase (NP) in Serum Have the Potential to Delineate Pancreatic Adenocarcinoma	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; LIQUID-CHROMATOGRAPHY; GEL-ELECTROPHORESIS; GAMMA-SYNUCLEIN; CANCER; PROTEIN; BIOMARKER; GENE	Pancreatic Adenocarcinoma (PDAC), the fourth highest cause of cancer related deaths in the United States, has the most aggressive presentation resulting in a very short median survival time for the affected patients. Early detection of PDAC is confounded by lack of specific markers that has motivated the use of high throughput molecular approaches to delineate potential biomarkers. To pursue identification of a distinct marker, this study profiled the secretory proteome in 16 PDAC, 2 carcinoma in situ (CIS) and 7 benign patients using label-free mass spectrometry coupled to 1D-SDS-PAGE and Strong Cation-Exchange Chromatography (SCX). A total of 431 proteins were detected of which 56 were found to be significantly elevated in PDAC. Included in this differential set were Parkinson disease autosomal recessive, early onset 7 (PARK 7) and Alpha Synuclein (aSyn), both of which are known to be pathognomonic to Parkinson's disease as well as metabolic enzymes like Purine Nucleoside Phosphorylase (NP) which has been exploited as therapeutic target in cancers. Tissue Microarray analysis confirmed higher expression of aSyn and NP in ductal epithelia of pancreatic tumors compared to benign ducts. Furthermore, extent of both aSyn and NP staining positively correlated with tumor stage and perineural invasion while their intensity of staining correlated with the existence of metastatic lesions in the PDAC tissues. From the biomarker perspective, NP protein levels were higher in PDAC sera and furthermore serum levels of its downstream metabolites guanosine and adenosine were able to distinguish PDAC from benign in an unsupervised hierarchical classification model. Overall, this study for the first time describes elevated levels of aSyn in PDAC as well as highlights the potential of evaluating NP protein expression and levels of its downstream metabolites to develop a multiplex panel for non-invasive detection of PDAC.	[Vareed, Shaiju K.; Vasu, Vihas T.; Gayatri, Sitaram; Putluri, Nagireddy; Thangjam, Gagan Singh; Cashikar, Anil G.; Sreekumar, Arun] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Cashikar, Anil G.] Med Coll Georgia, Ctr Mol Chaperones & Radiobiol, Augusta, GA 30912 USA; [Bhat, Vadiraja B.; Thompson, Christopher; Choi, Hyungwon; Kaur, Punit; Shabahang, Mohsen; Asea, Alexander A. A.; Rao, Arundhati] Scott & White Hosp, Dept Pathol, Temple, TX USA; [Fermin, Damian; Nesvizhskii, Alexey I.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Lan, Ling] Med Coll Georgia, Dept Biostat, Augusta, GA 30912 USA; [McLoughlin, James; Sreekumar, Arun] Med Coll Georgia, Dept Surg Oncol, Augusta, GA 30912 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Gayatri, Sitaram] IIT, Chicago, IL 60616 USA; [Giri, Judith G.] Med Coll Georgia, Tumor Bank Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Baylor College of Medicine; Illinois Institute of Technology; University System of Georgia; Augusta University	Vareed, SK (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	sreekuma@bcm.edu	Cashikar, Anil G/F-5968-2011; Choi, Hyungwon/S-8824-2019; Vasu, Vihas T/D-6673-2014; Gayatri, Sitaram/GLT-7340-2022; Vasu, Vihas T/G-7303-2012; Nesvizhskii, Alexey/A-5410-2012	Choi, Hyungwon/0000-0002-6687-3088; Vasu, Vihas T/0000-0003-2275-2476; Vasu, Vihas T/0000-0003-2275-2476; Nesvizhskii, Alexey/0000-0002-2806-7819; Gayatri, Sitaram/0000-0002-0773-6278; Putluri, Nagireddy/0000-0003-4488-7400; Cashikar, Anil/0000-0002-3671-684X	National Cancer Institute [RO1CA13345, 1 R03 CA139489-01, RCA145444A, PSRP00030CS, P30 CA125123, R01 CA-126239]; Georgia Cancer Research Distinguished Scientist award; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA126239, R03CA139489, R01CA133458] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Research Distinguished Scientist award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Cancer Institute grants RO1CA13345 (AS), 1 R03 CA139489-01 (AS), RCA145444A (AS), PSRP00030CS (AS, JM), P30 CA125123 (CJC), and R01 CA-126239 (AIN). A.S. is supported by Georgia Cancer Research Distinguished Scientist award. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bantia S, 2010, INT IMMUNOPHARMACOL, V10, P784, DOI 10.1016/j.intimp.2010.04.009; Berger AC, 2004, ANN SURG ONCOL, V11, P644, DOI 10.1245/ASO.2004.11.025; Bhat VB, 2005, J PROTEOME RES, V4, P1814, DOI 10.1021/pr0501463; Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888; Boeck S, 2010, CLIN CANCER RES, V16, P986, DOI 10.1158/1078-0432.CCR-09-2205; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Breci L, 2005, PROTEOMICS, V5, P2018, DOI 10.1002/pmic.200401103; Chen R, 2005, MOL CELL PROTEOMICS, V4, P523, DOI 10.1074/mcp.R500004-MCP200; Chen R, 2002, MOL CANCER, V9, P149; Chen R, 2007, PANCREAS, V34, P70, DOI 10.1097/01.mpa.0000240615.20474.fd; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Chintanaboina J, 2008, SOUTH MED J, V101, P661, DOI 10.1097/SMJ.0b013e318170584b; Chung JC, 2008, ANZ J SURG, V78, P245, DOI 10.1111/j.1445-2197.2008.04429.x; Conry RM, 1998, IMMUNOPHARMACOLOGY, V40, P1, DOI 10.1016/S0162-3109(98)00012-5; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Cui YZ, 2009, PANCREATOLOGY, V9, P89, DOI 10.1159/000178879; Cui YZ, 2009, CANCER INVEST, V27, P747, DOI 10.1080/07357900802672746; Dalal I, 2001, CLIN GENET, V59, P430, DOI 10.1034/j.1399-0004.2001.590608.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farrell James J., 2005, Cancer Biomarkers, V1, P157; GIBLETT ER, 1975, LANCET, V1, P1010, DOI 10.1016/S0140-6736(75)91950-9; Goggins M, 2000, J SURG ONCOL, V74, P243, DOI 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Hidalgo M, N ENGL J MED, V362, P1605; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia TL, 1999, CANCER RES, V59, P742; Kakisaka T, 2007, J CHROMATOGR B, V852, P257, DOI 10.1016/j.jchromb.2007.01.029; Kang TH, 2007, PROTEOMICS, V7, P2624, DOI 10.1002/pmic.200601028; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Kim YC, 2010, FEBS LETT, V584, P3891, DOI 10.1016/j.febslet.2010.08.010; Kristiansson MH, 2007, J PROTEOME RES, V6, P1735, DOI 10.1021/pr060497x; Li YG, 2009, DIGEST LIVER DIS, V41, P605, DOI 10.1016/j.dld.2008.11.010; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Markert ML, 1997, HUM MUTAT, V9, P118, DOI 10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Melle C, 2007, CLIN CHEM, V53, P629, DOI 10.1373/clinchem.2006.079194; MESAROSOVA A, 1993, NEOPLASMA, V40, P341; Mo JS, J CELL BIOCH, V110, P229; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; Morris PE, 2000, CURR PHARM DESIGN, V6, P943, DOI 10.2174/1381612003400083; Mougenot AL, J NEUROSCI METHODS; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nikov G, 2003, ANAL BIOCHEM, V320, P214, DOI 10.1016/S0003-2697(03)00359-2; Ortsater H, 2007, PROTEOMICS, V7, P3105, DOI 10.1002/pmic.200601019; Park IJ, 2009, ANTICANCER RES, V29, P4303; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; *R DEV COR, 2008, R LANG ENV STAT COMP; Rebours V, 2010, CLIN GASTROENTEROL H, V8, P206, DOI 10.1016/j.cgh.2009.09.009; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Ritts R E, 1998, Surg Oncol Clin N Am, V7, P93; Roberts ELL, 2004, CLIN CHIM ACTA, V344, P109, DOI 10.1016/j.cccn.2004.02.008; Rosty C, 2002, HEMATOL ONCOL CLIN N, V16, P37, DOI 10.1016/S0889-8588(01)00007-7; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; SCHNEIDER MU, 1984, SCAND J GASTROENTERO, V19, P139, DOI 10.1080/00365521.1984.12005699; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sitek B, 2009, J PROTEOME RES, V8, P1647, DOI 10.1021/pr800890j; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun ZL, 2007, BBA-PROTEINS PROTEOM, V1774, P764, DOI 10.1016/j.bbapap.2007.04.001; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Tonack S, 2009, PANCREATOLOGY, V9, P567, DOI 10.1159/000212083; van Duijn C. M., 2001, American Journal of Human Genetics, V69, P629, DOI 10.1086/322996; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Xu X, 2007, BLOOD CELL MOL DIS, V45, P227; Ye Q, 2010, ONCOL REP, V23, P429, DOI 10.3892/or_00000652; Ye Q, 2009, WORLD J GASTROENTERO, V15, P5035, DOI 10.3748/wjg.15.5035; Yoshioka Masato, 2002, J Hepatobiliary Pancreat Surg, V9, P376, DOI 10.1007/s005340200043; Zhao J, 2007, J PROTEOME RES, V6, P1126, DOI 10.1021/pr0604458; Zhou L, 2007, PROTEOMICS, V7, P1345, DOI 10.1002/pmic.200600086	81	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17177	10.1371/journal.pone.0017177	http://dx.doi.org/10.1371/journal.pone.0017177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448452	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500003
J	Barbagallo, APM; Wang, ZL; Zheng, H; D'Adamio, L				Barbagallo, Alessia P. M.; Wang, Zilai; Zheng, Hui; D'Adamio, Luciano			The Intracellular Threonine of Amyloid Precursor Protein That Is Essential for Docking of Pin1 Is Dispensable for Developmental Function	PLOS ONE			English	Article							JNK-INTERACTING PROTEIN-1; LONG-TERM POTENTIATION; PROLYL ISOMERASE PIN1; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; A-BETA; DEFICIENT MICE; DOMAIN; FE65; PHOSPHORYLATION	Background: Processing of Ab-precursor protein (APP) plays an important role in Alzheimer's Disease (AD) pathogenesis. Thr residue at amino acid 668 of the APP intracellular domain (AID) is highly conserved. When phosphorylated, this residue generates a binding site for Pin1. The interaction of APP with Pin1 has been involved in AD pathogenesis. Methodology/Principal Findings: To dissect the functions of this sequence in vivo, we created an APP knock-in allele, in which Thr(668) is replaced by an Ala (T-668 A). Doubly deficient APP/APP-like protein 2 (APLP2) mice present postnatal lethality and neuromuscular synapse defects. Previous work has shown that the APP intracellular domain is necessary for preventing early lethality and neuromuscular junctions (NMJ) defects. Crossing the T-668 A allele into the APLP2 knockout background showed that mutation of Thr(668) does not cause a defective phenotype. Notably, the T 668 A mutant APP is able to bind Mint1. Conclusions/Significance: Our results argue against an important role of the Thr 668 residue in the essential function of APP in developmental regulation. Furthermore, they indicate that phosphorylation at this residue is not functionally involved in those APP-mediated functions that prevent (NMJ) defects and early lethality in APLP2 null mice.	[Barbagallo, Alessia P. M.; D'Adamio, Luciano] Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA; [Wang, Zilai; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [D'Adamio, Luciano] CNR, Inst Neurobiol & Mol Med, Rome, Italy	Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Consiglio Nazionale delle Ricerche (CNR)	Barbagallo, APM (corresponding author), Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer Disease Research Grants [A2003-076, NIRG-10-173876]; NIH [AG033007, AG020670, AG032051]; NATIONAL INSTITUTE ON AGING [R01AG033007, R01AG032051, R01AG020670] Funding Source: NIH RePORTER	Alzheimer Disease Research Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Alzheimer Disease Research Grants (A2003-076 to L. D. and NIRG-10-173876 to APB), and grants from NIH (AG033007 to L. D, AG020670 and AG032051 to H. Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; BARBAGALLO AP, 2011, J BIOL CHEM; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Fitzjohn SM, 2000, NEUROSCI LETT, V288, P9, DOI 10.1016/S0304-3940(00)01204-0; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hata Y, 1996, J NEUROSCI, V16, P2488; Heber S, 2000, J NEUROSCI, V20, P7951; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Li HL, 1997, J NEUROBIOL, V32, P469, DOI 10.1002/(SICI)1097-4695(199705)32:5<469::AID-NEU3>3.3.CO;2-5; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Li ZW, 1996, P NATL ACAD SCI USA, V93, P6158, DOI 10.1073/pnas.93.12.6158; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Phinney AL, 1999, NEUROSCIENCE, V90, P1207, DOI 10.1016/S0306-4522(98)00645-9; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Swistowski A, 2009, J NEUROSCI, V29, P15703, DOI 10.1523/JNEUROSCI.4351-09.2009; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tremml P, 1998, BEHAV BRAIN RES, V95, P65, DOI 10.1016/S0166-4328(97)00211-8; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	59	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18006	10.1371/journal.pone.0018006	http://dx.doi.org/10.1371/journal.pone.0018006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445342	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100023
J	Immel, TA; Groth, U; Huhn, T; Ohlschlager, P				Immel, Timo A.; Groth, Ulrich; Huhn, Thomas; Oehlschlaeger, Peter			Titanium Salan Complexes Displays Strong Antitumor Properties In Vitro and In Vivo in Mice	PLOS ONE			English	Article							PLATINUM COMPLEXES; TITANOCENE DICHLORIDE; ANTICANCER DRUGS; CANCER-TREATMENT; METAL-COMPLEXES; CERVICAL-CANCER; HYDROLYSIS; DNA; VACCINATION; WOMEN	The anticancer activity of titanium complexes has been known since the groundbreaking studies of Kopf and Kopf-Maier on titanocen dichloride. Unfortunately, possibly due to their fast hydrolysis, derivatives of titanocen dichloride failed in clinical studies. Recently, the new family of titanium salan complexes containing tetradentate ONNO ligands with anti-cancer properties has been discovered. These salan complexes are much more stabile in aqueous media. In this study we describe the biological activity of two titanium salan complexes in a mouse model of cervical cancer. High efficiency of this promising complex family was demonstrated for the first time in vivo. From these data we conclude that titanium salan complexes display very strong antitumor properties exhibiting only minor side effects. Our results may influence the chemotherapy with metallo therapeutics in the future.	[Immel, Timo A.; Groth, Ulrich; Huhn, Thomas] Univ Konstanz, Dept Chem, Constance, Germany; [Immel, Timo A.; Groth, Ulrich; Huhn, Thomas] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Oehlschlaeger, Peter] Univ Konstanz, Dept Immunol, Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Immel, TA (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	peter.oehlschlaeger@uni-konstanz.de	Huhn, Thomas/A-2708-2009	Huhn, Thomas/0000-0001-6292-4215	Konstanz Research School Chemical Biology (KoRS-CB)	Konstanz Research School Chemical Biology (KoRS-CB)	This work was supported by Konstanz Research School Chemical Biology (KoRS-CB). Support for TAI was provided by a personal scholarship of KoRS-CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013; Caruso F, 2004, MINI-REV MED CHEM, V4, P49, DOI 10.2174/1389557043487565; Coluccia M, 2007, ANTI-CANCER AGENT ME, V7, P111, DOI 10.2174/187152007779314080; Desoize B, 2004, ANTICANCER RES, V24, P1529; Eger S, 2010, INORG CHEM, V49, P1292, DOI 10.1021/ic9022163; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Gatta G, 1998, EUR J CANCER, V34, P2218, DOI 10.1016/S0959-8049(98)00326-8; GIRALDI T, 1977, CANCER RES, V37, P2662; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Immel TA, 2010, J INORG BIOCHEM, V104, P863, DOI 10.1016/j.jinorgbio.2010.04.003; Immel TA, 2010, CHEM-EUR J, V16, P2775, DOI 10.1002/chem.200902312; Immel TA, 2009, CHEMMEDCHEM, V4, P738, DOI 10.1002/cmdc.200900038; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; Jakupec MA, 2008, DALTON T, P183, DOI 10.1039/b712656p; KOPF H, 1981, J ORGANOMET CHEM, V216, P185, DOI 10.1016/S0022-328X(00)85759-9; Lummen G, 1998, CANCER CHEMOTH PHARM, V42, P415, DOI 10.1007/s002800050838; Melendez E, 2002, CRIT REV ONCOL HEMAT, V42, P309, DOI 10.1016/S1040-8428(01)00224-4; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Ohlschlager P, 2009, INT J CANCER, V125, P189, DOI 10.1002/ijc.24333; Ohlschlager P, 2006, VACCINE, V24, P2880, DOI 10.1016/j.vaccine.2005.12.061; Ohlschlager P, 2003, J VIROL, V77, P4635, DOI 10.1128/JVI.77.8.4635-4645.2003; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Perez-Regadera J, 2010, INT J GYNECOL CANCER, V20, P164, DOI 10.1111/IGC.0b013e3181ad3e11; Pisani S, 1999, EUR J GYNAECOL ONCOL, V20, P69; Schilling T, 1996, Invest New Drugs, V13, P327; Strohfeldt K, 2008, CHEM SOC REV, V37, P1174, DOI 10.1039/b707310k; TONEY JH, 1985, J AM CHEM SOC, V107, P947, DOI 10.1021/ja00290a033; Tshuva EY, 2009, COORDIN CHEM REV, V253, P2098, DOI 10.1016/j.ccr.2008.11.015	29	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17869	10.1371/journal.pone.0017869	http://dx.doi.org/10.1371/journal.pone.0017869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445304	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300019
J	Stuckey, DW; Di Gregorio, A; Clements, M; Rodriguez, TA				Stuckey, Daniel W.; Di Gregorio, Aida; Clements, Melanie; Rodriguez, Tristan A.			Correct Patterning of the Primitive Streak Requires the Anterior Visceral Endoderm	PLOS ONE			English	Article							EARLY MOUSE EMBRYO; DIPHTHERIA-TOXIN; GENETIC ABLATION; FOREBRAIN FORMATION; NODAL ANTAGONISTS; TRANSGENIC MICE; NEURAL PLATE; EXPRESSION; EPIBLAST; AXIS	Anterior-posterior axis specification in the mouse requires signalling from a specialised extra-embryonic tissue called the anterior visceral endoderm (AVE). AVE precursors are induced at the distal tip of the embryo and move to the prospective anterior. Embryological and genetic analysis has demonstrated that the AVE is required for anterior patterning and for correctly positioning the site of primitive streak formation by inhibiting Nodal activity. We have carried out a genetic ablation of the Hex-expressing cells of the AVE (Hex-AVE) by knocking the Diphtheria toxin subunit A into the Hex locus in an inducible manner. Using this model we have identified that, in addition to its requirement in the anterior of the embryo, the Hex-AVE sub-population has a novel role between 5.5 and 6.5dpc in patterning the primitive streak. Embryos lacking the Hex-AVE display delayed initiation of primitive streak formation and miss-patterning of the anterior primitive streak. We demonstrate that in the absence of the Hex-AVE the restriction of Bmp2 expression to the proximal visceral endoderm is also defective and expression of Wnt3 and Nodal is not correctly restricted to the posterior epiblast. These results, coupled with the observation that reducing Nodal signalling in Hex-AVE ablated embryos increases the frequency of phenotypes observed, suggests that these primitive streak patterning defects are due to defective Nodal signalling. Together, our experiments demonstrate that the AVE is not only required for anterior patterning, but also that specific sub-populations of this tissue are required to pattern the posterior of the embryo.	[Stuckey, Daniel W.; Di Gregorio, Aida; Clements, Melanie; Rodriguez, Tristan A.] Univ London Imperial Coll Sci Technol & Med, Mol Embryol Grp, MRC, Ctr Clin Sci, London, England	Imperial College London	Stuckey, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Mol Embryol Grp, MRC, Ctr Clin Sci, London, England.	tristan.rodriguez@csc.mrc.ac.uk		Rodriguez, Tristan/0000-0002-3415-8493	Medical Research Council; Lister Institute of Preventive Medicine; MRC [MC_U120081320] Funding Source: UKRI; Medical Research Council [MC_U120081320] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute of Preventive Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and the Lister Institute of Preventive Medicine ( http://www.lister-institute.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1998, DEVELOPMENT, V125, P5091; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; HARRISON GS, 1991, HUM GENE THER, V2, P53, DOI 10.1089/hum.1991.2.1-53; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kimura C, 2001, DEV BIOL, V235, P12, DOI 10.1006/dbio.2001.0289; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Martinez-Barbera JP, 2001, INT J DEV BIOL, V45, P327; MAXWELL IH, 1986, CANCER RES, V46, P4660; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Miura S, 2007, DEV DYNAM, V236, P1602, DOI 10.1002/dvdy.21166; MORSUT L, DEVELOPMENT; Nagy A., 2003, MANIPULATING MOUSE E; Norris DP, 2002, DEVELOPMENT, V129, P3455; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Rhinn M, 1998, DEVELOPMENT, V125, P845; Rivera-Perez JA, 2003, DEV BIOL, V261, P470, DOI 10.1016/S0012-1606(03)00302-6; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; Shawlot W, 1999, DEVELOPMENT, V126, P4925; Srinivas S, 2004, DEVELOPMENT, V131, P1157, DOI 10.1242/dev.01005; Srinivas S, 2006, GENESIS, V44, P565, DOI 10.1002/dvg.20249; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Varlet I, 1997, DEVELOPMENT, V124, P1033; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17620	10.1371/journal.pone.0017620	http://dx.doi.org/10.1371/journal.pone.0017620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445260	gold, Green Published			2022-12-25	WOS:000288545100020
J	Damrauer, SM; Studer, P; da Silva, CG; Longo, CR; Ramsey, HE; Csizmadia, E; Shrikhande, GV; Scali, ST; Libermann, TA; Bhasin, MK; Ferran, C				Damrauer, Scott M.; Studer, Peter; da Silva, Cleide G.; Longo, Christopher R.; Ramsey, Haley E.; Csizmadia, Eva; Shrikhande, Gautam V.; Scali, Salvatore T.; Libermann, Towia A.; Bhasin, Manoj K.; Ferran, Christiane			A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; NF-KAPPA-B; GENE-EXPRESSION PATTERNS; PARTIAL-HEPATECTOMY; PROTECTS MICE; MOUSE-LIVER; MECHANISMS; DISRUPTION; INJURY; MASS	Background: Liver Regeneration is clinically of major importance in the setting of liver injury, resection or transplantation. We have demonstrated that the NF-kappa B inhibitory protein A20 significantly improves recovery of liver function and mass following extended liver resection (LR) in mice. In this study, we explored the Systems Biology modulated by A20 following extended LR in mice. Methodology and Principal Findings: We performed transcriptional profiling using Affymetrix-Mouse 430.2 arrays on liver mRNA retrieved from recombinant adenovirus A20 (rAd.A20) and rAd.beta galactosidase treated livers, before and 24 hours after 78% LR. A20 overexpression impacted 1595 genes that were enriched for biological processes related to inflammatory and immune responses, cellular proliferation, energy production, oxidoreductase activity, and lipid and fatty acid metabolism. These pathways were modulated by A20 in a manner that favored decreased inflammation, heightened proliferation, and optimized metabolic control and energy production. Promoter analysis identified several transcriptional factors that implemented the effects of A20, including NF-kappa B, CEBPA, OCT-1, OCT-4 and EGR1. Interactive scale-free network analysis captured the key genes that delivered the specific functions of A20. Most of these genes were affected at basal level and after resection. We validated a number of A20's target genes by real-time PCR, including p21, the mitochondrial solute carriers SLC25a10 and SLC25a13, and the fatty acid metabolism regulator, peroxisome proliferator activated receptor alpha. This resulted in greater energy production in A20-expressing livers following LR, as demonstrated by increased enzymatic activity of cytochrome c oxidase, or mitochondrial complex IV. Conclusion: This Systems Biology-based analysis unravels novel mechanisms supporting the pro-regenerative function of A20 in the liver, by optimizing energy production through improved lipid/fatty acid metabolism, and down-regulated inflammation. These findings support pursuit of A20-based therapies to improve patients' outcomes in the context of extreme liver injury and extensive LR for tumor treatment or donation.	[Damrauer, Scott M.; Studer, Peter; da Silva, Cleide G.; Longo, Christopher R.; Ramsey, Haley E.; Csizmadia, Eva; Shrikhande, Gautam V.; Scali, Salvatore T.; Ferran, Christiane] Harvard Univ, Sch Med, Div Vasc Surg, Vasc Biol Res Ctr, Boston, MA USA; [Damrauer, Scott M.; Studer, Peter; da Silva, Cleide G.; Longo, Christopher R.; Ramsey, Haley E.; Csizmadia, Eva; Shrikhande, Gautam V.; Scali, Salvatore T.; Ferran, Christiane] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr,Transplant Inst, Boston, MA 02115 USA; [Libermann, Towia A.; Bhasin, Manoj K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol,Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Damrauer, SM (corresponding author), Massachusetts Gen Hosp, Div Vasc Surg, Boston, MA 02114 USA.	mbhasin@bidmc.harvard.edu; cferran@bidmc.harvard.edu	Angolano, Cleide/AAZ-4154-2021	Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X; Damrauer, Scott/0000-0001-8009-1632	NIH [RO1 DK063275, RO1 HL080130, HL057791, T32 HL07734]; Juvenile Diabetes Research Foundation [1-2007-567]; National Swiss Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080130, T32HL007734, R01HL057791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Swiss Foundation(Swiss National Science Foundation (SNSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	research was supported by NIH grants RO1 DK063275, RO1 HL080130, HL057791 and Juvenile Diabetes Research Foundation grant 1-2007-567 to CF. SMD, CRL, GVS, STS, are recipients of a fellowship award from the NIH T32 HL07734. PS is the recipient of a grant from the National Swiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Arai M, 2003, J BIOL CHEM, V278, P29813, DOI 10.1074/jbc.M212648200; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Banz Y, 2007, TRANSPL INT, V20, P722, DOI 10.1111/j.1432-2277.2007.00512.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brasaemle DL, 2006, SCIENCE, V313, P1581, DOI 10.1126/science.1133253; Campbell JS, 2001, J CLIN INVEST, V107, P1285, DOI 10.1172/JCI11867; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Cooper JT, 1997, TRANSPL P, V29, P881, DOI 10.1016/S0041-1345(96)00185-6; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; COORNAERT B, 2008, J BIOL CHEM; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; de Jonge J, 2009, AM J TRANSPLANT, V9, P758, DOI 10.1111/j.1600-6143.2009.02557.x; De Paepe B, 2009, CURR PROTOC HUM GENE, VChapter 19, pUnit192; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Ezaki H, 2009, BIOCHEM BIOPH RES CO, V378, P68, DOI 10.1016/j.bbrc.2008.10.176; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Ferran C, 1998, BLOOD, V91, P2249, DOI 10.1182/blood.V91.7.2249.2249_2249_2258; Garnier D, 2009, HEPATOLOGY, V50, P1946, DOI 10.1002/hep.23225; Gazit V, 2010, HEPATOLOGY, V52, P2109, DOI 10.1002/hep.23920; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; Guo FZ, 2006, PROTEOMICS, V6, P3075, DOI 10.1002/pmic.200500322; Haberberger TC, 2000, GENE THER, V7, P903, DOI 10.1038/sj.gt.3301181; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ilyin GP, 2003, AM J PHYSIOL-GASTR L, V285, pG115, DOI 10.1152/ajpgi.00309.2002; Inderbitzin DT, 2007, BRIT J SURG, V94, P599, DOI 10.1002/bjs.5666; Inderbitzin D, 2007, J GASTROINTEST SURG, V11, P280, DOI 10.1007/s11605-007-0096-0; Inderbitzin D, 2007, METHODS, V43, P46, DOI 10.1016/j.ymeth.2007.03.010; Klune JR, 2008, J LEUKOCYTE BIOL, V83, P558, DOI 10.1189/jlb.0607406; Kunter U, 2005, KIDNEY INT, V68, P1520, DOI 10.1111/j.1523-1755.2005.00564.x; LAHERTY CD, 1993, J BIOL CHEM, V268, P5032; Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1; Leclercq IA, 2006, LAB INVEST, V86, P1161, DOI 10.1038/labinvest.3700474; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Li W, 2001, HEPATOLOGY, V33, P1377, DOI 10.1053/jhep.2001.24431; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo CR, 2005, HEPATOLOGY, V42, P156, DOI 10.1002/hep.20741; Mann DV, 2001, HEPATOLOGY, V34, P557, DOI 10.1053/jhep.2001.27012; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Nagata Y, 2005, EXP CELL RES, V305, P277, DOI 10.1016/j.yexcr.2004.12.028; NAKATANI T, 1982, CLIN SCI, V62, P295, DOI 10.1042/cs0620295; NAKATANI T, 1981, J LAB CLIN MED, V97, P887; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Okaya T, 2004, AM J PHYSIOL-GASTR L, V286, pG606, DOI 10.1152/ajpgi.00191.2003; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Ramsey HE, 2009, LIVER TRANSPLANT, V15, P1613, DOI 10.1002/lt.21879; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; Skrtic S, 2005, LIVER INT, V25, P33, DOI 10.1111/j.1478-3231.2004.0998.x; Stoupis C, 2007, EUR RADIOL, V17, P401, DOI 10.1007/s00330-006-0359-2; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	72	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17715	10.1371/journal.pone.0017715	http://dx.doi.org/10.1371/journal.pone.0017715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437236	Green Published, Green Submitted, gold			2022-12-25	WOS:000288514600011
J	Boswell, CA; Ferl, GZ; Mundo, EE; Bumbaca, D; Schweiger, MG; Theil, FP; Fielder, PJ; Khawli, LA				Boswell, C. Andrew; Ferl, Gregory Z.; Mundo, Eduardo E.; Bumbaca, Daniela; Schweiger, Michelle G.; Theil, Frank-Peter; Fielder, Paul J.; Khawli, Leslie A.			Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow	PLOS ONE			English	Article							PHARMACOKINETIC PBPK MODEL; HUMAN TUMOR XENOGRAFTS; MONOCLONAL-ANTIBODIES; RAT-TUMORS; MICE; CELLS; PERMEABILITY; BINDING; TC-99M; MOUSE	Background: The identification of clinically meaningful and predictive models of disposition kinetics for cancer therapeutics is an ongoing pursuit in drug development. In particular, the growing interest in preclinical evaluation of anti-angiogenic agents alone or in combination with other drugs requires a complete understanding of the associated physiological consequences. Methodology/Principal Findings: Technescan (TM) PYP (TM), a clinically utilized radiopharmaceutical, was used to measure tissue vascular volumes in beige nude mice that were naive or administered a single intravenous bolus dose of a murine anti-vascular endothelial growth factor (anti-VEGF) antibody (10 mg/kg) 24 h prior to assay. Anti-VEGF had no significant effect (p>0.05) on the fractional vascular volumes of any tissues studied; these findings were further supported by single photon emission computed tomographic imaging. In addition, apart from a borderline significant increase (p = 0.048) in mean hepatic blood flow, no significant anti-VEGF-induced differences were observed (p>0.05) in two additional physiological parameters, interstitial fluid volume and the organ blood flow rate, measured using indium-111-pentetate and rubidium-86 chloride, respectively. Areas under the concentration-time curves generated by a physiologically-based pharmacokinetic model changed substantially (>25%) in several tissues when model parameters describing compartmental volumes and blood flow rates were switched from literature to our experimentally derived values. However, negligible changes in predicted tissue exposure were observed when comparing simulations based on parameters measured in naive versus anti-VEGF-administered mice. Conclusions/Significance: These observations may foster an enhanced understanding of anti-VEGF effects in murine tissues and, in particular, may be useful in modeling antibody uptake alone or in combination with anti-VEGF.	[Boswell, C. Andrew; Ferl, Gregory Z.; Mundo, Eduardo E.; Bumbaca, Daniela; Theil, Frank-Peter; Fielder, Paul J.; Khawli, Leslie A.] Genentech Inc, Dept Pharmacokinet & Pharmacodynam Sci, San Francisco, CA 94080 USA; [Schweiger, Michelle G.] Genentech Inc, Dept Investigat Safety Assessment, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Boswell, CA (corresponding author), Genentech Inc, Dept Pharmacokinet & Pharmacodynam Sci, San Francisco, CA 94080 USA.	boswell.andy@gene.com		Ferl, Gregory/0000-0002-9943-1569; Boswell, Charles/0000-0002-0426-9846	Roche	Roche(Roche Holding)	Competing Interests: The authors have read the journal's policy and have the following conflicts: All authors are paid employees of Genentech, a member of the Roche Group, and hold financial interest in Roche in the form of stocks and/or options. Two drugs mentioned in this manuscript, trastuzumab and bevacizumab, are marketed by Genentech/Roche. In addition, CAB serves as an Academic Editor for PLoS ONE. None of these financial or competing interests alters the authors' adherence to all PLoS ONE policies on sharing data and materials.	ATKINS HL, 1980, RADIOLOGY, V136, P501, DOI 10.1148/radiology.136.2.7403531; Bagri A, CLIN CANC RES, V16, P3887; BAXTER LT, 1994, CANCER RES, V54, P1517; BAXTER LT, 1995, CANCER RES, V55, P4611; BISCHOFF KB, 1970, J PHARM SCI-US, V59, P149, DOI 10.1002/jps.2600590203; BJORKMAN S, 1994, J PHARMACOKINET BIOP, V22, P381, DOI 10.1007/BF02353862; Blumenthal RD, 2000, EUR J CANCER, V36, P1876, DOI 10.1016/S0959-8049(00)00177-5; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Boswell CA, 2009, J LABELLED COMPD RAD, V52, pS102; Boswell CA, 2010, MOL PHARMACEUT, V7, P1848, DOI 10.1021/mp100183k; Boswell CA, 2009, PROTEINS PEPTIDES PR; Boswell CA, MOL IMAGING PROBES C; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; CHERRY SR, 1990, J NUCL MED, V31, P1307; Davda JP, 2008, INT IMMUNOPHARMACOL, V8, P401, DOI 10.1016/j.intimp.2007.10.023; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Ferl GZ, 2005, ANN BIOMED ENG, V33, P1640, DOI 10.1007/s10439-005-7410-3; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garg A, 2007, J PHARMACOKINET PHAR, V34, P687, DOI 10.1007/s10928-007-9065-1; Green AJ, 2001, PHYS MED BIOL, V46, P1679, DOI 10.1088/0031-9155/46/6/307; GULLINO PM, 1962, J NATL CANCER I, V28, P211; HAMMERSLEY PAG, 1987, EUR J NUCL MED, V13, P90; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Levitt David G, 2003, BMC Clin Pharmacol, V3, P3, DOI 10.1186/1472-6904-3-3; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Nestorov I, 2007, EXPERT OPIN DRUG MET, V3, P235, DOI 10.1517/17425255.3.2.235; O'Connor JPB, 2009, CLIN CANCER RES, V15, P6674, DOI 10.1158/1078-0432.CCR-09-0731; OCONNOR SW, 1984, CANCER RES, V44, P3719; Park S, 2005, J PHARMACOL EXP THER, V312, P1249, DOI 10.1124/jpet.104.076216; PAVEL DG, 1977, J NUCL MED, V18, P305; REHANI MM, 1980, J NUCL MED, V21, P676; SANDS H, 1985, CANCER LETT, V27, P15, DOI 10.1016/0304-3835(85)90004-7; SANDS H, 1988, CANCER RES, V48, P188; Scheer MGW, 2008, EUR J CANCER, V44, P1835, DOI 10.1016/j.ejca.2008.05.026; SHOCKLEY TR, 1992, CANCER RES, V52, P357; SMITH TD, 1976, J NUCL MED, V17, P126; SRIVASTAVA SC, 1984, SEMIN NUCL MED, V14, P68, DOI 10.1016/S0001-2998(84)80022-7; SUNG C, 1990, CANCER RES, V50, P7382; WANG P, 1993, AM J PHYSIOL, V264, pH1166, DOI 10.1152/ajpheart.1993.264.4.H1166; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; ZANELLI GD, 1974, CANCER RES, V34, P1451	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17874	10.1371/journal.pone.0017874	http://dx.doi.org/10.1371/journal.pone.0017874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21436893	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900038
J	Meijer, HJG; Hassen, HH; Govers, F				Meijer, Harold J. G.; Hassen, Hussen Harrun; Govers, Francine			Phytophthora infestans Has a Plethora of Phospholipase D Enzymes Including a Subclass That Has Extracellular Activity	PLOS ONE			English	Article							ACTIVATION	In eukaryotes phospholipase D (PLD) is involved in many cellular processes. Currently little is known about PLDs in oomycetes. Here we report that the oomycete plant pathogen Phytophthora infestans has a large repertoire of PLDs divided over six subfamilies: PXPH-PLD, PXTM-PLD, TM-PLD, PLD-likes, and type A and B sPLD-likes. Since the latter have signal peptides we developed a method using metabolically labelled phospholipids to monitor if P. infestans secretes PLD. In extracellular medium of ten P. infestans strains PLD activity was detected as demonstrated by the production of phosphatidic acid and the PLD specific marker phosphatidylalcohol.	[Meijer, Harold J. G.; Hassen, Hussen Harrun; Govers, Francine] Wageningen Univ, Plant Sci Grp, Phytopathol Lab, Wageningen, Netherlands; [Govers, Francine] CBSG, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Meijer, HJG (corresponding author), Wageningen Univ, Plant Sci Grp, Phytopathol Lab, Wageningen, Netherlands.	Harold.Meijer@wur.nl	Meijer, HJG/AFN-5216-2022; Meijer, Harold/G-5703-2012; Govers, Francine/A-5616-2009; Meijer, Harold/S-3891-2019	Meijer, HJG/0000-0002-0883-219X; Govers, Francine/0000-0001-5311-929X; Meijer, Harold/0000-0002-0883-219X	Dutch Technology Foundation STW; applied science division of NWO; Ministry of Economic Affairs; Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Dutch Technology Foundation STW(Technologiestichting STW); applied science division of NWO(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Dutch Technology Foundation STW, applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs, in the framework of a VIDI project (HM) and by the Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Chae YC, 2005, J BIOL CHEM, V280, P3723, DOI 10.1074/jbc.M406987200; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Ho AYY, 2009, FUNCT PLANT BIOL, V36, P190, DOI 10.1071/FP08222; Lamour KH, 2006, MOL PLANT MICROBE IN, V19, P1359, DOI 10.1094/MPMI-19-1359; Latijnhouwers M, 2002, MOL PLANT MICROBE IN, V15, P939, DOI 10.1094/MPMI.2002.15.9.939; Madrid E, 2010, J EXP BOT, V61, P747, DOI 10.1093/jxb/erp339; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1337, DOI 10.1094/MPMI-19-1337; Meijer HJG, 2005, GENE, V350, P173, DOI 10.1016/j.gene.2005.02.012; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Pleskot R, 2010, PLANT J, V62, P494, DOI 10.1111/j.1365-313X.2010.04168.x; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zambonelli C, 2005, PROG NUCLEIC ACID RE, V79, P133, DOI 10.1016/S0079-6603(04)79003-0	16	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17767	10.1371/journal.pone.0017767	http://dx.doi.org/10.1371/journal.pone.0017767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423760	Green Submitted, Green Published, gold			2022-12-25	WOS:000288512400026
J	Chen, JM; Guan, RZ; Chang, SX; Du, TQ; Zhang, HS; Xing, H				Chen, Jianmei; Guan, Rongzhan; Chang, Shengxin; Du, Tongqing; Zhang, Hongsheng; Xing, Han			Substoichiometrically Different Mitotypes Coexist in Mitochondrial Genomes of Brassica napus L	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CYTOPLASMIC MALE-STERILITY; ARABIDOPSIS-THALIANA; DNA; GENES; HETEROPLASMY; EVOLUTION; REVERSION; FERTILE; HYBRIDS	Cytoplasmic male sterility (CMS) has been identified in numerous plant species. Brassica napus CMS plants, such as Polima (pol), MI, and Shaan 2A, have been identified independently by different researchers with different materials in conventional breeding processes. How this kind of CMS emerges is unclear. Here, we report the mitochondrial genome sequence of the prevalent mitotype in the most widely used pol-CMS line, which has a length of 223,412 bp and encodes 34 proteins, 3 ribosomal RNAs, and 18 tRNAs, including two near identical copies of trnH. Of these 55 genes, 48 were found to be identical to their equivalents in the "nap" cytoplasm. The nap mitotype carries only one copy of trnH, and the sequences of five of the six remaining genes are highly similar to their equivalents in the pol mitotype. Forty-four open reading frames (ORFs) with unknown function were detected, including two unique to the pol mitotype (orf122 and orf132). At least five rearrangement events are required to account for the structural differences between the pol and nap sequences. The CMS-related orf224 neighboring region (similar to 5 kb) rearranged twice. PCR profiling based on mitotype-specific primer pairs showed that both mitotypes are present in B. napus cultivars. Quantitative PCR showed that the pol cytoplasm consists mainly of the pol mitotype, and the nap mitotype is the main genome of nap cytoplasm. Large variation in the copy number ratio of mitotypes was found, even among cultivars sharing the same cytoplasm. The coexistence of mitochondrial mitotypes and substoichiometric shifting can explain the emergence of CMS in B. napus.	[Chen, Jianmei; Guan, Rongzhan; Chang, Shengxin; Du, Tongqing; Zhang, Hongsheng; Xing, Han] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China	Nanjing Agricultural University	Chen, JM (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China.	rapeseed@njau.edu.cn; rapeseed@njau.edu.cn		Guan, Rongzhan/0000-0001-9177-6610	National Basic Research Program of China (973 Program) [2011CB109300]; National Natural Science Foundation of China [30970289]; National Key Technology R&D Program in China [2010BAD01B02]; Ministry of Agriculture of China for Transgenic Research [2009ZX08009-040B]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in China(National Key Technology R&D Program); Ministry of Agriculture of China for Transgenic Research	This work was supported by the National Basic Research Program of China (973 Program) (2011CB109300); National Natural Science Foundation of China (30970289); National Key Technology R&D Program (2010BAD01B02) in China; and the Ministry of Agriculture of China for Transgenic Research (2009ZX08009-040B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Arrieta-Montiel M, 2001, GENETICS, V158, P851; Bellaoui M, 1998, MOL GEN GENET, V257, P177, DOI 10.1007/s004380050637; BLAND MM, 1985, THEOR APPL GENET, V69, P535, DOI 10.1007/BF00251100; Carlsson J, 2008, MITOCHONDRION, V8, P74, DOI 10.1016/j.mito.2007.09.006; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; FU S, 1989, Acta Agronomica Sinica, V15, P305; Fu T. D., 1981, Cruciferae Newsletter, P6; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hattori N, 2002, GENETICS, V160, P1619; HE SC, 1996, P NATL ACAD SCI USA, V93, P1176; Janska H, 1998, PLANT CELL, V10, P1163, DOI 10.1105/tpc.10.7.1163; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; LHOMME Y, 1993, NUCLEIC ACIDS RES, V21, P1903, DOI 10.1093/nar/21.8.1903; Li D.R., 1980, SHAANXI J AGR SCI, V1, P26; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Scotti N, 2004, CURR GENET, V45, P378, DOI 10.1007/s00294-004-0496-6; Shiga T., 1973, JPN J BREED, V23, P187, DOI DOI 10.1270/JSBBS1951.23.187; Shiga T., 1971, JAPANESE J BREED, V21, P16; SINGH M, 1991, PLANT CELL, V3, P1349, DOI 10.1105/tpc.3.12.1349; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON KF, 1972, HEREDITY, V29, P253, DOI 10.1038/hdy.1972.89; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Yang GuangSheng, 1998, Scientia Agricultura Sinica, V31, P27	40	78	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17662	10.1371/journal.pone.0017662	http://dx.doi.org/10.1371/journal.pone.0017662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423700	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100022
J	Martins-Silva, C; De Jaeger, X; Guzman, MS; Lima, RDF; Santos, MS; Kushmerick, C; Gomez, MV; Caron, MG; Prado, MAM; Prado, VF				Martins-Silva, Cristina; De Jaeger, Xavier; Guzman, Monica S.; Lima, Ricardo D. F.; Santos, Magda S.; Kushmerick, Christopher; Gomez, Marcus V.; Caron, Marc G.; Prado, Marco A. M.; Prado, Vania F.			Novel Strains of Mice Deficient for the Vesicular Acetylcholine Transporter: Insights on Transcriptional Regulation and Control of Locomotor Behavior	PLOS ONE			English	Article							CHOLINERGIC GENE LOCUS; INDUCED HYPERACTIVITY; KNOCKOUT MICE; EXPRESSION; NEURONS; IDENTIFICATION; RECEPTORS; TARGETS; LACKING; MICROINJECTIONS	Defining the contribution of acetylcholine to specific behaviors has been challenging, mainly because of the difficulty in generating suitable animal models of cholinergic dysfunction. We have recently shown that, by targeting the vesicular acetylcholine transporter (VAChT) gene, it is possible to generate genetically modified mice with cholinergic deficiency. Here we describe novel VAChT mutant lines. VAChT gene is embedded within the first intron of the choline acetyltransferase (ChAT) gene, which provides a unique arrangement and regulation for these two genes. We generated a VAChT allele that is flanked by loxP sequences and carries the resistance cassette placed in a ChAT intronic region (FloxNeo allele). We show that mice with the FloxNeo allele exhibit differential VAChT expression in distinct neuronal populations. These mice show relatively intact VAChT expression in somatomotor cholinergic neurons, but pronounced decrease in other cholinergic neurons in the brain. VAChT mutant mice present preserved neuromuscular function, but altered brain cholinergic function and are hyperactive. Genetic removal of the resistance cassette rescues VAChT expression and the hyperactivity phenotype. These results suggest that release of ACh in the brain is normally required to "turn down" neuronal circuits controlling locomotion.	[Martins-Silva, Cristina; De Jaeger, Xavier; Guzman, Monica S.; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Mol Brain Res Grp, Dept Anat & Cell Biol, London, ON, Canada; [Martins-Silva, Cristina; De Jaeger, Xavier; Guzman, Monica S.; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [De Jaeger, Xavier; Santos, Magda S.; Gomez, Marcus V.] Univ Fed Minas Gerais, Sch Med, Program Mol Pharmacol, Belo Horizonte, MG, Brazil; [Lima, Ricardo D. F.; Kushmerick, Christopher] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Duke University	Martins-Silva, C (corresponding author), Univ Fed Espirito Santo, Dept Physiol, Vitoria, Espirito Santo, Spain.	mprado@robarts.ca; vprado@robarts.ca	de Freitas Lima, Ricardo/T-7825-2017; santos, magda s/J-4509-2015; Kushmerick, Christopher/G-3578-2012; Prado, Vania Ferreira/K-7630-2013; Gomez, Marcus Vinicius/I-4081-2012; Prado, Marco Antonio Maximo/K-7638-2013; Martins-Silva, Cristina/F-8053-2016; Lima, Ricardo/G-2946-2013	de Freitas Lima, Ricardo/0000-0003-0250-5945; santos, magda s/0000-0003-0626-3015; Prado, Vania Ferreira/0000-0003-4994-6393; Gomez, Marcus Vinicius/0000-0002-6082-930X; Prado, Marco Antonio Maximo/0000-0002-3028-5778; De Jaeger, Xavier/0000-0003-2511-5659	Canadian Institutes of Health Research (CIHR) [MOP-89919]; Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); University of Western Ontario; National Institutes of Health (NIH); CAPES (Brazil); CNPq; FAPEMIG (Brazil)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); University of Western Ontario; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (CIHR; MOP-89919; for V.F.P. & M.A.M.P), Canadian Foundation for Innovation (CFI), the Ontario Research Fund (ORF) and the University of Western Ontario (V.F.P. & M.A.M.P.). M.G.C. received support from the National Institutes of Health (NIH). X. De J. received a PhD fellowship from CAPES (Brazil). C.K. was funded by CNPq and FAPEMIG (Brazil). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1994, J MOL BIOL, V241, P627, DOI 10.1006/jmbi.1994.1538; Balla A, 2001, NEUROPSYCHOPHARMACOL, V25, P157, DOI 10.1016/S0893-133X(01)00230-5; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; BYMASTER FP, 1993, J PHARMACOL EXP THER, V267, P16; CERVINI R, 1995, J BIOL CHEM, V270, P24654, DOI 10.1074/jbc.270.42.24654; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gerber DJ, 2001, P NATL ACAD SCI USA, V98, P15312, DOI 10.1073/pnas.261583798; Gil-Bea FJ, 2007, BEHAV NEUROSCI, V121, P340, DOI 10.1037/0735-7044.121.2.340; Gomeza J, 2001, LIFE SCI, V68, P2457, DOI 10.1016/S0024-3205(01)01039-6; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Granon S, 2006, ACTA PAEDIATR, V95, P645, DOI 10.1080/08035250600719747; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Guidine PAM, 2008, NEUROSCI LETT, V436, P201, DOI 10.1016/j.neulet.2008.03.020; Harper DG, 2004, NEUROBIOL AGING, V25, P771, DOI 10.1016/j.neurobiolaging.2003.04.009; Harper DG, 2005, AM J GERIAT PSYCHIAT, V13, P359, DOI 10.1176/appi.ajgp.13.5.359; Kitamoto T, 1998, J BIOL CHEM, V273, P2706, DOI 10.1074/jbc.273.5.2706; KITAMOTO T, 1995, J NEUROBIOL, V28, P70, DOI 10.1002/neu.480280107; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lee MH, 2002, J NEUROSCI, V22, P5291; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; LONNERBERG P, 1995, P NATL ACAD SCI USA, V92, P4046, DOI 10.1073/pnas.92.9.4046; Lonnerberg P, 1996, J BIOL CHEM, V271, P33358, DOI 10.1074/jbc.271.52.33358; Mattsson A, 2005, NEUROREPORT, V16, P1815, DOI 10.1097/01.wnr.0000185018.29316.87; Maubourguet N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000229; Mehler-Wex C, 2006, NEUROTOX RES, V10, P167, DOI 10.1007/BF03033354; Misawa H, 2003, GENESIS, V37, P44, DOI 10.1002/gene.10224; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MOLINENGO L, 1989, PHARMACOL BIOCHEM BE, V32, P1075, DOI 10.1016/0091-3057(89)90085-3; MUSEO E, 1990, PHARMACOL BIOCHEM BE, V37, P113, DOI 10.1016/0091-3057(90)90050-R; MUSEO E, 1990, PHARMACOL BIOCHEM BE, V35, P735, DOI 10.1016/0091-3057(90)90316-A; Naciff JM, 1999, J NEUROCHEM, V72, P17, DOI 10.1046/j.1471-4159.1999.0720017.x; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Panagis G, 1996, BRAIN RES, V730, P133; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; REAVILL C, 1990, BRIT J PHARMACOL, V99, P273, DOI 10.1111/j.1476-5381.1990.tb14693.x; SALVATERRA PM, 1993, PROG BRAIN RES, V98, P167; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Scarr E, 2009, NEUROSIGNALS, V17, P298, DOI 10.1159/000231896; Schutz B, 2003, J NEUROCHEM, V87, P1174, DOI 10.1046/j.1471-4159.2003.02095.x; Schutz B, 2000, NEUROSCIENCE, V96, P707, DOI 10.1016/S0306-4522(99)00587-4; SHANNON HE, 1990, J PHARMACOL EXP THER, V255, P549; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; UKAI M, 1994, GEN PHARMACOL, V25, P433, DOI 10.1016/0306-3623(94)90193-7; VIANNA MR, BRAZ J MED BIOL RES, V34, P233; Weisman D, 2006, VITAM HORM, V74, P505, DOI 10.1016/S0083-6729(06)74020-1; Wess J, 2003, LIFE SCI, V72, P2047, DOI 10.1016/S0024-3205(03)00082-1; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; YASUYAMA K, 1995, CELL TISSUE RES, V282, P193, DOI 10.1007/BF00319111	60	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17611	10.1371/journal.pone.0017611	http://dx.doi.org/10.1371/journal.pone.0017611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423695	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100019
J	Kowalczuk, L; Touchard, E; Omri, S; Jonet, L; Klein, C; Valamanes, F; Berdugo, M; Bigey, P; Massin, P; Jeanny, JC; Behar-Cohen, F				Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Klein, Christophe; Valamanes, Fatemeh; Berdugo, Marianne; Bigey, Pascal; Massin, Pascale; Jeanny, Jean-Claude; Behar-Cohen, Francine			Placental Growth Factor Contributes to Micro-Vascular Abnormalization and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy	PLOS ONE			English	Article							FACTOR GENE-EXPRESSION; HIGH-AFFINITY BINDING; FACTOR-I; TUMOR-GROWTH; ANGIOGENESIS; VEGF; NEOVASCULARIZATION; PATHOGENESIS; HYPOXIA; PLGF	Objective: There are controversies regarding the pro-angiogenic activity of placental growth factor (PGF) in diabetic retinopathy (DR). For a better understanding of its role on the retina, we have evaluated the effect of a sustained PGF overexpression in rat ocular media, using ciliary muscle electrotransfer (ET) of a plasmid encoding rat PGF-1 (pVAX2-rPGF-1). Materials and Methods: pVAX2-rPGF-1 ET in the ciliary muscle (200 V/cm) was achieved in non diabetic and diabetic rat eyes. Control eyes received saline or naked plasmid ET. Clinical follow up was carried out over three months using slit lamp examination and fluorescein angiography. After the control of rPGF-1 expression, PGF-induced effects on retinal vasculature and on the blood-external barrier were evaluated respectively by lectin and occludin staining on flat-mounts. Ocular structures were visualized through histological analysis. Results: After fifteen days of rPGF-1 over-expression in normal eyes, tortuous and dilated capillaries were observed. At one month, microaneurysms and moderate vascular sprouts were detected in mid retinal periphery in vivo and on retinal flat-mounts. At later stages, retinal pigmented epithelial cells demonstrated morphological abnormalities and junction ruptures. In diabetic retinas, PGF expression rose between 2 and 5 months, and, one month after ET, rPGF-1 over-expression induced glial activation and proliferation. Conclusion: This is the first demonstration that sustained intraocular PGF production induces vascular and retinal changes similar to those observed in the early stages of diabetic retinopathy. PGF and its receptor Flt-1 may therefore be looked upon as a potential regulatory target at this stage of the disease.	[Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Valamanes, Fatemeh; Berdugo, Marianne; Jeanny, Jean-Claude; Behar-Cohen, Francine] INSERM U872, Paris, France; [Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Klein, Christophe; Valamanes, Fatemeh; Berdugo, Marianne; Jeanny, Jean-Claude; Behar-Cohen, Francine] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Klein, Christophe; Valamanes, Fatemeh; Berdugo, Marianne; Jeanny, Jean-Claude; Behar-Cohen, Francine] Univ Paris 05, UMR S 872, Paris, France; [Valamanes, Fatemeh] Fdn Adolphe De Rothschild, Paris, France; [Bigey, Pascal] INSERM U640, Paris, France; [Bigey, Pascal] CNRS UMR8151, Paris, France; [Bigey, Pascal] Univ Paris 05, Chem & Genet Pharmacol Lab, Fac Pharm, Paris, France; [Bigey, Pascal] Ecole Natl Super Chim Paris ENSCP Chim ParisTech, Paris, France; [Massin, Pascale] Univ Paris 07, Hop Lariboisiere, AP HP, Dept Ophthalmol, Paris, France; [Behar-Cohen, Francine] Hop Hotel Dieu, AP HP, F-75181 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Kowalczuk, L (corresponding author), INSERM U872, Paris, France.	francine.behar@gmail.com	Kowalczuk, Laura/AAF-6230-2020	klein, christophe/0000-0001-8015-287X; bigey, pascal/0000-0002-6795-8569; Kowalczuk, Laura/0000-0003-0268-9430; Omri, Samy/0000-0002-2054-8298	ANR Emergence	ANR Emergence(French National Research Agency (ANR))	The work was supported by ANR Emergence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Arevalo JF, 2008, BRIT J OPHTHALMOL, V92, P213, DOI 10.1136/bjo.2007.127142; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bloquel C, 2006, FASEB J, V20, P389, DOI 10.1096/fj.05-4737fje; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; Campochiaro PA, 2006, GENE THER, V13, P559, DOI 10.1038/sj.gt.3302653; Cao RH, 2010, P NATL ACAD SCI USA, V107, P856, DOI 10.1073/pnas.0911661107; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; El Sanharawi M, 2010, PROG RETIN EYE RES, V29, P443, DOI 10.1016/j.preteyeres.2010.04.001; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Feeney SA, 2003, INVEST OPHTH VIS SCI, V44, P839, DOI 10.1167/iovs.02-0040; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; FRANK RN, 2005, RETINA, P1241; GARNER A, 1993, EYE, V7, P250, DOI 10.1038/eye.1993.58; Gigante B, 2006, FASEB J, V20, P970, DOI 10.1096/fj.05-4481fje; Green CJ, 2001, CANCER RES, V61, P2696; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Jacob M, 2004, IEEE T PATTERN ANAL, V26, P1007, DOI 10.1109/TPAMI.2004.44; Khaliq A, 1998, LAB INVEST, V78, P109; Kowalczuk L, 2009, INVEST OPHTH VIS SCI, V50, P1761, DOI 10.1167/iovs.08-3027; Lebherz C, 2005, DIABETES, V54, P1141, DOI 10.2337/diabetes.54.4.1141; Lin YL, 2007, J LEUKOCYTE BIOL, V82, P1473, DOI 10.1189/jlb.0307164; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Mitamura Y, 2002, DIABETES CARE, V25, P2352, DOI 10.2337/diacare.25.12.2352; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Odorisio T, 2002, J CELL SCI, V115, P2559; Paques M, 2006, VISION RES, V46, P1336, DOI 10.1016/j.visres.2005.09.037; PARK JE, 1994, J BIOL CHEM, V269, P25646; Parravano M, 2009, COCHRANE DB SYST REV, V4; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rakoczy PE, 2003, DIABETES, V52, P857, DOI 10.2337/diabetes.52.3.857; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Shen WY, 2006, DIABETOLOGIA, V49, P1690, DOI 10.1007/s00125-006-0274-8; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Spirin KS, 1999, CURR EYE RES, V18, P490, DOI 10.1076/ceyr.18.6.490.5267; Torry RJ, 2009, J HEART LUNG TRANSPL, V28, P183, DOI 10.1016/j.healun.2008.11.917; Touchard E, 2009, GENE THER, V16, P862, DOI 10.1038/gt.2009.43; TOUCHARD E, 2010, J GENE MED; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Viglietto G, 1996, ONCOGENE, V13, P577; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yonekura H, 1999, J BIOL CHEM, V274, P35172, DOI 10.1074/jbc.274.49.35172; Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289; Ziche M, 1997, LAB INVEST, V76, P517	56	56	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17462	10.1371/journal.pone.0017462	http://dx.doi.org/10.1371/journal.pone.0017462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408222	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800013
J	Robyr, D; Friedli, M; Gehrig, C; Arcangeli, M; Marin, M; Guipponi, M; Farinelli, L; Barde, I; Verp, S; Trono, D; Antonarakis, SE				Robyr, Daniel; Friedli, Marc; Gehrig, Corinne; Arcangeli, Melanie; Marin, Marilyn; Guipponi, Michel; Farinelli, Laurent; Barde, Isabelle; Verp, Sonia; Trono, Didier; Antonarakis, Stylianos E.			Chromosome Conformation Capture Uncovers Potential Genome-Wide Interactions between Human Conserved Non-Coding Sequences	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; IN-VIVO; EXPRESSION; ENHANCER; DISRUPTION; LIMB; DNA	Comparative analyses of various mammalian genomes have identified numerous conserved non-coding (CNC) DNA elements that display striking conservation among species, suggesting that they have maintained specific functions throughout evolution. CNC function remains poorly understood, although recent studies have identified a role in gene regulation. We hypothesized that the identification of genomic loci that interact physically with CNCs would provide information on their functions. We have used circular chromosome conformation capture (4C) to characterize interactions of 10 CNCs from human chromosome 21 in K562 cells. The data provide evidence that CNCs are capable of interacting with loci that are enriched for CNCs. The number of trans interactions varies among CNCs; some show interactions with many loci, while others interact with few. Some of the tested CNCs are capable of driving the expression of a reporter gene in the mouse embryo, and associate with the oligodendrocyte genes OLIG1 and OLIG2. Our results underscore the power of chromosome conformation capture for the identification of targets of functional DNA elements and raise the possibility that CNCs exert their functions by physical association with defined genomic regions enriched in CNCs. These CNC-CNC interactions may in part explain their stringent conservation as a group of regulatory sequences.	[Robyr, Daniel; Friedli, Marc; Gehrig, Corinne; Arcangeli, Melanie; Marin, Marilyn; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Robyr, Daniel; Friedli, Marc; Gehrig, Corinne; Arcangeli, Melanie; Marin, Marilyn; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Hosp Geneva, Geneva, Switzerland; [Farinelli, Laurent] FASTERIS SA, Plan Les Ouates, Switzerland; [Barde, Isabelle; Verp, Sonia; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Robyr, D (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Daniel.Robyr@unige.ch; Stylianos.Antonarakis@unige.ch	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	Lejeune Foundation; Swiss National Science Foundation; EU; European Research Council; NCCR Frontiers in Genetics	Lejeune Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); European Research Council(European Research Council (ERC)European Commission); NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Lejeune Foundation to DR, the Swiss National Science Foundation, the EU FP6 Integrated projects AnEUploidy, the European Research Council and the NCCR Frontiers in Genetics to SEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Attanasio C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r168; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chen CTL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003946; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	42	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17634	10.1371/journal.pone.0017634	http://dx.doi.org/10.1371/journal.pone.0017634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408183	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800029
J	Maingat, F; Halloran, B; Acharjee, S; van Marle, G; Church, D; Gill, MJ; Uwiera, RRE; Cohen, EA; Meddings, J; Madsen, K; Power, C				Maingat, Ferdinand; Halloran, Brendan; Acharjee, Shaona; van Marle, Guido; Church, Deirdre; Gill, M. John; Uwiera, Richard R. E.; Cohen, Eric A.; Meddings, Jon; Madsen, Karen; Power, Christopher			Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress	FASEB JOURNAL			English	Article						ER stress; HIV; FIV; gut; lentivirus; disease	IMMUNODEFICIENCY-VIRUS-INFECTION; UNFOLDED PROTEIN RESPONSE; LENTIVIRUS INFECTION; HIV-INFECTION; NEURONAL INJURY; INNATE IMMUNITY; FIV INFECTION; ACTIVATION; NEUROVIRULENCE; APOPTOSIS	Immunosuppressive lentivirus infections, including human, simian, and feline immunodeficiency viruses (HIV, SIV, and FIV, respectively), cause the acquired immunodeficiency syndrome (AIDS), frequently associated with AIDS enteropathy. Herein, we investigated the extent to which lentivirus infections affected mucosal integrity and intestinal permeability in conjunction with immune responses and activation of endoplasmic reticulum (ER) stress pathways. Duodenal biopsies from individuals with HIV/AIDS exhibited induction of IL-1 beta, CD3 epsilon, HLA-DRA, spliced XBP-1(Xbp-1s), and CHOP expression compared to uninfected persons (P < 0.05). Gut epithelial cells exposed to HIV-1 Vpr demonstrated elevated TNF-alpha, IL-1 beta, spliced Xbp-1s, and CHOP expression (P < 0.05) together with calcium activation and disruption of epithelial cell monolayer permeability. In addition to reduced blood CD4(+) T lymphocyte levels, viral loads in the gut and plasma were high in FIV-infected animals (P < 0.05). FIV-infected animals also exhibited a failure to gain weight and increased lactulose/mannitol ratios compared with uninfected animals (P < 0.05). Proinflammatory and ER stress gene expression were activated in the ileum of FIV-infected animals (P < 0.05), accompanied by intestinal epithelial damage with loss of epithelial cells and leukocyte infiltration of the lamina propria. Lentivirus infections cause gut inflammation and ensuing damage to intestinal epithelial cells, likely through induction of ER stress pathways, resulting in disruption of gut functional integrity.-Maingat, F., Halloran, B., Acharjee, S., van Marle, G., Church, D., Gill, M. J., Uwiera, R. R. E., Cohen, E. A., Meddings, J., Madsen, K., Power, C. Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress. FASEB J. 25, 2211-2220 (2011). www.fasebj.org	[Maingat, Ferdinand; Halloran, Brendan; Acharjee, Shaona; Meddings, Jon; Madsen, Karen; Power, Christopher] Univ Alberta, Dept Med, Heritage Med Res Ctr 6 11, Edmonton, AB T6G 2S2, Canada; [Uwiera, Richard R. E.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2S2, Canada; [van Marle, Guido; Gill, M. John; Power, Christopher] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Church, Deirdre] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol & Infect Dis, Montreal, PQ, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary; Universite de Montreal	Power, C (corresponding author), Univ Alberta, Dept Med, Heritage Med Res Ctr 6 11, Edmonton, AB T6G 2S2, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013; Madsen, Karen L/H-5898-2011; Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Gill, Michael John/0000-0002-8546-8790; Power, Christopher/0000-0002-5131-9711; van Marle, Guido/0000-0002-5148-6229	Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; U.S. National Institutes of Health (National Institute for Mental Health)	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health (National Institute for Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Naomi Hotte, Claire Arrieta, and Amber Paul for their technical assistance and the staff in the University of Alberta Health Sciences Laboratory Animal Services for their support and assistance. E. A. C. and C. P. hold Canada Research Chairs (CRCs; tier 1) in Human Retrovirology and Neurological Infection and Immunity, respectively. C. P. holds an Alberta Heritage Foundation for Medical Research senior scholarship. These studies were supported by the Canadian Institutes of Health Research (C. P., K. M.) and the U.S. National Institutes of Health (National Institute for Mental Health; C. P.). None of the authors have commercial interests or activities related to the contents of the present manuscript.	Batman PA, 2007, AIDS, V21, P433, DOI 10.1097/QAD.0b013e3280142ee8; Boven LA, 2007, J NEUROVIROL, V13, P173, DOI 10.1080/13550280701258399; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c; Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO;2-3; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Elder JH, 2008, VET IMMUNOL IMMUNOP, V123, P3, DOI 10.1016/j.vetimm.2008.01.007; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gemeniano MC, 2004, VIROLOGY, V325, P167, DOI 10.1016/j.virol.2004.05.007; GILL MJ, 1992, AIDS, V6, P553, DOI 10.1097/00002030-199206000-00005; Ishihara T, 2010, BIOCHEM PHARMACOL, V79, P1622, DOI 10.1016/j.bcp.2010.01.030; Johnston JB, 2002, J NEUROVIROL, V8, P420, DOI 10.1080/13550280260422721; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kennedy JM, 2004, AIDS, V18, P1241, DOI 10.1097/00002030-200406180-00002; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Maingat F, 2010, J IMMUNOL, V184, P1566, DOI 10.4049/jimmunol.0902575; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Meddings JB, 1998, GASTROENTEROLOGY, V114, P83, DOI 10.1016/S0016-5085(98)70636-5; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Orandle MS, 2007, J VIROL, V81, P6265, DOI 10.1128/JVI.02671-06; Planelles V, 2009, CURR TOP MICROBIOL, V339, P177, DOI 10.1007/978-3-642-02175-6_9; Power C, 1998, J VIROL, V72, P9109, DOI 10.1128/JVI.72.11.9109-9115.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Shacklett BL, 2000, VIROLOGY, V270, P317, DOI 10.1006/viro.2000.0299; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Tsutsui S, 2008, FASEB J, V22, P786, DOI 10.1096/fj.07-9002com; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhu Y, 2005, J IMMUNOL, V175, P1118, DOI 10.4049/jimmunol.175.2.1118; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819; Zink MC, 2006, CURR HIV RES, V4, P293	35	34	35	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2211	2220		10.1096/fj.10-175992	http://dx.doi.org/10.1096/fj.10-175992			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21427211	Green Published			2022-12-25	WOS:000292242200013
J	El-Kereamy, A; El-Sharkawy, I; Ramamoorthy, R; Taheri, A; Errampalli, D; Kumar, P; Jayasankar, S				El-Kereamy, Ashraf; El-Sharkawy, Islam; Ramamoorthy, Rengasamy; Taheri, Ali; Errampalli, Deena; Kumar, Prakash; Jayasankar, Subramanian			Prunus domestica Pathogenesis-Related Protein-5 Activates the Defense Response Pathway and Enhances the Resistance to Fungal Infection	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEIN; PHYTOALEXIN-DEFICIENT MUTANTS; TRANSGENIC WHEAT PLANTS; ARABIDOPSIS-THALIANA; CAMALEXIN BIOSYNTHESIS; DISEASE RESISTANCE; ACCUMULATION; ANTIFUNGAL; EXPRESSION; GENES	Pathogenesis-related protein-5 (PR-5) has been implicated in plant disease resistance and its antifungal activity has been demonstrated in some fruit species. However, their roles, especially their interactions with the other defense responses in plant cells, are still not fully understood. In this study, we have cloned and characterized a new PR-5 cDNA named PdPR5-1 from the European plum (Prunus domestica). Expression of PdPR5-1 was studied in different cultivars varying in resistance to the brown rot disease caused by the necrotrophic fungus Monilinia fructicola. In addition transgenic Arabidopsis, ectopically expressing PdPR5-1 was used to study its role in other plant defense responses after fungal infection. We show that the resistant cultivars exhibited much higher levels of transcripts than the susceptible cultivars during fruit ripening. However, significant rise in the transcript levels after infection with M. fructicola was observed in the susceptible cultivars too. Transgenic Arabidopsis plants exhibited more resistance to Alternaria brassicicola. Further, there was a significant increase in the transcripts of genes involved in the phenylpropanoid biosynthesis pathway such as phenylalanine ammonia-lyase (PAL) and phytoalexin (camalexin) pathway leading to an increase in camalexin content after fungal infection. Our results show that PdPR5-1 gene, in addition to its anti-fungal properties, has a possible role in activating other defense pathways, including phytoalexin production.	[El-Kereamy, Ashraf; El-Sharkawy, Islam; Jayasankar, Subramanian] Univ Guelph, Dept Plant Agr, Vineland Stn, ON, Canada; [Ramamoorthy, Rengasamy; Kumar, Prakash] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Taheri, Ali] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Errampalli, Deena] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, Vineland Stn, ON, Canada	University of Guelph; National University of Singapore; University of Guelph; Agriculture & Agri Food Canada	El-Kereamy, A (corresponding author), Univ Guelph, Dept Plant Agr, Vineland Stn, ON, Canada.	jsubrama@uoguelph.ca	Ramamoorthy, Rengasamy/C-2656-2011; Ramamoorthy, Rengasamy/AAW-8518-2020; Ramamoorthy, Rengasamy/L-3982-2015; EL-KEREAMY, ASHRAF/GON-9302-2022; Kumar, Prakash P/A-6236-2009	Ramamoorthy, Rengasamy/0000-0003-1045-9109; Ramamoorthy, Rengasamy/0000-0003-1045-9109; Kumar, Prakash P/0000-0002-0963-1664; Taheri, Ali/0000-0002-4019-7982	Ministry of Research and Innovation; OMAFRA	Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); OMAFRA	These studies were funded by an ERA grant by Ministry of Research and Innovation and OMAFRA SP2 grant to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; Barre A, 2000, PLANTA, V211, P791, DOI 10.1007/s004250000354; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; BROWNE LM, 1991, TETRAHEDRON, V47, P3909, DOI 10.1016/S0040-4020(01)86431-0; Chen WP, 1999, THEOR APPL GENET, V99, P755, DOI 10.1007/s001220051294; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Denby KJ, 2005, PLANT J, V41, P673, DOI 10.1111/j.1365-313X.2005.02327.x; Dhekney SA, 2010, 12 WORLD C INT ASS P; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; El Oirdi M, 2010, ENVIRON MICROBIOL, V12, P239, DOI 10.1111/j.1462-2920.2009.02063.x; FilsLycaon BR, 1996, PLANT PHYSIOL, V111, P269, DOI 10.1104/pp.111.1.269; Fu DL, 2005, PLANT SCI, V168, P671, DOI 10.1016/j.plantsci.2004.09.032; Glawischnig E, 2006, BIOCHEM SOC T, V34, P1206, DOI 10.1042/BST0341206; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Glazebrook J, 1997, GENETICS, V146, P381; GUSTINE DL, 1978, PLANT PHYSIOL, V61, P226, DOI 10.1104/pp.61.2.226; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; He XZ, 2000, PLANT CELL, V12, P1689, DOI 10.1105/tpc.12.9.1689; Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930; Hu X, 1997, PLANT MOL BIOL, V34, P949, DOI 10.1023/A:1005893119263; HU X, 1995, PLANT PHYSIOL, V107, P305, DOI 10.1104/pp.107.1.305; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Jayasankar S, 2003, FUNCT PLANT BIOL, V30, P1105, DOI 10.1071/FP03066; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Koga J, 2006, PLANT PHYSIOL, V140, P1475, DOI 10.1104/pp.105.070334; Koiwa H, 1997, PLANT CELL PHYSIOL, V38, P783, DOI 10.1093/oxfordjournals.pcp.a029236; Koiwa H, 1999, J MOL BIOL, V286, P1137, DOI 10.1006/jmbi.1998.2540; Krebitz M, 2003, J MOL BIOL, V329, P721, DOI 10.1016/S0022-2836(03)00403-0; Ladyzhenskaia E P, 2006, Prikl Biokhim Mikrobiol, V42, P462; LAWTON MA, 1987, MOL CELL BIOL, V7, P335, DOI 10.1128/MCB.7.1.335; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Pedras MSC, 2006, PHYTOCHEMISTRY, V67, P1503, DOI 10.1016/j.phytochem.2006.05.020; Rowe HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000861; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Saunders JA, 2004, BIOCONTROL, V49, P715, DOI 10.1007/s10526-004-5281-4; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; SHOWALTER AM, 1985, P NATL ACAD SCI USA, V82, P6551, DOI 10.1073/pnas.82.19.6551; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; Velazhahan R., 2001, Acta Phytopathologica et Entomologica Hungarica, V36, P311, DOI 10.1556/APhyt.36.2001.3-4.12; VIGERS AJ, 1992, PLANT SCI, V83, P155, DOI 10.1016/0168-9452(92)90074-V; Wang HX, 2002, PHYTOCHEMISTRY, V61, P1, DOI 10.1016/S0031-9422(02)00144-9; WHITEHEAD IM, 1982, PLANTA, V154, P156, DOI 10.1007/BF00387910; Yun DJ, 1998, MOL CELL, V1, P807, DOI 10.1016/S1097-2765(00)80080-5; Zhao JM, 1998, PLANT CELL, V10, P359, DOI 10.1105/tpc.10.3.359; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	60	62	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17973	10.1371/journal.pone.0017973	http://dx.doi.org/10.1371/journal.pone.0017973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448276	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500025
J	Espeseth, AS; Fishel, R; Hazuda, D; Huang, QA; Xu, M; Yoder, K; Zhou, HL				Espeseth, Amy S.; Fishel, Rick; Hazuda, Daria; Huang, Qian; Xu, Min; Yoder, Kristine; Zhou, Honglin			siRNA Screening of a Targeted Library of DNA Repair Factors in HIV Infection Reveals a Role for Base Excision Repair in HIV Integration	PLOS ONE			English	Article							RETROVIRAL DNA; T-CELLS; VIRUS; REPLICATION; PROTEINS; IDENTIFICATION; ACCUMULATION; TRANSDUCTION; POLYMERASE; MECHANISMS	Host DNA repair enzymes have long been assumed to play a role in HIV replication, and many different DNA repair factors have been associated with HIV. In order to identify DNA repair pathways required for HIV infection, we conducted a targeted siRNA screen using 232 siRNA pools for genes associated with DNA repair. Mapping the genes targeted by effective siRNA pools to well-defined DNA repair pathways revealed that many of the siRNAs targeting enzymes associated with the short patch base excision repair (BER) pathway reduced HIV infection. For six siRNA pools targeting BER enzymes, the negative effect of mRNA knockdown was rescued by expression of the corresponding cDNA, validating the importance of the gene in HIV replication. Additionally, mouse embryo fibroblasts (MEFs) lacking expression of specific BER enzymes had decreased transduction by HIV-based retroviral vectors. Examining the role BER enzymes play in HIV infection suggests a role for the BER pathway in HIV integration.	[Espeseth, Amy S.; Hazuda, Daria; Huang, Qian; Xu, Min; Zhou, Honglin] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA; [Fishel, Rick; Yoder, Kristine] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Merck & Company; University System of Ohio; Ohio State University	Espeseth, AS (corresponding author), Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA.	Amy.Espeseth@merck.com; Daria.Hazuda@merck.com	Yoder, Kristine/E-4353-2011	Yoder, Kristine/0000-0002-5598-9018	National Institutes of Health [AI82422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KY and RF are supported by National Institutes of Health grant AI82422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; Aukrust P, 2005, BLOOD, V105, P4730, DOI 10.1182/blood-2004-11-4272; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Daniel R, 2005, J VIROL, V79, P2058, DOI 10.1128/JVI.79.4.2058-2065.2005; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Imai K, 2005, J BIOL CHEM, V280, P26701, DOI 10.1074/jbc.M503313200; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smith JA, 2006, ACS CHEM BIOL, V1, P217, DOI 10.1021/cb600131q; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 2001, AIDS, V15, P433, DOI 10.1097/00002030-200103090-00001; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Waninger S, 2004, J VIROL, V78, P12829, DOI 10.1128/JVI.78.23.12829-12837.2004; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; YODER K, 2010, PLOS ONE IN PRESS; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	38	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17612	10.1371/journal.pone.0017612	http://dx.doi.org/10.1371/journal.pone.0017612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448273	gold, Green Published, Green Submitted			2022-12-25	WOS:000288810500009
J	Gray, ER; Garson, JA; Breuer, J; Edwards, S; Kellam, P; Pillay, D; Towers, GJ				Gray, Eleanor R.; Garson, Jeremy A.; Breuer, Judith; Edwards, Simon; Kellam, Paul; Pillay, Deenan; Towers, Greg J.			No Evidence of XMRV or Related Retroviruses in a London HIV-1-Positive Patient Cohort	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; BLOOD-CELLS; MOUSE DNA; CONTAMINATION; PREVALENCE; SEQUENCES; TISSUE	Background: Several studies have implicated a recently discovered gammaretrovirus, XMRV (Xenotropic murine leukaemia virus-related virus), in chronic fatigue syndrome and prostate cancer, though whether as causative agent or opportunistic infection is unclear. It has also been suggested that the virus can be found circulating amongst the general population. The discovery has been controversial, with conflicting results from attempts to reproduce the original studies. Methodology/Principal Findings: We extracted peripheral blood DNA from a cohort of 540 HIV-1-positive patients (approximately 20% of whom have never been on anti-retroviral treatment) and determined the presence of XMRV and related viruses using TaqMan PCR. While we were able to amplify as few as 5 copies of positive control DNA, we did not find any positive samples in the patient cohort. Conclusions/Significance: In view of these negative findings in this highly susceptible group, we conclude that it is unlikely that XMRV or related viruses are circulating at a significant level, if at all, in HIV-1-positive patients in London or in the general population.	[Gray, Eleanor R.; Garson, Jeremy A.; Breuer, Judith; Kellam, Paul; Pillay, Deenan; Towers, Greg J.] UCL, Dept Infect & Immun, London, England; [Edwards, Simon] Camden Primary Care Trust, Mortimer Market Ctr, London, England; [Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England	University of London; University College London; Wellcome Trust Sanger Institute	Gray, ER (corresponding author), UCL, Dept Infect & Immun, London, England.	e.gray@ucl.ac.uk	Towers, Greg J/H-8892-2012; Garson, Jeremy A/C-5357-2008	Garson, Jeremy/0000-0003-0553-0126; Towers, Gregory/0000-0002-7707-0264; Kellam, Paul/0000-0003-3166-4734; Gray, Eleanor/0000-0002-6515-839X; Breuer, Judith/0000-0001-8246-0534	Department of Health's NIHR Biomedical Research Centres; Wellcome Trust [WT090940]; Medical Research Council; Medical Research Council [G0801172, G9721629] Funding Source: researchfish; MRC [G0801172, G9721629] Funding Source: UKRI	Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. Additional funding was provided by a Wellcome Trust Senior Fellowship WT090940 to GJT and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi SM, 2007, PAK J MED SCI, V23, P510; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Jeziorski E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-63; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Luczkowiak J, 2011, EMERG INFECT DIS, V17, P314, DOI 10.3201/eid1702.100978; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; Ngo-Giang-Huong N, 2010, INT J INFECT DIS, V14, pE602, DOI 10.1016/j.ijid.2009.09.002; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Quiros-Roldan E, 2003, INFECTION, V31, P172, DOI 10.1007/s15010-003-3122-5; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	32	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18096	10.1371/journal.pone.0018096	http://dx.doi.org/10.1371/journal.pone.0018096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448291	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500034
J	Meijer, K; de Vries, M; Al-Lahham, S; Bruinenberg, M; Weening, D; Dijkstra, M; Kloosterhuis, N; van der Leij, RJ; van der Want, H; Kroesen, BJ; Vonk, R; Rezaee, F				Meijer, Kees; de Vries, Marcel; Al-Lahham, Saad; Bruinenberg, Marcel; Weening, Desiree; Dijkstra, Martijn; Kloosterhuis, Niels; van der Leij, Roelof Jan; van der Want, Han; Kroesen, Bart-Jan; Vonk, Roel; Rezaee, Farhad			Human Primary Adipocytes Exhibit Immune Cell Function: Adipocytes Prime Inflammation Independent of Macrophages	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN; OBESITY; EXPRESSION; LEPTIN; GENES	Background: Obesity promotes inflammation in adipose tissue (AT) and this is implicated in pathophysiological complications such as insulin resistance, type 2 diabetes and cardiovascular disease. Although based on the classical hypothesis, necrotic AT adipocytes (ATA) in obese state activate AT macrophages (ATM) that then lead to a sustained chronic inflammation in AT, the link between human adipocytes and the source of inflammation in AT has not been in-depth and systematically studied. So we decided as a new hypothesis to investigate human primary adipocytes alone to see whether they are able to prime inflammation in AT. Methods and Results: Using mRNA expression, human preadipocytes and adipocytes express the cytokines/chemokines and their receptors, MHC II molecule genes and 14 acute phase reactants including C-reactive protein. Using multiplex ELISA revealed the expression of 50 cytokine/chemokine proteins by human adipocytes. Upon lipopolysaccharide stimulation, most of these adipocyte-associated cytokines/chemokines and immune cell modulating receptors were up-regulated and a few down-regulated such as (ICAM-1, VCAM-1, MCP-1, IP-10, IL-6, IL-8, TNF-alpha and TNF-beta highly up-regulated and IL-2, IL-7, IL-10, IL-13 and VEGF down-regulated. In migration assay, human adipocyte-derived chemokines attracted significantly more CD4+ T cells than controls and the number of migrated CD4+ cells was doubled after treating the adipocytes with LPS. Neutralizing MCP-1 effect produced by adipocytes reduced CD4+ migration by approximately 30%. Conclusion: Human adipocytes express many cytokines/chemokines that are biologically functional. They are able to induce inflammation and activate CD4+ cells independent of macrophages. This suggests that the primary event in the sequence leading to chronic inflammation in AT is metabolic dysfunction in adipocytes, followed by production of immunological mediators by these adipocytes, which is then exacerbated by activated ATM, activation and recruitment of immune cells. This study provides novel knowledge about the prime of inflammation in human obese adipose tissue, opening a new avenue of investigations towards obesity-associated type 2 diabetes.	[Meijer, Kees; de Vries, Marcel; Al-Lahham, Saad; Weening, Desiree; Dijkstra, Martijn; Kloosterhuis, Niels; Vonk, Roel; Rezaee, Farhad] Univ Groningen, Ctr Med Biom, Univ Med Ctr Groningen, Groningen, Netherlands; [Bruinenberg, Marcel] Univ Groningen, Dept Med Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [van der Leij, Roelof Jan; Kroesen, Bart-Jan] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [van der Want, Han] Univ Groningen, Ctr Imaging, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Meijer, K (corresponding author), Univ Groningen, Ctr Med Biom, Univ Med Ctr Groningen, Groningen, Netherlands.	f.rezaee@med.umcg.nl		Meijer, Kees/0000-0002-6430-0155	Netherlands Proteomic Centre [6.3]; TI Pharma [T2-105]	Netherlands Proteomic Centre; TI Pharma	This work was supported by the Netherlands Proteomic Centre (project 6.3.) and TI Pharma (T2-105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; BOYDEN SV, 1962, IMMUNOLOGY, V5, P370; Christensen P, 2005, THERIOGENOLOGY, V63, P992, DOI 10.1016/j.theriogenology.2004.05.026; Considine RV, 1996, CLIN CHEM, V42, P843; ECKEL RH, 1992, DIABETES, V41, P641, DOI 10.2337/diabetes.41.5.641; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sartipy P, 2003, J BIOL CHEM, V278, P52298, DOI 10.1074/jbc.M306922200; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Skurk T, 2005, EUR J ENDOCRINOL, V152, P863, DOI 10.1530/eje.1.01897; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Trayhurn P, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2007.00316.x; Tzanavari T, 2007, MOL CELL ENDOCRINOL, V279, P26, DOI 10.1016/j.mce.2007.08.015; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yeh ETH, 2001, CIRCULATION, V104, P974, DOI 10.1161/01.CIR.104.9.974	28	155	159	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17154	10.1371/journal.pone.0017154	http://dx.doi.org/10.1371/journal.pone.0017154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448265	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500002
J	Satoh, K; Shimizu, T; Kondoh, H; Hiraguri, A; Sasaya, T; Choi, IR; Omura, T; Kikuchi, S				Satoh, Kouji; Shimizu, Takumi; Kondoh, Hiroaki; Hiraguri, Akihiro; Sasaya, Takahide; Choi, Il-Ryong; Omura, Toshihiro; Kikuchi, Shoshi			Relationship between Symptoms and Gene Expression Induced by the Infection of Three Strains of Rice dwarf virus	PLOS ONE			English	Article							DEFENSE-RELATED GENES; NAC-DOMAIN PROTEIN; TRANSCRIPTION FACTOR; EVOLUTIONARY EXPANSION; SIGNALING PATHWAYS; SALICYLIC-ACID; MOSAIC-VIRUS; BIOSYNTHESIS; RESISTANCE; OVEREXPRESSION	Background: Rice dwarf virus (RDV) is the causal agent of rice dwarf disease, which often results in severe yield losses of rice in East Asian countries. The disease symptoms are stunted growth, chlorotic specks on leaves, and delayed and incomplete panicle exsertion. Three RDV strains, O, D84, and S, were reported. RDV-S causes the most severe symptoms, whereas RDV-O causes the mildest. Twenty amino acid substitutions were found in 10 of 12 virus proteins among three RDV strains. Methodology/Principal Findings: We analyzed the gene expression of rice in response to infection with the three RDV strains using a 60-mer oligonucleotide microarray to examine the relationship between symptom severity and gene responses. The number of differentially expressed genes (DEGs) upon the infection of RDV-O, -D84, and -S was 1985, 3782, and 6726, respectively, showing a correlation between the number of DEGs and symptom severity. Many DEGs were related to defense, stress response, and development and morphogenesis processes. For defense and stress response processes, gene silencing-related genes were activated by RDV infection and the degree of activation was similar among plants infected with the three RDV strains. Genes for hormone-regulated defense systems were also activated by RDV infection, and the degree of activation seemed to be correlated with the concentration of RDV in plants. Some development and morphogenesis processes were suppressed by RDV infection, but the degree of suppression was not correlated well with the RDV concentration. Conclusions/Significance: Gene responses to RDV infection were regulated differently depending on the gene groups regulated and the strains infecting. It seems that symptom severity is associated with the degree of gene response in defense-related and development- and morphogenesis-related processes. The titer levels of RDV in plants and the amino acid substitutions in RDV proteins could be involved in regulating such gene responses.	[Satoh, Kouji; Shimizu, Takumi; Hiraguri, Akihiro; Sasaya, Takahide; Omura, Toshihiro] Natl Agr Res Ctr, Res Team Vector Borne Plant Pathogens, Tsukuba, Ibaraki 305, Japan; [Satoh, Kouji; Kondoh, Hiroaki; Kikuchi, Shoshi] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan; [Choi, Il-Ryong] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Manila, Philippines	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan; CGIAR; International Rice Research Institute (IRRI)	Satoh, K (corresponding author), Natl Agr Res Ctr, Res Team Vector Borne Plant Pathogens, Tsukuba, Ibaraki 305, Japan.	skikuchi@nias.affrc.go.jp	Hiraguri, Akihiro/O-4584-2014		Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by the project grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The subject of each study is not selected by the funder but only reported to the funder annually. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko M, 2008, GENES GENET SYST, V83, P237, DOI 10.1266/ggs.83.237; Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397; Anand A, 2003, MOL PLANT MICROBE IN, V16, P916, DOI 10.1094/MPMI.2003.16.10.916; Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Cao XS, 2005, J VIROL, V79, P13018, DOI 10.1128/JVI.79.20.13018-13027.2005; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Dill A, 2001, GENETICS, V159, P777; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Fischer U, 2004, MOL PLANT MICROBE IN, V17, P1162, DOI 10.1094/MPMI.2004.17.10.1162; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hirsch S, 2009, PLANT SIGNAL BEHAV, V4, P698, DOI 10.4161/psb.4.8.9176; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jain M, 2006, GENOMICS, V88, P360, DOI 10.1016/j.ygeno.2006.04.008; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; KIMURA I, 1987, J GEN VIROL, V68, P3211, DOI 10.1099/0022-1317-68-12-3211; KIMURA I, 1968, ANN PHYTOPATHOL SOC, V28, P205; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Li Y, 2004, J VIROL, V78, P5382, DOI 10.1128/JVI.78.10.5382-5389.2004; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Love AJ, 2007, MOL PLANT MICROBE IN, V20, P659, DOI 10.1094/MPMI-20-6-0659; Mao CZ, 2007, NEW PHYTOL, V176, P288, DOI 10.1111/j.1469-8137.2007.02177.x; Margis-Pinheiro M, 2005, PLANT CELL REP, V23, P819, DOI 10.1007/s00299-004-0896-6; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; OMURA T, 2005, VIRUS TAXONOMY, P543; Park SH, 2007, PLANTA, V227, P1, DOI 10.1007/s00425-007-0576-1; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Selth LA, 2004, MOL PLANT MICROBE IN, V17, P27, DOI 10.1094/MPMI.2004.17.1.27; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Shigyo M, 2007, PLANT CELL PHYSIOL, V48, P179, DOI 10.1093/pcp/pcl044; Shikata M, 2009, PLANT CELL PHYSIOL, V50, P2133, DOI 10.1093/pcp/pcp148; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Stotz HU, 2009, PLANT MOL BIOL, V71, P131, DOI 10.1007/s11103-009-9512-z; Szilassy D, 1999, MOL PLANT MICROBE IN, V12, P1105, DOI 10.1094/MPMI.1999.12.12.1105; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; TAKAHASHI Y, 1991, PLANT DIS, V75, P458, DOI 10.1094/PD-75-0458; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang LP, 2009, CELL RES, V19, P598, DOI 10.1038/cr.2009.36; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	69	41	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18094	10.1371/journal.pone.0018094	http://dx.doi.org/10.1371/journal.pone.0018094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445363	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100031
J	Yue, Y; Gui, J; Ai, WQ; Xu, W; Xiong, SD				Yue, Yan; Gui, Jun; Ai, Wenqing; Xu, Wei; Xiong, Sidong			Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-Induced Myocarditis by Blunting Th1 Immune Responses	PLOS ONE			English	Article							COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; VIRAL MYOCARDITIS; IN-VIVO; DILATED CARDIOMYOPATHY; DENDRITIC CELLS; HEART-DISEASE; CHEMOKINE; MICE; EXPRESSION; B3	Background: Myocarditis is an inflammation of the myocardium that often follows the enterovirus infections, with coxsackievirus B3 (CVB3) being the most dominant etiologic agent. We and other groups previously reported that chemokine IP-10 was significantly induced in the heart tissue of CVB3-infected mice and contributed to the migration of massive inflammatory cells into the myocardium, which represents one of the most important mechanisms of viral myocarditis. To evaluate the direct effect of IP-10 on the inflammatory responses in CVB3 myocarditis, herein an IP-10 mutant deprived of chemo-attractant function was introduced into mice to antagonize the endogenous IP-10 activity, and its therapeutic effect on CVB3-induced myocarditis was evaluated. Methodology/Principal Findings: The depletion mutant pIP-10-AT, with an additional methionine after removal of the 5 N-terminal amino acids, was genetically constructed and intramuscularly injected into BALB/c mice after CVB3 infection. Compared with vector or no treatment, pIP-10-AT treatment had significantly reduced heart/body weight ratio and serum CK-MB level, increased survival rate and improved heart histopathology, suggesting an ameliorated myocarditis. This therapeutic effect was not attributable to an enhanced viral clearance, but to a blunted Th1 immune response, as evidenced by significantly decreased splenic CD4(+)/CD8(+)IFN-gamma(+) T cell percentages and reduced myocardial Th1 cytokine levels. Conclusion/Significance: Our findings constitute the first preclinical data indicating that interfering in vivo IP-10 activity could ameliorate CVB3 induced myocarditis. This strategy may represent as a new therapeutic approach in treating viral myocarditis.	[Yue, Yan; Xiong, Sidong] Soochow Univ, Inst Biol Sci, Lab Infect & Immun, Suzhou, Peoples R China; [Yue, Yan; Xiong, Sidong] Soochow Univ, Inst Med Sci, Lab Infect & Immun, Suzhou, Peoples R China; [Gui, Jun; Ai, Wenqing; Xu, Wei; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Soochow University - China; Soochow University - China; Fudan University	Yue, Y (corresponding author), Soochow Univ, Inst Biol Sci, Lab Infect & Immun, Suzhou, Peoples R China.	wx2362@hotmail.com; sdxiongfd@126.com			China NSFC [81072413]; Jiangsu "Pan-Deng" Project [BK2010004]; National Science & Technology Key Projects during the Eleventh Five-Year Plan Period of China [2009ZX10004-104]; Jiangsu High Level "Shuang-Chuang" Project, Major State Basic Research Development Program of China [2007CB512401]; Program for Outstanding Medical Academic Leader [LJ06011]	China NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu "Pan-Deng" Project; National Science & Technology Key Projects during the Eleventh Five-Year Plan Period of China; Jiangsu High Level "Shuang-Chuang" Project, Major State Basic Research Development Program of China(National Basic Research Program of China); Program for Outstanding Medical Academic Leader	This work was funded by China NSFC grant (81072413), Jiangsu "Pan-Deng" Project (BK2010004), the National Science & Technology Key Projects during the Eleventh Five-Year Plan Period of China (2009ZX10004-104), Jiangsu High Level "Shuang-Chuang" Project, Major State Basic Research Development Program of China (2007CB512401), Program for Outstanding Medical Academic Leader (LJ06011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 1998, J IMMUNOL, V161, P6413; Athanassopoulos P, 2006, CELL BIOCHEM BIOPHYS, V44, P83, DOI 10.1385/CBB:44:1:083; Bujak M, 2009, CIRC RES, V105, P973, DOI 10.1161/CIRCRESAHA.109.199471; Calabrese F, 2003, CARDIOVASC RES, V60, P11, DOI 10.1016/S0008-6363(03)00475-9; Chen P, 2009, INT IMMUNOPHARMACOL, V9, P1304, DOI 10.1016/j.intimp.2009.07.014; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Dixon AE, 2000, AM J PHYSIOL-LUNG C, V279, pL592, DOI 10.1152/ajplung.2000.279.3.L592; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Filippatos G, 2003, CURR MOL MED, V3, P139, DOI 10.2174/1566524033361546; Frangogiannis NG, 2004, CURR VASC PHARMACOL, V2, P163, DOI 10.2174/1570161043476375; Frisancho-Kiss S, 2009, BRAIN BEHAV IMMUN, V23, P649, DOI 10.1016/j.bbi.2008.12.002; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Hasegawa H, 2006, ARTHRITIS RHEUM-US, V54, P1174, DOI 10.1002/art.21745; Huber SA, 2002, J VIROL, V76, P10785, DOI 10.1128/JVI.76.21.10785-10790.2002; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Ikejima H, 2010, CIRC J, V74, P337, DOI 10.1253/circj.CJ-09-0484; Jiang Z, 2008, J GENE MED, V10, P918, DOI 10.1002/jgm.1215; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; LODGE PA, 1987, AM J PATHOL, V128, P455; Luo HH, 2010, CARDIOVASC RES, V85, P347, DOI 10.1093/cvr/cvp225; Maekawa Y, 2007, CIRCULATION, V115, P5, DOI 10.1161/CIRCULATIONAHA.106.670554; Maier Reinhard, 2004, Clin Dev Immunol, V11, P1, DOI 10.1080/10446670410001670427; Maisch BD, 2002, CARDIOVASC PATHOL, V11, P112, DOI 10.1016/S1054-8807(01)00113-2; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Seko Y, 1998, CIRC RES, V82, P613, DOI 10.1161/01.RES.82.5.613; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Shen Yan, 2003, Zhonghua Yi Xue Za Zhi, V83, P981; Shi Y, 2009, J AM COLL CARDIOL, V53, P1219, DOI 10.1016/j.jacc.2008.10.064; Singh Udai P, 2008, BMC Immunol, V9, P25, DOI 10.1186/1471-2172-9-25; Tam PE, 2006, VIRAL IMMUNOL, V19, P133, DOI 10.1089/vim.2006.19.133; Vasquez RE, 2006, INFECT IMMUN, V74, P6769, DOI 10.1128/IAI.01073-06; Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828; Wang P, 2010, CANCER IMMUNOL IMMUN, V59, P1715, DOI 10.1007/s00262-010-0901-6; Weinzierl AO, 2008, J VIROL, V82, P8149, DOI 10.1128/JVI.00047-08; Yang XL, 2006, J LEUKOCYTE BIOL, V80, P1434, DOI 10.1189/jlb.0306212; Yuan J, 2009, CIRC RES, V104, P628, DOI 10.1161/CIRCRESAHA.108.192179; Zhang HFM, 2005, MOL CELL BIOL, V25, P6247, DOI 10.1128/MCB.25.14.6247-6258.2005	40	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18186	10.1371/journal.pone.0018186	http://dx.doi.org/10.1371/journal.pone.0018186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445362	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100034
J	Lavallard, VJ; Bonnafous, S; Patouraux, S; Saint-Paul, MC; Rousseau, D; Anty, R; Le Marchand-Brustel, Y; Tran, A; Gual, P				Lavallard, Vanessa Jeannette; Bonnafous, Stephanie; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Rousseau, Deborah; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe			Serum Markers of Hepatocyte Death and Apoptosis Are Non Invasive Biomarkers of Severe Fibrosis in Patients with Alcoholic Liver Disease	PLOS ONE			English	Article							POLYPEPTIDE-SPECIFIC ANTIGEN; NONALCOHOLIC STEATOHEPATITIS; NONINVASIVE BIOMARKER; CELL APOPTOSIS; CYTOKERATIN-18; HEPATITIS; INJURY; EXPRESSION; NECROSIS; OBESITY	Background: Quantification of hepatotocyte death is useful to evaluate the progression of alcoholic liver diseases. Our aims were to quantify and correlate the circulating levels of Cytokeratin 18 (CK18) and its caspases-generated fragment to disease severity in heavy alcoholics. Methodology/Principal Findings: CK18 and CK18-fragment were evaluated in the serum of 143 heavy alcoholics. Serum levels of markers of hepatocyte death (CK18), apoptosis (CK18 fragment) and necrosis (CK18 -CK18 fragment) increased in patients with severe fibrosis compared to patients with mild fibrosis. These markers strongly correlated with Mallory-Denk bodies, hepatocyte ballooning, fibrosis and with hepatic TNF alpha and TGF beta assessed in the liver of 24 patients. Elevated levels of serum hepatocyte death and apoptotic markers were independent risk factors in predicting severe fibrosis in a model combining alkaline phosphatase, bilirubin, prothrombin index, hyaluronate, hepatocyte death and apoptotic markers. The level of markers of hepatocyte death and apoptosis had an area under the receiving operator curve that predicted severe fibrosis of 0.84 and 0.76, respectively. Conclusion/Significance: Death of hepatocytes can be easily evaluated with serum markers and correlated with severe fibrosis in heavy alcohol drinkers. These biomarkers could be useful to rapidly evaluate liver injuries and the efficacy of therapies.	[Lavallard, Vanessa Jeannette; Bonnafous, Stephanie; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Rousseau, Deborah; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Fac Med Nice, INSERM, Team 8, U895, F-06034 Nice, France; [Lavallard, Vanessa Jeannette; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Rousseau, Deborah; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Lavallard, Vanessa Jeannette; Bonnafous, Stephanie; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice, Digest Ctr, Ctr Hosp, Nice, France; [Patouraux, Stephanie; Saint-Paul, Marie-Christine] Univ Nice, Ctr Biol, Ctr Hosp, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Lavallard, VJ (corresponding author), Fac Med Nice, INSERM, Team 8, U895, U210, F-06034 Nice, France.	gual@unice.fr	Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; Albert, TRAN/0000-0003-0003-5361; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; Lavallard, Vanessa/0000-0001-7328-7549; patouraux, stephanie/0000-0001-6004-7685	Institut National de la Sante et de la Recherche Medicale (France); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough; Association pour la Recherche sur le Cancer (France); Fondation Recherche Medicale; Centre Hospitalier Universitaire of Nice	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough(Merck & CompanySchering Plough Corporation); Association pour la Recherche sur le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); Fondation Recherche Medicale; Centre Hospitalier Universitaire of Nice	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France), the University of Nice, the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice), and charities (Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough to PG). VJL was successively supported by the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice) and the Association pour la Recherche sur le Cancer ( France). SP was supported by the Fondation Recherche Medicale. YLMB and PG are the recipients of an Interface Grant from the Centre Hospitalier Universitaire of Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anty R, 2010, ALIMENT PHARM THER, V32, P1315, DOI 10.1111/j.1365-2036.2010.04480.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bechmann LP, 2010, J HEPATOL, V53, P639, DOI 10.1016/j.jhep.2010.04.029; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Diab DL, 2008, CLIN GASTROENTEROL H, V6, P1249, DOI 10.1016/j.cgh.2008.07.016; Feldstein AE, 2005, FRONT BIOSCI-LANDMRK, V10, P3093, DOI 10.2741/1765; Feldstein A, 2009, J CLIN GASTROENTEROL, V43, P374, DOI 10.1097/MCG.0b013e318178d91f; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Gonzalez-Quintela A, 2006, ALCOHOL, V38, P45, DOI 10.1016/j.alcohol.2006.01.003; Gonzalez-Quintela A, 2009, DIGEST DIS SCI, V54, P648, DOI 10.1007/s10620-008-0371-2; Gonzalez-Quintela A, 2006, LIVER INT, V26, P1217, DOI 10.1111/j.1478-3231.2006.01380.x; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Li XH, 2010, HEPATOLOGY, V51, P1865, DOI 10.1002/hep.23433; Linder S, 2004, CANCER LETT, V214, P1, DOI 10.1016/j.canlet.2004.06.032; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Natori S, 2001, J HEPATOL, V34, P248, DOI 10.1016/S0168-8278(00)00089-1; Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Orrego H, 1987, GASTROENTEROLOGY, V92, P208, DOI 10.1016/0016-5085(87)90861-4; Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Taieb J, 1998, LANCET, V351, P1930, DOI 10.1016/S0140-6736(05)78614-1; Volkmann X, 2006, HEPATOLOGY, V43, P1311, DOI 10.1002/hep.21186; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Yilmaz Y, 2009, ALIMENT PHARM THER, V30, P1103, DOI 10.1111/j.1365-2036.2009.04148.x; Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y	36	45	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17599	10.1371/journal.pone.0017599	http://dx.doi.org/10.1371/journal.pone.0017599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445263	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100018
J	Sun, LA; Hu, FB; Yu, ZJ; Li, HX; Liu, HY; Wang, XD; Yu, DX; Wu, HY; Zhang, G; Zong, G; Liu, Y; Lin, X				Sun, Liang; Hu, Frank B.; Yu, Zhijie; Li, Huaixing; Liu, Huaiyu; Wang, Xiangdong; Yu, Danxia; Wu, Hongyu; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu			Lean Body Mass, Interleukin 18, and Metabolic Syndrome in Apparently Healthy Chinese	PLOS ONE			English	Article							FAT-FREE MASS; INSULIN-RESISTANCE; CIRCULATING IL-18; WEIGHT-LOSS; OBESITY; EXPRESSION; CYTOKINE; RISK; ASSOCIATION; SENSITIVITY	Objective: We aimed to investigate how lean body mass is related to circulating Interleukin 18 (IL-18) and its association with metabolic syndrome (MetS) among apparently healthy Chinese. Methods: A population-based sample of 1059 Chinese men and women aged 35-54 years was used to measure plasma IL-18, glucose, insulin, lipid profile, inflammatory markers and high-molecular-weight (HMW)-adiponectin. Fat mass index (FMI) and lean mass index (LMI) were measured by dual-energy X-ray absorptiometry. MetS was defined by the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian-Americans. Results: Circulating IL-18 was positively correlated with LMI after adjustment for FMI (correlation coefficient = 0.11, P < 0.001). The association with the MetS (odds ratio 3.43, 95% confidence interval 2.01-5.85) was substantially higher in the highest than the lowest quartile of IL-18 after multiple adjustments including body mass index. In the stratified multivariable regression analyses, the positive association between IL-18 and MetS was independent of tertiles of FMI, inflammatory markers and HMW-adiponectin, but significantly interacted with tertile of LMI (P for interaction = 0.010). Conclusion: Elevated plasma IL-18 was associated with higher MetS prevalence in apparently healthy Chinese, independent of traditional risk factors, FMI, inflammatory markers and HMW-adiponectin. More studies are needed to clarify the role of lean mass in IL-18 secretion and its associated cardio-metabolic disorders.	[Sun, Liang; Yu, Zhijie; Li, Huaixing; Yu, Danxia; Wu, Hongyu; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Liang; Yu, Zhijie; Li, Huaixing; Yu, Danxia; Wu, Hongyu; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yu, Zhijie] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Shanghai, Peoples R China; [Liu, Huaiyu] Shanghai Luwan Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wang, Xiangdong] Shanghai Zhabei Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Sun, LA (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Zong, Geng/ABG-6946-2021; Wang, Xiangdong/AAF-9148-2020	Yu, Danxia/0000-0002-1710-9382	National Natural Science Foundation of China [30930081, 81021002]; Ministry of Science and Technology of China [2011CB504002, 2009AA022704, 2008DFA31960]; Chinese Academy of Sciences [KSCX2-EW-R-10]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]; Novo Nordisk A/S	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Novo Nordisk A/S(Novo Nordisk)	This study was supported by the National Natural Science Foundation of China (30930081 and 81021002), the Ministry of Science and Technology of China (2011CB504002, 2009AA022704 and 2008DFA31960), the Chinese Academy of Sciences (KSCX2-EW-R-10), the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006) and the Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Bosch M, 2005, DIABETOLOGIA, V48, P1841, DOI 10.1007/s00125-005-1859-3; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Evans J, 2007, EUR J ENDOCRINOL, V157, P633, DOI 10.1530/EJE-07-0463; Fain JN, 2006, METABOLISM, V55, P1113, DOI 10.1016/j.metabol.2006.04.008; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Herder C, 2006, DIABETES CARE, V29, P174, DOI 10.2337/diacare.29.1.174-a; Hivert MF, 2009, DIABETOLOGIA, V52, P2101, DOI 10.1007/s00125-009-1455-z; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kojima H, 1999, J IMMUNOL, V162, P5063; Krogh-Madsen R, 2006, AM J PHYSIOL-ENDOC M, V291, pE108, DOI 10.1152/ajpendo.00471.2005; Lepper PM, 2007, J AM COLL CARDIOL, V50, P25, DOI 10.1016/j.jacc.2007.02.070; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nistala Ravi, 2006, J Cardiometab Syndr, V1, P47, DOI 10.1111/j.0197-3118.2006.05455.x; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Skurk T, 2005, EUR J ENDOCRINOL, V152, P863, DOI 10.1530/eje.1.01897; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; You TJ, 2004, J CLIN ENDOCR METAB, V89, P5517, DOI 10.1210/jc.2004-0480; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P2043, DOI 10.1161/ATVBAHA.107.149484	30	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18104	10.1371/journal.pone.0018104	http://dx.doi.org/10.1371/journal.pone.0018104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437204	Green Published, Green Submitted, gold			2022-12-25	WOS:000288545100068
J	Rhea, CK; Silver, TA; Hong, SL; Ryu, JH; Studenka, BE; Hughes, CML; Haddad, JM				Rhea, Christopher K.; Silver, Tobin A.; Hong, S. Lee; Ryu, Joong Hyun; Studenka, Breanna E.; Hughes, Charmayne M. L.; Haddad, Jeffrey M.			Noise and Complexity in Human Postural Control: Interpreting the Different Estimations of Entropy	PLOS ONE			English	Article							OF-PRESSURE TRAJECTORIES; TIME-SERIES; APPROXIMATE ENTROPY; SAMPLE ENTROPY; DYNAMICS; QUANTIFICATION; PERFORMANCE	Background: Over the last two decades, various measures of entropy have been used to examine the complexity of human postural control. In general, entropy measures provide information regarding the health, stability and adaptability of the postural system that is not captured when using more traditional analytical techniques. The purpose of this study was to examine how noise, sampling frequency and time series length influence various measures of entropy when applied to human center of pressure (CoP) data, as well as in synthetic signals with known properties. Such a comparison is necessary to interpret data between and within studies that use different entropy measures, equipment, sampling frequencies or data collection durations. Methods and Findings: The complexity of synthetic signals with known properties and standing CoP data was calculated using Approximate Entropy (ApEn), Sample Entropy (SampEn) and Recurrence Quantification Analysis Entropy (RQAEn). All signals were examined at varying sampling frequencies and with varying amounts of added noise. Additionally, an increment time series of the original CoP data was examined to remove long-range correlations. Of the three measures examined, ApEn was the least robust to sampling frequency and noise manipulations. Additionally, increased noise led to an increase in SampEn, but a decrease in RQAEn. Thus, noise can yield inconsistent results between the various entropy measures. Finally, the differences between the entropy measures were minimized in the increment CoP data, suggesting that long-range correlations should be removed from CoP data prior to calculating entropy. Conclusions: The various algorithms typically used to quantify the complexity (entropy) of CoP may yield very different results, particularly when sampling frequency and noise are different. The results of this study are discussed within the context of the neural noise and loss of complexity hypotheses.	[Rhea, Christopher K.] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Silver, Tobin A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Ryu, Joong Hyun; Haddad, Jeffrey M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Studenka, Breanna E.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Hughes, Charmayne M. L.] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, Bielefeld, Germany; [Haddad, Jeffrey M.] Purdue Univ, Ctr Aging & Life Course, W Lafayette, IN 47907 USA	University of North Carolina; University of North Carolina Greensboro; University of Massachusetts System; University of Massachusetts Amherst; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bielefeld; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rhea, CK (corresponding author), Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA.	ckrhea@uncg.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	Department of Veterans Affairs Center for Restorative and Regenerative Medicine (RRD) [A3772C]; Purdue University College of Liberal Arts Research Incentive	Department of Veterans Affairs Center for Restorative and Regenerative Medicine (RRD); Purdue University College of Liberal Arts Research Incentive	Funding for this project was provided by Department of Veterans Affairs Center for Restorative and Regenerative Medicine (RR&D A3772C) and the Purdue University College of Liberal Arts Research Incentive Grant in the form of salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; BELTRAMI E, 1999, WHAT RANDOM CHANCE O; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Farmer SF, 1999, J PHYSIOL-LONDON, V517, P3, DOI 10.1111/j.1469-7793.1999.0003z.x; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Govindan RB, 2007, PHYSICA A, V376, P158, DOI 10.1016/j.physa.2006.10.077; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Ho KKL, 1997, CIRCULATION, V96, P842; Kelso S., 1995, DYNAMIC PATTERNS SEL; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Mazaheri M, 2010, MED ENG PHYS, V32, P808, DOI 10.1016/j.medengphy.2010.04.019; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Pellecchia G. L., 2005, TUTORIALS CONT NONLI, P95; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 1999, AM J PHYSIOL-ENDOC M, V277, pE948, DOI 10.1152/ajpendo.1999.277.5.E948; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROERDINK M, 2010, HUM MOVEMEN IN PRESS; ROSENSTEIN MT, 1994, PHYSICA D, V73, P82, DOI 10.1016/0167-2789(94)90226-7; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; West B, 2006, MED WENT WRONG REDIS; Yamada N, 1995, HUM MOVEMENT SCI, V14, P711, DOI 10.1016/0167-9457(95)00032-1	35	75	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17696	10.1371/journal.pone.0017696	http://dx.doi.org/10.1371/journal.pone.0017696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437281	Green Published, gold			2022-12-25	WOS:000288514600008
J	Tsai, PW; Yang, CY; Chang, HT; Lan, CY				Tsai, Pei-Wen; Yang, Cheng-Yao; Chang, Hao-Teng; Lan, Chung-Yu			Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates	PLOS ONE			English	Article							HUMAN CATHELICIDIN; BIOFILM FORMATION; MULTIPLE ROLES; BETA-DEFENSINS; ADHERENCE; ANALOGS; BINDING; IDENTIFICATION; COLONIZATION; MECHANISM	Candida albicans is the major fungal pathogen of humans. Fungal adhesion to host cells is the first step of mucosal infiltration. Antimicrobial peptides play important roles in the initial mucosal defense against C. albicans infection. LL-37 is the only member of the human cathelicidin family of antimicrobial peptides and is commonly expressed in various tissues and cells, including epithelial cells of both the oral cavity and urogenital tract. We found that, at sufficiently low concentrations that do not kill the fungus, LL-37 was still able to reduce C. albicans infectivity by inhibiting C. albicans adhesion to plastic surfaces, oral epidermoid OECM-1 cells, and urinary bladders of female BALB/c mice. Moreover, LL-37-treated C. albicans floating cells that did not adhere to the underlying substratum aggregated as a consequence of LL-37 bound to the cell surfaces. According to the results of a competition assay, the inhibitory effects of LL-37 on cell adhesion and aggregation were mediated by its preferential binding to mannan, the main component of the C. albicans cell wall, and partially by its ability to bind chitin or glucan, which underlie the mannan layer. Therefore, targeting of cell-wall carbohydrates by LL-37 provides a new strategy to prevent C. albicans infection, and LL-37 is a useful, new tool to screen for other C. albicans components involved in adhesion.	[Tsai, Pei-Wen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Yang, Cheng-Yao] Anim Technol Inst Taiwan, Div Anim Med, Miaoli, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, Ctr Inflammat Res, Taichung, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; National Tsing Hua University	Tsai, PW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	htchang@mail.cmu.edu.tw; cylan@life.nthu.edu.tw	Chang, Hao-Teng/O-2875-2015	Chang, Hao-Teng/0000-0001-8756-5220; Lan, Chung-Yu/0000-0002-1533-3049; Yang, Cheng-Yao/0000-0002-8694-9561	National Science Council (Taiwan) [NSC98-2627-B-007-015, NSC99-2627-B-007-007]; China Medical University (Taiwan) [CMU97-289, CMU98-N2-13]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); China Medical University (Taiwan)(China Medical University)	This work was supported by grants NSC98-2627-B-007-015 and NSC99-2627-B-007-007 (to CYL) from the National Science Council (Taiwan) and in part by CMU97-289 and CMU98-N2-13 (to HTC) from China Medical University (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Calderone RA., 2002, CANDIDA CANDIDIASIS; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Dietrich DE, 2008, INFECT IMMUN, V76, P5714, DOI 10.1128/IAI.00997-08; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harris M, 2009, MICROBIOL-SGM, V155, P1058, DOI 10.1099/mic.0.026120-0; Hell E, 2010, LETT APPL MICROBIOL, V50, P211, DOI 10.1111/j.1472-765X.2009.02778.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kauffman CA, 2005, CLIN INFECT DIS, V41, pS371, DOI 10.1086/430918; Kauffman Carol A, 2006, Proc Am Thorac Soc, V3, P35, DOI 10.1513/pats.200510-110JH; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LI RK, 1993, J BIOL CHEM, V268, P18293; Li YF, 2007, PROTEIN EXPRES PURIF, V54, P157, DOI 10.1016/j.pep.2007.02.003; Loit E, 2010, INT J ANTIMICROB AG, V35, P410, DOI 10.1016/j.ijantimicag.2009.12.003; MAISCH PA, 1981, INFECT IMMUN, V32, P92, DOI 10.1128/IAI.32.1.92-97.1981; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Odds FC, 1979, CANDIDA CANDIDOSIS; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; SHIBATA N, 1985, ARCH BIOCHEM BIOPHYS, V243, P338, DOI 10.1016/0003-9861(85)90511-9; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tseng MC, 2007, ANAL BIOCHEM, V371, P1, DOI 10.1016/j.ab.2007.08.035; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS369, DOI 10.1086/430917; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zaparozhets T. S., 2010, Biomeditsinskaya Khimiya, V56, P350; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	69	109	121	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17755	10.1371/journal.pone.0017755	http://dx.doi.org/10.1371/journal.pone.0017755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21448240	Green Submitted, Green Published, gold			2022-12-25	WOS:000288512400025
J	Ciavarra, G; Ho, AT; Cobrinik, D; Zacksenhaus, E				Ciavarra, Giovanni; Ho, Andrew T.; Cobrinik, David; Zacksenhaus, Eldad			Critical Role of the Rb Family in Myoblast Survival and Fusion	PLOS ONE			English	Article							RETINOBLASTOMA GENE FAMILY; CELL-CYCLE CONTROL; SKELETAL-MUSCLE; TUMOR-SUPPRESSOR; P107 PROTEINS; MICE LACKING; DIFFERENTIATION; PRB; BINDING; MOUSE	The tumor suppressor Rb is thought to control cell proliferation, survival and differentiation. We recently showed that differentiating Rb-deficient mouse myoblasts can fuse to form short myotubes that quickly collapse through a mechanism involving autophagy, and that autophagy inhibitors or hypoxia could rescue the defect leading to long, twitching myotubes. Here we determined the contribution of pRb relatives, p107 and p130, to this process. We show that chronic or acute inactivation of Rb plus p107 or p130 increased myoblast cell death and reduced myotube formation relative to Rb loss alone. Treatment with autophagy antagonists or hypoxia extended survival of double-knockout myotubes, which appeared indistinguishable from control fibers. In contrast, triple mutations in Rb, p107 and p130, led to substantial increase in myoblast death and to elongated bi-nuclear myocytes, which seem to derive from nuclear duplication, as opposed to cell fusion. Under hypoxia, some rare, abnormally thin triple knockout myotubes survived and twitched. Thus, mutation of p107 or p130 reduces survival of Rb-deficient myoblasts during differentiation but does not preclude myoblast fusion or necessitate myotube degeneration, whereas combined inactivation of the entire Rb family produces a distinct phenotype, with drastically impaired myoblast fusion and survival.	[Ciavarra, Giovanni; Ho, Andrew T.; Zacksenhaus, Eldad] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Cobrinik, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Zacksenhaus, Eldad] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada	University of Toronto; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Ciavarra, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	zacksenhaus@utoronto.ca	Zacksenhaus, Eldad/AAD-3584-2020; Ho, Andrew Tri Van/D-9681-2019	Ho, Andrew Tri Van/0000-0002-5501-6419	Canadian Institutes of Health Research [MOP-93674]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number: MOP-93674. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Berman SD, 2009, P NATL ACAD SCI USA, V106, P14932, DOI 10.1073/pnas.0902408106; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Bremner R, 2010, CANCER RES, V70, P6114, DOI 10.1158/0008-5472.CAN-10-0358; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Carnac G, 2000, CURR BIOL, V10, P543, DOI 10.1016/S0960-9822(00)00471-1; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; CIAVARRA G, 2010, J CELL BIOL IN PRESS; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Ho AT, 2004, EMBO J, V23, P460, DOI 10.1038/sj.emboj.7600039; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jiang Z, 2002, J CELL BIOL, V156, P185, DOI 10.1083/jcb.200106084; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Jiang Z, 2001, J BIOL CHEM, V276, P593, DOI 10.1074/jbc.M005474200; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MacLellan WR, 2000, MOL CELL BIOL, V20, P8903, DOI 10.1128/MCB.20.23.8903-8915.2000; Macleod K, 1999, CURR OPIN GENET DEV, V9, P31, DOI 10.1016/S0959-437X(99)80005-7; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Scime A, 2010, J CELL BIOL, V190, P651, DOI 10.1083/jcb.201005076; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wirt SE, 2010, J CELL BIOL, V191, P809, DOI 10.1083/jcb.201003048; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; ZHU LG, 1995, MOL CELL BIOL, V15, P3552	65	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17682	10.1371/journal.pone.0017682	http://dx.doi.org/10.1371/journal.pone.0017682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423694	gold, Green Submitted, Green Published			2022-12-25	WOS:000288219100025
J	Gouya, G; Sturm, G; Lamina, C; Zitt, E; Freistatter, O; Struck, J; Wolzt, M; Knoll, F; Lins, F; Lhotta, K; Neyer, U; Kronenberg, F				Gouya, Ghazaleh; Sturm, Gisela; Lamina, Claudia; Zitt, Emanuel; Freistaetter, Otto; Struck, Joachim; Wolzt, Michael; Knoll, Florian; Lins, Friederike; Lhotta, Karl; Neyer, Ulrich; Kronenberg, Florian			The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; REFLECTS CARDIAC DYSFUNCTION; HEMODIALYSIS-PATIENTS; MIDREGIONAL PROADRENOMEDULLIN; IMMUNOLUMINOMETRIC ASSAY; CARDIOVASCULAR-DISEASE; PLASMA-CONCENTRATION; FOLLOW-UP; A-TYPE; MARKERS	High levels of the plasma peptides mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) are associated with clinical outcomes in the general population. Data in patients with chronic kidney disease are sparse. We therefore investigated the association of MR-proANP and MR-proADM levels with all-cause and cardiovascular (CV) mortality, CV events and peripheral arterial disease in 201 incident dialysis patients of the INVOR-Study prospectively followed for a period of up to more than 7 years. The overall mortality rate was 43%, thereof 43% due to CV events. Both baseline MR-proANP and MR-proADM were associated with higher risk of all-cause (HR = 1.44, p = 0.001 and HR = 1.32, p = 0.002, respectively) and CV mortality (HR = 1.75, p < 0.001 and HR = 1.41, p = 0.007, respectively) after adjustment for age, sex, previous CV events, diabetes mellitus and time-dependent type of renal replacement therapy. We then stratified patients in high risk (both peptides in the upper tertile), intermediate risk (only one of the two peptides in the upper tertile) and low risk (none in the upper tertile). Although demographic, clinical and laboratory variables were similar among the intermediate and high risk group, to be with both parameters in the upper tertile was associated with a 3-fold higher risk for all-cause (HR = 2.87, p < 0.001) and CV mortality (HR = 3.58, p = 0.001). In summary, among incident dialysis patients MR-proANP and MR-proADM were shown to be associated with all-cause and CV mortality, with the highest risk when both parameters were in the upper tertiles.	[Gouya, Ghazaleh; Wolzt, Michael] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Sturm, Gisela; Lamina, Claudia; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Zitt, Emanuel; Knoll, Florian; Lhotta, Karl; Neyer, Ulrich] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Freistaetter, Otto; Lins, Friederike; Lhotta, Karl; Neyer, Ulrich] VIVIT, Feldkirch, Austria; [Struck, Joachim] BRAHMS GmbH, Res Dept, Hennigsdorf, Germany	Medical University of Vienna; Medical University of Innsbruck; Thermo Fisher Scientific; Brahms AG	Gouya, G (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.	Florian.Kronenberg@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Lamina, Claudia/F-7608-2010; Zitt, Emanuel/ABE-1926-2020	Kronenberg, Florian/0000-0003-2229-1120; Lamina, Claudia/0000-0002-5398-5806; Zitt, Emanuel/0000-0001-6944-6041; Wolzt, Michael/0000-0001-6049-1890; Knoll, Florian/0000-0001-5357-8656				Ala-Kopsala M, 2004, CLIN CHEM, V50, P1576, DOI 10.1373/clinchem.2004.032490; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Dieplinger B, 2009, KIDNEY INT, V75, P408, DOI 10.1038/ki.2008.560; Franz M, 2001, KIDNEY INT, V59, P1928, DOI 10.1046/j.1523-1755.2001.0590051928.x; Goto T, 2002, NEPHRON, V92, P610, DOI 10.1159/000064100; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Kronenberg F, 1999, J AM SOC NEPHROL, V10, P1027; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Kwan BCH, 2007, J AM SOC NEPHROL, V18, P1246, DOI 10.1681/ASN.2006091006; Lewis LK, 1998, CLIN CHEM, V44, P571; Lo CS, 2009, J CELL PHYSIOL, V219, P776, DOI 10.1002/jcp.21728; Maier C, 2009, DIABETES CARE, V32, P1890, DOI 10.2337/dc08-2168; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Meeran K, 1997, J CLIN ENDOCR METAB, V82, P95, DOI 10.1210/jc.82.1.95; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Moertl D, 2009, J AM COLL CARDIOL, V53, P1783, DOI 10.1016/j.jacc.2009.01.057; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Nakatani T, 2003, BLOOD PURIFICAT, V21, P395, DOI 10.1159/000073442; Nishikimi T, 2007, CURR MED CHEM, V14, P1689, DOI 10.2174/092986707780830943; Odar-Cederlof I, 2003, ASAIO J, V49, P74, DOI 10.1097/01.MAT.0000044738.93079.F0; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Rutten JHW, 2006, PERITON DIALYSIS INT, V26, P598; Schwaiger JP, 2006, KIDNEY INT, V70, P543, DOI 10.1038/sj.ki.5001589; Schwaiger JP, 2006, AM J KIDNEY DIS, V47, P888, DOI 10.1053/j.ajkd.2006.01.011; Sturm G, 2010, NEPHROL DIAL TRANSPL, V25, P2715, DOI 10.1093/ndt/gfq101; Yoshihara F, 2005, KIDNEY INT, V68, P1355, DOI 10.1111/j.1523-1755.2005.00534.x; Yoshihara F, 2007, NEPHROL DIAL TRANSPL, V22, P2263, DOI 10.1093/ndt/gfm029; Zoccali C, 2001, J AM SOC NEPHROL, V12, P1508, DOI 10.1681/ASN.V1271508	30	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17803	10.1371/journal.pone.0017803	http://dx.doi.org/10.1371/journal.pone.0017803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408188	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800041
J	Zhang, JS; Koenig, A; Harrison, A; Ugolkov, AV; Fernandez-Zapico, ME; Couch, FJ; Billadeau, DD				Zhang, J-S; Koenig, A.; Harrison, A.; Ugolkov, A. V.; Fernandez-Zapico, M. E.; Couch, F. J.; Billadeau, D. D.			Mutant K-Ras increases GSK-3 beta gene expression via an ETS-p300 transcriptional complex in pancreatic cancer	ONCOGENE			English	Article						GSK-3 beta; K-Ras; MAPK; ETS; pancreatic cancer	GLYCOGEN-SYNTHASE KINASE-3-BETA; FACTOR-KAPPA-B; PROSTATE-CANCER; SIGNALING PATHWAYS; COLORECTAL-CANCER; BINDING-PROTEIN; CELL-SURVIVAL; C-MYC; ETS-1; FAMILY	Glycogen synthase kinase-3 beta (GSK-3 beta) is overexpressed in a number of human malignancies and has been shown to contribute to tumor cell proliferation and survival. Although regulation of GSK-3 beta activity has been extensively studied, the mechanisms governing GSK-3 beta gene expression are still unknown. Using pancreatic cancer as a model, we find that constitutively active Ras signaling increases GSK-3 beta gene expression via the canonical mitogen-activated protein kinase signaling pathway. Analysis of the mechanism revealed that K-Ras regulates the expression of this kinase through two highly conserved E-twenty six (ETS) binding elements within the proximal region. Furthermore, we demonstrate that mutant K-Ras enhances ETS2 loading onto the promoter, and ETS requires its transcriptional activity to increase GSK-3 beta gene transcription in pancreatic cancer cells. Lastly, we show that ETS2 cooperates with p300 histone acetyltransferase to remodel chromatin and promote GSK-3 beta expression. Taken together, these results provide a general mechanism for increased expression of GSK-3 beta in pancreatic cancer and perhaps other cancers, where Ras signaling is deregulated. Oncogene (2011) 30, 3705-3715; doi:10.1038/onc.2011.90; published online 28 March 2011	[Zhang, J-S; Koenig, A.; Harrison, A.; Ugolkov, A. V.; Fernandez-Zapico, M. E.; Billadeau, D. D.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Coll Med, Rochester, MN 55905 USA; [Zhang, J-S; Koenig, A.; Harrison, A.; Ugolkov, A. V.; Fernandez-Zapico, M. E.; Billadeau, D. D.] Mayo Clin, Dept Immunol, Schulze Ctr Novel Therapeut, Coll Med, Rochester, MN 55905 USA; [Koenig, A.] Univ Marburg, Dept Gastroenterol & Endocrinol, Marburg, Germany; [Couch, F. J.] Mayo Clin, Div Expt Pathol & Lab Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Philipps University Marburg; Mayo Clinic	Zhang, JS (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	zhang.jinsan@mayo.edu; billadeau.daniel@mayo.edu	Ugolkov, Andrey/T-3012-2019; Harrison, Andrew M./I-3708-2013	Harrison, Andrew M./0000-0003-0063-9421	Mayo Clinic Pancreatic Cancer SPORE [CA102701]; German Cancer Society; NATIONAL CANCER INSTITUTE [P20CA102701, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	Mayo Clinic Pancreatic Cancer SPORE; German Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Mayo Clinic Pancreatic Cancer SPORE grant CA102701 (DDB and MEF-Z). DDB is a Leukemia and Lymphoma Scholar. AK is supported by a Mildred-Scheel fellowship of German Cancer Society.	Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Billadeau DD, 2007, PANCREATOLOGY, V7, P398, DOI 10.1159/000108955; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Deramaudt T, 2005, BBA-REV CANCER, V1756, P97, DOI 10.1016/j.bbcan.2005.08.003; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fauquette V, 2005, BIOCHEM J, V386, P35, DOI 10.1042/BJ20040706; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Ito T, 1998, MODERN PATHOL, V11, P209; Ito Y, 2002, ONCOL REP, V9, P853; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Jedlicka P, 2008, HISTOL HISTOPATHOL, V23, P1417, DOI 10.14670/HH-23.1417; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kobberup S, 2007, DEV DYNAM, V236, P3100, DOI 10.1002/dvdy.21292; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Lau KF, 1999, GENOMICS, V60, P121, DOI 10.1006/geno.1999.5875; Lefter LP, 2009, CANCER GENE THER, V16, P137, DOI 10.1038/cgt.2008.65; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Li R, 2009, ANTICANCER RES, V29, P2077; Li YY, 2009, CANCER SCI, V100, P396, DOI 10.1111/j.1349-7006.2008.01059.x; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Maitra A, 2006, BEST PRACT RES CL GA, V20, P211, DOI 10.1016/j.bpg.2005.10.002; Narod SA, 2008, BRIT J CANCER, V99, P847, DOI 10.1038/sj.bjc.6604558; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Polakis P, 2000, GENE DEV, V14, P1837; Rowley M, 2011, GASTROENTEROLOGY; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	47	51	52	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	34					3705	3715		10.1038/onc.2011.90	http://dx.doi.org/10.1038/onc.2011.90			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21441955	Green Accepted			2022-12-25	WOS:000294244500006
J	Potez, S; Luginbul, M; Monastyrskaya, K; Hostettler, A; Draeger, A; Babiychuk, EB				Potez, Sarah; Luginbuehl, Miriam; Monastyrskaya, Katia; Hostettler, Andrea; Draeger, Annette; Babiychuk, Eduard B.			Tailored Protection against Plasmalemmal Injury by Annexins with Different Ca2+ Sensitivities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE REPAIR; INWARD VESICULATION; LIPID MICRODOMAINS; STREPTOLYSIN-O; LIVING CELLS; A1; DYNAMICS; FAMILY; ENDOCYTOSIS; EXOCYTOSIS	The annexins, a family of Ca2+- and lipid-binding proteins, are involved in a range of intracellular processes. Recent findings have implicated annexin A1 in the resealing of plasmalemmal injuries. Here, we demonstrate that another member of the annexin protein family, annexin A6, is also involved in the repair of plasmalemmal lesions induced by a bacterial pore-forming toxin, streptolysin O. An injury-induced elevation in the intracellular concentration of Ca2+ ([Ca2+](i)) triggers plasmalemmal repair. The highly Ca2+-sensitive annexin A6 responds faster than annexin A1 to [Ca2+](i) elevation. Correspondingly, a limited plasmalemmal injury can be promptly countered by annexin A6 even without the participation of annexin A1. However, its high Ca2+ sensitivity makes annexin A6 highly amenable to an unproductive binding to the uninjured plasmalemma; during an extensive injury accompanied by a massive elevation in [Ca2+](i), its active pool is severely depleted. In contrast, annexin A1 with a much lower Ca2+ sensitivity is ineffective at the early stages of injury; however, it remains available for the repair even at high [Ca2+](i). Our findings highlight the role of the annexins in the process of plasmalemmal repair; a number of annexins with different Ca2+-sensitivities provide a cell with the means to react promptly to a limited injury in its early stages and, at the same time, to withstand a sustained injury accompanied by the continuous formation of plasmalemmal lesions.	[Potez, Sarah; Luginbuehl, Miriam; Monastyrskaya, Katia; Hostettler, Andrea; Draeger, Annette; Babiychuk, Eduard B.] Univ Bern, Inst Anat, Dept Cell Biol, CH-3012 Bern, Switzerland	University of Bern	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, Baltzerstr 2, CH-3012 Bern, Switzerland.	edik@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021	Monastyrskaya, Katia/0000-0003-2042-1139; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [3100A0-121980/1, 320030_128064/1]; National Research Programme [NRP 53, 405340-104679/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Programme	This work was supported by Swiss National Science Foundation Grants 3100A0-121980/1 (to E. B. B.) and 320030_128064/1 (to A. D.) and the National Research Programme Grant NRP 53 "Musculoskeletal Health-Chronic Pain" 405340-104679/1 (to A. D.).	Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Buckingham JC, 1997, MOL MED TODAY, V3, P296, DOI 10.1016/S1357-4310(97)88908-3; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; John CD, 2008, CURR OPIN PHARMACOL, V8, P765, DOI 10.1016/j.coph.2008.09.005; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; MORGAN BP, 1986, CELL CALCIUM, V7, P399, DOI 10.1016/0143-4160(86)90042-4; Morgan RO, 1997, CELL MOL LIFE SCI, V53, P508, DOI 10.1007/s000180050064; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Skrahina T, 2008, EXP CELL RES, V314, P1039, DOI 10.1016/j.yexcr.2007.11.015; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759	32	76	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17982	17991		10.1074/jbc.M110.187625	http://dx.doi.org/10.1074/jbc.M110.187625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454475	Green Published, hybrid			2022-12-25	WOS:000290585200060
J	Cordes, CM; Bennett, RG; Siford, GL; Hamel, FG				Cordes, Crystal M.; Bennett, Robert G.; Siford, Gerri L.; Hamel, Frederick G.			Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHIC ANALYSIS; PROTEIN S-NITROSYLATION; NITRIC-OXIDE; ALZHEIMERS-DISEASE; CHROMOSOME 10Q; NITROSOGLUTATHIONE; GLUTATHIONE; SUSCEPTIBILITY; POLYMORPHISMS; PRODUCTS	Insulin-degrading enzyme (IDE) is a thiol sensitive peptidase that degrades insulin and amyloid beta, and has been linked to type 2 diabetes mellitus and Alzheimer's disease. We examined the thiol sensitivity of IDE using S-nitrosoglutathione, reduced glutathione, and oxidized glutathione to distinguish the effects of nitric oxide from that of the redox state. The in vitro activity of IDE was studied using either partially purified cytosolic enzyme from male Sprague-Dawley rats, or purified rat recombinant enzyme. We confirm that nitric oxide inhibits the degrading activity of IDE, and that it affects proteasome activity through this interaction with IDE, but does not affect the proteasome directly. Oxidized glutathione inhibits IDE through glutathionylation, which was reversible by dithiothreitol but not by ascorbic acid. Reduced glutathione had no effect on IDE, but reacted with partially degraded insulin to disrupt its disulfide bonds and accelerate its breakdown to trichloroacetic acid soluble fragments. Our results demonstrate the sensitivity of insulin degradation by IDE to the redox environment and suggest another mechanism by which the cell's oxidation state may contribute to the development of, and the link between, type 2 diabetes and Alzheimer's disease.	[Cordes, Crystal M.; Bennett, Robert G.; Siford, Gerri L.; Hamel, Frederick G.] Omaha Vet Affairs Med Ctr, Res Serv, Omaha, NE USA; [Bennett, Robert G.; Siford, Gerri L.; Hamel, Frederick G.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Cordes, Crystal M.; Hamel, Frederick G.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cordes, CM (corresponding author), Omaha Vet Affairs Med Ctr, Res Serv, Omaha, NE USA.	fghamel@unmc.edu		Krause, Crystal/0000-0001-9523-4798	Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development); Bly Memorial Research Fund; Merit Review grant	Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development)(US Department of Veterans Affairs); Bly Memorial Research Fund; Merit Review grant	This work was supported by a Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development), Merit Review grant (to Frederick G. Hamel, Ph.D.), and by the Bly Memorial Research Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett RG, 1997, DIABETES, V46, P197, DOI 10.2337/diabetes.46.2.197; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bjork BF, 2007, NEUROBIOL AGING, V28, P1374, DOI 10.1016/j.neurobiolaging.2006.06.017; Blomqvist MEL, 2005, NEUROBIOL AGING, V26, P795, DOI 10.1016/j.neurobiolaging.2004.07.011; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; DUCKWORT.WC, 1972, P NATL ACAD SCI USA, V69, P3698, DOI 10.1073/pnas.69.12.3698; DUCKWORTH WC, 1994, J BIOL CHEM, V269, P24575; DUCKWORTH WC, 1988, ENDOCRINOLOGY, V123, P2701, DOI 10.1210/endo-123-6-2701; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; HAMEL FG, 1986, ENDOCRINOLOGY, V118, P328, DOI 10.1210/endo-118-1-328; Hamel FG, 1998, ENDOCRINOLOGY, V139, P4061, DOI 10.1210/en.139.10.4061; HAMEL FG, 1987, DIABETES, V36, P702, DOI 10.2337/diabetes.36.6.702; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Huang KP, 2002, BIOCHEM PHARMACOL, V64, P1049, DOI 10.1016/S0006-2952(02)01175-9; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAFFREY SR, 2001, SCI STKE; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Noble DR, 1999, CHEM COMMUN, P2317, DOI 10.1039/a907891f; Nordman S, 2009, EXP CLIN ENDOCR DIAB, V117, P186, DOI 10.1055/s-0028-1100419; Ralat LA, 2009, J BIOL CHEM, V284, P34005, DOI 10.1074/jbc.M109.030627; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o	41	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18138	10.1371/journal.pone.0018138	http://dx.doi.org/10.1371/journal.pone.0018138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448434	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500044
J	Lin, M; Luo, ZY; Bai, BF; Xu, F; Lu, TJ				Lin, Min; Luo, Zheng Yuan; Bai, Bo Feng; Xu, Feng; Lu, Tian Jian			Fluid Mechanics in Dentinal Microtubules Provides Mechanistic Insights into the Difference between Hot and Cold Dental Pain	PLOS ONE			English	Article							THERMAL-STIMULATION; INTRADENTAL NERVES; SENSORY TRANSDUCTION; ION CHANNELS; A-DELTA; TEETH; FLOW; TUBULES; DISPLACEMENT; ODONTOBLASTS	Dental thermal pain is a significant health problem in daily life and dentistry. There is a long-standing question regarding the phenomenon that cold stimulation evokes sharper and more shooting pain sensations than hot stimulation. This phenomenon, however, outlives the well-known hydrodynamic theory used to explain dental thermal pain mechanism. Here, we present a mathematical model based on the hypothesis that hot or cold stimulation-induced different directions of dentinal fluid flow and the corresponding odontoblast movements in dentinal microtubules contribute to different dental pain responses. We coupled a computational fluid dynamics model, describing the fluid mechanics in dentinal microtubules, with a modified Hodgkin-Huxley model, describing the discharge behavior of intradental neuron. The simulated results agreed well with existing experimental measurements. We thence demonstrated theoretically that intradental mechano-sensitive nociceptors are not "equally sensitive" to inward (into the pulp) and outward (away from the pulp) fluid flows, providing mechanistic insights into the difference between hot and cold dental pain. The model developed here could enable better diagnosis in endodontics which requires an understanding of pulpal histology, neurology and physiology, as well as their dynamic response to the thermal stimulation used in dental practices.	[Lin, Min; Xu, Feng; Lu, Tian Jian] Xi An Jiao Tong Univ, Sch Aerosp, Biomed Engn & Biomech Ctr, Xian 710049, Peoples R China; [Luo, Zheng Yuan; Bai, Bo Feng] Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian 710049, Peoples R China; [Xu, Feng] Harvard Univ, Brigham & Womens Hosp, HST Ctr Biomed Engn, Dept Med,Med Sch, Boston, MA 02115 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lin, M (corresponding author), Xi An Jiao Tong Univ, Sch Aerosp, Biomed Engn & Biomech Ctr, Xian 710049, Peoples R China.	fxu2@rics.bwh.harvard.edu; tjlu@mail.xjtu.edu.cn	Xu, Feng/C-7430-2011; liu, fusheng/J-4815-2014; Luo, Zhengyuan/AAU-6325-2020; Xu, Feng/H-4468-2011; Lin, Min/F-1348-2018; bai, bofeng/C-7663-2011; Lu, Tian Jian/E-6063-2016; Xu, Feng/E-8549-2018	Xu, Feng/0000-0003-4351-0222; Lin, Min/0000-0002-6198-9022; Lin, Min/0000-0002-3259-1955	National Natural Science Foundation of China [10825210, 31050110125, 81000453]; National 111 Project of China [B06024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (10825210, 31050110125, 81000453) and the National 111 Project of China (B06024). The funders had no role in study design, data collection and ananlysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; Andrew D, 2000, J PHYSIOL-LONDON, V529, P791, DOI 10.1111/j.1469-7793.2000.00791.x; BERGGREN G, 1965, J DENT RES, V44, P408, DOI 10.1177/00220345650440021701; BRANNSTROM M, 1970, ACTA ODONTOL SCAND, V28, P59, DOI 10.3109/00016357009033132; BRANNSTROM M, 1986, J ENDODONT, V12, P453, DOI 10.1016/S0099-2399(86)80198-4; BRANNSTROM M, 1964, J DENT RES, V43, P619, DOI 10.1177/00220345640430041601; BRANNSTROM M, 1962, ORAL SURG ORAL MED O, V15, P203; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; Carda C, 2006, TISSUE CELL, V38, P141, DOI 10.1016/j.tice.2006.01.002; Cesare P, 1999, P NATL ACAD SCI USA, V96, P7658, DOI 10.1073/pnas.96.14.7658; Charoenlarp P, 2007, ARCH ORAL BIOL, V52, P625, DOI 10.1016/j.archoralbio.2006.12.014; Chidchuangchai W, 2007, ARCH ORAL BIOL, V52, P154, DOI 10.1016/j.archoralbio.2006.09.009; Choi CH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066001; Choi CH, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2337669; FEARNHEAD RW, 1957, J ANAT, V91, P267; Hermanstyne TO, 2008, J DENT RES, V87, P834, DOI 10.1177/154405910808700910; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOLLAND GR, 1987, J PHYSIOL-LONDON, V386, P31, DOI 10.1113/jphysiol.1987.sp016520; Ibuki T, 1996, J DENT RES, V75, P1963, DOI 10.1177/00220345960750120801; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; JYVASJARVI E, 1987, J PHYSIOL-LONDON, V391, P193, DOI 10.1113/jphysiol.1987.sp016733; Kim SY, 2010, J DENT, V38, P343, DOI 10.1016/j.jdent.2009.12.008; LIN M, 2011, ARCH ORAL BIOL, DOI DOI 10.1016/J.ARCHOALBIO.2011.02.011; Lin M, 2010, DENT MATER, V26, P501, DOI 10.1016/j.dental.2010.02.009; Linsulwanont P, 2007, ARCH ORAL BIOL, V52, P218, DOI 10.1016/j.archoralbio.2006.10.009; Linsuwanont P, 2008, ARCH ORAL BIOL, V53, P261, DOI 10.1016/j.archoralbio.2007.10.006; Marshall G W Jr, 1993, Quintessence Int, V24, P606; MATTHEWS B, 1994, ARCH ORAL BIOL, V39, pS87, DOI 10.1016/0003-9969(94)90193-7; MATTHEWS B, 1977, J PHYSIOL-LONDON, V264, P641, DOI 10.1113/jphysiol.1977.sp011687; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; MENGEL MKC, 1993, PAIN, V55, P159, DOI 10.1016/0304-3959(93)90145-F; Nixdorf DR, 2010, J ENDODONT, V36, P224, DOI 10.1016/j.joen.2009.11.007; Paphangkorakit J, 2000, ARCH ORAL BIOL, V45, P1033, DOI 10.1016/S0003-9969(00)00090-X; Park CK, 2006, J BIOL CHEM, V281, P17304, DOI 10.1074/jbc.M511072200; Pashley DH, 1996, CRIT REV ORAL BIOL M, V7, P104, DOI 10.1177/10454411960070020101; Ratih DN, 2007, DENT MATER, V23, P1405, DOI 10.1016/j.dental.2006.11.029; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Rugiero F, 2010, J PHYSIOL-LONDON, V588, P301, DOI 10.1113/jphysiol.2009.182360; SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Sherrington C.S., 1906, INTEGRATIVE ACTION N; Trowbridge H O, 1980, J Endod, V6, P405, DOI 10.1016/S0099-2399(80)80216-0; Vongsavan N, 2007, ARCH ORAL BIOL, V52, P640, DOI 10.1016/j.archoralbio.2006.12.019; Xu F, 2008, J THERM BIOL, V33, P223, DOI 10.1016/j.jtherbio.2008.01.004; Xu F, 2010, COMPUT BIOL MED, V40, P478, DOI 10.1016/j.compbiomed.2010.03.002; Xu F, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2939370	48	70	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18068	10.1371/journal.pone.0018068	http://dx.doi.org/10.1371/journal.pone.0018068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448459	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500032
J	Re, DE; Whitehead, RD; Xiao, DK; Perrett, DI				Re, Daniel E.; Whitehead, Ross D.; Xiao, Dengke; Perrett, David I.			Oxygenated-Blood Colour Change Thresholds for Perceived Facial Redness, Health, and Attractiveness	PLOS ONE			English	Article							SECONDARY SEXUAL COLOR; BIOLOGICAL COMPONENTS; RHESUS MACAQUES; SKIN; RED; SYMMETRY; TESTOSTERONE; AVERAGENESS; PREFERENCE; EVOLUTION	Blood oxygenation level is associated with cardiovascular fitness, and raising oxygenated blood colouration in human faces increases perceived health. The current study used a two-alternative forced choice (2AFC) psychophysics design to quantify the oxygenated blood colour (redness) change threshold required to affect perception of facial colour, health and attractiveness. Detection thresholds for colour judgments were lower than those for health and attractiveness, which did not differ. The results suggest redness preferences do not reflect a sensory bias, rather preferences may be based on accurate indications of health status. Furthermore, results suggest perceived health and attractiveness may be perceptually equivalent when they are assessed based on facial redness. Appearance-based motivation for lifestyle change can be effective; thus future studies could assess the degree to which cardiovascular fitness increases face redness and could quantify changes in aerobic exercise needed to increase facial attractiveness.	[Re, Daniel E.; Whitehead, Ross D.; Xiao, Dengke; Perrett, David I.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	University of St Andrews	Re, DE (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.	dr296@st-andrews.ac.uk	Whitehead, Ross D/G-8569-2014	Perrett, David/0000-0002-6025-0939	British Academy; Wolfson Foundation [WRP/2008/87]	British Academy; Wolfson Foundation	This research was supported by funding from the British Academy (http://www.britac.ac.uk) and the Wolfson Foundation (http://www.wolfson.org.uk) joint research fellowship, Reference: WRP/2008/87. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Armstrong N, 2001, EUR J APPL PHYSIOL, V85, P546, DOI 10.1007/s004210100485; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Brincat MP, 2000, MATURITAS, V35, P107, DOI 10.1016/S0378-5122(00)00097-9; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Charkoudian N, 1999, J APPL PHYSIOL, V87, P1719, DOI 10.1152/jappl.1999.87.5.1719; Claeys KG, 2004, CEREB CORTEX, V14, P803, DOI 10.1093/cercor/bhh040; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; COETZEE V, BODY IMAGE IN PRESS; Drummond PD, 1999, PSYCHOPHYSIOLOGY, V36, P325, DOI 10.1017/S0048577299980344; Drummond PD, 1997, PSYCHOPHYSIOLOGY, V34, P163, DOI 10.1111/j.1469-8986.1997.tb02127.x; Drummond PD, 1997, PERS INDIV DIFFER, V23, P575, DOI 10.1016/S0191-8869(97)00077-9; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Franklin A, 2010, DEVELOPMENTAL SCI, V13, P346, DOI 10.1111/j.1467-7687.2009.00884.x; Gerald MS, 2007, INT J PRIMATOL, V28, P1, DOI 10.1007/s10764-006-9110-8; Greenlees I, 2008, J SPORT SCI, V26, P569, DOI 10.1080/02640410701744446; Hagemann N, 2008, PSYCHOL SCI, V19, P769, DOI 10.1111/j.1467-9280.2008.02155.x; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Hurlbert AC, 2007, CURR BIOL, V17, pR623, DOI 10.1016/j.cub.2007.06.022; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; JACOBS L, 1990, INT MARKET REV, V8, P21; Jones BC, 2004, EVOL HUM BEHAV, V25, P24, DOI 10.1016/S1090-5138(03)00080-1; JONES JL, 1994, HEALTH PSYCHOL, V13, P86, DOI 10.1037/0278-6133.13.1.86; Katchadourian H. A., 1984, FUNDAMENTALS HUMAN S; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Little A.C., 2007, J EVOLUTIONARY PSYCH, V5, P161, DOI [10. 1556/JEP. 2007. 1008, DOI 10.1556/JEP.2007.1008, https://doi.org/10.1556/JEP.2007.1008]; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; Madden JR, 2003, ANIM BEHAV, V65, P1077, DOI 10.1006/anbe.2003.2126; Mehlman PT, 1997, PSYCHIAT RES, V72, P89, DOI 10.1016/S0165-1781(97)00084-X; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; Naz K., 2004, COLL STUDENT J, V38, P396; PAUERSTEIN CJ, 1978, AM J OBSTET GYNECOL, V130, P876, DOI 10.1016/0002-9378(78)90264-8; Perrett, 2010, YOUR FACE NEW SCI HU; Pierard GE, 1998, J EUR ACAD DERMATOL, V10, P1; REGAS JC, 1998, READ MY LIPS CULTU; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Rhodes L, 1997, J REPROD FERTIL, V111, P51; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; Smith C, 2004, P ROY SOC B-BIOL SCI, V271, P949, DOI 10.1098/rspb.2004.2690; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; Stadie WC, 1919, J EXP MED, V30, P215, DOI 10.1084/jem.30.3.215; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009	54	68	69	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17859	10.1371/journal.pone.0017859	http://dx.doi.org/10.1371/journal.pone.0017859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740QW	21448270	Green Published, gold			2022-12-25	WOS:000288810500018
J	Nanthakumar, N; Meng, D; Goldstein, AM; Zhu, WS; Lu, L; Uauy, R; Llanos, A; Claud, EC; Walker, WA				Nanthakumar, Nanda; Meng, Di; Goldstein, Allan M.; Zhu, Weishu; Lu, Lei; Uauy, Ricardo; Llanos, Adolfo; Claud, Erika C.; Walker, W. Allan			The Mechanism of Excessive Intestinal Inflammation in Necrotizing Enterocolitis: An Immature Innate Immune Response	PLOS ONE			English	Article							EPITHELIAL-CELLS; ENDOTOXIN TOLERANCE; BACTERIAL LIGANDS; UP-REGULATION; CORTICOSTEROIDS; ENTEROCYTES; EXPRESSION	Necrotizing enterocolitis (NEC) is a devastating neonatal intestinal inflammatory disease, occurring primarily in premature infants, causing significant morbidity and mortality. The pathogenesis of NEC is associated with an excessive inflammatory IL-8 response. In this study, we hypothesized that this excessive inflammatory response is related to an immature expression of innate immune response genes. To address this hypothesis, intestinal RNA expression analysis of innate immune response genes was performed after laser capture microdissection of resected ileal epithelium from fetuses, NEC patients and children and confirmed in ex vivo human intestinal xenografts. Changes in mRNA levels of toll-like receptors (TLR)-2 and -4, their signaling molecules and transcription factors (MyD88, TRAF-6 and NF kappa B1) and negative regulators (SIGIRR, IRAK-M, A-20 and TOLLIP) and the effector IL-8 were characterized by qRT-PCR. The expression of TLR2, TLR4, MyD88, TRAF-6, NFkB1 and IL-8 mRNA was increased while SIGIRR, IRAK-M, A-20 and TOLLIP mRNA were decreased in fetal vs. mature human enterocytes and further altered in NEC enterocytes. Similar changes in mRNA expression were observed in immature, but not mature, human intestinal xenografts. Confirmation of gene expression was also validated with selective protein measurements and with suggested evidence that immature TRL4 enterocyte surface expression was internalized in mature enterocytes. Cortisone, an intestinal maturation factor, treatment corrected the mRNA differences only in the immature intestinal xenograft. Using specific siRNA to attenuate expression of primary fetal enterocyte cultures, both TOLLIP and A-20 were confirmed to be important when knocked down by exhibiting the same excessive inflammatory response seen in the NEC intestine. We conclude that the excessive inflammatory response of the immature intestine, a hallmark of NEC, is due to a developmental immaturity in innate immune response genes.	[Nanthakumar, Nanda; Meng, Di; Zhu, Weishu; Lu, Lei; Walker, W. Allan] Harvard Univ, Sch Med, Dev Gastroenterol Lab, Boston, MA 02115 USA; [Goldstein, Allan M.] Harvard Univ, Sch Med, Pediat Surg Res Lab, MassGen Hosp Children, Boston, MA USA; [Uauy, Ricardo; Llanos, Adolfo] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile; [Claud, Erika C.] Univ Chicago, Dept Pediat & Med, Sect Neonatol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidad de Chile; University of Chicago	Nanthakumar, N (corresponding author), Harvard Univ, Sch Med, Dev Gastroenterol Lab, Boston, MA 02115 USA.	wwalker@partners.org			National Institutes of Health (NIH) [R01 HD059126, R01-HD012437, R01 DK070260, P01 DK033506, P30 DK040561, R01 DK080914, R01 HD059123, R21 HD055237, R21 AT004044]; March of Dimes Basil O'Connor Starter Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437, R01HD059126, R01HD059123] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351, R01DK080914, R01DK070260, P01DK033506] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Starter Award(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health (NIH): R01 HD059126 (Nanda Nanthakumar); R01-HD012437, R01 DK070260, P01 DK033506 and P30 DK040561 (W. Allan Walker); R01 DK080914 (Allan Goldstein); R01 HD059123, R21 HD055237, R21 AT004044 and the March of Dimes Basil O'Connor Starter Award (Erika Claud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, GASTROENTEROLOGY, V138, P39, DOI 10.1053/j.gastro.2009.11.031; CAPLAN MS, 2005, SEMIN PEDIATR SURG, V14, P14; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Doyle LW, 2000, J PAEDIATR CHILD H, V36, P101, DOI 10.1046/j.1440-1754.2000.00481.x; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; HALAC E, 1990, J PEDIATR-US, V117, P132, DOI 10.1016/S0022-3476(05)72461-6; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; Hayes EJ, 2008, OBSTET GYNECOL, V111, P921, DOI 10.1097/AOG.0b013e318169ce2d; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu L, 2008, GASTROENTEROLOGY, V135, P185, DOI 10.1053/j.gastro.2008.03.038; Lu L, 2009, AM J PHYSIOL-GASTR L, V296, pG1221, DOI 10.1152/ajpgi.90686.2008; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P50; Ohnuma K, 2005, MOL CELL BIOL, V25, P7743, DOI 10.1128/MCB.25.17.7743-7757.2005; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Weng M, 2007, PEDIATR RES, V62, P542, DOI 10.1203/PDR.0b013e318155a422; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012	28	230	238	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17776	10.1371/journal.pone.0017776	http://dx.doi.org/10.1371/journal.pone.0017776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445298	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000288613300015
J	Bocchi, L; Savi, M; Graiani, G; Rossi, S; Agnetti, A; Stillitano, F; Lagrasta, C; Baruffi, S; Berni, R; Frati, C; Vassalle, M; Squarcia, U; Cerbai, E; Macchi, E; Stilli, D; Quaini, F; Musso, E				Bocchi, Leonardo; Savi, Monia; Graiani, Gallia; Rossi, Stefano; Agnetti, Aldo; Stillitano, Francesca; Lagrasta, Costanza; Baruffi, Silvana; Berni, Roberta; Frati, Caterina; Vassalle, Mario; Squarcia, Umberto; Cerbai, Elisabetta; Macchi, Emilio; Stilli, Donatella; Quaini, Federico; Musso, Ezio			Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction	PLOS ONE			English	Article							STEM-CELLS; HEART-FAILURE; LIMINAL LENGTH; SOCIAL STRESS; THERAPY; TRANSPLANTATION; REGENERATE; ACTIVATION; EXPRESSION; INJECTION	Heart repair by stem cell treatment may involve life-threatening arrhythmias. Cardiac progenitor cells (CPCs) appear best suited for reconstituting lost myocardium without posing arrhythmic risks, being commissioned towards cardiac phenotype. In this study we tested the hypothesis that mobilization of CPCs through locally delivered Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 to heal chronic myocardial infarction (MI), lowers the proneness to arrhythmias. We used 133 adult male Wistar rats either with one-month old MI and treated with growth factors (GFs, n = 60) or vehicle (V, n = 55), or sham operated (n = 18). In selected groups of animals, prior to and two weeks after GF/V delivery, we evaluated stress-induced ventricular arrhythmias by telemetry-ECG, cardiac mechanics by echocardiography, and ventricular excitability, conduction velocity and refractoriness by epicardial multiple-lead recording. Invasive hemodynamic measurements were performed before sacrifice and eventually the hearts were subjected to anatomical, morphometric, immunohistochemical, and molecular biology analyses. When compared with untreated MI, GFs decreased stress-induced arrhythmias and concurrently prolonged the effective refractory period (ERP) without affecting neither the duration of ventricular repolarization, as suggested by measurements of QTc interval and mRNA levels for K-channel alpha-subunits Kv4.2 and Kv4.3, nor the dispersion of refractoriness. Further, markers of cardiomyocyte reactive hypertrophy, including mRNA levels for K-channel alpha-subunit Kv1.4 and beta-subunit KChIP2, interstitial fibrosis and negative structural remodeling were significantly reduced in peri-infarcted/remote ventricular myocardium. Finally, analyses of BrdU incorporation and distribution of connexin43 and N-cadherin indicated that cytokines generated new vessels and electromechanically-connected myocytes and abolished the correlation of infarct size with deterioration of mechanical function. In conclusion, local injection of GFs ameliorates electromechanical competence in chronic MI. Reduced arrhythmogenesis is attributable to prolongation of ERP resulting from improved intercellular coupling via increased expression of connexin43, and attenuation of unfavorable remodeling.	[Bocchi, Leonardo; Savi, Monia; Rossi, Stefano; Baruffi, Silvana; Berni, Roberta; Macchi, Emilio; Stilli, Donatella; Musso, Ezio] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy; [Graiani, Gallia; Lagrasta, Costanza; Frati, Caterina] Univ Parma, Dipartimento Patol & Med Lab, I-43100 Parma, Italy; [Agnetti, Aldo; Squarcia, Umberto] Univ Parma, Dipartimento Eta Evolut, I-43100 Parma, Italy; [Stillitano, Francesca; Cerbai, Elisabetta] Univ Florence, Dipartimento Farmacol Preclin & Clin, Florence, Italy; [Vassalle, Mario] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY USA; [Quaini, Federico] Univ Parma, Dipartimento Med Interna & Sci Biomed, I-43100 Parma, Italy; [Agnetti, Aldo; Lagrasta, Costanza; Squarcia, Umberto; Macchi, Emilio; Stilli, Donatella; Quaini, Federico; Musso, Ezio] Univ Parma, Ctr Interdipartimentale Cellule Staminali Cardiac, I-43100 Parma, Italy	University of Parma; University of Parma; University of Parma; University of Florence; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Parma; University of Parma	Bocchi, L (corresponding author), Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy.	ezio.musso@unipr.it	Savi, Monia/B-9562-2015; Cerbai, Elisabetta/J-2663-2013; Stilli, Donatella/M-5630-2018; Rossi, Stefano/L-2556-2016	Savi, Monia/0000-0002-7895-7756; Cerbai, Elisabetta/0000-0001-7839-1361; Rossi, Stefano/0000-0003-0346-8410; Frati, Caterina/0000-0002-3343-6471; BOCCHI, Leonardo/0000-0003-4799-2804; Quaini, Federico/0000-0003-2377-4810; Stillitano, Francesca/0000-0003-1898-5058; Graiani, Gallia/0000-0003-1926-7568	Italian Ministry of Education, University and Research [PRIN 062944 2005]; European Commission [NMP-214539 2007]; Italian Ministry of Health; Fondazione Cassa di Risparmio di Parma; Ente Cassa di Risparmio di Firenze; Compagnia di San Paolo; Istituto Nazionale di Ricerche Cardiovascolari	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cassa di Risparmio di Parma(Fondazione Cariparma); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Compagnia di San Paolo(Compagnia di San Paolo); Istituto Nazionale di Ricerche Cardiovascolari	This study was supported by the following grants: Italian Ministry of Education, University and Research PRIN 062944 2005, European Commission CORDIS FP7-BIOSCENT, NMP-214539 2007, Italian Ministry of Health THEAPPL 2008, and funding by "Fondazione Cassa di Risparmio di Parma", "Ente Cassa di Risparmio di Firenze", "Compagnia di San Paolo", and "Istituto Nazionale di Ricerche Cardiovascolari." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Camm AJ, 1996, CIRCULATION, V93, P1043; Chamuleau SAF, 2009, NETH HEART J, V17, P199, DOI 10.1007/BF03086247; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; DODGE HT, 1969, AM J CARDIOL, V23, P528, DOI 10.1016/0002-9149(69)90006-X; Duffy HS, 2008, NEW ENGL J MED, V358, P1397, DOI 10.1056/NEJMcibr0708922; FOZZARD HA, 1972, J PHYSIOL-LONDON, V226, P593, DOI 10.1113/jphysiol.1972.sp009999; Fozzard HA, 2001, J CARDIOVASC ELECTR, V12, P836, DOI 10.1046/j.1540-8167.2001.00836.x; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Fuller MS, 2000, CIRCULATION, V102, P685, DOI 10.1161/01.CIR.102.6.685; Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; KJEKSHUS J, 1990, AM J CARDIOL, V65, pI42; Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Ly HQ, 2009, CIRCULATION, V119, P1824, DOI 10.1161/CIRCULATIONAHA.108.812701; Macchi E, 1998, AM J PHYSIOL-HEART C, V275, pH1886, DOI 10.1152/ajpheart.1998.275.5.H1886; Macia E, 2009, CIRCULATION, V119, P1814, DOI 10.1161/CIRCULATIONAHA.108.779900; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; OGAWA S, 1991, CARDIOVASC RES, V25, P378, DOI 10.1093/cvr/25.5.378; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; OLIVETTI G, 1991, CIRC RES, V68, P856, DOI 10.1161/01.RES.68.3.856; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Pak HN, 2003, J CARDIOVASC ELECTR, V14, P841, DOI 10.1046/j.1540-8167.2003.03124.x; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011; Stilli D, 2004, EXP PHYSIOL, V89, P387, DOI 10.1113/expphysiol.2003.027110; Stilli D, 2007, BASIC RES CARDIOL, V102, P488, DOI 10.1007/s00395-007-0665-0; Tozakidou M, 2010, J MOL CELL CARDIOL, V48, P140, DOI 10.1016/j.yjmcc.2009.08.027; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van der Heyden MAG, 2006, CARDIOVASC RES, V71, P430, DOI 10.1016/j.cardiores.2006.04.012; van Rijen HVM, 2006, ADV CARDIOL, V42, P150, DOI 10.1159/000092567; Wang DG, 2011, INT J CARDIOL, V152, P314, DOI 10.1016/j.ijcard.2010.07.025	56	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17750	10.1371/journal.pone.0017750	http://dx.doi.org/10.1371/journal.pone.0017750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445273	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100029
J	Walenda, T; Bokermann, G; Jost, E; Galm, O; Schellenberg, A; Koch, CM; Piroth, DM; Drescher, W; Brummendorf, TH; Wagner, W				Walenda, Thomas; Bokermann, Gudrun; Jost, Edgar; Galm, Oliver; Schellenberg, Anne; Koch, Carmen M.; Piroth, Daniela M.; Drescher, Wolf; Bruemmendorf, Tim H.; Wagner, Wolfgang			Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; MESENCHYMAL STROMAL CELLS; FREE CULTURE-SYSTEM; STEM-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; STEM/PROGENITOR CELLS; SELF-RENEWAL; DIVISION	Regeneration after hematopoietic stem cell transplantation (HSCT) depends on enormous activation of the stem cell pool. So far, it is hardly understood how these cells are recruited into proliferation and self-renewal. In this study, we have addressed the question if systemically released factors are involved in activation of hematopoietic stem and progenitor cells (HPC) after autologous HSCT. Serum was taken from patients before chemotherapy, during neutropenia and after hematopoietic recovery. Subsequently, it was used as supplement for in vitro culture of CD34(+) cord blood HPC. Serum taken under hematopoietic stress (4 to 11 days after HSCT) significantly enhanced proliferation, maintained primitive immunophenotype (CD34(+), CD133(+), CD45(-)) for more cell divisions and increased colony forming units (CFU) as well as the number of cobblestone area-forming cells (CAFC). The stimulatory effect decays to normal levels after hematopoietic recovery (more than 2 weeks after HSCT). Chemokine profiling revealed a decline of several growth-factors during neutropenia, including platelet-derived growth factors PDGF-AA, PDGF-AB and PDGF-BB, whereas expression of monocyte chemotactic protein-1 (MCP-1) increased. These results demonstrate that systemically released factors play an important role for stimulation of hematopoietic regeneration after autologous HSCT. This feedback mechanism opens new perspectives for in vivo stimulation of the stem cell pool.	[Walenda, Thomas; Bokermann, Gudrun; Schellenberg, Anne; Koch, Carmen M.; Wagner, Wolfgang] RWTH Aachen Univ Med Sch, Helmholtz Inst Biomed Engn, Aachen, Germany; [Jost, Edgar; Galm, Oliver; Bruemmendorf, Tim H.] RWTH Aachen Univ Med Sch, Dept Hematol & Oncol, Aachen, Germany; [Piroth, Daniela M.] RWTH Aachen Univ Med Sch, Dept Gynecol, Aachen, Germany; [Drescher, Wolf] RWTH Aachen Univ Med Sch, Dept Orthoped, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Walenda, T (corresponding author), RWTH Aachen Univ Med Sch, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de		Wagner, Wolfgang/0000-0002-1971-3217	German Ministry of Education and Research (BMBF); Stem Cell Network North Rhine Westphalia	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Stem Cell Network North Rhine Westphalia	This work was supported by the German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine'' (CB-HERMES), and by the Stem Cell Network North Rhine Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PZ, 2010, MOL BIOSYST, V6, P1207, DOI 10.1039/b922637k; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Chen YM, 1996, JPN J CLIN ONCOL, V26, P18, DOI 10.1093/oxfordjournals.jjco.a023173; da Silva CL, 2005, EXP HEMATOL, V33, P828, DOI 10.1016/j.exphem.2005.03.017; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Frederik W, 2010, STEM CELL RES, V4, P129, DOI 10.1016/j.scr.2009.12.004; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gotze KS, 2007, EXP HEMATOL, V35, P1408, DOI 10.1016/j.exphem.2007.05.016; Goncalves R, 2006, EXP HEMATOL, V34, P1353, DOI 10.1016/j.exphem.2006.05.024; Gratwohl A, 2009, BONE MARROW TRANSPL, V43, P275, DOI 10.1038/bmt.2009.7; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Ho AD, 2007, CURR OPIN HEMATOL, V14, P330, DOI 10.1097/MOH.0b013e3281900f12; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Hsu HC, 2002, ONCOLOGY-BASEL, V63, P64, DOI 10.1159/000065722; Huang GP, 2007, CELL TRANSPLANT, V16, P579, DOI 10.3727/000000007783465073; Huang S, 1998, EXP HEMATOL, V26, P1162; Klaus J, 2007, EUR J HAEMATOL, V78, P21, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2895.x; Kurita M, 2008, PLAST RECONSTR SURG, V122, P438, DOI 10.1097/PRS.0b013e31817d618d; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NOROOZI AA, 2010, GROWTH FACTORS; Olivieri A, 1998, HAEMATOLOGICA, V83, P329; Oostendorp RAJ, 2000, BLOOD, V95, P855, DOI 10.1182/blood.V95.3.855.003k41_855_862; PLOEMACHER RE, 1989, BLOOD, V74, P2755; SARRIS AH, 1993, J EXP MED, V178, P1127, DOI 10.1084/jem.178.3.1127; Sauvageau G, 2010, SCIENCE, V329, P1291, DOI 10.1126/science.1195173; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Su RJ, 2002, BRIT J HAEMATOL, V117, P735, DOI 10.1046/j.1365-2141.2002.03500.x; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; WALENDA T, 2011, EXPT HEMATO IN PRESS; Walenda T, 2010, J CELL MOL MED, V14, P337, DOI 10.1111/j.1582-4934.2009.00776.x; Wang SR, 2007, TRANSFUSION, V47, P2207, DOI 10.1111/j.1537-2995.2007.01448.x; Weissinger Eva M., 2009, V506, P437, DOI 10.1007/978-1-59745-409-4_29; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yoshimura C, 2000, VOX SANG, V78, P106, DOI 10.1046/j.1423-0410.2000.7820106.x; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18012	10.1371/journal.pone.0018012	http://dx.doi.org/10.1371/journal.pone.0018012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437259	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100057
J	Arisue, N; Kawai, S; Hirai, M; Palacpac, NMQ; Jia, M; Kaneko, A; Tanabe, K; Horii, T				Arisue, Nobuko; Kawai, Satoru; Hirai, Makoto; Palacpac, Nirianne M. Q.; Jia, Mozhi; Kaneko, Akira; Tanabe, Kazuyuki; Horii, Toshihiro			Clues to Evolution of the SERA Multigene Family in 18 Plasmodium Species	PLOS ONE			English	Article							SERINE-REPEAT-ANTIGEN; PHYLOGENETIC ANALYSIS; EXPRESSION PATTERNS; AOTUS MONKEYS; FALCIPARUM; MALARIA; PROTEIN; PROTEASES; SEQUENCE; ORIGIN	SERA gene sequences were newly determined from 11 primate Plasmodium species including two human parasites, P. ovale and P. malariae, and the evolutionary history of SERA genes was analyzed together with 7 known species. All have one each of Group I to III cysteine-type SERA genes and varying number of Group IV serine-type SERA genes in tandem cluster. Notably, Group IV SERA genes were ascertained in all mammalian parasite lineages; and in two primate parasite lineages gene events such as duplication, truncation, fragmentation and gene loss occurred at high frequency in a manner that mimics the birth-and-death evolution model. Transcription profile of individual SERA genes varied greatly among rodent and monkey parasites. Results support the lineage-specific evolution of the Plasmodium SERA gene family. These findings provide further impetus for studies that could clarify/provide proof-of-concept that duplications of SERA genes were associated with the parasites' expansion of host range and the evolutionary conundrums of multigene families in Plasmodium.	[Arisue, Nobuko; Palacpac, Nirianne M. Q.; Jia, Mozhi; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Osaka, Japan; [Kawai, Satoru] Dokkyo Univ, Sch Med, Lab Trop Med & Parasitol, Shimotsuga, Tochigi, Japan; [Hirai, Makoto] Gunma Univ, Grad Sch Med, Dept Parasitol, Gunma, Japan; [Kaneko, Akira] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka 558, Japan; [Kaneko, Akira] Karolinska Inst, Isl Malaria Grp, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kaneko, Akira] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Osaka, Japan	Osaka University; Dokkyo Medical University; Gunma University; Osaka Metropolitan University; Karolinska Institutet; Nagasaki University; Osaka University	Arisue, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Osaka, Japan.	horii@biken.osaka-u.ac.jp		Palacpac, Nirianne Marie/0000-0003-4098-3972; Horii, Toshihiro/0000-0002-3000-2045; , Akira/0000-0003-2411-3352	Ministry of Education, Culture, Sports, Science and Technology [21570238, 20390120, 18073013]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: This work was supported by the Ministry of Education, Culture, Sports, Science and Technology grant (21570238 to N. A.; 20390120 to K. T.; 18073013 to T. H.) [http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; BZIK DJ, 1988, MOL BIOCHEM PARASIT, V30, P279, DOI 10.1016/0166-6851(88)90097-7; Chen XF, 1997, GENE, V185, P195, DOI 10.1016/S0378-1119(96)00637-3; COATNEY GR, 1971, PRIMATE MALARIAS; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1987, MOL BIOCHEM PARASIT, V23, P193, DOI 10.1016/0166-6851(87)90026-0; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Duval L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005520; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FOODEN J, 1994, INT J PRIMATOL, V15, P573, DOI 10.1007/BF02735972; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garzon-Ospina D, 2010, MOL PHYLOGENET EVOL, V55, P399, DOI 10.1016/j.ympev.2010.02.017; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Hayakawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007412; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Horii T, 2010, PARASITOL INT, V59, P380, DOI 10.1016/j.parint.2010.05.002; INSELBURG J, 1993, INFECT IMMUN, V61, P2048, DOI 10.1128/IAI.61.5.2048-2052.1993; INSELBURG J, 1993, INFECT IMMUN, V61, P2041, DOI 10.1128/IAI.61.5.2041-2047.1993; Janssen CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/nar/gkh907; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Li J, 2002, MOL BIOCHEM PARASIT, V120, P177, DOI 10.1016/S0166-6851(01)00452-2; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Okech BA, 2001, AM J TROP MED HYG, V65, P912, DOI 10.4269/ajtmh.2001.65.912; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Palacpac NMQ, 2006, MOL BIOCHEM PARASIT, V150, P353, DOI 10.1016/j.molbiopara.2006.07.006; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Ricklefs RE, 2010, SCIENCE, V329, P226, DOI 10.1126/science.1188954; Sugiyama T, 1996, VACCINE, V14, P1069, DOI 10.1016/0264-410X(95)00238-V; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015	48	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17775	10.1371/journal.pone.0017775	http://dx.doi.org/10.1371/journal.pone.0017775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423628	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900029
J	Sester, U; Fousse, M; Dirks, J; Mack, U; Prasse, A; Singh, M; Lalvani, A; Sester, M				Sester, Urban; Fousse, Mathias; Dirks, Jan; Mack, Ulrich; Prasse, Antje; Singh, Mahavir; Lalvani, Ajit; Sester, Martina			Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States	PLOS ONE			English	Article							INFECTED INDIVIDUALS; M. TUBERCULOSIS; RAPID DIAGNOSIS; IFN-GAMMA; IMMUNITY; DISEASE; CORRELATE	T-cell based IFN-gamma release assays do not permit distinction of active tuberculosis (TB) from successfully treated disease or latent M. tuberculosis infection. We postulated that IFN-gamma and IL-2 cytokine profiles of antigen-specific T cells measured by flow-cytometry ex vivo might correlate with TB disease activity in vivo. Tuberculin (PPD), ESAT-6 and CFP-10 were used as stimuli to determine antigen-specific cytokine profiles in CD4 T cells from 24 patients with active TB and 28 patients with successfully treated TB using flow-cytometry. Moreover, 25 individuals with immunity consistent with latent M. tuberculosis infection and BCG-vaccination, respectively, were recruited. Although the frequency of cytokine secreting PPD reactive CD4 T cells was higher in patients with active TB compared to patients with treated TB (median 0.81% vs. 0.39% of CD4 T cells, p = 0.02), the overlap in frequencies precluded distinction between the groups on an individual basis. When assessing cytokine profiles, PPD specific CD4 T cells secreting both IFN-gamma and IL-2 predominated in treated TB, latent infection and BCG-vaccination, whilst in active TB the cytokine profile was shifted towards cells secreting IFN-gamma only (p<0.0001). Cytokine profiles of ESAT-6 or CFP-10 reactive CD4 T cells did not differ between the groups. Receiver operator characteristics (ROC) analysis revealed that frequencies of PPD specific IFN-gamma/IL-2 dual-positive T cells below 56% were an accurate marker for active TB (specificity 100%, sensitivity 70%) enabling effective discrimination from non-active states. In conclusion, a frequency lower than 56% IFN-gamma/IL-2 dual positive PPD-specific circulating CD4 T-cells is strongly indicative of active TB.	[Sester, Urban] Univ Saarland, Dept Internal Med 4, D-6650 Homburg, Germany; [Fousse, Mathias; Dirks, Jan; Sester, Martina] Univ Saarland, Inst Virol, Dept Transplant & Infect Immunol, D-6650 Homburg, Germany; [Mack, Ulrich] Univ Saarland, Dept Internal Med 5, D-6650 Homburg, Germany; [Prasse, Antje] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany; [Singh, Mahavir] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Singh, Mahavir] Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Res Unit, Dept Resp Med, Natl Heart & Lung Inst, London, England	Saarland University; Saarland University; Saarland University; University of Freiburg; Helmholtz Association; Helmholtz-Center for Infection Research; Lionex Diagnostics & Therapeutics GmbH; Imperial College London	Sester, U (corresponding author), Univ Saarland, Dept Internal Med 4, D-6650 Homburg, Germany.	martina.sester@uks.eu	Prasse, Antje/AAM-7521-2021; Sester, Martina/AAA-3383-2022; Prasse, Antje/AAY-6279-2020	Prasse, Antje/0000-0002-7336-7458; Lalvani, Ajit/0000-0002-2396-246X; Sester, Urban/0000-0003-4007-5595; Sester, Martina/0000-0001-5482-0002	Else Kroner Fresenius Stiftung; HOMFOR	Else Kroner Fresenius Stiftung; HOMFOR	Funding: Financial support was given in part by grants from the Else Kroner Fresenius Stiftung and from "HOMFOR" to M. S. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mahavir Singh is the owner and director of LIONEX.	Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Dinser R, 2008, RHEUMATOLOGY, V47, P212, DOI 10.1093/rheumatology/kem351; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Jafari C, 2008, EUR RESPIR J, V31, P261, DOI 10.1183/09031936.00096707; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x; Sester U, 2009, EUR RESPIR J, V34, P702, DOI 10.1183/09031936.00013409; Sester U, 2006, NEPHROL DIAL TRANSPL, V21, P3258, DOI 10.1093/ndt/gfl416; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Strassburg A, 2008, EUR RESPIR J, V31, P1132, DOI 10.1183/09031936.00083707; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139	26	95	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17813	10.1371/journal.pone.0017813	http://dx.doi.org/10.1371/journal.pone.0017813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423578	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900035
J	Yin, RX; Li, YY; Liu, WY; Zhang, L; Wu, JZ				Yin, Rui-Xing; Li, Yi-Yang; Liu, Wan-Ying; Zhang, Lin; Wu, Jin-Zhen			Interactions of the Apolipoprotein A5 Gene Polymorphisms and Alcohol Consumption on Serum Lipid Levels	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSTPRANDIAL LIPOPROTEIN METABOLISM; PLASMA TRIGLYCERIDE LEVELS; ALL-CAUSE MORTALITY; HEI-YI-ZHUANG; AV GENE; ARTERY-DISEASE; APOA5 GENE; CHOLESTEROL LEVELS; HDL CHOLESTEROL	Background: Little is known about the interactions of apolipoprotein (Apo) A5 gene polymorphisms and alcohol consumption on serum lipid profiles. The present study was undertaken to detect the interactions of ApoA5-1131T > C, c.553G > T and c.457G > A polymorphisms and alcohol consumption on serum lipid levels. Methodology/Principal Findings: A total of 516 nondrinkers and 514 drinkers were randomly selected from our previous stratified randomized cluster samples. Genotyping was performed by polymerase chain reaction and restriction fragment length polymorphism. The levels of serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), ApoA1 and ApoB were higher in drinkers than in nondrinkers (P < 0.05-0.001). The genotypic and allelic frequencies of three loci were not different between the two groups. The interactions between -1131T > C genotypes and alcohol consumption on ApoB levels (P < 0.05) and the ApoA1/ApoB ratio (P < 0.01), between c.553G > T genotypes and alcohol consumption on low-density lipoprotein cholesterol (LDL-C) levels (P < 0.05) and the ApoA1/ApoB ratio (P < 0.05), and between c.457G > A genotypes and alcohol consumption on TG levels (P < 0.001) were detected by factorial regression analysis after controlling for potential confounders. Four haplotypes (T-G-G, C-G-G, T-A-G and C-G-T) had frequencies ranging from 0.06 to 0.87. Three haplotypes (C-G-G, T-A-G, and C-G-T) were significantly associated with serum lipid parameters. The -1131T > C genotypes were correlated with TG, and c.553G > T and c.457G > A genotypes were associated with HDL-C levels in nondrinkers (P < 0.05 for all). For drinkers, the -1131T > C genotypes were correlated with TC, TG, LDL-C, ApoB levels and the ApoA1/ApoB ratio (P < 0.01 for all); c.553G > T genotypes were correlated with TC, TG, HDL-C and LDL-C levels (P < 0.05-0.01); and c.457G > A genotypes were associated with TG, LDL-C, ApoA1 and ApoB levels (P < 0.05-0.01). Conclusions: The differences in some serum lipid parameters between the drinkers and nondrinkers might partly result from different interactions of the ApoA5 gene polymorphisms and alcohol consumption.	[Yin, Rui-Xing; Li, Yi-Yang; Liu, Wan-Ying; Zhang, Lin; Wu, Jin-Zhen] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China; [Li, Yi-Yang] Guangxi Natl Hosp, Dept Cardiol, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Yin, RX (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China.	yinruixing@yahoo.com.cn			National Natural Science Foundation of China [30360038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30360038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Aouizerat BE, 2003, J LIPID RES, V44, P1167, DOI 10.1194/jlr.M200480-JLR200; Austin MA, 2004, BBA-MOL BASIS DIS, V1688, P1, DOI 10.1016/j.bbadis.2003.10.003; Baum L, 2003, CLIN GENET, V63, P377, DOI 10.1034/j.1399-0004.2003.00063.x; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; Chaaba Raja, 2005, Lipids Health Dis, V4, P1, DOI 10.1186/1476-511X-4-1; Chen ES, 2006, CLIN CHEM LAB MED, V44, P32, DOI 10.1515/CCLM.2006.007; Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014; Chien KL, 2008, CLIN CHIM ACTA, V388, P78, DOI 10.1016/j.cca.2007.10.006; CHOUDHURY SR, 1994, INT J EPIDEMIOL, V23, P940, DOI 10.1093/ije/23.5.940; Corella D, 2001, AM J CLIN NUTR, V73, P736; Dallinga-Thie GM, 2006, DIABETOLOGIA, V49, P1505, DOI 10.1007/s00125-006-0261-0; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Endo K, 2002, HUM GENET, V111, P570, DOI 10.1007/s00439-002-0825-0; Evans D, 2003, J MOL MED-JMM, V81, P645, DOI 10.1007/s00109-003-0465-4; Gaziano JM, 1999, AM J CARDIOL, V83, P52, DOI 10.1016/S0002-9149(98)00782-6; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Havasi V, 2006, J MOL NEUROSCI, V29, P177, DOI 10.1385/JMN:29:2:177; Horinek A, 2003, ATHEROSCLEROSIS, V167, P369, DOI 10.1016/S0021-9150(03)00022-4; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Huang MC, 2008, KAOHSIUNG J MED SCI, V24, P171, DOI 10.1016/S1607-551X(08)70114-1; Hubacek JA, 2004, PHYSIOL RES, V53, P225; Hubacek JA, 2007, CLIN CHEM LAB MED, V45, P316, DOI 10.1515/CCLM.2007.056; Hubacek JA, 2009, PHARMACOGENOMICS, V10, P945, DOI 10.2217/PGS.09.17; HUMPHRIES S, 1989, ATHEROSCLEROSIS, V75, P249, DOI 10.1016/0021-9150(89)90183-4; IRVING S, 1992, CIRCULATION, V85, P1083; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Kluger M, 2008, J INHERIT METAB DIS, V31, P281, DOI 10.1007/s10545-008-0863-4; Koppes LLJ, 2005, J STUD ALCOHOL, V66, P713, DOI 10.15288/jsa.2005.66.713; Lai CQ, 2004, J LIPID RES, V45, P2096, DOI 10.1194/jlr.M400192-JLR200; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024; Li GP, 2004, CLIN GENET, V65, P470, DOI 10.1111/j.1399-0004.2004.00251.x; Liu HK, 2005, METABOLISM, V54, P568, DOI 10.1016/j.metabol.2004.11.009; Martin S, 2003, BBA-MOL BASIS DIS, V1637, P217, DOI 10.1016/S0925-4439(03)00033-4; Masana L, 2003, CLIN CHEM LAB MED, V41, P517, DOI 10.1515/CCLM.2003.078; Moreno R, 2006, ATHEROSCLEROSIS, V189, P163, DOI 10.1016/j.atherosclerosis.2005.11.029; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Nabika T, 2002, ATHEROSCLEROSIS, V165, P201, DOI 10.1016/S0021-9150(02)00252-6; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; Parker DR, 1996, AM J PUBLIC HEALTH, V86, P1022, DOI 10.2105/AJPH.86.7.1022; Pennacchio LA, 2003, ARTERIOSCL THROM VAS, V23, P529, DOI 10.1161/01.ATV.0000054194.78240.45; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Puddey IB, 1999, NEUROEPIDEMIOLOGY, V18, P292, DOI 10.1159/000026224; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ribalta J, 2002, CLIN CHEM, V48, P1597; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ruidavets J.-B., 2002, Journal of Epidemiology and Community Health, V56, P24, DOI 10.1136/jech.56.1.24; SAVOLAINEN MJ, 1995, CURR OPIN LIPIDOL, V6, P243, DOI 10.1097/00041433-199508000-00009; Seda O, 2003, PHYSIOL RES, V52, P141; Shanker J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-33; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; Theobald H, 2000, J STUD ALCOHOL, V61, P652, DOI 10.15288/jsa.2000.61.652; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Wannamethee SG, 1999, AM J PUBLIC HEALTH, V89, P685, DOI 10.2105/AJPH.89.5.685; Yin RX, 2006, HYPERTENS RES, V29, P423, DOI 10.1291/hypres.29.423; Yin RX, 2006, EUR J CARDIOV PREV R, V13, P977, DOI 10.1097/01.hjr.0000239476.79428.25; Yin RX, 2006, J INVEST MED, V54, P191, DOI 10.2310/6650.2006.05050; Yin RX, 2006, ARCH MED RES, V37, P787, DOI 10.1016/j.arcmed.2005.12.005; Yin RX, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-86; Yin RX, 2009, PUBLIC HEALTH NUTR, V12, P553, DOI 10.1017/S1368980008002437; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhou B., 2002, ZHONGHUA LIU XING BI, V23, P5; Zhou YJ, 2008, ALCOHOL, V42, P583, DOI 10.1016/j.alcohol.2008.08.004	74	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17954	10.1371/journal.pone.0017954	http://dx.doi.org/10.1371/journal.pone.0017954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423763	gold, Green Submitted, Green Published			2022-12-25	WOS:000288512400042
J	Kuppers, DA; Hwang, HC; Jackson, AL; Linsley, PS; Clurman, BE; Fero, ML				Kuppers, Daniel A.; Hwang, Harry C.; Jackson, Aimee L.; Linsley, Peter S.; Clurman, Bruce E.; Fero, Matthew L.			Effect of Xpcl1 Activation and p27Kip1 Loss on Gene Expression in Murine Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMAS; VIRUS-INDUCED LYMPHOMAS; MICROARRAY EXPERIMENTS; TUMOR SUPPRESSION; NONCODING RNA; T-CELL; MICRORNAS; P27(KIP1); LEUKEMIA; CLUSTER	Mice lacking the p27(Kip1) Cdk inhibitor (Cdkn1b) exhibit increased susceptibility to lymphomas from the Maloney murine leukemia virus (M-MuLV), and exhibit a high frequency of viral integrations at Xpcl1 (Kis2), a locus on the X-chromosome. Xpcl1 encodes miR-106a similar to 363, a cluster of microRNAs that are expressed in response to adjacent retroviral integrations. We report the first large-scale profile of microRNA expression in MuLV-induced lymphomas, in combination with microarray gene expression analysis. The source material was T-cell lymphomas induced by M-MuLV in p27(Kip1) knockout mice and normal thymus. Surprisingly, the overall levels of miRNA expression were equivalent in lymphomas and normal thymus. Nonetheless, the expression of specific microRNAs was altered in tumors. The miR-106a similar to 363 miRNA were over-expressed in lymphomas, particularly those with viral integrations at the Xpcl1 locus. In contrast, p27(Kip1) deletion itself was associated with a different pattern of microRNA expression. Gene expression was dramatically altered in lymphomas, yet paralleled data from T-cell lymphomas induced by other mechanisms. Genes with altered expression in association with the p27(Kip1) null genotype were of similar functional classes to those associated with Xpcl1 integration, but with the opposite pattern of expression. Thus, the effect of p27(Kip1) deletion may be to oppose an anti-oncogenic effect of Xpcl1 rather than enhancing its oncogenic functions. A subset of miR-106a similar to 363 target genes was consistently reduced in lymphomas with Xpcl1 integrations, particularly genes with cell cycle and immune functions. We identify four predicted target genes of miR-106a similar to 363 miRNA, including N-Myc (Mycn), and the TGF-beta receptor (Tgfbr2) using 3'UTR reporter assays. Still, bioinformatic miRNA target predictions were poor predictors of altered gene expression in lymphomas with Xpcl1 integration. Confirmation of miR-106a similar to 363 gene targeting relevant to the tumor phenotype requires in vivo validation, because only a subset of predicted targets are consistently reduced in tumors that overexpress miR-106a similar to 363.	[Kuppers, Daniel A.; Hwang, Harry C.; Clurman, Bruce E.; Fero, Matthew L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Jackson, Aimee L.; Linsley, Peter S.] Rosetta Inpharmat, Seattle, WA USA	Fred Hutchinson Cancer Center; Merck & Company	Kuppers, DA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	mfero@fhcrc.org	Clurman, Bruce/AAV-3854-2021	Jackson, Aimee/0000-0002-3786-7391; Fero, Matthew/0000-0002-9967-4659	National Cancer Institute [R01CA100053, R01CA084069, K08HL073670]; NIH; NATIONAL CANCER INSTITUTE [R01CA084069, R01CA100053, R01CA102742] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL073670] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Cancer Institute R01CA100053 (MLF), R01CA084069 (BEC), K08HL073670 (HCH) http://www.cancer.gov/, Rosetta Inpharmatics, Inc. (PSL, ALJ) provided materials and technical support for microarray processing and miRNA QPCR. The funders had no role in data analysis, the decision to publish, or preparation of the manuscript.; Salary support in the form of research grants from the NIH and NCI was provided to M. Fero, H. Hwang, B. Clurman. Both Regulus Inc. and Rosetta Inpharmatics, Inc (a subsidiary of Merck Inc.) have approved or pending patents involving miRNA and microarray technology. The Fred Hutchinson Cancer Research Center holds patents on p27-deficient mouse models. All individuals received salary support from their host institutions. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Garrett-Engele CM, 2007, PLOS GENET, V3, P2415, DOI 10.1371/journal.pgen.0030219; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landais S, 2005, J VIROL, V79, P11443, DOI 10.1128/JVI.79.17.11443-11456.2005; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lum AM, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-5; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Megason SG, 2002, DEVELOPMENT, V129, P2087; MELLORS RC, 1956, ANN NY ACAD SCI, V63, P1177, DOI 10.1111/j.1749-6632.1956.tb32129.x; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Petrocelli T, 2001, BREAST CANCER RES, V3, P356, DOI 10.1186/bcr322; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; SHIVDASANI RA, 2006, BLOOD; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; VASMEL WLE, 1989, INT J CANCER, V43, P1112, DOI 10.1002/ijc.2910430626; von BERTALANFFY LUDWIN, 1957, CALIFORNIA MED, V87, P248; Wang JB, 2002, BIOINFORMATICS, V18, P1139, DOI 10.1093/bioinformatics/18.8.1139; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WU J, 2009, METHOD MOL BIOL, P205	44	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e14758	10.1371/journal.pone.0014758	http://dx.doi.org/10.1371/journal.pone.0014758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412408	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800003
J	Lee, JY; Zhou, ZP; Taub, PJ; Ramcharan, M; Li, YH; Akinbiyi, T; Maharam, ER; Leong, DJ; Laudier, DM; Ruike, T; Torina, PJ; Zaidi, M; Majeska, RJ; Schaffler, MB; Flatow, EL; Sun, HB				Lee, Jonathan Y.; Zhou, Zuping; Taub, Peter J.; Ramcharan, Melissa; Li, Yonghui; Akinbiyi, Takintope; Maharam, Edward R.; Leong, Daniel J.; Laudier, Damien M.; Ruike, Takuya; Torina, Phillip J.; Zaidi, Mone; Majeska, Robert J.; Schaffler, Mitchell B.; Flatow, Evan L.; Sun, Hui B.			BMP-12 Treatment of Adult Mesenchymal Stem Cells In Vitro Augments Tendon-Like Tissue Formation and Defect Repair In Vivo	PLOS ONE			English	Article							GENE-TRANSFER; ROOF PLATE; DIFFERENTIATION; EXPRESSION; FAMILY; PROLIFERATION; OSTEOBLASTS; TENOMODULIN; TENOCYTES; GROWTH	We characterized the differentiation of rat bone marrow-derived mesenchymal stem cells (BM-MSCs) into tenocyte-like cells in response to bone morphogenetic protein-12 (BMP-12). BM-MSCs were prepared from Sprague-Dawley rats and cultured as monolayers. Recombinant BMP-12 treatment (10 ng/ml) of BM-MSCs for 12 hours in vitro markedly increased expression of the tenocyte lineage markers scleraxis (Scx) and tenomodulin (Tnmd) over 14 days. Treatment with BMP-12 for a further 12-hour period had no additional effect. Colony formation assays revealed that similar to 80% of treated cells and their progeny were Scx-and Tnmd-positive. BM-MSCs seeded in collagen scaffolds and similarly treated with a single dose of BMP-12 also expressed high levels of Scx and Tnmd, as well as type I collagen and tenascin-c. Furthermore, when the treated BM-MSC-seeded scaffolds were implanted into surgically created tendon defects in vivo, robust formation of tendon-like tissue was observed after 21 days as evidenced by increased cell number, elongation and alignment along the tensile axis, greater matrix deposition and the elevated expression of tendon markers. These results indicate that brief stimulation with BMP-12 in vitro is sufficient to induce BM-MSC differentiation into tenocytes, and that this phenotype is sustained in vivo. This strategy of pretreating BM-MSCs with BMP-12 prior to in vivo transplantation may be useful in MSC-based tendon reconstruction or tissue engineering.	[Lee, Jonathan Y.; Zhou, Zuping; Ramcharan, Melissa; Li, Yonghui; Akinbiyi, Takintope; Maharam, Edward R.; Leong, Daniel J.; Laudier, Damien M.; Ruike, Takuya; Majeska, Robert J.; Schaffler, Mitchell B.; Flatow, Evan L.; Sun, Hui B.] Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, New York, NY USA; [Lee, Jonathan Y.; Taub, Peter J.; Torina, Phillip J.] Mt Sinai Sch Med, Div Plast Surg, New York, NY USA; [Ramcharan, Melissa; Leong, Daniel J.; Majeska, Robert J.; Schaffler, Mitchell B.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Zaidi, Mone] Mt Sinai Sch Med, Mt Sinai Bone Program, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY); Icahn School of Medicine at Mount Sinai	Lee, JY (corresponding author), Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, New York, NY USA.	Herb.Sun@mssm.edu		Akinbiyi, Takintope/0000-0002-7208-9054	National Institutes of Health [AR47628, AR52743]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052743, R03AR047628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Institutes of Health to Hui B. Sun (AR47628 and AR52743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002; Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41; Inada M, 1996, BIOCHEM BIOPH RES CO, V222, P317, DOI 10.1006/bbrc.1996.0742; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Lee EH, 2006, J BONE JOINT SURG BR, V88B, P841, DOI 10.1302/0301-620X.88B7.17305; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Lou JR, 2001, J ORTHOPAED RES, V19, P1199, DOI 10.1016/S0736-0266(01)00042-0; Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74; Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011; Pereira RC, 2000, J CELL PHYSIOL, V182, P239, DOI 10.1002/(SICI)1097-4652(200002)182:2<239::AID-JCP13>3.0.CO;2-W; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Settle S, 2001, DEV BIOL, V234, P138, DOI 10.1006/dbio.2001.0244; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Wang QW, 2005, J BIOSCI BIOENG, V100, P418, DOI 10.1263/jbb.100.418; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403; Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023	31	28	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17531	10.1371/journal.pone.0017531	http://dx.doi.org/10.1371/journal.pone.0017531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412429	gold, Green Published			2022-12-25	WOS:000288247800011
J	Wang, XV; Verhaak, RGW; Purdom, E; Spellman, PT; Speed, TP				Wang, Xin Victoria; Verhaak, Roel G. W.; Purdom, Elizabeth; Spellman, Paul T.; Speed, Terence P.			Unifying Gene Expression Measures from Multiple Platforms Using Factor Analysis	PLOS ONE			English	Article							PROBE LEVEL DATA; MICROARRAY DATA; REPRODUCIBILITY; DISCOVERY; GENOME	In the Cancer Genome Atlas (TCGA) project, gene expression of the same set of samples is measured multiple times on different microarray platforms. There are two main advantages to combining these measurements. First, we have the opportunity to obtain a more precise and accurate estimate of expression levels than using the individual platforms alone. Second, the combined measure simplifies downstream analysis by eliminating the need to work with three sets of expression measures and to consolidate results from the three platforms. We propose to use factor analysis (FA) to obtain a unified gene expression measure (UE) from multiple platforms. The UE is a weighted average of the three platforms, and is shown to perform well in terms of accuracy and precision. In addition, the FA model produces parameter estimates that allow the assessment of the model fit. The R code is provided in File S2. Gene-level FA measurements for the TCGA data sets are available from http://tcga-data.nci.nih.gov/docs/publications/unified_expression/.	[Wang, Xin Victoria] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Wang, Xin Victoria] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Verhaak, Roel G. W.] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA USA; [Purdom, Elizabeth] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Spellman, Paul T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Wang, XV (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	vwang@jimmy.harvard.edu	Verhaak, Roel/ABE-7058-2020		National Institutes of Health [U24 CA126551]; Dutch Cancer Society KWF; NATIONAL CANCER INSTITUTE [U24CA126551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society KWF(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [U24 CA126551 to XVW, EP, PTS, and TPS] and Dutch Cancer Society KWF [fellowship to RGWV]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomew DKM, 1999, LATENT VARIABLE MODE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; EFRON B, 1997, INTRO BOOTSTRAP; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; *ILL, 2008, DIG GEN EXPR TAG PRO; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; *NAT CANC I, 2009, TCGA DAT PRIM; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-419; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth G., 2003, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Verhaak RGW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-105; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265	24	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17691	10.1371/journal.pone.0017691	http://dx.doi.org/10.1371/journal.pone.0017691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21436879	Green Submitted, Green Published, gold			2022-12-25	WOS:000288247800025
J	Whitney, HM; Poetes, R; Steiner, U; Chittka, L; Glover, BJ				Whitney, Heather M.; Poetes, Rosa; Steiner, Ullrich; Chittka, Lars; Glover, Beverley J.			Determining the Contribution of Epidermal Cell Shape to Petal Wettability Using Isogenic Antirrhinum Lines	PLOS ONE			English	Article							FORAGING BUMBLEBEES; PLANT-SURFACES; FLOWER COLOR; SCENT MARK; WATER; MAJUS; INSPIRATION; POLLINATION; REPELLENT; WETNESS	The petal epidermis acts not only as a barrier to the outside world but also as a point of interaction between the flower and potential pollinators. The presence of conical petal epidermal cells has previously been shown to influence the attractiveness of the flower to pollinating insects. Using Antirrhinum isogenic lines differing only in the presence of a single epidermal structure, conical cells, we were able to investigate how the structure of the epidermis influences petal wettability by measuring the surface contact angle of water drops. Conical cells have a significant impact on how water is retained on the flower surface, which may have indirect consequences for pollinator behaviour. We discuss how the petal epidermis is a highly multifunctional one and how a battery of methods, including the use of isogenic lines, is required to untangle the impacts of specific epidermal properties in an ecological context.	[Whitney, Heather M.; Glover, Beverley J.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Whitney, Heather M.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Poetes, Rosa; Steiner, Ullrich] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Chittka, Lars] Univ London, Sch Biol & Chem Sci, London, England	University of Cambridge; University of Bristol; University of Cambridge; University of London	Whitney, HM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	heather.whitney@bristol.ac.uk	Chittka, Lars/C-3110-2012; Steiner, Ullrich/K-4777-2013	Chittka, Lars/0000-0001-8153-1732; Steiner, Ullrich/0000-0001-5936-339X; Whitney, Heather/0000-0001-6450-8266	NERC [NE/C000552/1]; Cambridge University Research Exchange; Natural Environment Research Council [NE/C000552/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Cambridge University Research Exchange(University of Cambridge); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HMW was supported by a NERC grant NE/C000552/1 (to BJG and LC) and by the Cambridge University Research Exchange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal B, 2010, OECOLOGIA, V162, P1, DOI 10.1007/s00442-009-1437-3; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Brewer CA, 1997, PLANT CELL ENVIRON, V20, P1, DOI 10.1046/j.1365-3040.1997.d01-15.x; BREWER CA, 1991, PLANT CELL ENVIRON, V14, P955, DOI 10.1111/j.1365-3040.1991.tb00965.x; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; Dyer AG, 2007, ARTHROPOD-PLANT INTE, V1, P45, DOI 10.1007/s11829-007-9002-7; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; EVANS KJ, 1992, PHYTOPATHOLOGY, V82, P890, DOI 10.1094/Phyto-82-890; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Glover BJ, 1998, HEREDITY, V80, P778, DOI 10.1046/j.1365-2540.1998.00345.x; Goulson D, 2000, J CHEM ECOL, V26, P2897, DOI 10.1023/A:1026406330348; Holder CD, 2007, BIOTROPICA, V39, P767, DOI 10.1111/j.1744-7429.2007.00303.x; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a; Koch K, 2009, PHILOS T R SOC A, V367, P1487, DOI 10.1098/rsta.2009.0022; Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Saleh N, 2006, ANIM BEHAV, V71, P847, DOI 10.1016/j.anbehav.2005.06.014; SCHMITT U, 1990, OECOLOGIA, V82, P137, DOI 10.1007/BF00318545; van der Wal P, 2007, SOFT MATTER, V3, P426, DOI 10.1039/b613947g; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Whitney Heather M., 2009, Communicative & Integrative Biology, V2, P505; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051	25	25	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17576	10.1371/journal.pone.0017576	http://dx.doi.org/10.1371/journal.pone.0017576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423738	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100016
J	Lee, SH; Ooi, SK; Mahadi, NM; Tan, MW; Nathan, S				Lee, Song-Hua; Ooi, Soon-Keat; Mahadi, Nor Muhammad; Tan, Man-Wah; Nathan, Sheila			Complete Killing of Caenorhabditis elegans by Burkholderia pseudomallei Is Dependent on Prolonged Direct Association with the Viable Pathogen	PLOS ONE			English	Article							MODEL HOST; MELIOIDOSIS; VIRULENCE; INFECTION; DIVERSITY; DISEASE	Background: Burkholderia pseudomallei is the causative agent of melioidosis, a disease of significant morbidity and mortality in both human and animals in endemic areas. Much remains to be known about the contributions of genotypic variations within the bacteria and the host, and environmental factors that lead to the manifestation of the clinical symptoms of melioidosis. Methodology/Principal Findings: In this study, we showed that different isolates of B. pseudomallei have divergent ability to kill the soil nematode Caenorhabditis elegans. The rate of nematode killing was also dependent on growth media: B. pseudomallei grown on peptone-glucose media killed C. elegans more rapidly than bacteria grown on the nematode growth media. Filter and bacteria cell-free culture filtrate assays demonstrated that the extent of killing observed is significantly less than that observed in the direct killing assay. Additionally, we showed that B. pseudomallei does not persistently accumulate within the C. elegans gut as brief exposure to B. pseudomallei is not sufficient for C. elegans infection. Conclusions/Significance: A combination of genetic and environmental factors affects virulence. In addition, we have also demonstrated that a Burkholderia-specific mechanism mediating the pathogenic effect in C. elegans requires proliferating B. pseudomallei to continuously produce toxins to mediate complete killing.	[Lee, Song-Hua; Ooi, Soon-Keat; Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Ukm Bangi, Selangor, Malaysia; [Mahadi, Nor Muhammad; Nathan, Sheila] Malaysia Genome Inst, UKM MTDC Technol Ctr, Ukm Bangi, Selangor, Malaysia; [Tan, Man-Wah] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Tan, Man-Wah] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Stanford University; Stanford University	Lee, SH (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Ukm Bangi, Selangor, Malaysia.	sheila@ukm.my	Nathan, Sheila/C-1182-2011	Nathan, Sheila/0000-0002-2132-2346	Ministry of Science, Technology & Innovation, Malaysia	Ministry of Science, Technology & Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The project was funded by the Ministry of Science, Technology & Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Ashcroft N, 2002, GENESIS, V33, P1, DOI 10.1002/gene.10083; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Balaji V, 2004, INDIAN J MED RES, V119, P101; Bleich A, 2005, PATHOBIOLOGY, V72, P293, DOI 10.1159/000091327; BRENNER S, 1974, GENETICS, V77, P71; Chaowagul W, 2000, ACTA TROP, V74, P133, DOI 10.1016/S0001-706X(99)00062-5; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Gan YH, 2002, MOL MICROBIOL, V44, P1185, DOI 10.1046/j.1365-2958.2002.02957.x; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; JANSSON HB, 1994, J NEMATOL, V26, P430; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee SH, 2007, DIAGN MICR INFEC DIS, V58, P263, DOI 10.1016/j.diagmicrobio.2007.01.002; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Ou KL, 2005, J BACTERIOL, V187, P4276, DOI 10.1128/JB.187.12.4276-4285.2005; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TITBALL RW, 2008, T ROYAL SOC TROP S1, V102, P111; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WIXTON J, 2000, YEAST, V17, P37	34	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16707	10.1371/journal.pone.0016707	http://dx.doi.org/10.1371/journal.pone.0016707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408228	Green Published, gold, Green Submitted			2022-12-25	WOS:000288099800006
J	Veziris, N; Ibrahim, M; Lounis, N; Andries, K; Jarlier, V				Veziris, Nicolas; Ibrahim, Murad; Lounis, Nacer; Andries, Koen; Jarlier, Vincent			Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MICROBIAL ENUMERATION TECHNIQUE; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; MOUSE TISSUES; MOXIFLOXACIN; PYRAZINAMIDE; INFECTION; THERAPY; R207910	Rationale: The sterilizing activity of the regimen used to treat multidrug resistant tuberculosis (MDR TB) has not been studied in a mouse model. Objective and Methods: Swiss mice were intravenously inoculated with 6 log10 of Mycobacterium tuberculosis (TB) strain H37Rv, treated with second- line drug combinations with or without the diarylquinoline TMC207, and then followed without treatment for 3 more months to determine relapse rates (modified Cornell model). Measurements: Bactericidal efficacy was assessed by quantitative lung colony- forming unit (CFU) counts. Sterilizing efficacy was assessed by measuring bacteriological relapse rates 3 months after the end of treatment. Main Results: The relapse rate observed after 12 months treatment with the WHO recommended MDR TB regimen (amikacin, ethionamide, pyrazinamide and moxifloxacin) was equivalent to the relapse rate observed after 6 months treatment with the recommended drug susceptible TB regimen (rifampin, isoniazid and pyrazinamide). When TMC207 was added to this MDR TB regimen, the treatment duration needed to reach the same relapse rate dropped to 6 months. A similar relapse rate was also obtained with a 6- month completely oral regimen including TMC207, moxifloxacin and pyrazinamide but excluding both amikacin and ethionamide. Conclusions: In this murine model the duration of the WHO MDR TB treatment could be reduced to 12 months instead of the recommended 18- 24 months. The inclusion of TMC207 in the WHO MDR TB treatment regimen has the potential to further shorten the treatment duration and at the same time to simplify treatment by eliminating the need to include an injectable aminoglycoside. dd	[Veziris, Nicolas; Ibrahim, Murad; Jarlier, Vincent] Univ Paris 06, EA 1541, Lab Bacteriol Hyg, Paris, France; [Veziris, Nicolas; Ibrahim, Murad; Jarlier, Vincent] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg, Paris, France; [Veziris, Nicolas; Ibrahim, Murad; Jarlier, Vincent] Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France; [Ibrahim, Murad] Al Quds Univ Abu Dies, Fac Med, Dept Microbiol & Immunol, Jerusalem, Israel; [Lounis, Nacer; Andries, Koen] Tibotec BVBA, Dept Antimicrobial Res, Beerse, Belgium	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Johnson & Johnson	Veziris, N (corresponding author), Univ Paris 06, EA 1541, Lab Bacteriol Hyg, Paris, France.	nicolas.veziris@upmc.fr	Ibrahim, Murad/AAC-5781-2019; veziris, nicolas/O-9783-2017	veziris, nicolas/0000-0001-5660-6544	Johnson and Johnson, Beerse, Belgium; Universite Paris 6 [EA 1541]	Johnson and Johnson, Beerse, Belgium(Johnson & JohnsonJohnson & Johnson USA); Universite Paris 6	This work was partly supported by Johnson and Johnson, Beerse, Belgium (128106 euros grant). KA and NL are employees of Tibotec BVBA, a subsidiary of Johnson and Johnson, and participated in the design of the study, analysis of the results and writing of the manuscipt. The laboratory is supported by annual grant EA 1541 from Universite Paris 6, Pierre-et-Marie Curie.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Andries K, 2010, ANTIMICROB AGENTS CH, V54, P4540, DOI 10.1128/AAC.00934-10; Davies GR, 2007, ANTIMICROB AGENTS CH, V51, P403, DOI 10.1128/AAC.01246-06; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; DYEC, 2006, LANCET, V367, P938; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; GROSSET J, 1992, ANTIMICROB AGENTS CH, V36, P548, DOI 10.1128/AAC.36.3.548; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Grosset J, 1998, MYCOBACTERIA, VII, P51; GRUMBACH F, 1965, ETUDES CHIMIOTHERAPI, P31; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Ibrahim M, 2009, AM J RESP CRIT CARE, V180, P553, DOI 10.1164/rccm.200807-1152OC; LECOEUR HF, 1989, AM REV RESPIR DIS, V140, P1189, DOI 10.1164/ajrccm/140.5.1189; Lenaerts AJ, 2004, TUBERCULOSIS, V84, P361, DOI 10.1016/j.tube.2004.03.002; Lounis N, 1997, ANTIMICROB AGENTS CH, V41, P607, DOI 10.1128/AAC.41.3.607; Lounis N, 2006, ANTIMICROB AGENTS CH, V50, P3543, DOI 10.1128/AAC.00766-06; Lubasch A, 2000, ANTIMICROB AGENTS CH, V44, P2600, DOI 10.1128/AAC.44.10.2600-2603.2000; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; MCNEELEY DF, 2010, TMC207 VERSUS PLACEB; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Poissy J, 2010, ANTIMICROB AGENTS CH, V54, P4765, DOI 10.1128/AAC.00968-10; Rosenthal IM, 2005, AM J RESP CRIT CARE, V172, P1457, DOI 10.1164/rccm.200507-1072OC; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; TRUFFOTPERNOT C, 1991, TUBERCLE, V72, P57, DOI 10.1016/0041-3879(91)90025-N; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Veziris N, 2003, ANTIMICROB AGENTS CH, V47, P3117, DOI 10.1128/AAC.47.10.3117-3122.2003; VEZIRIS N, 2007, R207910 CONTAINING R; Williams B, 2007, AM J RESP CRIT CARE, V175, P6, DOI 10.1164/rccm.200609-1376ED; World Health Organization, 2006, GUID PROGR MAN DRUG; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	34	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17556	10.1371/journal.pone.0017556	http://dx.doi.org/10.1371/journal.pone.0017556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408613	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200025
J	Weissenmayer, BA; Prendergast, JGD; Lohan, AJ; Loftus, BJ				Weissenmayer, Barbara A.; Prendergast, James G. D.; Lohan, Amanda J.; Loftus, Brendan J.			Sequencing Illustrates the Transcriptional Response of Legionella pneumophila during Infection and Identifies Seventy Novel Small Non-Coding RNAs	PLOS ONE			English	Article							INTRACELLULAR MULTIPLICATION; SECRETION SYSTEM; 6S RNA; GENE; ACANTHAMOEBA; ACTIVATION; EXPRESSION; PATHWAYS; PROTEIN; AMEBAS	Second generation sequencing has prompted a number of groups to re-interrogate the transcriptomes of several bacterial and archaeal species. One of the central findings has been the identification of complex networks of small non-coding RNAs that play central roles in transcriptional regulation in all growth conditions and for the pathogen's interaction with and survival within host cells. Legionella pneumophila is a Gram-negative facultative intracellular human pathogen with a distinct biphasic lifestyle. One of its primary environmental hosts in the free-living amoeba Acanthamoeba castellanii and its infection by L. pneumophila mimics that seen in human macrophages. Here we present analysis of strand specific sequencing of the transcriptional response of L. pneumophila during exponential and post-exponential broth growth and during the replicative and transmissive phase of infection inside A. castellanii. We extend previous microarray based studies as well as uncovering evidence of a complex regulatory architecture underpinned by numerous non-coding RNAs. Over seventy new non-coding RNAs could be identified; many of them appear to be strain specific and in configurations not previously reported. We discover a family of non-coding RNAs preferentially expressed during infection conditions and identify a second copy of 6S RNA in L. pneumophila. We show that the newly discovered putative 6S RNA as well as a number of other non-coding RNAs show evidence for antisense transcription. The nature and extent of the non-coding RNAs and their expression patterns suggests that these may well play central roles in the regulation of Legionella spp. specific traits and offer clues as to how L. pneumophila adapts to its intracellular niche. The expression profiles outlined in the study have been deposited into Genbank's Gene Expression Omnibus (GEO) database under the series accession GSE27232.	[Weissenmayer, Barbara A.; Lohan, Amanda J.; Loftus, Brendan J.] UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Prendergast, James G. D.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University College Dublin; University of Edinburgh	Loftus, BJ (corresponding author), UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland.	brendan.loftus@ucd.ie	GenePool, The/D-8812-2012	Lohan, Amanda/0000-0002-3574-7572; loftus, brendan/0000-0001-8871-8356; Prendergast, James/0000-0001-8916-018X	Irish Science Foundation (SFI) [05/RP1/B908, 05/RP1/908/EC07]	Irish Science Foundation (SFI)(Science Foundation Ireland)	This work was funded by the Irish Science Foundation (SFI) grants 05/RP1/B908 & 05/RP1/908/EC07 awarded to BJL (http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Alsam S, 2006, J MED MICROBIOL, V55, P689, DOI 10.1099/jmm.0.46497-0; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Berk SG, 2006, ENVIRON SCI TECHNOL, V40, P7440, DOI 10.1021/es0604257; Brantl S, 2009, FUTURE MICROBIOL, V4, P85, DOI 10.2217/17460913.4.1.85; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cianciotto NP, 2001, INT J MED MICROBIOL, V291, P331, DOI 10.1078/1438-4221-00139; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Conover GM, 2008, CELL MICROBIOL, V10, P514, DOI 10.1111/j.1462-5822.2007.01066.x; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Jules M, 2007, FEBS LETT, V581, P2829, DOI 10.1016/j.febslet.2007.05.026; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; Kohler R, 2000, MOL GEN GENET, V262, P1060, DOI 10.1007/PL00008649; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Molmeret M, 2004, MICROBES INFECT, V6, P129, DOI 10.1016/j.micinf.2003.11.004; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Rossier O, 2008, APPL ENVIRON MICROB, V74, P753, DOI 10.1128/AEM.01944-07; Rubin CJ, 2005, INT J SYST EVOL MICR, V55, P2039, DOI 10.1099/ijs.0.63656-0; SAHR T, 2009, MOL MICROBIOL; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; TESH MJ, 1981, J CLIN MICROBIOL, V13, P865, DOI 10.1128/JCM.13.5.865-869.1981; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	54	66	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17570	10.1371/journal.pone.0017570	http://dx.doi.org/10.1371/journal.pone.0017570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408607	Green Published, gold, Green Submitted			2022-12-25	WOS:000287965200028
J	Osei-Sarfo, K; Martello, L; Ibrahim, S; Pellicer, A				Osei-Sarfo, K.; Martello, L.; Ibrahim, S.; Pellicer, A.			The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral	ONCOGENE			English	Article						Rgr; GEFs; Ras GTPases; Ral GTPases; T-cell lymphoma	GUANINE-NUCLEOTIDE EXCHANGE; DISSOCIATION STIMULATOR; HUMAN CANCER; KAPPA-B; ACTIVATION; GENE; GTPASE; PATHWAY; EFFECTOR; SOS	The Ras superfamily of GTPases is involved in the modification of many cellular processes including cellular motility, proliferation and differentiation. Our laboratory has previously identified the RalGDS-related (Rgr) oncogene in a DMBA (7,12-dimethylbenz[alpha]anthracene)-induced rabbit squamous cell carcinoma and its human orthologue, hRgr. In this study, we analyzed the expression levels of the human hRgr transcript in a panel of human hematopoietic malignancies and found that a truncated form (diseased-truncated (Dtr-hrgr)) was significantly overexpressed in many T-cell-derived neoplasms. Although the Rgr proto-oncogene belongs to the RalGDS family of guanine nucleotide exchange factors (GEFs), we show that upon the introduction of hRgr into fibroblast cell lines, it is able to elicit the activation of both Ral and Ras GTPases. Moreover, in vitro guanine nucleotide exchange assays confirm that hRgr promotes Ral and Ras activation through GDP dissociation, which is a critical characteristic of GEF proteins. hRgr has guanine nucleotide exchange activity for both small GTPases and this activity was reduced when a point mutation within the catalytic domain (CDC25) of the protein, (cd) Dtr-hRgr, was utilized. These observations prompted the analysis of the biological effects of hRgr and (cd) hRgr expression in cultured cells. Here, we show that hRgr increases proliferation in low serum, increases invasion, reduces anchorage dependence and promotes the progression into the S phase of the cell cycle; properties that are abolished or severely reduced in the presence of the catalytic dead mutant. We conclude that the ability of hRgr to activate both Ral and Ras is responsible for its transformation-inducing phenotype and it could be an important contributor in the development of some T-cell malignancies. Oncogene (2011) 30, 3661-3671; doi:10.1038/onc.2011.93; published online 28 March 2011	[Osei-Sarfo, K.; Martello, L.; Pellicer, A.] New York Univ, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Ibrahim, S.] New York Univ, Langone Med Ctr, Dept Hematopathol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Pellicer, A (corresponding author), New York Univ, Langone Med Ctr, Dept Pathol, 550 1st Ave,MSB 594, New York, NY 10016 USA.	Angel.Pellicer@nyumc.org	MARTINEZ, ANTONIO PELLICER/C-4832-2015	Pellicer, Angel/0000-0002-5062-0692	NIH [CA50434, CA36327]; NATIONAL CANCER INSTITUTE [R01CA036327, R37CA036327, R01CA050434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs M Philips, D Bar-Sagi and J Bos for the gift of expression plasmids. We thank Kamlesh Yadav and Pamela Sung for their assistance with the mant-guanine nucleotide exchange and cellular proliferation assays, respectively, and Dr M Liu for her assistance with the statistical analysis for the cellular proliferation assay. These studies were supported by NIH Grants CA50434 and CA36327 to AP.	ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; BOS JL, 1989, CANCER RES, V49, P4682; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Ceriani M, 2007, EXP CELL RES, V313, P2293, DOI 10.1016/j.yexcr.2007.03.016; CHARDIN P, 1986, EMBO J, V5, P2203, DOI 10.1002/j.1460-2075.1986.tb04485.x; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; COROMINAS M, 1989, P NATL ACAD SCI USA, V86, P6372, DOI 10.1073/pnas.86.16.6372; DAdamo DR, 1997, ONCOGENE, V14, P1295, DOI 10.1038/sj.onc.1200950; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Garcia-Espana A, 2005, CANCER RES, V65, P1150, DOI 10.1158/0008-5472.CAN-04-2074; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hernandez-Munoz I, 2000, ONCOGENE, V19, P2745, DOI 10.1038/sj.onc.1203586; Hernandez-Munoz I, 2003, CANCER RES, V63, P4188; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Leonardi P, 2002, ONCOGENE, V21, P5108, DOI 10.1038/sj.onc.1205694; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Linnemann T, 2002, J BIOL CHEM, V277, P7831, DOI 10.1074/jbc.M110800200; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mittar D, 2004, BIOCHEM BIOPH RES CO, V322, P203, DOI 10.1016/j.bbrc.2004.07.107; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Oxford G, 2003, J UROLOGY, V170, P1987, DOI 10.1097/01.ju.0000088670.02905.78; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SEKIDO Y, 1995, CANCER RES, V55, P1227; Senga T, 2001, J BIOL CHEM, V276, P32678, DOI 10.1074/jbc.M105749200; Shao HP, 2000, J BIOL CHEM, V275, P26914; Smith SC, 2006, CANCER RES, V66, P1917, DOI 10.1158/0008-5472.CAN-05-3855; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Sood R, 2000, BBA-GENE STRUCT EXPR, V1491, P285, DOI 10.1016/S0167-4781(00)00031-2; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tazmini G, 2009, BBA-MOL CELL RES, V1793, P447, DOI 10.1016/j.bbamcr.2008.12.019; Tchevkina E, 2005, ONCOGENE, V24, P329, DOI 10.1038/sj.onc.1208094; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023	52	8	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	34					3661	3671		10.1038/onc.2011.93	http://dx.doi.org/10.1038/onc.2011.93			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21441953	Green Accepted			2022-12-25	WOS:000294244500002
J	Durand, C; Roeth, R; Dweep, H; Vlatkovic, I; Decker, E; Schneider, KU; Rappold, G				Durand, Claudia; Roeth, Ralph; Dweep, Harsh; Vlatkovic, Irena; Decker, Eva; Schneider, Katja Ute; Rappold, Gudrun			Alternative Splicing and Nonsense-Mediated RNA Decay Contribute to the Regulation of SHOX Expression	PLOS ONE			English	Article							HOMEOBOX GENE SHOX; LERI-WEILL DYSCHONDROSTEOSIS; SHORT STATURE; TURNER-SYNDROME; HUMAN TRANSCRIPTOME; LIMB; EVOLUTION; DOWNSTREAM; PHENOTYPES; MICRORNAS	The human SHOX gene is composed of seven exons and encodes a paired-related homeodomain transcription factor. SHOX mutations or deletions have been associated with different short stature syndromes implying a role in growth and bone formation. During development, SHOX is expressed in a highly specific spatiotemporal expression pattern, the underlying regulatory mechanisms of which remain largely unknown. We have analysed SHOX expression in diverse embryonic, fetal and adult human tissues and detected expression in many tissues that were not known to express SHOX before, e. g. distinct brain regions. By using RT-PCR and comparing the results with RNA-Seq data, we have identified four novel exons (exon 2a, 7-1, 7-2 and 7-3) contributing to different SHOX isoforms, and also established an expression profile for the emerging new SHOX isoforms. Interestingly, we found the exon 7 variants to be exclusively expressed in fetal neural tissues, which could argue for a specific role of these variants during brain development. A bioinformatical analysis of the three novel 3'UTR exons yielded insights into the putative role of the different 3'UTRs as targets for miRNA binding. Functional analysis revealed that inclusion of exon 2a leads to nonsense-mediated RNA decay altering SHOX expression in a tissue and time specific manner. In conclusion, SHOX expression is regulated by different mechanisms and alternative splicing coupled with nonsense-mediated RNA decay constitutes a further component that can be used to fine tune the SHOX expression level.	[Durand, Claudia; Roeth, Ralph; Decker, Eva; Schneider, Katja Ute; Rappold, Gudrun] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [Dweep, Harsh] Univ Heidelberg, Med Res Ctr, Fac Med Mannheim, D-6800 Mannheim, Germany; [Vlatkovic, Irena] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Austrian Academy of Sciences	Durand, C (corresponding author), Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany.	gudrun_rappold@med.uni-heidelberg.de		Vlatkovic, Irena/0000-0001-8745-4299	Deutsche Forschungsgemeinschaft; Landesgraduiertenforderung Baden-Wurttemberg; MRC [G9900837, G0700089] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft. C. Durand was funded by a fellowship from Landesgraduiertenforderung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; Blaschke RJ, 2003, J BIOL CHEM, V278, P47820, DOI 10.1074/jbc.M306685200; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Boncinelli E, 1997, CURR OPIN GENET DEV, V7, P331, DOI 10.1016/S0959-437X(97)80146-3; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Danckwardt S, 2002, BLOOD, V99, P1811, DOI 10.1182/blood.V99.5.1811; Durand C, 2010, EUR J HUM GENET, V18, P527, DOI 10.1038/ejhg.2009.216; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Fukami M, 2006, AM J HUM GENET, V78, P167, DOI 10.1086/499254; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Grandemange S, 2009, HUM MOL GENET, V18, P4746, DOI 10.1093/hmg/ddp437; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rappold G, 2007, J MED GENET, V44, P306, DOI 10.1136/jmg.2006.046581; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Skandalis A, 2004, NUCLEIC ACIDS RES, V32, P6557, DOI 10.1093/nar/gkh967; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; THALMEIER K, 1994, BLOOD, V83, P1799; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Zhang X, 2007, GENE, V400, P131, DOI 10.1016/j.gene.2007.06.008	39	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18115	10.1371/journal.pone.0018115	http://dx.doi.org/10.1371/journal.pone.0018115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448463	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500039
J	Cheever, TR; Olson, EA; Ervasti, JM				Cheever, Thomas R.; Olson, Emily A.; Ervasti, James M.			Axonal Regeneration and Neuronal Function Are Preserved in Motor Neurons Lacking beta-Actin In Vivo	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; DIAPHRAGM MUSCLE DEVELOPMENT; DETERMINING GENE-PRODUCT; MESSENGER-RNA; NEUROMUSCULAR-JUNCTIONS; MOUSE MODEL; GROWTH CONES; PHRENIC-NERVE; SCHWANN-CELLS	In The proper localization of beta-actin mRNA and protein is essential for growth cone guidance and axon elongation in cultured neurons. In addition, decreased levels of beta-actin mRNA and protein have been identified in the growth cones of motor neurons cultured from a mouse model of Spinal Muscular Atrophy (SMA), suggesting that beta-actin loss-of-function at growth cones or pre-synaptic nerve terminals could contribute to the pathogenesis of this disease. However, the role of beta-actin in motor neurons in vivo and its potential relevance to disease has yet to be examined. We therefore generated motor neuron specific beta-actin knock-out mice (Actb-MNsKO) to investigate the function of beta-actin in motor neurons in vivo. Surprisingly, beta-actin was not required for motor neuron viability or neuromuscular junction maintenance. Skeletal muscle from Actb-MNsKO mice showed no histological indication of denervation and did not significantly differ from controls in several measurements of physiologic function. Finally, motor axon regeneration was unimpaired in Actb-MNsKO mice, suggesting that beta-actin is not required for motor neuron function or regeneration in vivo.	[Cheever, Thomas R.; Olson, Emily A.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Cheever, TR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020		National Institutes of Health [AR007612, AR049899]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR049899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health Training Program in Muscle Research (AR007612) and a grant from the National Institutes of Health (AR049899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DW, 1997, J COMP NEUROL, V382, P459, DOI 10.1002/(SICI)1096-9861(19970616)382:4<459::AID-CNE3>3.0.CO;2-1; Baloh RH, 2007, MUSCLE NERVE, V36, P107, DOI 10.1002/mus.20755; Bassell GJ, 1998, J NEUROSCI, V18, P251; BENHAMIDA C, 1994, MUSCLE NERVE, V17, P400; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; CHOO QL, 1978, J NEUROCHEM, V31, P217, DOI 10.1111/j.1471-4159.1978.tb12451.x; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Franz CK, 2008, BRAIN, V131, P1492, DOI 10.1093/brain/awn039; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; George LT, 2003, J RECONSTR MICROSURG, V19, P41, DOI 10.1055/s-2003-37190; GLINKA M, 2010, HUM MOL GENET; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Greer JJ, 1999, J APPL PHYSIOL, V86, P779, DOI 10.1152/jappl.1999.86.3.779; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jaeger MA, 2009, FASEB J, V23, P2205, DOI 10.1096/fj.09-129783; Jevsek M, 2006, P NATL ACAD SCI USA, V103, P6374, DOI 10.1073/pnas.0601468103; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lund LM, 1996, J NEUROBIOL, V31, P476; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Mantilla CB, 2008, J APPL PHYSIOL, V104, P1818, DOI 10.1152/japplphysiol.01192.2007; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; MENDE Y, 2010, HUM MOL GENET; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Prins KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002419; PRINS KW, 2011, J CELL SCI IN PRESS; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; TELERMANTOPPET N, 1978, MUSCLE NERVE, V1, P133, DOI 10.1002/mus.880010205; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Damme P, 2003, NEUROSCI LETT, V343, P81, DOI 10.1016/S0304-3940(03)00314-8; Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Weinberger R, 1996, J NEUROSCI, V16, P238; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87	71	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17768	10.1371/journal.pone.0017768	http://dx.doi.org/10.1371/journal.pone.0017768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445349	gold, Green Published, Green Submitted			2022-12-25	WOS:000288809100007
J	Muscarella, RA; Murray, KL; Ortt, D; Russell, AL; Fleming, TH				Muscarella, Robert A.; Murray, Kevin L.; Ortt, Derek; Russell, Amy L.; Fleming, Theodore H.			Exploring Demographic, Physical, and Historical Explanations for the Genetic Structure of Two Lineages of Greater Antillean Bats	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; LONG-DISTANCE DISPERSAL; POPULATION-STRUCTURE; EROPHYLLA-SEZEKORNI; PUERTO-RICO; LANDSCAPE GENETICS; MIGRATION RATES; EXTINCTION RISK; FLOW; PHYLLOSTOMIDAE	Observed patterns of genetic structure result from the interactions of demographic, physical, and historical influences on gene flow. The particular strength of various factors in governing gene flow, however, may differ between species in biologically relevant ways. We investigated the role of demographic factors (population size and sex-biased dispersal) and physical features (geographic distance, island size and climatological winds) on patterns of genetic structure and gene flow for two lineages of Greater Antillean bats. We used microsatellite genetic data to estimate demographic characteristics, infer population genetic structure, and estimate gene flow among island populations of Erophylla sezekorni/E. bombifrons and Macrotus waterhousii (Chiroptera: Phyllostomidae). Using a landscape genetics approach, we asked if geographic distance, island size, or climatological winds mediate historical gene flow in this system. Samples from 13 islands spanning Erophylla's range clustered into five genetically distinct populations. Samples of M. waterhousii from eight islands represented eight genetically distinct populations. While we found evidence that a majority of historical gene flow between genetic populations was asymmetric for both lineages, we were not able to entirely rule out incomplete lineage sorting in generating this pattern. We found no evidence of contemporary gene flow except between two genetic populations of Erophylla. Both lineages exhibited significant isolation by geographic distance. Patterns of genetic structure and gene flow, however, were not explained by differences in relative effective population sizes, island area, sex-biased dispersal (tested only for Erophylla), or surface-level climatological winds. Gene flow among islands appears to be highly restricted, particularly for M. waterhousii, and we suggest that this species deserves increased taxonomic attention and conservation concern.	[Muscarella, Robert A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Muscarella, Robert A.; Murray, Kevin L.; Fleming, Theodore H.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Ortt, Derek] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Ortt, Derek] ImpactWeather, Houston, TX USA; [Russell, Amy L.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA	Columbia University; University of Miami; University of Miami; Grand Valley State University	Muscarella, RA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	bob.muscarella@gmail.com	Russell, Amy L/B-2222-2010		National Geographic Society [7959-05]; United States National Science Foundation [DEB-05-05866]; Department of Biology; College of Arts and Sciences at the University of Miami	National Geographic Society(National Geographic Society); United States National Science Foundation(National Science Foundation (NSF)); Department of Biology; College of Arts and Sciences at the University of Miami	We thank the National Geographic Society (grant 7959-05) (http://www.nationalgeographic.com/field/grants-programs/cre.html), the United States National Science Foundation (DEB-05-05866) (http://www.nsf.gov/), the Department of Biology (W. Evoy Fund) (http://www.bio. miami.edu/), and the College of Arts and Sciences at the University of Miami (http://www.as.miami.edu/) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; ANDERSON S, 1969, Mammalian Species, V1, P1; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; Baker R.J., 2003, OCCASIONAL PAPERS MU, V230, P1, DOI DOI 10.5962/BHL.TITLE.156931; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P., 2004, MIGRATE DOCUMENTATIO; BELL GP, 1985, BEHAV ECOL SOCIOBIOL, V16, P343, DOI 10.1007/BF00295547; Calsbeek R, 2003, NATURE, V426, P552, DOI 10.1038/nature02143; Carstens BC, 2004, MOL ECOL, V13, P2557, DOI 10.1111/j.1365-294X.2004.02250.x; CAVIEDES C, 1991, GEOJOURNAL, V23; *CLARK LABS, 2006, IDRISI AND; Consuegra S, 2005, CONSERV GENET, V6, P823, DOI 10.1007/s10592-005-9042-4; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2007, B MATH BIOL, V69, P797, DOI 10.1007/s11538-006-9161-1; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Fleming Theodore H., 2009, P116; Fleming TH, 2009, BIOTROPICA, V41, P250, DOI 10.1111/j.1744-7429.2008.00466.x; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; FREELAND JR, 2006, MOL ECOLOGY; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; GANNON MR, 1994, BIOTROPICA, V26, P320, DOI 10.2307/2388854; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GRIFFITHS TA, 1988, BIOTROPICA, V20, P240, DOI 10.2307/2388240; HADLEY G, 1735, PHILOS T R SOC LOND, V34, P58; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Hare MP, 2005, EVOLUTION, V59, P2509, DOI 10.1554/05-150.1; Heaney LR, 2007, J BIOGEOGR, V34, P753, DOI 10.1111/j.1365-2699.2007.01692.x; Hedges SB, 1996, ANNU REV ECOL SYST, V27, P163, DOI 10.1146/annurev.ecolsys.27.1.163; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; JENNESS J, 2004, DISTANCE BEARING MAT; Jennings NV, 2004, ACTA CHIROPTEROL, V6, P75, DOI 10.3161/001.006.0106; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Jones KE, 2001, ANIM CONSERV, V4, P59, DOI 10.1017/S1367943001001068; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Kawecki TJ, 2002, AM NAT, V160, P333, DOI 10.1086/341519; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; MAC ARTHUR ROBERT H., 1967; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; MORGAN GS, 2001, BIOGEOGRAPHY W INDIE, P368; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Murray KL, 2008, MOL ECOL RESOUR, V8, P596, DOI 10.1111/j.1471-8286.2007.02007.x; Murray KL, 2008, J MAMMAL, V89, P1391, DOI 10.1644/08-MAMM-S-068.1; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Nowak RM, 1994, WALKERS BATS WORLD; Palstra FP, 2007, MOL ECOL, V16, P4504, DOI 10.1111/j.1365-294X.2007.03541.x; Pritchard JK, 2000, GENETICS, V155, P945; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; Roberts TE, 2006, MOL ECOL, V15, P2183, DOI 10.1111/j.1365-294X.2006.02928.x; RODRIGUEZDURAN A, 1995, COMP BIOCHEM PHYS A, V110, P347, DOI 10.1016/0300-9629(94)00174-R; Russell AL, 2008, J BIOGEOGR, V35, P995, DOI 10.1111/j.1365-2699.2008.01891.x; Safi K, 2004, CONSERV BIOL, V18, P1293, DOI 10.1111/j.1523-1739.2004.00155.x; SAHLEY CT, 1993, J MAMMAL, V74, P594, DOI 10.2307/1382278; Shamoun-Baranes J, 2007, J EXP BIOL, V210, P82, DOI 10.1242/jeb.02612; Simmons N. B., 2005, ORDER CHIROPTERA, P312; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Soto-Centeno JA, 2006, J MAMMAL, V87, P19, DOI 10.1644/05-MAMM-041R1.1; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Telschow A, 2006, J EVOLUTION BIOL, V19, P869, DOI 10.1111/j.1420-9101.2005.01049.x; VALDIVIESO D, 1968, COMP BIOCHEM PHYSIOL, V27, P133, DOI 10.1016/0010-406X(68)90760-3; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vuilleumier S, 2006, P ROY SOC B-BIOL SCI, V273, P1637, DOI 10.1098/rspb.2006.3469; Wares JP, 2001, EVOLUTION, V55, P295; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Westberg E, 2009, J BIOGEOGR, V36, P1398, DOI 10.1111/j.1365-2699.2008.01973.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilson GA, 2003, GENETICS, V163, P1177; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	80	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17704	10.1371/journal.pone.0017704	http://dx.doi.org/10.1371/journal.pone.0017704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445291	Green Published, gold			2022-12-25	WOS:000288613300010
J	Wills, J; Credle, J; Haggerty, T; Lee, JH; Oaks, AW; Sidhu, A				Wills, Jonathan; Credle, Joel; Haggerty, Thomas; Lee, Jae-Hoon; Oaks, Adam W.; Sidhu, Anita			Tauopathic Changes in the Striatum of A53T alpha-Synuclein Mutant Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							LEWY-BODY-DISEASE; ALZHEIMERS-DISEASE; TAU-PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; DEMENTIA COMPLEX; BODIES; BRAIN; PATHOLOGY; MUTATION; GENE	Tauopathic pathways lead to degenerative changes in Alzheimer's disease and there is evidence that they are also involved in the neurodegenerative pathology of Parkinson's disease [PD]. We have examined tauopathic changes in striatum of the alpha-synuclein (alpha-Syn) A53T mutant mouse. Elevated levels of alpha-Syn were observed in striatum of the adult A53T alpha-Syn mice. This was accompanied by increases in hyperphosphorylated Tau [ p-Tau], phosphorylated at Ser202, Ser262 and Ser396/404, which are the same toxic sites also seen in Alzheimer's disease. There was an increase in active p-GSK-3 beta, hyperphosphorylated at Tyr216, a major and primary kinase known to phosphorylate Tau at multiple sites. The sites of hyperphosphorylation of Tau in the A53T mutant mice were similar to those seen in post-mortem striata from PD patients, attesting to their pathophysiological relevance. Increases in p-Tau were not due to alterations on protein phosphatases in either A53T mice or in human PD, suggesting lack of involvement of these proteins in tauopathy. Extraction of striata with Triton X-100 showed large increases in oligomeric forms of alpha-Syn suggesting that alpha-Syn had formed aggregates the mutant mice. In addition, increased levels of p-GSK-3 beta and pSer396/404 were also found associated with aggregated alpha-Syn. Differential solubilization to measure protein binding to cytoskeletal proteins demonstrated that p-Tau in the A53T mutant mouse were unbound to cytoskeletal proteins, consistent with dissociation of p-Tau from the microtubules upon hyperphosphorylation. Interestingly, alpha-Syn remained tightly bound to the cytoskeleton, while p-GSK-3 beta was seen in the cytoskeleton-free fractions. Immunohistochemical studies showed that alpha-Syn, pSer396/404 Tau and p-GSK-3 beta co-localized with one another and was aggregated and accumulated into large inclusion bodies, leading to cell death of Substantia nigral neurons. Together, these data demonstrate an elevated state of tauopathy in striata of the A53T alpha-Syn mutant mice, suggesting that tauopathy is a common feature of synucleinopathies.	[Wills, Jonathan; Credle, Joel; Haggerty, Thomas; Lee, Jae-Hoon; Oaks, Adam W.; Sidhu, Anita] Georgetown Univ, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University	Wills, J (corresponding author), Georgetown Univ, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA.	sidhua@georgetown.edu			National Institute on Aging, Arizona Alzheimer's Disease Core Center [P30 AG19610]; Arizona Department of Health Services, Arizona Alzheimer's Research Center [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901]; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; National Institute on Aging [R01 NIA AGO28108]; NATIONAL INSTITUTE ON AGING [R01AG028108, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging, Arizona Alzheimer's Disease Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services, Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Brain Donation Program is supported by the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05-901 to the Arizona Parkinson's Disease Consortium), and the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research. This study was supported by a National Institute on Aging grant R01 NIA AGO28108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2000, J CELL SCI, V113, P3737; Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; Barroso-Chinea P, 2005, EUR J NEUROSCI, V21, P1815, DOI 10.1111/j.1460-9568.2005.04024.x; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Forman MS, 2002, AM J PATHOL, V160, P1725, DOI 10.1016/S0002-9440(10)61119-4; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Griffin WST, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-5; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hofer A, 2005, J NEURAL TRANSM, V112, P1249, DOI 10.1007/s00702-004-0263-3; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Iseki E, 1999, NEUROSCI LETT, V265, P9, DOI 10.1016/S0304-3940(99)00178-0; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jeannotte AM, 2008, J NEUROCHEM, V105, P1668, DOI 10.1111/j.1471-4159.2008.05258.x; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Jellinger KA, 2004, J NEURAL TRANSM, V111, P1219, DOI 10.1007/s00702-004-0138-7; Joyce JN, 2002, BRAIN RES, V955, P138, DOI 10.1016/S0006-8993(02)03396-6; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kozikowski AP, 2006, CHEMMEDCHEM, V1, P256, DOI 10.1002/cmdc.200500039; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; LEI P, 2010, INT J BIOCH CEL 0801; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Szpak GM, 2001, FOLIA NEUROPATHOL, V39, P63; Tsuboi Y, 2003, NEUROPATH APPL NEURO, V29, P503, DOI 10.1046/j.1365-2990.2003.00453.x; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Yamazaki M, 2000, J NEUROPATH EXP NEUR, V59, P585, DOI 10.1093/jnen/59.7.585; Zhong J, 1999, FEBS LETT, V453, P224, DOI 10.1016/S0014-5793(99)00715-2; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200	48	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17953	10.1371/journal.pone.0017953	http://dx.doi.org/10.1371/journal.pone.0017953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445308	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300024
J	Lucero, ME; Unc, A; Cooke, P; Dowd, S; Sun, SL				Lucero, Mary E.; Unc, Adrian; Cooke, Peter; Dowd, Scot; Sun, Shulei			Endophyte Microbiome Diversity in Micropropagated Atriplex canescens and Atriplex torreyi var griffithsii	PLOS ONE			English	Article							BOUTELOUA-ERIOPODA TORR.; DARK SEPTATE FUNGI; ENHANCED SPECIFICITY; BACTERIAL DIVERSITY; FOURWING SALTBUSH; TALL FESCUE; GROWTH; IDENTIFICATION; AMPLIFICATION; PRODUCTIVITY	Microbial diversity associated with micropropagated Atriplex species was assessed using microscopy, isolate culturing, and sequencing. Light, electron, and confocal microscopy revealed microbial cells in aseptically regenerated leaves and roots. Clone libraries and tag-encoded FLX amplicon pyrosequencing (TEFAP) analysis amplified sequences from callus homologous to diverse fungal and bacterial taxa. Culturing isolated some seed borne endophyte taxa which could be readily propagated apart from the host. Microbial cells were observed within biofilm-like residues associated with plant cell surfaces and intercellular spaces. Various universal primers amplified both plant and microbial sequences, with different primers revealing different patterns of fungal diversity. Bacterial and fungal TEFAP followed by alignment with sequences from curated databases revealed 7 bacterial and 17 ascomycete taxa in A. canescens, and 5 bacterial taxa in A. torreyi. Additional diversity was observed among isolates and clone libraries. Micropropagated Atriplex retains a complex, intimately associated microbiome which includes diverse strains well poised to interact in manners that influence host physiology. Microbiome analysis was facilitated by high throughput sequencing methods, but primer biases continue to limit recovery of diverse sequences from even moderately complex communities.	[Lucero, Mary E.] ARS, USDA, Las Cruces, NM USA; [Cooke, Peter] New Mexico State Univ, Electron Microscopy Lab, Las Cruces, NM 88003 USA; [Dowd, Scot] Res & Testing Labs LLC, Lubbock, TX USA; [Sun, Shulei] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	United States Department of Agriculture (USDA); New Mexico State University; University of California System; University of California San Diego	Lucero, ME (corresponding author), ARS, USDA, Las Cruces, NM USA.	malucero@nmsu.edu	Unc, Adrian/AAE-8345-2019; Dowd, Scot E/M-5386-2017; Unc, Adrian/F-1382-2010	Unc, Adrian/0000-0002-7265-9758; Dowd, Scot E/0000-0002-6296-1427; Unc, Adrian/0000-0002-7265-9758	USDA-ARS [6235-11210-005-00]; New Mexico State Office of the Bureau of Land Management [6235-11210-006-56]; International Arid Lands Consortium (IALC) [09R-05]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); New Mexico State Office of the Bureau of Land Management; International Arid Lands Consortium (IALC)	This work was funded by USDA-ARS National Program 215, Projects 6235-11210-005-00, summarized at http://www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=406494. Funding was also received from a cooperative agreement with the New Mexico State Office of the Bureau of Land Management (project 6235-11210-006-56), summarized at http://www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=412128. Research was also funded by the International Arid Lands Consortium (IALC) Project 09R-05, summarized at http://alic.arid.arizona.edu/ialc/ialc4.asp?proj=09R-05, through a competitive grant process. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Scot Dowd directs a commercial sequencing facility, and received payment (from Lucero, using funds from USDA-ARS National Program 215, Projects 6235-11210-005-00 and 6235-11210-006-56) for samples processed at the facility. The payment was based on the number of samples processed, and did not depend on successful endophyte detection. Lucero and Dowd worked together to identify some of the primers that were used to sequence some of the endophytes. Others were sequenced using standard proprietary primers from Research and Testing Labs.	ABREUTARAZI MF, 2009, WORLD J MICROB BIOT, P1; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Afkhami ME, 2008, AM NAT, V172, P405, DOI 10.1086/589893; Asghari HR, 2005, PLANT SOIL, V273, P245, DOI 10.1007/s11104-004-7942-6; Bacon CW, 1997, CROP SCI, V37, P1415, DOI 10.2135/cropsci1997.0011183X003700050001x; Barrow Jerry R, 2008, Commun Integr Biol, V1, P69; Barrow JR, 2004, IN VITRO CELL DEV-PL, V40, P608, DOI 10.1079/IVP2004584; Barrow JR, 2002, J ARID ENVIRON, V51, P449, DOI 10.1006/jare.2001.0925; Barrow JR, 2001, MYCORRHIZA, V11, P199, DOI 10.1007/s005720100111; Barrow JR, 1997, ARID SOIL RES REHAB, V11, P307, DOI 10.1080/15324989709381484; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Braun K, 2003, MYCOL RES, V107, P980, DOI 10.1017/S095375620300813X; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Cibils AF, 2000, J ARID ENVIRON, V46, P383, DOI 10.1006/jare.2000.0692; Clay K, 1996, RES POPUL ECOL, V38, P191, DOI 10.1007/BF02515727; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Almeida CV, 2009, WORLD J MICROB BIOT, V25, P1757, DOI 10.1007/s11274-009-0073-8; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Eberl L., 2007, BIOFILM MODE LIFE ME, V12, P215; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fett WF, 2005, FOOD MICROBIOL, V22, P253, DOI 10.1016/j.fm.2004.03.004; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibbens RP, 2005, J ARID ENVIRON, V61, P651, DOI 10.1016/j.jaridenv.2004.10.001; Glenn E, 1998, J ARID ENVIRON, V38, P45, DOI 10.1006/jare.1997.0320; GOBEL UB, 1995, J MICROBIOL METH, V23, P117, DOI 10.1016/0167-7012(95)00025-G; Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; ISHAK HD, 2011, MICROB ECOL, P1; KARIMI SH, 1989, BOT GAZ, V150, P68, DOI 10.1086/337749; Kluger CG, 2008, J TROP ECOL, V24, P351, DOI 10.1017/S0266467408005026; Kowalchuk GA, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P131; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lucero M, 2008, PLANT SCI, V174, P570, DOI 10.1016/j.plantsci.2008.02.012; Lucero ME, 2008, RANGELAND ECOL MANAG, V61, P124, DOI 10.2111/06-144R3.1; Lucero ME, 2006, J ARID ENVIRON, V65, P276, DOI 10.1016/j.jaridenv.2005.08.014; Mandyam K., 2005, STUD MYCOL, V53, P173, DOI [10.3114/sim.53.1.173, DOI 10.3114/SIM.53.1.173]; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; MCARTHUR ED, 1992, EVOLUTION, V46, P1708, DOI [10.2307/2410025, 10.1111/j.1558-5646.1992.tb01163.x]; McKeon C, 2006, J ARID ENVIRON, V64, P1, DOI 10.1016/j.jaridenv.2005.04.008; MILLER RM, 1983, NEW PHYTOL, V95, P241, DOI 10.1111/j.1469-8137.1983.tb03490.x; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Muller P, 2009, PLANT CELL TISS ORG, V98, P35, DOI 10.1007/s11240-009-9536-8; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Petroski Richard J., 1992, Natural Toxins, V1, P84, DOI 10.1002/nt.2620010205; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Piotrowski JS, 2008, ADV AGRON, V97, P111, DOI 10.1016/S0065-2113(07)00003-X; RALPHS MH, 2007, J CHEM ECOL, P1; Reyes-Vera I., 2010, Native Plants Journal, V11, P53, DOI 10.2979/NPJ.2010.11.1.53; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Rudgers JA, 2004, ECOL LETT, V7, P42, DOI 10.1046/j.1461-0248.2003.00543.x; Rudgers Jennifer A., 2007, Fungal Biology Reviews, V21, P107, DOI 10.1016/j.fbr.2007.05.002; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; SANDERSON SC, 2004, FOURWING SALTBUSH AT, P1; Sawalha MF, 2008, INT J ENVIRON POLLUT, V34, P28, DOI 10.1504/IJEP.2008.020780; Sawalha MF, 2007, J CHEM THERMODYN, V39, P488, DOI 10.1016/j.jct.2006.07.020; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sipos R, 2010, METHODS MOL BIOL, V599, P37, DOI 10.1007/978-1-60761-439-5_3; Spatafora J., 2005, MYCOL RES, V109, P755, DOI DOI 10.1017/S0953756205243551; STUTZ HC, 1978, GREAT BASIN NATURALI; Thomas P, 2007, CAN J MICROBIOL, V53, P380, DOI 10.1139/W06-141; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; WAGNER WL, 1978, MANUAL SALTBUSHES AT; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wink M, 2008, NAT PROD COMMUN, V3, P1205; Zhuang J, 2005, AGRON J, V97, P711, DOI 10.2134/agronj2004.0108	76	54	60	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17693	10.1371/journal.pone.0017693	http://dx.doi.org/10.1371/journal.pone.0017693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437280	Green Published, gold			2022-12-25	WOS:000288514600006
J	Cheriyan, J; Kumar, P; Mayadevi, M; Surolia, A; Omkumar, RV				Cheriyan, John; Kumar, Parimal; Mayadevi, Madhavan; Surolia, Avadhesha; Omkumar, Ramakrishnapillai V.			Calcium/Calmodulin Dependent Protein Kinase II Bound to NMDA Receptor 2B Subunit Exhibits Increased ATP Affinity and Attenuated Dephosphorylation	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; NR2B SUBUNIT; BINDING; CALMODULIN; CAMKII; MECHANISM; SWITCH; ACTIVATION; MEMORY	Calcium/calmodulin dependent protein kinase II (CaMKII) is implicated to play a key role in learning and memory. NR2B subunit of N-methyl-D-aspartate receptor (NMDAR) is a high affinity binding partner of CaMKII at the postsynaptic membrane. NR2B binds to the T-site of CaMKII and modulates its catalysis. By direct measurement using isothermal titration calorimetry (ITC), we show that NR2B binding causes about 11 fold increase in the affinity of CaMKII for ATP gamma S, an analogue of ATP. ITC data is also consistent with an ordered binding mechanism for CaMKII with ATP binding the catalytic site first followed by peptide substrate. We also show that dephosphorylation of phospho-Thr(286)-alpha-CaMKII is attenuated when NR2B is bound to CaMKII. This favors the persistence of Thr(286) autophosphorylated state of CaMKII in a CaMKII/phosphatase conjugate system in vitro. Overall our data indicate that the NR2B- bound state of CaMKII attains unique biochemical properties which could help in the efficient functioning of the proposed molecular switch supporting synaptic memory.	[Cheriyan, John; Mayadevi, Madhavan; Omkumar, Ramakrishnapillai V.] Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram, Kerala, India; [Kumar, Parimal; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Cheriyan, J (corresponding author), Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram, Kerala, India.	omkumar@rgcb.res.in	Kumar, Parimal/AAG-9653-2019		Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology; Department of Science and Technology, Government of India; University Grants Commission; Council of Scientific and Industrial Research of the Government of India	Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research of the Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by research grants from the Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology and Department of Science and Technology, Government of India. AS is a J.C. Bose Fellow of the Department of Science and Technology, Government of India. JC and PK received grants from the University Grants Commission and Council of Scientific and Industrial Research of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DR, 2007, BIOORG MED CHEM LETT, V17, P147, DOI 10.1016/j.bmcl.2006.09.070; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BOWDEN AC, 1995, FUNDAMENTALS ENZYME, P23; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; KATOH T, 1991, BIOCHIM BIOPHYS ACTA, V1091, P205, DOI 10.1016/0167-4889(91)90063-4; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KWIATKOWSKI AP, 1990, BIOCHEMISTRY-US, V29, P153, DOI 10.1021/bi00453a019; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Praseeda M, 2004, BIOCHEM J, V378, P391, DOI 10.1042/BJ20030741; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; SHENK, 1999, SCIENCE, V284, P162; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Wu K, 1997, P NATL ACAD SCI USA, V94, P13273, DOI 10.1073/pnas.94.24.13273; Yoshimura Y, 1996, J BIOCHEM, V119, P268; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	30	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e16495	10.1371/journal.pone.0016495	http://dx.doi.org/10.1371/journal.pone.0016495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423658	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000288513900003
J	Mihaila, C; Schramm, J; Strathmann, FG; Lee, DL; Gelein, RM; Luebke, AE; Mayer-Proschel, M				Mihaila, Camelia; Schramm, Jordan; Strathmann, Frederick G.; Lee, Dawn L.; Gelein, Robert M.; Luebke, Anne E.; Mayer-Proeschel, Margot			Identifying a Window of Vulnerability during Fetal Development in a Maternal Iron Restriction Model	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; BRAIN-STEM RESPONSE; DEFICIENCY ANEMIA; HORMONE-LEVELS; MOTOR-ACTIVITY; HUMAN INFANTS; TRANSFERRIN; PREGNANCY; SUPPLEMENTATION; GENERATION	It is well acknowledged from observations in humans that iron deficiency during pregnancy can be associated with a number of developmental problems in the newborn and developing child. Due to the obvious limitations of human studies, the stage during gestation at which maternal iron deficiency causes an apparent impairment in the offspring remains elusive. In order to begin to understand the time window(s) during pregnancy that is/are especially susceptible to suboptimal iron levels, which may result in negative effects on the development of the fetus, we developed a rat model in which we were able to manipulate and monitor the dietary iron intake during specific stages of pregnancy and analyzed the developing fetuses. We established four different dietary-feeding protocols that were designed to render the fetuses iron deficient at different gestational stages. Based on a functional analysis that employed Auditory Brainstem Response measurements, we found that maternal iron restriction initiated prior to conception and during the first trimester were associated with profound changes in the developing fetus compared to iron restriction initiated later in pregnancy. We also showed that the presence of iron deficiency anemia, low body weight, and changes in core body temperature were not defining factors in the establishment of neural impairment in the rodent offspring. Our data may have significant relevance for understanding the impact of suboptimal iron levels during pregnancy not only on the mother but also on the developing fetus and hence might lead to a more informed timing of iron supplementation during pregnancy.	[Mihaila, Camelia; Strathmann, Frederick G.; Mayer-Proeschel, Margot] Univ Rochester, Dept Biomed Genet, Rochester, NY 14627 USA; [Schramm, Jordan; Luebke, Anne E.; Mayer-Proeschel, Margot] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Luebke, Anne E.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Lee, Dawn L.] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA; [Gelein, Robert M.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Mihaila, C (corresponding author), Univ Rochester, Dept Biomed Genet, Rochester, NY 14627 USA.	Anne_Luebke@urmc.rochester.edu; Margot_Mayer-Proschel@urmc.rochester.edu	lee, dawn/GRJ-7459-2022	Schramm, Jordan/0000-0002-0896-1071; Luebke, Anne/0000-0001-5651-0278	NIH [R01HD059739, NIH R01NS39511]; Environment Health Science Center (EHSC) at the University of Rochester; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD059739] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Environment Health Science Center (EHSC) at the University of Rochester; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was funded by the NIH grants R01HD059739 and NIH R01NS39511, and was in part supported by the Environment Health Science Center (EHSC) at the University of Rochester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarin C, 2003, PEDIATR RES, V53, P217, DOI 10.1203/01.PDR.0000047657.23156.55; Amin SB, 2010, J PEDIATR-US, V156, P377, DOI 10.1016/j.jpeds.2009.09.049; Angulo-Kinzler RM, 2002, EARLY HUM DEV, V70, P85, DOI 10.1016/S0378-3782(02)00092-0; Angulo-Kinzler RM, 2002, EARLY HUM DEV, V66, P67, DOI 10.1016/S0378-3782(01)00238-9; Banhidy F., 2010, NUTRITION; Baynes R D, 1996, Curr Opin Hematol, V3, P145; BEARD J, 1984, AM J PHYSIOL, V247, pR114, DOI 10.1152/ajpregu.1984.247.1.R114; BEARD J, 1989, J NUTR, V119, P772, DOI 10.1093/jn/119.5.772; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; BEARD J, 1982, LIFE SCI, V30, P691, DOI 10.1016/0024-3205(82)90285-5; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beard JL, 2002, BEHAV BRAIN RES, V134, P517, DOI 10.1016/S0166-4328(02)00092-X; BEARD JL, 1993, PROG FOOD NUTR SCI, V17, P183; Beard J, 2007, J NUTR, V137, p524S, DOI 10.1093/jn/137.2.524S; Bourque SL, 2008, J NUTR, V138, P931, DOI 10.1093/jn/138.5.931; Brigham D, 1996, CRIT REV FOOD SCI, V36, P747, DOI 10.1080/10408399609527748; Brunette KE, 2010, DEV NEUROSCI-BASEL, V32, P238, DOI 10.1159/000314341; Burhans MS, 2005, NUTR NEUROSCI, V8, P31, DOI 10.1080/10284150500047070; Cankaya Hakan, 2003, Acta Paediatrica Taiwanica, V44, P21; Carlson ES, 2010, J NEURODEV DISORD, V2, P133, DOI 10.1007/s11689-010-9049-0; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Chong WS, 2005, HUM REPROD, V20, P3532, DOI 10.1093/humrep/dei246; Church MW, 2009, NEUROTOXICOL TERATOL, V31, P26, DOI 10.1016/j.ntt.2008.09.001; Conrad ME, 2000, AM J PHYSIOL-GASTR L, V279, pG767, DOI 10.1152/ajpgi.2000.279.4.G767; Conrad ME, 2001, AM J HEMATOL, V67, P215, DOI 10.1002/ajh.1114; Corapci F, 2006, J DEV BEHAV PEDIATR, V27, P371, DOI 10.1097/00004703-200610000-00001; Cutmore TRH, 2004, CLIN NEUROPHYSIOL, V115, P998, DOI 10.1016/j.clinph.2003.12.013; DALLMAN PR, 1986, ACTA PAEDIATR SCAND, P59; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; Deregnier RA, 2007, DEV NEUROPSYCHOL, V31, P379, DOI 10.1080/87565640701229524; DILLMAN E, 1980, AM J PHYSIOL, V239, pR377, DOI 10.1152/ajpregu.1980.239.5.R377; Ece A, 1999, PEDIATR INT, V41, P168, DOI 10.1046/j.1442-200X.1999.4121036.x; Eden Alvin N, 2005, Paediatr Drugs, V7, P347, DOI 10.2165/00148581-200507060-00003; El Guindi W, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P506; Badaracco ME, 2010, BIOFACTORS, V36, P98, DOI 10.1002/biof.90; Emamghorashi F, 2004, East Mediterr Health J, V10, P808; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; FAIRBANKS VF, 1994, MAYO CLIN PROC, V69, P889, DOI 10.1016/S0025-6196(12)61794-7; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Florentino Rodolfo F., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P31; Focht SJ, 1997, NEUROSCIENCE, V79, P255, DOI 10.1016/S0306-4522(96)00607-0; Gambling L, 2004, J PHYSIOL-LONDON, V561, P195, DOI 10.1113/jphysiol.2004.068825; Gambling L, 2001, BIOCHEM J, V356, P883, DOI 10.1042/0264-6021:3560883; Georgieff Michael K, 2006, Minn Med, V89, P44; Georgieff MK, 2002, J PEDIATR-US, V141, P405, DOI 10.1067/mpd.2002.127090; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Gregori N, 2002, J NEUROSCI, V22, P248, DOI 10.1523/JNEUROSCI.22-01-00248.2002; Hall J W 3rd, 1997, Adv Otorhinolaryngol, V53, P21; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Hartfield DS, 2009, CLIN PEDIATR, V48, P420, DOI 10.1177/0009922809331800; Hartfield DS, 1997, PEDIATR NEUROL, V16, P50, DOI 10.1016/S0887-8994(96)00290-1; Ito T, 2004, HEARING RES, V191, P119, DOI 10.1016/j.heares.2003.12.019; Jaime-Perez JC, 2005, ARCH MED RES, V36, P598, DOI 10.1016/j.arcmed.2005.03.023; KARP RJ, 1989, B NEW YORK ACAD MED, V65, P1085; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kurekci AE, 2006, TURKISH J PEDIATR, V48, P334; Kwik-Uribe CL, 2000, J NUTR, V130, P2821, DOI 10.1093/jn/130.11.2821; Kwik-Uribe CL, 2000, J NUTR, V130, P2040, DOI 10.1093/jn/130.8.2040; Lee HS, 2006, EUR J CLIN NUTR, V60, P1130, DOI 10.1038/sj.ejcn.1602429; Legatt AD, 2002, J CLIN NEUROPHYSIOL, V19, P396, DOI 10.1097/00004691-200210000-00003; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Love AL, 2008, AM J HEMATOL, V83, P403, DOI 10.1002/ajh.21106; LOZOFF B, 1986, PROG HEMATOL, V14, P23; Lozoff B, 1987, Hematol Oncol Clin North Am, V1, P449; LOZOFF B, 1989, B NEW YORK ACAD MED, V65, P1050; Lozoff B, 2003, PEDIATRICS, V112, P846; LOZOFF B, 1987, PEDIATRICS, V79, P981; Lozoff B, 2000, PEDIATR RES, V48, P137, DOI 10.1203/00006450-200008000-00003; Lozoff B, 2008, J PEDIATR-US, V152, P696, DOI 10.1016/j.jpeds.2007.09.048; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lukowski AF, 2010, NUTR NEUROSCI, V13, P54, DOI 10.1179/147683010X12611460763689; Maison SF, 2009, JARO-J ASSOC RES OTO, V10, P50, DOI 10.1007/s10162-008-0138-7; Melamed Nir, 2007, Archives of Gynecology and Obstetrics, V276, P601, DOI 10.1007/s00404-007-0388-3; Morath DJ, 2002, DEV NEUROSCI-BASEL, V24, P197, DOI 10.1159/000065688; Morath DJ, 2001, DEV BIOL, V237, P232, DOI 10.1006/dbio.2001.0352; MUNOZ C, 1994, EUR CYTOKINE NETW, V5, P401; Naghii Mohammad R., 2006, Nutrition and Health (Bicester), V18, P133; Nguyen Patricia, 2008, BMC Pregnancy Childbirth, V8, P17, DOI 10.1186/1471-2393-8-17; Noben-Trauth K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011459; Park HJ, 2009, HEARING RES, V257, P53, DOI 10.1016/j.heares.2009.08.001; Ponton CW, 1996, EAR HEARING, V17, P402, DOI 10.1097/00003446-199610000-00006; Reeves PG, 2006, J NUTR BIOCHEM, V17, P635, DOI 10.1016/j.jnutbio.2006.04.004; Roncagliolo M, 1998, AM J CLIN NUTR, V68, P683, DOI 10.1093/ajcn/68.3.683; Sarici SU, 2001, PEDIATR NEUROL, V24, P205, DOI 10.1016/S0887-8994(00)00270-8; Schmidt AT, 2007, BEHAV NEUROSCI, V121, P475, DOI 10.1037/0735-7044.121.3.475; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Shafir T, 2008, EARLY HUM DEV, V84, P479, DOI 10.1016/j.earlhumdev.2007.12.009; SHAW NA, 1995, PROG NEUROBIOL, V47, P95, DOI 10.1016/0301-0082(95)00021-M; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; Singla PN, 1997, J TROP PEDIATRICS, V43, P89, DOI 10.1093/tropej/43.2.89; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Sweet DG, 2001, ARCH DIS CHILD-FETAL, V84, pF40, DOI 10.1136/fn.84.1.F40; Tanaka C, 2009, HEARING RES, V250, P10, DOI 10.1016/j.heares.2008.12.010; TANG F, 1988, HORM METAB RES, V20, P616, DOI 10.1055/s-2007-1010899; Unger EL, 2007, J NUTR, V137, P118, DOI 10.1093/jn/137.1.118; VANGELDER W, 1995, J NEUROCHEM, V64, P2708; VANGELDER W, 1995, COMP BIOCHEM PHYS B, V111, P171, DOI 10.1016/0305-0491(94)00255-S; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; WALTER T, 1994, BAILLIERE CLIN HAEM, V7, P815, DOI 10.1016/S0950-3536(05)80126-X; Wang Y, 2005, J NEUROPHYSIOL, V94, P1814, DOI 10.1152/jn.00374.2005; Wu HP, 2010, HEARING RES, V267, P71, DOI 10.1016/j.heares.2010.03.082; Wu LL, 2008, BEHAV BRAIN RES, V188, P263, DOI 10.1016/j.bbr.2007.11.003; Xanthakos SA, 2009, PEDIATR CLIN N AM, V56, P1105, DOI 10.1016/j.pcl.2009.07.002; Zhou B, 2001, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V15, P173; Zhou GD, 2001, MUTAT RES-FUND MOL M, V479, P71, DOI 10.1016/S0027-5107(01)00148-8; Zimmermann MB, 2002, THYROID, V12, P867, DOI 10.1089/105072502761016494	107	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17483	10.1371/journal.pone.0017483	http://dx.doi.org/10.1371/journal.pone.0017483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423661	gold, Green Published, Green Submitted			2022-12-25	WOS:000288513900010
J	Lopatina, T; Kalinina, N; Karagyaur, M; Stambolsky, D; Rubina, K; Revischin, A; Pavlova, G; Parfyonova, Y; Tkachuk, V				Lopatina, Tatiana; Kalinina, Natalia; Karagyaur, Maxim; Stambolsky, Dmitry; Rubina, Kseniya; Revischin, Alexander; Pavlova, Galina; Parfyonova, Yelena; Tkachuk, Vsevolod			Adipose-Derived Stem Cells Stimulate Regeneration of Peripheral Nerves: BDNF Secreted by These Cells Promotes Nerve Healing and Axon Growth De Novo	PLOS ONE			English	Article							RAT SPINAL-CORD; STROMAL CELLS; BONE-MARROW; SYMPATHETIC NEURONS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; IFATS COLLECTION; SCHWANN-CELLS; PC12 CELLS; IN-VITRO	Transplantation of adipose-derived mesenchymal stem cells (ASCs) induces tissue regeneration by accelerating the growth of blood vessels and nerve. However, mechanisms by which they accelerate the growth of nerve fibers are only partially understood. We used transplantation of ASCs with subcutaneous matrigel implants (well-known in vivo model of angiogenesis) and model of mice limb reinnervation to check the influence of ASC on nerve growth. Here we show that ASCs stimulate the regeneration of nerves in innervated mice's limbs and induce axon growth in subcutaneous matrigel implants. To investigate the mechanism of this action we analyzed different properties of these cells and showed that they express numerous genes of neurotrophins and extracellular matrix proteins required for the nerve growth and myelination. Induction of neural differentiation of ASCs enhances production of brain-derived neurotrophic factor (BDNF) as well as ability of these cells to induce nerve fiber growth. BDNF neutralizing antibodies abrogated the stimulatory effects of ASCs on the growth of nerve sprouts. These data suggest that ASCs induce nerve repair and growth via BDNF production. This stimulatory effect can be further enhanced by culturing the cells in neural differentiation medium prior to transplantation.	[Lopatina, Tatiana; Kalinina, Natalia; Karagyaur, Maxim; Stambolsky, Dmitry; Rubina, Kseniya; Parfyonova, Yelena; Tkachuk, Vsevolod] Lomonosov Moscow State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia; [Revischin, Alexander; Pavlova, Galina] Russian Acad Sci, Inst Gene Biol, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Lopatina, T (corresponding author), Lomonosov Moscow State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia.	t.lopatina@gmail.com	Tkachuk, Vsevolod/AAE-1136-2022; Tkachuk, Vsevolod A/J-9357-2012; Parfyonova, Yelena V/B-9307-2014; Kalinina, Natalia I./L-6475-2013; Rubina, Kseniya A/A-8208-2014; Stambolsky, Dmitry/A-8358-2014; Pavlova, Galina/AAO-4691-2020; Revishchin, Alexander/AAO-4863-2020; Rubina, Kseniya/AAL-2675-2021; Karagyaur, Maxim N/A-8385-2014; Kalinina, Natalia/AAN-6763-2020	Parfyonova, Yelena V/0000-0002-0969-5780; Kalinina, Natalia I./0000-0003-3497-9619; Rubina, Kseniya A/0000-0002-7166-7406; Stambolsky, Dmitry/0000-0001-6983-9697; Pavlova, Galina/0000-0002-6885-6601; Rubina, Kseniya/0000-0002-7166-7406; Karagyaur, Maxim N/0000-0003-4289-3428; Kalinina, Natalia/0000-0003-3497-9619; Lopatina, Tatiana/0000-0002-8198-8887; Tkachuk, Vsevolod/0000-0002-7492-747X; Revishchin, Alexandr/0000-0002-6007-6440	Russian Government [02.740.11.0093];  [SS-3755.2010.7]	Russian Government; 	This study was supported by grants from Russian Government No 02.740.11.0093 and Russian President SS-3755.2010.7 (both to V.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Balezina O. P., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P37; Balezina OP, 2005, B EXP BIOL MED+, V139, P4, DOI 10.1007/s10517-005-0196-3; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Efimenko A Iu, 2010, Tsitologiia, V52, P144; Fuhrmann T, 2010, NEUROSCI LETT, V474, P37, DOI 10.1016/j.neulet.2010.03.002; Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; INAGAKI N, 1995, EUR J NEUROSCI, V7, P1125, DOI 10.1111/j.1460-9568.1995.tb01102.x; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Mantovani C, 2010, REGEN MED, V5, P403, DOI 10.2217/RME.10.15; McDonald DM, 1996, ADV EXP MED BIOL, V410, P453; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; PASSANITI A, 1992, LAB INVEST, V67, P519; Plant GW, 2002, J NEUROSCI, V22, P6083; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359; Traktuev DO, 2006, TSITOLOGIYA, V48, P83; Vard'ya I V, 2000, Dokl Biol Sci, V371, P112; Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wong M, 2011, EARLY CHILD DEV CARE, V181, P1199, DOI 10.1080/03004430.2010.520712; Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x; Yuan QJ, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-18; Yuan Y, 2010, BRAIN RES BULL, V81, P25, DOI 10.1016/j.brainresbull.2009.07.013; Zhang XM, 2010, MOL BIOL REP, V37, P1197, DOI 10.1007/s11033-009-9489-3; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	38	204	221	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17899	10.1371/journal.pone.0017899	http://dx.doi.org/10.1371/journal.pone.0017899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423756	Green Published, gold			2022-12-25	WOS:000288512400037
J	Fernandes, VC; Martins, EMN; Boeloni, JN; Coitinho, JB; Serakides, R; Goes, AM				Fernandes, Viviane C.; Martins, Estefania M. N.; Boeloni, Jankerle N.; Coitinho, Juliana B.; Serakides, Rogeria; Goes, Alfredo M.			Additive Effect of rPb27 Immunization and Chemotherapy in Experimental Paracoccidioidomycosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECOMBINANT 27-KILODALTON; ANTIGENIC PROTEIN; BRASILIENSIS; MICE; SERODIAGNOSIS; RESISTANCE; INFECTION; CELLS; DNA	Paracoccidioidomycosis, PCM, the major systemic mycosis in Latin America, is caused by the termally dimorphic fungus Paracoccidioides brasiliensis and requires extended periods of chemotherapy with a significant frequency of relapsing disease. The search for new alternatives of treatment is necessary. rPb27 is an antigenic protein from P. brasiliensis that already showed a significant protective activity as a vaccine for PCM in experimental models. The cDNA of rPb27 was subcloned into a pET-DEST 42 plasmid, expressed in E. coli with a his-tag and purified by affinity chromatography. Immunization with this recombinant protein and chemotherapy were used together in an attempt to improve treatment of PCM. For this, BALB/c mice were challenged with pathogenic P. brasiliensis strain and after immunized with rPb27, in the presence of Corynebacterium parvum and Al(OH)(3), some groups were also treated with fluconazole. After 40 days of treatment, the combined drug/rPb27 administration controlled PCM in the liver and spleen, with long lasting protection, and largely preserved tissues structures of these organs. Additionally, in the lungs after 40 days of treatment there was a significant reduction in the fungal load and size of lesions. At the same time, the levels of TNF-alpha were higher than infectedonly mice. Moreover, significant levels of anti-rPb27 specific IgG1, IgG2a and IgG2b isotypes were detected in the sera of mice immunized with rPb27 fluconazole treated or not. These results showed an additive protective effect of rPb27 immunization and chemotherapy, suggesting that an rPb27-based vaccine can be used to enhance PCM antifungal treatment.	[Fernandes, Viviane C.; Coitinho, Juliana B.; Goes, Alfredo M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Martins, Estefania M. N.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Boeloni, Jankerle N.; Serakides, Rogeria] Univ Fed Minas Gerais, Dept Clin & Cirurgia Vet, Escola Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Fernandes, VC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	cfernandes.viviane@gmail.com	Coitinho, Juliana Barbosa/AAI-4742-2021; Martins, Estefânia Mara do Nascimento/GQI-4671-2022; Serakides, Rogéria/C-7571-2016	Coitinho, Juliana Barbosa/0000-0002-5892-050X; Serakides, Rogéria/0000-0001-5374-6242	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais	This work was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais. Viviane C. Fernandes is a PhD student with a scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Araujo SD, 2009, BRAZ J INFECT DIS, V13, P394, DOI 10.1590/S1413-86702009000500017; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; Chakrabarti A., 2005, Journal of Postgraduate Medicine, V51, P16; de Almeida SM, 2004, J INFECTION, V48, P193, DOI 10.1016/j.jinf.2003.08.012; Dias MFRG, 2004, MED MYCOL, V42, P43, DOI 10.1080/13693780310001610074; Diez S, 2003, J CLIN MICROBIOL, V41, P1536, DOI 10.1128/JCM.41.4.1536-1542.2003; Diniz SN, 2004, VACCINE, V22, P485, DOI 10.1016/j.vaccine.2003.07.017; Hahn RC, 2003, MYCOSES, V46, P342; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Marques AF, 2006, ANTIMICROB AGENTS CH, V50, P2814, DOI 10.1128/AAC.00220-06; Marques AF, 2008, MICROBES INFECT, V10, P1251, DOI 10.1016/j.micinf.2008.07.027; McEwen JG, 1996, FUNGAL GENET BIOL, V20, P125, DOI 10.1006/fgbi.1996.0027; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Ortiz BL, 1996, CLIN DIAGN LAB IMMUN, V3, P239, DOI 10.1128/CDLI.3.2.239-241.1996; Ortiz BL, 1998, CLIN DIAGN LAB IMMUN, V5, P826, DOI 10.1128/CDLI.5.6.826-830.1998; Paniago Anamaria Mello Miranda, 2003, Rev. Soc. Bras. Med. Trop., V36, P455, DOI 10.1590/S0037-86822003000400004; Pereira Ricardo M., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P37, DOI 10.1590/S0036-46652004000100007; Pereira Ricardo Mendes, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P127, DOI 10.1590/S0036-46652004000300002; PINZAN CF, PLOS ONE, V5; Reis BS, 2008, VACCINE, V26, P5461, DOI 10.1016/j.vaccine.2008.07.097; Ribeiro AM, 2010, VACCINE, V28, P1528, DOI 10.1016/j.vaccine.2009.11.062; San-Blas G, 2008, MYCOPATHOLOGIA, V165, P183, DOI 10.1007/s11046-007-9040-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Visbal G., 2005, Current Drug Targets - Infectious Disorders, V5, P211, DOI 10.2174/1568005054880118	30	22	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17885	10.1371/journal.pone.0017885	http://dx.doi.org/10.1371/journal.pone.0017885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423771	gold, Green Published, Green Submitted			2022-12-25	WOS:000288219100043
J	Lightfield, J; Fram, NR; Ely, B				Lightfield, John; Fram, Noah R.; Ely, Bert			Across Bacterial Phyla, Distantly-Related Genomes with Similar Genomic GC Content Have Similar Patterns of Amino Acid Usage	PLOS ONE			English	Article							OPTIMAL-GROWTH TEMPERATURE; CYTOSINE CONTENT; BASE COMPOSITION; CODON USAGE; PROKARYOTES; PROTEINS; GUANINE; G+C; DNA	The GC content of bacterial genomes ranges from 16% to 75% and wide ranges of genomic GC content are observed within many bacterial phyla, including both Gram negative and Gram positive phyla. Thus, divergent genomic GC content has evolved repeatedly in widely separated bacterial taxa. Since genomic GC content influences codon usage, we examined codon usage patterns and predicted protein amino acid content as a function of genomic GC content within eight different phyla or classes of bacteria. We found that similar patterns of codon usage and protein amino acid content have evolved independently in all eight groups of bacteria. For example, in each group, use of amino acids encoded by GC-rich codons increased by approximately 1% for each 10% increase in genomic GC content, while the use of amino acids encoded by AT-rich codons decreased by a similar amount. This consistency within every phylum and class studied led us to conclude that GC content appears to be the primary determinant of the codon and amino acid usage patterns observed in bacterial genomes. These results also indicate that selection for translational efficiency of highly expressed genes is constrained by the genomic parameters associated with the GC content of the host genome.	[Lightfield, John; Fram, Noah R.; Ely, Bert] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lightfield, J (corresponding author), Ripon Coll, Ripon, WI USA.	ely@sc.edu		Fram, Noah/0000-0002-0234-9922	National Science Foundation (nsf.gov) [DBI-0451403, EF-0826792]	National Science Foundation (nsf.gov)(National Science Foundation (NSF))	This work was funded in part by National Science Foundation (nsf.gov) grants DBI-0451403 and EF-0826792 to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBU E, 1956, ANN I PASTEUR, V91, P212; BELOZERSKY AN, 1958, NATURE, V182, P111, DOI 10.1038/182111a0; Bohlin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008113; Chen LL, 2003, BIOCHEM BIOPH RES CO, V306, P310, DOI 10.1016/S0006-291X(03)00973-2; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Fryxell KJ, 2008, NOVA HEDWIGIA BIEHEF, V133, P285; Gu X, 1998, GENETICA, V102-3, P383, DOI 10.1023/A:1017028102013; Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010; Lobry JR, 1997, GENE, V205, P309, DOI 10.1016/S0378-1119(97)00403-4; Musto H, 2005, BIOCHEM BIOPH RES CO, V330, P357, DOI 10.1016/j.bbrc.2005.02.133; Musto H, 2004, FEBS LETT, V573, P73, DOI 10.1016/j.febslet.2004.07.056; Musto H, 2006, BIOCHEM BIOPH RES CO, V347, P1, DOI 10.1016/j.bbrc.2006.06.054; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; SUEOKA N, 1961, P NATL ACAD SCI USA, V47, P1141, DOI 10.1073/pnas.47.8.1141; Wilquet V, 1999, RES MICROBIOL, V150, P21, DOI 10.1016/S0923-2508(99)80043-6	19	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17677	10.1371/journal.pone.0017677	http://dx.doi.org/10.1371/journal.pone.0017677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423704	gold, Green Published			2022-12-25	WOS:000288219100024
J	Senchenko, VN; Krasnov, GS; Dmitriev, AA; Kudryavtseva, AV; Anedchenko, EA; Braga, EA; Pronina, IV; Kondratieva, TT; Ivanov, SV; Zabarovsky, ER; Lerman, MI				Senchenko, Vera N.; Krasnov, George S.; Dmitriev, Alexey A.; Kudryavtseva, Anna V.; Anedchenko, Ekaterina A.; Braga, Eleonora A.; Pronina, Irina V.; Kondratieva, Tatiana T.; Ivanov, Sergey V.; Zabarovsky, Eugene R.; Lerman, Michael I.			Differential Expression of CHL1 Gene during Development of Major Human Cancers	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR; CALL GENE; BREAST; L1; METASTASIS; PATTERNS; REGIONS; LUNG; POLYMORPHISM	Background: CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis. Methodology/Principal Findings: We used Clontech Cancer Profiling Arrays (19 different types of cancers, 395 samples) to analyze expression of the CHL1 gene. The results were further validated by RT-qPCR for breast, renal and lung cancer. Cancer Profiling Arrays revealed differential expression of the gene: down-regulation/silencing in a majority of primary tumors and up-regulation associated with invasive/metastatic growth. Frequent down-regulation (> 40% of cases) was detected in 11 types of cancer (breast, kidney, rectum, colon, thyroid, stomach, skin, small intestine, bladder, vulva and pancreatic cancer) and frequent up-regulation (> 40% of cases) - in 5 types (lung, ovary, uterus, liver and trachea) of cancer. Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P < 0.03 for all the cases). There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P = 0.02) without association with tumor progression. Conclusions/Significance: Our results suggested that CHL1 is involved in the development of different human cancers. Initially, during the primary tumor growth CHL1 could act as a putative tumor suppressor and is silenced to facilitate in situ tumor growth for 11 cancer types. We also suggested that re-expression of the gene on the edge of tumor mass might promote local invasive growth and enable further metastatic spread in ovary, colon and breast cancer. Our data also supported the role of CHL1 as a potentially novel specific biomarker in the early pathogenesis of two major histological types of renal cancer.	[Senchenko, Vera N.; Krasnov, George S.; Dmitriev, Alexey A.; Kudryavtseva, Anna V.; Anedchenko, Ekaterina A.; Zabarovsky, Eugene R.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Lab Struct & Funct Genom, Moscow, Russia; [Braga, Eleonora A.; Pronina, Irina V.] Russian State Genet Ctr GosNIIgenetika, Lab Mol Diag, Moscow, Russia; [Kondratieva, Tatiana T.] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow, Russia; [Ivanov, Sergey V.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY USA; [Zabarovsky, Eugene R.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Lerman, Michael I.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; New York University; NYU Langone Medical Center; Karolinska Institutet; Sodersjukhuset Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Senchenko, VN (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Lab Struct & Funct Genom, Moscow, Russia.	eugzab@ki.se	Dmitriev, Alexey A./D-6109-2011; Braga, Eleonora A./P-5574-2016; Kudryavtseva, Anna V/C-9032-2014; Krasnov, George S/Q-2591-2017; Zabarovsky, Eugene R/A-6645-2010; Krasnov, George S/E-6529-2014; Pronina, Irina/ABD-8018-2021; Pronina, Irina Valerievna/G-3951-2014; Senchenko, Vera N/C-8992-2014	Dmitriev, Alexey A./0000-0002-6827-9584; Kudryavtseva, Anna V/0000-0002-3722-8207; Krasnov, George S/0000-0002-6493-8378; Krasnov, George S/0000-0002-6493-8378; Pronina, Irina/0000-0002-0423-7801; Pronina, Irina Valerievna/0000-0002-0423-7801; Senchenko, Vera N/0000-0002-3119-515X; Braga, Eleonora/0000-0001-5188-4094; Ivanov, Sergey/0000-0001-9770-7237	Russian Foundation for Basic Research [08-04-01577, 10-04-01213]; Russian Ministry of Education and Science [02.740.11.5227, 16.740.11.0173]; Swedish Cancer Society; Swedish Research Council; Swedish Institute; Karolinska Institute; National Cancer Institute, Center for Cancer Research; NCI	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Karolinska Institute(Karolinska Institutet); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants 08-04-01577 and 10-04-01213 from the Russian Foundation for Basic Research; State Contracts 02.740.11.5227 and 16.740.11.0173 with the Russian Ministry of Education and Science; grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Institute and Karolinska Institute and National Cancer Institute, Center for Cancer Research, Intramural Research Program of NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anedchenko EA, 2008, MOL BIOL+, V42, P859, DOI 10.1134/S0026893308060058; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; CHEN LC, 1994, CANCER RES, V54, P3021; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lindlof A, 2008, BIOINFORM BIOL INSIG, V2, P215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machesky LM, 2009, CANCER CELL, V16, P5, DOI 10.1016/j.ccr.2009.06.009; Maddaluno L, 2009, J EXP MED, V206, P623, DOI 10.1084/jem.20081211; Manderson EN, 2009, INT J GYNECOL CANCER, V19, P513, DOI 10.1111/IGC.0b013e3181a3cd38; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Protopopov A, 2003, CANCER RES, V63, P404; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rokman A, 2005, HUM GENET, V116, P43, DOI 10.1007/s00439-004-1214-7; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sausville EA, 2004, EUR J CANCER, V40, P2544, DOI 10.1016/j.ejca.2004.08.006; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; SPIESSL B, 1989, TNM ATLAS ILLUSTRATE, V14, P341; Stoeck A, 2006, CANCER LETT, V239, P212, DOI 10.1016/j.canlet.2005.08.005; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; Travis WD, 1999, HISTOLOGICAL TYPING; Wei MH, 1996, CANCER RES, V56, P1487; Wei MH, 1998, HUM GENET, V103, P355, DOI 10.1007/s004390050829; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897	54	68	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e15612	10.1371/journal.pone.0015612	http://dx.doi.org/10.1371/journal.pone.0015612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408220	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800003
J	Lara, R; Mauri, FA; Taylor, H; Derua, R; Shia, A; Gray, C; Nicols, A; Shiner, RJ; Schofield, E; Bates, PA; Waelkens, E; Dallman, M; Lamb, J; Zicha, D; Downward, J; Seckl, MJ; Pardo, OE				Lara, R.; Mauri, F. A.; Taylor, H.; Derua, R.; Shia, A.; Gray, C.; Nicols, A.; Shiner, R. J.; Schofield, E.; Bates, P. A.; Waelkens, E.; Dallman, M.; Lamb, J.; Zicha, D.; Downward, J.; Seckl, M. J.; Pardo, O. E.			An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis	ONCOGENE			English	Article						ribosomal S6 kinase 1; metastasis; lung cancer; siRNA screen; VASP	RIBOSOMAL S6 KINASE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; HUMAN BREAST-CANCER; CELL-MIGRATION; ACTIN CYTOSKELETON; ENA/VASP PROTEINS; PHOSPHORYLATION; EXPRESSION; PROLIFERATION; REGULATORS	We performed a kinome-wide siRNA screen and identified 70 kinases altering cell migration in A549 lung cancer cells. In particular, ribosomal S6 kinase 1 (RSK1) silencing increased, whereas RSK2 and RSK4 downregulation inhibited cell motility. In a secondary collagen-based three-dimensional invasion screen, 38 of our hits cross-validated, including RSK1 and RSK4. In two further lung cancer cell lines, RSK1 but not RSK4 silencing showed identical modulation of cell motility. We therefore selected RSK1 for further investigation. Bioinformatic analysis followed by co-immunoprecipitation-based validation revealed that the actin regulators VASP and Mena interact with RSK1. Moreover, RSK1 phosphorylated VASP on T278, a site regulating its binding to actin. In addition, silencing of RSK1 enhanced the metastatic potential of these cells in vivo using a zebrafish model. Finally, we investigated the relevance of this finding in human lung cancer samples. In isogenically matched tissue, RSK1 was reduced in metastatic versus primary lung cancer lesions. Moreover, patients with RSK1-negative lung tumours showed increased number of metastases. Our results suggest that the findings of our high-throughput in vitro screen can reliably identify relevant clinical targets and as a proof of principle, RSK1 may provide a biomarker for metastasis in lung cancer patients. Oncogene (2011) 30, 3513-3521; doi:10.1038/onc.2011.61; published online 21 March 2011	[Lara, R.; Seckl, M. J.; Pardo, O. E.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W12 0NN, England; [Mauri, F. A.; Shiner, R. J.] Histopathol Imperial Coll London, London, England; [Taylor, H.; Shia, A.; Dallman, M.; Lamb, J.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, Div Cell & Mol Biol, London W12 0NN, England; [Derua, R.; Waelkens, E.] Katholieke Univ Leuven, Lab Prot Fosforylatie Prote, Louvain, Belgium; [Gray, C.; Nicols, A.; Zicha, D.] London Res Inst, Light Microscopy Dept, London, England; [Schofield, E.; Bates, P. A.] London Res Inst, Biomol Modelling Lab, London, England; [Lara, R.; Downward, J.] London Res Inst, Canc Res UK, Signal Transduct Lab, London, England	Imperial College London; Imperial College London; Imperial College London; KU Leuven; Cancer Research UK	Seckl, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Hammersmith Campus,Cyclotron Bldg,Du Cane Rd, London W12 0NN, England.	m.seckl@imperial.ac.uk; o.pardo@imperial.ac.uk	Bates, Paul A/AAF-8561-2020; Pardo, Oliver/AEM-2071-2022; Lara, Romain/AAE-8108-2020; Zicha, Daniel/H-9310-2016; Downward, Julian/A-3251-2012	Bates, Paul A/0000-0003-0621-0925; Pardo, Oliver/0000-0003-2223-1435; Downward, Julian/0000-0002-2331-4729; Zicha, Daniel/0000-0002-8808-8064; Mauri, Francesco/0000-0003-4818-8500; Dallman, Margaret/0000-0002-9079-3344	Cancer Treatment and Research Trust, Cancer Research UK, Department of Health; Experimental Cancer Medicine Centre; Cancer Research UK [10748] Funding Source: researchfish	Cancer Treatment and Research Trust, Cancer Research UK, Department of Health(Cancer Research UK); Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK)	This work was supported by grants from Cancer Treatment and Research Trust, Cancer Research UK, Department of Health and our Experimental Cancer Medicine Centre.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; BLENIS J, 1991, CELL GROWTH DIFFER, V2, P279; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Cavanna T, 2007, J CELL SCI, V120, P606, DOI 10.1242/jcs.000273; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Clark DE, 2005, CANCER RES, V65, P3108; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Dertsiz L, 2005, THORAX, V60, P576, DOI 10.1136/thx.2004.037622; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gurzu S, 2008, ROM J MORPHOL EMBRYO, V49, P345; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Herberger B, 2007, CLIN CANCER RES, V13, P4795, DOI 10.1158/1078-0432.CCR-07-0738; Hu LD, 2008, ONCOL REP, V19, P1015; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Pardo OE, 2001, ONCOGENE, V20, P7658, DOI 10.1038/sj.onc.1204994; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Smith JA, 2005, CANCER RES, V65, P1027; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Toyoda A, 2009, INT J ONCOL, V34, P53, DOI 10.3892/ijo_00000128; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zimmermann J, 2002, BIOCHEMISTRY-US, V41, P11143, DOI 10.1021/bi020379x	38	68	69	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	32					3513	3521		10.1038/onc.2011.61	http://dx.doi.org/10.1038/onc.2011.61			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	806CR	21423205				2022-12-25	WOS:000293782300004
J	Alattia, JR; Kuraishi, T; Dimitrov, M; Chang, I; Lemaitre, B; Fraering, PC				Alattia, Jean-Rene; Kuraishi, Takayuki; Dimitrov, Mitko; Chang, Isabelle; Lemaitre, Bruno; Fraering, Patrick C.			Mercury is a direct and potent gamma-secretase inhibitor affecting Notch processing and development in Drosophila	FASEB JOURNAL			English	Article						enzyme assay; metal toxicity; Notch signaling; embryonic neurodevelopment	MEDIATED TRANSMEMBRANE CLEAVAGE; SYNAPTIC PLASTICITY; METHYLMERCURY; RECEPTOR; PURIFICATION; MELANOGASTER; ACTIVATION; NICASTRIN; PATHOLOGY; EXPOSURE	Prenatal exposure to mercury causes neurodevelopmental disorders and neurological pathologies in infants, such as microcephaly and mental retardation. Despite critical importance, the molecular interactions leading to mercury toxicity are yet to be elucidated. We first used a cell-free assay to investigate mercury effects on purified gamma-secretase activity. Next, we treated adult Drosophila melanogaster with mercury and collected control and mercury-treated embryos, which were subjected to mild hypotonic protein extraction, or immunostained to reveal nervous system morphology. Embryos left to develop into adults were examined for wing phenotypes. Relative to control metals, we found that mercury strongly inhibits in vitro gamma-secretase processing of both amyloid-beta precursor protein (APP) and Notch. Mercury inhibited APP and Notch cleavage in a dose-dependent manner, with IC50 values of 50-125 nM, and is therefore comparable in potency to benchmark gamma-secretase inhibitors. Immunoblot analysis of embryonic protein extracts showed that mercury inhibits Notch cleavage by gamma-secretase in vivo. This is accompanied by severe neurodevelopmental abnormalities in embryos and adult wing-notching phenotypes. Our findings provide first evidence that mercury is a direct and potent gamma-secretase inhibitor and suggest that inhibition of gamma-secretase and disruption of the Notch developmental pathway potentially contribute to mercury-induced toxicity in the nervous system.-Alattia, J-R., Kuraishi, T., Dimitrov, M., Chang, I., Lemaitre, B., Fraering, P. C. Mercury is a direct and potent gamma-secretase inhibitor affecting Notch processing and development in Drosophila. FASEB J. 25, 2287-2295 (2011). www.fasebj.org	[Alattia, Jean-Rene; Dimitrov, Mitko; Chang, Isabelle; Fraering, Patrick C.] Swiss Fed Inst Technol, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Kuraishi, Takayuki; Lemaitre, Bruno] Swiss Fed Inst Technol, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fraering, PC (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Stn 15, CH-1015 Lausanne, Switzerland.	patrick.fraering@epfl.ch	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation; Swiss National Centres of Competence in Research, Neural Plasticity and Repair; EPFL-Merck-Serono; Grants-in-Aid for Scientific Research [23890014] Funding Source: KAKEN	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Centres of Competence in Research, Neural Plasticity and Repair; EPFL-Merck-Serono; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The C17.9C6 antibody developed by Prof. Spyros Artavanis-Tsakonas was obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA, USA), developed under the auspices of the U. S. National Institute of Child Health and Human Development and maintained by the University of Iowa Department of Biology. The authors thank M. Moniatte and D. Chiappe [Proteomics Core Facility, School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland] for technical assistance with mass spectrometry. The authors also thank F. Schweisguth for critical discussions. This work was supported by the Swiss National Science Foundation (P. C. F., B. L.); the Swiss National Centres of Competence in Research, Neural Plasticity and Repair (P. C. F.); and an EPFL-Merck-Serono grant (J.R.A. and M. D.).	APOSHIAN HV, 1995, TOXICOLOGY, V97, P23, DOI 10.1016/0300-483X(95)02965-B; ARTAVANISTSAKONAS S, 1991, ANNU REV CELL BIOL, V7, P427; Bland C, 2006, NEUROTOXICOLOGY, V27, P982, DOI 10.1016/j.neuro.2006.04.005; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Castoldi AF, 2008, REGUL TOXICOL PHARM, V51, P201, DOI 10.1016/j.yrtph.2008.01.016; Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Eto K, 1997, TOXICOL PATHOL, V25, P614, DOI 10.1177/019262339702500612; Fok TF, 2007, ENVIRON INT, V33, P84, DOI 10.1016/j.envint.2006.08.002; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Korbas M, 2010, ACS CHEM NEUROSCI, V1, P810, DOI 10.1021/cn1000765; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; MARKOVAC J, 1988, NATURE, V334, P71, DOI 10.1038/334071a0; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; MULLER A, 1993, J BIOL CHEM, V268, P26150; National Research Council, 2000, TOX EFF METH MERC; PANGBURN MK, 1975, BIOCHEMISTRY-US, V14, P4050, DOI 10.1021/bi00689a019; Rand MD, 2008, TOXICOL SCI, V104, P163, DOI 10.1093/toxsci/kfn060; Rush T, 2009, NEUROTOXICOLOGY, V30, P47, DOI 10.1016/j.neuro.2008.10.009; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; SUN BH, 1995, J NEUROCHEM, V65, P434, DOI 10.1046/j.1471-4159.1995.65010434.x; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; WELLS TNC, 1994, BIOCHEMISTRY-US, V33, P7641, DOI 10.1021/bi00190a018; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	34	21	21	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2287	2295		10.1096/fj.10-174078	http://dx.doi.org/10.1096/fj.10-174078			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21415381				2022-12-25	WOS:000292242200020
J	Lavery, DN; Villaronga, MA; Walker, MM; Patel, A; Belandia, B; Bevan, CL				Lavery, Derek N.; Villaronga, M. Angeles; Walker, Marjorie M.; Patel, Anup; Belandia, Borja; Bevan, Charlotte L.			Repression of Androgen Receptor Activity by HEYL, a Third Member of the Hairy/Enhancer-of-split-related Family of Notch Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; COFACTOR P44; CYCLIN D1; DOMAIN; NUCLEAR; TARGET; PROLIFERATION; COREPRESSOR	The Hairy/Enhancer-of-split-related with YRPW-like motif (HEY) family of proteins are transcriptional repressors and downstream effectors of Notch signaling. We previously reported that HEY1 and HEY2 selectively repress androgen receptor (AR) signaling in mammalian cell lines and have shown that in human tissue HEY1 is excluded from the nuclei in prostate cancer but not benign prostatic hyperplasia. We have now characterized a third member of this family, HEYL, which is a more potent repressor of AR activity. HEYL interacted with and repressed AR activation function-1 domain and competitively inhibited SRC1e activation of AR transcriptional activity. Using a cell line inducibly expressing exogenous HEYL, we showed that HEYL represses endogenous AR-regulated genes and reduces androgen-dependent prostate cancer cell growth. Using a transrepression assay, we identified both trichostatin-sensitive and -insensitive domains within HEYL; however, analysis of endogenous AR target genes suggested that HEYL represses AR activity through histone deacetylase I/II-independent mechanisms. Immunohistochemical analyses of tissue indicated that, in a fashion similar to that previously reported for HEY1, HEYL is excluded from the nuclei in prostate cancer but not adjacent benign tissue. This suggests that nuclear exclusion of HEY proteins may be an important step in the progression of prostate cancer.	[Lavery, Derek N.; Bevan, Charlotte L.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Androgen Signalling Lab, London W12 0NN, England; [Walker, Marjorie M.] Univ London Imperial Coll Sci Technol & Med, Ctr Pathol, Div Med, London W2 1NY, England; [Villaronga, M. Angeles; Belandia, Borja] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid 28029, Spain; [Patel, Anup] Imperial Coll Healthcare Trust, St Marys Hosp, Dept Urol, London W2 1NY, England	Imperial College London; Imperial College London; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Imperial College London	Bevan, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, Androgen Signalling Lab, London W12 0NN, England.	charlotte.bevan@imperial.ac.uk	Belandia, Borja/H-1509-2015; Bevan, Charlotte L/K-2276-2012; Walker, Marjorie Mary/F-6504-2013; Bevan, Charlotte/T-7769-2019; Lavery, Derek/C-6706-2011	Belandia, Borja/0000-0003-2448-206X; Bevan, Charlotte L/0000-0002-7533-0552; 	Cancer Research UK [C11509/A8570, C11509/A12426]; Ministerio de Ciencia e Innovacion [SAF2007-62642, SAF2010-21013]	Cancer Research UK(Cancer Research UK); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Cancer Research UK Grants C11509/A8570 and C11509/A12426 and Ministerio de Ciencia e Innovacion Grants SAF2007-62642 and SAF2010-21013.	Agoulnik IU, 2003, J BIOL CHEM, V278, P31136, DOI 10.1074/jbc.M305153200; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Belandia Borja, 2006, Nucl Recept Signal, V4, pe001; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Brooke GN, 2009, CURR GENOMICS, V10, P18, DOI 10.2174/138920209787581307; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; Burd CJ, 2006, ENDOCR-RELAT CANCER, V13, P979, DOI 10.1677/erc.1.01115; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Dart DA, 2009, ENDOCR-RELAT CANCER, V16, P1157, DOI 10.1677/ERC-09-0028; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2002, COLD SPRING HARB SYM, V67, P63, DOI 10.1101/sqb.2002.67.63; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Gamble SC, 2007, ONCOGENE, V26, P1757, DOI 10.1038/sj.onc.1209967; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gobinet J, 2001, BIOCHEMISTRY-US, V40, P15369, DOI 10.1021/bi011384o; He B, 2002, MOL GENET METAB, V75, P293, DOI 10.1016/S1096-7192(02)00009-4; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Schiewer MJ, 2009, ONCOGENE, V28, P1016, DOI 10.1038/onc.2008.446; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Villaronga MA, 2010, ONCOGENE, V29, P411, DOI 10.1038/onc.2009.309; Villaronga MA, 2008, CURR CANCER DRUG TAR, V8, P566, DOI 10.2174/156800908786241096; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062	46	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17796	17808		10.1074/jbc.M110.198655	http://dx.doi.org/10.1074/jbc.M110.198655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454491	Green Published, hybrid			2022-12-25	WOS:000290585200043
J	Ge, ZQ; Wang, HY; Parthun, MR				Ge, Zhongqi; Wang, Huanyu; Parthun, Mark R.			Nuclear Hat1p Complex (NuB4) Components Participate in DNA Repair-linked Chromatin Reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE HAT1P; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ACETYLATION SITES; CHAPERONE ASF1; LYSINE 56; IN-VIVO; S-PHASE; H3; YEAST	Chromatin is disassembled and reassembled during DNA repair. To assay chromatin reassembly accompanying DNA double strand break repair, ChIP analysis can be used to monitor the presence of histone H3 near the lesion. The chromatin assembly factor Asf1p, as well as the acetylation of histone H3 lysine 56, have been shown to promote chromatin reassembly when DNA double strand break repair is complete. Using Gal-HO-mediated double strand break repair, we have tested each of the components of the nuclear Hat1p-containing type B histone acetyltransferase complex (NuB4) and have found that they can affect repair-linked chromatin reassembly but that their contributions are not equivalent. In particular, deletion of the catalytic subunit, Hat1p, caused a significant defect in chromatin reassembly. In addition, loss of the histone chaperone Hif1p, when combined with an allele of H3 that mutates lysines 14 and 23 to arginine, has a pronounced effect on chromatin reassembly that is similar to that observed in an asf1 Delta. The role of Hat1p and Hif1p is at least partially redundant with the role of Asf1p. Consistent with a more prominent role for Hif1p in chromatin reassembly than either Hat1p or Hat2p, Hif1p exists in complex(es) independent of Hat1p and Hat2p and influences the activity of an H3-specific histone acetyltransferase activity. Our data directly demonstrate the role of the nuclear HAT1 complex (NuB4) components in DNA repair-linked chromatin reassembly.	[Ge, Zhongqi; Wang, Huanyu; Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Ge, ZQ (corresponding author), 357 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Parthun.1@osu.edu	Wang, Huanyu/W-3145-2019	Wang, Huanyu/0000-0002-5982-6371	National Institutes of Health [GM62970]; Ohio State University Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62970 (to M. R. P.).; Supported by a Pelotonia Predoctoral Fellowship from the Ohio State University Comprehensive Cancer Center.	Adams A, 1997, METHODS YEAST GENETI; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Annunziato AT, 2000, GENE EXPRESSION, V9, P37; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Campos EI, 2010, GENE DEV, V24, P1334, DOI 10.1101/gad.1946810; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Durairaj G, 2010, J BIOL CHEM, V285, P30472, DOI 10.1074/jbc.M110.113225; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kelly TJ, 2000, MOL CELL BIOL, V20, P7051, DOI 10.1128/MCB.20.19.7051-7058.2000; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; RUIZCARRILLO A, 1975, SCIENCE, V190, P117, DOI 10.1126/science.1166303; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tsukuda Toyoko, 2009, Methods, V48, P40, DOI 10.1016/j.ymeth.2009.02.007; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	55	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16790	16799		10.1074/jbc.M110.216846	http://dx.doi.org/10.1074/jbc.M110.216846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454479	hybrid, Green Published			2022-12-25	WOS:000290301900028
J	Grabrucker, AM; Garner, CC; Boeckers, TM; Bondioli, L; Ruozi, B; Forni, F; Vandelli, MA; Tosi, G				Grabrucker, Andreas M.; Garner, Craig C.; Boeckers, Tobias M.; Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni			Development of Novel Zn2+ Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FORCED SWIMMING TEST; BLOOD-BRAIN-BARRIER; POSTSYNAPTIC DENSITY; ZINC; ANTIDEPRESSANT; DEPRESSION; MICE; ACTIVATION; VIVO	Intact synaptic function and plasticity are fundamental prerequisites to a healthy brain. Therefore, synaptic proteins are one of the major targets for drugs used as neuro-chemical therapeutics. Unfortunately, the majority of drugs is not able to cross the blood-brain barrier (BBB) and is therefore distributed within the CNS parenchyma. Here, we report the development of novel biodegradable Nanoparticles (NPs), made of poly-lactide-co-glycolide (PLGA) conjugated with glycopeptides that are able to cross the BBB and deliver for example Zn2+ ions. We also provide a thorough characterization of loaded and unloaded NPs for their stability, cellular uptake, release properties, toxicity, and impact on cell trafficking. Our data reveal that these NPs are biocompatible, and can be used to elevate intracellular levels of Zn2+. Importantly, by engineering the surface of NPs with antibodies against NCAM1 and CD44, we were able to selectively target neurons or glial cells, respectively. Our results indicate that these biodegradable NPs provide a potential new venue for the delivery Zn2+ to the CNS and thus a means to explore the influence of altered zinc levels linked to neuropsychological disorders such as depression.	[Grabrucker, Andreas M.; Garner, Craig C.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford Sch Med, Stanford, CA 94305 USA; [Grabrucker, Andreas M.; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; [Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, TeFarTI Grp, Modena, Italy; [Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, TeFarTI Grp, Reggio Emilia, Italy	Stanford University; Ulm University; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Grabrucker, AM (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford Sch Med, Stanford, CA 94305 USA.	andreas.grabrucker@stanford.edu; giovanni.tosi@unimore.it	Forni, Flavio/D-5492-2015; Ruozi, Barbara/D-5500-2015; Vandelli, Maria Angela/D-5497-2015; Tosi, Giovanni/D-4547-2011	Forni, Flavio/0000-0001-5974-6286; Ruozi, Barbara/0000-0002-2400-9910; Vandelli, Maria Angela/0000-0003-1462-8133; Tosi, Giovanni/0000-0001-8318-667X; Garner, Craig/0000-0003-1970-5417; Grabrucker, Andreas/0000-0003-0005-4810	Deutsche Forschungsgemeinschaft (DFG); National Institutes of Health [PO1 NS053862, R21MH091471]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053862] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AMG has been supported by a fellowship from the Deutsche Forschungsgemeinschaft (DFG) and the National Institutes of Health (PO1 NS053862; R21MH091471) to CCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani R, 2010, BIOL TRACE ELEM RES, V137, P150, DOI 10.1007/s12011-009-8572-x; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Blanco MD, 1997, EUR J PHARM BIOPHARM, V43, P287, DOI 10.1016/S0939-6411(97)00056-8; BURKE M, 1999, CENTRAL NERVOUS SYST, P184; Canzoniero LMT, 1999, J NEUROSCI, V19; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013; Cunha MP, 2008, PROG NEURO-PSYCHOPH, V32, P1913, DOI 10.1016/j.pnpbp.2008.09.006; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Garcia-Garcia E, 2005, INT J PHARMACEUT, V298, P274, DOI 10.1016/j.ijpharm.2005.03.031; Goslin K., 1991, CULTURING NERVE CELL, P251; GRABRUCKER AM, 2011, EMBO J; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hansen GH, 2009, AM J PHYSIOL-GASTR L, V297, pG708, DOI 10.1152/ajpgi.00192.2009; Huttner W B, 1991, Curr Opin Neurobiol, V1, P388, DOI 10.1016/0959-4388(91)90058-F; Kreuter J, 2007, INT J PHARMACEUT, V331, P1, DOI 10.1016/j.ijpharm.2006.10.021; Kroczka B, 2001, BRAIN RES BULL, V55, P297, DOI 10.1016/S0361-9230(01)00473-7; Kroczka B, 2000, POL J PHARMACOL, V52, P403; Levenson CW, 2006, NUTR REV, V64, P39, DOI 10.1301/nr.2006.jan.39-42; Liu YT, 2010, BIOMATERIALS, V31, P9145, DOI 10.1016/j.biomaterials.2010.08.053; Lom B, 1999, J NEUROSCI, V19, P9928; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Manser W W, 1989, J Pak Med Assoc, V39, P269; Marchetti B, 2005, ANN NY ACAD SCI, V1057, P296, DOI 10.1196/annals.1356.023; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; MCLOUGHLIN IJ, 1990, ACTA PSYCHIAT SCAND, V82, P451, DOI 10.1111/j.1600-0447.1990.tb03077.x; Nowak G, 2005, PHARMACOL REP, V57, P713; Nowak G, 2003, BRAIN RES BULL, V61, P159, DOI 10.1016/S0361-9230(03)00104-7; Nowak G, 2002, POL J PHARMACOL, V54, P587; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rosa AO, 2003, BEHAV BRAIN RES, V144, P87, DOI 10.1016/S0166-4328(03)00069-X; Sawada T, 2010, EUR J CLIN NUTR, V64, P331, DOI 10.1038/ejcn.2009.158; SCHUBERT P, 2005, ALZHEIMERS DIS, P209; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497; Szewczyk B, 2002, POL J PHARMACOL, V54, P681; Tassabehji NM, 2008, PHYSIOL BEHAV, V95, P365, DOI 10.1016/j.physbeh.2008.06.017; Tosi G, 2007, J CONTROL RELEASE, V122, P1, DOI 10.1016/j.jconrel.2007.05.022; Tosi G, 2010, J CONTROL RELEASE, V145, P49, DOI 10.1016/j.jconrel.2010.03.008; TOSI G, 2010, INVESTIGATI IN PRESS; Tosi G, 2008, EXPERT OPIN DRUG DEL, V5, P155, DOI 10.1517/17425247.5.2.155; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Whittle N, 2009, AMINO ACIDS, V36, P147, DOI 10.1007/s00726-008-0195-6; Wojcik J, 2006, PHARMACOL REP, V58, P571; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4	48	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17851	10.1371/journal.pone.0017851	http://dx.doi.org/10.1371/journal.pone.0017851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448455	gold, Green Submitted, Green Published			2022-12-25	WOS:000288810500017
J	Tu, DQ; Li, YQ; Song, HK; Toms, AV; Gould, CJ; Ficarro, SB; Marto, JA; Goode, BL; Eck, MJ				Tu, Daqi; Li, Yiqun; Song, Hyun Kyu; Toms, Angela V.; Gould, Christopher J.; Ficarro, Scott B.; Marto, Jarrod A.; Goode, Bruce L.; Eck, Michael J.			Crystal Structure of a Coiled-Coil Domain from Human ROCK I	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; MYOSIN LIGHT-CHAIN; SMOOTH-MUSCLE CONTRACTION; SERINE/THREONINE KINASE; PROTEIN-KINASE; STRESS FIBERS; PHOSPHORYLATION; BINDING; ACTIVATION; CYTOKINESIS	The small GTPase Rho and one of its targets, Rho-associated kinase (ROCK), participate in a variety of actin-based cellular processes including smooth muscle contraction, cell migration, and stress fiber formation. The ROCK protein consists of an N-terminal kinase domain, a central coiled-coil domain containing a Rho binding site, and a C-terminal pleckstrin homology domain. Here we present the crystal structure of a large section of the central coiled-coil domain of human ROCK I (amino acids 535-700). The structure forms a parallel alpha-helical coiled-coil dimer that is structurally similar to tropomyosin, an actin filament binding protein. There is an unusual discontinuity in the coiled-coil; three charged residues (E613, R617 and D620) are positioned at what is normally the hydrophobic core of coiled-coil packing. We speculate that this conserved irregularity could function as a hinge that allows ROCK to adopt its autoinhibited conformation.	[Tu, Daqi; Toms, Angela V.; Ficarro, Scott B.; Marto, Jarrod A.; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tu, Daqi; Li, Yiqun; Toms, Angela V.; Ficarro, Scott B.; Marto, Jarrod A.; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Song, Hyun Kyu] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Gould, Christopher J.; Goode, Bruce L.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Gould, Christopher J.; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Korea University; Brandeis University; Brandeis University	Tu, DQ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Song, Hyun Kyu/D-6763-2016	Song, Hyun Kyu/0000-0001-5684-4059	National Institutes of Health (NIH) [GM071834]; Ministry of Education, Science and Technology [R33-10108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM071834, T32GM007596, R01GM071834] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grant GM071834 to M.J.E. and by WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-10108) to M.J.E. and H.K.S.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chiba Y, 1999, BRIT J PHARMACOL, V127, P597, DOI 10.1038/sj.bjp.0702585; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freedman SJ, 2003, J BIOL CHEM, V278, P13462, DOI 10.1074/jbc.M210483200; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nakajima M, 2003, EUR J PHARMACOL, V459, P113, DOI 10.1016/S0014-2999(02)02869-8; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086	48	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18080	10.1371/journal.pone.0018080	http://dx.doi.org/10.1371/journal.pone.0018080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445309	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300035
J	Cerqueira, GM; Souza, NM; Araujo, ER; Barros, AT; Morais, ZM; Vasconcellos, LA; Nascimento, ALTO				Cerqueira, Gustavo M.; Souza, Natalie M.; Araujo, Eduardo R.; Barros, Aline T.; Morais, Zenaide M.; Vasconcellos, Lvio A.; Nascimento, Ana L. T. O.			Development of Transcriptional Fusions to Assess Leptospira interrogans Promoter Activity	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; OUTER-MEMBRANE PROTEINS; INTERNATIONAL MULTICENTER EVALUATION; PROTECTIVE IMMUNITY; RECOMBINANT LIPL32; HEME OXYGENASE; DIPSTICK ASSAY; LIG GENES; EXPRESSION; SEROVAR	Background: Leptospirosis is a zoonotic infectious disease that affects both humans and animals. The existing genetic tools for Leptospira spp. have improved our understanding of the biology of this spirochete as well as the interaction of pathogenic leptospires with the mammalian host. However, new tools are necessary to provide novel and useful information to the field. Methodology and Principal Findings: A series of promoter-probe vectors carrying a reporter gene encoding green fluorescent protein (GFP) were constructed for use in L. biflexa. They were tested by constructing transcriptional fusions between the lipL41, Leptospiral Immunoglobulin-like A (ligA) and Sphingomielynase 2 (sph2) promoters from L. interrogans and the reporter gene. ligA and sph2 promoters were the most active, in comparison to the lipL41 promoter and the non-induced controls. The results obtained are in agreement with LigA expression from the L. interrogans Fiocruz L1-130 strain. Conclusions: The novel vectors facilitated the in vitro evaluation of L. interrogans promoter activity under defined growth conditions which simulate the mammalian host environment. The fluorescence and rt-PCR data obtained closely reflected transcriptional regulation of the promoters, thus demonstrating the suitability of these vectors for assessing promoter activity in L. biflexa.	[Cerqueira, Gustavo M.; Souza, Natalie M.; Araujo, Eduardo R.; Barros, Aline T.; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Morais, Zenaide M.; Vasconcellos, Lvio A.] Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas VPS, Sao Paulo, Brazil; [Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-05508 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo	Cerqueira, GM (corresponding author), Monash Univ, Dept Microbiol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	cerqueiragm@yahoo.com.br	Cerqueira, Gustavo/B-7180-2015; Nascimento, Ana L. T. O./E-8488-2012	Cerqueira, Gustavo/0000-0002-3029-6899; Nascimento, Ana L. T. O./0000-0003-4851-0870	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Butantan	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	Gustavo M. Cerqueira holds a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Ana L.T.O. Nascimento would like to acknowledge the support from FAPESP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, HUM LEPT GUID DIAGN; Artiushin S, 2004, INFECT IMMUN, V72, P742, DOI 10.1128/IAI.72.2.742-749.2004; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Aviat F, 2010, APPL ENVIRON MICROB, V76, P8135, DOI 10.1128/AEM.02199-10; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BOLIN CA, 1989, AM J VET RES, V50, P161; Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002; Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; CARLSON JPE, 2009, J BACTERIOL, V191, P10; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020; Chong PK, 2007, PROTEOMICS, V7, P424, DOI 10.1002/pmic.200600746; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dey S, 2004, VET MICROBIOL, V103, P99, DOI 10.1016/j.vetmic.2004.07.018; Dong HY, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-223; Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; FAISAL SM, 2009, VACCINE; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P6537, DOI 10.1016/j.vaccine.2009.08.051; Faisal SM, 2009, VACCINE, V27, P6129, DOI 10.1016/j.vaccine.2009.08.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1999, INFECT IMMUN, V67, P6572; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; HORZEMPA J, 2008, APPL ENVIRON MICROB, V74, P10; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; IGARASHI K, 2000, BIOCHEM BIOPH RES CO, V271, P6; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208; LI S, 2009, INNATE IMMUN; Lin X, 2008, CLIN VACCINE IMMUNOL, V15, P1711, DOI 10.1128/CVI.00189-08; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002; Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; MATYS V, 2003, NUCLEIC ACIDS RES, V31, P5; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Oliveira TR, 2008, CLIN VACCINE IMMUNOL, V15, P1715, DOI 10.1128/CVI.00214-08; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Patarakul K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-31; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; REESE MG, 2001, COMPUTATIONAL CHEM, V26, P6; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; SEGAL GM, 1987, KIDNEY INT, V31, P72, DOI 10.1038/ki.1987.11; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999; Smits HL, 2000, TROP MED INT HEALTH, V5, P124, DOI 10.1046/j.1365-3156.2000.00525.x; Smits HL, 2001, TROP MED INT HEALTH, V6, P114, DOI 10.1046/j.1365-3156.2001.00675.x; Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001; Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8; Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; SUZUKI I, 2006, J EXP BOT, V57, P6; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; WEISBURG WG, 1991, J BACTERIOL, V173, P7; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; YAN W, VACCINE, V28, P2277; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006	102	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17409	10.1371/journal.pone.0017409	http://dx.doi.org/10.1371/journal.pone.0017409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445252	gold, Green Published, Green Accepted			2022-12-25	WOS:000288545100013
J	Phuong, THN; Nakamura, T; Hori, E; Urakawa, S; Uwano, T; Zhao, JJ; Li, RX; Bac, ND; Hamashima, T; Ishii, Y; Matsushima, T; Ono, T; Sasahara, M; Nishijo, H				Phuong Thi Hong Nguyen; Nakamura, Tomoya; Hori, Etsuro; Urakawa, Susumu; Uwano, Teruko; Zhao, Juanjuan; Li, Ruixi; Nguyen Duy Bac; Hamashima, Takeru; Ishii, Yoko; Matsushima, Takako; Ono, Taketoshi; Sasahara, Masakiyo; Nishijo, Hisao			Cognitive and Socio-Emotional Deficits in Platelet-Derived Growth Factor Receptor-beta Gene Knockout Mice	PLOS ONE			English	Article							GENOME-WIDE SCAN; SUSCEPTIBILITY LOCUS; ANIMAL-MODEL; B-CHAIN; PREPULSE INHIBITION; MOUSE MODELS; FACTOR PDGF; SCHIZOPHRENIA; RAT; NEURONS	Platelet-derived growth factor (PDGF) is a potent mitogen. Extensive in vivo studies of PDGF and its receptor (PDGFR) genes have reported that PDGF plays an important role in embryogenesis and development of the central nervous system (CNS). Furthermore, PDGF and the beta subunit of the PDGF receptor (PDGFR-beta) have been reported to be associated with schizophrenia and autism. However, no study has reported on the effects of PDGF deletion on mice behavior. Here we generated novel mutant mice (PDGFR-beta KO) in which PDGFR-beta was conditionally deleted in CNS neurons using the Cre/loxP system. Mice without the Cre transgene but with floxed PDGFR-beta were used as controls. Both groups of mice reached adulthood without any apparent anatomical defects. These mice were further examined by conducting several behavioral tests for spatial memory, social interaction, conditioning, prepulse inhibition, and forced swimming. The test results indicated that the PDGFR-beta KO mice show deficits in all of these areas. Furthermore, an immunohistochemical study of the PDGFR-beta KO mice brain indicated that the number of parvalbumin (calcium-binding protein)-positive (i.e., putatively gamma-aminobutyric acid-ergic) neurons was low in the amygdala, hippocampus, and medial prefrontal cortex. Neurophysiological studies indicated that sensory-evoked gamma oscillation was low in the PDGFR-beta KO mice, consistent with the observed reduction in the number of parvalbumin-positive neurons. These results suggest that PDGFR-beta plays an important role in cognitive and socioemotional functions, and that deficits in this receptor may partly underlie the cognitive and socioemotional deficits observed in schizophrenic and autistic patients.	[Phuong Thi Hong Nguyen; Urakawa, Susumu; Ono, Taketoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Physiotherapy, Toyama 930, Japan; [Hamashima, Takeru; Ishii, Yoko; Matsushima, Takako; Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 930, Japan	University of Toyama; University of Toyama	Phuong, THN (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Physiotherapy, Toyama 930, Japan.	nishijo@med.u-toyama.ac.jp			CREST (Core Research for Evolutional Science and Technology); JST (Japan Science and Technology Agency) Japan; JSPS (Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture [22240051]; Grants-in-Aid for Scientific Research [22240051] Funding Source: KAKEN	CREST (Core Research for Evolutional Science and Technology)(Core Research for Evolutional Science and Technology (CREST)); JST (Japan Science and Technology Agency) Japan(Japan Science & Technology Agency (JST)); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Agency), Japan, JSPS (Japan Society for the Promotion of Science) Asian Core Program, and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A) (22240051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JD, 2004, NEUROPSYCHOPHARMACOL, V29, P1080, DOI 10.1038/sj.npp.1300394; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bannon Anthony W, 2007, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0809s41; Behrens MM, 2009, NEUROPHARMACOLOGY, V57, P193, DOI 10.1016/j.neuropharm.2009.06.002; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CHENG B, 1995, J NEUROSCI, V15, P7095; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; Devlin B, 2002, MOL PSYCHIATR, V7, P689, DOI 10.1038/sj.mp.4001056; ELISABETH B, 2009, NEUROSCIENCE, V10, P132; Fejgin K, 2009, NEUROPSYCHOPHARMACOL, V34, P1673, DOI 10.1038/npp.2008.225; Fendt M, 2000, NEUROSCIENCE, V98, P55, DOI 10.1016/S0306-4522(00)00086-5; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gaigg SB, 2007, NEUROPSYCHOLOGIA, V45, P2125, DOI 10.1016/j.neuropsychologia.2007.01.012; Gao ZY, 2005, J BIOL CHEM, V280, P9375, DOI 10.1074/jbc.M413081200; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hall MH, 2011, SCHIZOPHRENIA BULL, V37, P778, DOI 10.1093/schbul/sbp134; Hanlon FM, 2006, SCHIZOPHR RES, V87, P67, DOI 10.1016/j.schres.2006.05.021; Hauser J, 2005, MOL PSYCHIATR, V10, P201, DOI 10.1038/sj.mp.4001554; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Herzberg I, 2006, HUM MOL GENET, V15, P3146, DOI 10.1093/hmg/ddl254; Hof PR., 2000, COMP CYTOARCHITECTON; Hofer E, 2001, SCHIZOPHR RES, V51, P127, DOI 10.1016/S0920-9964(00)00118-3; Ishii Y, 2008, MOL CELL NEUROSCI, V37, P507, DOI 10.1016/j.mcn.2007.11.006; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Kajizuka M, 2010, PROG NEURO-PSYCHOPH, V34, P154, DOI 10.1016/j.pnpbp.2009.10.017; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Kim HJ, 2008, SCHIZOPHR RES, V103, P201, DOI 10.1016/j.schres.2008.04.031; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kurokawa M, 2003, CELL MOL NEUROBIOL, V23, P121, DOI 10.1023/A:1022956403708; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Lei SB, 1999, J BIOL CHEM, V274, P30617, DOI 10.1074/jbc.274.43.30617; Leicht G, 2010, BIOL PSYCHIAT, V67, P224, DOI 10.1016/j.biopsych.2009.07.033; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nabeshima T, 2006, ANN NY ACAD SCI, V1086, P160, DOI 10.1196/annals.1377.003; NEETA PN, 2005, J NEUROSCI, V25, P4659; O'Tuathaigh CMP, 2010, SCHIZOPHRENIA BULL, V36, P271, DOI 10.1093/schbul/sbp125; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; OTHBERG A, 1995, EXP BRAIN RES, V105, P111; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Pollack MH, 2008, PROG NEURO-PSYCHOPH, V32, P739, DOI 10.1016/j.pnpbp.2007.11.023; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Rojas DC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-66; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; Sasahara M, 1998, ONCOGENE, V16, P1571, DOI 10.1038/sj.onc.1201679; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Schmajuk NA, 2005, BEHAV NEUROSCI, V119, P1546, DOI 10.1037/0735-7044.119.6.1546; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shioda N, 2009, NEUROSCI RES, V65, pS67, DOI 10.1016/j.neures.2009.09.217; Silverman JM, 1996, AM J MED GENET, V67, P162, DOI 10.1002/(SICI)1096-8628(19960409)67:2<162::AID-AJMG6>3.0.CO;2-U; Sklar P, 2004, MOL PSYCHIATR, V9, P213, DOI 10.1038/sj.mp.4001418; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; SMITS A, 1993, EUR J NEUROSCI, V5, P986, DOI 10.1111/j.1460-9568.1993.tb00950.x; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stahl SM, 2007, ACTA PSYCHIAT SCAND, V115, P4, DOI 10.1111/j.1600-0447.2006.00947.x; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Suzuki M, 2005, BRAIN, V128, P2109, DOI 10.1093/brain/awh554; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Tandon R, 2009, SCHIZOPHR RES, V110, P1, DOI 10.1016/j.schres.2009.03.005; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; VUKMIR V, 2001, PEDIATR RES, V50, P236; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302	81	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18004	10.1371/journal.pone.0018004	http://dx.doi.org/10.1371/journal.pone.0018004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437241	gold, Green Submitted, Green Published			2022-12-25	WOS:000288545100055
J	Shaw, PJA; Shackleton, K				Shaw, Peter J. A.; Shackleton, Kyle			Carnivory in the Teasel Dipsacus fullonum - The Effect of Experimental Feeding on Growth and Seed Set	PLOS ONE			English	Article							NITROGEN; PLANTS; PREY; NUTRITION; FITNESS; DROSERA	The teasel, Dipsacus fullonum is known to catch invertebrates in its water filled leaf bases, but experimental testing of reproductive benefits of this have been lacking. We report the effects of insect supplementation/ removal and water removal during spring/summer on Dipsacus in two field populations. There were no significant treatment effects on biomass, but addition of dead dipteran larvae to leaf bases caused a 30% increase in seed set and the seed mass: biomass ratio. This study provides the first empirical evidence for reproductive benefit from carnivory in Dipsacus fullonum.	[Shaw, Peter J. A.; Shackleton, Kyle] Roehampton Univ, Dept Life Sci, Whitelands Coll, London, England	Roehampton University	Shaw, PJA (corresponding author), Roehampton Univ, Dept Life Sci, Whitelands Coll, London, England.	p.shaw@roehampton.ac.uk		shaw, peter/0000-0002-6621-2204				Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; CHANDLER GE, 1976, NEW PHYTOL, V76, P129, DOI 10.1111/j.1469-8137.1976.tb01445.x; Christy M., 1923, J BOT BRIT FOREIGN, V61, P33; Darwin C., 1875, CARNIVOROUS PLANTS; DARWIN F, 1877, P ROY SOC LONDON, V26, P245; *ECOFACT, 1999, RES REP, V2; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Hanslin HM, 1996, OECOLOGIA, V106, P370, DOI 10.1007/BF00334564; Juniper B.E., 1989, CARNIVOROUS PLANTS; Lloyd F.E., 1942, CARNIVOROUS PLANTS; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MEYERS DG, 1982, P ACAD NAT SCI PHILA, V134, P1; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; SIMONS P, 1981, CARNIVOROUS PLANT NE, V10, P65; SLACK A, CARNIVOROUS PLANTS; THUM M, 1989, OECOLOGIA, V81, P401, DOI 10.1007/BF00377091; Wakefield AE, 2005, ECOLOGY, V86, P1737, DOI 10.1890/04-1673; WERNER PA, 1975, OECOLOGIA, V20, P197, DOI 10.1007/BF00347472; WERNER PA, 1975, CAN J PLANT SCI, V55, P783, DOI 10.4141/cjps75-122	20	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17935	10.1371/journal.pone.0017935	http://dx.doi.org/10.1371/journal.pone.0017935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445274	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100045
J	Andersson, IE; Andersson, CD; Batsalova, T; Dzhambazov, B; Holmdahl, R; Kihlberg, J; Linusson, A				Andersson, Ida E.; Andersson, C. David; Batsalova, Tsvetelina; Dzhambazov, Balik; Holmdahl, Rikard; Kihlberg, Jan; Linusson, Anna			Design of Glycopeptides Used to Investigate Class II MHC Binding and T-Cell Responses Associated with Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ANCHOR-SUBSTITUTED VARIANT; PEPTIDE MIMETIC INHIBITORS; SCORING FUNCTIONS; ANTIGEN PRESENTATION; MOLECULAR DOCKING; LIGAND; COMPLEX; MODEL; DETERMINANT	The glycopeptide fragment CII259-273 from type II collagen (CII) binds to the murine A(q) and human DR4 class II Major Histocompatibility Complex (MHC II) proteins, which are associated with development of murine collagen-induced arthritis (CIA) and rheumatoid arthritis (RA), respectively. It has been shown that CII259-273 can be used in therapeutic vaccination of CIA. This glycopeptide also elicits responses from T-cells obtained from RA patients, which indicates that it has an important role in RA as well. We now present a methodology for studies of (glyco) peptide-receptor interactions based on a combination of structure-based virtual screening, ligand-based statistical molecular design and biological evaluations. This methodology included the design of a CII259-273 glycopeptide library in which two anchor positions crucial for binding in pockets of A(q) and DR4 were varied. Synthesis and biological evaluation of the designed glycopeptides provided novel structure-activity relationship (SAR) understanding of binding to A(q) and DR4. Glycopeptides that retained high affinities for these MHC II proteins and induced strong responses in panels of T-cell hybridomas were also identified. An analysis of all the responses revealed groups of glycopeptides with different response patterns that are of high interest for vaccination studies in CIA. Moreover, the SAR understanding obtained in this study provides a platform for the design of second-generation glycopeptides with tuned MHC affinities and T-cell responses.	[Andersson, Ida E.; Andersson, C. David; Kihlberg, Jan] Umea Univ, Dept Chem, Umea, Sweden; [Batsalova, Tsvetelina; Dzhambazov, Balik; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Kihlberg, Jan; Linusson, Anna] AstraZeneca R&D, Molndal, Sweden	Umea University; Karolinska Institutet; AstraZeneca	Andersson, IE (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	anna.linusson@chem.umu.se	Batsalova, Tsvetelina G/W-6340-2018; Batsalova, Tsvetelina/AAS-7000-2021; Kihlberg, Jan/S-4739-2019; Holmdahl, Rikard/AAI-7682-2020; Batsalova, Tsvetelina/K-3026-2016; Dzhambazov, Balik/H-1220-2015	Batsalova, Tsvetelina/0000-0002-6560-1945; Dzhambazov, Balik/0000-0001-8052-5840	Swedish Research Council [dnr 2008-3672]; Swedish Strategic Science Foundation (SSF); Umea University; JC Kempe Foundation (SJCKMS); EU [HEALTH-F2-2008-223404]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Science Foundation (SSF)(Swedish Foundation for Strategic Research); Umea University; JC Kempe Foundation (SJCKMS); EU(European Commission)	Funding: This work was supported by the Swedish Research Council (dnr 2008-3672), the Swedish Strategic Science Foundation (SSF), the Biotechnology Fund at Umea University, the JC Kempe Foundation (SJCKMS), and the EU project Masterswitch HEALTH-F2-2008-223404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EC, 1998, P NATL ACAD SCI USA, V95, P7574, DOI 10.1073/pnas.95.13.7574; Andersson IE, 2007, J MED CHEM, V50, P5627, DOI 10.1021/jm0705410; Andersson IE, 2010, ORG BIOMOL CHEM, V8, P2931, DOI 10.1039/c003640d; Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A; Backlund J, 2002, P NATL ACAD SCI USA, V99, P9960, DOI 10.1073/pnas.132254199; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Boots AMH, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2269; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Box G.E.P., 1987, EMPIRICAL MODEL BUIL; Broddefalk J, 1998, J AM CHEM SOC, V120, P7676, DOI 10.1021/ja980489k; BRUNSBERG U, 1994, EUR J IMMUNOL, V24, P1698, DOI 10.1002/eji.1830240736; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Haan EC, 2005, MOL IMMUNOL, V42, P355, DOI 10.1016/j.molimm.2004.07.044; de Haan EC, 2002, BIOORGAN MED CHEM, V10, P1939, DOI 10.1016/S0968-0896(01)00434-5; deAguiar PF, 1995, CHEMOMETR INTELL LAB, V30, P199, DOI 10.1016/0169-7439(94)00076-X; Desmond Molecular Dynamics System, 2010, 22 DE SHAW RES; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; DUMOUCHEL W, 1994, TECHNOMETRICS, V36, P37, DOI 10.2307/1269197; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Eriksson L, 1996, J CHEMOMETR, V10, P483; Evensen E, 2007, J COMPUT AID MOL DES, V21, P395, DOI 10.1007/s10822-007-9119-x; Falcioni F, 1999, NAT BIOTECHNOL, V17, P562, DOI 10.1038/9865; Feher M, 2006, DRUG DISCOV TODAY, V11, P421, DOI 10.1016/j.drudis.2006.03.009; Ford ML, 2003, J IMMUNOL, V171, P1247, DOI 10.4049/jimmunol.171.3.1247; Gad M, 2003, EUR J IMMUNOL, V33, P1624, DOI 10.1002/eji.200323698; GOLD, 2006, CAMBR CRYST DAT; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hanson GJ, 1996, BIOORG MED CHEM LETT, V6, P1931, DOI 10.1016/0960-894X(96)00348-4; HILL CM, 1994, J IMMUNOL, V152, P2890; Holm B, 2002, CHEMBIOCHEM, V3, P1209, DOI 10.1002/1439-7633(20021202)3:12<1209::AID-CBIC1209>3.0.CO;2-0; Holm L, 2005, BIOORGAN MED CHEM, V13, P473, DOI 10.1016/j.bmc.2004.10.011; Holm L, 2007, J MED CHEM, V50, P2049, DOI 10.1021/jm061209b; Holm L, 2006, BIOORGAN MED CHEM, V14, P5921, DOI 10.1016/j.bmc.2006.05.023; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jacobsson M, 2003, J MED CHEM, V46, P5781, DOI 10.1021/jm030896t; Jensen T, 2001, EUR J IMMUNOL, V31, P3197, DOI 10.1002/1521-4141(200111)31:11<3197::AID-IMMU3197>3.0.CO;2-5; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; Kjellen P, 1998, EUR J IMMUNOL, V28, P755, DOI 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2; KRCHNAK V, 1988, INT J PEPT PROT RES, V32, P415; Larsson A, 2005, J MED CHEM, V48, P935, DOI 10.1021/jm040818l; Lindgren F, 1996, J CHEMOMETR, V10, P521; Linusson A, 1998, MOL DIVERS, V4, P103, DOI 10.1023/A:1026416430656; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Margot CD, 2005, J IMMUNOL, V174, P3352, DOI 10.4049/jimmunol.174.6.3352; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; MICHAELSSON E, 1992, EUR J IMMUNOL, V22, P1819, DOI 10.1002/eji.1830220722; MYERS LK, 1993, J IMMUNOL, V150, P4652; Myers LK, 1998, J IMMUNOL, V161, P3589; Myers LK, 2002, ARTHRITIS RHEUM, V46, P3369, DOI 10.1002/art.10687; Nurbo J, 2007, J PEPT SCI, V13, P822, DOI 10.1002/psc.906; Oda A, 2006, J CHEM INF MODEL, V46, P380, DOI 10.1021/ci050283k; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; Rosloniec EF, 1996, CELL IMMUNOL, V172, P21, DOI 10.1006/cimm.1996.0210; Ryan KR, 2004, CELL IMMUNOL, V227, P70, DOI 10.1016/j.cellimm.2004.01.003; Sakurai Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2043; Smith AB, 1999, J AM CHEM SOC, V121, P9286, DOI 10.1021/ja991251e; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; STJOHN RC, 1975, TECHNOMETRICS, V17, P15; Syed BM, 2004, TETRAHEDRON, V60, P5571, DOI 10.1016/j.tet.2004.04.081; Tang B, 2009, CLIN IMMUNOL, V133, P145, DOI 10.1016/j.clim.2009.06.006; Terp GE, 2001, J MED CHEM, V44, P2333, DOI 10.1021/jm001090l; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Verkhivker GM, 2000, J COMPUT AID MOL DES, V14, P731, DOI 10.1023/A:1008158231558; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wei HY, 2005, J CHEM INF MODEL, V45, P1343, DOI 10.1021/ci050140y; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Xing L, 2004, J COMPUT AID MOL DES, V18, P333, DOI 10.1023/B:JCAM.0000047812.39758.ab; Zavala-Ruiz Z, 2003, J BIOL CHEM, V278, P44904, DOI 10.1074/jbc.M307652200	80	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17881	10.1371/journal.pone.0017881	http://dx.doi.org/10.1371/journal.pone.0017881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423632	gold, Green Submitted, Green Published			2022-12-25	WOS:000288513900039
J	da Rocha, AF; Rocha, FT; Massad, E				da Rocha, Armando Freitas; Rocha, Fabio Theoto; Massad, Eduardo			The Brain as a Distributed Intelligent Processing System: An EEG Study	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; NEURAL EFFICIENCY; NETWORKS; NEUROSCIENCE; PERFORMANCE; AGE	Background: Various neuroimaging studies, both structural and functional, have provided support for the proposal that a distributed brain network is likely to be the neural basis of intelligence. The theory of Distributed Intelligent Processing Systems (DIPS), first developed in the field of Artificial Intelligence, was proposed to adequately model distributed neural intelligent processing. In addition, the neural efficiency hypothesis suggests that individuals with higher intelligence display more focused cortical activation during cognitive performance, resulting in lower total brain activation when compared with individuals who have lower intelligence. This may be understood as a property of the DIPS. Methodology and Principal Findings: In our study, a new EEG brain mapping technique, based on the neural efficiency hypothesis and the notion of the brain as a Distributed Intelligence Processing System, was used to investigate the correlations between IQ evaluated with WAIS (Whechsler Adult Intelligence Scale) and WISC (Wechsler Intelligence Scale for Children), and the brain activity associated with visual and verbal processing, in order to test the validity of a distributed neural basis for intelligence. Conclusion: The present results support these claims and the neural efficiency hypothesis.	[da Rocha, Armando Freitas; Rocha, Fabio Theoto] RANI, Sao Paulo, Brazil; [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo	da Rocha, AF (corresponding author), RANI, Sao Paulo, Brazil.	edmassad@usp.br	Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011	Massad, Eduardo/0000-0002-7200-2916; 				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CHANDRASEKARAN B, 1981, IEEE T SYST MAN CYB, V11, P1, DOI 10.1109/TSMC.1981.4308573; Colom R, 2004, PERS INDIV DIFFER, V36, P75, DOI 10.1016/S0191-8869(03)00053-9; DAVIS R, 1983, ARTIF INTELL, V20, P63, DOI 10.1016/0004-3702(83)90015-2; Deary IJ, 1997, TRENDS NEUROSCI, V20, P365, DOI 10.1016/S0166-2236(97)01070-9; Doppelmayr M, 2005, NEUROSCI LETT, V381, P309, DOI 10.1016/j.neulet.2005.02.037; Doppelmayr M, 2002, INTELLIGENCE, V30, P289, DOI 10.1016/S0160-2896(01)00101-5; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fink A, 2006, INT J PSYCHOPHYSIOL, V62, P46, DOI 10.1016/j.ijpsycho.2006.01.001; Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HEWITT C, 1991, IEEE T SYST MAN CYB, V21, P1409, DOI 10.1109/21.135685; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jackson DN, 2006, INTELLIGENCE, V34, P479, DOI 10.1016/j.intell.2006.03.005; Jausovec N, 2000, INTELLIGENCE, V28, P213, DOI 10.1016/S0160-2896(00)00037-4; Jausovec N, 2005, BRAIN COGNITION, V59, P277, DOI 10.1016/j.bandc.2005.08.001; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; LESSER VR, 1991, IEEE T SYST MAN CYB, V21, P1347, DOI 10.1109/21.135681; Lynn R, 1999, INTELLIGENCE, V27, P1, DOI 10.1016/S0160-2896(99)00009-4; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Neubauer AC, 1997, PERS INDIV DIFFER, V22, P885, DOI 10.1016/S0191-8869(97)00003-2; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Njemanze PC, 2005, BRAIN LANG, V92, P234, DOI 10.1016/j.bandl.2004.06.104; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4; Rocha AF, 2004, BRAIN; Rocha AF, 1992, LECT NOTES ARTIFICIA; Rocha AF, 2002, PROGR NEUROBIOLOGY, V64, P555; Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008; Schmid RG, 2002, CLIN NEUROPHYSIOL, V113, P1647, DOI 10.1016/S1388-2457(02)00212-2; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Stauder JEA, 2003, INTELLIGENCE, V31, P257, DOI 10.1016/S0160-2896(02)00136-8; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Wats DJ, 1999, SMALL WORLDS DYNAMIC	42	11	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17355	10.1371/journal.pone.0017355	http://dx.doi.org/10.1371/journal.pone.0017355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423657	Green Published, gold			2022-12-25	WOS:000288513900007
J	Aruna, M; Dasgupta, S; Sirisha, PVS; Bhaskar, SA; Tarakeswari, S; Singh, L; Reddy, BM				Aruna, Meka; Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Bhaskar, Sadaranga Andal; Tarakeswari, Surapaneni; Singh, Lalji; Reddy, B. Mohan			Role of Androgen Receptor CAG Repeat Polymorphism and X-Inactivation in the Manifestation of Recurrent Spontaneous Abortions in Indian Women	PLOS ONE			English	Article							CHROMOSOME INACTIVATION; TRINUCLEOTIDE REPEATS; GENE; INFERTILITY; MISCARRIAGE; LENGTH	The aim of the present study was to investigate the role of CAG repeat polymorphism and X-chromosome Inactivation (XCI) pattern in Recurrent Spontaneous Abortions among Indian women which has not been hitherto explored. 117 RSA cases and 224 Controls were included in the study. Cases were recruited from two different hospitals - Lakshmi Fertility Clinic, Nellore and Fernandez Maternity Hospital, Hyderabad. Controls were roughly matched for age, ethnicity and socioeconomic status. The CAG repeats of the Androgen Receptor gene were genotyped using a PCR-based assay and were analysed using the GeneMapper software to determine the CAG repeat length. XCI analysis was also carried out to assess the inactivation percentages. RSA cases had a significantly greater frequency of allele sizes in the polymorphic range above 19 repeats (p = 0.006), which is the median value of the controls, and in the biallelic mean range above 21 repeats (p = 0.002). We found no evidence of abnormal incidence of skewed X-inactivation. We conclude that longer CAG repeat lengths are associated with increased odds for RSA with statistical power estimated to be similar to 90%.	[Aruna, Meka; Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Mol Anthropol Grp, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India; [Bhaskar, Sadaranga Andal] Lakshmi Fertil Clin & Res Ctr, Nellore, Andhra Pradesh, India; [Tarakeswari, Surapaneni] Fernandez Hosp, Hyderabad, Andhra Pradesh, India; [Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aruna, M (corresponding author), Indian Stat Inst, Mol Anthropol Grp, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in			Indian Statistical Institute, Kolkata, India	Indian Statistical Institute, Kolkata, India	Indian Statistical Institute, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; Bussen S, 1999, HUM REPROD, V14, P18, DOI 10.1093/humrep/14.1.18; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CLIFFORD K, 1995, HUM REPROD, V10, P694, DOI 10.1093/oxfordjournals.humrep.a136015; Cram DS, 2000, MOL HUM REPROD, V6, P861, DOI 10.1093/molehr/6.9.861; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; Ferk P, 2008, FERTIL STERIL, V90, P860, DOI 10.1016/j.fertnstert.2007.07.1291; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Hogge WA, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.012; HUSSAIN M A, 1976, Bangladesh Medical Research Council Bulletin, V2, P120; Jaaskelainen J, 2005, FERTIL STERIL, V83, P1724, DOI 10.1016/j.fertnstert.2004.11.080; Kim JJ, 2008, FERTIL STERIL, V90, P2318, DOI 10.1016/j.fertnstert.2007.10.030; Kim JW, 2004, J KOREAN MED SCI, V19, P258, DOI 10.3346/jkms.2004.19.2.258; Lanasa MC, 1999, AM J HUM GENET, V65, P252, DOI 10.1086/302441; Lanasa MC, 2000, SEMIN REPROD MED, V18, P97, DOI 10.1055/s-2000-13480; Liu QR, 2008, ENDOCRINE, V33, P165, DOI 10.1007/s12020-008-9069-7; Meka Aruna, 2006, International Journal of Human Genetics, V6, P109; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Mohlig M, 2006, EUR J ENDOCRINOL, V155, P127, DOI 10.1530/eje.1.02195; Pasquier E, 2007, HUM REPROD, V22, P2829, DOI 10.1093/humrep/dem264; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; REISS HE, 1998, REPROD MED A Z; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sangha KK, 1999, AM J HUM GENET, V65, P913, DOI 10.1086/302552; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Sharma R, 1992, Indian J Matern Child Health, V3, P36; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Sullivan AE, 2003, OBSTET GYNECOL, V101, P1236, DOI 10.1016/S0029-7844(03)00345-4; TULPPALA M, 1993, BRIT J OBSTET GYNAEC, V100, P348, DOI 10.1111/j.1471-0528.1993.tb12978.x; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382	33	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17718	10.1371/journal.pone.0017718	http://dx.doi.org/10.1371/journal.pone.0017718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423805	gold, Green Submitted, Green Published			2022-12-25	WOS:000288512400021
J	Hashemi, J; Worrall, C; Vasilcanu, D; Fryknas, M; Sulaiman, L; Karimi, M; Weng, WH; Lui, WO; Rudduck, C; Axelson, M; Jernberg-Wiklund, H; Girnita, L; Larsson, O; Larsson, C				Hashemi, Jamileh; Worrall, Claire; Vasilcanu, Daiana; Fryknas, Marten; Sulaiman, Luqman; Karimi, Mohsen; Weng, Wen-Hui; Lui, Weng-Onn; Rudduck, Christina; Axelson, Magnus; Jernberg-Wiklund, Helena; Girnita, Leonard; Larsson, Olle; Larsson, Catharina			Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)	PLOS ONE			English	Article							GROWTH-FACTOR-I; RECEPTOR TYROSINE KINASE; MOUSE MODEL; INHIBITOR; PROLIFERATION; NORMALIZATION; PROGRESSION; MECHANISMS; EXPRESSION; PROFILES	Background: Picropodophyllin (PPP) is a promising novel anti-neoplastic agent that efficiently kills tumor cells in vitro and causes tumor regression and increased survival in vivo. We have previously reported that PPP treatment induced moderate tolerance in two out of 10 cell lines only, and here report the acquired genomic and expression alterations associated with PPP selection over 1.5 years of treatment. Methodology/Principal Findings: Copy number alterations monitored using metaphase and array-based comparative genomic hybridization analyses revealed largely overlapping alterations in parental and maximally tolerant cells. Gain/amplification of the MYC and PVT1 loci in 8q24.21 were verified on the chromosome level. Abnormalities observed in connection to PPP treatment included regular gains and losses, as well as homozygous losses in 10q24.1-q24.2 and 12p12.3-p13.2 in one of the lines and amplification at 5q11.2 in the other. Abnormalities observed in both tolerant derivatives include amplification/gain of 5q11.2, gain of 11q12.1-q14.3 and gain of 13q33.3-qter. Using Nexus software analysis we combined the array-CGH data with data from gene expression profilings and identified genes that were altered in both inputs. A subset of genes identified as downregulated (ALDH1A3, ANXA1, TLR4 and RAB5A) or upregulated (COX6A1, NFIX, ME1, MAPK and TAP2) were validated by siRNA in the tolerant or parental cells to alter sensitivity to PPP and confirmed to alter sensitivity to PPP in further cell lines. Conclusions: Long-term PPP selection lead to altered gene expression in PPP tolerant cells with increase as well as decrease of genes involved in cell death such as PTEN and BCL2. In addition, acquired genomic copy number alterations were observed that were often reflected by altered mRNA expression levels for genes in the same regions.	[Hashemi, Jamileh; Sulaiman, Luqman; Karimi, Mohsen; Weng, Wen-Hui; Lui, Weng-Onn; Rudduck, Christina; Axelson, Magnus; Larsson, Catharina] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Karolinska Univ Hosp, Stockholm, Sweden; [Worrall, Claire; Vasilcanu, Daiana; Girnita, Leonard; Larsson, Olle] Karolinska Inst, Dept Oncol Pathol, Karolinska Univ Hosp, Stockholm, Sweden; [Fryknas, Marten; Jernberg-Wiklund, Helena] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Hashemi, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Karolinska Univ Hosp, CMM L8 01, Stockholm, Sweden.	Jamileh.Hashemi@ki.se	Weng, Wen Hui/AAV-7260-2021; Lui, Weng-Onn/G-6703-2013; Girnita, Leonard/A-4168-2008; Lui, Weng-Onn/X-5957-2019	Lui, Weng-Onn/0000-0003-4717-4473; Girnita, Leonard/0000-0003-0280-9500; Lui, Weng-Onn/0000-0003-4717-4473; Jernberg Wiklund, Helena/0000-0002-9319-7986	Swedish Cancer Society; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council; Swedish Children Cancer Society; Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council; Lund University; Knut & Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF)	Swedish Cancer Society(Swedish Cancer Society); Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council(Stockholm County Council); Lund University; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF)	Work was supported by the Swedish Cancer Society, Goran Gustafsson Foundation for Research in Natural Sciences and Medicine, Swedish Research Council, Swedish Children Cancer Society, Cancer Society in Stockholm, Gustav V Jubilee Foundation, and Stockholm County Council. The SCIBLU Genomics center is supported by grants from Lund University, the Knut & Alice Wallenberg Foundation, the IngaBritt and Arne Lundberg Foundation and by Governmental Funding of Clinical Research within the National Health Services (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Autio R, 2003, BIOINFORMATICS, V19, P1714, DOI 10.1093/bioinformatics/btg230; Cadoret A, 2005, INT J CANCER, V114, P668, DOI 10.1002/ijc.20805; Colon E, 2007, ENDOCRINOLOGY, V148, P128, DOI 10.1210/en.2006-0835; Conti L, 2007, BLOOD, V109, P2496, DOI 10.1182/blood-2006-07-034231; Duan ZF, 2009, MOL CANCER THER, V8, P2122, DOI 10.1158/1535-7163.MCT-09-0115; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2620, DOI 10.1167/iovs.07-0742; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2337, DOI 10.1167/iovs.07-0819; Eun SY, 2008, BIOCHEM BIOPH RES CO, V373, P58, DOI 10.1016/j.bbrc.2008.05.178; GENSLER WJ, 1966, J ORG CHEM, V31, P3224, DOI 10.1021/jo01348a030; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Menu E, 2007, INT J CANCER, V121, P1857, DOI 10.1002/ijc.22845; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Pang ST, 2006, PROSTATE, V66, P157, DOI 10.1002/pros.20328; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Roberti A, 2006, J CELL PHYSIOL, V207, P571, DOI 10.1002/jcp.20515; Saal LH, 2002, GENOME BIOL, V3; SalazarOnfray F, 1997, CANCER RES, V57, P4348; *SCN, 1995, INT SYST HUM CYT NOM; Strathdee G, 2007, DIS MARKERS, V23, P43, DOI 10.1155/2007/610815; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Weng WH, 2005, INT J ONCOL, V26, P5; Yang MCK, 2001, PHYSIOL GENOMICS, V7, P45, DOI 10.1152/physiolgenomics.00020.2001; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yin SC, 2010, NEURO-ONCOLOGY, V12, P19, DOI 10.1093/neuonc/nop008; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	41	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14757	10.1371/journal.pone.0014757	http://dx.doi.org/10.1371/journal.pone.0014757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423728	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400004
J	Halford, WP; Puschel, R; Gershburg, E; Wilber, A; Gershburg, S; Rakowski, B				Halford, William P.; Pueschel, Ringo; Gershburg, Edward; Wilber, Andrew; Gershburg, Svetlana; Rakowski, Brandon			A Live-Attenuated HSV-2 ICP0(-) Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; SIMPLEX-VIRUS; GUINEA-PIGS; IMMUNE-RESPONSES; MUCOSAL IMMUNITY; VARICELLA VACCINATION; ADJUVANT ACTIVITY; TYPE-2 VACCINE; ADVERSE EVENTS; INFECTION	Glycoprotein D (gD-2) is the entry receptor of herpes simplex virus 2 (HSV-2), and is the immunogen in the pharmaceutical industry's lead HSV-2 vaccine candidate. Efforts to prevent genital herpes using gD-2 subunit vaccines have been ongoing for 20 years at a cost in excess of $100 million. To date, gD-2 vaccines have yielded equivocal protection in clinical trials. Therefore, using a small animal model, we sought to determine if a live-attenuated HSV-2 ICP0(-) virus would elicit better protection against genital herpes than a gD-2 subunit vaccine. Mice immunized with gD-2 and a potent adjuvant (alum+monophosphoryl lipid A) produced high titers of gD-2 antibody. While gD-2-immunized mice possessed significant resistance to HSV-2, only 3 of 45 gD-2-immunized mice survived an overwhelming challenge of the vagina or eyes with wildtype HSV-2 (MS strain). In contrast, 114 of 115 mice immunized with a live HSV-2 ICP0(-) virus, 0 Delta NLS, survived the same HSV-2 MS challenges. Likewise, 0 Delta NLS-immunized mice shed an average 125-fold less HSV-2 MS challenge virus per vagina relative to gD-2-immunized mice. In vivo imaging demonstrated that a luciferase-expressing HSV-2 challenge virus failed to establish a detectable infection in 0 Delta DNLS-immunized mice, whereas the same virus readily infected naive and gD-2-immunized mice. Collectively, these results suggest that a HSV-2 vaccine might be more likely to prevent genital herpes if it contained a live-attenuated HSV-2 virus rather than a single HSV-2 protein.	[Halford, William P.; Pueschel, Ringo; Gershburg, Edward; Wilber, Andrew; Gershburg, Svetlana; Rakowski, Brandon] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu	Wilber, Andrew/I-9259-2019	Wilber, Andrew/0000-0002-8457-599X; Gershburg, Edward/0000-0003-3584-9947	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health [R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072] Funding Source: NIH RePORTER	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine, as well as a grant from the National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1990, J INFECT DIS, V162, P1043, DOI 10.1093/infdis/162.5.1043; ALLEN E M, 1990, Viral Immunology, V3, P207, DOI 10.1089/vim.1990.3.207; Aurelian L, 1999, VACCINE, V17, P1951, DOI 10.1016/S0264-410X(98)00470-8; BEHBEHANI AM, 1983, MICROBIOL REV, V47, P455, DOI 10.1128/MMBR.47.4.455-509.1983; Bernstein D I, 2001, Herpes, V8, P8; Bernstein DI, 2010, VACCINE, V28, P3748, DOI 10.1016/j.vaccine.2009.10.025; Bernstein DI, 2009, CLIN VACCINE IMMUNOL, V16, P699, DOI 10.1128/CVI.00370-08; BOBROWSKI PJ, 1991, INT J DERMATOL, V30, P29, DOI 10.1111/j.1365-4362.1991.tb05875.x; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Boursnell MEG, 1997, J INFECT DIS, V175, P16, DOI 10.1093/infdis/175.1.16; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brittle EE, 2008, J VIROL, V82, P8431, DOI 10.1128/JVI.00551-08; CENTIFANTOFITZGERALD YM, 1982, INFECT IMMUN, V35, P1125, DOI 10.1128/IAI.35.3.1125-1132.1982; CENTIFANTOFITZGERALD YM, 1985, P SOC EXP BIOL MED, V179, P55; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Cunningham A L, 2001, Herpes, V8 Suppl 1, p6A; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P449, DOI 10.1016/0035-9203(52)90062-X; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; Dunning R., 1800, SOME OBSERVATIONS VA; DUPAN RM, 1968, AM J DIS CHILD, V115, P658, DOI 10.1001/archpedi.1968.02100010660004; Eo SK, 2001, J IMMUNOL, V166, P5473, DOI 10.4049/jimmunol.166.9.5473; Eo SK, 2001, EXPERT OPIN BIOL TH, V1, P213, DOI 10.1517/14712598.1.2.213; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Girard MP, 2006, VACCINE, V24, P4062, DOI 10.1016/j.vaccine.2006.02.031; *GLAXOSMITHKLINE, 2010, GSK PROV UPD HERP TR; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; HAARR L, 1994, APMIS, V102, P321, DOI 10.1111/j.1699-0463.1994.tb04882.x; Halford WP, 2007, FUTURE VIROL, V2, P1, DOI 10.2217/17460794.2.1.1; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2011, VIRUSES AND INTERFERON: CURRENT RESEARCH, P85; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2005, J THEOR BIOL, V234, P439, DOI 10.1016/j.jtbi.2004.12.007; Higgins TJ, 2000, J INFECT DIS, V182, P1311, DOI 10.1086/315879; HILLEMAN MR, 1966, CLIN PHARMACOL THER, V7, P752; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; JENNNER E, 1798, INQUIRY CAUSES EFFEC; Jonsson MK, 2004, SCAND J INFECT DIS, V36, P93, DOI 10.1080/00365540310018905; Karem KL, 1997, J GEN VIROL, V78, P427, DOI 10.1099/0022-1317-78-2-427; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Krause PR, 2000, NAT MED, V6, P451, DOI 10.1038/74715; Kuklin N, 1997, J VIROL, V71, P3138, DOI 10.1128/JVI.71.4.3138-3145.1997; Kumaraguru U, 1998, Expert Opin Investig Drugs, V7, P219, DOI 10.1517/13543784.7.2.219; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008837; MAINGAY JP, 1988, MICROBIOL SCI, V5, P211; MANICKAN E, 1995, J VIROL, V69, P4711, DOI 10.1128/JVI.69.8.4711-4716.1995; Mansoor O, 1997, NEW ZEAL MED J, V110, P270; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MCDERMOTT MR, 1984, J VIROL, V51, P747, DOI 10.1128/JVI.51.3.747-753.1984; MEIGNIER B, 1988, J INFECT DIS, V158, P602, DOI 10.1093/infdis/158.3.602; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; PARR MB, 1994, LAB INVEST, V70, P369; Pollara G, 2004, CURR OPIN INFECT DIS, V17, P199, DOI 10.1097/00001432-200406000-00005; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Reszka NJ, 2010, VACCINE, V28, P2754, DOI 10.1016/j.vaccine.2010.01.030; Ruprecht RM, 2000, J HUMAN VIROL, V3, P88; SABIN AB, 1953, AMA AM J DIS CHILD, V86, P301, DOI 10.1001/archpedi.1953.02050080311006; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; SCHWARZ AJF, 1962, AM J DIS CHILD, V103, P386, DOI 10.1001/archpedi.1962.02080020398042; Sengupta N, 2008, EUR J PEDIATR, V167, P47, DOI 10.1007/s00431-007-0424-0; Solomon L, 2003, SEX TRANSM INFECT, V79, P456, DOI 10.1136/sti.79.6.456; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Spector FC, 1998, J INFECT DIS, V177, P1143, DOI 10.1086/515278; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P1913, DOI 10.1001/jama.284.15.1913; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; TAKAHASHI M, 1975, BIKEN J, V18, P25; Thompson HSG, 1998, VACCINE, V16, P1993, DOI 10.1016/S0264-410X(98)00088-7; Toka FN, 2004, IMMUNOL REV, V199, P100, DOI 10.1111/j.0105-2896.2004.0147.x; WATSON RJ, 1982, SCIENCE, V218, P381, DOI 10.1126/science.6289440; Wattigney WA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e83; WEIR JP, 1989, J GEN VIROL, V70, P2587, DOI 10.1099/0022-1317-70-10-2587; WILDY P, 1973, CANCER RES, V33, P1465; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Zimmerman DH, 2005, FRONT BIOSCI, V10, P790, DOI 10.2741/1572	90	74	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17748	10.1371/journal.pone.0017748	http://dx.doi.org/10.1371/journal.pone.0017748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412438	Green Submitted, Green Published, gold			2022-12-25	WOS:000288247800028
J	Berisha, SZ; Serre, D; Schauer, P; Kashyap, SR; Smith, JD				Berisha, Stela Z.; Serre, David; Schauer, Philip; Kashyap, Sangeeta R.; Smith, Jonathan D.			Changes in Whole Blood Gene Expression in Obese Subjects with Type 2 Diabetes Following Bariatric Surgery: a Pilot Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; WEIGHT-LOSS; LIPOCALIN-2; ADIPOCYTOKINES; INFLAMMATION	Background: A pilot study was performed in order to investigate the effects of bariatric surgery on whole blood gene expression profiles in obese subjects with type 2 diabetes. Methodology/Principal Findings: Whole blood from eleven obese subjects with type 2 diabetes was collected in PAXgene tubes prior to and 6-12 months after bariatric surgery. Total RNA was isolated, amplified, labeled and hybridized to Illumina gene expression microarrays. Clinical and expression data were analyzed using a paired t-test, and correlations between changes in clinical trait and transcript levels were calculated. Pathways were identified using Ingenuity Pathway Analysis and DAVID gene ontology software. Overall, bariatric surgery resulted in significant reduction of body mass index, fasting plasma glucose, fasting plasma insulin, and normalization of glycosylated hemoglobin levels. The expression levels of 204 transcripts, representing 200 unique genes, were significantly altered after bariatric surgery. Among the significantly regulated genes were GGT1, CAMP, DEFA1, LCN2, TP53, PDSS1, OLR1, CNTNAP5, DHCR24, HHAT and SARDH, which have been previously implicated in lipid metabolism, obesity and/or type 2 diabetes. Selected findings were replicated by quantitative real-time-PCR. The changes in expression of seven transcripts, WDR35, FLF45244, DHCR24, TIGD7, TOPBP1, TSHZ1, and FAM8A1 were strongly correlated with the changes in body weight, fasting plasma glucose and glycosylated hemoglobin content. The top pathways associated with gene expression changes after bariatric surgery was lipid metabolism, small molecule biochemistry and gene expression. Two antimicrobial peptides were among the transcripts with the largest changes in gene expression after bariatric surgery. Conclusions/Significance: Data from this pilot study suggest that whole blood expression levels of specific transcripts may be useful as biomarkers associated with susceptibility for type 2 diabetes and/or therapeutic response.	[Berisha, Stela Z.; Smith, Jonathan D.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Berisha, Stela Z.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Serre, David] Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44106 USA; [Serre, David; Smith, Jonathan D.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA; [Schauer, Philip] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44106 USA; [Kashyap, Sangeeta R.] Cleveland Clin, Dept Diabet Endocrinol & Metab, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Berisha, SZ (corresponding author), Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA.	kashyas@ccf.org; smithj4@ccf.org	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Schauer, Philip/0000-0002-4029-7537; Kashyap, Sangeeta/0000-0002-7489-6650	National Institute of Health [P50-HL077107, R01-HL098193]; National Center for Research Resources [5K12RR023264]; Clinical and Translational Science Award [1UL1RR024989]; Cleveland State University; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990, K12RR023264, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107, R01HL098193] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award; Cleveland State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grants P50-HL077107 and R01-HL098193 (http://www.nih.gov/) to J.D.S, by National Center for Research Resources Multidisciplinary Clinical Research Career Development Programs Grant 5K12RR023264 (http://www.ncrr.nih.gov/index.asp) and Clinical and Translational Science Award Grant 1UL1RR024989 (http://www.ctsaweb.org/) to S.R.K.. S.Z.B. was supported by Cellular and Molecular Medicine Coordinating Committee Research Assistantship from Cleveland State University (http://www.csuohio.edu/sciences/dept/biology/cmms/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2005, DIABETES METAB, V31, P542, DOI 10.1016/S1262-3636(07)70229-X; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145; BURIAN D, 2007, DOTFAAAM079; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Compher C, 2008, JPEN-PARENTER ENTER, V32, P645, DOI 10.1177/0148607108326070; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Gagliardi L, 2007, CURR DIABETES REV, V3, P95, DOI 10.2174/157339907780598207; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hindle AK, 2009, SURG ENDOSC, V23, P1292, DOI 10.1007/s00464-008-0152-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANCO M, 2010, OBES SURG       0409; Manco M, 2007, J CLIN ENDOCR METAB, V92, P483, DOI 10.1210/jc.2006-0960; Mathurin P, 2009, GASTROENTEROLOGY, V137, P532, DOI 10.1053/j.gastro.2009.04.052; McGrath KCY, 2009, ARTERIOSCL THROM VAS, V29, P877, DOI 10.1161/ATVBAHA.109.184663; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Otis M, 2008, J STEROID BIOCHEM, V109, P224, DOI 10.1016/j.jsbmb.2008.03.010; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Strasak AM, 2008, ARTERIOSCL THROM VAS, V28, P1857, DOI 10.1161/ATVBAHA.108.170597; Tan KCB, 2008, J LIPID RES, V49, P1438, DOI 10.1194/jlr.M700551-JLR200; Visvikis A, 2001, EUR J BIOCHEM, V268, P317; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	38	65	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16729	10.1371/journal.pone.0016729	http://dx.doi.org/10.1371/journal.pone.0016729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423737	Green Published, Green Submitted, gold			2022-12-25	WOS:000288219100002
J	Vanpouille-Box, C; Lacoeuille, F; Roux, J; Aube, C; Garcion, E; Lepareur, N; Oberti, F; Bouchet, F; Noiret, N; Garin, E; Benoit, JP; Couturier, O; Hindre, F				Vanpouille-Box, Claire; Lacoeuille, Franck; Roux, Jerome; Aube, Christophe; Garcion, Emmanuel; Lepareur, Nicolas; Oberti, Frederic; Bouchet, Francis; Noiret, Nicolas; Garin, Etienne; Benoit, Jean-Pierre; Couturier, Olivier; Hindre, Francois			Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DRUG ELUTING BEADS; RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; CHITOSAN NANOPARTICLES; MICROSPHERES; RADIOEMBOLIZATION; BIODISTRIBUTION; FORMULATION; LIPIODOL	Background: Due to their nanometric scale (50 nm) along with their biomimetic properties, lipid nanocapsules loaded with Rhenium-188 (LNC(188)Re-SSS) constitute a promising radiopharmaceutical carrier for hepatocellular carcinoma treatment as its size may improve tumor penetration in comparison with microspheres devices. This study was conducted to confirm the feasibility and to assess the efficacy of internal radiation with LNC(188)Re-SSS in a chemically induced hepatocellular carcinoma rat model. Methodology/Principal Findings: Animals were treated with an injection of LNC(188)Re-SSS (80 MBq or 120 MBq). The treated animals (80 MBq, n = 12; 120 MBq, n = 11) were compared with sham (n = 12), blank LNC (n = 7) and (188)Re-perrhenate (n = 4) animals. The evaluation criteria included rat survival, tumor volume assessment, and vascular endothelial growth factor quantification. Following treatment with LNC(188)Re-SSS (80 MBq) therapeutic efficiency was demonstrated by an increase in the median survival from 54 to 107% compared with control groups with up to 7 long-term survivors in the LNC(188)Re-SSS group. Decreased vascular endothelial growth factor expression in the treated rats could indicate alterations in the angiogenesis process. Conclusions/Significance: Overall, these results demonstrate that internal radiation with LNC(188)Re-SSS is a promising new strategy for hepatocellular carcinoma treatment.	[Vanpouille-Box, Claire; Lacoeuille, Franck; Garcion, Emmanuel; Benoit, Jean-Pierre; Couturier, Olivier; Hindre, Francois] Univ Angers, LUNAM Univ, INSERM U646, Angers, France; [Lacoeuille, Franck; Bouchet, Francis; Couturier, Olivier] CHU Angers, Dept Nucl Med, Angers, France; [Roux, Jerome] Univ Angers, LUNAM Univ, SCAHU, UFR Med, Angers, France; [Lepareur, Nicolas; Garin, Etienne] CRLCC Eugene Marquis, Dept Med Imaging, Rennes, France; [Noiret, Nicolas] European Univ Brittany, Rennes, France; [Aube, Christophe] CHU Angers, Dept Radiol, Angers, France; [Aube, Christophe; Oberti, Frederic] Univ Angers, LUNAM Univ, Lab HIFI, UPRES EA3589, Angers, France; [Lepareur, Nicolas] ENSCR, UMR CNRS 6226, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; UNICANCER; Centre Eugene Marquis; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Nationale Superieure de Chimie de Rennes (ENSCR)	Vanpouille-Box, C (corresponding author), Univ Angers, LUNAM Univ, INSERM U646, Angers, France.	francois.hindre@univ-angers.fr	Lepareur, Nicolas/N-8914-2019; Vanpouille-Box, Claire/F-7137-2011; Lepareur, Nicolas/K-7174-2018; Vanpouille-Box, Claire/AAO-5355-2021; hindré, françois/K-5613-2015; Benoit, Jean-Pierre/K-4387-2015; Couturier, Olivier F/L-6635-2015; GARCION, Emmanuel/K-5417-2015; LACOEUILLE, Franck/K-4430-2015	Lepareur, Nicolas/0000-0001-9860-5451; Lepareur, Nicolas/0000-0001-9860-5451; GARCION, Emmanuel/0000-0003-0887-272X; LACOEUILLE, Franck/0000-0002-7070-7664; couturier, olivier-francois/0000-0002-4900-7807; Garin, Etienne/0000-0003-1416-2863; Hindre, Francois/0000-0002-2727-7996; BENOIT, Jean-Pierre/0000-0002-6178-7199; Vanpouille-Box, Claire/0000-0001-7213-0670	Maine et Loire	Maine et Loire	This work was funded by "the Canceropole Grand Ouest" and "La Ligue Contre le Cancer" of "Maine et Loire." Claire Vanpouille-Box was a fellow from Angers Loire Metropole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballot S, 2006, EUR J NUCL MED MOL I, V33, P602, DOI 10.1007/s00259-005-0007-0; Brown DB, 2009, J VASC INTERV RADIOL, V20, pS425, DOI 10.1016/j.jvir.2009.04.021; Cha CH, 2010, CURR PROB SURG, V47, P10, DOI 10.1067/j.cpsurg.2009.09.003; Cheng JCH, 2002, RADIOTHER ONCOL, V63, P41, DOI 10.1016/S0167-8140(02)00061-0; Dai LC, 2009, WORLD J GASTROENTERO, V15, P1966, DOI 10.3748/wjg.15.1966; Dancey JE, 2000, J NUCL MED, V41, P1673; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; DEUTSCH E, 1986, NUCL MED BIOL, V13, P465, DOI 10.1016/0883-2897(86)90027-9; Dhanasekaran R, 2010, J SURG ONCOL, V101, P476, DOI 10.1002/jso.21522; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Garin E, 2005, LAB ANIM-UK, V39, P314, DOI 10.1258/0023677054307051; Gibaud S, 1996, J PHARM SCI, V85, P944, DOI 10.1021/js960032d; Hafeli UO, 1999, INT J RADIAT ONCOL, V44, P189, DOI 10.1016/S0360-3016(98)00554-9; Heurtault B, 2002, PHARMACEUT RES, V19, P875, DOI 10.1023/A:1016121319668; Hsieh BT, 1999, NUCL MED BIOL, V26, P967, DOI 10.1016/S0969-8051(99)00074-8; Jin-no K, 1998, J GASTROENTEROL, V33, P376, DOI 10.1007/s005350050099; Kulik LM, 2006, J SURG ONCOL, V94, P572, DOI 10.1002/jso.20609; Kumar A, 2007, RADIOLOGY, V243, P509, DOI 10.1148/radiol.2432051246; Lacoeuille F, 2007, INT J PHARM, V344, P143, DOI 10.1016/j.ijpharm.2007.06.014; Lau WY, 1998, INT J RADIAT ONCOL, V40, P583, DOI 10.1016/S0360-3016(97)00818-3; Lepareur N, 2004, J LABELLED COMPD RAD, V47, P857, DOI 10.1002/jlcr.863; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Malagari K, 2008, ABDOM IMAGING, V33, P512, DOI 10.1007/s00261-007-9334-x; Malagari K, 2008, CARDIOVASC INTER RAD, V31, P269, DOI 10.1007/s00270-007-9226-z; Salem R, 2005, J VASC INTERV RADIOL, V16, P1627; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Wang Q, 2010, NANOMED-NANOTECHNOL, V6, P371, DOI 10.1016/j.nano.2009.07.006; Wunderlich G, 2005, APPL RADIAT ISOTOPES, V62, P745, DOI 10.1016/j.apradiso.2004.11.003; Xu YL, 2009, ANTICANCER RES, V29, P5103; Xu ZH, 2009, BIOMATERIALS, V30, P226, DOI 10.1016/j.biomaterials.2008.09.014; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Zeng ZC, 2002, EUR J NUCL MED MOL I, V29, P1657, DOI 10.1007/s00259-002-0996-x	33	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16926	10.1371/journal.pone.0016926	http://dx.doi.org/10.1371/journal.pone.0016926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408224	Green Published, gold			2022-12-25	WOS:000288099800008
J	Wandhammer, M; Carletti, E; Van der Schans, M; Gillon, E; Nicolet, Y; Masson, P; Goeldner, M; Noort, D; Nachon, F				Wandhammer, Marielle; Carletti, Eugenie; Van der Schans, Marcel; Gillon, Emilie; Nicolet, Yvain; Masson, Patrick; Goeldner, Maurice; Noort, Daan; Nachon, Florian			Structural Study of the Complex Stereoselectivity of Human Butyrylcholinesterase for the Neurotoxic V-agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACETYLCHOLINESTERASE; PROTECTION; REACTIVATION; ENANTIOMERS	Nerve agents are chiral organophosphate compounds (OPs) that exert their acute toxicity by phosphorylating the catalytic serine of acetylcholinesterase (AChE). The inhibited cholinesterases can be reactivated using oximes, but a spontaneous time-dependent process called aging alters the adduct, leading to resistance toward oxime reactivation. Human butyrylcholinesterase (BChE) functions as a bioscavenger, protecting the cholinergic system against OPs. The stereoselectivity of BChE is an important parameter for its efficiency at scavenging the most toxic OPs enantiomer for AChE. Crystals of BChE inhibited in solution or in cristallo with racemic V-agents (VX, Russian VX, and Chinese VX) systematically show the formation of the PS adduct. In this configuration, no catalysis of aging seems possible as confirmed by the three-dimensional structures of the three conjugates incubated over a period exceeding a week. Crystals of BChE soaked in optically pure VXR-(+) and VXS-(-) solutions lead to the formation of the P-S and P-R adduct, respectively. These structural data support an in-line phosphonylation mechanism. Additionally, they show that BChE reacts with VXR-(+) in the presence of racemic mixture of V-agents, at odds with earlier kinetic results showing a moderate higher inhibition rate for VXS-(-). These combined results suggest that the simultaneous presence of both enantiomers alters the enzyme stereoselectivity. In summary, the three-dimensional data show that BChE reacts preferentially with P-R enantiomer of V-agents and does not age, in complete contrast to AChE, which is selectively inhibited by the PS enantiomer and ages.	[Wandhammer, Marielle; Carletti, Eugenie; Gillon, Emilie; Masson, Patrick; Nachon, Florian] Inst Rech Biomed Armees CRSSA, Dept Toxicol, F-38700 La Tronche, France; [Wandhammer, Marielle; Goeldner, Maurice] Fac Pharm, UMR 7199, Lab Concept & Applicat Mol Bioact, F-67400 Illkirch Graffenstaden, France; [Van der Schans, Marcel; Noort, Daan] TNO Def Secur & Safety, Business Unit Biol & Chem Protect, Res Grp Diag & Therapy, NL-2288 GJ Rijswijk, Netherlands; [Nicolet, Yvain] Inst Biol Struct, Cristallog & Cristallogenese Prot Lab, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Netherlands Organization Applied Science Research; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nachon, F (corresponding author), Inst Rech Biomed Armees CRSSA, Dept Toxicol, 24 Av Maquis du Gresivaudan, F-38700 La Tronche, France.	florian@nachon.net	Yvain, Nicolet/AAP-9763-2020; Masson, Patrick YM/J-3964-2013; Masson, Patrick/AAA-7213-2019	Yvain, Nicolet/0000-0002-4189-7067; Masson, Patrick YM/0000-0002-7837-3662; Masson, Patrick/0000-0002-7837-3662	Direction Generale de l'Armement [08co501, ANR-06-BLAN-0163, ANR-09-BLAN-0192]; Defense Threat Reduction Agency [CBDIF07-THER01-2-0038]	Direction Generale de l'Armement; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Direction Generale de l'Armement under Programme d'Etude Amont Grants 08co501, ANR-06-BLAN-0163, and ANR-09-BLAN-0192 (to F. N.) and Defense Threat Reduction Agency Grant CBDIF07-THER01-2-0038 (to D. N., F. N., and M. G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aurbek N, 2009, TOXICOLOGY, V259, P133, DOI 10.1016/j.tox.2009.02.014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOTER HL, 1969, BIOCHEM PHARMACOL, V18, P2403, DOI 10.1016/0006-2952(69)90355-4; Carletti E, 2010, J MED CHEM, V53, P4002, DOI 10.1021/jm901853b; Carletti E, 2009, BIOCHEM J, V421, P97, DOI 10.1042/BJ20090091; Cohen O, 2006, MOL PHARMACOL, V70, P1121, DOI 10.1124/mol.106.026179; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HALL CR, 1977, J PHARM PHARMACOL, V29, P574, DOI 10.1111/j.2042-7158.1977.tb11405.x; HOLMSTEDT B, 1959, PHARMACOL REV, V11, P567; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasten S. A., 2010, P 2010 MED DEF BIOSC; Lenz DE, 2005, CHEM-BIOL INTERACT, V157, P205, DOI 10.1016/j.cbi.2005.10.025; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li H, 2007, TOXICOL SCI, V100, P136, DOI 10.1093/toxsci/kfm215; Masson P, 1997, BIOCHEMISTRY-US, V36, P2266, DOI 10.1021/bi962484a; Masson P, 2010, CHEM-BIOL INTERACT, V187, P157, DOI 10.1016/j.cbi.2010.03.027; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Millard CB, 1999, J AM CHEM SOC, V121, P9883, DOI 10.1021/ja992704i; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachon F, 2002, EUR J BIOCHEM, V269, P630, DOI 10.1046/j.0014-2956.2001.02692.x; Nachon F, 2011, BIOCHEM J, V434, P73, DOI 10.1042/BJ20101648; Nachon F, 2010, CHEM-BIOL INTERACT, V187, P44, DOI 10.1016/j.cbi.2010.03.053; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Ordentlich A, 1999, BIOCHEMISTRY-US, V38, P3055, DOI 10.1021/bi982261f; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Reiter G, 2008, J CHROMATOGR B, V873, P86, DOI 10.1016/j.jchromb.2008.08.001; Saxena A, 2006, J MOL NEUROSCI, V30, P145, DOI 10.1385/JMN:30:1:145; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014	31	33	34	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16783	16789		10.1074/jbc.M110.209569	http://dx.doi.org/10.1074/jbc.M110.209569			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454498	Green Published, hybrid			2022-12-25	WOS:000290301900027
J	Kobayashi, K; Umeda-Yano, S; Yamamori, H; Takeda, M; Suzuki, H; Hashimoto, R				Kobayashi, Katsunori; Umeda-Yano, Satomi; Yamamori, Hidenaga; Takeda, Masatoshi; Suzuki, Hidenori; Hashimoto, Ryota			Correlated Alterations in Serotonergic and Dopaminergic Modulations at the Hippocampal Mossy Fiber Synapse in Mice Lacking Dysbindin	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; SANDY MICE; SCHIZOPHRENIA; DTNBP1; TRANSMISSION; PROTEIN; BLOC-1	Dysbindin-1 (dystrobrevin-binding protein 1, DTNBP1) is one of the promising schizophrenia susceptibility genes. Dysbindin protein is abundantly expressed in synaptic regions of the hippocampus, including the terminal field of the mossy fibers, and this hippocampal expression of dysbindin is strongly reduced in patients with schizophrenia. In the present study, we examined the functional role of dysbindin in hippocampal mossy fiber-CA3 synaptic transmission and its modulation using the sandy mouse, a spontaneous mutant with deletion in the dysbindin gene. Electrophysiological recordings were made in hippocampal slices prepared from adult male sandy mice and their wild-type littermates. Basic properties of the mossy fiber synaptic transmission in the mutant mice were generally normal except for slightly reduced frequency facilitation. Serotonin and dopamine, two major neuromodulators implicated in the pathophysiology of schizophrenia, can potentiate mossy fiber synaptic transmission probably via an increase in cAMP levels. Synaptic potentiation induced by serotonin and dopamine was very variable in magnitude in the mutant mice, with some mice showing prominent enhancement as compared with the wild-type mice. In addition, the magnitude of potentiation induced by these monoamines significantly correlated with each other in the mutant mice, indicating that a subpopulation of sandy mice has marked hypersensitivity to both serotonin and dopamine. While direct activation of the cAMP cascade by forskolin induced robust synaptic potentiation in both wildtype and mutant mice, this forskolin-induced potentaition correlated in magnitude with the serotonin-induced potentiation only in the mutant mice, suggesting a possible change in coupling of receptor activation to downstream signaling. These results suggest that the dysbindin deficiency could be an essential genetic factor that causes synaptic hypersensitivity to dopamine and serotonin. The altered monoaminergic modulation at the mossy fiber synapse could be a candidate pathophysiological basis for impairment of hippocampus-dependent brain functions in schizophrenia.	[Kobayashi, Katsunori; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Kobayashi, Katsunori; Suzuki, Hidenori; Hashimoto, Ryota] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Umeda-Yano, Satomi; Yamamori, Hidenaga] Osaka Univ, Dept Mol Neuropsychiat, Grad Sch Med, Osaka, Japan; [Yamamori, Hidenaga; Takeda, Masatoshi; Hashimoto, Ryota] Osaka Univ, Dept Psychiat, Grad Sch Med, Osaka, Japan; [Hashimoto, Ryota] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hashimoto, Ryota] Hamamatsu Univ Sch Med, Osaka, Japan	Nippon Medical School; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Kobayashi, K (corresponding author), Nippon Med Sch, Dept Pharmacol, 1-1-5 Sendagi, Tokyo 113, Japan.	kkatsu-tky@umin.ac.jp	Hashimoto, Ryota/P-8572-2014; Hashimoto, Ryota/AAE-3200-2019; Kobayashi, Katsunori/V-5326-2018	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Kobayashi, Katsunori/0000-0001-8537-8448	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Japan Science and Technology Agency, Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Hashimoto R, 2010, WORLD J BIOL PSYCHIA, V11, P431, DOI [10.3109/15622970902736503, 10.1080/15622970902736503]; Hashimoto R, 2009, PSYCHIAT CLIN NEUROS, V63, P550, DOI 10.1111/j.1440-1819.2009.01985.x; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hernandez-Rabaza V, 2007, BRAIN RES BULL, V72, P315, DOI 10.1016/j.brainresbull.2007.01.013; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kobayashi K, 2008, J NEUROSCI, V28, P6272, DOI 10.1523/JNEUROSCI.1656-08.2008; Kobayashi K, 2007, NEUROPHARMACOLOGY, V52, P552, DOI 10.1016/j.neuropharm.2006.08.026; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi K, 2009, MOL NEUROBIOL, V39, P24, DOI 10.1007/s12035-008-8049-5; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002; Reif A, 2007, EUR ARCH PSY CLIN N, V257, P290, DOI 10.1007/s00406-007-0733-3; Remington G, 2008, PROG BRAIN RES, V172, P117, DOI 10.1016/S0079-6123(08)00906-0; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18113	10.1371/journal.pone.0018113	http://dx.doi.org/10.1371/journal.pone.0018113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448290	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500037
J	Wang, EF; Bhattacharyya, S; Szabolcs, A; Rodriguez-Aguayo, C; Jennings, NB; Lopez-Berestein, G; Mukherjee, P; Sood, AK; Bhattacharya, R				Wang, Enfeng; Bhattacharyya, Sanjib; Szabolcs, Annamaria; Rodriguez-Aguayo, Cristian; Jennings, Nicholas B.; Lopez-Berestein, Gabriel; Mukherjee, Priyabrata; Sood, Anil K.; Bhattacharya, Resham			Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer	PLOS ONE			English	Article							SMALL INTERFERING RNA; LEUKEMIC STEM-CELLS; SELF-RENEWAL; TELOMERASE ACTIVITY; OXIDATIVE STRESS; EPITHELIAL-CELLS; POOR-PROGNOSIS; EXPRESSION; APOPTOSIS; CARCINOMA	Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates the self-renewal of normal stem and progenitor cells has been implicated in the pathogenesis of many human malignancies, yet a role for Bmi-1 in influencing chemotherapy response has not been addressed before. Here we demonstrate that silencing Bmi-1 reduces intracellular GSH levels and thereby sensitizes chemoresistant ovarian cancer cells to chemotherapeutics such as cisplatin. By exacerbating ROS production in response to cisplatin, Bmi-1 silencing activates the DNA damage response pathway, caspases and cleaves PARP resulting in the induction apoptosis in ovarian cancer cells. In an in vivo orthotopic mouse model of chemoresistant ovarian cancer, knockdown of Bmi-1 by nanoliposomal delivery significantly inhibits tumor growth. While cisplatin monotherapy was inactive, combination of Bmi-1 silencing along with cisplatin almost completely abrogated ovarian tumor growth. Collectively these findings establish Bmi-1 as an important new target for therapy in chemoresistant ovarian cancer.	[Wang, Enfeng; Bhattacharyya, Sanjib; Szabolcs, Annamaria; Mukherjee, Priyabrata; Bhattacharya, Resham] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Jennings, Nicholas B.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, EF (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	bhattacharya.resham@mayo.edu	Bhattacharyya, Sanjib/F-1577-2013	RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Bhattacharyya, Sanjib/0000-0001-8738-7188	Marsha Rivkin Pilot Award [CA136494, CA135011, P50 CA083639, U54 CA151668]; NATIONAL CANCER INSTITUTE [P50CA083639, R01CA136494, U54CA151668, R01CA135011] Funding Source: NIH RePORTER	Marsha Rivkin Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Marsha Rivkin Pilot Award (RB), CA136494, CA135011 (PM) and P50 CA083639, U54 CA151668 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, CHEM BIODIVERS, V7, P543, DOI 10.1002/cbdv.200800340; Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Armstrong DK, 2002, ONCOLOGIST, V7, P20, DOI 10.1634/theoncologist.7-suppl_5-20; Arrigo AP, 1999, FREE RADICAL BIO MED, V27, P936, DOI 10.1016/S0891-5849(99)00175-6; BHATTACHARYA R, 2009, CANC RES; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Borges HL, 2008, CELL RES, V18, P17, DOI 10.1038/cr.2007.110; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Dimri GP, 2002, CANCER RES, V62, P4736; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7, DOI 10.1152/ajpgi.1997.273.1.G7; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HAUPT Y, 1993, ONCOGENE, V8, P3161; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; Helm CW, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-2; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mangala LS, 2009, CLIN CANCER RES, V15, P3770, DOI 10.1158/1078-0432.CCR-08-2306; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Raaphorst FM, 2003, TRENDS IMMUNOL, V24, P522, DOI 10.1016/S1471-4906(03)00241-2; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sawa M, 2005, INT J HEMATOL, V82, P42, DOI 10.1532/IJH97.05013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Silva J, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1760; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Vrzalikova K, 2008, J CANCER RES CLIN, V134, P1037, DOI 10.1007/s00432-008-0361-y; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Yang GF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-133; Zhang F., 2008, Experimental Oncology, V30, P70; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	51	70	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17918	10.1371/journal.pone.0017918	http://dx.doi.org/10.1371/journal.pone.0017918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445297	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300022
J	Andley, UP; Hamilton, PD; Ravi, N; Weihl, CC				Andley, Usha P.; Hamilton, Paul D.; Ravi, Nathan; Weihl, Conrad C.			A Knock-In Mouse Model for the R120G Mutation of alpha B-Crystallin Recapitulates Human Hereditary Myopathy and Cataracts	PLOS ONE			English	Article							DESMIN-RELATED CARDIOMYOPATHY; POSTERIOR POLAR CATARACT; HEAT-SHOCK PROTEINS; A-CRYSTALLIN; MOLECULAR CHAPERONE; CONGENITAL CATARACT; MISSENSE MUTATION; LENS DEVELOPMENT; BETA-CRYSTALLIN; GENE CRYAA	An autosomal dominant missense mutation in alpha B-crystallin (alpha B-R120G) causes cataracts and desmin-related myopathy, but the underlying mechanisms are unknown. Here, we report the development of an alpha B-R120G crystallin knock-in mouse model of these disorders. Knock-in alpha B-R120G mice were generated and analyzed with slit lamp imaging, gel permeation chromatography, immunofluorescence, immunoprecipitation, histology, and muscle strength assays. Wild-type, age-matched mice were used as controls for all studies. Both heterozygous and homozygous mutant mice developed myopathy. Moreover, homozygous mutant mice were significantly weaker than wild-type control littermates at 6 months of age. Cataract severity increased with age and mutant gene dosage. The total mass, precipitation, and interaction with the intermediate filament protein vimentin, as well as light scattering of alpha B-crystallin, also increased in mutant lenses. In skeletal muscle, alpha B-R120G co-aggregated with desmin, became detergent insoluble, and was ubiquitinated in heterozygous and homozygous mutant mice. These data suggest that the cataract and myopathy pathologies in alpha B-R120G knock-in mice share common mechanisms, including increased insolubility of alpha B-crystallin and co-aggregation of alpha B-crystallin with intermediate filament proteins. These knock-in alpha B-R120G mice are a valuable model of the developmental and molecular biological mechanisms that underlie the pathophysiology of human hereditary cataracts and myopathy.	[Andley, Usha P.; Ravi, Nathan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Hamilton, Paul D.; Ravi, Nathan] Vet Affairs Med Ctr, Dept Res, St Louis, MO USA; [Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); US Department of Veterans Affairs; Veterans Health Administration (VHA); Washington University (WUSTL)	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	andley@vision.wustl.edu		Andley, Usha/0000-0001-7049-7591	National Institutes of Health [R01EY05681, R01AG031867, 5K08AG026271, EY02687]; RPB Inc.; Muscular Dystrophy Association; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin [P30 AR057235]; NATIONAL EYE INSTITUTE [P30EY002687, R01EY005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB Inc.; Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health [R01EY05681 to U.P.A. and R01AG031867, 5K08AG026271 to C. C. W., Core Grant EY02687 to the Department of Ophthalmology and Visual Sciences at Washington University], RPB Inc. [an unrestricted grant to the Department of Ophthalmology and Visual Sciences at Washington University], the Muscular Dystrophy Association [to C. C. W.], and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin [P30 AR057235 to the Washington University Center for Musculoskeletal Research]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2010, EXP EYE RES, V90, P699, DOI 10.1016/j.exer.2010.02.009; Andley UP, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-4; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; BATEMAN BJ, 1998, GENETICS EYE DIS, P1; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Head MW, 2000, NEUROREPORT, V11, P361, DOI 10.1097/00001756-200002070-00028; Head MW, 2000, NEUROPATH APPL NEURO, V26, P304, DOI 10.1046/j.1365-2990.2000.00269.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Moore AT, 2004, BRIT J OPHTHALMOL, V88, P2, DOI 10.1136/bjo.88.1.2; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; PIETROWSKI D, 1994, GENE, V144, P171, DOI 10.1016/0378-1119(94)90375-1; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Richter L, 2008, AM J MED GENET A, V146A, P833, DOI 10.1002/ajmg.a.32236; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; Skvorak K, 2006, GENESIS, V44, P345, DOI 10.1002/dvg.20222; Song SH, 2008, MOL VIS, V14, P1282; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Vanita V, 2006, MOL VIS, V12, P518; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Watson GW, 2010, BIOCHEM BIOPH RES CO, V401, P192, DOI 10.1016/j.bbrc.2010.09.023; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	60	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17671	10.1371/journal.pone.0017671	http://dx.doi.org/10.1371/journal.pone.0017671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445271	Green Submitted, gold, Green Published			2022-12-25	WOS:000288545100025
J	Zilliges, Y; Kehr, JC; Meissner, S; Ishida, K; Mikkat, S; Hagemann, M; Kaplan, A; Borner, T; Dittmann, E				Zilliges, Yvonne; Kehr, Jan-Christoph; Meissner, Sven; Ishida, Keishi; Mikkat, Stefan; Hagemann, Martin; Kaplan, Aaron; Boerner, Thomas; Dittmann, Elke			The Cyanobacterial Hepatotoxin Microcystin Binds to Proteins and Increases the Fitness of Microcystis under Oxidative Stress Conditions	PLOS ONE			English	Article							BOUND MICROCYSTINS; LIGHT; STRAIN; GENE; BIOSYNTHESIS; AVAILABILITY; COMPETITION; IMPACT; TOXINS; LR	Microcystins are cyanobacterial toxins that represent a serious threat to drinking water and recreational lakes worldwide. Here, we show that microcystin fulfils an important function within cells of its natural producer Microcystis. The microcystin deficient mutant Delta mcyB showed significant changes in the accumulation of proteins, including several enzymes of the Calvin cycle, phycobiliproteins and two NADPH-dependent reductases. We have discovered that microcystin binds to a number of these proteins in vivo and that the binding is strongly enhanced under high light and oxidative stress conditions. The nature of this binding was studied using extracts of a microcystin-deficient mutant in vitro. The data obtained provided clear evidence for a covalent interaction of the toxin with cysteine residues of proteins. A detailed investigation of one of the binding partners, the large subunit of RubisCO showed a lower susceptibility to proteases in the presence of microcystin in the wild type. Finally, the mutant defective in microcystin production exhibited a clearly increased sensitivity under high light conditions and after hydrogen peroxide treatment. Taken together, our data suggest a protein-modulating role for microcystin within the producing cell, which represents a new addition to the catalogue of functions that have been discussed for microbial secondary metabolites.	[Zilliges, Yvonne] Humboldt Univ, Inst Biol, Dept Mol Ecol, Berlin, Germany; [Kehr, Jan-Christoph; Meissner, Sven; Dittmann, Elke] Univ Potsdam, Inst Biochem & Biol, Dept Microbiol Potsdam Golm, Potsdam, Germany; [Ishida, Keishi] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Mikkat, Stefan] Univ Rostock, Fac Med, Core Facil Proteome Anal, Rostock, Germany; [Hagemann, Martin] Univ Rostock, Inst Biol, Dept Plant Physiol, Rostock, Germany; [Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel; [Boerner, Thomas] Humboldt Univ, Dept Genet, Inst Biol, Berlin, Germany	Humboldt University of Berlin; University of Potsdam; Hans Knoll Institute (HKI); University of Rostock; University of Rostock; Hebrew University of Jerusalem; Humboldt University of Berlin	Zilliges, Y (corresponding author), Humboldt Univ, Inst Biol, Dept Mol Ecol, Berlin, Germany.	editt@uni-potsdam.de	Kaplan, Aaron/GLN-5655-2022; Dittmann, Elke/B-4742-2018	Dittmann, Elke/0000-0002-7549-7918; Borner, Thomas/0000-0001-9548-3348; Kaplan, Aaron/0000-0002-0815-5731	German Israeli Foundation (GIF); German Ministry of Science (BMBF)	German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); German Ministry of Science (BMBF)(Federal Ministry of Education & Research (BMBF))	E.D., T.B. and A.K. were supported by a grant of the German Israeli Foundation (GIF) and the German Ministry of Science (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Borner T, 2005, AQUAT ECOL SER, V3, P25; Brandes HK, 1996, PLANT PHYSIOL, V111, P50003; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; CREIGHTON TE, 1980, NATURE, V287, P468, DOI 10.1038/287468b0; Davies J, 2006, J IND MICROBIOL BIOT, V33, P496, DOI 10.1007/s10295-006-0112-5; Dittmann E, 2006, MOL NUTR FOOD RES, V50, P7, DOI 10.1002/mnfr.200500162; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Perez-Perez ME, 2009, MOL PLANT, V2, P270, DOI 10.1093/mp/ssn070; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; Jahnichen S, 2007, APPL ENVIRON MICROB, V73, P6994, DOI 10.1128/AEM.01253-07; Juttner F, 2008, TOXICON, V51, P388, DOI 10.1016/j.toxicon.2007.10.013; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; Kuhn I, 2000, J BACTERIOL, V182, P4640, DOI 10.1128/JB.182.16.4640-4643.2000; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Marin-Navarro J, 2006, PLANT CELL ENVIRON, V29, P898, DOI 10.1111/j.1365-3040.2005.01469.x; Moreno J, 2008, J EXP BOT, V59, P1605, DOI 10.1093/jxb/erm310; Paerl H W, 2001, ScientificWorldJournal, V1, P76; PAERL HW, 1985, APPL ENVIRON MICROB, V49, P1046, DOI 10.1128/AEM.49.5.1046-1052.1985; Pearson LA, 2004, APPL ENVIRON MICROB, V70, P6370, DOI 10.1128/AEM.70.11.6370-6378.2004; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Rohrlack T, 1999, APPL ENVIRON MICROB, V65, P737; Rohrlack T, 2001, APPL ENVIRON MICROB, V67, P3523, DOI 10.1128/AEM.67.8.3523-3529.2001; RUNNEGAR M, 1995, BIOCHEM BIOPH RES CO, V216, P162, DOI 10.1006/bbrc.1995.2605; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; SUGIYAMA T, 1968, ARCH BIOCHEM BIOPHYS, V125, P98, DOI 10.1016/0003-9861(68)90643-7; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Vela L, 2008, TOXICOL IN VITRO, V22, P1714, DOI 10.1016/j.tiv.2008.07.008; Weller MG, 2001, ANAL SCI, V17, P1445, DOI 10.2116/analsci.17.1445; Zilliges Y, 2008, J BACTERIOL, V190, P2871, DOI 10.1128/JB.01867-07	36	272	277	10	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17615	10.1371/journal.pone.0017615	http://dx.doi.org/10.1371/journal.pone.0017615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445264	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100019
J	Yang, B; Wang, JW; Tang, B; Liu, YF; Guo, CD; Yang, PH; Yu, TA; Li, R; Zhao, JM; Zhang, L; Dai, YP; Li, N				Yang, Bin; Wang, Jianwu; Tang, Bo; Liu, Yufang; Guo, Chengdong; Yang, Penghua; Yu, Tian; Li, Rong; Zhao, Jianmin; Zhang, Lei; Dai, Yunping; Li, Ning			Characterization of Bioactive Recombinant Human Lysozyme Expressed in Milk of Cloned Transgenic Cattle	PLOS ONE			English	Article							MAMMARY-GLAND; HUMAN-SERUM; PROTEINS; GOATS; LACTOFERRIN; CLONING; YEAST; GENE; COW; PH	Background: There is great potential for using transgenic technology to improve the quality of cow milk and to produce biopharmaceuticals within the mammary gland. Lysozyme, a bactericidal protein that protects human infants from microbial infections, is highly expressed in human milk but is found in only trace amounts in cow milk. Methodology/Principal Findings: We have produced 17 healthy cloned cattle expressing recombinant human lysozyme using somatic cell nuclear transfer. In this study, we just focus on four transgenic cattle which were natural lactation. The expression level of the recombinant lysozyme was up to 25.96 mg/L, as measured by radioimmunoassay. Purified recombinant human lysozyme showed the same physicochemical properties, such as molecular mass and bacterial lysis, as its natural counterpart. Moreover, both recombinant and natural lysozyme had similar conditions for reactivity as well as for pH and temperature stability during in vitro simulations. The gross composition of transgenic and non-transgenic milk, including levels of lactose, total protein, total fat, and total solids were not found significant differences. Conclusions/Significance: Thus, our study not only describes transgenic cattle whose milk offers the similar nutritional benefits as human milk but also reports techniques that could be further refined for production of active human lysozyme on a large scale.	[Yang, Bin; Wang, Jianwu; Liu, Yufang; Guo, Chengdong; Yang, Penghua; Yu, Tian; Dai, Yunping; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Tang, Bo; Li, Rong; Zhao, Jianmin; Zhang, Lei] Beijing GenProt Biotechnol Co, Beijing, Peoples R China	China Agricultural University	Yang, B (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglbau@public3.bta.net.cn			State High-Tech Research Development Program of China [2007AA100501]; GenProtein Biotechnology Company	State High-Tech Research Development Program of China; GenProtein Biotechnology Company	This work was supported by a grant from the State High-Tech Research Development Program of China (2007AA100501). This study also was financially supported in part by GenProtein Biotechnology Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bowen WH, 2005, PEDIATRICS, V116, P921, DOI 10.1542/peds.2004-2462; Brundige DR, 2008, J NUTR, V138, P921, DOI 10.1093/jn/138.5.921; Brundige DR, 2010, TRANSGENIC RES, V19, P563, DOI 10.1007/s11248-009-9334-4; CHANDAN RC, 1964, NATURE, V204, P76, DOI 10.1038/204076a0; Clark AJ, 1998, J MAMMARY GLAND BIOL, V3, P337, DOI 10.1023/A:1018723712996; DAVIES RC, 1969, BIOCHIM BIOPHYS ACTA, V178, P294, DOI 10.1016/0005-2744(69)90397-0; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Gong GC, 2004, SCI CHINA SER C, V47, P183, DOI 10.1360/03yc0015; HANKIEWICZ J, 1974, CLIN CHIM ACTA, V57, P205, DOI 10.1016/0009-8981(74)90398-2; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Huang E, 2009, FOOD BIOPROCESS TECH, V2, P222, DOI 10.1007/s11947-008-0062-1; Huang JM, 2002, TRANSGENIC RES, V11, P229, DOI 10.1023/A:1015663706259; ITO Y, 1993, EUR J BIOCHEM, V213, P649, DOI 10.1111/j.1432-1033.1993.tb17805.x; Iwata T, 2004, BIOTECHNOL LETT, V26, P1803, DOI 10.1007/s10529-004-4614-9; Jackson KA, 2010, TRANSGENIC RES, V19, P977, DOI 10.1007/s11248-010-9371-z; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kim HR, 2009, REPROD DOMEST ANIM, V44, P714, DOI 10.1111/j.1439-0531.2007.01058.x; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Krepulat F, 2005, ONCOGENE, V24, P4645, DOI 10.1038/sj.onc.1208557; Laible G, 2007, THERIOGENOLOGY, V67, P166, DOI 10.1016/j.theriogenology.2006.09.028; Larsen MR, 2006, BIOTECHNIQUES, V40, P790, DOI 10.2144/000112201; Lee BH, 2008, J MICROBIOL BIOTECHN, V18, P1386; Lee-Huang S, 2005, BIOCHEMISTRY-US, V44, P4648, DOI 10.1021/bi0477081; Levy J, 1998, NUTRITION, V14, P641, DOI 10.1016/S0899-9007(98)00007-0; Li B, 2006, FEBS LETT, V580, P1877, DOI 10.1016/j.febslet.2006.02.051; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1535S; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 1995, J DAIRY SCI, V78, P2645, DOI 10.3168/jds.S0022-0302(95)76894-1; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; MASON DY, 1975, J CLIN PATHOL, V28, P124, DOI 10.1136/jcp.28.2.124; Montagne P, 2001, ADV EXP MED BIOL, V501, P241; MURAKI M, 1988, PROTEIN ENG, V2, P49, DOI 10.1093/protein/2.1.49; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; PARRY RM, 1969, ARCH BIOCHEM BIOPHYS, V130, P59, DOI 10.1016/0003-9861(69)90009-5; PEETERS TL, 1978, CLIN CHEM, V24, P2155; PETERS CWB, 1989, EUR J BIOCHEM, V182, P507, DOI 10.1111/j.1432-1033.1989.tb14857.x; Piccinini R, 2005, VET RES, V36, P747, DOI 10.1051/vetres:2005030; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Ranieri ML, 2009, J DAIRY SCI, V92, P4823, DOI 10.3168/jds.2009-2144; Sabikhi L, 2007, ADV FOOD NUTR RES, V53, P161, DOI 10.1016/S1043-4526(07)53005-6; Samaranayake YH, 1997, APMIS, V105, P875, DOI 10.1111/j.1699-0463.1997.tb05097.x; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Tian XC, 2005, P NATL ACAD SCI USA, V102, P6261, DOI 10.1073/pnas.0500140102; VASSTRAND EN, 1980, SCAND J DENT RES, V88, P219; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang J, 2008, J DAIRY SCI, V91, P4466, DOI 10.3168/jds.2008-1189; Wilken LR, 2006, BIOTECHNOL PROGR, V22, P745, DOI 10.1021/bp0600536; Williams A, 2008, NUCLEIC ACIDS RES, V36, P2320, DOI 10.1093/nar/gkn085; Wuensch A, 2007, BIOL REPROD, V76, P983, DOI 10.1095/biolreprod.106.058776; Xiong RS, 2008, BIOTECHNOL APPL BIOC, V51, P129, DOI 10.1042/BA20070205; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yu Z, 2006, J DAIRY SCI, V89, P2911, DOI 10.3168/jds.S0022-0302(06)72563-2; AGR QUALITY STANDARD	58	79	95	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17593	10.1371/journal.pone.0017593	http://dx.doi.org/10.1371/journal.pone.0017593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436886	Green Submitted, gold, Green Published			2022-12-25	WOS:000288514000004
J	Aporntewan, C; Phokaew, C; Piriyapongsa, J; Ngamphiw, C; Ittiwut, C; Tongsima, S; Mutirangura, A				Aporntewan, Chatchawit; Phokaew, Chureerat; Piriyapongsa, Jittima; Ngamphiw, Chumpol; Ittiwut, Chupong; Tongsima, Sissades; Mutirangura, Apiwat			Hypomethylation of Intragenic LINE-1 Represses Transcription in Cancer Cells through AGO2	PLOS ONE			English	Article							GENE-EXPRESSION; METHYLATION LEVEL; DNA HYPOMETHYLATION; L1 RETROTRANSPOSON; CARCINOMA; IDENTIFICATION; ASSOCIATION; HEAD; DIFFERENTIATION; PREDICTION	In human cancers, the methylation of long interspersed nuclear element -1 (LINE-1 or L1) retrotransposons is reduced. This occurs within the context of genome wide hypomethylation, and although it is common, its role is poorly understood. L1s are widely distributed both inside and outside of genes, intragenic and intergenic, respectively. Interestingly, the insertion of active full-length L1 sequences into host gene introns disrupts gene expression. Here, we evaluated if intragenic L1 hypomethylation influences their host gene expression in cancer. First, we extracted data from L1base (http://l1base.molgen.mpg.de), a database containing putatively active L1 insertions, and compared intragenic and intergenic L1 characters. We found that intragenic L1 sequences have been conserved across evolutionary time with respect to transcriptional activity and CpG dinucleotide sites for mammalian DNA methylation. Then, we compared regulated mRNA levels of cells from two different experiments available from Gene Expression Omnibus (GEO), a database repository of high throughput gene expression data, (http://www.ncbi.nlm.nih.gov/geo) by chi-square. The odds ratio of down-regulated genes between demethylated normal bronchial epithelium and lung cancer was high (p<1E(-27); OR = 3.14; 95% CI = 2.54-3.88), suggesting cancer genome wide hypomethylation down-regulating gene expression. Comprehensive analysis between L1 locations and gene expression showed that expression of genes containing L1s had a significantly higher likelihood to be repressed in cancer and hypomethylated normal cells. In contrast, many mRNAs derived from genes containing L1s are elevated in Argonaute 2 (AGO2 or EIF2C2)-depleted cells. Hypomethylated L1s increase L1 mRNA levels. Finally, we found that AGO2 targets intronic L1 pre-mRNA complexes and represses cancer genes. These findings represent one of the mechanisms of cancer genome wide hypomethylation altering gene expression. Hypomethylated intragenic L1s are a nuclear siRNA mediated cis-regulatory element that can repress genes. This epigenetic regulation of retrotransposons likely influences many aspects of genomic biology.	[Aporntewan, Chatchawit] Chulalongkorn Univ, Fac Sci, Dept Math, Bangkok, Thailand; [Phokaew, Chureerat] Chulalongkorn Univ, Fac Grad Sch, Inter Dept Program BioMed Sci, Bangkok, Thailand; [Piriyapongsa, Jittima; Ngamphiw, Chumpol; Tongsima, Sissades] Genome Inst, Natl Ctr Genet Engn & Biotechnol, Thailand Sci Pk, Pathumtani, Thailand; [Ittiwut, Chupong; Mutirangura, Apiwat] Chulalongkorn Univ, Ctr Excellence Mol Genet Canc & Human Dis, Fac Med, Dept Anat, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Aporntewan, C (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Math, Bangkok, Thailand.	mapiwat@chula.ac.th	Tongsima, Sissades/F-4891-2011; Piriyapongsa, Jittima/F-7581-2012; Ngamphiw, Chumpol/ABB-6488-2021; Mutirangura, Apiwat/C-8197-2009	Tongsima, Sissades/0000-0002-1491-1839; Ngamphiw, Chumpol/0000-0002-8581-397X; 	Thailand Research Fund (TRF); National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA); Four Seasons Hotel Bangkok; Thai Red Cross Society 4th Cancer Care Charity; Chulalongkorn University; Royal Golden Jubilee Ph.D. grant [PHD/0190/2550]; French embassy in Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA); Four Seasons Hotel Bangkok; Thai Red Cross Society 4th Cancer Care Charity; Chulalongkorn University(Chulalongkorn University); Royal Golden Jubilee Ph.D. grant; French embassy in Thailand	Funding: This study is supported in part by the Thailand Research Fund (TRF), the National Center for Genetic Engineering and Biotechnology (BIOTEC), the National Science and Technology Development Agency (NSTDA), Four Seasons Hotel Bangkok and the Thai Red Cross Society 4th Cancer Care Charity and Chulalongkorn University. Chureerat Phokaew is supported by a Royal Golden Jubilee Ph.D. grant (PHD/0190/2550), French embassy in Thailand and Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Herman JG, 2005, COLD SH Q B, V70, P329, DOI 10.1101/sqb.2005.70.036; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Kim BY, 2004, BBA-MOL BASIS DIS, V1739, P50, DOI 10.1016/j.bbadis.2004.07.004; KONGRUTTANACHOK N, MOL CANC, V9, P70; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Mecham BH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh071; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mutirangura A, 2007, ASIAN BIOMED, V1, P121; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pornthanakasem W, 2004, BIOTECHNIQUES, V37, P750, DOI 10.2144/04375BM07; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Subbalekha K, 2009, ORAL ONCOL, V45, P184, DOI 10.1016/j.oraloncology.2008.05.002; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Thanasupawat T, 2009, ASIAN BIOMED, V3, P279; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	68	79	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17934	10.1371/journal.pone.0017934	http://dx.doi.org/10.1371/journal.pone.0017934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423624	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900045
J	Arandjelovic, M; Head, J; Rabanal, LI; Schubert, G; Mettke, E; Boesch, C; Robbins, MM; Vigilant, L				Arandjelovic, Mimi; Head, Josephine; Rabanal, Luisa I.; Schubert, Grit; Mettke, Elisabeth; Boesch, Christophe; Robbins, Martha M.; Vigilant, Linda			Non-Invasive Genetic Monitoring of Wild Central Chimpanzees	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; POPULATION-SIZE; GOUALOUGO TRIANGLE; DNA AMPLIFICATION; PATERNITY; IDENTIFICATION; DECLINE; FIELD; RELATEDNESS; GORILLAS	Background: An assessment of population size and structure is an important first step in devising conservation and management plans for endangered species. Many threatened animals are elusive, rare and live in habitats that prohibit directly counting individuals. For example, a well-founded estimate of the number of great apes currently living in the wild is lacking. Developing methods to obtain accurate population estimates for these species is a priority for their conservation management. Genotyping non-invasively collected faecal samples is an effective way of evaluating a species' population size without disruption, and can also reveal details concerning population structure. Methodology/Principal Findings: We opportunistically collected wild chimpanzee faecal samples for genetic capture-recapture analyses over a four-year period in a 132 km 2 area of Loango National Park, Gabon. Of the 444 samples, 46% yielded sufficient quantities of DNA for genotyping analysis and the consequent identification of 121 individuals. Using genetic capture-recapture, we estimate that 283 chimpanzees (range: 208-316) inhabited the research area between February 2005 and July 2008. Since chimpanzee males are patrilocal and territorial, we genotyped samples from males using variable Y-chromosome microsatellite markers and could infer that seven chimpanzee groups are present in the area. Genetic information, in combination with field data, also suggested the occurrence of repeated cases of intergroup violence and a probable group extinction. Conclusions/Significance: The poor amplification success rate resulted in a limited number of recaptures and hence only moderate precision (38%, measured as the entire width of the 95% confidence interval), but this was still similar to the best results obtained using intensive nest count surveys of apes (40% to 63%). Genetic capture-recapture methods applied to apes can provide a considerable amount of novel information on chimpanzee population size and structure with minimal disturbance to the animals and represent a powerful complement to traditional field-based methods.	[Arandjelovic, Mimi; Head, Josephine; Rabanal, Luisa I.; Schubert, Grit; Mettke, Elisabeth; Boesch, Christophe; Robbins, Martha M.; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Max Planck Society	Arandjelovic, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	arandjel@eva.mpg.de		Arandjelovic, Mimi/0000-0001-8920-9684	Societe pour la Conservation et le Developpement (SCD); Wildlife Conservation Society (WCS); Max Planck Society	Societe pour la Conservation et le Developpement (SCD); Wildlife Conservation Society (WCS); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the Societe pour la Conservation et le Developpement (SCD), Wildlife Conservation Society (WCS), and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; ARANDJELOVIC M, 2010, BIOL CONSERVATION; Arrendal J, 2007, CONSERV GENET, V8, P1097, DOI 10.1007/s10592-006-9266-y; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P184; Boesch C, 2007, INT J PRIMATOL, V28, P1025, DOI 10.1007/s10764-007-9201-1; Boyko RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010754; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; Butynski Thomas M., 2001, P3; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Erler A, 2004, MOL ECOL, V13, P2921, DOI 10.1111/j.1365-294X.2004.02304.x; Eves Heather E., 2008, P327, DOI 10.1007/978-0-387-70721-1_17; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOODALL J, 1979, GREAT APES; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; GOOSSENS B, 2000, CONSERVATION GENETIC, V1; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Hajkova P, 2009, CONSERV GENET, V10, P1667, DOI 10.1007/s10592-008-9745-4; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Herbinger I, 2001, INT J PRIMATOL, V22, P143, DOI 10.1023/A:1005663212997; Inoue E, 2008, AM J PHYS ANTHROPOL, V137, P256, DOI 10.1002/ajpa.20865; K?hl H., 2008, BEST PRACTICE GUIDEL; Kalinowski ST, 2006, J WILDLIFE MANAGE, V70, P1148, DOI 10.2193/0022-541X(2006)70[1148:IIADOG]2.0.CO;2; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Leal M. E., 2001, Systematics and Geography of Plants, V71, P1073, DOI 10.2307/3668739; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; MARCHESI P, 1995, PRIMATES, V36, P591, DOI 10.1007/BF02382880; McGrew WC, 2004, AM J PRIMATOL, V63, P87, DOI 10.1002/ajp.20041; MCKELVEY KS, 2004, J WILDLIFE MANAGEMEN, V68; Melin AD, 2010, AM J PRIMATOL, V72, P61; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Mitani JC, 2008, CURR BIOL, V18, pR166, DOI 10.1016/j.cub.2007.12.022; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Mittermeier Russell A., 2009, Primate Conservation, V24, P1; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Morgan D, 2003, INT J PRIMATOL, V24, P369, DOI 10.1023/A:1023005417897; MORIN PA, 1993, PRIMATES, V34, P347, DOI 10.1007/BF02382630; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murray CM, 2008, CURR BIOL, V18, P20, DOI 10.1016/j.cub.2007.11.044; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Oates J.F., 1996, AFRICAN PRIMATES STA; PAETKAU D, 2003, MOL ECOLOGY, V12; Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; REED JZ, 1997, MOL ECOLOGY, V6; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; Sanz C, 2004, AM NAT, V164, P567, DOI 10.1086/424803; Sanz C, 2007, J APPL ECOL, V44, P263, DOI 10.1111/j.1365-2664.2007.01278.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Soulu M., 2001, CONSERVATION BIOL RE; Stumpf R., 2010, PRIMATES PERSPECTIVE; Thompson ME, 2006, INT J PRIMATOL, V27, P1601, DOI 10.1007/s10764-006-9098-0; UEHARA S, 1994, PRIMATES, V35, P275, DOI 10.1007/BF02382725; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Walsh PD, 2005, ECOL APPL, V15, P1342, DOI 10.1890/03-5283; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Watts DP, 2000, PRIMATES, V41, P357, DOI 10.1007/BF02557646; Watts DP, 2004, INT J PRIMATOL, V25, P507, DOI 10.1023/B:IJOP.0000023573.56625.59; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042	82	48	49	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e14761	10.1371/journal.pone.0014761	http://dx.doi.org/10.1371/journal.pone.0014761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423611	gold, Green Published, Green Submitted			2022-12-25	WOS:000288513900002
J	Yamamoto, M; Cid, E; Bru, S; Yamamoto, F				Yamamoto, Miyako; Cid, Emili; Bru, Samuel; Yamamoto, Fumiichiro			Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3 Genes That Are Both Downregulated in Expression in Breast and Prostate Cancers	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DNA METHYLATION; PROTEIN EXPRESSION; HOMEOBOX GENES; TEASHIRT GENE; HUMAN GENOME; HUMAN COLON; RT-PCR; DROSOPHILA; TRANSCRIPTION	Background: Neoplastic cells harbor both hypomethylated and hypermethylated regions of DNA. Whereas hypomethylation is found mainly in repeat sequences, regional hypermethylation has been linked to the transcriptional silencing of certain tumor suppressor genes. We attempted to search for candidate genes involved in breast/prostate carcinogenesis, using the criteria that they should be expressed in primary cultures of normal breast/prostate epithelial cells but are frequently downregulated in breast/prostate cancer cell lines and that their promoters are hypermethylated. Methodology/Principal Findings: We identified several dozens of candidates among 194 homeobox and related genes using Systematic Multiplex RT-PCR and among 23,000 known genes and 23,000 other expressed sequences in the human genome by DNA microarray hybridization. An additional examination, by real-time qRT-PCR of clinical specimens of breast cancer, further narrowed the list of the candidates. Among them, the most frequently downregulated genes in tumors were NP_775756 and ZNF537, from the homeobox gene search and the genome-wide search, respectively. To our surprise, we later discovered that these genes belong to the same gene family, the 3-member Teashirt family, bearing the new names of TSHZ2 and TSHZ3. We subsequently determined the methylation status of their gene promoters. The TSHZ3 gene promoter was found to be methylated in all the breast/prostate cancer cell lines and some of the breast cancer clinical specimens analyzed. The TSHZ2 gene promoter, on the other hand, was unmethylated except for the MDA-MB-231 breast cancer cell line. The TSHZ1 gene was always expressed, and its promoter was unmethylated in all cases. Conclusions/Significance: TSHZ2 and TSHZ3 genes turned out to be the most interesting candidates for novel tumor suppressor genes. Expression of both genes is downregulated. However, differential promoter methylation suggests the existence of distinctive mechanisms of transcriptional inactivation for these genes.	[Yamamoto, Miyako; Yamamoto, Fumiichiro] BIMR, La Jolla, CA USA; [Yamamoto, Miyako; Cid, Emili; Bru, Samuel; Yamamoto, Fumiichiro] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain		Yamamoto, M (corresponding author), BIMR, La Jolla, CA USA.	fyamamoto@imppc.org	Yamamoto, Fumiichiro/F-1478-2016; Cid, Emili/F-7207-2016; ravegnini, gloria/K-1330-2016; Yamamoto, Miyako/F-1722-2016	Yamamoto, Fumiichiro/0000-0001-9690-7034; Cid, Emili/0000-0002-5025-352X; ravegnini, gloria/0000-0002-7774-402X; Yamamoto, Miyako/0000-0001-9516-1402	NIH [1R01CA087069]; DOD BCRP at BIMR [W81XWH-05-1-0317]; IMPPC; NATIONAL CANCER INSTITUTE [R01CA087069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP at BIMR; IMPPC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant 1R01CA087069 and the DOD BCRP grant W81XWH-05-1-0317 at BIMR and by the institutional start-up fund at IMPPC to FY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Ahuja N, 1998, CANCER RES, V58, P5489; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; BIGGIN MD, 1989, CELL, V58, P433, DOI 10.1016/0092-8674(89)90424-8; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Core N, 2007, DEV BIOL, V308, P407, DOI 10.1016/j.ydbio.2007.05.038; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; Dostal A, 2009, J CRANIO MAXILL SURG, V37, P272, DOI 10.1016/j.jcms.2008.12.002; EE HC, 1995, AM J PATHOL, V147, P586; El Ghouzzi V, 2003, HUM MOL GENET, V12, P357, DOI 10.1093/hmg/ddg029; Erkner A, 1999, DEV BIOL, V215, P221, DOI 10.1006/dbio.1999.9452; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; FRIEDMANN Y, 1994, CANCER RES, V54, P5981; Gallet A, 1999, EMBO J, V18, P2208, DOI 10.1093/emboj/18.8.2208; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jenkins D, 2010, NEPHROL DIAL TRANSPL, V25, P54, DOI 10.1093/ndt/gfp453; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; KAMPS MP, 1990, MOL CELL BIOL, V10, P5464, DOI 10.1128/MCB.10.10.5464; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; Koebernick K, 2006, DEV BIOL, V298, P312, DOI 10.1016/j.ydbio.2006.06.041; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; MATHIES LD, 1994, DEVELOPMENT, V120, P2799; MAULBECKER CC, 1993, CELL GROWTH DIFFER, V4, P431; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Polakis P, 2000, GENE DEV, V14, P1837; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; RENUCCI A, 1992, EMBO J, V11, P1459, DOI 10.1002/j.1460-2075.1992.tb05190.x; Rots NY, 1998, MOL CELL BIOL, V18, P1911, DOI 10.1128/MCB.18.4.1911; RUBIN H, 1985, CANCER RES, V45, P2935; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WEINBERG RA, 1995, ANN NY ACAD SCI, V758, P331, DOI 10.1111/j.1749-6632.1995.tb24838.x; Yamamoto F, 2001, ELECTROPHORESIS, V22, P1946, DOI 10.1002/1522-2683(200106)22:10<1946::AID-ELPS1946>3.0.CO;2-Y; Yamamoto F, 2008, GENE EXPRESSION, V14, P217, DOI 10.3727/105221608786883816; Yamamoto M, 2003, ELECTROPHORESIS, V24, P2295, DOI 10.1002/elps.200305459; Yamamoto M, 2004, ELECTROPHORESIS, V25, P2201, DOI 10.1002/elps.200305952; Yamamoto M, 2003, GENE EXPRESSION, V11, P199, DOI 10.3727/000000003108749071; Yamamoto M, 2006, ELECTROPHORESIS, V27, P2529, DOI 10.1002/elps.200500875; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x	54	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17149	10.1371/journal.pone.0017149	http://dx.doi.org/10.1371/journal.pone.0017149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423795	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400009
J	Binder, MD; Xiao, JH; Kemper, D; Ma, GZM; Murray, SS; Kilpatrick, TJ				Binder, Michele D.; Xiao, Junhua; Kemper, Dennis; Ma, Gerry Z. M.; Murray, Simon S.; Kilpatrick, Trevor J.			Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MULTIPLE-SCLEROSIS; C57BL/6 MICE; REMYELINATION; SURVIVAL; PATHWAY; AXL; GROWTH; CELLS; CNS	Multiple sclerosis (MS) is a complex demyelinating disease of the central nervous system. Current research has shown that at least in some cases, the primary insult in MS could be directed at the oligodendrocyte, and that the earliest immune responses are primarily via innate immune cells. We have identified a family of receptor protein tyrosine kinases, known as the TAM receptors (Tyro3, Axl and Mertk), as potentially important in regulating both the oligodendrocyte and immune responses. We have previously shown that Gas6, a ligand for the TAM receptors, can affect the severity of demyelination in mice, with a loss of signalling via Gas6 leading to decreased oligodendrocyte survival and increased microglial activation during cuprizone-induced demyelination. We hypothesised TAM receptor signalling would also influence the extent of recovery in mice following demyelination. A significant effect of the absence of Gas6 was detected upon remyelination, with a lower level of myelination after 4 weeks of recovery in comparison with wild-type mice. The delay in remyelination was accompanied by a reduction in oligodendrocyte numbers. To understand the molecular mechanisms that drive the observed effects, we also examined the effect of exogenous Gas6 in in vitro myelination assays. We found that Gas6 significantly increased myelination in a dose-dependent manner, suggesting that TAM receptor signalling could be directly involved in myelination by oligodendrocytes. The reduced rate of remyelination in the absence of Gas6 could thus result from a lack of Gas6 at a critical time during myelin production after injury. These findings establish Gas6 as an important regulator of both CNS demyelination and remyelination.	[Binder, Michele D.; Xiao, Junhua; Kemper, Dennis; Ma, Gerry Z. M.; Murray, Simon S.; Kilpatrick, Trevor J.] Univ Melbourne, Multiple Sclerosis Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Binder, Michele D.; Xiao, Junhua; Ma, Gerry Z. M.; Murray, Simon S.; Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Murray, Simon S.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Binder, MD (corresponding author), Univ Melbourne, Multiple Sclerosis Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	mbinder@florey.edu.au	Xiao, Junhua/AAC-6898-2022	Xiao, Junhua/0000-0002-4320-2855; Murray, Simon/0000-0001-6671-192X; Kilpatrick, Trevor/0000-0003-3999-085X; Binder, Michele/0000-0002-4494-6717	National Health and Medical Research Council Australia [566830, 454330]; Australian Postgraduate Award; Multiple Sclerosis Research Australia; Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Multiple Sclerosis Research Australia; Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia	This work was supported by a grant from the National Health and Medical Research Council Australia (grant number 566830). GZMM is supported by an Australian Postgraduate Award. JX is the recipient of a Betty Cuthbert Fellowship (#454330) from National Health and Medical Research Council Australia and Multiple Sclerosis Research Australia. The Florey Neuroscience Institutes is supported by funding provided from the Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; BARRES BA, 1993, DEVELOPMENT, V118, P283; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; KLEITMAN NW, 1991, TISSUE CULTURE METHO, P337; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Ma GZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016964; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Paxinos G., 2001, MOUSE BRAIN STEREOTA; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; Taylor LC, 2010, J NEUROSCI RES, V88, P391, DOI 10.1002/jnr.22215; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009	29	42	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17727	10.1371/journal.pone.0017727	http://dx.doi.org/10.1371/journal.pone.0017727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423702	Green Published, gold			2022-12-25	WOS:000288219100031
J	Zhao, YJ; Zhang, YH; Cao, Y; Qi, JX; Mao, LW; Xue, YF; Gao, F; Peng, H; Wang, XW; Gao, GF; Ma, YH				Zhao, Yueju; Zhang, Yunhua; Cao, Yang; Qi, Jianxun; Mao, Liangwei; Xue, Yanfen; Gao, Feng; Peng, Hao; Wang, Xiaowei; Gao, George F.; Ma, Yanhe			Structural Analysis of Alkaline beta-Mannanase from Alkaliphilic Bacillus sp N16-5: Implications for Adaptation to Alkaline Conditions	PLOS ONE			English	Article							PRELIMINARY-X-RAY; CRYSTAL-STRUCTURE; CONFORMATIONAL FLEXIBILITY; ALPHA-AMYLASE; GENE CLONING; BLUE MUSSEL; PH; SEQUENCE; XYLANASE; ENZYMES	Significant progress has been made in isolating novel alkaline beta-mannanases, however, there is a paucity of information concerning the structural basis for alkaline tolerance displayed by these beta-mannanases. We report the catalytic domain structure of an industrially important beta-mannanase from the alkaliphilic Bacillus sp. N16-5 (BSP165 MAN) at a resolution of 1.6 angstrom. This enzyme, classified into subfamily 8 in glycosyl hydrolase family 5 (GH5), has a pH optimum of enzymatic activity at pH 9.5 and folds into a classic (beta/alpha)(8)-barrel. In order to gain insight into molecular features for alkaline adaptation, we compared BSP165 MAN with previously reported GH5 beta-mannanases. It was revealed that BSP165 MAN and other subfamily 8 beta-mannanases have significantly increased hydrophobic and Arg residues content and decreased polar residues, comparing to beta-mannanases of subfamily 7 or 10 in GH5 which display optimum activities at lower pH. Further, extensive structural comparisons show alkaline beta-mannanases possess a set of distinctive features. Position and length of some helices, strands and loops of the TIM barrel structures are changed, which contributes, to a certain degree, to the distinctly different shaped (beta/alpha)(8)-barrels, thus affecting the catalytic environment of these enzymes. The number of negatively charged residues is increased on the molecular surface, and fewer polar residues are exposed to the solvent. Two amino acid substitutions in the vicinity of the acid/base catalyst were proposed to be possibly responsible for the variation in pH optimum of these homologous enzymes in subfamily 8 of GH5, identified by sequence homology analysis and pK(a) calculations of the active site residues. Mutational analysis has proved that Gln91 and Glu226 are important for BSP165 MAN to function at high pH. These findings are proposed to be possible factors implicated in the alkaline adaptation of GH5 beta-mannanases and will help to further understanding of alkaline adaptation mechanism.	[Zhao, Yueju; Zhang, Yunhua; Xue, Yanfen; Wang, Xiaowei; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Zhao, Yueju; Cao, Yang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cao, Yang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Qi, Jianxun; Gao, Feng; Peng, Hao; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Mao, Liangwei] Hubei Univ, Coll Life Sci, Wuhan 430062, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Hubei University	Zhao, YJ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	Wang, Xiaowei/K-8352-2013; MA, YAN/HHN-2912-2022; Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021	Mao, Liangwei/0000-0002-4325-4962	National Natural Science Foundation of China (NSFC) [30621005]; Ministry of Sciences and Technology of China [2007CB707801, 2003CB716001, 2006 AA020201, 2007AA021306]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (NSFC: 30621005) and from the Ministry of Sciences and Technology of China (973 programs 2007CB707801 and 2003CB716001, 863 programs 2006 AA020201 and 2007AA021306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKINO T, 1987, APPL MICROBIOL BIOT, V26, P323; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; BETTIOL JP, 2002, Patent No. 6376445; Coughlan S, 2001, BBA-PROTEIN STRUCT M, V1544, P10, DOI 10.1016/S0167-4838(00)00200-4; Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fang TY, 1998, PROTEIN ENG, V11, P383, DOI 10.1093/protein/11.5.383; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatada Y, 2005, EXTREMOPHILES, V9, P497, DOI 10.1007/s00792-005-0460-5; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Horikoshi K, 2004, P JPN ACAD B-PHYS, V80, P166, DOI 10.2183/pjab.80.166; Ito S, 1998, EXTREMOPHILES, V2, P185, DOI 10.1007/s007920050059; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kansoh AL, 2004, ANTON LEEUW INT J G, V85, P103, DOI 10.1023/B:ANTO.0000020281.73208.62; KIM JR, 2002, J KOREAN CHEM SOC, V46, P432; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7888, DOI 10.1128/AEM.71.12.7888-7896.2005; Li YN, 2008, J MICROBIOL BIOTECHN, V18, P160; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; Mamo G, 2009, BIOCHIMIE, V91, P1187, DOI 10.1016/j.biochi.2009.06.017; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCCLEARY BV, 1983, CARBOHYD RES, V111, P297, DOI 10.1016/0008-6215(83)88314-1; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Petersen MTN, 2001, J BIOTECHNOL, V85, P115, DOI 10.1016/S0168-1656(00)00360-6; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Shirai T, 2007, PROTEINS, V66, P600, DOI 10.1002/prot.21255; Singh S, 2003, FEMS MICROBIOL REV, V27, P3, DOI 10.1016/S0168-6445(03)00018-4; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu BZ, 2002, J BIOTECHNOL, V92, P267, DOI 10.1016/S0168-1656(01)00367-4; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294; Yang JH, 2008, J BIOTECHNOL, V133, P294, DOI 10.1016/j.jbiotec.2007.10.008; YANG P, 2008, APPL BIOCHEM BIOTECH, P1559; Zhao YJ, 2008, ACTA CRYSTALLOGR F, V64, P957, DOI 10.1107/S1744309108028571	62	32	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14608	10.1371/journal.pone.0014608	http://dx.doi.org/10.1371/journal.pone.0014608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21436878	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100002
J	Cheng, F; Liu, J; Teh, C; Chong, SW; Korzh, V; Jiang, YJ; Deng, LW				Cheng, F.; Liu, J.; Teh, C.; Chong, S-W; Korzh, V.; Jiang, Y-J; Deng, L-W			Camptothecin-induced downregulation of MLL5 contributes to the activation of tumor suppressor p53	ONCOGENE			English	Article						MLL5; camptothecin; p53; p53 tetramer; Serine 392	HISTONE METHYLTRANSFERASE COMPLEX; TOPOISOMERASE-I INHIBITORS; DNA-DAMAGE; CELL-CYCLE; INDUCED PHOSPHORYLATION; H3K4 METHYLATION; PROTEIN-KINASE; DEGRADATION; ATR; TETRAMERIZATION	Mixed lineage leukemia 5 (MLL5) has been implicated in multiple aspects of cell physiology, such as hematopoiesis, cell cycle control and chromatin regulatory network. In this study, we present evidence that MLL5 is involved in the camptothecin (CPT)-induced p53 activation. CPT promoted the degradation of MLL5 protein in a time-and dose-dependent manner in actively replicating cells. The downregulation of MLL5 led to phosphorylation of p53 at Ser392, which was abrogated by exogenous overexpression of MLL5. In MLL5-knockdown cells, p53 protein was stabilized and bound to DNA with higher affinity, leading to activation of downstream genes. Co-immunoprecipitation showed that MLL5 preferentially interacted with the tetramerized form of p53, and knockdown of MLL5 promoted chromatin accumulation of p53 tetramers, suggesting that the association of MLL5 with p53 may prevent the p53 tetramers from binding to the chromatin target sites. The role of MLL5 in CPT-induced p53 activation was conserved in developing zebrafish, where CPT downregulated zebrafish Mll5 protein, and the microinjection of zebrafish mll5 mRNA substantially blocked the CPT-induced apoptosis. In summary, our study proposed MLL5 as a novel component in the regulation of p53 homeostasis and a new cellular determinant of CPT. Oncogene (2011) 30, 3599-3611; doi:10.1038/onc.2011.71; published online 21 March 2011	[Cheng, F.; Liu, J.; Deng, L-W] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Teh, C.; Korzh, V.] ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore, Singapore; [Chong, S-W; Jiang, Y-J] ASTAR, Inst Mol & Cell Biol, Genes & Dev Div, Singapore, Singapore; [Jiang, Y-J] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli Cty, Taiwan	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Health Research Institutes - Taiwan	Deng, LW (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, 8 Med Dr, Singapore 117597, Singapore.	lih_wen_deng@nuhs.edu.sg	Xie, Huangming/B-2260-2012; Jiang, Yun-Jin/E-3995-2010; Korzh, Vladimir P/H-1596-2011	Jiang, Yun-Jin/0000-0003-0499-7306; Korzh, Vladimir P/0000-0002-6580-7986; Deng, Lih-Wen/0000-0002-4985-7844	BMRC-A*STAR [R-183-000-164-305]; NMRC-A*STAR [R-183-000-220-275]; Ministry of Education [Tier2, R-183-000-195-112]; A*STAR-IMCB; Ministry of Education, Singapore	BMRC-A*STAR(Agency for Science Technology & Research (A*STAR)); NMRC-A*STAR; Ministry of Education; A*STAR-IMCB(Agency for Science Technology & Research (A*STAR)); Ministry of Education, Singapore(Ministry of Education, Singapore)	We are grateful to Dr Thilo Hagen and Dr Qiang Yu for their valuable suggestions. We thank Dr Bert Vogelstein for HCT116 p53<SUP>+/+</SUP> and HCT116 p53 / cells and Dr Victor Yu for pXJ-HA-p53 plasmid. This work was supported in part by BMRC-A*STAR, R-183-000-164-305; NMRC-A*STAR, R-183-000-220-275; and Ministry of Education Academic Research Fund Tier2, R-183-000-195-112 to LWD, and A*STAR-IMCB funding to YJJ and VK Both FC and JL are recipients of research scholarships from Ministry of Education, Singapore.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Claudio PP, 2006, J CELL PHYSIOL, V208, P602, DOI 10.1002/jcp.20698; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Desai SD, 2001, CANCER RES, V61, P5926; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; ENG WK, 1988, MOL PHARMACOL, V34, P755; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Houser S, 2001, BIOCHEM BIOPH RES CO, V289, P998, DOI 10.1006/bbrc.2001.6073; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; Liu J, 2010, J BIOL CHEM, V285, P20904, DOI 10.1074/jbc.M109.098558; Liu L, 1999, MOL CELL BIOL, V19, P1202; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sarkaria JN, 1999, CANCER RES, V59, P4375; Scheel H, 2003, TRENDS CELL BIOL, V13, P285, DOI 10.1016/S0962-8924(03)00102-8; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhao H, 2008, CELL CYCLE, V7, P3048, DOI 10.4161/cc.7.19.6750	57	11	12	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	33					3599	3611		10.1038/onc.2011.71	http://dx.doi.org/10.1038/onc.2011.71			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21423215				2022-12-25	WOS:000294005100004
J	Barnes, DC; Chapuis, J; Chaudhury, D; Wilson, DA				Barnes, Dylan C.; Chapuis, Julie; Chaudhury, Dipesh; Wilson, Donald A.			Odor Fear Conditioning Modifies Piriform Cortex Local Field Potentials Both during Conditioning and during Post-Conditioning Sleep	PLOS ONE			English	Article							SLOW-WAVE SLEEP; REM-SLEEP; LOW ACETYLCHOLINE; OLFACTORY CORTEX; DEPENDENT MEMORY; STATE; RAT; HIPPOCAMPUS; REPLAY; CONSOLIDATION	Background: Sleep plays an active role in memory consolidation. Sleep structure (REM/Slow wave activity [SWS]) can be modified after learning, and in some cortical circuits, sleep is associated with replay of the learned experience. While the majority of this work has focused on neocortical and hippocampal circuits, the olfactory system may offer unique advantages as a model system for exploring sleep and memory, given the short, non-thalamic pathway from nose to primary olfactory (piriform cortex), and rapid cortex-dependent odor learning. Methodology/Principal Findings: We examined piriform cortical odor responses using local field potentials (LFPs) from freely behaving Long-Evans hooded rats over the sleep-wake cycle, and the neuronal modifications that occurred within the piriform cortex both during and after odor-fear conditioning. We also recorded LFPs from naive animals to characterize sleep activity in the piriform cortex and to analyze transient odor-evoked cortical responses during different sleep stages. Naive rats in their home cages spent 40% of their time in SWS, during which the piriform cortex was significantly hypo-responsive to odor stimulation compared to awake and REM sleep states. Rats trained in the paired odor-shock conditioning paradigm developed enhanced conditioned odor evoked gamma frequency activity in the piriform cortex over the course of training compared to pseudo-conditioned rats. Furthermore, conditioned rats spent significantly more time in SWS immediately post-training both compared to pre-training days and compared to pseudo-conditioned rats. The increase in SWS immediately after training significantly correlated with the duration of odor-evoked freezing the following day. Conclusions/Significance: The rat piriform cortex is hypo-responsive to odors during SWS which accounts for nearly 40% of each 24 hour period. The duration of slow-wave activity in the piriform cortex is enhanced immediately post-conditioning, and this increase is significantly correlated with subsequent memory performance. Together, these results suggest the piriform cortex may go offline during SWS to facilitate consolidation of learned odors with reduced external interference.	[Barnes, Dylan C.; Chapuis, Julie; Chaudhury, Dipesh; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY USA; [Barnes, Dylan C.; Wilson, Donald A.] CUNY, Cognit Neurosci Program, New York, NY 10021 USA; [Wilson, Donald A.] NYU, Sch Med, New York, NY USA	Nathan Kline Institute for Psychiatric Research; City University of New York (CUNY) System; New York University	Barnes, DC (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY USA.	dbarnes@nki.rfmh.org		Wilson, Donald/0000-0001-8918-2151	NIDCD [DC003906]; Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC009910] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by grant DC003906 from the NIDCD (www.nih.gov) to DAW. JC was supported by a fellowship from the Fyssen Foundation (http://www.fondation-fyssen.org/subventionsUS.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G., 2006, RHYTHMS BRAIN; Cai DJ, 2009, LEARN MEMORY, V16, P595, DOI 10.1101/lm.1515609; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Carskadon MA, 2004, SLEEP, V27, P402; Chapuis J, 2009, J NEUROSCI, V29, P10287, DOI 10.1523/JNEUROSCI.0505-09.2009; CHEN CF, 2009, ACHEMS ANN M ABSTR; Cohen JD, 2010, J NEUROPHYSIOL, V104, P1661, DOI 10.1152/jn.00340.2010; Costa-Miserachs D, 2003, J NEUROSCI METH, V130, P93, DOI 10.1016/S0165-0270(03)00229-2; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hegoburu C, 2009, LEARN MEMORY, V16, P687, DOI 10.1101/lm.1584209; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Landsness EC, 2009, SLEEP, V32, P1273; LECONTE P, 1974, PHYSIOL BEHAV, V13, P675, DOI 10.1016/0031-9384(74)90239-X; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li AA, 2010, NEUROSCI LETT, V480, P44, DOI 10.1016/j.neulet.2010.05.093; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Magloire V, 2009, BEHAV BRAIN RES, V205, P568, DOI 10.1016/j.bbr.2009.08.039; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2009, NEUROPSYCHOPHARMACOL, V34, P1843, DOI 10.1038/npp.2009.6; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rosanova M, 2005, J PHYSIOL-LONDON, V562, P569, DOI 10.1113/jphysiol.2004.071381; Rowland NC, 2010, NEUROSCIENCE, V166, P698, DOI 10.1016/j.neuroscience.2009.12.048; Sevelinges Y, 2004, LEARN MEMORY, V11, P761, DOI 10.1101/lm.83604; Sevelinges Y, 2008, LEARN MEMORY, V15, P649, DOI 10.1101/lm.998508; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Stuck BA, 2007, SLEEP, V30, P506, DOI 10.1093/sleep/30.4.506; Tononi Giulio, 2009, J Clin Sleep Med, V5, pS16; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Walker MP, 2009, J CLIN SLEEP MED, V5, pS20; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wilson DA, 2001, LEARN MEMORY, V8, P279, DOI 10.1101/lm.42601; WILSON DA, 2010, J NEUROPHYS IN PRESS; Wilson DA, 2006, SEMIN CELL DEV BIOL, V17, P462, DOI 10.1016/j.semcdb.2006.04.008; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010	58	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18130	10.1371/journal.pone.0018130	http://dx.doi.org/10.1371/journal.pone.0018130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448432	Green Published, gold			2022-12-25	WOS:000288810500043
J	Wolkowitz, OM; Mellon, SH; Epel, ES; Lin, J; Dhabhar, FS; Su, YL; Reus, VI; Rosser, R; Burke, HM; Kupferman, E; Compagnone, M; Nelson, JC; Blackburn, EH				Wolkowitz, Owen M.; Mellon, Synthia H.; Epel, Elissa S.; Lin, Jue; Dhabhar, Firdaus S.; Su, Yali; Reus, Victor I.; Rosser, Rebecca; Burke, Heather M.; Kupferman, Eve; Compagnone, Mariana; Nelson, J. Craig; Blackburn, Elizabeth H.			Leukocyte Telomere Length in Major Depression: Correlations with Chronicity, Inflammation and Oxidative Stress - Preliminary Findings	PLOS ONE			English	Article							MASS-SPECTROMETRIC QUANTIFICATION; CENTRAL-NERVOUS-SYSTEM; CARDIOVASCULAR-DISEASE; RISK-FACTOR; DNA-DAMAGE; PREDICTS MORTALITY; LIPID-PEROXIDATION; BIOLOGICAL-FLUIDS; MONONUCLEAR-CELLS; PERIPHERAL-BLOOD	Background: Depression is associated with an unusually high rate of aging-related illnesses and early mortality. One aspect of "accelerated aging" in depression may be shortened leukocyte telomeres. When telomeres critically shorten, as often occurs with repeated mitoses or in response to oxidation and inflammation, cells may die. Indeed, leukocyte telomere shortening predicts early mortality and medical illnesses in non-depressed populations. We sought to determine if leukocyte telomeres are shortened in Major Depressive Disorder (MDD), whether this is a function of lifetime depression exposure and whether this is related to putative mediators, oxidation and inflammation. Methodology: Leukocyte telomere length was compared between 18 unmedicated MDD subjects and 17 controls and was correlated with lifetime depression chronicity and peripheral markers of oxidation (F2-isoprostane/Vitamin C ratio) and inflammation (IL-6). Analyses were controlled for age and sex. Principal Findings: The depressed group, as a whole, did not differ from the controls in telomere length. However, telomere length was significantly inversely correlated with lifetime depression exposure, even after controlling for age (p < 0.05). Average telomere length in the depressed subjects who were above the median of lifetime depression exposure (>= 9.2 years' cumulative duration) was 281 base pairs shorter than that in controls (p < 0.05), corresponding to approximately seven years of "accelerated cell aging." Telomere length was inversely correlated with oxidative stress in the depressed subjects (p < 0.01) and in the controls (p < 0.05) and with inflammation in the depressed subjects (p < 0.05). Conclusions: These preliminary data indicate that accelerated aging at the level of leukocyte telomeres is proportional to lifetime exposure to MDD. This might be related to cumulative exposure to oxidative stress and inflammation in MDD. This suggest that telomere shortening does not antedate depression and is not an intrinsic feature. Rather, telomere shortening may progress in proportion to lifetime depression exposure.	[Wolkowitz, Owen M.; Epel, Elissa S.; Reus, Victor I.; Rosser, Rebecca; Burke, Heather M.; Kupferman, Eve; Compagnone, Mariana; Nelson, J. Craig] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Mellon, Synthia H.] Univ Calif San Francisco, Sch Med, Dept OB GYN & Reprod Sci, San Francisco, CA USA; [Epel, Elissa S.; Burke, Heather M.] Univ Calif San Francisco, Sch Med, Hlth Psychol Program, San Francisco, CA USA; [Lin, Jue; Blackburn, Elizabeth H.] Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Dhabhar, Firdaus S.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Su, Yali] Kronos Sci Lab, Phoenix, AZ USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Wolkowitz, OM (corresponding author), Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA.	owen.wolkowitz@ucsf.edu	reus, victor i/I-7923-2015; Wolkowitz, Owen M/J-6649-2013	reus, victor i/0000-0002-8193-5697; Wolkowitz, Owen M/0000-0003-0655-5042	National Institute of Mental Health (NIMH) [R01-MH083784]; O'Shaughnessy Foundation; UCSF Academic Senate; UCSF Research Evaluation and Allocation Committee (REAC); Bernard and Barbro Foundation; National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083784] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); O'Shaughnessy Foundation; UCSF Academic Senate; UCSF Research Evaluation and Allocation Committee (REAC); Bernard and Barbro Foundation; National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from the National Institute of Mental Health (NIMH) (Grant Number R01-MH083784), the O'Shaughnessy Foundation and grants from the UCSF Academic Senate, the UCSF Research Evaluation and Allocation Committee (REAC) and the Bernard and Barbro Foundation. This project was also supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-CTSI Grant Number UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Andersen K, 2005, EPIDEMIOLOGY, V16, P233, DOI 10.1097/01.ede.0000152116.32580.24; Arfken CL, 1999, J GERONTOL A-BIOL, V54, pM152, DOI 10.1093/gerona/54.3.M152; Aviv A, 2002, J MOL MED, V80, P689, DOI 10.1007/s00109-002-0377-8; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Bauer ME, 2009, ANN NY ACAD SCI, V1153, P139, DOI 10.1111/j.1749-6632.2008.03966.x; Beyne-Rauzy O, 2005, BLOOD, V106, P3200, DOI 10.1182/blood-2005-04-1386; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Block G, 2002, AM J EPIDEMIOL, V156, P274, DOI 10.1093/aje/kwf029; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; CHODOSH J, 2007, AM J GERIATR PSYCHIA; Cumurcu BE, 2009, PSYCHIAT CLIN NEUROS, V63, P639, DOI 10.1111/j.1440-1819.2009.02004.x; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; De Meyer T, 2008, FRONT BIOSCI-LANDMRK, V13, P2960, DOI 10.2741/2901; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Dietrich M, 2003, NUTR CANCER, V45, P176, DOI 10.1207/S15327914NC4502_06; Dinan TG, 2009, CURR OPIN PSYCHIATR, V22, P32, DOI 10.1097/YCO.0b013e328315a561; Ding T, 2005, NEUROCHEM INT, V46, P435, DOI 10.1016/j.neuint.2004.12.009; DIPIETRO L, 1993, MED SCI SPORT EXER, V25, P628; Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Effros RB, 2009, J GERONTOL A-BIOL, V64, P511, DOI 10.1093/gerona/glp001; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2009, AGING-US, V1, P81; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; First MB, 2002, STRUCTURED CLIN INTE; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Franco Sonia, 2006, Alzheimers Dement, V2, P164, DOI 10.1016/j.jalz.2006.03.001; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; HARTMANN N, 2010, DEPRESS ANXIETY; Helmersson J, 2009, BRIT J NUTR, V101, P1775, DOI 10.1017/S0007114508147377; Heuser I, 2002, MATURITAS, V41, pS19; Hezel AF, 2005, CURR MOL MED, V5, P145, DOI 10.2174/1566524053586563; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Hornsby PJ, 2006, AGING CELL, V5, P577, DOI 10.1111/j.1474-9726.2006.00249.x; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; Hosoi Toru, 2002, Current Drug Targets - Inflammation and Allergy, V1, P257, DOI 10.2174/1568010023344599; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; HUZEN J, FRONT BIOSCI, V15, P35; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Irie M, 2005, J PSYCHIATR RES, V39, P553, DOI 10.1016/j.jpsychires.2005.01.009; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Khanzode SD, 2003, REDOX REP, V8, P365, DOI 10.1179/135100003225003393; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; KIECOLTGLASER JK, 2010, PSYCHOSOMAT IN PRESS; Leonard B, 2000, World J Biol Psychiatry, V1, P17, DOI 10.3109/15622970009150562; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Liu H, 2004, BRAIN RES, V1025, P43, DOI 10.1016/j.brainres.2004.07.071; Lukens JN, 2009, ALZHEIMERS DEMENT, V5, P463, DOI 10.1016/j.jalz.2009.05.666; Lung FW, 2007, PSYCHIAT GENET, V17, P195, DOI 10.1097/YPG.0b013e32808374f6; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; Maes M, 2000, J AFFECT DISORDERS, V58, P241, DOI 10.1016/S0165-0327(99)00121-4; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P462; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Margolis SA, 1997, J CHROMATOGR B, V690, P25, DOI 10.1016/S0378-4347(96)00401-X; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Mattson MP, 2001, J NEUROSCI RES, V63, P1; McCusker J, 2007, GEN HOSP PSYCHIAT, V29, P340, DOI 10.1016/j.genhosppsych.2007.03.007; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; McIntyre Roger S, 2007, Ann Clin Psychiatry, V19, P257, DOI 10.1080/10401230701653377; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Morrow Jason D, 2002, Methods Mol Biol, V186, P57; Morrow JD, 1999, DRUG METAB REV, V31, P117, DOI 10.1081/DMR-100101910; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Myint PK, 2008, AM J CLIN NUTR, V87, P64, DOI 10.1093/ajcn/87.1.64; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; POST RM, 1988, AM J PSYCHIAT, V145, P844; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramirez R, 2005, AM J KIDNEY DIS, V45, P353, DOI 10.1053/j.ajkd.2004.10.022; Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P844, DOI 10.1097/JGP.0b013e31818254eb; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Sanders JL, 2009, J BONE MINER RES, V24, P1531, DOI [10.1359/JBMR.090318, 10.1359/jbmr.090318]; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Sebastian C, 2009, J IMMUNOL, V183, P2356, DOI 10.4049/jimmunol.0901131; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Sheline YI, 1999, J NEUROSCI, V19, P5034; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Song C, 2009, PHARMACOPSYCHIATRY, V42, P182, DOI 10.1055/s-0029-1202263; SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006; Szuster-Ciesielska A, 2008, PROG NEURO-PSYCHOPH, V32, P686, DOI 10.1016/j.pnpbp.2007.11.012; Tsirpanlis G, 2006, NEPHROLOGY, V11, P506, DOI 10.1111/j.1440-1797.2006.00697.x; Tsuboi H, 2004, J PSYCHOSOM RES, V56, P53, DOI 10.1016/S0022-3999(03)00567-1; TYRKA AR, 2009, BIOL PSYCHIAT; Valdes AM, 2007, OSTEOPOROSIS INT, V18, P1203, DOI 10.1007/s00198-007-0357-5; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2010, ANN MED, V42, P36, DOI 10.3109/07853890903321567; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; WEINSTEIN AA, BIOL PSYCHOL; Wolkowitz OM, 2008, WORLD J BIOL PSYCHIA, V9, P2, DOI 10.1080/15622970701875601; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	133	300	311	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17837	10.1371/journal.pone.0017837	http://dx.doi.org/10.1371/journal.pone.0017837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448457	Green Published, gold			2022-12-25	WOS:000288810500016
J	Piper, ME; Sorenson, DR; Gerrard, SR				Piper, Mary E.; Sorenson, Dorothy R.; Gerrard, Sonja R.			Efficient Cellular Release of Rift Valley Fever Virus Requires Genomic RNA	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEIN; NUCLEOCAPSID PROTEIN; MATRIX PROTEIN; M-SEGMENT; S RNA; EXPRESSION STRATEGY; FUNCTIONAL-ANALYSIS; GLYCOPROTEINS GN; CYTOPLASMIC TAIL; INFLUENZA-VIRUS	The Rift Valley fever virus is responsible for periodic, explosive epizootics throughout sub-Saharan Africa. The development of therapeutics targeting this virus is difficult due to a limited understanding of the viral replicative cycle. Utilizing a virus-like particle system, we have established roles for each of the viral structural components in assembly, release, and virus infectivity. The envelope glycoprotein, Gn, was discovered to be necessary and sufficient for packaging of the genome, nucleocapsid protein and the RNA-dependent RNA polymerase into virus particles. Additionally, packaging of the genome was found to be necessary for the efficient release of particles, revealing a novel mechanism for the efficient generation of infectious virus. Our results identify possible conserved targets for development of anti-phlebovirus therapies.	[Piper, Mary E.; Gerrard, Sonja R.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Sorenson, Dorothy R.] Univ Michigan, Microscopy & Image Anal Lab, Ann Arbor, MI 48109 USA; [Gerrard, Sonja R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Piper, ME (corresponding author), Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.	srgerrard@gmail.com		Piper, Mary/0000-0003-2699-3840	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense; Emerging Infectious Diseases Research (RCE) [1-U54-AI-057153]; Rackham Graduate School at the University of Michigan; Ruth L. Kirschstein National Research Service [GM007315-32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emerging Infectious Diseases Research (RCE); Rackham Graduate School at the University of Michigan(University of Michigan System); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program (NIH award 1-U54-AI-057153) and the Rackham Graduate School at the University of Michigan. MEP is the recipient of a Ruth L. Kirschstein National Research Service Award, Grant No. GM007315-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 2007, J VIROL, V81, P5246, DOI 10.1128/JVI.02778-06; BESSELAAR TG, 1992, ARCH VIROL, V125, P239, DOI 10.1007/BF01309641; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; DENG MY, 1994, APPL ENVIRON MICROB, V60, P1927, DOI 10.1128/AEM.60.6.1927-1933.1994; Flick K, 2004, J VIROL, V78, P11726, DOI 10.1128/JVI.78.21.11726-11738.2004; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Garry Courtney E, 2004, Theor Biol Med Model, V1, P10, DOI 10.1186/1742-4682-1-10; Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hartlieb B, 2006, VIROLOGY, V344, P64, DOI 10.1016/j.virol.2005.09.018; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2007, J VIROL, V81, P8421, DOI 10.1128/JVI.02641-06; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; KAKACH LT, 1989, VIROLOGY, V170, P505, DOI 10.1016/0042-6822(89)90442-X; Kukkonen SKJ, 2004, J GEN VIROL, V85, P1181, DOI 10.1099/vir.0.19748-0; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; LOPEZ N, 1995, J VIROL, V69, P3972, DOI 10.1128/JVI.69.7.3972-3979.1995; Lowen AC, 2005, J VIROL, V79, P12861, DOI 10.1128/JVI.79.20.12861-12870.2005; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; MEEGAN JM, 1979, VET REC, V105, P124, DOI 10.1136/vr.105.6.124; MEEGAN JM, 1988, ARBOVIRUSES EPIDEMIO, P51; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Nugent CI, 1999, J VIROL, V73, P427, DOI 10.1128/JVI.73.1.427-435.1999; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; PHILIPPE B, 1989, B SOC PATHOL EXOT, V82, P611; Piper ME, 2010, VIRUSES-BASEL, V2, P731, DOI 10.3390/v2030731; Plassmeyer ML, 2007, VIROLOGY, V358, P273, DOI 10.1016/j.virol.2006.08.050; Plassmeyer ML, 2005, VIROLOGY, V338, P121, DOI 10.1016/j.virol.2005.04.026; Pohl C, 2007, J GEN VIROL, V88, P1243, DOI 10.1099/vir.0.82578-0; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Ravkov EV, 2001, J VIROL, V75, P1808, DOI 10.1128/JVI.75.4.1808-1815.2001; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; SIMONS JF, 1990, J VIROL, V64, P247, DOI 10.1128/JVI.64.1.247-255.1990; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; SUZICH JA, 1990, J VIROL, V64, P1549, DOI 10.1128/JVI.64.4.1549-1555.1990; Swenson DL, 2004, FEMS IMMUNOL MED MIC, V40, P27, DOI 10.1016/S0928-8244(03)00273-6; Venter PA, 2007, J VIROL, V81, P613, DOI 10.1128/JVI.01668-06; Venter PA, 2005, J VIROL, V79, P6239, DOI 10.1128/JVI.79.10.6239-6248.2005; WASMOEN TL, 1988, VIROLOGY, V166, P275, DOI 10.1016/0042-6822(88)90174-2; WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	59	44	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18070	10.1371/journal.pone.0018070	http://dx.doi.org/10.1371/journal.pone.0018070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445316	Green Submitted, gold, Green Published			2022-12-25	WOS:000288613300033
J	Venner, S; Pelisson, PF; Bel-Venner, MC; Debias, F; Rajon, E; Menu, F				Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Rajon, Etienne; Menu, Frederic			Coexistence of Insect Species Competing for a Pulsed Resource: Toward a Unified Theory of Biodiversity in Fluctuating Environments	PLOS ONE			English	Article							PROLONGED DIAPAUSE; COMMUNITY DYNAMICS; DESERT ANNUALS; NEUTRALITY; ECOLOGY; NICHE; DIVERSITY; PERSPECTIVES; MAINTENANCE; MECHANISMS	Background: One major challenge in understanding how biodiversity is organized is finding out whether communities of competing species are shaped exclusively by species-level differences in ecological traits (niche theory), exclusively by random processes (neutral theory of biodiversity), or by both processes simultaneously. Communities of species competing for a pulsed resource are a suitable system for testing these theories: due to marked fluctuations in resource availability, the theories yield very different predictions about the timing of resource use and the synchronization of the population dynamics between the competing species. Accordingly, we explored mechanisms that might promote the local coexistence of phytophagous insects (four sister species of the genus Curculio) competing for oak acorns, a pulsed resource. Methodology/Principal Findings: We analyzed the time partitioning of the exploitation of oak acorns by the four weevil species in two independent communities, and we assessed the level of synchronization in their population dynamics. In accordance with the niche theory, overall these species exhibited marked time partitioning of resource use, both within a given year and between different years owing to different dormancy strategies between species, as well as distinct demographic patterns. Two of the four weevil species, however, consistently exploited the resource during the same period of the year, exhibited a similar dormancy pattern, and did not show any significant difference in their population dynamics. Conclusions/Significance: The marked time partitioning of the resource use appears as a keystone of the coexistence of these competing insect species, except for two of them which are demographically nearly equivalent. Communities of consumers of pulsed resources thus seem to offer a promising avenue for developing a unifying theory of biodiversity in fluctuating environments which might predict the co-occurrence, within the same community, of species that are ecologically either very similar, or very different.	[Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Menu, Frederic] Univ Lyon 1, F-69622 Villeurbanne, France; [Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Menu, Frederic] Univ Lyon, Lyon, France; [Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Menu, Frederic] CNRS, Lab Biometrie & Biol Evolut, UMR5558, Villeurbanne, France; [Rajon, Etienne] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; University of Arizona	Venner, S (corresponding author), Univ Lyon 1, F-69622 Villeurbanne, France.	samuel.venner@univ-lyon1.fr	MENU, Frédéric/C-3107-2016; Venner, Samuel/ABC-7739-2020; Rajon, Etienne/AAE-3868-2020; Rajon, Etienne/E-7764-2010	Venner, Samuel/0000-0001-7127-3733; Rajon, Etienne/0000-0003-0658-8311	French National Research Agency (ANR) [JC09_470585]; CNRS; Envirhonalp (Sante et Environnement Cluster)	French National Research Agency (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Envirhonalp (Sante et Environnement Cluster)	This work was funded by the French National Research Agency (ANR: CoCoReCo project JC09_470585), by the CNRS and by Envirhonalp (Sante et Environnement Cluster). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coutin R., 1992, Memoires de la Societe Royale Belge d'Entomologie, V35, P259; Gewin V, 2006, PLOS BIOL, V4, P1306, DOI 10.1371/journal.pbio.0040278; GIBSON P, 1969, MISC PUBLS ENT SOC A, V6, P239; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hedlin A. F., 1980, CONE SEED INSECTS N; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Hughes J, 2004, MOL PHYLOGENET EVOL, V32, P601, DOI 10.1016/j.ympev.2004.02.007; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Liebhold A, 2004, OIKOS, V104, P156, DOI 10.1111/j.0030-1299.2004.12722.x; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maeto K, 2003, OECOLOGIA, V137, P392, DOI 10.1007/s00442-003-1381-6; MENU F, 1993, OECOLOGIA, V93, P367, DOI 10.1007/BF00317880; Menu F, 2000, AM NAT, V155, P724, DOI 10.1086/303355; Menu F, 2002, OECOLOGIA, V132, P167, DOI 10.1007/s00442-002-0969-6; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; OBERLI F, 2001, THESIS U LYONL FRANC; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Pelisson PF, 2011, ENTOMOL EXP APPL, V138, P77, DOI 10.1111/j.1570-7458.2010.01077.x; Rajon E, 2009, J EVOLUTION BIOL, V22, P2094, DOI 10.1111/j.1420-9101.2009.01825.x; Schauff ME, 1986, USDA MISC PUBL, V1443; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; SHMIDA A, 1984, VEGETATIO, V58, P29; Siepielski AM, 2010, ECOLOGY, V91, P847, DOI 10.1890/09-0609.1; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Venable DL, 2008, ECOLOGY, V89, P2218, DOI 10.1890/07-0386.1; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Verhulst J, 2008, OECOLOGIA, V156, P95, DOI 10.1007/s00442-008-0980-7; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1	43	40	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18039	10.1371/journal.pone.0018039	http://dx.doi.org/10.1371/journal.pone.0018039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445318	Green Published, gold, Green Submitted			2022-12-25	WOS:000288613300030
J	Ji, SC; Wang, X; Yun, SH; Jeon, HJ; Lee, HJ; Kim, H; Lim, HM				Ji, Sang Chun; Wang, Xun; Yun, Sang Hoon; Jeon, Heung Jin; Lee, Hee Jung; Kim, Hackjin; Lim, Heon M.			In Vivo Transcription Dynamics of the Galactose Operon: A Study on the Promoter Transition from P1 to P2 at Onset of Stationary Phase	PLOS ONE			English	Article							MESSENGER-RNA DECAY; ESCHERICHIA-COLI; CYCLIC-AMP; GENE-EXPRESSION; RECEPTOR PROTEIN; SIGMA-FACTOR; GAL OPERON; POLYMERASE; BINDING; ACTIVATION	Quantitative analyses of the 5' end of gal transcripts indicate that transcription from the galactose operon P1 promoter is higher during cell division. When cells are no longer dividing, however, transcription is initiated more often from the P2 promoter. Escherichia coli cells divide six times before the onset of the stationary phase when grown in LB containing 0.5% galactose at 37 degrees C. Transcription from the two promoters increases, although at different rates, during early exponential phase (until the third cell division, OD(600) 0.4), and then reaches a plateau. The steady-state transcription from P1 continues in late exponential phase (the next three cell divisions, OD(600) 3.0), after which transcription from this promoter decreases. However, steady-state transcription from P2 continues 1 h longer into the stationary phase, before decreasing. This longer steady-state P2 transcription constitutes the promoter transition from P1 to P2 at the onset of the stationary phase. The intracellular cAMP concentration dictates P1 transcription dynamics; therefore, promoter transition may result from a lack of cAMP-CRP complex binding to the gal operon. The decay rate of gal-specific transcripts is constant through the six consecutive cell divisions that comprise the exponential growth phase, increases at the onset of the stationary phase, and is too low to be measured during the stationary phase. These data suggest that a regulatory mechanism coordinates the synthesis and decay of gal mRNAs to maintain the observed gal transcription. Our analysis indicates that the increase in P1 transcription is the result of cAMP-CRP binding to increasing numbers of galactose operons in the cell population.	[Ji, Sang Chun; Wang, Xun; Yun, Sang Hoon; Jeon, Heung Jin; Lee, Hee Jung; Lim, Heon M.] Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon, South Korea; [Kim, Hackjin] Chungnam Natl Univ, Dept Chem, Coll Nat Sci, Taejon 305764, South Korea	Chungnam National University; Chungnam National University	Ji, SC (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon, South Korea.	hmlim@cnu.ac.kr	Ji, Sang Chun/Y-6863-2019; Ji, Sang Chun/C-5383-2012; Park, DongNyuk/F-5737-2013	Ji, Sang Chun/0000-0003-2858-1057; Lim, Heon/0000-0003-1711-2589	Korean government [MOST R01-2006-000-10902-0]; Korea Research Foundation [KRF-2008-2581]	Korean government(Korean Government); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MOST R01-2006-000-10902-0) and by the Korea Research Foundation grant (KRF-2008-2581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1979, NATURE, V279, P492, DOI 10.1038/279492a0; ADHYA S, 2003, SCI STKE, pPE22; Adhya S, 1987, ESCHERICHIA COLI SAL, P1503; Aki T, 1997, EMBO J, V16, P3666, DOI 10.1093/emboj/16.12.3666; Belyaeva TA, 1998, J MOL BIOL, V277, P789, DOI 10.1006/jmbi.1998.1666; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Cavanagh AT, 2008, MOL MICROBIOL, V67, P1242, DOI 10.1111/j.1365-2958.2008.06117.x; CHOY HE, 1992, P NATL ACAD SCI USA, V89, P11264, DOI 10.1073/pnas.89.23.11264; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FRITZ HJ, 1983, EMBO J, V2, P2129, DOI 10.1002/j.1460-2075.1983.tb01713.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GUIDIRONTANI C, 1984, MOL GEN GENET, V195, P96, DOI 10.1007/BF00332730; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; IRANI M, 1989, J BACTERIOL, V171, P1623, DOI 10.1128/jb.171.3.1623-1630.1989; IRANI MH, 1983, CELL, V32, P783, DOI 10.1016/0092-8674(83)90064-8; Jain V, 2006, J MICROBIOL, V44, P1; Ji SC, 2010, BMB REP, V43, P474, DOI 10.5483/BMBRep.2010.43.7.474; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; JOSEPH E, 1981, J BACTERIOL, V146, P149, DOI 10.1128/JB.146.1.149-154.1981; Lee HJ, 2008, J MOL BIOL, V378, P318, DOI 10.1016/j.jmb.2008.02.067; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; MUSSO RE, 1977, CELL, V12, P847, DOI 10.1016/0092-8674(77)90283-5; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; QUEEN C, 1981, CELL, V25, P241, DOI 10.1016/0092-8674(81)90249-X; Roy S, 1998, J BIOL CHEM, V273, P14059, DOI 10.1074/jbc.273.23.14059; Roy S, 2004, EMBO J, V23, P869, DOI 10.1038/sj.emboj.7600098; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 1989, MOL CLONING LAB; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; ULLMANN A, 1979, P NATL ACAD SCI USA, V76, P3194, DOI 10.1073/pnas.76.7.3194; WELPLY JK, 1980, J BACTERIOL, V142, P732, DOI 10.1128/JB.142.2.732-734.1980; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17646	10.1371/journal.pone.0017646	http://dx.doi.org/10.1371/journal.pone.0017646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445255	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100023
J	Johnson, CJ; Herbst, A; Duque-Velasquez, C; Vanderloo, JP; Bochsler, P; Chappell, R; McKenzie, D				Johnson, Chad J.; Herbst, Allen; Duque-Velasquez, Camilo; Vanderloo, Joshua P.; Bochsler, Phil; Chappell, Rick; McKenzie, Debbie			Prion Protein Polymorphisms Affect Chronic Wasting Disease Progression	PLOS ONE			English	Article							WHITE-TAILED DEER; INFLUENCE SUSCEPTIBILITY; GENE; PRNP; PATTERNS; SCRAPIE	Analysis of the PRNP gene in cervids naturally infected with chronic wasting disease (CWD) suggested that PRNP polymorphisms affect the susceptibility of deer to infection. To test this effect, we orally inoculated 12 white-tailed deer with CWD agent. Three different PRNP alleles, wild-type (wt; glutamine at amino acid 95 and glycine at 96), Q95H (glutamine to histidine at amino acid position 95) and G96S (glycine to serine at position 96) were represented in the study cohort with 5 wt/wt, 3 wt/G96S, and 1 each wt/Q95H and Q95H/G96S. Two animals were lost to follow-up due to intercurrent disease. The inoculum was prepared from Wisconsin hunter-harvested homozygous wt/wt animals. All infected deer presented with clinical signs of CWD; the orally infected wt/wt had an average survival period of 693 days post inoculation (dpi) and G96S/wt deer had an average survival period of 956 dpi. The Q95H/wt and Q95H/G96S deer succumbed to CWD at 1,508 and 1,596 dpi respectively. These data show that polymorphisms in the PRNP gene affect CWD incubation period. Deer heterozygous for the PRNP alleles had extended incubation periods with the Q95H allele having the greatest effect.	[Johnson, Chad J.; Vanderloo, Joshua P.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Herbst, Allen; Duque-Velasquez, Camilo; McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Herbst, Allen; Duque-Velasquez, Camilo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Bochsler, Phil] Univ Wisconsin, Wisconsin Vet Diagnost Lab, Madison, WI USA; [Chappell, Rick] Univ Wisconsin, Dept Biostat & Med Bioinformat, Madison, WI USA; [McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Alberta; University of Alberta; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Johnson, CJ (corresponding author), Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.	Debbie.mckenzie@ualberta.ca	McKenzie, Debbie/G-4459-2015	McKenzie, Debbie/0000-0002-9291-6977; Herbst, Allen/0000-0001-6601-1245	DoD's National Prion Research Program; Alberta Prion Research Institute	DoD's National Prion Research Program; Alberta Prion Research Institute	This work was funded by the DoD's National Prion Research Program and the Alberta Prion Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; CARLSON GA, 1994, PHILOS T R SOC B, V343, P363, DOI 10.1098/rstb.1994.0030; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; O'Neill GT, 2005, J ANIM BREED GENET, V122, P86, DOI 10.1111/j.1439-0388.2005.00520.x; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Prusiner SB, 1991, BRAIN PATHOL, V1, P297, DOI 10.1111/j.1750-3639.1991.tb00673.x; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Tranulis MA, 2002, APMIS, V110, P33, DOI 10.1034/j.1600-0463.2002.100105.x; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264	16	76	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17450	10.1371/journal.pone.0017450	http://dx.doi.org/10.1371/journal.pone.0017450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445256	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100015
J	Genetos, DC; Yellowley, CE; Loots, GG				Genetos, Damian C.; Yellowley, Clare E.; Loots, Gabriela G.			Prostaglandin E-2 Signals Through PTGER2 to Regulate Sclerostin Expression	PLOS ONE			English	Article							MEF2 TRANSCRIPTION FACTORS; FRIZZLED-RELATED PROTEIN-1; LOCAL BONE-FORMATION; VAN-BUCHEM-DISEASE; PARATHYROID-HORMONE; GENE-EXPRESSION; OSTEOBLASTIC CELLS; SELECTIVE AGONIST; ANABOLIC ACTIONS; CLONE MC3T3-E1	The Wnt signaling pathway is a robust regulator of skeletal homeostasis. Gain-of-function mutations promote high bone mass, whereas loss of Lrp5 or Lrp6 co-receptors decrease bone mass. Similarly, mutations in antagonists of Wnt signaling influence skeletal integrity, in an inverse relation to Lrp receptor mutations. Loss of the Wnt antagonist Sclerostin (Sost) produces the generalized skeletal hyperostotic condition of sclerosteosis, which is characterized by increased bone mass and density due to hyperactive osteoblast function. Here we demonstrate that prostaglandin E-2 (PGE(2)), a paracrine factor with pleiotropic effects on osteoblasts and osteoclasts, decreases Sclerostin expression in osteoblastic UMR106.01 cells. Decreased Sost expression correlates with increased expression of Wnt/TCF target genes Axin2 and Tcf3. We also show that the suppressive effect of PGE(2) is mediated through a cyclic AMP/PKA pathway. Furthermore, selective agonists for the PGE(2) receptor EP2 mimic the effect of PGE(2) upon Sost, and siRNA reduction in Ptger2 prevents PGE(2)-induced Sost repression. These results indicate a functional relationship between prostaglandins and the Wnt/beta-catenin signaling pathway in bone.	[Genetos, Damian C.; Yellowley, Clare E.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Loots, Gabriela G.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA USA	University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Genetos, DC (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA.	dgenetos@ucdavis.edu	Genetos, Damian/AAF-5953-2021; Loots, Gabriela G/AGA-4868-2022; Genetos, Damian C/A-6480-2012	Genetos, Damian/0000-0002-8599-2867; Loots, Gabriela G/0000-0001-9546-5561; 	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R03AR057547]; National Institute of Aging [R01AG022305]; National Institute of Diabetes and Digestive and Kidney Diseases [DK075730]; Alliance for Better Bone Health; U. S. Department of Energy by Lawrence Livermore National Laboratory [AC52-07NA27344]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022305] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Alliance for Better Bone Health; U. S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project described was supported by Award Number R03AR057547 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (DCG), R01AG022305 from the National Institute of Aging (CEY), DK075730 from the National Institute of Diabetes and Digestive and Kidney Diseases (GGL), and a grant from The Alliance for Better Bone Health (DCG). This work performed under the auspices of the U. S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010; Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burd TA, 2003, J BONE JOINT SURG BR, V85B, P700, DOI 10.1302/0301-620X.85B5.13970; Cameron KO, 2009, BIOORG MED CHEM LETT, V19, P2075, DOI 10.1016/j.bmcl.2009.01.059; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; CHYUN YS, 1984, PROSTAGLANDINS, V27, P97, DOI 10.1016/0090-6980(84)90223-5; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; FEYEN JHM, 1985, PROSTAGLANDINS, V30, P827, DOI 10.1016/0090-6980(85)90011-5; FLANAGAN AM, 1992, ENDOCRINOLOGY, V130, P443, DOI 10.1210/en.130.1.443; Forwood MR, 1996, J BONE MINER RES, V11, P1688; GARDINER PJ, 1986, BRIT J PHARMACOL, V87, P45, DOI 10.1111/j.1476-5381.1986.tb10155.x; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Gerstenfeld Louis C, 2004, Expert Opin Drug Saf, V3, P131, DOI 10.1517/14740338.3.2.131; Giannoudis PV, 2000, J BONE JOINT SURG BR, V82B, P655, DOI 10.1302/0301-620X.82B5.9899; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HAKEDA Y, 1985, J BIOCHEM, V97, P97, DOI 10.1093/oxfordjournals.jbchem.a135072; HAKEDA Y, 1986, J CELL PHYSIOL, V128, P155, DOI 10.1002/jcp.1041280204; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; JORGENSEN HRI, 1988, ACTA ORTHOP SCAND, V59, P464, DOI 10.3109/17453678809149406; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P1157, DOI 10.1210/en.135.3.1157; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lee CM, 2007, J CELL PHYSIOL, V212, P182, DOI 10.1002/jcp.21017; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li M, 2003, J BONE MINER RES, V18, P2033, DOI 10.1359/jbmr.2003.18.11.2033; LI X, 2010, J BONE MINER RES; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Maciel FMB, 1997, J RHEUMATOL, V24, P2429; Minamizaki T, 2009, BONE, V44, P1177, DOI 10.1016/j.bone.2009.02.010; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Papanicolaou SE, 2009, BIORHEOLOGY, V46, P389, DOI 10.3233/BIR-2009-0550; Paralkar VM, 2003, P NATL ACAD SCI USA, V100, P6736, DOI 10.1073/pnas.1037343100; PARTRIDGE NC, 1983, CANCER RES, V43, P4308; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Suda M, 1996, ENDOCRINOLOGY, V137, P1698, DOI 10.1210/en.137.5.1698; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963	69	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17772	10.1371/journal.pone.0017772	http://dx.doi.org/10.1371/journal.pone.0017772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436889	Green Submitted, Green Published, gold			2022-12-25	WOS:000288514000008
J	Kim, HM; Wangemann, P				Kim, Hyoung-Mi; Wangemann, Philine			Epithelial Cell Stretching and Luminal Acidification Lead to a Retarded Development of Stria Vascularis and Deafness in Mice Lacking Pendrin	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; ENLARGED VESTIBULAR AQUEDUCT; KCNJ10 PROTEIN EXPRESSION; ENDOLYMPHATIC SAC; POSTNATAL-DEVELOPMENT; H+-ATPASE; ORGAN; FLUID; CONTRIBUTES; INHIBITION	Loss-of-function mutations of SLC26A4/pendrin are among the most prevalent causes of deafness. Deafness and vestibular dysfunction in the corresponding mouse model, Slc26a4(-/-), are associated with an enlargement and acidification of the membranous labyrinth. Here we relate the onset of expression of the HCO3- transporter pendrin to the luminal pH and to enlargement-associated epithelial cell stretching. We determined expression with immunocytochemistry, cell stretching by digital morphometry and pH with double-barreled ion-selective electrodes. Pendrin was first expressed in the endolymphatic sac at embryonic day (E) 11.5, in the cochlear hook-region at E13.5, in the utricle and saccule at E14.5, in ampullae at E16.5, and in the upper turn of the cochlea at E17.5. Epithelial cell stretching in Slc26a4(-/-) mice began at E14.5. pH changes occurred first in the cochlea at E15.5 and in the endolymphatic sac at E17.5. At postnatal day 2, stria vascularis, outer sulcus and Reissner's membrane epithelial cells, and utricular and saccular transitional cells were stretched, whereas sensory cells in the cochlea, utricle and saccule did not differ between Slc26a4(+/-) and Slc26a4(-/-) mice. Structural development of stria vascularis, including vascularization, was retarded in Slc26a4(-/-) mice. In conclusion, the data demonstrate that the enlargement and stretching of non-sensory epithelial cells precedes luminal acidification in the cochlea and the endolymphatic sac. Stretching and luminal acidification may alter cell-to-cell communication and lead to the observed retarded development of stria vascularis, which may be an important step on the path to deafness in Slc26a4(-/-) mice, and possibly in humans, lacking functional pendrin expression.	[Kim, Hyoung-Mi; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Kim, HM (corresponding author), Pochon CHA Univ, Coll Med, Dept Otolaryngol, Seoul, South Korea.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013		 [KSU-SMILE];  [NIH-R01-DC00212];  [NIH-P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000212, R01DC001098] Funding Source: NIH RePORTER	; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following grants: KSU-SMILE, NIH-R01-DC00212, and NIH-P20-RR017686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1999, AM J MED GENET, V82, P322, DOI 10.1002/(SICI)1096-8628(19990212)82:4<322::AID-AJMG9>3.0.CO;2-0; Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Colvin IB, 2006, LARYNGOSCOPE, V116, P2027, DOI 10.1097/01.mlg.0000240908.88759.fe; Couloigner V, 1999, ACTA OTO-LARYNGOL, V119, P200; Couloigner V, 2000, AM J PHYSIOL-REG I, V279, pR1695, DOI 10.1152/ajpregu.2000.279.5.R1695; Dou HW, 2004, J HISTOCHEM CYTOCHEM, V52, P1377, DOI 10.1369/jhc.3A6228.2004; Dou HW, 2003, HEARING RES, V180, P76, DOI 10.1016/S0378-5955(03)00108-4; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; FRASER GR, 1965, ANN HUM GENET, V28, P201; Inoshita A, 2008, NEUROSCIENCE, V156, P1039, DOI 10.1016/j.neuroscience.2008.08.027; Ishida T, 2006, CELL STRUCT FUNCT, V31, P77, DOI 10.1247/csf.06013; Jabba SV, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-37; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Kim SH, 2009, AM J PHYSIOL-CELL PH, V296, pC544, DOI 10.1152/ajpcell.00338.2008; Kim YH, 2007, AM J PHYSIOL-RENAL, V293, pF1314, DOI 10.1152/ajprenal.00155.2007; Kudo T, 2003, HUM MOL GENET, V12, P995, DOI 10.1093/hmg/ddg116; Luxon LM, 2003, INT J AUDIOL, V42, P82, DOI 10.3109/14992020309078339; MARCUS DC, 1985, HEARING RES, V17, P79, DOI 10.1016/0378-5955(85)90133-9; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Peters TA, 2003, HEARING RES, V176, P94, DOI 10.1016/S0378-5955(02)00748-7; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; RUGH R, 1968, MOUSE ITS REPROD DEV, P430; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; THALMANN I, 1992, HEARING RES, V63, P37, DOI 10.1016/0378-5955(92)90071-T; Theiler K., 1972, HOUSE MOUSE; TSUJIKAWA S, 1992, ORL J OTO-RHINO-LARY, V54, P198, DOI 10.1159/000276298; Wang YF, 2009, BIOCHEM BIOPH RES CO, V385, P33, DOI 10.1016/j.bbrc.2009.05.023; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79	37	43	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17949	10.1371/journal.pone.0017949	http://dx.doi.org/10.1371/journal.pone.0017949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423764	Green Published, Green Submitted, gold			2022-12-25	WOS:000288512400041
J	Adlard, PA; Bica, L; White, AR; Nurjono, M; Filiz, G; Crouch, PJ; Donnelly, PS; Cappai, R; Finkelstein, DI; Bush, AI				Adlard, Paul A.; Bica, Laura; White, Anthony R.; Nurjono, Milawaty; Filiz, Gulay; Crouch, Peter J.; Donnelly, Paul S.; Cappai, Roberto; Finkelstein, David I.; Bush, Ashley I.			Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA; TRANSGENIC MICE; MOLECULAR-BASIS; KINASE-II; ABNORMALITIES; ACCUMULATION; PLASTICITY; RECEPTORS; COGNITION; DEFICITS	We have previously demonstrated that brief treatment of APP transgenic mice with metal ionophores (PBT2, Prana Biotechnology) rapidly and markedly improves learning and memory. To understand the potential mechanisms of action underlying this phenomenon we examined hippocampal dendritic spine density, and the levels of key proteins involved in learning and memory, in young (4 months) and old (14 months) female Tg2576 mice following brief (11 days) oral treatment with PBT2 (30 mg/kg/d). Transgenic mice exhibited deficits in spine density compared to littermate controls that were significantly rescued by PBT2 treatment in both the young (+17%, p<0.001) and old (+32%, p<0.001) animals. There was no effect of PBT2 on spine density in the control animals. In the transgenic animals, PBT2 treatment also resulted in significant increases in brain levels of CamKII (+57%, p = 0.005), spinophilin (+37%, p = 0.04), NMDAR1A (+126%, p = 0.02), NMDAR2A (+70%, p = 0.05), pro-BDNF (+19%, p = 0.02) and BDNF (+19%, p = 0.04). While PBT2-treatment did not significantly alter neurite-length in vivo, it did increase neurite outgrowth (+200%, p = 0.006) in cultured cells, and this was abolished by co-incubation with the transition metal chelator, diamsar. These data suggest that PBT2 may affect multiple aspects of snaptic health/efficacy. In Alzheimer's disease therefore, PBT2 may restore the uptake of physiological metal ions trapped within extracellular beta-amyloid aggregates that then induce biochemical and anatomical changes to improve cognitive function.	[Adlard, Paul A.; Nurjono, Milawaty; Filiz, Gulay; Finkelstein, David I.; Bush, Ashley I.] Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic, Australia; [Adlard, Paul A.; Finkelstein, David I.] Mental Hlth Res Inst, Synapt Neurobiol Lab, Parkville, Vic, Australia; [Adlard, Paul A.; Bica, Laura; White, Anthony R.; Crouch, Peter J.; Cappai, Roberto; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Bica, Laura; White, Anthony R.; Crouch, Peter J.; Finkelstein, David I.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Donnelly, Paul S.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Donnelly, Paul S.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Adlard, PA (corresponding author), Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic, Australia.	p.adlard@mhri.edu.au	Bush, Ashley/Y-2457-2019; Finkelstein, David/B-9617-2009; Bush, Ashley I/A-1186-2007; White, Anthony/P-5596-2016; Cappai, Roberto/B-3347-2010	Bush, Ashley/0000-0001-8259-9069; Finkelstein, David/0000-0002-8167-4917; Bush, Ashley I/0000-0001-8259-9069; Crouch, Peter/0000-0002-7777-4747; White, Anthony/0000-0003-1802-9891; Cappai, Roberto/0000-0002-9505-8496	Australian Research Council; National Health and Medical Research Council; Alzheimer's Association (USA)	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Association (USA)(Alzheimer's Association)	This work was supported by funds from the Australian Research Council, the National Health and Medical Research Council, and the Alzheimer's Association (USA). PBT2 was kindly provided by Prana Biotechnology Ltd (www.pranabio.com). These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Alpar A, 2006, BRAIN RES, V1099, P189, DOI 10.1016/j.brainres.2006.04.109; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; CATALA I, 1988, HUM NEUROBIOL, V6, P255; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DERUITER JP, 1987, BRAIN RES, V402, P217, DOI 10.1016/0006-8993(87)90028-X; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jourdain P, 2003, J NEUROSCI, V23, P10645; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Shimada A, 1998, J NEUROSCI, V18, P8559; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335	34	102	105	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17669	10.1371/journal.pone.0017669	http://dx.doi.org/10.1371/journal.pone.0017669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412423	Green Published, gold			2022-12-25	WOS:000288247800023
J	Blaser, C; Wittwer, M; Grandgirard, D; Leib, SL				Blaser, Cornelia; Wittwer, Matthias; Grandgirard, Denis; Leib, Stephen L.			Adjunctive Dexamethasone Affects the Expression of Genes Related to Inflammation, Neurogenesis and Apoptosis in Infant Rat Pneumococcal Meningitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDUCED LEUCINE-ZIPPER; ACTIVATED PROTEIN-KINASE; ALPHA CONVERTING-ENZYME; DENTATE GYRUS; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; HIPPOCAMPAL APOPTOSIS; BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID	Streptococcus pneumoniae is the most common pathogen causing non-epidemic bacterial meningitis worldwide. The immune response and inflammatory processes contribute to the pathophysiology. Hence, the anti-inflammatory dexamethasone is advocated as adjuvant treatment although its clinical efficacy remains a question at issue. In experimental models of pneumococcal meningitis, dexamethasone increased neuronal damage in the dentate gyrus. Here, we investigated expressional changes in the hippocampus and cortex at 72 h after infection when dexamethasone was given to infant rats with pneumococcal meningitis. Nursing Wistar rats were intracisternally infected with Streptococcus pneumoniae to induce experimental meningitis or were sham-infected with pyrogen-free saline. Besides antibiotics, animals were either treated with dexamethasone or saline. Expressional changes were assessed by the use of GeneChip (R) Rat Exon 1.0 ST Arrays and quantitative real-time PCR. Protein levels of brain-derived neurotrophic factor, cytokines and chemokines were evaluated in immunoassays using Luminex xMAP (R) technology. In infected animals, 213 and 264 genes were significantly regulated by dexamethasone in the hippocampus and cortex respectively. Separately for the cortex and the hippocampus, Gene Ontology analysis identified clusters of biological processes which were assigned to the predefined categories "inflammation'', "growth'', "apoptosis'' and others. Dexamethasone affected the expression of genes and protein levels of chemokines reflecting diminished activation of microglia. Dexamethasone-induced changes of genes related to apoptosis suggest the downregulation of the Akt-survival pathway and the induction of caspase-independent apoptosis. Signalling of pro-neurogenic pathways such as transforming growth factor pathway was reduced by dexamethasone resulting in a lack of pro-survival triggers. The anti-inflammatory properties of dexamethasone were observed on gene and protein level in experimental pneumococcal meningitis. Further dexamethasone-induced expressional changes reflect an increase of pro-apoptotic signals and a decrease of pro-neurogenic processes. The findings may help to identify potential mechanisms leading to apoptosis by dexamethasone in experimental pneumococcal meningitis.	[Blaser, Cornelia; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Wittwer, Matthias] Spiez Lab, Spiez, Switzerland	University of Bern	Blaser, C (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Wittwer, Matthias/K-4512-2014; Leib, Stephen L/A-7866-2011; Grandgirard, Denis/AAB-8786-2020; Kummer, Juerg/B-3322-2011	Leib, Stephen/0000-0002-1106-6123; Wittwer, Matthias/0000-0003-4713-8392; Leib, Stephen L/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; 	Swiss National Science Foundation [310030-116257]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by the Swiss National Science Foundation (Nr. 310030-116257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison J, 2006, LARYNGOSCOPE, V116, P279, DOI 10.1097/01.mlg.0000197315.79394.36; Andersen CO, 2007, DAN MED BULL, V54, P189; [Anonymous], 2010, R LANG ENV STAT COMP; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Braun JS, 2001, J INFECT DIS, V184, P1300, DOI 10.1086/324013; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Byts N, 2006, NEUROCHEM RES, V31, P1219, DOI 10.1007/s11064-006-9149-0; Coimbra RS, 2007, PEDIATR RES, V62, P291, DOI 10.1203/PDR.0b013e318123fb7c; Coimbra RS, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-15; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diab A, 1999, INFECT IMMUN, V67, P2590, DOI 10.1128/IAI.67.5.2590-2601.1999; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Ehrenreich H, 2005, P NATL ACAD SCI USA, V102, P862, DOI 10.1073/pnas.0406008102; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gehre F, 2008, J INTERN MED, V264, P143, DOI 10.1111/j.1365-2796.2008.01930.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; Grandgirard D, 2007, DEV NEUROSCI-BASEL, V29, P134, DOI 10.1159/000096218; Grandgirard D, 2010, ANTIMICROB AGENTS CH, V54, P1323, DOI 10.1128/AAC.00812-09; Guan Y, 2004, MOL ENDOCRINOL, V18, P214, DOI 10.1210/me.2003-0014; Hanisch UK, 2001, EUR J IMMUNOL, V31, P2104, DOI 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Horvat A, 2001, J NEUROSCI, V21, P865, DOI 10.1523/JNEUROSCI.21-03-00865.2001; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Inoue K, 2007, CELL ADHES MIGR, V1, P131, DOI 10.4161/cam.1.3.4937; Irazuzta J, 2005, INTENS CARE MED, V31, P146, DOI 10.1007/s00134-004-2462-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kalesnikoff J, 2003, Rev Physiol Biochem Pharmacol, V149, P87; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kim HH, 2007, LARYNGOSCOPE, V117, P1209, DOI 10.1097/MLG.0b013e318058195f; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Klein M, 2008, INFECTION, V36, P2, DOI 10.1007/s15010-007-7153-1; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2006, MICROBES INFECT, V8, P974, DOI 10.1016/j.micinf.2005.10.013; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Koedel U, 2010, CURR OPIN INFECT DIS, V23, P217, DOI 10.1097/QCO.0b013e328337f49e; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Leib SL, 2003, PEDIATR RES, V54, P353, DOI 10.1203/01.PDR.0000079185.67878.72; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Li L, 2003, J CHILD NEUROL, V18, P828, DOI 10.1177/088307380301801202; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Liu M, 2009, NEUROSCIENCE, V163, P296, DOI 10.1016/j.neuroscience.2009.06.027; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Meli DN, 2004, J NEUROIMMUNOL, V151, P6, DOI 10.1016/j.jneuroim.2004.01.026; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Ohnaka K, 2005, BIOCHEM BIOPH RES CO, V329, P177, DOI 10.1016/j.bbrc.2005.01.117; Rappaport JM, 1999, J INFECT DIS, V179, P264, DOI 10.1086/314531; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sarnoylenko A, 2008, CELL SIGNAL, V20, P154, DOI 10.1016/j.cellsig.2007.10.006; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHUKNECHT HF, 1970, ARCH KLIN EXP OHR, V195, P207, DOI 10.1007/BF00302950; Schutte M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003007; SELLNER J, 2010, BACTERIAL INFECT CEN, P1; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soverchia L, 2005, ADDICT BIOL, V10, P5, DOI 10.1080/13556210412331327803; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Spreer A, 2006, PEDIATR RES, V60, P210, DOI 10.1203/01.pdr.0000227553.47378.9f; Swartz MN, 2004, NEW ENGL J MED, V351, P1826, DOI 10.1056/NEJMp048246; Takagi Y, 2002, J CEREBR BLOOD F MET, V22, P1311, DOI 10.1097/01.WCB.0000034148.72481.F4; Takanohashi A, 2005, GLIA, V51, P266, DOI 10.1002/glia.20203; Tarozzo G, 2002, EUR J NEUROSCI, V15, P1663, DOI 10.1046/j.1460-9568.2002.02007.x; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; Taylor JM, 2005, J NEUROCHEM, V92, P283, DOI 10.1111/j.1471-4159.2004.02863.x; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wittwer M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-176; Yachi K, 2007, BRAIN RES, V1159, P141, DOI 10.1016/j.brainres.2007.05.024; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037; Zysk G, 1996, J NEUROPATH EXP NEUR, V55, P722, DOI 10.1097/00005072-199606000-00006; [No title captured]; [No title captured]; [No title captured]	93	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17840	10.1371/journal.pone.0017840	http://dx.doi.org/10.1371/journal.pone.0017840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412436	Green Published, gold, Green Submitted			2022-12-25	WOS:000288247800033
J	Norghauer, JM; Nock, CA; Grogan, J				Norghauer, Julian M.; Nock, Charles A.; Grogan, James			The Importance of Tree Size and Fecundity for Wind Dispersal of Big-Leaf Mahogany	PLOS ONE			English	Article							SWIETENIA-MACROPHYLLA KING; LONG-DISTANCE DISPERSAL; RAIN-FOREST TREE; SEED DISPERSAL; RECRUITMENT LIMITATION; SPATIAL-PATTERNS; WOODY-PLANTS; ECOLOGY; MANAGEMENT; CONSEQUENCES	Seed dispersal by wind is a critical yet poorly understood process in tropical forest trees. How tree size and fecundity affect this process at the population level remains largely unknown because of insufficient replication across adults. We measured seed dispersal by the endangered neotropical timber species big-leaf mahogany (Swietenia macrophylla King, Meliaceae) in the Brazilian Amazon at 25 relatively isolated trees using multiple 1-m wide belt transects extended 100 m downwind. Tree diameter and fecundity correlated positively with increased seed shadow extent; but in combination large, high fecundity trees contributed disproportionately to longer-distance dispersal events (> 60 m). Among three empirical models fitted to seed density vs. distance in one dimension, the Student-t (2Dt) generally fit best (compared to the negative exponential and inverse power). When seedfall downwind was modelled in two dimensions using a normalised sample, it peaked furthest downwind (c. 25 m) for large, high-fecundity trees; with the inverse Gaussian and Weibull functions providing comparable fits that were slightly better than the lognormal. Although most seeds fell within 30 m of parent trees, relatively few juveniles were found within this distance, resulting in juvenile-to-seed ratios peaking at c. 35-45 m. Using the 2Dt model fits to predict seed densities downwind, coupled with known fecundity data for 2000-2009, we evaluated potential Swietenia regeneration near adults (<= 30 m dispersal) and beyond 30 m. Mean seed arrival into canopy gaps > 30 m downwind was more than 3x greater for large, high fecundity trees than small, high-fecundity trees. Tree seed production did not necessarily scale up proportionately with diameter, and was not consistent across years, and this resulting intraspecific variation can have important consequences for local patterns of dispersal in forests. Our results have important implications for management and conservation of big-leaf mahogany populations, and may apply to other threatened wind-dispersed Meliaceae trees.	[Norghauer, Julian M.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Nock, Charles A.] Univ Quebec Montreal UQAM, Dept Biol Sci, Ctr Etud Foret, Montreal, PQ, Canada; [Grogan, James] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	University of Toronto; University of Quebec; University of Quebec Montreal; Yale University	Norghauer, JM (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	julian.norghauer@ips.unibe.ch		Norghauer, Julian/0000-0002-6484-6879	OAS (Organisation of American States); USDA Forest Service's International Institute of Tropical Forestry; University of Toronto; Faculty of Forestry	OAS (Organisation of American States); USDA Forest Service's International Institute of Tropical Forestry(United States Department of Agriculture (USDA)United States Forest Service); University of Toronto(University of Toronto); Faculty of Forestry	This study was partly funded by a Grant for Graduate Research Abroad from OAS (Organisation of American States) to JMN, and from the USDA Forest Service's International Institute of Tropical Forestry to JG. JMN is grateful for a University of Toronto Fellowship and V. J. Nordin Prize from the Faculty of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1983, AM J BOT, V70, P1031, DOI 10.2307/2442812; AUGSPURGER CK, 1983, OIKOS, V40, P189, DOI 10.2307/3544582; AUGSPURGER CK, 1992, ECOLOGY, V73, P1270, DOI 10.2307/1940675; BECKER P, 1985, OIKOS, V44, P382, DOI 10.2307/3565778; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; BULLOCK SH, 1982, OECOLOGIA, V55, P238, DOI 10.1007/BF00384493; Camara-Cabrales L, 2009, J TROP FOR SCI, V21, P235; Carson WP., 2008, TROPICAL FOREST COMM, P210; Chapman CA, 2005, J TROP ECOL, V21, P31, DOI 10.1017/S0266467404001993; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; CONNELL J H, 1971, P298; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Dauer JT, 2007, J APPL ECOL, V44, P105, DOI 10.1111/j.1365-2664.2006.01256.x; Dyer RJ, 2007, MOL ECOL, V16, P4881, DOI 10.1111/j.1365-294X.2007.03581.x; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Grogan J, 2006, BIOTROPICA, V38, P219, DOI 10.1111/j.1744-7429.2006.00121.x; Grogan J, 2005, CONSERV BIOL, V19, P973; Grogan J, 2008, FOREST ECOL MANAG, V255, P269, DOI 10.1016/j.foreco.2007.09.048; Grogan James, 2006, Acta Amaz., V36, P483, DOI 10.1590/S0044-59672006000400009; Grogan J, 2010, CONSERV LETT, V3, P12, DOI 10.1111/j.1755-263X.2009.00082.x; Gullison RE, 1996, BOT J LINN SOC, V122, P9; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Horn HS, 2001, ECOL RES, V16, P877, DOI 10.1046/j.1440-1703.2001.00456.x; HOUSE SM, 1992, J ECOL, V80, P57, DOI 10.2307/2261063; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1985, ECOLOGY, V66, P781, DOI 10.2307/1940539; HOWE HF, 1979, ECOLOGY, V60, P180, DOI 10.2307/1936479; Jansen PA, 2008, ECOGRAPHY, V31, P43, DOI 10.1111/j.2007.0906-7590.05156.x; JANZEN D H, 1978, P83; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Lamb FB., 1966, MAHOGANY TROPICAL AM; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Makana JR, 2004, OIKOS, V106, P67, DOI 10.1111/j.0030-1299.2004.13084.x; Martin PH, 2010, OIKOS, V119, P807, DOI 10.1111/j.1600-0706.2009.17941.x; Medjibe V, 2002, FOREST ECOL MANAG, V170, P249, DOI 10.1016/S0378-1127(01)00769-1; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Muller-Landau Helene C., 2005, P267, DOI 10.1017/CBO9780511541971.012; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2000, ECOLOGY, V81, P2156, DOI 10.1890/0012-9658(2000)081[2156:SVISDA]2.0.CO;2; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; Norghauer JM, 2010, ECOLOGY, V91, P2303, DOI 10.1890/09-0071.1; Norghauer JM, 2010, OECOLOGIA, V162, P405, DOI 10.1007/s00442-009-1476-9; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2009, R FDN STAT COMP; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; SINHA A, 1992, BIOTROPICA, V24, P519, DOI 10.2307/2389014; Skarpaas O, 2004, J ECOL, V92, P747, DOI 10.1111/j.0022-0477.2004.00915.x; Skarpaas O, 2005, J APPL ECOL, V42, P731, DOI 10.1111/j.1365-2664.2005.01056.x; Snook LK, 2005, FOREST ECOL MANAG, V206, P221, DOI 10.1016/j.foreco.2004.11.003; Svenning JC, 2005, J ECOL, V93, P853, DOI 10.1111/j.1365-2745.2005.01016.x; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; ZIMMERMAN JK, 2008, TROPICAL FOREST COMM, P89	62	14	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17488	10.1371/journal.pone.0017488	http://dx.doi.org/10.1371/journal.pone.0017488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408184	gold, Green Submitted, Green Published			2022-12-25	WOS:000288099800019
J	Wang, SF; Fouquet, S; Chapon, M; Salmon, H; Regnier, F; Labroquere, K; Badoual, C; Damotte, D; Validire, P; Maubec, E; Delongchamps, NB; Cazes, A; Gibault, L; Garcette, M; Dieu-Nosjean, MC; Zerbib, M; Avril, MF; Prevost-Blondel, A; Randriamampita, C; Trautmann, A; Bercovici, N				Wang, Shu-Fang; Fouquet, Stephane; Chapon, Maxime; Salmon, Helene; Regnier, Fabienne; Labroquere, Karine; Badoual, Cecile; Damotte, Diane; Validire, Pierre; Maubec, Eve; Delongchamps, Nicolas B.; Cazes, Aurelie; Gibault, Laure; Garcette, Marylene; Dieu-Nosjean, Marie-Caroline; Zerbib, Marc; Avril, Marie-Francoise; Prevost-Blondel, Armelle; Randriamampita, Clotilde; Trautmann, Alain; Bercovici, Nadege			Early T Cell Signalling Is Reversibly Altered in PD-1(+) T Lymphocytes Infiltrating Human Tumors	PLOS ONE			English	Article							PROGRAMMED DEATH-1; MELANOMA PATIENTS; OVARIAN-CANCER; LUNG-CANCER; RECEPTOR; TOLERANCE; ANERGY; RECOGNITION; ACTIVATION; CARCINOMA	To improve cancer immunotherapy, a better understanding of the weak efficiency of tumor-infiltrating T lymphocytes (TIL) is necessary. We have analyzed the functional state of human TIL immediately after resection of three types of tumors (NSCLC, melanoma and RCC). Several signalling pathways (calcium, phosphorylation of ERK and Akt) and cytokine secretion are affected to different extents in TIL, and show a partial spontaneous recovery within a few hours in culture. The global result is an anergy that is quite distinct from clonal anergy induced in vitro, and closer to adaptive tolerance in mice. PD-1 (programmed death -1) is systematically expressed by TIL and may contribute to their anergy by its mere expression, and not only when it interacts with its ligands PD-L1 or PD-L2, which are not expressed by every tumor. Indeed, the TCR-induced calcium and ERK responses were reduced in peripheral blood T cells transfected with PD-1. Inhibition by sodium stibogluconate of the SHP-1 and SHP-2 phosphatases that associate with several inhibitory receptors including PD-1, relieves part of the anergy apparent in TIL or in PD-1-transfected T cells. This work highlights some of the molecular modifications contributing to functional defects of human TIL.	[Wang, Shu-Fang; Fouquet, Stephane; Chapon, Maxime; Salmon, Helene; Regnier, Fabienne; Labroquere, Karine; Garcette, Marylene; Avril, Marie-Francoise; Prevost-Blondel, Armelle; Randriamampita, Clotilde; Trautmann, Alain; Bercovici, Nadege] INSERM, U1016, Inst Cochin, Paris, France; [Wang, Shu-Fang; Fouquet, Stephane; Chapon, Maxime; Salmon, Helene; Regnier, Fabienne; Labroquere, Karine; Garcette, Marylene; Avril, Marie-Francoise; Prevost-Blondel, Armelle; Randriamampita, Clotilde; Trautmann, Alain; Bercovici, Nadege] CNRS, UMR8104, Paris, France; [Badoual, Cecile] Univ Paris 05, PARCC, INSERM, U970, Paris, France; [Badoual, Cecile; Cazes, Aurelie] Hop Europeen Georges Pompidou, AP HP, Serv Anat Pathol, Paris, France; [Damotte, Diane; Dieu-Nosjean, Marie-Caroline] INSERM, U872, Ctr Rech Cordeliers, Lab Microenvironm Immunitaire & Tumeurs, Paris, France; [Damotte, Diane; Dieu-Nosjean, Marie-Caroline] Univ Paris 06, UMR S872, Paris, France; [Damotte, Diane; Dieu-Nosjean, Marie-Caroline] Univ Paris 05, UMR S872, Paris, France; [Damotte, Diane] Hop Hotel Dieu, AP HP, Serv Anat Pathol, F-75181 Paris, France; [Validire, Pierre] Inst Mutualiste Montsouris, Serv Anat Pathol, Paris, France; [Maubec, Eve] UnivParis Diderot, Hop Bichat, AP HP, Serv Dermatol, Paris, France; [Delongchamps, Nicolas B.; Zerbib, Marc] Hop Cochin, AP HP, Serv Urol, F-75674 Paris, France; [Cazes, Aurelie] Univ Paris 05, Coll France, INSERM, U833, Paris, France; [Gibault, Laure] Univ Paris 05, Grp Hosp Cochin St Vincent de Paul, Serv Anat & Cytol Pathol, Paris, France; [Avril, Marie-Francoise] Hop Cochin, AP HP, Serv Dermatol, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Wang, SF (corresponding author), INSERM, U1016, Inst Cochin, Paris, France.	alain.trautmann@inserm.fr; nadege.bercovici@inserm.fr	Dieu-Nosjean, Marie-Caroline/N-3736-2017; Maubec, Eve/V-4296-2017; Prevost-Blondel, Armelle/N-7643-2017; bercovici, nadege/P-5239-2017; Delongchamps, Nicolas Barry/AAE-8651-2020; Dieu-Nosjean, Marie-Caroline/AAD-3695-2022	Maubec, Eve/0000-0003-1658-6686; Dieu-Nosjean, Marie-Caroline/0000-0002-1697-8914; Badoual, Cecile/0000-0002-1143-3085; RENAULT, Shufang/0000-0001-9234-1002; Prevost-Blondel, Armelle/0000-0002-7268-5905; Randriamampita, Clotilde/0000-0001-8594-7831	CNRS; INSERM; Ligue Nationale Contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by CNRS, INSERM and Ligue Nationale Contre le Cancer. NB was supported by an INSERM grant, S-FW by a post-doctoral fellowship from Ligue Nationale contre le Cancer, SF by a CNRS post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; Broderick L, 2006, CLIN IMMUNOL, V118, P159, DOI 10.1016/j.clim.2005.09.008; Broderick L, 2006, J IMMUNOL, V177, P3082, DOI 10.4049/jimmunol.177.5.3082; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Dong HD, 2006, CELL MOL IMMUNOL, V3, P179; Fourcade J, 2009, J IMMUNOL, V182, P5240, DOI 10.4049/jimmunol.0803245; Fourmentraux-Neves E, 2008, BLOOD, V112, P2381, DOI 10.1182/blood-2007-12-127779; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Frey AB, 2008, IMMUNOL REV, V222, P192, DOI 10.1111/j.1600-065X.2008.00606.x; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rivas MN, 2009, J IMMUNOL, V183, P4284, DOI 10.4049/jimmunol.0901408; Sabil SD, 2007, CURR OPIN IMMUNOL, V19, P658, DOI 10.1016/j.coi.2007.08.005; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Sundar S, 2002, CURR OPIN INFECT DIS, V15, P593, DOI 10.1097/00001432-200212000-00007; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Woo EY, 2001, CANCER RES, V61, P4766; Zea AH, 1995, CLIN CANCER RES, V1, P1327; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	36	51	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17621	10.1371/journal.pone.0017621	http://dx.doi.org/10.1371/journal.pone.0017621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408177	Green Published, gold, Green Submitted			2022-12-25	WOS:000288099800028
J	White, S; Ohnesorg, T; Notini, A; Roeszler, K; Hewitt, J; Daggag, H; Smith, C; Turbitt, E; Gustin, S; van den Bergen, J; Miles, D; Western, P; Arboleda, V; Schumacher, V; Gordon, L; Bell, K; Bengtsson, H; Speed, T; Hutson, J; Warne, G; Harley, V; Koopman, P; Vilain, E; Sinclair, A				White, Stefan; Ohnesorg, Thomas; Notini, Amanda; Roeszler, Kelly; Hewitt, Jacqueline; Daggag, Hinda; Smith, Craig; Turbitt, Erin; Gustin, Sonja; van den Bergen, Jocelyn; Miles, Denise; Western, Patrick; Arboleda, Valerie; Schumacher, Valerie; Gordon, Lavinia; Bell, Katrina; Bengtsson, Henrik; Speed, Terry; Hutson, John; Warne, Garry; Harley, Vincent; Koopman, Peter; Vilain, Eric; Sinclair, Andrew			Copy Number Variation in Patients with Disorders of Sex Development Due to 46,XY Gonadal Dysgenesis	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; TRANSLOCATION BREAKPOINTS; DETERMINATION REVEALS; TESTIS DETERMINATION; KB UPSTREAM; ARRAY-CGH; SOX9; MUTATIONS	Disorders of sex development (DSD), ranging in severity from mild genital abnormalities to complete sex reversal, represent a major concern for patients and their families. DSD are often due to disruption of the genetic programs that regulate gonad development. Although some genes have been identified in these developmental pathways, the causative mutations have not been identified in more than 50% 46,XY DSD cases. We used the Affymetrix Genome-Wide Human SNP Array 6.0 to analyse copy number variation in 23 individuals with unexplained 46, XY DSD due to gonadal dysgenesis (GD). Here we describe three discrete changes in copy number that are the likely cause of the GD. Firstly, we identified a large duplication on the X chromosome that included DAX1 (NR0B1). Secondly, we identified a rearrangement that appears to affect a novel gonad-specific regulatory region in a known testis gene, SOX9. Surprisingly this patient lacked any signs of campomelic dysplasia, suggesting that the deletion affected expression of SOX9 only in the gonad. Functional analysis of potential SRY binding sites within this deleted region identified five putative enhancers, suggesting that sequences additional to the known SRY-binding TES enhancer influence human testis-specific SOX9 expression. Thirdly, we identified a small deletion immediately downstream of GATA4, supporting a role for GATA4 in gonad development in humans. These CNV analyses give new insights into the pathways involved in human gonad development and dysfunction, and suggest that rearrangements of non-coding sequences disturbing gene regulation may account for significant proportion of DSD cases.	[White, Stefan; Ohnesorg, Thomas; Notini, Amanda; Roeszler, Kelly; Hewitt, Jacqueline; Daggag, Hinda; Smith, Craig; Turbitt, Erin; Gustin, Sonja; van den Bergen, Jocelyn; Miles, Denise; Western, Patrick; Gordon, Lavinia; Bell, Katrina; Hutson, John; Warne, Garry; Sinclair, Andrew] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [White, Stefan; Hewitt, Jacqueline; Miles, Denise; Hutson, John; Warne, Garry; Sinclair, Andrew] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Schumacher, Valerie; Vilain, Eric] Univ Calif Los Angeles, Dept Med Genet, Los Angeles, CA USA; [Schumacher, Valerie] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Bengtsson, Henrik; Speed, Terry] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Harley, Vincent] Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Walter & Eliza Hall Institute; Prince Henry's Institute of Medical Research; University of Queensland	White, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	evilain@ucla.edu; andrew.sinclair@mcri.edu.au	Harley, Vincent/B-8092-2018; Turbitt, Erin/F-7419-2015; Arboleda, Valerie A/C-9608-2011; Sinclair, Andrew H/A-3598-2010; Hewitt, Jacqueline/F-6082-2012; Koopman, Peter A/C-9416-2009; Gordon, Lavinia/L-1310-2016	Harley, Vincent/0000-0002-2405-1262; Turbitt, Erin/0000-0002-6650-9702; Arboleda, Valerie A/0000-0002-9687-9122; Sinclair, Andrew H/0000-0003-2741-7992; Koopman, Peter A/0000-0001-6939-0914; Hewitt, Jacqueline/0000-0002-3809-8475; Ohnesorg, Thomas/0000-0001-9225-8911; Gordon, Lavinia/0000-0003-3469-8489; Western, Patrick/0000-0002-7587-8227; Roeszler, Kelly/0000-0002-9809-1507; Smith, Craig/0000-0002-1670-5545	Australian National Health and Medical Research Council [334314, 491293, 546478]; Helen Macpherson Smith Trust; Doris Duke Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044513] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Helen Macpherson Smith Trust; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided by the Australian National Health and Medical Research Council www.nhmrc.gov.au (334314 to AS, PK and VH; 491293 and 546478 to SW), the Helen Macpherson Smith Trust www.hmstrust.org.au (AS), and the Doris Duke Charitable Foundation www.ddcf.org (EV, VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Barbaro M, 2008, CLIN GENET, V73, P453, DOI 10.1111/j.1399-0004.2008.00980.x; Barbaro M, 2007, J CLIN ENDOCR METAB, V92, P3305, DOI 10.1210/jc.2007-0505; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bouma GJ, 2007, P NATL ACAD SCI USA, V104, P14994, DOI 10.1073/pnas.0701677104; Bouma GJ, 2005, DEVELOPMENT, V132, P3045, DOI 10.1242/dev.01890; Cameron FJ, 1997, HUM MUTAT, V9, P388; Canto P, 2004, J CLIN ENDOCR METAB, V89, P4480, DOI 10.1210/jc.2004-0863; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Domenice S, 2004, BRAZ J MED BIOL RES, V37, P145, DOI 10.1590/S0100-879X2004000100020; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Georg I, 2010, SEX DEV, V4, P321, DOI 10.1159/000320142; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hill-Harfe KL, 2005, AM J HUM GENET, V76, P663, DOI 10.1086/429254; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; KWOK C, 1995, AM J HUM GENET, V57, P1028; Kyuno J, 2008, MECH DEVELOP, V125, P571, DOI 10.1016/j.mod.2008.03.001; Lecointre C, 2009, AM J MED GENET A, V149A, P1183, DOI 10.1002/ajmg.a.32830; Ledig S, 2010, HUM REPROD, V25, P2637, DOI 10.1093/humrep/deq167; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Lourenco D, 2011, P NATL ACAD SCI USA, V108, P1597, DOI 10.1073/pnas.1010257108; Ludbrook LM, 2004, TRENDS ENDOCRIN MET, V15, P116, DOI 10.1016/j.tem.2004.02.002; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Ohnesorg T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-412; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smyk M, 2007, AM J MED GENET A, V143A, P866, DOI 10.1002/ajmg.a.31631; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Warne GL, 2009, MED J AUSTRALIA, V190, P612, DOI 10.5694/j.1326-5377.2009.tb02586.x; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; White SJ, 2004, METHOD CELL BIOL, V75, P751; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	63	90	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17793	10.1371/journal.pone.0017793	http://dx.doi.org/10.1371/journal.pone.0017793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408189	gold, Green Published			2022-12-25	WOS:000288099800040
J	Dulak, AM; Gubish, CT; Stabile, LP; Henry, C; Siegfried, JM				Dulak, A. M.; Gubish, C. T.; Stabile, L. P.; Henry, C.; Siegfried, J. M.			HGF-independent potentiation of EGFR action by c-Met	ONCOGENE			English	Article						c-Met; c-Src; EGFR; cross-talk	GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GASTRIN-RELEASING-PEPTIDE; TYROSINE KINASE-ACTIVITY; EPIDERMAL-GROWTH; SCATTER-FACTOR; THERAPEUTIC INHIBITION; GEFITINIB RESISTANCE; CARCINOMA-CELLS; BREAST-CANCER	The c-Met receptor is a potential therapeutic target for non-small cell lung cancer (NSCLC). Signaling interactions between c-Met and the mutant epidermal growth factor receptor (EGFR) have been studied extensively, but signaling intermediates and biological consequences of lateral signaling to c-Met in EGFR wild-type tumors are minimally understood. Our observations indicate that delayed c-Met activation in NSCLC cell lines is initiated by wild-type EGFR, the receptor most often found in NSCLC tumors. EGFR ligands induce accumulation of activated c-Met, which begins at 8 h and continues for 48 h. This effect is accompanied by an increase in c-Met expression and phosphorylation of critical c-Met tyrosine residues without activation of mitogen-activated protein kinase (MAPK) or Akt. Gene transcription is required for delayed c-Met activation; however, phosphorylation of c-Met by EGFR occurs without production of hepatocyte growth factor (HGF) or another secreted factor, supporting a ligand-independent mechanism. Lateral signaling is blocked by two selective c-Met tyrosine kinase inhibitors (TKIs), PF2341066 and SU11274, or with gefitinib, an EGFR TKI, suggesting kinase activity of both receptors is required for this effect. Prolonged c-Src phosphorylation is observed, and c-Src pathway is essential for EGFR to c-Met communication. Pretreatment with pan-Src family kinase inhibitors, PP2 and dasatinib, abolishes delayed c-Met phosphorylation. A c-Src dominant-negative construct reduces EGF-induced c-Met phosphorylation compared with control, further confirming a c-Src requirement. Inhibition of c-Met with PF2341066 and siRNA decreases EGF-induced phenotypes of invasion by similar to 86% and motility by similar to 81%, suggesting that a novel form of c-Met activation is utilized by EGFR to maximize these biological effects. Combined targeting of c-Met and EGFR leads to increased xenograft antitumor activity, demonstrating that inhibition of downstream and lateral signaling from the EGFR-c-Src-c-Met axis might be effective in treatment of NSCLC. Oncogene (2011) 30, 3625-3635; doi:10.1038/onc.2011.84; published online 21 March 2011	[Siegfried, J. M.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Siegfried, J. M.] Univ Pittsburgh, Univ Pittsburgh Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Siegfried, JM (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Hillman Canc Ctr, Suite 2-18,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	siegfriedjm@upmc.edu	Stabile, Laura/AAE-9235-2020		NIH, National Cancer Institute [R01 CA79882]; America Foundation; Predoctoral Fellowship in Pharmacology by Pharmaceutical Research; NATIONAL CANCER INSTITUTE [R01CA079882] Funding Source: NIH RePORTER	NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); America Foundation; Predoctoral Fellowship in Pharmacology by Pharmaceutical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 CA79882 to JMS from the National Cancer Institute and by a Predoctoral Fellowship in Pharmacology by Pharmaceutical Research and Manufacturers of America Foundation awarded to Austin M Dulak. We would like to thank Pfizer for kindly providing PF2341066.	Bergstrom JD, 2000, EXP CELL RES, V259, P293, DOI 10.1006/excr.2000.4967; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fischer OM, 2004, J BIOL CHEM, V279, P28970, DOI 10.1074/jbc.M402508200; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Liu XW, 2007, EXP CELL RES, V313, P1361, DOI 10.1016/j.yexcr.2007.01.016; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nakajima M, 1999, CANCER, V85, P1894; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; NALDINI L, 1991, ONCOGENE, V6, P501; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; PONZETTO C, 1991, ONCOGENE, V6, P553; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Presnell SC, 1997, MOL CARCINOGEN, V18, P244, DOI 10.1002/(SICI)1098-2744(199704)18:4<244::AID-MC8>3.3.CO;2-Y; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Siegfried JM, 2007, MOL PHARMACOL, V72, P769, DOI 10.1124/mol.107.034215; Siegfried JM, 1999, PULM PHARMACOL THER, V12, P291, DOI 10.1006/pupt.1999.0210; Stabile LP, 2008, MOL CANCER THER, V7, P1913, DOI 10.1158/1535-7163.MCT-07-2169; Stabile LP, 2004, GENE THER, V11, P325, DOI 10.1038/sj.gt.3302169; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Thomas SM, 2006, CANCER RES, V66, P11831, DOI 10.1158/0008-5472.CAN-06-2876; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xu L, 2010, ONCOGENE, V29, P2616, DOI 10.1038/onc.2010.16; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643	44	87	96	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	33					3625	3635		10.1038/onc.2011.84	http://dx.doi.org/10.1038/onc.2011.84			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21423210	Green Accepted			2022-12-25	WOS:000294005100006
J	Han, YJ; Ma, SF; Yourek, G; Park, YD; Garcia, JGN				Han, Yoo Jeong; Ma, Shwu Fan; Yourek, Gregory; Park, Yoon-Dong; Garcia, Joe G. N.			A transcribed pseudogene of MYLK promotes cell proliferation	FASEB JOURNAL			English	Article						myosin light chain kinase; human cancers; gene duplication; RNA stability	LIGHT-CHAIN KINASE; HUMAN GENOME; MESSENGER-RNA; MOUSE OOCYTES; IN-VIVO; MYOSIN; GENE; EXPRESSION; PROTEIN; DNA	Pseudogenes are considered nonfunctional genomic artifacts of catastrophic pathways. Recent evidence, however, indicates novel roles for pseudogenes as regulators of gene expression. We tested the functionality of myosin light chain kinase pseudogene (MYLKP1) in human cells and tissues by RT-PCR, promoter activity, and cell proliferation assays. MYLKP1 is partially duplicated from the original MYLK gene that encodes nonmuscle and smooth muscle myosin light chain kinase (smMLCK) isoforms and regulates cell contractility and cytokinesis. Despite strong homology with the smMLCK promoter (similar to 89.9%), the MYLKP1 promoter is minimally active in normal bronchial epithelial cells but highly active in lung adenocarcinoma cells. Moreover, MYLKP1 and smMLCK exhibit negatively correlated transcriptional patterns in normal and cancer cells with MYLKP1 strongly expressed in cancer cells and smMLCK highly expressed in non-neoplastic cells. For instance, expression of smMLCK decreased (19.5 +/- 4.7 fold) in colon carcinoma tissues compared to normal colon tissues. Mechanistically, MYLKP1 overexpression inhibits smMLCK expression in cancer cells by decreasing RNA stability, leading to increased cell proliferation. These studies provide strong evidence for the functional involvement of pseudogenes in carcinogenesis and suggest MYLKP1 as a potential novel diagnostic or therapeutic target in human cancers.-Han, Y. J., Ma, S. F., Yourek, G., Park, Y.-D., Garcia, J. G. N. A transcribed pseudogene of MYLK promotes cell proliferation. FASEB J. 25, 2305-2312 (2011). www.fasebj.org	[Park, Yoon-Dong; Garcia, Joe G. N.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Han, Yoo Jeong; Ma, Shwu Fan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Han, Yoo Jeong; Yourek, Gregory] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Garcia, Joe G. N.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Garcia, JGN (corresponding author), Univ Illinois, Dept Med, 1737 W Polk St,305D AOB, Chicago, IL 60612 USA.	jggarcia@uic.edu	Yourek, Gregory/I-6758-2019	Yourek, Gregory/0000-0001-8008-7967	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL058064] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dahia PLM, 1998, ONCOGENE, V16, P2403, DOI 10.1038/sj.onc.1201762; DELANEROLLE P, 1991, AM J PHYSIOL, V261, pL1, DOI 10.1152/ajplung.1991.261.2.L1; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Endoh A, 1998, MOL CELL ENDOCRINOL, V137, P13, DOI 10.1016/S0303-7207(97)00224-4; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Fujii GH, 1999, ONCOGENE, V18, P1765, DOI 10.1038/sj.onc.1202492; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; Gerstein M, 2006, SCI AM, V295, P48, DOI 10.1038/scientificamerican0806-48; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; Han YJ, 2008, AM J HYPERTENS, V21, P860, DOI 10.1038/ajh.2008.199; Han YJ, 2008, MOL CELL BIOL, V28, P863, DOI 10.1128/MCB.00960-07; Han YJ, 2006, MOL BIOL CELL, V17, P4039, DOI 10.1091/mbc.E06-04-0353; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Korneev S, 2002, MOL BIOL EVOL, V19, P1228, DOI 10.1093/oxfordjournals.molbev.a004183; Korneev SA, 1999, J NEUROSCI, V19, P7711; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; POTIER MC, 1995, GENOMICS, V29, P562, DOI 10.1006/geno.1995.9965; PROUDFOOT N, 1980, NATURE, V286, P840, DOI 10.1038/286840a0; Puget N, 2002, AM J HUM GENET, V70, P858, DOI 10.1086/339434; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; ZAKUTHOURI R, 1983, NATURE, V306, P594, DOI 10.1038/306594a0; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	35	64	68	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2305	2312		10.1096/fj.10-177808	http://dx.doi.org/10.1096/fj.10-177808			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21441351	Green Published			2022-12-25	WOS:000292242200022
J	Kommaddi, RP; Thomas, R; Ceni, C; Daigneault, K; Barker, PA				Kommaddi, Reddy P.; Thomas, Rhalena; Ceni, Claire; Daigneault, Kathleen; Barker, Philip A.			Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling	FASEB JOURNAL			English	Article						p75NTR; NGF; BDNF; alpha-secretase; gamma-secretase; TrkA	NECROSIS-FACTOR-ALPHA; NERVE GROWTH-FACTOR; INTRACELLULAR DOMAIN; SYMPATHETIC NEURONS; NUCLEAR TRANSLOCATION; CONVERTING ENZYME; RECEPTOR P75(NTR); POTENTIAL ROLE; P75 RECEPTOR; PC12 CELLS	Signaling by TrkA and TrkB receptor tyrosine kinase is required for peripheral neuron survival. TrkA and TrkB signaling is facilitated by the p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor (TNF) receptor superfamily, through mechanisms that remain obscure. Here, we demonstrate that TrkA and TrkB induces MEK-dependent phosphorylation of the transmembrane cysteine protease ADAM17 (a disintegrin and metalloprotease 17) at the intracellular residue threonine 735. Phosphorylation at this site activates ADAM17 and causes cleavage of p75NTR and production of the receptors' intracellular domain (p75NTR(ICD)) in PC12 cells and in primary cerebellar granule neurons. We show that Trk-induced ADAM17 phosphorylation and generation of the p75NTRICD is required for neurotrophin-induced Erk and Akt activation and for neurotrophin-dependent survival signaling. Survival of PC12 cells maintained in 10 ng/ml nerve growth factor drops by 47% in cells depleted of ADAM17; this survival deficit is resolved if the p75NTRICD is overexpressed in the ADAM17 depleted cells. These studies identify a novel signaling circuit in which Trk activates ADAM17-dependent p75NTRICD production to feedback to sustain Trk signaling and Trk-dependent survival.-Kommaddi, R. P., Thomas, R., Ceni, C., Daigneault, K., Barker, P. A. Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling. FASEB J. 25, 2061-2070 (2011). www.fasebj.org	[Kommaddi, Reddy P.; Thomas, Rhalena; Ceni, Claire; Daigneault, Kathleen; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	phil.barker@mcgill.ca	Thomas, Rhalena/AAT-2032-2021	Thomas, Rhalena/0000-0002-5396-7587	Canadian Institute of Health Research (CIHR) [MOP37850]; McGill studentships	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill studentships	The authors are thankful to Dr. Atanasio Pandiella (University of Salamanca, Salamanca, Spain), Dr. Moses Chao (New York University, New York, NY, USA), and Anthony Oliva (University of Miami, Miami, FL, USA) for kindly providing valuable reagents. R. P. K. was supported by a Canadian Institute of Health Research (CIHR)-HOPE Fellowship, and R. T. was supported by CIHR and McGill studentships. P. A. B. is a Chercheur Nationaux of the Fonds de Recherche en Sante du Quebec and William Dawson Scholar of McGill University. This project was supported by CIHR grant MOP37850.	BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Ito H, 2003, J NEUROSCI RES, V72, P211, DOI 10.1002/jnr.10564; Ito H, 2002, J NEUROSCI RES, V69, P653, DOI 10.1002/jnr.10359; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; LEE KF, 1994, DEVELOPMENT, V120, P1027; Majdan M, 1997, J NEUROSCI, V17, P6988; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	31	29	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2011	25	6					2061	2070		10.1096/fj.10-173740	http://dx.doi.org/10.1096/fj.10-173740			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21411748				2022-12-25	WOS:000291023800028
J	Kirchdoerfer, RN; Garner, AL; Flack, CE; Mee, JM; Horswill, AR; Janda, KD; Kaufmann, GF; Wilson, IA				Kirchdoerfer, Robert N.; Garner, Amanda L.; Flack, Caralyn E.; Mee, Jenny M.; Horswill, Alexander R.; Janda, Kim D.; Kaufmann, Gunnar F.; Wilson, Ian A.			Structural Basis for Ligand Recognition and Discrimination of a Quorum-quenching Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; STAPHYLOCOCCUS-AUREUS; RECEPTOR RECOGNITION; MAXIMUM-LIKELIHOOD; VIRULENCE; IDENTIFICATION; INHIBITION; REFINEMENT; ACTIVATION; EXPRESSION	In the postantibiotic era, available treatment options for severe bacterial infections caused by methicillin-resistant Staphylococcus aureus have become limited. Therefore, new and innovative approaches are needed to combat such life-threatening infections. Virulence factor expression in S. aureus is regulated in a cell density-dependent manner using "quorum sensing," which involves generation and secretion of autoinducing peptides (AIPs) into the surrounding environment to activate a bacterial sensor kinase at a particular threshold concentration. Mouse monoclonal antibody AP4-24H11 was shown previously to blunt quorum sensing-mediated changes in gene expression in vitro and protect mice from a lethal dose of S. aureus by sequestering the AIP signal. We have elucidated the crystal structure of the AP4-24H11 Fab in complex with AIP-4 at 2.5 angstrom resolution to determine its mechanism of ligand recognition. A key Glu(H95) provides much of the binding specificity through formation of hydrogen bonds with each of the four amide nitrogens in the AIP-4 macrocyclic ring. Importantly, these structural data give clues as to the interactions between the cognate staphylococcal AIP receptors AgrC and the AIPs, as AP4-24H11.AIP-4 binding recapitulates features that have been proposed for AgrC-AIP recognition. Additionally, these structural insights may enable the engineering of AIP cross-reactive antibodies or quorum quenching vaccines for use in active or passive immunotherapy for prevention or treatment of S. aureus infections.	[Kirchdoerfer, Robert N.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Garner, Amanda L.; Mee, Jenny M.; Janda, Kim D.; Kaufmann, Gunnar F.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Garner, Amanda L.; Mee, Jenny M.; Janda, Kim D.; Kaufmann, Gunnar F.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Janda, Kim D.; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA; [Flack, Caralyn E.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Iowa	Kaufmann, GF (corresponding author), 10550 N Torrey Pines Rd,BCC578, La Jolla, CA 92037 USA.	kaufmann@scripps.edu; wilson@scripps.edu		Flack, Caralyn/0000-0001-9200-4575	National Institutes of Health [AI078921, AI080715, AI042266, CA058896]; Skaggs Institute; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, R01AI042266, R37AI042266, R01AI080715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI078921 (to A. R. H.), AI080715 (to G. F. K.), and AI042266 and CA058896 (to I. A. W.). This work was also supported by The Skaggs Institute (to I. A. W. and K. D. J.). The Advanced Photon Source at Argonne National Laboratory is supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-06CH11357. This is Paper 20569 from The Scripps Research Institute.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chen LC, 2009, J MICROBIOL, V47, P572, DOI 10.1007/s12275-009-0004-2; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Debler EW, 2007, J MOL BIOL, V368, P1392, DOI 10.1016/j.jmb.2007.02.081; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Geisinger E, 2008, J BIOL CHEM, V283, P8930, DOI 10.1074/jbc.M710227200; Gruber K, 1999, BIOCHEMISTRY-US, V38, P7062, DOI 10.1021/bi990210s; HARLOW E, 1988, ANTIBODIES LAB MANUA, P626; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kaufmann GF, 2011, METHODS MOL BIOL, V692, P299, DOI 10.1007/978-1-60761-971-0_22; Koenig RL, 2004, J BACTERIOL, V186, P7549, DOI 10.1128/JB.186.22.7549-7555.2004; LEBEAU C, 1994, J BACTERIOL, V176, P5534, DOI 10.1128/JB.176.17.5534-5536.1994; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McDowell P, 2001, MOL MICROBIOL, V41, P503, DOI 10.1046/j.1365-2958.2001.02539.x; Morfeldt E, 1996, MOL MICROBIOL, V21, P1227, DOI 10.1046/j.1365-2958.1996.751447.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Suga H, 2003, CURR OPIN CHEM BIOL, V7, P586, DOI 10.1016/j.cbpa.2003.08.001; Thoendel M, 2009, J BIOL CHEM, V284, P21828, DOI 10.1074/jbc.M109.031757; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005; Wright JS, 2004, P NATL ACAD SCI USA, V101, P16168, DOI 10.1073/pnas.0404039101; Zhang LS, 2002, J BIOL CHEM, V277, P34736, DOI 10.1074/jbc.M205367200	48	43	48	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17351	17358		10.1074/jbc.M111.231258	http://dx.doi.org/10.1074/jbc.M111.231258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454495	Green Published, hybrid			2022-12-25	WOS:000290301900082
J	Leverrier, P; Declercq, JP; Denoncin, K; Vertommen, D; Hiniker, A; Cho, SH; Collet, JF				Leverrier, Pauline; Declercq, Jean-Paul; Denoncin, Katleen; Vertommen, Didier; Hiniker, Annie; Cho, Seung-Hyun; Collet, Jean-Francois			Crystal Structure of the Outer Membrane Protein RcsF, a New Substrate for the Periplasmic Protein-disulfide Isomerase DsbC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SIGNALING PATHWAY; CAPSULE SYNTHESIS; PHOSPHORELAY; BOND; REGULATOR; BIOSYNTHESIS; ENVELOPE; STRESS; SYSTEM	The bacterial Rcs phosphorelay is a stress-induced defense mechanism that controls the expression of numerous genes, including those for capsular polysaccharides, motility, and virulence factors. It is a complex multicomponent system that includes the histidine kinase (RcsC) and the response regulator (RcsB) and also auxiliary proteins such as RcsF. RcsF is an outer membrane lipoprotein that transmits signals from the cell surface to RcsC. The physiological signals that activate RcsF and how RcsF interacts with RcsC remain unknown. Here, we report the three-dimensional structure of RcsF. The fold of the protein is characterized by the presence of a central 4-stranded beta sheet, which is conserved in several other proteins, including the copper-binding domain of the amyloid precursor protein. RcsF, which contains four conserved cysteine residues, presents two nonconsecutive disulfides between Cys(74) and Cys(118) and between Cys(109) and Cys(124), respectively. These two disulfides are not functionally equivalent; the Cys(109)-Cys(124) disulfide is particularly important for the assembly of an active RcsF. Moreover, we show that formation of the nonconsecutive disulfides of RcsF depends on the periplasmic disulfide isomerase DsbC. We trapped RcsF in a mixed disulfide complex with DsbC, and we show that deletion of dsbC prevents the activation of the Rcs phosphorelay by signals that function through RcsF. The three-dimensional structure of RcsF provides the structural basis to understand how this protein triggers the Rcs signaling cascade.	[Leverrier, Pauline; Denoncin, Katleen; Vertommen, Didier; Cho, Seung-Hyun; Collet, Jean-Francois] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Leverrier, Pauline; Denoncin, Katleen; Cho, Seung-Hyun; Collet, Jean-Francois] Catholic Univ Louvain, Welbio Walloon Excellence Life Sci & Biotechnol, B-1200 Brussels, Belgium; [Declercq, Jean-Paul] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium; [Hiniker, Annie] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Princeton University	Collet, JF (corresponding author), 75-39 Av Hippocrate, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Collet, Jean Francois/F-2105-2010	Vertommen, Didier/0000-0001-7648-8282; Leverrier, Pauline/0000-0003-2465-8491; Collet, Jean-Francois/0000-0001-8069-7036; cho, seung-hyun/0000-0002-5548-4239	Belgian Science Policy, Network [P6/05]; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique; European Community [RII3-CT-2004-506008]	Belgian Science Policy, Network(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); European Community(European Commission)	This work was supported by the Interuniversity Attraction Pole Programme-Belgian Science Policy, Network P6/05 (to J.-F. C.), and by grants from the Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (to J.-F. C.).; We thank Asma Boujtat and Steve Calberson for technical assistance and Matthieu Depuydt for critical reading of the manuscript. We thank the European Community for Access to Research Infrastructure Action of the Improving Human Potential Programme to the EMBL Hamburg Outstation, Contract RII3-CT-2004-506008.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Callewaert L, 2009, J BACTERIOL, V191, P1979, DOI 10.1128/JB.01549-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Clarke DJ, 2002, J BACTERIOL, V184, P1204, DOI 10.1128/jb.184.4.1204-1208.2002; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Depuydt M., 2011, ANTIOXID RE IN PRESS; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris C, 2010, J BACTERIOL, V192, P4894, DOI 10.1128/JB.00505-10; GERVAIS FG, 1992, J BACTERIOL, V174, P8016, DOI 10.1128/JB.174.24.8016-8022.1992; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Hiniker A, 2003, BIOCHEMISTRY-US, V42, P1179, DOI 10.1021/bi027141t; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YH, 2006, RES MICROBIOL, V157, P206, DOI 10.1016/j.resmic.2005.11.005; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kelm O, 1997, MOL GEN GENET, V256, P72, DOI 10.1007/s004380050547; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Leverrier P, 2010, PROTEOMICS, V10, P771, DOI 10.1002/pmic.200900461; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Miller JH, 1992, SHORT COURSE BACTERI, P221; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; PROUVOST AF, 2008, THESIS U SCI TECHNOL; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Singh P, 2008, ANAL CHEM, V80, P8799, DOI 10.1021/ac801646f; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; STOUT V, 1994, RES MICROBIOL, V145, P389, DOI 10.1016/0923-2508(94)90086-8; Takeda S, 2001, MOL MICROBIOL, V40, P440, DOI 10.1046/j.1365-2958.2001.02393.x; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]	56	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16734	16742		10.1074/jbc.M111.224865	http://dx.doi.org/10.1074/jbc.M111.224865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454485	Green Published, hybrid			2022-12-25	WOS:000290301900021
J	Striem-Amit, E; Hertz, U; Amedi, A				Striem-Amit, Ella; Hertz, Uri; Amedi, Amir			Extensive Cochleotopic Mapping of Human Auditory Cortical Fields Obtained with Phase-Encoding fMRI	PLOS ONE			English	Article							SUPERIOR TEMPORAL REGION; RESONANCE-IMAGING FMRI; TONOTOPIC ORGANIZATION; FUNCTIONAL-ORGANIZATION; PLANUM TEMPORALE; VISUAL-CORTEX; HUMAN-BRAIN; SUBDIVISIONS; CONNECTIONS; AREAS	The primary sensory cortices are characterized by a topographical mapping of basic sensory features which is considered to deteriorate in higher-order areas in favor of complex sensory features. Recently, however, retinotopic maps were also discovered in the higher-order visual, parietal and prefrontal cortices. The discovery of these maps enabled the distinction between visual regions, clarified their function and hierarchical processing. Could such extension of topographical mapping to high-order processing regions apply to the auditory modality as well? This question has been studied previously in animal models but only sporadically in humans, whose anatomical and functional organization may differ from that of animals (e.g. unique verbal functions and Heschl's gyrus curvature). Here we applied fMRI spectral analysis to investigate the cochleotopic organization of the human cerebral cortex. We found multiple mirror-symmetric novel cochleotopic maps covering most of the core and high-order human auditory cortex, including regions considered non-cochleotopic, stretching all the way to the superior temporal sulcus. These maps suggest that topographical mapping persists well beyond the auditory core and belt, and that the mirror-symmetry of topographical preferences may be a fundamental principle across sensory modalities.	[Striem-Amit, Ella; Hertz, Uri; Amedi, Amir] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Med Neurobiol, Jerusalem, Israel; [Hertz, Uri; Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Jerusalem, Israel; [Amedi, Amir] Hebrew Univ Jerusalem, Cognit Sci Program, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Striem-Amit, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Med Neurobiol, Jerusalem, Israel.	amir.amedi@ekmd.huji.ac.il	Hertz, Uri/AAA-4799-2020; Striem-Amit, Ella/K-3715-2014	Hertz, Uri/0000-0003-4852-3516; Striem-Amit, Ella/0000-0002-5900-3455; Amedi, Amir/0000-0001-5042-2533	International Human Frontier Science Program Organization (HFSPO); Israel Science Foundation [1530/08]; European Union [MIRG-CT-2007-205357]; Edmond and Lily Safra Center for Brain Sciences; Alon fund; Sieratzki fund; Moscona fund; Hebrew University	International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Edmond and Lily Safra Center for Brain Sciences; Alon fund; Sieratzki fund; Moscona fund; Hebrew University	AA is supported by the International Human Frontier Science Program Organization (HFSPO); Israel Science Foundation (grant number 1530/08); a European Union Marie Curie International Reintegration Grant (MIRG-CT-2007-205357); the Edmond and Lily Safra Center for Brain Sciences; and the Alon, Sieratzki, and Moscona funds. ESA is supported by the Hebrew University Hoffman Leadership and Responsibility Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 1996, BRAIN, V119, P1239, DOI 10.1093/brain/119.4.1239; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brodmann, 1909, VERGLEICHENDE LOKALI; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; COLLIGNON O, 2008, EXP BRAIN RES; Counter SA, 1997, JMRI-J MAGN RESON IM, V7, P606, DOI 10.1002/jmri.1880070327; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Fullerton BC, 2007, J COMP NEUROL, V504, P470, DOI 10.1002/cne.21432; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Guiraud J, 2007, J NEUROSCI, V27, P7838, DOI 10.1523/JNEUROSCI.0154-07.2007; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Hackett TA, 2008, J AM ACAD AUDIOL, V19, P774, DOI 10.3766/jaaa.19.10.5; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; HERDENER M, 2010, TOPOGRAPHICALLY ORDE; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; IMIG TJ, 1977, J COMP NEUROL, V171, P111, DOI 10.1002/cne.901710108; JONES EG, 1995, J COMP NEUROL, V362, P153, DOI 10.1002/cne.903620202; JONES EG, 1976, J COMP NEUROL, V168, P197, DOI 10.1002/cne.901680203; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1998, AUDIOL NEURO-OTOL, V3, P73, DOI 10.1159/000013783; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Linden DEJ, 1999, PERCEPTION, V28, P469, DOI 10.1068/p2820; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; NELKEN I, 2008, CURR OPIN NEUROBIOL; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Pantev C, 2003, ANN NY ACAD SCI, V999, P438, DOI 10.1196/annals.1284.054; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Price C, 2005, TRENDS COGN SCI, V9, P271, DOI 10.1016/j.tics.2005.03.009; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Stevens AA, 2009, BEHAV BRAIN RES, V196, P134, DOI 10.1016/j.bbr.2008.07.041; Sweet RA, 2005, J COMP NEUROL, V491, P270, DOI 10.1002/cne.20702; Talairach J., 1988, COPLANAR STEREOTAXIC; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; TANJI K, 2009, NEUROIMAGE; Upadhyay J, 2007, CEREB CORTEX, V17, P2420, DOI 10.1093/cercor/bhl150; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Walters NB, 2003, P NATL ACAD SCI USA, V100, P2981, DOI 10.1073/pnas.0437896100; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; ZATORRE RJ, 2005, PLASTICITY CENTRAL A, P241; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	99	80	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17832	10.1371/journal.pone.0017832	http://dx.doi.org/10.1371/journal.pone.0017832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448274	gold, Green Published, Green Submitted			2022-12-25	WOS:000288810500015
J	Donia, MS; Fricke, WF; Ravel, J; Schmidt, EW				Donia, Mohamed S.; Fricke, W. Florian; Ravel, Jacques; Schmidt, Eric W.			Variation in Tropical Reef Symbiont Metagenomes Defined by Secondary Metabolism	PLOS ONE			English	Article							CYANOBACTERIAL SYMBIONT; NATURAL-PRODUCTS; GENE-CLUSTER; BIOSYNTHESIS; PROCHLORON; IDENTIFICATION; ASCIDIANS; DIVERSITY; PATHWAY; CLONING	The complex evolution of secondary metabolism is important in biology, drug development, and synthetic biology. To examine this problem at a fine scale, we compared the genomes and chemistry of 24 strains of uncultivated cyanobacteria, Prochloron didemni, that live symbiotically with tropical ascidians and that produce natural products isolated from the animals. Although several animal species were obtained along a>5500 km transect of the Pacific Ocean, P. didemni strains are >97% identical across much of their genomes, with only a few exceptions concentrated in secondary metabolism. Secondary metabolic gene clusters were sporadically present or absent in identical genomic locations with no consistent pattern of co-occurrence. Discrete mutations were observed, leading to new chemicals that we isolated from animals. Functional cassettes encoding diverse chemicals are exchanged among a single population of symbiotic P. didemni that spans the tropical Pacific, providing the host animals with a varying arsenal of secondary metabolites.	[Donia, Mohamed S.; Schmidt, Eric W.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Fricke, W. Florian; Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA	Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore	Donia, MS (corresponding author), Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.	ews1@utah.edu	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233; Fricke, W. Florian/0000-0003-1586-0962	National Institutes of Health (NIH) [GM071425, EF-0412226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071425] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH GM071425 and EF-0412226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banik JJ, 2010, CURR OPIN MICROBIOL, V13, P603, DOI 10.1016/j.mib.2010.08.012; Bode HB, 2003, MOL MICROBIOL, V47, P471, DOI 10.1046/j.1365-2958.2003.03309.x; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Bruntner C, 1999, MOL GEN GENET, V262, P102; Carroll AR, 1996, J ORG CHEM, V61, P4059, DOI 10.1021/jo951379o; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; COWAN ME, 1981, MAR ECOL PROG SER, V6, P335, DOI 10.3354/meps006335; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Haft DH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-15; KOIKE I, 1993, AUST J MAR FRESH RES, V44, P173; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ladygina N, 2006, PROCESS BIOCHEM, V41, P1001, DOI 10.1016/j.procbio.2005.12.007; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Lim-Fong GE, 2008, APPL ENVIRON MICROB, V74, P3605, DOI 10.1128/AEM.02798-07; Mayer AMS, 2010, TRENDS PHARMACOL SCI, V31, P255, DOI 10.1016/j.tips.2010.02.005; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Munchhoff J, 2007, ENVIRON MICROBIOL, V9, P890, DOI 10.1111/j.1462-2920.2006.01209.x; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schmidt EW, 2008, NAT CHEM BIOL, V4, P466, DOI 10.1038/nchembio.101; Schmidt EW, 2010, CURR OPIN BIOTECH, V21, P827, DOI 10.1016/j.copbio.2010.10.006; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Schmidt EW, 2004, J NAT PROD, V67, P1341, DOI 10.1021/np049948n; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Tomitani A, 1999, NATURE, V400, P159, DOI 10.1038/22101; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Yokobori S, 2006, MOL PHYLOGENET EVOL, V40, P8, DOI 10.1016/j.ympev.2005.11.025; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06	45	53	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17897	10.1371/journal.pone.0017897	http://dx.doi.org/10.1371/journal.pone.0017897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445351	Green Submitted, Green Published, gold			2022-12-25	WOS:000288809100015
J	Mccue, HV; Burgoyne, RD; Haynes, LP				McCue, Hannah V.; Burgoyne, Robert D.; Haynes, Lee P.			Determination of the Membrane Topology of the Small EF-Hand Ca2+-Sensing Proteins CaBP7 and CaBP8	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; FLUORESCENCE PROTEASE PROTECTION; CALCIUM SENSOR PROTEINS; CALDENDRIN; INSERTION; TRANSLOCATION; BINDING	The CaBPs represent a subfamily of small EF-hand containing calcium (Ca2+)-sensing proteins related to calmodulin that regulate key ion channels in the mammalian nervous system. In a recent bioinformatic analyses we determined that CaBP7 and CaBP8 form an evolutionarily distinct branch within the CaBPs ( also known as the calneurons) a finding that is consistent with earlier observations characterising a putative C-terminal transmembrane (TM) spanning helix in each of these proteins which is essential for their sub-cellular targeting to the Golgi apparatus and constitutive secretory vesicles. The C-terminal position of the predicted TM-helix suggests that CaBP7 and CaBP8 could be processed in a manner analogous to tail-anchored integral membrane proteins which exhibit the ability to insert across membranes post-translationally. In this study we have investigated the topology of CaBP7 and CaBP8 within cellular membranes through a combination of trypsin protection and epitope accessibility analyses. Our results indicate that the TM-helices of CaBP7 and CaBP8 insert fully across membranes such that their extreme C-termini are luminal. The observed type-II membrane topology is consistent with processing of CaBP7 and CaBP8 as true tail-anchored proteins. This targeting mechanism is distinct from any other calmodulin related Ca2+-sensor and conceivably underpins unique physiological functions of these proteins.	[McCue, Hannah V.; Burgoyne, Robert D.; Haynes, Lee P.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Mccue, HV (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	leeh@liv.ac.uk	Burgoyne, Robert/C-6706-2008; Burgoyne, Robert D/P-6641-2019	Burgoyne, Robert/0000-0002-9219-0387; Burgoyne, Robert D/0000-0002-9219-0387; McCue, Hannah/0000-0001-5237-3261	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust prize PhD studentship awarded to HVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Fries R, 2010, J NEUROCHEM, V113, P1150, DOI 10.1111/j.1471-4159.2010.06676.x; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2008, NAT CHEM BIOL, V4, P90, DOI 10.1038/nchembio0208-90; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; Kuroda R, 1996, J BIOCHEM-TOKYO, V120, P828; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mccue HV, 2009, BIOCHEM BIOPH RES CO, V380, P825, DOI 10.1016/j.bbrc.2009.01.177; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rieke F, 2008, INVEST OPHTH VIS SCI, V49, P5126, DOI 10.1167/iovs.08-2236; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; WATT R, 1983, P NATL ACAD SCI-BIOL, V80, P6307, DOI 10.1073/pnas.80.20.6307	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17853	10.1371/journal.pone.0017853	http://dx.doi.org/10.1371/journal.pone.0017853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445352	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100010
J	Kashyap, MP; Singh, AK; Kumar, V; Tripathi, VK; Srivastava, RK; Agrawal, M; Khanna, VK; Yadav, S; Jain, SK; Pant, AB				Kashyap, Mahendra Pratap; Singh, Abhishek Kumar; Kumar, Vivek; Tripathi, Vinay Kumar; Srivastava, Ritesh Kumar; Agrawal, Megha; Khanna, Vinay Kumar; Yadav, Sanjay; Jain, Swatantra Kumar; Pant, Aditya Bhushan			Monocrotophos Induced Apoptosis in PC12 Cells: Role of Xenobiotic Metabolizing Cytochrome P450s	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; GLUTATHIONE-S-TRANSFERASE; IN-VITRO; RODENT LIVER; HEPG2 CELLS; RAT-BRAIN; GST P1-1; STRESS; ACTIVATION	Monocrotophos (MCP) is a widely used organophosphate (OP) pesticide. We studied apoptotic changes and their correlation with expression of selected cytochrome P450s (CYPs) in PC12 cells exposed to MCP. A significant induction in reactive oxygen species (ROS) and decrease in glutathione (GSH) levels were observed in cells exposed to MCP. Following the exposure of PC12 cells to MCP (10(-5) M), the levels of protein and mRNA expressions of caspase-3/9, Bax, Bcl(2), P-53, P-21, GSTP1-1 were significantly upregulated, whereas the levels of Bclw, Mcl1 were downregulated. A significant induction in the expression of CYP1A1/1A2, 2B1/2B2, 2E1 was also observed in PC12 cells exposed to MCP (10(-5) M), whereas induction of CYPs was insignificant in cells exposed to 10(-6) M concentration of MCP. We believe that this is the first report showing altered expressions of selected CYPs in MCP-induced apoptosis in PC12 cells. These apoptotic changes were mitochondria mediated and regulated by caspase cascade. Our data confirm the involvement of specific CYPs in MCP-induced apoptosis in PC12 cells and also identifies possible cellular and molecular mechanisms of organophosphate pesticide-induced apoptosis in neuronal cells.	[Kashyap, Mahendra Pratap; Singh, Abhishek Kumar; Kumar, Vivek; Tripathi, Vinay Kumar; Srivastava, Ritesh Kumar; Agrawal, Megha; Khanna, Vinay Kumar; Yadav, Sanjay; Pant, Aditya Bhushan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Kashyap, Mahendra Pratap; Singh, Abhishek Kumar; Kumar, Vivek; Tripathi, Vinay Kumar; Srivastava, Ritesh Kumar; Agrawal, Megha; Khanna, Vinay Kumar; Yadav, Sanjay; Pant, Aditya Bhushan] CSIR, New Delhi, India; [Jain, Swatantra Kumar] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; Jamia Hamdard University	Kashyap, MP (corresponding author), Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Srivastava, Ritesh/V-6029-2019; Yadav, Sanjay/E-2902-2010; Singh, Abhishek K/G-4032-2011; Kashyap, Mahendra/G-4305-2011	Kashyap, Mahendra/0000-0001-7924-4793; Agrawal, Megha/0000-0001-5280-7699; Singh, Abhishek Kumar/0000-0002-3186-9898	Council of Scientific and Industrial Research, New Delhi [SIP-08]; University Grant Commission, New Delhi [GAP-155]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, New Delhi(University Grants Commission, India)	Financial support by Council of Scientific and Industrial Research, New Delhi, (SIP-08) is acknowledged. University Grant Commission, New Delhi is acknowledged for providing the fellowship to Mr. M.P. Kashyap (GAP-155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardini S, 2002, J CELL BIOCHEM, V86, P340, DOI 10.1002/jcb.10219; Bernardini S, 2000, J CELL BIOCHEM, V77, P645, DOI 10.1002/(SICI)1097-4644(20000615)77:4<645::AID-JCB12>3.3.CO;2-0; Bernardini S, 2006, ANN HEMATOL, V85, P681, DOI 10.1007/s00277-006-0139-8; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Cederbaum AI, 2006, MT SINAI J MED, V73, P657; Chan JYH, 2006, NEUROPHARMACOLOGY, V51, P1109, DOI 10.1016/j.neuropharm.2006.06.024; Chen Q, 1998, MOL PHARMACOL, V53, P638, DOI 10.1124/mol.53.4.638; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Fujita K, 2001, MUTAT RES-FUND MOL M, V483, P35, DOI 10.1016/S0027-5107(01)00223-8; Galluzzi L, 2008, CELL CYCLE, V7, P1949, DOI 10.4161/cc.7.13.6222; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gong PF, 2006, HEPATOLOGY, V43, P144, DOI 10.1002/hep.21004; Hashizume T, 2009, MUTAT RES-GEN TOX EN, V677, P1, DOI 10.1016/j.mrgentox.2009.03.009; Hewitt R, 2007, ENVIRON HEALTH PERSP, V115, P129, DOI 10.1289/ehp.9361; Huk OL, 2004, J ARTHROPLASTY, V19, P84, DOI 10.1016/j.arth.2004.09.011; Johri A, 2008, TOXICOL APPL PHARM, V231, P10, DOI 10.1016/j.taap.2008.03.019; Kapoor N, 2006, LIFE SCI, V79, P1514, DOI 10.1016/j.lfs.2006.04.023; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kaur P, 2007, NEUROTOXICOLOGY, V28, P1208, DOI 10.1016/j.neuro.2007.08.001; Kim JY, 2007, ENDOCRINOLOGY, V148, P5112, DOI 10.1210/en.2007-0096; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KUMAR S, 2009, BIOCHEM PHARMACOL, V79, P1182; Li Q, 2009, TOXICOLOGY, V255, P53, DOI 10.1016/j.tox.2008.10.003; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571; Lupp A, 2006, INT J CLIN PHARM TH, V44, P225; Mari M, 2001, HEPATOLOGY, V33, P652, DOI 10.1053/jhep.2001.22521; Masoud A, 2009, CELL MOL NEUROBIOL, V29, P1245, DOI 10.1007/s10571-009-9420-4; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; Moore PD, 2010, ENVIRON TOXICOL, V25, P221, DOI 10.1002/tox.20492; Namazi M R, 2009, J Autoimmune Dis, V6, P4, DOI 10.1186/1740-2557-6-4; Naraharisetti SB, 2009, ENVIRON TOXICOL PHAR, V28, P213, DOI 10.1016/j.etap.2009.04.006; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Perera PMS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-73; Perez-Maldonado IN, 2005, ENVIRON RES, V98, P177, DOI 10.1016/j.envres.2004.11.001; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001; Sarabia L, 2009, ECOTOX ENVIRON SAFE, V72, P938, DOI 10.1016/j.ecoenv.2008.04.022; Saulsbury MD, 2008, TOXICOLOGY, V244, P98, DOI 10.1016/j.tox.2007.10.020; Shenouda J, 2009, TOXICOL APPL PHARM, V241, P135, DOI 10.1016/j.taap.2009.08.014; Siddiqui MA, 2010, TOXICOL IN VITRO, V24, P1681, DOI 10.1016/j.tiv.2010.05.019; Singh Mohan, 2004, Indian Journal of Experimental Biology, V42, P292; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Slotkin TA, 2009, ENVIRON HEALTH PERSP, V117, P587, DOI 10.1289/ehp.0800251; Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014; Zhao MR, 2009, CHEM RES TOXICOL, V22, P504, DOI 10.1021/tx800358b	51	41	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17757	10.1371/journal.pone.0017757	http://dx.doi.org/10.1371/journal.pone.0017757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445290	gold, Green Published, Green Submitted			2022-12-25	WOS:000288613300012
J	Friman, VP; Hiltunen, T; Jalasvuori, M; Lindstedt, C; Laanto, E; Ormala, AM; Laakso, J; Mappes, J; Bamford, JKH				Friman, Ville-Petri; Hiltunen, Teppo; Jalasvuori, Matti; Lindstedt, Carita; Laanto, Elina; Ormala, Anni-Maria; Laakso, Jouni; Mappes, Johanna; Bamford, Jaana K. H.			High Temperature and Bacteriophages Can Indirectly Select for Bacterial Pathogenicity in Environmental Reservoirs	PLOS ONE			English	Article							SERRATIA-MARCESCENS; ESCHERICHIA-COLI; DECREASED VIRULENCE; RESISTANT MUTANTS; SHIGA TOXIN; EVOLUTION; PHAGE; ADAPTATION; EXPRESSION; PROTOZOA	The coincidental evolution hypothesis predicts that traits connected to bacterial pathogenicity could be indirectly selected outside the host as a correlated response to abiotic environmental conditions or different biotic species interactions. To investigate this, an opportunistic bacterial pathogen, Serratia marcescens, was cultured in the absence and presence of the lytic bacteriophage PPV (Podoviridae) at 25 degrees C and 37 degrees C for four weeks (N = 5). At the end, we measured changes in bacterial phage-resistance and potential virulence traits, and determined the pathogenicity of all bacterial selection lines in the Parasemia plantaginis insect model in vivo. Selection at 37 degrees C increased bacterial motility and pathogenicity but only in the absence of phages. Exposure to phages increased the phage-resistance of bacteria, and this was costly in terms of decreased maximum population size in the absence of phages. However, this small-magnitude growth cost was not greater with bacteria that had evolved in high temperature regime, and no trade-off was found between phage-resistance and growth rate. As a result, phages constrained the evolution of a temperature-mediated increase in bacterial pathogenicity presumably by preferably infecting the highly motile and virulent bacteria. In more general perspective, our results suggest that the traits connected to bacterial pathogenicity could be indirectly selected as a correlated response by abiotic and biotic factors in environmental reservoirs.	[Friman, Ville-Petri; Hiltunen, Teppo; Lindstedt, Carita; Ormala, Anni-Maria; Laakso, Jouni; Mappes, Johanna] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland; [Jalasvuori, Matti; Laanto, Elina; Ormala, Anni-Maria; Bamford, Jaana K. H.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Virus Res, Jyvaskyla, Finland; [Jalasvuori, Matti; Laanto, Elina; Ormala, Anni-Maria; Bamford, Jaana K. H.] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Friman, Ville-Petri; Laakso, Jouni] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki	Friman, VP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	vifriman@jyu.fi	Laanto, Elina/ABA-8049-2020; Laakso, Jouni/I-7794-2013; Mappes, Johanna/AAZ-3627-2021; Hiltunen, Teppo/A-4308-2015	Laakso, Jouni/0000-0001-8245-9912; Hiltunen, Teppo/0000-0001-7206-2399; Friman, Ville-Petri/0000-0002-1592-157X; Mappes, Johanna/0000-0002-1117-5629; Laanto, Elina/0000-0003-4172-3128	Academy of Finland (Centre of Excellence in Evolution Research) [218349]; Academy of Finland (Centre of excellence in Virus Research) [1213467, 1106993, 1130724]	Academy of Finland (Centre of Excellence in Evolution Research)(Academy of Finland); Academy of Finland (Centre of excellence in Virus Research)(Academy of Finland)	This study was funded by the Academy of Finland (Centre of Excellence in Evolution Research; grant 218349, Centre of excellence in Virus Research; grant 1213467 and projects No. 1106993 and 1130724 for JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; BAMFORD JKH, 1991, VIROLOGY, V181, P348, DOI 10.1016/0042-6822(91)90501-2; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Case RJ, 2010, ENV MICROB IN PRESS; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Ducel G, 2002, PREVENTION HOSP ACQU; Duriez P, 2008, APPL ENVIRON MICROB, V74, P3935, DOI 10.1128/AEM.02710-07; Ellis CN, 2010, APPL ENVIRON MICROB, V76, P2387, DOI 10.1128/AEM.01930-09; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Halpern M, 2007, ENVIRON MICROBIOL, V9, P584, DOI 10.1111/j.1462-2920.2006.01174.x; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; HEIERSON A, 1986, J BACTERIOL, V167, P18, DOI 10.1128/jb.167.1.18-24.1986; HINNEN R, 1974, EUR J BIOCHEM, V50, P1, DOI 10.1111/j.1432-1033.1974.tb03867.x; Iino T, 1967, J Virol, V1, P445; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Lai HC, 2005, J BACTERIOL, V187, P3407, DOI 10.1128/JB.187.10.3407-3414.2005; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; LENSKI RE, 1988, ADV MICROB ECOL, V10, P1; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; Liu JH, 2000, J BIOMED SCI, V7, P475, DOI 10.1159/000025483; Malik-Kale P, APPL ENV MICROBIOL, V73, P3123; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; MAUCHLINE WS, 1994, INFECT IMMUN, V62, P2995, DOI 10.1128/IAI.62.7.2995-2997.1994; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; MEYNELL EW, 1961, J GEN MICROBIOL, V25, P253, DOI 10.1099/00221287-25-2-253; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PARUCHURI DK, 1987, J BACTERIOL, V169, P61, DOI 10.1128/jb.169.1.61-65.1987; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Sambrook J, 2001, MOL CLONING LAB MANU; Samuel ADT, 1999, P NATL ACAD SCI USA, V96, P9863, DOI 10.1073/pnas.96.17.9863; Santander J, 2007, ELECTRON J BIOTECHN, V10, P627, DOI 10.2225/vol10-issue4-fulltext-14; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Wei JR, 2006, INT J MED MICROBIOL, V296, P117, DOI 10.1016/j.ijmm.2006.01.033	61	42	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17651	10.1371/journal.pone.0017651	http://dx.doi.org/10.1371/journal.pone.0017651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423610	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900015
J	Kaulfurst-Soboll, H; Mertens, M; Brehler, R; von Schaewen, A				Kaulfuerst-Soboll, Heidi; Mertens, Melanie; Brehler, Randolf; von Schaewen, Antje			Reduction of Cross-Reactive Carbohydrate Determinants in Plant Foodstuff: Elucidation of Clinical Relevance and Implications for Allergy Diagnosis	PLOS ONE			English	Article							IMMUNOGLOBULIN-E ANTIBODIES; SKIN PRICK TESTS; TOMATO FRUIT; REDUCED ALLERGENICITY; STRONGLY AFFECT; IGE ANTIBODIES; ACID INVERTASE; ORAL CHALLENGE; POSITIVE SKIN; IN-VIVO	Background: A longstanding debate in allergy is whether or not specific immunoglobulin-E antibodies (sIgE), recognizing cross-reactive carbohydrate determinants (CCD), are able to elicit clinical symptoms. In pollen and food allergy, >= 20% of patients display in-vitro CCD reactivity based on presence of alpha 1,3-fucose and/or beta 1,2-xylose residues on N-glycans of plant (xylose/fucose) and insect (fucose) glycoproteins. Because the allergenicity of tomato glycoallergen Lyc e 2 was ascribed to N-glycan chains alone, this study aimed at evaluating clinical relevance of CCD-reduced foodstuff in patients with carbohydrate-specific IgE (CCD-sIgE). Methodology/Principal Findings: Tomato and/or potato plants with stable reduction of Lyc e 2 (tomato) or CCD formation in general were obtained via RNA interference, and gene-silencing was confirmed by immunoblot analyses. Two different CCD-positive patient groups were compared: one with tomato and/or potato food allergy and another with hymenopteravenom allergy (the latter to distinguish between CCD- and peptide-specific reactions in the food-allergic group). Non-allergic and CCD-negative food-allergic patients served as controls for immunoblot, basophil activation, and ImmunoCAP analyses. Basophil activation tests (BAT) revealed that Lyc e 2 is no key player among other tomato (glyco) allergens. CCD-positive patients showed decreased (re) activity with CCD-reduced foodstuff, most obvious in the hymenoptera venom-allergic but less in the food-allergic group, suggesting that in-vivo reactivity is primarily based on peptide- and not CCD-sIgE. Peptide epitopes remained unaffected in CCD-reduced plants, because CCD-negative patient sera showed reactivity similar to wild-type. In-house-made ImmunoCAPs, applied to investigate feasibility in routine diagnosis, confirmed BAT results at the sIgE level. Conclusions/Significance: CCD-positive hymenoptera venom-allergic patients (control group) showed basophil activation despite no allergic symptoms towards tomato and potato. Therefore, this proof-of-principle study demonstrates feasibility of CCD-reduced foodstuff to minimize 'false-positive results' in routine serum tests. Despite confirming low clinical relevance of CCD antibodies, we identified one patient with ambiguous in-vitro results, indicating need for further component-resolved diagnosis.	[Kaulfuerst-Soboll, Heidi; von Schaewen, Antje] Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany; [Mertens, Melanie; Brehler, Randolf] Univ Munster, Dept Dermatol, D-4400 Munster, Germany	University of Munster; University of Munster	Kaulfurst-Soboll, H (corresponding author), Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany.	schaewen@uni-muenster.de			Deutsche Forschungsgemeinschaft [DFG-SCHA 541/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG-SCHA 541/9) to AvS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Bassler OY, 2009, J PROTEOME RES, V8, P1111, DOI 10.1021/pr800186d; Ballmer-Weber BK, 2001, J ALLERGY CLIN IMMUN, V108, P301, DOI 10.1067/mai.2001.116430; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Bublin M, 2003, FASEB J, V17, P1697, DOI 10.1096/fj.02-0872fje; Chen S, 2003, PLANT J, V36, P731, DOI 10.1046/j.1365-313X.2003.01914.x; Ebo DG, 2004, CLIN EXP ALLERGY, V34, P137, DOI 10.1111/j.1365-2222.2004.01837.x; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Foetisch K, 2001, EUR FOOD RES TECHNOL, V213, P259, DOI 10.1007/s002170100343; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Iacovacci P., 2002, Clinical and Experimental Allergy, V32, P1620, DOI 10.1046/j.1365-2222.2002.01516.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; KLANN E, 1992, PLANT PHYSIOL, V99, P351, DOI 10.1104/pp.99.1.351; Kondo Y, 2001, INT ARCH ALLERGY IMM, V126, P294, DOI 10.1159/000049526; Le LQ, 2006, J ALLERGY CLIN IMMUN, V118, P1176, DOI 10.1016/j.jaci.2006.06.031; Le LQ, 2006, PLANT BIOTECHNOL J, V4, P231, DOI 10.1111/j.1467-7652.2005.00175.x; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Ling HQ, 1998, PLANT CELL REP, V17, P843, DOI 10.1007/s002990050495; Lorenz Y, 2006, J ALLERGY CLIN IMMUN, V118, P711, DOI 10.1016/j.jaci.2006.05.014; Luttkopf D, 2000, J ALLERGY CLIN IMMUN, V106, P390, DOI 10.1067/mai.2000.108711; Majamaa H, 2001, PEDIAT ALLERG IMM-UK, V12, P283, DOI 10.1034/j.1399-3038.2001.00096.x; Mari A, 1999, J ALLERGY CLIN IMMUN, V103, P1005, DOI 10.1016/S0091-6749(99)70171-5; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mari A, 2008, ALLERGY, V63, P891, DOI 10.1111/j.1398-9995.2008.01703.x; Mertens M, 2010, CLIN EXP ALLERGY, V40, P1333, DOI 10.1111/j.1365-2222.2010.03535.x; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; OHYAMA A, 1992, JPN J GENET, V67, P491, DOI 10.1266/jjg.67.491; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; PARK WD, 1983, PLANT PHYSIOL, V71, P156, DOI 10.1104/pp.71.1.156; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; Pots AM, 1999, J AGR FOOD CHEM, V47, P4587, DOI 10.1021/jf981180n; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; RUDESCHKO O, 1995, ALLERGY, V50, P262, DOI 10.1111/j.1398-9995.1995.tb01144.x; Sander I, 2005, INT ARCH ALLERGY IMM, V136, P39, DOI 10.1159/000082583; Seppala U, 1999, J ALLERGY CLIN IMMUN, V103, P165, DOI 10.1016/S0091-6749(99)70541-5; Seppala U, 2001, ALLERGY, V56, P619, DOI 10.1034/j.1398-9995.2001.00058.x; SONNEWALD U, 1989, PLANTA, V179, P171, DOI 10.1007/BF00393687; Strasser R, 2004, GLYCOCONJUGATE J, V21, P275, DOI 10.1023/B:GLYC.0000045099.29038.04; Turner JD, 2005, MICROBES INFECT, V7, P990, DOI 10.1016/j.micinf.2005.03.036; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; VONKROGH G, 1981, J AM ACAD DERMATOL, V5, P328, DOI 10.1016/S0190-9622(81)70099-9; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Weangsripanaval T, 2003, BIOSCI BIOTECH BIOCH, V67, P1299, DOI 10.1271/bbb.67.1299; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; Westphal S, 2003, EUR J BIOCHEM, V270, P1327, DOI 10.1046/j.1432-1033.2003.03503.x	51	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17800	10.1371/journal.pone.0017800	http://dx.doi.org/10.1371/journal.pone.0017800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423762	Green Submitted, Green Published, gold			2022-12-25	WOS:000288512400030
J	Mendez, V; Agullo, L; Gonzalez, M; Seeger, M				Mendez, Valentina; Agullo, Loreine; Gonzalez, Myriam; Seeger, Michael			The Homogentisate and Homoprotocatechuate Central Pathways Are Involved in 3-and 4-Hydroxyphenylacetate Degradation by Burkholderia xenovorans LB400	PLOS ONE			English	Article							2-PROTEIN COMPONENT ENZYME; ESCHERICHIA-COLI; PSEUDOMONAS-PUTIDA; MOLECULAR CHARACTERIZATION; BACTERIAL-DEGRADATION; CATABOLIC PATHWAY; KLEBSIELLA-PNEUMONIAE; ASPERGILLUS-NIDULANS; AROMATIC-COMPOUNDS; STRESS-PROTEINS	Background: Genome characterization of the model PCB-degrading bacterium Burkholderia xenovorans LB400 revealed the presence of eleven central pathways for aromatic compounds degradation, among them, the homogentisate and the homoprotocatechuate pathways. However, the functionality of these central pathways in strain LB400 has not been assessed and related peripheral pathways has not been described. Methodology/Principal Findings: The aims of this study were to determine the functionality of the homogentisate and homoprotocatechuate central pathways in B. xenovorans LB400 and to establish their role in 3-hydroxyphenylacetate (3-HPA) and 4-hydroxyphenylacetate (4-HPA) catabolism. Strain LB400 was able to grow using 3-HPA and 4-HPA as sole carbon source. A genomic search in LB400 suggested the presence of mhaAB and hpaBC genes clusters encoding proteins of the 3-hydroxyphenylacetate and 4-hydroxyphenylacetate peripheral pathways. LB400 cells grown with 3-HPA and 4-HPA degraded homogentisate and homoprotocatechuate and showed homogentisate 1,2-dioxygenase and homoprotocatechuate 2,3-dioxygenase activities. Transcriptional analyses by RT-PCR showed the expression of two chromosomally-encoded homogentisate dioxygenases (BxeA2725 and BxeA3900) and the hpaD gene encoding the homoprotocatechuate 2,3-dioxygenase during 3-HPA and 4-HPA degradation. The proteome analyses by two-dimensional polyacrilamide gel electrophoresis of B. xenovorans LB400 grown in 3-HPA and 4-HPA showed the induction of fumarylacetoacetate hydrolase HmgB (BxeA3899). Conclusions/Significance: This study revealed that strain LB400 used both homogentisate and homoprotocatechuate ring-cleavage pathways for 3-hydroxyphenylacetate and 4-hydroxyphenylacetate catabolism and that these four catabolic routes are functional, confirming the metabolic versatility of B. xenovorans LB400.	[Mendez, Valentina] Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile; Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Mendez, V (corresponding author), Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile.	michael.seeger@usm.cl	Seeger, Michael/B-3774-2012; Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022	Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686	FONDECYT [1070507, 7090079, 1020221]; MILENIO [P04/007-F]; Center for Nanotechnology and Systems Biology; USM [130836, 130948]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MILENIO; Center for Nanotechnology and Systems Biology; USM	M.S. gratefully acknowledges financial support from FONDECYT (1070507, 7090079 and 1020221) (http://www.fondecyt.cl), MILENIO P04/007-F (MIDEPLAN) (http://www.iniciativamilenio.cl) Center for Nanotechnology and Systems Biology (http://www.usm.cl) and USM (130836, 130948) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Camara B, 2009, J BACTERIOL, V191, P4905, DOI 10.1128/JB.00331-09; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; CHAPMAN PJ, 1962, J GEN MICROBIOL, V28, P251, DOI 10.1099/00221287-28-2-251; COOPER RA, 1980, J BACTERIOL, V143, P302, DOI 10.1128/JB.143.1.302-306.1980; Diaz E, 2004, INT MICROBIOL, V7, P173; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; MARTIN M, 1991, J GEN MICROBIOL, V137, P621, DOI 10.1099/00221287-137-3-621; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Saavedra JM, 2010, APPL MICROBIOL BIOT, V87, P1543, DOI 10.1007/s00253-010-2575-6; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mohamed MES, 2002, ARCH MICROBIOL, V178, P180, DOI 10.1007/s00203-002-0438-y; NOGALES P, 2009, BMC SYSTEMS BIOL, V2, P79; OLIVERA ER, 1994, EUR J BIOCHEM, V221, P375, DOI 10.1111/j.1432-1033.1994.tb18749.x; Perez-Pantoja D, 2003, J BACTERIOL, V185, P1534, DOI 10.1128/JB.185.5.1534-1542.2003; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; PRIETO MA, 1994, J BIOL CHEM, V269, P22823; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; ROPER DI, 1993, MOL GEN GENET, V237, P241, DOI 10.1007/BF00282806; Sanchez-Amat A, 1998, COMP BIOCHEM PHYS B, V119, P557, DOI 10.1016/S0305-0491(98)00028-5; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; Seeger M, 2010, J SOIL SCI PLANT NUT, V10, P320, DOI 10.4067/S0718-95162010000100007; Seeger M, 2009, MICROBIOLOGY HYDROCA, P1179; SEEGMILLER J, 1961, J BIOL CHEM, V236, P774; SPARNINS VL, 1974, J BACTERIOL, V120, P159, DOI 10.1128/JB.120.1.159-167.1974; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	41	36	37	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17583	10.1371/journal.pone.0017583	http://dx.doi.org/10.1371/journal.pone.0017583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423751	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100017
J	Sajid, A; Arora, G; Gupta, M; Upadhyay, S; Nandicoori, VK; Singh, Y				Sajid, Andaleeb; Arora, Gunjan; Gupta, Meetu; Upadhyay, Sandeep; Nandicoori, Vinay K.; Singh, Yogendra			Phosphorylation of Mycobacterium tuberculosis Ser/Thr Phosphatase by PknA and PknB	PLOS ONE			English	Article							2C PROTEIN PHOSPHATASES; SERINE/THREONINE PHOSPHATASE; REGULATORY PROTEIN; RECEPTOR-KINASE; 3RD METAL; SUBSTRATE; VIRULENCE; TYROSINE; MECHANISM; DEPHOSPHORYLATES	Background: The integrated functions of 11 Ser/Thr protein kinases (STPKs) and one phosphatase manipulate the phosphorylation levels of critical proteins in Mycobacterium tuberculosis. In this study, we show that the lone Ser/Thr phosphatase (PstP) is regulated through phosphorylation by STPKs. Principal Findings: PstP is phosphorylated by PknA and PknB and phosphorylation is influenced by the presence of Zn2+-ions and inorganic phosphate (Pi). PstP is differentially phosphorylated on the cytosolic domain with Thr(137), Thr(141), Thr(174) and Thr(290) being the target residues of PknB while Thr(137) and Thr(174) are phosphorylated by PknA. The Mn2+-ion binding residues Asp(38) and Asp(229) are critical for the optimal activity of PstP and substitution of these residues affects its phosphorylation status. Native PstP and its phosphatase deficient mutant PstP(c)(D38G) are phosphorylated by PknA and PknB in E. coli and addition of Zn2+/Pi in the culture conditions affect the phosphorylation level of PstP. Interestingly, the phosphorylated phosphatase is more active than its unphosphorylated equivalent. Conclusions and Significance: This study establishes the novel mechanisms for regulation of mycobacterial Ser/Thr phosphatase. The results indicate that STPKs and PstP may regulate the signaling through mutually dependent mechanisms. Consequently, PstP phosphorylation may play a critical role in regulating its own activity. Since, the equilibrium between phosphorylated and non-phosphorylated states of mycobacterial proteins is still unexplained, understanding the regulation of PstP may help in deciphering the signal transduction pathways mediated by STPKs and the reversibility of the phenomena.	[Sajid, Andaleeb; Arora, Gunjan; Gupta, Meetu; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Upadhyay, Sandeep; Nandicoori, Vinay K.] Natl Inst Immunol, New Delhi 110067, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sajid, A (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	ysingh@igib.res.in	Arora, Gunjan/AAL-3448-2020; Sajid, Andaleeb/AAI-2960-2020; Upadhyay, Sandeep/ABF-5956-2020; Upadhyay, Sandeep/X-5218-2019	Arora, Gunjan/0000-0003-0575-6205; Sajid, Andaleeb/0000-0001-6248-4985; Upadhyay, Sandeep/0000-0001-5958-5419; Nandicoori, Vinay/0000-0002-5682-4178	Council of Scientific and Industrial Research [NWP-0038]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Financial support to the work was provided by Council of Scientific and Industrial Research (NWP-0038). AS is a Senior Research Fellow of University Grants Commission, India. GA and MG are Senior Research Fellows of Council of Scientific and Industrial Research, India. SU is a Junior Research Fellow of Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Awano K, 2008, BIOCHEMISTRY-US, V47, P7248, DOI 10.1021/bi800067p; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bukczynska P, 2004, BIOCHEM J, V380, P939, DOI 10.1042/BJ20031780; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dahche H, 2009, EXTREMOPHILES, V13, P371, DOI 10.1007/s00792-008-0211-5; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Halbedel S, 2006, J BIOL CHEM, V281, P26253, DOI 10.1074/jbc.M605010200; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Jan G, 2009, MICROBES INFECT, V11, P935, DOI 10.1016/j.micinf.2009.06.002; Jang JC, 2007, MOL MICROBIOL, V64, P347, DOI 10.1111/j.1365-2958.2007.05654.x; Jiang LH, 2010, MOL PLANT PATHOL, V11, P277, DOI 10.1111/j.1364-3703.2009.00598.x; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; KOBAYASHI T, 1993, BIOCHEM BIOPH RES CO, V195, P484, DOI 10.1006/bbrc.1993.2069; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Miyahara A, 2008, J BIOL CHEM, V283, P25381, DOI 10.1074/jbc.M800400200; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Sugiura T, 2009, BIOMETALS, V22, P469, DOI 10.1007/s10534-009-9204-9; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Travis SM, 1997, P NATL ACAD SCI USA, V94, P11055, DOI 10.1073/pnas.94.20.11055; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; van der Knaap E, 1999, PLANT PHYSIOL, V120, P559, DOI 10.1104/pp.120.2.559; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Zhao SM, 2000, J BACTERIOL, V182, P1053, DOI 10.1128/JB.182.4.1053-1061.2000	54	34	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17871	10.1371/journal.pone.0017871	http://dx.doi.org/10.1371/journal.pone.0017871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21423706	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900052
J	Wagh, PK; Gray, JK; Zinser, GM; Vasiliauskas, J; James, L; Monga, SP; Waltz, SE				Wagh, P. K.; Gray, J. K.; Zinser, G. M.; Vasiliauskas, J.; James, L.; Monga, S. P.; Waltz, S. E.			beta-Catenin is required for Ron receptor-induced mammary tumorigenesis	ONCOGENE			English	Article						beta-catenin; hepatocyte growth factor-like protein; Ron receptor; breast cancer; receptor tyrosine kinase	BREAST-CANCER; TUMOR-FORMATION; OVEREXPRESSION; ACTIVATION; PATHWAY; CARCINOMAS; EXPRESSION; GENE; MICE; DIFFERENTIATION	Our previous studies demonstrated that selective overexpression of the Ron receptor tyrosine kinase in the murine mammary epithelium leads to mammary tumor formation. Biochemical analysis of mammary tumor lysates showed that Ron overexpression was associated with increases in beta-catenin expression and tyrosine phosphorylation. beta-Catenin has also been shown to be regulated through tyrosine phosphorylation by the receptor tyrosine kinases Met, Fer and Fyn. However, the molecular and physiological roles of beta-catenin and beta-catenin tyrosine phosphorylation downstream of Ron are not known. To investigate this association, we show that Ron and beta-catenin are coordinately elevated in human breast cancers. Our data also demonstrate that activation of Ron, through ligand binding by hepatocyte growth factor-like protein (HGFL), induces the tyrosine phosphorylation of beta-catenin, primarily on tyrosine residues Tyr 654 and Tyr 670. In addition, HGFL-mediated Ron activation induces both beta-catenin nuclear localization and transcriptional activity, with Tyr 654 and Tyr 670 residues of beta-catenin being critical for these processes. We also demonstrate that a knockdown of Ron in breast cancer cell lines leads to a loss of HGFL-induced beta-catenin-dependent transcriptional activation and cell growth, which can be rescued by activation of canonical Wnt/beta-catenin signaling. Moreover, we show that HGFL-dependent Ron activation mediates upregulation of the beta-catenin target genes cyclin D1 and c-myc, and that expression of these target genes in breast cancer cells is decreased following inhibition of Ron and/or beta-catenin. Finally, we show that genetic ablation of beta-catenin in Ron-expressing breast cancer cells decreases cellular proliferation in vitro, as well as mammary tumor growth and metastasis, following orthotopic transplantation into the mammary fat pad. Together, our data suggest that beta-catenin is a crucial downstream regulator of Ron receptor activation and is an important mediator of mammary tumorigenesis. Oncogene (2011) 30, 3694-3704; doi:10.1038/onc.2011.86; published online 21 March 2011	[Wagh, P. K.; Gray, J. K.; Vasiliauskas, J.; Waltz, S. E.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA; [Zinser, G. M.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [James, L.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [Monga, S. P.] Univ Pittsburgh, Div Expt Pathol, Pittsburgh, PA USA; [Waltz, S. E.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Waltz, SE (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Vontz Bldg Mol Studies,3125 Eden Ave, Cincinnati, OH 45267 USA.	susan.waltz@uc.edu		Waltz, Susan/0000-0003-3572-4642; Monga, Satdarshan/0000-0002-8437-3378	National Institutes of Health [CA100002]; Cincinnati Veteran's Administration Medical Center [1I01BX000803]; University of Cincinnati Cancer Center; University of Cincinnati Research Council; NATIONAL CANCER INSTITUTE [R01CA100002, T32CA117846, T32CA059268] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Veteran's Administration Medical Center; University of Cincinnati Cancer Center; University of Cincinnati Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We would like to acknowledge Dr Susanne I Wells for providing adenoviral reagents and Allie K Varner for her technical support. This work was supported by Public Health Service Grant CA100002 (SEW) from the National Institutes of Health, by grant 1I01BX000803 (SEW) from the Cincinnati Veteran's Administration Medical Center, by a University of Cincinnati Cancer Center Grant (SEW) and University of Cincinnati Research Council Grant (PKW).	Apte U, 2006, HEPATOLOGY, V44, P992, DOI 10.1002/hep.21317; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Castellone MD, 2009, CANCER RES, V69, P1867, DOI 10.1158/0008-5472.CAN-08-1982; COOMBES RC, 1990, J STEROID BIOCHEM, V37, P833, DOI 10.1016/0960-0760(90)90428-N; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Gujral TS, 2008, CANCER RES, V68, P1338, DOI 10.1158/0008-5472.CAN-07-6052; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hynes NE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2406; Kizildag S, 2008, J BUON, V13, P533; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; McClaine RJ, 2010, NEOPLASIA, V12, P650, DOI 10.1593/neo.10476; Meyer SE, 2009, DEV BIOL, V333, P173, DOI 10.1016/j.ydbio.2009.06.028; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Miller KD, 2006, CLIN CANCER RES, V12, P281, DOI 10.1158/1078-0432.CCR-05-0219; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; O'Toole JM, 2006, CANCER RES, V66, P9162, DOI 10.1158/0008-5472.CAN-06-0283; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Peace BE, 2001, ONCOGENE, V20, P6142, DOI 10.1038/sj.onc.1204836; Ranganathan S, 2005, PEDIATR DEVEL PATHOL, V8, P435, DOI 10.1007/s10024-005-0028-5; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Shien T, 2005, J CLIN PATHOL, V58, P1299, DOI 10.1136/jcp.2005.026096; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Zeng G, 2006, EXP CELL RES, V312, P3620, DOI 10.1016/j.yexcr.2006.08.003; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	35	42	44	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	34					3694	3704		10.1038/onc.2011.86	http://dx.doi.org/10.1038/onc.2011.86			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21423209	Green Accepted			2022-12-25	WOS:000294244500005
J	Che, MX; Jiang, YJ; Xie, YY; Jiang, LL; Hu, HY				Che, Mei-Xia; Jiang, Ya-Jun; Xie, Yuan-Yuan; Jiang, Lei-Lei; Hu, Hong-Yu			Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing	FASEB JOURNAL			English	Article						delocalization; amyotrophic lateral sclerosis; TDP-35; seeding; pre-mRNA splicing	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; NUCLEAR FACTOR TDP-43; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; MESSENGER-RNA; CFTR EXON-9; IN-VIVO; MUTATIONS	TAR DNA binding protein of 43 kDa (TDP-43) is a nuclear factor functioning in RNA processing. It is also a major deposited protein in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin (FTLD-U). To understand the mechanism underlying the inclusion body formation and possible functional alteration, we studied some TDP-43 fragments and their effects on RNA processing in cell models. The results show that the 35-kDa fragment of TDP-43 (namely TDP-35, residues 90-414), but not TDP-25A (184-414), is capable of forming cytoplasmic inclusion bodies and altering pre-mRNA splicing. The inclusions formed by TDP-35 can also recruit full-length TDP-43 to cytoplasmic deposition from functionally nuclear localization. The in vitro studies demonstrate that TDP-35, rather than TDP-43 and TDP-25A, is prone to aggregation, and it further serves as a seed to facilitate aggregation of full-length TDP-43. This suggests that fragmentation of TDP-43 leads to cellular redistribution, inclusion body formation, and altered RNA processing, which are implicated in the molecular pathogenesis of ALS and FTLD.-Che, M.-X., Jiang, Y.-J., Xie, Y.-Y., Jiang, L.-L., Hu, H.-Y. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing. FASEB J. 25, 2344-2353 (2011). www.fasebj.org	[Che, Mei-Xia; Jiang, Ya-Jun; Xie, Yuan-Yuan; Jiang, Lei-Lei; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Jiang, Yajun/AAE-7853-2020; Xie, Yuanyuan/F-1974-2017; Hu, Hong-Yu/AAQ-2633-2020; Che, Meixia/Q-2119-2019	Che, Meixia/0000-0002-4515-1414; Jiang, Yajun/0000-0002-0886-292X	National Basic Research Program of China [2006CB910305, 2006CB806508]; Sino-Swiss Joint Research Projects [GJHZ0909]; National Natural Science Foundation of China [30870485]	National Basic Research Program of China(National Basic Research Program of China); Sino-Swiss Joint Research Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. I. C. Eperon, (University of Leicester, Leicester, UK), for providing the plasmids of pTN23 and pTN24, and Drs. E. Buratti and F. E. Baralle (International Center for Genetic Engineering and Biotechnology, Trieste, Italy) for the TG13T5 minigene. The authors also thank Ms. J. J. Wu for technical assistance in purification of TDP-25A, and Drs. Z. H. Qin and J. Y. Hui for critical reading of the manuscript and informative discussion. This work was supported by grants from the National Basic Research Program of China (2006CB910305, 2006CB806508), Sino-Swiss Joint Research Projects (GJHZ0909), and the National Natural Science Foundation of China (30870485).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; BARMADA SJ, 1943, J NEUROSCI, V30, P639; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E., HUM MOL GENET, V19, P671; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NISHIMOTO Y, 1943, J BIOL CHEM, V285, P608; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Rohn TT, 2009, HISTOL HISTOPATHOL, V24, P1081, DOI 10.14670/HH-24.1081; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Shearman MS, 1999, METHOD ENZYMOL, V309, P716; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; STRONG MJ, J NEUROL SCI, V288, P1; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; XIE YY, FASEB J, V24, P196; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	41	56	56	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2344	2353		10.1096/fj.10-174482	http://dx.doi.org/10.1096/fj.10-174482			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21450909				2022-12-25	WOS:000292242200026
J	Ryan, T; Sharma, P; Ignatchenko, A; MacLennan, DH; Kislinger, T; Gramolini, AO				Ryan, Timothy; Sharma, Parveen; Ignatchenko, Alex; MacLennan, David H.; Kislinger, Thomas; Gramolini, Anthony O.			Identification of Novel Ryanodine Receptor 1 (RyR1) Protein Interaction with Calcium Homeostasis Endoplasmic Reticulum Protein (CHERP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; CENTRAL CORE DISEASE; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; CELL-PROLIFERATION; EXPRESSION; PHOSPHORYLATION; PHOSPHOLAMBAN; MOBILIZATION; MOUSE	The ryanodine receptor type 1 (RyR1) is a homotetrameric Ca2+ release channel located in the sarcoplasmic reticulum of skeletal muscle where it plays a role in the initiation of skeletal muscle contraction. A soluble, 6x-histidine affinity-tagged cytosolic fragment of RyR1 (amino acids 1-4243) was expressed in HEK-293 cells, and metal affinity chromatography under native conditions was used to purify the peptide together with interacting proteins. When analyzed by gel-free liquid chromatography mass spectrometry (LC-MS), 703 proteins were identified under all conditions. This group of proteins was filtered to identify putative RyR interacting proteins by removing those proteins found in only 1 RyR purification and proteins for which average spectral counts were enriched by less than 4-fold over control values. This resulted in 49 potential RyR1 interacting proteins, and 4 were selected for additional interaction studies: calcium homeostasis endoplasmic reticulum protein (CHERP), endoplasmic reticulum-Golgi intermediate compartment 53-kDa protein (LMAN1), T-complex protein, and phosphorylase kinase. Western blotting showed that only CHERP co-purified with affinity-tagged RyR1 and was eluted with imidazole. Immunofluorescence showed that endogenous CHERP co-localizes with endogenous RyR1 in the sarcoplasmic reticulum of rat soleus muscle. A combination of overexpression of RyR1 in HEK-293 cells with siRNA-mediated suppression of CHERP showed that CHERP affects Ca2+ release from the ER via RyR1. Thus, we propose that CHERP is an RyR1 interacting protein that may be involved in the regulation of excitation-contraction coupling.	[Ryan, Timothy; Sharma, Parveen; Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Sharma, Parveen; MacLennan, David H.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Ignatchenko, Alex; Kislinger, Thomas] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gramolini, AO (corresponding author), 112 Coll St, Toronto, ON M5G 1L6, Canada.	anthony.gramolini@utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540; Sharma, Parveen/0000-0002-5534-2417; Ignatchenko, Alexandr/0000-0002-6083-941X	Heart and Stroke Foundation of Ontario [T-6281]; Canadian Institutes of Health Research [MOP-84267, MT-3399]; Canadian Foundation for Innovation; Connaught Foundation; Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Connaught Foundation(University of Toronto); Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	This work was supported by Heart and Stroke Foundation of Ontario Grant T-6281, Canadian Institutes of Health Research Grant MOP-84267, the Canadian Foundation for Innovation, Connaught Foundation, the Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence (to A. O. G.), and Canadian Institutes of Health Research Grant MT-3399 (to D. H. M.).	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BEAM KG, 1989, ANN NY ACAD SCI, V560, P127, DOI 10.1111/j.1749-6632.1989.tb24090.x; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Brushia R. J., 1999, FRONT BIOSCI, V4, pD618; Chen SRW, 1997, BIOPHYS J, V73, P1904, DOI 10.1016/S0006-3495(97)78221-3; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Gaberc-Porekar V, 2001, J BIOCHEM BIOPH METH, V49, P335, DOI 10.1016/S0165-022X(01)00207-X; Gramolini AO, 2008, MOL CELL PROTEOMICS, V7, P519, DOI 10.1074/mcp.M700245-MCP200; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HORWICH AL, 1993, PHILOS T R SOC B, V339, P313, DOI 10.1098/rstb.1993.0030; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Kowara R, 2007, BIOCHEM BIOPH RES CO, V363, P190, DOI 10.1016/j.bbrc.2007.08.163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaPlante JM, 2000, BIOCHEM J, V348, P189, DOI 10.1042/0264-6021:3480189; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; O'Rourke FA, 2003, BIOCHEM J, V373, P133, DOI 10.1042/BJ20030013; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Samso M, 1998, J STRUCT BIOL, V121, P172, DOI 10.1006/jsbi.1997.3955; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	32	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17060	17068		10.1074/jbc.M110.197186	http://dx.doi.org/10.1074/jbc.M110.197186			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454501	Green Published, hybrid			2022-12-25	WOS:000290301900056
J	Djegbe, I; Cornelie, S; Rossignol, M; Demettre, E; Seveno, M; Remoue, F; Corbel, V				Djegbe, Innocent; Cornelie, Sylvie; Rossignol, Marie; Demettre, Edith; Seveno, Martial; Remoue, Franck; Corbel, Vincent			Differential Expression of Salivary Proteins between Susceptible and Insecticide-Resistant Mosquitoes of Culex quinquefasciatus	PLOS ONE			English	Article							ADULT FEMALE MOSQUITO; ANOPHELES-GAMBIAE; PIPIENS DIPTERA; PROBING TIME; ACETYLCHOLINESTERASE; COST; ENHANCEMENT; INFECTION; CONFER; AEDES	Background: The Culex quinquefasciatus mosquito, a major pest and vector of filariasis and arboviruses in the tropics, has developed multiple resistance mechanisms to the main insecticide classes currently available in public health. Among them, the insensitive acetylcholinesterase (ace-1(R) allele) is widespread worldwide and confers cross-resistance to organophosphates and carbamates. Fortunately, in an insecticide-free environment, this mutation is associated with a severe genetic cost that can affect various life history traits. Salivary proteins are directly involved in human-vector contact during biting and therefore play a key role in pathogen transmission. Methods and Results: An original proteomic approach combining 2D-electrophoresis and mass spectrometry was adopted to compare the salivary expression profiles of two strains of C. quinquefasciatus with the same genetic background but carrying either the ace-1(R) resistance allele or not (wild type). Four salivary proteins were differentially expressed (> 2 fold, P < 0.05) in susceptible (SLAB) and resistant (SR) mosquito strains. Protein identification indicated that the D7 long form, a major salivary protein involved in blood feeding success, presented lower expression in the resistant strain than the susceptible strain. In contrast, three other proteins, including metabolic enzymes (endoplasmin, triosephosphate isomerase) were significantly over-expressed in the salivary gland of ace-1(R) resistant mosquitoes. A catalogue of 67 salivary proteins of C. quinquefasciatus sialotranscriptome was also identified and described. Conclusion: The "resistance"-dependent expression of salivary proteins in mosquitoes may have considerable impact on biting behaviour and hence on the capacity to transmit parasites/viruses to humans. The behaviour of susceptible and insecticide-resistant mosquitoes in the presence of vertebrate hosts and its impact on pathogen transmission urgently requires further investigation.	[Djegbe, Innocent; Remoue, Franck; Corbel, Vincent] CREC, IRD, CNRS IRD UM1 5290 224, Cotonou, Benin; [Cornelie, Sylvie; Rossignol, Marie; Remoue, Franck; Corbel, Vincent] Ctr IRD, Lab Lutte Insectes Nuisibles LIN, IRD, CNRS IRD UM1 5290 224, Montpellier, France; [Demettre, Edith; Seveno, Martial] Univ Montpellier I & II, IGF, CNRS UMR 5203, INSERM U661, Montpellier, France	Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Djegbe, I (corresponding author), CREC, IRD, CNRS IRD UM1 5290 224, Cotonou, Benin.	djegbe1@yahoo.fr	Corbel, VIncent/G-9576-2016	cornelie, sylvie/0000-0003-3662-1450; corbel, vincent/0000-0003-0995-3257; SEVENO, Martial/0000-0002-5000-8735	IRD (Departement Soutien et Formation); French Institut de Recherche pour le Developpement (IRD); Anopheles Biology & Control (ABC) network	IRD (Departement Soutien et Formation); French Institut de Recherche pour le Developpement (IRD); Anopheles Biology & Control (ABC) network	Innocent Djegbe was supported by a fellowship provided by the IRD (Departement Soutien et Formation). This research was supported by the French Institut de Recherche pour le Developpement (IRD) and the Anopheles Biology & Control (ABC) network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2004, EVOLUTION, V58, P579, DOI 10.1111/j.0014-3820.2004.tb01680.x; Alout H, 2009, INSECT BIOCH MOL BIO; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Berticat C, 2004, GENET RES, V83, P189, DOI 10.1017/S0016672304006792; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Bourguet D, 1997, GENETICS, V147, P1225; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; Champagne Donald E., 1996, P85; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Cui F, 2006, J MED ENTOMOL, V43, P878, DOI 10.1603/0022-2585(2006)43[878:REOIAI]2.0.CO;2; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Maxwell CA, 1999, B WORLD HEALTH ORGAN, V77; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Nascimento EP, 2000, ARCH INSECT BIOCHEM, V43, P9, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;9::AID-ARCH2&gt;3.0.CO;2-2; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; Weill M, 2003, M S-MED SCI, V19, P1190, DOI 10.1051/medsci/200319121190; Weill M, 2005, INSECTICIDE RESISTAN; World Health Organization, 2006, GUIDELINES FOOD FORT	39	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17496	10.1371/journal.pone.0017496	http://dx.doi.org/10.1371/journal.pone.0017496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448269	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500006
J	Foldi, CJ; Eyles, DW; McGrath, JJ; Burne, THJ				Foldi, Claire J.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.			The Effects of Breeding Protocol in C57BL/6J Mice on Adult Offspring Behaviour	PLOS ONE			English	Article							ADVANCING PATERNAL AGE; MALE GERM-CELLS; REPRODUCTIVE SUCCESS; EARLY EXPERIENCE; PRENATAL STRESS; PLUS-MAZE; ANXIETY; RISK; SCHIZOPHRENIA; EMOTIONALITY	Animal experiments have demonstrated that a wide range of prenatal exposures can impact on the behaviour of the offspring. However, there is a lack of evidence as to whether the duration of sire exposure could affect such outcomes. We compared two widely used methods for breeding offspring for behavioural studies. The first involved housing male and female C57Bl/6J mice together for a period of time (usually 10-12 days) and checking for pregnancy by the presence of a distended abdomen (Pair-housed; PH). The second involved daily introduction of female breeders to the male homecage followed by daily checks for pregnancy by the presence of vaginal plugs (Time-mated; TM). Male and female offspring were tested at 10 weeks of age on a behavioural test battery including the elevated plus-maze, hole board, light/dark emergence, forced swim test, novelty-suppressed feeding, active avoidance and extinction, tests for nociception and for prepulse inhibition (PPI) of the acoustic startle response. We found that length of sire exposure (LSE) had no significant effects on offspring behaviour, suggesting that the two breeding protocols do not differentially affect the behavioural outcomes of interest. The absence of LSE effects on the selected variables examined does not detract from the relevance of this study. Information regarding the potential influences of breeding protocol is not only absent from the literature, but also likely to be of particular interest to researchers studying the influence of prenatal manipulations on adult behaviour.	[Foldi, Claire J.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [McGrath, John J.] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Foldi, CJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	t.burne@uq.edu.au	Burne, Thomas H/C-5656-2009; Foldi, Claire J/I-9400-2019; Eyles, Darryl W/X-3386-2018; McGrath, John Joseph/G-5493-2010	Burne, Thomas H/0000-0003-3502-9789; Foldi, Claire J/0000-0002-3293-8242; Eyles, Darryl W/0000-0002-5023-7095; McGrath, John Joseph/0000-0002-4792-6068	National Health and Medical Research Council of Australia [569528]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant no. 569528 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER R, 1963, SCIENCE, V142, P411, DOI 10.1126/science.142.3590.411; Alter MD, 2009, BIOL PSYCHIAT, V66, P1061, DOI 10.1016/j.biopsych.2009.05.026; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; Brinkworth MH, 2000, INT J ANDROL, V23, P123, DOI 10.1046/j.1365-2605.2000.00222.x; Brown AS, 2002, AM J PSYCHIAT, V159, P1528, DOI 10.1176/appi.ajp.159.9.1528; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Chang T, 2007, PSYCHOPHARMACOLOGY, V191, P211, DOI 10.1007/s00213-006-0649-z; Chung S, 2005, ENDOCRINOLOGY, V146, P3202, DOI 10.1210/en.2004-1458; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dalman C, 2002, AM J PSYCHIAT, V159, P1591, DOI 10.1176/appi.ajp.159.9.1591; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Estanislau C, 2006, INT J DEV NEUROSCI, V24, P255, DOI 10.1016/j.ijdevneu.2006.03.001; Foldi CJ, 2010, EUR J NEUROSCI, V31, P556, DOI 10.1111/j.1460-9568.2010.07074.x; Frick KM, 2000, NEUROSCIENCE, V95, P293; GARCIAPALOMARES S, 2008, BIOL REPROD; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; Gowaty PA, 2003, ANIM BEHAV, V65, P95, DOI 10.1006/anbe.2002.2026; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Holmes A, 2005, NEUROSCI BIOBEHAV R, V29, P1335, DOI 10.1016/j.neubiorev.2005.04.012; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; LUPODIPRISCO C, 1978, PHYSIOL BEHAV, V20, P345, DOI 10.1016/0031-9384(78)90230-5; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Margulis SW, 2005, ANIM BEHAV, V69, P627, DOI 10.1016/j.anbehav.2004.04.021; Maruoka T, 2009, NEUROSCI LETT, V454, P28, DOI 10.1016/j.neulet.2009.02.052; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Pallares ME, 2007, PHYSIOL BEHAV, V92, P951, DOI 10.1016/j.physbeh.2007.06.021; PARKENING TA, 1988, J GERONTOL, V43, pB79, DOI 10.1093/geronj/43.3.B79; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Skeer M, 2009, DRUG ALCOHOL DEPEN, V104, P65, DOI 10.1016/j.drugalcdep.2009.03.017; Smith RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008456; Sternberg WF, 2003, PHYSIOL BEHAV, V78, P375, DOI 10.1016/S0031-9384(03)00015-5; STRONG R, 1980, NEUROBIOL AGING, V1, P59, DOI 10.1016/0197-4580(80)90025-1; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; WERBOFF J, 1968, PHYSIOL BEHAV, V3, P35, DOI 10.1016/0031-9384(68)90028-0; Wright SL, 2000, J COMP PSYCHOL, V114, P183, DOI 10.1037/0735-7036.114.2.183	51	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18152	10.1371/journal.pone.0018152	http://dx.doi.org/10.1371/journal.pone.0018152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448436	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500046
J	Neuwald, JL; Valenzuela, N				Neuwald, Jennifer L.; Valenzuela, Nicole			The Lesser Known Challenge of Climate Change: Thermal Variance and Sex-Reversal in Vertebrates with Temperature-Dependent Sex Determination	PLOS ONE			English	Article							TURTLES CHRYSEMYS-PICTA; FLUCTUATING INCUBATION TEMPERATURES; EMBRYONIC PAINTED TURTLES; HATCHLING PHENOTYPES; NATURAL NESTS; OFFSPRING SEX; CONSTANT; RATIO; DIFFERENTIATION; ENVIRONMENTS	Climate change is expected to disrupt biological systems. Particularly susceptible are species with temperature-dependent sex determination (TSD), as in many reptiles. While the potentially devastating effect of rising mean temperatures on sex ratios in TSD species is appreciated, the consequences of increased thermal variance predicted to accompany climate change remain obscure. Surprisingly, no study has tested if the effect of thermal variance around high-temperatures (which are particularly relevant given climate change predictions) has the same or opposite effects as around lower temperatures. Here we show that sex ratios of the painted turtle (Chrysemys picta) were reversed as fluctuations increased around low and high unisexual mean-temperatures. Unexpectedly, the developmental and sexual responses around female-producing temperatures were decoupled in a more complex manner than around male-producing values. Our novel observations are not fully explained by existing ecological models of development and sex determination, and provide strong evidence that thermal fluctuations are critical for shaping the biological outcomes of climate change.	[Neuwald, Jennifer L.; Valenzuela, Nicole] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Iowa City, IA USA	Iowa State University	Neuwald, JL (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Iowa City, IA USA.	nvalenzu@iastate.edu	Neuwald, Jennifer/AAH-3468-2021	Neuwald, Jennifer/0000-0002-8850-5534; Valenzuela, Nicole/0000-0003-1148-631X	United States National Science Foundation [IOS0743284];  [IOS-0826664];  [IOS-0824550];  [IOS-0924290];  [IOS-0925486]	United States National Science Foundation(National Science Foundation (NSF)); ; ; ; 	This study was supported in part by the research grant IOS0743284 from the United States National Science Foundation and associated supplements IOS-0826664, IOS-0824550, IOS-0924290, and IOS-0925486 to Nicole Valenzuela. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha SJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P597, DOI 10.1086/652245; Boer GJ, 2009, J CLIMATE, V22, P3098, DOI 10.1175/2008JCLI2835.1; BULL JJ, 1985, ECOLOGY, V66, P1115, DOI 10.2307/1939163; CAGLE KD, 1993, FUNCT ECOL, V7, P653, DOI 10.2307/2390185; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; DALLWITZ MJ, 1992, 2 CSIRO DIV ENT, P1; DEEMING DC, 1989, AM ZOOL, V29, P973; Doody JS, 2006, EVOL ECOL, V20, P307, DOI 10.1007/s10682-006-0003-2; Du WG, 2009, J THERM BIOL, V34, P250, DOI 10.1016/j.jtherbio.2009.03.002; ETCHBERGER CR, 1992, CAN J ZOOL, V70, P391, DOI 10.1139/z92-058; EWERT MA, 1991, COPEIA, P50, DOI 10.2307/1446248; EWERT MA, 1985, BIOL REPTILIA DEV A; Georges A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P18, DOI 10.1086/425200; GEORGES A, 1994, J EXP ZOOL, V270, P432, DOI 10.1002/jez.1402700504; Georges Arthur, 2004, P79; GUTZKE WHN, 1987, HERPETOLOGICA, V43, P393; GUTZKE WHN, 1984, COPEIA, P546, DOI 10.2307/1445216; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Janzen FJ, 2002, J HERPETOL, V36, P308, DOI 10.1670/0022-1511(2002)036[0308:ESITAP]2.0.CO;2; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; JANZEN FJ, 1994, ECOLOGY, V75, P1593, DOI 10.2307/1939620; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Les HL, 2007, J EXP ZOOL PART A, V307A, P274, DOI 10.1002/jez.374; Les HL, 2009, PHYSIOL BIOCHEM ZOOL, V82, P105, DOI 10.1086/590263; MAHMOUD IY, 1973, J MORPHOL, V141, P269, DOI 10.1002/jmor.1051410303; Morjan CL, 2003, BEHAV ECOL SOCIOBIOL, V53, P254, DOI 10.1007/s00265-002-0570-3; MROSOVSKY N, 1992, CAN J ZOOL, V70, P530, DOI 10.1139/z92-080; Mullins MA, 2006, HERPETOLOGICA, V62, P27, DOI 10.1655/04-02.1; PACKARD GC, 1991, HERPETOLOGICA, V47, P125; Paitz RT, 2010, CAN J ZOOL, V88, P479, DOI 10.1139/Z10-020; Parrott A, 2010, ECOL MODEL, V221, P1378, DOI 10.1016/j.ecolmodel.2010.02.004; Patterson LD, 2008, CAN J ZOOL, V86, P882, DOI 10.1139/Z08-067; PIEAU C, 1982, J EXP ZOOL, V220, P353, DOI 10.1002/jez.1402200310; Sarma SSS, 2005, HYDROBIOLOGIA, V542, P315, DOI 10.1007/s10750-004-3247-2; SCHWARZKOPF L, 1985, CAN J ZOOL, V63, P2543, DOI 10.1139/z85-378; SCHWARZKOPF L, 1987, COPEIA, P53, DOI 10.2307/1446037; Souza Roselis Remor De, 1994, Journal of Herpetology, V28, P453; Sternadel LL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1069, DOI 10.1086/507662; Stouffer RJ, 2007, J CLIMATE, V20, P5455, DOI 10.1175/2007JCLI1384.1; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Valenzuela N, 2001, EVOL ECOL RES, V3, P779; Valenzuela N, 2010, SEX DEV, V4, P39, DOI 10.1159/000277935; Valenzuela N, 2001, ECOLOGY, V82, P3010, DOI 10.2307/2679831; VALENZUELA N, 2009, PAINTED TURTLE CHRYS, DOI DOI 10.1101/PDB.EMO124; VALENZUELA N, 2009, EGG INCUBATION COLLE, DOI DOI 10.1101/PDB.PROT5238; VALENZUELA N, 2011, CHROMOSOME IN PRESS; VALENZUELA N, UNPUB; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Valenzuela Nicole, 2004, P131; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Weisrock DW, 1999, FUNCT ECOL, V13, P94, DOI 10.1046/j.1365-2435.1999.00288.x; WILHOFT DC, 1983, J HERPETOL, V17, P38, DOI 10.2307/1563778	52	75	76	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18117	10.1371/journal.pone.0018117	http://dx.doi.org/10.1371/journal.pone.0018117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448294	gold, Green Published			2022-12-25	WOS:000288810500040
J	Hojyo, S; Fukada, T; Shimoda, S; Ohashi, W; Bin, BH; Koseki, H; Hirano, T				Hojyo, Shintaro; Fukada, Toshiyuki; Shimoda, Shinji; Ohashi, Wakana; Bin, Bum-Ho; Koseki, Haruhiko; Hirano, Toshio			The Zinc Transporter SLC39A14/ZIP14 Controls G-Protein Coupled Receptor-Mediated Signaling Required for Systemic Growth	PLOS ONE			English	Article							HORMONE (PTH)/PTH-RELATED PEPTIDE; LIV-1 SUBFAMILY; ACRODERMATITIS-ENTEROPATHICA; CHONDROCYTE DIFFERENTIATION; PLATE; GENE; HOMEOSTASIS; EXPRESSION; BONE; INSULIN	Aberrant zinc (Zn) homeostasis is associated with abnormal control of mammalian growth, although the molecular mechanisms of Zn's roles in regulating systemic growth remain to be clarified. Here we report that the cell membrane-localized Zn transporter SLC39A14 controls G-protein coupled receptor (GPCR)-mediated signaling. Mice lacking Slc39a14 (Slc39a14-KO mice) exhibit growth retardation and impaired gluconeogenesis, which are attributable to disrupted GPCR signaling in the growth plate, pituitary gland, and liver. The decreased signaling is a consequence of the reduced basal level of cyclic adenosine monophosphate ( cAMP) caused by increased phosphodiesterase (PDE) activity in Slc39a14-KO cells. We conclude that SLC39A14 facilitates GPCR-mediated cAMP-CREB signaling by suppressing the basal PDE activity, and that this is one mechanism for Zn's involvement in systemic growth processes. Our data highlight SLC39A14 as an important novel player in GPCR-mediated signaling. In addition, the Slc39a14-KO mice may be useful for studying the GPCR-associated regulation of mammalian systemic growth.	[Hojyo, Shintaro; Fukada, Toshiyuki; Ohashi, Wakana; Bin, Bum-Ho; Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa, Japan; [Hojyo, Shintaro; Fukada, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Osaka, Japan; [Shimoda, Shinji] Tsurumi Univ, Sch Dent Med, Dept Anat 1, Kanagawa, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Kanagawa, Japan; [Bin, Bum-Ho; Hirano, Toshio] Osaka Univ, JST CREST, Grad Sch Med, Lab Dev Immunol,Grad Sch Frontier Biosci, Osaka, Japan; [Bin, Bum-Ho; Hirano, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan	RIKEN; Osaka University; Tsurumi University; RIKEN; Osaka University; Osaka University	Hojyo, S (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa, Japan.	hirano@molonc.med.osaka-u.ac.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854	KAKENHI [20249030]; JST-CREST	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by KAKENHI (#20249030) and the JST-CREST program (http://www.jst.go.jp/kisoken/crest/en/area03/2-05.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2005, SEMIN LIVER DIS, V25, P420, DOI 10.1055/s-2005-923314; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Brand IA, 1996, J BIOL CHEM, V271, P1941, DOI 10.1074/jbc.271.4.1941; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cousins RJ, 1996, PRESENT KNOWLEDGE NU, V7th, P293; Dufner-Beattie J, 2006, GENESIS, V44, P239, DOI 10.1002/dvg.20211; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Georgiev P, 2010, CELL METAB, V12, P386, DOI 10.1016/j.cmet.2010.08.012; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; GUO J, 1995, ENDOCRINOLOGY, V136, P3884, DOI 10.1210/en.136.9.3884; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Joyner AL, 2000, GENE TARGETING PRACT; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kasper G, 2005, INT J CANCER, V117, P961, DOI 10.1002/ijc.21235; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; MAYO KE, 1995, RECENT PROG HORM RES, V50, P35; Milon B, 2001, FEBS LETT, V507, P241, DOI 10.1016/S0014-5793(01)02950-7; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Nishida K, 2009, J EXP MED, V206, P1351, DOI 10.1084/jem.20082533; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Ovesen J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P428; Percival MD, 1997, BIOCHEM BIOPH RES CO, V241, P175, DOI 10.1006/bbrc.1997.7542; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; PRASAD AS, 1995, NUTRITION, V11, P93; Procter AM, 1998, HUM GENET, V103, P255, DOI 10.1007/s004390050815; Rossi L, 2001, J NUTR, V131, P1142, DOI 10.1093/jn/131.4.1142; Sakharova AA, 2008, J CLIN ENDOCR METAB, V93, P2755, DOI 10.1210/jc.2008-0079; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; VALLEE BL, 1993, BIOCHEMISTRY-US, V32, P6493, DOI 10.1021/bi00077a001; von Bulow V, 2005, J IMMUNOL, V175, P4697, DOI 10.4049/jimmunol.175.7.4697; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yoshida E, 2001, EXP CELL RES, V265, P64, DOI 10.1006/excr.2001.5161; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	60	122	123	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18059	10.1371/journal.pone.0018059	http://dx.doi.org/10.1371/journal.pone.0018059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445361	gold, Green Published, Green Submitted			2022-12-25	WOS:000288809100026
J	Yung, HW; Charnock-Jones, DS; Burton, GJ				Yung, Hong Wa; Charnock-Jones, D. Stephen; Burton, Graham J.			Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner	PLOS ONE			English	Article							PROTEIN-KINASE-B; RICTOR-MTOR COMPLEX; INDUCED APOPTOSIS; ACTIVATION; GRP78/BIP; CELLS; INSULIN; BINDING; ER; IDENTIFICATION	Endoplasmic reticulum (ER) stress is a common factor in the pathophysiology of diverse human diseases that are characterised by contrasting cellular behaviours, from proliferation in cancer to apoptosis in neurodegenerative disorders. Coincidently, dysregulation of AKT/PKB activity, which is the central regulator of cell growth, proliferation and survival, is often associated with the same diseases. Here, we demonstrate that ER stress modulates AKT substrate specificity in a severity-dependent manner, as shown by phospho-specific antibodies against known AKT targets. ER stress also reduces both total and phosphorylated AKT in a severity-dependent manner, without affecting activity of the upstream kinase PDK1. Normalisation to total AKT revealed that under ER stress phosphorylation of Thr308 is suppressed while that of Ser473 is increased. ER stress induces GRP78, and siRNA-mediated knock-down of GRP78 enhances phosphorylation at Ser473 by 3.6 fold, but not at Thr308. Substrate specificity is again altered. An in-situ proximity ligation assay revealed a physical interaction between GRP78 and AKT at the plasma membrane of cells following induction of ER stress. Staining was weak in cells with normal nuclear morphology but stronger in those displaying rounded, condensed nuclei. Co-immunoprecipitation of GRP78 and P-AKT(Ser473) confirmed the immuno-complex consists of non-phosphorylated AKT (Ser473 and Thr308). The interaction is likely specific as AKT did not bind to all molecular chaperones, and GRP78 did not bind to p70 S6 kinase. These findings provide one mechanistic explanation for how ER stress contributes to human pathologies demonstrating contrasting cell fates via modulation of AKT signalling.	[Yung, Hong Wa; Charnock-Jones, D. Stephen; Burton, Graham J.] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Charnock-Jones, D. Stephen] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Charnock-Jones, D. Stephen; Burton, Graham J.] Natl Inst Hlth Res, Cambridge Comprehens Biomed Res Ctr, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Yung, HW (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Cambridge, England.	gjb2@cam.ac.uk	Charnock-Jones, D. Stephen/AAE-3391-2020; Charnock-Jones, D. Stephen/B-3743-2009	Charnock-Jones, D. Stephen/0000-0002-2936-4890; Charnock-Jones, D. Stephen/0000-0002-2936-4890	Wellcome Trust [084804/2/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (084804/2/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barati MT, 2006, J PROTEOME RES, V5, P1636, DOI 10.1021/pr0502469; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; LIN Y, 2010, LUNG CANC; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Merrick BA, 1996, BBA-PROTEIN STRUCT M, V1297, P57; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; ZHANG Y, 2010, J BIOL CHEM; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	39	114	115	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17894	10.1371/journal.pone.0017894	http://dx.doi.org/10.1371/journal.pone.0017894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445305	gold, Green Published, Green Submitted			2022-12-25	WOS:000288613300020
J	Chen, SP; Fuh, JL; Wang, SJ; Tsai, SJ; Hong, CJ; Yang, AC				Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun; Tsai, Shih-Jen; Hong, Chen-Jee; Yang, Albert C.			Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Modulates Reversible Cerebral Vasoconstriction Syndromes	PLOS ONE			English	Article							BDNF; MEDIATOR	Background: Reversible cerebral vasoconstriction syndrome (RCVS) could be complicated by cerebral ischemic events. Hypothetical mechanisms of RCVS involve endothelial dysfunction and sympathetic overactivity, both of which were reported to be related to brain-derived neurotrophic factor (BDNF). The study investigated the association between functional BDNF Val66Met polymorphism and RCVS. Methods: Patients with RCVS and controls were prospectively recruited and genotyped for the BDNF Val66Met polymorphism. Magnetic resonance angiography (MRA) and transcranial color-coded Doppler sonography were employed to evaluate cerebral vasoconstriction. Genotyping results, clinical parameters, vasoconstriction scores, mean flow velocities of the middle cerebral artery (V-MCA), and Lindegaard indices were analyzed. Split-sample approach was employed to internally validate the data. Principal Findings: Ninety Taiwanese patients with RCVS and 180 age-and gender-matched normal controls of the same ethnicity completed the study. The genotype frequencies did not differ between patients and controls. Compared to patients with Met/Met homozygosity, patients with Val allele had higher mean vasoconstriction scores of all arterial segments (1.60 +/- 0.72 vs. 0.87 +/- 0.39, p < 0.001), V-MCA values (116.7 +/- 36.2 vs. 82.7 +/- 17.9 cm/s, p < 0.001), and LI (2.41 +/- 0.91 vs. 1.89 +/- 0.41, p = 0.001). None of the Met/Met homozygotes, but 38.9% of the Val carriers, had V-MCA values of > 120 cm/s (p < 0.001). Split-sample validation by randomization, age, entry time or residence of patients demonstrated concordant findings. Conclusions: Our findings link BDNF Val66Met polymorphism with the severity of RCVS for the first time and implicate possible pathogenic mechanisms for vasoconstriction in RCVS.	[Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun; Tsai, Shih-Jen; Hong, Chen-Jee; Yang, Albert C.] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Tsai, Shih-Jen; Hong, Chen-Jee] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wang, SJ (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.	sjwang@vghtpe.gov.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Fuh, Jong-Ling/0000-0001-9135-3351; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Wang, Shuu-Jiun/0000-0001-5179-5358	National Science Council of Taiwan [97-2628-B-010-007-MY3]; Taipei Veterans General Hospital [V98C1-143, V99B1-002]; Ministry of Education	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education	This study was supported in part by grants from the National Science Council of Taiwan (97-2628-B-010-007-MY3 to S-JW), Taipei Veterans General Hospital (V98C1-143 to S-JW and V99B1-002 to S-PC), and Ministry of Education (Aim for the Top University Plan to S-JW). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen SP, 2006, NEUROLOGY, V67, P2164, DOI 10.1212/01.wnl.0000249115.63436.6d; Chen SP, 2008, ANN NEUROL, V63, P751, DOI 10.1002/ana.21384; Chen SP, 2010, ANN NEUROL, V67, P648, DOI 10.1002/ana.21951; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; Dodick DW, 2002, J NEUROL NEUROSUR PS, V72, P6, DOI 10.1136/jnnp.72.1.6; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hong CJ, 2003, NEUROSCI LETT, V349, P206, DOI 10.1016/S0304-3940(03)00828-0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jiang H, 2009, CLIN CHIM ACTA, V400, P3, DOI 10.1016/j.cca.2008.10.017; Kasselman LJ, 2006, J NEUROIMMUNOL, V175, P118, DOI 10.1016/j.jneuroim.2006.03.008; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kumar S, 2010, NEUROLOGY, V74, P893, DOI 10.1212/WNL.0b013e3181d55efa; Luo KR, 2010, PROG NEURO-PSYCHOPH, V34, P1433, DOI 10.1016/j.pnpbp.2010.07.033; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; PICARD RR, 1990, AM STAT, V44, P140, DOI 10.2307/2684155; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slonimsky JD, 2003, MOL CELL NEUROSCI, V23, P648, DOI 10.1016/S1044-7431(03)00102-7; Springer J, 2004, REGUL PEPTIDES, V118, P19, DOI 10.1016/j.regpep.2003.10.020; Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Zukowska Z, 2003, CAN J PHYSIOL PHARM, V81, P89, DOI 10.1139/Y03-006	27	38	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18024	10.1371/journal.pone.0018024	http://dx.doi.org/10.1371/journal.pone.0018024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437208	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100062
J	Dang, X; Bialasiewicz, S; Nissen, MD; Sloots, TP; Koralnik, IJ; Tan, CS				Dang, Xin; Bialasiewicz, Seweryn; Nissen, Michael D.; Sloots, Theo P.; Koralnik, Igor J.; Tan, Chen S.			Infrequent Detection of KI, WU and MC Polyomaviruses in Immunosuppressed Individuals with or without Progressive Multifocal Leukoencephalopathy	PLOS ONE			English	Article							MERKEL CELL-CARCINOMA; ASYMPTOMATIC REACTIVATION; CEREBROSPINAL-FLUID; JC VIRUS; NATALIZUMAB; INFECTION; ADULTS; BK	Conflicting prevalence of newly identified KI(KIPyV), WU(WUPyV) and Merkel Cell Carcinoma(MCPyV) polyomaviruses have been reported in progressive multifocal leukoencephalopathy(PML) patient samples, ranging from 0 to 14.3%. We analyzed the prevalence of these polyomaviruses in cerebrospinal fluid(CSF), peripheral blood mononuclear cells(PBMC), and bone marrow samples from PML patients, immunosuppressed individuals with or without HIV, and multiple sclerosis(MS) patients. Distinct PCR tests for KIPyV, WUPyV and MCPyV DNA performed in two independent laboratories detected low levels of MCPyV DNA only in 1/269 samples. The infrequent detections of these viruses in multiple samples from immunosuppressed individuals including those with PML suggest that their reactivation mechanisms may be different from that of JC polyomavirus (JCPyV) and that they do not play a role in the pathogenesis of PML.	[Dang, Xin; Koralnik, Igor J.; Tan, Chen S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Dang, Xin; Koralnik, Igor J.; Tan, Chen S.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div NeuroVirol, Boston, MA 02215 USA; [Bialasiewicz, Seweryn; Nissen, Michael D.; Sloots, Theo P.] Sir Albert Sakzewski Virus Res Ctr, Queensland Pediat Infect Dis Lab, Brisbane, Qld, Australia; [Bialasiewicz, Seweryn; Nissen, Michael D.; Sloots, Theo P.] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Tan, Chen S.] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Dang, X (corresponding author), Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	ctan@bidmc.harvard.edu	Sloots, Theo P/E-6118-2011; Nissen, Michael D/M-6823-2013; Bialasiewicz, Seweryn/F-1414-2010	Nissen, Michael D/0000-0003-1686-3313; Bialasiewicz, Seweryn/0000-0001-9474-6943	Public Health Service [R01 NS 047029, R01 NS 041198, K24 NS 060950]; Harvard Medical School Center for AIDS Research (CFAR), National Institutes of Health [P30 AI60354]; Queensland Children's Medical Research Institute [50006]; NIH [K08 NS 064215-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047029, R01NS041198, K24NS060950, K08NS064215] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Harvard Medical School Center for AIDS Research (CFAR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Queensland Children's Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support was provided by Public Health Service R01 NS 047029, R01 NS 041198, K24 NS 060950 to I.J.K. The Harvard Medical School Center for AIDS Research (CFAR), a National Institutes of Health-funded program (P30 AI60354), NIH K08 NS 064215-01A1 to CST, and Queensland Children's Medical Research Institute Program Grant 50006 to M.D.N. and T. P. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Babakir-Mina M, 2010, EMERG INFECT DIS, V16, P1482, DOI 10.3201/eid1609.100211; Barzon L, 2009, J INFECT DIS, V200, P1755, DOI 10.1086/648095; Barzon L, 2009, J INFECT DIS, V200, P314, DOI 10.1086/599842; Barzon L, 2009, J CLIN VIROL, V45, P370, DOI 10.1016/j.jcv.2009.05.026; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Bialasiewicz S, 2009, J CLIN VIROL, V45, P249, DOI 10.1016/j.jcv.2009.05.002; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Focosi D, 2009, J CLIN VIROL, V45, P161, DOI 10.1016/j.jcv.2009.04.009; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gorelik L, 2009, NEW ENGL J MED, V361, P2487, DOI 10.1056/NEJMc0909622; Lam WY, 2010, J CLIN VIROL, V48, P11, DOI 10.1016/j.jcv.2010.01.017; Maggi F, 2010, J INFECT DIS, V201, P1276, DOI 10.1086/651379; Miller MA, 2009, EMERG INFECT DIS, V15, P1095, DOI 10.3201/eid1507.090150; Nguyen NL, 2009, EMERG INFECT DIS, V15, P1199, DOI 10.3201/eid1508.090270; Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008; Sharp CP, 2009, J INFECT DIS, V199, P398, DOI 10.1086/596062	18	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e16736	10.1371/journal.pone.0016736	http://dx.doi.org/10.1371/journal.pone.0016736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436884	Green Published, Green Submitted, gold			2022-12-25	WOS:000288514000001
J	Chen, C; Dow, C; Wang, P; Sidney, J; Read, A; Harmsen, A; Samuel, JE; Peters, B				Chen, Chen; Dow, Courtney; Wang, Peng; Sidney, John; Read, Amanda; Harmsen, Allen; Samuel, James E.; Peters, Bjoern			Identification of CD4(+) T Cell Epitopes in C-burnetii Antigens Targeted by Antibody Responses	PLOS ONE			English	Article							NODE B-CELLS; Q-FEVER; GAMMA-INTERFERON; DENDRITIC CELLS; PHASE-I; VACCINE PROPHYLAXIS; PROTEIN MICROARRAY; IMMUNE-COMPLEXES; MICE; INFECTION	Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute Q fever and chronic infections in humans. A killed, whole cell vaccine is efficacious, but vaccination can result in severe local or systemic adverse reactions. Although T cell responses are considered pivotal for vaccine derived protective immunity, the epitope targets of CD4(+) T cell responses in C. burnetii vaccination have not been elucidated. Since mapping CD4(+) epitopes in a genome with over 2,000 ORFs is resource intensive, we focused on 7 antigens that were known to be targeted by antibody responses. 117 candidate peptides were selected from these antigens based on bioinformatics predictions of binding to the murine MHC class II molecule H-2IA(b). We screened these peptides for recognition by IFN-gamma producing CD4(+) T cell in phase I C. burnetii whole cell vaccine (PI-WCV) vaccinated C57BL/6 mice and identified 8 distinct epitopes from four different proteins. The identified epitope targets account for 8% of the total vaccination induced IFN-gamma producing CD4(+) T cells. Given that less than 0.4% of the antigens contained in C. burnetii were screened, this suggests that prioritizing antigens targeted by antibody responses is an efficient strategy to identify at least a subset of CD4(+) targets in large pathogens. Finally, we examined the nature of linkage between CD4(+) T cell and antibody responses in PI-WCV vaccinated mice. We found a surprisingly non-uniform pattern in the help provided by epitope specific CD4(+) T cells for antibody production, which can be specific for the epitope source antigen as well as non-specific. This suggests that a complete map of CD4(+) response targets in PI-WCV vaccinated mice will likely include antigens against which no antibody responses are made.	[Chen, Chen; Samuel, James E.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX 77840 USA; [Dow, Courtney; Wang, Peng; Sidney, John; Peters, Bjoern] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA; [Read, Amanda; Harmsen, Allen] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; La Jolla Institute for Immunology; Montana State University System; Montana State University Bozeman	Chen, C (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX 77840 USA.	bpeters@liai.org		Chen, Chen/0000-0003-3862-062X	PSWRCE [U54 AI065359]; NIH [RO1A1057768, U54 AIO65359, U54 AI057156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U54AI065359] Funding Source: NIH RePORTER	PSWRCE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	study was supported by PSWRCE grant U54 AI065359 to BP, and NIH RO1A1057768, U54 AIO65359, U54 AI057156 to JES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND JR, 1994, MED J AUSTRALIA, V160, P704, DOI 10.5694/j.1326-5377.1994.tb125909.x; Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Beare PA, 2008, CLIN VACCINE IMMUNOL, V15, P1771, DOI 10.1128/CVI.00300-08; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Brennan RE, 2004, INFECT IMMUN, V72, P6666, DOI 10.1128/IAI.72.11.6666-6675.2004; BRETT SJ, 1989, EUR J IMMUNOL, V19, P1303, DOI 10.1002/eji.1830190723; Bynoe MS, 2005, P NATL ACAD SCI USA, V102, P2898, DOI 10.1073/pnas.0409880102; Chen C, 2009, CLIN MICROBIOL INFEC; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Cookson BT, 1997, J IMMUNOL, V158, P4310; Darrah PA, 2007, NAT MED ADV ONLINE P; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; HENDRIX LR, 1990, ANN NY ACAD SCI, V590, P534, DOI 10.1111/j.1749-6632.1990.tb42263.x; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; KAZAR J, 1977, ACTA VIROL, V21, P422; KAZAR J, 1986, ACTA VIROL, V30, P499; LAKE P, 1976, IMMUNOL COMMUN, V5, P795, DOI 10.3109/08820137609047620; MARMION BP, 1984, LANCET, V2, P1411; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; Morisawa Y, 2001, PEDIATR INFECT DIS J, V20, P546, DOI 10.1097/00006454-200105000-00018; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Murphey C, 2006, CELL IMMUNOL, V242, P110, DOI 10.1016/j.cellimm.2006.10.002; NOVAK M, 1992, ACTA VIROL, V36, P39; ORMSBEE RA, 1964, J IMMUNOL, V92, P404; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Roshick C, 2006, INFECT IMMUN, V74, P225, DOI 10.1128/IAI.74.1.225-238.2006; RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31; Southwood S, 1998, J IMMUNOL, V160, P3363; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Varghees S, 2002, INFECT IMMUN, V70, P6741, DOI 10.1128/IAI.70.12.6741-6750.2002; Vigil A, 2010, PROTEOMICS, V10, P2259, DOI 10.1002/pmic.201000064; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wykes M, 1998, J IMMUNOL, V161, P1313; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang GQ, 2005, INFECT IMMUN, V73, P1561, DOI 10.1128/IAI.73.3.1561-1567.2005; Zhang GQ, 2004, INFECT IMMUN, V72, P844, DOI 10.1128/IAI.72.2.844-852.2004; Zhang GQ, 2003, ANN NY ACAD SCI, V990, P510, DOI 10.1111/j.1749-6632.2003.tb07420.x; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372	56	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17712	10.1371/journal.pone.0017712	http://dx.doi.org/10.1371/journal.pone.0017712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423609	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900016
J	Chouquet, A; Paidassi, H; Ling, WL; Frachet, P; Houen, G; Arlaud, GJ; Gaboriaud, C				Chouquet, Anne; Paidassi, Helena; Ling, Wai Li; Frachet, Philippe; Houen, Gunnar; Arlaud, Gerard J.; Gaboriaud, Christine			X-Ray Structure of the Human Calreticulin Globular Domain Reveals a Peptide-Binding Area and Suggests a Multi-Molecular Mechanism	PLOS ONE			English	Article							CHAPERONE FUNCTION; IDENTIFICATION; CELLS; MOLECULES; SYSTEM	In the endoplasmic reticulum, calreticulin acts as a chaperone and a Ca2+-signalling protein. At the cell surface, it mediates numerous important biological effects. The crystal structure of the human calreticulin globular domain was solved at 1.55 angstrom resolution. Interactions of the flexible N-terminal extension with the edge of the lectin site are consistently observed, revealing a hitherto unidentified peptide-binding site. A calreticulin molecular zipper, observed in all crystal lattices, could further extend this site by creating a binding cavity lined by hydrophobic residues. These data thus provide a first structural insight into the lectin-independent binding properties of calreticulin and suggest new working hypotheses, including that of a multi-molecular mechanism.	[Chouquet, Anne; Paidassi, Helena; Ling, Wai Li; Gaboriaud, Christine] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Frachet, Philippe] UJF Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Arlaud, Gerard J.] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Statens Serum Institut; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Chouquet, A (corresponding author), CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France.	christine.gaboriaud@ibs.fr	Ling, Wai Li W/F-9823-2012; Paidassi, Helena/M-5739-2014; frachet, philippe/Q-2869-2019; Frachet, philippe/C-3797-2018	Ling, Wai Li W/0000-0002-4264-5750; frachet, philippe/0000-0002-1658-3859; Frachet, philippe/0000-0002-1658-3859; gaboriaud, christine/0000-0001-5308-0516; Paidassi, Helena/0000-0001-9915-4365; Houen, Gunnar/0000-0002-5948-4156	CNRS, CEA, Grenoble Universite 1; National Research Agency [ANR-09-PIRI-0021]	CNRS, CEA, Grenoble Universite 1(French Atomic Energy CommissionCentre National de la Recherche Scientifique (CNRS)); National Research Agency(French National Research Agency (ANR))	Funding: This work was supporting by CNRS, CEA, Grenoble Universite 1 and by the National Research Agency grant ANR-09-PIRI-0021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bricogne G., 2009, BUSTER; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Martins I, 2010, ANN NY ACAD SCI, V1209, P77, DOI 10.1111/j.1749-6632.2010.05740.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paidassi H, 2011, J MOL BIOL IN PRESS; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856	32	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17886	10.1371/journal.pone.0017886	http://dx.doi.org/10.1371/journal.pone.0017886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423620	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900040
J	Rojas, LA; Yanez, C; Gonzalez, M; Lobos, S; Smalla, K; Seeger, M				Rojas, Luis A.; Yanez, Carolina; Gonzalez, Myriam; Lobos, Soledad; Smalla, Kornelia; Seeger, Michael			Characterization of the Metabolically Modified Heavy Metal-Resistant Cupriavidus metallidurans Strain MSR33 Generated for Mercury Bioremediation	PLOS ONE			English	Article							PLASMID-BEARING STRAIN; ESCHERICHIA-COLI; ALCALIGENES-EUTROPHUS; WASTE-WATER; RALSTONIA-METALLIDURANS; IONIC MERCURY; BACTERIA; SOIL; GENES; REMOVAL	Background: Mercury-polluted environments are often contaminated with other heavy metals. Therefore, bacteria with resistance to several heavy metals may be useful for bioremediation. Cupriavidus metallidurans CH34 is a model heavy metal-resistant bacterium, but possesses a low resistance to mercury compounds. Methodology/Principal Findings: To improve inorganic and organic mercury resistance of strain CH34, the IncP-1 beta plasmid pTP6 that provides novel merB, merG genes and additional other mer genes was introduced into the bacterium by biparental mating. The transconjugant Cupriavidus metallidurans strain MSR33 was genetically and biochemically characterized. Strain MSR33 maintained stably the plasmid pTP6 over 70 generations under non-selective conditions. The organomercurial lyase protein MerB and the mercuric reductase MerA of strain MSR33 were synthesized in presence of Hg2+. The minimum inhibitory concentrations (mM) for strain MSR33 were: Hg2+, 0.12 and CH3Hg+, 0.08. The addition of Hg2+ (0.04 mM) at exponential phase had not an effect on the growth rate of strain MSR33. In contrast, after Hg2+ addition at exponential phase the parental strain CH34 showed an immediate cessation of cell growth. During exposure to Hg2+ no effects in the morphology of MSR33 cells were observed, whereas CH34 cells exposed to Hg2+ showed a fuzzy outer membrane. Bioremediation with strain MSR33 of two mercury-contaminated aqueous solutions was evaluated. Hg2+ (0.10 and 0.15 mM) was completely volatilized by strain MSR33 from the polluted waters in presence of thioglycolate (5 mM) after 2 h. Conclusions/Significance: A broad-spectrum mercury-resistant strain MSR33 was generated by incorporation of plasmid pTP6 that was directly isolated from the environment into C. metallidurans CH34. Strain MSR33 is capable to remove mercury from polluted waters. This is the first study to use an IncP-1 beta plasmid directly isolated from the environment, to generate a novel and stable bacterial strain useful for mercury bioremediation.	[Rojas, Luis A.; Yanez, Carolina; Gonzalez, Myriam; Seeger, Michael] Univ Tecn Federico Santa Mari, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile; [Rojas, Luis A.; Yanez, Carolina; Gonzalez, Myriam; Seeger, Michael] Univ Tecn Federico Santa Mari, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile; [Rojas, Luis A.; Lobos, Soledad] Univ Valparaiso, Lab Espectroscopia, Fac Farm, Valparaiso, Chile; [Smalla, Kornelia] Inst Epidemiol & Pathogen Diagnost, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Braunschweig, Germany	Universidad de Valparaiso; Julius Kuhn-Institut	Rojas, LA (corresponding author), Univ Tecn Federico Santa Mari, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile.	michael.seeger@usm.cl	Rojas, Luis/K-4679-2019; Seeger, Michael/B-3774-2012; Seeger, Michael/AFK-3436-2022; Smalla, Kornelia/H-4002-2011; Yáñez, Carolina/F-6114-2013	Rojas, Luis/0000-0001-6935-8711; Yáñez, Carolina/0000-0003-3969-2078	MIDEPLAN [MILENIO P04/007-F]; USM [130522, 130836, 130948]; FONDECYT (CONICYT) [1070507]; CONICYT-BMBF; Nucleus Millennium EMBA; USM; PIIC-2009-USM	MIDEPLAN; USM; FONDECYT (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-BMBF(Federal Ministry of Education & Research (BMBF)); Nucleus Millennium EMBA; USM; PIIC-2009-USM	M.S. gratefully acknowledges financial support from MILENIO P04/007-F (MIDEPLAN) (http://www.iniciativamilenio.cl), USM 130522, 130836, and 130948 (http://www.usm.cl), and FONDECYT 1070507 (CONICYT) (http://www.fondecyt.cl) grants. M.S. and K.S. gratefully acknowledge CONICYT-BMBF grant. L.A.R. gratefully acknowledges Nucleus Millennium EMBA, USM and PIIC-2009-USM fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; Baldrian P, 2000, APPL ENVIRON MICROB, V66, P2471, DOI 10.1128/AEM.66.6.2471-2478.2000; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; BHRIAIN NNN, 1983, J BACTERIOL, V155, P690, DOI 10.1128/JB.155.2.690-703.1983; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Champier L, 2004, MOL MICROBIOL, V52, P1475, DOI 10.1111/j.1365-2958.2004.04071.x; CHANG JS, 1994, BIOTECHNOL BIOENG, V44, P999, DOI 10.1002/bit.260440817; Deckwer WD, 2004, ENVIRON SCI TECHNOL, V38, P1858, DOI 10.1021/es0300517; DON RH, 1981, J BACTERIOL, V145, P681, DOI 10.1128/JB.145.2.681-686.1981; Fatta D, 2007, J HAZARD MATER, V145, P169, DOI 10.1016/j.jhazmat.2006.11.009; FOX B, 1982, J BIOL CHEM, V257, P2498; HORN JM, 1994, APPL ENVIRON MICROB, V60, P357, DOI 10.1128/AEM.60.1.357-362.1994; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kiyono M, 1999, J BACTERIOL, V181, P726, DOI 10.1128/JB.181.3.726-730.1999; Kiyono M, 2009, FEBS LETT, V583, P1127, DOI 10.1016/j.febslet.2009.02.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lejon DPH, 2007, FEMS MICROBIOL ECOL, V61, P424, DOI 10.1111/j.1574-6941.2007.00365.x; Liebert CA, 1997, APPL ENVIRON MICROB, V63, P1066, DOI 10.1128/AEM.63.3.1066-1076.1997; Saavedra JM, 2010, APPL MICROBIOL BIOT, V87, P1543, DOI 10.1007/s00253-010-2575-6; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; MISRA TK, 1992, PLASMID, V27, P4, DOI 10.1016/0147-619X(92)90002-R; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; MOORE MJ, 1990, ACCOUNTS CHEM RES, V23, P301, DOI 10.1021/ar00177a006; Morgante V, 2010, FEMS MICROBIOL ECOL, V71, P114, DOI 10.1111/j.1574-6941.2009.00790.x; NAKAMURA K, 1988, APPL ENVIRON MICROB, V54, P2871, DOI 10.1128/AEM.54.11.2871-2873.1988; Nakamura K, 1999, BIODEGRADATION, V10, P443, DOI 10.1023/A:1008329511391; Nascimento Andrea M A, 2003, Genet Mol Res, V2, P92; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; NIES A, 1990, J BIOL CHEM, V265, P5648; Oehmen A, 2009, J HAZARD MATER, V165, P1040, DOI 10.1016/j.jhazmat.2008.10.094; Okino S, 2000, BIOTECHNOL LETT, V22, P783, DOI 10.1023/A:1005653825272; Permina EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-49; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Pukall R, 1996, FEMS MICROBIOL ECOL, V20, P53, DOI 10.1016/0168-6496(96)00021-9; RAY S, 1989, J BIOSCIENCE, V14, P173, DOI 10.1007/BF02703169; RITTER JA, 1992, WATER SCI TECHNOL, V25, P165, DOI 10.2166/wst.1992.0089; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAOUTER E, 1995, J IND MICROBIOL, V14, P343, DOI 10.1007/BF01569949; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; SCHOTTEL JL, 1978, J BIOL CHEM, V253, P4341; SEEGER M, 1993, FEMS MICROBIOL LETT, V108, P35; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; SUMMERS AO, 1974, J BACTERIOL, V119, P242, DOI 10.1128/JB.119.1.242-249.1974; TOP E, 1990, APPL ENVIRON MICROB, V56, P2471, DOI 10.1128/AEM.56.8.2471-2479.1990; VAITUZIS Z, 1975, APPL MICROBIOL, V29, P275, DOI 10.1128/AEM.29.2.275-286.1975; Valls M, 2002, FEMS MICROBIOL REV, V26, P327, DOI 10.1111/j.1574-6976.2002.tb00618.x; von Canstein H, 1999, APPL ENVIRON MICROB, V65, P5279; Wagner-Dobler I, 2003, APPL MICROBIOL BIOT, V62, P124, DOI 10.1007/s00253-003-1322-7; Yurieva O, 1997, MOL MICROBIOL, V24, P321, DOI 10.1046/j.1365-2958.1997.3261688.x	54	66	69	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17555	10.1371/journal.pone.0017555	http://dx.doi.org/10.1371/journal.pone.0017555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423734	gold, Green Submitted, Green Published			2022-12-25	WOS:000288512400015
J	Gong, L; Cullinane, M; Treerat, P; Ramm, G; Prescott, M; Adler, B; Boyce, JD; Devenish, RJ				Gong, Lan; Cullinane, Meabh; Treerat, Puthayalai; Ramm, Georg; Prescott, Mark; Adler, Ben; Boyce, John D.; Devenish, Rodney J.			The Burkholderia pseudomallei Type III Secretion System and BopA Are Required for Evasion of LC3-Associated Phagocytosis	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; INTRACELLULAR SHIGELLA; INFECTED MACROPHAGES; AUTOPHAGIC PATHWAY; MELIOIDOSIS; SURVIVAL; ESCAPE; CELLS; HOST; VIRULENCE	Burkholderia pseudomallei is the causative agent of melioidosis, a fatal infectious disease endemic in tropical regions worldwide, and especially prevalent in southeast Asia and northern Australia. This intracellular pathogen can escape from phagosomes into the host cytoplasm, where it replicates and infects adjacent cells. We previously demonstrated that, in response to B. pseudomallei infection of macrophage cell line RAW 264.7, a subset of bacteria co-localized with the autophagy marker protein, microtubule-associated protein light chain 3 (LC3), implicating autophagy in host cell defence against infection. Recent reports have suggested that LC3 can be recruited to both phagosomes and autophagosomes, thereby raising questions regarding the identity of the LC3-positive compartments in which invading bacteria reside and the mechanism of the autophagic response to B. pseudomallei infection. Electron microscopy analysis of infected cells demonstrated that the invading bacteria were either free in the cytosol, or sequestered in single-membrane phagosomes rather than double-membrane autophagosomes, suggesting that LC3 is recruited to B. pseudomallei-containing phagosomes. Partial or complete loss of function of type III secretion system cluster 3 (TTSS3) in mutants lacking the BopA (effector) or BipD (translocator) proteins respectively, resulted in delayed or no escape from phagosomes. Consistent with these observations, bopA and bipD mutants both showed a higher level of co-localization with LC3 and the lysosomal marker LAMP1, and impaired survival in RAW264.7 cells, suggesting enhanced killing in phagolysosomes. We conclude that LC3 recruitment to phagosomes stimulates killing of B. pseudomallei trapped in phagosomes. Furthermore, BopA plays an important role in efficient escape of B. pseudomallei from phagosomes.	[Gong, Lan; Ramm, Georg; Prescott, Mark; Devenish, Rodney J.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Cullinane, Meabh; Treerat, Puthayalai; Adler, Ben; Boyce, John D.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gong, Lan; Treerat, Puthayalai; Adler, Ben; Boyce, John D.; Devenish, Rodney J.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Gong, L (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	John.Boyce@monash.edu; Rod.Devenish@monash.edu	Boyce, John D/F-5058-2012; Gong, Lan/O-7886-2019; Gong, Lan/J-6368-2016	Boyce, John D/0000-0002-8614-3074; Gong, Lan/0000-0003-3136-1565; Gong, Lan/0000-0003-3136-1565; Ramm, Georg/0000-0003-3596-2288; Cullinane, Meabh/0000-0003-4947-1826	Australian Research Council; National Health and Medical Research Council, Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Australian Research Council and the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; CALYOV EE, 2010, ANNU REV MICROBIOL, V64, P495; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harley VS, 1998, MICROBIOS, V96, P71; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kayath CA, 2010, MICROBES INFECT, V12, P956, DOI 10.1016/j.micinf.2010.06.006; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Lerena MC, 2010, CELL MICROBIOL, V12, P10, DOI 10.1111/j.1462-5822.2009.01403.x; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2006, CURR OPIN MICROBIOL, V9, P62, DOI 10.1016/j.mib.2005.12.007; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pei JM, 2009, PROTEINS, V77, P413, DOI 10.1002/prot.22447; PRUKSACHARTVUTHI S, 1990, J MED MICROBIOL, V31, P109, DOI 10.1099/00222615-31-2-109; Rodrigues PH, 2008, FRONT BIOSCI-LANDMRK, V13, P178, DOI 10.2741/2668; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tan KS, 2010, J IMMUNOL, V184, P5160, DOI 10.4049/jimmunol.0902663; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Yoshimori T, 2009, CURR TOP MICROBIOL, V335, P217, DOI 10.1007/978-3-642-00302-8_10	50	115	120	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17852	10.1371/journal.pone.0017852	http://dx.doi.org/10.1371/journal.pone.0017852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412437	gold, Green Published, Green Submitted			2022-12-25	WOS:000288247800035
J	Sacca, F; Puorro, G; Antenora, A; Marsili, A; Denaro, A; Piro, R; Sorrentino, P; Pane, C; Tessa, A; Morra, VB; Cocozza, S; De Michele, G; Santorelli, FM; Filla, A				Sacca, Francesco; Puorro, Giorgia; Antenora, Antonella; Marsili, Angela; Denaro, Alessandra; Piro, Raffaele; Sorrentino, Pierpaolo; Pane, Chiara; Tessa, Alessandra; Morra, Vincenzo Brescia; Cocozza, Sergio; De Michele, Giuseppe; Santorelli, Filippo M.; Filla, Alessandro			A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design	PLOS ONE			English	Article							REAL-TIME PCR; FRATAXIN PROTEIN; POINT MUTATIONS; ONSET; GENE; QUANTIFICATION; IMMUNOASSAY; PHENOTYPE; EXPANSION; CARRIERS	Background: Friedreich's ataxia (FRDA) is the most common hereditary ataxia among caucasians. The molecular defect in FRDA is the trinucleotide GAA expansion in the first intron of the FXN gene, which encodes frataxin. No studies have yet reported frataxin protein and mRNA levels in a large cohort of FRDA patients, carriers and controls. Methodology/Principal Findings: We enrolled 24 patients with classic FRDA phenotype (cFA), 6 late onset FRDA (LOFA), all homozygous for GAA expansion, 5 pFA cases who harbored the GAA expansion in compound heterozygosis with FXN point mutations (namely, p.I154F, c.482+3delA, p.R165P), 33 healthy expansion carriers, and 29 healthy controls. DNA was genotyped for GAA expansion, mRNA/FXN was quantified in real-time, and frataxin protein was measured using lateral-flow immunoassay in peripheral blood mononuclear cells (PBMCs). Mean residual levels of frataxin, compared to controls, were 35.8%, 65.6%, 33%, and 68.7% in cFA, LOFA, pFA and healthy carriers, respectively. Comparison of both cFA and pFA with controls resulted in 100% sensitivity and specificity, but there was overlap between LOFA, carriers and controls. Frataxin levels correlated inversely with GAA1 and GAA2 expansions, and directly with age at onset. Messenger RNA expression was reduced to 19.4% in cFA, 50.4% in LOFA, 52.7% in pFA, 53.0% in carriers, as compared to controls (p<0.0001). mRNA levels proved to be diagnostic when comparing cFA with controls resulting in 100% sensitivity and specificity. In cFA and LOFA patients mRNA levels correlated directly with protein levels and age at onset, and inversely with GAA1 and GAA2. Conclusion/Significance: We report the first explorative study on combined frataxin and mRNA levels in PBMCs from a cohort of FRDA patients, carriers and healthy individuals. Lateral-flow immunoassay differentiated cFA and pFA patients from controls, whereas determination of mRNA in q-PCR was sensitive and specific only in cFA.	[Sacca, Francesco; Puorro, Giorgia; Antenora, Antonella; Marsili, Angela; Denaro, Alessandra; Piro, Raffaele; Sorrentino, Pierpaolo; Pane, Chiara; Morra, Vincenzo Brescia; De Michele, Giuseppe; Filla, Alessandro] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Tessa, Alessandra; Santorelli, Filippo M.] IRCCS Stella Maris, Pisa, Italy; [Cocozza, Sergio] Univ Naples Federico II, Dept Cellular & Mol Biol, Naples, Italy	University of Naples Federico II; IRCCS Fondazione Stella Maris; University of Naples Federico II	Sacca, F (corresponding author), Univ Naples Federico II, Dept Neurol Sci, Naples, Italy.	francesco.sacca@unina.it	Sorrentino, Pierpaolo/K-4311-2018; Tessa, Alessandra/K-2325-2016; Santorelli, Filippo M/ABE-5124-2020; Tessa, Alessandra/AAA-4442-2021	Sorrentino, Pierpaolo/0000-0002-9556-9800; Tessa, Alessandra/0000-0002-1445-6434; Santorelli, Filippo M/0000-0002-1359-9062; Tessa, Alessandra/0000-0002-1445-6434; Sacca, Francesco/0000-0002-1323-6317; Pane, Chiara/0000-0002-3459-2644	"Associazione il Cuore in un Dono" Cardito, Napoli; "Associazione Italiana per la lotta alle Sindromi Atassiche (AISA) sez. Campania", Napoli; Fondazione Cassa di Risparmio di Livorno; Italian Ministry of Health	"Associazione il Cuore in un Dono" Cardito, Napoli; "Associazione Italiana per la lotta alle Sindromi Atassiche (AISA) sez. Campania", Napoli(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Livorno; Italian Ministry of Health(Ministry of Health, Italy)	The study was supported in part by "Associazione il Cuore in un Dono" Cardito, Napoli (to AF), "Associazione Italiana per la lotta alle Sindromi Atassiche (AISA) sez. Campania", Napoli (to AF) and grants from Fondazione Cassa di Risparmio di Livorno and the Italian Ministry of Health (to FMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Bhidayasiri R, 2005, ARCH NEUROL-CHICAGO, V62, P1865, DOI 10.1001/archneur.62.12.1865; BOEHM T, 2010, NEUROL SCI      0527; Boesch S, 2007, ANN NEUROL, V62, P521, DOI 10.1002/ana.21177; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cagnoli C, 2004, J MOL DIAGN, V6, P96, DOI 10.1016/S1525-1578(10)60496-5; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Michele G, 2000, NEUROLOGY, V54, P496, DOI 10.1212/WNL.54.2.496; DeMichele G, 1996, NEUROLOGY, V47, P1260, DOI 10.1212/WNL.47.5.1260; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Filla A, 2000, MOVEMENT DISORD, V15, P1255, DOI 10.1002/1531-8257(200011)15:6<1255::AID-MDS1031>3.0.CO;2-C; GAKH O, 2010, J BIOL CHEM     1002; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; MONTERMINI V, 1997, ANN NEUROL, V41, P675; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Ragno M, 1997, NEUROLOGY, V49, P1617, DOI 10.1212/WNL.49.6.1617; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Steinkellner H, 2010, ANAL CHIM ACTA, V659, P129, DOI 10.1016/j.aca.2009.11.036; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019	26	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17627	10.1371/journal.pone.0017627	http://dx.doi.org/10.1371/journal.pone.0017627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412413	Green Published, gold, Green Submitted			2022-12-25	WOS:000288247800019
J	Clem, BF; Clem, AL; Yalcin, A; Goswami, U; Arumugam, S; Telang, S; Trent, JO; Chesney, J				Clem, B. F.; Clem, A. L.; Yalcin, A.; Goswami, U.; Arumugam, S.; Telang, S.; Trent, J. O.; Chesney, J.			A novel small molecule antagonist of choline kinase-alpha that simultaneously suppresses MAPK and PI3K/AKT signaling	ONCOGENE			English	Article						chemotherapy; choline kinase; metabolism; in silico; phosphocholine	BREAST-CANCER-CELLS; PHOSPHATIDIC-ACID; PHOSPHOLIPASE-D; PROSTATE-CANCER; RAS ACTIVATION; GROWTH-FACTORS; PHOSPHATIDYLCHOLINE; INHIBITORS; RAF-1; P-31	Choline kinase-alpha expression and activity are increased in multiple human neoplasms as a result of growth factor stimulation and activation of cancer-related signaling pathways. The product of choline kinase-alpha, phosphocholine, serves as an essential metabolic reservoir for the production of phosphatidylcholine, the major phospholipid constituent of membranes and substrate for the production of lipid second messengers. Using in silico screening for small molecules that may interact with the choline kinase-alpha substrate binding domain, we identified a novel competitive inhibitor, N-(3,5-dimethylphenyl)-2-[[5-(4-ethylphenyl)-1H-1,2,4-triazol-3-yl] sulfanyl] acetamide (termed CK37) that inhibited purified recombinant human choline kinase-alpha activity, reduced the steady-state concentration of phosphocholine in transformed cells, and selectively suppressed the growth of neoplastic cells relative to normal epithelial cells. Choline kinase-alpha activity is required for the downstream production of phosphatidic acid, a promoter of several Ras signaling pathways. CK37 suppressed mitogen-activated protein kinase and phosphatidylinositol 3-kinase/AKT signaling, disrupted actin cytoskeletal organization, and reduced plasma membrane ruffling. Finally, administration of CK37 significantly decreased tumor growth in a lung tumor xenograft mouse model, suppressed tumor phosphocholine, and diminished activating phosphorylations of extracellular signal-regulated kinase and AKT in vivo. Together, these results further validate choline kinase-alpha as a molecular target for the development of agents that interrupt Ras signaling pathways, and indicate that receptor-based computational screening should facilitate the identification of new classes of choline kinase-alpha inhibitors. Oncogene (2011) 30, 3370-3380; doi:10.1038/onc.2011.51; published online 21 March 2011	[Clem, B. F.; Clem, A. L.; Yalcin, A.; Goswami, U.; Arumugam, S.; Telang, S.; Trent, J. O.; Chesney, J.] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Clem, B. F.; Yalcin, A.; Telang, S.; Trent, J. O.; Chesney, J.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Clem, B. F.; Clem, A. L.; Yalcin, A.; Goswami, U.; Telang, S.; Trent, J. O.; Chesney, J.] Univ Louisville, Mol Targets Grp, Louisville, KY 40202 USA; [Arumugam, S.; Trent, J. O.] Univ Louisville, Struct Biol Program, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Yalcin, A.] Uludag Univ, Dept Biochem, Sch Vet Med, Bursa, Turkey	University of Louisville; University of Louisville; University of Louisville; University of Louisville; Uludag University	Chesney, J (corresponding author), Univ Louisville, Dept Med, 505 S Hancock St,CTRB,Room 424, Louisville, KY 40202 USA.	jotrent01@louisville.edu; jason.chesney@louisville.edu	Yalcin, Abdullah/ABI-4164-2020; Yalcin, Abdullah/AAA-6938-2022	Yalcin, Abdullah/0000-0001-8519-8375; trent, John/0000-0002-7346-4231	Brown Foundation; NCCRR [1P20 RR18733]; James Graham Brown Cancer Center; Ky Lung Cancer Research Program; National Cancer Institute [2R56CA116428-0509]; NATIONAL CANCER INSTITUTE [R01CA116428, R56CA116428] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	Brown Foundation; NCCRR; James Graham Brown Cancer Center; Ky Lung Cancer Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge Deanna Siow and Binks Wattenburg for assistance with the thin layer chromatography protocol, Erin Brock for assisting with the confocal microscopy experiments, Bennet Jenson for histopathology assistance, and Andrew Lane for NMR interpretation. We also thank Dr Arnon Lavie for providing the Delta 49N-hCK alpha 2 plasmid for the expression of recombinant choline kinase. NMR experiments were carried out at the James Graham Brown Cancer Center NMR facility, supported in part by the Brown Foundation and NCCRR Grant 1P20 RR18733. This work was supported by institutional funds from the James Graham Brown Cancer Center and by grants from the Ky Lung Cancer Research Program (JC & BFC) and the National Cancer Institute (JC: 2R56CA116428-0509).	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Chung TW, 2000, CELL SIGNAL, V12, P279, DOI 10.1016/S0898-6568(00)00065-6; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; de Molina AR, 2004, CANCER LETT, V206, P137, DOI 10.1016/j.canlet.2003.08.031; DEGANI H, 1986, RADIOLOGY, V161, P53, DOI 10.1148/radiology.161.1.3020609; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fan TWM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-79; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2003, MOL CANCER RES, V1, P789; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Hancock JF, 2007, NAT CELL BIOL, V9, P615, DOI 10.1038/ncb0607-615; Hernandez-Alcoceba R, 1999, CANCER RES, V59, P3112; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; JIMENEZ B, 1995, J CELL BIOCHEM, V57, P141, DOI 10.1002/jcb.240570114; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; KO KWS, 1986, J BIOL CHEM, V261, P7846; Li GP, 1997, J BIOL CHEM, V272, P10337; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; McCubrey JA, 2007, ADV ENZYME REGUL, V47, P64, DOI 10.1016/j.advenzreg.2006.12.013; NEEMAN M, 1989, P NATL ACAD SCI USA, V86, P5585, DOI 10.1073/pnas.86.14.5585; ONODERA K, 1986, JPN J CANCER RES, V77, P1201; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 2002, PHARMACOL THERAPEUT, V94, P35, DOI 10.1016/S0163-7258(02)00170-5; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Rodriguez-Gonzalez A, 2003, ONCOGENE, V22, P8803, DOI 10.1038/sj.onc.1207062; Roovers K, 2003, MOL CELL BIOL, V23, P4283, DOI 10.1128/MCB.23.12.4283-4294.2003; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scales SJ, 1999, NATURE, V401, P123, DOI 10.1038/43582; TAETLE R, 1987, CANCER TREAT REP, V71, P297; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Uchida T, 1996, BBA-LIPID LIPID MET, V1304, P89, DOI 10.1016/S0005-2760(96)00109-9; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; WARDEN CH, 1985, J BIOL CHEM, V260, P6006; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	54	54	60	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	30					3370	3380		10.1038/onc.2011.51	http://dx.doi.org/10.1038/onc.2011.51			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21423211	Green Accepted			2022-12-25	WOS:000293215700007
J	Renault, VM; Thekkat, PU; Hoang, KL; White, JL; Brady, CA; Broz, DK; Venturelli, OS; Johnson, TM; Oskoui, PR; Xuan, Z; Santo, EE; Zhang, MQ; Vogel, H; Attardi, LD; Brunet, A				Renault, V. M.; Thekkat, P. U.; Hoang, K. L.; White, J. L.; Brady, C. A.; Broz, D. Kenzelmann; Venturelli, O. S.; Johnson, T. M.; Oskoui, P. R.; Xuan, Z.; Santo, E. E.; Zhang, M. Q.; Vogel, H.; Attardi, L. D.; Brunet, A.			The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor	ONCOGENE			English	Article						FoxO transcription factors; p53; tumor suppression; cancer; aging; longevity	TRANSCRIPTION FACTOR FOXO3A; PROMOTES CELL-SURVIVAL; WILD-TYPE P53; LIFE-SPAN; P53-DEPENDENT APOPTOSIS; CALORIC RESTRICTION; COLORECTAL-CANCER; DIRECT ACTIVATION; DNA-DAMAGE; EXPRESSION	FoxO transcription factors have a conserved role in longevity, and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the functional interaction between FoxO and p53 have not been fully explored. Here, we show that p53 regulates the expression of FoxO3, one of the four mammalian FoxO genes, in response to DNA damaging agents in both mouse embryonic fibroblasts and thymocytes. We find that p53 transactivates FoxO3 in cells by binding to a site in the second intron of the FoxO3 gene, a genomic region recently found to be associated with extreme longevity in humans. While FoxO3 is not necessary for p53-dependent cell cycle arrest, FoxO3 appears to modulate p53-dependent apoptosis. We also find that FoxO3 loss does not interact with p53 loss for tumor development in vivo, although the tumor spectrum of p53-deficient mice appears to be affected by FoxO3 loss. Our findings indicate that FoxO3 is a p53 target gene, and suggest that FoxO3 and p53 are part of a regulatory transcriptional network that may have an important role during aging and cancer. Oncogene (2011) 30, 3207-3221; doi:10.1038/onc.2011.35; published online 21 March 2011	[Renault, V. M.; Thekkat, P. U.; Hoang, K. L.; White, J. L.; Venturelli, O. S.; Oskoui, P. R.; Attardi, L. D.; Brunet, A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Brady, C. A.; Broz, D. Kenzelmann; Johnson, T. M.; Attardi, L. D.] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Brady, C. A.; Johnson, T. M.; Attardi, L. D.; Brunet, A.] Stanford Univ, Canc Biol Grad Program, Stanford, CA 94305 USA; [Xuan, Z.; Zhang, M. Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Santo, E. E.] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Zhang, M. Q.] Tsinghua Univ, TNLIS, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, M. Q.] Tsinghua Univ, TNLIS, Bioinformat Div, Beijing 100084, Peoples R China; [Vogel, H.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Dallas; University of Amsterdam; Academic Medical Center Amsterdam; Tsinghua University; Tsinghua University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.	anne.brunet@stanford.edu		Vogel, Otto Hannes/0000-0002-0960-3508; Xuan, Zhenyu/0000-0001-9344-8493	NIH [R01 AG026648, R01 HG001696]; McCormick Award for Women in Science; Stanford University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026648] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Award for Women in Science; Stanford University(Stanford University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr Ron DePinho for his generous gift of the FoxO3 <SUP>/</SUP> mice. We thank Julien Sage for critical discussion, reading of the manuscript, help with tumor analysis and for taking the pictures for Figure 8d. We thank Jamie Brett for reading the manuscript. We thank Pauline Chu (Comparative Medicine Department, Stanford Medical School) for her help in processing the histopathology samples. We thank Dan Calnan for participating in earlier aspects of this work. This work was supported by NIH R01 AG026648 and a McCormick Award for Women in Science (AB). ZX, EES and MQZ were supported partly by NIH R01 HG001696. VMR received support from the Dean's Fellowship at Stanford University. Author contributions: VMR designed, performed and analyzed the lifespan and tumor spectrum of compound FoxO3/p53 mice (Figure 8). PUT completed Figure 1b, Figure 5b, Figure 6b, Figure 6e, Figure 7a and helped with Figure 2 and Figure 6d. KLH completed Figure 5d, Figure 5e, Figure 6a, Figure 6b and Figure 6c. JLW completed Figure 2, Figure 6d, and helped with Figure 3 and Figure 7b. CAB completed Figure 3 and Figure 7b. DKB completed Figure 5c. OSV initiated this project as her Honors Thesis and completed Figure 1a. TMJ completed Figure 4b. PRO completed Figure 6f. ZX and EES identified p53 binding sites in FoxO3 regulatory regions (Figure 5a) under the supervision of MQZ. HV performed the tumor identification (Figure 8b). LDA supervised CAB, DKB and TMJ, and provided ideas. AB supervised VMR, PUT, KLH, JLW, OSV and PRO. The manuscript was written by AB, VMR and OSV, with input from LDA.	Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Arum O, 2007, J GERONTOL A-BIOL, V62, P951, DOI 10.1093/gerona/62.9.951; Attardi LD, 2000, GENE DEV, V14, P704; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; DENG G, 1994, CANCER RES, V54, P499; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; JUVEN T, 1993, ONCOGENE, V8, P3411; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kurinna S, 2010, HEPATOLOGY, V52, P1023, DOI 10.1002/hep.23746; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LOCOCO F, 1993, BLOOD, V82, P2289; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyaguchi Y, 2009, CELL BIOL INT, V33, P853, DOI 10.1016/j.cellbi.2009.04.017; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; QUINLAN DC, 1992, CANCER RES, V52, P4828; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SCOTT N, 1991, BRIT J CANCER, V63, P317, DOI 10.1038/bjc.1991.74; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sharpless NE, 2002, CANCER RES, V62, P2761; Shen J, 2010, EXP GERONTOL, V45, P97, DOI 10.1016/j.exger.2009.10.009; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang F, 2008, J MOL BIOL, V384, P590, DOI 10.1016/j.jmb.2008.09.025; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao RB, 2000, GENE DEV, V14, P981	94	93	94	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	29					3207	3221		10.1038/onc.2011.35	http://dx.doi.org/10.1038/onc.2011.35			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21423206	Green Accepted			2022-12-25	WOS:000293006800001
J	Barragan, F; Moreno, CE; Escobar, F; Halffter, G; Navarrete, D				Barragan, Felipe; Moreno, Claudia E.; Escobar, Federico; Halffter, Gonzalo; Navarrete, Dario			Negative Impacts of Human Land Use on Dung Beetle Functional Diversity	PLOS ONE			English	Article							ECOSYSTEM SERVICES; FOREST; BIODIVERSITY; FRAGMENTATION; SCARABAEINAE; CONSEQUENCES; CONSERVATION; ASSEMBLAGES; MECHANISMS; FRAMEWORK	The loss of biodiversity caused by human activity is assumed to alter ecosystem functioning. However our understanding of the magnitude of the effect of these changes on functional diversity and their impact on the dynamics of ecological processes is still limited. We analyzed the functional diversity of copro-necrophagous beetles under different conditions of land use in three Mexican biosphere reserves. In Montes Azules pastures, forest fragments and continuous rainforest were analyzed, in Los Tuxtlas rainforest fragments of different sizes were analyzed and in Barranca de Metztitlan two types of xerophile scrub with different degrees of disturbance from grazing were analyzed. We assigned dung beetle species to functional groups based on food relocation, beetle size, daily activity period and food preferences, and as measures of functional diversity we used estimates based on multivariate methods. In Montes Azules functional richness was lower in the pastures than in continuous rainforest and rainforest fragments, but fragments and continuous forest include functionally redundant species. In small rainforest fragments (< 5 ha) in Los Tuxtlas, dung beetle functional richness was lower than in large rainforest fragments (> 20 ha). Functional evenness and functional dispersion did not vary among habitat types or fragment size in these reserves. In contrast, in Metztitlan, functional richness and functional dispersion were different among the vegetation types, but differences were not related to the degree of disturbance by grazing. More redundant species were found in submontane than in crassicaule scrub. For the first time, a decrease in the functional diversity in communities of copro-necrophagous beetles resulting from changes in land use is documented, the potential implications for ecosystem functioning are discussed and a series of variables that could improve the evaluation of functional diversity for this biological group is proposed.	[Barragan, Felipe; Moreno, Claudia E.] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca, Hidalgo, Mexico; [Escobar, Federico; Halffter, Gonzalo] AC, Inst Ecol, Xalapa, Veracruz, Mexico; [Navarrete, Dario] El Colegio Frontera Sur, San Cristobal Casas, Chiapas, Mexico	Universidad Autonoma del Estado de Hidalgo; Instituto de Ecologia - Mexico; El Colegio de la Frontera Sur (ECOSUR)	Barragan, F (corresponding author), Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca, Hidalgo, Mexico.	cmoreno@uaeh.edu.mx	Moreno, Claudia E./B-2733-2013; Barragán, Felipe/AAR-9806-2021; Moreno, Claudia/GRJ-1036-2022; Escobar, Federico/C-1396-2011; Halffter, Gonzalo/R-3652-2018	Moreno, Claudia E./0000-0002-9584-2619; Barragán, Felipe/0000-0001-5658-6192; Escobar, Federico/0000-0003-0179-7528; 	FOMIX CONACYT-HIDALGO [95828]; SEP-CONACYT Basic Science [84127]; CONACYT [168898]	FOMIX CONACYT-HIDALGO; SEP-CONACYT Basic Science; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This paper is a result of projects 95828 of FOMIX CONACYT-HIDALGO, and 84127 of SEP-CONACYT Basic Science. F. Barragan received a scholarship from CONACYT (168898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Batalha MA, 2010, NAT CONSERVACAO, V8, P34, DOI 10.4322/natcon.00801005; Castillo-Campos G., 2004, TUXTLAS PAISAJE SIER, P231; CHAO A, 1984, SCAND J STAT, V11, P265; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONANP [Comision Nacional de Areas Naturales Protegidas], 2003, PROGR MAN RES BIOSF; Davis ALV, 2004, S AFR J SCI, V100, P415; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; DIRZO R, 1992, CONSERV BIOL, V6, P84, DOI 10.1046/j.1523-1739.1992.610084.x; DOF, 2000, RES PROGR MAN RES BI; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Giraldo C, 2011, INSECT CONSERV DIVER, V4, P115, DOI 10.1111/j.1752-4598.2010.00112.x; GUEVARA S, 1997, HIST NATURAL TUXTLAS, P44; Halffter G., 1982, NESTING BEHAV DUNG B; Halffter Gonzalo, 2009, Boletin de la SEA, V45, P1; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hanski I., 1991, P305; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; *INE, 1993, PROGR MAN RES INT BI; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Laborde J, 2004, TUXTLAS PAISAJE SIER, P271; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Moreno CE, 2006, OECOLOGIA, V149, P133, DOI 10.1007/s00442-006-0417-0; Navarrete D, 2008, BIODIVERS CONSERV, V17, P2869, DOI 10.1007/s10531-008-9402-8; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Pavon N. P, 2009, CAMBIO CLIMATICO EST; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; PUIC H., 1991, VEGETACION HUASTECA; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; RICKLEFS RE, 1993, SPECIES DIVERSITY EC, P416; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tilman D., 2001, ENCY BIODIVERSITY, P109, DOI DOI 10.1016/B0-12-226865-2/00132-2; Verdu JR, 2007, BIOL CONSERV, V140, P308, DOI 10.1016/j.biocon.2007.08.015; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Vulinec K, 2008, TROP CONSERV SCI, V1, P111, DOI 10.1177/194008290800100204; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	47	141	145	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17976	10.1371/journal.pone.0017976	http://dx.doi.org/10.1371/journal.pone.0017976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448292	Green Published, gold			2022-12-25	WOS:000288810500026
J	Kim, CH; Jeon, HM; Lee, SY; Ju, MK; Moon, JY; Park, HG; Yoo, MA; Choi, BT; Yook, JI; Lim, SC; Han, SI; Kang, HS				Kim, Cho Hee; Jeon, Hyun Min; Lee, Su Yeon; Ju, Min Kyung; Moon, Ji Young; Park, Hye Gyeong; Yoo, Mi-Ae; Choi, Byung Tae; Yook, Jong In; Lim, Sung-Chul; Han, Song Iy; Kang, Ho Sung			Implication of Snail in Metabolic Stress-Induced Necrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSCRIPTIONAL REPRESSOR SNAIL; SUPPRESSES TUMOR-GROWTH; MOBILITY GROUP BOX-1; BREAST-CANCER CELLS; PROTEIN AGGREGATION; E-CADHERIN; GLUCOSE DEPRIVATION; HEPATOCELLULAR-CARCINOMA	Background: Necrosis, a type of cell death accompanied by the rupture of the plasma membrane, promotes tumor progression and aggressiveness by releasing the pro-inflammatory and angiogenic cytokine high mobility group box 1. It is commonly found in the core region of solid tumors due to hypoxia and glucose depletion (GD) resulting from insufficient vascularization. Thus, metabolic stress-induced necrosis has important clinical implications for tumor development; however, its regulatory mechanisms have been poorly investigated. Methodology/Principal Findings: Here, we show that the transcription factor Snail, a key regulator of epithelial-mesenchymal transition, is induced in a reactive oxygen species (ROS)-dependent manner in both two-dimensional culture of cancer cells, including A549, HepG2, and MDA-MB-231, in response to GD and the inner regions of a multicellular tumor spheroid system, an in vitro model of solid tumors and of human tumors. Snail short hairpin (sh) RNA inhibited metabolic stress-induced necrosis in two-dimensional cell culture and in multicellular tumor spheroid system. Snail shRNA-mediated necrosis inhibition appeared to be linked to its ability to suppress metabolic stress-induced mitochondrial ROS production, loss of mitochondrial membrane potential, and mitochondrial permeability transition, which are the primary events that trigger necrosis. Conclusions/Significance: Taken together, our findings demonstrate that Snail is implicated in metabolic stress-induced necrosis, providing a new function for Snail in tumor progression.	[Kim, Cho Hee; Jeon, Hyun Min; Lee, Su Yeon; Ju, Min Kyung; Moon, Ji Young; Yoo, Mi-Ae; Kang, Ho Sung] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Park, Hye Gyeong] Pusan Natl Univ, Nanobiotechnol Ctr, Pusan 609735, South Korea; [Choi, Byung Tae] Pusan Natl Univ, Sch Oriental Med, Div Meridian & Struct Med, Pusan 609735, South Korea; [Yook, Jong In] Yonsei Univ, Dept Oral Pathol, Oral Canc Res Inst, Coll Dent, Seoul 120749, South Korea; [Lim, Sung-Chul; Han, Song Iy] Chosun Univ, Coll Med, Res Ctr Resistant Cells, Kwangju, South Korea; [Lim, Sung-Chul] Chosun Univ, Coll Med, Dept Pathol, Kwangju, South Korea	Pusan National University; Pusan National University; Pusan National University; Yonsei University; Yonsei University Health System; Chosun University; Chosun University	Kim, CH (corresponding author), DNA Identificat Ctr, Natl Forens Serv, Seoul, South Korea.	hspkang@pusan.ac.kr		Yook, Jong In/0000-0002-7318-6112	Ministry of Health & Welfare, Republic of Korea [0620010]; NRF, MEST [2009-0059210]; Korean government (MEST) through the Research Center for Resistant Cells [R13-2003-009]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NRF, MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean government (MEST) through the Research Center for Resistant Cells(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0620010), and Mid-career Researcher Program through NRF grant funded by the MEST (2009-0059210), and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) through the Research Center for Resistant Cells (R13-2003-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Choi YR, 2003, CANCER RES, V63, P2188; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Ivascu A, 2007, INT J ONCOL, V31, P1403; Jeong EK, 2010, INT J ONCOL, V37, P655, DOI 10.3892/ijo_00000714; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kim CH, 2007, J CELL PHYSIOL, V211, P371, DOI 10.1002/jcp.20941; Kim CH, 2010, INT J ONCOL, V37, P97, DOI 10.3892/ijo_00000657; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LaRue KEA, 2004, CANCER RES, V64, P1621, DOI 10.1158/0008-5472.CAN-2902-2; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Mancera PA, 2005, HUM MOL GENET, V14, P3449, DOI 10.1093/hmg/ddi373; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tomes L, 2003, BREAST CANCER RES TR, V81, P61, DOI 10.1023/A:1025476722493; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	64	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18000	10.1371/journal.pone.0018000	http://dx.doi.org/10.1371/journal.pone.0018000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448462	gold, Green Published, Green Submitted			2022-12-25	WOS:000288810500027
J	Carlisle, EM; Poroyko, V; Caplan, MS; Alverdy, JA; Liu, D				Carlisle, Erica M.; Poroyko, Valeriy; Caplan, Michael S.; Alverdy, John A.; Liu, Donald			Gram Negative Bacteria Are Associated with the Early Stages of Necrotizing Enterocolitis	PLOS ONE			English	Article							INTESTINAL INJURY; PRETERM INFANTS; RAT MODEL; PATHOGENESIS; REPERFUSION; DIVERSITY; ISCHEMIA; FLORA; TLR4; MICE	Introduction: Necrotizing enterocolitis (NEC) affects 5- 10% of infants born weighing less than 1500 g. Most models of NEC recapitulate late- stage disease with gut necrosis and elevated inflammatory mediators. Evaluation of NEC at earlier, less lethal stages of disease will allow investigation of initial disease triggers and may advance our understanding of temporal relationships between factors implicated in NEC pathogenesis. In this manuscript, we describe our investigation of early NEC and test the hypothesis that bacteria and inflammatory mediators differ between animals with early NEC and disease free animals. Methods: On DOL7 C3HeB/FeJ pups were fed liquid formula with 1610 4 Streptococcus thoraltensis, Serratia marcescens, and Pseudomonas aeruginosa every 3 h. To initiate NEC, pups underwent asphyxia (100% N2 for 90 s) and hypothermia (4uC for 10 min) after feeding. Pups were euthanized at 72 h. Intestines were collected for histologic NEC scoring and DNA/RNA extraction. Bacterial populations were identified by 16S rRNA pyrosequencing and principal component analysis (PCA). RNA isolates underwent QRT- PCR for Toll- like Receptor 4 (TLR4) and inducible nitric oxide synthase (iNOS). Results: Despite histologic, intestinal damage in mice with NEC, no gross necrosis was observed suggesting early disease. QRT- PCR yielded no difference between groups in TLR4 or iNOS mRNA levels. PCA demonstrated relative clustering of microbial communities based on presence or absence of NEC. 16S pyrosequencing demonstrated similar phyla between groups (Firmicutes and Proteobacteria predominated in all animals). However, the colonic microbiota of animals with NEC had more Citrobacter (p < 0.01), Klebsiella (p < 0.05), and Tatumella (p < 0.05), while that of animals without NEC had more Streptococcus (p < 0.01) and Enterococcus (p < 0.01). Conclusion: Citrobacter, Klebsiella, and Tatumella are associated with NEC. Differential colonic bacteria were identified despite the lack of inflammatory mediator elevation traditionally associated with NEC. This suggests a temporal relationship between bacteria and inflammatory mediators such that alterations in gut microbiota are associated with early NEC, while inflammatory mediator elevation is associated with advanced NEC.	[Carlisle, Erica M.; Poroyko, Valeriy; Alverdy, John A.; Liu, Donald] Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA; [Caplan, Michael S.] Northshore Univ Hlth Syst, Dept Pediat, Chicago, IL USA	University of Chicago; University of Chicago Medical Center; NorthShore University Health System	Carlisle, EM (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA.	dliu@surgery.bsd.uchicago.edu		Carlisle, Erica/0000-0002-3884-9793	University of Chicago	University of Chicago(University of Chicago)	This work was supported by an internal grant from the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; BARLOW B, 1975, SURGERY, V77, P687; BELL MJ, 1979, AM J SURG, V138, P629, DOI 10.1016/0002-9610(79)90333-7; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Carrasco R, 2004, J PEDIATR SURG, V39, P1693, DOI 10.1016/j.jpedsurg.2004.07.017; Ceylan H, 2005, EUR J PEDIATR SURG, V15, P325, DOI 10.1055/s-2005-865820; Cintra AESU, 2008, TRANSPL P, V40, P830, DOI 10.1016/j.transproceed.2008.02.044; Cordero L, 2004, AM J INFECT CONTROL, V32, P189, DOI 10.1016/j.ajic.2003.07.004; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Halpern MD, 2008, AM J PHYSIOL-GASTR L, V294, pG20, DOI 10.1152/ajpgi.00168.2007; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; KLIEGMAN RM, 1990, J PEDIATR-US, V117, pS2, DOI 10.1016/S0022-3476(05)81123-0; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lee Jane S, 2003, Semin Neonatol, V8, P449, DOI 10.1016/S1084-2756(03)00123-4; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; RADULESCU A, 1933, J PEDIAT SURG, V45; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sodhi C, 2008, DIS MODEL MECH, V1, P94, DOI 10.1242/dmm.000315; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Tudehope DI, 2005, J PAEDIATR CHILD H, V41, P167, DOI 10.1111/j.1440-1754.2005.00581.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Young C, 2009, PEDIATR RES, V65, p91R, DOI 10.1203/PDR.0b013e31819dba7d	30	42	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e18084	10.1371/journal.pone.0018084	http://dx.doi.org/10.1371/journal.pone.0018084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445365	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100029
J	Hoff, DR; Ryan, GJ; Driver, ER; Ssemakulu, CC; De Groote, MA; Basaraba, RJ; Lenaerts, AJ				Hoff, Donald R.; Ryan, Gavin J.; Driver, Emily R.; Ssemakulu, Cornelius C.; De Groote, Mary A.; Basaraba, Randall J.; Lenaerts, Anne J.			Location of Intra- and Extracellular M. tuberculosis Populations in Lungs of Mice and Guinea Pigs during Disease Progression and after Drug Treatment	PLOS ONE			English	Article							AEROSOL INFECTION MODEL; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ZIEHL-NEELSEN; PULMONARY TUBERCULOSIS; IN-VITRO; GRANULOMAS; MOUSE; EXPRESSION; METRONIDAZOLE	The lengthy treatment regimen for tuberculosis is necessary to eradicate a small sub-population of M. tuberculosis that persists in certain host locations under drug pressure. Limited information is available on persisting bacilli and their location within the lung during disease progression and after drug treatment. Here we provide a comprehensive histopathological and microscopic evaluation to elucidate the location of bacterial populations in animal models for TB drug development. To detect bacilli in tissues, a new combination staining method was optimized using auramine O and rhodamine B for staining acid-fast bacilli, hematoxylin QS for staining tissue and DAPI for staining nuclei. Bacillary location was studied in three animal models used in-house for TB drug evaluations: C57BL/6 mice, immunocompromised GKO mice and guinea pigs. In both mouse models, the bacilli were found primarily intracellularly in inflammatory lesions at most stages of disease, except for late stage GKO mice, which showed significant necrosis and extracellular bacilli after 25 days of infection. This is also the time when hypoxia was initially visualized in GKO mice by 2-piminidazole. In guinea pigs, the majority of bacteria in lungs are extracellular organisms in necrotic lesions and only few, if any, were ever visualized in inflammatory lesions. Following drug treatment in mice a homogenous bacillary reduction across lung granulomas was observed, whereas in guinea pigs the remaining extracellular bacilli persisted in lesions with residual necrosis. In summary, differences in pathogenesis between animal models infected with M. tuberculosis result in various granulomatous lesion types, which affect the location, environment and state of bacilli. The majority of M. tuberculosis bacilli in an advanced disease state were found to be extracellular in necrotic lesions with an acellular rim of residual necrosis. Drug development should be designed to target this bacillary population and should evaluate drug regimens in the appropriate animal models.	[Hoff, Donald R.; Ryan, Gavin J.; Driver, Emily R.; De Groote, Mary A.; Basaraba, Randall J.; Lenaerts, Anne J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ssemakulu, Cornelius C.] CSIR, CSIR Biosci, ZA-0001 Pretoria, South Africa	Colorado State University; Council for Scientific & Industrial Research (CSIR) - South Africa	Hoff, DR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	lenaerts@colostate.edu	Lenaerts, Anne/F-1353-2017	Ssemakalu, Cornelius/0000-0003-3895-2018	National Institutes of Health (NIH) [RO-1 AI061505-01A1, NO1 AI-95385]; Colorado State University, Fort Collins; Southern Research Institute, Birmingham, AL [N01-AI-95364]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095385, R01AI061505, N01AI095364] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University, Fort Collins; Southern Research Institute, Birmingham, AL; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health (NIH) grant RO-1 AI061505-01A1 and the NIH Contracts NO1 AI-95385 at Colorado State University, Fort Collins, and N01-AI-95364 at the Southern Research Institute, Birmingham, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Basaraba RJ, 2006, INFECT IMMUN, V74, P5397, DOI 10.1128/IAI.00332-06; Bishal WR, 2000, LANCET, V356, P2113, DOI 10.1016/S0140-6736(00)03485-1; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brooks JV, 1998, ANTIMICROB AGENTS CH, V42, P3047, DOI 10.1128/AAC.42.11.3047; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; CANCELA MMG, 1993, J COMP PATHOL, V109, P361, DOI 10.1016/S0021-9975(08)80299-X; Canetti G., 1955, TUBERCLE BACILLUS PU; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona Pere-Joan, 2007, Inflammation & Allergy Drug Targets, V6, P27; Cegielski JP, 1997, J CLIN MICROBIOL, V35, P3254, DOI 10.1128/JCM.35.12.3254-3257.1997; Converse PJ, 1996, INFECT IMMUN, V64, P4776, DOI 10.1128/IAI.64.11.4776-4787.1996; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Davies GR, 2007, ANTIMICROB AGENTS CH, V51, P403, DOI 10.1128/AAC.01246-06; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Goel Madhu Mati, 2007, Indian J Tuberc, V54, P24; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08; Jayaram R, 2004, ANTIMICROB AGENTS CH, V48, P2951, DOI 10.1128/AAC.48.8.2951-2957.2004; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jeyanathan M, 2006, J CLIN MICROBIOL, V44, P2942, DOI 10.1128/JCM.00585-06; JOHNSON CM, 2005, ANTIMICROB AGENTS CH; Kelly BP, 1996, ANTIMICROB AGENTS CH, V40, P2809, DOI 10.1128/AAC.40.12.2809; KOJIMA K, 1989, AM J CLIN PATHOL, V92, P57, DOI 10.1093/ajcp/92.1.57; Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004; Kumar N, 1998, CYTOPATHOLOGY, V9, P208, DOI 10.1046/j.1365-2303.1998.00057.x; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nikonenko Boris V, 2008, Recent Pat Antiinfect Drug Discov, V3, P102, DOI 10.2174/157489108784746579; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nuermberger E, 2008, SEMIN RESP CRIT CARE, V29, P542, DOI 10.1055/s-0028-1085705; *OJHAAEA, 2008, MOL MICROBI IN PRESS; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; OSTER G, 1951, CR HEBD ACAD SCI, V232, P1708; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pratt R., 2008, Morbidity and Mortality Weekly Report, V57, P281; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; ROSENTHAL IM, 2005, AM J RESP CRIT CARE; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; SALFINGER M, 1994, EUR J CLIN MICROBIOL, V13, P961, DOI 10.1007/BF02111498; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Sissons J, 2009, GENES IMMUN, V10, P37, DOI 10.1038/gene.2008.68; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; Somoskovi A, 2001, CHEST, V120, P250, DOI 10.1378/chest.120.1.250; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; van der Zanden AGM, 1998, J CLIN PATHOL-MOL PA, V51, P209, DOI 10.1136/mp.51.4.209; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Watrelot-Virieux D, 2006, J VET MED B, V53, P321, DOI 10.1111/j.1439-0450.2006.00957.x; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919	86	77	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17550	10.1371/journal.pone.0017550	http://dx.doi.org/10.1371/journal.pone.0017550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445321	Green Submitted, gold, Green Published			2022-12-25	WOS:000288613300008
J	Ringner, M; Fredlund, E; Hakkinen, J; Borg, A; Staaf, J				Ringner, Markus; Fredlund, Erik; Hakkinen, Jari; Borg, Ake; Staaf, Johan			GOBO: Gene Expression-Based Outcome for Breast Cancer Online	PLOS ONE			English	Article							CYCLIN B1; INTEGRATIVE ANALYSIS; HISTOLOGIC GRADE; SIGNATURE; PREDICTOR; METASTASIS; SURVIVAL; SUBTYPES; STROMA; CHEMOTHERAPY	Microarray-based gene expression analysis holds promise of improving prognostication and treatment decisions for breast cancer patients. However, the heterogeneity of breast cancer emphasizes the need for validation of prognostic gene signatures in larger sample sets stratified into relevant subgroups. Here, we describe a multifunctional user-friendly online tool, GOBO (http://co.bmc.lu.se/gobo), allowing a range of different analyses to be performed in an 1881-sample breast tumor data set, and a 51-sample breast cancer cell line set, both generated on Affymetrix U133A microarrays. GOBO supports a wide range of applications including: 1) rapid assessment of gene expression levels in subgroups of breast tumors and cell lines, 2) identification of co-expressed genes for creation of potential metagenes, 3) association with outcome for gene expression levels of single genes, sets of genes, or gene signatures in multiple subgroups of the 1881-sample breast cancer data set. The design and implementation of GOBO facilitate easy incorporation of additional query functions and applications, as well as additional data sets irrespective of tumor type and array platform.	[Ringner, Markus; Fredlund, Erik; Hakkinen, Jari; Borg, Ake; Staaf, Johan] Lund Univ, Dept Oncol, Lund, Sweden; [Ringner, Markus; Fredlund, Erik; Hakkinen, Jari; Borg, Ake; Staaf, Johan] Skane Univ Hosp, Lund, Sweden; [Ringner, Markus; Fredlund, Erik; Borg, Ake; Staaf, Johan] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Ringner, M (corresponding author), Lund Univ, Dept Oncol, Lund, Sweden.	johan.staaf@med.lu.se	Häkkinen, Jari/AHH-4463-2022; Ringnér, Markus/G-3641-2011	Ringnér, Markus/0000-0001-5469-8940; Hakkinen, Jari/0000-0002-8466-9179	Swedish Cancer Society; Foundation for Strategic Research through the Lund Strategic Centre for Translational Cancer Research (CREATE Health); Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Foundation for Strategic Research through the Lund Strategic Centre for Translational Cancer Research (CREATE Health); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The present study was supported by the Swedish Cancer Society, the Foundation for Strategic Research through the Lund Strategic Centre for Translational Cancer Research (CREATE Health), and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gene Expression Omnibus, GENE EXPRESSION OMNI; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nimeus-Malmstrom E, 2010, INT J CANCER, V127, P961, DOI 10.1002/ijc.25091; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rody A, 2009, BREAST CANCER RES TR, V113, P457, DOI 10.1007/s10549-008-9964-x; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Urban P, 2006, J CLIN ONCOL, V24, P4245, DOI 10.1200/JCO.2005.05.1912; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	55	297	303	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17911	10.1371/journal.pone.0017911	http://dx.doi.org/10.1371/journal.pone.0017911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445301	Green Published, Green Submitted, gold			2022-12-25	WOS:000288613300021
J	Power, P; Jeffery, D; Rehman, MA; Chatterji, A; Yankulov, K				Power, Patricia; Jeffery, Daniel; Rehman, Muhammad Attiq; Chatterji, Arjun; Yankulov, Krassimir			Sub-Telomeric core X and Y ' Elements in S.cerevisiae Suppress Extreme Variations in Gene Silencing	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; SACCHAROMYCES-CEREVISIAE; SUBTELOMERIC REGIONS; DNA-REPLICATION; TRANSCRIPTIONAL REPRESSION; PROTO-SILENCERS; LIFE-SPAN; ACETYLATION; CHROMATIN; HETEROCHROMATIN	Telomere Position Effect (TPE) is governed by strong repression signals emitted by telomeres via the Sir2/3/4 Histone Deacetylase complex. These signals are then relayed by weak proto-silencers residing in the subtelomeric core X and Y' elements. Subtelomeres also contain Sub-Telomeric Anti-silencing Regions (STARs). In this study we have prepared telomeres built of different combinations of core X, Y' and STARs and have analyzed them in strains lacking Histone-Acetyltransferase genes as well as in cdc6-1 and Delta rif1 strains. We show that core X and Y' dramatically reduce both positive and negative variations in TPE, that are caused by these mutations. We also show that the deletion of Histone-Acetyltransferase genes reduce the silencing activity of an ACS proto-silencer, but also reduce the anti-silencing activity of a STAR. We postulate that core X and Y' act as epigenetic "cushioning" cis-elements.	[Power, Patricia; Jeffery, Daniel; Rehman, Muhammad Attiq; Chatterji, Arjun; Yankulov, Krassimir] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Power, P (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	yankulov@uoguelph.ca	Rehman, Muhammad/L-1283-2019; Jeffery, Daniel/GVS-0791-2022	Rehman, Muhammad/0000-0002-2062-1969; Yankulov, Krassimir/0000-0001-9440-9234	National Science and Engineering Research Council of Canada (NSERC) (University of Guelph) [043230]	National Science and Engineering Research Council of Canada (NSERC) (University of Guelph)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the National Science and Engineering Research Council of Canada (NSERC) (University of Guelph grant # 043230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; Boscheron C, 1996, EMBO J, V15, P2184, DOI 10.1002/j.1460-2075.1996.tb00572.x; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dillin A, 1997, GENETICS, V147, P1053; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Fourel G, 2004, BIOESSAYS, V26, P523, DOI 10.1002/bies.20028; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lebrun E, 2001, GENETICS, V158, P167; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marcand S, 1997, CIBA F SYMP, V211, P76; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Muller HJ, 1930, GENETICS, V15, P283; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Rehman MA, 2006, GENETICS, V174, P1801, DOI 10.1534/genetics.106.063446; Rehman MA, 2009, CURR GENET, V55, P357, DOI 10.1007/s00294-009-0265-7; Rehman MA, 2009, MOL BIOL CELL, V20, P631, DOI 10.1091/mbc.E08-01-0099; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; WILEY EA, 1995, GENETICS, V139, P67; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xu EY, 1999, GENETICS, V153, P25	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17523	10.1371/journal.pone.0017523	http://dx.doi.org/10.1371/journal.pone.0017523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437278	Green Submitted, Green Published, gold			2022-12-25	WOS:000288514600004
J	Syed, Z; Pelletier, J; Flounders, E; Chitolina, RF; Leal, WS				Syed, Zainulabeuddin; Pelletier, Julien; Flounders, Eric; Chitolina, Rodrigo F.; Leal, Walter S.			Generic Insect Repellent Detector from the Fruit Fly Drosophila melanogaster	PLOS ONE			English	Article							MOLECULAR-BASIS; BED NETS; DEET; RECEPTORS; MALARIA	Background: Insect repellents are prophylactic tools against a number of vector-borne diseases. There is growing demand for repellents outperforming DEET in cost and safety, but with the current technologies R&D of a new product takes almost 10 years, with a prohibitive cost of $30 million dollar in part due to the demand for large-scale synthesis of thousands of test compounds of which only 1 may reach the market. R&D could be expedited and cost dramatically reduced with a molecular/physiological target to streamline putative repellents for final efficacy and toxicological tests. Methodology: Using olfactory-based choice assay we show here that the fruit fly is repelled by not only DEET, but also IR3535 and picaridin thus suggesting they might have "generic repellent detector(s)," which may be of practical applications in new repellent screenings. We performed single unit recordings from all olfactory sensilla in the antennae and maxillary palps. Although the ab3A neuron in the wild type flies responded to picaridin, it was unresponsive to DEET and IR3535. By contrast, a neuron housed in the palp basiconic sensilla pb1 responded to DEET, IR3535, and picaridin, with apparent sensitivity higher than that of the DEET detectors in the mosquitoes Culex quinquefasciatus and Aedes aegypti. DmOr42a was transplanted from pb1 to the "empty neuron" and showed to be sensitive to the three insect repellents. Conclusions: For the first time we have demonstrated that the fruit fly avoids not only DEET but also IR3535 and picaridin, and identified an olfactory receptor neuron (ORN), which is sensitive to these three major insect repellents. We have also identified the insect repellent-sensitive receptor, DmOr42a. This generic detector fulfils the requirements for a simplified bioassay for early screening of test insect repellents.	[Syed, Zainulabeuddin; Pelletier, Julien; Flounders, Eric; Chitolina, Rodrigo F.; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis	Syed, Z (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; syed, zainulabeuddin/L-4961-2016	Leal, Walter/0000-0002-6800-1240; syed, zainulabeuddin/0000-0002-6235-7115; Leal Filho, Walter/0000-0002-1241-5225	National Science Foundation [0918177]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under FIPSE-CAPSE	National Science Foundation(National Science Foundation (NSF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under FIPSE-CAPSE(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Science Foundation (0918177). R. F. C. (Universidade Federal do Parana, Curitiba, Brazil) received an undergraduate scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under a FIPSE-CAPSE sponsored US-Brazil Higher Education Consortium Program. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; BECKER HJ, 1970, MOL GEN GENET, V107, P194, DOI 10.1007/BF00333634; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faulde MK, 2010, PARASITOL RES, V106, P957, DOI 10.1007/s00436-010-1749-6; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; GOVERE JM, 2010, INSECT REPELLENTS PR, P147; Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Leal WS, 2010, NATURE, V464, P37, DOI 10.1038/464037a; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; Moore Sarah J., 2007, P3; Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2; Nasci Roger S., 1996, P85; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pennetier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007896; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; STANCZYK NM, 2010, P NATL ACAD SCI US; Strickman D., 2007, INSECT REPELLENTS PR, P195; SYED Z, 2010, P NATL ACAD SCI US; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; 2004, IMPACT MALARIA LEADI	38	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17705	10.1371/journal.pone.0017705	http://dx.doi.org/10.1371/journal.pone.0017705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436880	gold, Green Published			2022-12-25	WOS:000288514000007
J	Drier, Y; Domany, E				Drier, Yotam; Domany, Eytan			Do Two Machine-Learning Based Prognostic Signatures for Breast Cancer Capture the Same Biological Processes?	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MICROARRAY DATA; DISCOVERY; METASTASIS; VALIDATION; PREDICTION; ONTOLOGY; ANNOTATION; SURVIVAL; DATABASE	The fact that there is very little if any overlap between the genes of different prognostic signatures for early-discovery breast cancer is well documented. The reasons for this apparent discrepancy have been explained by the limits of simple machine-learning identification and ranking techniques, and the biological relevance and meaning of the prognostic gene lists was questioned. Subsequently, proponents of the prognostic gene lists claimed that different lists do capture similar underlying biological processes and pathways. The present study places under scrutiny the validity of this claim, for two important gene lists that are at the focus of current large-scale validation efforts. We performed careful enrichment analysis, controlling the effects of multiple testing in a manner which takes into account the nested dependent structure of gene ontologies. In contradiction to several previous publications, we find that the only biological process or pathway for which statistically significant concordance can be claimed is cell proliferation, a process whose relevance and prognostic value was well known long before gene expression profiling. We found that the claims reported by others, of wider concordance between the biological processes captured by the two prognostic signatures studied, were found either to be lacking statistical rigor or were in fact based on addressing some other question.	[Drier, Yotam; Domany, Eytan] Weizmann Inst Sci, Dept Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Drier, Y (corresponding author), Weizmann Inst Sci, Dept Phys, Complex Syst, IL-76100 Rehovot, Israel.	eytan.domany@weizmann.ac.il	Drier, Yotam/K-5208-2012; DOMANY, EYTAN/K-1560-2012	Drier, Yotam/0000-0003-1725-2995; 	Leir Charitable Foundation; Weizmann-Mario Negri collaborative research grant; German Research Foundation (DIP)	Leir Charitable Foundation; Weizmann-Mario Negri collaborative research grant; German Research Foundation (DIP)(German Research Foundation (DFG))	This research was supported by the Leir Charitable Foundation, a Weizmann-Mario Negri collaborative research grant and by a grant from the German Research Foundation (DIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; de Snoo F, 2009, SURG ONCOL, V18, P366, DOI 10.1016/j.suronc.2009.07.005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Farcomeni A, 2008, STAT METHODS MED RES, V17, P347, DOI 10.1177/0962280206079046; FISHER RA, 1970, STAT METHODS RES WOR, pR15; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim SJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-20; Koscielny S, 2008, CURR OPIN OBSTET GYN, V20, P47, DOI 10.1097/GCO.0b013e3282f39d9e; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pusztai L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2430; Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060; Ransohoff DF, 2003, NEW ENGL J MED, V348, P1716; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; Simon R, 2008, EUR J CANCER, V44, P2707, DOI 10.1016/j.ejca.2008.09.009; Sims AH, 2009, J CLIN PATHOL, V62, P879, DOI 10.1136/jcp.2008.060376; Sole X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004544; Sotiriou C, 2006, J CLIN ONCOL, V24, p4S; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi S, 2008, CANCER SCI, V99, P324, DOI 10.1111/j.1349-7006.2007.00691.x; TANAY A, THESIS TEL AVIV U; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Vegt B, 2009, CRIT REV ONCOL HEMAT, V70, P1, DOI 10.1016/j.critrevonc.2008.09.001; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	62	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17795	10.1371/journal.pone.0017795	http://dx.doi.org/10.1371/journal.pone.0017795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423753	gold, Green Submitted, Green Published			2022-12-25	WOS:000288512400029
J	McDougal, JS; McNicholl, JM; Wasinrapee, P; Branson, BM; Martin, M; Tappero, JW; Mock, PA; Green, TA; Hu, DJ; Parekh, B				McDougal, J. Steven; McNicholl, Janet M.; Wasinrapee, Punneeporn; Branson, Bernard M.; Martin, Michael; Tappero, Jordan W.; Mock, Philip A.; Green, Timothy A.; Hu, Dale J.; Parekh, Bharat		Thai US Bed Assay Validat Working	Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence	PLOS ONE			English	Article							INJECTION-DRUG USERS; VACCINE TRIAL; SUBTYPE E; BANGKOK; SURVEILLANCE; POPULATION	Background: Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated by using longitudinal specimens from persons with incident HIV infections, but questions remain about its accuracy. We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic. Design: BED testing was conducted in two longitudinal cohorts with only incident infections (a military conscript cohort and an injection drug user cohort) and in one longitudinal cohort (an HIV-1 vaccine efficacy trial cohort) that also included long-term infections. Methods: Incidence estimates were generated conventionally (based on the number of annual serocoversions) and by using BED test results in the three cohorts. Adjusted incidence was calculated where appropriate. Results: For each longitudinal cohort the BED incidence estimates and the conventional incidence estimates were similar when only newly infected persons were tested, whether infected with CRF01_AE or subtype B9. When the analysis included persons with long-term infections (to mimic a true cross-sectional cohort), BED incidence estimates were higher, although not significantly, than the conventional incidence estimates. After adjustment, the BED incidence estimates were closer to the conventional incidence estimates. When the conventional incidence varied over time, as in the early phase of the injection drug user cohort, the difference between the two estimates increased, but not significantly. Conclusions: Evaluation of the performance of incidence assays requires the inclusion of a substantial number of cohort-derived specimens from individuals with long-term HIV infection and, ideally, the use of cohorts in which incidence remained stable. Appropriate adjustments of the BED incidence estimates generate estimates similar to those generated conventionally.	[McDougal, J. Steven; McNicholl, Janet M.; Branson, Bernard M.; Martin, Michael; Tappero, Jordan W.; Green, Timothy A.; Hu, Dale J.; Parekh, Bharat] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	McDougal, JS (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	jkm7@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263	US Centers for Disease Control and Prevention (CDC)	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work was supported by the US Centers for Disease Control and Prevention (CDC). CDC investigators had significant roles in every phase of the work including design, data collection, analysis, manuscript writing, decisions to publish. The work was a collaboration between CDC investigators and investigators in Thailand who had collected informative specimens. Some of these specimens were collected using some CDC resources to support the cohort studies (BMA IDU and Vax003).	Ackers ML, 2003, J INFECT DIS, V187, P879, DOI 10.1086/368169; Brookmeyer R., 1994, AIDS EPIDEMIOLOGY QU; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kana Khunakorn, 2009, J Med Assoc Thai, V92 Suppl 1, pS112; Kellogg TA, 2005, JAIDS-J ACQ IMM DEF, V39, P112, DOI 10.1097/01.qai.0000144444.44518.a3; Killian MS, 2006, AIDS RES HUM RETROV, V22, P640, DOI 10.1089/aid.2006.22.640; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Nopkesorn T, 1998, J ACQ IMMUN DEF SYND, V18, P372, DOI 10.1097/00042560-199808010-00009; NOPKESORN T, 1993, AIDS, V7, P1233, DOI 10.1097/00002030-199309000-00013; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; PAREKH BS, 2010, AIDS RES HU IN PRESS; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2007, JAIDS-J ACQ IMM DEF, V44, P196, DOI 10.1097/01.qai.0000254323.86897.36; Rehle T, 2004, B WORLD HEALTH ORGAN, V82, P121; Rutherford GW, 2000, J ACQ IMMUN DEF SYND, V25, pS115, DOI 10.1097/00126334-200012152-00005; Saidel T, 1996, AM J EPIDEMIOL, V144, P214, DOI 10.1093/oxfordjournals.aje.a008916; Satten GA, 1999, BIOMETRICS, V55, P1224, DOI 10.1111/j.0006-341X.1999.01224.x; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; Subbarao S, 2000, AIDS RES HUM RETROV, V16, P699, DOI 10.1089/088922200308693; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Welte A, 2009, AIDS RES HUM RETROV, V25, P125, DOI 10.1089/aid.2008.0150	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e14748	10.1371/journal.pone.0014748	http://dx.doi.org/10.1371/journal.pone.0014748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21408214	Green Published, gold, Green Submitted			2022-12-25	WOS:000288025500002
J	Brecht, K; Weigert, A; Hu, J; Popp, R; Fisslthaler, B; Korff, T; Fleming, I; Geisslinger, G; Brune, B				Brecht, Kerstin; Weigert, Andreas; Hu, Jiong; Popp, Ruediger; Fisslthaler, Beate; Korff, Thomas; Fleming, Ingrid; Geisslinger, Gerd; Bruene, Bernhard			Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E-2	FASEB JOURNAL			English	Article						lipid signaling; cancer; cell death; myeloid cells	WOUND-HEALING DEFECT; SPHINGOSINE KINASE 2; TUMOR ANGIOGENESIS; MOUSE MODEL; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; GROWTH; CYCLOOXYGENASE-2; PHAGOCYTOSIS; SUPPRESSOR	Macrophages contribute to tissue homeostasis in the developing as well as the adult organism. They promote tissue regeneration and remodeling after injury, which requires efficient neoangiogenesis. Signaling pathways activating an angiogenic program in macrophages are still poorly defined. We report that apoptotic cells (ACs), which originate from stressed or damaged tissues, can induce angiogenic properties in primary human macrophages. The signal originating from ACs is the lipid mediator sphingosine-1-phosphate (S1P), which activates S1P1/3 on macrophages to up-regulate cyclooxygenase-2. The formation and liberation of prostaglandin E-2 (PGE(2)) then stimulates migration of endothelial cells. This is demonstrated by using PGE(2) receptor antagonists or a neutralizing PGE(2) antibody in vitro, thereby attenuating endothelial cell migration using a Boyden chamber assay. In vivo, neutralization of PGE(2) from proangiogenic macrophage supernatants blocked vessel formation into Matrigel plugs. In particular, apoptotic cancer cells shifted prostanoid formation in macrophages selectively toward PGE(2) by up-regulating cyclooxygenase-2 and microsomal prostaglandin E synthase-1 (mPGES1), while down-regulating the PGE(2)-degrading enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) or prostaglandin-D synthase (PGDS). Angiogenic programming of macrophages by ACs, therefore, may control responses to tissue stress such as in tumors, where macrophages support cancer progression.-Brecht, K., Weigert, A., Hu, J., Popp, R., Fisslthaler, B., Korff, T., Fleming, I., Geisslinger, G., Brune, B. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E-2. FASEB J. 25, 2408-2417 (2011). www.fasebj.org	[Brecht, Kerstin] Goethe Univ Frankfurt, Inst Bio Chem 1, ZAFES, D-60590 Frankfurt, Germany; [Hu, Jiong; Popp, Ruediger; Fisslthaler, Beate; Fleming, Ingrid] Goethe Univ Frankfurt, Inst Vasc Signaling, D-60590 Frankfurt, Germany; [Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Korff, Thomas; Geisslinger, Gerd] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Brecht, K (corresponding author), Goethe Univ Frankfurt, Inst Bio Chem 1, ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bruene@pathobiochemie1.de	Fleming, Ingrid/AAB-6123-2022; Fleming, Ingrid/L-1225-2014; Weigert, Andreas/E-6540-2010	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; Weigert, Andreas/0000-0002-7529-1952; Hu, Jiong/0000-0001-8266-0886	Deutsche Forschungsgemeinschaft [Br 999, FOG 784, Ge 695, Exzellenzcluster 147]; Sander Foundation; Hans Kroner-Graduiertenkolleg (HKG); Loewe Lipid Signaling Forschungszentrum Frankfurt (LiFF); Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sander Foundation; Hans Kroner-Graduiertenkolleg (HKG); Loewe Lipid Signaling Forschungszentrum Frankfurt (LiFF); Deutsche Krebshilfe(Deutsche Krebshilfe)	The authors thank Franz Josef Streb, Margarethe Wiebe, and Ender Serbest for excellent technical assistance. The authors thank Dr. C. J. S. Edgell (University of North Carolina, Chapel Hill, NC, USA) for providing the human EC line EA.hy926. This work was supported by grants from Deutsche Forschungsgemeinschaft (Br 999; FOG 784; Ge 695; and Exzellenzcluster 147, Cardio-Pulmonary Systems), the Sander Foundation, Hans Kroner-Graduiertenkolleg (HKG), the Loewe Lipid Signaling Forschungszentrum Frankfurt (LiFF), and Deutsche Krebshilfe (to B.B.).	Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Gough MJ, 2001, CANCER RES, V61, P7240; Herr B, 2009, BLOOD, V114, P2140, DOI 10.1182/blood-2009-01-201889; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Johann AM, 2008, J IMMUNOL, V180, P1239, DOI 10.4049/jimmunol.180.2.1239; Kamata H, 2010, BIOMED PHARMACOTHER, V64, P409, DOI 10.1016/j.biopha.2010.01.017; Kawanabe T, 2007, J DERMATOL SCI, V48, P53, DOI 10.1016/j.jdermsci.2007.06.002; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Korff T, 1999, J CELL SCI, V112, P3249; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Linke B, 2009, J PROTEOME RES, V8, P4851, DOI 10.1021/pr900106v; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35, DOI 10.1002/jlb.65.1.35; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Murata T, 2008, P NATL ACAD SCI USA, V105, P20009, DOI 10.1073/pnas.0805171105; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005	45	55	57	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2408	2417		10.1096/fj.10-179473	http://dx.doi.org/10.1096/fj.10-179473			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21450910				2022-12-25	WOS:000292242200032
J	Jaiswal, M; Gremer, L; Dvorsky, R; Haeusler, LC; Cirstea, IC; Uhlenbrock, K; Ahmadian, MR				Jaiswal, Mamta; Gremer, Lothar; Dvorsky, Radovan; Haeusler, Lars Christian; Cirstea, Ion C.; Uhlenbrock, Katharina; Ahmadian, Mohammad Reza			Mechanistic Insights into Specificity, Activity, and Regulatory Elements of the Regulator of G-protein Signaling (RGS)-containing Rho-specific Guanine Nucleotide Exchange Factors (GEFs) p115, PDZ-RhoGEF (PRG), and Leukemia-associated RhoGEF (LARG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; DBL FAMILY PROTEINS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PH DOMAINS; MONITORING INTERACTIONS; EFFICIENT ACTIVATION; FLUORESCENCE METHODS; BINDING PROTEINS; HOMOLOGY DOMAIN	The multimodular guanine nucleotide exchange factors (GEFs) of the Dbl family mostly share a tandem Dbl homology (DH) and pleckstrin homology (PH) domain organization. The function of these and other domains in the DH-mediated regulation of the GDP/GTP exchange reaction of the Rho proteins is the subject of intensive investigations. This comparative study presents detailed kinetic data on specificity, activity, and regulation of the catalytic DH domains of four GEFs, namely p115, p190, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). We demonstrate that (i) these GEFs are specific guanine nucleotide exchange factors for the Rho isoforms (RhoA, RhoB, and RhoC) and inactive toward other members of the Rho family, including Rac1, Cdc42, and TC10. (ii) The DH domain of LARG exhibits the highest catalytic activity reported for a Dbl protein till now with a maximal acceleration of the nucleotide exchange by 10(7)-fold, which is at least as efficient as reported for GEFs specific for Ran or the bacterial toxin SopE. (iii) A novel regulatory region at the N terminus of the DH domain is involved in its association with GDP-bound RhoA monitored by a fluorescently labeled RhoA. (iv) The tandem PH domains of p115 and PRG efficiently contribute to the DH-mediated nucleotide exchange reaction. (v) In contrast to the isolated DH or DH-PH domains, a p115 fragment encompassing both the regulator of G-protein signaling and the DH domains revealed a significantly reduced GEF activity, supporting the proposed models of an intramolecular autoinhibitory mechanism for p115-like RhoGEFs.	[Jaiswal, Mamta; Gremer, Lothar; Dvorsky, Radovan; Cirstea, Ion C.; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40255 Dusseldorf, Germany; [Dvorsky, Radovan; Haeusler, Lars Christian; Uhlenbrock, Katharina] Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Max Planck Society	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Cirstea, Ion Cristian/AAQ-7670-2020; Gremer, Lothar/H-9128-2013; jaiswal, mamta/B-8431-2012; Dvorsky, Radovan/ABE-3042-2020; jaiswal, mamta/E-5148-2016	Cirstea, Ion Cristian/0000-0003-3204-1598; Gremer, Lothar/0000-0001-7065-5027; jaiswal, mamta/0000-0002-5862-7506	Deutsche Forschungsgemeinschaft [AH 92/3-1, AH 92/5-1]; E-Rare project NSEuroNet; Forschungskommission der Medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf [9772337-09]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); E-Rare project NSEuroNet; Forschungskommission der Medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AH 92/3-1 and AH 92/5-1, by the E-Rare project NSEuroNet, and by Forschungskommission der Medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf Grant 9772337-09.	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Cool RH, 1999, MOL CELL BIOL, V19, P6297; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Haeusler LC, 2006, METHOD ENZYMOL, V406, P1, DOI 10.1016/S0076-6879(06)06001-0; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; HART MJ, 1994, J BIOL CHEM, V269, P62; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kraemer A, 2002, J MOL BIOL, V324, P763, DOI 10.1016/S0022-2836(02)01136-1; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nomanbhoy T, 1999, BIOCHEMISTRY-US, V38, P15878, DOI 10.1021/bi9916832; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stam J C, 1999, Prog Mol Subcell Biol, V22, P51; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Swiercz JM, 2002, N-S ARCH PHARMACOL, V365, pR53; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	86	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18202	18212		10.1074/jbc.M111.226431	http://dx.doi.org/10.1074/jbc.M111.226431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454492	hybrid, Green Published			2022-12-25	WOS:000290585200080
J	Botlagunta, M; Krishnamachary, B; Vesuna, F; Winnard, PT; Bol, GM; Patel, AH; Raman, V				Botlagunta, Mahendran; Krishnamachary, Balaji; Vesuna, Farhad; Winnard, Paul T., Jr.; Bol, Guus M.; Patel, Arvind H.; Raman, Venu			Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells	PLOS ONE			English	Article							BOX RNA HELICASE; FACTOR (HIF)-1-ALPHA; MOLECULAR-MECHANISMS; DEAD; CANCER; GENE; HIF-2-ALPHA; REQUIREMENT; SUPPRESSOR; PROTEIN-3	DEAD box protein, DDX3, is aberrantly expressed in breast cancer cells ranging from weakly invasive to aggressive phenotypes and functions as an important regulator of cancer cell growth and survival. Here, we demonstrate that hypoxia inducible factor-1 alpha is a transcriptional activator of DDX3 in breast cancer cells. Within the promoter region of the human DDX3 gene, we identified three putative hypoxia inducible factor-1 responsive elements. By luciferase reporter assays in combination with mutated hypoxia inducible factor-1 responsive elements, we determined that the hypoxia inducible factor-1 responsive element at position -153 relative to the translation start site is essential for transcriptional activation of DDX3 under hypoxic conditions. We also demonstrated that hypoxia inducible factor-1 binds to the DDX3 promoter and that the binding is specific, as revealed by siRNA against hypoxia inducible factor-1 and chromatin immunoprecipitation assays. Thus, the activation of DDX3 expression during hypoxia is due to the direct binding of hypoxia inducible factor-1 to hypoxia responsive elements in the DDX3 promoter. In addition, we observed a significant overlap in the protein expression pattern of hypoxia inducible factor-1 alpha and DDX3 in MDA-MB-231 xenograft tumors. Taken together, our results demonstrate, for the first time, the role of DDX3 as a hypoxia-inducible gene that exhibits enhanced expression through the interaction of hypoxia inducible factor-1 with hypoxia inducible factor-1 responsive elements in its promoter region.	[Botlagunta, Mahendran; Krishnamachary, Balaji; Vesuna, Farhad; Winnard, Paul T., Jr.; Bol, Guus M.; Raman, Venu] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Patel, Arvind H.] Univ Glasgow, Med Res Council Virol Unit, Glasgow, Lanark, Scotland; [Raman, Venu] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Glasgow; Johns Hopkins University	Botlagunta, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	vraman2@jhmi.edu	Vesuna, Farhad/G-3179-2010; Botlagunta, Mahendran/R-5140-2018	Vesuna, Farhad/0000-0002-0356-5096; Botlagunta, Mahendran/0000-0002-0490-2832; Bol, Guus/0000-0002-4021-3823	FAMRI; MRC [MC_U130184144] Funding Source: UKRI; Medical Research Council [MC_U130184144] Funding Source: researchfish	FAMRI; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by FAMRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Blancher C, 2000, CANCER RES, V60, P7106; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Brizel DM, 1996, CANCER RES, V56, P941; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dougherty GJ, 2009, CANCER GENE THER, V16, P279, DOI 10.1038/cgt.2008.72; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; GURURAJAN R, 1991, NATURE, V349, P717, DOI 10.1038/349717a0; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; JAMIESON DJ, 1991, MOL MICROBIOL, V5, P805, DOI 10.1111/j.1365-2958.1991.tb00753.x; Johnstone O, 2005, DEV BIOL, V277, P92, DOI 10.1016/j.ydbio.2004.09.009; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Knowles HJ, 2001, BREAST CANCER RES, V3, P318, DOI 10.1186/bcr314; Lahiri S, 2006, PROG BIOPHYS MOL BIO, V91, P249, DOI 10.1016/j.pbiomolbio.2005.07.001; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Niquet J, 2006, NEUROSCIENCE, V141, P77, DOI 10.1016/j.neuroscience.2006.03.073; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Reynolds TY, 1996, CANCER RES, V56, P5754; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sowter HM, 2003, CANCER RES, V63, P6130; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Teicher B A, 1994, In Vivo, V8, P125; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wenger RH, 1997, BIOL CHEM, V378, P609; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	52	35	37	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17563	10.1371/journal.pone.0017563	http://dx.doi.org/10.1371/journal.pone.0017563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448281	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500008
J	Lagendijk, DDG; Mackey, RL; Page, BR; Slotow, R				Lagendijk, D. D. Georgette; Mackey, Robin L.; Page, Bruce R.; Slotow, Rob			The Effects of Herbivory by a Mega- and Mesoherbivore on Tree Recruitment in Sand Forest, South Africa	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; PRIVATE GAME RESERVE; WOODLAND REGENERATION; SPECIES COMPOSITION; WOODY VEGETATION; RANGING PATTERNS; ELEPHANT; SIZE; DYNAMICS; POPULATION	Herbivory by megaherbivores on woody vegetation in general is well documented; however studies focusing on the individual browsing effects of both mega- and mesoherbivore species on recruitment are scarce. We determined these effects for elephant Loxodonta africana and nyala Tragelaphus angasii in the critically endangered Sand Forest, which is restricted to east southern Africa, and is conserved mainly in small reserves with high herbivore densities. Replicated experimental treatments (400 m(2)) in a single forest patch were used to exclude elephant, or both elephant and nyala. In each treatment, all woody individuals were identified to species and number of stems, diameter and height were recorded. Results of changes after two years are presented. Individual tree and stem densities had increased in absence of nyala and elephant. Seedling recruitment (based on height and diameter) was inhibited by nyala, and by elephant and nyala in combination, thereby preventing recruitment into the sapling stage. Neither nyala or elephant significantly reduced sapling densities. Excluding both elephant and nyala in combination enhanced recruitment of woody species, as seedling densities increased, indicating that forest regeneration is impacted by both mega-and mesoherbivores. The Sand Forest tree community approached an inverse J-shaped curve, with the highest abundance in the smaller size classes. However, the larger characteristic tree species in particular, such as Newtonia hildebrandtii, were missing cohorts in the middle size classes. When setting management goals to conserve habitats of key importance, conservation management plans need to consider the total herbivore assemblage present and the resulting browsing effects on vegetation. Especially in Africa, where the broadest suite of megaherbivores still persists, and which is currently dealing with the 'elephant problem', the individual effects of different herbivore species on recruitment and dynamics of forests and woodlands are important issues which need conclusive answers.	[Lagendijk, D. D. Georgette; Mackey, Robin L.; Page, Bruce R.; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa	University of Kwazulu Natal	Lagendijk, DDG (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa.	georgette.lagendijk@gmail.com	Page, Bruce R/G-1245-2010; Slotow, Rob/AAM-9053-2020	Page, Bruce R/0000-0001-7979-5229; Slotow, Rob/0000-0001-9469-1508	University of KwaZulu-Natal; Amarula Elephant Research Programme; South African National Research Foundation [FA2006032300024]	University of KwaZulu-Natal; Amarula Elephant Research Programme; South African National Research Foundation(National Research Foundation - South Africa)	This study was supported by the Amarula Elephant Research Programme, University of KwaZulu-Natal, and the South African National Research Foundation ( Grant FA2006032300024 to RS) http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; BELSKY AJ, 1984, AFR J ECOL, V22, P271, DOI 10.1111/j.1365-2028.1984.tb00701.x; Ben-Shahar R, 1998, PLANT ECOL, V136, P189, DOI 10.1023/A:1009708021735; Bergquist J, 1999, FOREST ECOL MANAG, V115, P171, DOI 10.1016/S0378-1127(98)00397-1; Biggs Harry C., 2008, P537; Bond WJ, 2003, INT J WILDLAND FIRE, V12, P381, DOI 10.1071/WF03024; Botes A, 2006, BIOL CONSERV, V130, P573, DOI 10.1016/j.biocon.2006.01.020; Burke A, 1997, BIODIVERS CONSERV, V6, P1203, DOI 10.1023/A:1018308907241; Cadenasso ML, 2002, J TORREY BOT SOC, V129, P228, DOI 10.2307/3088773; CAUGHLEY G, 1976, E AFR WILDL J, V14, P265; Clarke K. R., 2001, CHANGES MARINE COMMU; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; de Garine-Wichatitsky M, 2004, OECOLOGIA, V141, P66, DOI 10.1007/s00442-004-1630-3; Druce Heleen, 2006, Koedoe, V49, P77; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Eckhardt HC, 2000, AFR J ECOL, V38, P108, DOI 10.1046/j.1365-2028.2000.00217.x; Everard DA, 1995, S AFR J BOT, V61, P283, DOI 10.1016/S0254-6299(15)30548-2; Fenner M., 2005, ECOLOGY SEEDS; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Gadd ME, 2002, AFR J ECOL, V40, P328, DOI 10.1046/j.1365-2028.2002.00385.x; Gaugris JY, 2008, S AFR J BOT, V74, P85, DOI 10.1016/j.sajb.2007.09.001; Gaugris J, 2007, S AFR J BOT, V73, P611, DOI 10.1016/j.sajb.2007.06.004; Goheen JR, 2007, J ECOL, V95, P129, DOI 10.1111/j.1365-2745.2006.01196.x; Goheen JR, 2004, ECOLOGY, V85, P1555, DOI 10.1890/03-3060; Grant C.C., 2008, P329; HAGENAH N, 2006, THESIS WAGENINGEN U; Hawthorne WD, 2000, J TROP ECOL, V16, P133, DOI 10.1017/S0266467400001310; Jacobs OS, 2002, S AFR J WILDL RES, V32, P13; Kellerman MJS, 2007, BOTHALIA, V37, P249, DOI 10.4102/abc.v37i2.323; Kerley Graham I.H., 2008, P146; Kirby Taryn, 2008, Acta Zoologica Sinica, V54, P561; Kirkwood D, 1999, BOTHALIA, V29, P293, DOI 10.4102/abc.v29i2.602; KYLE R, 2004, INDIGENOUS FORESTS W, P713; LAGENDIJK DDG, 2003, THESIS WAGENINGEN U; LAGENDIJK G, 2011, SHORT TERM IN PRESS; Lawes MJ, 2004, INDIGENOUS FORESTS W, P227; Levick S, 2008, BIOL CONSERV, V141, P489, DOI 10.1016/j.biocon.2007.11.001; Lykke AM, 1998, BIODIVERS CONSERV, V7, P1261, DOI 10.1023/A:1008877819286; MATTHEWS W. S, 2005, THESIS U PRETORIA; Matthews WS, 2001, S AFR J BOT, V67, P573, DOI 10.1016/S0254-6299(15)31188-1; Merrill Evelyn H., 2003, Journal for Nature Conservation (Jena), V10, P221, DOI 10.1078/1617-1381-00022; MIDGLEY JJ, 1995, S AFR J SCI, V91, P7; Moe SR, 2009, J APPL ECOL, V46, P223, DOI 10.1111/j.1365-2664.2008.01595.x; Moll E.J., 1980, STUDIES ECOLOGY MAPU, P52; Mucina L., 2006, VEGETATION S AFRICA; Obiri J, 2002, FOREST ECOL MANAG, V166, P131, DOI 10.1016/S0378-1127(01)00665-X; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith R.N., 1988, P1; Pickett S. T. A., 2003, KRUGER EXPERIENCE EC, P22; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; REPTON M, 2007, THESIS U KWAZULU NAT; Riginos C, 2007, OECOLOGIA, V153, P985, DOI 10.1007/s00442-007-0799-7; Shannon G, 2008, J TROP ECOL, V24, P281, DOI 10.1017/S0266467408004951; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Shaw MT, 2002, OIKOS, V98, P385, DOI 10.1034/j.1600-0706.2002.980303.x; Siebert Frances, 2008, Koedoe, V50, P126; Siebert SJ, 2004, BOTHALIA, V34, P61, DOI 10.4102/abc.v34i1.414; Smallie JJ, 2000, AFR J ECOL, V38, P352, DOI 10.1046/j.1365-2028.2000.00258.x; TURNER IM, 1990, BIOTROPICA, V22, P146, DOI 10.2307/2388407; vanWyk GF, 1996, S AFR J BOT, V62, P133, DOI 10.1016/S0254-6299(15)30612-8; WALKER BH, 1986, S AFR J BOT, V52, P397, DOI 10.1016/S0254-6299(16)31502-2	62	24	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17983	10.1371/journal.pone.0017983	http://dx.doi.org/10.1371/journal.pone.0017983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445345	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100022
J	Poulsen, L; Soe, MJ; Moller, LB; Dufva, M				Poulsen, Lena; Soe, Martin Jensen; Moller, Lisbeth Birk; Dufva, Martin			Investigation of Parameters that Affect the Success Rate of Microarray-Based Allele-Specific Hybridization Assays	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OLIGONUCLEOTIDE MICROARRAYS; DNA MICROARRAYS; MOLECULAR-INTERACTIONS; PROBE SELECTION; CHIP; SURFACE; ARRAYS; OPTIMIZATION; ALGORITHMS	Background: The development of microarray-based genetic tests for diseases that are caused by known mutations is becoming increasingly important. The key obstacle to developing functional genotyping assays is that such mutations need to be genotyped regardless of their location in genomic regions. These regions include large variations in G+C content, and structural features like hairpins. Methods/Findings: We describe a rational, stable method for screening and combining assay conditions for the genetic analysis of 42 Phenylketonuria-associated mutations in the phenylalanine hydroxylase gene. The mutations are located in regions with large variations in G+C content (20-75%). Custom-made microarrays with different lengths of complementary probe sequences and spacers were hybridized with pooled PCR products of 12 exons from each of 38 individual patient DNA samples. The arrays were washed with eight buffers with different stringencies in a custom-made microfluidic system. The data were used to assess which parameters play significant roles in assay development. Conclusions: Several assay development methods found suitable probes and assay conditions for a functional test for all investigated mutation sites. Probe length, probe spacer length, and assay stringency sufficed as variable parameters in the search for a functional multiplex assay. We discuss the optimal assay development methods for several different scenarios.	[Poulsen, Lena; Soe, Martin Jensen; Dufva, Martin] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Moller, Lisbeth Birk] Kennedy Ctr, Dept Appl Human Mol Genet, Glostrup, Denmark	Technical University of Denmark	Poulsen, L (corresponding author), Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012; Søe, Martin J/F-7736-2014	Dufva, Martin/0000-0001-5449-0189; Søe, Martin J/0000-0002-0386-6294; Moller, Lisbeth/0000-0002-9524-4301	DTU	DTU	LP was funded by a DTU PhD stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2003, BIOTECHNIQUES, V34, P1082, DOI 10.2144/03345dd05; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Dorris DR, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-6; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; Hahnke K, 2007, J BIOTECHNOL, V128, P1, DOI 10.1016/j.jbiotec.2006.09.003; Halperin A, 2006, LANGMUIR, V22, P11290, DOI 10.1021/la0616606; Hong BJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni109; HOWELL WM, 1999, NAT BIOTECHNOL, P1787; Hu ZY, 2005, BIOTECHNIQUES, V38, P121, DOI 10.2144/05381MT02; Iwasaki H, 2002, DNA RES, V9, P59, DOI 10.1093/dnares/9.2.59; Jobs M, 2003, GENOME RES, V13, P916, DOI 10.1101/gr.801103; Kajiyama T, 2003, GENOME RES, V13, P467, DOI 10.1101/gr.790603; Lee HH, 2006, LAB CHIP, V6, P1163, DOI 10.1039/b605507a; Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332; Mao HB, 2002, ANAL CHEM, V74, P5071, DOI 10.1021/ac025851z; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Noerholm M, 2004, LAB CHIP, V4, P28, DOI 10.1039/b311991b; Petersen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004808; Petersen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1081; Poulsen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn600; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; Pullat J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-282; Russom A, 2006, ANAL CHEM, V78, P2220, DOI 10.1021/ac051771u; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Suzuki S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-373; Wick LM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj024; Wu HX, 2008, BIOTECHNIQUES, V45, P573, DOI 10.2144/000112952; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhang XX, 2009, ANAL BIOCHEM, V386, P222, DOI 10.1016/j.ab.2008.12.008	33	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14777	10.1371/journal.pone.0014777	http://dx.doi.org/10.1371/journal.pone.0014777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445337	gold, Green Submitted, Green Published			2022-12-25	WOS:000288809100004
J	Huo, XA; Qi, XA; Tang, FY; Zu, RQ; Li, LA; Wu, B; Qin, YF; Ji, H; Fu, JG; Wang, SJ; Tian, H; Hu, ZB; Yang, HT; Zhou, MH; Wang, H; Zhu, FC				Huo, Xiang; Qi, Xian; Tang, Fenyang; Zu, Rongqiang; Li, Liang; Wu, Bin; Qin, Yuanfang; Ji, Hong; Fu, Jianguang; Wang, Shenjiao; Tian, Hua; Hu, Zhibin; Yang, Haitao; Zhou, Minghao; Wang, Hua; Zhu, Fengcai			Seroprevalence of Pandemic (H1N1) 2009 in Pregnant Women in China: An Observational Study	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; INFLUENZA-VIRUS; IMMUNE-RESPONSES; RECOMMENDATIONS; PREVENTION; INFECTION	Background: We investigated the seropositive rates and persistence of antibody against pandemic (H1N1) 2009 virus (pH1N1) in pregnant women and voluntary blood donors after the second wave of the pandemic in Nanjing, China. Methodology/Principal Findings: Serum samples of unvaccinated pregnant women (n = 720) and voluntary blood donors (n = 320) were collected after the second wave of 2009 pandemic in Nanjing. All samples were tested against pH1N1 strain (A/California/7/2009) with hemagglutination inhibition assay. A significant decline in seropositive rates, from above 50% to about 20%, was observed in pregnant women and voluntary blood donors fifteen weeks after the second wave of the pandemic. A quarter of the samples were tested against a seasonal H1N1 strain (A/Brisbane/59/2007). The antibody titers against pH1N1 strain were found to correlate positively with those against seasonal H1N1 strain. The correlation was modest but statistically significant. Conclusions and Significance: The high seropositive rates in both pregnant women and voluntary blood donors suggested that the pH1N1 virus had widely spread in these two populations. Immunity derived from natural infection seemed not to be persistent well.	[Huo, Xiang; Qi, Xian; Tang, Fenyang; Zu, Rongqiang; Li, Liang; Wu, Bin; Qin, Yuanfang; Ji, Hong; Fu, Jianguang; Wang, Shenjiao; Tian, Hua; Yang, Haitao; Zhou, Minghao; Wang, Hua; Zhu, Fengcai] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Peoples R China; [Hu, Zhibin] Nanjing Med Univ, Coll Publ Hlth, Nanjing, Peoples R China	Nanjing Medical University	Huo, XA (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Peoples R China.	jszfc@vip.sina.com	zhou, minghao/GZA-7244-2022					Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Keynan Y, 2010, CLIN MICROBIOL INFEC, V16, P1179, DOI 10.1111/j.1469-0691.2010.03142.x; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lin JT, 2009, J INFECT DIS, V199, P184, DOI 10.1086/595832; Liu WT, 2010, CLIN INFECT DIS, V51, P251, DOI 10.1086/653680; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; MARGARETCHAN, 2009, WORLD NOW START 2009; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Moghadami M, 2010, IRAN J IMMUNOL, V7, P39, DOI IJIv7i1A5; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Tang Fen-yang, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P489; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	31	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17995	10.1371/journal.pone.0017995	http://dx.doi.org/10.1371/journal.pone.0017995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437256	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100054
J	Meis, S; Stork, O; Munsch, T				Meis, Susanne; Stork, Oliver; Munsch, Thomas			Neuropeptide S-Mediated Facilitation of Synaptic Transmission Enforces Subthreshold Theta Oscillations within the Lateral Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FEAR MEMORY; CONDITIONED FEAR; RECEPTOR; NEURONS; MECHANISMS; NETWORKS; PHARMACOLOGY; EXPRESSION; CIRCUITS	The neuropeptide S (NPS) receptor system modulates neuronal circuit activity in the amygdala in conjunction with fear, anxiety and the expression and extinction of previously acquired fear memories. Using in vitro brain slice preparations of transgenic GAD67-GFP (Delta neo) mice, we investigated the effects of NPS on neural activity in the lateral amygdala as a key region for the formation and extinction of fear memories. We are able to demonstrate that NPS augments excitatory glutamatergic synaptic input onto both projection neurons and interneurons of the lateral amygdala, resulting in enhanced spike activity of both types of cells. These effects were at least in part mediated by presynaptic mechanisms. In turn, inhibition of projection neurons by local interneurons was augmented by NPS, and subthreshold oscillations were strengthened, leading to their shift into the theta frequency range. These data suggest that the multifaceted effects of NPS on amygdaloid circuitry may shape behavior-related network activity patterns in the amygdala and reflect the peptide's potent activity in various forms of affective behavior and emotional memory.	[Meis, Susanne; Munsch, Thomas] Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany; [Meis, Susanne; Stork, Oliver; Munsch, Thomas] Ctr Behav Brain Sci, Magdeburg, Germany; [Stork, Oliver] Otto Von Guericke Univ, Inst Biol, Abt Genet & Mol Neurobiol, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Meis, S (corresponding author), Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany.	Thomas.munsch@med.ovgu.de		Stork, Oliver/0000-0003-4285-7507	Deutsche Forschungsgemeinschaft [SFB 426, TP B8, SFB 779, TP B5]; Federal State Saxony-Anhalt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal State Saxony-Anhalt	Supported by the Deutsche Forschungsgemeinschaft (SFB 426, TP B8, SFB 779, TP B5) and the Federal State Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia-Elder NE, 2008, ALCOHOL CLIN EXP RES, V32, P1380, DOI 10.1111/j.1530-0277.2008.00713.x; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Behan M, 1999, J COMP NEUROL, V408, P532; Bruce S, 2009, J MED GENET, V46, P159, DOI 10.1136/jmg.2007.055137; Camarda V, 2008, J MED CHEM, V51, P655, DOI 10.1021/jm701204n; Castro AA, 2009, PHARMACOL BIOCHEM BE, V91, P636, DOI 10.1016/j.pbb.2008.10.015; Chung S, 2006, NEUROPEPTIDES, V40, P233, DOI 10.1016/j.npep.2006.04.002; Cline MA, 2007, COMP BIOCHEM PHYS A, V148, P657, DOI 10.1016/j.cbpa.2007.08.016; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Dityatev AE, 2005, NEUROSCIENTIST, V11, P75, DOI 10.1177/1073858404270857; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Gupte J, 2004, P NATL ACAD SCI USA, V101, P1508, DOI 10.1073/pnas.0308250100; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Johnson LR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.003.2008; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Orsmark-Pietras C, 2008, HUM MOL GENET, V17, P1673, DOI 10.1093/hmg/ddn058; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Popescu AT, 2011, J NEUROPHYSIOL, V105, P687, DOI 10.1152/jn.00732.2010; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Smith Y, 2000, J COMP NEUROL, V416, P496; SPAMPANATO J, 2010, NEUROPHARMACOLOGY; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tancredi T, 2007, J MED CHEM, V50, P4501, DOI 10.1021/jm0706822; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	47	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18020	10.1371/journal.pone.0018020	http://dx.doi.org/10.1371/journal.pone.0018020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437203	Green Published, gold, Green Submitted			2022-12-25	WOS:000288545100060
J	Peng, R; Maklokova, VI; Chandrashekhar, JH; Lan, Q				Peng, Rong; Maklokova, Vilena I.; Chandrashekhar, Jayadevi H.; Lan, Que			In Vivo Functional Genomic Studies of Sterol Carrier Protein-2 Gene in the Yellow Fever Mosquito	PLOS ONE			English	Article							GERM-LINE TRANSFORMATION; AEDES-AEGYPTI MOSQUITOS; DIPTERA-CULICIDAE; EXPRESSION; DNA; ELEGANS; VECTOR; OOCYTE	A simple and efficient DNA delivery method to introduce extrachromosomal DNA into mosquito embryos would significantly aid functional genomic studies. The conventional method for delivery of DNA into insects is to inject the DNA directly into the embryos. Taking advantage of the unique aspects of mosquito reproductive physiology during vitellogenesis and an in vivo transfection reagent that mediates DNA uptake in cells via endocytosis, we have developed a new method to introduce DNA into mosquito embryos vertically via microinjection of DNA vectors in vitellogenic females without directly manipulating the embryos. Our method was able to introduce inducible gene expression vectors transiently into F0 mosquitoes to perform functional studies in vivo without transgenic lines. The high efficiency of expression knockdown was reproducible with more than 70% of the F0 individuals showed sufficient gene expression suppression(< 30% of the controls' levels). At the cohort level, AeSCP-2 expression knockdown in early instar larvae resulted in detectable phenotypes of the expression deficiency such as high mortality, lowered fertility, and distorted sex ratio after induction of AeSCP-2 siRNA expression in vivo. The results further confirmed the important role of AeSCP-2 in the development and reproduction of A. aegypti. In this study, we proved that extrachromosaomal transient expression of an inducible gene from a DNA vector vertically delivered via vitellogenic females can be used to manipulate gene expression in F0 generation. This new method will be a simple and efficient tool for in vivo functional genomic studies in mosquitoes.	[Peng, Rong] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Peng, Rong; Chandrashekhar, Jayadevi H.; Lan, Que] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Maklokova, Vilena I.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA	Central China Normal University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Peng, R (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.	qlan@entomology.wisc.edu			National Institutes of Health Research [5R01AI067422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067422] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Research Grant #5R01AI067422 to Q.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WA, 1971, J CELL BIOL, V50, P201, DOI 10.1083/jcb.50.1.201; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Berkowitz Laura A, 2008, J Vis Exp, DOI 10.3791/833; Beserra EB, 2009, NEOTROP ENTOMOL, V38, P847, DOI 10.1590/S1519-566X2009000600020; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Briegel H, 2003, J INSECT PHYSIOL, V49, P249, DOI 10.1016/S0022-1910(02)00272-X; Christophers, 1960, AEDES AEGYPTI L YELL; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Tejerina EF, 2009, ACTA TROP, V109, P45, DOI 10.1016/j.actatropica.2008.09.014; HICKEY WA, 1970, J MED ENTOMOL, V7, P727, DOI 10.1093/jmedent/7.6.727; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lan Q, 2004, INSECT MOL BIOL, V13, P519, DOI 10.1111/j.0962-1075.2004.00510.x; Lan Q, 1997, IN VITRO CELL DEV-AN, V33, P615; LANG CA, 1972, J NUTR, V102, P1057, DOI 10.1093/jn/102.8.1057; Larson RT, 2008, J MED ENTOMOL, V45, P439, DOI 10.1603/0022-2585(2008)45[439:LAOSCP]2.0.CO;2; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; Lobo NF, 2002, INSECT MOL BIOL, V11, P133, DOI 10.1046/j.1365-2583.2002.00317.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v; RAIKHEL AS, 1984, EUR J CELL BIOL, V35, P279; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; SAS Institute, 1999, US GUID VERS 8; Snigirevskaya ES, 1997, CELL TISSUE RES, V290, P129, DOI 10.1007/s004410050915; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; SVOBODA JA, 1982, LIPIDS, V17, P220, DOI 10.1007/BF02535107; TAMURA T, 1990, JPN J GENET, V65, P401, DOI 10.1266/jjg.65.401; *WHO, 2008, DENG HAEM FEV DIAGN; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	34	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18030	10.1371/journal.pone.0018030	http://dx.doi.org/10.1371/journal.pone.0018030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437205	gold, Green Published, Green Submitted			2022-12-25	WOS:000288545100065
J	Gassman, NR; Clodfelter, JE; McCauley, AK; Bonin, K; Salsbury, FR; Scarpinato, KD				Gassman, Natalie R.; Clodfelter, Jill E.; McCauley, Anita K.; Bonin, Keith; Salsbury, Freddie R., Jr.; Scarpinato, Karin D.			Cooperative Nuclear Localization Sequences Lend a Novel Role to the N-Terminal Region of MSH6	PLOS ONE			English	Article							DNA MISMATCH REPAIR; PROTEINS MSH2; IMPORTIN-ALPHA; CANCER; SIGNALS; MUTATIONS; IDENTIFICATION; TRANSLOCATION; BINDING; CELLS	Human mismatch repair proteins MSH2-MSH6 play an essential role in maintaining genetic stability and preventing disease. While protein functions have been extensively studied, the substantial amino-terminal region (NTR*) of MSH6 that is unique to eukaryotic proteins, has mostly evaded functional characterization. We demonstrate that a cluster of three nuclear localization signals (NLS) in the NTR direct nuclear import. Individual NLSs are capable of partially directing cytoplasmic protein into the nucleus; however only cooperative effects between all three NLSs efficiently transport MSH6 into the nucleus. In striking contrast to yeast and previous assumptions on required heterodimerization, human MSH6 does not determine localization of its heterodimeric partner, MSH2. A cancer-derived mutation localized between two of the three NLS significantly decreases nuclear localization of MSH6, suggesting altered protein localization can contribute to carcinogenesis. These results clarify the pending speculations on the functional role of the NTR in human MSH6 and identify a novel, cooperative nuclear localization signal.	[Gassman, Natalie R.; Clodfelter, Jill E.; Scarpinato, Karin D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [McCauley, Anita K.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Bonin, Keith; Salsbury, Freddie R., Jr.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Salsbury, Freddie R., Jr.; Scarpinato, Karin D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Gassman, NR (corresponding author), NIEHS, Durham, NC USA.	kscarpin@wfubmc.edu	Bonin, Keith/A-3207-2014; Salsbury, FR/A-5923-2008	Bonin, Keith/0000-0002-7594-823X; Salsbury, FR/0000-0002-2699-829X; Gassman, Natalie/0000-0002-8488-2332	National Cancer Institute (NCI) [CA101829, 5R01CA12937]; Comprehensive Cancer Center; National Science Foundation [0722926]; NATIONAL CANCER INSTITUTE [R01CA101829, R01CA129373, P30CA012197] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Comprehensive Cancer Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by a grant from the National Cancer Institute (NCI) (CA101829) and support from the Comprehensive Cancer Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the National Institutes of Health. FRS is partially supported by NCI grant 5R01CA12937. The Zeiss LSM 710 confocal microscope was funded by National Science Foundation MRI award number 0722926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Belvederesi L, 2008, HUM MUTAT, V29, pE296, DOI 10.1002/humu.20875; BOYER JC, 1995, CANCER RES, V55, P6063; Christmann M, 2002, NUCLEIC ACIDS RES, V30, P1959, DOI 10.1093/nar/30.9.1959; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Clark AB, 2007, NUCLEIC ACIDS RES, V35, P4114, DOI 10.1093/nar/gkm409; Collavoli A, 2003, J MOL CELL CARDIOL, V35, P1191, DOI 10.1016/S0022-2828(03)00231-1; Cyr JL, 2008, J BIOL CHEM, V283, P31641, DOI 10.1074/jbc.M806018200; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DINGWALL C, 1989, J CELL SCI, P243; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hayes AP, 2009, DNA REPAIR, V8, P739, DOI 10.1016/j.dnarep.2009.02.003; Hessabi B, 2000, BIOCHEM BIOPH RES CO, V270, P695, DOI 10.1006/bbrc.2000.2491; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Knudsen NO, 2007, NUCLEIC ACIDS RES, V35, P2609, DOI 10.1093/nar/gkl1166; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kolodner RD, 1999, CANCER RES, V59, P5068; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leong V, 2009, MOL CARCINOGEN, V48, P742, DOI 10.1002/mc.20514; Lightfoot J, 1999, HUM MOL GENET, V8, P1007, DOI 10.1093/hmg/8.6.1007; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mastrocola AS, 2010, DNA REPAIR, V9, P120, DOI 10.1016/j.dnarep.2009.11.003; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; Ripperger T, 2010, HAEMATOL-HEMATOL J, V95, P841, DOI 10.3324/haematol.2009.015503; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schaff J, 1997, BIOPHYS J, V73, P1135, DOI 10.1016/S0006-3495(97)78146-3; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Swedlow JR, 2007, METHOD CELL BIOL, V81, P447, DOI 10.1016/S0091-679X(06)81021-6; Umar A, 1998, GENETICS, V148, P1637; Umar A, 1997, CANCER RES, V57, P3949; UNDERWOOD MR, 1990, EMBO J, V9, P91, DOI 10.1002/j.1460-2075.1990.tb08084.x; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Zacksenhaus E, 1999, BBA-MOL CELL RES, V1451, P288, DOI 10.1016/S0167-4889(99)00103-2	48	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17907	10.1371/journal.pone.0017907	http://dx.doi.org/10.1371/journal.pone.0017907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437237	gold, Green Submitted, Green Published			2022-12-25	WOS:000288514600015
J	Godena, VK; Romano, G; Romano, M; Appocher, C; Klima, R; Buratti, E; Baralle, FE; Feiguin, F				Godena, Vinay K.; Romano, Giulia; Romano, Maurizio; Appocher, Chiara; Klima, Raffaella; Buratti, Emanuele; Baralle, Francisco E.; Feiguin, Fabian			TDP-43 Regulates Drosophila Neuromuscular Junctions Growth by Modulating Futsch/MAP1B Levels and Synaptic Microtubules Organization	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; IN-VIVO; POSTSYNAPTIC DIFFERENTIATION; FUNCTIONAL COMPONENTS; STRUCTURAL PLASTICITY; GENETIC DISSECTION; CFTR EXON-9; STABILITY; STABILIZATION	TDP-43 is an evolutionarily conserved RNA binding protein recently associated with the pathogenesis of different neurological diseases. At the moment, neither its physiological role in vivo nor the mechanisms that may lead to neurodegeneration are well known. Previously, we have shown that TDP-43 mutant flies presented locomotive alterations and structural defects at the neuromuscular junctions. We have now investigated the functional mechanism leading to these phenotypes by screening several factors known to be important for synaptic growth or bouton formation. As a result we found that alterations in the organization of synaptic microtubules correlate with reduced protein levels in the microtubule associated protein futsch/MAP1B. Moreover, we observed that TDP-43 physically interacts with futsch mRNA and that its RNA binding capacity is required to prevent futsch down regulation and synaptic defects.	[Godena, Vinay K.; Romano, Giulia; Appocher, Chiara; Klima, Raffaella; Buratti, Emanuele; Baralle, Francisco E.; Feiguin, Fabian] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Romano, Maurizio] Univ Trieste, Dept Life Sci, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste	Godena, VK (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	baralle@icgeb.org; feiguin@icgeb.org	Romano, Giulia/U-4156-2018; Buratti, Emanuele/K-4691-2016; Romano, Maurizio/G-9431-2012; Feiguin, Fabian/ABC-2514-2020	Romano, Giulia/0000-0003-0356-4947; Buratti, Emanuele/0000-0002-1356-9074; Romano, Maurizio/0000-0002-4820-2897; 	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)	We thank Bloomington Drosophila Stock Center at Indiana University for fly stocks and Developmental Hybridoma Bank at Iowa University for antibodies. This work was supported by the Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA).	Akbergenova Y, 2007, BRAIN RES, V1178, P52, DOI 10.1016/j.brainres.2007.08.042; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; BURATTI E, 2010, RNA BIOL, V7; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; CHENPLOTKIN AS, NAT REV NEUROL, V6, P211; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kabashi E., HUM MOL GENET, V19, P671; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lagier-Tourenne C, HUM MOL GENET, V19, pR46; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; MIGUEL L, 2010, NEUROBIOL DIS; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Rohrbough J, 2007, GENE DEV, V21, P2607, DOI 10.1101/gad.1574107; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Stewart BA, 1996, J NEUROSCI, V16, P3877; STRONG MJ, J NEUROL SCI, V288, P1; TAKEMURA R, 1992, J CELL SCI, V103, P953; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Zou B, 2008, BIOCHEM J, V414, P63, DOI 10.1042/BJ20071449	47	93	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17808	10.1371/journal.pone.0017808	http://dx.doi.org/10.1371/journal.pone.0017808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412434	gold, Green Published, Green Submitted			2022-12-25	WOS:000288247800031
J	Valverde-Islas, LE; Arrangoiz, E; Vega, E; Robert, L; Villanueva, R; Reynoso-Ducoing, O; Willms, K; Zepeda-Rodriguez, A; Fortoul, TI; Ambrosio, JR				Valverde-Islas, Laura E.; Arrangoiz, Esteban; Vega, Elio; Robert, Lilia; Villanueva, Rafael; Reynoso-Ducoing, Olivia; Willms, Kaethe; Zepeda-Rodriguez, Armando; Fortoul, Teresa I.; Ambrosio, Javier R.			Visualization and 3D Reconstruction of Flame Cells of Taenia solium (Cestoda)	PLOS ONE			English	Article							IN-VITRO; CYSTICERCI; ULTRASTRUCTURE; SYSTEM; ACTIN	Background: Flame cells are the terminal cells of protonephridial systems, which are part of the excretory systems of invertebrates. Although the knowledge of their biological role is incomplete, there is a consensus that these cells perform excretion/secretion activities. It has been suggested that the flame cells participate in the maintenance of the osmotic environment that the cestodes require to live inside their hosts. In live Platyhelminthes, by light microscopy, the cells appear beating their flames rapidly and, at the ultrastructural, the cells have a large body enclosing a tuft of cilia. Few studies have been performed to define the localization of the cytoskeletal proteins of these cells, and it is unclear how these proteins are involved in cell function. Methodology/Principal Findings: Parasites of two different developmental stages of T. solium were used: cysticerci recovered from naturally infected pigs and intestinal adults obtained from immunosuppressed and experimentally infected golden hamsters. Hamsters were fed viable cysticerci to recover adult parasites after one month of infection. In the present studies focusing on flame cells of cysticerci tissues was performed. Using several methods such as video, confocal and electron microscopy, in addition to computational analysis for reconstruction and modeling, we have provided a 3D visual rendition of the cytoskeletal architecture of Taenia solium flame cells. Conclusions/Significance: We consider that visual representations of cells open a new way for understanding the role of these cells in the excretory systems of Platyhelminths. After reconstruction, the observation of high resolution 3D images allowed for virtual observation of the interior composition of cells. A combination of microscopic images, computational reconstructions and 3D modeling of cells appears to be useful for inferring the cellular dynamics of the flame cell cytoskeleton.	[Valverde-Islas, Laura E.; Robert, Lilia; Villanueva, Rafael; Reynoso-Ducoing, Olivia; Willms, Kaethe; Ambrosio, Javier R.] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Zepeda-Rodriguez, Armando; Fortoul, Teresa I.] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City 04510, DF, Mexico; [Vega, Elio] Univ Nacl Autonoma Mexico, Direcc Gen Comp & Tecnol Informac & Comunicac DGT, Dept Visualizac, Mexico City 04510, DF, Mexico; [Arrangoiz, Esteban] Univ Nacl Autonoma Mexico, Fac Med, Lab 3D, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Valverde-Islas, LE (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	jrah@servidor.unam.mx	Fortoul, Teresa I./AAW-3936-2020; Ambrosio, Javier R/A-6099-2008	Fortoul, Teresa I./0000-0002-3507-1365; Ambrosio, Javier R/0000-0001-7441-0609	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM [IN201003, IN216107, IN200610]; DGAPA-IXTLI [0709008, IX200610]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [V43629-M, 080093]; CONACYT Mexico	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM(Universidad Nacional Autonoma de Mexico); DGAPA-IXTLI; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (IN201003, IN216107 and IN200610), DGAPA-IXTLI (0709008 and IX200610) and from Consejo Nacional de Ciencia y Tecnologia (CONACYT) V43629-M and 080093. LEVI was supported by a doctoral fellowship from CONACYT Mexico and her Doctoral degree was obtained from Posgrado-UNAM, Doctorado en Ciencias Biomedicas, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL, P907; Ambrosio J, 1997, PARASITOLOGY, V114, P545; Ambrosio J, 1994, Arch Med Res, V25, P325; Ambrosio JR, 2003, CELL BIOL INT, V27, P727, DOI 10.1016/S1065-6995(03)00142-2; Arafa SZ, 2007, PARASITOL INT, V56, P297, DOI 10.1016/j.parint.2007.06.005; Bahia D, 2006, PARASITOLOGY, V133, P321, DOI 10.1017/S0031182006000400; Barnes D, 1987, ZOOLOGIA INVERTEBRAD, P179; BOAL D, 2002, MECH CELL, P323; Bray D, 2001, CELL MOVEMENTS MOL M; BRUSCA CR, 2003, INVERTEBRATES, P285; Cardenas-Ramirez L., 1982, P281; Coil W.H., 1991, P211; Cruz-Rivera M, 2006, CELL BIOL INT, V30, P598, DOI 10.1016/j.cellbi.2006.02.010; Darenfed H, 2005, BIOCHEM CELL BIOL, V83, P711, DOI 10.1139/O05-164; Iwasa JH, 2010, TRENDS CELL BIOL, V20, P699, DOI 10.1016/j.tcb.2010.08.005; KARP G, 2005, BIOL CELULAR MOL, P357; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; LEMULLOIS M, 1990, J CELL SCI, V95, P423; LODISH H, 2000, MOL CELL BIOL, P796; LUMSDEN DR, 1983, BIOL EUCESTODA, P177; MCCULLOUGH JS, 1991, PARASITOL RES, V77, P157, DOI 10.1007/BF00935430; McGill G, 2008, CELL, V133, P1127, DOI 10.1016/j.cell.2008.06.013; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Moreno MJ, 2001, FOLIA PARASIT, V48, P163, DOI 10.14411/fp.2001.027; Neusser TP, 2006, J MORPHOL, V267, P231, DOI 10.1002/jmor.10398; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Palomares F, 2006, J ANTIMICROB CHEMOTH, V57, P482, DOI 10.1093/jac/dki484; Rivera N, 2004, PARASITOL RES, V93, P283, DOI 10.1007/s00436-004-1127-3; ROHDE K, 1992, INT J PARASITOL, V22, P443, DOI 10.1016/0020-7519(92)90145-B; Roman G, 2000, B WORLD HEALTH ORGAN, V78, P399; Smyth J.D., 1989, PHYSL BIOCH CESTODES, P5; Tan HHC, 2003, PARASITOLOGY, V126, P235, DOI 10.1017/S0031182002002846; Vargas-Parada L, 1999, PARASITOL RES, V85, P88, DOI 10.1007/s004360050514; VOGE M, 1963, J PARASITOL, V49, P85, DOI 10.2307/3275681; Wahlberg MH, 1998, CELL TISSUE RES, V291, P561, DOI 10.1007/s004410051025; Willms K, 2005, PARASITOL RES, V96, P296, DOI 10.1007/s00436-005-1348-0	37	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e14754	10.1371/journal.pone.0014754	http://dx.doi.org/10.1371/journal.pone.0014754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412407	Green Published, Green Submitted, gold			2022-12-25	WOS:000288247800001
J	Xia, JH; He, XP; Bai, ZY; Yue, GH				Xia, Jun Hong; He, Xiao Ping; Bai, Zhi Yi; Yue, Gen Hua			Identification and Characterization of 63 MicroRNAs in the Asian Seabass Lates calcarifer	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; CAENORHABDITIS-ELEGANS; ANIMAL DEVELOPMENT; RNA INTERFERENCE; GENE-EXPRESSION; CLONING; ZEBRAFISH; CONSERVATION; INFLAMMATION; BARRAMUNDI	Background: MicroRNAs (miRNAs) play an important role in the regulation of many fundamental biological processes. So far miRNAs have been only identified in a few fish species, although there are over 30,000 fish species living under different environmental conditions on the earth. Here, we described an approach to identify conserved miRNAs and characterized their expression patterns in different tissues for the first time in a food fish species Asian seabass (Lates calcarifer). Methodology/Principal Findings: By combining a bioinformatics analysis with an approach of homolog-based PCR amplification and sequencing, 63 novel miRNAs belonging to 29 conserved miRNA families were identified. Of which, 59 miRNAs were conserved across 10-86 species (E value <= 10(-4)) and 4 miRNAs were conserved only in fish species. qRT-PCR analysis showed that miR-29, miR-103, miR-125 and several let-7 family members were strongly and ubiquitously expressed in all tissues tested. Interestingly, miR-1, miR-21, miR-183, miR-184 and miR-192 showed highly conserved tissue-specific expression patterns. Exposure of the Asian seabass to lipopolysaccharide (LPS) resulted in up-regulation of over 50% of the identified miRNAs in spleen suggesting the importance of the miRNAs in acute inflammatory immune responses. Conclusions/Significance: The approach used in this study is highly effective for identification of conserved miRNAs. The identification of 63 miRNAs and determination of the spatial expression patterns of these miRNAs are valuable resources for further studies on post-transcriptional gene regulation in Asian seabass and other fish species. Further identification of the target genes of these miRNAs would shed new light on their regulatory roles of microRNAs in fish.	[Xia, Jun Hong; He, Xiao Ping; Bai, Zhi Yi; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore	National University of Singapore	Xia, JH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	Ministry of National Development	Ministry of National Development	This study is funded by Ministry of National Development for the project "To ensure self-sufficiency of safe seafood for Singapore through the development of aquaculture genomic tools for marker-assisted selective breeding of tropical marine foodfish''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BENSI G, 1987, GENE, V52, P95, DOI 10.1016/0378-1119(87)90398-2; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bromage ES, 1999, DIS AQUAT ORGAN, V36, P177, DOI 10.3354/dao036177; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; C?lix M., 2018, EUROPEAN RED LIST SA; CARSON J, 1993, J FISH DIS, V16, P209, DOI 10.1111/j.1365-2761.1993.tb01250.x; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; GRIFFITHSJONES S, 2006, MIRBASE MICRORNA SEQ, pD140; GRIFFITHSJONES S, 2008, MIRBASE TOOLS MICROR, pD154; GRIFFITHSJONES S, 2004, MICRORNA REGISTRY, pD109; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2002, J CELL BIOL, V156, P17, DOI 10.1083/jcb.200111033; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Jia WZ, 2008, CHINESE SCI BULL, V53, P169, DOI 10.1007/s11434-008-0106-y; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee IH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1165; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; MAUVIEL A, 1988, BIOCHEM BIOPH RES CO, V156, P1209, DOI 10.1016/S0006-291X(88)80761-7; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Takada S, 2007, NAT PROTOC, V2, P3136, DOI 10.1038/nprot.2007.457; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; 1998, CLONTECHNIQUES, V13, P12	79	44	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17537	10.1371/journal.pone.0017537	http://dx.doi.org/10.1371/journal.pone.0017537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412421	gold, Green Published, Green Submitted			2022-12-25	WOS:000288247800012
J	Hu, L; Huang, T; Liu, XJ; Cai, YD				Hu, Lele; Huang, Tao; Liu, Xiao-Jun; Cai, Yu-Dong			Predicting Protein Phenotypes Based on Protein-Protein Interaction Network	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; HIV-1 DRUG SUSCEPTIBILITY; SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; BREAST-CANCER; YEAST; GENOTYPE; GENES; IDENTIFICATION; LOCATION	Background: Identifying associated phenotypes of proteins is a challenge of the modern genetics since the multifactorial trait often results from contributions of many proteins. Besides the high-through phenotype assays, the computational methods are alternative ways to identify the phenotypes of proteins. Methodology/Principal Findings: Here, we proposed a new method for predicting protein phenotypes in yeast based on protein-protein interaction network. Instead of only the most likely phenotype, a series of possible phenotypes for the query protein were generated and ranked acording to the tethering potential score. As a result, the first order prediction accuracy of our method achieved 65.4% evaluated by Jackknife test of 1,267 proteins in budding yeast, much higher than the success rate (15.4%) of a random guess. And the likelihood of the first 3 predicted phenotypes including all the real phenotypes of the proteins was 70.6%. Conclusions/Significance: The candidate phenotypes predicted by our method provided useful clues for the further validation. In addition, the method can be easily applied to the prediction of protein associated phenotypes in other organisms.	[Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Lele] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Liu, Xiao-Jun] Shihezi Univ, Coll Anim Sci & Technol, Shihezi City, Xinjiang, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shihezi University; Fudan University	Hu, L (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	xiaojun.liu@ed.ac.uk; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	CYGD; STRING	CYGD; STRING	We thank CYGD and STRING for supply data to support not-for-profit research efforts.	Afjehi-Sadat L, 2007, NAT PROTOC, V2, P2318, DOI 10.1038/nprot.2007.317; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Cai HJ, 2006, GENETICS, V172, P1459, DOI 10.1534/genetics.105.053041; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Dwyer T, 2004, AM J EPIDEMIOL, V159, P826, DOI 10.1093/aje/kwh120; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foulkes AS, 2002, BIOMETRICS, V58, P145, DOI 10.1111/j.0006-341X.2002.00145.x; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaleta C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-37; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin TY, 2010, INT J RADIAT ONCOL, V78, P246, DOI 10.1016/j.ijrobp.2010.03.002; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; Morton CO, 2007, MOL MICROBIOL, V65, P494, DOI 10.1111/j.1365-2958.2007.05801.x; Onuki Ritsuko, 2010, V22, P132, DOI 10.1142/9781848165786_0011; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Piruzyan L A, 2004, Dokl Biochem Biophys, V395, P84, DOI 10.1023/B:DOBI.0000025552.40172.db; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Ungar L, 2009, NUCLEIC ACIDS RES, V37, P3840, DOI 10.1093/nar/gkp259; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; Vasilyev A. V., 2009, Voprosy Virusologii, V54, P17; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Watanabe M, 2009, CURR GENET, V55, P365, DOI 10.1007/s00294-009-0251-0; Whitfield PD, 2002, MOL GENET METAB, V75, P46, DOI 10.1006/mgme.2001.3269; Winzeler E A, 2000, Novartis Found Symp, V229, P105; Xu SG, 2007, J MICROBIOL, V45, P441; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	55	165	165	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17668	10.1371/journal.pone.0017668	http://dx.doi.org/10.1371/journal.pone.0017668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423698	gold, Green Published, Green Submitted			2022-12-25	WOS:000288219100023
J	Schnable, JC; Freeling, M				Schnable, James C.; Freeling, Michael			Genes Identified by Visible Mutant Phenotypes Show Increased Bias toward One of Two Subgenomes of Maize	PLOS ONE			English	Article							GENOME; GRASSES; ARABIDOPSIS; EVOLUTION; GENETICS; SORGHUM	Not all genes are created equal. Despite being supported by sequence conservation and expression data, knockout homozygotes of many genes show no visible effects, at least under laboratory conditions. We have identified a set of maize (Zea mays L.) genes which have been the subject of a disproportionate share of publications recorded at MaizeGDB. We manually anchored these "classical" maize genes to gene models in the B73 reference genome, and identified syntenic orthologs in other grass genomes. In addition to proofing the most recent version 2 maize gene models, we show that a subset of these genes, those that were identified by morphological phenotype prior to cloning, are retained at syntenic locations throughout the grasses at much higher levels than the average expressed maize gene, and are preferentially found on the maize1 subgenome even with a duplicate copy is still retained on the opposite subgenome. Maize1 is the subgenome that experienced less gene loss following the whole genome duplication in maize lineage 5-12 million years ago and genes located on this subgenome tend to be expressed at higher levels in modern maize. Links to the web based software that supported our syntenic analyses in the grasses should empower further research and support teaching involving the history of maize genetic research. Our findings exemplify the concept of "grasses as a single genetic system," where what is learned in one grass may be applied to another.	[Schnable, James C.; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schnable, JC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	jschnable@berkeley.edu		Schnable, James/0000-0001-6739-5527	NSF [DBI-0701871]; Chang-Lin Tien Graduate Fellowship	NSF(National Science Foundation (NSF)); Chang-Lin Tien Graduate Fellowship	Funded by NSF DBI-0701871 to MF and Chang-Lin Tien Graduate Fellowship to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; BENNETZEN JL, 1993, TRENDS GENET, V9, P259, DOI 10.1016/0168-9525(93)90001-X; Bennetzen JL, 1997, GENOME RES, V7, P301, DOI 10.1101/gr.7.4.301; Bomblies K, 2005, MOL BIOL EVOL, V22, P1082, DOI 10.1093/molbev/msi095; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; LAWRENCE CJ, 2008, INT J PLANT GENOMICS, DOI DOI 10.1155/2008/496957; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; MCCLINTOCK B, 1983, NATL LIB MED PROFILE; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; SCHNABLE JC, 2011, P NATL ACAD IN PRESS; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WEI F, ARIZONA GENOMICS WEB; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wilkerson MD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r58; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409	25	117	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17855	10.1371/journal.pone.0017855	http://dx.doi.org/10.1371/journal.pone.0017855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423772	Green Published, gold			2022-12-25	WOS:000288219100040
J	Deguchi, S				Deguchi, Shinji			Mechanism of and Threshold Biomechanical Conditions for Falsetto Voice Onset	PLOS ONE			English	Article							MYOELASTIC-AERODYNAMIC THEORY; COLLAPSIBLE-TUBE; FLOW SEPARATION; 2-MASS MODEL; VOCAL FOLDS; FUNDAMENTAL-FREQUENCY; NUMERICAL-ANALYSIS; AIR-FLOW; PHONATION; PRESSURE	The sound source of a voice is produced by the self-excited oscillation of the vocal folds. In modal voice production, a drastic increase in transglottal pressure after vocal fold closure works as a driving force that develops self-excitation. Another type of vocal fold oscillation with less pronounced glottal closure observed in falsetto voice production has been accounted for by the mucosal wave theory. The classical theory assumes a quasi-steady flow, and the expected driving force onto the vocal folds under wavelike motion is derived from the Bernoulli effect. However, wavelike motion is not always observed during falsetto voice production. More importantly, the application of the quasi-steady assumption to a falsetto voice with a fundamental frequency of several hundred hertz is unsupported by experiments. These considerations suggested that the mechanism of falsetto voice onset may be essentially different from that explained by the mucosal wave theory. In this paper, an alternative mechanism is submitted that explains how self-excitation reminiscent of the falsetto voice could be produced independent of the glottal closure and wavelike motion. This new explanation is derived through analytical procedures by employing only general unsteady equations of motion for flow and solids. The analysis demonstrated that a convective acceleration of a flow induced by rapid wall movement functions as a negative damping force, leading to the self-excitation of the vocal folds. The critical subglottal pressure and volume flow are expressed as functions of vocal fold biomechanical properties, geometry, and voice fundamental frequency. The analytically derived conditions are qualitatively and quantitatively reasonable in view of reported measurement data of the thresholds required for falsetto voice onset. Understanding of the voice onset mechanism and the explicit mathematical descriptions of thresholds would be beneficial for the diagnosis and treatment of voice diseases and the development of artificial vocal folds.	Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi 980, Japan	Tohoku University	Deguchi, S (corresponding author), Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi 980, Japan.	deguchi@bml.mech.tohoku.ac.jp		Deguchi, Shinji/0000-0002-0556-4599	Japan Ministry of Education, Culture, Sports, Science, and Technology [19700382]; Ono Acoustics Research Fund	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Acoustics Research Fund	This work was supported in part by Program for Exploring Advanced Interdisciplinary Frontiers and grant-in-aid for Scientific Research (19700382) from the Japan Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/english/) and the Ono Acoustics Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour F, 2004, J ACOUST SOC AM, V116, P1710, DOI 10.1121/1.1779274; Alipour F, 2009, J SPEECH LANG HEAR R, V52, P465, DOI [10.1044/1092-4388(2008/07-0212), 10.1044/1092-4388(2008/07-0212]; Aronson A., 2009, CLIN VOICE DISORDERS; Bailey BJ, 2006, HEAD NECK SURG OTOLA; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; BERTRAM CD, 1982, J BIOMECH, V15, P39, DOI 10.1016/0021-9290(82)90033-1; Bertram CD, 2008, RESP PHYSIOL NEUROBI, V163, P256, DOI 10.1016/j.resp.2008.04.011; CANCELLI C, 1985, J FLUID MECH, V157, P375, DOI 10.1017/S0022112085002427; Daniloff R, 1980, PHYSL SPEECH HEARING; DEGUCHI S., 2006, J BIOMECH SCI ENG, V1, P246; Deguchi S, 2007, ANN OTO RHINOL LARYN, V116, P128, DOI 10.1177/000348940711600209; Deguchi S, 2009, J BIOMECH, V42, P824, DOI 10.1016/j.jbiomech.2009.01.027; DEJONCKERE P, 1981, ARCH INT PHYSIOL BIO, V89, P127, DOI 10.3109/13813458109073992; FLANAGAN JL, 1968, IEEE T ACOUST SPEECH, VAU16, P57, DOI 10.1109/TAU.1968.1161949; Fung Y.C., 2002, INTRO THEORY AEROELA; Fung Y.C., 1993, BIOMECHANICS MECH PR; Fung YC, 1990, BIOMECHANICS MOTION; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; HOLLIEN H, 1962, J SPEECH HEAR RES, V5, P237, DOI 10.1044/jshr.0503.237; Horacek J, 2005, J FLUID STRUCT, V20, P853, DOI 10.1016/j.jfluidstructs.2005.05.003; Horacek J, 2002, J FLUID STRUCT, V16, P931, DOI 10.1006/jfls.2002.0454; Hottinger DG, 2007, LARYNGOSCOPE, V117, P1695, DOI 10.1097/MLG.0b013e3180959e38; Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006; HYAKUTAKE T, 2006, J BIOMECH SCI ENG, V1, P290; Ikeda T, 2001, J BIOMECH ENG-T ASME, V123, P571, DOI 10.1115/1.1408939; Ikeda T, 1999, J BIOMECH ENG-T ASME, V121, P153, DOI 10.1115/1.2835097; IKEDA T, 1994, T JPN SOC MECH ENG-B, V60, P1226; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Ishizaka K, 1972, SCRL MONOGR, V8; Ishizaka K., 1968, J ACOUST SOC JPN, V24, P311, DOI [10.20697/jasj.24.5_311, DOI 10.20697/JASJ.24.5_311]; Ishizaka K., 1968, J ACOUST SOC JPN, V24, P312, DOI [10.20697/jasj.24.5_312, DOI 10.20697/JASJ.24.5_312]; Jiang JJ, 2007, J ACOUST SOC AM, V121, P2873, DOI 10.1121/1.2710961; Kaneko T., 1972, J JPN BRONCHOESOPHAG, V25, P133, DOI 10.2468/jbes.25.133; KATZ AI, 1969, BIOPHYS J, V9, P1261, DOI 10.1016/S0006-3495(69)86451-9; Krane M, 2007, J ACOUST SOC AM, V122, P3659, DOI 10.1121/1.2409485; Krane MH, 2006, J ACOUST SOC AM, V120, P1578, DOI 10.1121/1.2215408; Lucero JC, 1999, J ACOUST SOC AM, V105, P423, DOI 10.1121/1.424572; Lucero JC, 1996, J ACOUST SOC AM, V100, P3355, DOI 10.1121/1.416976; Matsuzaki Y, 1998, J BIOMECH ENG-T ASME, V120, P594, DOI 10.1115/1.2834749; MATSUZAKI Y, 1994, J BIOMECH ENG-T ASME, V116, P469, DOI 10.1115/1.2895798; Miller DG, 2005, FOLIA PHONIATR LOGO, V57, P278, DOI 10.1159/000087081; PELORSON X, 1994, J ACOUST SOC AM, V96, P3416, DOI 10.1121/1.411449; Plant RL, 2004, J ACOUST SOC AM, V116, P3640, DOI 10.1121/1.1812309; Regner MF, 2008, LARYNGOSCOPE, V118, P1313, DOI 10.1097/MLG.0b013e31816e2ec7; RUBIN HENRY J., 1960, LARYNGOSCOPE, V70, P1305; Sciamarella D, 2008, EUR J MECH B-FLUID, V27, P42, DOI 10.1016/j.euromechflu.2007.06.004; Sciamarella D, 2004, ACTA ACUST UNITED AC, V90, P746; SLOAN SH, 1993, LARYNGOSCOPE, V103, P947; Solomon NP, 2007, J VOICE, V21, P541, DOI 10.1016/j.jvoice.2006.04.002; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Svec JG, 1999, J ACOUST SOC AM, V106, P1523, DOI 10.1121/1.427149; Tao C, 2008, J ACOUST SOC AM, V123, P1637, DOI 10.1121/1.2832328; Titze IR, 2009, J SPEECH LANG HEAR R, V52, P1062, DOI 10.1044/1092-4388(2009/08-0110); TITZE IR, 1992, J ACOUST SOC AM, V91, P2926, DOI 10.1121/1.402928; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; TITZE IR, 1980, J SPEECH HEAR RES, V23, P495, DOI 10.1044/jshr.2303.495; Titze IR, 1994, PRINCIPLES VOICE PRO; Tokuda IT, 2007, J ACOUST SOC AM, V122, P519, DOI 10.1121/1.2741210; VANDENBERG J, 1958, J SPEECH HEAR RES, V1, P227, DOI 10.1044/jshr.0103.227; VERDOLINIMARSTON K, 1990, J VOICE, V4, P142, DOI 10.1016/S0892-1997(05)80139-0; WALSH C, 1995, J FLUID STRUCT, V9, P393, DOI 10.1006/jfls.1995.1022; Wang TG, 2010, J FORMOS MED ASSOC, V109, P62, DOI 10.1016/S0929-6646(10)60022-8; Washio S, 2008, P I MECH ENG C-J MEC, V222, P1695, DOI 10.1243/09544062JMES965; WOODSON G, 1998, OFFICE BASED SURG OT, P159; YOSHIKAWA S, 1995, J ACOUST SOC AM, V97, P1929, DOI 10.1121/1.412066; Zhang ZY, 2008, J ACOUST SOC AM, V124, P1689, DOI 10.1121/1.2957938; Zhang ZY, 2006, J ACOUST SOC AM, V120, P1558, DOI 10.1121/1.2225682; Zhuang P, 2009, LARYNGOSCOPE, V119, P811, DOI 10.1002/lary.20165	68	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17503	10.1371/journal.pone.0017503	http://dx.doi.org/10.1371/journal.pone.0017503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408178	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800021
J	Yan, TC; Dudley, JA; Weir, RK; Grabowska, EM; Pena-Oliver, Y; Ripley, TL; Hunt, SP; Stephens, DN; Stanford, SC				Yan, Ting Carrie; Dudley, Julia A.; Weir, Ruth K.; Grabowska, Ewelina M.; Pena-Oliver, Yolanda; Ripley, Tamzin L.; Hunt, Stephen P.; Stephens, David N.; Stanford, S. Clare			Performance Deficits of NK1 Receptor Knockout Mice in the 5-Choice Serial Reaction-Time Task: Effects of d-Amphetamine, Stress and Time of Day	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FUNCTIONAL MAGNETIC-RESONANCE; MEDIAL PREFRONTAL CORTEX; HYPERACTIVITY DISORDER; SUBSTANCE-P; EXTRACELLULAR NORADRENALINE; SELECTIVE ATTENTION; RATS; ADHD; LESIONS	Background: The neurochemical status and hyperactivity of mice lacking functional substance P-preferring NK1 receptors (NK1R-/-) resemble abnormalities in Attention Deficit Hyperactivity Disorder (ADHD). Here we tested whether NK1R-/- mice express other core features of ADHD (impulsivity and inattentiveness) and, if so, whether they are diminished by d-amphetamine, as in ADHD. Prompted by evidence that circadian rhythms are disrupted in ADHD, we also compared the performance of mice that were trained and tested in the morning or afternoon. Methods and Results: The 5-Choice Serial Reaction-Time Task (5-CSRTT) was used to evaluate the cognitive performance of NK1R-/- mice and their wildtypes. After training, animals were tested using a long (LITI) and a variable (VITI) inter-trial interval: these tests were carried out with, and without, d-amphetamine pretreatment (0.3 or 1 mg/kg i.p.). NK1R-/- mice expressed greater omissions (inattentiveness), perseveration and premature responses (impulsivity) in the 5-CSRTT. In NK1R-/- mice, perseveration in the LITI was increased by injection-stress but reduced by d-amphetamine. Omissions by NK1R-/- mice in the VITI were unaffected by d-amphetamine, but premature responses were exacerbated by this psychostimulant. Omissions in the VITI were higher, overall, in the morning than the afternoon but, in the LITI, premature responses of NK1R-/- mice were higher in the afternoon than the morning. Conclusion: In addition to locomotor hyperactivity, NK1R-/- mice express inattentiveness, perseveration and impulsivity in the 5-CSRTT, thereby matching core criteria for a model of ADHD. Because d-amphetamine reduced perseveration in NK1R-/- mice, this action does not require functional NK1R. However, the lack of any improvement of omissions and premature responses in NK1R-/- mice given d-amphetamine suggests that beneficial effects of this psychostimulant in other rodent models, and ADHD patients, need functional NK1R. Finally, our results reveal experimental variables (stimulus parameters, stress and time of day) that could influence translational studies.	[Yan, Ting Carrie; Stanford, S. Clare] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Dudley, Julia A.; Grabowska, Ewelina M.; Pena-Oliver, Yolanda; Hunt, Stephen P.] UCL, Dept Cell & Dev Biol, London, England; [Pena-Oliver, Yolanda; Ripley, Tamzin L.; Stephens, David N.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of London; University College London; University of London; University College London; University of Sussex	Yan, TC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	c.stanford@ucl.ac.uk	Stephens, David/G-2384-2012	Hunt, Stephen/0000-0001-9453-5505; Weir, Ruth/0000-0002-7268-7038; Stanford, Susan/0000-0002-5623-1751	Medical Research Council (UK) [G0801038 (p6818)]; MRC [G0801038] Funding Source: UKRI; Medical Research Council [G0801038] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK); Grant no. G0801038 (p6818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSON KJ, 1994, J PERS SOC PSYCHOL, V67, P334, DOI 10.1037/0022-3514.67.2.334; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bejerot S, 2010, J CLIN PSYCHIAT, V71, P1590, DOI 10.4088/JCP.09m05168pur; Bizarro L, 2004, BEHAV PHARMACOL, V15, P195, DOI 10.1097/01.fbp.0000131574.61491.50; Bizarro L, 2003, PSYCHOPHARMACOLOGY, V170, P271, DOI 10.1007/s00213-003-1543-6; Blokland A, 2005, BEHAV PHARMACOL, V16, P93, DOI 10.1097/00008877-200503000-00004; Body S, 2009, PSYCHOPHARMACOLOGY, V203, P547, DOI 10.1007/s00213-008-1400-8; *BRIT MED ASS, 2010, BRIT NAT FORM, V59, P217; Caci H, 2009, J ATTEN DISORD, V13, P36, DOI 10.1177/1087054708320439; Calcagno E, 2009, J NEUROCHEM, V108, P521, DOI 10.1111/j.1471-4159.2008.05789.x; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Dalley JW, 2002, NEUROPSYCHOPHARMACOL, V26, P716, DOI 10.1016/S0893-133X(01)00412-2; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; de Bruin NMWJ, 2006, PHYSIOL BEHAV, V89, P692, DOI 10.1016/j.physbeh.2006.08.009; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; Fisher AS, 2007, EUR J NEUROSCI, V25, P1195, DOI 10.1111/j.1460-9568.2007.05369.x; Froger N, 2001, J NEUROSCI, V21, P8188, DOI 10.1523/JNEUROSCI.21-20-08188.2001; Gannon RL, 2005, EUR J PHARMACOL, V527, P86, DOI 10.1016/j.ejphar.2005.10.012; Harrison AA, 1997, PSYCHOPHARMACOLOGY, V133, P329, DOI 10.1007/s002130050410; Heal DJ, 2008, PHARMACOL BIOCHEM BE, V90, P184, DOI 10.1016/j.pbb.2008.03.016; Herpfer I, 2005, NEUROPHARMACOLOGY, V48, P706, DOI 10.1016/j.neuropharm.2004.12.016; Higgins GA, 2007, BEHAV BRAIN RES, V185, P32, DOI 10.1016/j.bbr.2007.07.013; Houghton S, 1999, J CHILD NEUROL, V14, P801, DOI 10.1177/088307389901401206; HUMBY T, 2005, CURRENT PROTOCOLS S, V31, pCH8; Koskinen T, 2000, NEUROPHARMACOLOGY, V39, P471, DOI 10.1016/S0028-3908(99)00159-8; KUCZENSKI R, 1989, J NEUROSCI, V9, P2051; MATTISON RE, 2010, J ATTEN DISORD; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; Mayorga AJ, 2000, BEHAV BRAIN RES, V109, P59, DOI 10.1016/S0166-4328(99)00165-5; MICK G, 1994, MOL BRAIN RES, V21, P157, DOI 10.1016/0169-328X(94)90388-3; Milstein JA, 2007, PSYCHOPHARMACOLOGY, V190, P51, DOI 10.1007/s00213-006-0594-x; Oades RD, 2008, PROG BRAIN RES, V172, P543, DOI 10.1016/S0079-6123(08)00926-6; Oliver YP, 2009, PSYCHOPHARMACOLOGY, V204, P679, DOI 10.1007/s00213-009-1500-0; Orsini C, 2004, PSYCHOPHARMACOLOGY, V172, P264, DOI 10.1007/s00213-003-1647-z; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; Piggins HD, 2001, J COMP NEUROL, V438, P50, DOI 10.1002/cne.1301; Pioli EY, 2008, NEUROSCIENCE, V153, P1213, DOI 10.1016/j.neuroscience.2008.01.084; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Pollier F, 2000, NEUROPSYCHOPHARMACOL, V22, P64, DOI 10.1016/S0893-133X(99)00092-5; Pum M, 2007, PSYCHOPHARMACOLOGY, V193, P375, DOI 10.1007/s00213-007-0791-2; Radonovich KJ, 2004, CHILD NEUROPSYCHOL, V10, P162, DOI 10.1080/09297040409609807; Renoldi G, 2006, J NEUROSCI RES, V84, P961, DOI 10.1002/jnr.20997; Sagvolden T, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-3; Schwabe K, 2004, BEHAV BRAIN RES, V153, P21, DOI 10.1016/j.bbr.2003.10.030; Sharp SI, 2009, NEUROPHARMACOLOGY, V57, P590, DOI 10.1016/j.neuropharm.2009.08.011; Singewald N, 2008, J NEUROCHEM, V106, P2476, DOI 10.1111/j.1471-4159.2008.05596.x; TANNOCK R, 1992, J CHILD PSYCHOL PSYC, V33, P1217, DOI 10.1111/j.1469-7610.1992.tb00940.x; Teicher MH, 2000, NAT MED, V6, P470, DOI 10.1038/74737; Toplak ME, 2003, J CHILD PSYCHOL PSYC, V44, P888, DOI 10.1111/1469-7610.00173; Tsutsui-Kimura I, 2009, BEHAV PHARMACOL, V20, P474, DOI 10.1097/FBP.0b013e3283305e65; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V170, P320, DOI 10.1007/s00213-003-1546-3; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Wood S, 2009, PSYCHOPHARMACOLOGY, V202, P197, DOI 10.1007/s00213-008-1185-9; Xu XH, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-48; Yan TC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/0269881108100255; Yan TC, 2009, NEUROPHARMACOLOGY, V57, P627, DOI 10.1016/j.neuropharm.2009.08.021; Yang SJ, 2007, PSYCHIAT RES, V153, P55, DOI 10.1016/j.psychres.2006.04.001	65	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17586	10.1371/journal.pone.0017586	http://dx.doi.org/10.1371/journal.pone.0017586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408181	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800025
J	Ashkenazi, A; Viard, M; Wexler-Cohen, Y; Blumenthal, R; Shai, Y				Ashkenazi, Avraham; Viard, Mathias; Wexler-Cohen, Yael; Blumenthal, Robert; Shai, Yechiel			Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41	FASEB JOURNAL			English	Article						HIV-1 fusion inhibitor; peptide-membrane interaction	IMMUNODEFICIENCY-VIRUS TYPE-1; DISULFIDE-ISOMERASE; INFLUENZA HEMAGGLUTININ; ATOMIC-STRUCTURE; 6-HELIX BUNDLE; CORE STRUCTURE; CELL FUSION; ENTRY; RECEPTOR; GLYCOPROTEIN	Fusion of human immunodeficiency virus (HIV-1) with target cells is mediated by the gp41 transmembrane envelope protein. The loop region within gp41 contains 2 crucial cysteines that play an unknown role in HIV-cell fusion. On the basis of cell-cell fusion assay, using human T-cell lines [Jurkat E6-1 and Jurkat HXBc2(4)], and virus-cell fusion assay, using fully infectious HIV-1 HXBc2 virus and TZM-bl human cell line, we provide evidence that the oxidation state of the disulfide bond within a loop domain peptide determines its activity. The oxidized (closed) form inhibits fusion, while the reduced (opened) form enhances hemifusion. These opposite activities reach 60% difference in viral fusion. Both forms of the loop domain interact with gp41: the opened form enhances gp41 folding into a bundle, whereas the closed form inhibits this folding. Therefore, the transformation of the cysteines from a reduced to an oxidized state enables the loop to convert from opened to closed conformations, which assists gp41 to fold and induces hemifusion. The significant conservation of the loop region within many envelope proteins suggests a general mechanism, which is exploited by viruses to enhance entry into their host cells.-Ashkenazi, A., Viard, M., Wexler-Cohen, Y., Blumenthal, R., Shai, Y. Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41. FASEB J. 25, 2156-2166 (2011). www.fasebj.org	[Ashkenazi, Avraham; Wexler-Cohen, Yael; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Viard, Mathias; Blumenthal, Robert] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA; [Viard, Mathias] Natl Canc Inst Frederick, SAIC Frederick Inc, Basic Res Program, Frederick, MD 21701 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	yechiel.shai@weizmann.ac.il		Ashkenazi, Avraham/0000-0002-1253-497X	Israel Science Foundation; National Cancer Institute, U.S. National Institutes of Health (NIH) [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008303] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Batya Zarmi for her valuable help with peptide purification, Dr. Ayala Sharp and Eitan Ariel, and the staff of the flow cytometry unit at the Weizmann Institute of Science for their valuable technical assistance and advice. This study was supported by the Israel Science Foundation and also has been funded, in part, with federal funds from the National Cancer Institute, U.S. National Institutes of Health (NIH), under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does it mention any trade names, commercial products, or organizations or imply endorsement by the U. S. Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Y.S. is the incumbent of the Harold S. and Harriet B. Brady Professorial Chair in Cancer Research.	Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Bellamy-McIntyre AK, 2010, BIOCHEM BIOPH RES CO, V394, P904, DOI 10.1016/j.bbrc.2010.03.071; Billington J, 2007, J VIROL, V81, P4604, DOI 10.1128/JVI.02138-06; Blumenthal R, 2002, CHEM PHYS LIPIDS, V116, P39, DOI 10.1016/S0009-3084(02)00019-1; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Cao J, 1996, J VIROL, V70, P1340, DOI 10.1128/JVI.70.3.1340-1354.1996; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Huerta L, 2002, CYTOMETRY, V47, P100, DOI 10.1002/cyto.10051; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Judice JK, 1997, P NATL ACAD SCI USA, V94, P13426, DOI 10.1073/pnas.94.25.13426; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Leikina E, 2001, BIOCHEMISTRY-US, V40, P8378, DOI 10.1021/bi010466+; Li KJ, 2008, J VIROL, V82, P7135, DOI 10.1128/JVI.00448-08; Liu J, 2010, J VIROL, V84, P201, DOI 10.1128/JVI.01558-09; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Maerz AL, 2000, J VIROL, V74, P6614, DOI 10.1128/JVI.74.14.6614-6621.2000; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; MORRIS SJ, 1989, J BIOL CHEM, V264, P3972; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Peisajovich SG, 2003, J MOL BIOL, V326, P1489, DOI 10.1016/S0022-2836(03)00040-8; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Pinter A, 1997, J VIROL, V71, P8073, DOI 10.1128/JVI.71.10.8073-8077.1997; Poranen MM, 2002, ANNU REV MICROBIOL, V56, P521, DOI 10.1146/annurev.micro.56.012302.160643; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; SCHULZ TF, 1992, AIDS RES HUM RETROV, V8, P1571, DOI 10.1089/aid.1992.8.1571; Sen J, 2007, PROTEIN SCI, V16, P1236, DOI 10.1110/ps.072771407; SYU WJ, 1991, J VIROL, V65, P6349, DOI 10.1128/JVI.65.11.6349-6352.1991; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Viard Mathias, 2004, Glycoconj J, V20, P213; Wallin M, 2004, EMBO J, V23, P54, DOI 10.1038/sj.emboj.7600012; WEISS A, 1984, J IMMUNOL, V133, P123; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803	70	15	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2156	2166		10.1096/fj.10-175752	http://dx.doi.org/10.1096/fj.10-175752			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21429941	Green Published			2022-12-25	WOS:000292242200008
J	Oh, JH; Cho, MC; Kim, JH; Lee, SY; Kim, HJ; Park, ES; Ban, JO; Kang, JW; Lee, DH; Shim, JH; Han, SB; Moon, DC; Park, YH; Yu, DY; Kim, JM; Kim, SH; Yoon, DY; Hong, JT				Oh, J. H.; Cho, M-C; Kim, J-H; Lee, S. Y.; Kim, H. J.; Park, E. S.; Ban, J. O.; Kang, J-W; Lee, D-H; Shim, J-H; Han, S. B.; Moon, D. C.; Park, Y. H.; Yu, D-Y; Kim, J-M; Kim, S. H.; Yoon, D-Y; Hong, J. T.			IL-32 gamma inhibits cancer cell growth through inactivation of NF-kappa B and STAT3 signals	ONCOGENE			English	Article						IL-32; cytokine; colon cancer; NF-kappa B; STAT3	PROINFLAMMATORY CYTOKINE; TUMOR-METASTASIS; PROSTATE-CANCER; TRANSGENIC MICE; T-CELLS; INTERLEUKIN-10; IL-32; INFLAMMATION; EXPRESSION; IDENTIFICATION	Several studies have shown physiological functions of interleukin (IL)-32, a novel cytokine. However, the role of IL-32 in cancer development has not been reported. In this study, we showed that IL-32 gamma inhibited tumor growth in IL-32 gamma-overexpressing transgenic mice inoculated with melanoma as well as colon tumor growth in xenograft nude mice inoculated with IL-32 gamma-transfected colon cancer cells (SW620). The inhibitory effect of IL-32 gamma on tumor growth was associated with the inhibition of constitutive activated nuclear transcription factor-kappa B (NF-kappa B) and of signal transducer and activator of transcription 3 (STAT3). The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1 beta-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased. In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor-alpha (TNF-alpha), IL-1 beta and IL-6 decreased. We also found that forced overexpression of IL-32 gamma inhibited colon cancer cell (SW620 and HCT116) growth accompanied with the inhibition of activated NF-kappa B and STAT3 in vitro. In addition, when IL-32 gamma was knocked down by small interfering RNA (siRNA) or neutralized with an anti-IL-32 gamma antibody, IL-32 gamma-induced colon cancer cell growth inhibition, the IL-32 gamma-induced decrease of TNF-alpha, IL-1 and IL-6 production, and the increase of IL-10 production were abolished. However, siRNA of NF kappa B and STAT3 augmented IL-32 gamma-induced colon cancer cell growth inhibition. These findings indicate significant pathophysiological roles of IL-32 gamma in cancer development. Oncogene (2011) 30, 3345-3359; doi:10.1038/onc.2011.52; published online 21 March 2011	[Oh, J. H.; Cho, M-C; Lee, S. Y.; Park, E. S.; Ban, J. O.; Han, S. B.; Moon, D. C.; Hong, J. T.] Chungbuk Natl Univ, Coll Pharm, Cheongju 361463, Chungbuk, South Korea; [Oh, J. H.; Cho, M-C; Lee, S. Y.; Park, E. S.; Han, S. B.; Moon, D. C.; Hong, J. T.] Chungbuk Natl Univ, Med Res Ctr, Cheongju 361463, Chungbuk, South Korea; [Kim, J-H; Kim, H. J.; Kang, J-W; Lee, D-H; Shim, J-H; Yoon, D-Y] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 143701, South Korea; [Park, Y. H.; Yu, D-Y] Korea Res Inst Biosci & Biotechnol, Anim Dis Res Ctr, Taejon, South Korea; [Kim, J-M] Chungnam Natl Univ, Pathol Lab, Taejon, South Korea; [Kim, S. H.] Konkuk Univ, Lab Cytokine Immunol, Med Immunol Ctr, Inst Biomed Sci & Technol, Seoul 143701, South Korea	Chungbuk National University; Chungbuk National University; Konkuk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Konkuk University; Konkuk University Medical Center	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, 12 Gaeshin Dong, Cheongju 361463, Chungbuk, South Korea.	ydy4218@konkuk.ac.kr; jinthong@chungbuk.ac.kr		kim, sunghoon/0000-0002-1570-3230; Shim, Jung-Hyun/0000-0002-4062-4016; KIM, JIN MAN/0000-0003-0905-9730	Korea Research Foundation (MRC) [R13-2008-001-00000-00]; Ministry for Health, Welfare and Family affairs, Republic of Korea [0920080]; National Research Foundation of Korea [2009-0093824, 2010-0019306]; KRIBB Research Initiative	Korea Research Foundation (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Research Foundation of Korea); Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); KRIBB Research Initiative	This work was supported by the Korea Research Foundation Grant (MRC, R13-2008-001-00000-00) and the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920080). D Yoon was partially from National Research Foundation of Korea (2009-0093824, 2010-0019306) and D Yu from KRIBB Research Initiative Program Grant. We thank Dr Howard P Glauert (University of Kentucky) who provided invaluable assistance with English legal manuscripts.	Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Ban JO, 2009, MOL CANCER THER, V8, P1613, DOI 10.1158/1535-7163.MCT-08-0694; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cacev T, 2008, CARCINOGENESIS, V29, P1572, DOI 10.1093/carcin/bgn164; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Choi JD, 2009, IMMUNOLOGY, V126, P535, DOI 10.1111/j.1365-2567.2008.02917.x; Choi J, 2010, P NATL ACAD SCI USA, V107, P21082, DOI 10.1073/pnas.1015418107; CHOI KC, 2002, CANCER RES, V69, P583; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Fujimoto J, 2002, ANN ONCOL, V13, P1598, DOI 10.1093/annonc/mdf248; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; GROSCURTH P, 1990, INT J CANCER, V45, P694, DOI 10.1002/ijc.2910450422; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Hou T, 2008, J BIOL CHEM, V283, P30725, DOI 10.1074/jbc.M805941200; Huang SY, 1996, CLIN CANCER RES, V2, P1969; Jee SH, 2001, ONCOGENE, V20, P198, DOI 10.1038/sj.onc.1204076; Jenkins BJ, 2005, BLOOD, V105, P3512, DOI 10.1182/blood-2004-09-3751; Kang JW, 2009, IMMUNOLOGY, V128, pe532, DOI 10.1111/j.1365-2567.2008.03025.x; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim KS, 2008, POLYM-KOREA, V32, P38; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kundu N, 1997, CELL IMMUNOL, V180, P55, DOI 10.1006/cimm.1997.1176; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee J, 1998, CANCER RES, V58, P1478; Lee S, 2010, HYBRIDOMA, V29, P501, DOI 10.1089/hyb.2010.0059; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Lu C, 2004, J CLIN ONCOL, V22, P4575, DOI 10.1200/JCO.2004.01.091; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Moretta L, 2000, IMMUNOL TODAY, V21, P420, DOI 10.1016/S0167-5699(00)01673-X; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Shurin MR, 2006, CANCER METAST REV, V25, P333, DOI 10.1007/s10555-006-9010-6; Son DJ, 2007, MOL CANCER THER, V6, P675, DOI 10.1158/1535-7163.MCT-06-0328; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400OC; Wang AG, 2005, J HEPATOL, V43, P836, DOI 10.1016/j.jhep.2005.04.012; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang F, 2009, CELL SIGNAL, V21, P1085, DOI 10.1016/j.cellsig.2009.02.018; Zheng LM, 1996, J EXP MED, V184, P579, DOI 10.1084/jem.184.2.579	54	80	84	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	30					3345	3359		10.1038/onc.2011.52	http://dx.doi.org/10.1038/onc.2011.52			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21423208	Green Published, hybrid			2022-12-25	WOS:000293215700005
J	Li, QA; Mavrodi, DV; Thomashow, LS; Roessle, M; Blankenfeldt, W				Li, Qi-Ang; Mavrodi, Dmitri V.; Thomashow, Linda S.; Roessle, Manfred; Blankenfeldt, Wulf			Ligand Binding Induces an Ammonia Channel in 2-Amino-2-desoxyisochorismate (ADIC) Synthase PhzE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORISMATE-UTILIZING ENZYMES; ISOCHORISMATE SYNTHASE; PHENAZINE BIOSYNTHESIS; ANTHRANILATE SYNTHASE; SALICYLATE SYNTHASE; MECHANISM; PSEUDOMONAS; REFINEMENT; PROTEINS; PYRUVATE	PhzE utilizes chorismate and glutamine to synthesize 2-amino-2-desoxyisochorismate (ADIC) in the first step of phenazine biosynthesis. The PhzE monomer contains both a chorismate-converting menaquinone, siderophore, tryptophan biosynthesis (MST) and a type 1 glutamine amidotransferase (GATase1) domain connected by a 45-residue linker. We present here the crystal structure of PhzE from Burkholderia lata 383 in a ligand-free open and ligand-bound closed conformation at 2.9 and 2.1 angstrom resolution, respectively. PhzE arranges in an intertwined dimer such that the GATase1 domain of one chain provides NH3 to the MST domain of the other. This quaternary structure was confirmed by small angle x-ray scattering. Binding of chorismic acid, which was found converted to benzoate and pyruvate in the MST active centers of the closed form, leads to structural rear-rangements that establish an ammonia transport channel approximately 25 angstrom in length within each of the two MST/GATase1 functional units of the dimer. The assignment of PhzE as an ADIC synthase was confirmed by mass spectrometric analysis of the product, which was also visualized at 1.9 angstrom resolution by trapping in crystals of an inactive mutant of PhzD, an isochorismatase that catalyzes the subsequent step in phenazine biosynthesis. Unlike in some of the related anthranilate synthases, no allosteric inhibition was observed in PhzE. This can be attributed to a tryptophan residue of the protein blocking the potential regulatory site. Additional electron density in the GATase1 active center was identified as zinc, and it was demonstrated that Zn2+, Mn2+, and Ni2+ reduce the activity of PhzE.	[Li, Qi-Ang; Blankenfeldt, Wulf] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Mavrodi, Dmitri V.; Thomashow, Linda S.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Thomashow, Linda S.] ARS, Root Dis & Biol Control Unit, USDA, Pullman, WA 99164 USA; [Roessle, Manfred] DESY, European Mol Biol Lab Hamburg Outstn, D-22603 Hamburg, Germany	Max Planck Society; Washington State University; United States Department of Agriculture (USDA); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Blankenfeldt, W (corresponding author), Univ Bayreuth, Lehrstuhl Biochem, Univ Str 30, D-95447 Bayreuth, Germany.	wulf.blankenfeldt@uni-bayreuth.de	Mavrodi, Dmitri/AAH-7712-2020; Mavrodi, Dmitri V./S-7894-2019; Blankenfeldt, Wulf/F-8877-2010; Mavrodi, Dmitri/J-2745-2013	Mavrodi, Dmitri V./0000-0002-9644-2094; Blankenfeldt, Wulf/0000-0001-9886-9668; Rossle, Manfred/0000-0003-4196-0430	Deutsche Forschungsgemeinschaft [BL587/1-1/2]; International Max Planck Research School in Chemical Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology	This work was supported by Deutsche Forschungsgemeinschaft Grant BL587/1-1/2 (to W. B.).; Supported by the International Max Planck Research School in Chemical Biology.	Ashenafi M, 2008, ETHNIC DIS, V18; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; DeClue MS, 2005, J AM CHEM SOC, V127, P15002, DOI 10.1021/ja055871t; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerbarh O, 2006, J MOL BIOL, V357, P524, DOI 10.1016/j.jmb.2005.12.078; Kolappan S, 2007, BIOCHEMISTRY-US, V46, P946, DOI 10.1021/bi0608515; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald M, 2001, J AM CHEM SOC, V123, P9459, DOI 10.1021/ja011243+; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; MOROLLO AA, 1993, P NATL ACAD SCI USA, V90, P9983, DOI 10.1073/pnas.90.21.9983; MOROLLO AA, 1993, J AM CHEM SOC, V115, P816, DOI 10.1021/ja00055a079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Parsons JF, 2008, ACTA CRYSTALLOGR D, V64, P607, DOI 10.1107/S0907444908005477; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; PIERSON LS, 1995, FEMS MICROBIOL LETT, V134, P299, DOI 10.1111/j.1574-6968.1995.tb07954.x; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; ROEMER A, 1982, Zeitschrift fuer Naturforschung Section C Journal of Biosciences, V37, P1070; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Spraggon G, 2001, P NATL ACAD SCI USA, V98, P6021, DOI 10.1073/pnas.111150298; Sridharan S, 2010, J MOL BIOL, V397, P290, DOI 10.1016/j.jmb.2010.01.019; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Teplyakov A, 2001, J MOL BIOL, V313, P1093, DOI 10.1006/jmbi.2001.5094; Van Lanen SG, 2008, P NATL ACAD SCI USA, V105, P494, DOI 10.1073/pnas.0708750105; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zwahlen J, 2007, BIOCHEMISTRY-US, V46, P954, DOI 10.1021/bi060852x	38	42	45	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18213	18221		10.1074/jbc.M110.183418	http://dx.doi.org/10.1074/jbc.M110.183418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454481	Green Published, hybrid			2022-12-25	WOS:000290585200081
J	Luukkonen, J; Liimatainen, A; Hoyto, A; Juutilainen, J; Naarala, J				Luukkonen, Jukka; Liimatainen, Anu; Hoyto, Anne; Juutilainen, Jukka; Naarala, Jonne			Pre-Exposure to 50 Hz Magnetic Fields Modifies Menadione-Induced Genotoxic Effects in Human SH-SY5Y Neuroblastoma Cells	PLOS ONE			English	Article							SINGLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; ELECTROMAGNETIC-FIELDS; MAMMALIAN-CELLS; IN-VITRO; REPAIR; LYMPHOCYTES; FREQUENCY; EXPOSURE; METAANALYSIS	Background: Extremely low frequency (ELF) magnetic fields (MF) are generated by power lines and various electric appliances. They have been classified as possibly carcinogenic by the International Agency for Research on Cancer, but a mechanistic explanation for carcinogenic effects is lacking. A previous study in our laboratory showed that pre-exposure to ELF MF altered cancer-relevant cellular responses (cell cycle arrest, apoptosis) to menadione-induced DNA damage, but it did not include endpoints measuring actual genetic damage. In the present study, we examined whether pre-exposure to ELF MF affects chemically induced DNA damage level, DNA repair rate, or micronucleus frequency in human SH-SY5Y neuroblastoma cells. Methodology/Principal Findings: Exposure to 50 Hz MF was conducted at 100 mu T for 24 hours, followed by chemical exposure for 3 hours. The chemicals used for inducing DNA damage and subsequent micronucleus formation were menadione and methyl methanesulphonate (MMS). Pre-treatment with MF enhanced menadione-induced DNA damage, DNA repair rate, and micronucleus formation in human SH-SY5Y neuroblastoma cells. Although the results with MMS indicated similar effects, the differences were not statistically significant. No effects were observed after MF exposure alone. Conclusions: The results confirm our previous findings showing that pre-exposure to MFs as low as 100 mu T alters cellular responses to menadione, and show that increased genotoxicity results from such interaction. The present findings also indicate that complementary data at several chronological points may be critical for understanding the MF effects on DNA damage, repair, and post-repair integrity of the genome.	[Luukkonen, Jukka; Liimatainen, Anu; Hoyto, Anne; Juutilainen, Jukka; Naarala, Jonne] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland	University of Eastern Finland	Luukkonen, J (corresponding author), Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland.	Jukka.Luukkonen@uef.fi	Höytö, Anne/G-5970-2012	Höytö, Anne/0000-0002-3152-534X	Finnish Ministry of Education (Graduate School in Environmental Health SYTYKE); University of Eastern Finland	Finnish Ministry of Education (Graduate School in Environmental Health SYTYKE); University of Eastern Finland	This work was supported by the Finnish Ministry of Education (Graduate School in Environmental Health SYTYKE) and University of Eastern Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akudugu JM, 2004, INT J RADIAT BIOL, V80, P93, DOI 10.1080/09553002310001655449; Andreoli C, 1999, MUTAGENESIS, V14, P497, DOI 10.1093/mutage/14.5.497; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; Bryce SM, 2007, MUTAT RES-GEN TOX EN, V630, P78, DOI 10.1016/j.mrgentox.2007.03.002; Cantoni O, 1996, BIOCHEM MOL BIOL INT, V38, P527; Chow KC, 2000, FEBS LETT, V478, P133, DOI 10.1016/S0014-5793(00)01822-6; COSSARIZZA A, 1989, RADIAT RES, V118, P161, DOI 10.2307/3577431; FISCHERNIELSEN A, 1995, BIOCHEM PHARMACOL, V49, P1469, DOI 10.1016/0006-2952(94)00525-Q; FRAZIER ME, 1990, BIOELECTROMAGNETICS, V11, P229, DOI 10.1002/bem.2250110304; *GARS GD NCSU, LIN MIX MOD RAND EFF; Halliwell B., 2007, FREE RADICAL BIO MED, P46; Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V659, P274, DOI 10.1016/j.mrrev.2008.05.006; International Agency for Research of Cancer (IARC), 2002, IARC MON EV CARC RIS, V80; Jeggo PA, 2009, HEALTH PHYS, V97, P416, DOI 10.1097/HP.0b013e3181aff9c8; Juutilainen J, 2006, INT J RADIAT BIOL, V82, P1, DOI 10.1080/09553000600577839; Juutilainen J, 2000, BIOELECTROMAGNETICS, V21, P122, DOI 10.1002/(SICI)1521-186X(200002)21:2<122::AID-BEM7>3.0.CO;2-D; Kumlin T, 1998, INT J RADIAT BIOL, V73, P113, DOI 10.1080/095530098142761; Luukkonen J, 2009, MUTAT RES-FUND MOL M, V662, P54, DOI 10.1016/j.mrfmmm.2008.12.005; Markkanen A, 2008, INT J RADIAT BIOL, V84, P742, DOI 10.1080/09553000802360836; MCCONKEY DJ, 1988, TOXICOL LETT, V42, P123, DOI 10.1016/0378-4274(88)90069-0; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Robison JG, 2002, BIOELECTROMAGNETICS, V23, P106, DOI 10.1002/bem.103; Rothfuss A, 2000, CANCER RES, V60, P390; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; World Health Organization (WHO), 2007, ENV HLTH CRIT, P347	26	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18021	10.1371/journal.pone.0018021	http://dx.doi.org/10.1371/journal.pone.0018021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448285	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500028
J	Seghier, ML; Kolanko, MA; Leff, AP; Jager, HR; Gregoire, SM; Werring, DJ				Seghier, Mohamed L.; Kolanko, Magdalena A.; Leff, Alexander P.; Jaeger, Hans R.; Gregoire, Simone M.; Werring, David J.			Microbleed Detection Using Automated Segmentation (MIDAS): A New Method Applicable to Standard Clinical MR Images	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; BRAIN MICROBLEEDS; UNIFIED SEGMENTATION; PREVALENCE; AGREEMENT; RISK	Background: Cerebral microbleeds, visible on gradient-recalled echo (GRE) T2* MRI, have generated increasing interest as an imaging marker of small vessel diseases, with relevance for intracerebral bleeding risk or brain dysfunction. Methodology/Principal Findings: Manual rating methods have limited reliability and are time-consuming. We developed a new method for microbleed detection using automated segmentation (MIDAS) and compared it with a validated visual rating system. In thirty consecutive stroke service patients, standard GRE T2* images were acquired and manually rated for microbleeds by a trained observer. After spatially normalizing each patient's GRE T2* images into a standard stereotaxic space, the automated microbleed detection algorithm (MIDAS) identified cerebral microbleeds by explicitly incorporating an "extra" tissue class for abnormal voxels within a unified segmentation-normalization model. The agreement between manual and automated methods was assessed using the intraclass correlation coefficient (ICC) and Kappa statistic. We found that MIDAS had generally moderate to good agreement with the manual reference method for the presence of lobar microbleeds (Kappa = 0.43, improved to 0.65 after manual exclusion of obvious artefacts). Agreement for the number of microbleeds was very good for lobar regions: (ICC = 0.71, improved to ICC = 0.87). MIDAS successfully detected all patients with multiple (>= 2) lobar microbleeds. Conclusions/Significance: MIDAS can identify microbleeds on standard MR datasets, and with an additional rapid editing step shows good agreement with a validated visual rating system. MIDAS may be useful in screening for multiple lobar microbleeds.	[Seghier, Mohamed L.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Kolanko, Magdalena A.; Jaeger, Hans R.; Gregoire, Simone M.; Werring, David J.] UCL, Inst Neurol, Stroke Res Grp, Dept Brain Repair & Rehabil, London, England; [Leff, Alexander P.] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Seghier, ML (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	d.werring@ion.ucl.ac.uk	Jäger, Hans Rolf/K-1868-2013; Seghier, Mohamed L/C-6314-2009; Seghier, Mohamed/O-8634-2019; Leff, Alexander P/C-1502-2008; Werring, David/Q-8435-2019	Jäger, Hans Rolf/0000-0002-6403-4184; Seghier, Mohamed L/0000-0002-1146-8800; Seghier, Mohamed/0000-0002-1146-8800; Werring, David/0000-0003-2074-1861; Kolanko, Magdalena/0000-0002-0058-5884; Leff, Alexander/0000-0002-0831-3541	Wellcome Trust; The Stroke Association; Department of Health and Higher Educational and Funding Council; UK Department of Health's National Institute for Health Research Biomedical Research Center (UCLH/UCL Comprehensive Biomedical Research Trust); Stroke Association [TSABHF2009/01] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); The Stroke Association; Department of Health and Higher Educational and Funding Council; UK Department of Health's National Institute for Health Research Biomedical Research Center (UCLH/UCL Comprehensive Biomedical Research Trust); Stroke Association	Mohamed Seghier and Alex Leff were funded by the Wellcome Trust. Simone Gregoire was supported by a grant from The Stroke Association. David Werring is supported by a Department of Health and Higher Educational and Funding Council for England Clinical Senior Lectureship Award. This work was undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme (UCLH/UCL Comprehensive Biomedical Research Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Filippi M, 1995, BRAIN, V118, P1593, DOI 10.1093/brain/118.6.1593; Ghazel M, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P6, DOI 10.1109/ISSPIT.2006.270760; Greenberg SM, 2009, STROKE, V40, P2382, DOI 10.1161/STROKEAHA.109.548974; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2010, J NEUROL NEUROSUR PS, V81, P679, DOI 10.1136/jnnp.2009.198994; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596; Rouainia M, 2006, PROC WRLD ACAD SCI E, V17, P301; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Soille P., 2013, MORPHOLOGICAL IMAGE; Soo YOY, 2008, J NEUROL, V255, P1679, DOI 10.1007/s00415-008-0967-7; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; VERMERSCH P, 1992, CLIN NEUROL NEUROSUR, V94, P213, DOI 10.1016/0303-8467(92)90091-G; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253	25	51	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17547	10.1371/journal.pone.0017547	http://dx.doi.org/10.1371/journal.pone.0017547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448456	gold, Green Submitted, Green Published			2022-12-25	WOS:000288810500007
J	Van Dorsselaer, A; Carapito, C; Delalande, F; Schaeffer-Reiss, C; Thierse, D; Diemer, H; McNair, DS; Krewski, D; Cashman, NR				Van Dorsselaer, Alain; Carapito, Christine; Delalande, Francois; Schaeffer-Reiss, Christine; Thierse, Daniele; Diemer, Helene; McNair, Douglas S.; Krewski, Daniel; Cashman, Neil R.			Detection of Prion Protein in Urine-Derived Injectable Fertility Products by a Targeted Proteomic Approach	PLOS ONE			English	Article							TRUNCATED FORMS; JAKOB-DISEASE; BLOOD; RECOMBINANT; INFECTIVITY; EXCRETION; RISK	Background: Iatrogenic transmission of human prion disease can occur through medical or surgical procedures, including injection of hormones such as gonadotropins extracted from cadaver pituitaries. Annually, more than 300,000 women in the United States and Canada are prescribed urine-derived gonadotropins for infertility. Although menopausal urine donors are screened for symptomatic neurological disease, incubation of Creutzfeldt-Jakob disease (CJD) is impossible to exclude by non-invasive testing. Risk of carrier status of variant CJD (vCJD), a disease associated with decades-long peripheral incubation, is estimated to be on the order of 100 per million population in the United Kingdom. Studies showing infectious prions in the urine of experimental animals with and without renal disease suggest that prions could be present in asymptomatic urine donors. Several human fertility products are derived from donated urine; recently prion protein has been detected in preparations of human menopausal gonadotropin (hMG). Methodology/Principal Findings: Using a classical proteomic approach, 33 and 34 non-gonadotropin proteins were identified in urinary human chorionic gonadotropin (u-hCG) and highly-purified urinary human menopausal gonadotropin (hMG-HP) products, respectively. Prion protein was identified as a major contaminant in u-hCG preparations for the first time. An advanced prion protein targeted proteomic approach was subsequently used to conduct a survey of gonadotropin products; this approach detected human prion protein peptides in urine-derived injectable fertility products containing hCG, hMG and hMG-HP, but not in recombinant products. Conclusions/Significance: The presence of protease-sensitive prion protein in urinary-derived injectable fertility products containing hCG, hMG, and hMG-HP suggests that prions may co-purify in these products. Intramuscular injection is a relatively efficient route of transmission of human prion disease, and young women exposed to prions can be expected to survive an incubation period associated with a minimal inoculum. The risks of urine-derived fertility products could now outweigh their benefits, particularly considering the availability of recombinant products.	[Van Dorsselaer, Alain; Carapito, Christine; Delalande, Francois; Schaeffer-Reiss, Christine; Thierse, Daniele; Diemer, Helene] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, IPHC, CNRS,UMR7178, Strasbourg, France; [McNair, Douglas S.] Cerner Corp, Kansas City, MO USA; [Krewski, Daniel] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON K1N 6N5, Canada; [Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Ottawa; University of British Columbia	Van Dorsselaer, A (corresponding author), Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, IPHC, CNRS,UMR7178, Strasbourg, France.	vandors@unistra.fr; neil.cashman@vch.ca	McNair, Douglas/GSJ-0611-2022	Carapito, Christine/0000-0002-0079-319X; Delalande, Francois/0000-0003-3590-9874; McNair, Douglas/0000-0003-0965-883X	Merck Serono; PrioNet Canada; Natural Sciences and Engineering Research Council of Canada	Merck Serono(Merck & Company); PrioNet Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The Laboratoire de Spectrometrie de Masse Bio-Organique (AVD) received an unrestricted financial support from Merck Serono for the development of new characterization strategies of therapeutic proteins. Other background grants not directly related to this urinary pharmaceuticals project came from PrioNet Canada (http://www.prionetcanada.ca/) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). Dr. McNair is Vice-President of Cerner Corporation, which had no role in the initiation or conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, VARIANT CREUTZFELDT; Balen AH, 2005, HUM REPROD, V20, P2994, DOI 10.1093/humrep/dei209; Bassett R, 2009, REPROD BIOMED ONLINE, V19, P300, DOI 10.1016/S1472-6483(10)60163-0; Boyd A, 2001, Commun Dis Intell Q Rep, V25, P248; Brown P, 2006, NEUROLOGY, V67, P389, DOI 10.1212/01.wnl.0000231528.65069.3f; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Dagdanova A, 2010, J BIOL CHEM, V285, P30489, DOI 10.1074/jbc.M110.161794; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gerber Scott A, 2007, Methods Mol Biol, V359, P71; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Krewski D, 2009, ENV FORUM, V26, P50; Kuwabara Y, 2009, J REPROD MED, V54, P459; Leiss William, 2010, International Journal of Risk Assessment & Management, V14, P381, DOI 10.1504/IJRAM.2010.035935; Leiss W, 2008, TRANSFUS MED REV, V22, P35, DOI 10.1016/j.tmrv.2007.09.002; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Reichl H, 2002, HUM REPROD, V17, P2501, DOI 10.1093/humrep/17.10.2501; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; World Health Organization, WHO TABL TISS INF DI	27	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17815	10.1371/journal.pone.0017815	http://dx.doi.org/10.1371/journal.pone.0017815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448279	Green Published, Green Submitted, gold			2022-12-25	WOS:000288810500013
J	De, DD; Bhattacharjya, S; Maitra, M; Datta, A; Choudhury, A; Dhali, GK; Roychoudhury, S				De, Dipanjana Datta; Bhattacharjya, Sumana; Maitra, Meenakshi; Datta, Arindam; Choudhury, Abhijit; Dhali, G. K.; Roychoudhury, Susanta			IL1B Induced Smad 7 Negatively Regulates Gastrin Expression	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GROWTH FACTOR-BETA/SMAD; TGF-BETA; DUODENAL-ULCER; ACID-SECRETION; MESSENGER-RNA; PROMOTER; MUCOSA; POLYMORPHISMS; INTERLEUKIN-1	Background: Helicobacter pylori elicited IL1B is one of the various modulators responsible for perturbation of acid secretion in gut. We have earlier reported that IL1B activated NFkB downregulates gastrin, a major modulator of acid secretion. However, we hypothesized that regulation of gastrin by IL1B would depend on the cell's ability to integrate inputs from multiple signaling pathways to generate appropriate biological response. Principal Finding: In this study, we report that IL1B induces Smad 7 expression by about 4.5 fold in gastric carcinoma cell line, AGS. Smad 7 resulted in transcriptional repression of gastrin promoter by about 6.5 fold when co-transfected with Smad 7 expression vector and gastrin-promoter luciferase in AGS cells. IL1B inhibited phosphorylation of Smad 3 and subsequently interfered with nuclear translocation of the positive Smad complex, thus occluding it off the gastrin promoter. IL1B promoter polymorphisms (-511T/-31C IL1B) are known to be associated with H. pylori associated gastro-duodenal ulcer. We observed that IL1B expressed from -31T promoter driven IL1B cDNA elicited 3.5 fold more Smad 7 than that expressed from the IL1B-31C variant in AGS cells. This differential activation of Smad 7 by IL1B promoter variants translated into differential downregulation of gastrin expression. We further analyzed Smad 7, NFkB, IL1B and gastrin expression in antral gut biopsy samples of patients with H. pylori associated duodenal ulcer and normal individuals. We observed that individuals with duodenal ulcer had significantly lower levels of IL1B, Smad 7, NFkB and corresponding higher level of gastrin expression. Conclusion: Pro-inflammatory cytokine IL1B repress gastrin expression by activating Smad 7 and subsequent inhibition of nuclear localization of Smad 3/4 complex. Polymorphic promoter variants of IL1B gene can modulate the IL1B expression which resulted in differential activation Smad 7 and consequent repression of gastrin expression, respectively. Analysis of H. pylori infected duodenal ulcer patient's gut biopsy samples also supported this observation.	[De, Dipanjana Datta; Bhattacharjya, Sumana; Datta, Arindam; Roychoudhury, Susanta] CSIR, Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, India; [Maitra, Meenakshi] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Choudhury, Abhijit; Dhali, G. K.] Inst Postgrad Med & Expt Res, Dept Med, Kolkata, India; [Choudhury, Abhijit; Dhali, G. K.] Inst Postgrad Med & Expt Res, Dept Gastroenterol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Texas System; University of Texas Southwestern Medical Center Dallas; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	De, DD (corresponding author), CSIR, Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, India.	susanta@iicb.res.in	Datta, Arindam/ADR-8763-2022; Dhali, Gopal Krishna/AAE-5331-2022; Roychoudhury, Susanta/AAD-7946-2021	Datta, Arindam/0000-0002-0617-9908; Dhali, Gopal Krishna/0000-0002-6759-5067; 	Indian Council of Medical Research [63/147/2001-BMS]; Council of Scientific and Industrial Research, India [IAP 001]; Council of Medical Research, India [5/8-1(161)/H.pylori/2000-ECD-II]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Medical Research, India	This study was partially supported by research grants from the Indian Council of Medical Research (63/147/2001-BMS) and the Council of Scientific and Industrial Research, India (IAP 001), awarded to S. Roychoudhury; and the Council of Medical Research, India (5/8-1(161)/H.pylori/2000-ECD-II), awarded to A. Choudhury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON JH, 1998, CLIN TESTS GASTRIC S; Beales ILP, 2000, DIGEST DIS SCI, V45, P289, DOI 10.1023/A:1005452307860; Bitzer M, 2000, GENE DEV, V14, P187; Chakravorty M, 2006, HUM MUTAT, V27, P411, DOI 10.1002/humu.20299; Chakravorty M, 2009, INT J BIOCHEM CELL B, V41, P1502, DOI 10.1016/j.biocel.2008.12.017; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FIGURA N, 1987, J CLIN MICROBIOL, V25, P1341, DOI 10.1128/JCM.25.7.1341-1342.1987; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Harris AW, 1996, GUT, V38, P663, DOI 10.1136/gut.38.5.663; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; KONDO S, 1994, AM J PHYSIOL-GASTR L, V267, pG966, DOI 10.1152/ajpgi.1994.267.6.G966; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Monteleone G, 2004, GASTROENTEROLOGY, V126, P674, DOI 10.1053/j.gastro.2003.11.048; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nedrud JG, 1997, GASTROENTEROLOGY, V112, P670, DOI 10.1053/gast.1997.v112.agast970670a; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Tanigawa T, 2005, J PHYSIOL PHARMACOL, V56, P3; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wang MC, 1999, J GASTROENTEROL, V34, P10; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e14775	10.1371/journal.pone.0014775	http://dx.doi.org/10.1371/journal.pone.0014775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445336	gold, Green Published, Green Submitted			2022-12-25	WOS:000288809100002
J	Cui, YF; Xu, JC; Hargus, G; Jakovcevski, I; Schachner, M; Bernreuther, C				Cui, Yi-Fang; Xu, Jin-Chong; Hargus, Gunnar; Jakovcevski, Igor; Schachner, Melitta; Bernreuther, Christian			Embryonic Stem Cell-Derived L1 Overexpressing Neural Aggregates Enhance Recovery after Spinal Cord Injury in Mice	PLOS ONE			English	Article							ADHESION MOLECULE L1; FUNCTIONAL RECOVERY; BIOCHEMICAL-CHARACTERIZATION; NERVOUS-SYSTEM; ADULT MICE; H-REFLEX; MOUSE; RATS; TRANSPLANTATION; REGENERATION	An obstacle to early stem cell transplantation into the acutely injured spinal cord is poor survival of transplanted cells. Transplantation of embryonic stem cells as substrate adherent embryonic stem cell-derived neural aggregates (SENAs) consisting mainly of neurons and radial glial cells has been shown to enhance survival of grafted cells in the injured mouse brain. In the attempt to promote the beneficial function of these SENAs, murine embryonic stem cells constitutively overexpressing the neural cell adhesion molecule L1 which favors axonal growth and survival of grafted and imperiled cells in the inhibitory environment of the adult mammalian central nervous system were differentiated into SENAs and transplanted into the spinal cord three days after compression lesion. Mice transplanted with L1 overexpressing SENAs showed improved locomotor function when compared to mice injected with wild-type SENAs. L1 overexpressing SENAs showed an increased number of surviving cells, enhanced neuronal differentiation and reduced glial differentiation after transplantation when compared to SENAs not engineered to overexpress L1. Furthermore, L1 overexpressing SENAs rescued imperiled host motoneurons and parvalbumin-positive interneurons and increased numbers of catecholaminergic nerve fibers distal to the lesion. In addition to encouraging the use of embryonic stem cells for early therapy after spinal cord injury L1 overexpression in the microenvironment of the lesioned spinal cord is a novel finding in its functions that would make it more attractive for pre-clinical studies in spinal cord regeneration and most likely other diseases of the nervous system.	[Cui, Yi-Fang; Xu, Jin-Chong; Hargus, Gunnar; Jakovcevski, Igor; Schachner, Melitta; Bernreuther, Christian] Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Univ Krankenhaus Hamburg Eppendorf, Hamburg, Germany; [Cui, Yi-Fang] Leibniz Inst Primate Res, Clin Neurobiol Lab, German Primate Ctr, Gottingen, Germany; [Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08855 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Bernreuther, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Deutsches Primatenzentrum (DPZ); Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cui, YF (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Univ Krankenhaus Hamburg Eppendorf, Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de; c.bernreuther@uke.de		Jakovcevski, Igor/0000-0001-7673-9600	New Jersey Commission for Spinal Cord Research	New Jersey Commission for Spinal Cord Research	This work was supported by the New Jersey Commission for Spinal Cord Research (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; APPEL F, 1993, J NEUROSCI, V13, P4764; BARNES CD, 1979, PROG NEUROBIOL, V12, P1, DOI 10.1016/0301-0082(79)90008-X; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belegu V, 2007, NEUROSURG CLIN N AM, V18, P143, DOI 10.1016/j.nec.2006.10.012; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Celio M.R., 1984, NEUROSCI LETT S, V18, pS332; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; DAVIDOFF MS, 1986, HISTOCHEMISTRY, V84, P515, DOI 10.1007/BF00482985; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Dekkers J, 2002, DEV NEUROSCI-BASEL, V24, P283, DOI 10.1159/000066742; Di Giovanni S, 2006, EXPERT OPIN THER TAR, V10, P363, DOI 10.1517/14728222.10.3.363; Dihne M, 2003, J NEUROSCI, V23, P6638; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Gozariu M, 1998, BRAIN RES, V782, P343, DOI 10.1016/S0006-8993(97)01402-9; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Howard MJ, 2005, SOMATOSENS MOT RES, V22, P37, DOI 10.1080/08990220500084909; Hulley P, 1998, J NEUROSCI RES, V53, P129, DOI 10.1002/(SICI)1097-4547(19980715)53:2<129::AID-JNR1>3.0.CO;2-9; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; Jain KK, 2009, MOL BIOTECHNOL, V42, P367, DOI 10.1007/s12033-009-9166-8; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr DA, 2003, J NEUROSCI, V23, P5131; KIEHN O, 1992, J COMP NEUROL, V325, P527, DOI 10.1002/cne.903250406; Kimura H, 2005, NEUROL RES, V27, P812, DOI 10.1179/016164105X63629; LAVDAS AA, 2009, EXP NEUROL; Lee HJ, 2009, EXP NEUROL, V216, P365, DOI 10.1016/j.expneurol.2008.12.009; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LI D, 2010, J CELL BIOL; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Nishimune H, 2005, J NEUROSCI RES, V80, P593, DOI 10.1002/jnr.20517; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437; RATHJEN FG, 1984, EMBO J, V3, P1; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Shapiro S, 1997, NEUROSURGERY, V40, P168, DOI 10.1097/00006123-199701000-00037; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Tewarie RSN, 2009, J SPINAL CORD MED, V32, P105, DOI 10.1080/10790268.2009.11760761; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955	58	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17126	10.1371/journal.pone.0017126	http://dx.doi.org/10.1371/journal.pone.0017126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445247	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100010
J	Malek, R; Matta, J; Taylor, N; Perry, ME; Mendrysa, SM				Malek, Reem; Matta, Jennifer; Taylor, Natalie; Perry, Mary Ellen; Mendrysa, Susan M.			The p53 Inhibitor MDM2 Facilitates Sonic Hedgehog-Mediated Tumorigenesis and Influences Cerebellar Foliation	PLOS ONE			English	Article							EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NEURON PRECURSORS; TUMOR SUPPRESSION; MOUSE MODEL; N-MYC; CELL; MEDULLOBLASTOMA; PATHWAY; GROWTH	Disruption of cerebellar granular neuronal precursor (GNP) maturation can result in defects in motor coordination and learning, or in medulloblastoma, the most common childhood brain tumor. The Sonic Hedgehog (Shh) pathway is important for GNP proliferation; however, the factors regulating the extent and timing of GNP proliferation, as well as GNP differentiation and migration are poorly understood. The p53 tumor suppressor has been shown to negatively regulate the activity of the Shh effector, Gli1, in neural stem cells; however, the contribution of p53 to the regulation of Shh signaling in GNPs during cerebellar development has not been determined. Here, we exploited a hypomorphic allele of Mdm2 (Mdm2(puro)), which encodes a critical negative regulator of p53, to alter the level of wild-type MDM2 and p53 in vivo. We report that mice with reduced levels of MDM2 and increased levels of p53 have small cerebella with shortened folia, reminiscent of deficient Shh signaling. Indeed, Shh signaling in Mdm2-deficient GNPs is attenuated, concomitant with decreased expression of the Shh transducers, Gli1 and Gli2. We also find that Shh stimulation of GNPs promotes MDM2 accumulation and enhances phosphorylation at serine 166, a modification known to increase MDM2-p53 binding. Significantly, loss of MDM2 in Ptch1(+/-) mice, a model for Shh-mediated human medulloblastoma, impedes cerebellar tumorigenesis. Together, these results place MDM2 at a major nexus between the p53 and Shh signaling pathways in GNPs, with key roles in cerebellar development, GNP survival, cerebellar foliation, and MB tumorigenesis.	[Malek, Reem; Taylor, Natalie; Mendrysa, Susan M.] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Matta, Jennifer] NCI, Lab Anim Sci Program, NIH, Frederick, MD 21701 USA; [Perry, Mary Ellen] NCI, Lab Prot Dynam & Signaling, NIH, Frederick, MD 21701 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malek, R (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	mendrysa@purdue.edu			NIH, National Cancer Institute, Center for Cancer Research; Concern Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Concern Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer	This work was supported by the Intramural Program of the NIH, National Cancer Institute, Center for Cancer Research (M. E. P.) and by grants to S. M. M. from the Concern Foundation (www.concernfoundation.org) and Alex's Lemonade Stand Foundation for Childhood Cancer (www.alexslemonade.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barel D, 1998, CANCER GENET CYTOGEN, V103, P1, DOI 10.1016/S0165-4608(97)00258-6; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Cowan R, 1997, BRIT J CANCER, V76, P141, DOI 10.1038/bjc.1997.354; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; Huard JMT, 1999, DEVELOPMENT, V126, P1927; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kim JYH, 2003, DEV BIOL, V263, P50, DOI 10.1016/S0012-1606(03)00434-2; Kleihues P, 1997, AM J PATHOL, V150, P1; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; LUNA RMD, 1995, NATURE, V378, P203; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marino S, 2000, GENE DEV, V14, P994; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Prykhozhij SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013549; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tavano A, 2007, BRAIN, V130, P2646, DOI 10.1093/brain/awm201; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2001, CANCER RES, V61, P513; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399	68	33	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17884	10.1371/journal.pone.0017884	http://dx.doi.org/10.1371/journal.pone.0017884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437245	Green Submitted, gold, Green Published			2022-12-25	WOS:000288545100042
J	Liu, DY; Chang, XA; Liu, ZR; Chen, LN; Wang, RQ				Liu, Dengyu; Chang, Xiao; Liu, Zengrong; Chen, Luonan; Wang, Ruiqi			Bistability and Oscillations in Gene Regulation Mediated by Small Noncoding RNAs	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; POSITIVE-FEEDBACK; MESSENGER-RNA; MICRORNA; PROTEIN; EXPRESSION; NETWORK; MULTISTABILITY; DEGRADATION; ACTIVATION	The interplay of small noncoding RNAs (sRNAs), mRNAs, and proteins has been shown to play crucial roles in almost all cellular processes. As key post-transcriptional regulators of gene expression, the mechanisms and roles of sRNAs in various cellular processes still need to be fully understood. When participating in cellular processes, sRNAs mainly mediate mRNA degradation or translational repression. Here, we show how the dynamics of two minimal architectures is drastically affected by these two mechanisms. A comparison is also given to reveal the implication of the fundamental differences. This study may help us to analyze complex networks assembled by simple modules more easily. A better knowledge of the sRNA-mediated motifs is also of interest for bio-engineering and artificial control.	[Liu, Dengyu; Chang, Xiao; Liu, Zengrong; Wang, Ruiqi] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Liu, Dengyu] Jinggangshan Univ, Coll Phys & Math, Jian 343009, Jiangxi, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Key Lab Syst Biol, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai University; Jinggangshan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk	Wang, RQ (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	rqwang@shu.edu.cn			National Natural Science Foundation of China [10832006, 10701052]; Shanghai Pujiang Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by the National Natural Science Foundation of China (Grant No. 10832006 and Youth Research Grant No. 10701052) and the Shanghai Pujiang Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; LEVINE E, 2007, PLOS BIOL; Levine E, 2007, BIOPHYS J, V93, pL52, DOI 10.1529/biophysj.107.118448; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Saez-Rodriguez J, 2008, IET SYST BIOL, V2, P80, DOI 10.1049/iet-syb:20070012; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhdanov VP, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/28/285101; Zhdanov VP, 2009, BIOSYSTEMS, V95, P75, DOI 10.1016/j.biosystems.2008.07.002	36	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17029	10.1371/journal.pone.0017029	http://dx.doi.org/10.1371/journal.pone.0017029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437279	Green Published, gold, Green Submitted			2022-12-25	WOS:000288514600003
J	Yuan, ZD; Sun, XA; Liu, HD; Xie, JM				Yuan, Zhidong; Sun, Xiao; Liu, Hongde; Xie, Jianming			MicroRNA Genes Derived from Repetitive Elements and Expanded by Segmental Duplication Events in Mammalian Genomes	PLOS ONE			English	Article							COPY NUMBER; TRANSPOSABLE ELEMENTS; EVOLUTION; ARABIDOPSIS; MOUSE; EXPRESSION; SEQUENCES; IDENTIFICATION; BROWSER; RETROTRANSPOSONS	MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression by targeting mRNAs for translation repression or mRNA degradation. Many miRNAs are being discovered and studied, but in most cases their origin, evolution and function remain unclear. Here, we characterized miRNAs derived from repetitive elements and miRNA families expanded by segmental duplication events in the human, rhesus and mouse genomes. We applied a comparative genomics approach combined with identifying miRNA paralogs in segmental duplication pair data in a genome-wide study to identify new homologs of human miRNAs in the rhesus and mouse genomes. Interestingly, using segmental duplication pair data, we provided credible computational evidence that two miRNA genes are located in the pseudoautosomal region of the human Y chromosome. We characterized all the miRNAs whether they were derived from repetitive elements or not and identified significant differences between the repeat-related miRNAs (RrmiRs) and non-repeat-derived miRNAs in (1) their location in protein-coding and intergenic regions in genomes, (2) the minimum free energy of their hairpin structures, and (3) their conservation in vertebrate genomes. We found some lineage-specific RrmiR families and three lineage-specific expansion families, and provided evidence indicating that some RrmiR families formed and expanded during evolutionary segmental duplication events. We also provided computational and experimental evidence for the functions of the conservative RrmiR families in the three species. Together, our results indicate that repetitive elements contribute to the origin of miRNAs, and large segmental duplication events could prompt the expansion of some miRNA families, including RrmiR families. Our study is a valuable contribution to the knowledge of evolution and function of non-coding region in genome.	[Yuan, Zhidong; Sun, Xiao; Liu, Hongde] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Yuan, Zhidong; Xie, Jianming] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Peoples R China	Southeast University - China; Hunan University of Science & Technology	Yuan, ZD (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	xsun@seu.edu.cn			National Natural Science Foundation of China [61073141, 60971099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 61073141 and No. 60971099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; BELL GI, 1992, COMPUT CHEM, V16, P135, DOI 10.1016/0097-8485(92)80040-7; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Devor EJ, 2009, GENE, V448, P187, DOI 10.1016/j.gene.2009.06.019; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; FAHLGREN N, 2010, PLANT CELL; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; He XJ, 2007, ACTA BIOCH BIOPH SIN, V39, P708, DOI 10.1111/j.1745-7270.2007.00324.x; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hikosaka A, 2004, J MOL EVOL, V59, P738, DOI 10.1007/s00239-004-2664-1; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang DH, 2006, CELL RES, V16, P507, DOI 10.1038/sj.cr.7310062; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Kozomara A, 2010, NUCL ACIDS RES; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Ogata H, 2002, GENOME RES, V12, P808, DOI 10.1101/gr.227602; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; R Development Core Team, 2009, R FDN STAT COMP; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smit A, 1996, REPEATMASKER OPEN 30; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Verduci L, 2010, J BIOL CHEM, V285, P39551, DOI 10.1074/jbc.M110.114736; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yuan ZD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-346; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	81	48	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17666	10.1371/journal.pone.0017666	http://dx.doi.org/10.1371/journal.pone.0017666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436881	gold, Green Submitted, Green Published			2022-12-25	WOS:000288514000005
J	Forsgren, J; Pedersen, C; Stromme, M; Engqvist, H				Forsgren, Johan; Pedersen, Christian; Stromme, Maria; Engqvist, Hakan			Synthetic Geopolymers for Controlled Delivery of Oxycodone: Adjustable and Nanostructured Porosity Enables Tunable and Sustained Drug Release	PLOS ONE			English	Article							PAIN; ADSORPTION; SYSTEMS	In this article we for the first time present a fully synthetic mesoporous geopolymer drug carrier for controlled release of opioids. Nanoparticulate precursor powders with different Al/Si-ratios were synthesized by a sol-gel route and used in the preparation of different geopolymers, which could be structurally tailored by adjusting the Al/Si-ratio and the curing temperatures. In particular, it was shown that the pore sizes of the geopolymers decreased with increasing Al/Si ratio and that completely mesoporous geopolymers could be produced from precursor particles with the Al/Si ratio 2:1. The mesoporosity was shown to be associated with a sustained and linear in vitro release profile of the opioid oxycodone. A clinically relevant release period of about 12 h was obtained by adjusting the size of the pellets. The easily fabricated and tunable geopolymers presented in this study constitute a novel approach in the development of controlled release formulations, not only for opioids, but whenever the clinical indication is best treated with a constant supply of drugs and when the mechanical stability of the delivery vehicle is crucial.	[Forsgren, Johan; Pedersen, Christian; Stromme, Maria; Engqvist, Hakan] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden	Uppsala University	Forsgren, J (corresponding author), Uppsala Univ, Dept Engn Sci, Uppsala, Sweden.	maria.stromme@angstrom.uu.se		Engqvist, Hakan/0000-0001-9529-650X				Al-Ghananeem AM, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070123; [Anonymous], CANC PAIN REL GUID O; Aulton M.E., 2002, PHARM SCI DOSAGE FOR, Vsecond; Bakharev T, 2005, CEMENT CONCRETE RES, V35, P658, DOI 10.1016/j.cemconres.2004.06.005; Bernards DA, 2010, ADV MATER, V22, P2358, DOI 10.1002/adma.200903439; Bonica JJ, 1987, CHRONIC NONCANCER PA, P11; Brohede U, 2007, J PHARM SCI-US, V96, P3087, DOI 10.1002/jps.20915; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Casolco SR, 2008, SCRIPTA MATER, V58, P516, DOI 10.1016/j.scriptamat.2007.11.014; Cui XM, 2008, J POWER SOURCES, V184, P652, DOI 10.1016/j.jpowsour.2008.03.021; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; Duxson P, 2007, J MATER SCI, V42, P3044, DOI 10.1007/s10853-006-0535-4; El-Safy SA, 2005, ADV MATER, V17, P47, DOI 10.1002/adma.200401317; *FDA, 72005 FDA ALERT; Forsgren J, 2010, J PHARM SCI-US, V99, P219, DOI 10.1002/jps.21814; Gourlay GK, 1998, CLIN PHARMACOKINET, V35, P173, DOI 10.2165/00003088-199835030-00002; *ISO, 58332002 ISO; Jamstorp E, 2010, J CONTROL RELEASE, V146, P370, DOI 10.1016/j.jconrel.2010.05.029; Muijsers RBR, 2001, DRUGS, V61, P2289, DOI 10.2165/00003495-200161150-00014; Okada K, 1999, J MATER CHEM, V9, P1307, DOI 10.1039/a900611g; Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7; POMONIS PJ, 2006, ENCY SURFACE COLLOID, P444; Rubio-Hernandez FJ, 2006, J COLLOID INTERF SCI, V298, P967, DOI 10.1016/j.jcis.2006.01.009; Shader RI, 2007, J CLIN PSYCHOPHARM, V27, P327, DOI 10.1097/JCP.0b013e318133fc23; TARAZONA P, 1987, MOL PHYS, V60, P573, DOI 10.1080/00268978700100381; TARAZONA P, 1985, PHYS REV A, V31, P2672, DOI 10.1103/PhysRevA.31.2672; Thommes M, 2006, LANGMUIR, V22, P756, DOI 10.1021/la051686h; Turner JA, 2007, CLIN J PAIN, V23, P180, DOI 10.1097/01.ajp.0000210955.93878.44; Walden M, 2007, DRUG DEV IND PHARM, V33, P1101, DOI 10.1080/03639040701377292; Weibel A, 2005, CHEM MATER, V17, P2378, DOI 10.1021/cm0403762; WEN H, 2010, ORAL CONTROLLED RELE; Zheng GJ, 2009, J MATER SCI, V44, P3991, DOI 10.1007/s10853-009-3549-x	32	11	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17759	10.1371/journal.pone.0017759	http://dx.doi.org/10.1371/journal.pone.0017759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423616	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900022
J	Tate, MD; Ioannidis, LJ; Croker, B; Brown, LE; Brooks, AG; Reading, PC				Tate, Michelle D.; Ioannidis, Lisa J.; Croker, Ben; Brown, Lorena E.; Brooks, Andrew G.; Reading, Patrick C.			The Role of Neutrophils during Mild and Severe Influenza Virus Infections of Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; POLYMORPHONUCLEAR LEUKOCYTES; MIGRATING NEUTROPHILS; ALVEOLAR MACROPHAGES; PULMONARY INFECTION; A VIRUS; REPLICATION; RECEPTOR; PATHOGENICITY; INVOLVEMENT	Neutrophils have been implicated in both protective and pathological responses following influenza virus infections. We have used mAb 1A8 (anti-Ly6G) to specifically deplete LyG6(high) neutrophils and induce neutropenia in mice infected with virus strains known to differ in virulence. Mice were also treated with mAb RB6-8C5 (anti-Ly6C/G or anti-Gr-1), a mAb widely used to investigate the role of neutrophils in mice that has been shown to bind and deplete additional leukocyte subsets. Using mAb 1A8, we confirm the beneficial role of neutrophils in mice infected with virus strains of intermediate (HKx31; H3N2) or high (PR8; H1N1) virulence whereas treatment of mice infected with an avirulent strain (BJx109; H3N2) did not affect disease or virus replication. Treatment of BJx109-infected mice with mAb RB6-8C5 was, however, associated with significant weight loss and enhanced virus replication indicating that other Gr-1(+) cells, not neutrophils, limit disease severity during mild influenza infections.	[Tate, Michelle D.; Ioannidis, Lisa J.; Brown, Lorena E.; Brooks, Andrew G.; Reading, Patrick C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Croker, Ben] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Reading, Patrick C.] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	University of Melbourne; Walter & Eliza Hall Institute; World Health Organization	Tate, MD (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	preading@unimelb.edu.au		Brown, Lorena/0000-0001-9342-909X; Reading, Patrick/0000-0002-8860-5308; Croker, Ben/0000-0002-0885-3599; Brooks, Andrew/0000-0002-4085-9683; Tate, Michelle/0000-0002-0587-5514	The National Health and Medical Research Council (NH&MRC) of Australia [509230, 567122]; Australian Government Department of Health and Ageing	The National Health and Medical Research Council (NH&MRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This study was supported by Project Grant 509230 and Program Grant 567122 from The National Health and Medical Research Council (NH&MRC) of Australia. PCR is a NH&MRC R.D. Wright Research Fellow. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CASSIDY LF, 1988, J CLIN MICROBIOL, V26, P1267, DOI 10.1128/JCM.26.7.1267-1270.1988; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Egan CE, 2008, IMMUNOL RES, V40, P35, DOI 10.1007/s12026-007-0061-8; Ennis M, 2003, CURR ALLERGY ASTHM R, V3, P159, DOI 10.1007/s11882-003-0029-2; FRANKOVA V, 1975, ACTA VIROL, V19, P29; FUJISAWA H, 1987, J GEN VIROL, V68, P425, DOI 10.1099/0022-1317-68-2-425; Fujisawa H, 2001, MICROBIOL IMMUNOL, V45, P679, DOI 10.1111/j.1348-0421.2001.tb01302.x; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; Matsuzaki J, 2003, CELL IMMUNOL, V224, P98, DOI 10.1016/j.cellimm.2003.08.009; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; RATCLIFFE D, 1992, CELL MOL BIOL, V38, P63; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; RODGERS B, 1981, INFECT IMMUN, V31, P751, DOI 10.1128/IAI.31.2.751-757.1981; Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; TATE MD, 2010, IMMUNOL CEL IN PRESS; TATE MD, 2011, VIRAL IMMUN IN PRESS; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 1996, J VIROL, V70, P898, DOI 10.1128/JVI.70.2.898-904.1996; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Zhao YY, 2008, CLIN INFECT DIS, V47, P1575, DOI 10.1086/593196; Zhou JH, 2003, J IMMUNOL, V170, P3331, DOI 10.4049/jimmunol.170.6.3331	38	136	138	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17618	10.1371/journal.pone.0017618	http://dx.doi.org/10.1371/journal.pone.0017618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423798	Green Published, gold			2022-12-25	WOS:000288512400016
J	Roychoudhury, J; Sinha, R; Ali, N				Roychoudhury, Jayeeta; Sinha, Roma; Ali, Nahid			Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; AZAR DERMAL LEISHMANIASIS; IN-VITRO SUSCEPTIBILITY; NITRIC-OXIDE SYNTHASE; AMPHOTERICIN-B; ANTIMONY GLUCONATE; CATIONIC LIPOSOMES; KALA-AZAR; INTRACELLULAR INFECTION; IMMUNE-RESPONSES	Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment of visceral leishmaniasis (VL), has become a critical issue worldwide. Second-line and new drugs are also not devoid of limitations. Suitable drug-delivery systems can improve the mode of administration and action of the existing antimonials, thus increasing their clinical life. Methodology/Principal Findings: We investigated the efficacy of sodium stibogluconate (SSG) in phosphatidylcholine (PC)-stearylamine-bearing liposomes (PC-SA-SSG), PC-cholesterol liposomes (PC-Chol-SSG) and free amphotericin B (AmB) against SSG-resistant L. donovani strains in 8-wk infected BALB/c mice. Animals were sacrificed and parasites in liver, spleen and bone marrow were estimated 4-wk post-treatment by microscopic examination of stamp smears and limiting dilution assay. A set of PC-SA-SSG and AmB treated mice were further studied for protection against reinfection. Serum antibodies and cytokine profiles of ex-vivo cultured splenocytes were determined by ELISA. Uptake of free and liposomal SSG in intracellular amastigotes was determined by atomic absorption spectroscopy. Rhodamine 123 and 5-carboxyfluorescein, known substrates of Pgp and MRP transporter proteins, respectively, were used in free and liposomal forms for efflux studies to estimate intracellular drug retention. Unlike free and PC-Chol-SSG, PC-SA-SSG was effective in curing mice infected with two differentially originated SSG-unresponsive parasite strains at significantly higher levels than AmB. Successful therapy correlated with complete suppression of disease-promoting IL-10 and TGF-beta, upregulation of Th1 cytokines and expression of macrophage microbicidal NO. Cure due to elevated accumulation of SSG in intracellular parasites, irrespective of SSG-resistance, occurs as a result of increased drug retention and improved therapy when administered as PC-SA-SSG versus free SSG. Conclusions/Significance: The design of this single-dose combination therapy with PC-SA-SSG for VL, having reduced toxicity and long-term efficacy, irrespective of SSG-sensitivity may prove promising, not only to overcome SSG-resistance in Leishmania, but also for drugs with similar resistance-related problems in other diseases.	[Roychoudhury, Jayeeta; Sinha, Roma; Ali, Nahid] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roychoudhury, J (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	nali@iicb.res.in	bhattacharyya, Anirban/F-6067-2015; Sinha, Roma/B-3808-2010		Indian Council of Medical Research; University Grants Commission, Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grants Commission, Government of India(University Grants Commission, India)	This study was supported by grants from the Indian Council of Medical Research, and University Grants Commission, Government of India. JR was a Senior Research Fellow of Council for Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Afrin F, 2001, J PARASITOL, V87, P188, DOI 10.1645/0022-3395(2001)087[0188:LAOSBL]2.0.CO;2; Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10&lt;2935::AID-IMMU2935&gt;3.0.CO;2-Q; ALVING CR, 1978, P NATL ACAD SCI USA, V75, P2959, DOI 10.1073/pnas.75.6.2959; ALVING CR, 1978, LIFE SCI, V22, P1021, DOI 10.1016/0024-3205(78)90270-9; Anderson CF, 2008, J IMMUNOL, V180, P4090, DOI 10.4049/jimmunol.180.6.4090; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; BAILLIE AJ, 1986, J PHARM PHARMACOL, V38, P502, DOI 10.1111/j.2042-7158.1986.tb04623.x; BANERJEE A, 2011, ANTIMICROB IN PRESS, DOI DOI 10.1128/AAC.00524-10); Banerjee A, 2008, J IMMUNOL, V181, P1386, DOI 10.4049/jimmunol.181.2.1386; Banerjee A, 2008, J ANTIMICROB CHEMOTH, V61, P103, DOI 10.1093/jac/dkm396; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhattacharyya A, 2002, J BIOSCIENCES, V27, P503, DOI 10.1007/BF02705047; BLACK CDV, 1977, T ROY SOC TROP MED H, V71, P550, DOI 10.1016/0035-9203(77)90155-9; CARTER KC, 1989, J PHARM PHARMACOL, V41, P87, DOI 10.1111/j.2042-7158.1989.tb06399.x; Carter KC, 2003, ANTIMICROB AGENTS CH, V47, P1529, DOI 10.1128/AAC.47.5.1529-1535.2003; Carter KC, 2001, ANTIMICROB AGENTS CH, V45, P3555, DOI 10.1128/AAC.45.12.3555-3559.2001; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; CHUNGE CN, 1990, T ROY SOC TROP MED H, V84, P221, DOI 10.1016/0035-9203(90)90263-E; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dey T, 2000, ANTIMICROB AGENTS CH, V44, P1739, DOI 10.1128/AAC.44.6.1739-1742.2000; DING AH, 1988, J IMMUNOL, V141, P2407; Feng GJ, 1999, J IMMUNOL, V163, P6403; Frezard F, 2009, MOLECULES, V14, P2317, DOI 10.3390/molecules14072317; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; HALDAR JP, 1983, INFECT IMMUN, V42, P702, DOI 10.1128/IAI.42.2.702-707.1983; HUNTER CA, 1988, J PHARM PHARMACOL, V40, P161, DOI 10.1111/j.2042-7158.1988.tb05210.x; Iwaoka S, 2006, J LEUKOCYTE BIOL, V79, P184, DOI 10.1189/jlb.0405181; Kang DI, 2009, DRUG DELIV, V16, P261, DOI 10.1080/10717540902937562; Kok JW, 2000, INT J CANCER, V87, P172, DOI 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; Mamot C, 2003, DRUG RESIST UPDATE, V6, P271, DOI 10.1016/S1368-7646(03)00082-7; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; Mastroianni A, 2004, Infez Med, V12, P197; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Melaku Y, 2007, AM J TROP MED HYG, V77, P89, DOI 10.4269/ajtmh.2007.77.89; Mora M, 2002, PHARMACEUT RES, V19, P1430, DOI 10.1023/A:1020440229102; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; MURRAY HW, 1989, J CLIN INVEST, V83, P1253, DOI 10.1172/JCI114009; Murray HW, 2005, J IMMUNOL, V174, P4916, DOI 10.4049/jimmunol.174.8.4916; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V240, P793, DOI 10.1006/bbrc.1997.7749; NEW RRC, 1978, NATURE, V272, P55, DOI 10.1038/272055a0; Olliaro PL, 2010, CURR OPIN INFECT DIS, V23, P595, DOI 10.1097/QCO.0b013e32833fca9d; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; Owais M., 2005, Current Drug Delivery, V2, P311, DOI 10.2174/156720105774370177; Padigel UM, 2003, J IMMUNOL, V171, P3705, DOI 10.4049/jimmunol.171.7.3705; Pal S, 2004, ANTIMICROB AGENTS CH, V48, P3591, DOI 10.1128/AAC.48.9.3591-3593.2004; Ranatunga D, 2009, P NATL ACAD SCI USA, V106, P17123, DOI 10.1073/pnas.0904955106; ROBERTS WL, 1993, ANAL BIOCHEM, V211, P1, DOI 10.1006/abio.1993.1223; Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592; Stauber AL, 1956, RICE I PAM, V45, P80; Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972; Sundar S, 2006, INDIAN J MED RES, V123, P345; Teng S, 2003, DRUG METAB DISPOS, V31, P1296, DOI 10.1124/dmd.31.11.1296; Valiathan R, 2006, EXP PARASITOL, V114, P103, DOI 10.1016/j.exppara.2006.02.015; WEBB MS, 1995, BBA-BIOMEMBRANES, V1238, P147, DOI 10.1016/0005-2736(95)00121-I	65	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17376	10.1371/journal.pone.0017376	http://dx.doi.org/10.1371/journal.pone.0017376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423750	Green Submitted, Green Published, gold			2022-12-25	WOS:000288219100007
J	Davies, AH; Barrett, I; Pambid, MR; Hu, K; Stratford, AL; Freeman, S; Berquin, IM; Pelech, S; Hieter, P; Maxwell, C; Dunn, SE				Davies, A. H.; Barrett, I.; Pambid, M. R.; Hu, K.; Stratford, A. L.; Freeman, S.; Berquin, I. M.; Pelech, S.; Hieter, P.; Maxwell, C.; Dunn, S. E.			YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification	ONCOGENE			English	Article						YB-1; premalignancy; centrosome; cell cycle; HER2 amplification; breast cancer	MAMMARY EPITHELIAL-CELLS; BOX-BINDING-PROTEIN; GROWTH-FACTOR RECEPTOR; HUMAN-BREAST-CANCER; COLD SHOCK DOMAIN; CHROMOSOMAL INSTABILITY; CENTROSOME AMPLIFICATION; TUMOR-SUPPRESSOR; DRUG-RESISTANCE; LIM KINASES	Y-box binding protein-1 (YB-1) expression in the mammary gland promotes breast carcinoma that demonstrates a high degree of genomic instability. In the present study, we developed a model of pre-malignancy to characterize the role of this gene during breast cancer initiation and early progression. Antibody microarray technology was used to ascertain global changes in signal transduction following the conditional expression of YB-1 in human mammary epithelial cells (HMEC). Cell cycle-associated proteins were frequently altered with the most dramatic being LIM kinase 1/2 (LIMK1/2). Consequently, the misexpression of LIMK1/2 was associated with cytokinesis failure that acted as a precursor to centrosome amplification. Detailed investigation revealed that YB-1 localized to the centrosome in a phosphorylation-dependent manner, where it complexed with pericentrin and gamma-tubulin. This was found to be essential in maintaining the structural integrity and microtubule nucleation capacity of the organelle. Prolonged exposure to YB-1 led to rampant acceleration toward tumorigenesis, with the majority of cells acquiring numerical and structural chromosomal abnormalities. Slippage through the G(1)/S checkpoint due to overexpression of cyclin E promoted continued proliferation of these genomically compromised cells. As malignancy further progressed, we identified a subset of cells harboring HER2 amplification. Our results recognize YB-1 as a cancer susceptibility gene, with the capacity to prime cells for tumorigenesis. Oncogene (2011) 30, 3649-3660; doi:10.1038/onc.2011.82; published online 21 March 2011	[Davies, A. H.; Pambid, M. R.; Hu, K.; Stratford, A. L.; Dunn, S. E.] Univ British Columbia, Dept Pediat, Lab Oncogenom Res, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Davies, A. H.; Pambid, M. R.; Hu, K.; Stratford, A. L.; Dunn, S. E.] Univ British Columbia, Dept Expt Med, Lab Oncogenom Res, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Barrett, I.; Hieter, P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 4H4, Canada; [Freeman, S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 4H4, Canada; [Berquin, I. M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Pelech, S.] Wake Forest Univ, Brain Res Ctr, Div Neurol, Winston Salem, NC USA; [Pelech, S.] Kinexus Bioinformat Corp, Vancouver, BC, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Dunn, SE (corresponding author), Univ British Columbia, Dept Pediat, Lab Oncogenom Res, Child & Family Res Inst, 950 W 28th Ave,Room 3083, Vancouver, BC V5Z 4H4, Canada.	sedunn@interchange.ubc.ca	Maxwell, Christopher A/B-3044-2011	Maxwell, Christopher A/0000-0002-0713-7136; Maxwell, Christopher/0000-0002-0860-4031	National Institutes of Health [RO1 CA114017]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; Canadian Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA114017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ching-Shih Chen (The Ohio State University) for providing BI-D1870 and Michel Lebel (l'Universite Laval) for providing plasmid encoding GFP-tagged YB-1. This study was supported by the National Institutes of Health RO1 CA114017 (SED, IMB), the Michael Smith Foundation for Health Research (AHD), the Canadian Institutes of Health Research (AHD, SED) and the Canadian Breast Cancer Foundation (ALS).	Alliegro MC, 2006, P NATL ACAD SCI USA, V103, P9034, DOI 10.1073/pnas.0602859103; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Basaki Y, 2010, EUR J CANCER, V46, P954, DOI 10.1016/j.ejca.2009.12.024; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Berquin IM, 2005, ONCOGENE, V24, P3177, DOI 10.1038/sj.onc.1208504; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Chakrabarti R, 2007, CELL CYCLE, V6, P2944, DOI 10.4161/cc.6.23.4957; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Dhillon J, 2010, ONCOGENE, V29, P6294, DOI 10.1038/onc.2010.365; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Dumont N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2457; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Guay D, 2006, INT J BIOCHEM CELL B, V38, P1300, DOI 10.1016/j.biocel.2006.01.008; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Ise T, 1999, CANCER RES, V59, P342; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Raouf A, 2005, JNCI-J NATL CANCER I, V97, P1302, DOI 10.1093/jnci/dji254; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Scully R, 2000, BREAST CANCER RES, V2, P324, DOI 10.1186/bcr76; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shibao K, 1999, INT J CANCER, V83, P732; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sumi T, 2006, EXP CELL RES, V312, P1021, DOI 10.1016/j.yexcr.2005.12.030; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tlsty TD, 2004, J MAMMARY GLAND BIOL, V9, P263, DOI 10.1023/B:JOMG.0000048773.95897.5f; To K, 2010, CANCER RES, V70, P2840, DOI 10.1158/0008-5472.CAN-09-3155; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yu YN, 2010, INT J ONCOL, V37, P483, DOI 10.3892/ijo_00000697	52	43	43	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	34					3649	3660		10.1038/onc.2011.82	http://dx.doi.org/10.1038/onc.2011.82			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	811VO	21423216	Green Accepted			2022-12-25	WOS:000294244500001
J	Mullany, LK; Fan, HY; Liu, Z; White, LD; Marshall, A; Gunaratne, P; Anderson, ML; Creighton, CJ; Xin, L; Deavers, M; Wong, KK; Richards, JS				Mullany, L. K.; Fan, H-Y; Liu, Z.; White, L. D.; Marshall, A.; Gunaratne, P.; Anderson, M. L.; Creighton, C. J.; Xin, L.; Deavers, M.; Wong, K-K; Richards, J. S.			Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo	ONCOGENE			English	Article						Kras; Pten; Trp53; ovarian cancer; serous	GENE-EXPRESSION PROFILES; SEROUS CARCINOMA; GRANULOSA-CELLS; PATHWAY ACTIVATION; WNT/BETA-CATENIN; K-RAS; CANCER; P53; ORIGIN; PROLIFERATION	Ovarian cancer is a complex and deadly disease that remains difficult to detect at an early curable stage. Furthermore, although some oncogenic (Kras, Pten/PI3K and Trp53) pathways that are frequently mutated, deleted or amplified in ovarian cancer are known, how these pathways initiate and drive specific morphological phenotypes and tumor outcomes remain unclear. We recently generated Pten(fl/fl); Kras(G12D); Amhr2-Cre mice to disrupt the Pten gene and express a stable mutant form of Kras(G12D) in ovarian surface epithelial (OSE) cells. On the basis of histopathologic criteria, the mutant mice developed low-grade ovarian serous papillary adenocarcinomas at an early age and with 100% penetrance. This highly reproducible phenotype provides the first mouse model in which to study this ovarian cancer subtype. OSE cells isolated from ovaries of mutant mice at 5 and 10 weeks of age exhibit temporal changes in the expression of specific Mullerian epithelial marker genes, grow in soft agar and develop ectopic invasive tumors in recipient mice, indicating that the cells are transformed. Gene profiling identified specific mRNAs and microRNAs differentially expressed in purified OSE cells derived from tumors of the mutant mice compared with wild-type OSE cells. Mapping of transcripts or genes between the mouse OSE mutant data sets, the Kras signature from human cancer cell lines and the human ovarian tumor array data sets, documented significant overlap, indicating that KRAS is a key driver of OSE transformation in this context. Two key hallmarks of the mutant OSE cells in these mice are the elevated expression of the tumor-suppressor Trp53 (p53) and its microRNA target, miR-34a-c. We propose that elevated TRP53 and miR-34a-c may exert negatively regulatory effects that reduce the proliferative potential of OSE cells leading to the low-grade serous adenocarcinoma phenotype. Oncogene (2011) 30, 3522-3536; doi:10.1038/onc.2011.70; published online 21 March 2011	[Mullany, L. K.; Fan, H-Y; Liu, Z.; Marshall, A.; Xin, L.; Richards, J. S.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [White, L. D.; Creighton, C. J.] Baylor Coll Med, Dept Mol & Human Genet & Mol & Cellular Biol, Houston, TX 77030 USA; [White, L. D.; Creighton, C. J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Gunaratne, P.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Anderson, M. L.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Deavers, M.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wong, K-K] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Richards, JS (corresponding author), Baylor Coll Med BCM130, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	joanner@bcm.tmc.edu	Parry, Lee/A-9623-2011; Wong, K.-k./AAA-6589-2020; Anderson, Matthew/C-4755-2019	Parry, Lee/0000-0002-4467-9196; Wong, K.-k./0000-0002-0375-6669; Anderson, Matthew/0000-0002-2081-4672; Marshall, Alexandra/0000-0003-4888-643X	NRSA; Ovarian Cancer Research Fund; The University of Texas MD Anderson Cancer Center [P50 CA08369];  [NIH-HD-16229]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495, R01HD016229] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016229, R56HD016229] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; The University of Texas MD Anderson Cancer Center; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We Alan J Herron DVM, Professor and Head of the Comparative Pathology Laboratory for his advice and insights into the mouse ovarian tumor phenotype, Yuet Lo and Azam Zariff for technical assistance and the Microscopy Core at Baylor College of Medicine for their expertise. We also thank the Immunohistochemistry Laboratory at The University of Texas MD Anderson Cancer Center for performing the calretinin and ESR1 immunostaining. Supported in part by NIH-HD-16229 (JSR), NRSA (LM), a Program Project Development Grant from the Ovarian Cancer Research Fund (CJC, PG, MA) and The University of Texas MD Anderson Cancer Center Specialized Program of Research Excellence in Ovarian Cancer (P50 CA08369) (KKW).	Abdullah M, 2009, PATHOL RES PRACT, V205, P639, DOI 10.1016/j.prp.2009.04.007; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2008, GYNECOL ONCOL, V110, P452, DOI 10.1016/j.ygyno.2008.05.031; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bohlig L, 2008, CELL CYCLE, V7, P1254, DOI 10.4161/cc.7.9.5812; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Cho KR, 2009, ARCH PATHOL LAB MED, V133, P1775, DOI 10.1043/1543-2165-133.11.1775; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Clark-Knowles KV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008534; Connolly DC, 2003, CANCER RES, V63, P1389; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; DAHLYA N, 2008, PLOS ONE, V3, P1; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Gaval N, 2008, J MOL ENDOCRINOL, V40, P281, DOI 10.1677/JME-07-0149; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; *GSK, 2008, CANC CELL LIN GEN PR; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; KAPLINAS K, 2009, J CELL BIOCHEM, V108, P216; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Ko SY, 2010, MOL CELL ENDOCRINOL, V317, P112, DOI 10.1016/j.mce.2009.12.025; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Liang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004295; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Miller KA, 2009, CANCER RES, V69, P3689, DOI 10.1158/0008-5472.CAN-09-0024; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; PAGE CL, 2006, BRIT J CANCER, V94, P436; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Raimondi AR, 2009, CANCER RES, V69, P4159, DOI 10.1158/0008-5472.CAN-08-4645; Roh MH, 2010, MODERN PATHOL, V23, P1316, DOI 10.1038/modpathol.2010.119; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Schwartz DR, 2002, CANCER RES, V62, P4722; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Wong KK, 2007, INT J GYNECOL PATHOL, V26, P404, DOI 10.1097/pgp.0b013e31803025cd; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	68	62	64	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	32					3522	3536		10.1038/onc.2011.70	http://dx.doi.org/10.1038/onc.2011.70			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	806CR	21423204	Green Accepted			2022-12-25	WOS:000293782300005
J	Yu, ZX; Brodsky, B; Inouye, M				Yu, Zhuoxin; Brodsky, Barbara; Inouye, Masayori			Dissecting a Bacterial Collagen Domain from Streptococcus pyogenes SEQUENCE AND LENGTH-DEPENDENT VARIATIONS IN TRIPLE HELIX STABILITY AND FOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE; PROCOLLAGEN-II; SCL2 PROTEINS; STABILIZATION; STABILITY; IDENTIFICATION; DELETION	To better investigate the relationship between sequence, stability, and folding, the Streptococcus pyogenes collagenous domain CL (Gly-Xaa-Yaa)(79) was divided to create three recombinant triple helix subdomains A, B, and C of almost equal size with distinctive amino acid features: an A domain high in polar residues, a B domain containing the highest concentration of Pro residues, and a very highly charged C domain. Each segment was expressed as a monomer, a linear dimer, and a linear trimer fused with the trimerization domain (V domain) in Escherichia coli. All recombinant proteins studied formed stable triple helical structures, but the stability varied depending on the amino acid sequence in the A, B, and C segments and increased as the triple helix got longer. V-AAA was found to melt at a much lower temperature (31.0 degrees C) than V-ABC (V-CL), whereas V-BBB melted at almost the same temperature (similar to 36-37 degrees C). When heat-denatured, the V domain enhanced refolding for all of the constructs; however, the folding rate was affected by their amino acid sequences and became reduced for longer constructs. The folding rates of all the other constructs were lower than that of the natural V-ABC protein. Amino acid substitution mutations at all Pro residues in the C fragment dramatically decreased stability but increased the folding rate. These results indicate that the thermostability of the bacterial collagen is dominated by the most stable domain in the same manner as found with eukaryotic collagens.	[Yu, Zhuoxin; Brodsky, Barbara; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Yu, Zhuoxin; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University	Brodsky, B (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	Barbara.Brodsky@tufts.edu; inouye@umdnj.edu	Yu, Zhuoxin/L-1512-2013		National Institutes of Health [GM60048]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to B. B.).	Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; JOSSE J, 1964, J MOL BIOL, V9, P269, DOI 10.1016/S0022-2836(64)80207-2; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Ramachandran G.N., 1967, TREATISE COLLAGEN, P103; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; SIERON AL, 1993, J BIOL CHEM, V268, P21232; Steplewski A, 2004, J MOL BIOL, V338, P989, DOI 10.1016/j.jmb.2004.03.037; XU C, BIOMACROMOLECULES, V11, P348; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	22	29	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18960	18968		10.1074/jbc.M110.217422	http://dx.doi.org/10.1074/jbc.M110.217422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454494	hybrid, Green Published			2022-12-25	WOS:000290785700067
J	Peng, Z; Tang, Y; Luo, HJ; Jiang, F; Yang, JA; Sun, L; Li, JD				Peng, Zhen; Tang, Yong; Luo, Hunjin; Jiang, Fang; Yang, Jiannan; Sun, Lin; Li, Jia-Da			Disease-causing Mutation in PKR2 Receptor Reveals a Critical Role of Positive Charges in the Second Intracellular Loop for G-protein Coupling and Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-ACTIVATED RHODOPSIN; COVALENT CROSS-LINKING; KALLMANN-SYNDROME; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; OLFACTORY-BULB; PROKINETICIN 2; CONTACT SITES; AMINO-ACIDS; IDENTIFICATION	Prokineticins are a pair of signal factors involved in many physiological processes by binding to two closely related G-protein-coupled receptors, PKR1 and PKR2. Recently, mutations in prokineticin 2 (PK2) and PKR2 are found to be associated with Kallmann syndrome and/or idiopathic hypogonadotropic hypogonadism, disorders characterized by delayed puberty and infertility. However, little is known how PKRs interact and activate G-proteins to elicit signal transduction. In the present study, we took advantage of one disease-associated mutation (R164Q) located in the second intracellular (IL2) loop of PKR2, to investigate the role of IL2 loop in the cell signaling, G-protein binding and receptor trafficking. R164Q mutant PKR2 showed normal cell surface expression and ligand binding capacity. However, the PKR2 signaling was abolished by R164Q mutation. We demonstrated that R164Q mutation disrupted the interaction of IL2 loop to the G alpha(q), G alpha(i), and G alpha(16)-proteins. A positive-charged amino acid at this position is required for proper function, and the signaling efficacy and potency depend on the net amount of positive charges. We also demonstrated that the interactive partner of Arg-164 may localize in the C-terminal five residues of G alpha(q)-protein. Aseries of mutation analysis indicated that the basic amino acids at the C terminus of IL2 loop may function cooperatively in GPCRs. Furthermore, R164Q mutation also results in minimal ligand-induced endocytosis of PKR2. As many GPCRs share structural homology in the C terminus of IL2 loop, our findings may have general application in understanding structure and function of GPCRs.	[Peng, Zhen; Tang, Yong; Luo, Hunjin; Jiang, Fang; Yang, Jiannan; Sun, Lin; Li, Jia-Da] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Li, Jia-Da] Cent S Univ, Sch Biol Sci & Technol, Changsha 410078, Hunan, Peoples R China	Central South University; Central South University	Li, JD (corresponding author), 110 Xiangya St, Changsha 410078, Hunan, Peoples R China.	lijiada@sklmg.edu.cn		Li, Jia-Da/0000-0002-4236-3518	National Natural Science Foundation of China [30970958, 81070481]; Hunan Province Government; Central South University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Government; Central South University of China	This project was supported by National Natural Science Foundation of China (Grants 30970958 and 81070481), the Lotus Scholar Professorship Funds from Hunan Province Government, and a research grant provided by the Central South University of China.	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; IidaKlein A, 1997, J BIOL CHEM, V272, P6882, DOI 10.1074/jbc.272.11.6882; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; Jaakola VP, 2010, CURR OPIN STRUC BIOL, V20, P401, DOI 10.1016/j.sbi.2010.05.002; Keramidas M, 2008, J ENDOCRINOL, V196, P473, DOI 10.1677/JOE-07-0255; Li JD, 2009, NEUROPSYCHOPHARMACOL, V34, P367, DOI 10.1038/npp.2008.61; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; MORO O, 1993, J BIOL CHEM, V268, P22273; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Saito Y, 2005, ENDOCRINOLOGY, V146, P3452, DOI 10.1210/en.2005-0115; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; Sinisi AA, 2008, HUM REPROD, V23, P2380, DOI 10.1093/humrep/den247; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Xia S, 2004, P NATL ACAD SCI USA, V101, P15207, DOI 10.1073/pnas.0406571101; Xie W, 1997, J BIOL CHEM, V272, P24948, DOI 10.1074/jbc.272.40.24948; Zhou Q. -Y., 2008, V46, P181, DOI 10.1007/400_2007_053	37	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16615	16622		10.1074/jbc.M111.223784	http://dx.doi.org/10.1074/jbc.M111.223784			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454486	Green Published, hybrid			2022-12-25	WOS:000290301900010
J	Allen, LZ; Ishoey, T; Novotny, MA; McLean, JS; Lasken, RS; Williamson, SJ				Allen, Lisa Zeigler; Ishoey, Thomas; Novotny, Mark A.; McLean, Jeffrey S.; Lasken, Roger S.; Williamson, Shannon J.			Single Virus Genomics: A New Tool for Virus Discovery	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; FLOW-CYTOMETRY; MARINE VIRUSES; DNA-POLYMERASE; CELL; COMMUNITIES; SAMPLES; ENUMERATION; PROKARYOTES; SEQUENCES	Whole genome amplification and sequencing of single microbial cells has significantly influenced genomics and microbial ecology by facilitating direct recovery of reference genome data. However, viral genomics continues to suffer due to difficulties related to the isolation and characterization of uncultivated viruses. We report here on a new approach called 'Single Virus Genomics', which enabled the isolation and complete genome sequencing of the first single virus particle. A mixed assemblage comprised of two known viruses; E. coli bacteriophages lambda and T4, were sorted using flow cytometric methods and subsequently immobilized in an agarose matrix. Genome amplification was then achieved in situ via multiple displacement amplification (MDA). The complete lambda phage genome was recovered with an average depth of coverage of approximately 437X. The isolation and genome sequencing of uncultivated viruses using Single Virus Genomics approaches will enable researchers to address questions about viral diversity, evolution, adaptation and ecology that were previously unattainable.	[Allen, Lisa Zeigler; Ishoey, Thomas; Novotny, Mark A.; McLean, Jeffrey S.; Lasken, Roger S.; Williamson, Shannon J.] J Craig Venter Inst, San Diego, CA 92121 USA; [Allen, Lisa Zeigler] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography	Allen, LZ (corresponding author), J Craig Venter Inst, San Diego, CA 92121 USA.	swilliamson@jcvi.org	McLean, Jeffrey S/A-8014-2012	McLean, Jeffrey S/0000-0001-9934-5137	J. Craig Venter Institute; Office of Science (BER), U.S. Department of Energy [De-FC02-02ER63453]	J. Craig Venter Institute; Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by the J. Craig Venter Institute and the Office of Science (BER), U.S. Department of Energy, Cooperative Agreement No. De-FC02-02ER63453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BLAINEY PC, NUCL ACIDS RES; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard Corina P. D., 2009, V501, P97, DOI 10.1007/978-1-60327-164-6_11; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Fuhrman JA, 1998, NATURE, V393, P410, DOI 10.1038/30839; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Ishey T, 2006, APPL MICROBIOL BIOT, V69, P510, DOI 10.1007/s00253-005-0014-x; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; LASKEN RS, 2005, METHODS EXPRESS, P119; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Luef B, 2009, FEMS MICROBIOL ECOL, V68, P372, DOI 10.1111/j.1574-6941.2009.00675.x; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; MENG X, 1995, NAT GENET, V9, P432, DOI 10.1038/ng0495-432; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Panelli S, 2005, BIOTECHNIQUES, V39, P174, DOI 10.2144/05392BM03; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Storrie-Lombardi M. C., 1994, Vistas in Astronomy, V38, P331, DOI 10.1016/0083-6656(94)90044-2; Tzvetkov MV, 2005, ELECTROPHORESIS, V26, P710, DOI 10.1002/elps.200410121; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Winget DM, 2008, APPL ENVIRON MICROB, V74, P2612, DOI 10.1128/AEM.02829-07; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	47	98	109	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17722	10.1371/journal.pone.0017722	http://dx.doi.org/10.1371/journal.pone.0017722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21436882	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500010
J	Arizono, N; Yamada, M; Tegoshi, T; Takaoka, Y; Ohta, M; Sakaeda, T				Arizono, Naoki; Yamada, Minoru; Tegoshi, Tatsuya; Takaoka, Yutaka; Ohta, Mika; Sakaeda, Toshiyuki			Hsp12.6 Expression Is Inducible by Host Immunity in Adult Worms of the Parasitic Nematode Nippostrongylus brasiliensis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MAST-CELLS; INDEPENDENT EXPRESSION; INTESTINAL EPITHELIUM; C-ELEGANS; INFECTION; LONGEVITY; DAF-16; GENE; MIGRATION	Heat shock proteins (Hsp) are a family of stress-inducible molecular chaperones that play multiple roles in a wide variety of animals. However, the roles of Hsps in parasitic nematodes remain largely unknown. To elucidate the roles of Hsps in the survival and longevity of nematodes, particularly at the 2 most critical stages in their lifecycle, the infective-L3 stage and adult stage, which is subjected to host-derived immunological pressure, we examined the temporal gene transcription patterns of Hsp12.6, Hsp20, Hsp70, and Hsp90 throughout the developmental course of the nematode Nippostrongylus brasiliensis by reverse transcriptase real-time PCR. Nb-Hsp70 and Nb-Hsp90 expression were observed throughout the nematode's lifecycle, while the expression of Nb-Hsp20 was restricted to adults. Interestingly, Nb-Hsp12.6 showed a biphasic temporal expression pattern; i.e., it was expressed in infective-L3 larvae and in adults during worm expulsion from immunocompetent rats. However, the activation of Nb-Hsp12.6 in adult worms was aborted when they infected permissive athymic-rnu/rnu rats and was only marginal when they infected mast-cell-deficient Ws/Ws rats, which exhibited a low response of rat mast cell protease (RMCP) II and resistin-like molecule (Relm)- beta expression compared to those observed in immunocompetent rats. Moreover, the activation of Nb-Hsp12.6 was reversed when adult worms were transplanted into the naive rat intestine. These features of Nb-Hsp12.6, the expression of which is not only stage-specific in infective-L3, but is also inducible by mucosal immunity in adults, have implications for the survival strategies of parasitic nematodes in deleterious environmental conditions both outside and inside the host.	[Arizono, Naoki; Yamada, Minoru; Tegoshi, Tatsuya] Kyoto Prefectural Univ Med, Dept Med Zool, Kyoto, Japan; [Takaoka, Yutaka; Ohta, Mika] Kobe Univ, Div Appl Genome Sci & Bioinformat, Grad Sch Med, Kobe, Hyogo 657, Japan; [Sakaeda, Toshiyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Frontier Educ Ctr, Ctr Integrat Educ Pharm Frontier, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kobe University; Kyoto University	Arizono, N (corresponding author), Kyoto Prefectural Univ Med, Dept Med Zool, Kyoto, Japan.	arizonon@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science [20659064]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research #20659064 from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	ARIZONO N, 1993, BLOOD, V81, P2572; Artis D, 2008, MUCOSAL IMMUNOL, V1, P252, DOI 10.1038/mi.2008.21; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; BLAXTER ML, 1994, MOL BIOCHEM PARASIT, V68, P1, DOI 10.1016/0166-6851(94)00127-8; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; Cherkasova V, 2000, J MOL BIOL, V300, P433, DOI 10.1006/jmbi.2000.3880; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; Gnanasekar M, 2008, MOL BIOCHEM PARASIT, V159, P98, DOI 10.1016/j.molbiopara.2008.02.010; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hartman D, 2003, EXP PARASITOL, V104, P96, DOI 10.1016/S0014-4894(03)00138-3; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Huot J, 1996, CANCER RES, V56, P273; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Jones LM, 2010, J PROTEOME RES, V9, P2871, DOI 10.1021/pr9009639; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kawai Y, 2007, APMIS, V115, P210, DOI 10.1111/j.1600-0463.2007.apm_510.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KITAMURA Y, 1993, AM J MED SCI, V306, P185, DOI 10.1097/00000441-199309000-00011; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lawrence CE, 2003, PARASITE IMMUNOL, V25, P271, DOI 10.1046/j.1365-3024.2003.00630.x; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; NAWA Y, 1994, PARASITE IMMUNOL, V16, P333, DOI 10.1111/j.1365-3024.1994.tb00358.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Newton-Howes J, 2006, INT J PARASITOL, V36, P467, DOI 10.1016/j.ijpara.2005.12.001; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Nishida M, 1999, APMIS, V107, P929, DOI 10.1111/j.1699-0463.1999.tb01493.x; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; OGILVIE BM, 1971, EXP PARASITOL, V29, P138, DOI 10.1016/0014-4894(71)90021-X; Raghavan N, 1999, MOL BIOCHEM PARASIT, V104, P233, DOI 10.1016/S0166-6851(99)00150-4; ROTHSTEIN NM, 1989, MOL BIOCHEM PARASIT, V33, P229, DOI 10.1016/0166-6851(89)90084-4; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sasaki Y, 2005, J EXP MED, V202, P607, DOI 10.1084/jem.20042202; TWEEDIE S, 1993, MOL BIOCHEM PARASIT, V61, P149, DOI 10.1016/0166-6851(93)90168-W; TWOHY DW, 1956, AM J HYG, V63, P165, DOI 10.1093/oxfordjournals.aje.a119801; Uchikawa R, 1996, PARASITOLOGY, V112, P339, DOI 10.1017/S0031182000065860; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; VANLEEUWEN MAW, 1995, PARASITOL RES, V81, P706, DOI 10.1007/BF00931852; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; WEINSTEIN PP, 1956, J PARASITOL, V42, P215, DOI 10.2307/3274846; Winter AD, 2007, J BIOL CHEM, V282, P12813, DOI 10.1074/jbc.M700274200; Yamauchi J, 2006, APMIS, V114, P270, DOI 10.1111/j.1600-0463.2006.apm_353.x; Yokogawa S., 1922, Parasitology Cambridge, V14, P127; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	53	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18141	10.1371/journal.pone.0018141	http://dx.doi.org/10.1371/journal.pone.0018141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448458	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500045
J	Sousa, AP; Amaral, A; Baptista, M; Tavares, R; Campo, PC; Peregrin, PC; Freitas, A; Paiva, A; Almeida-Santos, T; Ramalho-Santos, J				Sousa, Ana Paula; Amaral, Alexandra; Baptista, Marta; Tavares, Renata; Caballero Campo, Pedro; Caballero Peregrin, Pedro; Freitas, Albertina; Paiva, Artur; Almeida-Santos, Teresa; Ramalho-Santos, Joao			Not All Sperm Are Equal: Functional Mitochondria Characterize a Subpopulation of Human Sperm with Better Fertilization Potential	PLOS ONE			English	Article							DENSITY GRADIENT CENTRIFUGATION; HUMAN-SPERMATOZOA; SWIM-UP; DNA FRAGMENTATION; INTRACYTOPLASMIC INJECTION; TYROSINE PHOSPHORYLATION; NONAPOPTOTIC SPERMATOZOA; MEMBRANE TRANSLOCATION; APOPTOTIC MARKERS; HEPARAN-SULFATE	Human sperm samples are very heterogeneous and include a low amount of truly functional gametes. Distinct strategies have been developed to characterize and isolate this specific subpopulation. In this study we have used fluorescence microscopy and fluorescence-activated cell sorting to determine if mitochondrial function, as assessed using mitochondrial-sensitive probes, could be employed as a criterion to obtain more functional sperm from a given ejaculate. We first determined that mitochondrial activity correlated with the quality of distinct human samples, from healthy donors to patients with decreased semen quality. Furthermore, using fluorescence-activated cell sorting to separate sperm with active and inactive mitochondria we found that this was also true within samples. Indeed, sperm with active mitochondria defined a more functional subpopulation, which contained more capacitated and acrosome intact cells, sperm with lower chromatin damage, and, crucially, sperm more able to decondense and participate in early development using both chemical induction and injection into mature bovine oocytes. Furthermore, cell sorting using mitochondrial activity produced a more functional sperm subpopulation than classic swim-up, both in terms of improvement in a variety of functional sperm parameters and in statistical significance. In conclusion, whatever the true biological role of sperm mitochondria in fertilization, mitochondrial activity is a clear hallmark of human sperm functionality.	[Sousa, Ana Paula; Amaral, Alexandra; Baptista, Marta; Tavares, Renata; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Sousa, Ana Paula; Almeida-Santos, Teresa] Univ Hosp Coimbra, Human Reprod Serv, Coimbra, Portugal; [Caballero Campo, Pedro; Caballero Peregrin, Pedro] Tambre Clin, Human Reprod Unit, Madrid, Spain; [Caballero Campo, Pedro; Caballero Peregrin, Pedro] Tambre Fdn, Madrid, Spain; [Freitas, Albertina; Paiva, Artur] Histocompatibil Ctr Coimbra, Coimbra, Portugal; [Almeida-Santos, Teresa] Univ Coimbra, Fac Med, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra	Sousa, AP (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	jramalho@ci.uc.pt	Almeida-Santos, Teresa/M-7830-2016; Paiva, Artur/AFM-0035-2022; Amaral, Alexandra/A-7521-2013; Paiva, Artur/AAH-2330-2022; Ramalho-Santos, João/F-8641-2012; Santos, João/HHZ-5595-2022; Almeida Santos, Teresa/G-2000-2014	Almeida-Santos, Teresa/0000-0001-7423-2996; Paiva, Artur/0000-0002-6562-5859; Amaral, Alexandra/0000-0003-2354-8258; Paiva, Artur/0000-0002-6562-5859; Ramalho-Santos, João/0000-0002-1172-4018; Almeida Santos, Teresa/0000-0001-7423-2996; Tavares, Renata/0000-0002-4082-3701; Sousa, Ana Paula/0000-0002-4190-6138	Portuguese National Science Foundation (Fundacao para a Ciencia e Tecnologia) [POCTI/CVT/49102/2002]; Instituto de Investigacao Interdisciplinar of the University of Coimbra [III/BIO/50/2005]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/23571/2005, SFRH/BPD/63120/2009, SFRH/BD/46002/2008, SFRH/BD/46078/2008]	Portuguese National Science Foundation (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); Instituto de Investigacao Interdisciplinar of the University of Coimbra; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by a Grant to J.R.-S. from the Portuguese National Science Foundation (Fundacao para a Ciencia e Tecnologia; POCTI/CVT/49102/2002), and by the Instituto de Investigacao Interdisciplinar of the University of Coimbra (III/BIO/50/2005). A.P.S., A.A., M.B. and R.T. are supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/23571/2005; SFRH/BPD/63120/2009; SFRH/BD/46002/2008; SFRH/BD/46078/2008). The funding entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JG, 1992, J ANDROL, V13, P232; Amaral A, 2010, INT J ANDROL, V33, pE180, DOI 10.1111/j.1365-2605.2009.00987.x; Amaral A, 2007, HUM REPROD, V22, P1585, DOI 10.1093/humrep/dem030; Arrighi CD, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-1; AUGER J, 1993, J HISTOCHEM CYTOCHEM, V41, P1247, DOI 10.1177/41.8.8331289; AUSTIN CR, 1965, FERTILISATION FDN DE; Barroso G, 2006, FERTIL STERIL, V85, P149, DOI 10.1016/j.fertnstert.2005.06.046; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Buffone MG, 2004, HUM REPROD, V19, P139, DOI 10.1093/humrep/deh040; Chantler E, 2004, INT J ANDROL, V27, P350, DOI 10.1111/j.1365-2605.2004.00498.x; COHEN J, 1980, J REPROD FERTIL, V60, P213, DOI 10.1530/jrf.0.0600213; COHEN J, 1974, J REPROD FERTIL, V39, P297, DOI 10.1530/jrf.0.0390297; Dirican EK, 2008, J ASSIST REPROD GEN, V25, P375, DOI 10.1007/s10815-008-9250-1; Donnelly ET, 2000, HUM REPROD, V15, P1552, DOI 10.1093/humrep/15.7.1552; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Garner DL, 2006, THERIOGENOLOGY, V65, P943, DOI 10.1016/j.theriogenology.2005.09.009; GORUS FK, 1981, FERTIL STERIL, V35, P662; Grunewald Sonja, 2006, Cell and Tissue Banking, V7, P99, DOI 10.1007/s10561-005-1367-1; Grunewald Sonja, 2001, Cell and Tissue Banking, V2, P127, DOI 10.1023/A:1020188913551; Grunewald S, 2009, FERTIL STERIL, V92, P572, DOI 10.1016/j.fertnstert.2008.07.1705; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; Holt WV, 2005, HUM REPROD, V20, P2983, DOI 10.1093/humrep/dei189; Holt WV, 2004, REPRODUCTION, V127, P527, DOI 10.1530/rep.1.00134; Hoogendijk CF, 2009, FERTIL STERIL, V91, P1285, DOI 10.1016/j.fertnstert.2008.01.042; Kasai T, 2002, ASIAN J ANDROL, V4, P97; KATZ DF, 1982, J REPROD FERTIL, V65, P171; Kotwicka M, 2008, REPROD BIOMED ONLINE, V16, P657, DOI 10.1016/S1472-6483(10)60479-8; Lee TH, 2010, HUM REPROD, V25, P839, DOI 10.1093/humrep/deq009; LOPATA A, 1976, FERTIL STERIL, V27, P677, DOI 10.1016/S0015-0282(16)41899-6; Marchetti C, 2004, HUM REPROD, V19, P2267, DOI 10.1093/humrep/deh416; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Paasch U, 2004, BIOL REPROD, V71, P1828, DOI 10.1095/biolreprod.103.025627; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; Piomboni P, 2006, ARCH ANDROLOGY, V52, P51, DOI 10.1080/01485010500203741; POUSETTE A, 1986, INT J ANDROL, V9, P1, DOI 10.1111/j.1365-2605.1986.tb00862.x; Ramalho-Santos J, 2004, FERTIL STERIL, V82, P1654, DOI 10.1016/j.fertnstert.2004.05.086; Ramalho-Santos J, 2007, MODERN RES ED TOPICS, V1, P394; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ricci G, 2009, FERTIL STERIL, V91, P632, DOI 10.1016/j.fertnstert.2007.11.068; Romanato M, 2008, HUM REPROD, V23, P1145, DOI 10.1093/humrep/den028; Romanato M, 2003, HUM REPROD, V18, P1868, DOI 10.1093/humrep/deg354; RYBOUCHKIN A, 1995, HUM REPROD, V10, P1130, DOI 10.1093/oxfordjournals.humrep.a136105; Said T, 2006, BIOL REPROD, V74, P530, DOI 10.1095/biolreprod.105.046607; Said TM, 2005, REPROD BIOMED ONLINE, V10, P740, DOI 10.1016/S1472-6483(10)61118-2; Sakkas D, 2000, HUM REPROD, V15, P1112, DOI 10.1093/humrep/15.5.1112; Sousa APM, 2009, HUM REPROD, V24, P28, DOI 10.1093/humrep/den365; Spano M, 1999, MOL HUM REPROD, V5, P29, DOI 10.1093/molehr/5.1.29; Sutovsky P, 2000, INT REV CYTOL, V195, P1; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tomlinson MJ, 2001, HUM REPROD, V16, P2160, DOI 10.1093/humrep/16.10.2160; Turner RMO, 1999, MOL HUM REPROD, V5, P816, DOI 10.1093/molehr/5.9.816; Varum S, 2007, FERTIL STERIL, V87, P572, DOI 10.1016/j.fertnstert.2006.07.1528; World Health Organization, 2010, LAB MAN EX PROC HUM; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471; Younglai EV, 2001, HUM REPROD, V16, P1950, DOI 10.1093/humrep/16.9.1950; Zini A, 1999, FERTIL STERIL, V72, P496, DOI 10.1016/S0015-0282(99)00295-2; Zini A, 2000, UROLOGY, V56, P1081, DOI 10.1016/S0090-4295(00)00770-6	59	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18112	10.1371/journal.pone.0018112	http://dx.doi.org/10.1371/journal.pone.0018112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21448461	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500036
J	Cohen-Or, I; Katz, C; Ron, EZ				Cohen-Or, Ifat; Katz, Chen; Ron, Eliora Z.			AGEs Secreted by Bacteria Are Involved in the Inflammatory Response	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MULTIDRUG EFFLUX; PATHOGENESIS; COMPLICATIONS; INHIBITORS; INSIGHTS; RECEPTOR; SEPSIS	Advanced Glycated End Products (AGEs) are formed by non-enzymatic protein glycation and are implicated in several physiological aspects including cell aging and diseases. Recent data indicate that bacteria - although short lived - produce, metabolize and accumulate AGEs. Here we show that Escherichia coli cells secret AGEs by the energy-dependent efflux pump systems. Moreover, we show that in the presence of these AGEs there is an upshift of pro-inflammatory cytokins by mammalian cells. Thus, we propose that secretion of AGEs by bacteria is a novel avenue of bacterial-induced inflammation which is potentially important in the pathophysiology of bacterial infections. Moreover, the sensing of AGEs by the host cells may constitute a warning system for the presence of bacteria.	[Cohen-Or, Ifat; Katz, Chen; Ron, Eliora Z.] Tel Aviv Univ, Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Cohen-Or, I (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	eliora@post.tau.ac.il			Alfried Krupp Wissenschaftskolleg Greifswald	Alfried Krupp Wissenschaftskolleg Greifswald	CK was supported by a fellowship of the Alfried Krupp Wissenschaftskolleg Greifswald. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas AA, 2010, NETH J MED, V68, P147; Augustus AM, 2004, J BACTERIOL, V186, P1851, DOI 10.1128/JB.186.6.1851-1860.2004; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Huang SM, 2006, MOL NUTR FOOD RES, V50, P1129, DOI 10.1002/mnfr.200600075; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Lehman TD, 2001, BBA-MOL BASIS DIS, V1535, P110, DOI 10.1016/S0925-4439(00)00087-9; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Lutterloh EC, 2007, EXPERT OPIN PHARMACO, V8, P1193, DOI 10.1517/14656566.8.9.1193; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Sharff A, 2001, EUR J BIOCHEM, V268, P5011, DOI 10.1046/j.0014-2956.2001.02442.x; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Takeuchi M, 2009, J ALZHEIMERS DIS, V16, P845, DOI 10.3233/JAD-2009-0974; Turk N, 2004, DIABETES METAB, V30, P187, DOI 10.1016/S1262-3636(07)70106-4; Unoshima Masako, 2004, Nihon Rinsho, V62, P2323; Van Nguyen C, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; WHITNEY EN, 1971, GENETICS, V67, P39; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301	32	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17974	10.1371/journal.pone.0017974	http://dx.doi.org/10.1371/journal.pone.0017974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445354	gold, Green Published, Green Submitted			2022-12-25	WOS:000288809100019
J	Macadangdang, B; Zhang, N; Lund, PE; Marple, AH; Okabe, M; Gottesman, MM; Appella, DH; Kimchi-Sarfaty, C				Macadangdang, Benjamin; Zhang, Ning; Lund, Paul E.; Marple, Andrew H.; Okabe, Mitsunori; Gottesman, Michael M.; Appella, Daniel H.; Kimchi-Sarfaty, Chava			Inhibition of Multidrug Resistance by SV40 Pseudovirion Delivery of an Antigene Peptide Nucleic Acid (PNA) in Cultured Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN; GENE-EXPRESSION; IN-VITRO; SV40-DERIVED VECTORS; LOCALIZATION SIGNAL; CELLULAR DELIVERY; ANTICANCER DRUGS; CHROMOSOMAL DNA; CANCER-CELLS; SEQUENCE	Peptide nucleic acid (PNA) is known to bind with extraordinarily high affinity and sequence-specificity to complementary nucleic acid sequences and can be used to suppress gene expression. However, effective delivery into cells is a major obstacle to the development of PNA for gene therapy applications. Here, we present a novel method for the in vitro delivery of antigene PNA to cells. By using a nucleocapsid protein derived from Simian virus 40, we have been able to package PNA into pseudovirions, facilitating the delivery of the packaged PNA into cells. We demonstrate that this system can be used effectively to suppress gene expression associated with multidrug resistance in cancer cells, as shown by RT-PCR, flow cytometry, Western blotting, and cell viability under chemotherapy. The combination of PNA with the SV40-based delivery system is a method for suppressing a gene of interest that could be broadly applied to numerous targets.	[Macadangdang, Benjamin; Lund, Paul E.; Marple, Andrew H.; Okabe, Mitsunori; Gottesman, Michael M.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhang, Ning; Appella, Daniel H.] NIDDK, Bioorgan Chem Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Kimchi-Sarfaty, Chava] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Food & Drug Administration (FDA)	Macadangdang, B (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	appellad@niddk.nih.gov; chava.kimchi-sarfaty@fda.hhs.gov		Kimchi-Sarfaty, Chava/0000-0002-9355-8585	National Institutes of Health; National Cancer InstituteNational Institute of Diabetes and Digestive and Kidney Diseases; Food and Drug Administration; NATIONAL CANCER INSTITUTE [ZIABC005598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer InstituteNational Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Food and Drug Administration(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases, and the Food and Drug Administration. The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent an Agency determination or policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050283q; BOEKHORST PAW, 1993, BLOOD, V82, P3157; Braun K, 2002, J MOL BIOL, V318, P237, DOI 10.1016/S0022-2836(02)00031-1; Chiarantini L, 2005, J CONTROL RELEASE, V109, P24, DOI 10.1016/j.jconrel.2005.09.013; Chiarantini L, 2002, BIOCHEMISTRY-US, V41, P8471, DOI 10.1021/bi020079f; CHITNIS M, 1991, SELECT CANCER THER, V7, P165, DOI 10.1089/sct.1991.7.165; Cogoi S, 2005, BIOCHEMISTRY-US, V44, P10510, DOI 10.1021/bi0505215; Cordelier P, 2003, OLIGONUCLEOTIDES, V13, P281, DOI 10.1089/154545703322616961; Corradini R, 2007, CURR TOP MED CHEM, V7, P681, DOI 10.2174/156802607780487759; Cutrona G, 2000, NAT BIOTECHNOL, V18, P300, DOI 10.1038/73745; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P16104, DOI 10.1021/ja063383v; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FOJO AT, 1987, J CLIN ONCOL, V5, P1922, DOI 10.1200/JCO.1987.5.12.1922; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo Hua, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P300; Hille S, 2006, ANTI-CANCER DRUG, V17, P1041, DOI 10.1097/01.cad.0000231480.07654.b5; Hotta T, 1999, SURG TODAY, V29, P591, DOI 10.1007/BF02482982; Hu JX, 2007, BIOCHEMISTRY-US, V46, P7581, DOI 10.1021/bi700230a; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Kaihatsu K, 2004, BIOCHEMISTRY-US, V43, P14340, DOI 10.1021/bi048519l; Kimchi-Sarfaty C, 2006, CANCER GENE THER, V13, P648, DOI 10.1038/sj.cgt.7700943; Kimchi-Sarfaty C, 2005, HUM GENE THER, V16, P1110, DOI 10.1089/hum.2005.16.1110; Kimchi-Sarfaty C, 2004, BIOTECHNIQUES, V37, P270, DOI 10.2144/04372RR04; Kimchi-Sarfaty C, 2002, HUM GENE THER, V13, P299, DOI 10.1089/10430340252769815; Koppelhus U, 2003, ADV DRUG DELIVER REV, V55, P267, DOI 10.1016/S0169-409X(02)00182-5; Larsen HJ, 1999, BBA-GENE STRUCT EXPR, V1489, P159, DOI 10.1016/S0167-4781(99)00145-1; Miyake K, 1999, CANCER RES, V59, P8; Mukherjee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000765; Nielsen P. E., 2004, PEPTIDE NUCL ACIDS P, V2nd, P37; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Pokorski JK, 2004, J AM CHEM SOC, V126, P15067, DOI 10.1021/ja046280q; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; Shiraishi T, 2006, BIOCONJUGATE CHEM, V17, P189, DOI 10.1021/bc050246z; Shiraishi T, 2005, CHEM BIOL, V12, P923, DOI 10.1016/j.chembiol.2005.06.009; Strayer DS, 2000, GENE THER, V7, P886, DOI 10.1038/sj.gt.3301159; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P6837, DOI 10.1093/nar/gki991; UEDA K, 1987, J BIOL CHEM, V262, P17432; WARNER E, 1995, AM J CLIN ONCOL-CANC, V18, P251, DOI 10.1097/00000421-199506000-00013; Wei HL, 2003, ACTA PHARMACOL SIN, V24, P805; WITTUNG P, 1995, FEBS LETT, V365, P27, DOI 10.1016/0014-5793(95)00409-3	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17981	10.1371/journal.pone.0017981	http://dx.doi.org/10.1371/journal.pone.0017981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445346	Green Published, gold, Green Submitted			2022-12-25	WOS:000288809100021
J	Sugiura, Y; Taguchi, R; Setou, M				Sugiura, Yuki; Taguchi, Ryo; Setou, Mitsutoshi			Visualization of Spatiotemporal Energy Dynamics of Hippocampal Neurons by Mass Spectrometry during a Kainate-Induced Seizure	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; RAT-HEART MITOCHONDRIA; ACID CYCLE ACTIVITY; KAINIC ACID; CELL-DEATH; REGULATORY PROTEINS; APOPTOSIS; TISSUE; BRAIN; SUSCEPTIBILITY	We report the use of matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry combined with capillary electrophoresis (CE) mass spectrometry to visualize energy metabolism in the mouse hippocampus by imaging energy-related metabolites. We show the distribution patterns of ATP, ADP, and AMP in the hippocampus as well as changes in their amounts and distribution patterns in a murine model of limbic, kainate-induced seizure. As an acute response to kainate administration, we found massive and moderate reductions in ATP and ADP levels, respectively, but no significant changes in AMP levels-especially in cells of the CA3 layer. The results suggest the existence of CA3 neuron-selective energy metabolism at the anhydride bonds of ATP and ADP in the hippocampal neurons during seizure. In addition, metabolome analysis of energy synthesis pathways indicates accelerated glycolysis and possibly TCA cycle activity during seizure, presumably due to the depletion of ATP. Consistent with this result, the observed energy depletion significantly recovered up to 180 min after kainate administration. However, the recovery rate was remarkably low in part of the data-pixel population in the CA3 cell layer region, which likely reflects acute and CA3-selective neural death. Taken together, the present approach successfully revealed the spatiotemporal energy metabolism of the mouse hippocampus at a cellular resolution-both quantitatively and qualitatively. We aim to further elucidate various metabolic processes in the neural system.	[Sugiura, Yuki; Setou, Mitsutoshi] Hamamatsu Med Sch, Dept Mol Anat, Higashi Ku, Shizuoka, Japan; [Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Sugiura, Y (corresponding author), Hamamatsu Med Sch, Dept Mol Anat, Higashi Ku, Shizuoka, Japan.	setou@hama-med.ac.jp		Sugiura, Yuki/0000-0002-6983-8958	Human Metabolomics Technology; SENTAN	Human Metabolomics Technology; SENTAN(Japan Science & Technology Agency (JST))	This research, particularly of CE-MS metabolomic research, was supported by a grant for leading metabolome research 2010 provided by Human Metabolomics Technology (http://humanmetabolome.com/?p=921=en) to YS. A Grant-in-Aid for Scientific Research (WAKATE-S:20670004, http://www.jsps.go.jp) to MS, and SENTAN program-P to KO (http://www.jst.go.jp/sentan/en/) support conducting other parts of this research. Shimazdu Corp. and Eisai contributed data analysis and manuscript preparation. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Benabdellah F, 2009, ANAL CHEM, V81, P5557, DOI 10.1021/ac9005364; BIZIERE K, 1978, J NEUROCHEM, V31, P513, DOI 10.1111/j.1471-4159.1978.tb02666.x; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GARRETT TJ, 2006, INT J MASS SPECTROM, V260, P11; GRIFFITHS T, 1984, NEUROSCIENCE, V12, P557, DOI 10.1016/0306-4522(84)90073-3; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; HATTORI K, ANTIOXID REDOX SIGNA; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; HILLENKAMP F, 1975, NATURE, V256, P119, DOI 10.1038/256119a0; Jackson SN, 2007, J MASS SPECTROM, V42, P1093, DOI 10.1002/jms.1245; Konishi Y, 2003, J NEUROSCI, V23, P1649; KUPKA K-D, 1980, Scanning Electron Microscopy, P635; LANOUE K, 1970, J BIOL CHEM, V245, P102; LANOUE KF, 1972, J BIOL CHEM, V247, P667; LEBOVITZ R M, 1971, International Journal of Neuroscience, V2, P99, DOI 10.3109/00207457109146996; LEVY DE, 1977, J NEUROCHEM, V28, P63, DOI 10.1111/j.1471-4159.1977.tb07709.x; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Lust W., 1989, CARBOHYDRATES ENERGY; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MORITA Y, 2010, CANC SCI IN PRESS; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; PINARD E, 1984, NEUROSCIENCE, V13, P1039, DOI 10.1016/0306-4522(84)90287-2; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Ridenour WB, 2010, ANAL CHEM, V82, P1881, DOI 10.1021/ac9026115; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054; SUGIURA Y, 2006, J MASS SPECTROM SOC, V54, P4; SUGIURA Y, 2009, J NEUROIMMUNE PHARM; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; TREMBLAY E, 1983, NEUROSCIENCE, V8, P299, DOI 10.1016/0306-4522(83)90068-4; Wang XQ, 2003, J CELL SCI, V116, P2099, DOI 10.1242/jcs.00420; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121	46	57	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17952	10.1371/journal.pone.0017952	http://dx.doi.org/10.1371/journal.pone.0017952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445350	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100018
J	Beebe, DW; Byars, KC				Beebe, Dean W.; Byars, Kelly C.			Adolescents with Obstructive Sleep Apnea Adhere Poorly to Positive Airway Pressure (PAP), but PAP Users Show Improved Attention and School Performance	PLOS ONE			English	Article							CHILDREN; THERAPY; METAANALYSIS; QUALITY; ADULTS	Background: Obstructive Sleep Apnea (OSA) is associated with medical and neurobehavioral morbidity across the lifespan. Positive airway pressure (PAP) treatment has demonstrated efficacy in treating OSA and has been shown to improve daytime functioning in adults, but treatment adherence can be problematic. There are nearly no published studies examining functional outcomes such as academic functioning in adolescents treated with PAP. This study was conducted as an initial step towards determining whether PAP treatment improves daytime functioning among adolescents with OSA. Methods: Self-reported academic grades, self-and parent-reported academic quality of life, and objectively-measured attention were assessed before and after PAP was clinically initiated in a sample of 13 obese adolescents with OSA, as well as 15 untreated obese Controls without OSA. Based on adherence data, the treated group was divided into PAP Users (n = 6) and Non-Adherent participants (n = 7). Results: Though demographically similar, the three groups significantly differed in how their academic performance and attention scores changed from baseline to follow-up. Non-Adherent participants showed worsening functioning over time, while PAP Users showed stable or improved functioning, similar to controls. Conclusion: Although many adolescents prescribed PAP for OSA are non-adherent to the treatment, those who adhere to treatment can display improved attention and academic functioning.	[Beebe, Dean W.; Byars, Kelly C.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Beebe, Dean W.; Byars, Kelly C.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Beebe, DW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA.	dean.beebe@cchmc.org			United States National Institutes of Health (NIH) [K23 HL075369, R01 HL092149, UL1 RR026314]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092149, K23HL075369] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the United States National Institutes of Health (NIH) grants K23 HL075369, R01 HL092149, and UL1 RR026314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbold KH, 2009, CURR OPIN PULM MED, V15, P585, DOI 10.1097/MCP.0b013e3283319b3f; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P69, DOI 10.1093/jpepsy/jsj104; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Beebe DW, 2010, SLEEP, V33, P1447, DOI 10.1093/sleep/33.11.1447; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Costa DJ, 2009, OTOLARYNG HEAD NECK, V140, P455, DOI 10.1016/j.otohns.2008.12.038; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; Gordon M, 1983, GORDON DIAGNOSTIC SY; Sanchez AI, 2009, SLEEP MED REV, V13, P223, DOI 10.1016/j.smrv.2008.07.002; Marcus CL, 2006, PEDIATRICS, V117, pE442, DOI 10.1542/peds.2005-1634; O'Donnell AR, 2006, SLEEP, V29, P651; Uong EC, 2007, PEDIATRICS, V120, pE1203, DOI 10.1542/peds.2006-2731; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351	15	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e16924	10.1371/journal.pone.0016924	http://dx.doi.org/10.1371/journal.pone.0016924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437285	Green Submitted, gold, Green Published			2022-12-25	WOS:000288514600001
J	Tadema, H; Kallenberg, CGM; Stegeman, CA; Heeringa, P				Tadema, Henko; Kallenberg, Cees G. M.; Stegeman, Coen A.; Heeringa, Peter			Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; ANTIRIBOSOMAL P AUTOANTIBODIES; STAPHYLOCOCCUS-AUREUS; SYSTEMIC VASCULITIS; MOLECULAR MIMICRY; NASAL CARRIAGE; AUTOIMMUNITY; INFECTIONS; ANTIBODIES; GRANULOMATOSIS	The etiology of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitides (AAV) is unknown, but the association between infections and autoimmunity has been studied extensively. In 2004, a novel theory was proposed that could link infection and autoimmunity. This 'theory of autoantigen complementarity' was based on the serendipitous finding of antibodies against complementary-PR3 (cPR3) in patients with PR3-ANCA-associated vasculitis. cPR3 demonstrated homology to several bacterial proteins, and it was hypothesized that PR3-ANCA develop in response to anti-cPR3 antibodies, as a consequence of the anti-idiotypic network. These data have not been confirmed in other patient cohorts. We investigated the presence of anti-cPR3 antibodies in a Dutch cohort of PR3-ANCA-associated vasculitis patients. Anti-cPR3 reactivity was determined in serum using ELISA. Two separate batches of cPR3 were used to determine reactivity in two separate cohorts of PR3-ANCA-associated vasculitis patients. We found that anti-cPR3-reactivity was not increased in our PR3-ANCA-associated vasculitis patients, in comparison to control groups. Further research will be necessary to prove the concept of autoantigen complementarity in autoimmune diseases.	[Tadema, Henko; Kallenberg, Cees G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Tadema, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	h.tadema@reuma.umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Stegeman, Coen/0000-0002-0224-0927	Dutch Arthritis Association [06-1-401]	Dutch Arthritis Association	This work was supported by the Dutch Arthritis Association (06-1-401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 1998, ARTHRITIS RHEUM, V41, P33, DOI 10.1002/1529-0131(199801)41:1<33::AID-ART5>3.0.CO;2-5; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Getts MT, 2010, CLIN EXP IMMUNOL, V160, P15, DOI 10.1111/j.1365-2249.2010.04132.x; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; JAYNE DRW, 1993, J AUTOIMMUN, V6, P207, DOI 10.1006/jaut.1993.1018; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kallenberg CGM, 2008, AUTOIMMUN REV, V8, P29, DOI 10.1016/j.autrev.2008.07.020; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Pan ZJ, 1998, J CLIN INVEST, V102, P215, DOI 10.1172/JCI1969; Pendergraft WF, 2004, NAT MED, V10, P72, DOI 10.1038/nm968; Preston GA, 2005, CURR OPIN NEPHROL HY, V14, P217, DOI 10.1097/01.mnh.0000165886.93427.b1; ROSSI F, 1991, CLIN EXP IMMUNOL, V83, P298; SFRISO P, 2009, J LEUKOC BIOL; SHOENFELD Y, 1994, FASEB J, V8, P1296, DOI 10.1096/fasebj.8.15.8001742; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Vani J, 2009, MOL IMMUNOL, V46, P1250, DOI 10.1016/j.molimm.2008.11.019; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Yang JJ, 2008, KIDNEY INT, V74, P1159, DOI 10.1038/ki.2008.309; Zycinska K, 2008, J PHYSIOL PHARMACOL, V59, P825	23	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17972	10.1371/journal.pone.0017972	http://dx.doi.org/10.1371/journal.pone.0017972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437233	Green Published, gold, Green Submitted			2022-12-25	WOS:000288514600019
J	Corona, C; Frazzini, V; Silvestri, E; Lattanzio, R; La Sorda, R; Piantelli, M; Canzoniero, LMT; Ciavardelli, D; Rizzarelli, E; Sensi, SL				Corona, Carlo; Frazzini, Valerio; Silvestri, Elena; Lattanzio, Rossano; La Sorda, Rossana; Piantelli, Mauro; Canzoniero, Lorella M. T.; Ciavardelli, Domenico; Rizzarelli, Enrico; Sensi, Stefano L.			Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice	PLOS ONE			English	Article							INCREASES BDNF LEVELS; TARGETING A-BETA; ZINC L-CARNOSINE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MEMORY DEFICITS; MOUSE MODEL; AMINO-ACID; PROTEIN; TAU	Background: The pathogenic road map leading to Alzheimer's disease (AD) is still not completely understood; however, a large body of studies in the last few years supports the idea that beside the classic hallmarks of the disease, namely the accumulation of amyloid-beta (A beta) and neurofibrillary tangles, other factors significantly contribute to the initiation and the progression of the disease. Among them, mitochondria failure, an unbalanced neuronal redox state, and the dyshomeostasis of endogenous metals like copper, iron, and zinc have all been reported to play an important role in exacerbating AD pathology. Given these factors, the endogenous peptide carnosine may be potentially beneficial in the treatment of AD because of its free-radical scavenger and metal chelating properties. Methodology: In this study, we explored the effect of L-carnosine supplementation in the 3xTg-AD mouse, an animal model of AD that shows both A beta- and tau-dependent pathology. Principal Findings: We found that carnosine supplementation in 3xTg-AD mice promotes a strong reduction in the hippocampal intraneuronal accumulation of A beta and completely rescues AD and aging-related mitochondrial dysfunctions. No effects were found on tau pathology and we only observed a trend toward the amelioration of cognitive deficits. Conclusions and Significance: Our data indicate that carnosine can be part of a combined therapeutic approach for the treatment of AD.	[Corona, Carlo; Frazzini, Valerio; Ciavardelli, Domenico; Sensi, Stefano L.] Univ G dAnnunzio, Ctr Excellence Aging CeSI, Mol Neurol Unit, Chieti, Italy; [Corona, Carlo; Frazzini, Valerio; Sensi, Stefano L.] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Silvestri, Elena; Canzoniero, Lorella M. T.] Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy; [Lattanzio, Rossano; La Sorda, Rossana; Piantelli, Mauro] Univ G dAnnunzio, Dept Oncol & Neurosci, Chieti, Italy; [Rizzarelli, Enrico] Univ Catania, Dept Chem, Catania, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Sannio; G d'Annunzio University of Chieti-Pescara; University of Catania; University of California System; University of California Irvine	Corona, C (corresponding author), Univ G dAnnunzio, Ctr Excellence Aging CeSI, Mol Neurol Unit, Chieti, Italy.	ssensi@uci.edu	Rizzarelli, Enrico/M-6974-2017; Lattanzio, Rossano/K-1927-2018; Sensi, Stefano L./J-3164-2016; Sensi, Stefano L./O-1335-2019; Frazzini, Valerio/R-3643-2016	Rizzarelli, Enrico/0000-0001-5367-0823; Lattanzio, Rossano/0000-0001-9803-4476; Sensi, Stefano L./0000-0002-0710-2574; Sensi, Stefano L./0000-0002-0710-2574; Silvestri, Elena/0000-0002-0592-9033; Piantelli, Mauro/0000-0003-0154-482X; Frazzini, Valerio/0000-0003-1187-3352; CANZONIERO, Lorella Maria Teresa/0000-0003-2255-5341	Italian Department of Education	Italian Department of Education	Funding: SLS and ER are supported by funds from the Italian Department of Education [Fondo per gli Investimenti della Ricerca di Base (FIRB) 2003; Progetti Ricerca Interesse Nazionale (PRIN) 2006 and PRIN 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Baran EJ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P789; Bellia F, 2009, ANTIOXID REDOX SIGN, V11, P2759, DOI 10.1089/ARS.2009.2738; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BOLDYREV AA, 1994, TRENDS NEUROSCI, V17, P468, DOI 10.1016/0166-2236(94)90134-1; Brownson C, 2000, FREE RADICAL BIO MED, V28, P1564, DOI 10.1016/S0891-5849(00)00270-7; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Calabrese V, 2005, NEUROCHEM RES, V30, P797, DOI 10.1007/s11064-005-6874-8; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Corona C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.73; Crouch PJ, 2007, REJUV RES, V10, P349, DOI 10.1089/rej.2007.0592; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Gazaryan IG, 2007, J BIOL CHEM, V282, P24373, DOI 10.1074/jbc.M611376200; Hipkiss AR, 1998, BBA-GEN SUBJECTS, V1380, P46, DOI 10.1016/S0304-4165(97)00123-2; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; Hipkiss AR, 2001, MECH AGEING DEV, V122, P1431, DOI 10.1016/S0047-6374(01)00272-X; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Horning MS, 2000, BRAIN RES, V852, P56, DOI 10.1016/S0006-8993(99)02215-5; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Mineo P, 2002, RAPID COMMUN MASS SP, V16, P722, DOI 10.1002/rcm.633; Odashima M, 2002, DIGEST DIS SCI, V47, P2799, DOI 10.1023/A:1021029927386; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Schagger H, 1996, Methods Enzymol, V264, P555, DOI 10.1016/S0076-6879(96)64048-8; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2008, EXP GERONTOL, V43, P488, DOI 10.1016/j.exger.2007.10.018; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; Trombley PQ, 1998, NEUROREPORT, V9, P3503, DOI 10.1097/00001756-199810260-00031; Ueda K, 2009, J PHARMACOL SCI, V110, P285, DOI 10.1254/jphs.09056FP; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	53	129	130	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17971	10.1371/journal.pone.0017971	http://dx.doi.org/10.1371/journal.pone.0017971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423579	gold, Green Published			2022-12-25	WOS:000288513900048
J	Hijazi, A; Haenlin, M; Waltzer, L; Roch, F				Hijazi, Assia; Haenlin, Marc; Waltzer, Lucas; Roch, Fernando			The Ly6 Protein Coiled Is Required for Septate Junction and Blood Brain Barrier Organisation in Drosophila	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; EPITHELIAL-CELLS; NEUREXIN IV; MELANOGASTER; ENCODES; FAMILY; GENE; DIFFERENTIATION; SUPERFAMILY; POLARITY	Background: Genetic analysis of the Drosophila septate junctions has greatly contributed to our understanding of the mechanisms controlling the assembly of these adhesion structures, which bear strong similarities with the vertebrate tight junctions and the paranodal septate junctions. These adhesion complexes share conserved molecular components and have a common function: the formation of paracellular barriers restraining the diffusion of solutes through epithelial and glial envelopes. Methodology/Principal Findings: In this work we characterise the function of the Drosophila cold gene, that codes for a protein belonging to the Ly6 superfamily of extracellular ligands. Analysis of cold mutants shows that this gene is specifically required for the organisation of the septate junctions in epithelial tissues and in the nervous system, where its contribution is essential for the maintenance of the blood-brain barrier. We show that cold acts in a cell autonomous way, and we present evidence indicating that this protein could act as a septate junction component. Conclusion/Significance: We discuss the specific roles of cold and three other Drosophila members of the Ly6 superfamily that have been shown to participate in a non-redundant way in the process of septate junction assembly. We propose that vertebrate Ly6 proteins could fulfill analogous roles in tight junctions and/or paranodal septate junctions.	[Hijazi, Assia; Haenlin, Marc; Waltzer, Lucas; Roch, Fernando] Univ Toulouse 3, Ctr Dev Biol, UPS, F-31062 Toulouse, France; [Hijazi, Assia; Haenlin, Marc; Waltzer, Lucas; Roch, Fernando] Ctr Dev Biol, CNRS, UMR 5547, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hijazi, A (corresponding author), Univ Toulouse 3, Ctr Dev Biol, UPS, F-31062 Toulouse, France.	roch@cict.fr		Haenlin, Marc/0000-0003-2728-8457; Waltzer, Lucas/0000-0002-5361-727X	Lebanese CNRS; Association pour la Recherche sur le Cancer (ARC); CNRS	Lebanese CNRS; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	A. H. is recipient of PhD fellowships awarded by the Lebanese CNRS (www.cnrs.edu.lb) and the Association pour la Recherche sur le Cancer (ARC, http://www.arc-cancer.net/). This work has been supported by the CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bamezai A, 2004, ARCH IMMUNOL THER EX, V52, P255; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Carlson SD, 1997, J NEUROCYTOL, V26, P377, DOI 10.1023/A:1018564904170; Chou TB, 1996, GENETICS, V144, P1673; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, DEV DYNAM, V233, P1056, DOI 10.1002/dvdy.20389; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Takashima S, 2001, MECH DEVELOP, V101, P79, DOI 10.1016/S0925-4773(00)00555-4; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008	39	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17763	10.1371/journal.pone.0017763	http://dx.doi.org/10.1371/journal.pone.0017763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423573	Green Published, gold, Green Submitted			2022-12-25	WOS:000288513900025
J	Krueger, S; Giavalisco, P; Krall, L; Steinhauser, MC; Bussis, D; Usadel, B; Flugge, UI; Fernie, AR; Willmitzer, L; Steinhauser, D				Krueger, Stephan; Giavalisco, Patrick; Krall, Leonard; Steinhauser, Marie-Caroline; Buessis, Dirk; Usadel, Bjoern; Fluegge, Ulf-Ingo; Fernie, Alisdair R.; Willmitzer, Lothar; Steinhauser, Dirk			A Topological Map of the Compartmentalized Arabidopsis thaliana Leaf Metabolome	PLOS ONE			English	Article							MASS-SPECTROMETRY; HIGHER-PLANTS; INTRACELLULAR-LOCALIZATION; GLUCOSE PYROPHOSPHORYLASE; NONAQUEOUS FRACTIONATION; EPITHIOSPECIFIER PROTEIN; BRASSICA-OLERACEA; SUCROSE SYNTHESIS; AMINO-ACIDS; ADP-GLUCOSE	Background: The extensive subcellular compartmentalization of metabolites and metabolism in eukaryotic cells is widely acknowledged and represents a key factor of metabolic activity and functionality. In striking contrast, the knowledge of actual compartmental distribution of metabolites from experimental studies is surprisingly low. However, a precise knowledge of, possibly all, metabolites and their subcellular distributions remains a key prerequisite for the understanding of any cellular function. Methodology/Principal Findings: Here we describe results for the subcellular distribution of 1,117 polar and 2,804 lipophilic mass spectrometric features associated to known and unknown compounds from leaves of the model plant Arabidopsis thaliana. Using an optimized non-aqueous fractionation protocol in conjunction with GC/MS- and LC/MS-based metabolite profiling, 81.5% of the metabolic data could be associated to one of three subcellular compartments: the cytosol (including the mitochondria), vacuole, or plastids. Statistical analysis using a marker-'free' approach revealed that 18.5% of these metabolites show intermediate distributions, which can either be explained by transport processes or by additional subcellular compartments. Conclusion/Significance: Next to a functional and conceptual workflow for the efficient, highly resolved metabolite analysis of the fractionated Arabidopsis thaliana leaf metabolome, a detailed survey of the subcellular distribution of several compounds, in the graphical format of a topological map, is provided. This complex data set therefore does not only contain a rich repository of metabolic information, but due to thorough validation and testing by statistical methods, represents an initial step in the analysis of metabolite dynamics and fluxes within and between subcellular compartments.	[Krueger, Stephan; Fluegge, Ulf-Ingo] Univ Cologne, Inst Bot, D-5000 Cologne, Germany; [Buessis, Dirk] Max Planck Inst Mol Plant Physiol, GABI Managing Off, Potsdam, Germany	University of Cologne; Max Planck Society	Krueger, S (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-5000 Cologne, Germany.	steinhauser@mpimp-golm.mpg.de	Steinhauser, Dirk/J-6484-2012; Willmitzer, Lothar/F-7377-2011; Usadel, Björn/E-1932-2011	Usadel, Björn/0000-0003-0921-8041; steinhauser, dirk/0000-0001-7792-2896	University of Cologne; Federal Ministry of Education and Research (BMBF) [BMBF - 0315075]; Max Planck Society (MPG)	University of Cologne; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society (MPG)(Max Planck Society)	Funding: S.K and U.-I.F were funded and supported by the University of Cologne; D. B was funded by a grant (BMBF - 0315075) of the Federal Ministry of Education and Research (BMBF); P. G., L. K., M.-C. S, B. U., A. R. F., L. W., and D. S. by the Max Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Agarwal R, 2009, MOL PLANT, V2, P32, DOI 10.1093/mp/ssn075; Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Arnon DI, 1939, SCIENCE, V89, P512, DOI 10.1126/science.89.2318.512; Aubert S, 2004, J EXP BOT, V55, P2179, DOI 10.1093/jxb/erh235; Behrens M., 1932, H-S Z PHYSIOL CHEM, V209, P59; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benkeblia N, 2007, METABOLOMICS, V3, P297, DOI 10.1007/s11306-007-0078-y; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Cox TF, 1994, MONOGRAPHS STAT APPL; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Doniwa Y, 2007, PLANT BIOTECHNOL-NAR, V24, P441, DOI 10.5511/plantbiotechnology.24.441; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Echeverria E, 2000, PLANT PHYSIOL, V123, P1217, DOI 10.1104/pp.123.4.1217; Eisenreich W, 2007, PHYTOCHEMISTRY, V68, P2799, DOI 10.1016/j.phytochem.2007.09.028; ELBERS R, 1974, H-S Z PHYSIOL CHEM, V355, P378, DOI 10.1515/bchm2.1974.355.1.378; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Farre EM, 2008, METABOLOMICS, V4, P161, DOI 10.1007/s11306-008-0107-5; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; GERHARDT R, 1987, PLANT PHYSIOL, V83, P399, DOI 10.1104/pp.83.2.399; Goldberg D.M., 1987, METHODS ENZYMATIC AN, P258; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; HELL R, 1990, PLANTA, V180, P603, DOI 10.1007/BF02411460; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Ischebeck T, 2006, J BIOL CHEM, V281, P2470, DOI 10.1074/jbc.M509222200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelly PJ, 1998, PLANTA, V206, P370, DOI 10.1007/s004250050412; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Krall L, 2009, J CHROMATOGR B, V877, P2952, DOI 10.1016/j.jchromb.2009.07.006; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Lawson CL, 1995, SIAM; LEHMANN S, 2010, AMINO ACIDS; Lin WL, 2008, PLANT SCI, V175, P233, DOI 10.1016/j.plantsci.2008.04.003; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Logan DC, 2010, BIOCHEM SOC T, V38, P789, DOI 10.1042/BST0380789; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Nakabayashi R, 2009, PHYTOCHEMISTRY, V70, P1017, DOI 10.1016/j.phytochem.2009.03.021; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Ohara K, 2004, PLANT J, V40, P734, DOI 10.1111/j.1365-313X.2004.02246.x; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ono E, 2006, PLANT J, V45, P133, DOI 10.1111/j.1365-313X.2005.02625.x; OPARKA KJ, 1992, ENV PLANT B, P91; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Paris N, 1996, CELL, V85, P563, DOI 10.1016/S0092-8674(00)81256-8; RAUCH U, 1994, CIRC RES, V75, P760, DOI 10.1161/01.RES.75.4.760; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Ripley B. D., 1996, PATTERN RECOGNITION; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; ROSA EAS, 1994, J SCI FOOD AGR, V66, P457, DOI 10.1002/jsfa.2740660406; Rosa EAS, 1996, J SCI FOOD AGR, V71, P237, DOI 10.1002/(SICI)1097-0010(199606)71:2&lt;237::AID-JSFA574&gt;3.0.CO;2-P; Sambrook J, 1989, MOL CLONING LABORATO; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; SCHULTZ CJ, 1995, PLANT J, V7, P61, DOI 10.1046/j.1365-313X.1995.07010061.x; Schulze-Lefert P, 2004, CURR OPIN PLANT BIOL, V7, P377, DOI 10.1016/j.pbi.2004.05.004; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; Sircar D, 2008, J PLANT PHYSIOL, V165, P407, DOI 10.1016/j.jplph.2007.05.005; SOBOLL S, 1980, BIOCHEM J, V192, P951, DOI 10.1042/bj1920951; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STITT M, 1982, PLANT PHYSIOL, V70, P971, DOI 10.1104/pp.70.4.971; Stitt M, 2003, CURR OPIN BIOTECH, V14, P136, DOI 10.1016/S0958-1669(03)00023-5; STITT M, 1983, PLANT PHYSIOL, V72, P767, DOI 10.1104/pp.72.3.767; SUSS KH, 1993, P NATL ACAD SCI USA, V90, P5514, DOI 10.1073/pnas.90.12.5514; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Taira M, 2004, PLANT CELL, V16, P2048, DOI 10.1105/tpc.104.022046; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Weber APM, 2007, FEBS LETT, V581, P2215, DOI 10.1016/j.febslet.2007.02.010; Werner E, 2008, ANAL CHEM, V80, P4918, DOI 10.1021/ac800094p; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; WINTER H, 1993, PLANTA, V191, P180, DOI 10.1007/BF00199748; Wiseman JM, 2008, P NATL ACAD SCI USA, V105, P18120, DOI 10.1073/pnas.0801066105; Yamada K, 2009, PLANTA, V230, P1115, DOI 10.1007/s00425-009-1011-6; YAMAGA Y, 1993, PHYTOCHEMISTRY, V32, P633, DOI 10.1016/S0031-9422(00)95147-1; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; ZRENNER R, 1993, PLANTA, V190, P247, DOI 10.1007/BF00196618	98	78	78	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17806	10.1371/journal.pone.0017806	http://dx.doi.org/10.1371/journal.pone.0017806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423574	gold, Green Published, Green Submitted			2022-12-25	WOS:000288513900033
J	Lemjabbar-Alaoui, H; Sidhu, SS; Mengistab, A; Gallup, M; Basbaum, C				Lemjabbar-Alaoui, Hassan; Sidhu, Sukhvinder S.; Mengistab, Aklilu; Gallup, Marianne; Basbaum, Carol			TACE/ADAM-17 Phosphorylation by PKC-Epsilon Mediates Premalignant Changes in Tobacco Smoke-Exposed Lung Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; ALPHA-CONVERTING-ENZYME; GROWTH-FACTOR; FACTOR RECEPTOR; CANCER-CELLS; EPITHELIAL-CELLS; POTENTIAL ROLE; ACTIVATION; DELTA; PROLIFERATION	Background: Tobacco smoke predisposes humans and animals to develop lung tumors, but the molecular events responsible for this are poorly understood. We recently showed that signaling mechanisms triggered by smoke in lung cells could lead to the activation of a growth factor signaling pathway, thereby promoting hyperproliferation of lung epithelial cells. Hyperproliferation is considered a premalignant change in the lung, in that increased rates of DNA synthesis are associated with an increased number of DNA copying errors, events that are exacerbated in the presence of tobacco smoke carcinogens. Despite the existence of DNA repair mechanisms, a small percentage of these errors go unrepaired and can lead to tumorigenic mutations. The results of our previous study showed that an early event following smoke exposure was the generation of oxygen radicals through the activation of NADPH oxidase. Although it was clear that these radicals transduced signals through the epidermal growth factor receptor (EGFR), and that this was mediated by TACE-dependent cleavage of amphiregulin, it remained uncertain how oxygen radicals were able to activate TACE. Principal Findings: In the present study, we demonstrate for the first time that phosphorylation of TACE at serine/threonine residues by tobacco smoke induces amphiregulin release and EGFR activation. TACE phosphorylation is triggered in smoke-exposed lung cells by the ROS-induced activation of PKC through the action of SRC kinase. Furthermore, we identified PKC epsilon as the PKC isoform involved in smoke-induced TACE activation and hyperproliferation of lung cells. Conclusions: Our data elucidate new signaling paradigms by which tobacco smoke promotes TACE activation and hyperproliferation of lung cells.	[Lemjabbar-Alaoui, Hassan; Mengistab, Aklilu] Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Sidhu, Sukhvinder S.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care, San Francisco, CA USA; [Sidhu, Sukhvinder S.] Univ Calif San Francisco, Dept Med, Div Allergy Immunol, San Francisco, CA USA; [Gallup, Marianne; Basbaum, Carol] Univ Calif San Francisco, Cardiovasc Res Inst, Program Biomed Sci, San Francisco, CA 94143 USA; [Gallup, Marianne; Basbaum, Carol] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lemjabbar-Alaoui, H (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA.	hassan.alaoui@ucsf.edu		Sidhu, Sukhvinder/0000-0002-2999-4358	University of California [17RT-0216]; National Institutes of Health [R01 HD075602]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD075602] Funding Source: NIH RePORTER	University of California(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was performed with support from the Tobacco-Related Disease Research Program of the University of California Grant 17RT-0216 and the National Institutes of Health grant R01 HD075602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Basuroy S, 2010, AM J PHYSIOL-GASTR L, V299, pG186, DOI 10.1152/ajpgi.00368.2009; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Carpenter G, 2000, SCI STKE, V2000, ppe1, DOI DOI 10.1126/SCISIGNAL.152000PE1; CHAKRAVARTHY BR, 1991, ANAL BIOCHEM, V196, P144, DOI 10.1016/0003-2697(91)90130-L; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Ding L, 2002, J BIOL CHEM, V277, P35305, DOI 10.1074/jbc.M201460200; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Duffy MJ, 2009, CLIN CHIM ACTA, V403, P31, DOI 10.1016/j.cca.2009.01.007; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gebremichael A, 1996, TOXICOL APPL PHARM, V141, P76; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Karl PI, 1996, BIOCHEM J, V320, P831, DOI 10.1042/bj3200831; Kirkegaard T, 2004, CLIN EXP IMMUNOL, V135, P146, DOI 10.1111/j.1365-2249.2004.02348.x; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Leserer M, 2000, IUBMB LIFE, V49, P405; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Madani S, 2001, FASEB J, V15, P2595, DOI 10.1096/fj.01-0753int; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Paulissen G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-127; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Proctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; TANG EKY, 1992, BIOCHEM J, V283, P341, DOI 10.1042/bj2830341; Tazzari PL, 2008, CANCER RES, V68, P9394, DOI 10.1158/0008-5472.CAN-08-2815; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wheeler DL, 2003, CANCER RES, V63, P6547; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zhang ZL, 2001, FASEB J, V15, P303	53	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17489	10.1371/journal.pone.0017489	http://dx.doi.org/10.1371/journal.pone.0017489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423656	Green Published, Green Submitted, gold			2022-12-25	WOS:000288513900011
J	Ajoge, HO; Gordon, ML; de Oliveira, T; Green, TN; Ibrahim, S; Shittu, OS; Olonitola, SO; Ahmad, AA; Ndung'u, T				Ajoge, Hannah O.; Gordon, Michelle L.; de Oliveira, Tulio; Green, Taryn N.; Ibrahim, Sani; Shittu, Oladapo S.; Olonitola, Stephen O.; Ahmad, Aliyu A.; Ndung'u, Thumbi			Genetic Characteristics, Coreceptor Usage Potential and Evolution of Nigerian HIV-1 Subtype G and CRF02_AG Isolates	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; GAG PROTEIN; MOLECULAR EPIDEMIOLOGY; SEQUENCE-ANALYSIS; DRUG-RESISTANCE; VIRAL LOAD; OYO-STATE; DIVERSITY; STRAINS	HIV-1 CRF02_AG and subtype G (HIV-1G) account for most HIV infections in Nigeria, but their evolutionary trends have not been well documented. To better elucidate the dynamics of the epidemic in Nigeria we characterised the gag and env genes of North-Central Nigerian HIV-1 isolates from pregnant women. Of 28 samples sequenced in both genes, the predominant clades were CRF02_AG (39%) and HIV-1G (32%). Higher predicted proportion of CXCR4-tropic (X4) HIV-1G isolates was noted compared to CRF02_AG (p = 0.007, Fisher's exact test). Phylogenetic and Bayesian analysis conducted on our sequences and all the dated available Nigerian sequences on the Los Alamos data base showed that CRF02_AG and HIV-1G entered into Nigeria through multiple entries, with presence of HIV-1G dating back to early 1980s. This study underlines the genetic complexity of the HIV-1 epidemic in Nigeria, possible subtype-specific differences in co-receptor usage, and the evolutionary trends of the predominant HIV-1 strains in Nigeria, which may have implications for the design of biomedical interventions and better understanding of the epidemic.	[Ajoge, Hannah O.; Olonitola, Stephen O.; Ahmad, Aliyu A.] Ahmadu Bello Univ, Dept Microbiol, Zaria, Nigeria; [Ajoge, Hannah O.; Gordon, Michelle L.; Green, Taryn N.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Ibrahim, Sani] Ahmadu Bello Univ, Dept Biochem, Zaria, Nigeria; [Shittu, Oladapo S.] Ahmadu Bello Univ, Ahmadu Bello Univ Teaching Hosp, Dept Gyneacol & Obstet, Zaria, Nigeria	Ahmadu Bello University; University of Kwazulu Natal; University of Kwazulu Natal; Ahmadu Bello University; Ahmadu Bello University	Ajoge, HO (corresponding author), Ahmadu Bello Univ, Dept Microbiol, Zaria, Nigeria.	ndungu@ukzn.ac.za		Gordon, Michelle/0000-0001-9945-1394; Ndung'u, Thumbi/0000-0003-2962-3992; Green, Taryn Natalie/0000-0001-9527-5960	Third World Academy of Sciences (TWAS); Hasso Plattner Foundation; South African Research Chair in Systems Biology of HIV/AIDS	Third World Academy of Sciences (TWAS); Hasso Plattner Foundation; South African Research Chair in Systems Biology of HIV/AIDS	HOA was supported by the Third World Organization for Women in Science (TWOWS) postgraduate fellowship from the Third World Academy of Sciences (TWAS). This study was supported by funding from the Hasso Plattner Foundation and the South African Research Chair in Systems Biology of HIV/AIDS to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIMIKU AG, 1994, AIDS RES HUM RETROV, V10, P1581, DOI 10.1089/aid.1994.10.1581; Agwale SM, 2006, AIDS RES HUM RETROV, V22, P22, DOI 10.1089/aid.2006.22.22; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Bibollet-Ruche F, 1998, AIDS RES HUM RETROV, V14, P1281, DOI 10.1089/aid.1998.14.1281; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Campbell GR, 2010, J BIOL CHEM, V285, P1681, DOI 10.1074/jbc.M109.049957; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Descamps D, 1998, AIDS, V12, P1109; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Entonu PE, 2007, BRAZ J INFECT DIS, V11, P579, DOI 10.1590/S1413-86702007000600011; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; *FED MIN HLTH, 2009, TECHN REP 2008 NAT H, P1; *FED MIN HLTH, 2006, TECHN REP 2005 NAT H, P1; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Gatanaga H, 2006, J BIOL CHEM, V281, P1241, DOI 10.1074/jbc.M505920200; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Gordon M, 2003, J VIROL, V77, P2587, DOI 10.1128/JVI.77.4.2587-2599.2003; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413; HOWARD TM, 1994, AIDS RES HUM RETROV, V10, P1755, DOI 10.1089/aid.1994.10.1755; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; Klimas N, 2008, PSYCHOSOM MED, V70, P523, DOI 10.1097/PSY.0b013e31817ae69f; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; KORBER B, SODROSKI J NUMBERING; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; KORBER BTM, 1994, J VIROL, V68, P6730, DOI 10.1128/JVI.68.10.6730-6744.1994; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; LEWIS M, 2008, 15 C RETR OPP INF BO; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; Marcelin AG, 2009, CURR OPIN HIV AIDS, V4, P531, DOI 10.1097/COH.0b013e328331d4b1; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; McCutchan FE, 1999, VIROLOGY, V254, P226, DOI 10.1006/viro.1998.9505; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; MORI J, 2007, 16 INT HIV DRUG RES; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Ojesina AI, 2007, AIDS RES HUM RETROV, V23, P1587, DOI 10.1089/aid.2007.0064; Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sankale JL, 2007, AIDS RES HUM RETROV, V23, P1020, DOI 10.1089/aid.2006.0304; Shaheen F, 2004, CURR OPIN INFECT DIS, V17, P7, DOI 10.1097/00001432-200402000-00003; Sing T, 2007, ANTIVIR THER, V12, P1097; Singh A, 2009, VIROLOGY, V393, P56, DOI 10.1016/j.virol.2009.07.021; Soulie C, 2008, AIDS, V22, P2212, DOI 10.1097/QAD.0b013e328313bf9c; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAMURA K, 2007, MOL BIO EVO, V24; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; Triques K, 1999, VIROLOGY, V259, P99, DOI 10.1006/viro.1999.9720; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; LOS ALAMOS HIV SEQUE	83	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17865	10.1371/journal.pone.0017865	http://dx.doi.org/10.1371/journal.pone.0017865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423811	Green Published, gold			2022-12-25	WOS:000288512400036
J	Oliver, SP; Hussey, NE; Turner, JR; Beckett, AJ				Oliver, Simon P.; Hussey, Nigel E.; Turner, John R.; Beckett, Alison J.			Oceanic Sharks Clean at Coastal Seamount	PLOS ONE			English	Article							LABROIDES-DIMIDIATUS; PROXIMATE CAUSE; FISH DIVERSITY; PARASITE; BEHAVIOR; ECOLOGY	Interactions between pelagic thresher sharks (Alopias pelagicus) and cleaner wrasse were investigated at a seamount in the Philippines. Cleaning associations between sharks and teleosts are poorly understood, but the observable interactions seen at this site may explain why these mainly oceanic sharks regularly venture into shallow coastal waters where they are vulnerable to disturbance from human activity. From 1,230 hours of observations recorded by remote video camera between July 2005 and December 2009, 97 cleaner-thresher shark events were analyzed, 19 of which were interrupted. Observations of pelagic thresher sharks interacting with cleaners at the seamount were recorded at all times of day but their frequency declined gradually from morning until evening. Cleaners showed preferences for foraging on specific areas of a thresher shark's body. For all events combined, cleaners were observed to conduct 2,757 inspections, of which 33.9% took place on the shark's pelvis, 23.3% on the pectoral fins, 22.3% on the caudal fin, 8.6% on the body, 8.3% on the head, 2.1% on the dorsal fin, and 1.5% on the gills respectively. Cleaners did not preferentially inspect thresher sharks by time of day or by shark sex, but there was a direct correlation between the amount of time a thresher shark spent at a cleaning station and the number of inspections it received. Thresher shark clients modified their behavior by "circular-stance-swimming,'' presumably to facilitate cleaner inspections. The cleaner-thresher shark association reflected some of the known behavioral trends in the cleaner-reef teleost system since cleaners appeared to forage selectively on shark clients. Evidence is mounting that in addition to acting as social refuges and foraging grounds for large visiting marine predators, seamounts may also support pelagic ecology by functioning as cleaning stations for oceanic sharks and rays.	[Oliver, Simon P.; Turner, John R.] Univ Wales, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Oliver, Simon P.; Beckett, Alison J.] Thresher Shark Res & Conservat Project, Malapascua Isl, Cebu, Philippines; [Hussey, Nigel E.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Beckett, Alison J.] Univ Liverpool, Sch Biomed Sci, Nuffield BD, Liverpool L69 3BX, Merseyside, England	University of Windsor; University of Liverpool	Oliver, SP (corresponding author), Univ Wales, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	s.p.oliver@threshersharkproject.org	Oliver, Simon/AAK-1712-2020; Hussey, Nigel E/F-9699-2015	Oliver, Simon/0000-0002-2975-1233	Natural Environment Research Council (NERC)	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was supported in part by the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Becker JHA, 2005, ANIM BEHAV, V70, P991, DOI 10.1016/j.anbehav.2005.01.004; BENZ GW, 1990, CAN J ZOOL, V68, P1180, DOI 10.1139/z90-175; BOEHLERT GW, 1987, ISLANDS, V43, P319; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Bshary R, 2002, MAR ECOL PROG SER, V235, P217, DOI 10.3354/meps235217; Bshary Redouan, 2008, P563; Caira JN, 2004, CRC MAR BIOL SER, P523; Carlson JK, 2004, CRC MAR BIOL SER, P203; Cheney KL, 2003, BEHAV ECOL, V14, P892, DOI 10.1093/beheco/arg079; CLARK E, 1975, NATL GEOGR, V147, P570; Compagno LJV., 1984, FAO FISH SYNOP, P20; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Cote IM, 1998, J FISH BIOL, V53, P256, DOI 10.1111/j.1095-8649.1998.tb01031.x; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; FOSTER SA, 1985, COPEIA, P875, DOI 10.2307/1445236; GRUBER SH, 1977, AM ZOOL, V17, P471; Grutter AS, 2008, J FISH BIOL, V73, P2094, DOI 10.1111/j.1095-8649.2008.02073.x; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 1997, J FISH BIOL, V50, P1303; Grutter AS, 2004, CURR BIOL, V14, P1080, DOI 10.1016/j.cub.2004.05.048; Grutter AS, 2003, CURR BIOL, V13, P64, DOI 10.1016/S0960-9822(02)01393-3; Grutter AS, 2002, J FISH BIOL, V61, P1098, DOI 10.1006/jfbi.2002.2121; Grutter AS, 2001, P ROY SOC B-BIOL SCI, V268, P1361, DOI 10.1098/rspb.2001.1658; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Henderson AC, 2002, J NAT HIST, V36, P1995, DOI 10.1080/00222930110078834; Heupel MR, 1999, INT J PARASITOL, V29, P321, DOI 10.1016/S0020-7519(98)00218-5; KEYES RS, 1982, COPEIA, P225, DOI 10.2307/1444305; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Liu KM, 1999, COPEIA, P68; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; PAPERNA I, 1977, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V24, P195; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; POTTS GW, 1973, ANIM BEHAV, V21, P250, DOI 10.1016/S0003-3472(73)80068-5; REED P, 2009, IFAS FA, V28, P1; Sazima I, 2000, COPEIA, P297; Sikkel PC, 2004, ANIM BEHAV, V68, P241, DOI 10.1016/j.anbehav.2003.10.023; Slater PJB, 1978, QUANTITATIVE ETHOLOG, P15; Stephens D.W., 1986, pi; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; WAHNBAECK C, 2007, MORE OCEANIC SHARKS; WEIHS D, 1981, COPEIA, P219, DOI 10.2307/1444062; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Yano K, 2000, ENVIRON BIOL FISH, V59, P329, DOI 10.1023/A:1007649227422	45	30	32	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14755	10.1371/journal.pone.0014755	http://dx.doi.org/10.1371/journal.pone.0014755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423796	Green Submitted, Green Published, gold			2022-12-25	WOS:000288512400003
J	Moon, S; Kim, YG; Dong, LS; Lombardi, M; Haeggstrom, E; Jensen, RV; Hsiao, LL; Demirci, U				Moon, Sangjun; Kim, Yun-Gon; Dong, Lingsheng; Lombardi, Michael; Haeggstrom, Edward; Jensen, Roderick V.; Hsiao, Li-Li; Demirci, Utkan			Drop-on-Demand Single Cell Isolation and Total RNA Analysis	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION ANALYSIS; AMPLIFICATION; GENOME; PROVIDE; ARRAYS; SORTER	Technologies that rapidly isolate viable single cells from heterogeneous solutions have significantly contributed to the field of medical genomics. Challenges remain both to enable efficient extraction, isolation and patterning of single cells from heterogeneous solutions as well as to keep them alive during the process due to a limited degree of control over single cell manipulation. Here, we present a microdroplet based method to isolate and pattern single cells from heterogeneous cell suspensions (10% target cell mixture), preserve viability of the extracted cells (97.0 +/- 0.8%), and obtain genomic information from isolated cells compared to the non-patterned controls. The cell encapsulation process is both experimentally and theoretically analyzed. Using the isolated cells, we identified 11 stem cell markers among 1000 genes and compare to the controls. This automated platform enabling high-throughput cell manipulation for subsequent genomic analysis employs fewer handling steps compared to existing methods.	[Moon, Sangjun; Kim, Yun-Gon; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bio Acoust MEMS Med BAMM Lab,Ctr Bioengn, Boston, MA 02115 USA; [Dong, Lingsheng; Lombardi, Michael; Hsiao, Li-Li; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Haeggstrom, Edward] Univ Helsinki, Dept Phys, Elect Res Lab, Helsinki, Finland; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Demirci, Utkan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Helsinki; Virginia Polytechnic Institute & State University; Harvard University; Massachusetts Institute of Technology (MIT)	Moon, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bio Acoust MEMS Med BAMM Lab,Ctr Bioengn, Boston, MA 02115 USA.	lhsiao@partners.org; udemirci@rics.bwh.harvard.edu			NIH [R21 EB007707]; W.H. Coulter Foundation; U.S. Army Medical Research Acquisition Activity Cooperative Agreement; U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD;  [RO1 A1081534];  [R21 AI087107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.H. Coulter Foundation; U.S. Army Medical Research Acquisition Activity Cooperative Agreement; U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge NIH R21 EB007707, and the W.H. Coulter Foundation Young Investigation Award. This was also partially supported by RO1 A1081534, R21 AI087107, and Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity Cooperative Agreement, as well as made possible by a research grant that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Fabbri R, 2001, HUM REPROD, V16, P411, DOI 10.1093/humrep/16.3.411; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Grinstead C. M., 1997, INTRO PROBABILITY; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Ino K, 2008, LAB CHIP, V8, P134, DOI 10.1039/b712330b; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lin LI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006710; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Ross Sheldon, 2008, 1 COURSE PROBABILITY; SA M, 2007, APPL STAT USING SPSS; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Song YS, 2010, P NATL ACAD SCI USA, V107, P4596, DOI 10.1073/pnas.0914059107; Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108; Svahn HA, 2007, LAB CHIP, V7, P544, DOI 10.1039/b704632b; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toriello NM, 2008, P NATL ACAD SCI USA, V105, P20173, DOI 10.1073/pnas.0806355106; Walker A, 2008, NAT REV MICROBIOL, V6, P176, DOI 10.1038/nrmicro1862; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Zeng Y, 2010, ANAL CHEM, V82, P3183, DOI 10.1021/ac902683t; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030	40	42	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17455	10.1371/journal.pone.0017455	http://dx.doi.org/10.1371/journal.pone.0017455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412416	Green Published, gold, Green Submitted			2022-12-25	WOS:000288247800007
J	Kinney, VC; Heemeyer, JL; Pessier, AP; Lannoo, MJ				Kinney, Vanessa C.; Heemeyer, Jennifer L.; Pessier, Allan P.; Lannoo, Michael J.			Seasonal Pattern of Batrachochytrium dendrobatidis Infection and Mortality in Lithobates areolatus: Affirmation of Vredenburg's "10,000 Zoospore Rule"	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; YELLOW-LEGGED FROG; ANTIMICROBIAL PEPTIDE DEFENSES; POPULATION DECLINES; NORTHERN QUEENSLAND; CUTANEOUS BACTERIA; EMERGING PATHOGEN; AMERICAN BULLFROG; RANA-CATESBEIANA; WILD FROGS	To fully comprehend chytridiomycosis, the amphibian disease caused by the chytrid fungus Batrachochytrium dendrobatidis (Bd), it is essential to understand how Bd affects amphibians throughout their remarkable range of life histories. Crawfish Frogs (Lithobates areolatus) are a typical North American pond-breeding species that forms explosive spring breeding aggregations in seasonal and semipermanent wetlands. But unlike most species, when not breeding Crawfish Frogs usually live singly-in nearly total isolation from conspecifics-and obligately in burrows dug by crayfish. Crayfish burrows penetrate the water table, and therefore offer Crawfish Frogs a second, permanent aquatic habitat when not breeding. Over the course of two years we sampled for the presence of Bd in Crawfish Frog adults. Sampling was conducted seasonally, as animals moved from post-winter emergence through breeding migrations, then back into upland burrow habitats. During our study, 53% of Crawfish Frog breeding adults tested positive for Bd in at least one sample; 27% entered breeding wetlands Bd positive; 46% exited wetlands Bd positive. Five emigrating Crawfish Frogs (12%) developed chytridiomycosis and died. In contrast, all 25 adult frogs sampled while occupying upland crayfish burrows during the summer tested Bd negative. One percent of postmetamorphic juveniles sampled were Bd positive. Zoospore equivalents/swab ranged from 0.8 to 24,436; five out of eight frogs with zoospore equivalents near or > 10,000 are known to have died. In summary, Bd infection rates in Crawfish Frog populations ratchet up from near zero during the summer to over 25% following overwintering; rates then nearly double again during and just after breeding-when mortality occurs-before the infection wanes during the summer. Bd-negative postmetamorphic juveniles may not be exposed again to this pathogen until they take up residence in crayfish burrows, or until their first breeding, some years later.	[Kinney, Vanessa C.; Heemeyer, Jennifer L.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Pessier, Allan P.] San Diego Zoo Inst Conservat Res, Wildlife Dis Labs, San Diego, CA USA; [Lannoo, Michael J.] Indiana Univ Sch Med, Terre Haute Ctr Med Educ, Terre Haute, IN USA	Indiana State University; Zoological Society of San Diego; Indiana University System	Kinney, VC (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	mlannoo@iupui.edu			Indiana Department of Natural Resources [E2-08-WDS13]; Indiana University School of Medicine; United States Department of Defense [09-426]	Indiana Department of Natural Resources; Indiana University School of Medicine; United States Department of Defense(United States Department of Defense)	Support for this project came from a State Wildlife Grant (E2-08-WDS13) awarded through the Indiana Department of Natural Resources (http://www.in.gov/dnr), start-up funds provided by Indiana University School of Medicine (http://www.medicine.iu.edu), and a United States Department of Defense Legacy grant (# 09-426; https://www.dodlegacy.org/legacy/index.aspx). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael J., 2008, Herpetological Review, V39, P324; Adams Michael J., 2007, Herpetological Review, V38, P430; Anchukaitis KJ, 2010, P NATL ACAD SCI USA, V107, P5036, DOI 10.1073/pnas.0908572107; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; BRIGGS CJ, 2010, PNAS0912886107; Chatfield Matthew W. H., 2009, Herpetological Review, V40, P176; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Deguise Isabelle, 2009, Northwestern Naturalist, V90, P35; Di Rosa I, 2007, NATURE, V447, pE4, DOI 10.1038/nature05941; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Frias-Alvarez P, 2008, ECOHEALTH, V5, P18, DOI 10.1007/s10393-008-0155-3; Gaertner James P., 2010, Herpetological Review, V41, P456; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Gaertner James P., 2009, Herpetological Review, V40, P184; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Goldberg Caren S., 2009, Herpetological Review, V40, P309; Grant EHC, 2008, APPL HERPETOL, V5, P233; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Heemeyer Jennifer L., 2010, Herpetological Review, V41, P168; Heemeyer Jennifer L., 2010, Herpetological Review, V41, P42; HEEMEYER JL, 2011, WINTERKILL IN PRESS, V42; Hillis DM, 2005, MOL PHYLOGENET EVOL, V34, P299, DOI 10.1016/j.ympev.2004.10.007; Hoffman AS, 2010, BIOSCIENCE, V60, P829, DOI 10.1525/bio.2010.60.10.9; Hossack BR, 2010, J HERPETOL, V44, P253, DOI 10.1670/09-058.1; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kiernan J.A, 1990, HISTOLOGICAL HISTOCH; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Lampo M, 2006, HERPETOL J, V16, P395; Lampo Margarita, 2008, Herpetological Review, V39, P449; Lannoo Michael J., 2009, Diversity, V1, P118; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, J HERPETOL, V37, P215, DOI 10.1670/0022-1511(2003)037[0215:CIWFFS]2.0.CO;2; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; MINTON SA, 2001, INDIAN ACAD SCI MONO, V3; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2004, COPEIA, P344, DOI 10.1643/CE-03-116R1; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Pessier A. P., 2010, MANUAL CONTROL INFEC; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Peterson JD, 2007, J WILDLIFE DIS, V43, P450, DOI 10.7589/0090-3558-43.3.450; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Redmer Michael, 2000, Journal of the Iowa Academy of Science, V107, P128; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richards Corinne L., 2008, Herpetological Review, V39, P200; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rosenblum EB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000550; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rowley JJL, 2007, ECOHEALTH, V4, P31, DOI 10.1007/s10393-006-0075-z; Rowley JJL, 2006, ECOHEALTH, V3, P49, DOI 10.1007/s10393-005-0005-5; Sadinski Walt, 2010, Herpetological Review, V41, P170; Scalera Riccardo, 2008, Herpetological Review, V39, P199; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SMITH HM, 1950, MISCELLANEOUS PUBLIC, V2; Smith KG, 2007, DIS AQUAT ORGAN, V74, P159, DOI 10.3354/dao074159; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; THOMPSON C, 1915, OCCASIONAL PAPERS MU, V9; VOORDOUW MJ, 2010, BMC ECOL, DOI DOI 10.1186/1472-6785-10-6; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; VREDENBURG VT, 2010, PNAS0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Waldman B., 2001, Surveillance (Wellington), V28, P9; Walker SF, 2007, DIS AQUAT ORGAN, V77, P105, DOI 10.3354/dao01850; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; WOODHAMS DC, 2007, HERP REV, V39, P66; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004	116	97	104	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16708	10.1371/journal.pone.0016708	http://dx.doi.org/10.1371/journal.pone.0016708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423745	Green Published, gold, Green Submitted			2022-12-25	WOS:000288219100001
J	Zhu, X; Wang, F; Lin, MCM; Tian, LW; Fan, WG; Ng, SS; Liu, MJ; Huang, JQ; Xu, ZH; Li, DP; Kung, HF				Zhu, Xiao; Wang, Fang; Lin, Marie C. M.; Tian, Linwei; Fan, Wenguo; Ng, Samuel S.; Liu, Minjuan; Huang, Jianqing; Xu, Zhenhua; Li, Dongpei; Kung, Hsiangfu			The 3 ' UTR Variants in the GRP78 Are Not Associated with Overall Survival in Resectable Hepatocellular Carcinoma	PLOS ONE			English	Article							PROGNOSIS; RISK; GENE; SUSCEPTIBILITY; POLYMORPHISM	Background: Elevated glucose-regulated protein 78 (GRP78) levels in tissues have been known to be related with poor prognosis in hepatocellular carcinoma (HCC) patients. Though the variants in the 39 untranslated region (UTR) of GRP78 gene were not associated with HCC risk, we wonder whether these polymorphisms affect survival of HCC patients. Methodology/Principal Findings: Blood samples of HCC patients were maintained in our specimen bank between 1996 to 2003. DNA from 576 unrelated and resectable patients with HCC was typed for rs16927997 (T>C), rs1140763 (T>C) and rs12009 (T. C) by TaqMan assays. The Kaplan-Meier method and log-rank test were used to estimate overall survival. Linkage disequilibrium (LD) analysis identified a total of 3 haplotypes and 6 diplotypes in this region. The distribution of haplotype was not related to the clinical characteristics. Univariate analysis showed that the allele, genotype, haplotype and diplotype did not effect the survival. None of the clinical features show a significant association (P-correced > 0.05) with overall patient outcome in multiple comparisons. Conclusions/Significance: There is no noteworthy influence of 39 UTR variants in the GRP78 on prognosis of resectable HCC in the Chinese population.	[Zhu, Xiao; Wang, Fang; Kung, Hsiangfu] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xiao; Liu, Minjuan; Huang, Jianqing] Affiliated Tumor Hosp, Guangzhou Med Coll, Guangzhou, Guangdong, Peoples R China; [Lin, Marie C. M.; Xu, Zhenhua] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Dept Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Fan, Wenguo; Li, Dongpei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Ng, Samuel S.] Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Xiao; Kung, Hsiangfu] Chinese Univ Hong Kong, Li Ka Shing Inst Med Sci, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Sun Yat Sen University; University of Hong Kong; Chinese University of Hong Kong	Zhu, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	bioxzhu@yahoo.com; lidp@mail.sysu.edu.cn	Tian, Linwei/A-9736-2009; wang, fang/GYD-4295-2022; Xu, Zhenhua/J-9200-2015	Tian, Linwei/0000-0002-4739-1534; Xu, Zhenhua/0000-0001-9481-5611; Tian, Linwei/0000-0003-2240-8886; Li, Dongpei/0000-0002-4734-6776	National Nature Science Foundation of China [81071697]; Research Project of Health Bureau of Guangzhou City [201102A213005]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Health Bureau of Guangzhou City	This work was supported by the National Nature Science Foundation of China ( Grant No. 81071697) and the Research Project of Health Bureau of Guangzhou City (Grant No. 201102A213005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellavance EC, 2008, J GASTROINTEST SURG, V12, P1699, DOI 10.1007/s11605-008-0652-2; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Kew MC, 2002, TOXICOLOGY, V181, P35, DOI 10.1016/S0300-483X(02)00251-2; Kim KA, 2003, CLIN IMAG, V27, P340, DOI 10.1016/S0899-7071(02)00574-0; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nogueira JA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-204; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; Vormfelde SV, 2007, NAT REV GENET, V8, DOI 10.1038/nrg1916-c2; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Woodcock J, 2009, NEW ENGL J MED, V360, P811, DOI 10.1056/NEJMe0810630; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yano M, 2007, EUR J CANCER, V43, P1092, DOI 10.1016/j.ejca.2007.01.032; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; ZHU X, HEPATOGASTR IN PRESS; Zhu X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-83; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	24	151	158	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17783	10.1371/journal.pone.0017783	http://dx.doi.org/10.1371/journal.pone.0017783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445355	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100008
J	Zhou, XH; Wong, LL; Karakoti, AS; Seal, S; McGinnis, JF				Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.			Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; NADPH OXIDASE; SUBRETINAL NEOVASCULARIZATION; PHOTORECEPTOR DEGENERATION; PIGMENT EPITHELIUM; MODEL; MICE; PROTECTION; INJURY	Many neurodegenerative diseases are known to occur and progress because of oxidative stress, the presence of reactive oxygen species (ROS) in excess of the cellular defensive capabilities. Age related macular degeneration (AMD), diabetic retinopathy (DR) and inherited retinal degeneration share oxidative stress as a common node upstream of the blinding effects of these diseases. Knockout of the Vldlr gene results in a mouse that develops intraretinal and subretinal neovascular lesions within the first month of age and is an excellent model for a form of AMD called retinal angiomatous proliferation (RAP). Cerium oxide nanoparticles (nanoceria) catalytically scavenge ROS by mimicking the activities of superoxide dismutase and catalase. A single intravitreal injection of nanoceria into the Vldlr-/- eye was shown to inhibit: the rise in ROS in the Vldlr-/- retina, increases in vascular endothelial growth factor (VEGF) in the photoreceptor layer, and the formation of intraretinal and subretinal neovascular lesions. Of more therapeutic interest, injection of nanoceria into older mice (postnatal day 28) resulted in the regression of existing vascular lesions indicating that the pathologic neovessels require the continual production of excessive ROS. Our data demonstrate the unique ability of nanoceria to prevent downstream effects of oxidative stress in vivo and support their therapeutic potential for treatment of neurodegenerative diseases such as AMD and DR.	[Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.] Univ Oklahoma, Coll Med, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA; [Karakoti, Ajay S.; Seal, Sudipta] Univ Cent Florida, Adv Mat Proc Anal Ctr, Mech Mat Aerosp Engn Nanosci & Technol Ctr, Orlando, FL 32816 USA; [McGinnis, James F.] Oklahoma Ctr Neurosci, Dept Ophthalmol & Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Central Florida	Zhou, XH (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA 02115 USA.	lily-wong@ouhsc.edu; james-mcginnis@ouhsc.edu	Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AGI-8160-2022; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Wong, Li Lian/AAG-5568-2020; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; Wong, Lily/0000-0003-0569-3398; Na-Nakorn, Uthairat/0000-0002-0804-3561; KARAKOTI, AJAY/0000-0001-9081-2325	NIH [P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724]; FFB [C-NP-0707-0404-UOK08]; NSF [CBET-0708172]; OCAST [HR06-075]; Presbyterian Health Foundation; Research to Prevent Blindness; RPB; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018306, P30EY012190, R01EY018724] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FFB; NSF(National Science Foundation (NSF)); OCAST; Presbyterian Health Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from: NIH: P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724; FFB (http://www.blindness.org/): C-NP-0707-0404-UOK08; NSF: CBET-0708172; OCAST(http://www.ok.gov/ocast/Programs/Oklahoma_Health_Research_(OHR)/index.html): HR06-075, and unrestricted funds from Presbyterian Health Foundation (http://www.phfokc.com/research.htm) and Research to Prevent Blindness (http://www.rpbusa.org/rpb/) (RPB). JFM is a recipient of an RPB Senior Scientific Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L P, 1997, Curr Opin Ophthalmol, V8, P19; Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Butler D, 2006, ANTIOXID REDOX SIGN, V8, P185, DOI 10.1089/ars.2006.8.185; Cao W, 2000, J NEUROSCI RES, V60, P195, DOI 10.1002/(SICI)1097-4547(20000415)60:2<195::AID-JNR8>3.0.CO;2-7; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; FRIED R, 1975, J NEUROCHEM, V24, P433, DOI 10.1111/j.1471-4159.1975.tb07658.x; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hogg R, 2004, CURR EYE RES, V29, P387, DOI 10.1080/02713680490517890; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Kaluzny J J, 1996, Klin Oczna, V98, P145; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Korystov YN, 2007, RADIAT RES, V168, P226, DOI 10.1667/RR0925.1; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; OLIVEIRA CR, 1994, ANN NY ACAD SCI, V738, P130; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Poon HF, 2004, J GERONTOL A-BIOL, V59, P478; Sacca SC, 2009, MUTAT RES-FUND MOL M, V667, P98, DOI 10.1016/j.mrfmmm.2008.11.002; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; STERNBERG P, 1993, INVEST OPHTH VIS SCI, V34, P3661; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; van Reyk DM, 2003, REDOX REP, V8, P187, DOI 10.1179/135100003225002673; Wu MY, 2008, INVEST OPHTH VIS SCI, V49, P2679, DOI 10.1167/iovs.07-1440; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373	50	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16733	10.1371/journal.pone.0016733	http://dx.doi.org/10.1371/journal.pone.0016733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21423623	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600014
J	Shieh, JC; Schaar, BT; Srinivasan, K; Brodsky, FM; McConnell, SK				Shieh, Jennifer C.; Schaar, Bruce T.; Srinivasan, Karpagam; Brodsky, Frances M.; McConnell, Susan K.			Endocytosis Regulates Cell Soma Translocation and the Distribution of Adhesion Proteins in Migrating Neurons	PLOS ONE			English	Article							ALPHA-3-BETA-1 INTEGRIN; MEDIATED ENDOCYTOSIS; RADIAL MIGRATION; FOCAL ADHESIONS; MYOSIN-II; DYNAMIN; MEMBRANE; GROWTH; BETA-1-INTEGRINS; CONTRACTION	Newborn neurons migrate from their birthplace to their final location to form a properly functioning nervous system. During these movements, young neurons must attach and subsequently detach from their substrate to facilitate migration, but little is known about the mechanisms cells use to release their attachments. We show that the machinery for clathrin-mediated endocytosis is positioned to regulate the distribution of adhesion proteins in a subcellular region just proximal to the neuronal cell body. Inhibiting clathrin or dynamin function impedes the movement of migrating neurons both in vitro and in vivo. Inhibiting dynamin function in vitro shifts the distribution of adhesion proteins to the rear of the cell. These results suggest that endocytosis may play a critical role in regulating substrate detachment to enable cell body translocation in migrating neurons.	[Shieh, Jennifer C.; Srinivasan, Karpagam; McConnell, Susan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Shieh, Jennifer C.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Schaar, Bruce T.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shieh, JC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	suemcc@stanford.edu		Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health (NIH) [MH51864, GM038093]; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864, R37MH051864] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by National Institutes of Health (NIH) MH51864 (SKM) and NIH GM038093 (FMB). JCS was supported by a National Defense Science and Engineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Bretscher MS, 2008, J CELL SCI, V121, P2625, DOI 10.1242/jcs.031120; BRETSCHER MS, 1976, NATURE, V260, P21, DOI 10.1038/260021a0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; BRODSKY FM, 1983, J MOL BIOL, V167, P197, DOI 10.1016/S0022-2836(83)80041-2; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DAVIES PJA, 1984, DIABETES CARE, V7, P35; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hawthorne AL, 2010, J NEUROSCI, V30, P420, DOI 10.1523/JNEUROSCI.2333-09.2010; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; NANDI PK, 1981, BIOCHEMISTRY-US, V20, P6706, DOI 10.1021/bi00526a028; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palecek SP, 1996, J CELL SCI, V109, P941; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Pierini LM, 2000, BLOOD, V95, P2471; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Rid R, 2005, CELL MOTIL CYTOSKEL, V61, P161, DOI 10.1002/cm.20076; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shastry BS, 2007, J HUM GENET, V52, P104, DOI 10.1007/s10038-006-0088-z; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Strachan LR, 2004, J CELL BIOL, V167, P545, DOI 10.1083/jcb.200405024; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Ward Michael E., 2004, V294, P137; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Yuasa S, 1996, INT J DEV NEUROSCI, V14, P429, DOI 10.1016/S0736-5748(96)00021-4; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	105	58	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17802	10.1371/journal.pone.0017802	http://dx.doi.org/10.1371/journal.pone.0017802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21573063	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100009
J	Wei, J; Wu, A; Kong, LY; Wang, YT; Fuller, G; Fokt, I; Melillo, G; Priebe, W; Heimberger, AB				Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Fuller, Gregory; Fokt, Isabella; Melillo, Giovanni; Priebe, Waldemar; Heimberger, Amy B.			Hypoxia Potentiates Glioma-Mediated Immunosuppression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; IMMUNE DYSFUNCTION; SIGNAL TRANSDUCERS; INDUCIBLE FACTORS; TUMOR; MACROPHAGE; CANCER; EXPRESSION; HIF-1-ALPHA	Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GBM associated cancer stem cells (gCSCs) as a treatment resistant population that has been shown to inhibit both innate and adaptive immune responses, we compared immunosuppressive properties under both normoxic and hypoxic conditions. Functional immunosuppression was characterized based on production of immunosuppressive cytokines and chemokines, the inhibition of T cell proliferation and effector responses, induction of FoxP3+ regulatory T cells, effect on macrophage phagocytosis, and skewing to the immunosuppressive M2 phenotype. We found that hypoxia potentiated the gCSC-mediated inhibition of T cell proliferation and activation and especially the induction of FoxP3+T cells, and further inhibited macrophage phagocytosis compared to normoxia condition. These immunosuppressive hypoxic effects were mediated by signal transducer and activator of transcription 3 (STAT3) and its transcriptionally regulated products such as hypoxia inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF). Inhibitors of STAT3 and HIF-1 alpha down modulated the gCSCs' hypoxia-induced immunosuppressive effects. Thus, hypoxia further enhances GBM-mediated immunosuppression, which can be reversed with therapeutic inhibition of STAT3 and HIF-1 alpha and also helps to reconcile the disparate findings that immune therapeutic approaches can be used successfully in model systems but have yet to achieve generalized successful responses in the vast majority of GBM patients by demonstrating the importance of the tumor hypoxic environment.	[Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Heimberger, Amy B.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Fuller, Gregory] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fokt, Isabella; Priebe, Waldemar] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Melillo, Giovanni] NCI, Frederick, MD 21701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wei, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	aheimber@mdanderson.org		Fuller, Gregory/0000-0001-9447-2647	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health [CA120813-03, A177225-01, P50 CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459, R01CA120813] Funding Source: NIH RePORTER	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Anthony Bullock III Foundation (ABH), the Mitchell Foundation (ABH), the Dr. Marnie Rose Foundation (ABH), and the U.S. National Institutes of Health grants CA120813-03, A177225-01, P50 CA093459 (ABH), and P50 CA093459 (WP). The funding organizations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Biollaz G, 2009, EUR J IMMUNOL, V39, P1323, DOI 10.1002/eji.200838921; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Brault MS, 2005, J BIOMED BIOTECHNOL, P37, DOI 10.1155/JBB.2005.37; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; CRANE CA, NEURO ONCOL, V12, P7; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Faderl S, 2001, ANTICANCER RES, V21, P3777; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Johnson B, 2009, CURR MOL MED, V9, P702, DOI 10.2174/156652409788970634; Johnson BF, 2007, EXPERT OPIN BIOL TH, V7, P449, DOI 10.1517/14712598.7.4.449; Jordan JT, 2008, CANCER IMMUNOL IMMUN, V57, P123, DOI 10.1007/s00262-007-0336-x; Jung JI, 2005, FASEB J, V19, pA81; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Kuklinski S, 2000, J NEUROSCI RES, V60, P45, DOI 10.1002/(SICI)1097-4547(20000401)60:1<45::AID-JNR5>3.0.CO;2-Y; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lucas T, 2008, FRONT BIOSCI, V13, P5580; MAEDA H, 1995, J IMMUNOL, V155, P4926; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Negus RPM, 1997, AM J PATHOL, V150, P1723; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Owegi Henry O, 2010, Biomed Sci Instrum, V46, P57; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sarwat AM, 2009, J NEURO-ONCOL, V92, P111, DOI 10.1007/s11060-008-9729-8; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Tabatabai G, 2006, BRAIN, V129, P2426, DOI 10.1093/brain/awl173; WEI J, CLIN CANC RES, V16, P461; WEI J, MOL CANC THER, V9, P67; WU A, NEURO ONCOL; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102	58	149	156	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16195	10.1371/journal.pone.0016195	http://dx.doi.org/10.1371/journal.pone.0016195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283755	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200035
J	Wong, LL; Peatman, E; Lu, JG; Kucuktas, H; He, SP; Zhou, CJ; Na-nakorn, U; Liu, ZJ				Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; He, Shunping; Zhou, Chuanjiang; Na-nakorn, Uthairat; Liu, Zhanjiang			DNA Barcoding of Catfish: Species Authentication and Phylogenetic Assessment	PLOS ONE			English	Article							SILURIFORMES; SEQUENCE; TUNA	As the global market for fisheries and aquaculture products expands, mislabeling of these products has become a growing concern in the food safety arena. Molecular species identification techniques hold the potential for rapid, accurate assessment of proper labeling. Here we developed and evaluated DNA barcodes for use in differentiating United States domestic and imported catfish species. First, we sequenced 651 base-pair barcodes from the cytochrome oxidase I (COI) gene from individuals of 9 species (and an Ictalurid hybrid) of domestic and imported catfish in accordance with standard DNA barcoding protocols. These included domestic Ictalurid catfish, and representative imported species from the families of Clariidae and Pangasiidae. Alignment of individual sequences from within a given species revealed highly consistent barcodes (98% similarity on average). These alignments allowed the development and analyses of consensus barcode sequences for each species and comparison with limited sequences in public databases (GenBank and Barcode of Life Data Systems). Validation tests carried out in blinded studies and with commercially purchased catfish samples (both frozen and fresh) revealed the reliability of DNA barcoding for differentiating between these catfish species. The developed protocols and consensus barcodes are valuable resources as increasing market and governmental scrutiny is placed on catfish and other fisheries and aquaculture products labeling in the United States.	[Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA; [He, Shunping; Zhou, Chuanjiang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Zhou, Chuanjiang] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Na-nakorn, Uthairat] Kasetsart Univ, Fac Fisheries, Dept Aquaculture, Bangkok, Thailand	Auburn University System; Auburn University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Southwest University - China; Kasetsart University	Wong, LL (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AGI-8160-2022; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Wong, Li Lian/AAG-5568-2020; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; Wong, Lily/0000-0003-0569-3398; Na-Nakorn, Uthairat/0000-0002-0804-3561; KARAKOTI, AJAY/0000-0001-9081-2325	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP) [2009-35205-05101]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018306, P30EY012190, R01EY018724] Funding Source: NIH RePORTER	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP)(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This project was supported in part by a grant from USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP award # 2009-35205-05101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BOONBRAHM M, 1977, EXPT HYBRIDIZATION F; Botti S, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-60; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; DAWNAY NR, 2007, VALIDATION IN PRESS; DONSAKUL T, 1989, P 27 KAS U C JAN 30, P421; Dugan KA, 2002, J FORENSIC SCI, V47, P811; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferraris Carl J. Jr., 1999, Proceedings of the California Academy of Sciences, V51, P1; *FISH BOL, 2010, FISH BARC LIF IN CAM; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GARCIAFRANCO M, 1993, THESIS TOKYO U FISHE; HANSON T, CATFISH DATABASE USD; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jondeung A, 2007, GENE, V387, P49, DOI 10.1016/j.gene.2006.08.001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LEGRANDE WH, 1981, COPEIA, P33; Liu Z, 1998, MOL GEN GENET, V258, P260, DOI 10.1007/s004380050730; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Na-Nakorn U, 2002, J FISH BIOL, V60, P1051, DOI [10.1111/j.1095-8649.2002.tb02428.x, 10.1006/jfbi.2002.1906]; NEI M, 2000, MOL EVOLUTION PHYLOG; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SMITH EG, 2002, CAMBODIAN J AGR; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Teugels GG, 1999, CYBIUM, V23, P285; *USDA, 2002, CATF PROD; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	35	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17812	10.1371/journal.pone.0017812	http://dx.doi.org/10.1371/journal.pone.0017812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423623	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900034
J	Yu, DX; Yu, ZJ; Sun, Q; Sun, LA; Li, HX; Song, J; Mi, M; Wu, HY; Lu, L; Liu, C; Zhang, G; Hu, FB; Lin, X				Yu, Danxia; Yu, Zhijie; Sun, Qi; Sun, Liang; Li, Huaixing; Song, Jun; Mi, Ming; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Hu, Frank B.; Lin, Xu			Effects of Body Fat on the Associations of High-Molecular-Weight Adiponectin, Leptin and Soluble Leptin Receptor with Metabolic Syndrome in Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK-FACTORS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; OBESITY; WOMEN; SENSITIVITY; HEALTH; ADIPOCYTOKINES	Background: Little is known regarding the associations between high-molecular-weight (HMW-) adiponectin, leptin and soluble leptin receptor (sOB-R) and metabolic syndrome (MetS) in Chinese. Also few studies elucidate the effects of inflammation and body fat mass on the relations. Methods: Plasma HMW-adiponectin, leptin and sOB-R were measured among 1055 Chinese men and women (35 similar to 54 yrs). Whole body and trunk fat mass were determined by Dual-energy X-ray absorptiometry. MetS was defined by the updated NCEP/ATPIII criterion for Asian-Americans. Results: HMW-adiponectin was inversely associated with MetS in multivariate model including fat mass index (FMI), inflammatory markers, leptin and sOB-R (OR in the highest quartile =0.30, 95%CI 0.18 similar to 0.50, P<.0001). Plasma sOB-R was also inversely associated with MetS independent of body fatness and inflammatory markers, whereas the association was somewhat attenuated after adjusting HMW-adiponectin (OR for the highest quartile =0.78, 95%CI 0.47 similar to 1.32, P = 0.15). In contrast, leptin was associated with increased odds of MetS independent of inflammatory markers, HMW-adiponectin, and sOB-R (OR for the highest quartile =2.64, 95%CI 1.35 similar to 5.18, P = 0.006), although further adjustment for FMI abolished this association. Conclusions: HMW-adiponectin exhibited strong inverse associations with MetS independent of body composition, inflammation, leptin and sOB-R; while the associations of leptin and sOB-R were largely explained by fat mass or HMW-adiponectin, respectively.	[Yu, Danxia; Yu, Zhijie; Sun, Liang; Li, Huaixing; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Song, Jun; Mi, Ming] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health; Shanghai Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health	Yu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	xlin@sibs.ac.cn		Sun, Xinli/0000-0002-6592-6168; Yu, Danxia/0000-0002-1710-9382; Wang, Guo-Liang/0000-0001-8877-3064	Chinese Academy of Sciences [KSCX2-YW-R-116, KSCX2-EW-R-10]; Ministry of Science and Technology of China [2008DFA31960, 2009AA022704, 2011CB504002]; National Natural Science Foundation of China [30930081, 81021002]; Shanghai Institutes [SIBS2008006]; Unilever Corporate Research	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes; Unilever Corporate Research(Unilever)	This study was supported by grant from the Chinese Academy of Sciences (KSCX2-YW-R-116, KSCX2-EW-R-10); the Ministry of Science and Technology of China (2008DFA31960, 863 Program 2009AA022704, 973 program 2011CB504002); the National Natural Science Foundation of China (30930081, 81021002); the Chief Scientist Program of Shanghai Institutes and (SIBS2008006). Dr. Qi Sun was supported by a postdoctoral fellowship from the Unilever Corporate Research before September 2010. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; *COMM IR, 2009, GUID DAT PROC AN INT; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Franks PW, 2005, OBES RES, V13, P1476, DOI 10.1038/oby.2005.178; Furler SM, 2006, OBESITY, V14, P228, DOI 10.1038/oby.2006.29; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Ingelsson E, 2008, J CLIN ENDOCR METAB, V93, P3149, DOI 10.1210/jc.2008-0207; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Sepilian VP, 2006, FERTIL STERIL, V85, P1441, DOI 10.1016/j.fertnstert.2005.10.038; Shimamura M, 2004, BIOCHEM BIOPH RES CO, V322, P1080, DOI 10.1016/j.bbrc.2004.08.024; Soderberg S, 2007, INT J OBESITY, V31, P1126, DOI 10.1038/sj.ijo.0803561; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; SUN Q, 2009, LEPTIN SOLUBLE LEPTI, V59, P611; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ukkola O, 2007, METABOLISM, V56, P1221, DOI 10.1016/j.metabol.2007.04.019; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574; Zhai F, 2006, NUTR HLTH STATUS CHI; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	41	66	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16818	10.1371/journal.pone.0016818	http://dx.doi.org/10.1371/journal.pone.0016818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347230	gold, Green Submitted, Green Published			2022-12-25	WOS:000287369200008
J	Pawlowski, DR; Metzger, DJ; Raslawsky, A; Howlett, A; Siebert, G; Karalus, RJ; Garrett, S; Whitehouse, CA				Pawlowski, David R.; Metzger, Daniel J.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.; Garrett, Stephanie; Whitehouse, Chris A.			Entry of Yersinia pestis into the Viable but Nonculturable State in a Low-Temperature Tap Water Microcosm	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIBRIO-VULNIFICUS; RESUSCITATION; SURVIVAL; CELLS; STARVATION; VIRULENCE; PERSISTENCE; POPULATION; RECOVERY	Yersinia pestis, the causative agent of plague, has caused several pandemics throughout history and remains endemic in the rodent populations of the western United States. More recently, Y. pestis is one of several bacterial pathogens considered to be a potential agent of bioterrorism. Thus, elucidating potential mechanisms of survival and persistence in the environment would be important in the event of an intentional release of the organism. One such mechanism is entry into the viable but non-culturable (VBNC) state, as has been demonstrated for several other bacterial pathogens. In this study, we showed that Y. pestis became nonculturable by normal laboratory methods after 21 days in a low-temperature tap water microcosm. We further show evidence that, after the loss of culturability, the cells remained viable by using a variety of criteria, including cellular membrane integrity, uptake and incorporation of radiolabeled amino acids, and protection of genomic DNA from DNase I digestion. Additionally, we identified morphological and ultrastructural characteristics of Y. pestis VBNC cells, such as cell rounding and large periplasmic spaces, by electron microscopy, which are consistent with entry into the VBNC state in other bacteria. Finally, we demonstrated resuscitation of a small number of the non-culturable cells. This study provides compelling evidence that Y. pestis persists in a low-temperature tap water microcosm in a viable state yet is unable to be cultured under normal laboratory conditions, which may prove useful in risk assessment and remediation efforts, particularly in the event of an intentional release of this organism.	[Pawlowski, David R.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.] CUBRC Inc, Buffalo, NY USA; [Garrett, Stephanie; Whitehouse, Chris A.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Pawlowski, David R.; Metzger, Daniel J.; Karalus, Richard J.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pawlowski, DR (corresponding author), CUBRC Inc, Buffalo, NY USA.	pawlowski@cubrc.org		Pawlowski, Jan/0000-0003-2421-388X; Shahbazkia, Hamid Reza/0000-0002-5661-0612; Christen, Richard/0000-0002-3396-4362; Guillou, Laure/0000-0003-1032-7958	CUBRC [00291.01]; USAMRIID [114509]; Oak Ridge Institute for Science and Education	CUBRC; USAMRIID; Oak Ridge Institute for Science and Education(General Electric)	The authors acknowledge the CUBRC Internal Research and Development program (no. 00291.01) and the USAMRIID In-House Laboratory Research program (no. 114509) for financial support. This research was supported in part by an appointment to the Student Research Participation Program at USAMRIID by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Albertini MC, 2006, CYTOM PART A, V69A, P260, DOI 10.1002/cyto.a.20263; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Bjergbaek LA, 2005, J APPL MICROBIOL, V99, P1090, DOI 10.1111/j.1365-2672.2005.02706.x; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Breneva N. V., 2006, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P7; Buzoleva LS, 2000, B EXP BIOL MED+, V129, P374, DOI 10.1007/BF02439275; Chaiyanan S, 2001, SYST APPL MICROBIOL, V24, P331, DOI 10.1078/0723-2020-00032; Chaiyanan S, 2007, ENVIRON MICROBIOL, V9, P393, DOI 10.1111/j.1462-2920.2006.01150.x; Czyzewska Izabela, 2003, Przegl Epidemiol, V57, P263; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Forsman M, 2000, FEMS MICROBIOL ECOL, V31, P217, DOI 10.1111/j.1574-6941.2000.tb00686.x; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Garcia-Armisen T, 2004, J MICROBIOL METH, V58, P269, DOI 10.1016/j.mimet.2004.04.014; Halvorson HO, 1933, J BACTERIOL, V25, P101, DOI 10.1128/JB.25.2.101-121.1933; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Jang KI, 2007, J MICROBIOL BIOTECHN, V17, P202; Keep NH, 2006, CELL MOL LIFE SCI, V63, P2555, DOI 10.1007/s00018-006-6188-2; LINDER K, 1989, APPL ENVIRON MICROB, V55, P2837, DOI 10.1128/AEM.55.11.2837-2842.1989; Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; NOVITSKY JA, 1976, APPL ENVIRON MICROB, V32, P617, DOI 10.1128/AEM.32.4.617-622.1976; Oliver James D., 2005, Journal of Water and Health, V3, P249; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; OLIVER JD, 2005, FOODBORNE PATHOGENS; RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994; Rose LJ, 2007, APPL ENVIRON MICROB, V73, P3437, DOI 10.1128/AEM.00051-07; Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; ROSZAK DB, 1987, APPL ENVIRON MICROB, V53, P2889, DOI 10.1128/AEM.53.12.2889-2893.1987; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SMITH JJ, 1994, APPL ENVIRON MICROB, V60, P2977, DOI 10.1128/AEM.60.8.2977-2984.1994; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Suchkov Iu G, 1997, Zh Mikrobiol Epidemiol Immunobiol, P42; Torosian SD, 2009, CAN J MICROBIOL, V55, P1125, DOI [10.1139/W09-061, 10.1139/w09-061]; Torosian SD, 2009, CAN J MICROBIOL, V55, P1119, DOI [10.1139/w09-060, 10.1139/W09-060]; Troitskaia V V, 1996, Zh Mikrobiol Epidemiol Immunobiol, P13; Whitesides MD, 1997, APPL ENVIRON MICROB, V63, P1002, DOI 10.1128/AEM.63.3.1002-1005.1997; WILM, 1897, HYGIENISCHE RUNDSCHA, V7, P285; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662	44	92	96	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17585	10.1371/journal.pone.0017585	http://dx.doi.org/10.1371/journal.pone.0017585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21483744	Green Published, Green Submitted, gold			2022-12-25	WOS:000288514000003
J	Zhou, JX; Brusch, L; Huang, S				Zhou, Joseph Xu; Brusch, Lutz; Huang, Sui			Predicting Pancreas Cell Fate Decisions and Reprogramming with a Hierarchical Multi-Attractor Model	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ROBUST DEVELOPMENT; NETWORK MODELS; STEM-CELLS; DIFFERENTIATION; EXPRESSION; ALPHA; DIVERSIFICATION; PRECURSORS; PLASTICITY	Cell fate reprogramming, such as the generation of insulin-producing beta cells from other pancreas cells, can be achieved by external modulation of key transcription factors. However, the known gene regulatory interactions that form a complex network with multiple feedback loops make it increasingly difficult to design the cell reprogramming scheme because the linear regulatory pathways as schemes of causal influences upon cell lineages are inadequate for predicting the effect of transcriptional perturbation. However, sufficient information on regulatory networks is usually not available for detailed formal models. Here we demonstrate that by using the qualitatively described regulatory interactions as the basis for a coarse-grained dynamical ODE (ordinary differential equation) based model, it is possible to recapitulate the observed attractors of the exocrine and beta, delta, alpha endocrine cells and to predict which gene perturbation can result in desired lineage reprogramming. Our model indicates that the constraints imposed by the incompletely elucidated regulatory network architecture suffice to build a predictive model for making informed decisions in choosing the set of transcription factors that need to be modulated for fate reprogramming.	[Zhou, Joseph Xu; Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	Technische Universitat Dresden; University of Calgary; University of California System; University of California Santa Barbara	Zhou, JX (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	joseph.x.zhou@gmail.com	Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Mahara, Sylvia/0000-0001-7261-1423	German Ministry for Education and Research [0315259]; National Science Foundation [PHY05-51164]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	This research was partially supported by the German Ministry for Education and Research through grant no. 0315259. It was also supported in part by the National Science Foundation under Grant No. PHY05-51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu Masahiko, 2006, Curr Stem Cell Res Ther, V1, P267, DOI 10.2174/157488806776956887; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foster DV, 2009, J THEOR BIOL, V260, P589, DOI 10.1016/j.jtbi.2009.07.005; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Furusawa C, 2003, J THEOR BIOL, V224, P413, DOI 10.1016/S0022-5193(03)00189-9; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guney MA, 2009, BIRTH DEFECTS RES C, V87, P232, DOI 10.1002/bdrc.20156; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2001, PHARMACOGENOMICS, V2, P203, DOI 10.1517/14622416.2.3.203; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kaneko K, 1999, J THEOR BIOL, V199, P243, DOI 10.1006/jtbi.1999.0952; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mehta S, 2005, J HEPATO-BILIARY-PAN, V12, P208, DOI 10.1007/s00534-005-0981-4; Miyatsuka T, 2008, EXPERT OPIN THER TAR, V12, P1431, DOI [10.1517/14728222.12.11.1431, 10.1517/14728222.12.11.1431 ]; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Offield MF, 1996, DEVELOPMENT, V122, P983; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; ZHOU Q, 2008, NATURE	57	110	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14752	10.1371/journal.pone.0014752	http://dx.doi.org/10.1371/journal.pone.0014752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21589872	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400002
J	Chen, YJ; Huang, WC; Wei, YL; Hsu, SC; Yuan, P; Lin, HY; Wistuba, II; Lee, JJ; Yen, CJ; Su, WC; Chang, KY; Chang, WC; Chou, TC; Chou, CK; Tsai, CH; Hung, MC				Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Yuan, Ping; Lin, Heather Y.; Wistuba, Ignacio I.; Lee, J. Jack; Yen, Chia-Jui; Su, Wu-Chou; Chang, Kwang-Yu; Chang, Wen-Chang; Chou, Tse-Chuan; Chou, Chao-Kai; Tsai, Chang-Hai; Hung, Mien-Chie			Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; GENE-MUTATIONS; PHASE-II; ERLOTINIB; PROTEIN	Background: The sensitivity of non-small cell lung cancer (NSCLC) patients to EGFR tyrosine kinase inhibitors (TKIs) is strongly associated with activating EGFR mutations. Although not as sensitive as patients harboring these mutations, some patients with wild-type EGFR (wtEGFR) remain responsive to EGFR TKIs, suggesting that the existence of unexplored mechanisms renders most of wtEGFR-expressing cancer cells insensitive. Methodology/Principal Findings: Here, we show that acquired resistance of wtEGFR-expressing cancer cells to an EGFR TKI, gefitinib, is associated with elevated expression of breast cancer resistance protein (BCRP/ABCG2), which in turn leads to gefitinib efflux from cells. In addition, BCRP/ABCG2 expression correlates with poor response to gefitinib in both cancer cell lines and lung cancer patients with wtEGFR. Co-treatment with BCRP/ABCG2 inhibitors enhanced the anti-tumor activity of gefitinib. Conclusions/Significance: Thus, BCRP/ABCG2 expression may be a predictor for poor efficacy of gefitinib treatment, and targeting BCRP/ABCG2 may broaden the use of gefitinib in patients with wtEGFR.	[Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yuan, Ping; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lin, Heather Y.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Su, Wu-Chou] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chou, Tse-Chuan] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chou, Tse-Chuan] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Tatung University	Chen, YJ (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council of Taiwan [NSC-96-2917-I-006-004, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002]; National Health Research Institutes of Taiwan [NHRI-EX-98-9812BC, NSC-2632-B-001]; Cancer Center Research of Excellence [DOH-TD-C-111-005]; National Institutes of Health [NIH PO1 CA099031, NIH RO1 CA109311]; National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Cancer Center Research of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council of Taiwan (NSC-96-2917-I-006-004 to Y.J. Chen; NSC-97-2320-B-039-033-MY3 and NSC-98-3112-B-039-002 to W.C. Huang), the National Health Research Institutes of Taiwan (NHRI-EX-98-9812BC to W.C. Huang), NSC-2632-B-001, and Cancer Center Research of Excellence (DOH-TD-C-111-005), National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Kadoorie Charitable Foundation, and The University of Texas MD Anderson Cancer Center and CMUH Sister Institution Fund (to M.C. Hung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang GC, 2006, J THORAC ONCOL, V1, P520, DOI 10.1097/01243894-200607000-00004; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; HUANG WC, 2011, J BIOL CHEM; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Lee DH, 2008, ANN ONCOL, V19, P2039, DOI 10.1093/annonc/mdn423; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Vasile E, 2008, J THORAC ONCOL, V3, P912, DOI 10.1097/JTO.0b013e318180275e; Wang XD, 2007, DRUG METAB DISPOS, V35, P268, DOI 10.1124/dmd.106.011684; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang CH, 2006, CANCER-AM CANCER SOC, V107, P1873, DOI 10.1002/cncr.22220; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhang SZ, 2005, DRUG METAB DISPOS, V33, P341, DOI 10.1124/dmd.104.002501; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	43	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21428	10.1371/journal.pone.0021428	http://dx.doi.org/10.1371/journal.pone.0021428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21437249	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400036
J	Chen, YT; Ross, DS; Chiu, R; Zhou, XK; Chen, YY; Lee, PS; Hoda, SA; Simpson, AJ; Old, LJ; Caballero, O; Neville, AM				Chen, Yao-Tseng; Ross, Dara S.; Chiu, Rita; Zhou, Xi K.; Chen, Yunn-Yi; Lee, Peishan; Hoda, Syed A.; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro			Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers	PLOS ONE			English	Article							T-CELL RESPONSES; NY-ESO-1 EXPRESSION; PROTEIN EXPRESSION; ANTIBODY; IMMUNOGENICITY; IDENTIFICATION; CARCINOMA; FAMILY; GENES; CT45	Background: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. Methodology/Principal Findings: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them-MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p < 0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p < 0.001 to p = 0.01) and larger in size (> 2 cm). Conclusions/Significance: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored.	[Chen, Yao-Tseng; Ross, Dara S.; Hoda, Syed A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, Rita; Lee, Peishan; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro] Ludwig Inst Canc Res, New York Branch, New York, NY USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Cornell University; Ludwig Institute for Cancer Research; Cornell University; University of California System; University of California San Francisco	Chen, YT (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	ytchen@med.cornell.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ludwig Institute for Cancer Research < http://www.licr.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandic D, 2006, CROAT MED J, V47, P32; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2010, P NATL ACAD SCI USA, V107, P3093, DOI 10.1073/pnas.0915050107; Chen YT, 2009, INT J CANCER, V124, P2893, DOI 10.1002/ijc.24296; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; CHEN YT, 1994, P NATL ACAD SCI USA, V91, P1004, DOI 10.1073/pnas.91.3.1004; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kurashige T, 2001, CANCER RES, V61, P4671; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Rimoldi D, 2000, INT J CANCER, V86, P749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhuang Ran, 2006, Cancer Immun, V6, P7	29	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17876	10.1371/journal.pone.0017876	http://dx.doi.org/10.1371/journal.pone.0017876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437249	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100041
